PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Li, K; Yao, J; Shi, LY; Sawada, N; Chi, Y; Yan, QJ; Matsue, H; Kitamura, M; Takeda, M				Li, Kai; Yao, Jian; Shi, Liye; Sawada, Norifumi; Chi, Yuan; Yan, Qiaojing; Matsue, Hiroyuki; Kitamura, Masanori; Takeda, Masayuki			Reciprocal Regulation between Proinflammatory Cytokine-induced Inducible NO Synthase (iNOS) and Connexin43 in Bladder Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; NF-KAPPA-B; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; UROPATHOGENIC ESCHERICHIA-COLI; NITRIC-OXIDE SYNTHASE; GAP-JUNCTIONS; URINARY-BLADDER; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; HUMAN DETRUSOR	Gap junctions (GJs) play an important role in the control of bladder contractile response and in the regulation of various immune inflammatory processes. Here, we investigated the possible interaction between inflammation and GJs in bladder smooth muscle cells (BSMCs). Stimulation of BSMCs with IL1 beta and TNF alpha increased connexin43 (Cx43) expression and function, which was associated with increased phosphorylation of vasodilator-stimulated phosphoprotein. Inhibition of PKA with H89 or down-regulation of CREB with specific siRNAs largely abolished the Cx43-elevating effect. Further analysis revealed that IL1 beta/TNF alpha induced NF kappa B-dependent inducible NO synthase (iNOS) expression. Inhibition of iNOS with G-nitro-L-arginine methyl ester abrogated and an exogenous NO donor mimicked the effect of the cytokines on Cx43. Intraperitoneal injection of LPS into mice also induced bladder Cx43 expression, which was largely blocked by an iNOS inhibitor. Finally, the elevated Cx43 was found to negatively regulate iNOS expression. Dysfunction of GJs with various blockers or down-regulation of Cx43 with siRNA significantly potentiated the expression of iNOS. Fibroblasts from Cx43 knock-out (Cx43(-/-)) mice also displayed a significantly higher response to the cytokine-induced iNOS expression than cells from Cx43 wild-type (Cx43(+/+)) littermates. Collectively, our study revealed a previously unrecognized reciprocal regulation loop between cytokine-induced NO and GJs. Our findings may provide an important molecular mechanism for the symptoms of bladder infection. In addition, it may further our understanding of the roles of GJs in inflammatory diseases.	[Li, Kai; Yao, Jian; Chi, Yuan; Yan, Qiaojing; Kitamura, Masanori] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Yamanashi 4093898, Japan; [Li, Kai; Sawada, Norifumi; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Yamanashi 4093898, Japan; [Matsue, Hiroyuki] Chiba Univ, Grad Sch Med, Dept Dermatol, Chiba 2608670, Japan; [Li, Kai] China Med Univ, Affiliated Hosp 1, Dept Oncol, Shenyang 110001, Peoples R China; [Shi, Liye] China Med Univ, Affiliated Hosp 1, Dept Cardiol, Shenyang 110001, Peoples R China	University of Yamanashi; University of Yamanashi; Chiba University; China Medical University; China Medical University	Yao, J (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Yamanashi 4093898, Japan.	yao@yamanashi.ac.jp		Yao, Jian/0000-0003-2622-0215	Ministry of Education, Culture, Sports, Science and Technology, Japan [23591187, 20590953]; University of Yamanashi; Grants-in-Aid for Scientific Research [23591187] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Yamanashi(University of Yamanashi); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 23591187 and 20590953 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to). Y.), and a strategic project grant from the University of Yamanashi.	Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; Billips BK, 2007, INFECT IMMUN, V75, P5353, DOI 10.1128/IAI.00922-07; Bouchelouche K, 2006, UROLOGY, V67, P214, DOI 10.1016/j.urology.2005.07.049; BUTT E, 1994, J BIOL CHEM, V269, P14509; Christ GJ, 2003, AM J PHYSIOL-REG I, V284, pR1241, DOI 10.1152/ajpregu.00030.2002; Civitelli R, 1998, J CELL BIOCHEM, V68, P8, DOI 10.1002/(SICI)1097-4644(19980101)68:1<8::AID-JCB2>3.0.CO;2-#; Cronier L, 2003, BIOL REPROD, V69, P1472, DOI 10.1095/biolreprod.103.016360; Dowling-Warriner CV, 2000, NEUROSCIENCE, V95, P859; Drake MJ, 2003, J UROLOGY, V170, P276, DOI 10.1097/01.ju.0000069722.35137.e0; Ehrlich HP, 2000, J CELL PHYSIOL, V184, P86, DOI 10.1002/(SICI)1097-4652(200007)184:1<86::AID-JCP9>3.0.CO;2-5; Eugenin EA, 2003, J IMMUNOL, V170, P1320, DOI 10.4049/jimmunol.170.3.1320; Eugenin EA, 2007, CELL IMMUNOL, V247, P103, DOI 10.1016/j.cellimm.2007.08.001; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Fernandez-Cobo M, 1998, SHOCK, V10, P97, DOI 10.1097/00024382-199808000-00003; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Haferkamp A, 2004, EUR UROL, V46, P799, DOI 10.1016/j.eururo.2004.08.020; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Jimenez-Feltstrom J, 2005, CELL TISSUE RES, V319, P221, DOI 10.1007/s00441-004-1013-4; Kasper CA, 2010, IMMUNITY, V33, P804, DOI 10.1016/j.immuni.2010.10.015; Kielian T, 2008, J NEUROCHEM, V106, P1000, DOI 10.1111/j.1471-4159.2008.05405.x; Li LK, 2007, AM J PHYSIOL-CELL PH, V293, pC1627, DOI 10.1152/ajpcell.00122.2007; Liao CK, 2010, INT J BIOCHEM CELL B, V42, P762, DOI 10.1016/j.biocel.2010.01.016; Matsue H, 2006, J IMMUNOL, V176, P181, DOI 10.4049/jimmunol.176.1.181; Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Neuhaus J, 2002, WORLD J UROL, V20, P250, DOI 10.1007/s00345-002-0289-9; Neuhaus J, 2009, EUR UROL, V55, P491, DOI 10.1016/j.eururo.2008.03.090; Okamoto T, 2011, EXP CELL RES, V317, P348, DOI 10.1016/j.yexcr.2010.10.018; Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605; Paulson AF, 2000, J CELL SCI, V113, P3037; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x; Sawada N, 2008, LAB INVEST, V88, P553, DOI 10.1038/labinvest.2008.21; Scheckenbach KEL, 2011, J VASC RES, V48, P91, DOI 10.1159/000316942; Simon AM, 2004, J VASC RES, V41, P323, DOI 10.1159/000079614; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; TAKENSKWAK BR, 1992, AM J PHYSIOL, V262, pC1531, DOI 10.1152/ajpcell.1992.262.6.C1531; Veliz LP, 2008, AM J PHYSIOL-HEART C, V295, pH1056, DOI 10.1152/ajpheart.00266.2008; Wang XC, 2000, J UROLOGY, V163, P993, DOI 10.1016/S0022-5347(05)67870-6; Wein AJ, 2002, UROLOGY, V60, P7, DOI 10.1016/S0090-4295(02)01784-3; Weng TI, 2009, INFECT IMMUN, V77, P3312, DOI 10.1128/IAI.00013-09; Wu F, 2008, J CELL PHYSIOL, V217, P207, DOI 10.1002/jcp.21495; Yao J, 2007, BRIT J PHARMACOL, V151, P457, DOI 10.1038/sj.bjp.0707255; Yao J, 2006, AM J PHYSIOL-RENAL, V290, pF1083, DOI 10.1152/ajprenal.00134.2005; Yao J, 2002, J AM SOC NEPHROL, V13, P2018, DOI 10.1097/01.ASN.0000023436.71816.56; Yao JA, 2010, BRIT J PHARMACOL, V160, P2055, DOI 10.1111/j.1476-5381.2010.00860.x; Yao J, 2009, AM J PHYSIOL-RENAL, V296, pF939, DOI 10.1152/ajprenal.90612.2008; Yao JJ, 2005, J AM SOC NEPHROL, V16, P1300, DOI 10.1681/ASN.2004110991; Zhao Y, 2006, GLIA, V54, P775, DOI 10.1002/glia.20418	50	29	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41552	41562		10.1074/jbc.M111.274449	http://dx.doi.org/10.1074/jbc.M111.274449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965676	Green Published, hybrid			2022-12-25	WOS:000298057500041
J	Berta, AI; Boesze-Battaglia, K; Genini, S; Goldstein, O; O'Brien, PJ; Szel, A; Acland, GM; Beltran, WA; Aguirre, GD				Berta, Agnes I.; Boesze-Battaglia, Kathleen; Genini, Sem; Goldstein, Orly; O'Brien, Paul J.; Szel, Agoston; Acland, Gregory M.; Beltran, William A.; Aguirre, Gustavo D.			Photoreceptor Cell Death, Proliferation and Formation of Hybrid Rod/S-Cone Photoreceptors in the Degenerating STK38L Mutant Retina	PLOS ONE			English	Article							NUCLEAR RECEPTOR NR2E3; NEURAL REGENERATION; EXPRESSION; TRANSCRIPTION; NEUROGENESIS; MUTATIONS; MULTIPLE; MODEL	A homozygous mutation in STK38L in dogs impairs the late phase of photoreceptor development, and is followed by photoreceptor cell death (TUNEL) and proliferation (PCNA, PHH3) events that occur independently in different cells between 7-14 weeks of age. During this period, the outer nuclear layer (ONL) cell number is unchanged. The dividing cells are of photoreceptor origin, have rod opsin labeling, and do not label with markers specific for macrophages/microglia (CD18) or Muller cells (glutamine synthetase, PAX6). Nestin labeling is absent from the ONL although it labels the peripheral retina and ciliary marginal zone equally in normals and mutants. Cell proliferation is associated with increased cyclin A1 and LATS1 mRNA expression, but CRX protein expression is unchanged. Coincident with photoreceptor proliferation is a change in the photoreceptor population. Prior to cell death the photoreceptor mosaic is composed of L/M-and S-cones, and rods. After proliferation, both cone types remain, but the majority of rods are now hybrid photoreceptors that express rod opsin and, to a lesser extent, cone S-opsin, and lack NR2E3 expression. The hybrid photoreceptors renew their outer segments diffusely, a characteristic of cones. The results indicate the capacity for terminally differentiated, albeit mutant, photoreceptors to divide with mutations in this novel retinal degeneration gene.	[Berta, Agnes I.; Genini, Sem; Beltran, William A.; Aguirre, Gustavo D.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Berta, Agnes I.; Szel, Agoston] Semmelweis Univ, Dept Human Morphol & Dev Biol, H-1085 Budapest, Hungary; [Boesze-Battaglia, Kathleen] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA; [Goldstein, Orly; Acland, Gregory M.] Cornell Univ, Coll Vet Med, JA Baker Inst, Ithaca, NY 14853 USA; [O'Brien, Paul J.] NEI, Retinal Cell & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	University of Pennsylvania; Semmelweis University; University of Pennsylvania; Cornell University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Berta, AI (corresponding author), Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA.	gda@vet.upenn.edu	Berta-Antalics, Agnes/AAK-5788-2021	Berta-Antalics, Agnes/0000-0001-9000-8177; Aguirre, Gustavo/0000-0002-5228-256X	National Eye Institute, National Institutes of Health [EY-06855, -13132, -17549, -10420, 18705, P30 EY-001583]; Foundation Fighting Blindness center; Van Sloun Fund for Canine Genetic Research; Hope for Vision; ONCE International Prize for R&D in Biomedicine; New Technologies for the Blind; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026365] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018705, P30EY001583, R01EY006855, R01EY010420, R01EY013132, R29EY010420, R01EY017549] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness center; Van Sloun Fund for Canine Genetic Research; Hope for Vision; ONCE International Prize for R&D in Biomedicine; New Technologies for the Blind; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, National Institutes of Health grants EY-06855, -13132, -17549, -10420, 18705, P30 EY-001583, a Fulbright Educational Exchange Program Fellowship, Foundation Fighting Blindness center and individual grants, Van Sloun Fund for Canine Genetic Research, Hope for Vision, The ONCE International Prize for R&D in Biomedicine, and New Technologies for the Blind. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACLAND GM, 1987, EXP EYE RES, V44, P491, DOI 10.1016/S0014-4835(87)80160-4; AGUIRRE G, 1986, INVEST OPHTH VIS SCI, V27, P635; Aguirre GD, 2006, COLD SPRING HARB MON, V44, P291; Akhmedov NB, 2005, BBA-GENE STRUCT EXPR, V1728, P11, DOI 10.1016/j.bbaexp.2005.01.003; ALUBAIDI MR, 1992, P NATL ACAD SCI USA, V89, P1194, DOI 10.1073/pnas.89.4.1194; Baehr W, 2009, VISION RES, V49, P2636, DOI 10.1016/j.visres.2009.04.008; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Beltran WA, 2007, EXP EYE RES, V84, P753, DOI 10.1016/j.exer.2006.12.019; Belvindrah R, 2002, J NEUROSCI, V22, P3594; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Conley SM, 2010, BIOCHEMISTRY-US, V49, P905, DOI 10.1021/bi901622w; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; dit Huart LM, 2004, MOL CELL NEUROSCI, V26, P441, DOI 10.1016/j.mcn.2004.04.002; Doonan F, 2005, INVEST OPHTH VIS SCI, V46, P3530, DOI 10.1167/iovs.05-0248; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Goldstein O, 2010, GENOMICS, V96, P362, DOI 10.1016/j.ygeno.2010.09.003; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Lamba D, 2008, CELL STEM CELL, V2, P538, DOI 10.1016/j.stem.2008.05.002; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Mowat FM, 2008, MOL VIS, V14, P2518; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; ROHLICH P, 1993, CURR EYE RES, V12, P935, DOI 10.3109/02713689309020400; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; SZEL A, 1986, EXP EYE RES, V43, P871, DOI 10.1016/0014-4835(86)90066-7; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; YOUNG RW, 1969, INVEST OPHTH VISUAL, V8, P222; Zeiss CJ, 2004, INVEST OPHTH VIS SCI, V45, P971, DOI 10.1167/iovs.03-0301; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993	40	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24074	10.1371/journal.pone.0024074	http://dx.doi.org/10.1371/journal.pone.0024074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980341	Green Published, Green Submitted, gold			2022-12-25	WOS:000295941300004
J	Jones, EA; van Remoortere, A; van Zeijl, RJM; Hogendoorn, PCW; Bovee, JVMG; Deelder, AM; McDonnell, LA				Jones, Emrys A.; van Remoortere, Alexandra; van Zeijl, Rene J. M.; Hogendoorn, Pancras C. W.; Bovee, Judith V. M. G.; Deelder, Andre M.; McDonnell, Liam A.			Multiple Statistical Analysis Techniques Corroborate Intratumor Heterogeneity in Imaging Mass Spectrometry Datasets of Myxofibrosarcoma	PLOS ONE			English	Article							MS; CANCER; HISTOLOGY; CLASSIFICATION; PROTEINS; FRAGMENT; COMPLEX; IMAGES; GRADE	MALDI mass spectrometry can generate profiles that contain hundreds of biomolecular ions directly from tissue. Spatially-correlated analysis, MALDI imaging MS, can simultaneously reveal how each of these biomolecular ions varies in clinical tissue samples. The use of statistical data analysis tools to identify regions containing correlated mass spectrometry profiles is referred to as imaging MS-based molecular histology because of its ability to annotate tissues solely on the basis of the imaging MS data. Several reports have indicated that imaging MS-based molecular histology may be able to complement established histological and histochemical techniques by distinguishing between pathologies with overlapping/identical morphologies and revealing biomolecular intratumor heterogeneity. A data analysis pipeline that identifies regions of imaging MS datasets with correlated mass spectrometry profiles could lead to the development of novel methods for improved diagnosis (differentiating subgroups within distinct histological groups) and annotating the spatio-chemical makeup of tumors. Here it is demonstrated that highlighting the regions within imaging MS datasets whose mass spectrometry profiles were found to be correlated by five independent multivariate methods provides a consistently accurate summary of the spatio-chemical heterogeneity. The corroboration provided by using multiple multivariate methods, efficiently applied in an automated routine, provides assurance that the identified regions are indeed characterized by distinct mass spectrometry profiles, a crucial requirement for its development as a complementary histological tool. When simultaneously applied to imaging MS datasets from multiple patient samples of intermediate-grade myxofibrosarcoma, a heterogeneous soft tissue sarcoma, nodules with mass spectrometry profiles found to be distinct by five different multivariate methods were detected within morphologically identical regions of all patient tissue samples. To aid the further development of imaging MS based molecular histology as a complementary histological tool the Mat lab code of the agreement analysis, instructions and a reduced dataset are included as supporting information.	[Jones, Emrys A.; van Remoortere, Alexandra; van Zeijl, Rene J. M.; Deelder, Andre M.; McDonnell, Liam A.] Leiden Univ Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands; [Hogendoorn, Pancras C. W.; Bovee, Judith V. M. G.] Leiden Univ Med Ctr, Dept Pathol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Jones, EA (corresponding author), Leiden Univ Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands.	l.a.mcdonnell@lumc.nl	Hogendoorn, Pancras/O-6494-2019; Hogendoorn, Pancras C.W./H-5859-2015	Hogendoorn, Pancras/0000-0002-1513-8104; Hogendoorn, Pancras C.W./0000-0002-1513-8104; McDonnell, Liam/0000-0003-0595-9491; Jones, Emrys/0000-0001-9834-217X; Bovee, Judith/0000-0003-1155-0481	ZonMw [93519026, 93511027]	ZonMw(Netherlands Organization for Health Research and Development)	EAJ and LMD were supported by the following ZonMw grants (both awarded to LMD, www.zonmw.nl): Multiplex Imaging of Tissue Arrays, Project Number 93519026, and Targeted, quantitative, multiplex, imaging mass spectrometry, Project Number 93511027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov T, 2010, J PROTEOME RES, V9, P6535, DOI 10.1021/pr100734z; Broersen A, 2008, J AM SOC MASS SPECTR, V19, P823, DOI 10.1016/j.jasms.2008.02.015; Caldwell Robert L., 2006, Cancer Genomics & Proteomics, V3, P279; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Chaurand P, 2004, ANAL CHEM, V76, p86A, DOI 10.1021/ac0415197; Chaurand P, 2004, ANAL CHEM, V76, P1145, DOI 10.1021/ac0351264; Chaurand P, 2007, J MASS SPECTROM, V42, P476, DOI 10.1002/jms.1180; Chen XY, 2003, ANAL CHEM, V75, P5944, DOI 10.1021/ac030127h; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; Cohen SL, 1996, ANAL CHEM, V68, P31, DOI 10.1021/ac9507956; Cornett DS, 2006, MOL CELL PROTEOMICS, V5, P1975, DOI 10.1074/mcp.M600119-MCP200; Corney D, 2010, CLUSTERING MATLAB; Deininger SO, 2008, J PROTEOME RES, V7, P5230, DOI 10.1021/pr8005777; Djidja MC, 2009, J PROTEOME RES, V8, P4876, DOI 10.1021/pr900522m; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Hanselmann M, 2008, ANAL CHEM, V80, P9649, DOI 10.1021/ac801303x; Hilario M, 2006, MASS SPECTROM REV, V25, P409, DOI 10.1002/mas.20072; Kang S, 2010, J PROTEOME RES, V9, P1157, DOI 10.1021/pr900666q; Klerk LA, 2007, INT J MASS SPECTROM, V260, P222, DOI 10.1016/j.ijms.2006.11.014; Lagarrigue M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005991; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lemaire R, 2007, J PROTEOME RES, V6, P4127, DOI 10.1021/pr0702722; Mantini D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-101; McCombie G, 2005, ANAL CHEM, V77, P6118, DOI 10.1021/ac051081q; McDonnell LA, 2008, J PROTEOME RES, V7, P3619, DOI 10.1021/pr800214d; McDonnell LA, 2007, MASS SPECTROM REV, V26, P606, DOI 10.1002/mas.20124; McDonnell LA, 2010, J AM SOC MASS SPECTR, V21, P1969, DOI 10.1016/j.jasms.2010.08.008; McDonnell LA, 2010, J PROTEOMICS, V73, P1921, DOI 10.1016/j.jprot.2010.05.007; Mentzel T, 2004, TUMOURS SOFT TISSUE, P102; Nielsen AA, 2010, MAXIMUM AUTOCORRELAT; Norris JL, 2007, INT J MASS SPECTROM, V260, P212, DOI 10.1016/j.ijms.2006.10.005; Oppenheimer SR, 2010, J PROTEOME RES, V9, P2182, DOI 10.1021/pr900936z; Rauser S, 2010, J PROTEOME RES, V9, P1854, DOI 10.1021/pr901008d; Rompp A, 2010, ANGEW CHEM INT EDIT, V49, P3834, DOI 10.1002/anie.200905559; Schwamborn K, 2007, INT J MOL MED, V20, P155; Stoeckli M, 2007, INT J MASS SPECTROM, V260, P195, DOI 10.1016/j.ijms.2006.10.007; Switzer P., 1985, Computer Science and Statistics. Proceedings of the Sixteenth Symposium on the Interface, P13; van Hove ERA, 2010, CANCER RES, V70, P9012, DOI 10.1158/0008-5472.CAN-10-0360; Willems SM, 2006, MODERN PATHOL, V19, P407, DOI 10.1038/modpathol.3800550; Willems SM, 2010, J PATHOL, V222, P400, DOI 10.1002/path.2771; Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8	43	82	85	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e24913	10.1371/journal.pone.0024913	http://dx.doi.org/10.1371/journal.pone.0024913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980364	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600008
J	Wong, ZS; Hedges, LM; Brownlie, JC; Johnson, KN				Wong, Zhee Sheen; Hedges, Lauren M.; Brownlie, Jeremy C.; Johnson, Karyn N.			Wolbachia-Mediated Antibacterial Protection and Immune Gene Regulation in Drosophila	PLOS ONE			English	Article							LIFE-SHORTENING WOLBACHIA; HOST-DEFENSE; INFECTION; INCOMPATIBILITY; INDUCTION; SIMULANS; POPULATIONS; CHIKUNGUNYA; PHYLOGENY	The outcome of microbial infection of insects is dependent not only on interactions between the host and pathogen, but also on the interactions between microbes that co-infect the host. Recently the maternally inherited endosymbiotic bacteria Wolbachia has been shown to protect insects from a range of microbial and eukaryotic pathogens. Mosquitoes experimentally infected with Wolbachia have upregulated immune responses and are protected from a number of pathogens including viruses, bacteria, Plasmodium and filarial nematodes. It has been hypothesised that immune upregulation underpins Wolbachia-mediated protection. Drosophila is a strong model for understanding host-Wolbachia-pathogen interactions. Wolbachia-mediated antiviral protection in Drosophila has been demonstrated for a number of different Wolbachia strains. In this study we investigate whether Wolbachia-infected flies are also protected against pathogenic bacteria. Drosophila simulans lines infected with five different Wolbachia strains were challenged with the pathogenic bacteria Pseudomonas aeruginosa PAW, Serratia marcescens and Erwinia carotovora and mortality compared to paired lines without Wolbachia. No difference in mortality was observed in the flies with or without Wolbachia. Similarly no antibacterial protection was observed for D. melanogaster infected with Wolbachia. Interestingly, D. melanogaster Oregon RC flies which are naturally infected with Wolbachia showed no upregulation of the antibacterial immune genes TepIV, Defensin, Diptericin B, PGRP-SD, Cecropin A1 and Attacin D compared to paired flies without Wolbachia. Taken together these results indicate that Wolbachia-mediated antibacterial protection is not ubiquitous in insects and furthermore that the mechanisms of antibacterial and antiviral protection are independent. We suggest that the immune priming and antibacterial protection observed in Wolbachia-infected mosquitoes may be a consequence of the recent artificial introduction of the symbiont into insects that normally do not carry Wolbachia and that antibacterial protection is unlikely to be found in insects carrying long-term Wolbachia infections.	[Wong, Zhee Sheen; Hedges, Lauren M.; Johnson, Karyn N.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Brownlie, Jeremy C.] Griffith Univ, Sch Biomol & Phys Sci, Brisbane, Qld 4111, Australia	University of Queensland; Griffith University	Wong, ZS (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	karynj@uq.edu.au	Johnson, Karyn N/B-7980-2008	Johnson, Karyn N/0000-0001-8647-8985; Brownlie, Jeremy/0000-0003-0161-2204	Australian Research Council [DP1092492]	Australian Research Council(Australian Research Council)	This research was supported by funds from the Australian Research Council (grant DP1092492). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Chevalier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018531; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Fenton A, 2011, AM NAT, V178, P333, DOI 10.1086/661247; Glaser RL, 2011, PLOS ONE, V5, pe11977; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hedges LM, 2008, J GEN VIROL, V89, P1497, DOI 10.1099/vir.0.83684-0; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Huston WM, 2002, MOL MICROBIOL, V45, P1741, DOI 10.1046/j.1365-2958.2002.03132.x; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kemp C, 2009, CURR OPIN IMMUNOL, V21, P3, DOI 10.1016/j.coi.2009.01.007; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Mercot H, 1998, ENTOMOL EXP APPL, V86, P97, DOI 10.1023/A:1003170928067; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; ONEILL SL, 1990, NATURE, V348, P178, DOI 10.1038/348178a0; Osborne RJ, 1996, J GEN VIROL, V77, P839, DOI 10.1099/0022-1317-77-5-839; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Poinsot D, 1998, GENETICS, V150, P227; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Rozen S, 2000, Methods Mol Biol, V132, P365; Siozios S, 2008, INSECT SCI, V15, P89, DOI 10.1111/j.1744-7917.2008.00189.x; Suh E, 2009, APPL ENVIRON MICROB, V75, P7783, DOI 10.1128/AEM.01331-09; Teixeira L, 2008, PLOS BIOL, V6, DOI doi:1000010.1001371/journal.pbio.1000002; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607; XI ZY, 2008, BMC GENOMICS, V9; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	42	88	94	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25430	10.1371/journal.pone.0025430	http://dx.doi.org/10.1371/journal.pone.0025430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980455	Green Published, gold			2022-12-25	WOS:000295939600026
J	Jiang, JH; Yun, YZ; Yang, QQ; Shim, WB; Wang, ZY; Ma, ZH				Jiang, Jinhua; Yun, Yingzi; Yang, Qianqian; Shim, Won-Bo; Wang, Zhengyi; Ma, Zhonghua			A Type 2C Protein Phosphatase FgPtc3 Is Involved in Cell Wall Integrity, Lipid Metabolism, and Virulence in Fusarium graminearum	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MAGNAPORTHE-GRISEA; SER/THR PHOSPHATASE; GIBBERELLA-ZEAE; APPRESSORIUM TURGOR; REDUCED VIRULENCE; CANDIDA-ALBICANS; LITHIUM TOXICITY; GENE-EXPRESSION; LYTIC SYSTEM	Type 2C protein phosphatases (PP2Cs) play important roles in regulating many biological processes in eukaryotes. Currently, little is known about functions of PP2Cs in filamentous fungi. The causal agent of wheat head blight, Fusarium graminearum, contains seven putative PP2C genes, FgPTC1, -3, -5, -5R, -6, -7 and -7R. In order to investigate roles of these PP2Cs, we constructed deletion mutants for all seven PP2C genes in this study. The FgPTC3 deletion mutant (Delta FgPtc3-8) exhibited reduced aerial hyphae formation and deoxynivalenol (DON) production, but increased production of conidia. The mutant showed increased resistance to osmotic stress and cell wall-damaging agents on potato dextrose agar plates. Pathogencity assays showed that Delta FgPtc3-8 is unable to infect flowering wheat head. All of the defects were restored when Delta FgPtc3-8 was complemented with the wild-type FgPTC3 gene. Additionally, the FgPTC3 partially rescued growth defect of a yeast PTC1 deletion mutant under various stress conditions. Ultrastructural and histochemical analyses showed that conidia of Delta FgPtc3-8 contained an unusually high number of large lipid droplets. Furthermore, the mutant accumulated a higher basal level of glycerol than the wild-type progenitor. Quantitative real-time PCR assays showed that basal expression of FgOS2, FgSLT2 and FgMKK1 in the mutant was significantly higher than that in the wild-type strain. Serial analysis of gene expression in Delta FgPtc3-8 revealed that FgPTC3 is associated with various metabolic pathways. In contrast to the FgPTC3 mutant, the deletion mutants of FgPTC1, FgPTC5, FgPTC5R, FgPTC6, FgPTC7 or FgPTC7R did not show aberrant phenotypic features when grown on PDA medium or inoculated on wheat head. These results indicate FgPtc3 is the key PP2C that plays a critical role in a variety of cellular and biological functions, including cell wall integrity, lipid and secondary metabolisms, and virulence in F. graminearum.	[Jiang, Jinhua; Yun, Yingzi; Yang, Qianqian; Wang, Zhengyi; Ma, Zhonghua] Zhejiang Univ, Inst Biotechnol, Key Lab Mol Biol Crop Pathogens & Insects, Hangzhou 310003, Zhejiang, Peoples R China; [Shim, Won-Bo] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA	Zhejiang University; Texas A&M University System; Texas A&M University College Station	Jiang, JH (corresponding author), Zhejiang Univ, Inst Biotechnol, Key Lab Mol Biol Crop Pathogens & Insects, Hangzhou 310003, Zhejiang, Peoples R China.	zhma@zju.edu.cn	Ma, Zhonghua/J-6972-2014	Ma, Zhonghua/0000-0002-5426-0997	earmarked fund for Modern Agro-industry Technology Research System [CARS-3-1-15]; Zhejiang Provincial Natural Science Foundation [Z3110057]; Fundamental Research Funds for the Central Universities	earmarked fund for Modern Agro-industry Technology Research System; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The research was supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-3-1-15), Zhejiang Provincial Natural Science Foundation (Z3110057), and the Fundamental Research Funds for the Central Universities to Dr. Ma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARINO J, 2010, EYKARYOTIC CELL, V10, P21; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai GH, 1996, PLANT DIS, V80, P975, DOI 10.1094/PD-80-0975; Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; Blandino M, 2006, EUR J AGRON, V25, P193, DOI 10.1016/j.eja.2006.05.001; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Desjardins AE, 1996, MOL PLANT MICROBE IN, V9, P775, DOI 10.1094/MPMI-9-0775; Dong B, 2009, AUTOPHAGY, V5, P946, DOI 10.4161/auto.5.7.9161; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; Faucher SP, 2008, FEMS MICROBIOL LETT, V281, P160, DOI 10.1111/j.1574-6968.2008.01094.x; Gaits F, 1999, MOL BIOL CELL, V10, P2647, DOI 10.1091/mbc.10.8.2647; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Gonzalez A, 2006, J BIOL CHEM, V281, P35057, DOI 10.1074/jbc.M607919200; Jiang JH, 2011, MOL PLANT PATHOL, V12, P425, DOI 10.1111/j.1364-3703.2010.00684.x; Jiang LH, 2001, FEBS LETT, V509, P142, DOI 10.1016/S0014-5793(01)03125-8; Jiang LH, 2010, MOL PLANT PATHOL, V11, P277, DOI 10.1111/j.1364-3703.2009.00598.x; Jin Y, 2009, MOL BIOL CELL, V20, P1312, DOI 10.1091/mbc.E08-09-0954; Jongeneel CV, 2003, P NATL ACAD SCI USA, V100, P4702, DOI 10.1073/pnas.0831040100; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Liu X, 2010, PLANT DIS, V94, P1137, DOI 10.1094/PDIS-94-9-1137; Mapes J, 2004, EMBO J, V23, P302, DOI 10.1038/sj.emboj.7600036; Meskiene I, 2003, J BIOL CHEM, V278, P18945, DOI 10.1074/jbc.M300878200; Mirocha CJ, 1998, J AGR FOOD CHEM, V46, P1414, DOI 10.1021/jf970857o; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Ochiai N, 2007, BIOCHEM BIOPH RES CO, V363, P639, DOI 10.1016/j.bbrc.2007.09.027; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Ramos CW, 2000, IUBMB LIFE, V50, P371, DOI 10.1080/152165400300089411; ROBINSON MK, 1994, MOL CELL BIOL, V14, P3634, DOI 10.1128/MCB.14.6.3634; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Ruan HH, 2007, FEMS YEAST RES, V7, P209, DOI 10.1111/j.1567-1364.2006.00160.x; Ruiz A, 2006, MOL MICROBIOL, V62, P263, DOI 10.1111/j.1365-2958.2006.05370.x; SanJose C, 1996, J BACTERIOL, V178, P5850, DOI 10.1128/jb.178.19.5850-5852.1996; Sasaki M, 2007, MECH DEVELOP, V124, P489, DOI 10.1016/j.mod.2007.04.001; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shitamukai A, 2004, J BIOL CHEM, V279, P3651, DOI 10.1074/jbc.M306098200; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Steensma HY, 2008, YEAST, V25, P9, DOI 10.1002/yea.1543; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Travesa A, 2008, J BIOL CHEM, V283, P17123, DOI 10.1074/jbc.M801402200; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Weber RWS, 1999, HISTOCHEM J, V31, P293, DOI 10.1023/A:1003713901179; Wojda I, 2003, MICROBIOL-SGM, V149, P1193, DOI 10.1099/mic.0.26110-0; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yin Y, 2009, LETT APPL MICROBIOL, V48, P680, DOI 10.1111/j.1472-765X.2009.02595.x; Young C, 2002, EUKARYOT CELL, V1, P1032, DOI 10.1128/EC.1.6.1032-1040.2002; Zhao XM, 2009, J PROTEOME RES, V8, P4714, DOI 10.1021/pr900415b	59	32	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25311	10.1371/journal.pone.0025311	http://dx.doi.org/10.1371/journal.pone.0025311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980420	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900049
J	Fontan-Lozano, A; Suarez-Pereira, I; Gonzalez-Forero, D; Carrion, AM				Fontan-Lozano, Angela; Suarez-Pereira, Irene; Gonzalez-Forero, David; Manuel Carrion, Angel			The A-Current Modulates Learning via NMDA Receptors Containing the NR2B Subunit	PLOS ONE			English	Article							LONG-TERM POTENTIATION; POTASSIUM CHANNELS; K+ CHANNELS; TRANSCRIPTIONAL REPRESSOR; MOLECULAR-PROPERTIES; SYNAPTIC PLASTICITY; KV4.2; DREAM; MEMORY; EXCITABILITY	Synaptic plasticity involves short- and long-term events, although the molecular mechanisms that underlie these processes are not fully understood. The transient A-type K+ current (I-A) controls the excitability of the dendrites from CA1 pyramidal neurons by regulating the back-propagation of action potentials and shaping synaptic input. Here, we have studied how decreases in I-A affect cognitive processes and synaptic plasticity. Using wild-type mice treated with 4-AP, an I-A inhibitor, and mice lacking the DREAM protein, a transcriptional repressor and modulator of the I-A, we demonstrate that impairment of I-A decreases the stimulation threshold for learning and the induction of early-LTP. Hippocampal electrical recordings in both models revealed alterations in basal electrical oscillatory properties toward low-theta frequencies. In addition, we demonstrated that the facilitated learning induced by decreased I-A requires the activation of NMDA receptors containing the NR2B subunit. Together, these findings point to a balance between the I-A and the activity of NR2B-containing NMDA receptors in the regulation of learning.	[Fontan-Lozano, Angela; Suarez-Pereira, Irene; Manuel Carrion, Angel] Univ Pablo de Olavide Sevilla, Div Neurociencias, Seville, Spain; [Gonzalez-Forero, David] Univ Cadiz, Fac Med, Area Fisiol, Cadiz, Spain	Universidad Pablo de Olavide; Universidad de Cadiz	Fontan-Lozano, A (corresponding author), Andalusian Ctr Mol Biol & Regenerat Med, Dept Stem Cell, Seville, Spain.	angela.fontan@cabimer.es; amancar@upo.es	Gonzalez-Forero, David/AAU-2935-2020; Pereira, Irene Suárez/K-9867-2014; Carrion, Angel Manuel/K-5875-2014; FONTÁN-LOZANO, ÁNGELA/R-9081-2019	Pereira, Irene Suárez/0000-0003-3559-5852; Carrion, Angel Manuel/0000-0001-8158-9512; FONTÁN-LOZANO, ÁNGELA/0000-0003-1646-0952; Gonzalez Forero, David/0000-0001-5748-9546	Junta de Andalucia [BIO-122]; Fundacion Ramon Areces; DGICYT [BFU2008-01552]; Spanish Science Ministry; University Pablo de Olavide	Junta de Andalucia(Junta de Andalucia); Fundacion Ramon Areces; DGICYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Science Ministry(Spanish Government); University Pablo de Olavide	This work was supported by grants from the Junta de Andalucia (BIO-122), Fundacion Ramon Areces and DGICYT (BFU2008-01552). AF-L and IS-P were supported by a Juan de la Cierva program from Spanish Science Ministry and a University Pablo de Olavide grant, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Alexander JC, 2009, LEARN MEMORY, V16, P167, DOI 10.1101/lm.1261709; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Campos D, 2003, MOL CELL NEUROSCI, V22, P135, DOI 10.1016/S1044-7431(03)00040-X; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Cash S, 1998, J NEUROSCI, V18, P10; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; de los Santos-Arteaga M, 2003, J NEUROSCI, V23, P11120; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fontan-Lozano A, 2007, J NEUROSCI, V27, P10185, DOI 10.1523/JNEUROSCI.2757-07.2007; Fontan-Lozano A, 2011, HIPPOCAMPUS, V21, P22, DOI 10.1002/hipo.20717; Fontan-Lozano A, 2009, CURR BIOL, V19, P54, DOI 10.1016/j.cub.2008.11.056; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P49, DOI 10.1113/jphysiol.2003.042580; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Inda MC, 2005, J NEUROSCI, V25, P2070, DOI 10.1523/JNEUROSCI.4163-04.2005; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Jung SC, 2011, BRAIN RES BULL, V84, P17, DOI 10.1016/j.brainresbull.2010.09.012; Jung SC, 2008, NEURON, V60, P657, DOI 10.1016/j.neuron.2008.08.029; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kim J, 2008, NEUROSCIENTIST, V14, P276, DOI 10.1177/1073858408315041; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Kohr G, 2003, J NEUROSCI, V23, P10791; Ledo F, 2002, EMBO J, V21, P4583, DOI 10.1093/emboj/cdf440; Ledo F, 2000, MOL CELL BIOL, V20, P9120, DOI 10.1128/MCB.20.24.9120-9126.2000; Lei Z, 2010, NEUROSCIENCE, V165, P350, DOI 10.1016/j.neuroscience.2009.10.041; Lilliehook C, 2003, J NEUROSCI, V23, P9097; Lockridge A, 2011, HIPPOCAMPUS, V21, P1152, DOI 10.1002/hipo.20877; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Rivas M, 2004, J BIOL CHEM, V279, P33114, DOI 10.1074/jbc.M403526200; Romero-Granados R, 2010, HIPPOCAMPUS, V20, P584, DOI 10.1002/hipo.20669; Ruiz-Gomez A, 2007, J BIOL CHEM, V282, P1205, DOI 10.1074/jbc.M607166200; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Storm JF, 2000, J PHYSIOL-LONDON, V525, P565, DOI 10.1111/j.1469-7793.2000.t01-1-00565.x; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Wu LJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-3; Zhang Y, 2010, J NEUROSCI, V30, P7575, DOI 10.1523/JNEUROSCI.1312-10.2010	57	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e24915	10.1371/journal.pone.0024915	http://dx.doi.org/10.1371/journal.pone.0024915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966384	Green Published, Green Submitted, gold			2022-12-25	WOS:000295932100007
J	Sun, L; Yau, HY; Lau, OC; Huang, Y; Yao, XQ				Sun, Lei; Yau, Ho-Yan; Lau, On-Chai; Huang, Yu; Yao, Xiaoqiang			Effect of Hydrogen Peroxide and Superoxide Anions on Cytosolic Ca2+: Comparison of Endothelial Cells from Large-Sized and Small-Sized Arteries	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; INTRACELLULAR CALCIUM; DILATION; INVOLVEMENT; GENERATION; INCREASES	We compared the Ca2+ responses to reactive oxygen species (ROS) between mouse endothelial cells derived from large-sized arteries, aortas (aortic ECs), and small-sized arteries, mesenteric arteries (MAECs). Application of hydrogen peroxide (H2O2) caused an increase in cytosolic Ca2+ levels ([Ca2+](i)) in both cell types. The [Ca2+](i) rises diminished in the presence of U73122, a phospholipase C inhibitor, or Xestospongin C (XeC), an inhibitor for inositol-1,4,5-trisphosphate (IP3) receptors. Removal of Ca2+ from the bath also decreased the [Ca2+](i) rises in response to H2O2. In addition, treatment of endothelial cells with H2O2 reduced the [Ca2+](i) responses to subsequent challenge of ATP. The decreased [Ca2+](i) responses to ATP were resulted from a pre-depletion of intracellular Ca2+ stores by H2O2. Interestingly, we also found that Ca2+ store depletion was more sensitive to H2O2 treatment in endothelial cells of mesenteric arteries than those of aortas. Hypoxanthine-xanthine oxidase (HX-XO) was also found to induce [Ca2+](i) rises in both types of endothelial cells, the effect of which was mediated by superoxide anions and H2O2 but not by hydroxyl radical. H2O2 contribution in HX-XO-induced [Ca2+](i) rises were more significant in endothelial cells from mesenteric arteries than those from aortas. In summary, H2O2 could induce store Ca2+ release via phospholipase C-IP3 pathway in endothelial cells. Resultant emptying of intracellular Ca2+ stores contributed to the reduced [Ca2+](i) responses to subsequent ATP challenge. The [Ca2+](i) responses were more sensitive to H2O2 in endothelial cells of small-sized arteries than those of large-sized arteries.	[Sun, Lei] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Sun, L (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk	Yao, Xiaoqiang/I-5413-2016; Huang, Yu/K-2866-2017	Yao, Xiaoqiang/0000-0002-0687-8186; Huang, Yu/0000-0002-1277-6784; Lau, Eva On-Chai/0000-0001-7998-0061	Hong Kong Research Grant Council [CUHK477408, CUHK479109, CUHK478710]; Strategic Research Investment Scheme C; Li Ka Shing Institute of Health Sciences	Hong Kong Research Grant Council(Hong Kong Research Grants Council); Strategic Research Investment Scheme C; Li Ka Shing Institute of Health Sciences	This work was supported by CUHK477408, CUHK479109 and CUHK478710 from the Hong Kong Research Grant Council, Strategic Research Investment Scheme C and Li Ka Shing Institute of Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley RA, 2002, PEDIATR RES, V51, P472, DOI 10.1203/00006450-200204000-00012; Az-ma T, 1999, BRIT J PHARMACOL, V126, P1462, DOI 10.1038/sj.bjp.0702438; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; DOAN TN, 1994, BIOCHEM J, V297, P209, DOI 10.1042/bj2970209; DREHER D, 1995, J CELL PHYSIOL, V162, P147, DOI 10.1002/jcp.1041620118; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Graier WF, 1998, ARTERIOSCL THROM VAS, V18, P1470, DOI 10.1161/01.ATV.18.9.1470; Harmer AR, 2002, BIOCHEM J, V367, P137, DOI 10.1042/BJ20020305; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Hu QH, 2000, J BIOL CHEM, V275, P15749, DOI 10.1074/jbc.M000381200; Hu QH, 1998, CIRCULATION, V97, P268, DOI 10.1161/01.CIR.97.3.268; Kimura C, 2000, AM J PHYSIOL-HEART C, V279, pH2310, DOI 10.1152/ajpheart.2000.279.5.H2310; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Liu YP, 2003, CIRC RES, V93, P573, DOI 10.1161/01.RES.0000091261.19387.AE; Miura H, 2003, CIRC RES, V92, pE31, DOI 10.1161/01.RES.0000054200.44505.AB; Owicki JC, 2000, J BIOMOL SCREEN, V5, P297, DOI 10.1177/108705710000500501; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; REPINE JE, 1981, P NATL ACAD SCI-BIOL, V78, P1001, DOI 10.1073/pnas.78.2.1001; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; SiflingerBirnboim A, 1996, AM J PHYSIOL-LUNG C, V270, pL973, DOI 10.1152/ajplung.1996.270.6.L973; Thengchaisri N, 2003, AM J PHYSIOL-HEART C, V285, pH2255, DOI 10.1152/ajpheart.00487.2003; Thomas TW, 1998, CELL CALCIUM, V24, P285, DOI 10.1016/S0143-4160(98)90052-5; Volk T, 1997, MOL CELL BIOCHEM, V171, P11, DOI 10.1023/A:1006886215193; Wesson Donald E., 1995, Microcirculation (New York), V2, P195, DOI 10.3109/10739689509146767; Yang ZW, 1999, GEN PHARMACOL-VASC S, V33, P325, DOI 10.1016/S0306-3623(99)00019-1; Zheng Y, 2005, REDOX REP, V10, P29, DOI 10.1179/135100005X21660	27	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25432	10.1371/journal.pone.0025432	http://dx.doi.org/10.1371/journal.pone.0025432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966527	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100039
J	Sweeney, TE; Suliman, HB; Hollingsworth, JW; Welty-Wolf, KE; Piantadosi, CA				Sweeney, Timothy E.; Suliman, Hagir B.; Hollingsworth, John W.; Welty-Wolf, Karen E.; Piantadosi, Claude A.			A Toll-Like Receptor 2 Pathway Regulates the Ppargc1a/b Metabolic Co-Activators in Mice with Staphylococcal aureus Sepsis	PLOS ONE			English	Article							NF-KAPPA-B; MITOCHONDRIAL BIOGENESIS; IMMUNE-RESPONSE; ORGAN DYSFUNCTION; LIPOTEICHOIC ACID; ADAPTER MOLECULE; CUTTING EDGE; ACTIVATION; TLR4; INTERFERON	Activation of the host antibacterial defenses by the toll-like receptors (TLR) also selectively activates energy-sensing and metabolic pathways, but the mechanisms are poorly understood. This includes the metabolic and mitochondrial biogenesis master co-activators, Ppargc1a (PGC-1 alpha) and Ppargc1b (PGC-1 beta) in Staphylococcus aureus (S. aureus) sepsis. The expression of these genes in the liver is markedly attenuated in TLR2(-/-) mice and markedly accentuated in TLR4(-/-) mice compared with wild type (WT) mice. We sought to explain this difference by using specific TLR-pathway knockout mice to test the hypothesis that these co-activator genes are directly regulated through TLR2 signaling. By comparing their responses to S. aureus with WT mice, we found that MyD88-deficient and MAL-deficient mice expressed hepatic Ppargc1a and Ppargc1b normally, but that neither gene was activated in TRAM-deficient mice. Ppargc1a/b activation did not require NF-k beta, but did require an interferon response factor (IRF), because neither gene was activated in IRF-3/7 double-knockout mice in sepsis, but both were activated normally in Unc93b1-deficient (3d) mice. Nuclear IRF-7 levels in TLR2(-/-) and TLR4(-/-) mice decreased and increased respectively post-inoculation and IRF-7 DNA-binding at the Ppargc1a promoter was demonstrated by chromatin immunoprecipitation. Also, a TLR2-TLR4-TRAM native hepatic protein complex was detected by immunoprecipitation within 6 h of S. aureus inoculation that could support MyD88-independent signaling to Ppargc1a/b. Overall, these findings disclose a novel MyD88-independent pathway in S. aureus sepsis that links TLR2 and TLR4 signaling in innate immunity to Ppargc1a/b gene regulation in a critical metabolic organ, the liver, by means of TRAM, TRIF, and IRF-7.	[Sweeney, Timothy E.; Piantadosi, Claude A.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Suliman, Hagir B.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Hollingsworth, John W.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Hollingsworth, John W.; Welty-Wolf, Karen E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Sweeney, TE (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	piant001@mc.duke.edu		Sweeney, Timothy/0000-0002-3596-1093	National Institutes of Health [AI064769, ES016126, GM084116]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI064769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health AI064769, ES016126, and GM084116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alvira CM, 2007, AM J RESP CRIT CARE, V175, P805, DOI 10.1164/rccm.200608-1162OC; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Cox KH, 2007, INFECT IMMUN, V75, P2638, DOI 10.1128/IAI.01320-06; Crouser ED, 2004, MITOCHONDRION, V4, P729, DOI 10.1016/j.mito.2004.07.023; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Demoulins T, 2009, VIROLOGY, V386, P225, DOI 10.1016/j.virol.2009.01.024; Dessing MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007993; Dewan MZ, 2003, J VIROL, V77, P5286, DOI 10.1128/JVI.77.9.5286-5294.2003; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Hoshino K, 1999, J IMMUNOL, V162, P3749; Inden K, 2009, MICROBES INFECT, V11, P245, DOI 10.1016/j.micinf.2008.11.013; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kielian T, 2007, J IMMUNOL, V178, P4528, DOI 10.4049/jimmunol.178.7.4528; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Knapp S, 2008, J IMMUNOL, V180, P3478, DOI 10.4049/jimmunol.180.5.3478; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lee HK, 2004, J BIOL CHEM, V279, P10564, DOI 10.1074/jbc.M311564200; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Levy RJ, 2004, SHOCK, V21, P110, DOI 10.1097/01.shk.0000108400.56565.ab; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Morin P, 2002, J MOL BIOL, V316, P1009, DOI 10.1006/jmbi.2001.5401; Murphey ED, 2008, CRIT CARE MED, V36, P3067, DOI 10.1097/CCM.0b013e31818c6fb7; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Phelps CB, 2000, J BIOL CHEM, V275, P29840, DOI 10.1074/jbc.M004899200; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Prakash A, 2006, BIOCHEM BIOPH RES CO, V342, P50, DOI 10.1016/j.bbrc.2006.01.122; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Stenzel W, 2008, AM J PATHOL, V172, P132, DOI 10.2353/ajpath.2008.070567; Suliman HB, 2010, J CELL SCI, V123, P2565, DOI 10.1242/jcs.064089; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; Sweeney E, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011606, 10.1371/journal.pone.0009518]; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001	62	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25249	10.1371/journal.pone.0025249	http://dx.doi.org/10.1371/journal.pone.0025249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966468	gold, Green Published, Green Submitted			2022-12-25	WOS:000295932100028
J	Xiong, J; Miller, VM; Hunter, LW; Li, YM; Jayachandran, M				Xiong, Jing; Miller, Virginia M.; Hunter, Larry W.; Li, Yunman; Jayachandran, Muthuvel			Leukocyte- and Platelet-Derived Microvesicle Interactions following In Vitro and In Vivo Activation of Toll-Like Receptor 4 by Lipopolysaccharide	PLOS ONE			English	Article							CIRCULATING MICROPARTICLES; ENDOTHELIAL MICROPARTICLES; INFLAMMATION; AGGREGATION; MACROPHAGES; INVOLVEMENT; COAGULATION; EXPRESSION; INFECTION; CORRELATE	Background: Pro-coagulant membrane microvesicles (MV) derived from platelets and leukocytes are shed into the circulation following receptor-mediated activation, cell-cell interaction, and apoptosis. Platelets are sentinel markers of toll-like receptor 4 (TLR4) activation. Experiments were designed to evaluate the time course and mechanism of direct interactions between platelets and leukocytes following acute activation of TLR4 by bacterial lipopolysaccharide (LPS). Methodology/Principal Findings: Blood from age-matched male and female wild type (WT) and TLR4 gene deleted (dTLR4) mice was incubated with ultra-pure E. coli LPS (500 ng/ml) for up to one hour. At designated periods, leukocyte antigen positive platelets, platelet antigen positive leukocytes and cell-derived MV were quantified by flow cytometry. Numbers of platelet-or leukocyte-derived MV did not increase within one hour following in vitro exposure of blood to LPS. However, with LPS stimulation numbers of platelets staining positive for both platelet-and leukocyte-specific antigens increased in blood derived from WT but not dTLR4 mice. This effect was blocked by inhibition of TLR4 signaling mediated by My88 and TRIF. Seven days after a single intravenous injection of LPS (500 ng/mouse or 20 ng/gm body wt) to WT mice, none of the platelets stained for leukocyte antigen. However, granulocytes, monocytes and apoptotic bodies stained positive for platelet antigens. Conclusions/Significance: Within one hour of exposure to LPS, leukocytes exchange surface antigens with platelets through TLR4 activation. In vivo, leukocyte expression of platelet antigen is retained after a single exposure to LPS following turn over of the platelet pool. Acute expression of leukocyte antigen on platelets within one hour of exposure to LPS and the sustained expression of platelet antigen on leukocytes following a single acute exposure to LPS in vivo explains, in part, associations of platelets and leukocytes in response to bacterial infection and changes in thrombotic propensity of the blood.	[Xiong, Jing; Li, Yunman] China Pharmaceut Univ, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R China; [Xiong, Jing; Miller, Virginia M.; Hunter, Larry W.] Mayo Clin, Dept Surg, Rochester, MN USA; [Miller, Virginia M.; Jayachandran, Muthuvel] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	China Pharmaceutical University; Mayo Clinic; Mayo Clinic	Xiong, J (corresponding author), China Pharmaceut Univ, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R China.	miller.virginia@mayo.edu; yunmanlicpu@126.com	Jayachandran, Muthuvel/AAG-6532-2019	Jayachandran, Muthuvel/0000-0002-3007-0769; Xiong, Jing/0000-0002-9712-6771	American Heart Association [AHA30503Z]; Mayo Clinic; China Scholarship Council	American Heart Association(American Heart Association); Mayo Clinic; China Scholarship Council(China Scholarship Council)	This work was funded by grants from the American Heart Association AHA30503Z and the Mayo Clinic and China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Baj-Krzyworzeka M, 2002, EXP HEMATOL, V30, P450, DOI 10.1016/S0301-472X(02)00791-9; Bernal-Mizrachi L, 2004, INT J CARDIOL, V97, P439, DOI 10.1016/j.ijcard.2003.10.029; Brogan PA, 2004, ARTHRITIS RHEUM, V50, P927, DOI 10.1002/art.20199; Cerletti C, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.023; Comfurius P, 1996, BIOCHEMISTRY-US, V35, P7631, DOI 10.1021/bi9606859; Corti R, 2004, J THROMB THROMBOLYS, V17, P35, DOI 10.1023/B:THRO.0000036027.39353.70; DACHARYPRIGENT J, 1995, BIOCHEMISTRY-US, V34, P11625, DOI 10.1021/bi00036a039; de Vos AF, 2009, J IMMUNOL, V183, P533, DOI 10.4049/jimmunol.0802189; Eriksson M, 1998, ACTA ANAESTH SCAND, V42, P551, DOI 10.1111/j.1399-6576.1998.tb05165.x; Hashimoto K, 2009, J CARDIOVASC PHARM, V54, P57, DOI 10.1097/FJC.0b013e3181ab373d; Jayachandran M, 2009, CLIMACTERIC, V12, P177, DOI 10.1080/13697130802488607; Jayachandran M, 2011, J CARDIOVASC TRANSL, DOI 101007/s12265-011-9296-9; Jayachandran M, 2008, AM J PHYSIOL-HEART C, V295, pH931, DOI 10.1152/ajpheart.00193.2008; Jayachandran M, 2007, J APPL PHYSIOL, V102, P429, DOI 10.1152/japplphysiol.01576.2005; Jayachandran M, 2010, THROMB RES, V126, P414, DOI 10.1016/j.thromres.2009.05.005; Jayachandran M, 2010, AGE, V32, P109, DOI 10.1007/s11357-009-9119-y; Joop K, 2001, THROMB HAEMOSTASIS, V85, P810; Kalvegren H, 2003, ARTERIOSCL THROM VAS, V23, P1677, DOI 10.1161/01.ATV.0000084810.52464.D5; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li XM, 2009, TEX HEART I J, V36, P134; Li ZY, 2011, THROMB RES, V127, P184, DOI 10.1016/j.thromres.2010.10.010; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; May AE, 2007, SEMIN THROMB HEMOST, V33, P123, DOI 10.1055/s-2007-969023; Mostefai HA, 2008, PHYSIOL RES, V57, P311, DOI 10.33549/physiolres.931533; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Obregon C, 2006, AM J PATHOL, V169, P2127, DOI 10.2353/ajpath.2006.060453; Pasceri V, 2006, AM HEART J, V151, P1215, DOI 10.1016/j.ahj.2005.06.041; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Pluskota E, 2008, BLOOD, V112, P2327, DOI 10.1182/blood-2007-12-127183; Poltorak A, 2001, J IMMUNOL, V167, P2106, DOI 10.4049/jimmunol.167.4.2106; Premkumar Vummidigiridhar, 2010, BMC Chemical Biology, V10, P3, DOI 10.1186/1472-6769-10-3; Ratajczak MZ, 2009, BLOOD, V113, P981, DOI 10.1182/blood-2008-10-182964; Seizer P, 2008, CURR MED CHEM, V15, P1976, DOI 10.2174/092986708785132852; Simak J, 2006, J THROMB HAEMOST, V4, P1296, DOI 10.1111/j.1538-7836.2006.01911.x; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Spiewak R, 2008, ANN AGR ENV MED, V15, P153; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Turgut B, 2011, J NEUROL SCI, V305, P126, DOI 10.1016/j.jns.2011.02.026; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Varon David, 2009, Discov Med, V8, P237; Wang JG, 2009, J THROMB HAEMOST, V7, P1092, DOI 10.1111/j.1538-7836.2009.03448.x; Weerheim AM, 2002, ANAL BIOCHEM, V302, P191, DOI 10.1006/abio.2001.5552; Willershausen B, 2009, J ENDODONT, V35, P626, DOI 10.1016/j.joen.2009.01.012; WILLIAMSON P, 1994, MOL MEMBR BIOL, V11, P199, DOI 10.3109/09687689409160430; Xiong J, 2011, J CARDIOVASC PHARM, DOI 101097/FJC0b013e31820c6254; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; Zheng H, 2010, EUR J IMMUNOL, V40, P162, DOI 10.1002/eji.200839156	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25504	10.1371/journal.pone.0025504	http://dx.doi.org/10.1371/journal.pone.0025504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966536	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100044
J	Shuya, LL; Menkhorst, EM; Yap, J; Li, P; Lane, N; Dimitriadis, E				Shuya, Lorraine Lin; Menkhorst, Ellen Melaleuca; Yap, Joanne; Li, Priscilla; Lane, Natalie; Dimitriadis, Evdokia			Leukemia Inhibitory Factor Enhances Endometrial Stromal Cell Decidualization in Humans and Mice	PLOS ONE			English	Article							EARLY-PREGNANCY; LIF-RECEPTOR; MOUSE UTERUS; BLASTOCYST IMPLANTATION; EMBRYO IMPLANTATION; IN-VITRO; EXPRESSION; INTERLEUKIN-11; PROGESTERONE; DIFFERENTIATION	Adequate differentiation or decidualization of endometrial stromal cells (ESC) is critical for successful pregnancy in humans and rodents. Here, we investigated the role of leukemia inhibitory factor (LIF) in human and murine decidualization. Ex vivo human (H) ESC decidualization was induced by estrogen (E, 10(-8) M) plus medroxyprogesterone acetate (MPA, 10(-7) M). Exogenous LIF (>= 50 ng/ml) induced STAT3 phosphorylation in non-decidualized and decidualized HESC and enhanced E+MPA-induced decidualization (measured by PRL secretion, P<0.05). LIF mRNA in HESC was down-regulated by decidualization treatment (E+MPA) whereas LIF receptor (R) mRNA was up-regulated, suggesting that the decidualization stimulus 'primed' HESC for LIF action, but that factors not present in our in vitro model were required to induce LIF expression. Ex vivo first trimester decidual biopsies secreted >100 pg/mg G-CSF, IL6, IL8, and MCP1. Decidualized HESC secreted IL6, IL8, IL15 and MCP1. LIF (50 ng/ml) up-regulated IL6 and IL15 (P<0.05) secretion in decidualized HESC compared to 0.5 ng/ml LIF. In murine endometrium, LIF and LIFR immunolocalized to decidualized stromal cells on day 5 of gestation (day 0 = day of plug detection). Western blotting confirmed that LIF and the LIFR were up-regulated in intra-implantation sites compared to inter-implantation sites on Day 5 of gestation. To determine the role of LIF during in vivo murine decidualization, intra-peritoneal injections of a long-acting LIF antagonist (PEGLA; 900 or 1200 mu g) were given just post-attachment, during the initiation of decidualization on day 4. PEGLA treatment reduced implantation site decidual area (P<0.05) and desmin staining immuno-intensity (P<0.05) compared to control on day 6 of gestation. This study demonstrated that LIF was an important regulator of decidualization in humans and mice and data provides insight into the processes underlying decidualization, which are important for understanding implantation and placentation.	[Shuya, Lorraine Lin; Menkhorst, Ellen Melaleuca; Yap, Joanne; Li, Priscilla; Lane, Natalie; Dimitriadis, Evdokia] Prince Henrys Inst, Embryo Implantat Lab, Melbourne, Vic, Australia; [Shuya, Lorraine Lin; Dimitriadis, Evdokia] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia	Prince Henry's Institute of Medical Research; Monash University	Shuya, LL (corresponding author), Prince Henrys Inst, Embryo Implantat Lab, Melbourne, Vic, Australia.	evdokia.dimitriadis@princehenrys.org	Menkhorst, Ellen/AAU-4329-2021; Menkhorst, Ellen/P-5759-2014; dimitriadis, e/AAD-7601-2021	Menkhorst, Ellen/0000-0003-2440-6665; dimitriadis, eva/0000-0003-1425-950X; Dimitriadis, Eva/0000-0001-8698-1927	Consortium for Industrial Collaboration in Contraceptive Research, Eastern Virginia Medical School [CIG-07-116]; National Health and Medical Research Council (Australia) [550905, 611827]; Victorian (Australia) Government	Consortium for Industrial Collaboration in Contraceptive Research, Eastern Virginia Medical School; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian (Australia) Government	This work was supported by the Consortium for Industrial Collaboration in Contraceptive Research Program of the Contraceptive Research and Development Program, Eastern Virginia Medical School (Sub-project CIG-07-116), the National Health and Medical Research Council (Australia) fellowships to ED (#550905) and EM (#611827), and the Victorian (Australia) Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSOHN PA, 1993, J EXP ZOOL, V266, P603, DOI 10.1002/jez.1402660610; Aghajanova L, 2003, FERTIL STERIL, V79, P808, DOI 10.1016/S0015-0282(02)04830-6; Aghajanova L, 2009, FERTIL STERIL, V91, P2602, DOI 10.1016/j.fertnstert.2008.04.010; Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937; BHATT H, 1991, P NATL ACAD SCI USA, V88, P11408, DOI 10.1073/pnas.88.24.11408; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; CHARNOCKJONES DS, 1994, J REPROD FERTIL, V101, P421; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; Das SK, 1999, J MOL ENDOCRINOL, V22, P91, DOI 10.1677/jme.0.0220091; Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Dimitriadis E, 2002, MOL HUM REPROD, V8, P636, DOI 10.1093/molehr/8.7.636; Dimitriadis E, 2010, PLACENTA, V31, pS99, DOI 10.1016/j.placenta.2009.12.027; Dimitriadis E, 2006, ENDOCRINOLOGY, V147, P3809, DOI 10.1210/en.2006-0264; Ding T, 2008, REPRODUCTION, V135, P41, DOI 10.1530/REP-07-0013; Evans J, 2009, FASEB J, pfj08; Fairlie WD, 2004, J BIOL CHEM, V279, P2125, DOI 10.1074/jbc.M310103200; Garcia MG, 2007, PLACENTA, V28, P650, DOI 10.1016/j.placenta.2006.09.010; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Jones RL, 2002, J CLIN ENDOCR METAB, V87, P4001, DOI 10.1210/jc.87.8.4001; Kitaya K, 2000, BIOL REPROD, V63, P683, DOI 10.1095/biolreprod63.3.683; Marwood M, 2009, ENDOCRINOLOGY, V150, P2915, DOI 10.1210/en.2008-1538; MASLAR IA, 1979, AM J OBSTET GYNECOL, V135, P751, DOI 10.1016/0002-9378(79)90386-7; Menkhorst E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019665; Menkhorst E, 2009, BIOL REPROD, V80, P920, DOI 10.1095/biolreprod.108.073601; Mohamet L, 2009, REPRODUCTION, V138, P827, DOI 10.1530/REP-09-0113; Nakajima S, 2003, INT J MOL MED, V11, P353; Nashta AAF, 2004, J ENDOCRINOL, V181, P477, DOI 10.1677/joe.0.1810477; Ni H, 2002, MOL REPROD DEV, V63, P143, DOI 10.1002/mrd.10168; Nilsson U, 2010, REPROD FERT DEVELOP, V22, P71; Okada S, 2000, MOL HUM REPROD, V6, P75, DOI 10.1093/molehr/6.1.75; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Sawai K, 1997, BIOL REPROD, V56, P1274, DOI 10.1095/biolreprod56.5.1274; Sharkey AM, 1999, BIOL REPROD, V60, P355, DOI 10.1095/biolreprod60.2.355; Simpson KJ, 2000, J BIOL CHEM, V275, P23074, DOI 10.1074/jbc.M002161200; Song G, 2009, REPRODUCTION, V137, P553, DOI 10.1530/REP-08-0437; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STEWART CL, 1994, ANN NY ACAD SCI, V734, P157, DOI 10.1111/j.1749-6632.1994.tb21743.x; Teng CB, 2004, MOL REPROD DEV, V69, P1, DOI 10.1002/mrd.20149; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104; YANG ZM, 1995, MOL REPROD DEV, V42, P407, DOI 10.1002/mrd.1080420406	44	66	70	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25288	10.1371/journal.pone.0025288	http://dx.doi.org/10.1371/journal.pone.0025288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966484	Green Published, gold			2022-12-25	WOS:000295267100040
J	Monti, L; Menci, E; Ulivelli, M; Cerase, A; Bartalini, S; Piu, P; Marotti, N; Leonini, S; Galluzzi, P; Romano, DG; Casasco, AE; Venturi, C				Monti, Lucia; Menci, Elisabetta; Ulivelli, Monica; Cerase, Alfonso; Bartalini, Sabina; Piu, Pietro; Marotti, Nicola; Leonini, Sara; Galluzzi, Paolo; Romano, Daniele G.; Casasco, Alfredo E.; Venturi, Carlo			Quantitative ColourDopplerSonography Evaluation of Cerebral Venous Outflow: A Comparative Study between Patients with Multiple Sclerosis and Controls	PLOS ONE			English	Article							BLOOD-FLOW VOLUME; NO EVIDENCE; INSUFFICIENCY; HEMODYNAMICS; IMPAIRMENT; SONOGRAPHY; CRITERIA; VEINS	Background: Internal Jugular Veins (IJVs) are the principle outflow pathway for intracranial blood in clinostatism condition. In the seated position, IJVs collapse, while Vertebral Veins (VVs) increase the venous outflow and partially compensate the venous drainage. Spinal Epidural Veins are an additional drainage pathway in the seated position. Colour- Doppler- Sonography (CDS) examination is able to demonstrate IJVs and VVs outflow in different postural and respiratory conditions. The purpose of this study was to evaluate CDS quantification of the cerebral venous outflow (CVF) in healthy subjects and patients with multiple sclerosis (MS). Methodology/Principal Findings: In a group of 27 healthy adults (13 females and 14 males; mean age 37.8 +/- 11.2 years), and 52 patients with MS (32 females and 20 males; mean age 42.6 +/- 12.1 years), CVF has been measured in clinostatism and in the seated position as the sum of the flow in IJVs and VVs. The difference between CVF in clinostatism and CVF in the seated position (Delta CVF) has been correlated with patients' status (healthy or MS), and a number of clinical variables in MS patients. Statistical analysis was performed by Fisher's exact test, non-parametric Mann-Whitney U test, ANOVA Kruskal-Wallis test, and correntropy coefficient. The value of Delta CVF was negative in 59.6% of patients with MS and positive in 96.3% of healthy subjects. Negative Delta CVF values were significantly associated with MS (p<0.0001). There was no significant correlation with clinical variables. Conclusions/Significance: Negative Delta CVF has a hemodynamic significance, since it reflects an increased venous return in the seated position. This seems to be a pathologic condition. In MS patients, a vascular dysregulation resulting from involvement of the autonomous nervous system may be supposed. Delta CVF value should be included in the quantitative CDS evaluation of the cerebral venous drainage, in order to identify cerebral venous return abnormalities.	[Monti, Lucia; Menci, Elisabetta; Cerase, Alfonso; Marotti, Nicola; Leonini, Sara; Galluzzi, Paolo; Romano, Daniele G.; Venturi, Carlo] Univ Senese, Santa Maria Scotte Gen Hosp, Dept Neurol & Sensorial Sci, Unit Neuroimaging & Neurointervent,Azienda Osped, Siena, Italy; [Ulivelli, Monica; Bartalini, Sabina; Piu, Pietro] Univ Siena, Dept Neurosci, I-53100 Siena, Italy; [Casasco, Alfredo E.] Clin Nuestra Senora Rosario, Unit Endovasc & Percutaneous Therapy, Madrid, Spain	University of Siena; University Hospital of Siena; University of Siena	Monti, L (corresponding author), Univ Senese, Santa Maria Scotte Gen Hosp, Dept Neurol & Sensorial Sci, Unit Neuroimaging & Neurointervent,Azienda Osped, Siena, Italy.	l.monti@ao-siena.toscana.it	MONTI, LUCIA/ABF-7076-2021; Romano, Daniele/AAN-6699-2020; Ulivelli, Monica/K-7270-2016	Ulivelli, Monica/0000-0003-3463-6341; Galluzzi, Paolo/0000-0002-7553-5064; Romano, Daniele Giuseppe/0000-0002-7357-7770; Piu, Pietro/0000-0002-7504-1822; Cerase, Alfonso/0000-0003-4753-6649				Al-Omari MH, 2010, INT ANGIOL, V29, P115; Alexander J Steven, 2011, Pathophysiology, V18, P3, DOI 10.1016/j.pathophys.2010.04.002; Baracchini C, 2011, ANN NEUROL, V70, P181, DOI 10.1002/ana.22465; Baracchini C, 2011, ANN NEUROL, V69, P90, DOI 10.1002/ana.22228; Bartolomei I, 2010, INT ANGIOL, V29, P183; Centonze D, 2011, ANN NEUROL, V70, P51, DOI 10.1002/ana.22436; D'haeseleer M, 2011, LANCET NEUROL, V10, P657, DOI 10.1016/S1474-4422(11)70105-3; Doepp F, 2004, NEURORADIOLOGY, V46, P565, DOI 10.1007/s00234-004-1213-3; Doepp F, 2008, J CLIN ULTRASOUND, V36, P480, DOI 10.1002/jcu.20470; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Dorfler P, 2000, J CEREBR BLOOD F MET, V20, P269; Flachenecker P, 1999, J NEUROL, V246, P578, DOI 10.1007/s004150050407; Gisolf J, 2004, J PHYSIOL-LONDON, V560, P317, DOI 10.1113/jphysiol.2004.070409; Gold SM, 2003, MULT SCLER J, V9, P404, DOI 10.1191/1352458503ms927oa; Hoffmann O, 1999, J NEUROIMAGING, V9, P198, DOI 10.1111/jon199994198; Hojnacki D, 2010, INT ANGIOL, V29, P127; Khan O, 2010, ANN NEUROL, V67, P286, DOI 10.1002/ana.22001; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lassmann H, 2005, BRAIN PATHOL, V15, P217; Lepori D, 1999, EUR RADIOL, V9, P1222, DOI 10.1007/s003300050822; Liu WF, 2007, IEEE T SIGNAL PROCES, V55, P5286, DOI 10.1109/TSP.2007.896065; Mayer CA, 2011, J NEUROL NEUROSUR PS, V82, P436, DOI 10.1136/jnnp.2010.231613; Menegatti E, 2008, CURR NEUROVASC RES, V5, P260, DOI 10.2174/156720208786413442; Nedelmann M, 2005, J NEUROIMAGING, V15, P70, DOI 10.1177/1051228404267997; Nezamfar H, 2015, IEEE SIG PROC MED; Pache M, 2003, EUR NEUROL, V49, P164, DOI 10.1159/000069085; Principe JC, 2010, INFORM SCI STAT, P1, DOI 10.1007/978-1-4419-1570-2; Ruiz DS, 2002, AM J NEURORADIOL, V23, P1500; Santamaria I, 2006, IEEE T SIGNAL PROCES, V54, P2187, DOI 10.1109/TSP.2006.872524; Scheel P, 2000, STROKE, V31, P147, DOI 10.1161/01.STR.31.1.147; SCHONING M, 1994, STROKE, V25, P17, DOI 10.1161/01.STR.25.1.17; Schreiber SJ, 2003, J APPL PHYSIOL, V94, P1802, DOI 10.1152/japplphysiol.00782.2002; Singh AV, 2009, J CEREBR BLOOD F MET, V29, P1867, DOI 10.1038/jcbfm.2009.180; Valdueza JM, 2000, LANCET, V355, P200; Valdueza JM, 1996, STROKE, V27, P1221, DOI 10.1161/01.STR.27.7.1221; Wang DC, 2009, IEEE T BIO-MED ENG, V56, P1691, DOI 10.1109/TBME.2009.2015576; Xu JW, 2008, NEURAL NETWORKS, V21, P222, DOI 10.1016/j.neunet.2007.12.039; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2009, J VASC SURG, V50, P1348, DOI 10.1016/j.jvs.2009.07.096; Zamboni P, 2009, CURR NEUROVASC RES, V6, P204, DOI 10.2174/156720209788970054; Zivadinov R, 2011, NEUROLOGY, V77, P138, DOI 10.1212/WNL.0b013e318212a901; Zivadinov R, 2011, ANN NEUROL, V69, P1062, DOI 10.1002/ana.22420	42	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25012	10.1371/journal.pone.0025012	http://dx.doi.org/10.1371/journal.pone.0025012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966398	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100039
J	Jayaraman, T; Tejero, J; Chen, BB; Blood, AB; Frizzell, S; Shapiro, C; Tiso, M; Hood, BL; Wang, XD; Zhao, XJ; Conrads, TP; Mallampalli, RK; Gladwin, MT				Jayaraman, Thottala; Tejero, Jesus; Chen, Bill B.; Blood, Arlin B.; Frizzell, Sheila; Shapiro, Calli; Tiso, Mauro; Hood, Brian L.; Wang, Xunde; Zhao, Xuejun; Conrads, Thomas P.; Mallampalli, Rama K.; Gladwin, Mark T.			14-3-3 Binding and Phosphorylation of Neuroglobin during Hypoxia Modulate Six-to-Five Heme Pocket Coordination and Rate of Nitrite Reduction to Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; INDUCIBLE FACTOR-1-ALPHA; GLOBIN; ACTIVATION; CYTOGLOBIN; EXPRESSION; REACTIVITY; INHIBITOR; PROTECTS; SURVIVAL	Neuroglobin protects neurons from hypoxia in vitro and in vivo; however, the underlying mechanisms for this effect remain poorly understood. Most of the neuroglobin is present in a hexacoordinate state with proximal and distal histidines in the heme pocket directly bound to the heme iron. At equilibrium, the concentration of the five-coordinate neuroglobin remains very low (0.1-5%). Recent studies have shown that post-translational redox regulation of neuroglobin surface thiol disulfide formation increases the open probability of the heme pocket and allows nitrite binding and reaction to form NO. We hypothesized that the equilibrium between the six-and five-coordinate states and secondary reactions with nitrite to form NO could be regulated by other hypoxia-dependent post-translational modification(s). Protein sequence models identified candidate sites for both 14-3-3 binding and phosphorylation. In both in vitro experiments and human SH-SY5Y neuronal cells exposed to hypoxia and glucose deprivation, we observed that 1) neuroglobin phosphorylation and protein-protein interactions with 14-3-3 increase during hypoxic and metabolic stress; 2) neuroglobin binding to 14-3-3 stabilizes and increases the half-life of phosphorylation; and 3) phosphorylation increases the open probability of the heme pocket, which increases ligand binding (CO and nitrite) and accelerates the rate of anaerobic nitrite reduction to form NO. These data reveal a series of hypoxia-dependent post-translational modifications to neuroglobin that regulate the six-to-five heme pocket equilibrium and heme access to ligands. Hypoxia-regulated reactions of nitrite and neuroglobin may contribute to the cellular adaptation to hypoxia.	[Hood, Brian L.; Conrads, Thomas P.; Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA; [Jayaraman, Thottala; Tejero, Jesus; Frizzell, Sheila; Shapiro, Calli; Tiso, Mauro; Zhao, Xuejun; Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA; [Jayaraman, Thottala; Chen, Bill B.; Mallampalli, Rama K.; Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA; [Wang, Xunde] NHLBI, NIH, Bethesda, MD 20892 USA; [Blood, Arlin B.] Loma Linda Univ, Sch Med, Dept Pediat, Div Neonatol, Loma Linda, CA 92354 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Loma Linda University	Gladwin, MT (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA.	gladwinmt@upmc.edu	Tejero, Jesus/G-3953-2017; Blood, Arlin/AAG-8897-2020	Tejero, Jesus/0000-0003-3245-9978; Blood, Arlin/0000-0002-4803-5021	National Institutes of Health [R01 HL098032, R01 HL096973, P01 HL103455, R01 HL096376, R01 HL097376, R01 HL098174]; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098032, R01HL097376, R01HL095973, R01HL096376, R01HL096973, R01HL098174, P01HL103455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL098032, R01 HL096973, and P01 HL103455 (to M. T. G.) and R01 HL096376, R01 HL097376, and R01 HL098174 (to R. K. M.). This work was also supported by the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania (to M. T. G.). M. Tiso and M. T. Gladwin are listed as co-inventors on a patent application entitled "Neuroglobin as a Six-to-Five Coordinate-regulated Nitrite Reductase."	Abbruzzetti S, 2009, P NATL ACAD SCI USA, V106, P18984, DOI 10.1073/pnas.0905433106; Arany I, 2005, KIDNEY INT, V68, P1573, DOI 10.1111/j.1523-1755.2005.00569.x; Ascenzi P, 2004, BIOCHEM MOL BIOL EDU, V32, P305, DOI 10.1002/bmb.2004.494032050386; Brunori M, 2006, FASEB J, V20, P2192, DOI 10.1096/fj.06-6643rev; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Fago A, 2006, J INORG BIOCHEM, V100, P1339, DOI 10.1016/j.jinorgbio.2006.03.009; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; Jayaraman T, 2000, J BIOL CHEM, V275, P6417, DOI 10.1074/jbc.275.9.6417; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Li J, 2008, J PHYS CHEM B, V112, P8715, DOI 10.1021/jp711919f; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Liu XH, 2002, J BIOL CHEM, V277, P50081, DOI 10.1074/jbc.M201095200; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Milton SL, 2006, J BIOMED SCI, V13, P509, DOI 10.1007/s11373-006-9084-8; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Nadra AD, 2008, PROTEINS, V71, P695, DOI 10.1002/prot.21814; Nicolis S, 2007, BIOCHEM J, V407, P89, DOI 10.1042/BJ20070372; Nienhaus K, 2007, IUBMB LIFE, V59, P490, DOI 10.1080/15216540601188538; Nienhaus K, 2010, CHEMPHYSCHEM, V11, P119, DOI 10.1002/cphc.200900637; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Saurin AT, 2000, FASEB J, V14, P2237, DOI 10.1096/fj.99-0671com; Shang AJ, 2006, BRAIN RES, V1078, P219, DOI 10.1016/j.brainres.2006.01.064; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vos MH, 2008, BIOCHEMISTRY-US, V47, P5718, DOI 10.1021/bi800288z; Wang XZ, 2004, J BIOL CHEM, V279, P49460, DOI 10.1074/jbc.M406059200; Watanabe S, 2008, BIOCHEM BIOPH RES CO, V369, P695, DOI 10.1016/j.bbrc.2008.02.089; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; Ye SQ, 2009, ACTA PHARMACOL SIN, V30, P913, DOI 10.1038/aps.2009.70; Yu ZY, 2009, NEUROL RES, V31, P122, DOI 10.1179/174313209X389866; Zhu YH, 2002, BLOOD, V100, P2494, DOI 10.1182/blood-2002-01-0280	48	59	61	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42679	42689		10.1074/jbc.M111.271973	http://dx.doi.org/10.1074/jbc.M111.271973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965683	hybrid, Green Published			2022-12-25	WOS:000298180900075
J	Convertino, M; Vitalis, A; Caflisch, A				Convertino, Marino; Vitalis, Andreas; Caflisch, Amedeo			Disordered Binding of Small Molecules to A beta(12-28)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; A-BETA-PEPTIDE; ALPHA-SYNUCLEIN AGGREGATION; ALZHEIMERS-DISEASE; IN-VITRO; PROTEIN AGGREGATION; INTRINSIC DISORDER; CONGO RED; INHIBITORS; OLIGOMERS	In recent years, an increasing number of small molecules and short peptides have been identified that interfere with aggregation and/or oligomerization of the Alzheimer beta-amyloid peptide (A beta). Many of them possess aromatic moieties, suggesting a dominant role for those in interacting with A beta along various stages of the aggregation process. In this study, we attempt to elucidate whether interactions of such aromatic inhibitors with monomeric A beta(12-28) point to a common mechanism of action by performing atomistic molecular dynamics simulations at equilibrium. Our results suggest that, independently of the presence of inhibitors, monomeric A beta(12-28) populates a partially collapsed ensemble that is largely devoid of canonical secondary structure at 300 K and neutral pH. The small molecules have different affinities for A beta(12-28) that can be partially rationalized by the balance of aromatic and charged moieties constituting the molecules. There are no predominant binding modes, although aggregation inhibitors preferentially interact with the N-terminal portion of the fragment (residues 13-20). Analysis of the free energy landscape of A beta(12-28) reveals differences highlighted by altered populations of a looplike conformer in the presence of inhibitors. We conclude that intrinsic disorder of AB persists at the level of binding small molecules and that inhibitors can significantly alter properties of monomeric AB via multiple routes of differing specificity.	[Convertino, Marino; Vitalis, Andreas; Caflisch, Amedeo] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Vitalis, A (corresponding author), Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland.	a.vitalis@bioc.uzh.ch; caflisch@bioc.uzh.ch	Caflisch, Amedeo/I-3459-2012		Swiss National Science Foundation; UZH Forschungskredit	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UZH Forschungskredit	This work was supported by a grant of the Swiss National Science Foundation (to A. C.) and a grant of the UZH Forschungskredit (to A. V.).	Armstrong AH, 2011, BIOCHEMISTRY-US, V50, P4058, DOI 10.1021/bi200268w; Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Bastianetto S, 2008, MINI-REV MED CHEM, V8, P429, DOI 10.2174/138955708784223512; Baumketner A, 2008, P NATL ACAD SCI USA, V105, P6027, DOI 10.1073/pnas.0708193105; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009; Carter P, 2003, NUCLEIC ACIDS RES, V31, P3293, DOI 10.1093/nar/gkg626; Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046; Chebaro Y, 2009, PROTEINS, V75, P442, DOI 10.1002/prot.22254; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cohen T, 2006, BIOCHEMISTRY-US, V45, P4727, DOI 10.1021/bi051525c; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Convertino M, 2009, PROTEIN SCI, V18, P792, DOI 10.1002/pro.87; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Evers F, 2009, J AM CHEM SOC, V131, P9516, DOI 10.1021/ja8097417; Fawzi NL, 2007, J MOL BIOL, V365, P535, DOI 10.1016/j.jmb.2006.10.011; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130; FIELDS GB, 1992, J PHYS CHEM-US, V96, P3974, DOI 10.1021/j100189a013; Frydman-Marom A, 2009, ANGEW CHEM INT EDIT, V48, P1981, DOI 10.1002/anie.200802123; Frydman-Marorn A., 2011, ACS CHEM BI IN PRESS; Gervais F, 2007, NEUROBIOL AGING, V28, P537, DOI 10.1016/j.neurobiolaging.2006.02.015; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Hawkes CA, 2009, DRUG DEVELOP RES, V70, P111, DOI 10.1002/ddr.20290; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hillmer AS, 2010, BIOCHEM BIOPH RES CO, V391, P461, DOI 10.1016/j.bbrc.2009.11.080; Hong DP, 2008, J MOL BIOL, V383, P214, DOI 10.1016/j.jmb.2008.08.039; Jiang P, 2011, BIOPHYS J, V100, P1550, DOI 10.1016/j.bpj.2011.02.010; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanapathipillai M, 2005, FEBS LETT, V579, P4775, DOI 10.1016/j.febslet.2005.07.057; Kim J, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-20; Kim S, 2011, BIOPHYS J, V100, P2024, DOI 10.1016/j.bpj.2011.02.044; Kim S, 2010, BIOPHYS J, V99, P1949, DOI 10.1016/j.bpj.2010.07.008; Kokkoni N, 2006, BIOCHEMISTRY-US, V45, P9906, DOI 10.1021/bi060837s; Krivov SV, 2006, J PHYS CHEM B, V110, P12689, DOI 10.1021/jp060039b; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Latawiec D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009234; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Mishra R, 2008, ANGEW CHEM INT EDIT, V47, P4679, DOI 10.1002/anie.200705372; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Pandey N, 2008, ACTA NEUROPATHOL, V115, P479, DOI 10.1007/s00401-007-0332-4; Pappu RV, 2008, ARCH BIOCHEM BIOPHYS, V469, P132, DOI 10.1016/j.abb.2007.08.033; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pellarin R, 2006, J MOL BIOL, V360, P882, DOI 10.1016/j.jmb.2006.05.033; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Re F, 2010, CURR MED CHEM, V17, P2990, DOI 10.2174/092986710791959729; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Schafer L, 1999, EXCLUDED VOLUME EFFE; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Schutz AK, 2011, ANGEW CHEM INT EDIT, V50, P5956, DOI 10.1002/anie.201008276; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Stempler S, 2011, J COMPUT AID MOL DES, V25, P135, DOI 10.1007/s10822-010-9405-x; Straub JE, 2002, ACCOUNTS CHEM RES, V35, P473, DOI 10.1021/ar010031e; Szegedi V, 2006, FASEB J, V20, P1191, DOI 10.1096/fj.05-4891fje; Takeda T, 2010, J PHYS CHEM B, V114, P15394, DOI 10.1021/jp107955v; Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205; Tarus B, 2005, J MOL BIOL, V345, P1141, DOI 10.1016/j.jmb.2004.11.022; Tarus B, 2008, J MOL BIOL, V379, P815, DOI 10.1016/j.jmb.2008.04.028; TERRY RD, 1994, PROG BRAIN RES, V101, P383; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tran HT, 2006, BIOPHYS J, V91, P1868, DOI 10.1529/biophysj.106.086264; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vitalis A, 2007, BIOPHYS J, V93, P1923, DOI 10.1529/biophysj.107.110080; Vitalis A, 2010, J MOL BIOL, V403, P148, DOI 10.1016/j.jmb.2010.08.003; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu C, 2011, CURR OPIN STRUC BIOL, V21, P209, DOI 10.1016/j.sbi.2011.02.002; Wurth C, 2002, J MOL BIOL, V319, P1279, DOI 10.1016/S0022-2836(02)00399-6; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Zagrovic B, 2006, PROTEINS, V63, P210, DOI 10.1002/prot.20872; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288; Zhang SS, 1998, FOLD DES, V3, P413, DOI 10.1016/S1359-0278(98)00054-6; Zhou WB, 2009, J MOL BIOL, V388, P597, DOI 10.1016/j.jmb.2009.03.053	104	45	45	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41578	41588		10.1074/jbc.M111.285957	http://dx.doi.org/10.1074/jbc.M111.285957			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21969380	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000298057500043
J	Chow, YP; Wan, KL; Blake, DP; Tomley, F; Nathan, S				Chow, Yock-Ping; Wan, Kiew-Lian; Blake, Damer P.; Tomley, Fiona; Nathan, Sheila			Immunogenic Eimeria tenella Glycosylphosphatidylinositol-Anchored Surface Antigens (SAGs) Induce Inflammatory Responses in Avian Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; DEVELOPMENT IN-VITRO; PROTECTIVE IMMUNITY; TOXOPLASMA-GONDII; ANTIBODY-RESPONSE; LAMINA PROPRIA; CHICKENS; INFECTIONS; PROTEINS; COCCIDIOSIS	Background: At least 19 glycosylphosphatidylinositol (GPI)-anchored surface antigens (SAGs) are expressed specifically by second-generation merozoites of Eimeria tenella, but the ability of these proteins to stimulate immune responses in the chicken is unknown. Methodology/Principal Findings: Ten SAGs, belonging to two previously defined multigene families (A and B), were expressed as soluble recombinant (r) fusion proteins in E. coli. Chicken macrophages were treated with purified rSAGs and changes in macrophage nitrite production, and in mRNA expression profiles of inducible nitric oxide synthase (iNOS) and of a panel of cytokines were measured. Treatment with rSAGs 4, 5, and 12 induced high levels of macrophage nitric oxide production and IL-1 beta mRNA transcription that may contribute to the inflammatory response observed during E. tenella infection. Concomitantly, treatment with rSAGs 4, 5 and 12 suppressed the expression of IL-12 and IFN-gamma and elevated that of IL-10, suggesting that during infection these molecules may specifically impair the development of cellular mediated immunity. Conclusions/Significance: In summary, some E. tenella SAGs appear to differentially modulate chicken innate and humoral immune responses and those derived from multigene family A (especially rSAG 12) may be more strongly linked with E. tenella pathogenicity associated with the endogenous second generation stages.	[Chow, Yock-Ping; Wan, Kiew-Lian; Nathan, Sheila] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor DE, Malaysia; [Wan, Kiew-Lian; Nathan, Sheila] Malaysia Genome Inst, Kajang, Selangor DE, Malaysia; [Blake, Damer P.; Tomley, Fiona] Univ London, Royal Vet Coll, N Mymms, England	Universiti Kebangsaan Malaysia; University of London; University of London Royal Veterinary College	Chow, YP (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor DE, Malaysia.	sheila@ukm.my	Nathan, Sheila/C-1182-2011; Tomley, Fiona/GWM-9070-2022; Wan, Kiew-Lian/A-4632-2012	Nathan, Sheila/0000-0002-2132-2346; Tomley, Fiona/0000-0003-2188-8013; Blake, Damer/0000-0003-1077-2306; Wan, Kiew-Lian/0000-0003-4027-1211	Malaysia Genome Institute, Ministry of Science, Technology and Innovation Malaysia [07-05-16-MGI-GMB006]; Biotechnology and Biological Sciences Research Council [BBS/B/04196, BB/F002564/1] Funding Source: researchfish; BBSRC [BB/F002564/1] Funding Source: UKRI	Malaysia Genome Institute, Ministry of Science, Technology and Innovation Malaysia; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Genomics and Molecular Biology Initiatives Programme of the Malaysia Genome Institute, Ministry of Science, Technology and Innovation Malaysia (grant number 07-05-16-MGI-GMB006). The funder had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Allen PC, 1997, POULTRY SCI, V76, P810, DOI 10.1093/ps/76.6.810; Arondel J, 1999, INFECT IMMUN, V67, P6056, DOI 10.1128/IAI.67.11.6056-6066.1999; Brunet LR, 2001, INT IMMUNOPHARMACOL, V1, P1457, DOI 10.1016/S1567-5769(01)00090-X; Constantiniou CC, 2007, VET PARASITOL, V150, P306, DOI 10.1016/j.vetpar.2007.09.019; Constantinoiu CC, 2008, VET PARASITOL, V154, P193, DOI 10.1016/j.vetpar.2008.03.029; Dalloul RA, 2007, MOL IMMUNOL, V44, P558, DOI 10.1016/j.molimm.2006.02.004; Dalloul RA, 2006, EXPERT REV VACCINES, V5, P143, DOI 10.1586/14760584.5.1.143; Dimier IH, 1998, AVIAN DIS, V42, P239, DOI 10.2307/1592473; Espinoza EY, 2002, PARASITE IMMUNOL, V24, P511, DOI 10.1046/j.1365-3024.2002.00598.x; FERNANDO MA, 1983, PARASITOLOGY, V86, P391, DOI 10.1017/S0031182000050587; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P209, DOI 10.1016/j.vetimm.2006.07.007; Howe DK, 2005, INFECT IMMUN, V73, P1023, DOI 10.1128/IAI.73.2.1023-1033.2005; Jeurissen SHM, 1996, VET IMMUNOL IMMUNOP, V54, P231, DOI 10.1016/S0165-2427(96)05689-9; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laurent F, 2001, INFECT IMMUN, V69, P2527, DOI 10.1128/IAI.69.4.2527-2534.2001; Lillehoj HS, 1998, AVIAN DIS, V42, P307, DOI 10.2307/1592481; LILLEHOJ HS, 1987, INFECT IMMUN, V55, P1616, DOI 10.1128/IAI.55.7.1616-1621.1987; LILLEHOJ HS, 1987, AVIAN DIS, V31, P112, DOI 10.2307/1590782; Liu LH, 2009, VET PARASITOL, V164, P173, DOI 10.1016/j.vetpar.2009.05.016; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910; Mattner F, 1997, INFECT IMMUN, V65, P4378, DOI 10.1128/IAI.65.11.4378-4383.1997; Mattner J, 2004, J IMMUNOL, V172, P7574, DOI 10.4049/jimmunol.172.12.7574; MCDONALD V, 1988, PARASITE IMMUNOL, V10, P649, DOI 10.1111/j.1365-3024.1988.tb00251.x; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rath NC, 2003, VET IMMUNOL IMMUNOP, V96, P93, DOI 10.1016/S0165-2427(03)00143-0; Rothwell L, 2004, J IMMUNOL, V173, P2675, DOI 10.4049/jimmunol.173.4.2675; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Shirley MW, 1995, BIOTECHNOLOGY GUIDEL, VXII, P1; SMITH NC, 1993, VET PARASITOL, V51, P13, DOI 10.1016/0304-4017(93)90191-O; Stafford JL, 2002, CRIT REV MICROBIOL, V28, P187, DOI 10.1080/1040-840291046731; Tabares E, 2004, MOL BIOCHEM PARASIT, V135, P123, DOI 10.1016/j.molbiopara.2004.01.013; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; VERVELDE L, 1995, ADV EXP MED BIOL, V371, P953; Vervelde L, 1996, PARASITE IMMUNOL, V18, P247, DOI 10.1046/j.1365-3024.1996.d01-94.x; Wallach M, 2010, TRENDS PARASITOL, V26, P382, DOI 10.1016/j.pt.2010.04.004; Wan KL, 1999, INT J PARASITOL, V29, P1885, DOI 10.1016/S0020-7519(99)00160-5; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628	43	33	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25233	10.1371/journal.pone.0025233	http://dx.doi.org/10.1371/journal.pone.0025233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980402	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900036
J	Cheng, LH; Jin, CM; Lv, W; Ding, QP; Han, X				Cheng, Lihua; Jin, Chengmeng; Lv, Wen; Ding, Qiuping; Han, Xu			Developing a Highly Stable PLGA-mPEG Nanoparticle Loaded with Cisplatin for Chemotherapy of Ovarian Cancer	PLOS ONE			English	Article							SOLID LIPID NANOPARTICLES; TOXICITY; RELEASE; DRUGS; CIS-DICHLORODIAMMINEPLATINUM(II); FORMULATION; LIPOSOMES; CARCINOMA; CELLS	Background: Cisplatin is a potent anticancer drug, but its clinical application has been limited due to its undesirable physicochemical characteristics and severe side effects. Better drug formulations for cisplatin are highly desired. Methodology/Principal Findings: Herein, we have developed a nanoparticle formulation for cisplatin with high encapsulation efficiency and reduced toxicity by using cisplatin-crosslinked carboxymethyl cellulose (CMC) core nanoparticles made from poly(lactide-co-glycolide)-monomethoxy-poly(polyethylene glycol) copolymers (PLGA-mPEG). The nanoparticles have an average diameter of approximately 80 nm measured by transmission electron microscope (TEM). The encapsulation efficiency of cisplatin in the nanoparticles is up to 72%. Meanwhile, we have also observed a controlled release of cisplatin in a sustained manner and dose-dependent treatment efficacy of cisplatin-loaded nanoparticles against IGROV1-CP cells. Moreover, the median lethal dose (LD50) of the cisplatin-loaded nanoparticles was more than 100 mg/kg by intravenous administration, which was much higher than that of free cisplatin. Conclusion: This developed cisplatin-loaded nanoparticle is a promising formulation for the delivery of cisplatin, which will be an effective therapeutic regimen of ovarian cancer without severe side effects and cumulative toxicity.	[Cheng, Lihua; Jin, Chengmeng; Ding, Qiuping; Han, Xu] Zhejiang Univ, Zhejiang California Int NanoSyst Inst, Hangzhou, Zhejiang, Peoples R China; [Lv, Wen] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Cheng, LH (corresponding author), Zhejiang Univ, Zhejiang California Int NanoSyst Inst, Hangzhou, Zhejiang, Peoples R China.	chenglihua75@gmail.com			China International Science and Technology Cooperation Foundation [2007DFC30306]; Zhejiang Province Technology Project Foundation [2009C11122]	China International Science and Technology Cooperation Foundation; Zhejiang Province Technology Project Foundation	The authors acknowledge support from the China International Science and Technology Cooperation Foundation (2007DFC30306, http://www.cistc.gov.cn/), and the Zhejiang Province Technology Project Foundation (2009C11122, http://www.zjkjt.gov.cn/html/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avgoustakis K, 2002, J CONTROL RELEASE, V79, P123, DOI 10.1016/S0168-3659(01)00530-2; Boulikas T, 2004, ONCOL REP, V11, P559; Boulikas T, 2009, EXPERT OPIN INV DRUG, V18, P1197, DOI 10.1517/13543780903114168; Cuong NV, 2009, CURR DRUG METAB, V10, P842, DOI 10.2174/138920009790274586; Doijad RC, 2008, INDIAN J PHARM SCI, V70, P203, DOI 10.4103/0250-474X.41456; Elvira C, 1997, J MATER SCI-MATER M, V8, P743, DOI 10.1023/A:1018504410878; Bosch ME, 2008, J PHARMACEUT BIOMED, V47, P451, DOI 10.1016/j.jpba.2008.01.047; Fujiyama J, 2003, J CONTROL RELEASE, V89, P397, DOI 10.1016/S0168-3659(03)00131-7; Gryparis EC, 2007, EUR J PHARM BIOPHARM, V67, P1, DOI 10.1016/j.ejpb.2006.12.017; Hirai M, 2010, INT J PHARMACEUT, V391, P274, DOI 10.1016/j.ijpharm.2010.02.030; Iseri S, 2007, TOXICOLOGY, V230, P256, DOI 10.1016/j.tox.2006.11.073; Jakupec MA, 2003, REV PHYSIOL BIOCH P, V146, P1, DOI 10.1007/s10254-002-0001-x; Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9; LAMBERT HE, 1985, BRIT MED J, V290, P889, DOI 10.1136/bmj.290.6472.889; Marsh S, 2007, J CLIN ONCOL, V25, P4528, DOI 10.1200/JCO.2006.10.4752; Miyamoto Yohei, 2007, J Toxicol Sci, V32, P311, DOI 10.2131/jts.32.311; Moreno D, 2008, EUR J PHARM BIOPHARM, V68, P503, DOI 10.1016/j.ejpb.2007.08.006; Nishiyama N, 2001, J CONTROL RELEASE, V74, P83, DOI 10.1016/S0168-3659(01)00314-5; Nosko M. M., 2010, Experimental Oncology, V32, P40; Sahin K, 2010, NUTR CANCER, V62, P988, DOI 10.1080/01635581.2010.509838; Takei T, 2005, J NUCL MED, V46, P794; Tian J, 2008, PHARMAZIE, V63, P593, DOI 10.1691/ph.2008.8017; Verma Anita K., 2008, Current Drug Delivery, V5, P120, DOI 10.2174/156720108783954806; WILTSHAW E, 1976, CANCER TREAT REP, V60, P55; Xiao CJ, 2004, J PHARM SCI-US, V93, P1718, DOI 10.1002/jps.20086	25	43	45	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25433	10.1371/journal.pone.0025433	http://dx.doi.org/10.1371/journal.pone.0025433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966528	Green Published, Green Submitted, gold			2022-12-25	WOS:000295932100040
J	Dizayee, S; Kaestner, S; Kuck, F; Hein, P; Klein, C; Piekorz, RP; Meszaros, J; Matthes, J; Nurnberg, B; Herzig, S				Dizayee, Sara; Kaestner, Sonja; Kuck, Fabian; Hein, Peter; Klein, Christoph; Piekorz, Roland P.; Meszaros, Janos; Matthes, Jan; Nuernberg, Bernd; Herzig, Stefan			G alpha(i2)- and G alpha(i3)-Specific Regulation of Voltage-Dependent L-Type Calcium Channels in Cardiomyocytes	PLOS ONE			English	Article							G-PROTEIN G(I3); HEART-FAILURE; CARDIAC MYOCYTES; CA2+ CHANNELS; VENTRICULAR MYOCYTES; BETA-SUBUNITS; GENE KNOCKOUT; CELL-DEATH; INHIBITION; RECEPTOR	Background: Two pertussis toxin sensitive G(i) proteins, G(i2) and G(i3), are expressed in cardiomyocytes and upregulated in heart failure. It has been proposed that the highly homologous G(i) isoforms are functionally distinct. To test for isoform-specific functions of G(i) proteins, we examined their role in the regulation of cardiac L-type voltage-dependent calcium channels (L-VDCC). Methods: Ventricular tissues and isolated myocytes were obtained from mice with targeted deletion of either G alpha(i2) (G alpha(-/-)(i2)) or G alpha(i3) (G alpha(-/-)(i3)). mRNA levels of G alpha(i/o) isoforms and L-VDCC subunits were quantified by real-time PCR. G alpha(i) and Ca-v alpha(1) protein levels as well as protein kinase B/Akt and extracellular signal-regulated kinases 1/2 (ERK1/2) phosphorylation levels were assessed by immunoblot analysis. L-VDCC function was assessed by whole-cell and single-channel current recordings. Results: In cardiac tissue from G alpha(-/-)(i2) mice, G alpha(i3) mRNA and protein expression was upregulated to 187 +/- 21% and 567 +/- 59%, respectively. In G alpha(-/-)(i3) mouse hearts, G alpha(i2) mRNA (127 +/- 5%) and protein (131 +/- 10%) levels were slightly enhanced. Interestingly, L-VDCC current density in cardiomyocytes from G alpha(-/-)(i2) mice was lowered (-7.9 +/- 0.6 pA/pF, n = 11, p<0.05) compared to wild-type cells (-10.7 +/- 0.5 pA/pF, n = 22), whereas it was increased in myocytes from G alpha(-/-)(i3) mice (-14.3 +/- 0.8 pA/pF, n = 14, p<0.05). Steady-state inactivation was shifted to negative potentials, and recovery kinetics slowed in the absence of G alpha(i2) (but not of G alpha(i3)) and following treatment with pertussis toxin in G alpha(-/-)(i3). The pore forming Ca-v alpha(1) protein level was unchanged in all mouse models analyzed, similar to mRNA levels of Ca-v alpha(1) and Ca-v beta(2) subunits. Interestingly, at the cellular signalling level, phosphorylation assays revealed abolished carbachol-triggered activation of ERK1/2 in mice lacking G alpha(i2). Conclusion: Our data provide novel evidence for an isoform-specific modulation of L-VDCC by G alpha(i) proteins. In particular, loss of G alpha(i2) is reflected by alterations in channel kinetics and likely involves an impairment of the ERK1/2 signalling pathway.	[Dizayee, Sara; Kaestner, Sonja; Hein, Peter; Klein, Christoph; Meszaros, Janos; Matthes, Jan; Herzig, Stefan] Univ Cologne, Dept Pharmacol, Cologne, Germany; [Kuck, Fabian; Piekorz, Roland P.; Nuernberg, Bernd] Univ Dusseldorf, Dept Biochem & Mol Biol 2, Univ Hosp & Clin, Dusseldorf, Germany; [Nuernberg, Bernd] Univ Tubingen, Dept Pharmacol & Toxicol, Interfac Ctr Pharmacogen & Pharmaceut Res, Tubingen, Germany	University of Cologne; Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen	Dizayee, S (corresponding author), Univ Cologne, Dept Pharmacol, Cologne, Germany.	stefan.herzig@uni-koeln.de	Hein, Peter/A-7477-2008; Matthes, Jan/AAF-1229-2020	Hein, Peter/0000-0002-5899-3979; Matthes, Jan/0000-0003-2754-1555; Nurnberg, Bernd/0000-0002-5995-6555; Herzig, Stefan/0000-0001-8107-5204	Deutsche Forschungsgemeinschaft (DFG) [He 1578/13-1, SFB 612]; Forschungskommission der Medizinischen Fakultat der HHU Dusseldorf	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Forschungskommission der Medizinischen Fakultat der HHU Dusseldorf	This study was supported by Deutsche Forschungsgemeinschaft (DFG), He 1578/13-1 and 2 to Dr. Herzig. Work in the lab of Dr. Piekorz and Dr. Nurnberg was supported by DFG (SFB 612) and the Forschungskommission der Medizinischen Fakultat der HHU Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DR, 1999, NEW ENGL J MED, V341, P1447, DOI 10.1056/NEJM199911043411907; Albarran-Juarez J, 2009, J PHARMACOL EXP THER, V331, P35, DOI 10.1124/jpet.109.157230; ASANO T, 1988, J NEUROCHEM, V51, P1711, DOI 10.1111/j.1471-4159.1988.tb01149.x; Beetz N, 2009, CARDIOVASC RES, V84, P396, DOI 10.1093/cvr/cvp251; BOHM M, 1992, HYPERTENSION, V20, P103, DOI 10.1161/01.HYP.20.1.103; Catalucci D, 2009, J CELL BIOL, V184, P923, DOI 10.1083/jcb.200805063; Chen FH, 2001, AM J PHYSIOL-HEART C, V280, pH1989, DOI 10.1152/ajpheart.2001.280.5.H1989; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Correll RN, 2007, J BIOL CHEM, V282, P28431, DOI 10.1074/jbc.M706176200; DeGeorge BR, 2008, CIRCULATION, V117, P1378, DOI 10.1161/CIRCULATIONAHA.107.752618; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; ESCHENHAGEN T, 1993, CELL BIOL INT, V17, P723, DOI 10.1006/cbir.1993.1135; Exner T, 1999, P NATL ACAD SCI USA, V96, P1327, DOI 10.1073/pnas.96.4.1327; FELDMAN AM, 1988, J CLIN INVEST, V82, P189, DOI 10.1172/JCI113569; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Foerster K, 2003, P NATL ACAD SCI USA, V100, P14475, DOI 10.1073/pnas.1936026100; Gohla A, 2007, AUTOPHAGY, V3, P393, DOI 10.4161/auto.4256; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; Gonzalez-Gutierrez G, 2008, P NATL ACAD SCI USA, V105, P14198, DOI 10.1073/pnas.0806558105; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Heubach JF, 1999, CARDIOVASC RES, V42, P173, DOI 10.1016/S0008-6363(98)00262-4; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Ikuno Y, 2000, INVEST OPHTH VIS SCI, V41, P3107; Jangsangthong W, 2009, PFLUGERS ARCH, V459, P399; Jiang MS, 2002, METHOD ENZYMOL, V344, P277; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Meszaros J, 1997, EXP PHYSIOL, V82, P71, DOI 10.1113/expphysiol.1997.sp004016; Mittmann C, 2003, J MOL CELL CARDIOL, V35, P1241, DOI 10.1016/S0022-2828(03)00235-9; Nagata K, 2000, CIRC RES, V87, P903, DOI 10.1161/01.RES.87.10.903; NEUMANN J, 1988, LANCET, V2, P936; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Ruan HM, 2007, CIRCULATION, V116, P596, DOI 10.1161/CIRCULATIONAHA.106.682773; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Schroder EA, 2006, ANN NY ACAD SCI, V1080, P63, DOI 10.1196/annals.1380.006; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; Smani T, 2010, CARDIOVASC RES, V87, P459, DOI 10.1093/cvr/cvq063; Tsuruta F, 2009, J CELL BIOL, V187, P279, DOI 10.1083/jcb.200903028; Volkers M, 2011, CIRC RES, V108, P27, DOI 10.1161/CIRCRESAHA.110.225201; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xiao RP, 1999, CIRC RES, V84, P43; XIAO RP, 1995, MOL PHARMACOL, V47, P322; Xu XH, 2009, PHYSIOLOGY, V24, P210, DOI 10.1152/physiol.00010.2009; Yada H, 2007, CIRC RES, V101, P69, DOI 10.1161/CIRCRESAHA.106.146399; Yang TT, 2010, J PHYSIOL-LONDON, V588, P1665, DOI 10.1113/jphysiol.2010.187203; ZUBERI Z, 2010, CIRC ARRHYT IN PRESS, DOI DOI 10.1161/CIRCEP.1109.894329	49	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e24979	10.1371/journal.pone.0024979	http://dx.doi.org/10.1371/journal.pone.0024979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966394	Green Submitted, Green Published, gold			2022-12-25	WOS:000295932100009
J	Roper, J; Richardson, MP; Wang, WV; Richard, LG; Chen, W; Coffee, EM; Sinnamon, MJ; Lee, L; Chen, PC; Bronson, RT; Martin, ES; Hung, KE				Roper, Jatin; Richardson, Michael P.; Wang, Wei Vivian; Richard, Larissa Georgeon; Chen, Wei; Coffee, Erin M.; Sinnamon, Mark J.; Lee, Lydia; Chen, Peng-Chieh; Bronson, Roderick T.; Martin, Eric S.; Hung, Kenneth E.			The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Induces Tumor Regression in a Genetically Engineered Mouse Model of PIK3CA Wild-Type Colorectal Cancer	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; RAPAMYCIN INHIBITOR; MAMMALIAN TARGET; MTORC1 PATHWAY; PI3K; GROWTH; CELLS; APOPTOSIS; PROLIFERATION; COMBINATION	Purpose: To examine the in vitro and in vivo efficacy of the dual PI3K/mTOR inhibitor NVP-BEZ235 in treatment of PIK3CA wild-type colorectal cancer (CRC). Experimental Design: PIK3CA mutant and wild-type human CRC cell lines were treated in vitro with NVP-BEZ235, and the resulting effects on proliferation, apoptosis, and signaling were assessed. Colonic tumors from a genetically engineered mouse (GEM) model for sporadic wild-type PIK3CA CRC were treated in vivo with NVP-BEZ235. The resulting effects on macroscopic tumor growth/regression, proliferation, apoptosis, angiogenesis, and signaling were examined. Results: In vitro treatment of CRC cell lines with NVP-BEZ235 resulted in transient PI3K blockade, sustained decreases in mTORC1/mTORC2 signaling, and a corresponding decrease in cell viability (median IC50 = 9.0-14.3 nM). Similar effects were seen in paired isogenic CRC cell lines that differed only in the presence or absence of an activating PIK3CA mutant allele. In vivo treatment of colonic tumor-bearing mice with NVP-BEZ235 resulted in transient PI3K inhibition and sustained blockade of mTORC1/mTORC2 signaling. Longitudinal tumor surveillance by optical colonoscopy demonstrated a 97% increase in tumor size in control mice (p = 0.01) vs. a 43% decrease (p = 0.008) in treated mice. Ex vivo analysis of the NVP-BEZ235-treated tumors demonstrated a 56% decrease in proliferation (p = 0.003), no effects on apoptosis, and a 75% reduction in angiogenesis (p = 0.013). Conclusions: These studies provide the preclinical rationale for studies examining the efficacy of the dual PI3K/mTOR inhibitor NVP-BEZ235 in treatment of PIK3CA wild-type CRC.	[Roper, Jatin; Richardson, Michael P.; Wang, Wei Vivian; Chen, Wei; Coffee, Erin M.; Sinnamon, Mark J.; Lee, Lydia; Hung, Kenneth E.] Tufts Med Ctr, Dept Med, Div Gastroenterol, Boston, MA USA; [Richard, Larissa Georgeon; Chen, Peng-Chieh] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Genet, Boston, MA 02115 USA; [Bronson, Roderick T.; Martin, Eric S.] Harvard Univ, Sch Med, Dana Farber Harvard Canc Ctr, Boston, MA USA	Tufts Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Roper, J (corresponding author), Tufts Med Ctr, Dept Med, Div Gastroenterol, Boston, MA USA.	khung@tuftsmedicalcenter.org		Roper, Jatin/0000-0002-8851-1352; Chen, Peng-Chieh ( Jessica )/0000-0002-2060-1765	National Cancer Institute [2U01CA084301]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5K08DK7803325, R03DK088014, T32-DK07542]; NATIONAL CANCER INSTITUTE [U01CA084301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK088014, P30DK043351, T32DK007542, K08DK078033] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Cancer Institute (2U01CA084301) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(5K08DK7803325, R03DK088014, and T32-DK07542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bhatt AP, 2010, BLOOD, V115, P4455, DOI 10.1182/blood-2009-10-251082; Bhende PM, 2010, LEUKEMIA, V24, P1781, DOI 10.1038/leu.2010.154; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Brunner-Kubath C, 2011, BREAST CANCER RES TR, V129, P387, DOI 10.1007/s10549-010-1232-1; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Cao P, 2009, BRIT J CANCER, V100, P1267, DOI 10.1038/sj.bjc.6604995; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang Q, 2009, CANCER BIOL THER, V8, P1893, DOI 10.4161/cbt.8.20.9430; Chapuis N, 2010, CLIN CANCER RES, V16, P5424, DOI 10.1158/1078-0432.CCR-10-1102; Chiarini F, 2010, CANCER RES, V70, P8097, DOI 10.1158/0008-5472.CAN-10-1814; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Fujishita T, 2009, CELL CYCLE, V8, P3684, DOI 10.4161/cc.8.22.9946; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Guo XN, 2007, CANCER RES, V67, P5851, DOI 10.1158/0008-5472.CAN-07-0049; Herrera VA, 2011, ANTICANCER RES, V31, P849; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Lang SA, 2007, INT J CANCER, V120, P1803, DOI 10.1002/ijc.22442; Lee M, 2011, MOL CANCER THER, V10, P1450, DOI 10.1158/1535-7163.MCT-11-0188; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu TJ, 2009, MOL CANCER THER, V8, P2204, DOI 10.1158/1535-7163.MCT-09-0160; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Mallon R, 2011, CLIN CANCER RES, V17, P3193, DOI 10.1158/1078-0432.CCR-10-1694; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366; Martin SK, 2010, J BONE MINER RES, V25, P2126, DOI 10.1002/jbmr.114; Martin-Fernandez C, 2009, MOL CANCER RES, V7, P955, DOI 10.1158/1541-7786.MCR-08-0445; MASUDA M, 2011, ONCOL REP; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Pollizzi K, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-38; Roccaro AM, 2010, BLOOD, V115, P559, DOI 10.1182/blood-2009-07-235747; Roulin D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-90; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Santiskulvong C, 2011, CLIN CANCER RES, V17, P2373, DOI 10.1158/1078-0432.CCR-10-2289; Schnell CR, 2008, CANCER RES, V68, P6598, DOI 10.1158/0008-5472.CAN-08-1044; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Sturgill TW, 2009, ACS CHEM BIOL, V4, P999, DOI 10.1021/cb900193e; Sunayama J, 2010, NEURO-ONCOLOGY, V12, P1205, DOI 10.1093/neuonc/noq103; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Tanaka H, 2011, CLIN CANCER RES, V17, P3272, DOI 10.1158/1078-0432.CCR-10-2882; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020899; XU CX, 2011, CANC BIOL THER, V12; Zitzmann K, 2010, CANCER LETT, V295, P100, DOI 10.1016/j.canlet.2010.02.018; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	69	107	117	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25132	10.1371/journal.pone.0025132	http://dx.doi.org/10.1371/journal.pone.0025132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966435	Green Published, Green Submitted, gold			2022-12-25	WOS:000295932100020
J	Stokes, A; Drozdov, I; Guerra, E; Ouzounis, CA; Warnakulasuriya, S; Gleeson, MJ; McGurk, M; Tavassoli, M; Odell, EW				Stokes, Angela; Drozdov, Ignat; Guerra, Eliete; Ouzounis, Christos A.; Warnakulasuriya, Saman; Gleeson, Michael J.; McGurk, Mark; Tavassoli, Mahvash; Odell, Edward W.			Copy Number and Loss of Heterozygosity Detected by SNP Array of Formalin-Fixed Tissues Using Whole-Genome Amplification	PLOS ONE			English	Article							DNA; CANCER; SAMPLES; WIDE	The requirement for large amounts of good quality DNA for whole-genome applications prohibits their use for small, laser capture micro-dissected (LCM), and/or rare clinical samples, which are also often formalin-fixed and paraffin-embedded (FFPE). Whole-genome amplification of DNA from these samples could, potentially, overcome these limitations. However, little is known about the artefacts introduced by amplification of FFPE-derived DNA with regard to genotyping, and subsequent copy number and loss of heterozygosity (LOH) analyses. Using a ligation adaptor amplification method, we present data from a total of 22 Affymetrix SNP 6.0 experiments, using matched paired amplified and non-amplified DNA from 10 LCM FFPE normal and dysplastic oral epithelial tissues, and an internal method control. An average of 76.5% of SNPs were called in both matched amplified and non-amplified DNA samples, and concordance was a promising 82.4%. Paired analysis for copy number, LOH, and both combined, showed that copy number changes were reduced in amplified DNA, but were 99.5% concordant when detected, amplifications were the changes most likely to be 'missed', only 30% of non-amplified LOH changes were identified in amplified pairs, and when copy number and LOH are combined similar to 50% of gene changes detected in the unamplified DNA were also detected in the amplified DNA and within these changes, 86.5% were concordant for both copy number and LOH status. However, there are also changes introduced as similar to 20% of changes in the amplified DNA are not detected in the non-amplified DNA. An integrative network biology approach revealed that changes in amplified DNA of dysplastic oral epithelium localize to topologically critical regions of the human protein-protein interaction network, suggesting their functional implication in the pathobiology of this disease. Taken together, our results support the use of amplification of FFPE-derived DNA, provided sufficient samples are used to increase power and compensate for increased error rates.	[Stokes, Angela; Guerra, Eliete; Tavassoli, Mahvash; Odell, Edward W.] Kings Coll London, Inst Dent, Dept Oral Pathol, London WC2R 2LS, England; [Drozdov, Ignat] Kings Coll London, British Heart Fdn Ctr Res Excellence, Div Cardiovasc, London WC2R 2LS, England; [Drozdov, Ignat; Ouzounis, Christos A.] Kings Coll London, Ctr Bioinformat, Dept Informat, Sch Nat & Math Sci, London WC2R 2LS, England; [Guerra, Eliete] Univ Brasilia, Fac Hlth Sci, Dept Dent, Brasilia, DF, Brazil; [Warnakulasuriya, Saman] Kings Coll London, Inst Dent, Dept Oral Med, London WC2R 2LS, England; [Gleeson, Michael J.] Guys Hosp, Dept Otolaryngol, London SE1 9RT, England; [McGurk, Mark] Kings Coll London, Inst Dent, Dept Oral & Maxillofacial Surg, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Universidade de Brasilia; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Stokes, A (corresponding author), Kings Coll London, Inst Dent, Dept Oral Pathol, London WC2R 2LS, England.	angela.stokes@kcl.ac.uk	odell, edward w/E-9920-2012; Ouzounis, Christos A/G-2302-2010; Guerra, Eliete Neves Silva/E-1021-2016; , WARNAKULASURIYA/ABB-3793-2020	odell, edward w/0000-0001-8435-0048; Ouzounis, Christos A/0000-0002-0086-8657; Guerra, Eliete Neves Silva/0000-0002-7622-1550; Drozdov, Ignat/0000-0001-6727-4688; Warnakulasuriya, Saman/0000-0003-2103-0746	Guy's and St Thomas' Charity; Department of Health via the National Institute for Health Research (NIHR); King's College London; CAPES, Brazil; Network of Excellence ENFIN [LSHG-CT-2005-518254]; European Commission; BHF Centre of Excellence, Cardiovascular Division, King's College London	Guy's and St Thomas' Charity; Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); King's College London; CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Network of Excellence ENFIN; European Commission(European CommissionEuropean Commission Joint Research Centre); BHF Centre of Excellence, Cardiovascular Division, King's College London	This work was supported by the Guy's and St Thomas' Charity (E.W.O.), the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London (to E.W.O. and A.S.), CAPES, Brazil (to E.G.) and in part by the Network of Excellence ENFIN (contract number LSHG-CT-2005-518254 to C.A.O.) funded by the European Commission. I.D. is supported by a pre-doctoral Fellowship from the BHF Centre of Excellence, Cardiovascular Division, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DL, 2004, GENOME RES, V14, P901, DOI 10.1101/gr.1949704; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Carvalho BS, 2010, BIOINFORMATICS, V26, P242, DOI 10.1093/bioinformatics/btp624; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Corneveaux JJ, 2007, BIOTECHNIQUES, V42, P77, DOI 10.2144/000112308; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dutt A, 2007, CURR OPIN ONCOL, V19, P43, DOI 10.1097/CCO.0b013e328011a8c1; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Huang J, 2009, J MOL DIAGN, V11, P109, DOI 10.2353/jmoldx.2009.080143; Hughes S, 2005, PROG BIOPHYS MOL BIO, V88, P173, DOI 10.1016/j.pbiomolbio.2004.01.007; Jacobs S, 2007, CANCER RES, V67, P2544, DOI 10.1158/0008-5472.CAN-06-3597; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Mead S, 2008, HUM MUTAT, V29, P1452, DOI 10.1002/humu.20782; Park JW, 2005, CLIN CHEM, V51, P1520, DOI 10.1373/clinchem.2004.047076; Pugh TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn378; Siwoski A, 2002, MODERN PATHOL, V15, P889, DOI 10.1097/01.MP.0000024288.63070.4F; Thompson ER, 2005, HUM MUTAT, V26, P384, DOI 10.1002/humu.20220; Tuefferd M, 2008, GENE CHROMOSOME CANC, V47, P957, DOI 10.1002/gcc.20599; Xing JC, 2008, GENOMICS, V92, P452, DOI 10.1016/j.ygeno.2008.08.007; AFFYMETRIX TECHNICAL	25	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e24503	10.1371/journal.pone.0024503	http://dx.doi.org/10.1371/journal.pone.0024503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966361	gold, Green Published, Green Submitted			2022-12-25	WOS:000295932100004
J	Bin Ali, A; Nin, DS; Tam, J; Khan, M				Bin Ali, Azhar; Nin, Dawn Sijin; Tam, John; Khan, Matiullah			Role of Chaperone Mediated Autophagy (CMA) in the Degradation of Misfolded N-CoR Protein in Non-Small Cell Lung Cancer (NSCLC) Cells	PLOS ONE			English	Article							NUCLEAR RECEPTOR COREPRESSOR; PML-RAR-ALPHA; TRANSCRIPTIONAL REPRESSION; ENDOPLASMIC-RETICULUM; TUMOR-SUPPRESSOR; C/EBP-ALPHA; MSIN3; ACTIVATION; APOPTOSIS; SPECTRUM	Nuclear receptor co-repressor (N-CoR) plays important role in transcriptional control mediated by several tumor suppressor proteins. Recently, we reported a role of misfolded-conformation dependent loss (MCDL) of N-CoR in the activation of oncogenic survival pathway in acute promyelocytic leukemia (APL). Since N-CoR plays important role in cellular homeostasis in various tissues, therefore, we hypothesized that an APL like MCDL of N-CoR might also be involved in other malignancy. Indeed, our initial screening of N-CoR status in various leukemia and solid tumor cells revealed an APL like MCDL of N-CoR in primary and secondary tumor cells derived from non-small cell lung cancer (NSCLC). The NSCLC cell specific N-CoR loss could be blocked by Kaletra, a clinical grade protease inhibitor and by genistein, an inhibitor of N-CoR misfolding previously characterized by us. The misfolded N-CoR presented in NSCLC cells was linked to the amplification of ER stress and was subjected to degradation by NSCLC cell specific aberrant protease activity. In NSCLC cells, misfolded N-CoR was found to be associated with Hsc70, a molecular chaperone involved in chaperone mediated autophagy (CMA). Genetic and chemical inhibition of Lamp2A, a rate limiting factor of CMA, significantly blocked the loss of N-CoR in NSCLC cells, suggesting a crucial role of CMA in N-CoR degradation. These findings identify an important role of CMA-induced degradation of misfolded N-CoR in the neutralization of ER stress and suggest a possible role of misfolded N-CoR protein in the activation of oncogenic survival pathway in NSCLC cells.	[Bin Ali, Azhar; Nin, Dawn Sijin; Khan, Matiullah] Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst, Singapore 117595, Singapore; [Nin, Dawn Sijin; Khan, Matiullah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Tam, John] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Tam, John] Natl Univ Singapore Hosp, Dept Cardiac, Singapore, Singapore; [Tam, John] Natl Univ Singapore Hosp, Dept Thorac, Singapore, Singapore; [Tam, John] Natl Univ Singapore Hosp, Dept Vasc Surg, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Bin Ali, A (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst, Singapore 117595, Singapore.	csimmk@nus.edu.sg	Tam, John/B-6048-2012; Ali, Azhar/J-3507-2019	Ali, Azhar/0000-0002-5895-9076	Singapore Stem Cell Consortium [SSCC-04-06]; National Medical Research Council of Singapore [NMRC/1213/2009]	Singapore Stem Cell Consortium; National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by grants SSCC-04-06 and NMRC/1213/2009 to MK from Singapore Stem Cell Consortium and National Medical Research Council of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Conde E, 2006, CLIN CANCER RES, V12, P710, DOI 10.1158/1078-0432.CCR-05-1362; CUERVO JAM, 1997, J BIOL CHEM, V272, P5606; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Furuya F, 2007, MOL CELL BIOL, V27, P6116, DOI 10.1128/MCB.00900-07; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Halmos B, 2004, CANCER RES, V64, P4137, DOI 10.1158/0008-5472.CAN-03-4052; Halmos B, 2002, CANCER RES, V62, P528; Hamano T, 2008, EUR J NEUROSCI, V27, P1119, DOI 10.1111/j.1460-9568.2008.06084.x; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Kaushik S., 2008, V445, P227, DOI 10.1007/978-1-59745-157-4_15; Khan MM, 2004, J BIOL CHEM, V279, P11814, DOI 10.1074/jbc.M312121200; Khan MM, 2001, J BIOL CHEM, V276, P43491, DOI 10.1074/jbc.C100532200; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Mallakin A, 2007, CANCER CELL, V12, P381, DOI 10.1016/j.ccr.2007.08.034; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Moran CA, 2006, ARCH PATHOL LAB MED, V130, P958; Ng APP, 2007, MOL CANCER THER, V6, P2240, DOI 10.1158/1535-7163.MCT-06-0705; Ng APP, 2006, CANCER RES, V66, P9903, DOI 10.1158/0008-5472.CAN-06-0002; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Schiller JH, 2001, ONCOLOGY-BASEL, V61, P3, DOI 10.1159/000055386; Sena-Esteves M, 1999, J VIROL, V73, P10426, DOI 10.1128/JVI.73.12.10426-10439.1999; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902	35	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25268	10.1371/journal.pone.0025268	http://dx.doi.org/10.1371/journal.pone.0025268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966475	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100036
J	Higashi, H; Barendregt, JJ				Higashi, Hideki; Barendregt, Jan J.			Cost-Effectiveness of Total Hip and Knee Replacements for the Australian Population with Osteoarthritis: Discrete-Event Simulation Model	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; OUTCOME MEASURES; NATIONAL-HEALTH; ARTHROPLASTY; MINIMUM; EPIDEMIOLOGY; PROGRESSION; PREVALENCE; SURGERY	Background: Osteoarthritis constitutes a major musculoskeletal burden for the aged Australians. Hip and knee replacement surgeries are effective interventions once all conservative therapies to manage the symptoms have been exhausted. This study aims to evaluate the cost-effectiveness of hip and knee replacements in Australia. To our best knowledge, the study is the first attempt to account for the dual nature of hip and knee osteoarthritis in modelling the severities of right and left joints separately. Methodology/Principal Findings: We developed a discrete-event simulation model that follows up the individuals with osteoarthritis over their lifetimes. The model defines separate attributes for right and left joints and accounts for several repeat replacements. The Australian population with osteoarthritis who were 40 years of age or older in 2003 were followed up until extinct. Intervention effects were modelled by means of disability-adjusted life-years (DALYs) averted. Both hip and knee replacements are highly cost effective (AUD 5,000 per DALY and AUD 12,000 per DALY respectively) under an AUD 50,000/DALY threshold level. The exclusion of cost offsets, and inclusion of future unrelated health care costs in extended years of life, did not change the findings that the interventions are cost-effective (AUD 17,000 per DALY and AUD 26,000 per DALY respectively). However, there was a substantial difference between hip and knee replacements where surgeries administered for hips were more cost-effective than for knees. Conclusions/Significance: Both hip and knee replacements are cost-effective interventions to improve the quality of life of people with osteoarthritis. It was also shown that the dual nature of hip and knee OA should be taken into account to provide more accurate estimation on the cost-effectiveness of hip and knee replacements.	[Higashi, Hideki; Barendregt, Jan J.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	University of Queensland	Higashi, H (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia.	h.higashi@uqconnect.edu.au	Higashi, Hideki/D-3797-2011; Barendregt, Jan J/F-6895-2010	Higashi, Hideki/0000-0002-5534-0905; 	Australian National Health and Medical Research Council [351558]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Financial support for this study was provided by a grant from the Australian National Health and Medical Research Council (Health Services Research grant no. 351558). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AUSTR BUR STAT, PERS NOT LAB FORC; *AUSTR BUR STAT, 2004, AV WEEKL EARN; *AUSTR GOV DEP HLT, 2005, NAT HOSP COST DAT CO; *AUSTR I HLTH WELF, 2005, AUSTR HOSP STAT 2003; *AUSTR I HTLH WELF, 2001, DIS COSTS IMP STUD 2; *AUSTR ORTH ASS NA, 2004, ANN REP; *AUSTR ORTH ASS NA, 2007, ANN REP; *AUSTR ORTH ASS NA, 2005, ANN REP S; Australian Bureau of Statistics, 2006, NAT HLTH SURV SUMM R; Australian Institute of Health and Welfare, 2005, HLTH EXP AUSTR 2003; Australian Institute of Health and Welfare, 2005, ARTHR MUSC COND AUST; Bachmeier CJM, 2001, OSTEOARTHR CARTILAGE, V9, P137, DOI 10.1053/joca.2000.0369; Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535; BAYLEY K, 1995, MEASURING SUCCESS TR; Begg S., 2007, BURDEN DIS INJURY AU; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bennett KJ, 1997, J RHEUMATOL, V24, P1796; Brand C., 2009, GUIDELINE NONSURGICA; Brazier JE, 1999, RHEUMATOLOGY, V38, P870, DOI 10.1093/rheumatology/38.9.870; BRIGGS A, 2003, MODELLING COST EFFEC; Callaghan JJ, 2004, J BONE JOINT SURG AM, V86A, P690, DOI 10.2106/00004623-200404000-00004; Callaghan JJ, 2000, J BONE JOINT SURG AM, V82A, P487, DOI 10.2106/00004623-200004000-00004; *CAN I HTLH INF, 2007, CAN JOINT REPL REG R; CAO X, 2006, BIRMINGHAM, P1123; Chang RW, 1996, JAMA-J AM MED ASSOC, V275, P858, DOI 10.1001/jama.275.11.858; COMAS M, 2008, APPL DISCRETE EVENT; DAVIS MA, 1990, SEMIN ARTHRITIS RHEU, V20, P34, DOI 10.1016/0049-0172(90)90045-H; Dawson J, 2004, RHEUMATOLOGY, V43, P497, DOI 10.1093/rheumatology/keh086; Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859; Dieppe P, 2000, OSTEOARTHR CARTILAGE, V8, P63, DOI 10.1053/joca.1999.0272; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; *EP INT PTY LTD, 2010, ERS 1 1; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; FELSON DT, 1990, SEMIN ARTHRITIS RHEU, V20, P42, DOI 10.1016/0049-0172(90)90046-I; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; GUCCIONE A, 1990, DEFINING ARTHRITIS M, P945; Gunal MM, 2010, J SIMUL, V4, P42, DOI 10.1057/jos.2009.25; Heck DA, 1998, CLIN ORTHOP RELAT R, P93, DOI 10.1097/00003086-199811000-00015; HOCHBERG MC, 1995, J RHEUMATOL, V22, P488; Hollocks BW, 2006, J OPER RES SOC, V57, P1383, DOI 10.1057/palgrave.jors.2602128; HOZACK WJ, 1997, CLIN ORTHOP RELAT R, V344, P88; Ingvarsson T, 1999, ANN RHEUM DIS, V58, P201, DOI 10.1136/ard.58.4.201; Jones CA, 2001, ARCH INTERN MED, V161, P454, DOI 10.1001/archinte.161.3.454; Jones CA, 2000, J RHEUMATOL, V27, P1745; Kiebzak G M, 1997, J South Orthop Assoc, V6, P169; Kiebzak GM, 2002, AM J MANAG CARE, V8, P463; Lacey RJ, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-82; Lavernia CJ, 1997, CLIN ORTHOP RELAT R, P134; LEDINGHAM J, 1995, ANN RHEUM DIS, V54, P53, DOI 10.1136/ard.54.1.53; Madey SM, 1997, J BONE JOINT SURG AM, V79A, P53, DOI 10.2106/00004623-199701000-00006; Mannoni A, 2003, ANN RHEUM DIS, V62, P576, DOI 10.1136/ard.62.6.576; March L, 2002, J RHEUMATOL, V29, P1006; Mortimer D, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-33; *NAT ARTHR MUSC CO, 2005, NAT ACT PLAN OST RHE; RAND JA, 1991, J BONE JOINT SURG AM, V73A, P397, DOI 10.2106/00004623-199173030-00011; Rand JA, 2003, J BONE JOINT SURG AM, V85A, P259, DOI 10.2106/00004623-200302000-00012; Rissanen P, 1997, INT J TECHNOL ASSESS, V13, P575, DOI 10.1017/S0266462300010059; *ROYAL AUSTR COLL, 2007, REF JOINT REPL MAN G; Schreurs BW, 2004, J BONE JOINT SURG BR, V86B, P492, DOI 10.1302/0301-620X.86B4.14769; SCHULTE KR, 1993, J BONE JOINT SURG AM, V75A, P961, DOI 10.2106/00004623-199307000-00002; SEGAL L, 2004, PRIORITY SETTING OST; Shields RK, 1999, ARCH PHYS MED REHAB, V80, P572, DOI 10.1016/S0003-9993(99)90202-2; Stouthard MEA, 1997, DISABILITY WEIGHTS D; Taylor SJE, 2006, J SIMUL, V1, P1, DOI 10.1057/palgrave.jos.4250002; Taylor SJE, 2009, J OPER RES SOC, V60, pS69, DOI 10.1057/jors.2008.196; TEPPER S, 1993, AM J EPIDEMIOL, V137, P1081, DOI 10.1093/oxfordjournals.aje.a116611; *UN, 2003, OP RAT EXCH; van Essen G J, 1998, J Qual Clin Pract, V18, P135; Veerman L., 2010, ASSESSING COST EFFEC; Viney RC, 2004, MED J AUSTRALIA, V181, P338, DOI 10.5694/j.1326-5377.2004.tb06305.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weinstein MC, 2006, PHARMACOECONOMICS, V24, P1043, DOI 10.2165/00019053-200624110-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zhang YQ, 2001, ARTHRITIS RHEUM, V44, P2065, DOI 10.1002/1529-0131(200109)44:9<2065::AID-ART356>3.0.CO;2-Z	74	61	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25403	10.1371/journal.pone.0025403	http://dx.doi.org/10.1371/journal.pone.0025403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966520	Green Submitted, Green Published, gold			2022-12-25	WOS:000295267100056
J	Yap, PT; Fan, Y; Chen, YS; Gilmore, JH; Lin, WL; Shen, DG				Yap, Pew-Thian; Fan, Yong; Chen, Yasheng; Gilmore, John H.; Lin, Weili; Shen, Dinggang			Development Trends of White Matter Connectivity in the First Years of Life	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; SMALL-WORLD; HUMAN BRAIN; SEXUAL-DIMORPHISM; NETWORKS; PATTERNS; TENSOR; GRAY; ANATOMY; FETAL	The human brain is organized into a collection of interacting networks with specialized functions to support various cognitive functions. Recent research has reached a consensus that the brain manifests small-world topology, which implicates both global and local efficiency at minimal wiring costs, and also modular organization, which indicates functional segregation and specialization. However, the important questions of how and when the small-world topology and modular organization come into existence remain largely unanswered. Taking a graph theoretic approach, we attempt to shed light on this matter by an in vivo study, using diffusion tensor imaging based fiber tractography, on 39 healthy pediatric subjects with longitudinal data collected at average ages of 2 weeks, 1 year, and 2 years. Our results indicate that the small-world architecture exists at birth with efficiency that increases in later stages of development. In addition, we found that the networks are broad scale in nature, signifying the existence of pivotal connection hubs and resilience of the brain network to random and targeted attacks. We also observed, with development, that the brain network seems to evolve progressively from a local, predominantly proximity based, connectivity pattern to a more distributed, predominantly functional based, connectivity pattern. These observations suggest that the brain in the early years of life has relatively efficient systems that may solve similar information processing problems, but in divergent ways.	[Yap, Pew-Thian; Fan, Yong; Chen, Yasheng; Lin, Weili; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27514 USA; [Yap, Pew-Thian; Fan, Yong; Chen, Yasheng; Lin, Weili; Shen, Dinggang] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA; [Gilmore, John H.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Yap, PT (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27514 USA.	dgshen@med.unc.edu	Yap, Pew-Thian/G-3292-2012; Gilmore, John H./AAE-1398-2019; Shen, Dinggang/ABF-6812-2020; Fan, Yong/O-4412-2014	Gilmore, John H./0000-0002-0939-6764; Shen, Dinggang/0000-0002-7934-5698; Fan, Yong/0000-0001-9869-4685	National Institutes of Health [EB009634, MH076970, HD05300, MH064065]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH076970, P50MH064065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health grants: EB009634, MH076970, HD05300 and MH064065. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chechik G, 1999, NEURAL COMPUT, V11, P2151; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friman O, 2006, IEEE T MED IMAGING, V25, P965, DOI 10.1109/TMI.2006.877093; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Gilmore JH, 2006, AM J PSYCHIAT, V163, P2046, DOI 10.1176/appi.ajp.163.12.2046; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Gur RC, 1999, J NEUROSCI, V19, P4065; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jbabdi S, 2007, NEUROIMAGE, V37, P116, DOI 10.1016/j.neuroimage.2007.04.039; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Kagen J, 2005, YOUNG MIND GROWING B; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Leemans A., 2009, P INT SOC MAG RESON, P3537, DOI DOI 10.1093/OCCMED/KQR069; LILEY DTJ, 1994, NETWORK-COMP NEURAL, V5, P175, DOI 10.1088/0954-898X/5/2/004; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; NICOLL A, 1993, NEURAL COMPUT, V5, P665, DOI 10.1162/neco.1993.5.5.665; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tuch DS, 1999, MAGN RESON MED, P321; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yap PT, 2010, IEEE T MED IMAGING, V29, P1192, DOI 10.1109/TMI.2010.2043680; Yap PT, 2009, LECT NOTES COMPUT SC, V5761, P721; Zalesky A, 2008, IEEE T MED IMAGING, V27, P1458, DOI 10.1109/TMI.2008.923644; Zhu HT, 2007, J AM STAT ASSOC, V102, P1085, DOI 10.1198/016214507000000581	57	143	145	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e24678	10.1371/journal.pone.0024678	http://dx.doi.org/10.1371/journal.pone.0024678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966364	Green Submitted, gold, Green Published			2022-12-25	WOS:000295267100006
J	Ahmed, MH; Spyrakis, F; Cozzini, P; Tripathi, PK; Mozzarelli, A; Scarsdale, JN; Safo, MA; Kellogg, GE				Ahmed, Mostafa H.; Spyrakis, Francesca; Cozzini, Pietro; Tripathi, Parijat K.; Mozzarelli, Andrea; Scarsdale, J. Neel; Safo, Martin A.; Kellogg, Glen E.			Bound Water at Protein-Protein Interfaces: Partners, Roles and Hydrophobic Bubbles as a Conserved Motif	PLOS ONE			English	Article							HYDROGEN-BOND NETWORK; FREE-ENERGY; MEDIATED INTERACTIONS; COMPUTATIONAL DESIGN; CORRELATED MUTATIONS; QUATERNARY STRUCTURE; LIGAND INTERACTIONS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; SCORING FUNCTIONS	Background: There is a great interest in understanding and exploiting protein-protein associations as new routes for treating human disease. However, these associations are difficult to structurally characterize or model although the number of X-ray structures for protein-protein complexes is expanding. One feature of these complexes that has received little attention is the role of water molecules in the interfacial region. Methodology: A data set of 4741 water molecules abstracted from 179 high-resolution (<= 2.30 angstrom) X-ray crystal structures of protein-protein complexes was analyzed with a suite of modeling tools based on the HINT forcefield and hydrogen-bonding geometry. A metric termed Relevance was used to classify the general roles of the water molecules. Results: The water molecules were found to be involved in: a) (bridging) interactions with both proteins (21%), b) favorable interactions with only one protein (53%), and c) no interactions with either protein (26%). This trend is shown to be independent of the crystallographic resolution. Interactions with residue backbones are consistent for all classes and account for 21.5% of all interactions. Interactions with polar residues are significantly more common for the first group and interactions with non-polar residues dominate the last group. Waters interacting with both proteins stabilize on average the proteins' interaction (-0.46 kcal mol(-1)), but the overall average contribution of a single water to the protein-protein interaction energy is unfavorable (+0.03 kcal mol(-1)). Analysis of the waters without favorable interactions with either protein suggests that this is a conserved phenomenon: 42% of these waters have SASA <= 10 angstrom(2) and are thus largely buried, and 69% of these are within predominantly hydrophobic environments or "hydrophobic bubbles''. Such water molecules may have an important biological purpose in mediating protein-protein interactions.	[Ahmed, Mostafa H.; Safo, Martin A.; Kellogg, Glen E.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Scarsdale, J. Neel; Kellogg, Glen E.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Ahmed, Mostafa H.; Scarsdale, J. Neel; Safo, Martin A.; Kellogg, Glen E.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA USA; [Spyrakis, Francesca; Cozzini, Pietro; Tripathi, Parijat K.] Univ Parma, Dept Gen & Inorgan Chem, I-43100 Parma, Italy; [Spyrakis, Francesca; Mozzarelli, Andrea] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Spyrakis, Francesca; Cozzini, Pietro; Mozzarelli, Andrea] Inst Biostruct & Biosyst, Rome, Italy	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Parma; University of Parma	Ahmed, MH (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA.	glen.kellogg@vcu.edu	Mozzarelli, Andrea/C-3615-2014; Safo, Martin/AAJ-9833-2020	Mozzarelli, Andrea/0000-0003-3762-0062; spyrakis, francesca/0000-0002-4016-227X; Kellogg, Glen/0000-0002-6282-6794	United States National Institutes of Health (NIH) [R01 GM071894]; Italian Ministry of University and Research; Fulbright Foreign Student Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071894] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Fulbright Foreign Student Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the United States National Institutes of Health (NIH, www.nih.gov) grant R01 GM071894 to G. E. K., from the Italian Ministry of University and Research to A. M., and the Fulbright Foreign Student Program to M. H. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadasi A, 2006, J MOL BIOL, V358, P289, DOI 10.1016/j.jmb.2006.01.053; Amadasi A, 2008, J MED CHEM, V51, P1063, DOI 10.1021/jm701023h; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bayden AS, 2009, J COMPUT AID MOL DES, V23, P621, DOI 10.1007/s10822-009-9270-7; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betzi S, 2009, COMB CHEM HIGH T SCR, V12, P968, DOI 10.2174/138620709789824736; Bidwell GL, 2009, EXPERT OPIN DRUG DEL, V6, P1033, DOI 10.1517/17425240903143745; Burnett JC, 2000, BIOCHEMISTRY-US, V39, P1622, DOI 10.1021/bi991724u; Burnett JC, 2001, PROTEINS, V42, P355, DOI 10.1002/1097-0134(20010215)42:3<355::AID-PROT60>3.0.CO;2-F; Castillo V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000476; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cho S, 2010, BIOCHEMISTRY-US, V49, P9256, DOI 10.1021/bi1008968; Cozzini P, 2004, CURR MED CHEM, V11, P3093, DOI 10.2174/0929867043363929; de Graaf C, 2005, J MED CHEM, V48, P2308, DOI 10.1021/jm049650u; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Dutta S, 2005, STRUCTURE, V13, P381, DOI 10.1016/j.str.2005.01.008; Englebienne P, 2009, J CHEM INF MODEL, V49, P1568, DOI 10.1021/ci8004308; Fornabaio M, 2004, J MED CHEM, V47, P4507, DOI 10.1021/jm030596b; Garcia-Sosa AT, 2003, J MOL MODEL, V9, P172, DOI 10.1007/s00894-003-0129-x; Garner AL, 2011, CURR TOP MED CHEM, V11, P258; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; GREGORET LM, 1993, P NATL ACAD SCI USA, V90, P4246, DOI 10.1073/pnas.90.9.4246; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; Hamelberg Donald, 2008, P95; Hardcastle IR, 2011, J MED CHEM, V54, P1233, DOI 10.1021/jm1011929; Hart PJ, 2002, NAT STRUCT BIOL, V9, P203, DOI 10.1038/nsb766; Huang R, 2010, NAT STRUCT MOL BIOL, V17, P646, DOI 10.1038/nsmb0610-646; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Jackson RM, 1998, J MOL BIOL, V276, P265, DOI 10.1006/jmbi.1997.1519; Jain AN, 2006, CURR PROTEIN PEPT SC, V7, P407, DOI 10.2174/138920306778559395; Jang DS, 2004, BIOCHEM J, V382, P967, DOI 10.1042/BJ20031871; Janin J, 1999, STRUCT FOLD DES, V7, pR277, DOI 10.1016/S0969-2126(00)88333-1; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jiang L, 2005, PROTEINS, V58, P893, DOI 10.1002/prot.20347; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Joachimiak LA, 2006, J MOL BIOL, V361, P195, DOI 10.1016/j.jmb.2006.05.022; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KARPLUS PA, 1994, CURR OPIN STRUC BIOL, V4, P770, DOI 10.1016/S0959-440X(94)90178-3; Kastritis PL, 2011, PROTEIN SCI, V20, P482, DOI 10.1002/pro.580; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kellogg G.E., 2005, INTERNET ELECT J MOL, V4, P194; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; Kellogg GE, 2004, CHEM BIODIVERS, V1, P98, DOI 10.1002/cbdv.200490016; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kier LB, 2002, J THEOR BIOL, V215, P415, DOI 10.1006/jtbi.2001.2525; Knight JDR, 2009, PROTEINS, V76, P527, DOI 10.1002/prot.22451; Langhorst U, 2000, BIOCHEMISTRY-US, V39, P6586, DOI 10.1021/bi992131m; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee BC, 2009, BIOINFORMATICS, V25, P2506, DOI 10.1093/bioinformatics/btp455; LEE C, 1991, NATURE, V352, P448, DOI 10.1038/352448a0; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; LEVITT M, 1983, J MOL BIOL, V168, P595, DOI 10.1016/S0022-2836(83)80304-0; LEVITT M, 1993, STRUCTURE, V1, P223, DOI 10.1016/0969-2126(93)90011-5; Li Z, 2007, PHYS CHEM CHEM PHYS, V9, P573, DOI 10.1039/b612449f; Lu YP, 2007, J CHEM INF MODEL, V47, P668, DOI 10.1021/ci6003527; Marabotti A, 2008, J COMPUT CHEM, V29, P1955, DOI 10.1002/jcc.20954; Matallanas D, 2010, CURR OPIN MOL THER, V12, P674; Meenan NAG, 2010, P NATL ACAD SCI USA, V107, P10080, DOI 10.1073/pnas.0910756107; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Mueller M, 2007, CURR OPIN STRUC BIOL, V17, P572, DOI 10.1016/j.sbi.2007.09.004; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Papageorgiou AC, 1997, EMBO J, V16, P5162, DOI 10.1093/emboj/16.17.5162; Papoian GA, 2003, J AM CHEM SOC, V125, P9170, DOI 10.1021/ja034729u; Qin S, 2007, PROTEINS, V69, P743, DOI 10.1002/prot.21752; Raymer ML, 1997, J MOL BIOL, V265, P445, DOI 10.1006/jmbi.1996.0746; Reichmann D, 2008, BIOCHEMISTRY-US, V47, P1051, DOI 10.1021/bi7019639; Rhee YM, 2004, P NATL ACAD SCI USA, V101, P6456, DOI 10.1073/pnas.0307898101; Ritchie DW, 2008, BIOINFORMATICS, V24, P1865, DOI 10.1093/bioinformatics/btn334; Rodier F, 2005, PROTEINS, V60, P36, DOI 10.1002/prot.20478; Safo MK, 2005, BIOCHEMISTRY-US, V44, P8347, DOI 10.1021/bi050412q; Samsonov S, 2008, PROTEINS, V73, P515, DOI 10.1002/prot.22076; Samsonov SA, 2011, J COMPUT AID MOL DES, V25, P477, DOI 10.1007/s10822-011-9433-1; Samsonov SA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-22; Sarkar A, 2010, CURR TOP MED CHEM, V10, P67, DOI 10.2174/156802610790232233; SILVA MM, 1992, J BIOL CHEM, V267, P17248; Spyrakis F, 2004, J AM CHEM SOC, V126, P11764, DOI 10.1021/ja0465754; Spyrakis F., 2010, BURGERS MED CHEM DRU, P601, DOI [10.1002/0471266949.bmc140, DOI 10.1002/0471266949.BMC140]; Spyrakis F, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-4; SUNDARALINGAM M, 1989, SCIENCE, V244, P1333, DOI 10.1126/science.2734612; Teyra J, 2007, PROTEINS, V67, P1087, DOI 10.1002/prot.21394; TOTROV M, 1994, NAT STRUCT BIOL, V1, P259, DOI 10.1038/nsb0494-259; Tripathi A, 2011, METHODS MOL BIOL, V716, P39, DOI 10.1007/978-1-61779-012-6_3; Tripathi A, 2010, PROTEINS, V78, P825, DOI 10.1002/prot.22608; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; Wang L, 2011, P NATL ACAD SCI USA, V108, P1326, DOI 10.1073/pnas.1016793108; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000531; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Wlodawer A, 2008, FEBS J, V275, P1, DOI 10.1111/j.1742-4658.2007.06178.x; Wolfe KJ, 2011, SEMIN CELL IN PRESS; Young T, 2010, US Patent, Patent No. [7,756,674, 7756674]; Zacharias M, 2010, PROTEIN PROTEIN COMP; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27; Zuo ZL, 2010, J CHEM INF MODEL, V50, P2201, DOI 10.1021/ci100321h	98	41	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24712	10.1371/journal.pone.0024712	http://dx.doi.org/10.1371/journal.pone.0024712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961043	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100016
J	Azzurro, E; Moschella, P; Maynou, F				Azzurro, Ernesto; Moschella, Paula; Maynou, Francesc			Tracking Signals of Change in Mediterranean Fish Diversity Based on Local Ecological Knowledge	PLOS ONE			English	Article							PISCES; GROUPER; RANGES; WATERS; SEA	One of the expected effects of global change is increased variability in the abundance and distribution of living organisms, but information at the appropriate temporal and geographical scales is often lacking to observe these patterns. Here we use local knowledge as an alternative information source to study some emerging changes in Mediterranean fish diversity. A pilot study of thirty-two fishermen was conducted in 2009 from four Mediterranean locations along a south-north gradient. Semi-quantitative survey information on changes in species abundance was recorded by year and suggests that 59 fish species belonging to 35 families have experienced changes in their abundance. We distinguished species that increased from species that decreased or fluctuated. Multivariate analysis revealed significant differences between these three groups of species, as well as significant variation between the study locations. A trend for thermophilic taxa to increase was recorded at all the study locations. The Carangidae and the Sphyraenidae families typically were found to increase over time, while Scombridae and Clupeidae were generally identified as decreasing and Fistularidae and Scaridae appeared to fluctuate in abundance. Our initial findings strongly suggest the northward expansion of termophilic species whose occurrence in the northern Mediterranean has only been noted previously by occasional records in the scientific literature.	[Azzurro, Ernesto; Maynou, Francesc] CSIC, ICM, Barcelona, Spain; [Azzurro, Ernesto] High Inst Environm Protect & Res ISPRA, Lab Milazzo, Milazzo, Italy; [Moschella, Paula] CIESM, Monaco, Monaco	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Italian Institute for Environmental Protection & Research (ISPRA)	Azzurro, E (corresponding author), CSIC, ICM, Barcelona, Spain.	eazzurr@tin.it	Maynou, Francesc/A-6433-2011	Maynou, Francesc/0000-0001-7200-6485; Azzurro, Ernesto/0000-0002-9805-3164	CIESM/Albert II Foundation; Euro-Mediterranean Center for Climatic Change; Italian Ministry for the Environment; Territory	CIESM/Albert II Foundation; Euro-Mediterranean Center for Climatic Change; Italian Ministry for the Environment; Territory	This study has been partially supported by the CIESM/Albert II Foundation (Project: Tropical signals) and by the Euro-Mediterranean Center for Climatic Change and the Italian Ministry for the Environment and the Territory (Project: The impacts of biological invasions and climate change on the biodiversity of the Mediterranean Sea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ASTRALDI M, 1995, OCEANOL ACTA, V18, P139; Azzurro E, 2004, CYBIUM, V28, P72; AZZURRO E, 2010, CHANGE, P99; Azzurro Ernesto, 2008, CIESM Workshop Monographs, V35, P39; BAIJ, 1994, J TIME SER ANAL, V15, P453; Banon Diaz R., 1997, Boletin del Instituto Espanol de Oceanografia, V13, P79; Banon R, 2002, J MAR BIOL ASSOC UK, V82, P877, DOI 10.1017/S0025315402006288; Bianchi C.N., 1997, P ITALIAN ASS OCEANO, V12, P3; Bianchi C. N., 1994, B MUS I BIOL U GEN, V58-59, P181; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Bradai MN, 2004, CYBIUM, V28, P315; Briand F., 2008, CIESM WORKSHOP MONOG, V35; Chapman PM, 2007, MAR POLLUT BULL, V54, P1839, DOI 10.1016/j.marpolbul.2007.10.033; Anadon JD, 2009, CONSERV BIOL, V23, P617, DOI 10.1111/j.1523-1739.2008.01145.x; Dulcic J, 1999, J PLANKTON RES, V21, P1171, DOI 10.1093/plankt/21.6.1171; DULCIC J, 1997, ANNALES, V11, P271; Dulcic Jakov, 2001, Annales Series Historia Naturalis, V23, P35; Dulcic Jakov, 2004, Annales Series Historia Naturalis, V14, P225; Dulvy NK, 2004, ANIM CONSERV, V7, P365, DOI 10.1017/S1367943004001519; Ferguson MAD, 1998, ARCTIC, V51, P201, DOI 10.14430/arctic1062; Fogerty J.E., 2005, HIST ECOLOGY HDB, P101; FRANCOUR P, 1994, MAR POLLUT BULL, V28, P523, DOI 10.1016/0025-326X(94)90071-X; Gerhardinger LC, 2009, NEOTROP ICHTHYOL, V7, P93, DOI 10.1590/S1679-62252009000100012; Golani D, 2000, J FISH BIOL, V56, P1545, DOI 10.1006/jfbi.2000.1263; Guidetti P, 2002, ARCH FISH MAR RES, V49, P259; Guidetti P, 2001, J MAR BIOL ASSOC UK, V81, P717, DOI 10.1017/S0025315401004507; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; HUNTLEY B, 1991, ANN BOT-LONDON, V67, P15, DOI 10.1093/oxfordjournals.aob.a088205; Karachle Paraskevi K., 2004, Acta Ichthyologica et Piscatoria, V34, P103; Lasram FB, 2010, GLOBAL CHANGE BIOL, V16, P3233, DOI 10.1111/j.1365-2486.2010.02224.x; Lasram FB, 2009, BIOL INVASIONS, V11, P697, DOI 10.1007/s10530-008-9284-4; Lavides MN, 2009, ENVIRON CONSERV, V36, P235, DOI 10.1017/S0376892909990385; Moller H, 2004, ECOL SOC, V9; MOREAU E, 1891, HIST NATURELLE POISS; NINNI E, 1924, B I ZOOL U ROMA, V24, P71; Olsson P, 2001, ECOSYSTEMS, V4, P85, DOI 10.1007/s100210000061; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Polunin Nicholas V. C., 2008, P353, DOI 10.1017/CBO9780511751790.031; PSOMADAKIS PN, 2010, ITAL J ZOOL, V1, P1; Quignard J.-P., 1986, P943; Quignard J.P., 2000, Biologia Marina Mediterranea, V7, P1; Rasalato E, 2010, ENVIRON CONSERV, V37, P90, DOI 10.1017/S0376892910000317; RIERA F, 1995, ACT C SCI MED VAR CL, P213; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saenz-Arroyo A, 2005, FISH FISH, V6, P121, DOI 10.1111/j.1467-2979.2005.00185.x; Sanchez-Tocino L., 2007, Zoologica Baetica, V18, P79; Soljan T., 1975, PESCI ADRIATICO A MO; Swaby SE, 1996, J MAR BIOL ASSOC UK, V76, P543, DOI 10.1017/S0025315400030745; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; TORTONESE E., 1975, FAUNA ITALIA OSTEICH, VXI; Ulmer Eugen, 2005, GUIDE IDENTIFICATION, V2nd; VACCHI M, 1999, PORCUPINE MARINE NAT, V3, P13; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Zeileis A, 2003, COMPUT STAT DATA AN, V44, P109, DOI 10.1016/S0167-9473(03)00030-6	59	126	146	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24885	10.1371/journal.pone.0024885	http://dx.doi.org/10.1371/journal.pone.0024885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966376	Green Published, gold			2022-12-25	WOS:000295265100024
J	Matos-Cruz, V; Blasic, J; Nickle, B; Robinson, PR; Hattar, S; Halpern, ME				Matos-Cruz, Vanessa; Blasic, Joseph; Nickle, Benjamin; Robinson, Phyllis R.; Hattar, Samer; Halpern, Marnie E.			Unexpected Diversity and Photoperiod Dependence of the Zebrafish Melanopsin System	PLOS ONE			English	Article							GANGLION-CELL PHOTORECEPTORS; DEEP BRAIN; DIFFERENTIAL EXPRESSION; CIRCADIAN EXPRESSION; MAMMALIAN RETINA; VISUAL PIGMENTS; LIGHT RESPONSE; VA-OPSIN; PINEAL; GENES	Animals have evolved specialized photoreceptors in the retina and in extraocular tissues that allow them to measure light changes in their environment. In mammals, the retina is the only structure that detects light and relays this information to the brain. The classical photoreceptors, rods and cones, are responsible for vision through activation of rhodopsin and cone opsins. Melanopsin, another photopigment first discovered in Xenopus melanophores (Opn4x), is expressed in a small subset of retinal ganglion cells (RGCs) in the mammalian retina, where it mediates non-image forming functions such as circadian photoentrainment and sleep. While mammals have a single melanopsin gene (opn4), zebrafish show remarkable diversity with two opn4x-related and three opn4-related genes expressed in distinct patterns in multiple neuronal cell types of the developing retina, including bipolar interneurons. The intronless opn4.1 gene is transcribed in photoreceptors as well as in horizontal cells and produces functional photopigment. Four genes are also expressed in the zebrafish embryonic brain, but not in the photoreceptive pineal gland. We discovered that photoperiod length influences expression of two of the opn4-related genes in retinal layers involved in signaling light information to RGCs. Moreover, both genes are expressed in a robust diurnal rhythm but with different phases in relation to the light-dark cycle. The results suggest that melanopsin has an expanded role in modulating the retinal circuitry of fish.	[Matos-Cruz, Vanessa; Halpern, Marnie E.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA; [Matos-Cruz, Vanessa; Hattar, Samer; Halpern, Marnie E.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Blasic, Joseph; Nickle, Benjamin; Robinson, Phyllis R.] Univ Maryland, Dept Biol Sci, Baltimore, MD 21201 USA	Carnegie Institution for Science; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Matos-Cruz, V (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA.	shattar@jhu.edu; halpern@ciwemb.edu	Hattar, Samer/W-6927-2019		National Eye Institute of the National Institutes of Health [F31EY019843]; National Science Foundation; National Eye Institute [R01EY019053];  [IOS0721608]; NATIONAL EYE INSTITUTE [F31EY019843, R01EY019053] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Vanessa Matos-Cruz was supported by a National Research Service Award from the National Eye Institute of the National Institutes of Health (F31EY019843) and Phyllis R. Robinson by grants from the National Science Foundation and (IOS0721608) and National Eye Institute (R01EY019053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 2000, Methods Mol Biol, V132, P221; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Arendt D, 2003, INT J DEV BIOL, V47, P563; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Blackshaw S, 1997, J NEUROSCI, V17, P8083; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Cameron DA, 2002, VISUAL NEUROSCI, V19, P365, DOI 10.1017/S0952523802192121; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; Cheng N, 2009, NATURE, V460, P899, DOI 10.1038/nature08175; Chinen A, 2003, GENETICS, V163, P663; Doyle S, 2007, COLD SPRING HARB SYM, V72, P499, DOI 10.1101/sqb.2007.72.003; Drivenes O, 2003, J COMP NEUROL, V456, P84, DOI 10.1002/cne.10523; Easter SS, 1996, DEV BIOL, V180, P646; Easter SS, 1997, DEV PSYCHOBIOL, V31, P267, DOI 10.1002/(SICI)1098-2302(199712)31:4<267::AID-DEV4>3.0.CO;2-P; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Falcon J, 2003, J NEUROENDOCRINOL, V15, P378, DOI 10.1046/j.1365-2826.2003.00993.x; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Grone BP, 2007, J BIOL RHYTHM, V22, P558, DOI 10.1177/0748730407308285; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hawtin SR, 2005, MOL PHARMACOL, V68, P1172, DOI 10.1124/mol.105.013359; Hukriede N, 2001, GENOME RES, V11, P2127, DOI 10.1101/gr.210601; Jenkins A, 2003, CURR BIOL, V13, P1269, DOI 10.1016/S0960-9822(03)00509-8; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Kojima D, 2000, J NEUROSCI, V20, P2845; Kojima D, 2008, J NEUROCHEM, V104, P1364, DOI 10.1111/j.1471-4159.2007.05093.x; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; Mano H, 2007, PHOTOCHEM PHOTOBIOL, V83, P11, DOI 10.1562/2006-02-24-IR-813; MAX M, 1995, SCIENCE, V267, P1502, DOI 10.1126/science.7878470; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; NAWROCKI L, 1985, VISION RES, V25, P1569, DOI 10.1016/0042-6989(85)90127-0; Nayak SK, 2007, CELL MOL LIFE SCI, V64, P144, DOI 10.1007/s00018-006-5581-1; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Pujic Z, 2006, DEV BIOL, V293, P330, DOI 10.1016/j.ydbio.2005.12.056; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thisse B, 2004, ZFIN DIRECT DATA SUB; Tomonari S, 2007, GENE EXPR PATTERNS, V7, P746, DOI 10.1016/j.modgep.2007.06.001; Torii M, 2007, FEBS LETT, V581, P5327, DOI 10.1016/j.febslet.2007.10.019; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Vigh B, 2002, HISTOL HISTOPATHOL, V17, P555, DOI 10.14670/HH-17.555; Vuilleumier R, 2006, ENDOCRINOLOGY, V147, P2273, DOI 10.1210/en.2005-1565; Walker C, 1999, METHOD CELL BIOL, V60, P43; Weng K, 1997, J BIOL CHEM, V272, P33100, DOI 10.1074/jbc.272.52.33100; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105; Zhang JY, 2003, EUR J PHARMACOL, V472, P33, DOI 10.1016/S0014-2999(03)01855-7	63	57	59	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25111	10.1371/journal.pone.0025111	http://dx.doi.org/10.1371/journal.pone.0025111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966429	Green Submitted, gold, Green Published			2022-12-25	WOS:000295265100060
J	Novensa, L; Novella, S; Medina, P; Segarra, G; Castillo, N; Heras, M; Hermenegildo, C; Dantas, AP				Novensa, Laura; Novella, Susana; Medina, Pascual; Segarra, Gloria; Castillo, Nadia; Heras, Magda; Hermenegildo, Carlos; Dantas, Ana Paula			Aging Negatively Affects Estrogens-Mediated Effects on Nitric Oxide Bioavailability by Shifting ER alpha/ER beta Balance in Female Mice	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE ENTERPRISES; SPONTANEOUSLY HYPERTENSIVE-RATS; POSTMENOPAUSAL HORMONE-THERAPY; CPG-ISLAND METHYLATION; CORONARY-HEART-DISEASE; ENDOTHELIAL FUNCTION; MAJOR SHAREHOLDERS; PLUS PROGESTIN; RECEPTOR GENE; MOUSE AORTA	Aims: Aging is among the major causes for the lack of cardiovascular protection by estrogen (E2) during postmenopause. Our study aims to determine the mechanisms whereby aging changes E2 effects on nitric oxide (NO) production in a mouse model of accelerated senescence (SAM). Methods and Results: Although we found no differences on NO production in females SAM prone (SAMP, aged) compared to SAM resistant (SAMR, young), by either DAF-2 fluorescence or plasmatic nitrite/nitrate (NO2/NO3), in both cases, E2 treatment increased NO production in SAMR but had no effect in SAMP. Those results are in agreement with changes of eNOS protein and gene expression. E2 up-regulated eNOS expression in SAMR but not in SAMP. E2 is also known to increase NO by decreasing its catabolism by superoxide anion (O-2(-)). Interestingly, E2 treatment decreased O-2(-) production in young females, while increased O-2(-) in aged ones. Furthermore, we observed that aging changed expression ratio of estrogen receptors (ER beta/ER alpha) and levels of DNA methylation. Increased ratio ER beta/ER alpha in aged females is associated to a lack of estrogen modulation of NO production and with a reversal in its antioxidant effect to a pro-oxidant profile. Conclusions: Together, our data suggest that aging has detrimental effects on E2-mediated benefits on NO bioavailability, partially by affecting the ability of E2 to induce up regulation of eNOS and decrease of O-2(-). These modifications may be associated to aging-mediated modifications on global DNA methylation status, but not to a specific methylation at 5'flanking region of ER alpha gene.	[Novensa, Laura; Castillo, Nadia; Heras, Magda; Dantas, Ana Paula] Inst dInvestigac Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain; [Novensa, Laura; Castillo, Nadia; Heras, Magda; Dantas, Ana Paula] Hosp Clin Barcelona, Inst Clin Torax, Barcelona, Spain; [Novella, Susana; Medina, Pascual; Segarra, Gloria; Hermenegildo, Carlos] Univ Valencia, Dept Physiol, Valencia, Spain; [Novella, Susana] Hosp Clin Univ, Res Fdn, Valencia, Spain; [Novella, Susana; Medina, Pascual; Segarra, Gloria; Hermenegildo, Carlos] Hosp Clini Univ, Inst Investigacion Sanitaria INCLIVA, Valencia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Valencia; Hospital Clinic Universitari de Valencia	Novensa, L (corresponding author), Inst dInvestigac Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain.	adantas@clinic.ub.es	Medina, Pascual/A-5461-2008; Hermenegildo, Carlos/C-5995-2008; Dantas, Ana Paula V/I-4100-2015; Novella, Susana/A-7406-2017; Segarra, Gloria/L-2495-2017	Medina, Pascual/0000-0002-0916-3311; Dantas, Ana Paula V/0000-0001-8514-4094; Novella, Susana/0000-0001-8303-7252; Segarra, Gloria/0000-0003-3069-2717; Hermenegildo, Carlos/0000-0002-4015-2645	Ministerio de Ciencia e Innovacion; Instituto de Salud Carlos III [FIS PI1000518, FIS PI080176, Red HERACLES RD06/0009]; Conselleria de Sanidad [AP-131/10, AP-117/10, GE-021/10]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Conselleria de Sanidad	This work was supported by a Spanish Grant from Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III (grants FIS PI1000518, FIS PI080176 and Red HERACLES RD06/0009), and Conselleria de Sanidad (grants AP-131/10, AP-117/10, and GE-021/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhavnani BR, 2008, ENDOCRINOLOGY, V149, P4857, DOI 10.1210/en.2008-0304; Chen YF, 2005, AM J PHYSIOL-RENAL, V289, pF749, DOI 10.1152/ajprenal.00115.2005; Darblade B, 2002, CIRC RES, V90, P413, DOI 10.1161/hh0402.105096; Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003; Fortepiani LA, 2003, HYPERTENSION, V41, P640, DOI 10.1161/01.HYP.0000046924.94886.EF; Fujiwara H, 2002, ANAL BIOCHEM, V307, P386, DOI 10.1016/S0003-2697(02)00053-2; Grodstein F, 2006, J WOMENS HEALTH, V15, P35, DOI 10.1089/jwh.2006.15.35; Harman S Mitchell, 2006, Gend Med, V3, P254, DOI 10.1016/S1550-8579(06)80214-7; Harrison DG, 1997, CLIN CARDIOL, V20, P11; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Issa JP, 2000, CURR TOP MICROBIOL, V249, P101; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; LeBlanc AJ, 2009, AM J PHYSIOL-REG I, V297, pR1713, DOI 10.1152/ajpregu.00178.2009; Lekontseva ON, 2010, MENOPAUSE, V17, P516, DOI 10.1097/gme.0b013e3181c91f04; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Meyer MR, 2009, CARDIOVASC RES, V83, P605, DOI 10.1093/cvr/cvp187; Miller VM, 2008, PHARMACOL REV, V60, P210, DOI 10.1124/pr.107.08002; Miro AM, 2011, J STEROID BIOCHEM, V123, P133, DOI 10.1016/j.jsbmb.2010.12.004; Moien-Afshari F, 2003, MATURITAS, V45, P213, DOI 10.1016/S0378-5122(03)00149-X; Novella S, 2010, EXP GERONTOL, V45, P868, DOI 10.1016/j.exger.2010.07.007; Novensa L, 2010, HYPERTENSION, V56, P405, DOI 10.1161/HYPERTENSIONAHA.110.151969; Oakes CC, 2006, EPIGENETICS-US, V1, P146, DOI 10.4161/epi.1.3.3392; Onetti Y, 2010, HYPERTENSION, V56, P1172; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Prentice RL, 2009, AM J EPIDEMIOL, V170, P12, DOI 10.1093/aje/kwp115; Riazi S, 2006, KIDNEY INT, V69, P471, DOI 10.1038/sj.ki.5000140; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rubanyi GM, 1997, J CLIN INVEST, V99, P2429, DOI 10.1172/JCI119426; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Sherwood A, 2007, ARTERIOSCL THROM VAS, V27, P1782, DOI 10.1161/ATVBAHA.107.145383; Stirone C, 2005, MOL PHARMACOL, V68, P959, DOI 10.1124/mol.105.014662; Sumi D, 2003, P NATL ACAD SCI USA, V100, P14451, DOI 10.1073/pnas.2235590100; Virdis A, 2000, CIRCULATION, V101, P2258, DOI 10.1161/01.CIR.101.19.2258; Wynne FL, 2004, HYPERTENSION, V43, P405, DOI 10.1161/01.HYP.0000111833.82664.0c; Yuan M, 2005, REPROD FERT DEVELOP, V17, P507, DOI 10.1071/RD04099; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009	40	46	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25335	10.1371/journal.pone.0025335	http://dx.doi.org/10.1371/journal.pone.0025335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966501	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100090
J	Theodoratou, E; Zhang, JSF; Kolcic, I; Davis, AM; Bhopal, S; Nair, H; Chan, KY; Liu, L; Johnson, H; Rudan, I; Campbell, H				Theodoratou, Evropi; Zhang, Jian Shayne F.; Kolcic, Ivana; Davis, Andrew M.; Bhopal, Sunil; Nair, Harish; Chan, Kit Yee; Liu, Li; Johnson, Hope; Rudan, Igor; Campbell, Harry			Estimating Pneumonia Deaths of Post-Neonatal Children in Countries of Low or No Death Certification in 2008	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; CHILDHOOD PNEUMONIA; MORTALITY; VACCINES	Background: Pneumonia is the leading cause of child deaths globally. The aims of this study were to: a) estimate the number and global distribution of pneumonia deaths for children 1-59 months for 2008 for countries with low (<85%) or no coverage of death certification using single-cause regression models and b) compare these country estimates with recently published ones based on multi-cause regression models. Methods and Findings: For 35 low child-mortality countries with <85% coverage of death certification, a regression model based on vital registration data of low child-mortality and >85% coverage of death certification countries was used. For 87 high child-mortality countries pneumonia death estimates were obtained by applying a regression model developed from published and unpublished verbal autopsy data from high child-mortality settings. The total number of 1-59 months pneumonia deaths for the year 2008 for these 122 countries was estimated to be 1.18 M (95% CI 0.77 M-1.80 M), which represented 23.27% (95% CI 17.15%-32.75%) of all 1-59 month child deaths. The country level estimation correlation coefficient between these two methods was 0.40. Interpretation: Although the overall number of post-neonatal pneumonia deaths was similar irrespective to the method of estimation used, the country estimate correlation coefficient was low, and therefore country-specific estimates should be interpreted with caution. Pneumonia remains the leading cause of child deaths and is greatest in regions of poverty and high child-mortality. Despite the concerns about gender inequity linked with childhood mortality we could not estimate sex-specific pneumonia mortality rates due to the inadequate data. Life-saving interventions effective in preventing and treating pneumonia mortality exist but few children in high pneumonia disease burden regions are able to access them. To achieve the United Nations Millennium Development Goal 4 target to reduce child deaths by two-thirds in year 2015 will require the scale-up of access to these effective pneumonia interventions.	[Theodoratou, Evropi; Zhang, Jian Shayne F.; Davis, Andrew M.; Nair, Harish; Rudan, Igor; Campbell, Harry] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Kolcic, Ivana] Univ Zagreb, Sch Med, Sch Publ Hlth, Zagreb 41001, Croatia; [Bhopal, Sunil] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bhopal, Sunil] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Nair, Harish] Publ Hlth Fdn India, New Delhi, India; [Chan, Kit Yee] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [Chan, Kit Yee] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Liu, Li; Johnson, Hope] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia	University of Edinburgh; University of Zagreb; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Public Health Foundation of India; University of Melbourne; Peking University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Split	Theodoratou, E (corresponding author), Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	E.Theodoratou@ed.ac.uk	Kolcic, Ivana/E-2713-2017; Campbell, Harry/E-2959-2010; Theodoratou, Evropi/C-3430-2014; Rudan, Igor/I-1467-2012; Nair, Harish/E-7431-2010; liu, li/HGC-0900-2022	Kolcic, Ivana/0000-0001-7918-6052; Campbell, Harry/0000-0002-6169-6262; Theodoratou, Evropi/0000-0001-5887-9132; Rudan, Igor/0000-0001-6993-6884; Nair, Harish/0000-0002-9432-9100; Chan, Kit Yee/0000-0002-3465-8383; Bhopal, Sunil/0000-0003-1229-781X	Bill and Melinda Gates Foundation [50140, 51285]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the grant from the Bill and Melinda Gates Foundation No. 50140 ("Strengthening the evidence on maternal and child health'') and by the grant from the Bill and Melinda Gates Foundation No. 51285 ("Modelling the impact of emerging interventions against pneumonia''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GLOBAL ACTION PLAN P; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Johnson HL, 2010, INT J EPIDEMIOL, V39, P1103, DOI 10.1093/ije/dyq074; Lanata CF, 2004, INT J EPIDEMIOL, V33, P1362, DOI 10.1093/ije/dyh229; Madhi SA, 2008, B WORLD HEALTH ORGAN, V86, P365, DOI 10.2471/BLT.07.044503; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; UNICEF, 2006, STAT WORLDS CHILDR 2; *WHO UNICEF, 2011, WHO UNICEF EST HIB3; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	14	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25095	10.1371/journal.pone.0025095	http://dx.doi.org/10.1371/journal.pone.0025095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966425	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000295265100057
J	Hsu, CH; Peng, KL; Jhang, HC; Lin, CH; Wu, SY; Chiang, CM; Lee, SC; Yu, WCY; Juan, LJ				Hsu, C-H; Peng, K-L; Jhang, H-C; Lin, C-H; Wu, S-Y; Chiang, C-M; Lee, S-C; Yu, W. C. Y.; Juan, L-J			The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription	ONCOGENE			English	Article						HMT; chromatin; HPV; E6; p53	HUMAN-PAPILLOMAVIRUS TYPE-16; PROTEIN ARGININE METHYLATION; P53 ACTIVITY; NONHISTONE PROTEINS; LYSINE METHYLATION; HIGH-RISK; ACETYLATION; DEGRADATION; PRMT1; UBIQUITINATION	Expression of viral proteins causes important epigenetic changes leading to abnormal cell growth. Whether viral proteins directly target histone methyltransferases (HMTs), a key family enzyme for epigenetic regulation, and modulate their enzymatic activities remains elusive. Here we show that the E6 proteins of both low-risk and high-risk human papillomavirus (HPV) interact with three coactivator HMTs, CARM1, PRMT1 and SET7, and downregulate their enzymatic activities in vitro and in HPV-transformed HeLa cells. Furthermore, these three HMTs are required for E6 to attenuate p53 transactivation function. Mechanistically, E6 hampers CARM1- and PRMT1-catalyzed histone methylation at p53-responsive promoters, and suppresses the binding of p53 to chromatinized DNA independently of E6-mediated p53 degradation. p53 pre-methylated at lysine-372 (p53K372 monomethylation) by SET7 protects p53 from E6-induced degradation. Consistently, E6 downregulates p53K372 mono-methylation and thus reduces p53 protein stability. As a result of the E6-mediated inhibition of HMT activity, expression of p53 downstream genes is suppressed. Together, our results not only reveal a clever approach for the virus to interfere with p53 function, but also demonstrate the modulation of HMT activity as a novel mechanism of epigenetic regulation by a viral oncoprotein. Oncogene (2012) 31, 2335-2349; doi:10.1038/onc.2011.415; published online 3 October 2011	[Hsu, C-H; Peng, K-L; Jhang, H-C; Lin, C-H; Juan, L-J] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Peng, K-L; Juan, L-J] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Lin, C-H; Lee, S-C; Juan, L-J] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10764, Taiwan; [Lin, C-H] Natl Hlth Res Inst, Inst Canc Res, Zhunan Town, Miaoli County, Taiwan; [Wu, S-Y; Chiang, C-M] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Wu, S-Y; Chiang, C-M] Univ Texas SW Med Ctr Dallas, Dept Biochem, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Yu, W. C. Y.] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town, Miaoli County, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Health Research Institutes - Taiwan; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Health Research Institutes - Taiwan	Juan, LJ (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	ljjuan@gate.sinica.edu.tw	Juan, Li-Jung/H-6631-2015; Hsu, Chih-Hung/AEM-8298-2022; Yu, C.Y./E-3666-2010	Hsu, Chih-Hung/0000-0001-8071-0122; 	Academia Sinica; NRPGM/DOH; NHRI; National Institutes of Health [CA103867, CA124760]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER	Academia Sinica(Academia Sinica - Taiwan); NRPGM/DOH; NHRI(National Health Research Institutes - Taiwan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs WH Lee and Y Zhang for valuable suggestions; WH Lee for critical reading of the manuscript; MR Stallcup for providing pSG5HA, pSG5HA-CARM1, pSG5HA-CARM1 E267Q, pSG5HA-PRMT1 and pSG5HA-PRMT1 E153Q; D Reinberg for pcDNA3.1-SET7 and SET7H297A; G Trave for p513-16E66C/6S F47R; SY Shieh for p21-Luc and pcDNA3.1-p53; and CW Wu for partial funding support. We also thank the GRC Peptide Synthesis Core for providing the p53 peptide. This research was primarily supported by grants from Academia Sinica and NRPGM/DOH to L-JJ, and partly from NHRI to L-JJ, as well as Grants CA103867 and CA124760 from the National Institutes of Health to C-MC.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Boisvert FM, 2005, CELL CYCLE, V4, P1834, DOI 10.4161/cc.4.12.2250; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen YC, 2004, CANCER-AM CANCER SOC, V101, P1428, DOI 10.1002/cncr.20538; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Ganguly N, 2009, J BIOSCIENCES, V34, P113, DOI 10.1007/s12038-009-0013-7; Ghosh MK, 2003, MOL CELL, V12, P255, DOI 10.1016/S1097-2765(03)00225-9; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; Howley Peter M, 2006, Trans Am Clin Climatol Assoc, V117, P113; Howley PM, 2009, VIROLOGY, V384, P256, DOI 10.1016/j.virol.2008.12.006; Howley PM., 2006, T AM CLIN CLIMAT ASS, V117, P126; Hsu CH, 2004, EMBO J, V23, P2269, DOI 10.1038/sj.emboj.7600239; Hu D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.064; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Lee DY, 2007, MOL ENDOCRINOL, V21, P1381, DOI 10.1210/me.2006-0389; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Massimi P, 2008, ONCOGENE, V27, P1800, DOI 10.1038/sj.onc.1210810; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; Miremadi A, 2007, HUM MOL GENET, V16, pR28, DOI 10.1093/hmg/ddm021; Mujtaba S, 2008, NAT CELL BIOL, V10, P1114, DOI 10.1038/ncb1772; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; Pim D, 2010, APMIS, V118, P471, DOI 10.1111/j.1600-0463.2010.02618.x; Pradhan S, 2009, EPIGENETICS, V4, P282; Reeves M, 2006, J VIROL, V80, P9998, DOI 10.1128/JVI.01297-06; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Shukla A, 2009, CELL MOL LIFE SCI, V66, P1419, DOI 10.1007/s00018-008-8605-1; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang YH, 2003, J BIOL CHEM, V278, P25568, DOI 10.1074/jbc.M212574200; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zimmermann H, 1999, J VIROL, V73, P6209, DOI 10.1128/JVI.73.8.6209-6219.1999	63	57	59	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	18					2335	2349		10.1038/onc.2011.415	http://dx.doi.org/10.1038/onc.2011.415			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	936SR	21963854	Green Published, hybrid			2022-12-25	WOS:000303610800008
J	Ogawa, M; Yamaji, R; Higashimura, Y; Harada, N; Ashida, H; Nakano, Y; Inui, H				Ogawa, Masahiro; Yamaji, Ryoichi; Higashimura, Yasuki; Harada, Naoki; Ashida, Hitoshi; Nakano, Yoshihisa; Inui, Hiroshi			17 beta-Estradiol Represses Myogenic Differentiation by Increasing Ubiquitin-specific Peptidase 19 through Estrogen Receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE ATROPHY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BREAST-CANCER; ER-BETA; ANDROGEN RECEPTOR; GENE-EXPRESSION; CELLS; PROTEASOME; SYSTEM; RATS	Skeletal muscles express estrogen receptor (ER) alpha and ER beta. However, the roles of estrogens acting through the ERs in skeletal muscles remain unclear. The effects of 17 beta-estradiol (E2) on myogenesis were studied in C2C12 myoblasts. E2 and an ER alpha-selective agonist propylpyrazole-triol depressed myosin heavy chain (MHC), tropomyosin, and rnyogenin levels and repressed the fusion of myoblasts into myotubes. ER antagonist ICI 182,780 cancelled E2-repressed myogenesis. E2 induced ubiquitin-specific peptidase 19 (USP19) expression during myogenesis. E2 replacement increased USP19 expression in the gastrocnemius and soleus muscles of ovariectomized mice. Knockdown of USP19 inhibited E2-repressed myogenesis. Mutant forms of USP19 lacking deubiquitinating activity increased MHC and tropomyosin levels. E2 decreased ubiquitinated proteins during rnyogenesis, and the E2-decreased ubiquitinated proteins were increased by knockdown of USP19. Propylpyrazole-triol increased USP19 expression, and ICI 182,780 inhibited E2-increased USP19 expression. Overexpression of ER alpha or knockdown of ER beta enhanced the effects of E2 on the levels of USP19, MHC, and tropomyosin, whereas knockdown of ER alpha, overexpression of ER beta, or an ER beta-selective agonist diarylpropionitrile abolished their effects. A mutant form of ER alpha that is constitutively localized in the nucleus increased USP19 expression and decreased MHC and tropomyosin expression in the presence of E2. Furthermore, in skeletal muscle satellite cells, E2 inhibited myogenesis and increased USP19 expression, and diarylpropionitrile repressed E2-increased USP19 expression. These results demonstrate that (i) E2 induces USP19 expression through nuclear ER alpha, (ii) increased USP19-mediated deubiquitiunating activity represses myogenesis, and (iii) ER beta inhibits ER alpha-activated USP19 expression.	[Ogawa, Masahiro; Yamaji, Ryoichi; Higashimura, Yasuki; Harada, Naoki; Inui, Hiroshi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan; [Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan; [Nakano, Yoshihisa] Osaka Womens Jr Coll, Osaka 5838558, Japan	Osaka Metropolitan University; Kobe University	Yamaji, R (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan.	yamaji@biochem.osakafu-u.ac.jp	Harada, Naoki/AAP-2868-2020	Harada, Naoki/0000-0003-3846-388X; Ogawa, Masahiro/0000-0002-8347-5268	Japan Society for the Promotion of Science [23580182]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid 23580182 for scientific research (to R. Y.) from the Japan Society for the Promotion of Science.	Allen RE, 1997, METHOD CELL BIOL, V52, P155, DOI 10.1016/S0091-679X(08)60378-7; Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Charbonnier F, 2002, J BIOL CHEM, V277, P1139, DOI 10.1074/jbc.M107018200; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Combaret L, 2005, AM J PHYSIOL-ENDOC M, V288, pE693, DOI 10.1152/ajpendo.00281.2004; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Harada N, 2008, BIOCHEM BIOPH RES CO, V373, P373, DOI 10.1016/j.bbrc.2008.06.024; Harada N, 2007, J BIOL CHEM, V282, P22651, DOI 10.1074/jbc.M610724200; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayashi SI, 2003, ENDOCR-RELAT CANCER, V10, P193, DOI 10.1677/erc.0.0100193; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; IHEMELANDU EC, 1981, ACTA ANAT, V110, P311; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; McClung JM, 2006, J APPL PHYSIOL, V100, P2012, DOI 10.1152/japplphysiol.01583.2005; McCormick KM, 2004, J MUSCLE RES CELL M, V25, P21, DOI 10.1023/B:JURE.0000021398.78327.39; MEDINA R, 1991, BIOMED BIOCHIM ACTA, V50, P347; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Nakopoulou L, 2004, J CLIN PATHOL, V57, P523, DOI 10.1136/jcp.2003.008599; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Park KC, 2002, P NATL ACAD SCI USA, V99, P9733, DOI 10.1073/pnas.152011799; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Picotto G, 1996, MOL CELL ENDOCRINOL, V119, P129, DOI 10.1016/0303-7207(96)03799-9; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Sundaram P, 2009, AM J PHYSIOL-ENDOC M, V297, pE1283, DOI 10.1152/ajpendo.00409.2009; Tsai WJA, 2007, EXP BIOL MED, V232, P1314, DOI 10.3181/0704-RM-92; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Wiik A, 2009, HISTOCHEM CELL BIOL, V131, P181, DOI 10.1007/s00418-008-0512-x; Yamaji R, 2003, BBA-MOL CELL RES, V1593, P269, DOI 10.1016/S0167-4889(02)00397-X; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013	37	45	49	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41455	41465		10.1074/jbc.M111.276824	http://dx.doi.org/10.1074/jbc.M111.276824			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21971047	Green Published, hybrid			2022-12-25	WOS:000298057500032
J	Chen, B; Dores, MR; Grinnsey, N; Canto, I; Barker, BL; Trejo, J				Chen, Buxin; Dores, Michael R.; Grinnsey, Neil; Canto, Isabel; Barker, Breann L.; Trejo, JoAnn			Adaptor Protein Complex-2 (AP-2) and Epsin-1 Mediate Protease-activated Receptor-1 Internalization via Phosphorylation- and Ubiquitination-dependent Sorting Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 NEF; RNA INTERFERENCE; THROMBIN RECEPTORS; BETA-ARRESTINS; LIQUID FACETS; CLATHRIN; ENDOCYTOSIS; BINDING; TRAFFICKING; TERMINATION	Signaling by protease-activated receptor-1 (PAR1), a G protein-coupled receptor (GPCR) for thrombin, is regulated by desensitization and internalization. PAR1 desensitization is mediated by beta-arrestins, like most classic GPCRs. In contrast, internalization of PAR1 occurs through a clathrin- and dynamin-dependent pathway independent of beta-arrestins. PAR1 displays two modes of internalization. Constitutive internalization of unactivated PAR1 is mediated by the clathrin adaptor protein complex-2 (AP-2), where the mu 2-adaptin subunit binds directly to a tyrosine-based motif localized within the receptor C-tail domain. However, AP-2 depletion only partially inhibits agonist-induced internalization of PAR!, suggesting a function for other clathrin adaptors in this process. Here, we now report that AP-2 and epsin-1 are both critical mediators of agonist-stimulated PAR1 internalization, We show that ubiquitination of PAR1 and the ubiquitin-interacting motifs of epsin-1 are required for epsin-l-dependent internalization of activated PAR1. In addition, activation of PAR1 promotes epsin-1 de-ubiquitination, which may increase its endocytic adaptor activity to facilitate receptor internalization. AP-2 also regulates activated PAR1 internalization via recognition of distal C-tail phosphorylation sites rather than the canonical tyrosine-based motif. Thus, AP-2 and epsin-1 are both required to promote efficient internalization of activated PAR1 and recognize discrete receptor sorting signals. This study defines a new pathway for internalization of mammalian GPCRs.	[Chen, Buxin; Dores, Michael R.; Grinnsey, Neil; Trejo, JoAnn] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Canto, Isabel] Univ Calif San Diego, Biomed Sci Grad Program, Sch Med, La Jolla, CA 92093 USA; [Barker, Breann L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Jefferson University	Trejo, J (corresponding author), 9500 Gilman Dr,BSB Rm 3044A, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu	Grimsey, Neil/B-1634-2015	Grimsey, Neil/0000-0002-0481-4920; Dores, Michael/0000-0001-9243-0582; TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [HL073328]; University of California; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007444, R01HL073328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL073328 (to IT.) and a University of California Tobacco related Disease Research Program Exploratory Award (to J. T.).; Supported by an American Heart Association Postdoctoral Fellowship Award.	Aguilar RC, 2003, J BIOL CHEM, V278, P10737, DOI 10.1074/jbc.M211622200; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Hammes SR, 1999, BIOCHEMISTRY-US, V38, P2486, DOI 10.1021/bi982527i; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; HEIN L, 1994, J BIOL CHEM, V269, P27719; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; ISHII K, 1994, J BIOL CHEM, V269, P1125; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Oldham W. M., 2008, NAT REV, V9, P60; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98	35	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40760	40770		10.1074/jbc.M111.299776	http://dx.doi.org/10.1074/jbc.M111.299776			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965661	Green Published, hybrid			2022-12-25	WOS:000297315400037
J	Kaiser, HJ; Surma, MA; Mayer, F; Levental, I; Grzybek, M; Klemm, RW; Da Cruz, S; Meisinger, C; Muller, V; Simons, K; Lingwood, D				Kaiser, Hermann-Josef; Surma, Michal A.; Mayer, Florian; Levental, Ilya; Grzybek, Michal; Klemm, Robin W.; Da Cruz, Sandrine; Meisinger, Chris; Mueller, Volker; Simons, Kai; Lingwood, Daniel			Molecular Convergence of Bacterial and Eukaryotic Surface Order	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOTGUN MASS-SPECTROMETRY; ALPHA-HELICAL PEPTIDES; MODEL MEMBRANES; LIPID RAFTS; HOMEOVISCOUS ADAPTATION; BIOLOGICAL-MEMBRANES; SECRETORY VESICLES; BILAYER THICKNESS; PLASMA-MEMBRANES; PHASE-DIAGRAMS	The conservation of fluidity is a theme common to all cell membranes. In this study, an analysis of lipid packing was conducted via C-laurdan spectroscopy of cell surface membranes prepared from representative species of Bacteria and Eukarya. We found that despite their radical differences in composition (namely the presence and absence of membrane-rigidifying sterol) the membrane order of all taxa converges on a remarkably similar level, To understand how this similarity is constructed, we reconstituted membranes with either bacterial or eukaryotic components. We found that transmembrane segments of proteins have an important role in buffering lipid-mediated packing. This buffering ensures that sterol-free and sterol-containing membranes exhibit similar barrier properties.	[Kaiser, Hermann-Josef; Surma, Michal A.; Levental, Ilya; Grzybek, Michal; Simons, Kai; Lingwood, Daniel] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Mayer, Florian; Mueller, Volker] Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, D-60438 Frankfurt, Germany; [Klemm, Robin W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Da Cruz, Sandrine] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Da Cruz, Sandrine] Univ Calif San Diego, Ludwig Inst, La Jolla, CA 92093 USA; [Meisinger, Chris] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Meisinger, Chris] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany	Max Planck Society; Goethe University Frankfurt; Harvard University; Harvard Medical School; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of Freiburg; University of Freiburg	Lingwood, D (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	daniel.lingwood@nih.gov	Klemm, Robin/ABA-2252-2020; Meisinger, Chris/J-1110-2014; Klemm, Robin/C-5463-2014; Grzybek, Michal/D-3802-2017; Mueller, Volker/ABE-4305-2021; Surma, Michal/B-1955-2016; Levental, Ilya/F-4707-2011	Klemm, Robin/0000-0003-2313-8240; Meisinger, Chris/0000-0002-8326-3548; Klemm, Robin/0000-0003-2313-8240; Grzybek, Michal/0000-0003-2083-0506; Mueller, Volker/0000-0001-7955-5508; Surma, Michal/0000-0001-7833-2214; Levental, Ilya/0000-0002-1206-9545; Simons, Kai/0000-0002-9231-9996	Max Planck Institute for Molecular Cell Biology and Genetics; Deutsche Forschungsgemeinschaft (DFG) Sonderforschungsbereiche [807]; DFG Schwerpunktprogramm1175 [SI459/2-1]; DFG Transregio [TRR83 TP02]; European Science Foundation LIPIDPROD [SI459/3-1]; Bundesministerium fur Bildung und Forschung ForMaT [03FO1212]; Klaus Tschira Foundation	Max Planck Institute for Molecular Cell Biology and Genetics; Deutsche Forschungsgemeinschaft (DFG) Sonderforschungsbereiche(German Research Foundation (DFG)); DFG Schwerpunktprogramm1175; DFG Transregio(German Research Foundation (DFG)); European Science Foundation LIPIDPROD; Bundesministerium fur Bildung und Forschung ForMaT(Federal Ministry of Education & Research (BMBF)); Klaus Tschira Foundation	This work was supported by a Max Planck Institute for Molecular Cell Biology and Genetics stipend (to D. L.), by Deutsche Forschungsgemeinschaft (DFG) Sonderforschungsbereiche Grant 807 (to V. M.), and by DFG Schwerpunktprogramm1175 Grant SI459/2-1, DFG Transregio 83 Grant TRR83 TP02; European Science Foundation LIPIDPROD Grant SI459/3-1; Bundesministerium fur Bildung und Forschung ForMaT Grant 03FO1212, and The Klaus Tschira Foundation (to K. S.).	BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; Castanho MARB, 1997, EUR BIOPHYS J BIOPHY, V26, P253, DOI 10.1007/s002490050078; Chintalapati S, 2004, CELL MOL BIOL, V50, P631; de Planque MRR, 1998, BIOCHEMISTRY-US, V37, P9333, DOI 10.1021/bi980233r; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dupuy AD, 2008, P NATL ACAD SCI USA, V105, P2848, DOI 10.1073/pnas.0712379105; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Fastenberg ME, 2003, BIOCHEMISTRY-US, V42, P12376, DOI 10.1021/bi034718d; Feigenson GW, 2009, BBA-BIOMEMBRANES, V1788, P47, DOI 10.1016/j.bbamem.2008.08.014; Ge MT, 2003, BIOPHYS J, V85, P1278, DOI 10.1016/S0006-3495(03)74563-9; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; Huang JY, 1999, BBA-BIOMEMBRANES, V1417, P89, DOI 10.1016/S0005-2736(98)00260-0; HUSCHILT JC, 1989, BIOCHIM BIOPHYS ACTA, V979, P139, DOI 10.1016/0005-2736(89)90534-8; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; JAHNIG F, 1981, BIOPHYS J, V36, P329, DOI 10.1016/S0006-3495(81)84735-2; Kaiser HJ, 2011, P NATL ACAD SCI USA, V108, P16628, DOI 10.1073/pnas.1103742108; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kalvodova L, 2009, J VIROL, V83, P7996, DOI 10.1128/JVI.00635-09; Killian JA, 2006, CURR OPIN STRUC BIOL, V16, P473, DOI 10.1016/j.sbi.2006.06.007; Kim HM, 2007, CHEMBIOCHEM, V8, P553, DOI 10.1002/cbic.200700003; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; LEWIS BA, 1983, J MOL BIOL, V166, P203, DOI 10.1016/S0022-2836(83)80006-0; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lonnfors M, 2011, BIOPHYS J, V100, P2633, DOI 10.1016/j.bpj.2011.03.066; Lundbaek JA, 2003, BIOPHYS J, V84, P2080, DOI 10.1016/S0006-3495(03)75015-2; MacDonald A.G., 1985, Symposia of the Society for Experimental Biology, P301; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; MOURITSEN OG, 1993, ANNU REV BIOPH BIOM, V22, P145, DOI 10.1146/annurev.bb.22.060193.001045; Mykytczuk NCS, 2007, PROG BIOPHYS MOL BIO, V95, P60, DOI 10.1016/j.pbiomolbio.2007.05.001; NEZIL FA, 1992, BIOPHYS J, V61, P1176, DOI 10.1016/S0006-3495(92)81926-4; Niemela PS, 2009, BBA-BIOMEMBRANES, V1788, P122, DOI 10.1016/j.bbamem.2008.08.018; Noireaux V, 2011, P NATL ACAD SCI USA, V108, P3473, DOI 10.1073/pnas.1017075108; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Ren JH, 1999, BIOCHEMISTRY-US, V38, P5905, DOI 10.1021/bi982942a; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Sajbidor J, 1997, CRIT REV BIOTECHNOL, V17, P87, DOI 10.3109/07388559709146608; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; SEELIG J, 1980, Q REV BIOPHYS, V13, P19, DOI 10.1017/S0033583500000305; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Smith WL, 2001, J BIOL CHEM, V276, P32393, DOI 10.1074/jbc.R100044200; Surma MA, 2011, TRAFFIC, V12, P1139, DOI 10.1111/j.1600-0854.2011.01221.x; TANFORD C, 1978, SCIENCE, V200, P1012, DOI 10.1126/science.653353; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101	51	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40631	40637		10.1074/jbc.M111.276444	http://dx.doi.org/10.1074/jbc.M111.276444			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965671	hybrid, Green Published			2022-12-25	WOS:000297315400024
J	Sue, XE; Hansen, BG; Hedstrom, L				Sue, Xin E.; Hansen, Bjarne Gram; Hedstrom, Lizbeth			Kinetically Controlled Drug Resistance HOW PENICILLIUM BREVICOMPACTUM SURVIVES MYCOPHENOLIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE MONOPHOSPHATE DEHYDROGENASE; IMP DEHYDROGENASE; 5'-MONOPHOSPHATE DEHYDROGENASE; MOLECULAR-BASIS; MECHANISM; IMMUNOSUPPRESSANT; 5-MONOPHOSPHATE; INHIBITION; BINDING; COMPLEX	The filamentous fungus Penicillium brevicompactum produces the immunosuppressive drug mycophenolic acid (MPA), which is a potent inhibitor of eukaryotic IMP dehydrogenases (IMPDHs). IMPDH catalyzes the conversion of IMP to XMP via a covalent enzyme intermediate, E-XMP*; MPA inhibits by trapping E-XMP*. P. brevicompactum (Pb) contains two MPA-resistant IMPDHs, PbIMPDH-A and PhIMPDH-B, which are 17- and 10(3)-fold more resistant to MPA than typically observed. Surprisingly, the active sites of these resistant enzymes are essentially identical to those of MPA-sensitive enzymes, so the mechanistic basis of resistance is not apparent. Here, we show that, unlike MPA-sensitive IMPDHs, formation of E-XMP* is rate-limiting for both PbIMPDH-A and PbIMPDH-B. Therefore, MPA resistance derives from the failure to accumulate the drug-sensitive intermediate.	[Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, Waltham, MA 02453 USA; [Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, Waltham, MA 02453 USA; [Sue, Xin E.] Brandeis Univ, Grad Program Biochem, Waltham, MA 02453 USA; [Hansen, Bjarne Gram] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Kongens Lyngby, Denmark	Brandeis University; Brandeis University; Brandeis University; Technical University of Denmark	Hedstrom, L (corresponding author), Brandeis Univ, Dept Biol, MS009,415 South St, Waltham, MA 02453 USA.	hedstrom@brandeis.edu			National Institutes of Health [GM54403, P41 RR001081]; Danish Council for Independent Research, Technology and Product Sciences [09-064240, 09-064967]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596, R01GM054403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Technology and Product Sciences(Det Frie Forskningsrad (DFF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54403 (to L. H.). The work performed by B. G. H. was supported by Grants 09-064240 and 09-064967 from the Danish Council for Independent Research, Technology and Product Sciences.; Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081).	Bentley R, 2000, CHEM REV, V100, P3801, DOI 10.1021/cr990097b; Bruzzese FJ, 1997, BIOCHEMISTRY-US, V36, P10428, DOI 10.1021/bi9708040; Digits JA, 1999, BIOCHEMISTRY-US, V38, P2295, DOI 10.1021/bi982305k; Gan L, 2003, BIOCHEMISTRY-US, V42, P857, DOI 10.1021/bi0271401; Hansen B.G., 2011, BIOCH J IN PRESS; Hansen BG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-202; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; HERMES JD, 1984, BIOCHEMISTRY-US, V23, P5479, DOI 10.1021/bi00318a016; Jenks MH, 2005, YEAST, V22, P1181, DOI 10.1002/yea.1300; Kohler GA, 2005, J BIOL CHEM, V280, P11295, DOI 10.1074/jbc.M409847200; Link JO, 1996, J AM CHEM SOC, V118, P2091, DOI 10.1021/ja9534056; MacPherson IS, 2010, J AM CHEM SOC, V132, P1230, DOI 10.1021/ja909947a; Min DH, 2008, PLOS BIOL, V6, P1802, DOI 10.1371/journal.pbio.0060206; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; NOTO T, 1969, J ANTIBIOT, V22, P165, DOI 10.7164/antibiotics.22.165; Regueira TB, 2011, APPL ENVIRON MICROB, V77, P3035, DOI 10.1128/AEM.03015-10; Riera TV, 2008, BIOCHEMISTRY-US, V47, P8689, DOI 10.1021/bi800674a; Schlippe YVG, 2004, BIOCHEMISTRY-US, V43, P4511, DOI 10.1021/bi035823q; Sintchak MD, 1996, CELL, V85, P921, DOI 10.1016/S0092-8674(00)81275-1; Wang W, 1996, BIOCHEMISTRY-US, V35, P95, DOI 10.1021/bi951499q; Wang W, 1997, BIOCHEMISTRY-US, V36, P8479, DOI 10.1021/bi970226n	21	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40595	40600		10.1074/jbc.M111.305235	http://dx.doi.org/10.1074/jbc.M111.305235			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21979957	hybrid, Green Published			2022-12-25	WOS:000297315400019
J	Ma, XY; Yu, JM; Zhang, SZ; Liu, XY; Wu, BH; Wei, XL; Yan, JQ; Sun, HL; Yan, HT; Zheng, JQ				Ma, Xiao-Yun; Yu, Jin-Mei; Zhang, Shu-Zhuo; Liu, Xiao-Yan; Wu, Bao-Hong; Wei, Xiao-Li; Yan, Jia-Qing; Sun, Hong-Liang; Yan, Hai-Tao; Zheng, Jian-Quan			External Ba2(+) Block of the Two-pore Domain Potassium Channel TREK-1 Defines Conformational Transition in Its Selectivity Filter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; FUNCTIONAL EXPRESSION; XENOPUS OOCYTES; OUTER PORE; INACTIVATION; CONDUCTANCE; MECHANISM; BA2+; LOCALIZATION; BARIUM	TREK-1 is a member of the two-pore domain potassium channel family that is known as a leak channel and plays a key role in many physiological and pathological processes. The conformational transition of the selectivity filter is considered as an effective strategy for potassium channels to control the course of potassium efflux. It is well known that TREK-1 is regulated by a large volume of extracellular and intracellular signals. However, until now, little was known about the selectivity filter gating mechanism of the channel. In this research, it was found that Ba2+ blocked the TREK-1 channel in a concentration-and time-dependent manner. A mutagenesis analysis showed that overlapped binding of Ba2+ at the assumed K+ binding site 4 (S4) within the selectivity filter was responsible for the inhibitory effects on TREK-1. Then, Ba2+ was used as a probe to explore the conformational transition in the selectivity filter of the channel. It was confirmed that collapsed conformations were induced by extracellular K+-free and acidification at the selectivity filters, leading to nonconductive to permeable ions. Further detailed characterization demonstrated that the two conformations presented different properties. Additionally, the N-terminal truncated isoform (Delta N41), a product derived from alternative translation initiation, was identified as a constitutively nonconductive variant. Together, these results illustrate the important role of selectivity filter gating in the regulation of TREK-1 by the extracellular K+ and proton.	[Ma, Xiao-Yun; Yu, Jin-Mei; Zhang, Shu-Zhuo; Liu, Xiao-Yan; Wu, Bao-Hong; Wei, Xiao-Li; Yan, Jia-Qing; Sun, Hong-Liang; Yan, Hai-Tao; Zheng, Jian-Quan] Beijing Inst Pharmacol & Toxicol, Dept Biochem Pharmacol, Beijing 100850, Peoples R China	Academy of Military Medical Sciences - China	Zheng, JQ (corresponding author), 27 Taiping Rd, Beijing 100850, Peoples R China.	zhengjq@bmi.ac.cn	Yan, Jia-qing/AAI-1974-2020		National Program on Key Basic Research Project of China [2007CB512307]	National Program on Key Basic Research Project of China(National Basic Research Program of China)	This work was supported by National Program on Key Basic Research Project of China Grant 2007CB512307.	Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bhate MP, 2010, J MOL BIOL, V401, P155, DOI 10.1016/j.jmb.2010.06.031; Bruening-Wright A, 2007, J GEN PHYSIOL, V130, P601, DOI 10.1085/jgp.200709828; Chang HK, 2009, BBA-BIOMEMBRANES, V1788, P500, DOI 10.1016/j.bbamem.2008.10.016; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Chatelain FC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007496; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Cheng YM, 2008, BIOPHYS J, V95, P4456, DOI 10.1529/biophysj.108.133165; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Cohen A, 2008, J BIOL CHEM, V283, P19448, DOI 10.1074/jbc.M801273200; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Domene C, 2008, J AM CHEM SOC, V130, P9474, DOI 10.1021/ja801792g; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Es-Salah-Lamoureux Z, 2010, TRENDS PHARMACOL SCI, V31, P587, DOI 10.1016/j.tips.2010.09.001; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Gibor G, 2004, J GEN PHYSIOL, V124, P83, DOI 10.1085/jgp.200409068; Gibor G, 2007, BIOPHYS J, V93, P4159, DOI 10.1529/biophysj.107.107987; Harris RE, 1998, BIOPHYS J, V74, P1808, DOI 10.1016/S0006-3495(98)77891-9; Inglis SK, 2007, AM J PHYSIOL-LUNG C, V292, pL1304, DOI 10.1152/ajplung.00424.2006; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Kim SJ, 2006, CARDIOVASC RES, V69, P13, DOI 10.1016/j.cardiores.2005.10.013; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; Meadows HJ, 2000, PFLUG ARCH EUR J PHY, V439, P714, DOI 10.1007/s004240050997; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; O'Connell AD, 2005, J PHYSIOL-LONDON, V562, P687, DOI 10.1113/jphysiol.2004.079020; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Shieh RC, 1998, BIOPHYS J, V75, P2313, DOI 10.1016/S0006-3495(98)77675-1; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; Thompson AN, 2008, P NATL ACAD SCI USA, V105, P6900, DOI 10.1073/pnas.0800873105; Vergara C, 1999, J GEN PHYSIOL, V114, P365, DOI 10.1085/jgp.114.3.365; Wang DT, 2011, NAT STRUCT MOL BIOL, V18, P35, DOI 10.1038/nsmb.1966; Yuill KH, 2007, PFLUG ARCH EUR J PHY, V455, P333, DOI 10.1007/s00424-007-0282-7; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7; Zuniga L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016141	43	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39813	39822		10.1074/jbc.M111.264788	http://dx.doi.org/10.1074/jbc.M111.264788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965685	Green Published, hybrid			2022-12-25	WOS:000296925700015
J	Gomes, CS; Izar, B; Pazan, F; Mohamed, W; Abu Mraheil, M; Mukherjee, K; Billion, A; Aharonowitz, Y; Chakraborty, T; Hain, T				Gomes, Christa Seifart; Izar, Benjamin; Pazan, Farhad; Mohamed, Walid; Abu Mraheil, Mobarak; Mukherjee, Krishnendu; Billion, Andre; Aharonowitz, Yair; Chakraborty, Trinad; Hain, Torsten			Universal Stress Proteins Are Important for Oxidative and Acid Stress Resistance and Growth of Listeria monocytogenes EGD-e In Vitro and In Vivo	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; GENE-EXPRESSION; VIRULENCE; SALMONELLA; SURVIVAL; SIGMA(B); REGULATOR; CLONING; USPA	Background: Pathogenic bacteria maintain a multifaceted apparatus to resist damage caused by external stimuli. As part of this, the universal stress protein A (UspA) and its homologues, initially discovered in Escherichia coli K-12 were shown to possess an important role in stress resistance and growth in several bacterial species. Methods and Findings: We conducted a study to assess the role of three homologous proteins containing the UspA domain in the facultative intracellular human pathogen Listeria monocytogenes under different stress conditions. The growth properties of three UspA deletion mutants (Delta lmo0515, Delta lmo1580 and Delta lmo2673) were examined either following challenge with a sublethal concentration of hydrogen peroxide or under acidic conditions. We also examined their ability for intracellular survival within murine macrophages. Virulence and growth of usp mutants were further characterized in invertebrate and vertebrate infection models. Tolerance to acidic stress was clearly reduced in Dlmo1580 and Dlmo0515, while oxidative stress dramatically diminished growth in all mutants. Survival within macrophages was significantly decreased in Dlmo1580 and Dlmo2673 as compared to the wild-type strain. Viability of infected Galleria mellonella larvae was markedly higher when injected with Dlmo1580 or Dlmo2673 as compared to wild-type strain inoculation, indicating impaired virulence of bacteria lacking these usp genes. Finally, we observed severely restricted growth of all chromosomal deletion mutants in mice livers and spleens as compared to the load of wild-type bacteria following infection. Conclusion: This work provides distinct evidence that universal stress proteins are strongly involved in listerial stress response and survival under both in vitro and in vivo growth conditions.	[Gomes, Christa Seifart; Izar, Benjamin; Pazan, Farhad; Mohamed, Walid; Abu Mraheil, Mobarak; Billion, Andre; Chakraborty, Trinad; Hain, Torsten] Univ Giessen, Inst Med Microbiol, Giessen, Germany; [Mukherjee, Krishnendu] Univ Giessen, Inst Phytopathol & Appl Zool, Giessen, Germany; [Aharonowitz, Yair] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Justus Liebig University Giessen; Justus Liebig University Giessen; Tel Aviv University	Gomes, CS (corresponding author), Univ Giessen, Inst Med Microbiol, Giessen, Germany.	torsten.hain@mikrobio.med.uni-giessen.de	Mukherjee, Krishnendu/U-7159-2017; Mukherjee, Krishnendu/A-8186-2011	Mukherjee, Krishnendu/0000-0003-3470-9117; 	German Federal Ministry of Education and Research (BMBF, ERA-NET PathoGenomics Network) [sncRNAomics 0315437A, LISTRESS 0315907A]	German Federal Ministry of Education and Research (BMBF, ERA-NET PathoGenomics Network)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF, ERA-NET PathoGenomics Network projects sncRNAomics 0315437A to TH and LISTRESS 0315907A to TH and TC) and through the LOEWE program of the state Hessia by the collaborative research project Insect Biotechnology to TH and TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaha CAG, 2003, ANTON LEEUW INT J G, V83, P35, DOI 10.1023/A:1022937828186; Boes N, 2008, J BACTERIOL, V190, P7189, DOI 10.1128/JB.00600-08; Boes N, 2006, J BACTERIOL, V188, P6529, DOI 10.1128/JB.00308-06; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Chen J, 2007, J FOOD PROTECT, V70, P2392, DOI 10.4315/0362-028X-70.10.2392; Chen W, 2006, FEMS MICROBIOL LETT, V264, P15, DOI 10.1111/j.1574-6968.2006.00426.x; Cotter PD, 2000, INT J FOOD MICROBIOL, V60, P137, DOI 10.1016/S0168-1605(00)00305-6; Drumm JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000460; Ferreira A, 2003, APPL ENVIRON MICROB, V69, P2692, DOI 10.1128/AEM.69.5.2692-2698.2003; Fink RC, 2007, J BACTERIOL, V189, P2262, DOI 10.1128/JB.00726-06; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; Glaser P, 2001, SCIENCE, V294, P849; Gury J, 2009, APPL ENVIRON MICROB, V75, P5273, DOI 10.1128/AEM.00774-09; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Kuenne CT, 2007, BIOINFORMATICS, V23, P125, DOI 10.1093/bioinformatics/btl556; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Licandro-Seraut H, 2008, J MOL MICROB BIOTECH, V14, P41, DOI 10.1159/000106081; Liu WT, 2007, MICROB PATHOGENESIS, V42, P2, DOI 10.1016/j.micpath.2006.09.002; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; O'Toole R, 2003, RES MICROBIOL, V154, P387, DOI 10.1016/S0923-2508(03)00081-0; O'Toole R, 2003, J BACTERIOL, V185, P1543, DOI 10.1128/JB.185.5.1543-1554.2003; Persson O, 2007, MOL MICROBIOL, V65, P968, DOI 10.1111/j.1365-2958.2007.05838.x; Rea R, 2005, APPL ENVIRON MICROB, V71, P8314, DOI 10.1128/AEM.71.12.8314-8322.2005; Sagurthi SR, 2007, ACTA CRYSTALLOGR F, V63, P957, DOI 10.1107/S1744309107048610; SCHAFERKORDT S, 1995, BIOTECHNIQUES, V19, P720; Schobert M, 2010, INT J MED MICROBIOL, V300, P549, DOI 10.1016/j.ijmm.2010.08.007; Schreiber K, 2006, J BACTERIOL, V188, P659, DOI 10.1128/JB.188.2.659-668.2006; Sousa MC, 2001, STRUCTURE, V9, P1135, DOI 10.1016/S0969-2126(01)00680-3; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wemekamp-Kamphuis HH, 2004, APPL ENVIRON MICROB, V70, P3457, DOI 10.1128/AEM.70.6.3457-3466.2004; 2007, MICROBIOLOGY, V153, P3593	38	52	52	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24965	10.1371/journal.pone.0024965	http://dx.doi.org/10.1371/journal.pone.0024965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980369	Green Submitted, Green Published, gold			2022-12-25	WOS:000295941300015
J	Suzuki, T; Kondo, C; Kanamori, T; Inouye, S				Suzuki, Takahiro; Kondo, Chihiro; Kanamori, Takao; Inouye, Satoshi			Video-Rate Bioluminescence Imaging of Matrix Metalloproteinase-2 Secreted from a Migrating Cell	PLOS ONE			English	Article							INVASIVE CELLS; SURFACE; MMP-2; ACTIVATION; CYTOSKELETON; LUCIFERASE; EXOCYTOSIS; EXPRESSION; MICROSCOPY; MOTILITY	Background: Matrix metalloproteinase-2 (MMP-2) plays an important role in cancer progression and metastasis. MMP-2 is secreted as a pro-enzyme, which is activated by the membrane-bound proteins, and the polarized distribution of secretory and the membrane-associated MMP-2 has been investigated. However, the real-time visualizations of both MMP-2 secretion from the front edge of a migration cell and its distribution on the cell surface have not been reported. Methodology/Principal Findings: The method of video-rate bioluminescence imaging was applied to visualize exocytosis of MMP-2 from a living cell using Gaussia luciferase (GLase) as a reporter. The luminescence signals of GLase were detected by a high speed electron-multiplying charge-coupled device camera (EM-CCD camera) with a time resolution within 500 ms per image. The fusion protein of MMP-2 to GLase was expressed in a HeLa cell and exocytosis of MMP-2 was detected in a few seconds along the leading edge of a migrating HeLa cell. The membrane-associated MMP-2 was observed at the specific sites on the bottom side of the cells, suggesting that the sites of MMP-2 secretion are different from that of MMP-2 binding. Conclusions: We were the first to successfully demonstrate secretory dynamics of MMP-2 and the specific sites for polarized distribution of MMP-2 on the cell surface. The video-rate bioluminescence imaging using GLase is a useful method to investigate distribution and dynamics of secreted proteins on the whole surface of polarized cells in real time.	[Suzuki, Takahiro; Kondo, Chihiro; Kanamori, Takao] Aichi Gakuin Univ, Sch Dent, Dept Biochem, Nagoya, Aichi 464, Japan; [Inouye, Satoshi] JNC Corp, Yokohama Res Ctr, Yokohama, Kanagawa, Japan	Aichi Gakuin University	Suzuki, T (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Biochem, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	tsuzuki@dpc.agu.ac.jp; sinouye@jnc-corp.co.jp		Inouye, Satoshi/0000-0001-8732-7839	Japan Society for the Promotion of Science (JSPS); Strategic Research AGU-Platform Formation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research AGU-Platform Formation	This work was supported in part by Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (JSPS) and by Strategic Research AGU-Platform Formation (2008-2012). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SJ, 1995, J BIOL CHEM, V270, P30479, DOI 10.1074/jbc.270.51.30479; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Chen WT, 1999, ANN NY ACAD SCI, V878, P361, DOI 10.1111/j.1749-6632.1999.tb07695.x; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; INOUYE S, 1992, P NATL ACAD SCI USA, V89, P9584, DOI 10.1073/pnas.89.20.9584; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Lafleur Marc A, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006628; Ma ZD, 2004, J BIOL CHEM, V279, P46326, DOI 10.1074/jbc.M405438200; Miesenbock G, 1997, P NATL ACAD SCI USA, V94, P3402, DOI 10.1073/pnas.94.7.3402; Nabeshima K, 2000, CANCER RES, V60, P3364; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Oheim M, 1999, PHILOS T R SOC B, V354, P307, DOI 10.1098/rstb.1999.0382; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Schnaeker EM, 2004, CANCER RES, V64, P8924, DOI 10.1158/0008-5472.CAN-04-0324; Seiki M, 2002, CURR OPIN CELL BIOL, V14, P624, DOI 10.1016/S0955-0674(02)00363-0; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P17374; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suzuki T, 2007, FEBS LETT, V581, P4551, DOI 10.1016/j.febslet.2007.08.036; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; THOMPSON EM, 1995, P NATL ACAD SCI USA, V92, P1317, DOI 10.1073/pnas.92.5.1317; Tonti GA, 2009, INT J DEV BIOL, V53, P1, DOI 10.1387/ijdb.082573gt; VanSaun Michael N., 2006, Birth Defects Research, V78, P69, DOI 10.1002/bdrc.20061; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	34	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25243	10.1371/journal.pone.0025243	http://dx.doi.org/10.1371/journal.pone.0025243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969874	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900038
J	van Beilen, M; Bult, H; Renken, R; Stieger, M; Thumfart, S; Cornelissen, F; Kooijman, V				van Beilen, Marije; Bult, Harold; Renken, Remco; Stieger, Markus; Thumfart, Stefan; Cornelissen, Frans; Kooijman, Valesca			Effects of Visual Priming on Taste-Odor Interaction	PLOS ONE			English	Article							OLFACTORY PERCEPTION; SUCROSE SOLUTIONS; PERCEIVED FLAVOR; COLOR; SWEETNESS; DISCRIMINATION; INTENSITY; MIXTURES; TEXTURE; VISION	Little is known about the influence of visual characteristics other than colour on flavor perception, and the complex interactions between more than two sensory modalities. This study focused on the effects of recognizability of visual (texture) information on flavor perception of odorized sweet beverages. Participants rated the perceived sweetness of odorized sucrose solutions in the presence or absence of either a congruent or incongruent visual context. Odors were qualitatively reminiscent of sweet foods (strawberry and caramel) or not (savoury). Visual context was either an image of the same sweet foods (figurative context) or a visual texture derived from this product (non-figurative context). Textures were created using a texture synthesis method that preserved perceived food qualities while removing object information. Odor-taste combinations were rated sweeter within a figurative than a non-figurative context. This behaviour was exhibited for all odor-taste combinations, even in trials without images, indicating sustained priming by figurative visual context. A non-figurative context showed a transient sweetening effect. Sweetness was generally enhanced most by the strawberry odor. We conclude that the degree of recognizability of visual information (figurative versus non-figurative), influences flavor perception differently. Our results suggest that this visual context priming is mediated by separate sustained and transient processes that are differently evoked by figurative and non-figurative visual contexts. These components operate independent of the congruency of the image-odor-taste combinations.	[van Beilen, Marije; Renken, Remco; Cornelissen, Frans] Univ Groningen, Univ Med Ctr, Lab Expt Ophthalmol, Groningen, Netherlands; [Kooijman, Valesca] Top Inst Food & Nutr, Wageningen, Netherlands; [Bult, Harold; Stieger, Markus] Ctr Innovat Consumer Studies, Ede, Netherlands; [van Beilen, Marije; Renken, Remco; Cornelissen, Frans] Univ Groningen, Univ Med Ctr, Sch Behav & Cognit Neurosci, NeuroImaging Ctr, Groningen, Netherlands; [Thumfart, Stefan] Profactor GmbH, Steyr Gleink, Austria; [van Beilen, Marije] Univ Groningen, Univ Med Ctr, Dept Neurol, Groningen, Netherlands; [Stieger, Markus] Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands	University of Groningen; Top Institute Food & Nutrition; University of Groningen; Upper Austrian Research GmbH; PROFACTOR; University of Groningen; Wageningen University & Research	van Beilen, M (corresponding author), Univ Groningen, Univ Med Ctr, Lab Expt Ophthalmol, Groningen, Netherlands.	m.van.beilen@umcg.nl	van Beilen, Marije/A-7435-2011; Stieger, Markus/O-7727-2014	Renken, Remco Jan/0000-0002-7777-9484; Stieger, Markus/0000-0002-8736-6026				Bult JHF, 2007, NEUROSCI LETT, V411, P6, DOI 10.1016/j.neulet.2006.09.036; CHRISTENSEN CM, 1977, CEREAL FOOD WORLD, V22, P243; CLARK CC, 1994, CHEM SENSES, V19, P583, DOI 10.1093/chemse/19.6.583; CLYDESDALE FM, 1993, CRIT REV FOOD SCI, V33, P83, DOI 10.1080/10408399309527614; Dalton P, 2000, NAT NEUROSCI, V3, P431, DOI 10.1038/74797; De Bonet J. S., 1997, SIGGRAPH 97, P361, DOI [10.1145/258734.258882, DOI 10.1145/258734.258882]; Delwiche J, 2004, FOOD QUAL PREFER, V15, P137, DOI 10.1016/S0950-3293(03)00041-7; Dematte ML, 2009, CHEM SENSES, V34, P103, DOI 10.1093/chemse/bjn055; DUBOSE CN, 1980, J FOOD SCI, V45, P1393, DOI 10.1111/j.1365-2621.1980.tb06562.x; FRANK RA, 1989, CHEM SENSES, V14, P371, DOI 10.1093/chemse/14.3.371; FRANK RA, 1993, PERCEPT PSYCHOPHYS, V54, P343, DOI 10.3758/BF03205269; Gilbert AN, 1996, AM J PSYCHOL, V109, P335, DOI 10.2307/1423010; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; JOHNSON J, 1982, J FOOD SCI, V47, P747, DOI 10.1111/j.1365-2621.1982.tb12706.x; JOHNSON JL, 1983, J FOOD PROTECT, V46, P21, DOI 10.4315/0362-028X-46.1.21; Koster EP, 2005, CHEM SENSES, V30, pI236, DOI 10.1093/chemse/bjh201; Labbe D, 2007, CHEM SENSES, V32, P205, DOI 10.1093/chemse/bjl040; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; LAWRENCE JF, 1987, J CHROMATOGR SCI, V25, P444, DOI 10.1093/chromsci/25.10.444; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Livermore A, 1998, PHYSIOL BEHAV, V65, P311, DOI 10.1016/S0031-9384(98)00168-1; Livermore A, 1998, PERCEPT PSYCHOPHYS, V60, P650, DOI 10.3758/BF03206052; MACKAY A, 1956, FOOD TECHNOL, P238; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; Osterbauer RA, 2005, J NEUROPHYSIOL, V93, P3434, DOI 10.1152/jn.00555.2004; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; PHILIPSEN DH, 1995, J FOOD SCI, V60, P364, DOI 10.1111/j.1365-2621.1995.tb05674.x; Sakai N, 2005, CHEM SENSES, V30, pI244, DOI 10.1093/chemse/bjh205; Schendan HE, 2009, NEUROIMAGE, V44, P1423, DOI 10.1016/j.neuroimage.2008.09.061; Schifferstein HNJ, 2006, ACTA PSYCHOL, V121, P41, DOI 10.1016/j.actpsy.2005.06.004; Schifferstein HNJ, 2005, ACTA PSYCHOL, V118, P293, DOI 10.1016/j.actpsy.2004.10.009; Schifferstein HNJ, 1996, ACTA PSYCHOL, V94, P87, DOI 10.1016/0001-6918(95)00040-2; Stevenson RJ, 2007, PERCEPTION, V36, P1821, DOI 10.1068/p5563; Stevenson RJ, 2007, PSYCHOL BULL, V133, P294, DOI 10.1037/0033-2909.133.2.294; Stevenson RJ, 1999, CHEM SENSES, V24, P627, DOI 10.1093/chemse/24.6.627; Weel KGC, 2002, J AGR FOOD CHEM, V50, P5149, DOI 10.1021/jf0202786; Wei LY, 2000, COMP GRAPH, P479, DOI 10.1145/344779.345009; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Zampini M, 2007, FOOD QUAL PREFER, V18, P975, DOI 10.1016/j.foodqual.2007.04.001; ZELLNER DA, 1990, J EXP PSYCHOL HUMAN, V16, P391, DOI 10.1037/0096-1523.16.2.391	40	16	16	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e23857	10.1371/journal.pone.0023857	http://dx.doi.org/10.1371/journal.pone.0023857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969852	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900003
J	Dupont, YL; Damgaard, C; Simonsen, V				Dupont, Yoko L.; Damgaard, Christian; Simonsen, Vibeke			Quantitative Historical Change in Bumblebee (Bombus spp.) Assemblages of Red Clover Fields	PLOS ONE			English	Article							POLLINATION; DECLINE; BEES; CONSERVATION; HYMENOPTERA; RARITY; APIDAE; VULNERABILITY; DISTANCES; IMPACTS	Background: Flower visiting insects provide a vitally important pollination service for many crops and wild plants. Recent decline of pollinating insects due to anthropogenic modification of habitats and climate, in particular from 1950's onwards, is a major and widespread concern. However, few studies document the extent of declines in species diversity, and no studies have previously quantified local abundance declines. We here make a quantitative assessment of recent historical changes in bumblebee assemblages by comparing contemporary and historical survey data. Methodology/Principal Findings: We take advantage of detailed, quantitative historical survey data from the 1930's on bumblebee (Bombus spp.) abundances and species composition in red clover (Trifolium pratense) fields, an important floral resource and an attractant of all bumblebee species. We used the historical survey data as a pre-industrialization baseline, and repeated the same sampling protocol at nearly the same localities at present, hence setting up a historical experiment. We detected historical changes in abundances (bees/m(2)) of both workers (the "pollinatory units") and queens (effective population size), in addition to species composition. In particular, long-tongued bumblebee species showed consistent and dramatic declines in species richness and abundances throughout the flowering season of red clover, while short-tongued species were largely unaffected. Of 12 Bombus species observed in the 1930's, five species were not observed at present. The latter were all long-tongued, late-emerging species. Conclusions/Significance: Because bumblebees are important pollinators, historical changes in local bumblebee assemblages are expected to severely affect plant reproduction, in particular long-tubed species, which are pollinated by long-tongued bumblebees.	[Dupont, Yoko L.] Aarhus Univ, Dept Biosci, Sect Ecol & Genet, Aarhus, Denmark; [Damgaard, Christian; Simonsen, Vibeke] Aarhus Univ, Dept Biosci, Sect Terr Ecol NERI, Silkeborg, Denmark	Aarhus University; Aarhus University	Dupont, YL (corresponding author), Aarhus Univ, Dept Biosci, Sect Ecol & Genet, Aarhus, Denmark.	yoko.dupont@biology.au.dk	Dupont, Yoko/GOE-4804-2022; Damgaard, Christian/G-2441-2010	Damgaard, Christian/0000-0003-3932-4312	Aarhus University Research Foundation [AUFF-F-2009-FLS-5-7]; Danish Natural Sciences Research Council [09-063874]	Aarhus University Research Foundation; Danish Natural Sciences Research Council(Danish Natural Science Research Council)	The project was financed by the Aarhus University Research Foundation (AUFF-F-2009-FLS-5-7). During the writing of the manuscript, YLD was supported by the Danish Natural Sciences Research Council (grant number 09-063874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Benton T., 2006, BUMBLEBEES NATURAL H; Bertsch Andreas, 2004, Beitraege zur Entomologie, V54, P365; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; BRODSGAARD CJ, 2002, 71 DIAS MIN FOOD AGR, P3; BUCHMANN SL, 1985, J KANSAS ENTOMOL SOC, V58, P517; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; CORBET SA, 1993, ECOL ENTOMOL, V18, P17, DOI 10.1111/j.1365-2311.1993.tb01075.x; Corbet SA, 2000, CONSERV BIOL, V14, P1229, DOI 10.1046/j.1523-1739.2000.00014.x; DUPONT YL, 2010, NAT MUS, V1, P1; Fitzpatrick U, 2007, BIOL CONSERV, V136, P185, DOI 10.1016/j.biocon.2006.11.012; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Free JB, 1959, BUMBLEBEES; FUSSELL M, 1992, J APPL ECOL, V29, P451, DOI 10.2307/2404513; Gabriel D, 2010, ECOL LETT, V13, P858, DOI 10.1111/j.1461-0248.2010.01481.x; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; GOULSON D, 2005, NZ J ECOL, V28, P225; GOULSON D, 2003, BUMBLEBEES THEIR BEH; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hagen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019997; Hammer K., 1970, NATUR MUSEUM POPULAE, V14, P3; Heinrich B., 1979, BUMBLEBEE EC; HOLM SN, 1966, ANNU REV ENTOMOL, V11, P155, DOI 10.1146/annurev.en.11.010166.001103; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kells AR, 2003, BIOL CONSERV, V109, P165, DOI 10.1016/S0006-3207(02)00131-3; Kleijn D, 2008, ECOLOGY, V89, P1811, DOI 10.1890/07-1275.1; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Kosior A, 2007, ORYX, V41, P79, DOI 10.1017/S0030605307001597; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kreyer D, 2004, BIOL CONSERV, V116, P111, DOI 10.1016/S0006-3207(03)00182-4; MADSEN HB, 2009, DANISH RED LIST; Marletto Franco, 2003, Bulletin of Insectology, V56, P155; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Murray TE, 2009, APIDOLOGIE, V40, P211, DOI 10.1051/apido/2009015; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; RASMONT P, 1988, ANN SOC ROY ZOOL BEL, V118, P141; SKOVGAARD OS, 1936, DET KONGELIGE DANSKE, V96, P1; SKOVGAARD OS, 1943, TIDSSKRIFT PLANTEAVL, V47, P287; Stout JC, 2009, APIDOLOGIE, V40, P388, DOI 10.1051/apido/2009023; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Wermuth KH, 2010, APIDOLOGIE, V41, P657, DOI 10.1051/apido/2010038; Williams P, 2005, BIOL CONSERV, V122, P33, DOI 10.1016/j.biocon.2004.06.019; Williams P, 2009, CONSERV BIOL, V23, P931, DOI 10.1111/j.1523-1739.2009.01176.x; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Winfree R, 2008, CURR BIOL, V18, pR968, DOI 10.1016/j.cub.2008.09.010	52	76	79	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25172	10.1371/journal.pone.0025172	http://dx.doi.org/10.1371/journal.pone.0025172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966445	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100021
J	Di Palma, T; Conti, A; de Cristofaro, T; Scala, S; Nitsch, L; Zannini, M				Di Palma, Tina; Conti, Anna; de Cristofaro, Tiziana; Scala, Serena; Nitsch, Lucio; Zannini, Mariastella			Identification of Novel Pax8 Targets in FRTL-5 Thyroid Cells by Gene Silencing and Expression Microarray Analysis	PLOS ONE			English	Article							CATENIN-INDEPENDENT PATHWAY; TRANSCRIPTION FACTORS; CONGENITAL HYPOTHYROIDISM; GLAND DEVELOPMENT; DEVELOPING KIDNEY; FOLLICULAR CELLS; EPITHELIAL-CELLS; BINDING-PROTEIN; TAZ INTERACTS; CADHERIN GENE	Background: The differentiation program of thyroid follicular cells (TFCs), by far the most abundant cell population of the thyroid gland, relies on the interplay between sequence-specific transcription factors and transcriptional coregulators with the basal transcriptional machinery of the cell. However, the molecular mechanisms leading to the fully differentiated thyrocyte are still the object of intense study. The transcription factor Pax8, a member of the Paired-box gene family, has been demonstrated to be a critical regulator required for proper development and differentiation of thyroid follicular cells. Despite being Pax8 well-characterized with respect to its role in regulating genes involved in thyroid differentiation, genomics approaches aiming at the identification of additional Pax8 targets are lacking and the biological pathways controlled by this transcription factor are largely unknown. Methodology/Principal Findings: To identify unique downstream targets of Pax8, we investigated the genome-wide effect of Pax8 silencing comparing the transcriptome of silenced versus normal differentiated FRTL-5 thyroid cells. In total, 2815 genes were found modulated 72 h after Pax8 RNAi, induced or repressed. Genes previously reported to be regulated by Pax8 in FRTL-5 cells were confirmed. In addition, novel targets genes involved in functional processes such as DNA replication, anion transport, kinase activity, apoptosis and cellular processes were newly identified. Transcriptome analysis highlighted that Pax8 is a key molecule for thyroid morphogenesis and differentiation. Conclusions/Significance: This is the first large-scale study aimed at the identification of new genes regulated by Pax8, a master regulator of thyroid development and differentiation. The biological pathways and target genes controlled by Pax8 will have considerable importance to understand thyroid disease progression as well as to set up novel therapeutic strategies.	[Di Palma, Tina; de Cristofaro, Tiziana; Scala, Serena; Zannini, Mariastella] CNR, Inst Expt Endocrinol & Oncol G Salvatore IEOS, Naples, Italy; [Conti, Anna; Nitsch, Lucio] Univ Naples Federico 2, Dept Cellular & Mol Biol & Pathol, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Di Palma, T (corresponding author), CNR, Inst Expt Endocrinol & Oncol G Salvatore IEOS, Naples, Italy.	s.zannini@ieos.cnr.it	Scala, Serena/Y-6756-2019; De+Cristofaro, Tiziana/AAX-4405-2020; Conti, Anna/G-5130-2012; Di+Palma, Tina/AAN-6853-2021; Zannini, Mariastella/I-1735-2012	Scala, Serena/0000-0002-8579-3809; Conti, Anna/0000-0002-2054-7375; DECRISTOFARO, TIZIANA/0000-0003-0121-0002	Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian Ministry of Economy and Finance	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Economy and Finance	This work was supported by a grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC) to M.Z. and by a grant from the Italian Ministry of Economy and Finance to the CNR for the Project FaReBio di Qualita. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambesi-Impiombato F. S., 1979, INT REV CYTOL S, P163; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bowen NJ, 2007, GYNECOL ONCOL, V104, P331, DOI 10.1016/j.ygyno.2006.08.052; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Brisken C, 2000, GENE DEV, V14, P650; Cali G, 2007, ENDOCRINOLOGY, V148, P2737, DOI 10.1210/en.2006-1344; Chen YJ, 2008, CANCER RES, V68, P5724, DOI 10.1158/0008-5472.CAN-08-0058; Chia WK, 2010, CANCER GENET CYTOGEN, V196, P7, DOI 10.1016/j.cancergencyto.2009.08.001; CIVITAREALE D, 1989, EMBO J, V8, P2537, DOI 10.1002/j.1460-2075.1989.tb08391.x; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; D'Adamo MC, 2011, J BIOL CHEM, V286, P192, DOI 10.1074/jbc.M110.189290; D'Andrea B, 2006, MOL ENDOCRINOL, V20, P1810, DOI 10.1210/me.2005-0463; Damante G, 2001, PROG NUCLEIC ACID RE, V66, P307; de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; di Magliano MP, 2000, P NATL ACAD SCI USA, V97, P13144; Di Palma T, 2003, J BIOL CHEM, V278, P3395, DOI 10.1074/jbc.M205977200; Di Palma T, 2010, CLIN ENDOCRINOL, V73, P808, DOI 10.1111/j.1365-2265.2010.03851.x; Di Palma T, 2009, EXP CELL RES, V315, P162, DOI 10.1016/j.yexcr.2008.10.016; Di Palma T, 2008, J MOL ENDOCRINOL, V41, P379, DOI 10.1677/JME-08-0056; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Endo T, 2008, J CLIN ENDOCR METAB, V93, P2409, DOI 10.1210/jc.2007-2805; Endo T, 2010, MOL ENDOCRINOL, V24, P1267, DOI 10.1210/me.2010-0056; Gonzalez YR, 2008, J NEUROSCI, V28, P5559, DOI 10.1523/JNEUROSCI.1014-08.2008; Hegedus Z, 2006, CELL MOL LIFE SCI, V63, P1632, DOI 10.1007/s00018-006-6007-9; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Kikuchi A, 2008, CANCER SCI, V99, P202, DOI 10.1111/j.1349-7006.2007.00675.x; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Marques AR, 2002, J CLIN ENDOCR METAB, V87, P3947, DOI 10.1210/jc.87.8.3947; Miyakoshi T, 2008, ENDOCR PATHOL, V19, P261, DOI 10.1007/s12022-008-9048-9; Mok SC, 1996, ONCOGENE, V12, P1895; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; Nishida Y, 2005, GENE, V344, P133, DOI 10.1016/j.gene.2004.09.007; Ohno M, 1999, MOL CELL BIOL, V19, P2051; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; PLACHOV D, 1990, DEVELOPMENT, V110, P643; Provenzano C, 2010, MOL CELL ENDOCRINOL, V323, P215, DOI 10.1016/j.mce.2010.02.038; Puppin C, 2004, MOL CELL ENDOCRINOL, V214, P117, DOI 10.1016/j.mce.2003.10.061; Roider HG, 2009, BIOINFORMATICS, V25, P435, DOI 10.1093/bioinformatics/btn627; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Torban E, 2006, J BIOL CHEM, V281, P12705, DOI 10.1074/jbc.M513181200; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Whyte DA, 1999, AM J PHYSIOL-RENAL, V277, pF587, DOI 10.1152/ajprenal.1999.277.4.F587; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; WU ZZ, 2010, J CELL PHYSL; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16	57	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25162	10.1371/journal.pone.0025162	http://dx.doi.org/10.1371/journal.pone.0025162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966443	Green Submitted, Green Published, gold			2022-12-25	WOS:000295267100021
J	Devbhandari, RP; Shi, GM; Ke, AW; Wu, FZ; Huang, XY; Wang, XY; Shi, YH; Ding, ZB; Xu, Y; Dai, Z; Fan, J; Zhou, J				Devbhandari, Ranjan Prasad; Shi, Guo-Ming; Ke, Ai-Wu; Wu, Fei-Zhen; Huang, Xiao-Yong; Wang, Xiao-Ying; Shi, Ying-Hong; Ding, Zhen-Bin; Xu, Yang; Dai, Zhi; Fan, Jia; Zhou, Jian			Profiling of the Tetraspanin CD151 Web and Conspiracy of CD151/Integrin beta 1 Complex in the Progression of Hepatocellular Carcinoma	PLOS ONE			English	Article							CELL-CELL ADHESION; IN-VIVO; SIGNALING COMPLEXES; C-MET; EXPRESSION; METASTASIS; CANCER; ALPHA-3-BETA-1; ASSOCIATION; MIGRATION	Tetraspanin CD151 has been implicated in metastasis through forming complexes with different molecular partners. In this study, we mapped tetraspanin web proteins centered on CD151, in order to explore the role of CD151 complexes in the progression of hepatocellular carcinoma (HCC). Immunoprecipitation was used to isolate tetraspanin complexes from HCCLM3 cells using a CD151 antibody, and associated proteins were identified by mass spectrometry. The interaction of CD151 and its molecular partners, and their roles in invasiveness and metastasis of HCC cells were assayed through disruption of the CD151 network. Finally, the clinical implication of CD151 complexes in HCC patients was also examined. In this study, we identified 58 proteins, characterized the tetraspanin CD151 web, and chose integrin beta 1 as a main partner to further investigate. When the CD151/integrin beta 1 complex in HCC cells was disrupted, migration, invasiveness, secretion of matrix metalloproteinase 9, and metastasis were markedly influenced. However, both CD151 and integrin beta 1 expression were untouched. HCC patients with high expression of CD151/integrin beta 1 complex had the poorest prognosis of the whole cohort of patients. Together, our data show that CD151 acts as an important player in the progression of HCC in an integrin beta 1-dependent manner.	[Devbhandari, Ranjan Prasad; Shi, Guo-Ming; Huang, Xiao-Yong; Wang, Xiao-Ying; Shi, Ying-Hong; Ding, Zhen-Bin; Xu, Yang; Dai, Zhi; Zhou, Jian] Fudan Univ, Liver Canc Inst, Shanghai Med Sch, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Ke, Ai-Wu] Tongji Univ, Dept Gastroenterol, Sch Med, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Wu, Fei-Zhen] Fudan Univ, Lab Epigenet, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Fan, Jia] Fudan Univ, Ctr Canc, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University; Fudan University	Devbhandari, RP (corresponding author), Fudan Univ, Liver Canc Inst, Shanghai Med Sch, Zhongshan Hosp, Shanghai 200433, Peoples R China.	jiafan99@yahoo.com; zhou.jian@zs-hospital.sh.cn	Shi, Ying-Hong/B-7063-2017; Wu, Feizhen/AGR-5215-2022; Wu, Feizhen/R-6415-2019; Fan, Jia/C-6689-2017	Wu, Feizhen/0000-0002-1265-9887; Ke, Ai-Wu/0000-0002-7964-6909	National Key Sci-Tech Special Project of China [2008ZX10002-022, 2008ZX10002-019]; NSFC [N.81030038]; National Hi-Tech Research and Development Program of China [2007AA02Z479]; National Natural Science Foundation [81071741, 30972949]; Ph.D. Programs Foundation of Ministry of Education of China [20090071120025]; Shanghai Municipal Natural Science Foundation [11ZR1428300]; China Postdoctoral Science Foundation [201003236]	National Key Sci-Tech Special Project of China; NSFC(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Shanghai Municipal Natural Science Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Key Sci-Tech Special Project of China (2008ZX10002-022; 2008ZX10002-019), the Major Program of NSFC (N.81030038), the National Hi-Tech Research and Development Program of China (2007AA02Z479), National Natural Science Foundation (81071741; 30972949), the Ph.D. Programs Foundation of Ministry of Education of China (20090071120025), Shanghai Municipal Natural Science Foundation (11ZR1428300) and the special program of China Postdoctoral Science Foundation (201003236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Chattopadhyay N, 2003, J CELL BIOL, V163, P1351, DOI 10.1083/jcb.200306067; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Franco M, 2010, J BIOL CHEM, V285, P38756, DOI 10.1074/jbc.M110.145417; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; He B, 2005, J BIOL CHEM, V280, P3346, DOI 10.1074/jbc.M406680200; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Katabami K, 2005, CLIN EXP METASTAS, V22, P539, DOI 10.1007/s10585-005-5260-x; Ke AW, 2011, GASTROENTEROLOGY, V140, P1629, DOI 10.1053/j.gastro.2011.02.008; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Kramer B, 2009, EUR J IMMUNOL, V39, P3447, DOI 10.1002/eji.200939234; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Masumoto A, 1999, HEPATOLOGY, V29, P68, DOI 10.1002/hep.510290146; Mazzocca A, 2005, J BIOL CHEM, V280, P11329, DOI 10.1074/jbc.M410161200; Rolink AG, 2000, IMMUNOL REV, V175, P104, DOI 10.1034/j.1600-065X.2000.017512.x; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Sauer G, 2003, ONCOL REP, V10, P405; SHI GM, 2008, J CANC RES CLIN ONCO; Shi GM, 2008, J CANCER RES CLIN, V134, P1155, DOI 10.1007/s00432-008-0407-1; Shi GM, 2010, HEPATOLOGY, V52, P183, DOI 10.1002/hep.23661; Shigeta M, 2003, J CELL BIOL, V163, P165, DOI 10.1083/jcb.200301075; Sterk LMT, 2002, J CELL SCI, V115, P1161; Takahashi M, 2007, INT J CANCER, V121, P1919, DOI 10.1002/ijc.22887; Testa JE, 1999, CANCER RES, V59, P3812; Todeschini AR, 2008, P NATL ACAD SCI USA, V105, P1925, DOI 10.1073/pnas.0709619104; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Wittekind C, 2006, PATHOLOGE, V27, P289, DOI 10.1007/s00292-006-0834-1; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Yang CQ, 2003, CANCER RES, V63, P8312; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Yunta M, 2003, CELL SIGNAL, V15, P559, DOI 10.1016/S0898-6568(02)00147-X; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	45	28	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24901	10.1371/journal.pone.0024901	http://dx.doi.org/10.1371/journal.pone.0024901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961047	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100025
J	Huang, Y; Cai, ML; Clore, GM; Craigie, R				Huang, Ying; Cai, Mengli; Clore, G. Marius; Craigie, Robert			No Interaction of Barrier-to-Autointegration Factor (BAF) with HIV-1 MA, Cone-Rod Homeobox (Crx) or MAN1-C in Absence of DNA	PLOS ONE			English	Article							NUCLEAR-ENVELOPE; STRUCTURAL BASIS; RETROVIRAL DNA; IN-VITRO; BINDING; PROTEIN; COMPLEX; MATRIX; DOMAIN	Barrier-to-autointegration factor is a cellular protein that protects retroviral DNA from autointegration. Its cellular role is not well understood, but genetic studies show that it is essential and depletion or knockout results in lethal nuclear defects. In addition to binding DNA, BAF interacts with the LEM domain, a domain shared among a family of lamin-associated polypeptides. BAF has also been reported to interact with several other viral and cellular proteins suggesting that these interactions may be functionally relevant. We find that, contrary to previous reports, BAF does not interact with HIV-1 MA, cone-rod homeobox (Crx) or MAN1-C. The reported interactions can be explained by indirect association through DNA binding and are unlikely to be biologically relevant. A mutation that causes a premature aging syndrome lies on the previously reported MAN1-C binding surface of BAF. The absence of direct binding of BAF to MAN1-C eliminates disruption of this interaction as the cause of the premature aging phenotype.	[Huang, Ying; Craigie, Robert] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Cai, Mengli; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Huang, Y (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	bobc@helix.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027	NIDDK, National Institutes of Health (NIH); Office of the Director of the NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023, ZIADK029038, ZIADK036171] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of the Director of the NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Program of NIDDK, National Institutes of Health (NIH), and by the AIDS Targeted Antiviral Program of the Office of the Director of the NIH (to GMC and RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson L, 2006, MOL BIOL CELL, V17, P1154, DOI 10.1091/mbc.E05-04-0356; Bradley CM, 2005, NAT STRUCT MOL BIOL, V12, P935, DOI 10.1038/nsmb989; Cai M, 1998, NAT STRUCT BIOL, V5, P903, DOI 10.1038/2345; Cai ML, 2007, J BIOL CHEM, V282, P14525, DOI 10.1074/jbc.M700576200; Cai ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015675; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Furukawa K, 2003, J CELL SCI, V116, P3811, DOI 10.1242/jcs.00682; Furukawa K, 1999, J CELL SCI, V112, P2485; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Hearps AC, 2008, BIOCHEMISTRY-US, V47, P2199, DOI 10.1021/bi701360j; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Mansharamani M, 2005, J BIOL CHEM, V280, P13863, DOI 10.1074/jbc.M413020200; Mansharamani M, 2003, J VIROL, V77, P13084, DOI 10.1128/JVI.77.24.13084-13092.2003; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Puente XS, 2011, AM J HUM GENET, V88, P650, DOI 10.1016/j.ajhg.2011.04.010; Skoko D, 2009, P NATL ACAD SCI USA, V106, P16610, DOI 10.1073/pnas.0909077106; Umland TC, 2000, BIOCHEMISTRY-US, V39, P9130, DOI 10.1021/bi000572w; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wang XJ, 2002, J BIOL CHEM, V277, P43288, DOI 10.1074/jbc.M207952200; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197	22	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25123	10.1371/journal.pone.0025123	http://dx.doi.org/10.1371/journal.pone.0025123			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966431	Green Published, gold			2022-12-25	WOS:000295265100061
J	Klijs, B; Nusselder, WJ; Looman, CW; Mackenbach, JP				Klijs, Bart; Nusselder, Wilma J.; Looman, Caspar W.; Mackenbach, Johan P.			Contribution of Chronic Disease to the Burden of Disability	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LOW-BACK-PAIN; FUNCTIONAL DECLINE; RISK-FACTORS; HEALTH EXPECTANCY; DUTCH POPULATION; ELDERLY-PEOPLE; OLDER PERSONS; FREE LIFE; WOMEN	Background: Population ageing is expected to lead to strong increases in the number of persons with one or more disabilities, which may result in substantial declines in the quality of life. To reduce the burden of disability and to prevent concomitant declines in the quality of life, one of the first steps is to establish which diseases contribute most to the burden. Therefore, this paper aims to determine the contribution of specific diseases to the prevalence of disability and to years lived with disability, and to assess whether large contributions are due to a high disease prevalence or a high disabling impact. Methodology/Principal Findings: Data from the Dutch POLS-survey (Permanent Onderzoek Leefsituatie, 2001-2007) were analyzed. Using additive regression and accounting for co-morbidity, the disabling impact of selected chronic diseases was calculated, and the prevalence and years lived with ADL and mobility disabilities were partitioned into contributions of specific disease. Musculoskeletal and cardiovascular disease contributed most to the burden of disability, but chronic nonspecific lung disease (males) and diabetes (females) also contributed much. Within the musculoskeletal and cardiovascular disease groups, back pain, peripheral vascular disease and stroke contributed particularly by their high disabling impact. Arthritis and heart disease were less disabling but contributed substantially because of their high prevalence. The disabling impact of diseases was particularly high among persons older than 80. Conclusions/Significance: To reduce the burden of disability, the extent diseases such as back pain, peripheral vascular disease and stroke lead to disability should be reduced, particularly among the oldest old. But also moderately disabling diseases with a high prevalence, such as arthritis and heart disease, should be targeted.	[Klijs, Bart; Nusselder, Wilma J.; Looman, Caspar W.; Mackenbach, Johan P.] Univ Med Ctr, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Klijs, B (corresponding author), Univ Med Ctr, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands.	b.klijs@erasmusmc.nl	Klijs, Bart/B-3330-2013	Klijs, Bart/0000-0001-7543-2287	Netspar; European Public Health Programme [2006109]; Erasmus MC, University Medical Centre	Netspar; European Public Health Programme; Erasmus MC, University Medical Centre	This study was part of the project "Living longer in good health," which was financially supported by Netspar, an independent network for research, education and knowledge exchange in the field of pensions, aging and retirement. This work was supported by the European Public Health Programme (2006109) and the Erasmus MC, University Medical Centre. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; DAVIES PT, 1982, J R STAT SOC C-APPL, V31, P244; Efron B., 1994, INTRO BOOTSTRAP; European health expectancy monitoring unit (EHEMU), 2010, EHEMU DAT INF SYST; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; Freedman VA, 2000, AM J PUBLIC HEALTH, V90, P1755, DOI 10.2105/AJPH.90.11.1755; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried TR, 2001, ARCH INTERN MED, V161, P2602, DOI 10.1001/archinte.161.21.2602; Hills, 1993, STAT MODELS EPIDEMIO; Howard BV, 1998, DIABETES CARE, V21, P1258, DOI 10.2337/diacare.21.8.1258; Hubert HB, 2002, J GERONTOL A-BIOL, V57, pM347, DOI 10.1093/gerona/57.6.M347; Jagger C, 2007, J GERONTOL A-BIOL, V62, P408, DOI 10.1093/gerona/62.4.408; Juutilainen A, 2004, DIABETES CARE, V27, P2898, DOI 10.2337/diacare.27.12.2898; Kattainen A, 2004, J CLIN EPIDEMIOL, V57, P513, DOI 10.1016/j.jclinepi.2003.10.004; Klerk M, 2005, LANDELIJK OVERZICHT; Kovacs FM, 2004, SPINE, V29, P206, DOI 10.1097/01.BRS.0000107235.47465.08; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Manton K. G., 1984, RECENT TRENDS MORTAL; Mathers CD, 1999, DISABIL REHABIL, V21, P211, DOI 10.1080/096382899297639; Nusselder WJ, 2005, AM J PUBLIC HEALTH, V95, P2035, DOI 10.2105/AJPH.2004.054700; Nusselder WJ, 2004, DEMOGRAPHY, V41, P315, DOI 10.1353/dem.2004.0017; Nusselder WJ, 1996, AM J PUBLIC HEALTH, V86, P187, DOI 10.2105/AJPH.86.2.187; Picavet HSJ, 1997, AM J PUBLIC HEALTH, V87, P1680, DOI 10.2105/AJPH.87.10.1680; Poos M, 2009, DEMENTIE OMVANG PROB; Puts MTE, 2008, AGE AGEING, V37, P187, DOI 10.1093/ageing/afm185; Rejeski WJ, 2009, J GERONTOL A-BIOL, V64, P462, DOI 10.1093/gerona/gln041; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Spiers NA, 2005, J GERONTOL A-BIOL, V60, P248, DOI 10.1093/gerona/60.2.248; Stam S, 2009, LANGE TIJDREEKSEN GE; Statistics Netherlands, 2010, STATL DAT BEV PROGN; Statistics Netherlands, 2007, GEZ ZORG CIJF 2007; Steinberg HO, 2000, CIRCULATION, V101, P2040, DOI 10.1161/01.CIR.101.17.2040; Stel VS, 2004, AGE AGEING, V33, P58, DOI 10.1093/ageing/afh028; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; The Netherlands Institute for Social Research, 2006, RAPP OUD 2006 VER LE; Truchon M, 2001, DISABIL REHABIL, V23, P758, DOI 10.1080/09638280110061744; van Gool CH, 2005, SOC SCI MED, V60, P25, DOI 10.1016/j.socscimed.2004.04.021; VERBRUGGE LM, 1995, AM J PUBLIC HEALTH, V85, P173, DOI 10.2105/AJPH.85.2.173; Wiesenfeld-Hallin Zsuzsanna, 2005, Gend Med, V2, P137, DOI 10.1016/S1550-8579(05)80042-7; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yee TW, 2003, STAT MODEL, V3, P15, DOI 10.1191/1471082X03st045oa	45	74	77	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25325	10.1371/journal.pone.0025325	http://dx.doi.org/10.1371/journal.pone.0025325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825IJ	21966497	Green Published, gold			2022-12-25	WOS:000295265100088
J	Labay, B; Cohen, AE; Sissel, B; Hendrickson, DA; Martin, FD; Sarkar, S				Labay, Ben; Cohen, Adam E.; Sissel, Blake; Hendrickson, Dean A.; Martin, F. Douglas; Sarkar, Sahotra			Assessing Historical Fish Community Composition Using Surveys, Historical Collection Data, and Species Distribution Models	PLOS ONE			English	Article							CLIMATE-CHANGE; NICHE MODELS; GEOGRAPHIC DISTRIBUTIONS; REFERENCE SITES; SAMPLE-SIZE; CONSERVATION; ASSEMBLAGES; PERFORMANCE; CHALLENGES; INTEGRITY	Accurate establishment of baseline conditions is critical to successful management and habitat restoration. We demonstrate the ability to robustly estimate historical fish community composition and assess the current status of the urbanized Barton Creek watershed in central Texas, U. S. A. Fish species were surveyed in 2008 and the resulting data compared to three sources of fish occurrence information: (i) historical records from a museum specimen database and literature searches; (ii) a nearly identical survey conducted 15 years earlier; and (iii) a modeled historical community constructed with species distribution models (SDMs). This holistic approach, and especially the application of SDMs, allowed us to discover that the fish community in Barton Creek was more diverse than the historical data and survey methods alone indicated. Sixteen native species with high modeled probability of occurrence within the watershed were not found in the 2008 survey, seven of these were not found in either survey or in any of the historical collection records. Our approach allowed us to more rigorously establish the true baseline for the pre-development fish fauna and then to more accurately assess trends and develop hypotheses regarding factors driving current fish community composition to better inform management decisions and future restoration efforts. Smaller, urbanized freshwater systems, like Barton Creek, typically have a relatively poor historical biodiversity inventory coupled with long histories of alteration, and thus there is a propensity for land managers and researchers to apply inaccurate baseline standards. Our methods provide a way around that limitation by using SDMs derived from larger and richer biodiversity databases of a broader geographic scope. Broadly applied, we propose that this technique has potential to overcome limitations of popular bioassessment metrics (e. g., IBI) to become a versatile and robust management tool for determining status of freshwater biotic communities.	[Labay, Ben; Cohen, Adam E.; Hendrickson, Dean A.; Martin, F. Douglas] Univ Texas Austin, Austin, TX 78712 USA; [Sissel, Blake; Sarkar, Sahotra] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Sarkar, Sahotra] Univ Texas Austin, Dept Philosophy, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Labay, B (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	benlabay@mail.utexas.edu	Hendrickson, Dean A./G-9451-2018	Hendrickson, Dean A./0000-0001-7835-0295; Martin, F. Douglas/0000-0002-3421-4408	Texas Parks and Wildlife Department [T-27-P]; Texas Natural Science Center, University of Texas at Austin	Texas Parks and Wildlife Department; Texas Natural Science Center, University of Texas at Austin	This work was funded by the Texas Parks and Wildlife Department's State Wildlife Grant "Data Standardization and Georeferencing of the Fishes of Texas Database (T-27-P)" (http://www.tpwd.state.tx.us). The Texas Natural Science Center, University of Texas at Austin (http://www.utexas.edu/tmm/) provided support through the use of the laboratory at the Texas Natural History Collection and the salary of Dean Hendrickson, Curator of Ichthyology at the Texas Natural History Collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bailey RC, 2004, BIOASSESSMENT FRESHW; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Carroll C, 2010, BIOL CONSERV, V143, P1432, DOI 10.1016/j.biocon.2010.03.018; Chapman AD, 2006, GLOBAL BIODIVERSITY; Chessman BC, 2004, J N AM BENTHOL SOC, V23, P599, DOI 10.1899/0887-3593(2004)023&lt;0599:BWRSUO&gt;2.0.CO;2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Esselman PC, 2011, FRESHWATER BIOL, V56, P71, DOI 10.1111/j.1365-2427.2010.02417.x; Freeman MC, 2007, J AM WATER RESOUR AS, V43, P5, DOI 10.1111/j.1752-1688.2007.00002.x; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hendrickson DA, 2010, FISHES TEXAS PROJECT; Herlihy AT, 2008, J N AM BENTHOL SOC, V27, P860, DOI 10.1899/08-081.1; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; HUBBS C, 1991, TEX J SCI, V43, P1; HUGHES RM, 1986, ENVIRON MANAGE, V10, P629, DOI 10.1007/BF01866767; Jordan DS, 1886, P US NATL MUSEUM, P9; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; KARR JR, 1991, ECOL APPL, V1, P66, DOI 10.2307/1941848; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Love JW, 2008, AM MIDL NAT, V160, P265, DOI 10.1674/0003-0031(2008)160[265:EOSDOF]2.0.CO;2; Meyer JL, 2007, J AM WATER RESOUR AS, V43, P86, DOI 10.1111/j.1752-1688.2007.00008.x; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Murienne J, 2009, BIOL J LINN SOC, V97, P177, DOI 10.1111/j.1095-8312.2008.01184.x; Nadeau TL, 2007, J AM WATER RESOUR AS, V43, P118, DOI 10.1111/j.1752-1688.2007.00010.x; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Norris RH, 2000, HYDROBIOLOGIA, V435, P5, DOI 10.1023/A:1004176507184; Page L.M., 1983, HDB DARTERS; Page L.M., 1998, FIELD GUIDE FRESHWAT; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2008, J VECTOR ECOL, V33, P342, DOI 10.3376/1081-1710-33.2.342; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; ROSS ST, 1985, AM NAT, V126, P24, DOI 10.1086/284393; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836; Scanlon BR, 2002, GROUNDWATER AVAILABI; Scardi M, 2008, ECOL INFORM, V3, P55, DOI 10.1016/j.ecoinf.2007.10.001; Stoddard JL, 2006, ECOL APPL, V16, P1267, DOI 10.1890/1051-0761(2006)016[1267:SEFTEC]2.0.CO;2; Suter GW, 2002, ENVIRON TOXICOL CHEM, V21, P1101, DOI 10.1897/1551-5028(2002)021<1101:AMFITC>2.0.CO;2; Thompson FD, 1943, TEXAS GAME FISH, V1, P8; Thorpe AS, 2011, J APPL ECOL, V48, P275, DOI 10.1111/j.1365-2664.2011.01972.x; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; Williams SE, 2009, P NATL ACAD SCI USA, V106, P19737, DOI 10.1073/pnas.0901640106; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; [No title captured]	59	33	35	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25145	10.1371/journal.pone.0025145	http://dx.doi.org/10.1371/journal.pone.0025145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966438	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100066
J	Tian, J; Dang, H; Kaufman, DL				Tian, Jide; Dang, Hoa; Kaufman, Daniel L.			Combining Antigen-Based Therapy with GABA Treatment Synergistically Prolongs Survival of Transplanted beta-Cells in Diabetic NOD Mice	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; INFLAMMATORY RESPONSES; COMBINATION THERAPY; INSULIN-SECRETION; CHLORIDE CHANNELS; PRONE MICE; TYPE-1; IMMUNOTHERAPY; LYMPHOCYTES; INHIBITION	Antigen-based therapies (ABTs) very effectively prevent the development of type 1 diabetes (T1D) when given to young nonobese diabetic (NOD) mice, however, they have little or no ability to reverse hyperglycemia in newly diabetic NOD mice. More importantly, ABTs have not yet demonstrated an ability to effectively preserve residual beta-cells in individuals newly diagnosed with type 1 diabetes (T1D). Accordingly, there is great interest in identifying new treatments that can be combined with ABTs to safely protect beta-cells in diabetic animals. The activation of gamma-aminobutyric acid (GABA) receptors (GABA-Rs) on immune cells has been shown to prevent T1D, experimental autoimmune encephalomyelitis (EAE) and rheumatoid arthritis in mouse models. Based on GABA's ability to inhibit different autoimmune diseases and its safety profile, we tested whether the combination of ABT with GABA treatment could prolong the survival of transplanted beta-cells in newly diabetic NOD mice. Newly diabetic NOD mice were untreated, or given GAD/alum (20 or 100 mu g) and placed on plain drinking water, or water containing GABA (2 or 6 mg/ml). Twenty-eight days later, they received syngenic pancreas grafts and were monitored for the recurrence of hyperglycemia. Hyperglycemia reoccurred in the recipients given plain water, GAD monotherapy, GABA monotherapy, GAD (20 mu g)+GABA (2 mg/ml), GAD (20 mu g)+GABA (6 mg/ml) and GAD (100 mu g)+GABA (6 mg/ml) about 1, 2-3, 3, 2-3, 3-8 and 10-11 weeks post-transplantation, respectively. Thus, combined GABA and ABT treatment had a synergistic effect in a dose-dependent fashion. These findings suggest that co-treatment with GABA (or other GABA-R agonists) may provide a new strategy to safely enhance the efficacy of other therapeutics designed to prevent or reverse T1D, as well as other T cell-mediated autoimmune diseases.	[Tian, Jide; Dang, Hoa; Kaufman, Daniel L.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Tian, J (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	dkaufman@mednet.ucla.edu	Kaufman, Daniel/AAU-1228-2021	Kaufman, Daniel/0000-0002-9844-5918	National Institutes of Health [R21 DK075070, R21 DK080461]; Juvenile Diabetes Research Foundation International [17-2010-210]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075070, R21DK080461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institutes of Health (R21 DK075070, R21 DK080461) and Juvenile Diabetes Research Foundation International (17-2010-210) to DLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh CD, 2005, J DIABETES COMPLICAT, V19, P238, DOI 10.1016/j.jdiacomp.2004.12.003; Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; CAHALAN MD, 1994, CURR TOP MEMBR, V42, P103, DOI 10.1016/S0070-2161(08)60820-5; GU XH, 1993, LIFE SCI, V52, P687, DOI 10.1016/0024-3205(93)90229-V; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Ligon B, 2007, DIABETOLOGIA, V50, P764, DOI 10.1007/s00125-007-0601-8; LOEB C, 1987, EPILEPSY RES, V1, P209, DOI 10.1016/0920-1211(87)90043-X; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; Olcott AP, 2005, J IMMUNOL, V175, P1991, DOI 10.4049/jimmunol.175.3.1991; OTOMO E, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1511; Peakman M, 2010, DIABETES, V59, P2087, DOI 10.2337/db10-0630; Pop SM, 2007, DIABETES, V56, P1395, DOI 10.2337/db06-0543; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Suarez-Pinzon WL, 2008, TRANSPL P, V40, P529, DOI 10.1016/j.transproceed.2008.01.005; Tian J, 1999, J NEUROIMMUNOL, V96, P21, DOI 10.1016/S0165-5728(98)00264-1; TIAN J, 2011, PLOS ONE IN PRESS; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; Tian JD, 1996, NAT MED, V2, P1348, DOI 10.1038/nm1296-1348; Tian JD, 2011, AUTOIMMUNITY, V44, P465, DOI 10.3109/08916934.2011.571223; Tian J, 2009, DIABETES, V58, P1939, DOI 10.2337/db09-0451; Tower DB, 1960, INHIBITION NERVOUS S, P562; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7; Yip HC, 1999, J IMMUNOL, V162, P3942	27	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25337	10.1371/journal.pone.0025337	http://dx.doi.org/10.1371/journal.pone.0025337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966502	gold, Green Published			2022-12-25	WOS:000295265100091
J	Zahner, D; Gandhi, AR; Yi, H; Stephens, DS				Zaehner, Dorothea; Gandhi, Ashish R.; Yi, Hong; Stephens, David S.			Mitis Group Streptococci Express Variable Pilus Islet 2 Pili	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; SURFACE-STRUCTURES; CRYSTAL-STRUCTURE; REVEALS PILI; S-MITIS; PNEUMONIAE; ORALIS; GENES; EVOLUTION; ADHERENCE	Background: Streptococcus oralis, Streptococcus mitis, and Streptococcus sanguinis are members of the Mitis group of streptococci and agents of oral biofilm, dental plaque and infective endocarditis, disease processes that involve bacteria-bacteria and bacteria-host interactions. Their close relative, the human pathogen S. pneumoniae uses pilus-islet 2 (PI-2)-encoded pili to facilitate adhesion to eukaryotic cells. Methodology/Principal Findings: PI-2 pilus-encoding genetic islets were identified in S. oralis, S. mitis, and S. sanguinis, but were absent from other isolates of these species. The PI-2 islets resembled the genetic organization of the PI-2 islet of S. pneumoniae, but differed in the genes encoding the structural pilus proteins PitA and PitB. Two and three variants of pitA (a pseudogene in S. pneumoniae) and pitB, respectively, were identified that showed approximate to 20% difference in nucleotide as well as corresponding protein sequence. Species-independent combinations of pitA and pitB variants indicated prior intra-and interspecies horizontal gene transfer events. Polyclonal antisera developed against PitA and PitB of S. oralis type strain ATCC35037 revealed that PI-2 pili in oral streptococci were composed of PitA and PitB. Electronmicrographs showed pilus structures radiating >700 nm from the bacterial surface in the wild type strain, but not in an isogenic PI-2 deletion mutant. Anti-PitB-antiserum only reacted with pili containing the same PitB variant, whereas anti-PitA antiserum was cross-reactive with the other PitA variant. Electronic multilocus sequence analysis revealed that all PI-2-encoding oral streptococci were closely-related and cluster with non-PI-2-encoding S. oralis strains. Conclusions/Significance: This is the first identification of PI-2 pili in Mitis group oral streptococci. The findings provide a striking example of intra-and interspecies horizontal gene transfer. The PI-2 pilus diversity provides a possible key to link strain-specific bacterial interactions and/or tissue tropisms with pathogenic traits in the Mitis group streptococci.	[Zaehner, Dorothea; Gandhi, Ashish R.; Stephens, David S.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Stephens, David S.] Emory Univ, Dept Microbiol & Immunol, Sch Med, Atlanta, GA 30322 USA; [Zaehner, Dorothea; Stephens, David S.] Dept Vet Affairs Med Ctr Atlanta, Decatur, GA USA	Emory University; Emory University	Zahner, D (corresponding author), Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	dzahner@emory.edu	Stephens, David S/A-8788-2012		National Institutes of Health [R01AI070829]; Department of Veterans Affairs VA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs VA(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant #R01AI070829 (www.nih.gov) and Department of Veterans Affairs VA Merit Award (www.va.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; BRACCO RM, 1957, J EXP MED, V106, P247, DOI 10.1084/jem.106.2.247; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Chen P, 2007, INFECT IMMUN, V75, P4181, DOI 10.1128/IAI.01955-06; Chi F, 2007, INT J MED MICROBIOL, V297, P503, DOI 10.1016/j.ijmm.2007.02.009; COLMAN G, 1969, J GEN MICROBIOL, V57, P247, DOI 10.1099/00221287-57-2-247; COLOMBATTI A, 1991, BLOOD, V77, P2305; COWAN MM, 1992, J GEN MICROBIOL, V138, P2707, DOI 10.1099/00221287-138-12-2707; Doern CD, 2010, J CLIN MICROBIOL, V48, P3829, DOI 10.1128/JCM.01563-10; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; DOWSON CG, 1993, MOL MICROBIOL, V9, P635, DOI 10.1111/j.1365-2958.1993.tb01723.x; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Elliott D, 2003, ORAL MICROBIOL IMMUN, V18, P114, DOI 10.1034/j.1399-302X.2003.00052.x; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Gong K, 1998, INFECT IMMUN, V66, P5388, DOI 10.1128/IAI.66.11.5388-5392.1998; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Handel PH, 1999, AIP CONF PROC, V466, P145; HANDLEY PS, 1985, INFECT IMMUN, V47, P217, DOI 10.1128/IAI.47.1.217-227.1985; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; JAMESON MW, 1995, MICROBIOL-UK, V141, P2729, DOI 10.1099/13500872-141-10-2729; Johnston C, 2010, J CLIN MICROBIOL, V48, P2762, DOI 10.1128/JCM.01746-09; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; Kilian M, 2005, TOPELY WILSONS MICRO; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; King SJ, 2005, J BACTERIOL, V187, P5376, DOI 10.1128/JB.187.15.5376-5386.2005; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; MCINTIRE FC, 1978, INFECT IMMUN, V21, P978, DOI 10.1128/IAI.21.3.978-988.1978; McNicol A, 2010, CAN J PHYSIOL PHARM, V88, P510, DOI [10.1139/Y10-029, 10.1139/y10-029]; Mishra A, 2010, MOL MICROBIOL, V77, P841, DOI 10.1111/j.1365-2958.2010.07252.x; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2911, DOI 10.1128/IAI.00039-11; NARIKAWA S, 1995, ARCH ORAL BIOL, V40, P685, DOI 10.1016/0003-9969(95)00042-N; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Okahashi N, 2010, BIOCHEM BIOPH RES CO, V391, P1192, DOI 10.1016/j.bbrc.2009.12.029; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; Reichmann P, 2011, J BACTERIOL, V193, P2888, DOI 10.1128/JB.00321-11; RONDA C, 1988, MOL GEN GENET, V215, P53, DOI 10.1007/BF00331302; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Sillanpaa J, 2009, J CLIN MICROBIOL, V47, P896, DOI 10.1128/JCM.02283-08; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Soriani M, 2010, FUTURE MICROBIOL, V5, P735, DOI [10.2217/fmb.10.37, 10.2217/FMB.10.37]; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; WILLCOX MDP, 1989, MICROBIOS, V59, P19; Willcox MDP, 2001, INT J SYST EVOL MICR, V51, P1277, DOI 10.1099/00207713-51-4-1277; Yamaguchi T, 2009, RES MICROBIOL, V160, P809, DOI 10.1016/j.resmic.2009.09.014; Yi H, 2001, J HISTOCHEM CYTOCHEM, V49, P279, DOI 10.1177/002215540104900301; Yoshida Y, 2008, J BIOL CHEM, V283, P12654, DOI 10.1074/jbc.M801412200; Zahner D, 2011, BIOCHEM BIOPH RES CO, V409, P526, DOI 10.1016/j.bbrc.2011.05.038; Zahner D, 2008, J BACTERIOL, V190, P527, DOI 10.1128/JB.01520-07; Zahner D, 2010, EMERG INFECT DIS, V16, P955, DOI 10.3201/eid1606.091820	70	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25124	10.1371/journal.pone.0025124	http://dx.doi.org/10.1371/journal.pone.0025124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966432	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100062
J	Park, JS; Lee, WC; Yeo, KJ; Ryu, KS; Kumarasiri, M; Hesek, D; Lee, M; Mobashery, S; Song, JH; Kim, SI; Lee, JC; Cheong, C; Jeon, YH; Kim, HY				Park, Jeong Soon; Lee, Woo Cheol; Yeo, Kwon Joo; Ryu, Kyoung-Seok; Kumarasiri, Malika; Hesek, Dusan; Lee, Mijoon; Mobashery, Shahriar; Song, Jung Hyun; Kim, Seung Il; Lee, Je Chul; Cheong, Chaejoon; Jeon, Young Ho; Kim, Hye-Yeon			Mechanism of anchoring of OmpA protein to the cell wall peptidoglycan of the gram-negative bacterial outer membrane	FASEB JOURNAL			English	Article						diaminopimelate; lysine; molecular recognition; nosocomial pathogen	ACINETOBACTER-BAUMANNII; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; GENETIC ALGORITHM; CRYSTAL-STRUCTURE; FLAGELLAR MOTOR; NMR SYSTEM; RECOGNITION; VESICLES; CRYSTALLOGRAPHY	The outer membrane protein A (OmpA) plays important roles in anchoring of the outer membrane to the bacterial cell wall. The C-terminal periplasmic domain of OmpA (OmpA-like domain) associates with the peptidoglycan (PGN) layer noncovalently. However, there is a paucity of information on the structural aspects of the mechanism of PGN recognition by OmpA-like domains. To elucidate this molecular recognition process, we solved the high-resolution crystal structure of an OmpA-like domain from Acinetobacter baumannii bound to diaminopimelate (DAP), a unique bacterial amino acid from the PGN. The structure clearly illustrates that two absolutely conserved Asp271 and Arg286 residues are the key to the binding to DAP of PGN. Identification of DAP as the central anchoring site of PGN to OmpA is further supported by isothermal titration calorimetry and a pulldown assay with PGN. An NMR-based computational model for complexation between the PGN and OmpA emerged, and this model is validated by determining the crystal structure in complex with a synthetic PGN fragment. These structural data provide a detailed glimpse of how the anchoring of OmpA to the cell wall of gram-negative bacteria takes place in a DAP-dependent manner.-Park, J. S., Lee, W. C., Yeo, K. J., Ryu, K.-S., Kumarasiri, M., Hesek, D., Lee, M., Mobashery, S., Song, J. H., Lim, S. I., Lee, J. C., Cheong, C., Jeon, Y. H., Kim, H.-Y. Mechanism of anchoring of OmpA protein to the cell wall peptidoglycan of the gram-negative bacterial outer membrane. FASEB J. 26, 219-228 (2012). www.fasebj.org	[Park, Jeong Soon; Lee, Woo Cheol; Yeo, Kwon Joo; Ryu, Kyoung-Seok; Song, Jung Hyun; Cheong, Chaejoon; Jeon, Young Ho; Kim, Hye-Yeon] Korea Basic Sci Inst, Div Magnet Resonance Res, Ochang, South Korea; [Kumarasiri, Malika; Hesek, Dusan; Lee, Mijoon; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Kim, Seung Il] Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea; [Lee, Je Chul] Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea; [Cheong, Chaejoon] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon, South Korea; [Jeon, Young Ho] Korea Univ, Coll Pharm, Jochiwon, South Korea	Korea Basic Science Institute (KBSI); University of Notre Dame; Korea Basic Science Institute (KBSI); Kyungpook National University; Korea University	Kim, HY (corresponding author), Korea Basic Sci Inst, Div Magnet Resonance Res, 804-1 Ochang, Chungbuk 363883, South Korea.	yhjeon@korea.ac.kr; hyeyeon@kbsi.re.kr	Cheong, Chaejoon/GWC-3135-2022; Lee, Mijoon/AFK-1543-2022	Lee, Mijoon/0000-0001-7432-0427; Park, Jeong Soon/0000-0002-8239-1978	Korean Membrane Protein Initiative of Korean Ministry of Education, Science, and Technology; Global Frontier Project [NRF-M1AXA002-2010-0029765]; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090348] Funding Source: NIH RePORTER	Korean Membrane Protein Initiative of Korean Ministry of Education, Science, and Technology; Global Frontier Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the staff of beamline 17A at the Photon Factory (Tsukuba, Japan) and Yeon-Gil Kim, Kyung-Jin Kim, and Ghyung-Hwa Kim of beamlines 4A and 6C1 at the Pohang Accelerator Laboratory (Pohang, Korea) for help with X-ray data collection. We are grateful to Myung Hee Kim at the Korea Research Institute of Bioscience and Biotechnology (Daejeon, Korea) for the use of isothermal titration calorimetry (VP-ITC) and assistance in ITC data analysis. This work was supported by the Korean Membrane Protein Initiative program of the Korean Ministry of Education, Science, and Technology (to H.-Y.K.) and Global Frontier Project grant NRF-M1AXA002-2010-0029765 (to Y.H.J.). The work in the United States was supported by the National Institutes of Health (to S. M.). The coordinates and structural factors of AbOmpA-PD native structure and structures in complex with DAP and compound 5 have been deposited in the PDB under the access codes of 3TD3, 3TD4, and 3TD5, respectively.	Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BLAIR DF, 1991, J BACTERIOL, V173, P4049, DOI 10.1128/jb.173.13.4049-4055.1991; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cascales E, 2004, MOL MICROBIOL, V51, P873, DOI 10.1046/j.1365-2958.2003.03881.x; Case D, 2006, AMBER 9; Cho S, 2007, P NATL ACAD SCI USA, V104, P8761, DOI 10.1073/pnas.0701453104; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Clavel T, 1998, MOL MICROBIOL, V29, P359, DOI 10.1046/j.1365-2958.1998.00945.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEMOT R, 1994, MOL MICROBIOL, V12, P333; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dramsi S, 2008, FEMS MICROBIOL REV, V32, P307, DOI 10.1111/j.1574-6976.2008.00102.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Goddard T. D., 2006, SPARKY 3; Gootz TD, 2010, CRIT REV IMMUNOL, V30, P79, DOI 10.1615/CritRevImmunol.v30.i1.60; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Hamid N, 2008, CLIN VACCINE IMMUNOL, V15, P1461, DOI 10.1128/CVI.00093-08; HANCOCK REW, 1994, N COMP BIOC, V27, P263, DOI DOI 10.1016/S0167-7306(08)60415-9; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jyothisri K, 1999, FEBS LETT, V443, P57, DOI 10.1016/S0014-5793(98)01679-2; Kim KA, 2004, FEBS LETT, V565, P181, DOI 10.1016/j.febslet.2004.03.062; KOEBNIK R, 1995, MOL MICROBIOL, V16, P1269, DOI 10.1111/j.1365-2958.1995.tb02348.x; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larbig M, 2001, VACCINE, V19, P2291, DOI 10.1016/S0264-410X(00)00550-8; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee MJ, 2009, J AM CHEM SOC, V131, P8742, DOI 10.1021/ja9025566; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THORNE KJI, 1973, J BACTERIOL, V116, P410, DOI 10.1128/JB.116.1.410-417.1973; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x	50	119	125	1	38	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					219	228		10.1096/fj.11-188425	http://dx.doi.org/10.1096/fj.11-188425			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21965596	Green Published			2022-12-25	WOS:000299202200023
J	Rahman, NA; Bennink, HJTC; Chrusciel, M; Sharp, V; Zimmerman, Y; Dina, R; Li, XD; Ellonen, A; Rivero-Muller, A; Dilworth, S; Ghaem-Maghami, S; Vainio, O; Huhtaniemi, I				Rahman, Nafis A.; Bennink, Herjan J. T. Coelingh; Chrusciel, Marcin; Sharp, Victoria; Zimmerman, Yvette; Dina, Roberto; Li, Xiangdong; Ellonen, Antti; Rivero-Mueller, Adolfo; Dilworth, Stephen; Ghaem-Maghami, Sadaf; Vainio, Olli; Huhtaniemi, Ilpo			A novel treatment strategy for ovarian cancer based on immunization against zona pellucida protein (ZP) 3	FASEB JOURNAL			English	Article						granulosa cell; target-defined tumor associated antigen; vaccine	GRANULOSA-CELL TUMORS; FOLLICLE-STIMULATING-HORMONE; SIMIAN-VIRUS-40 T-ANTIGEN; GONADAL TUMORIGENESIS; MICE BEARING; FUSION GENE; INHIBIN; GONADOTROPIN; ESTABLISHMENT; SPECIFICITY	We tested the principle of treating malignant ovarian tumors by vaccination against their ectopically expressed protein, zona pellucida glycoprotein (ZP) 3, using as the experimental model the granulosa cell tumors that develop in transgenic mice expressing the simian virus 40 T-antigen under the inhibin-alpha promoter (inh alpha/Tag). We found high ZP3 expression in granulosa cell tumors of the transgenic mice, in human surface ovarian cancer and granulosa cell lines, and in human granulosa cell tumors and their metastases. Early preventive immunization (between 2 and 5.5 mo of age) of transgenic mice with recombinant human (rh) ZP3 prevented ovarian tumorigenesis, and delayed therapeutic immunization (between 4.5 and 7 mo) reduced weights of existing tumors by 86 and 75%, respectively (P<0.001), compared to vehicle-treated control mice. No objective side effects of the immunizations were observed. Liver metastases were found in nontreated/vehicletreated controls (n = 7/39), but none following active rhZP3 immunizations (n = 0/36; P<0.05). Immunization with rhZP3 was highly effective, as demonstrated by the induction of anti-ZP3 antibodies, as well as proliferative responses to the ZP3 antigen. These results signal rhZP3 immunization as a novel strategy to be developed for the immunotherapy of ovarian granulosa cell tumors, as well as for that of other malignancies that may express ZP3.-Rahman, N. A., Coelingh Bennink, H. J. T., Chrusciel, M., Sharp, V., Zimmerman, Y., Dina, R., Li, X., Ellonen, A., Rivero-Muller, A., Dilworth, S., Ghaem-Maghami, S., Vainio, O., Huhtaniemi, I. A novel treatment strategy for ovarian cancer based on immunization against zona pellucida protein (ZP) 3. FASEB J. 26, 324-333 (2012). www.fasebj.org	[Rahman, Nafis A.; Chrusciel, Marcin; Ellonen, Antti; Rivero-Mueller, Adolfo; Huhtaniemi, Ilpo] Univ Turku, Dept Physiol, Turku 20540, Finland; [Rahman, Nafis A.] Florida Int Univ, Coll Med, Dept Cell Biol, Miami, FL 33199 USA; [Rahman, Nafis A.] Florida Int Univ, Coll Med, Dept Human Mol Genet, Miami, FL 33199 USA; [Rahman, Nafis A.] Florida Int Univ, Coll Med, Dept Obstet & Gynecol, Miami, FL 33199 USA; [Bennink, Herjan J. T. Coelingh; Zimmerman, Yvette] Pantarhei Biosci BV, NL-3701 Zeist, Netherlands; [Sharp, Victoria; Dilworth, Stephen; Huhtaniemi, Ilpo] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod & Dev Biol, London, England; [Dina, Roberto; Ghaem-Maghami, Sadaf] Univ London Imperial Coll Sci Technol & Med, Dept Gynecol Oncol, Inst Reprod & Dev Biol, London, England; [Li, Xiangdong] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Vainio, Olli] Univ Oulu, Oulu Univ Hosp, Dept Microbiol & Immunol, Oulu, Finland; [Vainio, Olli] Univ Oulu, Oulu Univ Hosp, Clin Microbiol Lab, Oulu, Finland	University of Turku; State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; Imperial College London; Imperial College London; China Agricultural University; University of Oulu; University of Oulu	Rahman, NA (corresponding author), Univ Turku, Dept Physiol, Turku 20540, Finland.	nafis.rahman@utu.fi; hcb@pantarheibio.com	Rivero-Muller, Adolfo/A-5120-2008	Rivero-Muller, Adolfo/0000-0002-9794-802X; Ghaem-Maghami, Sadaf/0000-0002-7369-5080; Li, Xiangdong/0000-0003-2261-2393	Pantarhei Bioscience	Pantarhei Bioscience	This study was supported by an unrestricted grant from Pantarhei Bioscience. The authors thank Drs. Yoshihiro Nishi and Toshihiko Yanase (Department of Endocrinology and Diabetes Mellitus, School of Medicine, Fukuoka University, Fukuoka, Japan) for providing the KGN human granulosa cancer cell line. H. C. B. is the inventor of the treatment concept; N.A.R., H. C. B., and I. H. designed the research; N.A.R., M. C., V. S., R. D., A. E., and X. L. performed the experiments; V. S., S. D., and I. H. produced the rhZP3 protein; N.A.R., H. C. B, Y.Z., A. R. M., S. G. M., O.V., and I. H. analyzed and interpreted the results; and N.A.R., H. C. B., and I. H. wrote the manuscript. H. C. B. and Y.Z. are employees, and H. C. B. is a shareholder, of Pantarhei Bioscience, the company developing the treatment of ovarian granulosa cell cancer by ZP3 immunization. The other authors declare no conflicts of interest.	Amling CL, 2001, CURR PROB CANCER, V25, P219; BEAMER WG, 1986, JNCI-J NATL CANCER I, V77, P1117; BLAAKAER J, 1995, EUR J OBSTET GYN R B, V59, P53, DOI 10.1016/0028-2243(95)93678-H; Boggess JF, 1997, GYNECOL ONCOL, V64, P64, DOI 10.1006/gyno.1996.4520; COOKE I, 1995, BRIT J CANCER, V71, P1046, DOI 10.1038/bjc.1995.201; Cronje HS, 1999, AM J OBSTET GYNECOL, V180, P323, DOI 10.1016/S0002-9378(99)70207-3; Gupta SK, 1997, HUM REPROD UPDATE, V3, P311, DOI 10.1093/humupd/3.4.311; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Harris JD, 1999, PROTEIN EXPRES PURIF, V16, P298, DOI 10.1006/prep.1999.1060; Honda S, 1997, Int J Urol, V4, P68, DOI 10.1111/j.1442-2042.1997.tb00143.x; Hung CF, 2008, IMMUNOL REV, V222, P43, DOI 10.1111/j.1600-065X.2008.00622.x; JOBLING T, 1994, GYNECOL ONCOL, V55, P285, DOI 10.1006/gyno.1994.1291; Kananen K, 1997, ENDOCRINOLOGY, V138, P3521, DOI 10.1210/en.138.8.3521; Kananen K, 1996, MOL CELL ENDOCRINOL, V119, P135, DOI 10.1016/0303-7207(96)03802-6; KANANEN K, 1995, MOL ENDOCRINOL, V9, P616, DOI 10.1210/me.9.5.616; Kananen K, 1996, MOL ENDOCRINOL, V10, P1667, DOI 10.1210/me.10.12.1667; KAYE SB, 1986, GYNECOL ONCOL, V24, P261, DOI 10.1016/0090-8258(86)90035-1; Koukourakis GV, 2008, INTEGR CANCER THER, V7, P204, DOI 10.1177/1534735408322845; Kristensen GB, 1997, LANCET, V349, P113, DOI 10.1016/S0140-6736(96)06071-0; LAPPOHN RE, 1989, NEW ENGL J MED, V321, P790, DOI 10.1056/NEJM198909213211204; Li JY, 2007, J GENE MED, V9, P1095, DOI 10.1002/jgm.1069; LOU YH, 1993, J IMMUNOL, V151, P5790; MAHIBROWN CA, 1988, AM J REPROD IMMUNOL, V18, P94; MALMSTROM H, 1994, GYNECOL ONCOL, V52, P50, DOI 10.1006/gyno.1994.1010; Matzuk MM, 1996, RECENT PROG HORM RES, V51, P123; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; MILLAR SE, 1989, SCIENCE, V246, P935, DOI 10.1126/science.2479101; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; PATERSON M, 1992, BIOL REPROD, V46, P523, DOI 10.1095/biolreprod46.4.523; Paterson M, 1998, AM J REPROD IMMUNOL, V40, P198; Pectasides D, 2008, ANTICANCER RES, V28, P1421; Pectasides D, 2008, CANCER TREAT REV, V34, P1, DOI 10.1016/j.ctrv.2007.08.007; PESCHON JJ, 1992, MOL ENDOCRINOL, V6, P1403, DOI 10.1210/me.6.9.1403; Rahman NA, 1998, MOL CELL ENDOCRINOL, V145, P167, DOI 10.1016/S0303-7207(98)00184-1; Rahman NA, 2001, BIOL REPROD, V64, P1122, DOI 10.1095/biolreprod64.4.1122; Rath A, 2003, VACCINE, V21, P1913, DOI 10.1016/S0264-410X(02)00824-1; RHIM SH, 1992, J CLIN INVEST, V89, P28, DOI 10.1172/JCI115572; Riggs DR, 1997, CANCER, V79, P1987, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1987::AID-CNCR21>3.0.CO;2-Q; Rilianawati, 1999, MOL CELL ENDOCRINOL, V149, P9, DOI 10.1016/S0303-7207(99)00004-0; Savage P, 1998, Clin Oncol (R Coll Radiol), V10, P242, DOI 10.1016/S0936-6555(98)80008-3; Sole K., 2006, NAT CLIN PRACT UROL, V3, P292; Trope C, 1997, SEMIN ONCOL, V24, P1; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Wassarman Paul M., 2008, V475, P99, DOI 10.1007/978-1-59745-250-2_6; Wassarman PM, 2004, CYTOGENET GENOME RES, V105, P228, DOI 10.1159/000078193	45	7	9	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					324	333		10.1096/fj.11-192468	http://dx.doi.org/10.1096/fj.11-192468			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21974931				2022-12-25	WOS:000299202200032
J	Marom, M; Dayan, D; Demishtein-Zohary, K; Mokranjac, D; Neupert, W; Azem, A				Marom, Milit; Dayan, Dana; Demishtein-Zohary, Keren; Mokranjac, Dejana; Neupert, Walter; Azem, Abdussalam			Direct Interaction of Mitochondrial Targeting Presequences with Purified Components of the TIM23 Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; PRECURSOR PROTEINS; IMPORT MOTOR; PREPROTEIN TRANSLOCASE; TIM50; HSP70; BINDING; OUTER; SITE; SPECIFICITY	Precursor proteins that are imported from the cytosol into the matrix of mitochondria carry positively charged amphipathic presequences and cross the inner membrane with the help of vital components of the TIM23 complex. It is currently unclear which subunits of the TIM23 complex recognize and directly bind to presequences. Here we analyzed the binding of presequence peptides to purified components of the TIM23 complex. The interaction of three different presequences with purified soluble domains of yeast Tim50 (Tim50(IMS)), Tim23 (Tim23(IMS)), and full-length Tim44 was examined. Using chemical cross-linking and surface plasmon resonance we demonstrate, for the first time, the ability of purified Tim50IMS and Tim44 to interact directly with the yeast Hsp60 presequence. We also analyzed their interaction with presequences derived from precursors of yeast mitochondrial 70-kDa heat shock protein (mHsp70) and of bovine cytochrome P450(SCC). Moreover, we characterized the nature of the interactions and determined their K(D)s. On the basis of our results, we suggest a mechanism of translocation where stronger interactions of the presequences on the trans side of the channel support the import of precursor proteins through TIM23 into the matrix.	[Marom, Milit; Dayan, Dana; Demishtein-Zohary, Keren; Azem, Abdussalam] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel; [Neupert, Walter] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Mokranjac, Dejana] Univ Munich, Inst Physiol Chem, D-81377 Munich, Germany	Tel Aviv University; Max Planck Society; University of Munich	Azem, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	azema@tauex.tau.ac.il		Mokranjac, Dejana/0000-0002-4005-6979	German-Israeli Foundation for Scientific Research and Development [GIF-1012/08, SFB594]; Israel Science Foundation [452/09]; Tel-Aviv University; Ori Foundation	German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Tel-Aviv University; Ori Foundation	This work was supported by the German-Israeli Foundation for Scientific Research and Development Grant GIF-1012/08, SFB594 and Israel Science Foundation Grant 452/09. This work was also supported by the Argentinean Friends of Tel-Aviv University and by the Ori Foundation in Memory of Ori Levi (to D. D.).	Alder NN, 2008, MOL BIOL CELL, V19, P159, DOI 10.1091/mbc.E07-07-0669; Azem A, 1997, J BIOL CHEM, V272, P20901, DOI 10.1074/jbc.272.33.20901; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; BLOM J, 1993, MOL CELL BIOL, V13, P7364, DOI 10.1128/MCB.13.12.7364; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; de la Cruz L, 2010, PROTEIN SCI, V19, P2045, DOI 10.1002/pro.482; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Gevorkyan-Airapetov L, 2009, J BIOL CHEM, V284, P4865, DOI 10.1074/jbc.M807041200; Gruhler A, 1997, J BIOL CHEM, V272, P17410, DOI 10.1074/jbc.272.28.17410; Kanamori T, 1997, P NATL ACAD SCI USA, V94, P485, DOI 10.1073/pnas.94.2.485; Komiya T, 1997, EMBO J, V16, P4267, DOI 10.1093/emboj/16.14.4267; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Marom M, 2011, BBA-BIOMEMBRANES, V1808, P990, DOI 10.1016/j.bbamem.2010.07.011; Marom M, 2009, BIOCHEMISTRY-US, V48, P11185, DOI 10.1021/bi900998v; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Merlin A, 1999, J CELL BIOL, V145, P961, DOI 10.1083/jcb.145.5.961; Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Mokranjac D, 2010, BBA-BIOENERGETICS, V1797, P1045, DOI 10.1016/j.bbabio.2010.01.026; Mokranjac D, 2009, MOL BIOL CELL, V20, P1400, DOI 10.1091/mbc.E08-09-0934; Moro F, 1999, EMBO J, V18, P3667, DOI 10.1093/emboj/18.13.3667; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; SCHERER PE, 1992, P NATL ACAD SCI USA, V89, P11930, DOI 10.1073/pnas.89.24.11930; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Slutsky-Leiderman O, 2007, J BIOL CHEM, V282, P33935, DOI 10.1074/jbc.M704435200; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; van der Laan M, 2005, MOL CELL BIOL, V25, P7449, DOI 10.1128/MCB.25.17.7449-7458.2005; van der Laan M, 2006, FEMS YEAST RES, V6, P849, DOI 10.1111/j.1567-1364.2006.00134.x; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X; Yamamoto H, 2011, P NATL ACAD SCI USA, V108, P91, DOI 10.1073/pnas.1014918108; Yosef E, 2009, J MOL BIOL, V385, P1470, DOI 10.1016/j.jmb.2008.09.053	38	45	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43809	43815		10.1074/jbc.M111.261040	http://dx.doi.org/10.1074/jbc.M111.261040			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21969381	Green Published, hybrid			2022-12-25	WOS:000298402300023
J	Chung, J; Grant, RI; Kaplan, DR; Irwin, MS				Chung, Jacky; Grant, R. Ian; Kaplan, David R.; Irwin, Meredith S.			Special AT-rich Binding Protein-2 (SATB2) Differentially Affects Disease-causing p63 Mutant Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 HOMOLOG; SAM DOMAIN; ECTODERMAL DYSPLASIAS; TETRAMERIZATION DOMAIN; EPITHELIAL DEVELOPMENT; GENE-EXPRESSION; CLEFT-PALATE; AEC SYNDROME; PERP; P73	p63, a p53 family member, is critical for proper skin and limb development and directly regulates gene expression in the ectoderm. Mice lacking p63 exhibit skin and craniofacial defects including cleft palate. In humans p63 mutations are associated with several distinct developmental syndromes. p63 sterile-alpha-motif domain, AEC (ankyloblepharon-ectodermal dysplasiaclefting)-associated mutations are associated with a high prevalence of orofacial clefting disorders, which are less common in EEC (ectrodactyly-ectoderrnal dysplasia-defting) patients with DNA binding domain p63 mutations. However, the mechanisms by which these mutations differentially influence p63 function remain unclear, and interactions with other proteins implicated in craniofacial development have not been identified. Here, we show that AEC p63 mutations affect the ability of the p63 protein to interact with special AT-rich binding protein-2 (SATB2), which has recently also been implicated in the development of cleft palate. p63 and SATB2 are co-expressed early in development in the ectoderm of the first and second branchial arches, two essential sites where signaling is required for craniofacial patterning. SATB2 attenuates p63-mediated gene expression of perp (p53 apoptosis effector related to PMP-22), a critical downstream target gene during development, and specifically decreases p63 perp promoter binding. Interestingly, AEC but not EEC p63 mutations affect the ability of p63 to interact with SATB2 and the inhibitory effects of SATB2 on p63 transactivation of perp are most pronounced for AEC-associated p63 mutations. Our findings reveal a novel gain-of-function property of AEC-causing p63 mutations and identify SATB2 as the first p63 binding partner that differentially influences AEC and EEC p63 mutant proteins.	[Chung, Jacky; Kaplan, David R.; Irwin, Meredith S.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Irwin, Meredith S.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Irwin, Meredith S.] Univ Toronto, Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Chung, Jacky; Grant, R. Ian; Kaplan, David R.] Hosp Sick Children, Res Inst, Cell Biol Program, Div Hemato Oncol, Toronto, ON M5G 1L7, Canada; [Irwin, Meredith S.] Hosp Sick Children, Res Inst, Dept Paediat, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Irwin, MS (corresponding author), MaRS Ctr TMDT E Tower, Rm 12-601C,101 Coll St, Toronto, ON M5G 1L7, Canada.	meredith.irwin@sickkids.ca			Canadian Cancer Society [018054]; Canadian Institutes of Health Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Cancer Society Grant 018054.; Recipient of a doctoral Canada graduate scholarship from the Canadian Institutes of Health Research.	Attardi LD, 2000, GENE DEV, V14, P704; Beaudry VG, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001168; Beaudry VG, 2009, AM J MED GENET A, V149A, P1952, DOI 10.1002/ajmg.a.32760; Bellomaria A, 2010, CELL CYCLE, V9, P3730, DOI 10.4161/cc.9.18.12933; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; Browne G, 2011, J CELL SCI, V124, P2200, DOI 10.1242/jcs.079327; Brunner HG, 2002, J MED GENET, V39, P377, DOI 10.1136/jmg.39.6.377; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Chi SW, 1999, EMBO J, V18, P4438, DOI 10.1093/emboj/18.16.4438; Chung J, 2010, EMBO REP, V11, P777, DOI 10.1038/embor.2010.125; Cicero DO, 2006, CELL BIOCHEM BIOPHYS, V44, P475, DOI 10.1385/CBB:44:3:475; Coutandin D, 2009, CELL DEATH DIFFER, V16, P1582, DOI 10.1038/cdd.2009.139; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; Deutsch GB, 2011, CELL, V144, P566, DOI 10.1016/j.cell.2011.01.013; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Dugani CB, 2009, J NEUROSCI, V29, P6710, DOI 10.1523/JNEUROSCI.5878-08.2009; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Jacobs WB, 2005, NEURON, V48, P743, DOI 10.1016/j.neuron.2005.10.027; Kaustov L, 2007, J BIOL CHEM, V282, P11300, DOI 10.1074/jbc.M611297200; Laptenko O, 2011, P NATL ACAD SCI USA, V108, P10385, DOI 10.1073/pnas.1105680108; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lo Iacono N, 2008, DEVELOPMENT, V135, P1377, DOI 10.1242/dev.011759; Lopardo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002715; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Moretti F, 2010, J CLIN INVEST, V120, P1570, DOI 10.1172/JCI40267; Ou HD, 2007, EMBO J, V26, P3463, DOI 10.1038/sj.emboj.7601764; Radoja N, 2007, DEVELOPMENT, V134, P13, DOI 10.1242/dev.02703; Reczek EE, 2003, MOL CANCER RES, V1, P1048; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Sathyamurthy A, 2011, FEBS J, V278, P2680, DOI 10.1111/j.1742-4658.2011.08194.x; Soussi T, 2006, NAT REV CANCER, V6, P83, DOI 10.1038/nrc1783; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Thomason HA, 2008, DEV BIOL, V321, P273, DOI 10.1016/j.ydbio.2008.06.030; Thomason HA, 2010, J CLIN INVEST, V120, P1561, DOI 10.1172/JCI40266; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	49	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40671	40680		10.1074/jbc.M111.271189	http://dx.doi.org/10.1074/jbc.M111.271189			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965674	hybrid, Green Published			2022-12-25	WOS:000297315400028
J	Olmedo-Verd, E; Santamaria-Gomez, J; de Alda, JAGO; de Pouplana, LR; Luque, I				Olmedo-Verd, Elvira; Santamaria-Gomez, Javier; Ochoa de Alda, Jesus A. G.; Ribas de Pouplana, Lluis; Luque, Ignacio			Membrane Anchoring of Aminoacyl-tRNA Synthetases by Convergent Acquisition of a Novel Protein Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-I; SEQUENCE; COMPLEX; EVOLUTION; REVEALS; EXPRESSION; PREDICTION; TRNA(ILE); TRNA(VAL); MECHANISM	Four distinct aminoacyl-tRNA synthetases (aaRSs) found in some cyanobacterial species contain a novel protein domain that bears two putative transmembrane helices. This CAAD domain is present in glutamyl-, isoleucyl-, leucyl-, and valyl-tRNA synthetases, the latter of which has probably recruited the domain more than once during evolution. Deleting the CAAD domain from the valyl-tRNA synthetase of Anabaena sp. PCC 7120 did not significantly modify the catalytic properties of this enzyme, suggesting that it does not participate in its canonical tRNA-charging function. Multiple lines of evidence suggest that the function of the CAAD domain is structural, mediating the membrane anchorage of the enzyme, although membrane localization of aaRSs has not previously been described in any living organism. Synthetases containing the CAAD domain were localized in the intracytoplasmic thylakoid membranes of cyanobacteria and were largely absent from the plasma membrane. The CAAD domain was necessary and apparently sufficient for protein targeting to membranes. Moreover, localization of aaRSs in thylakoids was important under nitrogen limiting conditions. In Anabaena, a multicellular filamentous cyanobacterium often used as a model for prokaryotic cell differentiation, valyl-tRNA synthetase underwent subcellular relocation at the cell poles during heterocyst differentiation, a process also dependent on the CAAD domain.	[Olmedo-Verd, Elvira; Santamaria-Gomez, Javier; Luque, Ignacio] CSIC, Inst Bioquim Vegetal & Fotosintesis, E-41092 Seville, Spain; [Olmedo-Verd, Elvira; Santamaria-Gomez, Javier; Luque, Ignacio] Univ Seville, E-41092 Seville, Spain; [Ochoa de Alda, Jesus A. G.] IE Univ, Sch Biol, E-40003 Segovia, Spain; [Ribas de Pouplana, Lluis] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Ribas de Pouplana, Lluis] ICREA, Barcelona 08010, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); University of Sevilla; IE University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Luque, I (corresponding author), CSIC, Inst Bioquim Vegetal & Fotosintesis, Avda Americo Vespucio 49, E-41092 Seville, Spain.	ignacio.luque@ibvf.csic.es	de Alda, Jesús A. G. Ochoa/I-7613-2012; de Pouplana, Lluis Ribas/AAA-4738-2019; Luque, Inmaculada/K-9464-2014; Luque, Ignacio/D-5060-2009; Santamaría Gómez, Javier/F-3080-2015; Olmedo-Verd, Elvira/G-2549-2015	de Alda, Jesús A. G. Ochoa/0000-0002-4688-2470; de Pouplana, Lluis Ribas/0000-0002-2087-0359; Luque, Inmaculada/0000-0003-1838-2636; Luque, Ignacio/0000-0002-0336-5094; Santamaría Gómez, Javier/0000-0002-4379-1020; Olmedo-Verd, Elvira/0000-0003-0687-5767	Ministerio de Ciencia e Innovacion and Fondo Social Europeo [BFU2007-66589/BMC, BFU2010-19544/BMC]; Junta de Castilla y Leon [IEU002A10-2]; Proyectos de Excelencia, Junta de Andalucia y FEDER [P07-CVI-03167]; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion and Fondo Social Europeo(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Proyectos de Excelencia, Junta de Andalucia y FEDER; ICREA(ICREA)	This work was supported by Ministerio de Ciencia e Innovacion and Fondo Social Europeo Grants BFU2007-66589/BMC and BFU2010-19544/BMC, Junta de Castilla y Leon Grant IEU002A10-2, and Proyectos de Excelencia, Junta de Andalucia y FEDER Grant P07-CVI-03167.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel FM, 2010, CURRENT PROTOCOLS MO; Banerjee R, 2010, FEBS LETT, V584, P387, DOI 10.1016/j.febslet.2009.11.013; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; Cusack S., 1997, MANY FACES RNA, P55; de Pouplana LR, 2000, CELL MOL LIFE SCI, V57, P865, DOI 10.1007/PL00000729; DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007; Eddy SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000069; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Facey SJ, 2004, BBA-MOL CELL RES, V1694, P55, DOI 10.1016/j.bbamcr.2004.03.012; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Fukai S, 2003, RNA, V9, P100, DOI 10.1261/rna.2760703; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Hansson M, 2003, MOL CELL PROTEOMICS, V2, P550, DOI 10.1074/mcp.M300050-MCP200; Herrero A, 2004, FEMS MICROBIOL REV, V28, P469, DOI 10.1016/j.femsre.2004.04.003; Hsu JL, 2008, J MOL BIOL, V376, P482, DOI 10.1016/j.jmb.2007.11.065; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Khrouchtchova A, 2005, FEBS LETT, V579, P4808, DOI 10.1016/j.febslet.2005.07.061; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LANG NJ, 1971, PROC R SOC SER B-BIO, V178, P193, DOI 10.1098/rspb.1971.0061; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Liberton M, 2006, PROTOPLASMA, V227, P129, DOI 10.1007/s00709-006-0145-7; Liberton Michelle, 2008, P271; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Luque I, 2008, MOL BIOL EVOL, V25, P2369, DOI 10.1093/molbev/msn197; Luque I, 2006, MOL MICROBIOL, V60, P1276, DOI 10.1111/j.1365-2958.2006.05170.x; MacKinney G, 1941, J BIOL CHEM, V140, P315; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Merino-Puerto V, 2010, MOL MICROBIOL, V75, P1159, DOI 10.1111/j.1365-2958.2009.07031.x; Mirande M, 2010, FEBS LETT, V584, P443, DOI 10.1016/j.febslet.2009.11.027; Mullineaux CW, 2008, EMBO J, V27, P1299, DOI 10.1038/emboj.2008.66; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; ORR J, 1981, J BIOL CHEM, V256, P3099; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Raczniak G, 2001, J BIOL CHEM, V276, P45862, DOI 10.1074/jbc.M109494200; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; STEWART WDP, 1975, BIOCHEM BIOPH RES CO, V65, P846, DOI 10.1016/S0006-291X(75)80463-3; Ting CS, 2007, J BACTERIOL, V189, P4485, DOI 10.1128/JB.01948-06; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; Trifonov EN, 2009, CURR OPIN STRUC BIOL, V19, P335, DOI 10.1016/j.sbi.2009.03.007; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wolf YI, 1999, GENOME RES, V9, P689; Wong FC, 2003, J BIOL CHEM, V278, P52857, DOI 10.1074/jbc.M309627200; Xu Xudong, 2008, P383; Yuan JJ, 2010, CELL MOL LIFE SCI, V67, P179, DOI 10.1007/s00018-009-0160-x	81	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41057	41068		10.1074/jbc.M111.242461	http://dx.doi.org/10.1074/jbc.M111.242461			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965654	hybrid, Green Published			2022-12-25	WOS:000297315400065
J	Hoskins, ER; Hood, BL; Sun, M; Krivak, TC; Edwards, RP; Conrads, TP				Hoskins, Ebony R.; Hood, Brian L.; Sun, Mai; Krivak, Thomas C.; Edwards, Robert P.; Conrads, Thomas P.			Proteomic Analysis of Ovarian Cancer Proximal Fluids: Validation of Elevated Peroxiredoxin 1 in Patient Peripheral Circulation	PLOS ONE			English	Article							OXIDATIVE STRESS; EXPRESSION; CARCINOMA; ABUNDANCE; RESOURCE; PROTEIN	Background: Epithelial ovarian cancer (EOC) is the deadliest gynecologic malignancy in the United States. Unfortunately, a validated protein biomarker-screening test to detect early stage disease from peripheral blood has not yet been developed. The present investigation assesses the ability to identify tumor relevant proteins from ovarian cancer proximal fluids, including tissue interstitial fluid (TIF) and corresponding ascites, from patients with papillary serous EOC and translates these findings to targeted blood-based immunoassays. Methodology/Principal Findings: Paired TIF and ascites collected from four papillary serous EOC patients at the time of surgery underwent immunodepletion, resolution by 1D gel electrophoresis and in-gel digestion for analysis by liquid chromatography-tandem mass spectrometry, which resulted in an aggregate identification of 569 and 171 proteins from TIF and ascites, respectively. Of these, peroxiredoxin I (PRDX1) was selected for validation in serum by ELISA and demonstrated to be present and significantly elevated (p = 0.0188) in 20 EOC patients with a mean level of 26.0 ng/mL (+/- 9.27 SEM) as compared to 4.19 ng/mL (+/- 2.58 SEM) from 16 patients with normal/benign ovarian pathology. Conclusions/Significance: We have utilized a workflow for harvesting EOC-relevant proximal biofluids, including TIF and ascites, for proteomic analysis. Among the differentially abundant proteins identified from these proximal fluids, PRDX1 was demonstrated to be present in serum and shown by ELISA to be elevated by nearly 6-fold in papillary serous EOC patients relative to normal/benign patients. Our findings demonstrate the facile ability to discover potential EOC-relevant proteins in proximal fluids and confirm their presence in peripheral blood serum. In addition, our finding of elevated levels of PRDX1 in the serum of EOC patients versus normal/benign patients warrants further evaluation as a tumor specific biomarker for EOC.	[Hoskins, Ebony R.; Krivak, Thomas C.; Edwards, Robert P.] Univ Pittsburgh, Magee Womens Hosp, Sch Med, Div Gynecol Oncol,Dept Obstet Gynecol & Reprod Sc, Pittsburgh, PA 15213 USA; [Hood, Brian L.; Conrads, Thomas P.] Inova Hlth Syst, Womens Hlth Integrated Res Ctr, Gynecol Canc Ctr Excellence, Annandale, VA USA; [Sun, Mai] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Inova Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hoskins, ER (corresponding author), Univ Pittsburgh, Magee Womens Hosp, Sch Med, Div Gynecol Oncol,Dept Obstet Gynecol & Reprod Sc, Pittsburgh, PA 15213 USA.	conrads@whirc.org		Sun, Mai/0000-0003-0489-1616	Scaife Foundation	Scaife Foundation	Financial support was provided by The Scaife Foundation Pilot Project Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW JJ, 1983, CLIN OBSTET GYNAECOL, V10, P187; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Chen MF, 2006, INT J RADIAT ONCOL, V64, P581, DOI 10.1016/j.ijrobp.2005.10.012; Chung KH, 2010, J PROTEOME RES, V9, P451, DOI 10.1021/pr900811x; Davidson B, 2006, CLIN CANCER RES, V12, P791, DOI 10.1158/1078-0432.CCR-05-2516; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; Gromov P, 2010, MOL ONCOL, V4, P65, DOI 10.1016/j.molonc.2009.11.003; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Hoshino I, 2007, ONCOL REP, V18, P867; JACOBS I, 1993, BRIT MED J, V306, P1030, DOI 10.1136/bmj.306.6884.1030; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Konstantinopoulos PA, 2008, NAT CLIN PRACT ONCOL, V5, P577, DOI 10.1038/ncponc1178; KOSARY C, 2007, CANC OVARY; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Maxwell GL, 2011, GYNECOL ONCOL, V121, P586, DOI 10.1016/j.ygyno.2011.02.031; OLIVER KE, 2011, GYNECOL ONCOL; Pylvas M, 2010, EUR J CANCER, V46, P1661, DOI 10.1016/j.ejca.2010.02.006; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Riddell JR, 2011, CANCER RES, V71, P1637, DOI 10.1158/0008-5472.CAN-10-3674; Roessner A, 2008, PATHOL RES PRACT, V204, P511, DOI 10.1016/j.prp.2008.04.011; Teng PN, 2011, J PROTEOME RES, V10, P1333, DOI 10.1021/pr101074p; Wu XY, 2010, HISTOL HISTOPATHOL, V25, P1297, DOI 10.14670/HH-25.1297	23	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25056	10.1371/journal.pone.0025056	http://dx.doi.org/10.1371/journal.pone.0025056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980378	gold, Green Accepted, Green Published			2022-12-25	WOS:000295941300017
J	Nakagawa, T; Suzuki, Y; Nagayasu, K; Kitaichi, M; Shirakawa, H; Kaneko, S				Nakagawa, Takayuki; Suzuki, Yuichi; Nagayasu, Kazuki; Kitaichi, Maiko; Shirakawa, Hisashi; Kaneko, Shuji			Repeated Exposure to Methamphetamine, Cocaine or Morphine Induces Augmentation of Dopamine Release in Rat Mesocorticolimbic Slice Co-Cultures	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; BEHAVIORAL SENSITIZATION; RECEPTOR ACTIVATION; SEROTONIN RELEASE; NUCLEUS ACCUMBENS; VENTRAL STRIATUM; D-AMPHETAMINE; NEUROTRANSMISSION; NEURONS; ADDICTION	Repeated intermittent exposure to psychostimulants and morphine leads to progressive augmentation of its locomotor activating effects in rodents. Accumulating evidence suggests the critical involvement of the mesocorticolimbic dopaminergic neurons, which project from the ventral tegmental area to the nucleus accumbens and the medial prefrontal cortex, in the behavioral sensitization. Here, we examined the acute and chronic effects of psychostimulants and morphine on dopamine release in a reconstructed mesocorticolimbic system comprised of a rat triple organotypic slice co-culture of the ventral tegmental area, nucleus accumbens and medial prefrontal cortex regions. Tyrosine hydroxylase-positive cell bodies were localized in the ventral tegmental area, and their neurites projected to the nucleus accumbens and medial prefrontal cortex regions. Acute treatment with methamphetamine (0.1-1000 mu M), cocaine (0.1-300 mu M) or morphine (0.1-100 mu M) for 30 min increased extracellular dopamine levels in a concentration-dependent manner, while 3,4-methylenedioxyamphetamine (0.1-1000 mu M) had little effect. Following repeated exposure to methamphetamine (10 mu M) for 30 min every day for 6 days, the dopamine release gradually increased during the 30-min treatment. The augmentation of dopamine release was maintained even after the withdrawal of methamphetamine for 7 days. Similar augmentation was observed by repeated exposure to cocaine (1-300 mu M) or morphine (10 and 100 mu M). Furthermore, methamphetamine-induced augmentation of dopamine release was prevented by an NMDA receptor antagonist, MK-801 (10 mu M), and was not observed in double slice co-cultures that excluded the medial prefrontal cortex slice. These results suggest that repeated psychostimulant-or morphine-induced augmentation of dopamine release, i.e. dopaminergic sensitization, was reproduced in a rat triple organotypic slice co-cultures. In addition, the slice co-culture system revealed that the NMDA receptors and the medial prefrontal cortex play an essential role in the dopaminergic sensitization. This in vitro sensitization model provides a unique approach for studying mechanisms underlying behavioral sensitization to drugs of abuse.	[Nakagawa, Takayuki; Suzuki, Yuichi; Nagayasu, Kazuki; Kitaichi, Maiko; Shirakawa, Hisashi; Kaneko, Shuji] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Kyoto, Japan	Kyoto University	Nakagawa, T (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Kyoto, Japan.	tnakaga@pharm.kyoto-u.ac.jp	Kaneko, Shuji/AAR-1005-2021; Nagayasu, Kazuki/B-4095-2014	Nakagawa, Takayuki/0000-0003-1890-0843; Kaneko, Shuji/0000-0001-5152-5809; Shirakawa, Hisashi/0000-0002-4129-0978	Ministry of Education, Culture, Sports, Science and Technology of Japan [20790062]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 20790062). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENMANSOUR S, 1992, PSYCHOPHARMACOLOGY, V106, P459, DOI 10.1007/BF02244815; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Cador M, 1999, NEUROSCIENCE, V94, P705, DOI 10.1016/S0306-4522(99)00361-9; Cass WA, 1998, NEUROSCI LETT, V248, P175, DOI 10.1016/S0304-3940(98)00374-7; Chefer VI, 2000, NEUROSCIENCE, V101, P619, DOI 10.1016/S0306-4522(00)00417-6; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203; Gifford AN, 2000, N-S ARCH PHARMACOL, V362, P413, DOI 10.1007/s002100000293; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; Good CH, 2010, J NEUROSCI, V30, P7900, DOI 10.1523/JNEUROSCI.1507-10.2010; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Hedou G, 2001, NEUROPHARMACOLOGY, V40, P366, DOI 10.1016/S0028-3908(00)00174-X; Higuchi M, 2008, J NEUROCHEM, V106, P2410, DOI 10.1111/j.1471-4159.2008.05583.x; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; KALIVAS PW, 1989, J PHARMACOL EXP THER, V251, P378; KALIVAS PW, 1988, J NEUROCHEM, V50, P1498, DOI 10.1111/j.1471-4159.1988.tb03036.x; KARLER R, 1989, LIFE SCI, V45, P599, DOI 10.1016/0024-3205(89)90045-3; Kim S, 2000, J PHARMACOL EXP THER, V293, P625; Kita T, 2003, J PHARMACOL SCI, V92, P178; Kitai ST, 1999, CURR OPIN NEUROBIOL, V9, P690, DOI 10.1016/S0959-4388(99)00040-9; KOLTA MG, 1989, NEUROPHARMACOLOGY, V28, P9, DOI 10.1016/0028-3908(89)90060-9; Maeda T, 2004, BRAIN RES, V1015, P34, DOI 10.1016/j.brainres.2004.04.033; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; OHMORI T, 1994, PHARMACOL BIOCHEM BE, V48, P587, DOI 10.1016/0091-3057(94)90318-2; PAULSON PE, 1995, SYNAPSE, V19, P56, DOI 10.1002/syn.890190108; Paxinos G., 1991, ATLAS DEV RAT BRAIN; PERIS J, 1989, PHARMACOL BIOCHEM BE, V32, P71, DOI 10.1016/0091-3057(89)90212-8; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; ROBINSON TE, 1988, BRAIN RES, V462, P211, DOI 10.1016/0006-8993(88)90549-5; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rouge-Pont F, 1999, EUR J NEUROSCI, V11, P2343, DOI 10.1046/j.1460-9568.1999.00650.x; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; RYAN LJ, 1988, LIFE SCI, V43, P1403, DOI 10.1016/0024-3205(88)90307-4; Schmidt HD, 2010, ANN NY ACAD SCI, V1187, P35, DOI 10.1111/j.1749-6632.2009.05144.x; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Sorg BA, 1997, J PHARMACOL EXP THER, V281, P54; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; White FJ, 1996, ANNU REV NEUROSCI, V19, P405, DOI 10.1146/annurev.ne.19.030196.002201; White SR, 1996, PROG NEUROBIOL, V49, P455, DOI 10.1016/0301-0082(96)00027-5; Williams JM, 2005, NEUROPHARMACOLOGY, V48, P51, DOI 10.1016/j.neuropharm.2004.09.004; WOLF ME, 1995, NEUROSCIENCE, V69, P417, DOI 10.1016/0306-4522(95)00248-H; Wu WR, 2003, BRAIN RES, V991, P232, DOI 10.1016/j.brainres.2003.03.001	44	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24865	10.1371/journal.pone.0024865	http://dx.doi.org/10.1371/journal.pone.0024865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980362	gold, Green Submitted, Green Published			2022-12-25	WOS:000295941300013
J	Moroni, M; Lombardini, E; Salber, R; Kazemzedeh, M; Nagy, V; Olsen, C; Whitnall, MH				Moroni, Maria; Lombardini, Eric; Salber, Rudolph; Kazemzedeh, Mehdi; Nagy, Vitaly; Olsen, Cara; Whitnall, Mark H.			Hematological Changes as Prognostic Indicators of Survival: Similarities Between Gottingen Minipigs, Humans, and Other Large Animal Models	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NONHUMAN PRIMATE MODEL; INDUCED MARROW APLASIA; MULTILINEAGE HEMATOPOIETIC RECOVERY; RADIATION-INDUCED MYELOSUPPRESSION; G-CSF; HUMAN INTERLEUKIN-6; RECEPTOR AGONIST; COMBINATION; EXPOSURE	Background: The animal efficacy rule addressing development of drugs for selected disease categories has pointed out the need to develop alternative large animal models. Based on this rule, the pathophysiology of the disease in the animal model must be well characterized and must reflect that in humans. So far, manifestations of the acute radiation syndrome (ARS) have been extensively studied only in two large animal models, the non-human primate (NHP) and the canine. We are evaluating the suitability of the minipig as an additional large animal model for development of radiation countermeasures. We have previously shown that the Gottingen minipig manifests hematopoietic ARS phases and symptoms similar to those observed in canines, NHPs, and humans. Principal Findings: We establish here the LD50/30 dose (radiation dose at which 50% of the animals succumb within 30 days), and show that at this dose the time of nadir and the duration of cytopenia resemble those observed for NHP and canines, and mimic closely the kinetics of blood cell depletion and recovery in human patients with reversible hematopoietic damage (H3 category, METREPOL approach). No signs of GI damage in terms of diarrhea or shortening of villi were observed at doses up to 1.9 Gy. Platelet counts at days 10 and 14, number of days to reach critical platelet values, duration of thrombocytopenia, neutrophil stress response at 3 hours and count at 14 days, and CRP-to-platelet ratio were correlated with survival. The ratios between neutrophils, lymphocytes and platelets were significantly correlated with exposure to irradiation at different time intervals. Significance: As a non-rodent animal model, the minipig offers a useful alternative to NHP and canines, with attractive features including ARS resembling human ARS, cost, and regulatory acceptability. Use of the minipig may allow accelerated development of radiation countermeasures.	[Moroni, Maria; Salber, Rudolph; Kazemzedeh, Mehdi; Whitnall, Mark H.] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Radiat Countermeasures Program, Sci Res Dept, Bethesda, MD 20814 USA; [Lombardini, Eric] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Dept Vet Sci, Bethesda, MD 20814 USA; [Nagy, Vitaly] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Dept Radiat Sci, Bethesda, MD 20814 USA; [Olsen, Cara] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Biostat Consulting Ctr, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Moroni, M (corresponding author), Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Radiat Countermeasures Program, Sci Res Dept, Bethesda, MD 20814 USA.	moroni@afrri.usuhs.mil			National Institute of Allergy and Infectious Diseases [OD-0505-01]; Armed Forced Radiobiology Research Institute [RBB2DG]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Armed Forced Radiobiology Research Institute	This work was supported by funding from National Institute of Allergy and Infectious Diseases OD-0505-01 and Armed Forced Radiobiology Research Institute RBB2DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizova TV, 2008, HEALTH PHYS, V94, P255, DOI 10.1097/01.HP.0000290833.66789.df; Belyi DA, 2009, RADIAT PROT DOSIM, V134, P159, DOI 10.1093/rpd/ncp077; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; BURSTEIN SA, 1992, BLOOD, V80, P420; Carsten AL., 1984, RESPONSE DIFFERENT S; CORASH L, 1978, BLOOD, V52, P726; Deeg HJ, 1997, ANN HEMATOL, V74, P117, DOI 10.1007/s002770050268; DEUBELBEISS KA, 1975, J CLIN INVEST, V55, P833, DOI 10.1172/JCI107994; Drouet M, 2010, INT J RADIAT BIOL, V86, P636, DOI 10.3109/09553001003789604; ELTRINGHAM JR, 1967, RADIAT RES, V31, P533; FARESE AM, 1993, BLOOD, V82, P3012; Farese AM, 1996, J CLIN INVEST, V97, P2145, DOI 10.1172/JCI118652; Farese AM, 2001, STEM CELLS, V19, P522, DOI 10.1634/stemcells.19-6-522; Fliedner TM, 2007, EXP HEMATOL, V35, P8, DOI 10.1016/j.exphem.2007.01.006; Fliedner TM, 2001, MED MANAGEMENT RAD A, P18; Forster R, 2010, J PHARMACOL TOX MET, V62, P227, DOI 10.1016/j.vascn.2010.05.007; Goans RE, 1997, HEALTH PHYS, V72, P513, DOI 10.1097/00004032-199704000-00001; HERODIN F, 1992, BLOOD, V80, P688; Herodin F, 2007, EXP HEMATOL, V35, P1172, DOI 10.1016/j.exphem.2007.04.017; Jacobs A, 2006, EXPERT OPIN DRUG MET, V2, P345, DOI 10.1517/17425255.2.3.345; JAIN NC, 1993, ESSENTIALS VET HEMAT, P23; Larsen MH, 2001, COMPARATIVE MED, V51, P436; MacVittie TJ, 2005, HEALTH PHYS, V89, P546, DOI 10.1097/01.HP.0000173143.69659.5b; MACVITTIE TJ, 1994, BLOOD, V84, P2515; MacVittie TJ, 2000, BLOOD, V95, P837, DOI 10.1182/blood.V95.3.837.003k08_837_845; MacVittie TJ, 1996, BLOOD, V87, P4129, DOI 10.1182/blood.V87.10.4129.bloodjournal87104129; MANDEL L, 1980, Z VERSUCHSTIERKD, V22, P96; MOORE DM, 2006, SCHALMS VET HEMATOLO; Moroni M, 2011, RADIAT RES, V176, P89, DOI 10.1667/RR2481.1; Moroni M, 2011, J AM ASSOC LAB ANIM, V50, P65; NORRIS WP, 1968, RADIAT RES, V35, P681, DOI 10.2307/3572525; NOTHDURFT W, 1992, INT J RADIAT BIOL, V61, P519, DOI 10.1080/09553009214551281; ROTH JA, 2006, DIS SWINE; RUST JH, 1954, RADIOLOGY, V62, P569, DOI 10.1148/62.4.569; Simianer H, 2010, J PHARMACOL TOX MET, V62, P221, DOI 10.1016/j.vascn.2010.05.004; SMITH GS, 2006, SCHALMS VET HEMATOLO; SMITH RD, 1975, INFECT IMMUN, V11, P1216, DOI 10.1128/IAI.11.6.1216-1221.1975; Stickney DR, 2007, INT IMMUNOPHARMACOL, V7, P500, DOI 10.1016/j.intimp.2006.12.005; Stockham SL., 2008, FUNDAMENTALS VET CLI, V2nd; TULLIS JL, 1949, RADIOLOGY, V52, P396, DOI 10.1148/52.3.396; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1	41	55	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25210	10.1371/journal.pone.0025210	http://dx.doi.org/10.1371/journal.pone.0025210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969873	Green Submitted, gold, Green Published			2022-12-25	WOS:000295936900035
J	Tang, XL; Sanganalmath, SK; Sato, H; Bi, QL; Hunt, G; Vincent, RJ; Peng, Y; Shirk, G; Dawn, B; Bolli, R				Tang, Xian-Liang; Sanganalmath, Santosh K.; Sato, Hiroshi; Bi, Qiuli; Hunt, Greg; Vincent, Robert J.; Peng, Yong; Shirk, Gregg; Dawn, Buddhadeb; Bolli, Roberto			Atorvastatin Therapy during the Peri-Infarct Period Attenuates Left Ventricular Dysfunction and Remodeling after Myocardial Infarction	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; NONISCHEMIC HEART-FAILURE; DILATED CARDIOMYOPATHY; ECHOCARDIOGRAPHIC-ASSESSMENT; DIASTOLIC DYSFUNCTION; EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISMS; REDUCTASE INHIBITOR; CARDIAC-HYPERTROPHY; CHOLESTEROL LEVELS	Although statins impart a number of cardiovascular benefits, whether statin therapy during the peri-infarct period improves subsequent myocardial structure and function remains unclear. Thus, we evaluated the effects of atorvastatin on cardiac function, remodeling, fibrosis, and apoptosis after myocardial infarction (MI). Two groups of rats were subjected to permanent coronary occlusion. Group II (n = 14) received oral atorvastatin (10 mg/kg/d) daily for 3 wk before and 4 wk after MI, while group I (n = 12) received equivalent doses of vehicle. Infarct size (Masson's trichrome-stained sections) was similar in both groups. Compared with group I, echocardiographic left ventricular ejection fraction (LVEF) and fractional area change (FAC) were higher while LV end-diastolic volume (LVEDV) and LV end-systolic and end-diastolic diameters (LVESD and LVEDD) were lower in treated rats. Hemodynamically, atorvastatin-treated rats exhibited significantly higher dP/dt(max), end-systolic elastance (Ees), and preload recruitable stroke work (PRSW) and lower LV end-diastolic pressure (LVEDP). Morphometrically, infarct wall thickness was greater in treated rats. The improvement of LV function by atorvastatin was associated with a decrease in hydroxyproline content and in the number of apoptotic cardiomyocyte nuclei. We conclude that atorvastatin therapy during the peri-infarct period significantly improves LV function and limits adverse LV remodeling following MI independent of a reduction in infarct size. These salubrious effects may be due in part to a decrease in myocardial fibrosis and apoptosis.	[Tang, Xian-Liang; Sanganalmath, Santosh K.; Sato, Hiroshi; Bi, Qiuli; Hunt, Greg; Peng, Yong; Shirk, Gregg; Bolli, Roberto] Univ Louisville, Div Cardiovasc Med, Louisville, KY 40292 USA; [Tang, Xian-Liang; Sanganalmath, Santosh K.; Sato, Hiroshi; Bi, Qiuli; Hunt, Greg; Peng, Yong; Shirk, Gregg; Bolli, Roberto] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA; [Vincent, Robert J.; Dawn, Buddhadeb] Univ Kansas, Med Ctr, Cardiovasc Res Inst, Kansas City, KS 66103 USA	University of Louisville; University of Louisville; University of Kansas; University of Kansas Medical Center	Tang, XL (corresponding author), Univ Louisville, Div Cardiovasc Med, Louisville, KY 40292 USA.	rbolli@louisville.edu	Peng, Yong/G-9270-2018; Tang, Xian-Liang/L-5703-2015; Bolli, Roberto/A-6870-2010; Stefanadis, Christodoulos/ABH-2232-2020	Peng, Yong/0000-0001-8390-7668; Tang, Xian-Liang/0000-0002-5987-340X; Stefanadis, Christodoulos/0000-0001-5974-6454	National Institutes of Health (NIH) [R0170897, HL-76794, HL-78825, HL-55757, HL-74351]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074351, R01HL076794, P01HL078825, R37HL055757, R01HL055757, R01HL070897] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by National Institutes of Health (NIH) Grants R0170897, HL-76794, HL-78825, HL-55757, and HL-74351. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT NR, 1979, ANNU REV PHYSIOL, V41, P521, DOI 10.1146/annurev.ph.41.030179.002513; ANVERSA P, 1985, AM J PHYSIOL, V248, pH883, DOI 10.1152/ajpheart.1985.248.6.H883; Aronow HD, 2008, AM J CARDIOL, V102, P1119, DOI 10.1016/j.amjcard.2008.06.032; Assayag P, 1997, CARDIOVASC RES, V34, P439, DOI 10.1016/S0008-6363(97)00073-4; Bauersachs J, 2001, CIRCULATION, V104, P982, DOI 10.1161/hc3401.095946; Birnbaum Y, 2003, CARDIOVASC DRUG THER, V17, P25, DOI 10.1023/A:1024251607923; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; COVELL JW, 1990, CIRCULATION, V81, P155; Didenko VV, 1999, BIOTECHNIQUES, V27, P1130, DOI 10.2144/99276bm09; Didenko VV, 1998, AM J PATHOL, V152, P897; Filusch A, 2008, ECHOCARDIOGR-J CARD, V25, P974, DOI 10.1111/j.1540-8175.2008.00724.x; Hayashidani S, 2002, CIRCULATION, V105, P868, DOI 10.1161/hc0702.104164; Herrmann J, 2002, CIRCULATION, V106, P2180, DOI 10.1161/01.CIR.0000037520.89770.5E; Heusch G, 2009, CIRCULATION, V120, P1822, DOI 10.1161/CIRCULATIONAHA.109.888784; Iliodromitis EK, 2010, BASIC RES CARDIOL, V105, P193, DOI 10.1007/s00395-009-0078-3; Kang L, 2007, PHARMACOLOGY, V80, P120, DOI 10.1159/000103251; Krum H, 2007, J CARD FAIL, V13, P1, DOI 10.1016/j.cardfail.2006.09.008; Laufs U, 2004, Z KARDIOL, V93, P103, DOI 10.1007/s00392-004-1005-0; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; LITWIN SE, 1994, CIRCULATION, V89, P345, DOI 10.1161/01.CIR.89.1.345; Node K, 2003, CIRCULATION, V108, P839, DOI 10.1161/01.CIR.0000084539.58092.DE; Oi S, 1999, EUR J PHARMACOL, V376, P139, DOI 10.1016/S0014-2999(99)00282-4; PEDERSEN TR, 1994, LANCET, V344, P1383; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Plenge JK, 2002, CIRCULATION, V106, P1447, DOI 10.1161/01.CIR.0000029743.68247.31; Pliquett RU, 2003, CIRCULATION, V107, P2493, DOI 10.1161/01.CIR.0000065606.63163.B9; Rossi MA, 1998, J HYPERTENS, V16, P1031, DOI 10.1097/00004872-199816070-00018; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schmechel A, 2009, CARDIOVASC RES, V82, P100, DOI 10.1093/cvr/cvp005; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Stefanadi E, 2009, INT J CARDIOL, V133, P266, DOI 10.1016/j.ijcard.2007.11.025; Stein AB, 2007, BASIC RES CARDIOL, V102, P28, DOI 10.1007/s00395-006-0627-y; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; SWITZER BR, 1971, ANAL BIOCHEM, V39, P487, DOI 10.1016/0003-2697(71)90438-6; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Trochu JN, 2003, CARDIOVASC RES, V60, P250, DOI 10.1016/j.cardiores.2003.08.003; Van Linthout S, 2007, DIABETOLOGIA, V50, P1977, DOI 10.1007/s00125-007-0719-8; Vaughan CJ, 2000, J AM COLL CARDIOL, V35, P1, DOI 10.1016/S0735-1097(99)00525-2; Weber KT, 1997, CIRCULATION, V96, P4065; Weinberg EO, 2005, AM J PHYSIOL-HEART C, V288, pH1802, DOI 10.1152/ajpheart.00962.2004; Wojnicz R, 2006, AM J CARDIOL, V97, P899, DOI 10.1016/j.amjcard.2005.09.142; Wu YM, 2004, J MOL CELL CARDIOL, V37, P111, DOI 10.1016/j.yjmcc.2004.04.010; Yao L, 2009, BASIC RES CARDIOL, V104, P258, DOI 10.1007/s00395-008-0751-y; Ye YM, 2008, AM J PHYSIOL-HEART C, V295, pH343, DOI 10.1152/ajpheart.01350.2007; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	48	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25320	10.1371/journal.pone.0025320	http://dx.doi.org/10.1371/journal.pone.0025320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980426	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900053
J	Hu, MJ; Cox, KD; Schnabel, G; Luo, CX				Hu, Meng-Jun; Cox, Kerik D.; Schnabel, Guido; Luo, Chao-Xi			Monilinia Species Causing Brown Rot of Peach in China	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR PHYLOGENY; FRUIT CROPS; 1ST REPORT; FRUCTICOLA; IDENTIFICATION; FUNGI; LAXA; DNA; FRUCTIGENA	In this study, 145 peaches and nectarines displaying typical brown rot symptoms were collected from multiple provinces in China. A subsample of 26 single-spore isolates were characterized phylogenetically and morphologically to ascertain species. Phylogenetic analysis of internal transcribed spacer (ITS) regions 1 and 2, glyceraldehyde-3-phosphate dehydrogenase (G3PDH), b-tubulin (TUB2) revealed the presence of three distinct Monilinia species. These species included Monilinia fructicola, Monilia mumecola, and a previously undescribed species designated Monilia yunnanensis sp. nov. While M. fructicola is a well-documented pathogen of Prunus persica in China, M. mumecola had primarily only been isolated from mume fruit in Japan. Koch's postulates for M. mumecola and M. yunnanensis were fulfilled confirming pathogenicity of the two species on peach. Phylogenetic analysis of ITS, G3PDH, and TUB2 sequences indicated that M. yunnanensis is most closely related to M. fructigena, a species widely prevalent in Europe. Interestingly, there were considerable differences in the exon/intron structure of the cytochrome b (Cyt b) gene between the two species. Morphological characteristics, including spore size, colony morphology, lesion growth rate, and sporulation, support the phylogenetic evidence suggesting the designation of M. yunnanensis as a new species. A new multiplex PCR method was developed to facilitate the detection of M. yunnanensis and differentiation of Monilinia spp. causing brown rot of peach in China.	[Hu, Meng-Jun; Luo, Chao-Xi] Huazhong Agr Univ, Coll Plant Sci & Technol, Dept Plant Pathol, Wuhan, Peoples R China; [Hu, Meng-Jun; Luo, Chao-Xi] Huazhong Agr Univ, Key Lab Crop Dis Monitoring & Safety Control Hube, Wuhan, Peoples R China; [Cox, Kerik D.] Cornell Univ, New York State Agr Expt Stn, Dept Plant Pathol & Plant Microbe Biol, Geneva, NY 14456 USA; [Schnabel, Guido] Clemson Univ, Dept Entomol Soils & Plant Sci, Clemson, SC USA	Huazhong Agricultural University; Huazhong Agricultural University; Cornell University; Clemson University	Luo, CX (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Dept Plant Pathol, Wuhan, Peoples R China.	cxluo@mail.hzau.edu.cn		Hu, Mengjun/0000-0003-1567-0843	Program for New Century Excellent Talents in University [NCET-08-0783]; Fundamental Research Funds for the Central Universities [2009PY010]; National Natural Science Foundation of China [31071703]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This material is based upon work supported by Program for New Century Excellent Talents in University (NCET-08-0783) and the Fundamental Research Funds for the Central Universities (Program No. 2009PY010), also partially sponsored by Project supported by the National Natural Science Foundation of China (Grant No. 31071703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baldwin BG, 1992, MOL PHYLOGENET EVOL, V1, P3, DOI 10.1016/1055-7903(92)90030-K; Bryde RJ, 1977, BROWN ROT FUNGI FRUI; CABI, 2010, CROP PROT COMP; Chen YC, 2001, J CLIN MICROBIOL, V39, P4042, DOI 10.1128/JCM.39.11.4042-4051.2001; Cote MJ, 2004, PLANT DIS, V88, P1219, DOI 10.1094/PDIS.2004.88.11.1219; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; de Jong SN, 2001, MYCOL RES, V105, P658, DOI 10.1017/S0953756201003926; Fan JY, 2010, J EUKARYOT MICROBIOL, V57, P206, DOI 10.1111/j.1550-7408.2009.00467.x; Fan JinYan, 2007, Acta Phytophylacica Sinica, V34, P289; Fournier E, 2006 APS CPS MSA JOI, P195; Fournier E, 2005, MYCOLOGIA, V97, P1251, DOI 10.3852/mycologia.97.6.1251; Fulton CE, 1999, EUR J PLANT PATHOL, V105, P495, DOI 10.1023/A:1008711107347; Gell I, 2007, J APPL MICROBIOL, V103, P2629, DOI 10.1111/j.1365-2672.2007.03495.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harada Y, 1990, ANN PHYTOPATHOLOGICA, V59, P387; Harada Yukio, 2004, Journal of General Plant Pathology, V70, P297, DOI 10.1007/s10327-004-0137-4; Hily JM, 2011, PEST MANAG SCI, V67, P385, DOI 10.1002/ps.2074; HolstJensen A, 1997, AM J BOT, V84, P686, DOI 10.2307/2445905; Hu MJ, 2011, PLANT DIS, V95, P225, DOI 10.1094/PDIS-11-10-0779; Ioos R, 2000, EUR J PLANT PATHOL, V106, P373, DOI 10.1023/A:1008798520882; Iwen PC, 2002, MED MYCOL, V40, P87, DOI 10.1080/mmy.40.1.87.109; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; KHOKHRIAKOVA TM, 1978, MIKOL FITOPATOL, V12, P154; Lane C. R., 2002, Bulletin OEPP, V32, P489, DOI 10.1046/j.1365-2338.2002.00595.x; Lehman JS, 2000, PHYTOPATHOLOGY, V90, P390, DOI 10.1094/PHYTO.2000.90.4.390; LI ZL, 1984, HORTSCIENCE, V19, P348; Luo Chao-Xi, 2002, Journal of General Plant Pathology, V68, P300, DOI 10.1007/PL00013095; Ma Z, 2003, J PHYTOPATHOL, V151, P312, DOI 10.1046/j.1439-0434.2003.00725.x; Ma ZH, 2005, PEST MANAG SCI, V61, P449, DOI 10.1002/ps.982; Miessner S, 2010, J PLANT DIS PROTECT, V117, P162, DOI 10.1007/BF03356354; Nakao S, 1992, KONGETSU NO NOYAKU, P92; O'Gorman DT, 2008, MYCOLOGIA, V100, P227, DOI 10.3852/mycologia.100.2.227; Shao W, 2009, ETIOLOGY OCCURRENCE; Sholberg PL, 2005, POSTHARVEST BIOL TEC, V36, P41, DOI 10.1016/j.postharvbio.2004.07.011; Staats M, 2005, MOL BIOL EVOL, V22, P333, DOI 10.1093/molbev/msi020; Tai F. L., 1979, Sylloge fungorum Sinicorum.; Takahashi Yukiko, 2005, Mycoscience, V46, P106, DOI 10.1007/s10267-004-0219-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang Q., 2007, DPS DATA PROCESSING; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Leeuwen GCM, 1998, CAN J BOT, V76, P2042, DOI 10.1139/cjb-76-12-2042; van Leeuwen GCM, 2002, MYCOL RES, V106, P444, DOI 10.1017/S0953756202005695; Wang YX, 1998, J YUNNAN AGR U, V13, P29; White T., 1990, PCR PROTOCOLS GUIDE, P315; WILLETTS HJ, 1984, MYCOLOGIA, V76, P314, DOI 10.2307/3793107; WILLETTS HJ, 1968, T BRIT MYCOL SOC, V51, P625, DOI 10.1016/S0007-1536(68)80082-8; Willetts HJ, 1968, T BRIT MYCOLOGICAL S, V51, pIN621; Wormald H, 1927, ANN BOT-LONDON, V41, P287, DOI 10.1093/oxfordjournals.aob.a090073; Xiang W. N., 1957, REFERENCE MYCOLOGY P; [薛伟 Xue Wei], 2010, [微生物学通报, Microbiology], V37, P71; Zhu XQ, 2010, PLANT DIS, V94, P478, DOI 10.1094/PDIS-94-4-0478A; Zhu XQ, 2005, PLANT PATHOL, V54, P575, DOI 10.1111/j.1365-3059.2005.01199.x; Zhuang WY, 1998, FLORA FUNGORUM SINIC, V8, P57	55	89	102	6	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24990	10.1371/journal.pone.0024990	http://dx.doi.org/10.1371/journal.pone.0024990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980371	Green Submitted, gold, Green Published			2022-12-25	WOS:000295933700013
J	Chen, RL; Hu, Z; Wei, L; Ma, Y; Liu, ZM; Copeland, JR				Chen, Ruoling; Hu, Zhi; Wei, Li; Ma, Ying; Liu, Zhuming; Copeland, John R.			Incident Dementia in a Defined Older Chinese Population	PLOS ONE			English	Article							GERIATRIC MENTAL STATE; REPUBLIC-OF-CHINA; SOCIOECONOMIC DEPRIVATION; CARDIOVASCULAR-DISEASE; ALZHEIMERS-DISEASE; MRC-ALPHA; DEPRESSION; PREVALENCE; COMMUNITY; PEOPLE	Background: Current knowledge about incident dementia is mainly derived from studies undertaken in the West, showing that dementia is related to older age, low socio-economic status, lack of social network, depression and cardiovascular disease risk factors. We know little about incidence and predictors of dementia in China, where the prevalence is increasing and the patterns of risk factors are different. Methods: Using a standard interview method, we examined 1526 non-demented people aged >= 65 years who had at least minimal educational level in China in a 7.5-year follow up. Incident dementia was diagnosed by GMS-AGECAT algorithms and psychiatrists. Results: Age-standardised incidence of dementia was 14.7 per 1000 person-years (95%CI 11.3-18.2 per 1000 person-years). The increased risk was significantly associated with age, female gender (adjusted odds ratio 2.48, 95%CI 1.20-5.13), low educational levels, smoking, angina (2.58, 1.01-6.59) and living with fewer family members. Among participants with low educational level, the increased risk was associated with higher income, and with the highest and lowest occupational classes; adjusted odds ratio 2.74 (95%CI 1.12-6.70) for officers/teachers, 3.11 (1.61-6.01) for manual labourers/peasants. Conclusions: Our findings of high incidence of dementia and increased risk among people having low education levels but high income suggest a more potential epidemic and burden of dementia populations in China. Maintaining social network and activities and reducing cardiovascular factors in late life could be integrated into current multi-faceted preventive strategies for curbing the epidemic of dementia.	[Chen, Ruoling] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England; [Chen, Ruoling; Hu, Zhi; Liu, Zhuming] Anhui Med Univ, Sch Hlth Adm, Anhuisheng, Peoples R China; [Wei, Li; Ma, Ying] Univ Dundee, Ninewells Hosp & Med Sch, MEMO, Dundee DD1 9SY, Scotland; [Copeland, John R.] Univ Liverpool, Div Psychiat, Liverpool L69 3BX, Merseyside, England	University of London; King's College London; Anhui Medical University; University of Dundee; University of Liverpool	Chen, RL (corresponding author), Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England.	ruoling.chen@kcl.ac.uk		Chen, Ruoling/0000-0002-3033-8753	BUPA Foundation, UK [45NOV06]; Royal Society [574006.G603/22085]; Australia National University (Ageing Research Unit, and Centre for Mental Health Research); Alzheimer's Research Trust, UK [ART/PPG2007B/2]; Medical Research Council [G106/1249] Funding Source: researchfish; MRC [G106/1249] Funding Source: UKRI	BUPA Foundation, UK; Royal Society(Royal Society of London); Australia National University (Ageing Research Unit, and Centre for Mental Health Research); Alzheimer's Research Trust, UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a research grant from the BUPA Foundation, UK (45NOV06). The Royal Society supported the baseline data collection (Grant No. 574006.G603/22085), and awarded Dr. Chen an international travel grant to visit Australia National University (Ageing Research Unit, and Centre for Mental Health Research). The Research Programme of Dementia in China led by Dr. Chen was also supported by Alzheimer's Research Trust, UK (ART/PPG2007B/2). The opinions expressed in this report are not necessarily those of the funders. The funders had no role in study design, data analysis, data interpretation or writing of the paper.	ALMEIDA OP, 2006, AM J GERIATR PSYCHIA; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; Chen R, 1999, INT J GERIATR PSYCH, V14, P821, DOI 10.1002/(SICI)1099-1166(199910)14:10<821::AID-GPS21>3.0.CO;2-0; CHEN R, 2011, INT J GERIA IN PRESS; Chen RL, 2005, ARCH INTERN MED, V165, P2019, DOI 10.1001/archinte.165.17.2019; Chen RL, 2004, INT J GERIATR PSYCH, V19, P407, DOI 10.1002/gps.1103; Chen RL, 2005, EUR J EPIDEMIOL, V20, P141, DOI 10.1007/s10654-004-4498-y; Chen RL, 2008, BRIT J PSYCHIAT, V193, P373, DOI 10.1192/bjp.bp.107.044974; Copeland JRM, 2002, INT J GERIATR PSYCH, V17, P729, DOI 10.1002/gps.667; Copeland JRM, 1999, BRIT J PSYCHIAT, V175, P340, DOI 10.1192/bjp.175.4.340; CRONK BB, 2009, BODY MASS INDEX COGN; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P751, DOI 10.1002/gps.397.abs; Dong MJ, 2007, AGE AGEING, V36, P619, DOI 10.1093/ageing/afm128; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Ganguli M, 2006, ARCH GEN PSYCHIAT, V63, P153, DOI 10.1001/archpsyc.63.2.153; Hesketh T, 1997, BRIT MED J, V314, P1543, DOI 10.1136/bmj.314.7093.1543; Jorm AF, 2001, AUST NZ J PSYCHIAT, V35, P776, DOI 10.1046/j.1440-1614.2001.00967.x; KUA EH, 1992, AUST NZ J PSYCHIAT, V26, P502, DOI 10.3109/00048679209072077; Li S, 2007, ACTA PSYCHIAT SCAND, V115, P73, DOI 10.1111/j.1600-0447.2006.00859.x; Newman AB, 2005, J AM GERIATR SOC, V53, P1101, DOI 10.1111/j.1532-5415.2005.53360.x; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Prince M, 2004, BRIT J PSYCHIAT, V185, P429, DOI 10.1192/bjp.185.5.429; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince MJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-219; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Rosano C, 2006, NEUROL RES, V28, P612, DOI 10.1179/016164106X130407; Ruitenberg A, 2001, NEUROBIOL AGING, V22, P575, DOI 10.1016/S0197-4580(01)00231-7; Wilson KCM, 1999, BRIT J PSYCHIAT, V175, P549, DOI 10.1192/bjp.175.6.549; Woo J, 2002, INT J EPIDEMIOL, V31, P772, DOI 10.1093/ije/31.4.772; Zhang MY, 1998, PSYCHIAT CLIN NEUROS, V52, pS291, DOI 10.1111/j.1440-1819.1998.tb03248.x	30	50	50	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e24817	10.1371/journal.pone.0024817	http://dx.doi.org/10.1371/journal.pone.0024817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825IZ	21966372	Green Published, gold, Green Submitted			2022-12-25	WOS:000295267100011
J	Horn, S; Barnard, S; Rothkamm, K				Horn, Simon; Barnard, Stephen; Rothkamm, Kai			Gamma-H2AX-Based Dose Estimation for Whole and Partial Body Radiation Exposure	PLOS ONE			English	Article							STRAND BREAK REPAIR; IONIZING-RADIATION; HUMAN-LYMPHOCYTES; BIOLOGICAL DOSIMETRY; POISSON-DISTRIBUTION; MEDICAL-MANAGEMENT; BLOOD-LYMPHOCYTES; RESIDUAL DNA; CELLS; FOCI	Most human exposures to ionising radiation are partial body exposures. However, to date only limited tools are available for rapid and accurate estimation of the dose distribution and the extent of the body spared from the exposure. These parameters are of great importance for emergency triage and clinical management of exposed individuals. Here, measurements of gamma-H2AX immunofluorescence by microscopy and flow cytometry were compared as rapid biodosimetric tools for whole and partial body exposures. Ex vivo uniformly X-irradiated blood lymphocytes from one donor were used to generate a universal biexponential calibration function for gamma-H2AX foci/intensity yields per unit dose for time points up to 96 hours post exposure. Foci - but not intensity - levels remained significantly above background for 96 hours for doses of 0.5 Gy or more. Foci-based dose estimates for ex vivo X-irradiated blood samples from 13 volunteers were in excellent agreement with the actual dose delivered to the targeted samples. Flow cytometric dose estimates for X-irradiated blood samples from 8 volunteers were in excellent agreement with the actual dose delivered at 1 hour post exposure but less so at 24 hours post exposure. In partial body exposures, simulated by mixing ex vivo irradiated and unirradiated lymphocytes, foci/intensity distributions were significantly over-dispersed compared to uniformly irradiated lymphocytes. For both methods and in all cases the estimated fraction of irradiated lymphocytes and dose to that fraction, calculated using the zero contaminated Poisson test and gamma-H2AX calibration function, were in good agreement with the actual mixing ratios and doses delivered to the samples. In conclusion, gamma-H2AX analysis of irradiated lymphocytes enables rapid and accurate assessment of whole body doses while dispersion analysis of foci or intensity distributions helps determine partial body doses and the irradiated fraction size in cases of partial body exposures.	[Horn, Simon; Barnard, Stephen; Rothkamm, Kai] Hlth Protect Agcy, Ctr Radiat Chem & Environm Hazards, Chilton, Oxon, England; [Horn, Simon] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Health Protection Agency; Queens University Belfast	Horn, S (corresponding author), Hlth Protect Agcy, Ctr Radiat Chem & Environm Hazards, Chilton, Oxon, England.	sjh.horn@gmail.com	Rothkamm, Kai/A-2164-2014	Rothkamm, Kai/0000-0001-7414-5729; Barnard, Stephen/0000-0002-1041-8908	National Institute for Health Research; EU [FP7-241536]	National Institute for Health Research(National Institute for Health Research (NIHR)); EU(European Commission)	This work was supported by the National Institute for Health Research and was in part funded by the EU Multibiodose project [FP7-241536]. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsbury EA, 2011, RADIAT PROT DOSIM, V147, P573, DOI 10.1093/rpd/ncq499; Andrievski A, 2009, INT J RADIAT BIOL, V85, P369, DOI 10.1080/09553000902781147; Barber PR, 2007, PROC SPIE, V6441, DOI 10.1117/12.705217; Beels L, 2010, INT J RADIAT BIOL, V86, P760, DOI 10.3109/09553002.2010.484479; Benderitter M, 2010, HEALTH PHYS, V98, P851, DOI 10.1097/HP.0b013e3181c9f79a; Bohning D, 1998, BIOMETRICAL J, V40, P833, DOI 10.1002/(SICI)1521-4036(199811)40:7<833::AID-BIMJ833>3.0.CO;2-O; Boker W, 2006, RADIAT RES, V165, P113, DOI 10.1667/RR3486.1; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Cavalcanti MB, 2008, MOL CELL BIOCHEM, V308, P127, DOI 10.1007/s11010-007-9620-5; Chua MLK, 2011, RADIOTHER ONCOL, V99, P362, DOI 10.1016/j.radonc.2011.05.071; Chua MLK, 2011, RADIOTHER ONCOL, V99, P225, DOI 10.1016/j.radonc.2011.04.009; EDWARDS AA, 1979, RADIAT ENVIRON BIOPH, V16, P89, DOI 10.1007/BF01323216; Golfier S, 2009, RADIAT PROT DOSIM, V134, P55, DOI 10.1093/rpd/ncp061; Gourmelon P, 2010, HEALTH PHYS, V98, P825, DOI 10.1097/HP.0b013e3181ce64d4; Horn S, 2011, RADIAT MEAS, V46, P903, DOI 10.1016/j.radmeas.2011.02.001; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; International Atomic Energy Agency, 2011, TECHN REP S IN PRESS; Ismail IH, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1169; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; LLOYD DC, 1973, PHYS MED BIOL, V18, P421, DOI 10.1088/0031-9155/18/3/007; Pope IA, 2011, RADIAT MEAS, V46, P907, DOI 10.1016/j.radmeas.2011.02.004; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Prise KM, 2001, RADIAT RES, V156, P572, DOI 10.1667/0033-7587(2001)156[0572:AROSOI]2.0.CO;2; RAO CR, 1956, BIOMETRICS, V12, P264, DOI 10.2307/3001466; Redon CE, 2011, RADIAT MEAS, V46, P877, DOI 10.1016/j.radmeas.2011.02.017; Redon CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015544; Roch-Lefevre S, 2010, RADIAT RES, V174, P185, DOI 10.1667/RR1775.1; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2007, RADIOLOGY, V242, P244, DOI 10.1148/radiol.2421060171; Rothkamm K, 2009, ANN I SUPER SANITA, V45, P265; Sak A, 2007, INT J RADIAT BIOL, V83, P639, DOI 10.1080/09553000701596118; SASAKI MS, 1968, NATURE, V220, P1189, DOI 10.1038/2201189a0; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Stenerlow B, 2003, RADIAT RES, V159, P502, DOI 10.1667/0033-7587(2003)159[0502:MOPDDS]2.0.CO;2; Valente M, 2011, RADIAT MEAS, V46, P871, DOI 10.1016/j.radmeas.2011.05.012; Werbrouck J, 2011, INT J RADIAT BIOL, V87, P46, DOI 10.3109/09553002.2010.518213; Werbrouck J, 2010, ONCOL REP, V23, P571, DOI 10.3892/or_00000671	38	103	105	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25113	10.1371/journal.pone.0025113	http://dx.doi.org/10.1371/journal.pone.0025113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966430	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100020
J	Pineda, MC; Lopez-Legentil, S; Turon, X				Pineda, Mari Carmen; Lopez-Legentil, Susanna; Turon, Xavier			The Whereabouts of an Ancient Wanderer: Global Phylogeography of the Solitary Ascidian Styela plicata	PLOS ONE			English	Article							MICROCOSMUS-SQUAMIGER ASCIDIACEA; CYTOCHROME-C-OXIDASE; BIOLOGICAL INVASIONS; CIONA-INTESTINALIS; GENETIC-STRUCTURE; PHENOTYPIC ASSOCIATIONS; MULTIPLE INTRODUCTIONS; CLADISTIC-ANALYSIS; POPULATION-GROWTH; ATLANTIC-OCEAN	Genetic tools have greatly aided in tracing the sources and colonization history of introduced species. However, recurrent introductions and repeated shuffling of populations may have blurred some of the genetic signals left by ancient introductions. Styela plicata is a solitary ascidian distributed worldwide. Although its origin remains unclear, this species is believed to have spread worldwide by travelling on ship's hulls. The goals of this study were to infer the genetic structure and global phylogeography of S. plicata and to look for present-day and historical genetic patterns. Two genetic markers were used: a fragment of the mitochondrial gene Cytochrome Oxidase subunit I (COI) and a fragment of the nuclear gene Adenine Nucleotide Transporter/ADP-ATP Translocase (ANT). A total of 368 individuals for COI and 315 for ANT were sequenced from 17 locations worldwide. The levels of gene diversity were moderate for COI to high for ANT. The Mediterranean populations showed the least diversity and allelic richness for both markers, while the Indian, Atlantic and Pacific Oceans had the highest gene and nucleotide diversities. Network and phylogenetic analyses with COI and ANT revealed two groups of alleles separated by 15 and 4 mutational steps, respectively. The existence of different lineages suggested an ancient population split. However, the geographic distributions of these groups did not show any consistent pattern, indicating different phylogeographic histories for each gene. Genetic divergence was significant for many population-pairs irrespective of the geographic distance among them. Stochastic introduction events are reflected in the uneven distribution of COI and ANT allele frequencies and groups among many populations. Our results confirmed that S. plicata has been present in all studied oceans for a long time, and that recurrent colonization events and occasional shuffling among populations have determined the actual genetic structure of this species.	[Pineda, Mari Carmen; Lopez-Legentil, Susanna] Univ Barcelona, Dept Anim Biol Invertebrates, Barcelona, Spain; [Turon, Xavier] Consejo Super Invest Cient CEAB CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Pineda, MC (corresponding author), Univ Barcelona, Dept Anim Biol Invertebrates, Barcelona, Spain.	xturon@ceab.csic.es	Lopez-Legentil, Susanna/B-8194-2008; Turon, Xavier/J-9211-2012	Lopez-Legentil, Susanna/0000-0001-8737-6729; Turon, Xavier/0000-0002-9229-5541	European Community [FP7-PEOPLE-2010-RG 277038]; Spanish Government [CTM2010-22218, CTM2010-17755]; University of Barcelona	European Community(European Commission); Spanish Government(Spanish GovernmentEuropean Commission); University of Barcelona	This study was funded by the Marie Curie International Reintegration Grant FP7-PEOPLE-2010-RG 277038 (within the 7th European Community Framework Program), by the Spanish Government projects CTM2010-22218 and CTM2010-17755, and by an APIF fellowship of the University of Barcelona to MCP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Donald P., 2007, P949; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barros R.C., 2009, AQUAT INVASIONS, V4, P45, DOI [http://dx.doi.org/10.3391/ai.2009.4.1.4, DOI 10.3391/AI.2009.4.1.4]; Bastrop R, 1998, MOL BIOL EVOL, V15, P97, DOI 10.1093/oxfordjournals.molbev.a025919; Bax N, 2001, CONSERV BIOL, V15, P1234, DOI 10.1046/j.1523-1739.2001.99487.x; Belkhir K, 2004, 5171 CNRS UMR LAB GE; Blakeslee AMH, 2010, DIVERS DISTRIB, V16, P879, DOI 10.1111/j.1472-4642.2010.00703.x; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Carlton James T., 2009, V204, P13; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Carlton JT, 2003, HYDROBIOLOGIA, V503, P1, DOI 10.1023/B:HYDR.0000008479.90581.e1; CARLTON JT, 1989, CONSERV BIOL, V3, P265, DOI 10.1111/j.1523-1739.1989.tb00086.x; Carlton JT, 2006, BIOSCIENCE, V56, P694; Carman Mary R., 2009, Aquatic Invasions, V4, P65, DOI 10.3391/ai.2009.4.1.6; Castilla JC, 2004, P NATL ACAD SCI USA, V101, P8517, DOI 10.1073/pnas.0401921101; CHAO A., 2009, SPADE SPECIES PREDIC; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Cornuet JM, 1996, GENETICS, V144, P2001; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Dafforn KA, 2009, BIOFOULING, V25, P277, DOI 10.1080/08927010802710618; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; David GK, 2010, MAR BIOL, V157, P1955, DOI 10.1007/s00227-010-1464-y; Drew JA, 2010, CORAL REEFS, V29, P439, DOI 10.1007/s00338-010-0586-5; Dupont L, 2007, DIVERS DISTRIB, V13, P808, DOI 10.1111/j.1472-4642.2007.00405.x; Dupont L, 2010, BIOL INVASIONS, V12, P2707, DOI 10.1007/s10530-009-9676-0; Dupont L, 2009, MOL ECOL, V18, P442, DOI 10.1111/j.1365-294X.2008.04045.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feral JP, 2002, J EXP MAR BIOL ECOL, V268, P121, DOI 10.1016/S0022-0981(01)00382-3; Folino-Rorem NC, 2009, BIOL INVASIONS, V11, P1869, DOI 10.1007/s10530-008-9365-4; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Galil Bella S., 2000, Biological Invasions, V2, P177, DOI 10.1023/A:1010057010476; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Gerber AS, 2001, ANNU REV GENET, V35, P539, DOI 10.1146/annurev.genet.35.102401.091106; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Goldstien SJ, 2010, MOL ECOL, V19, P874, DOI 10.1111/j.1365-294X.2010.04527.x; Goldstien SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016755; Govindarajan AF, 2005, MAR BIOL, V146, P213, DOI 10.1007/s00227-004-1434-3; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Holland BS, 2000, HYDROBIOLOGIA, V420, P63, DOI 10.1023/A:1003929519809; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kelly DW, 2006, EVOLUTION, V60, P257; Lafferty KD, 1996, ECOLOGY, V77, P1989, DOI 10.2307/2265695; Lambert CC, 2003, MAR ECOL PROG SER, V259, P145, DOI 10.3354/meps259145; Lambert G, 2001, BIOLOGY OF ASCIDIANS, P249; Lambert G, 2007, J EXP MAR BIOL ECOL, V342, P3, DOI 10.1016/j.jembe.2006.10.009; Lejeusne C, 2011, BIOL INVASIONS, V13, P635, DOI 10.1007/s10530-010-9854-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Locke Andrea, 2009, Aquatic Invasions, V4, P249, DOI 10.3391/ai.2009.4.1.25; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lopez-Legentil S, 2006, MOL ECOL, V15, P3957, DOI 10.1111/j.1365-294X.2006.03087.x; Mack MC, 1998, TRENDS ECOL EVOL, V13, P195, DOI 10.1016/S0169-5347(97)01286-X; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; McDonald J, 2004, MAR POLLUT BULL, V49, P868, DOI 10.1016/j.marpolbul.2004.08.024; MCDONALD JH, 1991, NATURE, V354, P116, DOI 10.1038/354116a0; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Orensanz Jose Maria (Lobo), 2002, Biological Invasions, V4, P115; PAPACONSTANTINOU C, 1990, Scientia Marina, V54, P313; Perez-Portela R, 2009, MOL PHYLOGENET EVOL, V50, P560, DOI 10.1016/j.ympev.2008.11.014; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ramsay Aaron, 2009, Aquatic Invasions, V4, P169, DOI 10.3391/ai.2009.4.1.17; Rawson PD, 2002, P NATL ACAD SCI USA, V99, P12955, DOI 10.1073/pnas.202335899; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 1997, GENETICS, V145, P1219; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz GM, 1997, AM ZOOL, V37, P621; Sabbadin A, 1957, ARCH OCEANOGR LIMNOL, VXI, P1; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schizas NV, 2002, MAR BIOL, V140, P585, DOI 10.1007/s00227-001-0728-y; Sciscioli M., 1978, Memorie di Biologia Marina e di Oceanografia, V8, P65; Shaw PW, 2004, MOL ECOL, V13, P3293, DOI 10.1111/j.1365-294X.2004.02327.x; Simon-Bouhet B, 2006, MOL ECOL, V15, P1699, DOI 10.1111/j.1365-294X.2006.02881.x; SIMS LL, 1984, J EXP MAR BIOL ECOL, V82, P117, DOI 10.1016/0022-0981(84)90098-4; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1987, GENETICS, V117, P343; TEMPLETON AR, 1993, GENETICS, V134, P659; Thiyagarajan V, 2003, J EXP MAR BIOL ECOL, V290, P133, DOI 10.1016/S0022-0981(03)00071-6; Turon X, 2003, HYDROBIOLOGIA, V503, P29, DOI 10.1023/B:HYDR.0000008481.10705.c2; Turon X, 2007, J EXP MAR BIOL ECOL, V342, P185, DOI 10.1016/j.jembe.2006.10.040; Tyrrell MC, 2007, J EXP MAR BIOL ECOL, V342, P54, DOI 10.1016/j.jembe.2006.10.014; VANNAME WG, 1945, B AM MUS NAT HIST, V84, P1; Vermeij GJ, 1996, BIOL CONSERV, V78, P3, DOI 10.1016/0006-3207(96)00013-4; Wasson K, 2001, BIOL CONSERV, V102, P143, DOI 10.1016/S0006-3207(01)00098-2; YAMAGUCHI M, 1975, MAR BIOL, V29, P253, DOI 10.1007/BF00391851; Zenetos A, 2010, BIOL INVASIONS, V12, P3379, DOI 10.1007/s10530-009-9679-x; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x; Zibrowius Helmut, 1991, Mesogee, V51, P83	106	65	65	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25495	10.1371/journal.pone.0025495	http://dx.doi.org/10.1371/journal.pone.0025495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966535	Green Published, gold			2022-12-25	WOS:000295267100063
J	Chakraborty, N; Menze, MA; Malsam, J; Aksan, A; Hand, SC; Toner, M				Chakraborty, Nilay; Menze, Michael A.; Malsam, Jason; Aksan, Alptekin; Hand, Steven C.; Toner, Mehmet			Cryopreservation of Spin-Dried Mammalian Cells	PLOS ONE			English	Article							DESICCATION TOLERANCE; TREHALOSE; VITRIFICATION; LIPOSOMES; PRESERVATION; KINETICS	This study reports an alternative approach to achieve vitrification where cells are pre-desiccated prior to cooling to cryogenic temperatures for storage. Chinese Hamster Ovary (CHO) cells suspended in a trehalose solution were rapidly and uniformly desiccated to a low moisture content (<0.12 g of water per g of dry weight) using a spin-drying technique. Trehalose was also introduced into the cells using a high-capacity trehalose transporter (TRET1). Fourier Transform Infrared Spectroscopy (FTIR) was used to examine the uniformity of water concentration distribution in the spin-dried samples. 62% of the cells were shown to survive spin-drying in the presence of trehalose following immediate rehydration. The spin-dried samples were stored in liquid nitrogen (LN2) at a vitrified state. It was shown that following re-warming to room temperature and re-hydration with a fully complemented cell culture medium, 51% of the spin-dried and vitrified cells survived and demonstrated normal growth characteristics. Spin-drying is a novel strategy that can be used to improve cryopreservation outcome by promoting rapid vitrification.	[Chakraborty, Nilay; Toner, Mehmet] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA 02114 USA; [Chakraborty, Nilay; Toner, Mehmet] Harvard Univ, Massachusetts Gen Hosp, Sch Med, BioMEMS Resource Ctr, Boston, MA USA; [Chakraborty, Nilay; Toner, Mehmet] Shriners Hosp Children, Boston, MA USA; [Menze, Michael A.] Eastern Illinois Univ, Dept Biol Sci, Charleston, IL 61920 USA; [Malsam, Jason; Aksan, Alptekin] Univ Minnesota, Dept Mech Engn, Biostabilizat Lab, Minneapolis, MN 55455 USA; [Hand, Steven C.] Louisiana State Univ, Dept Biol Sci, Div Cellular Dev & Integrat Biol, Baton Rouge, LA 70803 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Eastern Illinois University; University of Minnesota System; University of Minnesota Twin Cities; Louisiana State University System; Louisiana State University	Chakraborty, N (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA 02114 USA.	chakraborty.nilay@mgh.harvard.edu	Aksan, Alptekin/C-1579-2014; Menze, Michael/AAP-8165-2020; Chakraborty, Nilay/C-3118-2009; Chakraborty, Nilay/AAK-4812-2020; Aksan, Alptekin/P-5671-2019	Aksan, Alptekin/0000-0001-9891-1715; Chakraborty, Nilay/0000-0001-8138-3506; Aksan, Alptekin/0000-0001-9891-1715; Menze, Michael/0000-0003-1072-5462	National Institutes of Health [2 RO1 DK046270-14A1, 5 R01 GM086886]; Biopreservation Core Resource, University of Minnesota, Minneapolis, Minnesota; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biopreservation Core Resource, University of Minnesota, Minneapolis, Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (www.NIH.gov) grants 2 RO1 DK046270-14A1 and 5 R01 GM086886. The authors would like to thank the Biopreservation Core Resource, University of Minnesota, Minneapolis, Minnesota 55455 for providing necessary funding for the Fourier Transform Infrared Spectroscopy Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JP, 2002, CELL PRESERV TECHNOL, V1, P129; Adams DR, 2008, LANGMUIR, V24, P7688, DOI 10.1021/la703835w; Aksan A, 2006, J APPL PHYS, V99, DOI 10.1063/1.2181280; Aksan A, 2004, LANGMUIR, V20, P5521, DOI 10.1021/la0355186; Buchanan SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012518; Chakraborty N, 2011, ANN BIOMED ENG, V39, P1582, DOI 10.1007/s10439-011-0253-1; Chen TN, 2000, CRYOBIOLOGY, V40, P277, DOI 10.1006/cryo.2000.2244; Cochran WG, 1934, P CAMB PHILOS SOC, V30, P365, DOI 10.1017/S0305004100012561; CROWE LM, 1985, ARCH BIOCHEM BIOPHYS, V242, P240, DOI 10.1016/0003-9861(85)90498-9; Elliott GD, 2008, BIOPRESERV BIOBANK, V6, DOI 10.1089/bio.2008.0011; FAHY GM, 1987, CRYOBIOLOGY, V24, P196, DOI 10.1016/0011-2240(87)90023-X; Fahy GM, 2004, CRYOBIOLOGY, V48, P22, DOI 10.1016/j.cryobiol.2003.11.004; Gordon SL, 2001, CRYOBIOLOGY, V43, P182, DOI 10.1006/cryo.2001.2361; Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616; HANCOCK BC, 1995, PHARMACEUT RES, V12, P799, DOI 10.1023/A:1016292416526; He XM, 2008, CRYOBIOLOGY, V56, P223, DOI 10.1016/j.cryobiol.2008.03.005; HINTON HE, 1960, J INSECT PHYSIOL, V5, P286, DOI 10.1016/0022-1910(60)90011-1; Imamura K, 2009, J PHARM SCI-US, V98, P3088, DOI 10.1002/jps.21568; Karlsson JOM, 2001, CRYOBIOLOGY, V42, P154, DOI 10.1006/cryo.2001.2318; Kikawada T, 2007, P NATL ACAD SCI USA, V105, P5093; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P608, DOI 10.1016/S1472-6483(10)61169-8; Li MW, 2007, REPRODUCTION, V133, P919, DOI 10.1530/REP-06-0096; Ma XC, 2005, CRYOBIOLOGY, V51, P15, DOI 10.1016/j.cryobiol.2005.04.007; MacFarlane DR, 2002, CRYOBIOLOGY, V45, P188, DOI 10.1016/S0011-2240(02)00127-X; Malsam J, 2009, J PHYS CHEM B, V113, P6792, DOI 10.1021/jp8099434; Menze MA, 2005, AM J PHYSIOL-REG I, V288, pR501, DOI 10.1152/ajpregu.00490.2004; Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515; Ragoonanan V, 2008, BIOPHYS J, V94, P2212, DOI 10.1529/biophysj.107.110684; Reategui EE, 2008, CHEM ENG RES DES, V86, P1187, DOI 10.1016/j.cherd.2008.06.004; Sun WQ, 1996, BIOPHYS J, V70, P1769, DOI 10.1016/S0006-3495(96)79740-0; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V	31	13	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24916	10.1371/journal.pone.0024916	http://dx.doi.org/10.1371/journal.pone.0024916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966385	Green Published, gold			2022-12-25	WOS:000295265100030
J	Khajo, A; Bryan, RA; Friedman, M; Burger, RM; Levitsky, Y; Casadevall, A; Magliozzo, RS; Dadachova, E				Khajo, Abdelahad; Bryan, Ruth A.; Friedman, Matthew; Burger, Richard M.; Levitsky, Yan; Casadevall, Arturo; Magliozzo, Richard S.; Dadachova, Ekaterina			Protection of Melanized Cryptococcus neoformans from Lethal Dose Gamma Irradiation Involves Changes in Melanin's Chemical Structure and Paramagnetism	PLOS ONE			English	Article							SYNTHETIC DOPA-MELANIN; SHEWANELLA-ALGAE BRY; IONIZING-RADIATION; ELECTRON-TRANSFER; FREE-RADICALS; MALONALDEHYDE; EPR; SUSCEPTIBILITY; DEGRADATION; ALDEHYDES	Certain fungi thrive in highly radioactive environments including the defunct Chernobyl nuclear reactor. Cryptococcus neoformans (C. neoformans), which uses L-3,4-dihydroxyphenylalanine (L-DOPA) to produce melanin, was used here to investigate how gamma radiation under aqueous aerobic conditions affects the properties of melanin, with the aim of gaining insight into its radioprotective role. Exposure of melanized fungal cell in aqueous suspensions to doses of gamma-radiation capable of killing 50 to 80% of the cells did not lead to a detectable loss of melanin integrity according to EPR spectra of melanin radicals. Moreover, upon UV-visible (Xe-lamp) illumination of melanized cells, the increase in radical population was unchanged after gamma-irradiation. Gamma-irradiation of frozen cell suspensions and storage of samples for several days at 77 K however, produced melanin modification noted by a reduced radical population and reduced photoresponse. More direct evidence for structural modification of melanin came from the detection of soluble products with absorbance maxima near 260 nm in supernatants collected after gamma-irradiation of cells and cell-free melanin. These products, which include thiobarbituric acid (TBA)-reactive aldehydes, were also generated by Fenton reagent treatment of cells and cell-free melanin. In an assay of melanin integrity based on the metal (Bi(+3)) binding capacity of cells, no detectable loss in binding was detected after gamma-irradiation. Our results show that melanin in C. neoformans cells is susceptible to some damage by hydroxyl radical formed in lethal radioactive aqueous environments and serves a protective role in melanized fungi that involves sacrificial breakdown.	[Khajo, Abdelahad; Burger, Richard M.; Levitsky, Yan; Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Khajo, Abdelahad; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Chem, New York, NY USA; [Khajo, Abdelahad; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Biochem, New York, NY USA; [Bryan, Ruth A.; Friedman, Matthew; Dadachova, Ekaterina] Yeshiva Univ, Albert Einstein Coll Med, Dept Nucl Med, Bronx, NY USA; [Casadevall, Arturo; Dadachova, Ekaterina] Yeshiva Univ, Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Khajo, A (corresponding author), CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA.	RMaglioz@brooklyn.cuny.edu	Dadachova, Ekaterina/I-7838-2013		NIH [AI52733]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant Support: NIH AI52733 (A.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENA V, 1971, IONIZING RAD LIFE IN, P298; Bednarek J, 1996, J AM CHEM SOC, V118, P9387, DOI 10.1021/ja960518w; BIRD RP, 1984, METHOD ENZYMOL, V105, P299; Boll RA, 1997, RADIOCHIM ACTA, V79, P145; Bolton J. R., 1972, BIOL APPL ELECT SPIN; BOX HC, 1969, J CHEM PHYS, V50, P5422, DOI 10.1063/1.1671067; Bryan RA, 2005, EUKARYOT CELL, V4, P465, DOI 10.1128/EC.4.2.465-475.2005; BURGER RM, 1979, J BIOL CHEM, V254, P906; Dadachova E, 2008, PIGM CELL MELANOMA R, V21, P192, DOI 10.1111/j.1755-148X.2007.00430.x; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; FELIX CC, 1978, J AM CHEM SOC, V100, P3922, DOI 10.1021/ja00480a044; Grotto D, 2009, QUIM NOVA, V32, P169, DOI 10.1590/S0100-40422009000100032; GuzmanChozas M, 1997, J AGR FOOD CHEM, V45, P2452, DOI 10.1021/jf960965v; HALMANN M, 1979, BIOSYSTEMS, V11, P227, DOI 10.1016/0303-2647(79)90023-6; Hong L, 2007, J PHYS CHEM B, V111, P7938, DOI 10.1021/jp071439h; Howell RC, 2008, NUCL MED BIOL, V35, P353, DOI 10.1016/j.nucmedbio.2007.12.006; Ito S, 1998, PIGM CELL RES, V11, P120, DOI 10.1111/j.1600-0749.1998.tb00721.x; JACOBSON ES, 1982, J BACTERIOL, V150, P1292, DOI 10.1128/JB.150.3.1292-1296.1982; KORYTOWSKI W, 1990, J BIOL CHEM, V265, P12410; KOSUGI H, 1986, LIPIDS, V21, P537, DOI 10.1007/BF02534048; KWON TW, 1963, J FOOD SCI, V28, P627, DOI 10.1111/j.1365-2621.1963.tb01666.x; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; NAPOLITANO A, 1995, TETRAHEDRON, V51, P5913, DOI 10.1016/0040-4020(95)00259-B; Pan YM, 2008, PHYS CHEM MINER, V35, P387, DOI 10.1007/s00269-008-0233-7; PASCUTTI PG, 1992, J PHOTOCH PHOTOBIO B, V16, P257, DOI 10.1016/1011-1344(92)80014-M; PASENKIEWICZGIERULA M, 1986, BIOCHIM BIOPHYS ACTA, V884, P510, DOI 10.1016/0304-4165(86)90202-3; SARNA T, 1986, BIOCHIM BIOPHYS ACTA, V883, P162, DOI 10.1016/0304-4165(86)90147-9; Sarna T., 1998, PIGMENTARY SYSTEM PH, P333; SARNA T, 2005, BIOMEDICAL EPR A, P125; Schweitzer AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007229; SEALY RC, 1982, SCIENCE, V217, P545, DOI 10.1126/science.6283638; STEINERT M, 1995, APPL ENVIRON MICROB, V61, P2428, DOI 10.1128/AEM.61.6.2428-2430.1995; Turick CE, 2003, FEMS MICROBIOL LETT, V220, P99, DOI 10.1016/S0378-1097(03)00096-X; Turick CE, 2002, APPL ENVIRON MICROB, V68, P2436, DOI 10.1128/AEM.68.5.2436-2444.2002; Turick CE, 2009, FEMS MICROBIOL ECOL, V68, P223, DOI 10.1111/j.1574-6941.2009.00670.x; Usatyi AF, 1996, APPL RADIAT ISOTOPES, V47, P1351, DOI 10.1016/S0969-8043(96)00146-7; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; WANG YL, 1994, APPL ENVIRON MICROB, V60, P3864, DOI 10.1128/AEM.60.10.3864-3866.1994; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; WANG YL, 1994, INFECT IMMUN, V62, P3004, DOI 10.1128/IAI.62.7.3004-3007.1994; Zughaier SM, 1999, INFECT IMMUN, V67, P908, DOI 10.1128/IAI.67.2.908-913.1999	43	32	33	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25092	10.1371/journal.pone.0025092	http://dx.doi.org/10.1371/journal.pone.0025092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966422	Green Published, gold			2022-12-25	WOS:000295265100054
J	Lathia, JD; Gallagher, J; Myers, JT; Li, MZ; Vasanji, A; McLendon, RE; Hjelmeland, AB; Huang, AY; Rich, JN				Lathia, Justin D.; Gallagher, Joseph; Myers, Jay T.; Li, Meizhang; Vasanji, Amit; McLendon, Roger E.; Hjelmeland, Anita B.; Huang, Alex Y.; Rich, Jeremy N.			Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells	PLOS ONE			English	Article							IDENTIFICATION; PROLIFERATION; ANGIOGENESIS; GROWTH	High-grade gliomas (World Health Organization grade III anaplastic astrocytoma and grade IV glioblastoma multiforme), the most prevalent primary malignant brain tumors, display a cellular hierarchy with self-renewing, tumorigenic cancer stem cells (CSCs) at the apex. While the CSC hypothesis has been an attractive model to describe many aspects of tumor behavior, it remains controversial due to unresolved issues including the use of ex vivo analyses with differential growth conditions. A CSC population has been confirmed in malignant gliomas by preferential tumor formation from cells directly isolated from patient biopsy specimens. However, direct comparison of multiple tumor cell populations with analysis of the resulting phenotypes of each population within a representative tumor environment has not been clearly described. To directly test the relative tumorigenic potential of CSCs and non-stem tumor cells in the same microenvironment, we interrogated matched tumor populations purified from a primary human tumor transplanted into a xenograft mouse model and monitored competitive in vivo tumor growth studies using serial in vivo intravital microscopy. While CSCs were a small minority of the initial transplanted cancer cell population, the CSCs, not the non-stem tumor cells, drove tumor formation and yielded tumors displaying a cellular hierarchy. In the resulting tumors, a fraction of the initial transplanted CSCs maintained expression of stem cell and proliferation markers, which were significantly higher compared to the non-stem tumor cell population and demonstrated that CSCs generated cellular heterogeneity within the tumor. These head-to-head comparisons between matched CSCs and non-stem tumor cells provide the first functional evidence using live imaging that in the same microenvironment, CSCs more than non-stem tumor cells are responsible for tumor propagation, confirming the functional definition of a CSC.	[Lathia, Justin D.; Gallagher, Joseph; Li, Meizhang; Hjelmeland, Anita B.; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Myers, Jay T.; Huang, Alex Y.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [McLendon, Roger E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Hjelmeland, Anita B.; Rich, Jeremy N.] Case Western Reserve Univ, Program Mol Med, Sch Med, Cleveland Clin,Lerner Coll Med, Cleveland, OH USA	Cleveland Clinic Foundation; Case Western Reserve University; Duke University; Case Western Reserve University; Cleveland Clinic Foundation	Lathia, JD (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA.	lathiaj@ccf.org; richj@ccf.org	Huang, Alex Y./ABG-8182-2021; Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022	Huang, Alex Y./0000-0002-5701-4521; 	Damon Runyon Cancer Research Foundation; National Brain Tumor Society; Goldhirsh Foundation; James S. McDonnell Foundation; NIH [CA112958, CA116659, CA154130, CA151522, 5P50-NS-20023-26]; National Research Service Award [CA142159]; Pediatric Brain Tumor Foundation; St. Baldrick's Foundation; Dana Foundation; Cancer Research Institute; Gabrielle's Angel Foundation; American Brain Tumor Association; Case Comprehensive Cancer Center [RES50-5509]; NATIONAL CANCER INSTITUTE [R01CA116659, R01CA154130, F32CA142159, R01CA154656, R01CA151522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020023] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; National Brain Tumor Society; Goldhirsh Foundation; James S. McDonnell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; St. Baldrick's Foundation; Dana Foundation; Cancer Research Institute; Gabrielle's Angel Foundation; American Brain Tumor Association; Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work in the Rich lab is supported by the Damon Runyon Cancer Research Foundation, National Brain Tumor Society, Goldhirsh Foundation, James S. McDonnell Foundation, and NIH grants CA112958 (JNR), CA116659 (JNR), CA154130 (JNR), CA151522 (ABH), 5P50-NS-20023-26 (REM) and a National Research Service Award CA142159 (JDL). REM is supported by the Pediatric Brain Tumor Foundation. JNR is a Damon Runyon-Lilly Clinical Investigator supported by the Damon Runyon Cancer Research Foundation. ABH is supported by the National Brain Tumor Society. AYH is supported by the St. Baldrick's Foundation, the Dana Foundation, Cancer Research Institute, and the Gabrielle's Angel Foundation. JDL is supported by an American Brain Tumor Association Fellowship (sponsored by the Joelle Syverson Fund). AYH and JDL acknowledge pilot grant funds from the Case Comprehensive Cancer Center (RES50-5509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Dinca EB, 2007, J NEUROSURG, V107, P610, DOI 10.3171/JNS-07/09/0610; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; MOSTANY R, 2008, J VIS EXP, V15; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2010, NATURE; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Sun A, 2010, NEUROSURGERY, V66, P751, DOI 10.1227/01.NEU.0000367452.37534.B1; Wang R, 2010, NATURE; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	33	105	107	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24807	10.1371/journal.pone.0024807	http://dx.doi.org/10.1371/journal.pone.0024807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961046	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100021
J	Ruger, N; Berger, U; Hubbell, SP; Vieilledent, G; Condit, R				Rueger, Nadja; Berger, Uta; Hubbell, Stephen P.; Vieilledent, Ghislain; Condit, Richard			Growth Strategies of Tropical Tree Species: Disentangling Light and Size Effects	PLOS ONE			English	Article							RAIN-FOREST; NEIGHBORHOOD ANALYSIS; SAPLING GROWTH; MOIST FOREST; CANOPY; MORTALITY; RESPONSES; RECRUITMENT; SEEDLINGS; PERFORMANCE	An understanding of the drivers of tree growth at the species level is required to predict likely changes of carbon stocks and biodiversity when environmental conditions change. Especially in species-rich tropical forests, it is largely unknown how species differ in their response of growth to resource availability and individual size. We use a hierarchical Bayesian approach to quantify the impact of light availability and tree diameter on growth of 274 woody species in a 50-ha long-term forest census plot in Barro Colorado Island, Panama. Light reaching each individual tree was estimated from yearly vertical censuses of canopy density. The hierarchical Bayesian approach allowed accounting for different sources of error, such as negative growth observations, and including rare species correctly weighted by their abundance. All species grew faster at higher light. Exponents of a power function relating growth to light were mostly between 0 and 1. This indicates that nearly all species exhibit a decelerating increase of growth with light. In contrast, estimated growth rates at standardized conditions (5 cm dbh, 5% light) varied over a 9-fold range and reflect strong growth-strategy differentiation between the species. As a consequence, growth rankings of the species at low (2%) and high light (20%) were highly correlated. Rare species tended to grow faster and showed a greater sensitivity to light than abundant species. Overall, tree size was less important for growth than light and about half the species were predicted to grow faster in diameter when bigger or smaller, respectively. Together light availability and tree diameter only explained on average 12% of the variation in growth rates. Thus, other factors such as soil characteristics, herbivory, or pathogens may contribute considerably to shaping tree growth in the tropics.	[Rueger, Nadja] Univ Leipzig, Spezielle Botan & Funktionelle Biodiversitat, Leipzig, Germany; [Berger, Uta] Tech Univ Dresden, Inst Waldwachstum & Forstliche Informat, Dresden, Tharandt, Germany; [Hubbell, Stephen P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Hubbell, Stephen P.; Condit, Richard] Ctr Trop Forest Sci, Smithsonian Trop Res Inst, Washington, DE USA; [Vieilledent, Ghislain] Forest Ecosystem Goods & Serv, UR105, Montpellier, France; [Vieilledent, Ghislain] DRP Foret & Biodiversite, Antananarivo, Madagascar	Leipzig University; Technische Universitat Dresden; University of California System; University of California Los Angeles; Smithsonian Institution; Smithsonian Tropical Research Institute	Ruger, N (corresponding author), Univ Leipzig, Spezielle Botan & Funktionelle Biodiversitat, Leipzig, Germany.	nadja.rueger@uni-leipzig.de	Rüger, Nadja/J-6393-2015; Rüger, Nadja/Q-6418-2019; Vieilledent, Ghislain/D-8323-2011	Rüger, Nadja/0000-0003-2371-4172; Rüger, Nadja/0000-0003-2371-4172; Vieilledent, Ghislain/0000-0002-1685-4997	Deutsche Forschungsgemeinschaft (DFG) [RU 1536/2-1]; Center for Tropical Forest Science (CTFS); United States National Science Foundation; John D. and Catherine T. McArthur Foundation; Smithsonian Tropical Research Institute	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Center for Tropical Forest Science (CTFS); United States National Science Foundation(National Science Foundation (NSF)); John D. and Catherine T. McArthur Foundation; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute)	NR was partially funded by research grants from Deutsche Forschungsgemeinschaft (DFG) (RU 1536/2-1) and the Center for Tropical Forest Science (CTFS). The Barro Colorado Island plot has been made possible through the support of the United States National Science Foundation, the John D. and Catherine T. McArthur Foundation and the Smithsonian Tropical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Balderrama SIV, 2005, J TROP ECOL, V21, P383, DOI 10.1017/S026646740500235X; Baraloto C, 2006, J TROP ECOL, V22, P487, DOI 10.1017/S0266467406003439; Bloor JMG, 2003, J ECOL, V91, P77, DOI 10.1046/j.1365-2745.2003.00743.x; Brienen RJW, 2006, FOREST ECOL MANAG, V237, P179, DOI 10.1016/j.foreco.2006.09.042; BROWN ND, 1992, PHILOS T R SOC B, V335, P369, DOI 10.1098/rstb.1992.0028; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Clark DA, 1999, ECOL APPL, V9, P981, DOI 10.1890/1051-0761(1999)009[0981:ATGOTR]2.0.CO;2; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Clark JS, 2007, ECOL APPL, V17, P1942, DOI 10.1890/06-1039.1; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Coates KD, 2009, J ECOL, V97, P118, DOI 10.1111/j.1365-2745.2008.01458.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONDIT R, 1993, FOREST ECOL MANAG, V62, P107, DOI 10.1016/0378-1127(93)90045-O; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Croat T.B., 1978, FLORA BARRO COLORADO; Dalling JW, 2004, FUNCT ECOL, V18, P725, DOI 10.1111/j.0269-8463.2004.00868.x; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; de Gouvenain RC, 2007, J TROP ECOL, V23, P569, DOI 10.1017/S0266467407004385; Denslow JS, 1998, J ECOL, V86, P597, DOI 10.1046/j.1365-2745.1998.00295.x; DENSLOW JS, 1990, ECOLOGY, V71, P165, DOI 10.2307/1940257; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Dent DH, 2009, BIOTROPICA, V41, P424, DOI 10.1111/j.1744-7429.2009.00505.x; Foster RB, 1982, ECOLOGY TROPICAL FOR, P67; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Herault B, 2010, J APPL ECOL, V47, P821, DOI 10.1111/j.1365-2664.2010.01826.x; Hubbell S.P., 1983, TROPICAL RAIN FOREST, P25; Johnson SE, 2009, TREE PHYSIOL, V29, P1317, DOI 10.1093/treephys/tpp068; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; King DA, 2005, FUNCT ECOL, V19, P445, DOI 10.1111/j.1365-2435.2005.00982.x; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; Kohyama T, 2003, J ECOL, V91, P797, DOI 10.1046/j.1365-2745.2003.00810.x; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Leigh E. G., 1996, ECOLOGY TROPICAL FOR; LEIGH EG, 1999, TROPICAL FOREST ECOL; Lichstein JW, 2010, ECOL APPL, V20, P684, DOI 10.1890/08-2334.1; LIEBERMAN M, 1989, ECOLOGY, V70, P550, DOI 10.2307/1940201; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McMahon SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016253; Metcalf CJE, 2009, ECOLOGY, V90, P2766, DOI 10.1890/08-1645.1; Montgomery RA, 2002, OECOLOGIA, V131, P165, DOI 10.1007/s00442-002-0872-1; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Niklas K.., 1994, PLANT ALLOMETRY; PACALA SW, 1994, CAN J FOREST RES, V24, P2172, DOI 10.1139/x94-280; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Poorter L, 2003, PLANT ECOL, V166, P295, DOI 10.1023/A:1023295806147; Poorter L, 2005, J ECOL, V93, P256, DOI 10.1111/j.1365-2745.2004.00956.x; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; Ruger N, 2011, OIKOS, V120, P1047, DOI 10.1111/j.1600-0706.2010.19021.x; Ruger N, 2009, J ECOL, V97, P1360, DOI 10.1111/j.1365-2745.2009.01552.x; Sack L, 2001, FUNCT ECOL, V15, P145, DOI 10.1046/j.1365-2435.2001.00507.x; Sheil D, 2006, J ECOL, V94, P494, DOI 10.1111/j.1365-2745.2006.01111.x; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Uriarte M, 2004, J ECOL, V92, P348, DOI 10.1111/j.0022-0477.2004.00867.x; van der Meer PJ, 1998, J TROP ECOL, V14, P119, DOI 10.1017/S026646749800011X; WELDEN CW, 1991, ECOLOGY, V72, P35, DOI 10.2307/1938900; Windsor D.M., 1990, CLIMATE MOISTURE VAR; Windsor DM, 1990, ECOLOGIA BOSQUE TROP, P53; Wirth R, 2001, ACTA OECOL, V22, P235, DOI 10.1016/S1146-609X(01)01123-7; Wright S Joseph, 2010, Ecology, V91, P3664, DOI 10.1890/09-2335.1; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Wyckoff PH, 2005, CAN J FOREST RES, V35, P13, DOI 10.1139/x04-142; Yavitt JB, 2008, J TROP ECOL, V24, P19, DOI 10.1017/S0266467407004713; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	74	68	73	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25330	10.1371/journal.pone.0025330	http://dx.doi.org/10.1371/journal.pone.0025330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966498	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100089
J	Martin, DDO; Ahpin, CY; Heit, RJ; Perinpanayagam, MA; Yap, MC; Veldhoen, RA; Goping, IS; Berthiaume, LG				Martin, Dale D. O.; Ahpin, Chrisselle Y.; Heit, Ryan J.; Perinpanayagam, Maneka A.; Yap, Megan C.; Veldhoen, Richard A.; Goping, Ing Swie; Berthiaume, Luc G.			Tandem reporter assay for myristoylated proteins post-translationally (TRAMPP) identifies novel substrates for post-translational myristoylation: PKC epsilon, a case study	FASEB JOURNAL			English	Article						apoptosis; caspases	KINASE-C-EPSILON; BAX-DEPENDENT APOPTOSIS; N-MYRISTOYLATION; PROTEOLYTIC ACTIVATION; MUTANT HUNTINGTIN; CASPASE CLEAVAGE; RAPID DETECTION; HUMAN GELSOLIN; AMINO-ACIDS; PHOSPHORYLATION	Myristoylation, the addition of a 14-carbon fatty acid to the N-terminal glycine of a protein, is key to protein-membrane and protein-protein interactions. Typically, myristoylation occurs cotranslationally; however, post-translational myristoylation of caspase-cleaved proteins is now emerging as a well-established protein modification and as a novel regulator of apoptosis. To identify additional post-translationally myristoylated proteins, we engineered a plasmid vector encoding for a caspase-cleavable reporter protein named tandem reporter assay for myristoylation of proteins post-translationally (TRAMPP). pTRAMPP consists of tdTomato-DEVD-"test myristoylation sequence"-enhanced green fluorescent protein (EGFP). After induction of apoptosis, the reporter protein is cleaved by caspases, which frees a new N-terminal glycine residue attached to EGFP that can be myristoylated. We used pTRAMPP in appropriately transfected cells to identify 7 post-translationally myristoylated proteins. First, we confirmed the post-translational myristoylation of two previously identified putative substrates, cytoplasmic dynein intermediate chain 2A and PKC epsilon (ctPKC epsilon), and identified 5 more caspase-cleaved potential substrates for myristoylation that include the antiapoptotic regulator of apoptosis, Mcl-1, and the causative agent of Huntington's disease, huntingtin protein. Further investigation revealed that post-translationally myristoylated ctPKC epsilon localized to membranes and increased Erk signaling and degradation of the proapoptotic protein Bim, which prevented a significant loss of mitochondrial potential of 17% over nonmyristoylated ctPKC epsilon in HeLa cells in the presence of apoptotic stimuli. Taken together, these findings suggest a possible antiapoptotic role for post-translationally myristoylated caspase-cleaved ctPKC epsilon. Martin, D. D. O., Ahpin, C. Y., Heit, R. J., Perinpanayagam, M. A., Yap, M. C., Veldhoen, R. A., Goping, I. S., Berthiaume, L. G. Tandem reporter assay for myristoylated proteins post-translationally (TRAMPP) identifies novel substrates for post-translational myristoylation: PKC epsilon, a case study. FASEB J. 26, 13-28 (2012). www.fasebj.org	[Martin, Dale D. O.; Ahpin, Chrisselle Y.; Heit, Ryan J.; Perinpanayagam, Maneka A.; Yap, Megan C.; Berthiaume, Luc G.] Univ Alberta, Dept Cell Biol, Sch Mol & Syst Med, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada; [Veldhoen, Richard A.; Goping, Ing Swie] Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Berthiaume, LG (corresponding author), Univ Alberta, Dept Cell Biol, Sch Mol & Syst Med, Fac Med & Dent, 5-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	luc.berthiaume@ualberta.ca	Veldhoen, Richard/M-8168-2019; Martin, Dale/L-6351-2015	Veldhoen, Richard/0000-0003-4643-2960; Berthiaume, Luc/0000-0003-0926-059X	Alberta Cancer Research Institute (ACRI) [24425]; Canadian Institutes of Health Research; Alberta Heritage Foundation Medical Research	Alberta Cancer Research Institute (ACRI); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation Medical Research(Alberta Heritage Foundation for Medical Research)	This work was supported by an Alberta Cancer Research Institute (ACRI) grant (24425) to L.G.B. D.D.O.M. held a Canada Graduate Scholarships Doctoral Award from the Canadian Institutes of Health Research and a Medical Research Studentship Incentive Award from Alberta Heritage Foundation Medical Research. C.Y.A. and M.A.P. held a Summer Studentship and a Graduate Studentship, respectively, from ACRI.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Akita Y, 2002, J BIOCHEM, V132, P847, DOI 10.1093/oxfordjournals.jbchem.a003296; Aslan JE, 2009, TRAFFIC, V10, P1390, DOI 10.1111/j.1600-0854.2009.00951.x; Basu A, 2002, J BIOL CHEM, V277, P41850, DOI 10.1074/jbc.M205997200; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Dasgupta S, 2011, BBA-MOL BASIS DIS, V1812, P495, DOI 10.1016/j.bbadis.2011.01.001; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Ehrnhoefer DE, 2011, NEUROSCIENTIST, V17, P475, DOI 10.1177/1073858410390378; Eisenhaber B, 2004, PROTEOMICS, V4, P1614, DOI 10.1002/pmic.200300781; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Fryer JD, 2006, NAT NEUROSCI, V9, P1088, DOI 10.1038/nn0906-1088; Garczarczyk D, 2009, CELL SIGNAL, V21, P745, DOI 10.1016/j.cellsig.2009.01.017; Giang DG, 1998, J BIOL CHEM, V273, P6595, DOI 10.1074/jbc.273.12.6595; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; GUASCH RM, 1993, EXP CELL RES, V207, P136, DOI 10.1006/excr.1993.1172; Hang HC, 2007, J AM CHEM SOC, V129, P2744, DOI 10.1021/ja0685001; Hannoush AN, 2010, NAT CHEM BIOL, V6, P498, DOI [10.1038/NCHEMBIO.388, 10.1038/nchembio.388]; Hannoush RN, 2009, ACS CHEM BIOL, V4, P581, DOI 10.1021/cb900085z; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Koriyama H, 1999, CELL SIGNAL, V11, P831, DOI 10.1016/S0898-6568(99)00055-8; Koya RC, 2000, J BIOL CHEM, V275, P15343, DOI 10.1074/jbc.275.20.15343; KRONEBUSCH PJ, 1987, J CELL SCI, V88, P25; Kusano H, 2000, ONCOGENE, V19, P4807, DOI 10.1038/sj.onc.1203868; Lane JD, 2001, J CELL BIOL, V153, P1415, DOI 10.1083/jcb.153.7.1415; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Leverrier S, 2002, BIOCHEM J, V368, P905, DOI 10.1042/BJ20021253; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Martin DDO, 2008, FASEB J, V22, P797, DOI 10.1096/fj.07-9198com; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; MATHESON AT, 1975, CAN J BIOCHEM CELL B, V53, P1323, DOI 10.1139/o75-179; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; O'Reilly LA, 2009, J IMMUNOL, V183, P261, DOI 10.4049/jimmunol.0803853; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Sakurai N, 2006, J BIOL CHEM, V281, P14288, DOI 10.1074/jbc.M510338200; Sallese M, 2006, EMBO J, V25, P2663, DOI 10.1038/sj.emboj.7601172; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Selvakumar P, 2006, FEBS LETT, V580, P2021, DOI 10.1016/j.febslet.2006.02.076; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shnyder SD, 2002, J HISTOCHEM CYTOCHEM, V50, P557, DOI 10.1177/002215540205000413; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Utsumi T, 2004, EUR J BIOCHEM, V271, P863, DOI 10.1111/j.1432-1033.2004.03991.x; Utsumi T, 2003, FEBS LETT, V539, P37, DOI 10.1016/S0014-5793(03)00180-7; Vilas GL, 2006, P NATL ACAD SCI USA, V103, P6542, DOI 10.1073/pnas.0600824103; Wellington CL, 2002, J NEUROSCI, V22, P7862; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wright MM, 2004, BIOCHEM CELL BIOL, V82, P18, DOI 10.1139/o03-092; Wyllie AH, 1997, BRIT MED BULL, V53, P451; Wyllie AH, 1999, BRIT J CANCER, V80, P34; Xu TR, 2009, J CELL BIOCHEM, V106, P633, DOI 10.1002/jcb.22043; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Yim H, 2003, MOL BIOL CELL, V14, P4250, DOI 10.1091/mbc.E03-01-0029; Yim H, 2006, J CELL BIOL, V174, P77, DOI 10.1083/jcb.200509141; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	63	18	19	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					13	28		10.1096/fj.11-182360	http://dx.doi.org/10.1096/fj.11-182360			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21965604				2022-12-25	WOS:000299202200004
J	Zhang, HJ; Gu, S; Al-Sabeq, B; Wang, S; He, J; Tam, A; Cifelli, C; Mathalone, N; Tirgari, S; Boyd, S; Heximer, SP				Zhang, Hangjun; Gu, Steven; Al-Sabeq, Basil; Wang, Sean; He, Janet; Tam, Alex; Cifelli, Carlo; Mathalone, Nurit; Tirgari, Sam; Boyd, Shelley; Heximer, Scott P.			Origin-specific epigenetic program correlates with vascular bed-specific differences in Rgs5 expression	FASEB JOURNAL			English	Article						G-protein signaling; regulators of G-protein signaling; vascular smooth muscle development	GTPASE-ACTIVATING PROTEINS; CARDIAC NEURAL CREST; SMOOTH-MUSCLE-CELLS; DNA METHYLATION; SIGNALING RGS; BINDING; DIFFERENTIATION; TRANSCRIPTION; REGULATORS; GROWTH	Cells from multiple origins contribute to vascular smooth muscle cell (VSMC) development. Phenotypic heterogeneity of VSMCs is associated with their point of developmental origin; however, the mechanisms driving such differences are unknown. We here examined the mechanisms controlling vascular bed-specific differences in Rgs5 expression during development. Rgs5 levels were similar across different regions of the vasculature in neonatal animals but were > 15-fold higher in descending aortas compared with carotid arteries of adult mice. Thus, vessel bed-specific changes in regulation of Rgs5 expression occurred during vessel maturation. Examination of adult Rgs5-LacZ reporter mice revealed lower Rgs5 expression in VSMCs originating from the third (carotid artery) branchial arch compared with those originating in the fourth and sixth (aortic B segment, right subclavian, and ductus arteriosus) branchial arches. Indeed, a mosaic Rgs5 expression pattern, with discreet LacZ boundaries between VSMCs derived from different developmental origins, was observed. Furthermore, Rgs5-LacZ expression was correlated with the site of VSMC origin (splanchic mesoderm approximate to local mesenchyme > somites > proepicardium > mesothelium). Surprisingly, Rgs5 reporter activity in cultured carotid artery-and descending aorta-derived cells did not recapitulate the differences observed in vivo. Consistent with a developmental origin-specific epigenetic mechanism driving the observed expression differences in vivo, the Rgs5 promoter showed increased methylation on CpG dinucleotides in carotid arteries compared with that in descending aortas in adult but not in neonatal mice. In vitro methylation of the Rgs5 promoter confirmed that its activity is sensitive to transcriptional down-regulation by CpG methylation. These data suggest that an origin-dependent epigenetic program regulates vascular bed- and maturation state-dependent regulation of VSMC-specific gene transcription.-Zhang, H., Gu, S., Al-Sabeq, B., Wang, S., He, J., Tam, A., Cifelli, C., Mathalone, N., Tirgari, S., Boyd, S., Heximer, S. P. Origin-specific epigenetic program correlates with vascular bed-specific differences in Rgs5 expression. FASEB J. 26, 181-191 (2012). www.fasebj.org	[Zhang, Hangjun; Gu, Steven; Al-Sabeq, Basil; Wang, Sean; He, Janet; Tam, Alex; Cifelli, Carlo; Tirgari, Sam; Heximer, Scott P.] Univ Toronto, Dept Physiol Heart & Stroke, Toronto, ON M5S 1A8, Canada; [Zhang, Hangjun; Gu, Steven; Al-Sabeq, Basil; Wang, Sean; He, Janet; Tam, Alex; Cifelli, Carlo; Tirgari, Sam; Heximer, Scott P.] Univ Toronto, Richard Lewar Ctr Excellence Cardiovasc Res, Toronto, ON M5S 1A8, Canada; [Mathalone, Nurit; Boyd, Shelley] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON M5S 1A8, Canada; [Mathalone, Nurit; Boyd, Shelley] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Heximer, SP (corresponding author), Univ Toronto, Dept Physiol Heart & Stroke, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	scott.heximer@utoronto.ca		Al-Sabeq, Basil/0000-0001-8880-0165				Adams LD, 2000, CIRC RES, V87, P623, DOI 10.1161/01.RES.87.7.623; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Bergwerff M, 1999, CARDIOVASC RES, V44, P185, DOI 10.1016/S0008-6363(99)00186-8; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Christ B, 2004, ANAT EMBRYOL, V208, P333, DOI 10.1007/s00429-004-0408-z; Cifelli C, 2008, CIRC RES, V103, P527, DOI 10.1161/CIRCRESAHA.108.180984; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; CORNWELL TL, 1989, J BIOL CHEM, V264, P1146; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Doupnik CA, 2001, BBA-GENE STRUCT EXPR, V1522, P97, DOI 10.1016/S0167-4781(01)00342-6; Esner M, 2006, DEVELOPMENT, V133, P737, DOI 10.1242/dev.02226; Fish JE, 2005, J BIOL CHEM, V280, P24824, DOI 10.1074/jbc.M502115200; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Heximer SP, 2001, J BIOL CHEM, V276, P14195, DOI 10.1074/jbc.M009942200; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kapoor M, 2008, J CLIN INVEST, V118, P3279, DOI 10.1172/JCI35381; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Larminie C, 2004, MOL BRAIN RES, V122, P24, DOI 10.1016/j.molbrainres.2003.11.014; Madura JA, 1996, J VASC RES, V33, P53; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nisancioglu MH, 2008, MOL CELL BIOL, V28, P2324, DOI 10.1128/MCB.01252-07; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Seki N, 1998, J HUM GENET, V43, P202, DOI 10.1007/s100380050071; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Topouzis S, 1996, DEV BIOL, V178, P430, DOI 10.1006/dbio.1996.0229; WALDO KL, 1993, ANAT RECORD, V237, P385, DOI 10.1002/ar.1092370312; Waldo KL, 1999, DEV BIOL, V208, P307, DOI 10.1006/dbio.1999.9219; Zhou J, 2001, LIFE SCI, V68, P1457, DOI 10.1016/S0024-3205(01)00939-0	42	22	22	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					181	191		10.1096/fj.11-185454	http://dx.doi.org/10.1096/fj.11-185454			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21965603				2022-12-25	WOS:000299202200019
J	Bhat, UG; Jagadeeswaran, R; Halasi, M; Gartel, AL				Bhat, Uppoor G.; Jagadeeswaran, Ramasamy; Halasi, Marianna; Gartel, Andrei L.			Nucleophosmin Interacts with FOXM1 and Modulates the Level and Localization of FOXM1 in Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXM1; GENE-EXPRESSION PROFILES; TUMOR-CELLS; HEPATOCELLULAR CARCINOMAS; MICROARRAY ANALYSIS; INDUCE APOPTOSIS; CDNA MICROARRAY; IDENTIFICATION; PROLIFERATION; PROGRESSION	Using mass spectrometric analysis we found that oncogenic transcription factor FOXM1 that is overexpressed in a majority of human cancers interacts with multifunctional protein NPM, which is also overexpressed in a variety of human tumors. Coimmunoprecipitation and glutathione S-transferase pull-down experiments demonstrated that NPM forms a complex with FOXM1 and also identified the regions responsible for their interaction. Immunofluorescence microscopy confirmed the interaction between FOXM1 and NPM in cancer and immortal cells. Furthermore, knockdown of NPM in immortal and cancer cells led to significant down-regulation of FOXM1 similar to its levels in normal cells, suggesting that NPNI might modulate FOXM1 level. In addition, in OCI/AMI.3 leukemia cells where mutant NPM is localized in the cytoplasm we found that typically nuclear FOXM1 was predominantly co-localized with NPM in the cytoplasm, while NPM knockdown led to the disappearance of FOXM1 from the cytoplasm, suggesting that NPM may also determine intracellular localization of FOXM1. Knockdown of FOXM1 or NPM in MIA PaCa-2 pancreatic cancer cells inhibited anchorage-dependent and independent growth in cell culture, and tumor growth in nude mice. In addition, over-expression of FOXM1 reversed the effect of NPM knockdown in vitro. Our data suggest that in cancer cells NPM interacts with Foxm1 and their interaction is required for sustaining the level and localization of FOXM1. Targeting the interaction between FOXM1 and NPM by peptides or small molecules may represent a novel therapeutic strategy against cancer.	[Bhat, Uppoor G.; Jagadeeswaran, Ramasamy; Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Gartel, Andrei L.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gartel, AL (corresponding author), Univ Illinois, Dept Med, 840 S Wood St,Room 1041, Chicago, IL 60612 USA.	agartel@uic.edu	Jagadeeswaran, Ramasamy/C-9987-2013	Ramasamy, Jagadeesh/0000-0002-7906-4239	National Institutes of Health [1R01 CA1294414, 1R21 CA134615]; NATIONAL CANCER INSTITUTE [R01CA129414, R01CA124414, R21CA134615, R01CA194414, R01CA129444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01 CA1294414 and 1R21 CA134615 (to A. L. G.).	Ahmad A., 2009, BREAST CANC TREATMEN; Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Douard R, 2006, SURGERY, V139, P665, DOI 10.1016/j.surg.2005.10.012; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nozawa Y, 1996, J PATHOL, V178, P48; Okabe H, 2001, CANCER RES, V61, P2129; Pandit B, 2009, CELL CYCLE, V8, P3425, DOI 10.4161/cc.8.20.9628; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Penzo M, 2009, J CELL PHYSIOL, V218, P215, DOI 10.1002/jcp.21596; Pianta A, 2011, ENDOCR PATHOL, V22, P18, DOI 10.1007/s12022-011-9147-x; Quentmeier H, 2005, LEUKEMIA, V19, P1760, DOI 10.1038/sj.leu.2403899; Radhakrishnan Senthil K, 2008, Nat Rev Cancer, V8, pc2, DOI 10.1038/nrc2223-c1; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Romagnoli S, 2009, AM J PATHOL, V174, P762, DOI 10.2353/ajpath.2009.080721; Subong ENP, 1999, PROSTATE, V39, P298; TANAKA M, 1992, CANCER RES, V52, P3372; Teh MT, 2002, CANCER RES, V62, P4773; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Wang HF, 2011, CANCER RES, V71, P68, DOI 10.1158/0008-5472.CAN-10-0030; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Wu HW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-125; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626	46	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41425	41433		10.1074/jbc.M111.270843	http://dx.doi.org/10.1074/jbc.M111.270843			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21979956	Green Published, hybrid			2022-12-25	WOS:000298057500029
J	Brandes, N; Reichmann, D; Tienson, H; Leichert, LI; Jakob, U				Brandes, Nicolas; Reichmann, Dana; Tienson, Heather; Leichert, Lars I.; Jakob, Ursula			Using Quantitative Redox Proteomics to Dissect the Yeast Redoxome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; DISULFIDE FORMATION; HYDROGEN-PEROXIDE; CELLULAR THIOL; PROTEINS; CYSTEINE; DAMAGE; PK(A); LOCALIZATION	To understand and eventually predict the effects of changing redox conditions and oxidant levels on the physiology of an organism, it is essential to gain knowledge about its redoxome: the proteins whose activities are controlled by the oxidation status of their cysteine thiols. Here, we applied the quantitative redox proteomic method OxICAT to Saccharomyces cerevisiae and determined the in vivo thiol oxidation status of almost 300 different yeast proteins distributed among various cellular compartments. We found that a substantial number of cytosolic and mitochondrial proteins are partially oxidized during exponential growth. Our results suggest that prevailing redox conditions constantly control central cellular pathways by fine-tuning oxidation status and hence activity of these proteins. Treatment with sublethal H2O2 concentrations caused a subset of 41 proteins to undergo substantial thiol modifications, thereby affecting a variety of different cellular pathways, many of which are directly or indirectly involved in increasing oxidative stress resistance. Classification of the identified protein thiols according to their steady-state oxidation levels and sensitivity to peroxide treatment revealed that redox sensitivity of protein thiols does not predict peroxide sensitivity. Our studies provide experimental evidence that the ability of protein thiols to react to changing peroxide levels is likely governed by both thermodynamic and kinetic parameters, making predicting thiol modifications challenging and de novo identification of peroxide sensitive protein thiols indispensable.	[Brandes, Nicolas; Reichmann, Dana; Tienson, Heather; Leichert, Lars I.; Jakob, Ursula] Univ Michigan, Dept Mol Cellular & Dev Biol, Nat Sci Bldg,Rm 4041,830 N Univ, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Nat Sci Bldg,Rm 4041,830 N Univ, Ann Arbor, MI 48109 USA.	ujakob@umich.edu	Leichert, Lars I./B-4762-2009; Reichmann, Dana/J-4999-2019	Leichert, Lars I./0000-0002-5666-9681; Reichmann, Dana/0000-0003-0315-5334	National Institutes of Health, NIA [AG027349]; NIA [AG000114]; European Molecular Biology Organization and Human Frontiers; Michigan Life Sciences Corridor; NATIONAL INSTITUTE ON AGING [T32AG000114, Z01AG000114, R01AG027349] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Molecular Biology Organization and Human Frontiers; Michigan Life Sciences Corridor; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health, NIA Grant AG027349 (to U. J.) and by Postdoctoral Fellowship NIA Training Grant AG000114 (to H. T.). This work was also supported by the European Molecular Biology Organization and Human Frontiers postdoctoral fellowship (to D. R.). The Michigan Proteome was supported in part by funds from the Michigan Life Sciences Corridor.	Allen S, 2003, J BIOL CHEM, V278, P38505, DOI 10.1074/jbc.M306027200; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Azimi I, 2011, ANTIOXID REDOX SIGN, V14, P113, DOI 10.1089/ars.2010.3620; Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; Colgreave I. A., 2002, METHOD ENZYMOL, V348, P175; Cook JA, 2004, SEMIN RADIAT ONCOL, V14, P259, DOI 10.1016/j.semradonc.2004.04.001; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dixon BM, 2008, ANTIOXID REDOX SIGN, V10, P963, DOI 10.1089/ars.2007.1869; Dove JE, 1998, METHOD CELL BIOL, V53, P33; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Garcia-Santamarina S., 2011, J PROTEOMICS; Gerstein M, 2001, INT TABLES CRYSTALLO, V22, P531; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kumsta C, 2011, ANTIOXID REDOX SIGN, V14, P1023, DOI 10.1089/ars.2010.3203; Le Moan N, 2006, J BIOL CHEM, V281, P10420, DOI 10.1074/jbc.M513346200; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leichert LI, 2006, ANTIOXID REDOX SIGN, V8, P763, DOI 10.1089/ars.2006.8.763; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Magherini F, 2009, CELL MOL LIFE SCI, V66, P933, DOI 10.1007/s00018-009-8574-z; Marino SM, 2010, BIOCHEMISTRY-US, V49, P7709, DOI 10.1021/bi100677a; MATTIASSON B, 1982, EUR J APPL MICROBIOL, V16, P52, DOI 10.1007/BF01008243; McDonagh B, 2009, J PROTEOMICS, V72, P677, DOI 10.1016/j.jprot.2009.01.023; Mehta R, 2010, ADV EXP MED BIOL, V694, P14; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Minard KI, 2007, FREE RADICAL BIO MED, V42, P106, DOI 10.1016/j.freeradbiomed.2006.09.024; Poole Leslie B., 2007, V44, P61; Reichmann D, 2008, BIOCHEMISTRY-US, V47, P1051, DOI 10.1021/bi7019639; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Rhee S G, 2000, Sci STKE, V2000, ppe1; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Sanchez R, 2008, PROTEIN SCI, V17, P473, DOI 10.1110/ps.073252408; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; Tajc SG, 2004, J AM CHEM SOC, V126, P10508, DOI 10.1021/ja047929u; Thamsen M, 2011, CURR OPIN CHEM BIOL, V15, P113, DOI 10.1016/j.cbpa.2010.11.013; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; ZHANG RM, 1989, J BIOL CHEM, V264, P18472; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012	53	81	82	0	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41893	41903		10.1074/jbc.M111.296236	http://dx.doi.org/10.1074/jbc.M111.296236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21976664	Green Published, hybrid			2022-12-25	WOS:000298057500071
J	Fujitani, N; Takegawa, Y; Ishibashr, Y; Araki, K; Furukawa, J; Mitsutake, S; Igarashi, Y; Ito, M; Shinohara, Y				Fujitani, Naoki; Takegawa, Yasuhiro; Ishibashr, Yohei; Araki, Kayo; Furukawa, Jun-ichi; Mitsutake, Susumu; Igarashi, Yasuyuki; Ito, Makoto; Shinohara, Yasuro			Qualitative and Quantitative Cellular Glycomics of Glycosphingolipids Based on Rhodococcal Endoglycosylceramidase-assisted Glycan Cleavage, Glycoblotting-assisted Sample Preparation, and Matrix-assisted Laser Desorption Ionization Tandem Time-of-flight Mass Spectrometry Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; SIALIC-ACID; EXPRESSION; TERATOCARCINOMA; ENDOGLYCOCERAMIDASE; ANTIGENS; SERIES; DIFFERENTIATION; SPHINGOLIPIDS; GANGLIOSIDES	Glycosphingolipids (GSLs) are crucially important components of the cellular membrane, where they comprise microdomains with many critical biological functions. Despite this fact, qualitative and quantitative techniques for the analysis of GSLs still lag behind the needs of researchers. In this study, a reliable procedure for the elucidation of cellular GSL-glycomes was established based on (a) enzymatic glycan cleavage by endoglycosylceramidases derived from Rhodococcus sp. in combination with (b) glycoblotting-assisted sample preparation. The mixture of endoglycosylce-ramidase I and II was employed to maximize the release of glycan moieties from the major classes of GSLs (i.e. ganglio-, (neo)lacto- and globo-series GSLs). The glycoblotting technique enabled the quantitative detection of GSL-glycans using as few as 2 x 10(5) cells. Thirty-seven different kinds of cellular GSL glycans were successfully observed in 11 kinds of cells, including Chinese hamster ovary cells and their lectin-resistant mutants as well as murine and human embryonic carcinoma cells. Furthermore, in-depth structural clarification in terms of discrimination of isomers was achieved by MALDI-TOF/TOF mass spectrometry analysis and/or linkage-specific glycosidase digestion. These novel analytical techniques were shown to be capable of delineating cell-specific GSL-glycomes. Thus, they are anticipated to have a broad range of applications for the characterization, description, and comparison of various cellular/tissue samples in the fields of drug discovery and regenerative medicine.	[Fujitani, Naoki; Takegawa, Yasuhiro; Araki, Kayo; Furukawa, Jun-ichi; Shinohara, Yasuro] Hokkaido Univ, Lab Med & Funct Glyc, Grad Sch Adv Life Sci, Sapporo, Hokkaido 0010021, Japan; [Mitsutake, Susumu; Igarashi, Yasuyuki] Hokkaido Univ, Lab Biomembrane & Biofunct Chem, Grad Sch Adv Life Sci, Sapporo, Hokkaido 0010021, Japan; [Mitsutake, Susumu; Igarashi, Yasuyuki] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido 0010021, Japan; [Ishibashr, Yohei; Ito, Makoto] Kyushu Univ, Lab Marine Resource Chem, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 8128581, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Kyushu University	Shinohara, Y (corresponding author), Hokkaido Univ, Lab Med & Funct Glyc, Grad Sch Adv Life Sci, Sapporo, Hokkaido 0010021, Japan.	yshinohara@sci.hokudai.ac.jp	Ito, Makoto/Q-6164-2019; Mitsutake, Susumu/A-4082-2012; Fujitani, Naoki/A-4072-2012	ito, Makoto/0000-0003-3159-7818; Fujitani, Naoki/0000-0002-4035-7317	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23780344] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	BRILES EB, 1977, J BIOL CHEM, V252, P1107; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; HAKOMORI SI, 1966, J LIPID RES, V7, P789; ITO M, 1989, J BIOL CHEM, V264, P9510; ITO M, 1993, EUR J BIOCHEM, V218, P637, DOI 10.1111/j.1432-1033.1993.tb18417.x; Izu H, 1997, J BIOL CHEM, V272, P19846, DOI 10.1074/jbc.272.32.19846; KANNAGI R, 1983, J BIOL CHEM, V258, P8934; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KANNAGI R, 1983, BLOOD, V62, P1230; Kawazoe S, 2009, DEV GROWTH DIFFER, V51, P81, DOI 10.1111/j.1440-169X.2008.01082.x; KRUPNICK JG, 1994, INT J CANCER, V59, P692, DOI 10.1002/ijc.2910590518; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; MACHER BA, 1980, J BIOL CHEM, V255, P2092; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Miura Y, 2007, CHEM-EUR J, V13, P4797, DOI 10.1002/chem.200601872; Nakashima N, 2004, BIOTECHNOL BIOENG, V86, P136, DOI 10.1002/bit.20024; Naven TJP, 1996, RAPID COMMUN MASS SP, V10, P1361, DOI 10.1002/(SICI)1097-0231(199608)10:11<1361::AID-RCM642>3.0.CO;2-A; NOJIRI H, 1984, BLOOD, V64, P534; Parry S, 2007, GLYCOBIOLOGY, V17, P646, DOI 10.1093/glycob/cwm024; Rosales, 1997, BIOCHIM BIOPHYS ACTA, V1354, P153; STANLEY P, 1980, ACS SYM SER, V128, P213; Stroud MR, 1996, BIOCHEMISTRY-US, V35, P758, DOI 10.1021/bi951600r; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Uematsu R, 2005, MOL CELL PROTEOMICS, V4, P1977, DOI 10.1074/mcp.M500203-MCP200; Visco V, 2000, HISTOCHEM CELL BIOL, V113, P43, DOI 10.1007/s004180050006; WIEGANDT H, 1970, EUR J BIOCHEM, V15, P287, DOI 10.1111/j.1432-1033.1970.tb01006.x; WILLISON KR, 1982, J IMMUNOL, V129, P603; WILLISON KR, 1978, CELL, V14, P785, DOI 10.1016/0092-8674(78)90334-3; YOGEESWARAN G, 1972, J BIOL CHEM, V247, P5146; Yowler BC, 2001, J LIPID RES, V42, P659; ZHOU B, 1989, J BIOL CHEM, V264, P12272	35	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41669	41679		10.1074/jbc.M111.301796	http://dx.doi.org/10.1074/jbc.M111.301796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965662	Green Published, hybrid			2022-12-25	WOS:000298057500051
J	Holz-Schietinger, C; Matje, DM; Harrison, MF; Reich, NO				Holz-Schietinger, Celeste; Matje, Douglas M.; Harrison, Madeleine Flexer; Reich, Norbert O.			Oligomerization of DNMT3A Controls the Mechanism of de Novo DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLTRANSFERASE 3A; ECORV ENDONUCLEASE; PROCESSIVITY; MUTATIONS; TRANSCRIPTION; MAINTENANCE; BINDING; PATTERNS; REVEALS; FAMILY	DNMT3A is one of two human de novo DNA methyltransferases essential for regulating gene expression through cellular development and differentiation. Here we describe the consequences of single amino acid mutations, including those implicated in the development of acute myeloid leukemia (AML) and myelodysplastic syndromes, at the DNMT3A.DNMT3A homotetramer and DNMT3A.DNMT3L heterotetramer interfaces. A model for the DNMT3A homotetramer was developed via computational interface scanning and tested using light scattering and electrophoretic mobility shift assays. Distinct oligomeric states were functionally characterized using fluorescence anisotropy and steady-state kinetics. Replacement of residues that result in DNMT3A dimers, including those identified in AML patients, show minor changes in methylation activity but lose the capacity for processive catalysis on multisite DNA substrates, unlike the highly processive wild-type enzyme. Our results are consistent with the bimodal distribution of DNA methylation in vivo and the loss of clustered methylation in AML patients. Tetramerization with the known interacting partner DNMT3L, rescues processive catalysis, demonstrating that protein binding at the DNMT3A tetramer interface can modulate methylation patterning. Our results provide a structural mechanism for the regulation of DNMT3A activity and epigenetic imprinting.	[Holz-Schietinger, Celeste; Reich, Norbert O.] Univ Calif Santa Barbara, Interdept Program Biomol Sci Engn, Santa Barbara, CA 93106 USA; [Matje, Douglas M.; Harrison, Madeleine Flexer; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Interdept Program Biomol Sci Engn, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu						Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aravin AA, 2008, GENE DEV, V22, P970, DOI 10.1101/gad.1669408; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fersht A., 1999, STRUCTURE MECH PROTE, Vxxi, P103; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Hata K, 2002, DEVELOPMENT, V129, P1983; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Hiller DA, 2003, BIOCHEMISTRY-US, V42, P14375, DOI 10.1021/bi035520w; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Lindstrom WM, 2000, J BIOL CHEM, V275, P4912, DOI 10.1074/jbc.275.7.4912; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Malygin EG, 2009, BIOL CHEM, V390, P835, DOI 10.1515/BC.2009.082; Matje DM, 2011, BIOCHEMISTRY-US, V50, P1465, DOI 10.1021/bi101446g; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Shah MY, 2011, NAT GENET, V43, P289, DOI 10.1038/ng0411-289; Sharma V, 2005, J BIOMOL STRUCT DYN, V22, P533, DOI 10.1080/07391102.2005.10507023; Shieh FK, 2006, J MOL BIOL, V362, P516, DOI 10.1016/j.jmb.2006.07.030; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P14977, DOI 10.1021/bi050988f; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Van Emburgh BO, 2011, NUCLEIC ACIDS RES, V39, P4984, DOI 10.1093/nar/gkr116; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	54	45	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41479	41488		10.1074/jbc.M111.284687	http://dx.doi.org/10.1074/jbc.M111.284687			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21979949	hybrid, Green Published			2022-12-25	WOS:000298057500034
J	Luo, HY; Charpentier, T; Wang, XH; Qi, SJ; Han, B; Wu, T; Terra, R; Lamarre, A; Wu, JP				Luo, Hongyu; Charpentier, Tania; Wang, Xuehai; Qi, Shijie; Han, Bing; Wu, Tao; Terra, Rafik; Lamarre, Alain; Wu, Jiangping			Efnb1 and Efnb2 Proteins Regulate Thymocyte Development Peripheral T Cell Differentiation, and Antiviral Immune Responses and Are Essential for Interleukin-6 (IL-6) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; STIMULATES MIGRATION; EPHA RECEPTORS; ACTIVATION; MICE; HOMEOSTASIS; EPHRIN-B1; COSTIMULATION; LYMPHOCYTES; SELECTION	Erythropoietin-producing hepatocellular kinases (Eph kinases) constitute the largest family of cell membrane receptor tyrosine kinases, and their ligand ephrins are also cell surface molecules. Because of promiscuous interaction between Ephs and ephrins, there is considerable redundancy in this system, reflecting the essential roles of these molecules in the biological system through evolution. In this study, both Efnb1 and Efnb2 were null-mutated in the T cell compartment of mice through loxP-mediated gene deletion. Mice with this double conditional mutation (double KO mice) showed reduced thymus and spleen size and cellularity. There was a significant decrease in the DN4, double positive, and single positive thymocyte subpopulations and mature CD4 and CD8 cells in the periphery. dKO thymocytes and peripheral T cells failed to compete with their WT counterparts in irradiated recipients, and the T cells showed compromised ability of homeostatic expansion. dKO naive T cells were inferior in differentiating into Th1 and Th17 effectors in vitro. The dKO mice showed diminished immune response against LCMV infection. Mechanistic studies revealed that IL-6 signaling in dKO T cells was compromised, in terms of abated induction of STAT3 phosphorylation upon IL-6 stimulation. This defect likely contributed to the observed in vitro and in vivo phenotype in dKO mice. This study revealed novel roles of Efnb1 and Efnb2 in T cell development and function.	[Luo, Hongyu; Wang, Xuehai; Qi, Shijie; Han, Bing; Wu, Tao; Terra, Rafik; Wu, Jiangping] Notre Dame Hosp, CHUM, Res Ctr, Immunol Lab, Montreal, PQ H2L 4M1, Canada; [Wu, Jiangping] Notre Dame Hosp, CHUM, Res Ctr, Serv Nephrol, Montreal, PQ H2L 4M1, Canada; [Charpentier, Tania; Lamarre, Alain] Inst Armand Frappier, INRS, Laval, PQ H7V 1B7, Canada; [Wu, Tao] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Cardiol, Hangzhou 310003, Zhejiang, Peoples R China	Universite de Montreal; Universite de Montreal; University of Quebec; Institut national de la recherche scientifique (INRS); Zhejiang University	Wu, JP (corresponding author), Notre Dame Hosp, CHUM, Res Ctr, Immunol Lab, Rm Y-5616,1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.	jianping.wu@umontreal.ca			Canadian Institutes of Health Research [MOP57697, MOP69089, IMH 79565, MOP97829, MOP89797]; Heart and Stroke Foundation of Quebec; Quebec Ministry of Economic Development, Innovation, and Exportation [PSR-SIIRI-069]; J.-Louis Levesque Foundation; Fonds de la Recherche en Sante du Quebec; Zhejiang Provincial Natural Science Foundation of China [Y2080374]; National Natural Sciences Foundation of China [30800999]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Quebec Ministry of Economic Development, Innovation, and Exportation; J.-Louis Levesque Foundation; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Canadian Institutes of Health Research Grants MOP57697 and MOP69089 (to J. W.), IMH 79565 and MOP97829 to H. L.), and MOP89797 (to A. L.), by grants from the Heart and Stroke Foundation of Quebec, the Quebec Ministry of Economic Development, Innovation, and Exportation Grant PSR-SIIRI-069, by The J.-Louis Levesque Foundation (to J. W.), a group grant from the Fonds de la Recherche en Sante du Quebec for Transfusional and Hemovigilance Medical Research (to J. W.), and a J.-Louis Levesque Foundation grant (to A. L.).; Supported in part by Zhejiang Provincial Natural Science Foundation of China Grant Y2080374 and National Natural Sciences Foundation of China (Projects for Young Scientists Grant 30800999).	Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; ALLEN JM, 1992, MOL CELL BIOL, V12, P2758, DOI 10.1128/MCB.12.6.2758; Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; [Anonymous], 1997, Cell, V90, P403; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bong YS, 2007, P NATL ACAD SCI USA, V104, P17305, DOI 10.1073/pnas.0702337104; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Foster KE, 2010, P NATL ACAD SCI USA, V107, P13414, DOI 10.1073/pnas.1003747107; Freywald A, 2002, J BIOL CHEM, V277, P3823, DOI 10.1074/jbc.M108011200; Freywald A, 2006, J IMMUNOL, V176, P4066, DOI 10.4049/jimmunol.176.7.4066; Hashimoto T, 2007, KIDNEY INT, V72, P954, DOI 10.1038/sj.ki.5002454; Holen HL, 2010, J LEUKOCYTE BIOL, V87, P1059, DOI 10.1189/jlb.0709497; Kalo MS, 2001, J BIOL CHEM, V276, P38940, DOI 10.1074/jbc.M105815200; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; Lee HS, 2006, NAT CELL BIOL, V8, P55, DOI 10.1038/ncb1344; Luo HY, 2002, J CLIN INVEST, V110, P1141, DOI 10.1172/JCI200215883; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Munoz JJ, 2006, J IMMUNOL, V177, P804, DOI 10.4049/jimmunol.177.2.804; Noren NK, 2007, CANCER RES, V67, P3994, DOI 10.1158/0008-5472.CAN-07-0525; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Sharfe N, 2002, EUR J IMMUNOL, V32, P3745, DOI 10.1002/1521-4141(200212)32:12<3745::AID-IMMU3745>3.0.CO;2-M; Smith LM, 2004, EXP CELL RES, V292, P295, DOI 10.1016/j.yexcr.2003.08.021; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wohlfahrt JG, 2004, J IMMUNOL, V172, P843, DOI 10.4049/jimmunol.172.2.843; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Yu G, 2006, J BIOL CHEM, V281, P10222, DOI 10.1074/jbc.M510320200; Yu G, 2003, J IMMUNOL, V171, P106, DOI 10.4049/jimmunol.171.1.106; Yu G, 2004, J BIOL CHEM, V279, P55531, DOI 10.1074/jbc.M410814200; Yu G, 2003, J BIOL CHEM, V278, P47209, DOI 10.1074/jbc.M306659200; Zaragoza B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017423; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	53	46	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41135	41152		10.1074/jbc.M111.302596	http://dx.doi.org/10.1074/jbc.M111.302596			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21976681	Green Published, hybrid			2022-12-25	WOS:000298057500003
J	Mitra, D; Das, PM; Huynh, FC; Jones, FE				Mitra, Doyel; Das, Partha M.; Huynh, Felicia C.; Jones, Frank E.			Jumonji/ARID1 B (JARID1B) Protein Promotes Breast Tumor Cell Cycle Progression through Epigenetic Repression of MicroRNA let-7e	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; GENE-EXPRESSION; MAMMARY-GLAND; CANCER; PROLIFERATION; RECEPTOR; PLU-1; DIFFERENTIATION; ACTIVATION; RESISTANCE	MicroRNAs (miRs) function as tumor suppressors or oncogenes in multiple tumor types. Although miR expression is tightly regulated, the molecular basis of miR regulation is poorly understood. Here, we investigated the influence of the histone demethylase Junionji/ARID1 B (JARID1B) on miR regulation in breast tumor cells. In MCF-7 cells with stable RNAi-mediated suppression of JARID1B expression we identified altered regulation of multiple miRs including let-7e, a member of the let-7 family of tumor suppressor miRs. Chromatin immunoprecipitation analysis demonstrated JARID1B binding to the let-7e promoter region as well as removal of the of H3K4me3 histone mark associated with active gene expression. These results suggest that JARID1B epigenetically represses let-7e expression. JARID1B stimulates tumor cell proliferation by promoting the G, to S transition. As predicted, suppression of JARID1B resulted in an accumulation of MCF-7 cells in G We confirmed that cyclin D1, which also promotes G, progression, is a direct target of let-7e, and we show that cydin D1 expression is suppressed in JARID1B knockdown cells. Cyclin D1 expression and cell cycle progression were restored following inhibition of let-7e, suggesting that JARID1B repression of let-7e contributes to cydin D1 expression and JARID1B-mediated cell cycle progression. Our results indicate that the JARID1B demethylase contributes to tumor cell proliferation through the epigenetic repression of a tumor suppressor miR.	[Mitra, Doyel] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA; [Das, Partha M.; Huynh, Felicia C.; Jones, Frank E.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Tulane University	Jones, FE (corresponding author), 6400 Freret St, New Orleans, LA 70118 USA.	fjones3@tulane.edu	Das, Partha/C-6898-2012		United States Army Medical Research and Materiel Command [W81XWH-08-1-0506]	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by United States Army Medical Research and Materiel Command Grant W81XWH-08-1-0506 (to D. M. and F. E. J.).	Barrett A, 2002, INT J CANCER, V101, P581, DOI 10.1002/ijc.10644; Barrett A, 2007, INT J CANCER, V121, P265, DOI 10.1002/ijc.22673; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Catchpole S, 2011, INT J ONCOL, V38, P1267, DOI 10.3892/ijo.2011.956; Cittelly DM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-317; Cittelly DM, 2010, CARCINOGENESIS, V31, P2049, DOI 10.1093/carcin/bgq192; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Lan FF, 2011, INT J CANCER, V128, P319, DOI 10.1002/ijc.25336; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Verghese ET, 2008, J PATHOL, V215, P214, DOI 10.1002/path.2359; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	33	63	67	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40531	40535		10.1074/jbc.M111.304865	http://dx.doi.org/10.1074/jbc.M111.304865			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969366	Green Published, hybrid			2022-12-25	WOS:000297315400012
J	Pan, LF; Chen, J; Yu, J; Yu, HY; Zhang, MJ				Pan, Lifeng; Chen, Jia; Yu, Jiang; Yu, Haoyue; Zhang, Mingjie			The Structure of the PDZ3-SH3-GuK Tandem of ZO-1 Protein Suggests a Supramodular Organization of the Membrane-associated Guanylate Kinase (MAGUK) Family Scaffold Protein Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION; DOMAINS; MECHANISM; BINDING; TIGHT	Membrane-associated guanylate kinases (MAGUKs) are a large family of scaffold proteins that play essential roles in tethering membrane receptors, adhesion molecules, and macromolecular signaling complexes for tissue developments, cell-cell communications, and intracellular signal transductions. The defining feature of the MAGUK family scaffolds is that each member contains a conserved core consisting of a PSD-95/Dlg/ZO-1 (PDZ) domain, an Src homology 3 (SH3) domain, and a catalytically inactive guanylate kinase (GuK) domain arranged in tandem, although the structural features and functional implications of the PDZ-SH3-GuK tandem arrangement are unclear. The structure of the ZO-1 PDZ3-SH3-GuK tandem solved in this study reveals that the PDZ domain directly interacts with the SH3-GuK module, forming a structural supramodule with distinct target binding properties with respect to the isolated domains. Structure-based sequence analysis suggests that the PDZ-SH3-GuK tandems of other members of the MAGUK family also form supramodules.	[Pan, Lifeng; Chen, Jia; Yu, Jiang; Yu, Haoyue; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China; [Chen, Jia] Hong Kong Univ Sci & Technol, Nano Sci & Technol Program, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Yu, Jiang/C-6980-2012	Zhang, Mingjie/0000-0001-9404-0190; Chen, Jia/0000-0003-0080-0748	Research Grants Council of Hong Kong [663808, 664009, 660709, 663610, HKUST6/CRF/10, SEG_HKUST06, AoE/B-15/01-II, AoE/M-04/04]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Grants 663808, 664009, 660709, 663610, HKUST6/CRF/10, SEG_HKUST06, AoE/B-15/01-II, and AoE/M-04/04 from the Research Grants Council of Hong Kong (to M. Z.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brenman JE, 1998, J NEUROSCI, V18, P8805; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; de Mendoza A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-93; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lye MF, 2010, J BIOL CHEM, V285, P13907, DOI 10.1074/jbc.M109.093674; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newman RA, 2009, J BIOL CHEM, V284, P12924, DOI 10.1074/jbc.M809304200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; te Velthuis A. J., 2007, GUT, V7, P129; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Yan J, 2010, P NATL ACAD SCI USA, V107, P4040, DOI 10.1073/pnas.0911385107	24	45	47	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40069	40074		10.1074/jbc.C111.293084	http://dx.doi.org/10.1074/jbc.C111.293084			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965684	hybrid, Green Published			2022-12-25	WOS:000296925700039
J	Roy, S; Calcedo, R; Medina-Jaszek, A; Keough, M; Peng, H; Wilson, JM				Roy, Soumitra; Calcedo, Roberto; Medina-Jaszek, Angelica; Keough, Martin; Peng, Hui; Wilson, James M.			Adenoviruses in Lymphocytes of the Human Gastro-Intestinal Tract	PLOS ONE			English	Article							HUMAN LYMPHOID-CELLS; POLYMERASE-CHAIN-REACTION; NEUTRALIZING ANTIBODIES; VACCINE DEVELOPMENT; LATENT ADENOVIRUS; INFECTIOUS VIRUS; VIRAL-INFECTIONS; HUMAN TONSILS; T-CELLS; DNA	Objective: Persistent adenoviral shedding in stools is known to occur past convalescence following acute adenoviral infections. We wished to establish the frequency with which adenoviruses may colonize the gut in normal human subjects. Methods: The presence of adenoviral DNA in intestinal specimens obtained at surgery or autopsy was tested using a nested PCR method. The amplified adenoviral DNA sequences were compared to each other and to known adenoviral species. Lamina propria lymphocytes (LPLs) were isolated from the specimens and the adenoviral copy numbers in the CD4+ and CD8+ fractions were determined by quantitative PCR. Adenoviral gene expression was tested by amplification of adenoviral mRNA. Results: Intestinal tissue from 21 of 58 donors and LPLs from 21 of 24 donors were positive for the presence of adenoviral DNA. The majority of the sequences could be assigned to adenoviral species E, although species B and C sequences were also common. Multiple sequences were often present in the same sample. Forty-one non-identical sequences were identified from 39 different tissue donors. Quantitative PCR for adenoviral DNA in CD4+ and CD8+ fractions of LPLs showed adenoviral DNA to be present in both cell types and ranged from a few hundred to several million copies per million cells on average. Active adenoviral gene expression as evidenced by the presence of adenoviral messenger RNA in intestinal lymphocytes was demonstrated in 9 of the 11 donors tested. Conclusion: Adenoviral DNA is highly prevalent in lymphocytes from the gastro-intestinal tract indicating that adenoviruses may be part of the normal gut flora.	[Roy, Soumitra; Calcedo, Roberto; Medina-Jaszek, Angelica; Keough, Martin; Peng, Hui; Wilson, James M.] Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Div Transfus Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Roy, S (corresponding author), Crucell Holland, Leiden, Netherlands.	wilsonjm@mail.med.upenn.edu	Wilson, James M/F-9220-2011; Roy, Soumitra/B-9113-2008	Wilson, James M/0000-0002-9630-3131; 	Bill and Melinda Gates Foundation; GlaxoSmithKline; National Institute of Diabetes and Digestive and Kidney Diseases [5P30DK047757-15]; National Heart, Lung, and Blood Institute [5P01HL059407-10]; Cystic Fibrosis Foundation [R881-CR07]; ReGenX Holdings; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047757] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); GlaxoSmithKline(GlaxoSmithKline); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); ReGenX Holdings; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was sponsored by grants from the Bill and Melinda Gates Foundation, GlaxoSmithKline, National Institute of Diabetes and Digestive and Kidney Diseases (5P30DK047757-15), National Heart, Lung, and Blood Institute (5P01HL059407-10), and the Cystic Fibrosis Foundation (R881-CR07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SR is an inventor on patents licensed to various biopharmaceutical companies. JMW is a consultant to ReGenX Holdings, and is a founder of, holds equity in, and receives a grant from affiliates of ReGenX Holdings; in addition, he is an inventor on patents licensed to various biopharmaceutical companies, including affiliates of ReGenX Holdings. This work was also partially funded by a commercial source (GlaxoSmithKline). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ADRIAN T, 1988, EPIDEMIOL INFECT, V101, P503, DOI 10.1017/S0950268800029393; Appaiahgari MB, 2007, CLIN VACCINE IMMUNOL, V14, P1053, DOI 10.1128/CVI.00173-07; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Calcedo R, 2009, J VIROL, V83, P2623, DOI 10.1128/JVI.02160-08; Chen H, 2010, J VIROL, V84, P10522, DOI 10.1128/JVI.00450-10; CHU Y, 1992, VIROLOGY, V188, P793, DOI 10.1016/0042-6822(92)90534-V; CUNNINGHAM AL, 1988, J INFECT DIS, V158, P386, DOI 10.1093/infdis/158.2.386; Durepaire N, 1997, J ACQ IMMUN DEF SYND, V14, P189; Echavarria M, 2008, CLIN MICROBIOL REV, V21, P704, DOI 10.1128/CMR.00052-07; EVANS AS, 1958, AM J HYG, V67, P256, DOI 10.1093/oxfordjournals.aje.a119932; Flomenberg P, 1997, J MED VIROL, V51, P182, DOI 10.1002/(SICI)1096-9071(199703)51:3<182::AID-JMV7>3.0.CO;2-2; FOX JP, 1969, AM J EPIDEMIOL, V89, P25, DOI 10.1093/oxfordjournals.aje.a120913; FOX JP, 1977, AM J EPIDEMIOL, V105, P362, DOI 10.1093/oxfordjournals.aje.a112394; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; HORVATH J, 1986, J VIROL, V59, P189, DOI 10.1128/JVI.59.1.189-192.1986; Hutnick NA, 2010, VACCINE, V28, P1932, DOI 10.1016/j.vaccine.2009.10.091; LAVERY D, 1987, J VIROL, V61, P1466, DOI 10.1128/JVI.61.5.1466-1472.1987; Lu S, 2008, EXPERT REV VACCINES, V7, P151, DOI 10.1586/14760584.7.2.151; McManus TE, 2007, RESP MED, V101, P2084, DOI 10.1016/j.rmed.2007.05.015; McNees AL, 2004, J VIROL, V78, P6955, DOI 10.1128/JVI.78.13.6955-6966.2004; NEUMANN R, 1987, VIRUS RES, V7, P93, DOI 10.1016/0168-1702(87)90060-8; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Roy S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000503; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; SILVER L, 1988, VIROLOGY, V165, P377, DOI 10.1016/0042-6822(88)90582-X; STROHL WA, 1965, VIROLOGY, V26, P199, DOI 10.1016/0042-6822(65)90047-4; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; TOP FH, 1971, J INFECT DIS, V124, P155, DOI 10.1093/infdis/124.2.155; Tucker SN, 2008, EXPERT REV VACCINES, V7, P25, DOI 10.1586/14760584.7.1.25; VANDERVE.J, 1973, INFECT IMMUN, V7, P604, DOI 10.1128/IAI.7.4.604-609.1973; WOLD WSM, 2007, FIELD VIROLOGY, P02395; Zhang YG, 2010, J VIROL, V84, P8799, DOI 10.1128/JVI.00562-10	37	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24859	10.1371/journal.pone.0024859	http://dx.doi.org/10.1371/journal.pone.0024859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980361	Green Published, gold, Green Submitted			2022-12-25	WOS:000295941300012
J	Watahiki, A; Wang, YW; Morris, J; Dennis, K; O'Dwyer, HM; Gleave, M; Gout, PW; Wang, YZ				Watahiki, Akira; Wang, Yuwei; Morris, James; Dennis, Kristopher; O'Dwyer, Helena M.; Gleave, Martin; Gout, Peter W.; Wang, Yuzhuo			MicroRNAs Associated with Metastatic Prostate Cancer	PLOS ONE			English	Article							SUBRENAL CAPSULE XENOGRAFTS; TUMOR-SUPPRESSOR; DOWN-REGULATION; CELL-GROWTH; SCID MICE; EXPRESSION; GENE; INVASION; PREDICTION; REVEALS	Objective: Metastasis is the most common cause of death of prostate cancer patients. Identification of specific metastasis biomarkers and novel therapeutic targets is considered essential for improved prognosis and management of the disease. MicroRNAs (miRNAs) form a class of non-coding small RNA molecules considered to be key regulators of gene expression. Their dysregulation has been shown to play a role in cancer onset, progression and metastasis, and miRNAs represent a promising new class of cancer biomarkers. The objective of this study was to identify down-and up-regulated miRNAs in prostate cancer that could provide potential biomarkers and/or therapeutic targets for prostate cancer metastasis. Methods: Next generation sequencing technology was applied to identify differentially expressed miRNAs in a transplantable metastatic versus a non-metastatic prostate cancer xenograft line, both derived from one patient's primary cancer. The xenografts were developed via subrenal capsule grafting of cancer tissue into NOD/SCID mice, a methodology that tends to preserve properties of the original cancers (e. g., tumor heterogeneity, genetic profiles). Results: Differentially expressed known miRNAs, isomiRs and 36 novel miRNAs were identified. A number of these miRNAs (21/104) have previously been reported to show similar down-or up-regulation in prostate cancers relative to normal prostate tissue, and some of them (e. g., miR-16, miR-34a, miR-126*, miR-145, miR-205) have been linked to prostate cancer metastasis, supporting the validity of the analytical approach. Conclusions: The use of metastatic and non-metastatic prostate cancer subrenal capsule xenografts derived from one patient's cancer makes it likely that the differentially expressed miRNAs identified in this study include potential biomarkers and/or therapeutic targets for human prostate cancer metastasis.	[Watahiki, Akira; Wang, Yuwei; Gout, Peter W.; Wang, Yuzhuo] British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 4E6, Canada; [Morris, James; Dennis, Kristopher] British Columbia Canc Agcy, Dept Radiat Oncol, Vancouver, BC V5Z 4E6, Canada; [O'Dwyer, Helena M.] British Columbia Canc Agcy, Dept Diagnost Imaging, Vancouver, BC V5Z 4E6, Canada; [Gleave, Martin; Gout, Peter W.; Wang, Yuzhuo] Univ British Columbia, Fac Med, Dept Urol Sci, Vancouver, BC, Canada; [Watahiki, Akira; Gleave, Martin; Wang, Yuzhuo] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Watahiki, A (corresponding author), British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 4E6, Canada.	ywang@bccrc.ca		Gleave, Martin/0000-0003-4235-0167; Wang, Yuzhuo/0000-0002-9749-8591	Canadian Institutes of Health Research; National Natural Science Foundation of China [30928027]; International Cancer Alliance for Cancer Research and Education; Fibrolamellar Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cancer Alliance for Cancer Research and Education; Fibrolamellar Cancer Foundation	This study was supported by the Canadian Institutes of Health Research (YZW/MG). YZW is a recipient of an Overseas Chinese Scholar Award from the National Natural Science Foundation of China (No 30928027), and a recipient of an Innovative Scholar Award from International Cancer Alliance for Cancer Research and Education and the Fibrolamellar Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bogner PN, 2009, BIOCHEM BIOPH RES CO, V386, P305, DOI 10.1016/j.bbrc.2009.06.021; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Cutz JC, 2006, CLIN CANCER RES, V12, P4043, DOI 10.1158/1078-0432.CCR-06-0252; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Epis MR, 2009, J BIOL CHEM, V284, P24696, DOI 10.1074/jbc.M109.030098; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Fu H, 2009, ACTA BIOCH BIOPH SIN, V41, P648, DOI 10.1093/abbs/gmp053; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gandellini P, 2010, DISCOV MED, V9, P212; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134; Khew-Goodall Y, 2010, NAT CELL BIOL, V12, P209, DOI 10.1038/ncb0310-209; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kortmann U, 2011, CLIN CANCER RES, V17, P783, DOI 10.1158/1078-0432.CCR-10-1382; Kusters B, 2007, ONCOGENE, V26, P5808, DOI 10.1038/sj.onc.1210360; Lee CH, 2005, GYNECOL ONCOL, V96, P48, DOI 10.1016/j.ygyno.2004.09.025; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; LEITE KR, 2009, UROL ONCOL      0415; Lin D, 2008, CANCER RES, V68, P4352, DOI 10.1158/0008-5472.CAN-07-5237; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Makarov DV, 2009, ANNU REV MED, V60, P139, DOI 10.1146/annurev.med.60.042307.110714; Manzur M, 2009, CELL DEATH DIFFER, V16, P312, DOI 10.1038/cdd.2008.152; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Murata T, 2010, PROSTATE CANCER P D, V13, P356, DOI 10.1038/pcan.2010.32; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pass HI, 2010, CANCER RES, V70, P1916, DOI 10.1158/0008-5472.CAN-09-3993; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Sato T, 2009, ONCOL REP, V21, P211, DOI 10.3892/or_00000210; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sethi S, 2011, AM J TRANSL RES, V3, P90; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Tsang WP, 2009, CARCINOGENESIS, V30, P953, DOI 10.1093/carcin/bgp094; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang YW, 2005, LAB INVEST, V85, P1392, DOI 10.1038/labinvest.3700335; Wang YZ, 2005, PROSTATE, V64, P149, DOI 10.1002/pros.20225; Zhang J, 2010, CYTOKINE GROWTH F R, V21, P41, DOI 10.1016/j.cytogfr.2009.11.009; Zhang JJ, 2011, CANCER-AM CANCER SOC, V117, P86, DOI 10.1002/cncr.25522; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729	81	166	204	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24950	10.1371/journal.pone.0024950	http://dx.doi.org/10.1371/journal.pone.0024950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980368	Green Submitted, Green Published, gold			2022-12-25	WOS:000295941300014
J	Sen, S; Garcia-Ojalvo, J; Elowitz, MB				Sen, Shaunak; Garcia-Ojalvo, Jordi; Elowitz, Michael B.			Dynamical Consequences of Bandpass Feedback Loops in a Bacterial Phosphorelay	PLOS ONE			English	Article							BACILLUS-SUBTILIS; GENE-EXPRESSION; SPO0E GENE; SPORULATION; INITIATION; TRANSCRIPTION; DIFFERENTIATION; VARIABILITY; INTEGRATION; MECHANISM	Under conditions of nutrient limitation, Bacillus subtilis cells terminally differentiate into a dormant spore state. Progression to sporulation is controlled by a genetic circuit consisting of a phosphorelay embedded in multiple transcripional feedback loops, which is used to activate the master regulator Spo0A by phosphorylation. These transcriptional regulatory interactions are "bandpass"-like, in the sense that activation occurs within a limited band a Spo0A similar to P concentrations. Additionally, recent result show that the phosphorelay activation occurs in pulses, in a cell-cycle dependent fashion. However, the impact of these pulsed bandpass interactions on the circuit dynamics preceding sporulation remains unclear order to address this question, we measured key features of the bandpass interactions at the single-cell level and zed them in the context of a simple mathematical model. The model predicted the emergence of a delayed phase shift between the pulsing activity of the different sporulation genes, as well as the existence of a stable state, with elevated Spo0A activity but no sporulation embedded within the dynamical structure of the system. To test the model, we used time-lapse fluorescence microscopy to measure dynamics of single cells initiating sporulation. We obserbed the delayed phase shift emerging during the progression to sporulation, while a re-engineering of the sporulation circuit revealed behavior resembling the predicted additional state. These results show that periodically-driven bandpass feedback loops can give rise to complex dynamics in the progression towards sporulation.	[Sen, Shaunak] CALTECH, Div Engn & Appl Sci, Dept Control & Dynam Syst, Pasadena, CA 91125 USA; [Garcia-Ojalvo, Jordi] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Terrassa, Spain; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Div Biol, Dept Bioengn & Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology; Universitat Politecnica de Catalunya; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Sen, S (corresponding author), CALTECH, Div Engn & Appl Sci, Dept Control & Dynam Syst, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520	Betty and Gordon Moore Foundation; Ministerio de Ciencia e Innovacion (Spain) [FIS2009-13360]; Instituto de Salud Carlos III (Spain, REEM network); ICREA; NIH [R01GM079771]; US National Science Foundation [0644463]; Caltech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079771] Funding Source: NIH RePORTER	Betty and Gordon Moore Foundation(Gordon and Betty Moore Foundation); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III (Spain, REEM network)(Instituto de Salud Carlos III); ICREA(ICREA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Caltech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.S. acknowledges financial support from the Betty and Gordon Moore Foundation, Caltech through the Poincare Fellowship. Funding for J.G.-O. is provided by the Ministerio de Ciencia e Innovacion (Spain, project FIS2009-13360), Instituto de Salud Carlos III (Spain, REEM network), and by the ICREA Academia Programme. Funding for M.B.E. is provided by NIH grant R01GM079771 and US National Science Foundation CAREER Award 0644463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bick MJ, 2009, J MOL BIOL, V386, P163, DOI 10.1016/j.jmb.2008.12.006; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; CHAPMAN JW, 1987, J GEN MICROBIOL, V133, P2079; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Eldar A, 2009, NATURE, V460, P510, DOI 10.1038/nature08150; Fujita M, 2005, GENE DEV, V19, P2236, DOI 10.1101/gad.1335705; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Fujita M, 1998, J BIOCHEM-TOKYO, V124, P98, DOI 10.1093/oxfordjournals.jbchem.a022103; Gilbert S.F., 2000, DEV BIOL, V6th ed.; Grimshaw CE, 1998, BIOCHEMISTRY-US, V37, P1365, DOI 10.1021/bi971917m; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; LEVINE JH, UNPUB; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; PEREGO M, 1994, CELL, V79, P1047, DOI 10.1016/0092-8674(94)90035-3; PEREGO M, 1987, MOL MICROBIOL, V1, P125, DOI 10.1111/j.1365-2958.1987.tb00536.x; PEREGO M, 1991, J BACTERIOL, V173, P2514, DOI 10.1128/jb.173.8.2514-2520.1991; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Ptashne M, 2004, GENETIC SWITCH PHAGE, Vxiv; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Veening JW, 2009, GENE DEV, V23, P1959, DOI 10.1101/gad.528209; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	28	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25102	10.1371/journal.pone.0025102	http://dx.doi.org/10.1371/journal.pone.0025102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980382	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000295939600010
J	Krstic, G				Krstic, Goran			Apparent Temperature and Air Pollution vs. Elderly Population Mortality in Metro Vancouver	PLOS ONE			English	Article							DAILY RESPIRATORY MORTALITY; VITAMIN-D; AMBIENT-TEMPERATURE; PM10 POLLUTION; MEXICO-CITY; FINE; PARTICLES; WEATHER; ASSOCIATION; HEALTH	Background: Meteorological conditions and air pollution in urban environments have been associated with general population and elderly mortality, showing seasonal variation. Objectives: This study is designed to evaluate the relationship between apparent temperature (AT) and air pollution (PM2.5) vs. mortality in elderly population of Metro Vancouver. Methods: Statistical analyses are performed on moving sum daily mortality rates vs. moving average AT and PM2.5 in 1-, 2-, 3-, 5-, and 7-day models for all seasons, warm temperatures above 15 degrees C, and cold temperatures below 10 degrees C. Results: Approximately 37% of the variation in all-season mortality from circulatory and respiratory causes can be explained by the variation in 7-day moving average apparent temperature (r(2) = 0.37, p<0.001). Although the analytical results from air pollution models show increasingly better prediction ability of longer time-intervals (r(2) = 0.012, p<0.001 in a 7-day model), a very weak negative association between elderly mortality and air pollution is observed. Conclusions: Apparent temperature is associated with mortality from respiratory and circulatory causes in elderly population of Metro Vancouver. In a changing climate, one may anticipate to observe potential health impacts from the projected high- and particularly from the low-temperature extremes.	Fraser Hlth, Environm Hlth Serv, New Westminster, BC, Canada		Krstic, G (corresponding author), Fraser Hlth, Environm Hlth Serv, New Westminster, BC, Canada.	Goran.Krstic@fraserhealth.ca						Almeida SP, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-12; Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Bernstein L., 2007, CLIMATE CHANGE SYNTH; Borja-Aburto VH, 1998, ENVIRON HEALTH PERSP, V106, P849, DOI 10.2307/3434129; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; BRISTOW KL, 1984, AGR FOREST METEOROL, V31, P159, DOI 10.1016/0168-1923(84)90017-0; Cakmak S, 2007, ENVIRON HEALTH PERSP, V115, P524, DOI 10.1289/ehp.9567; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Cutolo M, 2009, RHEUMATOLOGY, V48, P210, DOI 10.1093/rheumatology/ken394; Dabek-Zlotorzynska E, 2011, ATMOS ENVIRON, V45, P673, DOI 10.1016/j.atmosenv.2010.10.024; Daniels MJ, 2000, AM J EPIDEMIOL, V152, P397, DOI 10.1093/aje/152.5.397; Filleul L, 2001, EUR RESPIR J, V17, P1055; Fioletov VE, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004820; Grass D, 2008, INT J CLIMATOL, V28, P1113, DOI 10.1002/joc.1592; Hughes DA, 2009, CLIN EXP IMMUNOL, V158, P20, DOI 10.1111/j.1365-2249.2009.04001.x; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Kimlin MG, 2007, J PHOTOCH PHOTOBIO B, V86, P234, DOI 10.1016/j.jphotobiol.2006.10.004; KUNST AE, 1994, AM J PUBLIC HEALTH, V84, P1738, DOI 10.2105/AJPH.84.11.1738; Laschewski G, 2002, CLIMATE RES, V21, P91, DOI 10.3354/cr021091; Mar TF, 2000, ENVIRON HEALTH PERSP, V108, P347, DOI 10.2307/3454354; Marris E, 2006, NATURE, V444, P248, DOI 10.1038/444248a; Marshall JD, 2008, ATMOS ENVIRON, V42, P1359, DOI 10.1016/j.atmosenv.2007.08.012; Mead MN, 2008, ENVIRON HEALTH PERSP, V116, pA160, DOI 10.1289/ehp.116-a160; Medina-Ramon M, 2006, ENVIRON HEALTH PERSP, V114, P1331, DOI 10.1289/ehp.9074; Moolgavkar S, 2007, NATURE, V445, P21, DOI 10.1038/445021c; Neuberger M, 2007, ATMOS ENVIRON, V41, P8549, DOI 10.1016/j.atmosenv.2007.07.013; Ostro B, 2006, ENVIRON HEALTH PERSP, V114, P29, DOI 10.1289/ehp.8335; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Rocklov J, 2010, INT J ENV RES PUB HE, V7, P2607, DOI 10.3390/ijerph7062607; Schwartz J, 2008, ENVIRON HEALTH PERSP, V116, P64, DOI 10.1289/ehp.9955; Spagnolo J, 2003, BUILD ENVIRON, V38, P721, DOI 10.1016/S0360-1323(02)00209-3; Steadman R. G., 1994, Australian Meteorological Magazine, V43, P1; Tellez-Rojo MM, 2000, EUR RESPIR J, V16, P391, DOI 10.1034/j.1399-3003.2000.016003391.x; Vedal S, 2003, ENVIRON HEALTH PERSP, V111, P45, DOI 10.1289/ehp.5276; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang XH, 2006, ENVIRON MONIT ASSESS, V119, P425, DOI 10.1007/s10661-005-9034-3	38	26	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25101	10.1371/journal.pone.0025101	http://dx.doi.org/10.1371/journal.pone.0025101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980381	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900023
J	Li, HY; Xi, QY; Xiong, YY; Cheng, X; Qi, Q; Yang, L; Shu, G; Wang, SB; Wang, LN; Gao, P; Zhu, XT; Jiang, QY; Zhang, YL; Yuan, L				Li, Hongyi; Xi, Qianyun; Xiong, Yuanyan; Cheng, Xiao; Qi, Qien; Yang, Lin; Shu, Gang; Wang, Songbo; Wang, Lina; Gao, Ping; Zhu, Xiaotong; Jiang, Qingyan; Zhang, Yongliang; Yuan, Li			A Comprehensive Expression Profile of MicroRNAs in Porcine Pituitary	PLOS ONE			English	Article							GENE-EXPRESSION; RNA; PROLIFERATION; DISCOVERY; TARGETS; IMPACT; GROWTH; TISSUE; CELLS	MicroRNAs (miRNAs) are an abundant class of small RNAs that regulate expressions of most genes. miRNAs play important roles in the pituitary, the "master" endocrine organ. However, we still don't know which role miRNAs play in the development of pituitary tissue or how much they contribute to the pituitary function. By applying a combination of microarray analysis and Solexa sequencing, we detected a total of 450 miRNAs in the porcine pituitary. Verification with RTPCR showed a high degree of confidence for the obtained data. According to the current miRBase release17.0, the detected miRNAs included 169 known porcine miRNAs, 163 conserved miRNAs not yet identified in the pig, and 12 potentially new miRNAs not yet identified in any species, three of which were revealed using Northern blot. The pituitary might contain about 80.17% miRNA types belonging to the animal. Analysis of 10 highly expressed miRNAs with the Kyoto Encyclopedia of Genes and Genomes (KEGG) indicated that the enriched miRNAs were involved not only in the development of the organ but also in a variety of inter-cell and inner cell processes or pathways that are involved in the function of the organ. We have revealed the existence of a large number of porcine miRNAs as well as some potentially new miRNAs and established for the first time a comprehensive miRNA expression profile of the pituitary. The pituitary gland contains unexpectedly many miRNA types and miRNA actions are involved in important processes for both the development and function of the organ.	[Li, Hongyi; Xi, Qianyun; Cheng, Xiao; Qi, Qien; Yang, Lin; Shu, Gang; Wang, Songbo; Wang, Lina; Gao, Ping; Zhu, Xiaotong; Jiang, Qingyan; Zhang, Yongliang] S China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Yuan, Li] Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen, Peoples R China; [Xiong, Yuanyan] Sun Yat Sen Univ, Coll Life Sci, Guangzhou 510275, Guangdong, Peoples R China	South China Agricultural University; Xiamen University; Sun Yat Sen University	Li, HY (corresponding author), S China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.	zhangyl@scau.edu.cn; yuanli@xmu.edu.cn			Chinese Key Basic Plan [2009CB941601]; National Natural Science Foundation of China [31072105, u0731004]; national Key project [2009ZX0890-024B]	Chinese Key Basic Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); national Key project	This work was supported by grants from the Chinese Key Basic Plan (No. 2009CB941601), the National Natural Science Foundation of China (31072105), the national Key project 2009ZX0890-024B, the Joint Funds of National Natural Science Foundation of China, u0731004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Amaral FC, 2009, J CLIN ENDOCR METAB, V94, P320, DOI 10.1210/jc.2008-1451; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Harding CJ, 2008, PHYS CHEM CHEM PHYS, V10, P5875, DOI 10.1039/b805688a; Hawkins PG, 2008, CELL CYCLE, V7, P602, DOI 10.4161/cc.7.5.5522; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Kim, 2006, PROQUEST BIOL J; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Nielsen M, 2009, ANIM GENET; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Rocha KM, 2003, MICROSC RES TECHNIQ, V61, P268, DOI 10.1002/jemt.10336; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sawera M, 2005, MAMM GENOME, V16, P594, DOI 10.1007/s00335-005-0013-3; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smrt RD, 2010, STEM CELLS; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Takeuchi Yasuhiro, 2009, Clin Calcium, V19, P977, DOI CliCa0907977983; Tan YL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-12; Wang LL, 2009, HUM REPROD, V24, P562, DOI 10.1093/humrep/den439; WEISS S, 1978, P SOC EXP BIOL MED, V159, P409; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Younger ST, 2011, NUCL ACIDS RES; Yousef M, 2009, FEBS J, V276, P2150, DOI 10.1111/j.1742-4658.2009.06933.x; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441	46	22	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24883	10.1371/journal.pone.0024883	http://dx.doi.org/10.1371/journal.pone.0024883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969866	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900017
J	Michels, KB; Harris, HR; Barault, L				Michels, Karin B.; Harris, Holly R.; Barault, Ludovic			Birthweight, Maternal Weight Trajectories and Global DNA Methylation of LINE-1 Repetitive Elements	PLOS ONE			English	Article							DEVELOPMENTAL ORIGINS; PLACENTAL EXPRESSION; PRENATAL EXPOSURE; IMPRINTED GENES; GROWTH; DISEASE; BIOMARKER; OBESITY; FAMINE; REGION	Low birthweight, premature birth, intrauterine growth retardation, and maternal malnutrition have been related to an increased risk of cardiovascular disease, type 2 diabetes mellitus, obesity, and neuropsychiatric disorders later in life. Conversely, high birthweight has been linked to future risk of cancer. Global DNA methylation estimated by the methylation of repetitive sequences in the genome is an indicator of susceptibility to chronic diseases. We used data and biospecimens from an epigenetic birth cohort to explore the association between trajectories of fetal and maternal weight and LINE-1 methylation in 319 mother-child dyads. Newborns with low or high birthweight had significantly lower LINE-1 methylation levels in their cord blood compared to normal weight infants after adjusting for gestational age, sex of the child, maternal age at delivery, and maternal smoking during pregnancy (p = 0.007 and p = 0.036, respectively), but the magnitude of the difference was small. Infants born prematurely also had lower LINE-1 methylation levels in cord blood compared to term infants, and this difference, though small, was statistically significant (p = 0.004). We did not find important associations between maternal prepregnancy BMI or gestational weight gain and global methylation of the cord blood or fetal placental tissue. In conclusion, we found significant differences in cord blood LINE-1 methylation among newborns with low and high birthweight as well as among prematurely born infants. Future studies may elucidate whether chromosomal instabilities or other functional consequences of these changes contribute to the increased risk of chronic diseases among individuals with these characteristics.	[Michels, Karin B.; Harris, Holly R.; Barault, Ludovic] Harvard Univ, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr,Med Sch, Boston, MA 02115 USA; [Michels, Karin B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Michels, KB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr,Med Sch, Boston, MA 02115 USA.	kmichels@rics.bwh.harvard.edu	Barault, Ludovic/J-2472-2016; Harris, Holly/AAK-6844-2020	Barault, Ludovic/0000-0001-5227-5047; Harris, Holly/0000-0002-2572-6727	National Cancer Institute, National Institutes of Health [5R21CA128382]; NATIONAL CANCER INSTITUTE [R21CA128382] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Research Grant 5R21CA128382 from the National Cancer Institute, National Institutes of Health (to K. B. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams B, 2009, WEIGHT GAIN PREGNANC; Adkins RM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-47; Adkins RM, 2011, BIRTH DEFECTS RES A, V91, P728, DOI 10.1002/bdra.20770; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1988, BRIT MED J, V297, P134, DOI 10.1136/bmj.297.6641.134-b; BARKER DJP, 1986, LANCET, V1, P1077; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bollati V, 2011, BRAIN BEHAV IMMUN, V25, P1078, DOI 10.1016/j.bbi.2011.01.017; Bourque DK, 2010, PLACENTA, V31, P197, DOI 10.1016/j.placenta.2009.12.003; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Diplas AI, 2009, EPIGENETICS-US, V4, P235, DOI 10.4161/epi.9019; Einstein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008887; Filiberto AC, 2011, EPIGENETICS-US, V6, P566, DOI 10.4161/epi.6.5.15236; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; Hanson M, 2011, PROG BIOPHYS MOL BIO, V106, P272, DOI 10.1016/j.pbiomolbio.2010.12.008; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; McMinn J, 2006, PLACENTA, V27, P540, DOI 10.1016/j.placenta.2005.07.004; Michels KB, 2006, INT J CANCER, V119, P2007, DOI 10.1002/ijc.22004; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; Perrin D, 2007, ONCOGENE, V26, P2518, DOI 10.1038/sj.onc.1210039; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Schulz WA, 2006, CURR TOP MICROBIOL, V310, P211; Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504; Stuebe AM, 2009, INT J OBESITY, V33, P743, DOI 10.1038/ijo.2009.101; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335	42	118	121	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25254	10.1371/journal.pone.0025254	http://dx.doi.org/10.1371/journal.pone.0025254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980406	gold, Green Submitted, Green Published			2022-12-25	WOS:000295936900041
J	Millet, JP; Orcau, A; Rius, C; Casals, M; de Olalla, PG; Moreno, A; Nelson, JL; Cayla, JA				Millet, Juan-Pablo; Orcau, Angels; Rius, Cristina; Casals, Marti; Garcia de Olalla, Patricia; Moreno, Antonio; Nelson, Jeanne L.; Cayla, Joan A.		Barcelona TB Working Grp	Predictors of Death among Patients Who Completed Tuberculosis Treatment: A Population-Based Cohort Study	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; RISK-FACTORS; RECURRENT TUBERCULOSIS; HIV-INFECTION; DRUG-USE; MORTALITY; DISEASE; FATALITY; RELAPSE	Background: Mortality among patients who complete tuberculosis (TB) treatment is still high among vulnerable populations. The objective of the study was to identify the probability of death and its predictive factors in a cohort of successfully treated TB patients. Methods: A population-based retrospective longitudinal study was performed in Barcelona, Spain. All patients who successfully completed TB treatment with culture-confirmation and available drug susceptibility testing between 1995-1997 were retrospectively followed-up until December 31, 2005 by the Barcelona TB Control Program. Socio-demographic, clinical, microbiological and treatment variables were examined. Mortality, TB Program and AIDS registries were reviewed. Kaplan-Meier and a Cox regression methods with time-dependent covariates were used for the survival analysis, calculating the hazard ratio (HR) with 95% confidence intervals (CI). Results: Among the 762 included patients, the median age was 36 years, 520 (68.2%) were male, 178 (23.4%) HIV-infected, and 208 (27.3%) were alcohol abusers. Of the 134 (17.6%) injecting drug users (IDU), 123 (91.8%) were HIV-infected. A total of 30 (3.9%) recurrences and 173 deaths (22.7%) occurred (mortality rate: 3.4/100 person-years of follow-up). The predictors of death were: age between 41-60 years old (HR: 3.5; CI: 2.1-5.7), age greater than 60 years (HR: 14.6; CI: 8.9-24), alcohol abuse (HR: 1.7; CI: 1.2-2.4) and HIV-infected IDU (HR: 7.9; CI: 4.7-13.3). Conclusions: The mortality rate among TB patients who completed treatment is associated with vulnerable populations such as the elderly, alcohol abusers, and HIV-infected IDU. We therefore need to fight against poverty, and promote and develop interventions and social policies directed towards these populations to improve their survival.	[Millet, Juan-Pablo; Orcau, Angels; Rius, Cristina; Casals, Marti; Garcia de Olalla, Patricia; Moreno, Antonio; Nelson, Jeanne L.; Cayla, Joan A.] Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain; [Millet, Juan-Pablo; Orcau, Angels; Casals, Marti; Garcia de Olalla, Patricia; Moreno, Antonio; Cayla, Joan A.] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Millet, Juan-Pablo; Cayla, Joan A.] Univ Autonoma Barcelona, Dept Pediat Ginecol & Med Prevent, E-08193 Barcelona, Spain; [Casals, Marti] Univ Barcelona, Dept Salut Publ, Barcelona, Spain; [Casals, Marti] Univ Int Catalunya, Dept Ciencies Basiques, Barcelona, Spain	Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; University of Barcelona; Universitat Internacional de Catalunya (UIC)	Millet, JP (corresponding author), Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain.	jmillet@aspb.es	Casals, Martí/M-8388-2019	Casals, Martí/0000-0002-1775-8331; Ocana, Inma/0000-0003-3699-0790; Millet, Joan Pau/0000-0003-0200-2459; Cayla, Joan A./0000-0003-3891-111X; de Souza Galvao, Maria Luiza/0000-0001-9703-989X	CIBER de Epidemiologia y Salud Publica (CIBERESP), Spain; Amsterdam Health Service/Academic Medical Center; Santiago Perez-Hoyos of the Barcelona Centre for International Health Research (CRESIB)	CIBER de Epidemiologia y Salud Publica (CIBERESP), Spain; Amsterdam Health Service/Academic Medical Center; Santiago Perez-Hoyos of the Barcelona Centre for International Health Research (CRESIB)	This work was supported by the CIBER de Epidemiologia y Salud Publica (CIBERESP), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to all the health and administrative personnel of the Epidemiology Service, Public Health Agency of Barcelona (PHAB), without whom this work would not have been possible. Thanks to Dr. Pablo Marcone for starting to study TB recurrences in Barcelona. Thanks to Dr. Anna Rodes and Elsa Plasencia (Generalitat de Catalunya), to Dr. Teresa Brugal and Dr. Josep M<SUP>a</SUP> Jansa (PHAB). Thank you also to Gloria Ribas of the Mortality Register of Catalonia, Servei d'Informacio i Estudis de la Direccio General de Recursos Sanitaris del Departament de Salut de la Generalitat de Catalunya. Thanks to Laia Fina and Lucia del Bano for their help with the translation. Finally, many thanks to Dr. Ronald Geskus of the Amsterdam Health Service/Academic Medical Center and Santiago Perez-Hoyos of the Barcelona Centre for International Health Research (CRESIB) for his support and help with the survival analysis.	Borgdorff MW, 1998, EUR RESPIR J, V11, P816, DOI 10.1183/09031936.98.11040816; Cayla JA, 1996, AIDS, V10, P1446, DOI 10.1097/00002030-199610000-00029; Cayla JA, 2004, INT J TUBERC LUNG D, V8, P458; Cayla JA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-121; Centers for Disease Control and Prevention (CDC), 1996, TUB CAS DEF 1996; Chiang CY, 2007, INT J TUBERC LUNG D, V11, P258; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Crofts JP, 2010, THORAX, V65, P310, DOI 10.1136/thx.2009.124677; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Garcia-Garcia MD, 2002, EMERG INFECT DIS, V8, P1327; Geng E, 2005, JAMA-J AM MED ASSOC, V293, P2740, DOI 10.1001/jama.293.22.2740; Girardi E, 2004, EUR RESPIR J, V24, P11, DOI 10.1183/09031936.04.00109303; Gordon S, 2009, THORAX, V64, P649, DOI 10.1136/thx.2009.116400; Institut Municipal de Salut Publica, SAL BARC AN 2000; Jha UM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008873; Lefebvre N, 2008, EUR RESPIR J, V31, P1256, DOI 10.1183/09031936.00131107; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Manoff SB, 1996, J INFECT DIS, V174, P299, DOI 10.1093/infdis/174.2.299; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; PablosMendez A, 1996, JAMA-J AM MED ASSOC, V276, P1223, DOI 10.1001/jama.276.15.1223; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; Perez-Guzman Carlos, 1999, Chest, V116, P961, DOI 10.1378/chest.116.4.961; Rajagopalan S, 2001, CLIN INFECT DIS, V33, P1034, DOI 10.1086/322671; Red Nacional de Vigilancia Epidemiologica, 2003, AMPL DEF CAS TUB RED; Rodger AJ, 2010, THORAX, V65, P63, DOI 10.1136/thx.2009.122754; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; Straetemans M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020755; Tocque K, 2005, INT J TUBERC LUNG D, V9, P797; Vasankari T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-291; Veen J, 1998, EUR RESPIR J, V12, P505, DOI 10.1183/09031936.98.12020505; Vree M, 2007, INT J TUBERC LUNG D, V11, P392; Walpola HC, 2003, INT J TUBERC LUNG D, V7, P742; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2010, GLOB TUB CONTR SURV; Wu P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010468; Yew WW, 2005, AM J RESP CRIT CARE, V171, P1324, DOI 10.1164/rccm.2502005; Zignol M, 2007, CLIN INFECT DIS, V44, P61, DOI 10.1086/509328	44	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25315	10.1371/journal.pone.0025315	http://dx.doi.org/10.1371/journal.pone.0025315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980423	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900051
J	Smith, I; Broos, A; de Jong, C; Zeddeman, A; Smith, C; Smith, G; Moore, F; Barr, J; Crameri, G; Marsh, G; Tachedjian, M; Yu, M; Kung, YH; Wang, LF; Field, H				Smith, Ina; Broos, Alice; de Jong, Carol; Zeddeman, Anne; Smith, Craig; Smith, Greg; Moore, Fred; Barr, Jennifer; Crameri, Gary; Marsh, Glenn; Tachedjian, Mary; Yu, Meng; Kung, Yu Hsin; Wang, Lin-Fa; Field, Hume			Identifying Hendra Virus Diversity in Pteropid Bats	PLOS ONE			English	Article							EQUINE MORBILLIVIRUS; FRUIT BATS; INFECTION; HORSES; TRANSMISSION; OUTBREAK; GENOME	Hendra virus (HeV) causes a zoonotic disease with high mortality that is transmitted to humans from bats of the genus Pteropus (flying foxes) via an intermediary equine host. Factors promoting spillover from bats to horses are uncertain at this time, but plausibly encompass host and/or agent and/or environmental factors. There is a lack of HeV sequence information derived from the natural bat host, as previously sequences have only been obtained from horses or humans following spillover events. In order to obtain an insight into possible variants of HeV circulating in flying foxes, collection of urine was undertaken in multiple flying fox roosts in Queensland, Australia. HeV was found to be geographically widespread in flying foxes with a number of HeV variants circulating at the one time at multiple locations, while at times the same variant was found circulating at disparate locations. Sequence diversity within variants allowed differentiation on the basis of nucleotide changes, and hypervariable regions in the genome were identified that could be used to differentiate circulating variants. Further, during the study, HeV was isolated from the urine of flying foxes on four occasions from three different locations. The data indicates that spillover events do not correlate with particular HeV isolates, suggesting that host and/or environmental factors are the primary determinants of bat-horse spillover. Thus future spillover events are likely to occur, and there is an on-going need for effective risk management strategies for both human and animal health.	[Smith, Ina; Barr, Jennifer; Crameri, Gary; Marsh, Glenn; Tachedjian, Mary; Yu, Meng; Wang, Lin-Fa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Smith, Ina; Broos, Alice; Smith, Greg; Moore, Fred] Queensland Hlth Forens & Sci Serv, Publ Hlth Virol, Coopers Plains, Qld, Australia; [de Jong, Carol; Zeddeman, Anne; Smith, Craig; Kung, Yu Hsin; Field, Hume] Queensland Ctr Emerging Infect Dis, Dept Employment Econ Dev & Innovat, Coopers Plains, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland Health	Smith, I (corresponding author), CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia.	ina.smith@csiro.au; hume.field@qld.gov.au	Smith, Ina/H-7225-2013; Crameri, Gary/H-8441-2013; Marsh, Glenn A/A-5418-2013; wang, lin/GSE-3040-2022; Barr, Jennifer A/H-9254-2013; Tachedjian, Mary/H-4572-2013	Smith, Ina/0000-0001-5807-3737; Marsh, Glenn A/0000-0002-3469-1837; Barr, Jennifer/0000-0001-5266-9142; Tachedjian, Mary/0000-0002-8936-6564; Broos, Alice/0000-0001-7593-1000; Wang, Lin-Fa/0000-0003-2752-0535	Wildlife and Exotic Disease Preparedness Program; Australian Biosecurity Collaborative Research Centre for Emerging Diseases	Wildlife and Exotic Disease Preparedness Program; Australian Biosecurity Collaborative Research Centre for Emerging Diseases	This work was supported in part by funding from the Wildlife and Exotic Disease Preparedness Program and Australian Biosecurity Collaborative Research Centre for Emerging Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, HENDRA VIRUS EQUINE; [Anonymous], 2008, HENDRA VIRUS HUMAN E; [Anonymous], 2007, HENDRA VIRUS HUMAN E; [Anonymous], 2009, HENDRA VIRUS HUMAN E; [Anonymous], 2009, HENDRA VIRUS EQUINE; Arthur R, 2006, ANIMAL HLTH SURVEILL, V11, P8; Chua KB, 2003, MICROBES INFECT, V5, P487, DOI 10.1016/S1286-4579(03)00067-4; Cowled C, 2011, DEV COMP IMMUNOL, V35, P7, DOI 10.1016/j.dci.2010.07.006; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Eaton BT, 2006, FIELDS VIROLOGY, P1587; Field H, 2011, PLOS ONE UNPUB; Field HE, 2000, AUST VET J, V78, P279, DOI 10.1111/j.1751-0813.2000.tb11758.x; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hanna JN, 2006, MED J AUSTRALIA, V185, P562, DOI 10.5694/j.1326-5377.2006.tb00692.x; Hooper PT, 1996, AUST VET J, V74, P244, DOI 10.1111/j.1751-0813.1996.tb15414.x; Hyatt AD, 1996, VIRUS RES, V43, P1, DOI 10.1016/0168-1702(96)01307-X; Marsh GA, 2010, EMERG INFECT DIS, V16, P1767, DOI 10.3201/eid1611.100501; Murray G, 2005, DIS INFORM, V18, P66; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; Murray K., 1998, EMERG INFECT DIS, V1, P43; OIE, 2010, MAN DIAGN TESTS VACC; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P BIOL SCI; Rogers RJ, 1996, AUST VET J, V74, P243, DOI 10.1111/j.1751-0813.1996.tb15413.x; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Smith IL, 2010, MOL DETECTION HUMAN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wang LF, 2000, J VIROL, V74, P9972, DOI 10.1128/JVI.74.21.9972-9979.2000; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	35	64	67	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25275	10.1371/journal.pone.0025275	http://dx.doi.org/10.1371/journal.pone.0025275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980413	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900046
J	Wolstenholme, JT; Taylor, JA; Shetty, SRJ; Edwards, M; Connelly, JJ; Rissman, EF				Wolstenholme, Jennifer T.; Taylor, Julia A.; Shetty, Savera R. J.; Edwards, Michelle; Connelly, Jessica J.; Rissman, Emilie F.			Gestational Exposure to Low Dose Bisphenol A Alters Social Behavior in Juvenile Mice	PLOS ONE			English	Article							TRANSPORTER GENE SLC1A1; PERINATAL EXPOSURE; SEXUAL-DIFFERENTIATION; OXYTOCIN RECEPTOR; ENVIRONMENTAL ESTROGENS; DEVELOPMENTAL EXPOSURE; SOCIOSEXUAL BEHAVIOR; SYNAPTIC PLASTICITY; GENOME-WIDE; IN-VITRO	Bisphenol A (BPA) is a man-made compound used to make polycarbonate plastics and epoxy resins; public health concerns have been fueled by findings that BPA exposure can reduce sex differences in brain and some behaviors. We asked if a low BPA dose, within the range measured in humans, ingested during pregnancy, would affect social behaviors in prepubertal mice. We noted sex differences in social interactions whereby females spent more time sitting side-by-side, while males engaged in more exploring and sitting alone. In addition BPA increased display of nose-to-nose contacts, play solicitations and approaches in both sexes. Interactions between sex and diet were found for self grooming, social interactions while sitting side-by-side and following the other mouse. In all these cases interactions were produced by differences between control and BPA females. We examined brains from embryos during late gestation to determine if gene expression differences might be correlated with some of the sexually dimorphic or BPA affected behaviors we observed. Because BPA treatments ended at birth we took the brains during embryogenesis to increase the probability of discovering BPA mediated effects. We also selected this embryonic age (E18.5) because it coincides with the onset of sexual differentiation of the brain. Interestingly, mRNA for the glutamate transporter, Slc1a1, was enhanced by exposure to BPA in female brains. Also we noted that BPA changed the expression of two of the three DNA methyltransferase genes, Dnmt1 and Dnmt3a. We propose that BPA affects DNA methylation of Sc1a1 during neural development. Sex differences in juvenile social interactions are affected by BPA and in particular this compound modifies behavior in females.	[Wolstenholme, Jennifer T.; Shetty, Savera R. J.; Edwards, Michelle; Rissman, Emilie F.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Taylor, Julia A.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Connelly, Jessica J.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA	University of Virginia; University of Missouri System; University of Missouri Columbia; University of Virginia	Wolstenholme, JT (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	Rissman@virginia.edu	WOLSTENHOLME, JENNIFER/GWV-6224-2022		National Institute of Mental Health (NIMH) [R01 MH086711]; Autism [4802]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [T32 DK007646]; National Research Service Award (NRSA) [F32ES01940]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES019404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086711] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Autism; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by National Institute of Mental Health (NIMH) R01 MH086711 and Autism Speaks grant #4802 (EFR). JTW received 21 support from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) T32 DK007646 and is now supported by National Research Service Award (NRSA) F32ES01940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency USEP, 1993, 80057 CASRN AG USEP; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Arnold AP, 2009, FRONT NEUROENDOCRIN, V30, P1, DOI 10.1016/j.yfrne.2008.11.001; Arnold PD, 2006, ARCH GEN PSYCHIAT, V63, P769, DOI 10.1001/archpsyc.63.7.769; Bailey CG, 2011, J CLIN INVEST, V121, P446, DOI 10.1172/JCI44474; Balakrishnan B, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.025; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Cox KH, 2011, GENES BRAIN BEHAV; Cox KH, 2010, HORM BEHAV, V58, P754, DOI 10.1016/j.yhbeh.2010.07.008; Curley JP, 2010, BEHAV GENET, V40, P220, DOI 10.1007/s10519-010-9334-4; Dessi-Fulgheri F, 2002, ENVIRON HEALTH PERSP, V110, P403, DOI 10.1289/ehp.02110s3403; Dickel DE, 2006, ARCH GEN PSYCHIAT, V63, P778, DOI 10.1001/archpsyc.63.7.778; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Farabollino F, 2002, ENVIRON HEALTH PERSP, V110, P409, DOI 10.1289/ehp.02110s3409; Flynn KM, 2000, TOXICOL SCI, V55, P311, DOI 10.1093/toxsci/55.2.311; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; GANDELMAN R, 1977, NATURE, V266, P722, DOI 10.1038/266722a0; Gatewood JD, 2006, J NEUROSCI, V26, P2335, DOI 10.1523/JNEUROSCI.3743-05.2006; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Hajszan T, 2010, FRONT NEUROENDOCRIN, V31, P519, DOI 10.1016/j.yfrne.2010.06.004; Imwalle DB, 2005, PHYSIOL BEHAV, V84, P157, DOI 10.1016/j.physbeh.2004.11.002; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; Kudwa AE, 2009, PHYSIOL BEHAV, V97, P146, DOI 10.1016/j.physbeh.2009.02.023; Kudwa AE, 2007, BEHAV NEUROSCI, V121, P356, DOI 10.1037/0735-7044.121.2.356; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kwon JS, 2009, ARCH GEN PSYCHIAT, V66, P1233, DOI 10.1001/archgenpsychiatry.2009.155; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Lauritsen MB, 2006, MOL PSYCHIATR, V11, P37, DOI 10.1038/sj.mp.4001754; Laviola G, 2005, BRAIN RES BULL, V65, P235, DOI 10.1016/j.brainresbull.2004.11.015; Leranth C, 2008, P NATL ACAD SCI USA, V105, P14187, DOI 10.1073/pnas.0806139105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nakagami A, 2009, PSYCHONEUROENDOCRINO, V34, P1189, DOI 10.1016/j.psyneuen.2009.03.005; Nakamura K, 2006, J NEUROSCI RES, V84, P1197, DOI 10.1002/jnr.21020; Negri-Cesi P, 2004, J Endocrinol Invest, V27, P120; Nishikawa M, 2010, ENVIRON HEALTH PERSP, V118, P1196, DOI 10.1289/ehp.0901575; Palanza P, 2002, ENVIRON HEALTH PERSP, V110, P415, DOI 10.1289/ehp.02110s3415; Pathak S, 2010, MOL CELL ENDOCRINOL, V314, P110, DOI 10.1016/j.mce.2009.08.005; Patisaul HB, 2006, NEUROTOXICOL TERATOL, V28, P111, DOI 10.1016/j.ntt.2005.11.004; Patisaul HB, 2008, BRAIN RES REV, V57, P352, DOI 10.1016/j.brainresrev.2007.06.008; Poimenova A, 2010, NEUROSCIENCE, V167, P741, DOI 10.1016/j.neuroscience.2010.02.051; Porrini S, 2005, BRAIN RES BULL, V65, P261, DOI 10.1016/j.brainresbull.2004.11.014; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189; Ruhlen RL, 2011, J DEV ORIG HLTH DIS, V2, P36, DOI 10.1017/S2040174410000711; Ruhlen RL, 2008, ENVIRON HEALTH PERSP, V116, P322, DOI 10.1289/ehp.10448; Ryan BC, 2006, HORM BEHAV, V50, P85, DOI 10.1016/j.yhbeh.2006.01.007; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Scimemi A, 2009, J NEUROSCI, V29, P14581, DOI 10.1523/JNEUROSCI.4845-09.2009; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Stewart SE, 2007, AM J MED GENET B, V144B, P1027, DOI 10.1002/ajmg.b.30533; Stichter JP, 2010, J AUTISM DEV DISORD, V40, P1067, DOI [10.1007/s10803-010-0959-1, 10.1007/s10803-010-0961-7]; Tian YH, 2010, SYNAPSE, V64, P432, DOI 10.1002/syn.20746; Timms BG, 2005, P NATL ACAD SCI USA, V102, P7014, DOI 10.1073/pnas.0502544102; van der Veen R, 2008, GENES BRAIN BEHAV, V7, P184, DOI 10.1111/j.1601-183X.2007.00337.x; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Wilson ME, 2011, HORM BEHAV, V59, P353, DOI 10.1016/j.yhbeh.2010.08.004; Wolstenholme JT, 2011, HORM BEHAV, V59, P296, DOI 10.1016/j.yhbeh.2010.10.001; Xu LC, 2005, TOXICOLOGY, V216, P197, DOI 10.1016/j.tox.2005.08.006; Xu XH, 2010, HORM BEHAV, V58, P326, DOI 10.1016/j.yhbeh.2010.02.012; Xu XH, 2010, ENVIRON TOXICOL CHEM, V29, P176, DOI 10.1002/etc.18; Zhang J, 2011, J CHROMATOGR B, V879, P209, DOI 10.1016/j.jchromb.2010.11.031; Zhou R, 2009, NEUROSCIENCE, V159, P161, DOI 10.1016/j.neuroscience.2008.12.028	75	124	125	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25448	10.1371/journal.pone.0025448	http://dx.doi.org/10.1371/journal.pone.0025448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980460	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900066
J	Harjanto, D; Maffei, JS; Zaman, MH				Harjanto, Dewi; Maffei, Joseph S.; Zaman, Muhammad H.			Quantitative Analysis of the Effect of Cancer Invasiveness and Collagen Concentration on 3D Matrix Remodeling	PLOS ONE			English	Article							CONFOCAL REFLECTION MICROSCOPY; HUMAN PROSTATIC-CARCINOMA; MECHANICAL-PROPERTIES; CELL-MIGRATION; METALLOPROTEINASE INHIBITORS; EXTRACELLULAR-MATRIX; ELASTIC-MODULI; INVASION; GELS; CONTRACTION	Extracellular matrix (ECM) remodeling is a key component of cell migration and tumor metastasis, and has been associated with cancer progression. Despite the importance of matrix remodeling, systematic and quantitative studies on the process have largely been lacking. Furthermore, it remains unclear if the disrupted tensional homeostasis characteristic of malignancy is due to initially altered ECM and tissue properties, or to the alteration of the tissue by tumor cells. To explore these questions, we studied matrix remodeling by two different prostate cancer cell lines in a three-dimensional collagen system. Over one week, we monitored structural changes in gels of varying collagen content using confocal reflection microscopy and quantitative image analysis, tracking metrics of fibril fraction, pore size, and fiber length and diameter. Gels that were seeded with no cells (control), LNCaP cells, and DU-145 cells were quantitatively compared. Gels with higher collagen content initially had smaller pore sizes and higher fibril fractions, as expected. However, over time, LNCaP- and DU-145-populated matrices showed different structural properties compared both to each other and to the control gels, with LNCaP cells appearing to favor microenvironments with lower collagen fiber fractions and larger pores than DU-145 cells. We posit that the DU-145 cells' preference for denser matrices is due to their higher invasiveness and proteolytic capabilities. Inhibition of matrix proteases resulted in reduced fibril fractions for high concentration gels seeded with either cell type, supporting our hypothesis. Our novel quantitative results probe the dynamics of gel remodeling in three dimensions and suggest that prostate cancer cells remodel their ECM in a synergistic manner that is dependent on both initial matrix properties as well as their invasiveness.	[Harjanto, Dewi; Maffei, Joseph S.; Zaman, Muhammad H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University	Harjanto, D (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	zaman@bu.edu			National Institutes of Health [1R01CA132633]; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA132633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge support from National Institutes of Health (1R01CA132633). DH is supported by the National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablin R. J., 2007, METASTASIS PROSTATE; Brightman AO, 2000, BIOPOLYMERS, V54, P222; Burns-Cox N, 2001, J UROLOGY, V166, P1698, DOI 10.1016/S0022-5347(05)65656-X; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chen LM, 2001, PROSTATE, V48, P93, DOI 10.1002/pros.1085; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Davis GE, 2001, J CELL SCI, V114, P917; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Erikson A, 2008, BIOPOLYMERS, V89, P135, DOI 10.1002/bip.20874; Fisher KE, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-69; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gehler S, 2009, MOL BIOL CELL, V20, P3224, DOI 10.1091/mbc.E08-12-1186; Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654; Hoekstra R, 2001, ONCOLOGIST, V6, P415, DOI 10.1634/theoncologist.6-5-415; HOOSEIN NM, 1991, CANCER COMMUN, V3, P255, DOI 10.3727/095535491820873146; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Jawerth LM, 2010, BIOPHYS J, V98, pL1, DOI 10.1016/j.bpj.2009.09.065; Kim HD, 2008, MOL BIOL CELL, V19, P4249, DOI 10.1091/mbc.E08-05-0501; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Li YY, 2002, AM J PHYSIOL-HEART C, V282, pH983, DOI 10.1152/ajpheart.00233.2001; Makareeva E, 2010, CANCER RES, V70, P4366, DOI 10.1158/0008-5472.CAN-09-4057; Morgia G, 2005, UROL RES, V33, P44, DOI 10.1007/s00240-004-0440-8; Nagakawa O, 1999, CANCER LETT, V147, P207, DOI 10.1016/S0304-3835(99)00309-2; Nagakawa O, 2000, CANCER LETT, V155, P173, DOI 10.1016/S0304-3835(00)00425-0; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Roeder BA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005331; Scott KA, 1998, FEBS LETT, V441, P137, DOI 10.1016/S0014-5793(98)01542-7; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Stuart K, 2008, BIOPOLYMERS, V89, P841, DOI 10.1002/bip.21024; TOTH M, 2001, METASTASIS RES PROTO; Voytik-Harbin SL, 2001, METHOD CELL BIOL, V63, P583; Witte MB, 1998, SURGERY, V124, P464, DOI 10.1016/S0039-6060(98)70154-0; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wozniak MA, 2005, BIOL PROCED ONLINE, V7, P144, DOI 10.1251/bpo112; Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035; Yang YL, 2009, BIOPHYS J, V96, P1566, DOI [10.1016/j.bpj.2008.10.063, 10.1016/j.bpj.20()8.10.063]	41	46	46	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24891	10.1371/journal.pone.0024891	http://dx.doi.org/10.1371/journal.pone.0024891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980363	Green Published, Green Submitted, gold			2022-12-25	WOS:000295933700010
J	Tian, YH; Huang, Y; Zhou, K; Humphreys, GW; Riddoch, MJ; Wang, K				Tian, Yanghua; Huang, Yan; Zhou, Ke; Humphreys, Glyn W.; Riddoch, M. Jane; Wang, Kai			When Connectedness Increases Hemispatial Neglect	PLOS ONE			English	Article							UNILATERAL SPATIAL NEGLECT; RIGHT-HEMISPHERE STROKE; VISUAL NEGLECT; VISUOSPATIAL NEGLECT; PERCEPTUAL ORGANIZATION; EGOCENTRIC NEGLECT; OBJECT; ATTENTION; SPACE; REPRESENTATION	Patients with left neglect were tested with "chimeric" figures composed of the right and left halves of two different objects. The connectivity relation was modulated between the two half figures. For some displays, the two chimeric halves were separated by a small gap, while in others, the separate halves were connected by a line segment. In line with previous reports, performance on reporting the left half improved when the chimera were separated; but when a line connected the two separated halves the advantage was lost. If the connecting line was broken, the performance was again enhanced. The results suggest an important role for connectedness in the representation of perceptual objects and in the distribution of attention in neglect.	[Tian, Yanghua; Wang, Kai] Anhui Med Univ, Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China; [Huang, Yan; Zhou, Ke] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Huang, Yan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Humphreys, Glyn W.; Riddoch, M. Jane] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	Anhui Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Birmingham	Tian, YH (corresponding author), Anhui Med Univ, Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China.	M.J.Riddoch@bham.ac.uk; wangkai1964@126.com		Tian, Yanghua/0000-0001-5038-0599	National Basic Research Program of China (973 Program) [2011CB707805]; Natural Science Foundation of Anhui province [KJ2010B395]; International Program of Anhui province [10080703040]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Anhui province(Natural Science Foundation of Anhui Province); International Program of Anhui province	This work was supported by grants from National Basic Research Program of China (973 Program) (Grant #2011CB707805; http://www.most.gov.cn/); the Natural Science Foundation of Anhui province (Grant #KJ2010B395; http://www.ahkjt.gov.cn/); International Program of Anhui province (Grant #10080703040; http://www.ahkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Bartolomeo P, 2002, NEUROSCI BIOBEHAV R, V26, P217, DOI 10.1016/S0149-7634(01)00065-3; Brooks JL, 2005, NEUROPSYCHOLOGIA, V43, P572, DOI 10.1016/j.neuropsychologia.2004.07.009; BUXBAUM LJ, 1994, NEUROPSYCHOLOGIA, V32, P275, DOI 10.1016/0028-3932(94)90131-7; Chechlacz M, 2010, COGN NEUROPSYCHOL, V27, P277, DOI 10.1080/02643294.2010.519699; Chen L, 2005, VIS COGN, V12, P553, DOI 10.1080/13506280444000256; CHEN L, 1982, SCIENCE, V218, P699, DOI 10.1126/science.7134969; COSTELLO AD, 1987, J NEUROL NEUROSUR PS, V50, P1110, DOI 10.1136/jnnp.50.9.1110; CUBELLI R, 1991, BRAIN COGNITION, V15, P139, DOI 10.1016/0278-2626(91)90023-2; Cubelli R, 2001, CORTEX, V37, P159, DOI 10.1016/S0010-9452(08)70565-3; DRIVER J, 1992, NATURE, V360, P73, DOI 10.1038/360073a0; DRIVER J, 1991, COGNITIVE NEUROPSYCH, V8, P475, DOI 10.1080/02643299108253384; Driver J, 2000, J COGNITIVE NEUROSCI, V12, P542, DOI 10.1162/089892900562192; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; FARAH MJ, 1990, NEUROPSYCHOLOGIA, V28, P335, DOI 10.1016/0028-3932(90)90060-2; Gilchrist ID, 1996, COGNITIVE NEUROPSYCH, V13, P1223, DOI 10.1080/026432996381737; GRABOWECKY M, 1993, J COGNITIVE NEUROSCI, V5, P288, DOI 10.1162/jocn.1993.5.3.288; Halligan P, 1990, Int Disabil Stud, V12, P95; HALLIGAN PW, 1994, NEUROREPORT, V5, P537, DOI 10.1097/00001756-199401000-00001; Heinke D, 2003, PSYCHOL REV, V110, P29, DOI 10.1037//0033-295X.110.1.29; HUMPHREYS G, 1992, ATTENTION PERFORM, V14, P143; Humphreys G. W., 1993, UNILATERAL NEGLECT C, P139; Humphreys GW, 1998, PHILOS T R SOC B, V353, P1341, DOI 10.1098/rstb.1998.0288; HUMPHREYS GW, 1993, ATTENTION PERFORM, V14, P143; MARK VW, 1988, NEUROLOGY, V38, P1207, DOI 10.1212/WNL.38.8.1207; Mattingley JB, 1997, SCIENCE, V275, P671, DOI 10.1126/science.275.5300.671; PALMER S, 1994, PSYCHON B REV, V1, P29, DOI 10.3758/BF03200760; Pavlovskaya M, 1997, J COGNITIVE NEUROSCI, V9, P824, DOI 10.1162/jocn.1997.9.6.824; POSNER MI, 1984, J NEUROSCI, V4, P1863; RIDDOCH MJ, 1995, COGNITIVE NEUROPSYCH, V12, P569, DOI 10.1080/02643299508252008; Sarri M, 2009, NEUROPSYCHOLOGIA, V47, P91, DOI 10.1016/j.neuropsychologia.2008.08.020; SERON X, 1989, COGNITIVE NEUROPSYCH, V6, P475, DOI 10.1080/02643298908253427; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; STONE SP, 1993, AGE AGEING, V22, P46, DOI 10.1093/ageing/22.1.46; Tipper SP, 1996, J EXP PSYCHOL HUMAN, V22, P1261, DOI 10.1037/0096-1523.22.5.1261; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Walker R, 1995, NEUROCASE, V1, P371; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; YOUNG AW, 1992, BRAIN, V115, P51, DOI 10.1093/brain/115.1.51	40	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24760	10.1371/journal.pone.0024760	http://dx.doi.org/10.1371/journal.pone.0024760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980355	gold, Green Published, Green Submitted			2022-12-25	WOS:000295933700008
J	Tomter, AB; Zoppellaro, G; Schmitzberger, F; Andersen, NH; Barra, AL; Engman, H; Nordlund, P; Andersson, KK				Tomter, Ane B.; Zoppellaro, Giorgio; Schmitzberger, Florian; Andersen, Niels H.; Barra, Anne-Laure; Engman, Henrik; Nordlund, Par; Andersson, K. Kristoffer			HF-EPR, Raman, UV/VIS Light Spectroscopic, and DFT Studies of the Ribonucleotide Reductase R2 Tyrosyl Radical from Epstein-Barr Virus	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HIGH-FIELD EPR; MAGNETIC CIRCULAR-DICHROISM; HIGH-FREQUENCY EPR; ESCHERICHIA-COLI; IRON CENTER; RESONANCE RAMAN; HYDROGEN-BOND; G-VALUES; ALLOSTERIC REGULATION	Epstein-Barr virus (EBV) belongs to the gamma subfamily of herpes viruses, among the most common pathogenic viruses in humans worldwide. The viral ribonucleotide reductase small subunit (RNR R2) is involved in the biosynthesis of nucleotides, the DNA precursors necessary for viral replication, and is an important drug target for EBV. RNR R2 generates a stable tyrosyl radical required for enzymatic turnover. Here, the electronic and magnetic properties of the tyrosyl radical in EBV R2 have been determined by X-band and high-field/high-frequency electron paramagnetic resonance (EPR) spectroscopy recorded at cryogenic temperatures. The radical exhibits an unusually low g(1)-tensor component at 2.0080, indicative of a positive charge in the vicinity of the radical. Consistent with these EPR results a relatively high C-O stretching frequency associated with the phenoxyl radical (at 1508 cm 21) is observed with resonance Raman spectroscopy. In contrast to mouse R2, EBV R2 does not show a deuterium shift in the resonance Raman spectra. Thus, the presence of a water molecule as a hydrogen bond donor moiety could not be identified unequivocally. Theoretical simulations showed that a water molecule placed at a distance of 2.6 angstrom from the tyrosyl-oxygen does not result in a detectable deuterium shift in the calculated Raman spectra. UV/VIS light spectroscopic studies with metal chelators and tyrosyl radical scavengers are consistent with a more accessible dimetal binding/radical site and a lower affinity for Fe2+ in EBV R2 than in Escherichia coli R2. Comparison with previous studies of RNR R2s from mouse, bacteria, and herpes viruses, demonstrates that finely tuned electronic properties of the radical exist within the same RNR R2 Ia class.	[Tomter, Ane B.; Zoppellaro, Giorgio; Andersen, Niels H.; Andersson, K. Kristoffer] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Schmitzberger, Florian; Engman, Henrik; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Barra, Anne-Laure] CNRS, Lab Natl Champs Magnet Intenses, LNCMI G, UPR 3228, Grenoble, France	University of Oslo; Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Tomter, AB (corresponding author), Univ Oslo, Dept Mol Biosci, Oslo, Norway.	k.k.andersson@imbv.uio.no	Zoppellaro, Giorgio/F-8453-2012; Schmitzberger, Florian/B-4532-2013	Zoppellaro, Giorgio/0000-0003-2304-2564; Schmitzberger, Florian/0000-0001-9343-5561; Andersen, Niels Hojmark/0000-0003-3668-2800	European Community [PIEF-GA-2009-235237]; Research Council of Norway [177661/V30]; Cancer Foundation of Norway; Swedish Cancer Foundation; Swedish Research Council; Karolinska Institute Foundation; Howard Hughes Medical Institute	European Community(European Commission); Research Council of Norway(Research Council of Norway); Cancer Foundation of Norway; Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute Foundation(Karolinska Institutet); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	GZ thanks the Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (PIEF-GA-2009-235237) for financial support, KKA the Research Council of Norway (Grant 177661/V30) and The Cancer Foundation of Norway, PN the Swedish Cancer Foundation and the Swedish Research Council, FS a Karolinska Institute Foundation grant and a Howard Hughes Medical Institute fellowship. The Raman instrument and laser equipment was funded by a grant from the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 1996, J AM CHEM SOC, V118, P895, DOI 10.1021/ja9529192; Andersson K. K., 1995, ADV INORG CHEM, V43, P359; Andersson K.K., 2008, RIBONUCLEOTIDE REDUC; Andersson KK, 2003, J BIOL INORG CHEM, V8, P235, DOI 10.1007/s00775-002-0429-0; Andersson KK, 2002, SPECTROCHIM ACTA A, V58, P1101, DOI 10.1016/S1386-1425(01)00700-4; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; ATOR MA, 1986, J BIOL CHEM, V261, P3595; ATTA M, 1993, BIOCHEM J, V290, P807, DOI 10.1042/bj2900807; Atta M, 1996, J BIOL INORG CHEM, V1, P210, DOI 10.1007/s007750050045; ATTA M, 1994, J AM CHEM SOC, V116, P6429, DOI 10.1021/ja00093a051; Barra AL, 2004, BIO MAGN RE, V22, P145; Brynda M, 2007, RES CHEM INTERMEDIAT, V33, P863, DOI 10.1163/156856707782169426; Campbell KA, 1997, J AM CHEM SOC, V119, P4787, DOI 10.1021/ja9706155; Chodosh J, 1998, J INFECT DIS, V177, P1194, DOI 10.1086/515290; CONNER J, 1994, REV MED VIROL, V4, P25, DOI 10.1002/rmv.1980040107; Cornvik T, 2005, NAT METHODS, V2, P507, DOI 10.1038/NMETH767; Dahlroth SL, 2009, PROTEIN EXPRES PURIF, V68, P121, DOI 10.1016/j.pep.2009.07.010; Engstrom M, 2000, J PHYS CHEM A, V104, P5149, DOI 10.1021/jp0006633; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; GALLI C, 1995, J AM CHEM SOC, V117, P740, DOI 10.1021/ja00107a017; GERFEN GJ, 1993, J AM CHEM SOC, V115, P6420, DOI 10.1021/ja00067a071; GLERUP J, 1991, ACTA CHEM SCAND, V45, P444, DOI 10.3891/acta.chem.scand.45-0444; Hanson MA, 1999, J AM CHEM SOC, V121, P6755, DOI 10.1021/ja990995p; Himo F, 1997, BIOPHYS J, V72, P1556, DOI 10.1016/S0006-3495(97)78803-9; Hoganson CW, 1996, J AM CHEM SOC, V118, P4672, DOI 10.1021/ja953979a; Ivancich A, 1999, J AM CHEM SOC, V121, P5743, DOI 10.1021/ja990562m; Jiang R, 2004, J MED VIROL, V73, P589, DOI 10.1002/jmv.20130; JOHNSON CR, 1986, J AM CHEM SOC, V108, P905, DOI 10.1021/ja00265a010; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; Katterle B, 1997, J BIOL CHEM, V272, P10414; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Lamarche N, 1996, BIOCHEM J, V320, P129, DOI 10.1042/bj3200129; Liu Xiyong, 2008, V477, P195, DOI 10.1007/978-1-60327-517-0_15; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; McCreery R.L., 2005, RAMAN SPECTROSCOPY C, VVolume 225; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; NYHOLM S, 1993, BIOCHEMISTRY-US, V32, P11569, DOI 10.1021/bi00094a013; NYHOLM S, 1993, J BIOL CHEM, V268, P26200; Offenbacher AR, 2009, J AM CHEM SOC, V131, P7496, DOI 10.1021/ja901908j; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; POTSCH S, 1995, FEBS LETT, V374, P95, DOI 10.1016/0014-5793(95)01082-P; Range K, 2006, J PHYS CHEM B, V110, P10970, DOI 10.1021/jp061503f; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; SAHLIN M, 1987, BIOCHEMISTRY-US, V26, P5541, DOI 10.1021/bi00391a049; Schmidt PP, 1996, J BIOL CHEM, V271, P23615, DOI 10.1074/jbc.271.39.23615; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Smith P, 2009, BIOCHEMISTRY-US, V48, P11134, DOI 10.1021/bi9001425; Strand KR, 2004, J BIOL CHEM, V279, P46794, DOI 10.1074/jbc.M407346200; Strand KR, 2003, BIOCHEMISTRY-US, V42, P12223, DOI 10.1021/bi035248q; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; Svistunenko DA, 2009, PHYS CHEM CHEM PHYS, V11, P6600, DOI 10.1039/b905522c; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Un S, 2005, MAGN RESON CHEM, V43, pS229, DOI 10.1002/mrc.1660; UN S, 1995, J AM CHEM SOC, V117, P10713, DOI 10.1021/ja00148a013; Un S, 2001, J AM CHEM SOC, V123, P3048, DOI 10.1021/ja003650b; van Dam PJ, 1998, J AM CHEM SOC, V120, P5080, DOI 10.1021/ja9737127; Wakisaka N, 2005, INT J CANCER, V116, P640, DOI 10.1002/ijc.21096; Wei PP, 2006, BIOCHEMISTRY-US, V45, P14043, DOI 10.1021/bi061127p; Weihe H, SIM SOFTWARE; Wnuk SF, 2006, ANTIVIR RES, V71, P122, DOI 10.1016/j.antiviral.2006.03.002	63	20	20	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25022	10.1371/journal.pone.0025022	http://dx.doi.org/10.1371/journal.pone.0025022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980375	Green Published, gold, Green Submitted			2022-12-25	WOS:000295933700017
J	Esberg, A; Muller, LAH; McCusker, JH				Esberg, Anders; Muller, Ludo A. H.; McCusker, John H.			Genomic Structure of and Genome-Wide Recombination in the Saccharomyces cerevisiae S288C Progenitor Isolate EM93	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MEIOTIC GENE CONVERSION; HIS4 LOCUS; CROSSOVER INTERFERENCE; CHROMATIN-STRUCTURE; HOT-SPOT; YEAST; MEIOSIS; CHROMOSOMES; HOTSPOT	The diploid isolate EM93 is the main ancestor to the widely used Saccharomyces cerevisiae haploid laboratory strain, S288C. In this study, we generate a high-resolution overview of the genetic differences between EM93 and S288C. We show that EM93 is heterozygous for >45,000 polymorphisms, including large sequence polymorphisms, such as deletions and a Saccharomyces paradoxus introgression. We also find that many large sequence polymorphisms (LSPs) are associated with Ty-elements and sub-telomeric regions. We identified 2,965 genetic markers, which we then used to genotype 120 EM93 tetrads. In addition to deducing the structures of all EM93 chromosomes, we estimate that the average EM93 meiosis produces 144 detectable recombination events, consisting of 87 crossover and 31 non-crossover gene conversion events. Of the 50 polymorphisms showing the highest levels of non-crossover gene conversions, only three deviated from parity, all of which were near heterozygous LSPs. We find that non-telomeric heterozygous LSPs significantly reduce meiotic recombination in adjacent intervals, while sub-telomeric LSPs have no discernable effect on recombination. We identified 203 recombination hotspots, relatively few of which are hot for both non-crossover gene conversions and crossovers. Strikingly, we find that recombination hotspots show limited conservation. Some novel hotspots are found adjacent to heterozygous LSPs that eliminate other hotspots, suggesting that hotspots may appear and disappear relatively rapidly.	[Esberg, Anders; Muller, Ludo A. H.; McCusker, John H.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University	Esberg, A (corresponding author), Umea Univ, Fac Med, Dept Odontol, Umea, Sweden.	mccus001@mc.duke.edu		McCusker, John/0000-0002-8803-9131	Wenner-Gren Foundations; National Institutes of Health [GM02054, GM081690]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081690] Funding Source: NIH RePORTER	Wenner-Gren Foundations; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by Wenner-Gren Foundations (http://www.swgc.org/) (to AE) and the National Institutes of Health grants GM02054 and GM081690 (to JHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argueso JL, 2009, GENOME RES, V19, P2258, DOI 10.1101/gr.091777.109; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Ben-Aroya S, 2004, MOL CELL, V15, P221, DOI 10.1016/j.molcel.2004.06.002; Bengtsson H., 2008, 745 U CAL DEP STAT; Berchowitz LE, 2009, GENOME RES, V19, P2245, DOI 10.1101/gr.096297.109; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Bullard SA, 1996, P NATL ACAD SCI USA, V93, P13054, DOI 10.1073/pnas.93.23.13054; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Carvalho AB, 2003, NAT GENET, V34, P128, DOI 10.1038/ng0603-128; DETLOFF P, 1992, GENETICS, V132, P113; DICAPRIO L, 1976, GENETICS, V84, P697; Fan QQ, 1996, MOL CELL BIOL, V16, P2037; FOGEL S, 1979, COLD SPRING HARB SYM, V43, P1325, DOI 10.1101/SQB.1979.043.01.152; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; HAN M, 1988, EMBO J, V7, P2221, DOI 10.1002/j.1460-2075.1988.tb03061.x; Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038; HURST DD, 1972, P NATL ACAD SCI USA, V69, P101, DOI 10.1073/pnas.69.1.101; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Kearney HM, 2001, GENETICS, V158, P1457; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Keller PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000533; Kirkpatrick DT, 1999, MOL CELL BIOL, V19, P7661; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; LAMBIE EJ, 1988, CELL, V52, P863, DOI 10.1016/0092-8674(88)90428-X; LAMBIE EJ, 1986, GENETICS, V114, P769; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Liti G, 2005, ANNU REV MICROBIOL, V59, P135, DOI 10.1146/annurev.micro.59.030804.121400; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; MALONE RE, 1994, GENETICS, V137, P5; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; MORTIMER RK, 1986, GENETICS, V113, P35; Muller LAH, 2009, FEMS YEAST RES, V9, P143, DOI 10.1111/j.1567-1364.2008.00464.x; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; PERKINS DD, 1949, GENETICS, V34, P607; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; PORTER SE, 1993, GENETICS, V134, P5; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Qi J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-475; R Development Core Team, 2007, R LANG ENV STAT COMP; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Ronald J, 2006, GENETICS, V174, P541, DOI 10.1534/genetics.106.060863; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SHERMAN F, 1991, METHOD ENZYMOL, P132; Sherman F., 1974, METHODS YEAST GENETI; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; Walker MY, 2000, CHROMOSOMA, V109, P3, DOI 10.1007/s004120050407; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; ZENVIRTH D, 1992, EMBO J, V11, P3441, DOI 10.1002/j.1460-2075.1992.tb05423.x; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; [No title captured]	57	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25211	10.1371/journal.pone.0025211	http://dx.doi.org/10.1371/journal.pone.0025211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966457	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100025
J	Jeffries, TC; Seymour, JR; Gilbert, JA; Dinsdale, EA; Newton, K; Leterme, SSC; Roudnew, B; Smith, RJ; Seuront, L; Mitchell, JG				Jeffries, Thomas C.; Seymour, Justin R.; Gilbert, Jack A.; Dinsdale, Elizabeth A.; Newton, Kelly; Leterme, Sophie S. C.; Roudnew, Ben; Smith, Renee J.; Seuront, Laurent; Mitchell, James G.			Substrate Type Determines Metagenomic Profiles from Diverse Chemical Habitats	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; BACTERIA; ENUMERATION; DYNAMICS; PATTERNS; PROJECT	Environmental parameters drive phenotypic and genotypic frequency variations in microbial communities and thus control the extent and structure of microbial diversity. We tested the extent to which microbial community composition changes are controlled by shifting physiochemical properties within a hypersaline lagoon. We sequenced four sediment metagenomes from the Coorong, South Australia from samples which varied in salinity by 99 Practical Salinity Units (PSU), an order of magnitude in ammonia concentration and two orders of magnitude in microbial abundance. Despite the marked divergence in environmental parameters observed between samples, hierarchical clustering of taxonomic and metabolic profiles of these metagenomes showed striking similarity between the samples (>89%). Comparison of these profiles to those derived from a wide variety of publically available datasets demonstrated that the Coorong sediment metagenomes were similar to other sediment, soil, biofilm and microbial mat samples regardless of salinity (>85% similarity). Overall, clustering of solid substrate and water metagenomes into discrete similarity groups based on functional potential indicated that the dichotomy between water and solid matrices is a fundamental determinant of community microbial metabolism that is not masked by salinity, nutrient concentration or microbial abundance.	[Jeffries, Thomas C.; Newton, Kelly; Leterme, Sophie S. C.; Roudnew, Ben; Smith, Renee J.; Seuront, Laurent; Mitchell, James G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Jeffries, Thomas C.; Seymour, Justin R.] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Gilbert, Jack A.] Plymouth Marine Lab, Plymouth, Devon, England; [Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Gilbert, Jack A.] Argonne Natl Lab, Dept Biosci, Argonne, IL 60439 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Dinsdale, Elizabeth A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Leterme, Sophie S. C.; Seuront, Laurent] S Australian Res & Dev Inst, Henley Beach, SA, Australia; [Seuront, Laurent] Ctr Natl Rech Sci, Paris, France	Flinders University South Australia; University of Technology Sydney; Plymouth Marine Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; California State University System; San Diego State University; Centre National de la Recherche Scientifique (CNRS)	Jeffries, TC (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	jeffries.thomas@gmail.com	Jeffries, Thomas/D-4270-2018; Gilbert, Jack/AAF-3270-2019; Jeffries, Thomas/E-8679-2013; Leterme, Sophie C/A-5013-2013	Leterme, Sophie C/0000-0001-8455-7049; Newton, Kelly/0000-0001-8405-7140; Jeffries, Thomas/0000-0001-6479-0353; Mitchell, Jim/0000-0002-8445-0935; Seuront, Laurent/0000-0002-0051-5202; dinsdale, elizabeth/0000-0002-2177-203X; Seymour, Justin/0000-0002-3745-6541	Australian Research Council (ARC)	Australian Research Council (ARC)(Australian Research Council)	This work was supported by an Australian Research Council (ARC) Discovery Grant (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Clarke A, 2006, PRIMER V6 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Delmont TO, 2011, ISME J; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Doolittle WF, 2010, BIOSCIENCE, V60, P102, DOI 10.1525/bio.2010.60.2.5; Drake LA, 1998, AQUAT MICROB ECOL, V16, P17, DOI 10.3354/ame016017; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Gasol JM, 2004, AQUAT MICROB ECOL, V34, P193, DOI 10.3354/ame034193; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Helton RR, 2006, APPL ENVIRON MICROB, V72, P4767, DOI 10.1128/AEM.00297-06; Hewson I, 2009, LIMNOL OCEANOGR, V54, P1981, DOI 10.4319/lo.2009.54.6.1981; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Hugenholtz P, 2002, GENOME BIOL, V3; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Javor B, 1989, HYPERSALINE ENV MICR, Vviii; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Kunin Victor, 2008, Mol Syst Biol, V4, P198, DOI 10.1038/msb.2008.35; Lester RE, 2009, ESTUAR COAST SHELF S, V85, P1, DOI 10.1016/j.ecss.2009.04.018; Li WZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-359; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mitra S, 2010, ISME J, V4, P1236, DOI 10.1038/ismej.2010.51; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schapira Mathilde, 2010, Saline Syst, V6, P2, DOI 10.1186/1746-1448-6-2; Schapira M, 2009, AQUAT MICROB ECOL, V54, P171, DOI 10.3354/ame01262; Segar DA, 1998, INTRO OCEAN SCI, Vxxiii, P497; Seymour JR, 2005, MAR ECOL PROG SER, V288, P1, DOI 10.3354/meps288001; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tamames J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-85; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	51	24	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25173	10.1371/journal.pone.0025173	http://dx.doi.org/10.1371/journal.pone.0025173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966446	Green Submitted, gold, Green Published			2022-12-25	WOS:000295267100023
J	Rossen, NS; Hansen, AJ; Selhuber-Unkel, C; Oddershede, LB				Rossen, Ninna Struck; Hansen, Anker Jon; Selhuber-Unkel, Christine; Oddershede, Lene Broeng			Arachidonic Acid Randomizes Endothelial Cell Motion and Regulates Adhesion and Migration	PLOS ONE			English	Article							ANGIOGENESIS; DYNAMICS; DISEASE; CANCER	Cell adhesion and migration are essential for the evolution, organization, and repair of living organisms. An example of a combination of these processes is the formation of new blood vessels (angiogenesis), which is mediated by a directed migration and adhesion of endothelial cells (ECs). Angiogenesis is an essential part of wound healing and a prerequisite of cancerous tumor growth. We investigated the effect of the amphiphilic compound arachidonic acid (AA) on EC adhesion and migration by combining live cell imaging with biophysical analysis methods. AA significantly influenced both EC adhesion and migration, in either a stimulating or inhibiting fashion depending on AA concentration. The temporal evolution of cell adhesion area was well described by a two-phase model. In the first phase, the spreading dynamics were independent of AA concentration. In the latter phase, the spreading dynamics increased at low AA concentrations and decreased at high AA concentrations. AA also affected EC migration; though the instantaneous speed of individual cells remained independent of AA concentration, the individual cells lost their sense of direction upon addition of AA, thus giving rise to an overall decrease in the collective motion of a confluent EC monolayer into vacant space. Addition of AA also caused ECs to become more elongated, this possibly being related to incorporation of AA in the EC membrane thus mediating a change in the viscosity of the membrane. Hence, AA is a promising non-receptor specific regulator of wound healing and angiogenesis.	[Rossen, Ninna Struck; Selhuber-Unkel, Christine; Oddershede, Lene Broeng] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Hansen, Anker Jon] Novo Nordisk AS, Malov, Denmark	University of Copenhagen; Niels Bohr Institute; Novo Nordisk	Rossen, NS (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	oddershede@nbi.dk	Selhuber-Unkel, Christine/D-9715-2016	Selhuber-Unkel, Christine/0000-0002-5051-4822	University of Copenhagen	University of Copenhagen	The work was supported by the University of Copenhagen Excellence Program. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AJH is employed at Novo Nordisk A/S and contributed to the design and analysis of the study.	Angelos MG, 2010, BIOPHYS J, V99, P3545, DOI 10.1016/j.bpj.2010.10.004; Barden A, 2011, FREE RADICAL RES, V45, P469, DOI 10.3109/10715762.2010.544730; Baynes J.W., 2005, MED BIOCH, VVolume 2; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Chamaraux F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158102; Chamaraux F, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036009; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Dobereiner HG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108105; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1994, J CLIN ONCOL, V12, P441, DOI 10.1200/JCO.1994.12.3.441; Ghosh PK, 2002, NAT CELL BIOL, V4, P894, DOI 10.1038/ncb873; Jensen Lasse D. E., 2007, Angiogenesis, V10, P13, DOI 10.1007/s10456-006-9060-y; Li Y, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3298361; Liu DQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003291; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Lundbaek JA, 2006, J PHYS-CONDENS MAT, V18, pS1305, DOI 10.1088/0953-8984/18/28/S13; Mahmud G, 2009, NAT PHYS, V5, P606, DOI 10.1038/NPHYS1306; MCGIFF JC, 1991, ANNU REV PHARMACOL, V31, P339, DOI 10.1146/annurev.pa.31.040191.002011; Norman LL, 2010, BIOPHYS J, V99, P1726, DOI 10.1016/j.bpj.2010.07.031; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Pozzi A, 2009, WIRES SYST BIOL MED, V1, P254, DOI 10.1002/wsbm.7; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001; Sengupta K, 2006, BIOPHYS J, V91, P4638, DOI [10.1529/biophysj.105.080382, 10.1529/biophysj.106.080382]; Streicher P, 2009, BBA-BIOMEMBRANES, V1788, P2291, DOI 10.1016/j.bbamem.2009.07.025; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510	29	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25196	10.1371/journal.pone.0025196	http://dx.doi.org/10.1371/journal.pone.0025196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966453	Green Submitted, Green Published, gold			2022-12-25	WOS:000295267100027
J	Huff, DD; Lindley, ST; Rankin, PS; Mora, EA				Huff, David D.; Lindley, Steven T.; Rankin, Polly S.; Mora, Ethan A.			Green Sturgeon Physical Habitat Use in the Coastal Pacific Ocean	PLOS ONE			English	Article							ACIPENSER-MEDIROSTRIS; SPATIAL AUTOCORRELATION; PARAMETER-ESTIMATION; MARINE DISTRIBUTION; MOVEMENT PATTERNS; RED HERRINGS; ROGUE RIVER; MIGRATION; CONSEQUENCES; CALIFORNIA	The green sturgeon (Acipenser medirostris) is a highly migratory, oceanic, anadromous species with a complex life history that makes it vulnerable to species-wide threats in both freshwater and at sea. Green sturgeon population declines have preceded legal protection and curtailment of activities in marine environments deemed to increase its extinction risk. Yet, its marine habitat is poorly understood. We built a statistical model to characterize green sturgeon marine habitat using data from a coastal tracking array located along the Siletz Reef near Newport, Oregon, USA that recorded the passage of 37 acoustically tagged green sturgeon. We classified seafloor physical habitat features with high-resolution bathymetric and backscatter data. We then described the distribution of habitat components and their relationship to green sturgeon presence using ordination and subsequently used generalized linear model selection to identify important habitat components. Finally, we summarized depth and temperature recordings from seven green sturgeon present off the Oregon coast that were fitted with pop-off archival geolocation tags. Our analyses indicated that green sturgeon, on average, spent a longer duration in areas with high seafloor complexity, especially where a greater proportion of the substrate consists of boulders. Green sturgeon in marine habitats are primarily found at depths of 20-60 meters and from 9.5-16.0 degrees C. Many sturgeon in this study were likely migrating in a northward direction, moving deeper, and may have been using complex seafloor habitat because it coincides with the distribution of benthic prey taxa or provides refuge from predators. Identifying important green sturgeon marine habitat is an essential step towards accurately defining the conditions that are necessary for its survival and will eventually yield range-wide, spatially explicit predictions of green sturgeon distribution.	[Huff, David D.; Lindley, Steven T.] Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Santa Cruz, CA USA; [Rankin, Polly S.] Oregon Dept Fish & Wildlife, Newport, OR USA; [Mora, Ethan A.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Davis	Huff, DD (corresponding author), Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Santa Cruz, CA USA.	david.huff@noaa.gov	Lindley, Steven T/G-3997-2014; Huff, David/A-8166-2008	Lindley, Steven T/0000-0001-9556-0411; Huff, David/0000-0001-9061-7685	National Oceanic and Atmospheric Administration	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	The authors' research was supported by funds from the National Oceanic and Atmospheric Administration, California Current Integrated Ecosystem Assessment Program (http://www.st.nmfs.noaa.gov/iea/index.html) and a Species of Concern Program (http://www.nmfs.noaa.gov/pr/species/concern/grant.htm) grant to S. T. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PB, 2007, ENVIRON BIOL FISH, V79, P339, DOI 10.1007/s10641-006-9062-z; Afonso P, 2008, MAR ECOL PROG SER, V359, P215, DOI 10.3354/meps07272; [Anonymous], 2010, MAR POLLUT BULL, V60, P640; Barton K, 2011, MUM1 PACKAGE MULTIMO; Bemis WE, 1997, ENVIRON BIOL FISH, V48, P167, DOI 10.1023/A:1007312524792; Benson RL, 2007, ENVIRON BIOL FISH, V79, P269, DOI 10.1007/s10641-006-9023-6; Berthold P., 1993, BIRD MIGRATION GEN S; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Comeau LA, 2002, CAN J FISH AQUAT SCI, V59, P1845, DOI 10.1139/F02-152; Commerce Do, 2008, END THREAT WILDL PLA, P52084; Cook RD, 1997, J AM STAT ASSOC, V92, P490, DOI 10.2307/2965698; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Donnellan M., 2009, RESOLVING SPATIAL SC; Edwards Randy E., 2003, Gulf of Mexico Science, V21, P59; Erdey-Heydorn MD, 2008, MAR GEOD, V31, P318, DOI 10.1080/01490410802466819; Erickson DL, 2007, AM FISH S S, V56, P197; Erickson DL, 2007, ENVIRON BIOL FISH, V79, P255, DOI 10.1007/s10641-006-9072-x; Erickson DL, 2002, J APPL ICHTHYOL, V18, P565, DOI 10.1046/j.1439-0426.2002.00403.x; Erickson DL, 2011, COMMUNICATION; Evans K, 2009, REV-METHODS TECHNOL, V9, P343, DOI 10.1007/978-1-4020-9640-2_21; Fairchild EA, 2009, REV-METHODS TECHNOL, V9, P5, DOI 10.1007/978-1-4020-9640-2_1; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fox DA, 2002, AM FISH S S, V28, P111; Fox J., 2011, CAR PACKAGE COMPANIO; GODAMBE VP, 1987, INT STAT REV, V55, P231, DOI 10.2307/1403403; Grothues TM, 2009, REV-METHODS TECHNOL, V9, P77, DOI 10.1007/978-1-4020-9640-2_5; Hannah RW, 2011, N AM J FISH MANAGE, V31, P483, DOI 10.1080/02755947.2011.591239; Hawkins BA, 2007, ECOGRAPHY, V30, P375, DOI 10.1111/j.2007.0906-7590.05117.x; Hayes Daniel B., 1996, P193; Heublein JC, 2009, ENVIRON BIOL FISH, V84, P245, DOI 10.1007/s10641-008-9432-9; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; IHAKA R., 1996, J COMPUTATIONAL GRAP, V5, P239; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kelly JT, 2007, ENVIRON BIOL FISH, V79, P281, DOI 10.1007/s10641-006-0036-y; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Laney RW, 2007, AM FISH S S, V56, P167; Lavenberg R. N., 1971, MARINE FOOD GAME FIS, V28; Lindley ST, 2008, T AM FISH SOC, V137, P182, DOI 10.1577/T07-055.1; Lindley ST, 2011, T AM FISH SOC, V140, P108, DOI 10.1080/00028487.2011.557017; Lowe CG, 2003, MAR ECOL PROG SER, V256, P205, DOI 10.3354/meps256205; Lundblad E., 2006, GEOD, V29, P89, DOI [10.1080/01490410600738021, DOI 10.1080/01490410600738021]; Mather P. M., 1976, COMPUTATIONAL METHOD; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McCune B., 2006, PC ORD MULTIVARIATE; Merems A, 2004, NEARSHORE ROCKY REEF, P15; Monk J, 2010, MAR ECOL PROG SER, V420, P157, DOI 10.3354/meps08858; Moser ML, 2007, ENVIRON BIOL FISH, V79, P243, DOI 10.1007/s10641-006-9028-1; Moyle P.B., 2002, INLAND FISHES CALIFO; Munro J, 2007, AM FISH S S, V56, P1; Nasby-Lucas NM, 2002, FISH B-NOAA, V100, P739; [National Oceanic and Atmospheric Administration Commerce Do], 2007, NOAA FISH NAM PAN EX; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; OKSANEN J, 2004, VEGAN COMMUNITY ECOL; Parauka FM, 2011, J APPL ICHTHYOL, V27, P343, DOI 10.1111/j.1439-0426.2011.01671.x; Parauka Frank M., 2001, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V55, P280; Parker SJ, 2007, LOW WAKE FI, V23, P39; ROBERTS DW, 1986, VEGETATIO, V66, P123, DOI 10.1007/BF00039905; Rochard E, 1997, AQUAT LIVING RESOUR, V10, P101, DOI 10.1051/alr:1997011; Ross ST, 2009, ESTUAR COAST, V32, P360, DOI 10.1007/s12237-008-9122-z; Salemaa M, 2008, BOREAL ENVIRON RES, V13, P48; Segurado P, 2006, J APPL ECOL, V43, P433, DOI 10.1111/j.1365-2664.2006.01162.x; Semmens BX, 2008, CAN J FISH AQUAT SCI, V65, P2053, DOI 10.1139/F08-107; Stein AB, 2004, T AM FISH SOC, V133, P527, DOI 10.1577/T02-151.1; Stephens PA, 2002, J ANIM ECOL, V71, P343, DOI 10.1046/j.1365-2656.2002.00605.x; Sulak KJ, 2002, J APPL ICHTHYOL, V18, P519, DOI 10.1046/j.1439-0426.2002.00413.x; U. S. Geological Survey, 1986, ATL EXCL EC ZON W CO; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Virtanen R, 2006, J VEG SCI, V17, P519, DOI 10.1111/j.1654-1103.2006.tb02473.x; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Weisberg S, 2005, APPL LINEAR REGRESSI, V3rd, DOI DOI 10.1002/0471704091; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; WINKER K, 1995, OECOLOGIA, V101, P211, DOI 10.1007/BF00317286; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240; Wright D.J., 2005, BENTHIC TERRAIN MODE; Young MA, 2010, MAR ECOL PROG SER, V415, P247, DOI 10.3354/meps08760	77	14	14	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25156	10.1371/journal.pone.0025156	http://dx.doi.org/10.1371/journal.pone.0025156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966442	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100070
J	Sebastiani, G; Gkouvatsos, K; Maffettone, C; Busatto, G; Guido, M; Pantopoulos, K				Sebastiani, Giada; Gkouvatsos, Kostas; Maffettone, Carmen; Busatto, Graziella; Guido, Maria; Pantopoulos, Kostas			Accelerated CCl4-Induced Liver Fibrosis in Hjv-/- Mice, Associated with an Oxidative Burst and Precocious Profibrogenic Gene Expression	PLOS ONE			English	Article							DIETARY IRON OVERLOAD; NF-KAPPA-B; HEPATIC IRON; MEDICAL PROGRESS; RODENT MODEL; ANIMAL-MODEL; EXCESS IRON; LONG-TERM; HEMOCHROMATOSIS; ACTIVATION	Hereditary hemochromatosis is commonly associated with liver fibrosis. Likewise, hepatic iron overload secondary to chronic liver diseases aggravates liver injury. To uncover underlying molecular mechanisms, hemochromatotic hemojuvelin knockout (Hjv-/-) mice and wild type (wt) controls were intoxicated with CCl4. Hjv-/- mice developed earlier (by 2-4 weeks) and more acute liver damage, reflected in dramatic levels of serum transaminases and ferritin and the development of severe coagulative necrosis and fibrosis. These responses were associated with an oxidative burst and early upregulation of mRNAs encoding alpha 1-(I)-collagen, the profibrogenic cytokines TGF-beta 1, endothelin-1 and PDGF and, notably, the iron-regulatory hormone hepcidin. Hence, CCl4-induced liver fibrogenesis was exacerbated and progressed precociously in Hjv-/- animals. Even though livers of naive Hjv-/- mice were devoid of apparent pathology, they exhibited oxidative stress and immunoreactivity towards alpha-SMA antibodies, a marker of hepatic stellate cells activation. Furthermore, they expressed significantly higher (2-3 fold vs. wt, p<0.05) levels of alpha 1-(I)-collagen, TGF-beta 1, endothelin-1 and PDGF mRNAs, indicative of early fibrogenesis. Our data suggest that hepatic iron overload in parenchymal cells promotes oxidative stress and triggers premature profibrogenic gene expression, contributing to accelerated onset and precipitous progression of liver fibrogenesis.	[Sebastiani, Giada; Gkouvatsos, Kostas; Maffettone, Carmen; Pantopoulos, Kostas] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Sebastiani, Giada; Gkouvatsos, Kostas; Maffettone, Carmen; Pantopoulos, Kostas] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Busatto, Graziella; Guido, Maria] Univ Padua, Dept Diagnost Sci & Special Therapies, Padua, Italy	Lady Davis Institute; McGill University; McGill University; University of Padua	Sebastiani, G (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	kostas.pantopoulos@mcgill.ca	Pantopoulos, Kostas/A-9668-2008	Pantopoulos, Kostas/0000-0002-2305-0057; Sebastiani, Giada/0000-0003-2655-8283	Canadian Institutes for Health Research (CIHR) [MOP-86515]; Fonds de la Recherche en Sante du Quebec (FRSQ); J. Latsis; A. Onassis; Government of Canada	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); J. Latsis; A. Onassis; Government of Canada(CGIAR)	This work was supported by a grant from the Canadian Institutes for Health Research: (CIHR; www.cihr-irsc.gc.ca); grant number: MOP-86515. KP holds a Chercheur National career award from the Fonds de la Recherche en Sante du Quebec (FRSQ; www.frsq.gouv.qc.ca). KG is supported by doctoral awards from the J. Latsis (www.latsis-foundation.org) and A. Onassis (www.onassis.gr) Public Benefit Foundations and CM was a recipient of a Government of Canada Post-Doctoral Research Fellowship (PDRF; www.scholarships.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alla V, 2005, SEMIN LIVER DIS, V25, P461, DOI 10.1055/s-2005-923317; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Arezzini B, 2003, INT J BIOCHEM CELL B, V35, P486, DOI 10.1016/S1357-2725(02)00298-4; Asare GA, 2008, TOXICOLOGY, V254, P11, DOI 10.1016/j.tox.2008.08.024; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Beutler E, 2006, ANNU REV MED, V57, P331, DOI 10.1146/annurev.med.57.121304.131310; CARTHEW P, 1993, LAB INVEST, V69, P217; Constandinou C, 2005, METH MOLEC MED, V117, P237; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; De Domenico I, 2010, J CLIN INVEST, V120, P2395, DOI 10.1172/JCI42011; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fracanzani AL, 2010, HEPATOLOGY, V51, P501, DOI 10.1002/hep.23333; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]; GUALDI R, 1994, GASTROENTEROLOGY, V107, P1118, DOI 10.1016/0016-5085(94)90237-2; Hider RC, 2002, EUR J CLIN INVEST, V32, P50, DOI 10.1046/j.1365-2362.2002.0320s1050.x; Houglum K, 1997, HEPATOLOGY, V26, P605, DOI 10.1002/hep.510260311; HOUGLUM K, 1990, J CLIN INVEST, V86, P1991, DOI 10.1172/JCI114934; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kowdley KV, 2004, GASTROENTEROLOGY, V127, pS79, DOI 10.1016/j.gastro.2004.09.019; Krijt J, 2004, BLOOD, V104, P4308, DOI 10.1182/blood-2004-06-2422; Lebeau A, 2002, EUR J CLIN INVEST, V32, P603, DOI 10.1046/j.1365-2362.2002.01026.x; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lee PL, 2009, ANNU REV PATHOL-MECH, V4, P489, DOI 10.1146/annurev.pathol.4.110807.092205; Lewis JH, 2006, MACSWEENS PATHOLOGY, P650; MACKINNON M, 1995, HEPATOLOGY, V21, P1083; Maffettone C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010163; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; OLYNYK J, 1995, J HEPATOL, V22, P671, DOI 10.1016/0168-8278(95)80222-3; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; PARK CH, 1987, LAB INVEST, V57, P555; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; PIETRANGELO A, 1995, J CLIN INVEST, V95, P1824, DOI 10.1172/JCI117861; PIETRANGELO A, 1994, HEPATOLOGY, V19, P714, DOI 10.1002/hep.1840190325; PIETRANGELO A, 1990, HEPATOLOGY, V11, P798, DOI 10.1002/hep.1840110513; Pietrangelo A, 2010, J HEPATOL, V53, P3, DOI 10.1016/j.jhep.2010.03.001; Ramm GA, 2005, SEMIN LIVER DIS, V25, P433, DOI 10.1055/s-2005-923315; Ramm GA, 1997, J HEPATOL, V26, P584, DOI 10.1016/S0168-8278(97)80424-2; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rippe RA, 2004, GASTROENTEROLOGY, V127, P1260, DOI 10.1053/j.gastro.2004.08.028; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; Sebastiani G, 2006, J VIRAL HEPATITIS, V13, P199, DOI 10.1111/j.1365-2893.2005.00662.x; Sebastiani G, 2007, WORLD J GASTROENTERO, V13, P4673, DOI 10.3748/wjg.v13.i35.4673; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; Ueberham E, 2003, HEPATOLOGY, V37, P1067, DOI 10.1053/jhep.2003.50196; Wang GS, 1999, J HEPATOL, V30, P689, DOI 10.1016/S0168-8278(99)80201-3; Weiler-Normann C, 2007, Z GASTROENTEROL, V45, P43, DOI 10.1055/s-2006-927387; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Weiss G, 2010, NAT REV GASTRO HEPAT, V7, P50, DOI 10.1038/nrgastro.2009.201; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Xiong SG, 2003, ALCOHOL, V30, P107, DOI 10.1016/S0741-8329(03)00100-9; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200	54	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25138	10.1371/journal.pone.0025138	http://dx.doi.org/10.1371/journal.pone.0025138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966437	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100065
J	Shimba, S; Ogawa, T; Hitosugi, S; Ichihashi, Y; Nakadaira, Y; Kobayashi, M; Tezuka, M; Kosuge, Y; Ishige, K; Ito, Y; Komiyama, K; Okamatsu-Ogura, Y; Kimura, K; Saito, M				Shimba, Shigeki; Ogawa, Tomohiro; Hitosugi, Shunsuke; Ichihashi, Yuya; Nakadaira, Yuki; Kobayashi, Munehiro; Tezuka, Masakatsu; Kosuge, Yasuhiro; Ishige, Kumiko; Ito, Yoshihisa; Komiyama, Kazuo; Okamatsu-Ogura, Yuko; Kimura, Kazuhiro; Saito, Masayuki			Deficient of a Clock Gene, Brain and Muscle Arnt-Like Protein-1 (BMAL1), Induces Dyslipidemia and Ectopic Fat Formation	PLOS ONE			English	Article							SHIFT-WORK; CIRCADIAN-RHYTHM; METABOLIC SYNDROME; MESSENGER-RNA; HEART-DISEASE; LIPODYSTROPHY; COMPONENT; RISK; CATECHOLAMINES; CHOLESTEROL	A link between circadian rhythm and metabolism has long been discussed. Circadian rhythm is controlled by positive and negative transcriptional and translational feedback loops composed of several clock genes. Among clock genes, the brain and muscle Arnt-like protein-1 (BMAL1) and circadian locomotor output cycles kaput (CLOCK) play important roles in the regulation of the positive rhythmic transcription. In addition to control of circadian rhythm, we have previously shown that BMAL1 regulates adipogenesis. In metabolic syndrome patients, the function of BMAL1 is dysregulated in visceral adipose tissue. In addition, analysis of SNPs has revealed that BMAL1 is associated with susceptibility to hypertension and type II diabetes. Furthermore, the significant roles of BMAL1 in pancreatic beta cells proliferation and maturation were recently reported. These results suggest that BMAL1 regulates energy homeostasis. Therefore, in this study, we examined whether loss of BMAL1 function is capable of inducing metabolic syndrome. Deficient of the Bmal1 gene in mice resulted in elevation of the respiratory quotient value, indicating that BMAL1 is involved in the utilization of fat as an energy source. Indeed, lack of Bmal1 reduced the capacity of fat storage in adipose tissue, resulting in an increase in the levels of circulating fatty acids, including triglycerides, free fatty acids, and cholesterol. Elevation of the circulating fatty acids level induced the formation of ectopic fat in the liver and skeletal muscle in Bmal1 -/- mice. Interestingly, ectopic fat formation was not observed in tissue-specific (liver or skeletal muscle) Bmal1 -/- mice even under high fat diet feeding condition. Therefore, we were led to conclude that BMAL1 is a crucial factor in the regulation of energy homeostasis, and disorders of the functions of BMAL1 lead to the development of metabolic syndrome.	[Shimba, Shigeki; Ogawa, Tomohiro; Hitosugi, Shunsuke; Ichihashi, Yuya; Nakadaira, Yuki; Kobayashi, Munehiro; Tezuka, Masakatsu] Nihon Univ, Dept Hlth Sci, Sch Pharm, Chiba, Japan; [Kosuge, Yasuhiro; Ishige, Kumiko; Ito, Yoshihisa] Nihon Univ, Dept Pharmacol, Sch Pharm, Chiba, Japan; [Komiyama, Kazuo] Nihon Univ, Sch Dent, Dept Pathol, Tokyo 101, Japan; [Okamatsu-Ogura, Yuko; Kimura, Kazuhiro] Hokkaido Univ, Dept Biomed Sci, Grad Sch Vet Med, Kita Ku, Sapporo, Hokkaido, Japan; [Saito, Masayuki] Tenshi Coll, Dept Nutr, Sch Nursing & Nutr, Sapporo, Hokkaido, Japan	Nihon University; Nihon University; Nihon University; Hokkaido University	Shimba, S (corresponding author), Nihon Univ, Dept Hlth Sci, Sch Pharm, Chiba, Japan.	shimba.shigeki@nihon-u.ac.jp	Okamatsu-Ogura, Yuko/AAI-5602-2020; Kimura, Kazuhiro/A-5029-2012	Kosuge, Yasuhiro/0000-0002-7513-5132	Ministry of Education, Sciences, Sports, and Culture of Japan; Nihon University; High-Tech Research Center from the Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Sciences, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nihon University; High-Tech Research Center from the Ministry of Education, Culture, Sports, Science, and Technology	This work was supported in part by a grant from the Ministry of Education, Sciences, Sports, and Culture of Japan (to S. S.); a General Individual Research grant from Nihon University (to S. S.); an Interdisciplinary General Joint Research grant from Nihon University (to S. S.); and the "High-Tech Research Center'' Project for Private Universities, a matching fund subsidy from the Ministry of Education, Culture, Sports, Science, and Technology 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen CP, 2004, J NEUROCHEM, V88, P1547, DOI 10.1046/j.1471-4159.2003.02300.x; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujino Y, 2006, AM J EPIDEMIOL, V164, P128, DOI 10.1093/aje/kwj185; FUJIWARA S, 1992, INT ARCH OCC ENV HEA, V63, P409, DOI 10.1007/BF00386937; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Gomez-Santos C, 2009, OBESITY, V17, P1481, DOI 10.1038/oby.2009.164; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hemmeryckx B, 2011, ARTERIOSCLE IN PRESS; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; KAWACHI I, 1995, CIRCULATION, V92, P3178, DOI 10.1161/01.CIR.92.11.3178; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kovac J, 2009, MOL CELLS, V28, P75, DOI 10.1007/s10059-009-0113-0; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oishi K, 2000, BIOCHEM BIOPH RES CO, V268, P164, DOI 10.1006/bbrc.1999.2054; ORTHGOMER K, 1983, PSYCHOSOM MED, V45, P407, DOI 10.1097/00006842-198310000-00004; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; ROBBINS DC, 1979, METABOLISM, V28, P908, DOI 10.1016/0026-0495(79)90090-8; ROBBINS DC, 1982, METABOLISM, V31, P445, DOI 10.1016/0026-0495(82)90232-3; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Takahata S, 1988, BIOCHEM BIOPH RES CO, V248, P789; Tenkane L, 1977, SCAND J WORK ENV HEA, V23, P257; THEORELL T, 1976, ACTA MED SCAND, V200, P47; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Usui S, 2002, J LIPID RES, V43, P805; van Amelsvoort LGPM, 2001, OCCUP ENVIRON MED, V58, P678, DOI 10.1136/oem.58.10.678; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOKAC Z, 1980, SCAND J WORK ENV HEA, V6, P188, DOI 10.5271/sjweh.2617; WALDHAUSER F, 1986, NEW ENGL J MED, V315, P1614; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Yamasaki F, 1998, HYPERTENSION, V32, P417, DOI 10.1161/01.HYP.32.3.417; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811; Young ME, 2002, J MOL CELL CARDIOL, V34, P223, DOI 10.1006/jmcc.2001.1504; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	47	201	207	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25231	10.1371/journal.pone.0025231	http://dx.doi.org/10.1371/journal.pone.0025231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966465	gold, Green Submitted, Green Published			2022-12-25	WOS:000295265100075
J	Wang, ZX; Oh, E; Clapp, DW; Chernoff, J; Thurmond, DC				Wang, Zhanxiang; Oh, Eunjin; Clapp, D. Wade; Chernoff, Jonathan; Thurmond, Debbie C.			Inhibition or Ablation of p21-activated Kinase (PAK1) Disrupts Glucose Homeostatic Mechanisms in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUT4 TRANSLOCATION; INSULIN-SECRETION; MUSCLE-CELLS; SKELETAL-MUSCLE; PHOSPHATIDYLINOSITOL 3-KINASE; CYTOSKELETAL DYNAMICS; SIGNALING PATHWAY; REGULATED KINASE; ACTIN; ACTIVATION	The p21-activated kinase PAK1 is implicated in tumorigenesis, and efforts to inhibit PAK1 signaling as a means to induce tumor cell apoptosis are underway. However, PAK1 has also been implicated as a positive effector of mechanisms in clonal pancreatic beta cells and skeletal myotubes that would be crucial to maintaining glucose homeostasis in vivo. Of relevance, human islets of Type 2 diabetic donors contained similar to 80% less PAK1 protein compared with non-diabetics, implicating PAK1 in islet signaling/scaffolding functions. Mimicking this, islets from PAK1(-/-) knock-out mice exhibited profound defects in the second/sustained-phase of insulin secretion. Reiteration of this specific defect by human islets treated with the PAK1 signaling inhibitor IPA3 revealed PAK1 signaling to be of primary functional importance. Analyses of human and mouse islet beta cell signaling revealed PAK1 activation to be 1) dependent upon Cdc42 abundance, 2) crucial for signaling downstream to activate ERK1/2, but 3) dispensable for cofilin phosphorylation. Importantly, the PAK1(-/-) knock-out mice were found to exhibit whole body glucose intolerance in vivo. Exacerbating this, the PAK1(-/-) knock-out mice also exhibited peripheral insulin resistance. Insulin resistance was coupled to ablation of insulin-stimulated GLUT4 translocation in skeletal muscle from PAK1(-/-) knock-out mice, and in sharp contrast to islet beta cells, skeletal muscle PAK1 loss was underscored by defective cofilin phosphorylation but normal ERK1/2 activation. Taken together, these data provide the first human islet and mammalian in vivo data unveiling the key and crucial roles for differential PAK1 signaling in the multi-tissue regulation of whole body glucose homeostasis.	[Wang, Zhanxiang; Oh, Eunjin; Clapp, D. Wade; Thurmond, Debbie C.] Herman B Wells Ctr Pediat Res, Dept Pediat, Basic Diabet Grp, Indianapolis, IN 46202 USA; [Chernoff, Jonathan] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Thurmond, DC (corresponding author), Herman B Wells Ctr Pediat Res, Dept Pediat, Basic Diabet Grp, 635 Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu	Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836	National Institutes of Health [DK067912, DK076614, CTSI-KL2 RR025760, CA058836]; Showalter Trust of Indiana University School of Medicine; NATIONAL CANCER INSTITUTE [R01CA058836] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076614, R01DK067912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Trust of Indiana University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported, in whole or in part, by Grants DK067912 and DK076614 (to D. C. T.), CTSI-KL2 RR025760 (to Z. W.), and CA058836 (to J. C.) from the National Institutes of Health and from the Showalter Trust of Indiana University School of Medicine (to E. O.).	Abramovici H, 2009, MOL BIOL CELL, V20, P2049, DOI 10.1091/mbc.E07-12-1248; Alejandro E. U., 2011, FASEB J IN PRESS; Allen JD, 2009, BLOOD, V113, P2695, DOI 10.1182/blood-2008-06-160861; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Arias-Romero Luis E, 2010, Small GTPases, V1, P124, DOI 10.4161/sgtp.1.2.14109; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; Chiu TT, 2010, MOL BIOL CELL, V21, P3529, DOI 10.1091/mbc.E10-04-0316; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Ke YB, 2008, PROG BIOPHYS MOL BIO, V98, P238, DOI 10.1016/j.pbiomolbio.2009.01.007; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Khayat ZA, 2000, J CELL SCI, V113, P279; Kowluru A, 2010, DIABETES, V59, P967, DOI 10.2337/db09-1334; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Ong CC, 2011, ONCOTARGET, V2, P491; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Spurlin BA, 2003, DIABETES, V52, P1910, DOI 10.2337/diabetes.52.8.1910; Stanley FM, 2007, ENDOCRINOLOGY, V148, P5874, DOI 10.1210/en.2007-0127; Stockton R, 2007, MOL BIOL CELL, V18, P2346, DOI 10.1091/mbc.E06-07-0584; Sun J, 2009, ONCOGENE, V28, P3132, DOI 10.1038/onc.2009.167; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Trumper J, 2005, DIABETOLOGIA, V48, P1534, DOI 10.1007/s00125-005-1820-5; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; Ueda S, 2010, FASEB J, V24, P2254, DOI 10.1096/fj.09-137380; Usui I, 2003, J BIOL CHEM, V278, P13765, DOI 10.1074/jbc.M208904200; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Yu JS, 1998, BIOCHEM J, V334, P121, DOI 10.1042/bj3340121; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhou M, 1998, AM J PHYSIOL-ENDOC M, V275, pE187, DOI 10.1152/ajpendo.1998.275.2.E187	50	93	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41359	41367		10.1074/jbc.M111.291500	http://dx.doi.org/10.1074/jbc.M111.291500			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21969371	Green Published, hybrid			2022-12-25	WOS:000298057500023
J	Andalman, AS; Foerster, JN; Fee, MS				Andalman, Aaron S.; Foerster, Jakob N.; Fee, Michale S.			Control of Vocal and Respiratory Patterns in Birdsong: Dissection of Forebrain and Brainstem Mechanisms Using Temperature	PLOS ONE			English	Article							ZEBRA FINCH SONG; NUCLEUS ROBUSTUS-ARCHISTRIATALIS; INSPIRATORY PREMOTOR NEURONS; SEQUENCE GENERATION; SYRINGEAL MUSCLES; NEURAL ACTIVITY; CONTROL-SYSTEM; AIR-FLOW; CANARY; MODEL	Learned motor behaviors require descending forebrain control to be coordinated with midbrain and brainstem motor systems. In songbirds, such as the zebra finch, regular breathing is controlled by brainstem centers, but when the adult songbird begins to sing, its breathing becomes tightly coordinated with forebrain-controlled vocalizations. The periods of silence (gaps) between song syllables are typically filled with brief breaths, allowing the bird to sing uninterrupted for many seconds. While substantial progress has been made in identifying the brain areas and pathways involved in vocal and respiratory control, it is not understood how respiratory and vocal control is coordinated by forebrain motor circuits. Here we combine a recently developed technique for localized brain cooling, together with recordings of thoracic air sac pressure, to examine the role of cortical premotor nucleus HVC (proper name) in respiratory-vocal coordination. We found that HVC cooling, in addition to slowing all song timescales as previously reported, also increased the duration of expiratory pulses (EPs) and inspiratory pulses (IPs). Expiratory pulses, like song syllables, were stretched uniformly by HVC cooling, but most inspiratory pulses exhibited non-uniform stretch of pressure waveform such that the majority of stretch occurred late in the IP. Indeed, some IPs appeared to change duration by the earlier or later truncation of an underlying inspiratory event. These findings are consistent with the idea that during singing the temporal structure of EPs is under the direct control of forebrain circuits, whereas that of IPs can be strongly influenced by circuits downstream of HVC, likely in the brainstem. An analysis of the temporal jitter of respiratory and vocal structure suggests that IPs may be initiated by HVC at the end of each syllable and terminated by HVC immediately before the onset of the next syllable.	[Andalman, Aaron S.; Foerster, Jakob N.; Fee, Michale S.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Andalman, AS (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.	fee@mit.edu	Andalman, Aaron S/C-7694-2011	Fee, Michale/0000-0001-7539-1745	National Institutes of Health [R01 DC009183, R01 MH067105]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Institutes of Health (Grants R01 DC009183 and R01 MH067105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov D, 2007, SOC NEUR ABSTR, V430, P5; Aronov D, 2011, J NEUROSCI METH, V197, P32, DOI 10.1016/j.jneumeth.2011.01.024; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Ashmore RC, 2008, J NEUROSCI, V28, P2613, DOI 10.1523/JNEUROSCI.4547-07.2008; CALDER WA, 1970, COMP BIOCHEM PHYSIOL, V32, P251, DOI 10.1016/0010-406X(70)90938-2; Chein R, 2004, APPL THERM ENG, V24, P2207, DOI 10.1016/j.applthermaleng.2004.03.001; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Cooper BG, 2006, J NEUROPHYSIOL, V95, P3798, DOI 10.1152/jn.01123.2005; CYNX J, 1990, J COMP PSYCHOL, V104, P3, DOI 10.1037/0735-7036.104.1.3; Fee MS, 2010, ILAR J, V51, P362, DOI 10.1093/ilar.51.4.362; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fee MS, 2011, CURR OPIN N IN PRESS, V21; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Franz M, 2003, J EXP BIOL, V206, P967, DOI 10.1242/jeb.00196; Franz M, 2002, J NEUROBIOL, V51, P129, DOI 10.1002/neu.10043; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Goller F, 1996, J NEUROPHYSIOL, V75, P867, DOI 10.1152/jn.1996.75.2.867; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Guillery RW, 2002, PHILOS T R SOC B, V357, P1809, DOI 10.1098/rstb.2002.1171; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HARTLEY RS, 1989, J COMP PHYSIOL A, V165, P15, DOI 10.1007/BF00613795; HARTLEY RS, 1990, RESP PHYSIOL, V81, P177, DOI 10.1016/0034-5687(90)90044-Y; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kubke MF, 2005, J NEUROPHYSIOL, V94, P2379, DOI 10.1152/jn.00257.2005; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Levelt W.J., 1993, SPEAKING INTENTION A; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Moody SL, 1998, J COGNITIVE NEUROSCI, V10, P35, DOI 10.1162/089892998563761; Northcutt RG, 2002, INTEGR COMP BIOL, V42, P743, DOI 10.1093/icb/42.4.743; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Paton JFR, 2006, NAT NEUROSCI, V9, P311, DOI 10.1038/nn1650; Reinke H, 1998, J COMP NEUROL, V391, P147; Reinke H, 1997, J COMP NEUROL, V379, P347; Riede T, 2010, BRAIN LANG, V115, P69, DOI 10.1016/j.bandl.2009.11.003; Rubin JE, 2009, J NEUROPHYSIOL, V101, P2146, DOI 10.1152/jn.90958.2008; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schmidt MF, 2008, PLOS BIOL, V6, P2089, DOI 10.1371/journal.pbio.0060269; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Schwartz AB, 2000, EUR J NEUROSCI, V12, P1851, DOI 10.1046/j.1460-9568.2000.00097.x; SELLER TJ, 1981, TRENDS NEUROSCI, V4, P301, DOI 10.1016/0166-2236(81)90094-1; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Striedter GF, 1998, J NEUROBIOL, V34, P27, DOI 10.1002/(SICI)1097-4695(199801)34:1<27::AID-NEU3>3.0.CO;2-E; Suthers RA, 1997, J NEUROBIOL, V33, P632, DOI 10.1002/(SICI)1097-4695(19971105)33:5<632::AID-NEU10>3.0.CO;2-B; SUTHERS RA, 1994, J NEUROBIOL, V25, P917, DOI 10.1002/neu.480250803; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; VICARIO DS, 1988, J COMP NEUROL, V271, P346, DOI 10.1002/cne.902710305; VICARIO DS, 1993, NEUROREPORT, V4, P983, DOI 10.1097/00001756-199307000-00037; VICARIO DS, 1991, J COMP NEUROL, V309, P486, DOI 10.1002/cne.903090405; Vu ET, 1998, J NEUROSCI, V18, P9088; VU ET, 1994, J NEUROSCI, V14, P6924; Wang CZH, 2008, PLOS BIOL, V6, P2154, DOI 10.1371/journal.pbio.0060250; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; WILD JM, 1993, BRAIN RES, V606, P319, DOI 10.1016/0006-8993(93)91001-9; Wild JM, 1998, J NEUROBIOL, V36, P441, DOI 10.1002/(SICI)1097-4695(19980905)36:3<441::AID-NEU11>3.0.CO;2-E; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; ZANN R, 1996, ZEBRA FINCH	65	49	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25461	10.1371/journal.pone.0025461	http://dx.doi.org/10.1371/journal.pone.0025461			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980466	gold, Green Submitted, Green Published			2022-12-25	WOS:000295936900067
J	Lutz, R; Pataky, K; Gadhari, N; Marelli, M; Brugger, J; Chiquet, M				Lutz, Roman; Pataky, Kristopher; Gadhari, Neha; Marelli, Mattia; Brugger, Juergen; Chiquet, Matthias			Nano-Stenciled RGD-Gold Patterns That Inhibit Focal Contact Maturation Induce Lamellipodia Formation in Fibroblasts	PLOS ONE			English	Article							CELL-MATRIX ADHESIONS; EXTRACELLULAR-MATRIX; FIBRONECTIN FIBRILLOGENESIS; DYNAMICS; RHO; RAC; ACTIVATION; GTPASES; SHAPE; ALPHA-5-BETA-1	Cultured fibroblasts adhere to extracellular substrates by means of cell-matrix adhesions that are assembled in a hierarchical way, thereby gaining in protein complexity and size. Here we asked how restricting the size of cell-matrix adhesions affects cell morphology and behavior. Using a nanostencil technique, culture substrates were patterned with gold squares of a width and spacing between 250 nm and 2 mu m. The gold was functionalized with RGD peptide as ligand for cellular integrins, and mouse embryo fibroblasts were plated. Limiting the length of cell-matrix adhesions to 500 nm or less disturbed the maturation of vinculin-positive focal complexes into focal contacts and fibrillar adhesions, as indicated by poor recruitment of alpha 5-integrin. We found that on sub-micrometer patterns, fibroblasts spread extensively, but did not polarize. Instead, they formed excessive numbers of lamellipodia and a fine actin meshwork without stress fibers. Moreover, these cells showed aberrant fibronectin fibrillogenesis, and their speed of directed migration was reduced significantly compared to fibroblasts on 2 mu m square patterns. Interference with RhoA/ROCK signaling eliminated the pattern-dependent differences in cell morphology. Our results indicate that manipulating the maturation of cell-matrix adhesions by nanopatterned surfaces allows to influence morphology, actin dynamics, migration and ECM assembly of adhering fibroblasts.	[Lutz, Roman] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Pataky, Kristopher; Marelli, Mattia; Brugger, Juergen] Ecole Polytech Fed Lausanne, Microsyst Lab, Lausanne, Switzerland; [Gadhari, Neha; Chiquet, Matthias] Univ Bern, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland	Friedrich Miescher Institute for Biomedical Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bern	Lutz, R (corresponding author), CLS Behring AG, Bern, Switzerland.	matthias.chiquet@zmk.unibe.ch	Brugger, Juergen/C-5357-2009	Brugger, Juergen/0000-0002-7710-5930; Gadhari, Neha/0000-0003-1443-3088; Pataky, Kristopher/0000-0002-9059-9111; Chiquet, Matthias/0000-0001-7812-4853	Swiss National Science Foundation [CR2312_125290/1]; Novartis Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Research Foundation	This work was funded by grant CR2312_125290/1 from the Swiss National Science Foundation ( http://www.snf.ch/E/Pages/default.aspx) and by the Novartis Research Foundation (http://www.fmi.ch/About/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d; Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Csucs G, 2003, BIOMATERIALS, V24, P1713, DOI 10.1016/S0142-9612(02)00568-9; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Fernandez-Sauze S, 2009, EXP CELL RES, V315, P2092, DOI 10.1016/j.yexcr.2009.03.017; Gallant ND, 2007, J NANOSCI NANOTECHNO, V7, P803, DOI 10.1166/jnn.2007.507; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Graness A, 2006, CELL SIGNAL, V18, P433, DOI 10.1016/j.cellsig.2005.05.011; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harjanto D, 2010, ORG BIOMOL CHEM, V8, P299, DOI 10.1039/b913064k; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Kim GM, 2003, MICROELECTRON ENG, V67-8, P609, DOI 10.1016/S0167-9317(03)00121-7; Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Lutz R, 2010, J CELL SCI, V123, P1511, DOI 10.1242/jcs.060905; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; May T, 2005, J BIOTECHNOL, V120, P99, DOI 10.1016/j.jbiotec.2005.03.027; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sarasa-Renedo A, 2006, EXP CELL RES, V312, P1361, DOI 10.1016/j.yexcr.2005.12.025; Smith PG, 2003, AM J RESP CELL MOL, V28, P436, DOI 10.1165/rcmb.4754; Thery M., 2019, COLD SPRING HARB PRO, V2009; Vazquez-Mena O, 2008, NANO LETT, V8, P3675, DOI 10.1021/nl801778t; WEHRLE B, 1990, DEVELOPMENT, V110, P401; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Wolfenson H, 2009, CELL MOTIL CYTOSKEL, V66, P1017, DOI 10.1002/cm.20410; Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 2001, J CELL SCI, V114, P3583	37	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25459	10.1371/journal.pone.0025459	http://dx.doi.org/10.1371/journal.pone.0025459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980465	gold, Green Submitted, Green Published			2022-12-25	WOS:000295933700038
J	Oliveira-Maia, AJ; Roberts, CD; Walker, QD; Luo, B; Kuhn, C; Simon, SA; Nicolelis, MAL				Oliveira-Maia, Albino J.; Roberts, Craig D.; Walker, Q. David; Luo, Brooke; Kuhn, Cynthia; Simon, Sidney A.; Nicolelis, Miguel A. L.			Intravascular Food Reward	PLOS ONE			English	Article							CONDITIONED FLAVOR PREFERENCES; NUCLEUS-ACCUMBENS SHELL; BLOOD-GLUCOSE LEVELS; INTRAVENOUS GLUCOSE; DOPAMINE RELEASE; INTESTINAL NUTRIENTS; VENTRAL STRIATUM; PLACE PREFERENCE; PLASMA-GLUCOSE; RATS	Consumption of caloriecontaining sugars elicits appetitive behavioral responses and dopamine release in the ventral striatum, even in the absence of sweet-taste transduction machinery. However, it is unclear if such reward-related postingestive effects reflect preabsorptive or postabsorptive events. In support of the importance of postabsorptive glucose detection, we found that, in rat behavioral tests, high concentration glucose solutions administered in the jugular vein were sufficient to condition a side-bias. Additionally, a lower concentration glucose solution conditioned robust behavioral responses when administered in the hepatic-portal, but not the jugular vein. Furthermore, enteric administration of glucose at a concentration that is sufficient to elicit behavioral conditioning resulted in a glycemic profile similar to that observed after administration of the low concentration glucose solution in the hepatic-portal, but not jugular vein. Finally using fast-scan cyclic voltammetry we found that, in accordance with behavioral findings, a low concentration glucose solution caused an increase in spontaneous dopamine release events in the nucleus accumbens shell when administered in the hepatic-portal, but not the jugular vein. These findings demonstrate that the postabsorptive effects of glucose are sufficient for the postingestive behavioral and dopaminergic reward-related responses that result from sugar consumption. Furthermore, glycemia levels in the hepatic-portal venous system contribute more significantly for this effect than systemic glycemia, arguing for the participation of an intra-abdominal visceral sensor for glucose.	[Oliveira-Maia, Albino J.; Roberts, Craig D.; Luo, Brooke; Simon, Sidney A.; Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Walker, Q. David; Kuhn, Cynthia] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Simon, Sidney A.; Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC USA; [Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Psychol & Neurosci, Durham, NC USA; [Simon, Sidney A.; Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Ctr Neuroengn, Durham, NC USA; [Nicolelis, Miguel A. L.] Edmond & Lily Safra Int, Inst Neurosci Natal, Natal, RN, Brazil	Duke University; Duke University; Duke University; Duke University; Duke University	Oliveira-Maia, AJ (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Program, Lisbon, Portugal.	albinojorgemai@gmail.com	Oliveira-Maia, AJ/B-7976-2009	Oliveira-Maia, AJ/0000-0001-5071-3007	National Institute on Deafness and Other Communication Disorders (NIDCD) [R01DC001065]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001065] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Grant Number R01DC001065 to Sidney Simon from the National Institute on Deafness and Other Communication Disorders (NIDCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDCD or the National Institutes of Health.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Ackroff K, 2010, PHYSIOL BEHAV, V99, P402, DOI 10.1016/j.physbeh.2009.12.012; ADKINS BA, 1987, J CLIN INVEST, V79, P557, DOI 10.1172/JCI112847; Agmo A, 1997, APPETITE, V29, P269, DOI 10.1006/appe.1997.0101; Aragona BJ, 2008, J NEUROSCI, V28, P8821, DOI 10.1523/JNEUROSCI.2225-08.2008; Aragona BJ, 2009, EUR J NEUROSCI, V30, P1889, DOI 10.1111/j.1460-9568.2009.07027.x; Baird JP, 1999, AM J PHYSIOL-REG I, V277, pR1136, DOI 10.1152/ajpregu.1999.277.4.R1136; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Bello NT, 2006, PHYSIOL BEHAV, V88, P138, DOI 10.1016/j.physbeh.2006.03.027; Bermudez-Rattoni F, 2004, NAT REV NEUROSCI, V5, P209, DOI 10.1038/nrn1344; BRADLEY RM, 1971, J COMP PHYSIOL PSYCH, V75, P186, DOI 10.1037/h0030813; Cahill PS, 1996, ANAL CHEM, V68, P3180, DOI 10.1021/ac960347d; CHAMBERS RM, 1956, J COMP PHYSIOL PSYCH, V49, P558, DOI 10.1037/h0047138; Cheer JF, 2004, J NEUROSCI, V24, P4393, DOI 10.1523/JNEUROSCI.0529-04.2004; COPPOCK HW, 1954, J COMP PHYSIOL PSYCH, V47, P355, DOI 10.1037/h0061319; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; EPSTEIN AN, 1962, J COMP PHYSIOL PSYCH, V55, P753, DOI 10.1037/h0040455; Friedman MI, 2005, CHEM SENSES, V30, pI182, DOI 10.1093/chemse/bjh174; GOWANS SE, 1991, AM J PHYSIOL, V261, pR1409, DOI 10.1152/ajpregu.1991.261.6.R1409; GREEN JH, 1981, Q J EXP PHYSIOL CMS, V66, P465, DOI 10.1113/expphysiol.1981.sp002588; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Hajnal A, 2001, BRAIN RES, V904, P76, DOI 10.1016/S0006-8993(01)02451-9; Haltia LT, 2007, SYNAPSE, V61, P748, DOI 10.1002/syn.20418; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Heien MLAV, 2003, ANALYST, V128, P1413, DOI 10.1039/b307024g; HOLM S, 1979, SCAND J STAT, V6, P65; HOLMAN GL, 1969, J COMP PHYSIOL PSYCH, V69, P432, DOI 10.1037/h0028233; JOUHANEAU J, 1982, PHYSIOL BEHAV, V29, P241, DOI 10.1016/0031-9384(82)90010-5; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; le Magnen J, 1999, APPETITE, V33, P14, DOI 10.1006/appe.1999.0252; le Magnen J, 1999, APPETITE, V33, P8, DOI 10.1006/appe.1999.0251; Levin BE, 2000, BRAIN RES, V874, P158, DOI 10.1016/S0006-8993(00)02573-7; Lucas F, 1996, AM J PHYSIOL-REG I, V270, pR1059, DOI 10.1152/ajpregu.1996.270.5.R1059; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; MATHER P, 1978, NATURE, V273, P461, DOI 10.1038/273461a0; MILLER NE, 1952, J COMP PHYSIOL PSYCH, V45, P555, DOI 10.1037/h0060113; Miras AD, 2010, CURR OPIN GASTROEN, V26, P140, DOI 10.1097/MOG.0b013e328333e94a; MYERS SR, 1991, J CLIN INVEST, V87, P930, DOI 10.1172/JCI115100; NIIJIMA A, 1982, J PHYSIOL-LONDON, V332, P315, DOI 10.1113/jphysiol.1982.sp014415; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; PUERTO A, 1976, SCIENCE, V192, P485, DOI 10.1126/science.1257784; RAWSON NE, 1994, AM J PHYSIOL, V266, pR112, DOI 10.1152/ajpregu.1994.266.1.R112; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; REVUSKY SH, 1971, PHYSIOL BEHAV, V6, P341, DOI 10.1016/0031-9384(71)90165-X; Robinson DL, 2004, J NEUROCHEM, V90, P894, DOI 10.1111/j.1471-4159.2004.02559.x; Robinson DL, 2002, J NEUROSCI, V22, P10477; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Schultes B, 2010, AM J CLIN NUTR, V92, P277, DOI 10.3945/ajcn.2009.29007; Sclafani A, 1996, PHYSIOL BEHAV, V60, P447, DOI 10.1016/S0031-9384(96)80018-7; Sclafani A, 2004, PHYSIOL BEHAV, V81, P773, DOI 10.1016/j.physbeh.2004.04.031; Sclafani A, 2001, APPETITE, V36, P79, DOI 10.1006/appe.2000.0370; Sclafani A, 2003, PHYSIOL BEHAV, V78, P285, DOI 10.1016/S0031-9384(02)00968-X; SCLAFANI A, 1988, AM J PHYSIOL, V255, pR672, DOI 10.1152/ajpregu.1988.255.4.R672; Sclafani A, 2010, AM J PHYSIOL-REG I, V299, pR1643, DOI 10.1152/ajpregu.00495.2010; SHERMAN JE, 1983, ANIM LEARN BEHAV, V11, P101, DOI 10.3758/BF03212315; Sombers LA, 2009, J NEUROSCI, V29, P1735, DOI 10.1523/JNEUROSCI.5562-08.2009; STRUBBE JH, 1977, PHYSIOL BEHAV, V19, P303, DOI 10.1016/0031-9384(77)90342-0; Stuber GD, 2005, NEUROPSYCHOPHARMACOL, V30, P853, DOI 10.1038/sj.npp.1300619; TORDOFF MG, 1986, AM J PHYSIOL, V251, pR192, DOI 10.1152/ajpregu.1986.251.1.R192; Touzani K, 2008, EUR J NEUROSCI, V27, P1525, DOI 10.1111/j.1460-9568.2008.06127.x; Venton BJ, 2007, SYNAPSE, V61, P37, DOI 10.1002/syn.20343; Wheeler RA, 2011, BIOL PSYCHIAT, V69, P1067, DOI 10.1016/j.biopsych.2011.02.014; WHITE NM, 1985, PHARMACOL BIOCHEM BE, V23, P37, DOI 10.1016/0091-3057(85)90127-3; Wightman RM, 2007, EUR J NEUROSCI, V26, P2046, DOI 10.1111/j.1460-9568.2007.05772.x; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Zuurbier CJ, 2008, ANESTH ANALG, V106, P135, DOI 10.1213/01.ane.0000297299.91527.74	67	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24992	10.1371/journal.pone.0024992	http://dx.doi.org/10.1371/journal.pone.0024992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980372	Green Published, gold, Green Submitted			2022-12-25	WOS:000295933700014
J	Fung, SJ; Joshi, D; Allen, KM; Sivagnanasundaram, S; Rothmond, DA; Saunders, R; Noble, PL; Webster, MJ; Weickert, CS				Fung, Samantha J.; Joshi, Dipesh; Allen, Katherine M.; Sivagnanasundaram, Sinthuja; Rothmond, Debora A.; Saunders, Richard; Noble, Pamela L.; Webster, Maree J.; Weickert, Cynthia Shannon			Developmental Patterns of Doublecortin Expression and White Matter Neuron Density in the Postnatal Primate Prefrontal Cortex and Schizophrenia	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; NEWLY GENERATED NEURONS; CELL-ADHESION MOLECULE; PSA-NCAM EXPRESSION; CEREBRAL-CORTEX; HUMAN BRAIN; CORTICAL DEVELOPMENT; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; GABAERGIC NEURONS	Postnatal neurogenesis occurs in the subventricular zone and dentate gyrus, and evidence suggests that new neurons may be present in additional regions of the mature primate brain, including the prefrontal cortex (PFC). Addition of new neurons to the PFC implies local generation of neurons or migration from areas such as the subventricular zone. We examined the putative contribution of new, migrating neurons to postnatal cortical development by determining the density of neurons in white matter subjacent to the cortex and measuring expression of doublecortin (DCX), a microtubule-associated protein involved in neuronal migration, in humans and rhesus macaques. We found a striking decline in DCX expression (human and macaque) and density of white matter neurons (humans) during infancy, consistent with the arrival of new neurons in the early postnatal cortex. Considering the expansion of the brain during this time, the decline in white matter neuron density does not necessarily indicate reduced total numbers of white matter neurons in early postnatal life. Furthermore, numerous cells in the white matter and deep grey matter were positive for the migration-associated glycoprotein polysialiated-neuronal cell adhesion molecule and GAD65/67, suggesting that immature migrating neurons in the adult may be GABAergic. We also examined DCX mRNA in the PFC of adult schizophrenia patients (n = 37) and matched controls (n = 37) and did not find any difference in DCX mRNA expression. However, we report a negative correlation between DCX mRNA expression and white matter neuron density in adult schizophrenia patients, in contrast to a positive correlation in human development where DCX mRNA and white matter neuron density are higher earlier in life. Accumulation of neurons in the white matter in schizophrenia would be congruent with a negative correlation between DCX mRNA and white matter neuron density and support the hypothesis of a migration deficit in schizophrenia.	[Fung, Samantha J.; Joshi, Dipesh; Allen, Katherine M.; Sivagnanasundaram, Sinthuja; Rothmond, Debora A.; Weickert, Cynthia Shannon] Schizophrenia Res Inst, Sydney, NSW, Australia; [Fung, Samantha J.; Joshi, Dipesh; Allen, Katherine M.; Sivagnanasundaram, Sinthuja; Rothmond, Debora A.; Weickert, Cynthia Shannon] Neurosci Res Australia, Sydney, NSW, Australia; [Fung, Samantha J.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Allen, Katherine M.; Weickert, Cynthia Shannon] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Saunders, Richard] NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; [Noble, Pamela L.] Natl Inst Mental Hlth NIMH IRP Nonhuman Primate C, Poolesville, MD USA; [Webster, Maree J.] Stanley Med Res Inst, Rockville, MD USA	Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Fung, SJ (corresponding author), Schizophrenia Res Inst, Sydney, NSW, Australia.	s.fung@neura.edu.au	Joshi, Dipesh/I-2918-2012; Fung, Samantha/C-9660-2011; Weickert, Cynthia Shannon/G-3171-2011	Shannon Weickert, Cynthia/0000-0002-4560-0259	Schizophrenia Research Institute; NSW Health; Macquarie Group Foundation; Neuroscience Research Australia; University of New South Wales; National Health and Medical Research Council of Australia [630452]; University of Sydney; National Institute of Alcohol Abuse and Alcoholism [R24AA012725]; NSW Department of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012725] Funding Source: NIH RePORTER	Schizophrenia Research Institute; NSW Health; Macquarie Group Foundation; Neuroscience Research Australia; University of New South Wales; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NSW Department of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Schizophrenia Research Institute, utilizing funding from NSW Health and the Macquarie Group Foundation; Neuroscience Research Australia; the University of New South Wales; and National Health and Medical Research Council of Australia (grant number 630452). Tissues were received from the Australian Brain Donor Programs NSW Tissue Resource Centre, which is supported by the University of Sydney, National Health and Medical Research Council of Australia, Schizophrenia Research Institute, National Institute of Alcohol Abuse and Alcoholism (grant number R24AA012725) and NSW Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P169; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; Anderson SA, 1996, SCHIZOPHR RES, V19, P111, DOI 10.1016/0920-9964(96)88521-5; Gomez-Climent MA, 2008, CEREB CORTEX, V18, P2229, DOI 10.1093/cercor/bhm255; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Bartkowska K, 2010, BRAIN BEHAV EVOLUT, V76, P128, DOI 10.1159/000320944; Beltaifa S, 2005, EUR J NEUROSCI, V21, P2433, DOI 10.1111/j.1460-9568.2005.04074.x; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cai Y, 2009, EXP NEUROL, V216, P342, DOI 10.1016/j.expneurol.2008.12.008; Choi KH, 2009, J PSYCHIATR NEUROSCI, V34, P450; Chong VZ, 2008, INT J DEV NEUROSCI, V26, P791, DOI 10.1016/j.ijdevneu.2008.06.004; Corbo JC, 2002, J NEUROSCI, V22, P7548; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Cox ET, 2009, NEUROSCIENCE, V162, P96, DOI 10.1016/j.neuroscience.2009.04.037; Cruz DA, 2003, J COMP NEUROL, V465, P385, DOI 10.1002/cne.10833; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; des Portes V, 1998, CELL, V92, P51; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; Eastwood SL, 2005, SCHIZOPHR RES, V79, P181, DOI 10.1016/j.schres.2005.07.001; Eastwood SL, 2003, MOL PSYCHIATR, V8, P821, DOI 10.1038/sj.mp.4001371; Erickson SL, 2002, J COMP NEUROL, V448, P186, DOI 10.1002/cne.10249; ESTRADA C, 1993, J CEREBR BLOOD F MET, V13, P978, DOI 10.1038/jcbfm.1993.122; Estrada C, 1998, CEREB CORTEX, V8, P193, DOI 10.1093/cercor/8.3.193; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2007, J NEUROSCI, V27, P3875, DOI 10.1523/JNEUROSCI.4530-06.2007; Fung SJ, 2010, AM J PSYCHIAT, V167, P1479, DOI 10.1176/appi.ajp.2010.09060784; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gomez-Climent MA, 2010, ARCH ITAL BIOL, V148, P159; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Grateron L, 2003, J CHEM NEUROANAT, V26, P311, DOI 10.1016/j.jchemneu.2003.09.005; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Iwasaki N, 1997, NEURORADIOLOGY, V39, P841, DOI 10.1007/s002340050517; Kalkman HO, 2009, PHARMACOL THERAPEUT, V121, P115, DOI 10.1016/j.pharmthera.2008.11.002; Kanold PO, 2006, NEURON, V51, P627, DOI 10.1016/j.neuron.2006.07.008; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kirkpatrick B, 2003, J NERV MENT DIS, V191, P563, DOI 10.1097/01.nmd.0000087181.61164.e1; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; KOSTOVIC I, 1980, J NEUROCYTOL, V9, P219, DOI 10.1007/BF01205159; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Levitt P, 2003, J PEDIATR-US, V143, pS35, DOI 10.1067/S0022-3476(03)00400-1; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; Suarez-Sola ML, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.007.2009; Luzzati F, 2003, P NATL ACAD SCI USA, V100, P13036, DOI 10.1073/pnas.1735482100; Luzzati F, 2009, CEREB CORTEX, V19, P1028, DOI 10.1093/cercor/bhn145; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; MEYER G, 1992, EXP BRAIN RES, V88, P204, DOI 10.1007/BF02259143; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Ohira K, 2011, CELL MOL LIFE SCI, V68, P1645, DOI 10.1007/s00018-010-0552-y; Petanjek Z, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.026.2009; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; Ramos RL, 2006, CEREB CORTEX, V16, P1323, DOI 10.1093/cercor/bhj074; Reep RL, 2000, BRAIN BEHAV EVOLUT, V56, P212, DOI 10.1159/000047206; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Reynolds GP, 2001, J CHEM NEUROANAT, V22, P95, DOI 10.1016/S0891-0618(01)00113-2; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Shankle WR, 1998, J THEOR BIOL, V191, P115, DOI 10.1006/jtbi.1997.0570; Shapiro LA, 2007, BRAIN STRUCT FUNCT, V212, P133, DOI 10.1007/s00429-007-0151-3; Shapiro LA, 2009, EPILEPSY BEHAV, V14, P74, DOI 10.1016/j.yebeh.2008.09.011; Varea E, 2007, J CHEM NEUROANAT, V33, P202, DOI 10.1016/j.jchemneu.2007.03.006; Varea E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00017; WAHLE P, 1987, J COMP NEUROL, V261, P165, DOI 10.1002/cne.902610202; Wang C., 2011, CELL RES; Webster MJ, 2011, INT J DEV NEUROSCI, V29, P225, DOI 10.1016/j.ijdevneu.2010.09.006; Weickert CS, 2009, MOL PSYCHIATR, V14, P558, DOI 10.1038/mp.2009.5; Weickert CS, 2000, J COMP NEUROL, V423, P359, DOI 10.1002/1096-9861(20000731)423:3<359::AID-CNE1>3.0.CO;2-0; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Xiong K, 2008, EXP NEUROL, V211, P271, DOI 10.1016/j.expneurol.2008.02.003; Yang HKC, 2004, J NEUROSCI RES, V76, P282, DOI 10.1002/jnr.20071; Yang Y, 2011, BIOL PSYCHIAT, V69, P63, DOI 10.1016/j.biopsych.2010.08.020; Zecevic N, 2011, DEV NEUROBIOL, V71, P18, DOI 10.1002/dneu.20812; Zhang XM, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.017.2009	84	32	34	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25194	10.1371/journal.pone.0025194	http://dx.doi.org/10.1371/journal.pone.0025194			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966452	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100023
J	Gao, W; Gilmore, JH; Giovanello, KS; Smith, JK; Shen, DG; Zhu, HT; Lin, WL				Gao, Wei; Gilmore, John H.; Giovanello, Kelly S.; Smith, Jeffery Keith; Shen, Dinggang; Zhu, Hongtu; Lin, Weili			Temporal and Spatial Evolution of Brain Network Topology during the First Two Years of Life	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; DEFAULT MODE; CORTEX; ORGANIZATION; EMERGENCE; ANATOMY; MATTER	The mature brain features high wiring efficiency for information transfer. However, the emerging process of such an efficient topology remains elusive. With resting state functional MRI and a large cohort of normal pediatric subjects (n = 147) imaged during a critical time period of brain development, 3 wk- to 2 yr-old, the temporal and spatial evolution of brain network topology is revealed. The brain possesses the small world topology immediately after birth, followed by a remarkable improvement in whole brain wiring efficiency in 1 yr olds and becomes more stable in 2 yr olds. Regional developments of brain wiring efficiency and the evolution of functional hubs suggest differential development trend for primary and higher order cognitive functions during the first two years of life. Simulations of random errors and targeted attacks reveal an age-dependent improvement of resilience. The lower resilience to targeted attack observed in 3 wk old group is likely due to the fact that there are fewer well-established long-distance functional connections at this age whose elimination might have more profound implications in the overall efficiency of information transfer. Overall, our results offer new insights into the temporal and spatial evolution of brain topology during early brain development.	[Gao, Wei; Smith, Jeffery Keith; Shen, Dinggang; Lin, Weili] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27514 USA; [Gao, Wei; Giovanello, Kelly S.; Shen, Dinggang; Zhu, Hongtu; Lin, Weili] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA; [Gilmore, John H.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Giovanello, Kelly S.] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Zhu, Hongtu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gao, W (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27514 USA.	weili_lin@med.unc.edu	Gilmore, John H./AAE-1398-2019; Gao, Wei/F-2777-2013; Shen, Dinggang/ABF-6812-2020; Smith, J Keith/AAD-3968-2021	Gilmore, John H./0000-0002-0939-6764; Shen, Dinggang/0000-0002-7934-5698; Smith, J Keith/0000-0001-7588-3520	National Institutes of Health [MH064065, HD053000, NS055754]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH064065, R01MH070890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from National Institutes of Health, including MH064065, HD053000, and NS055754. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Afif A, 2007, BRAIN STRUCT FUNCT, V212, P335, DOI 10.1007/s00429-007-0161-1; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Benjamini Y, 2001, ANN STAT, V29, P1165; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cepeda NJ, 2001, DEV PSYCHOL, V37, P715, DOI 10.1037/0012-1649.37.5.715; Conel J.L., 1939, POSTNATAL DEV HUMAN; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gao W, 2008, AM J NEURORADIOL; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Goursaud APS, 2007, BEHAV BRAIN RES, V176, P75, DOI 10.1016/j.bbr.2006.09.020; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Grossmann T, 2010, BIOL LETTERS, V6, P540, DOI 10.1098/rsbl.2009.1069; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Haynes RL, 2005, J COMP NEUROL, V484, P156, DOI 10.1002/cne.20453; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hill J, 2010, J NEUROSCI, V30, P2268, DOI 10.1523/JNEUROSCI.4682-09.2010; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; KELLEHER JF, 1990, MED HYPOTHESES, V31, P55, DOI 10.1016/0306-9877(90)90055-J; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; POTEGAL M, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P479; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ross-Sheehy S, 2003, CHILD DEV, V74, P1807, DOI 10.1046/j.1467-8624.2003.00639.x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Streeter GL., 1912, DEV NERVOUS SYSTEM; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	50	158	159	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25278	10.1371/journal.pone.0025278	http://dx.doi.org/10.1371/journal.pone.0025278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966479	gold, Green Submitted, Green Published			2022-12-25	WOS:000295267100039
J	Lavasani, M; Gehrmann, S; Gharaibeh, B; Clark, KA; Kaufmann, RA; Peault, B; Goitz, RJ; Huard, J				Lavasani, Mitra; Gehrmann, Sebastian; Gharaibeh, Burhan; Clark, Katherine A.; Kaufmann, Robert A.; Peault, Bruno; Goitz, Robert J.; Huard, Johnny			Venous Graft-Derived Cells Participate in Peripheral Nerve Regeneration	PLOS ONE			English	Article							AUTOGENOUS VEIN GRAFT; ENDOTHELIAL-CELLS; HISTOPATHOLOGIC FINDINGS; TUNNEL-SYNDROME; EXTREMITY; DEFECTS; CONDUIT; GROWTH	Background: Based on growing evidence that some adult multipotent cells necessary for tissue regeneration reside in the walls of blood vessels and the clinical success of vein wrapping for functional repair of nerve damage, we hypothesized that the repair of nerves via vein wrapping is mediated by cells migrating from the implanted venous grafts into the nerve bundle. Methodology/Principal Findings: To test the hypothesis, severed femoral nerves of rats were grafted with venous grafts from animals of the opposite sex. Nerve regeneration was impaired when decellularized or irradiated venous grafts were used in comparison to untreated grafts, supporting the involvement of venous graft-derived cells in peripheral nerve repair. Donor cells bearing Y chromosomes integrated into the area of the host injured nerve and participated in remyelination and nerve regeneration. The regenerated nerve exhibited proper axonal myelination, and expressed neuronal and glial cell markers. Conclusions/Significance: These novel findings identify the mechanism by which vein wrapping promotes nerve regeneration.	[Lavasani, Mitra; Gharaibeh, Burhan; Peault, Bruno; Huard, Johnny] UPMC, Childrens Hosp Pittsburgh, Stem Cell Res Ctr, Pittsburgh, PA 15261 USA; [Peault, Bruno] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; [Gehrmann, Sebastian; Gharaibeh, Burhan; Kaufmann, Robert A.; Goitz, Robert J.; Huard, Johnny] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Clark, Katherine A.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Ctr Biol Imaging, Pittsburgh, PA 15260 USA; [Lavasani, Mitra; Huard, Johnny] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Huard, Johnny] Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lavasani, M (corresponding author), UPMC, Childrens Hosp Pittsburgh, Stem Cell Res Ctr, Pittsburgh, PA 15261 USA.	mil39@pitt.edu; jhuard@pitt.edu	Gharaibeh, Burhan/A-7696-2017		Henry J. Mankin Endowed Chair for Orthopaedic Research at the University of Pittsburgh; William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh; Hirtzel Foundation; National Institutes of Health [R01AR049684]; Department of Defense [W81XWH-04-1-0003]; Foundation of Hand Research; MRC [G1000816] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049684] Funding Source: NIH RePORTER; Medical Research Council [G1000816] Funding Source: researchfish	Henry J. Mankin Endowed Chair for Orthopaedic Research at the University of Pittsburgh(University of Pittsburgh); William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh; Hirtzel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Foundation of Hand Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funding from the Henry J. Mankin Endowed Chair for Orthopaedic Research at the University of Pittsburgh, the William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh, the Hirtzel Foundation, and by grants awarded to J. Huard from the National Institutes of Health (R01AR049684) and the Department of Defense (W81XWH-04-1-0003), and to R. Goitz from the Foundation of Hand Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel GE, 2006, TISSUE ENG, V12, P2355, DOI 10.1089/ten.2006.12.2355; Battiston B, 2000, MICROSURG, V20, P32, DOI 10.1002/(SICI)1098-2752(2000)20:1<32::AID-MICR6>3.0.CO;2-D; Campbell JT, 1998, FOOT ANKLE INT, V19, P766, DOI 10.1177/107110079801901111; CHIU DTW, 1982, SURGERY, V91, P226; CHIU DTW, 1990, PLAST RECONSTR SURG, V86, P928, DOI 10.1097/00006534-199011000-00015; Chou KH, 2003, J HAND SURG-AM, V28A, P262, DOI 10.1053/jhsu.2003.50029; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; DEGOWIN RL, 1976, RADIAT RES, V68, P244, DOI 10.2307/3574475; Easley ME, 2000, FOOT ANKLE INT, V21, P492, DOI 10.1177/107110070002100608; Fornaro M, 2001, MICROSURG, V21, P153, DOI 10.1002/micr.1029; Geuna S, 2004, NEUROL RES, V26, P139, DOI 10.1179/016164104225013752; GOULD JS, 1991, TREATMENT PAINFUL IN, P1541; Kakinoki R, 2003, INT ORTHOP, V27, P60, DOI 10.1007/s00264-002-0390-0; Koch H, 2003, ANN PLAS SURG, V51, P45, DOI 10.1097/01.SAP.0000054187.72439.57; Kokkalis Zinon T, 2010, J Shoulder Elbow Surg, V19, P91, DOI 10.1016/j.jse.2009.12.019; Levine MH, 2002, J ORAL MAXIL SURG, V60, P729, DOI 10.1053/joms.2002.33237; Masear V.R., 1990, J HAND SURG, V15, P817; Masear VR, 1996, HAND CLIN, V12, P773; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Oberlin E, 2002, DEVELOPMENT, V129, P4147; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033; Schon LC, 2001, CLIN ORTHOP RELAT R, P156; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Sotereanos DG, 1995, MICROSURG, V16, P752, DOI 10.1002/micr.1920161110; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Terzis JK, 1995, INT ANGIOL, V14, P264; Vardakas DG, 2001, J HAND SURG-AM, V26A, P60, DOI 10.1053/jhsu.2001.21536; Varitimidis SE, 2001, J HAND SURG-AM, V26A, P296, DOI 10.1053/jhsu.2001.22528; WERTS ED, 1977, RADIAT RES, V71, P214, DOI 10.2307/3574722; Xu JM, 1998, J RECONSTR MICROSURG, V14, P323, DOI 10.1055/s-2007-1000185; Xu JM, 2000, J HAND SURG-AM, V25A, P93; Zambidis ET, 2006, TRENDS CARDIOVAS MED, V16, P95, DOI 10.1016/j.tcm.2006.01.005; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334	34	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e24801	10.1371/journal.pone.0024801	http://dx.doi.org/10.1371/journal.pone.0024801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966370	Green Published, gold, Green Accepted			2022-12-25	WOS:000295267100010
J	Marques-da-Silva, C; Chaves, MM; Rodrigues, JC; Corte-Real, S; Coutinho-Silva, R; Persechini, PM				Marques-da-Silva, Camila; Chaves, Mariana Martins; Rodrigues, Juliany Cola; Corte-Real, Suzana; Coutinho-Silva, Robson; Persechini, Pedro Muanis			Differential Modulation of ATP-Induced P2X7-Associated Permeabilities to Cations and Anions of Macrophages by Infection with Leishmania amazonensis	PLOS ONE			English	Article							P2X(7) RECEPTOR; TOXOPLASMA-GONDII; TRYPANOSOMA-CRUZI; EXTRACELLULAR ATP; INDUCED APOPTOSIS; DENDRITIC CELLS; INNATE IMMUNITY; PARASITE; INFLAMMATION; AMASTIGOTES	Leishmania and other parasites display several mechanisms to subvert host immune cell function in order to achieve successful infection. The ATP receptor P2X7, an agonist-gated cation channel widely expressed in macrophages and other cells of the immune system, is also coupled to inflammasome activation, IL-1 beta secretion, production of reactive oxygen species, cell death and the induction of the permeabilization of the plasma membrane to molecules of up to 900 Da. P2X7 receptors can function as an effective microbicidal triggering receptor in macrophages infected with several microorganisms including Mycobacteria tuberculosis, Chlamydia and Leishmania. We have previously shown that its expression is up-regulated in macrophages infected with L. amazonensis and that infected cells also display an increase in P2X7-induced apoptosis and membrane permeabilization to some anionic fluorescent dyes. In an independent study we recently showed that the phenomenon of macrophage membrane permeabilization can involve at least two distinct pathways for cations and anions respectively. Here, we re-addressed the effects of ATP-induced P2X7-associated phenomena in macrophages infected with L. amazonensis and demonstrated that the P2X7-associated dye uptake mechanisms are differentially modulated. While the membrane permeabilization for anionic dyes is up-modulated, as previously described, the uptake of cationic dyes is strongly down-modulated. These results unveil new characteristics of two distinct permeabilization mechanisms associated with P2X7 receptors in macrophages and provide the first evidence indicating that these pathways can be differentially modulated in an immunologically relevant situation. The possible importance of these results to the L. amazonensis escape mechanism is discussed.	[Marques-da-Silva, Camila; Chaves, Mariana Martins; Rodrigues, Juliany Cola; Coutinho-Silva, Robson; Persechini, Pedro Muanis] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Corte-Real, Suzana] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Marques-da-Silva, C (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	rcsilva@biof.ufrj.br	Coutinho-Silva, Robson/M-4690-2013; Marques-da-Silva, Camila/B-9284-2014; Fisiologia, Ciencias Biologicas/C-2407-2012; Chaves, Mariana/H-2333-2015; Rodrigues, Juliany Cola Fernandes/X-4977-2019; Chaves, Mariana Martins/F-2663-2014; Rodrigues, Juliany Cola Fernandes/H-2836-2012; Persechini, Pedro/A-9477-2009	Coutinho-Silva, Robson/0000-0002-7318-0204; Rodrigues, Juliany Cola Fernandes/0000-0001-6807-8101; Persechini, Pedro/0000-0002-3278-1951; M Chaves, Mariana/0000-0002-7515-3461; Silva, Camila/0000-0003-1132-1793	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa de Nucleos de Excelencia (PRONEX-CNPq); Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/MCT (INCT-INPeTAm/CNPq/MCT), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Nucleos de Excelencia (PRONEX-CNPq); Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/MCT (INCT-INPeTAm/CNPq/MCT), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(www.cnpq.br), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(www.faperj.br), Programa de Nucleos de Excelencia (PRONEX-CNPq) and Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/MCT (INCT-INPeTAm/CNPq/MCT), Brazil.(http://www.cnpq.br/programas/inct/_apresentacao/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Barcinski MA, 1999, BRAZ J MED BIOL RES, V32, P395, DOI 10.1590/S0100-879X1999000400003; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bhardwaj S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/109189; Bogdan C, 2008, CELL MICROBIOL, V10, P1221, DOI 10.1111/j.1462-5822.2008.01146.x; Bowdish DME, 2007, MICROBES INFECT, V9, P1680, DOI 10.1016/j.micinf.2007.09.002; Burchmore RJS, 2001, INT J PARASITOL, V31, P1311, DOI 10.1016/S0020-7519(01)00259-4; Burnstock G, 2010, ACTA PHYSIOL, V199, P93, DOI 10.1111/j.1748-1716.2010.02114.x; Cankurtaran-Sayar S, 2009, MOL PHARMACOL, V76, P1323, DOI 10.1124/mol.109.059923; Cassol E, 2010, J LEUKOCYTE BIOL, V87, P599, DOI 10.1189/jlb.1009673; Chaves SP, 2009, MICROBES INFECT, V11, P842, DOI 10.1016/j.micinf.2009.05.001; Correa G, 2010, MICROBES INFECT, V12, P497, DOI 10.1016/j.micinf.2010.03.004; Costa HM, 2009, PROSTAG OTH LIPID M, V88, P51, DOI 10.1016/j.prostaglandins.2008.09.004; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Coutinho-Silva R, 1997, AM J PHYSIOL-CELL PH, V273, pC1793, DOI 10.1152/ajpcell.1997.273.6.C1793; Coutinho-Silva R, 1999, AM J PHYSIOL-CELL PH, V276, pC1139, DOI 10.1152/ajpcell.1999.276.5.C1139; Coutinho-Silva R, 2009, PURINERG SIGNAL, V5, P197, DOI 10.1007/s11302-009-9130-x; DARDANONI L., 1956, RIV 1ST SIEROTERAP ITAL, V31, P1; de Souza MC, 2010, ACTA TROP, V115, P262, DOI 10.1016/j.actatropica.2010.04.007; Denkers EY, 2005, TRENDS PARASITOL, V21, P35, DOI 10.1016/j.pt.2004.10.004; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Di Virgilio F, 2007, PURINERG SIGNAL, V3, P1, DOI 10.1007/s11302-006-9048-5; Donovan MJ, 2009, EXP PARASITOL, V123, P58, DOI 10.1016/j.exppara.2009.05.012; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Forero ME, 1999, J MEMBRANE BIOL, V170, P173, DOI 10.1007/s002329900547; Fortea JOY, 2007, IMMUNOL REV, V219, P66, DOI 10.1111/j.1600-065X.2007.00559.x; Fortes FSA, 2004, J CELL SCI, V117, P4717, DOI 10.1242/jcs.01345; Gregory DJ, 2005, PARASITOLOGY, V130, pS27, DOI 10.1017/S0031182005008139; Heussler VT, 2001, INT J PARASITOL, V31, P1166, DOI 10.1016/S0020-7519(01)00271-5; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688; LAMY L, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P964; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; MAUEL J, 1990, J LEUKOCYTE BIOL, V47, P187, DOI 10.1002/jlb.47.2.187; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Monteiro-da-Cruz C, 2006, BRIT J PHARMACOL, V147, P324; NOGUEIRA N, 1976, J EXP MED, V143, P1402, DOI 10.1084/jem.143.6.1402; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2008, DRUG NEWS PERSPECT, V21, P424, DOI 10.1358/dnp.2008.21.8.1265800; Persechini PM, 1998, BRAZ J MED BIOL RES, V31, P25, DOI 10.1590/S0100-879X1998000100004; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Pinheiro CM, 2006, EXP PARASITOL, V114, P16, DOI 10.1016/j.exppara.2006.02.007; POPOVIC M, 1987, LANCET, V2, P916; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; RUSSELL DG, 1992, J CELL SCI, V103, P1193; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Schachter J, 2008, J CELL SCI, V121, P3261, DOI 10.1242/jcs.029991; Sharma U, 2009, INDIAN J EXP BIOL, V47, P412; Sikora A, 1999, J IMMUNOL, V163, P558; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Valdes-Reyes L, 2009, EXP PARASITOL, V121, P199, DOI 10.1016/j.exppara.2008.10.020; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; Wanderley JLM, 2005, BRAZ J MED BIOL RES, V38, P807, DOI 10.1590/S0100-879X2005000600001	64	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25356	10.1371/journal.pone.0025356	http://dx.doi.org/10.1371/journal.pone.0025356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966508	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100048
J	Cao, L; Shao, M; Schilder, J; Guise, T; Mohammad, KS; Matei, D				Cao, L.; Shao, M.; Schilder, J.; Guise, T.; Mohammad, K. S.; Matei, D.			Tissue transglutaminase links TGF-beta, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer	ONCOGENE			English	Article						TG2; TGF-beta; ovarian cancer; cancer stem cells; epithelial to mesenchymal transition; metastasis	GROWTH-FACTOR-BETA; METASTATIC BREAST-CANCER; E-CADHERIN; SANDWICH DOMAIN; GENE-EXPRESSION; UP-REGULATION; KAPPA-B; CARCINOMA; ACTIVATION; PATHWAY	Tissue transglutaminase (TG2), an enzyme involved in cell proliferation, differentiation and apoptosis is over-expressed in ovarian carcinomas, where it modulates epithelial-to-mesenchymal transition (EMT) and promotes metastasis. Its regulation in ovarian cancer (OC) remains unexplored. Here, we show that transforming growth factor (TGF)-beta, a cytokine involved in tumor dissemination is abundantly secreted in the OC microenvironment and induces TG2 expression and enzymatic activity. This is mediated at transcriptional level by SMADs and by TGF-beta-activated kinase 1-mediated activation of the nuclear factor-kappa B complex. TGF-beta-stimulated OC cells aggregate as spheroids, which enable peritoneal dissemination. We show that TGF-beta-induced TG2 regulates EMT, formation of spheroids and OC metastasis. TG2 knock-down in OC cells decreases the number of cells harboring a cancer stem cell phenotype (CD44+ /CD117+). Furthermore, CD44+ /CD117+ cells isolated from human ovarian tumors express high levels of TG2. In summary, TGF-beta-induced TG2 enhances ovarian tumor metastasis by inducing EMT and a cancer stem cell phenotype. Oncogene (2012) 31, 2521-2534; doi:10.1038/onc.2011.429; published online 3 October 2011	[Cao, L.; Shao, M.; Guise, T.; Mohammad, K. S.; Matei, D.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA; [Cao, L.; Matei, D.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Schilder, J.; Matei, D.] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN USA; [Schilder, J.; Guise, T.; Mohammad, K. S.; Matei, D.] Indiana Univ Sch Med, Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA; [Matei, D.] Indiana Univ Sch Med, VA Roudebush Hosp, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Matei, D (corresponding author), Indiana Univ, Dept Med, Simon Canc Ctr, 535 Barnhill Dr,RT 473, Indianapolis, IN 46202 USA.	dmatei@iupui.edu	Mohammad, Khalid/AAE-9569-2022; Mohammad, Khalid/AFE-4205-2022	Matei, Daniela/0000-0003-2169-5035	US Department of Veterans Affairs; American Cancer Society; NATIONAL CANCER INSTITUTE [U01CA143057] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs J Tucholski, H Nakshatri, Y Xu, A Belkin and R Bigsby for reagents and Dr A Belkin for useful discussion. This work was supported by the US Department of Veterans Affairs through a VA Merit Award and by the American Cancer Society through a Research Scholar grant to DM.	Abendstein B, 2000, CYTOKINE, V12, P1115, DOI 10.1006/cyto.1999.0632; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Baldwin RL, 2003, CANCER RES, V63, P1413; Bartlett JM, 1997, EUR J CANCER, V33, P2397, DOI 10.1016/S0959-8049(97)00304-3; Bristow RE, 1999, CANCER, V85, P658, DOI 10.1002/(SICI)1097-0142(19990201)85:3<658::AID-CNCR16>3.0.CO;2-M; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Cardillo MR, 1997, J EXP CLIN CANC RES, V16, P49; Chen T, 2001, CANCER RES, V61, P4679; Chou CY, 2011, J BIOL CHEM, V286, P27825, DOI 10.1074/jbc.M111.226340; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dowdy SC, 2003, J BIOL CHEM, V278, P44377, DOI 10.1074/jbc.M307202200; Dumon N, 2003, J BIOL CHEM, V278, P3275, DOI 10.1074/jbc.M204623200; Gillan L, 2002, CANCER RES, V62, P5358; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; Hocevar BA, 2005, J BIOL CHEM, V280, P25920, DOI 10.1074/jbc.M501150200; Hu W, 2000, ANTICANCER RES, V20, P729; Hurteau JA, 2001, GYNECOL ONCOL, V83, P292, DOI 10.1006/gyno.2001.6376; KOPP A, 1995, CANCER RES, V55, P4512; Lopez-Rovira T, 2000, J BIOL CHEM, V275, P28937, DOI 10.1074/jbc.M909923199; Lynch MA, 1998, CANCER RES, V58, P4227; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Matei D, 2002, ONCOGENE, V21, P6289, DOI 10.1038/sj.onc.1205785; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; Nilsson E, 2001, MOL CELL ENDOCRINOL, V182, P145, DOI 10.1016/S0303-7207(01)00584-6; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; PINCUS JH, 1968, ARCH BIOCHEM BIOPHYS, V126, P44, DOI 10.1016/0003-9861(68)90557-2; Qiao B, 2005, J BIOL CHEM, V280, P17562, DOI 10.1074/jbc.M500646200; Rodriguez GC, 2001, GYNECOL ONCOL, V80, P245, DOI 10.1006/gyno.2000.6042; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Tobin SW, 2002, ONCOGENE, V21, P108, DOI 10.1038/sj.onc.1205026; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wakahara K, 2004, J CELL BIOCHEM, V93, P437, DOI 10.1002/jcb.20160; Yamada SD, 1999, GYNECOL ONCOL, V75, P72, DOI 10.1006/gyno.1999.5535; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	55	148	158	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	20					2521	2534		10.1038/onc.2011.429	http://dx.doi.org/10.1038/onc.2011.429			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	944ID	21963846				2022-12-25	WOS:000304191800003
J	Baarsma, HA; Spanjer, AIR; Haitsma, G; Engelbertink, LHJM; Meurs, H; Jonker, MR; Timens, W; Postma, DS; Kerstjens, HAM; Gosens, R				Baarsma, Hoeke A.; Spanjer, Anita I. R.; Haitsma, Gertruud; Engelbertink, Lilian H. J. M.; Meurs, Herman; Jonker, Marnix R.; Timens, Wim; Postma, Dirkje S.; Kerstjens, Huib A. M.; Gosens, Reinoud			Activation of WNT/beta-Catenin Signaling in Pulmonary Fibroblasts by TGF-beta(1) Is Increased in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AIRWAY SMOOTH-MUSCLE; BETA-CATENIN; GENE-EXPRESSION; TGF-BETA; TRANSCRIPTIONAL ACTIVATION; LUNG FIBROBLASTS; WNT PATHWAY; MOLECULE; VERSICAN	Background: Chronic obstructive pulmonary disease (COPD) is characterized by abnormal extracellular matrix (ECM) turnover. Recently, activation of the WNT/beta-catenin pathway has been associated with abnormal ECM turnover in various chronic diseases. We determined WNT-pathway gene expression in pulmonary fibroblasts of individuals with and without COPD and disentangled the role of beta-catenin in fibroblast phenotype and function. Methods: We assessed the expression of WNT-pathway genes and the functional role of beta-catenin, using MRC-5 human lung fibroblasts and primary pulmonary fibroblasts of individuals with and without COPD. Results: Pulmonary fibroblasts expressed mRNA of genes required for WNT signaling. Stimulation of fibroblasts with TGF-beta(1), a growth factor important in COPD pathogenesis, induced WNT-5B, FZD(8), DVL3 and beta-catenin mRNA expression. The induction of WNT-5B, FZD(6), FZD(8) and DVL3 mRNA by TGF-beta(1) was higher in fibroblasts of individuals with COPD than without COPD, whilst basal expression was similar. Accordingly, TGF-beta(1) activated beta-catenin signaling, as shown by an increase in transcriptionally active and total beta-catenin protein expression. Furthermore, TGF-beta(1) induced the expression of collagen1 alpha 1, alpha-sm-actin and fibronectin, which was attenuated by beta-catenin specific siRNA and by pharmacological inhibition of beta-catenin, whereas the TGF-beta(1)-induced expression of PAI-1 was not affected. The induction of transcriptionally active beta-catenin and subsequent fibronectin deposition induced by TGF-beta(1) were enhanced in pulmonary fibroblasts from individuals with COPD. Conclusions: beta-catenin signaling contributes to ECM production by pulmonary fibroblasts and contributes to myofibroblasts differentiation. WNT/beta-catenin pathway expression and activation by TGF-beta(1) is enhanced in pulmonary fibroblasts from individuals with COPD. This suggests an important role of the WNT/beta-catenin pathway in regulating fibroblast phenotype and function in COPD.	[Baarsma, Hoeke A.; Spanjer, Anita I. R.; Haitsma, Gertruud; Engelbertink, Lilian H. J. M.; Meurs, Herman; Gosens, Reinoud] Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands; [Jonker, Marnix R.; Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Postma, Dirkje S.; Kerstjens, Huib A. M.] Univ Groningen, Dept Pulmonol, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Baarsma, HA (corresponding author), Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands.	H.A.Baarsma@rug.nl	Timens, Wim/K-5570-2013; Kerstjens, Huib/N-4754-2017	Timens, Wim/0000-0002-4146-6363; Kerstjens, Huib/0000-0001-7705-7927; Baarsma, Hoeke/0000-0002-0792-0374; Jonker, Marnix R./0000-0001-6309-871X; Gosens, Reinoud/0000-0002-5595-152X	Netherlands Asthma Foundation [3.2.07.23]; Dutch Organization for Scientific Research (NWO) [916.86.036]	Netherlands Asthma Foundation; Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by the Netherlands Asthma Foundation (Grant 3.2.07.23). Reinoud Gosens is supported by a Veni fellowship from the Dutch Organization for Scientific Research (NWO Veni 916.86.036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Chung K.F., 2001, EUR RESPIR J, V34, P50, DOI DOI 10.1183/09031936.01.00229701; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Doyle JL, 2009, J CELL BIOCHEM, V107, P272, DOI 10.1002/jcb.22123; Gosens R, 2007, AM J PHYSIOL-LUNG C, V293, pL1348, DOI 10.1152/ajplung.00346.2007; Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hallgren O, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-55; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Howe LR, 1999, CANCER RES, V59, P1572; Hwang I, 2009, ARCH PHARM RES, V32, P1653, DOI 10.1007/s12272-009-2200-3; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Kneidinger N, 2011, AM J RESP CRIT CARE, V183, P723, DOI 10.1164/rccm.200910-1560OC; Konigshoff M, 2009, SWISS MED WKLY, V139, P554, DOI smw-12528; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Kotaru C, 2006, AM J RESP CRIT CARE, V173, P1208, DOI 10.1164/rccm.200508-1218OC; Laeremans H, 2010, CARDIOVASC RES, V87, P514, DOI 10.1093/cvr/cvq067; Lam AP, 2011, AM J RESP CELL MOL, V45, P915, DOI 10.1165/rcmb.2010-0113OC; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Letamendia A, 2001, J BONE JOINT SURG AM, V83A, pS31; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Merrilees MJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-41; Minke KS, 2009, EUR J HAEMATOL, V82, P165, DOI 10.1111/j.1600-0609.2008.01188.x; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Noordhoek JA, 2003, EXP LUNG RES, V29, P291, DOI 10.1080/01902140303789; Noordhoek Jacobien A, 2005, COPD, V2, P17; Nunes RO, 2008, AM J PHYSIOL-LUNG C, V294, pL1110, DOI 10.1152/ajplung.00500.2007; Pauwels R A, 2001, Respir Care, V46, P798; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Plantier Laurent, 2007, Int J Chron Obstruct Pulmon Dis, V2, P463; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Read JT, 2007, J BIOL CHEM, V282, P31954, DOI 10.1074/jbc.M702099200; Sato M, 2006, ACTA DERM-VENEREOL, V86, P300, DOI 10.2340/00015555-0101; Schiller M, 2004, J DERMATOL SCI, V35, P83, DOI 10.1016/j.jdermsci.2003.12.006; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Shafer SL, 2009, J MOL CELL CARDIOL, V46, P621, DOI 10.1016/j.yjmcc.2009.01.005; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zandvoort A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-83; Zhang XB, 2001, CANCER RES, V61, P6050	58	113	123	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25450	10.1371/journal.pone.0025450	http://dx.doi.org/10.1371/journal.pone.0025450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980461	Green Published, gold, Green Submitted			2022-12-25	WOS:000295941300032
J	Fox, AA; Pretorius, M; Liu, KY; Collard, CD; Perry, TE; Shernan, SK; De Jager, PL; Hafler, DA; Herman, DS; DePalma, SR; Roden, DM; Muehlschlegel, JD; Donahue, BS; Darbar, D; Seidman, JG; Body, SC; Seidman, CE				Fox, Amanda A.; Pretorius, Mias; Liu, Kuang-Yu; Collard, Charles D.; Perry, Tjorvi E.; Shernan, Stanton K.; De Jager, Philip L.; Hafler, David A.; Herman, Daniel S.; DePalma, Steven R.; Roden, Dan M.; Muehlschlegel, Jochen D.; Donahue, Brian S.; Darbar, Dawood; Seidman, J. G.; Body, Simon C.; Seidman, Christine E.			Genome-Wide Assessment for Genetic Variants Associated with Ventricular Dysfunction after Primary Coronary Artery Bypass Graft Surgery	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; HEART-FAILURE; MORTALITY	Background: Postoperative ventricular dysfunction (VnD) occurs in 9-20% of coronary artery bypass graft (CABG) surgical patients and is associated with increased postoperative morbidity and mortality. Understanding genetic causes of postoperative VnD should enhance patient risk stratification and improve treatment and prevention strategies. We aimed to determine if genetic variants associate with occurrence of in-hospital VnD after CABG surgery. Methods: A genome-wide association study identified single nucleotide polymorphisms (SNPs) associated with postoperative VnD in male subjects of European ancestry undergoing isolated primary CABG surgery with cardiopulmonary bypass. VnD was defined as the need for >= 2 inotropes or mechanical ventricular support after CABG surgery. Validated SNPs were assessed further in two replication CABG cohorts and meta-analysis was performed. Results: Over 100 SNPs were associated with VnD (P<10(-4)), with one SNP (rs17691914) encoded at 3p22.3 reaching genome-wide significance (P-additive (model) = 2.14 x 10(-8)). Meta-analysis of validation and replication study data for 17 SNPs identified three SNPs associated with increased risk for developing postoperative VnD after adjusting for clinical risk factors. These SNPs are located at 3p22.3 (rs17691914, ORadditive model = 2.01, P = 0.0002), 3p14.2 (rs17061085, ORadditive model = 1.70, P = 0.0001) and 11q23.2 (rs12279572, ORrecessive (model) = 2.19, P = 0.001). Conclusions: No SNPs were consistently associated with strong risk (ORadditive model >2.1) of developing in-hospital VnD after CABG surgery. However, three genetic loci identified by meta-analysis were more modestly associated with development of postoperative VnD. Studies of larger cohorts to assess these loci as well as to define other genetic mechanisms and related biology that link genetic variants to postoperative ventricular dysfunction are warranted.	[Fox, Amanda A.; Liu, Kuang-Yu; Shernan, Stanton K.; Muehlschlegel, Jochen D.; Body, Simon C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Pretorius, Mias; Donahue, Brian S.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Collard, Charles D.] St Lukes Episcopal Hosp, Texas Heart Inst, Div Cardiovasc Anesthesia, Houston, TX USA; [Perry, Tjorvi E.] NW Anesthesia PA, Minneapolis, MN USA; [De Jager, Philip L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Herman, Daniel S.; DePalma, Steven R.; Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Herman, Daniel S.; DePalma, Steven R.; Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Partners HealthCare Ctr Genet & Genom, Boston, MA 02115 USA; [Roden, Dan M.; Darbar, Dawood] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Seidman, Christine E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiol, Boston, MA 02115 USA; [Seidman, Christine E.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Vanderbilt University; Saint Lukes Episcopal Hospital; Texas Heart Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Partners Healthcare System; Vanderbilt University; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Fox, AA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.	afox@partners.org	Body, Simon C/O-2605-2013; Roden, Dan/ABD-5412-2021; Body, Simon/AAQ-7572-2020; Muehlschlegel, Danny/A-2993-2011; Perry, Tjorvi E/ABB-2736-2020; Darbar, Dawood/C-9079-2015	Body, Simon C/0000-0001-6721-7050; Body, Simon/0000-0001-6721-7050; Darbar, Dawood/0000-0002-4103-5977; Muehlschlegel, Jochen/0000-0002-6209-7253; DePalma, Steven/0000-0002-0381-5016; Donahue, Brian/0000-0001-9195-7374; Fox, Amanda/0000-0002-7027-5806; Pretorius, Mias/0000-0002-8777-3940	Foundation for Anesthesia, Research and Education, Rochester, Minnesota; American Geriatrics Society, New York, New York; National Inistitutes of Health National Heart, Lung, and Blood Institute, Bethesda, Maryland [K23 HL068774, RO1 098601, U19 HL065962, RO1 HL092217]; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Division of Cardiovascular Anesthesia at the Texas Heart Institute, Saint Luke's Episcopal Hospital, Houston, Texas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092217, U19HL065962, K23HL068774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Foundation for Anesthesia, Research and Education, Rochester, Minnesota; American Geriatrics Society, New York, New York; National Inistitutes of Health National Heart, Lung, and Blood Institute, Bethesda, Maryland; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Division of Cardiovascular Anesthesia at the Texas Heart Institute, Saint Luke's Episcopal Hospital, Houston, Texas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Foundation for Anesthesia, Research and Education, Rochester, Minnesota (Principal Investigator: AF; URL http://www.faer.org/programs/grants/index.html); Dennis W. Jahnigen Career Development Scholars Award, American Geriatrics Society, New York, New York (Principal Investigator: AF; URL http://specialists.americangeriatrics.org/jahnigen/apply/about_dennis.php); the National Inistitutes of Health National Heart, Lung, and Blood Institute, Bethesda, Maryland (K23 HL068774 and RO1 098601 Principal Investigator: SB; U19 HL065962 and RO1 HL092217 Principal Investigator: DD), and Funding from the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts and Division of Cardiovascular Anesthesia at the Texas Heart Institute, Saint Luke's Episcopal Hospital, Houston, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouyel P, 2009, ARTERIOSCL THROM VAS, V29, P774, DOI 10.1161/ATVBAHA.108.181388; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; *CA UOS, 2009, QUANT; Fox AA, 2008, J THORAC CARDIOV SUR, V136, P452, DOI 10.1016/j.jtcvs.2007.12.036; Fox AA, 2010, ANESTHESIOLOGY, V112, P842, DOI 10.1097/ALN.0b013e3181d23168; Fox AA, 2009, ANESTHESIOLOGY, V110, P738, DOI 10.1097/ALN.0b013e31819c7496; Haddad GE, 2008, PHYSIOL GENOMICS, V33, P267, DOI 10.1152/physiolgenomics.00265.2007; Hutfless R, 2004, J AM COLL CARDIOL, V43, P1873, DOI 10.1016/j.jacc.2003.12.048; Jung H, 2008, ONCOGENE, V27, P2635, DOI 10.1038/sj.onc.1210914; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khaper N, 2010, ANTIOXID REDOX SIGN, V13, P1033, DOI 10.1089/ars.2009.2930; Li MY, 2008, EUR J HUM GENET, V16, P635, DOI 10.1038/sj.ejhg.5202007; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Medeiros-Domingo A, 2007, CIRCULATION, V116, P134, DOI 10.1161/CIRCULATIONAHA.106.659086; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Morrison AC, 2010, CIRC-CARDIOVASC GENE, V3, P248, DOI 10.1161/CIRCGENETICS.109.895995; Nieminen MS, 2008, EUR J HEART FAIL, V10, P140, DOI 10.1016/j.ejheart.2007.12.012; Ohki-Kaneda R, 2004, BIOCHEM BIOPH RES CO, V320, P1328, DOI 10.1016/j.bbrc.2004.06.090; Okumura H, 2009, CANCER SCI, V100, P1145, DOI 10.1111/j.1349-7006.2009.01168.x; Provenchere S, 2006, CRIT CARE MED, V34, P995, DOI 10.1097/01.CCM.0000206110.94385.C4; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rao V, 1996, J THORAC CARDIOV SUR, V112, P38, DOI 10.1016/S0022-5223(96)70176-9; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Watanabe H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P268, DOI 10.1161/CIRCEP.108.779181	24	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24593	10.1371/journal.pone.0024593	http://dx.doi.org/10.1371/journal.pone.0024593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980348	Green Published, gold, Green Submitted			2022-12-25	WOS:000295941300006
J	Schutz, SV; Schrader, AJ; Zengerling, F; Genze, F; Cronauer, MV; Schrader, M				Schuetz, Stefanie V.; Schrader, Andres J.; Zengerling, Friedemann; Genze, Felicitas; Cronauer, Marcus V.; Schrader, Mark			Inhibition of Glycogen Synthase Kinase-3 beta Counteracts Ligand-Independent Activity of the Androgen Receptor in Castration Resistant Prostate Cancer	PLOS ONE			English	Article							NUCLEAR EXPORT; GLUCOCORTICOID-RECEPTOR; GROWTH-INHIBITION; BINDING DOMAIN; LNCAP CELLS; ACTIVATION; PROTEIN; PROGRESSION; EXPRESSION; APOPTOSIS	In order to generate genomic signals, the androgen receptor (AR) has to be transported into the nucleus upon androgenic stimuli. However, there is evidence from in vitro experiments that in castration-resistant prostate cancer (CRPC) cells the AR is able to translocate into the nucleus in a ligand-independent manner. The recent finding that inhibition of the glycogen-synthase-kinase 3 beta (GSK-3 beta) induces a rapid nuclear export of the AR in androgen stimulated prostate cancer cells prompted us to analyze the effects of a GSK-3 beta inhibition in the castration-resistant LNCaP sublines C4-2 and LNCaP-SSR. Both cell lines exhibit high levels of nuclear AR in the absence of androgenic stimuli. Exposure of these cells to the maleimide SB216763, a potent GSK-3 beta inhibitor, resulted in a rapid nuclear export of the AR even under androgen-deprived conditions. Moreover, the ability of C4-2 and LNCaP-SSR cells to grow in the absence of androgens was diminished after pharmacological inhibition of GSK-3 beta in vitro. The ability of SB216763 to modulate AR signalling and function in CRPC in vivo was additionally demonstrated in a modified chick chorioallantoic membrane xenograft assay after systemic delivery of SB216763. Our data suggest that inhibition of GSK-3 beta helps target the AR for export from the nucleus thereby diminishing the effects of mislocated AR in CRPC cells. Therefore inhibition of GSK-3 beta could be an interesting new strategy for the treatment of CRPC.	[Schuetz, Stefanie V.; Schrader, Andres J.; Zengerling, Friedemann; Genze, Felicitas; Cronauer, Marcus V.; Schrader, Mark] Univ Ulm, Dept Urol, Ulm, Germany	Ulm University	Schutz, SV (corresponding author), Univ Ulm, Dept Urol, Ulm, Germany.	marcus.cronauer@uni-ulm.de	Cronauer, Marcus/AAG-7457-2021		Action Lions Vaincre le Cancer, Luxembourg	Action Lions Vaincre le Cancer, Luxembourg	Funding was provided by the Action Lions Vaincre le Cancer, Luxembourg (to MVC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Black BE, 2001, CURR BIOL, V11, P1749, DOI 10.1016/S0960-9822(01)00537-1; Chang CY, 2001, CANCER RES, V61, P8712; Chen MW, 2002, ONCOGENE, V21, P7861, DOI 10.1038/sj.onc.1205991; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Cronauer MV, 2007, ONCOGENE, V26, P1875, DOI 10.1038/sj.onc.1209984; Dehm SM, 2006, J BIOL CHEM, V281, P27882, DOI 10.1074/jbc.M605002200; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P2892; Hobisch A, 1996, PROSTATE, V28, P129; HOBISCH A, 1995, CANCER RES, V55, P3068; JENSTER G, 1992, J STEROID BIOCHEM, V41, P671, DOI 10.1016/0960-0760(92)90402-5; JIN F, 2009, NUCLEIC ACIDS RES, V37; Jones JO, 2008, ACS CHEM BIOL, V3, P412, DOI 10.1021/cb800054w; Koivisto P, 1997, CANCER RES, V57, P314; Kuefer R, 2004, BRIT J CANCER, V90, P535, DOI 10.1038/sj.bjc.6601510; Kumar AS, 2004, ONCOGENE, V23, P3454, DOI 10.1038/sj.onc.1207473; Kunzi-Rapp K, 2001, J UROLOGY, V166, P1502, DOI 10.1016/S0022-5347(05)65820-X; Li R, 2009, ANTICANCER RES, V29, P2077; Liao XB, 2004, ENDOCRINOLOGY, V145, P2941, DOI 10.1210/en.2003-1519; Liao XB, 2003, MOL CANCER THER, V2, P1215; Liu S, 2008, ONCOGENE, V27, P499, DOI 10.1038/sj.onc.1210671; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Mazor M, 2004, ONCOGENE, V23, P7882, DOI 10.1038/sj.onc.1208068; Molina A, 2011, J UROLOGY, V185, P787, DOI 10.1016/j.juro.2010.10.042; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nguyen MM, 2009, MOL CELL ENDOCRINOL, V302, P65, DOI 10.1016/j.mce.2008.12.010; Nienhaus GU, 2006, PHOTOCHEM PHOTOBIOL, V82, P351, DOI 10.1562/2005-05-19-RA-533; Poukka H, 2000, J CELL SCI, V113, P2991; Rinnab L, 2008, NEOPLASIA, V10, P624, DOI 10.1593/neo.08248; Sadar MD, 2008, ORG LETT, V10, P4947, DOI 10.1021/ol802021w; Salas TR, 2004, J BIOL CHEM, V279, P19191, DOI 10.1074/jbc.M309560200; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; Saporita AJ, 2007, PROSTATE, V67, P509, DOI 10.1002/pros.20541; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Schutz SV, 2010, J CELL BIOCHEM, V109, P1192, DOI 10.1002/jcb.22500; Shank LC, 2008, J BIOL CHEM, V283, P10568, DOI 10.1074/jbc.M800810200; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; THALMANN GN, 1994, CANCER RES, V54, P2577; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	47	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25341	10.1371/journal.pone.0025341	http://dx.doi.org/10.1371/journal.pone.0025341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980429	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600020
J	Schofer, MD; Roessler, PP; Schaefer, J; Theisen, C; Schlimme, S; Heverhagen, JT; Voelker, M; Dersch, R; Agarwal, S; Fuchs-Winkelmann, S; Paletta, JRJ				Schofer, Markus D.; Roessler, Philip P.; Schaefer, Jan; Theisen, Christina; Schlimme, Sonja; Heverhagen, Johannes T.; Voelker, Maximilian; Dersch, Roland; Agarwal, Seema; Fuchs-Winkelmann, Susanne; Paletta, Juergen R. J.			Electrospun PLLA Nanofiber Scaffolds and Their Use in Combination with BMP-2 for Reconstruction of Bone Defects	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SIZE CALVARIAL DEFECT; OSTEOGENIC DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; HYBRID SCAFFOLD; DUAL DELIVERY; STROMAL CELLS; GROWTH-FACTOR; ECTOPIC BONE; GENE-THERAPY	Introduction: Adequate migration and differentiation of mesenchymal stem cells is essential for regeneration of large bone defects. To achieve this, modern graft materials are becoming increasingly important. Among them, electrospun nanofiber scaffolds are a promising approach, because of their high physical porosity and potential to mimic the extracellular matrix (ECM). Materials and Methods: The objective of the present study was to examine the impact of electrospun PLLA nanofiber scaffolds on bone formation in vivo, using a critical size rat calvarial defect model. In addition we analyzed whether direct incorporation of bone morphogenetic protein 2 (BMP-2) into nanofibers could enhance the osteoinductivity of the scaffolds. Two critical size calvarial defects (5 mm) were created in the parietal bones of adult male Sprague-Dawley rats. Defects were either (1) left unfilled, or treated with (2) bovine spongiosa, (3) PLLA scaffolds alone or (4) PLLA/BMP-2 scaffolds. Cranial CT-scans were taken at fixed intervals in vivo. Specimens obtained after euthanasia were processed for histology, histomorphometry and immunostaining (Osteocalcin, BMP-2 and Smad5). Results: PLLA scaffolds were well colonized with cells after implantation, but only showed marginal ossification. PLLA/BMP-2 scaffolds showed much better bone regeneration and several ossification foci were observed throughout the defect. PLLA/BMP-2 scaffolds also stimulated significantly faster bone regeneration during the first eight weeks compared to bovine spongiosa. However, no significant differences between these two scaffolds could be observed after twelve weeks. Expression of osteogenic marker proteins in PLLA/BMP-2 scaffolds continuously increased throughout the observation period. After twelve weeks osteocalcin, BMP-2 and Smad5 were all significantly higher in the PLLA/BMP-2 group than in all other groups. Conclusion: Electrospun PLLA nanofibers facilitate colonization of bone defects, while their use in combination with BMP-2 also increases bone regeneration in vivo and thus combines osteoconductivity of the scaffold with the ability to maintain an adequate osteogenic stimulus.	[Schofer, Markus D.; Roessler, Philip P.; Schaefer, Jan; Theisen, Christina; Schlimme, Sonja; Fuchs-Winkelmann, Susanne; Paletta, Juergen R. J.] Univ Hosp Marburg, Dept Orthoped & Rheumatol, Marburg, Germany; [Heverhagen, Johannes T.; Voelker, Maximilian] Univ Hosp Marburg, Dept Diagnost Radiol, Marburg, Germany; [Dersch, Roland; Agarwal, Seema] Univ Marburg, Dept Macromol Chem, Marburg, Germany	University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg; Philipps University Marburg	Schofer, MD (corresponding author), Univ Hosp Marburg, Dept Orthoped & Rheumatol, Marburg, Germany.	paletta@med.uni-marburg.de	Agarwal, Seema/O-3307-2014; Roessler, Philip P./H-4342-2013	Agarwal, Seema/0000-0002-3174-3152; Roessler, Philip P./0000-0002-1574-0111; Heverhagen, Johannes/0000-0002-5416-6650; Volker, Maximilian/0000-0002-8792-4462	Deutsche Forschungsgemeinschaft DFG [BO 3065/1-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft DFG (Grant No. BO 3065/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014; Akita S, 2004, WOUND REPAIR REGEN, V12, P252, DOI 10.1111/j.1067-1927.2004.012118.x; Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; Ashammakhi N, 2009, J BIOMED NANOTECHNOL, V5, P1, DOI 10.1166/jbn.2009.1003; Blum JS, 2003, HUM GENE THER, V14, P1689, DOI 10.1089/104303403322611719; Boyne PJ, 1996, BONE, V19, pS83, DOI 10.1016/S8756-3282(96)00144-5; Chen VJ, 2006, BIOMATERIALS, V27, P3708, DOI 10.1016/j.biomaterials.2006.02.020; Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004; Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029; Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020; DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307; Dersch R, 2003, J POLYM SCI POL CHEM, V41, P545, DOI 10.1002/pola.10609; DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8; Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.0.CO;2-U; Formhals A., 1934, U.S. Patent, Patent No. [1975504, 1,975,504]; Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648; Giavaresi G, 2004, BIOMED PHARMACOTHER, V58, P411, DOI 10.1016/j.biopha.2004.08.001; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Greiner A., 2007, ANGEW CHEM, V119, P5770, DOI DOI 10.1002/ANGE.200604646; Gysin R, 2002, GENE THER, V9, P991, DOI 10.1038/sj.gt.3301772; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383; Hosseinkhani H, 2006, BIOMED MATER, V1, P8, DOI 10.1088/1748-6041/1/1/002; Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018; Hosseinkhani H, 2007, TISSUE ENG, V13, P11, DOI 10.1089/ten.2006.0120; Hosseinkhani H, 2006, BIOMATERIALS, V27, P5089, DOI 10.1016/j.biomaterials.2006.05.050; Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030; Inoda H, 2007, INT J ORAL MAX SURG, V36, P39, DOI 10.1016/j.ijom.2006.07.011; Jager M, 2008, J ORTHOP RES, V26, P1440, DOI 10.1002/jor.20565; Jun Z, 2003, E-POLYMERS; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260; Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x; Lane JM, 1999, CLIN ORTHOP RELAT R, pS107; Levengood SKL, 2010, ACTA BIOMATER, V6, P3283, DOI 10.1016/j.actbio.2010.02.026; Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005; Meijer GJ, 2007, PLOS MED, V4, P260, DOI 10.1371/journal.pmed.0040009; Nie H, 2008, BIOTECHNOL BIOENG, V99, P223, DOI 10.1002/bit.21517; Paletta J R J, 2011, Eur Cell Mater, V21, P384; Paletta JRJ, 2009, THESCIENTIFICWORLDJO, V9, P1382, DOI 10.1100/tsw.2009.149; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047; Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611; Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009; Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168; Schofer MD, 2008, THESCIENTIFICWORLDJO, V8, P1269, DOI 10.1100/tsw.2008.163; Schofer MD, 2009, THESCIENTIFICWORLDJO, V9, P118, DOI 10.1100/tsw.2009.13; SCHOFER MD, 2008, J MAT SCI MAT MED; Seeherman HJ, 2006, J BONE JOINT SURG AM, V88A, P1553, DOI 10.2106/JBJS.E.01006; SRINIVASAN G, 1995, POLYM INT, V36, P195, DOI 10.1002/pi.1995.210360210; Srouji S, 2008, J MATER SCI-MATER M, V19, P1249, DOI 10.1007/s10856-007-3218-z; Suzuki A, 2008, EUR POLYM J, V44, P2499, DOI 10.1016/j.eurpolymj.2008.05.021; Theisen C, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-9; Tian F, 2008, J BIOMED MATER RES A, V84A, P291, DOI 10.1002/jbm.a.31304; Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2; Waris E, 2004, J HAND SURG-BRIT EUR, V29B, P590, DOI 10.1016/j.jhsb.2004.02.005; Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013; Woo KM, 2009, TISSUE ENG PT A, V15, P2155, DOI 10.1089/ten.tea.2008.0433; Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510; Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z; Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656; Zhang R, 2002, PROCESSING POLYM SCA, P715; Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L; Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x	64	116	120	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25462	10.1371/journal.pone.0025462	http://dx.doi.org/10.1371/journal.pone.0025462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980467	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900068
J	Stolc, V; Shmygelska, A; Griko, Y				Stolc, Viktor; Shmygelska, Alena; Griko, Yuri			Adaptation of Organisms by Resonance of RNA Transcription with the Cellular Redox Cycle	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; DNA-DAMAGE; METABOLIC CYCLE; YEAST-CELLS; CODON USAGE; MECHANISM; ORIGIN; PHASE; STATE	Sequence variation in organisms differs across the genome and the majority of mutations are caused by oxidation, yet its origin is not fully understood. It has also been shown that the reduction-oxidation reaction cycle is the fundamental biochemical cycle that coordinates the timing of all biochemical processes in the cell, including energy production, DNA replication, and RNA transcription. We show that the temporal resonance of transcriptome biosynthesis with the oscillating binary state of the reduction-oxidation reaction cycle serves as a basis for non-random sequence variation at specific genome-wide coordinates that change faster than by accumulation of chance mutations. This work demonstrates evidence for a universal, persistent and iterative feedback mechanism between the environment and heredity, whereby acquired variation between cell divisions can outweigh inherited variation.	[Stolc, Viktor; Griko, Yuri] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Shmygelska, Alena] Carnegie Mellon Univ, Moffett Field, CA USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Carnegie Mellon University	Stolc, V (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	vstolc@mail.arc.nasa.gov			NASA [NNX08BA52A]	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by the NASA Human Research Program, and NASA contract to the Carnegie Mellon University Silicon Valley #NNX08BA52A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Boole R. G., 1848, CAMBRIDGE DUBLIN MAT, V3, P183; Bridges BA, 1997, NATURE, V387, P557, DOI 10.1038/42370; Burkhardt RW, 1984, ZOOLOGICAL PHILOS JB; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Chambers JM, GRAPHICAL METHODS DA; CHARLESWORTH D, 1988, NATURE, V336, P525, DOI 10.1038/336525a0; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; DAVIS BD, 1989, P NATL ACAD SCI USA, V86, P5005, DOI 10.1073/pnas.86.13.5005; Degtyareva NP, 2008, MOL CELL BIOL, V28, P5432, DOI 10.1128/MCB.00307-08; Demasi APD, 2006, FEBS J, V273, P805, DOI 10.1111/j.1742-4658.2006.05116.x; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Eghbal MA, 2004, TOXICOLOGY, V203, P69, DOI 10.1016/j.tox.2004.05.020; Eide L, 1996, P NATL ACAD SCI USA, V93, P10735, DOI 10.1073/pnas.93.20.10735; Eldredge N., 1972, P82; Evans DJ, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.051105; Evert BA, 2004, J BIOL CHEM, V279, P22585, DOI 10.1074/jbc.M400468200; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fedorov A, 2002, P NATL ACAD SCI USA, V99, P16128, DOI 10.1073/pnas.242624899; Fehrenbach E, 2001, EXERC IMMUNOL REV, V7, P66; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Georgiou G, 2002, CELL, V111, P607, DOI 10.1016/S0092-8674(02)01165-0; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; Iraqui I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000524; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; KOROGODIN VI, 1991, YEAST, V7, P105, DOI 10.1002/yea.320070204; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; Kwak WJ, 2003, FEMS MICROBIOL LETT, V219, P99, DOI 10.1016/S0378-1097(02)01198-9; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Li CM, 2006, P NATL ACAD SCI USA, V103, P16254, DOI 10.1073/pnas.0604860103; Lloyd D, 2007, BIOESSAYS, V29, P465, DOI 10.1002/bies.20575; Lloyd D, 2006, FEBS LETT, V580, P2830, DOI 10.1016/j.febslet.2006.02.066; Mayr E, 1979, ORIGIN SPECIES FACSI, p[11, 43, 134, 135, 136, 137, 447, 454, 455, 472, 479, 480]; Mendel JG., 1865, VERHANDLUNGEN NATURF, V4, P3, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A106151; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ragu S, 2007, P NATL ACAD SCI USA, V104, P9747, DOI 10.1073/pnas.0703192104; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Samanta MP, 2006, P NATL ACAD SCI USA, V103, P4192, DOI 10.1073/pnas.0507669103; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Selpi, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-451; *SGD PROJ, SACCH GEN DAT; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Silverman SJ, 2010, P NATL ACAD SCI USA, V107, P6946, DOI 10.1073/pnas.1002422107; Thatcher JW, 1998, P NATL ACAD SCI USA, V95, P253, DOI 10.1073/pnas.95.1.253; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Trefil J, 2009, AM SCI, V97, P206, DOI 10.1511/2009.78.206; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2009, P NATL ACAD SCI USA, V106, P14293, DOI 10.1073/pnas.0907786106; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Ward P., 2006, OUT THIN AIR DINOSAU; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wright BE, 2000, J BACTERIOL, V182, P2993, DOI 10.1128/JB.182.11.2993-3001.2000	60	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25270	10.1371/journal.pone.0025270	http://dx.doi.org/10.1371/journal.pone.0025270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980411	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900044
J	Song, LB; Lin, CY; Wu, ZQ; Gong, H; Zeng, Y; Wu, JH; Li, MF; Li, J				Song, Libing; Lin, Chuyong; Wu, Zhiqiang; Gong, Hui; Zeng, Yong; Wu, Jueheng; Li, Mengfeng; Li, Jun			miR-18a Impairs DNA Damage Response through Downregulation of Ataxia Telangiectasia Mutated (ATM) Kinase	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; MICRORNA EXPRESSION; GENE; MUTATIONS; PROTEIN; REPAIR; CELLS; METHYLATION; CHECKPOINTS	The DNA damage response (DDR) encompasses multi-step processes by which cells evolve to sense DNA damage, transduce the signal and initiate the repair of damaged DNA. Ataxia Telangiectasia Mutated (ATM) Kinase, which functions as the primary sensor and transducer of DNA damage signal, has been demonstrated to play an important role in the DDR and cancer prevention. Hence, understanding the molecular mechanisms underlying the regulation of ATM has received much attention. Here, we found that miR-18a was upregulated in both cell lines and patients' tissue samples of breast cancer. Furthermore, we demonstrated that ectopically expressing miR-18a downregulated ATM expression by directly targeting the ATM-39-UTR and abrogated the IR-induced cell cycle arrest. Similar to the effect of ATM siRNA, overexpressing miR-18a in breast cancer cells reduced the DNA damage repair ability and the efficiency of homologous recombination-based DNA repair (HRR) and sensitized cells to c-irradiation (IR) treatment. However, inhibition of miR-18a led to augmentation of DNA damage repair, increase of HRR efficiency and reduced cellular radiosensitivity. Moreover, we showed that the phorsphorylation level and nuclear foci formation of H2AX and 53BP1, the downstream substrates of ATM kinase, were significantly deceased in miR-18a overexpressing cells. Taken together, our results uncover a new regulatory mechanism of ATM expression and suggest that miR-18a might be a novel therapeutic target.	[Song, Libing; Zeng, Yong] Sun Yat Sen Univ, State Key Lab Oncol So China, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Chuyong; Wu, Zhiqiang; Gong, Hui; Li, Jun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Jueheng; Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Song, LB (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol So China, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	junli99@gmail.com	Lin, Chuyong/AAA-9931-2020; meng, li/GVT-2063-2022; Song, LB/AAL-1968-2020	Lin, Chuyong/0000-0003-4887-5386; 	Natural Science Foundation of China [81030048, 30870963, 30831160517, 81071647, 81071762, 30872930, 81071780]; Program for New Century Excellent Talents in Universities [NCET-07-0877]; Science and Technology Department of Guangdong Province, China [8251008901000006, 2008A030201006]; Ministry of Education of China [(2008)890, 200805580047, 20100171110080]; Fundamental Research Funds for the Central Universities [10ykzd03]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Science and Technology Department of Guangdong Province, China; Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was funded by The Natural Science Foundation of China (No. 81030048, 30870963, 30831160517, 81071647, 81071762, 30872930, 81071780); Program for New Century Excellent Talents in Universities (No. NCET-07-0877); The Science and Technology Department of Guangdong Province, China (No. 8251008901000006, 2008A030201006); Ministry of Education of China (No.(2008)890, No. 200805580047 and No. 20100171110080); The Fundamental Research Funds for the Central Universities (No. 10ykzd03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Al-Nakhle H, 2010, CANCER RES, V70, P4778, DOI 10.1158/0008-5472.CAN-09-4104; Appleby JM, 1997, BRIT J CANCER, V76, P1546, DOI 10.1038/bjc.1997.593; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Boultwood J, 2001, J CLIN PATHOL, V54, P512, DOI 10.1136/jcp.54.7.512; Bullrich F, 1999, CANCER RES, V59, P24; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gonzalez MB, 2004, HAEMATOLOGICA, V89, P1213; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ji M, 2011, AM J PATHOL; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim K, 2011, ONCOGENE; Kim WJ, 2002, ONCOGENE, V21, P3864, DOI 10.1038/sj.onc.1205485; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lawrie CH, 2007, EXPERT OPIN BIOL TH, V7, P1363, DOI 10.1517/14712598.7.9.1363; Lees-Miller SP, 2003, BIOCHIMIE, V85, P1161, DOI 10.1016/j.biochi.2003.10.011; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Mavrou A, 2008, ANTICANCER RES, V28, P401; Mills KD, 2004, GENE DEV, V18, P1283, DOI 10.1101/gad.1204304; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Ota A, 2004, IDENTIFICATION CHARA; Patry C, 2003, CANCER RES, V63, P7679; Roy K, 2006, BIOCHEM BIOPH RES CO, V344, P821, DOI 10.1016/j.bbrc.2006.03.222; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Taghian DG, 1997, MOL CELL BIOL, V17, P6386, DOI 10.1128/MCB.17.11.6386; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vorechovsky I, 1997, NAT GENET, V17, P96, DOI 10.1038/ng0997-96; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; WEINERT T, 1993, SEMIN CANCER BIOL, V4, P129; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Yu GZ, 2004, PANCREAS, V28, P421, DOI 10.1097/00006676-200405000-00011; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	49	101	109	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25454	10.1371/journal.pone.0025454	http://dx.doi.org/10.1371/journal.pone.0025454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980462	gold, Green Published, Green Submitted			2022-12-25	WOS:000295933700036
J	Tadavarty, R; Rajput, PS; Wong, JM; Kumar, U; Sastry, BR				Tadavarty, Ramakrishna; Rajput, Padmesh S.; Wong, Jennifer M.; Kumar, Ujendra; Sastry, Bhagavatula R.			Sleep-Deprivation Induces Changes in GABA(B) and mGlu Receptor Expression and Has Consequences for Synaptic Long-Term Depression	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; HIPPOCAMPAL CA1 NEURONS; RAT HIPPOCAMPUS; INCREASED SUSCEPTIBILITY; SOMATOSTATIN RECEPTORS; PYRAMIDAL NEURONS; OPIOID RECEPTORS; MEMORY; INDUCTION; POTENTIATION	Long term depression (LTD) in the CA1 region of the hippocampus, induced with a 20-Hz, 30 s tetanus to Schaffer collaterals, is enhanced in sleep-deprived (SD) rats. In the present study, we investigated the role of metabotropic glutamate receptors (mGluRs), gamma-Aminobutyric acid (GABA) B receptors (GABA(B)-Rs) and N-methyl-D-aspartic acid receptors (NMDARs) in the LTD of the population excitatory postsynaptic potential (pEPSP). The requirement of Ca2+ from L-and T-type voltage-gated calcium channels (VGCCs) and intracellular stores was also studied. Results indicate that mGluRs, a release of Ca2+ from intracellular stores and GABAB-Rs are required for LTD. Interestingly, while mGlu1Rs seem to be involved in both short-term depression and LTD, mGlu5Rs appear to participate mostly in LTD. CGP 55845, a GABA(B)-R antagonist, partially suppressed LTD in normally sleeping (NS) rats, while completely blocking LTD in SD rats. Moreover, GS-39783, a positive allosteric modulator for GABA(B)-R, suppressed the pEPSP in SD, but not NS rats. Since both mGluRs and GABA(B)-Rs seem to be involved in the LTD, especially in SD rats, we examined if the receptor expression pattern and/or dimerization changed, using immunohistochemical, co-localization and co-immunoprecipitation techniques. Sleep-deprivation induced an increase in the expression of GABA(B)-R1 and mGlu1 alpha R in the CA1 region of the hippocampus. In addition, co-localization and heterodimerization between mGlu1aR/GABA(B)-R1 and mGlu1aR/GABA(B)-R2 is enhanced in SD rats. Taken together, our findings present a novel form of LTD sensitive to the activation of mGluRs and GABA(B)-Rs, and reveal, for the first time, that sleep-deprivation induces alterations in the expression and dimerization of these receptors.	[Tadavarty, Ramakrishna; Wong, Jennifer M.; Sastry, Bhagavatula R.] Univ British Columbia, Fac Med, Dept Anesthesiol Pharmacol & Therapeut, Neurosci Res Lab, Vancouver, BC, Canada; [Rajput, Padmesh S.; Kumar, Ujendra] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Tadavarty, R (corresponding author), Univ British Columbia, Fac Med, Dept Anesthesiol Pharmacol & Therapeut, Neurosci Res Lab, Vancouver, BC, Canada.	sastry@interchange.ubc.ca			Canadian Institutes of Health Research [TGS-109219, MOP-10268]; Dept. of Anesthesiology, Pharmacology and Therapeutics at The University of British Columbia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Dept. of Anesthesiology, Pharmacology and Therapeutics at The University of British Columbia	This work was supported by a Canadian Institutes of Health Research Grant (TGS-109219) to Dr. Sastry and Canadian Institutes of Health Research Grant (MOP-10268) to Dr. Kumar. Dr. Tadavarty was supported by the Dept. of Anesthesiology, Pharmacology and Therapeutics at The University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Billinton A, 2001, TRENDS NEUROSCI, V24, P277, DOI 10.1016/S0166-2236(00)01815-4; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Campbell IG, 2002, J NEUROPHYSIOL, V88, P1073, DOI 10.1152/jn.2002.88.2.1073; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Congar P, 1997, J NEUROSCI, V17, P5366; Cozzi A, 2002, NEUROPHARMACOLOGY, V43, P119, DOI 10.1016/S0028-3908(02)00080-1; Davis CJ, 2003, BRAIN RES, V973, P293, DOI 10.1016/S0006-8993(03)02508-3; DAYAN P, 1991, BIOL CYBERN, V65, P253, DOI 10.1007/BF00206223; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Fagni L, 2004, SEMIN CELL DEV BIOL, V15, P289, DOI 10.1016/j.semcdb.2003.12.018; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Gama L, 2001, J BIOL CHEM, V276, P39053, DOI 10.1074/jbc.M105662200; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Grant M, 2004, J BIOL CHEM, V279, P38636, DOI 10.1074/jbc.M406276200; GUERINEAU NC, 1994, J PHYSIOL-LONDON, V474, P27, DOI 10.1113/jphysiol.1994.sp019999; Hanson JE, 1999, J NEUROSCI, V19, P6488; Hirono M, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn764; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kornau HC, 2006, CELL TISSUE RES, V326, P517, DOI 10.1007/s00441-006-0264-7; Kulik A, 2003, J NEUROSCI, V23, P11026; Kumar A, 2005, BRAIN RES, V1031, P125, DOI 10.1016/j.brainres.2004.10.023; Kumar U, 2010, RESULTS PROBL CELL D, V50, P137, DOI 10.1007/400_2009_29; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Manahan-Vaughan D, 2000, CEREB CORTEX, V10, P482, DOI 10.1093/cercor/10.5.482; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McDermott CM, 2003, J NEUROSCI, V23, P9687; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MILES R, 1987, NATURE, V329, P724, DOI 10.1038/329724a0; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; MORISHITA W, 1993, NEUROREPORT, V4, P719, DOI 10.1097/00001756-199306000-00030; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Norris CM, 1996, J NEUROSCI, V16, P5382; PITLER TA, 1992, J NEUROSCI, V12, P4122; Rajput PS, 2009, NEUROSCI RES, V65, P53, DOI 10.1016/j.neures.2009.05.005; Rajput PS, 2009, J CHEM NEUROANAT, V38, P20, DOI 10.1016/j.jchemneu.2009.05.004; Ray K, 2000, J BIOL CHEM, V275, P34245, DOI 10.1074/jbc.M005581200; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; SASTRY BR, 1984, LIFE SCI, V34, P1075, DOI 10.1016/0024-3205(84)90021-3; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; SOLIS JM, 1992, J NEUROSCI, V12, P3466; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; STELZER A, 1992, INT REV NEUROBIOL, V33, P195, DOI 10.1016/S0074-7742(08)60693-5; STERN WC, 1971, PHYSIOL BEHAV, V7, P345, DOI 10.1016/0031-9384(71)90312-X; Stickgold R, 2005, TRENDS NEUROSCI, V28, P408, DOI 10.1016/j.tins.2005.06.004; Sullivan R, 2000, J PHARMACOL EXP THER, V293, P460; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; Tabata T, 2004, P NATL ACAD SCI USA, V101, P16952, DOI 10.1073/pnas.0405387101; Tadavarty R, 2009, EXP NEUROL, V216, P239, DOI 10.1016/j.expneurol.2008.11.012; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Urwyler S, 2003, J PHARMACOL EXP THER, V307, P322, DOI 10.1124/jpet.103.053074; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xie Z, 1995, CAN J PHYSIOL PHARM, V73, P1706, DOI 10.1139/y95-734	68	34	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24933	10.1371/journal.pone.0024933	http://dx.doi.org/10.1371/journal.pone.0024933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980366	Green Submitted, gold, Green Published			2022-12-25	WOS:000295933700011
J	Piwosz, K; Pernthaler, J				Piwosz, Kasia; Pernthaler, Jakob			Enrichment of Omnivorous Cercozoan Nanoflagellates from Coastal Baltic Sea Waters	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; MICROBIAL FOOD-WEB; INTRAGUILD PREDATION; BACTERIA; COMMUNITIES; POPULATION; BACTERIOPLANKTON; MICROFLAGELLATE; PHYTOPLANKTON; COMPETITORS	Free-living nano-sized flagellates are important bacterivores in aquatic habitats. However, some slightly larger forms can also be omnivorous, i.e., forage upon both bacterial and eukaryotic resources. This hitherto largely ignored feeding mode may have pronounced implications for the interpretation of experiments about protistan bacterivory. We followed the response of an uncultured group of omnivorous cercozoan nanoflagellates from the Novel Clade 2 (Cerc_BAL02) to experimental food web manipulation in samples from the Gulf of Gdansk (Southern Baltic Sea). Seawater was either prefiltered through 5 mu m filters to exclude larger predators of nanoflagellates (F-treatment), or prefiltered and subsequently 1:10 diluted with sterile seawater (F+D-treatment) to stimulate the growth of both, flagellates and bacteria. Initially, Cerc_BAL02 were rapidly enriched under both conditions. They foraged on both, eukaryotic prey and bacteria, and were highly competitive at low concentrations of food. However, these omnivores were later only successful in the F+D treatment, where they eventually represented almost one fifth of all aplastidic nanoflagellates. By contrast, their numbers stagnated in the F-treatment, possibly due to top-down control by a concomitant bloom of other, unidentified flagellates. In analogy with observations about the enrichment of opportunistically growing bacteria in comparable experimental setups we suggest that the low numbers of omnivorous Cerc_Bal02 flagellates in waters of the Gulf of Gdansk might also be related to their vulnerability to grazing pressure.	[Piwosz, Kasia] Sea Fisheries Inst Gdynia, Dept Fisheries Oceanog & Marine Ecol, Gdynia, Poland; [Pernthaler, Jakob] Univ Zurich, Inst Plant Biol, Limnol Stn, Kilchberg, Switzerland	National Marine Fisheries Research Institute; University of Zurich	Piwosz, K (corresponding author), Sea Fisheries Inst Gdynia, Dept Fisheries Oceanog & Marine Ecol, Gdynia, Poland.	pernthaler@limnol.uzh.ch	Piwosz, Kasia/B-1131-2010	Piwosz, Kasia/0000-0002-3248-3364	Foundation for Hydrobiology and Limnology Zurich; University of Zurich; Polish Ministry of Science and Higher Education [N304 032 32/1616]	Foundation for Hydrobiology and Limnology Zurich; University of Zurich; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The Foundation for Hydrobiology and Limnology Zurich and the University of Zurich are gratefully acknowledged for supporting K.P. during her stays in Switzerland. This study was supported by the Polish Ministry of Science and Higher Education, project no. N304 032 32/1616. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apple JK, 2011, APPL ENVIRON MICROB, V77, P3074, DOI 10.1128/AEM.02241-10; Arim M, 2004, ECOL LETT, V7, P557, DOI 10.1111/j.1461-0248.2004.00613.x; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bass D, 2004, INT J SYST EVOL MICR, V54, P2393, DOI 10.1099/ijs.0.63229-0; Beardsley C, 2003, APPL ENVIRON MICROB, V69, P2624, DOI 10.1128/AEM.69.5.2624-2630.2003; Calbet A, 2001, AQUAT MICROB ECOL, V23, P283, DOI 10.3354/ame023283; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Eilers H, 2000, APPL ENVIRON MICROB, V66, P4634, DOI 10.1128/AEM.66.11.4634-4640.2000; Evans C, 2003, AQUAT MICROB ECOL, V30, P207, DOI 10.3354/ame030207; Fagan WF, 1997, AM NAT, V150, P554, DOI 10.1086/286081; Flynn KJ, 1996, J EXP MAR BIOL ECOL, V196, P357, DOI 10.1016/0022-0981(95)00140-9; Fuchs BM, 2000, ENVIRON MICROBIOL, V2, P191, DOI 10.1046/j.1462-2920.2000.00092.x; Gasiunaite ZR, 2005, ESTUAR COAST SHELF S, V65, P239, DOI 10.1016/j.ecss.2005.05.018; GASOL JM, 1994, MAR ECOL PROG SER, V113, P291, DOI 10.3354/meps113291; Glucksman E, 2010, ENVIRON MICROBIOL, V12, P3105, DOI 10.1111/j.1462-2920.2010.02283.x; GOLDMAN JC, 1985, DEEP-SEA RES, V32, P899, DOI 10.1016/0198-0149(85)90035-4; HOLMFELDT K, 2009, ENV MICROBIOL; Hornak K, 2005, FEMS MICROBIOL ECOL, V52, P315, DOI 10.1016/j.femsec.2004.11.013; Jezbera J, 2005, FEMS MICROBIOL ECOL, V52, P351, DOI 10.1016/j.femsec.2004.12.001; Jiang L, 2004, OIKOS, V106, P217, DOI 10.1111/j.0030-1299.2004.13056.x; Jurgens K., 2008, MICROB ECOL OCEAN, P383, DOI [DOI 10.1002/9780470281840.CH11, 10.1002/9780470281840.ch11]; KIRCHMAN DL, 1993, CURRENT METHODS AQUA, P513; Krivan V, 2003, EVOL ECOL RES, V5, P623; LANDRY MR, 1984, MAR ECOL PROG SER, V16, P127, DOI 10.3354/meps016127; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; Liess A, 2006, OIKOS, V114, P15, DOI 10.1111/j.2006.0030-1299.14516.x; Lim EL, 1999, LIMNOL OCEANOGR, V44, P37, DOI 10.4319/lo.1999.44.1.0037; Mackiewicz T, 1991, ACTA ICHTHYOL PISC S, V21, P125; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Massana R, 2007, ENVIRON MICROBIOL, V9, P2660, DOI 10.1111/j.1462-2920.2007.01378.x; McCann K, 1997, P ROY SOC B-BIOL SCI, V264, P1249, DOI 10.1098/rspb.1997.0172; Nakazawa T, 2010, OIKOS, V119, P418, DOI 10.1111/j.1600-0706.2009.17953.x; NEEF A, 1997, ANWENDUNG SITU EINZE; Piwosz K, 2010, ENVIRON MICROBIOL, V12, P364, DOI 10.1111/j.1462-2920.2009.02074.x; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rodriguez F, 2005, ENVIRON MICROBIOL, V7, P853, DOI 10.1111/j.1462-2920.2005.00758.x; ROLLER C, 1994, MICROBIOL-UK, V140, P2849, DOI 10.1099/00221287-140-10-2849; Rothhaupt KO, 1996, ECOLOGY, V77, P716, DOI 10.2307/2265496; Salcher MM, 2005, AQUAT MICROB ECOL, V38, P215, DOI 10.3354/ame038215; Samuelsson K, 2003, AQUAT MICROB ECOL, V30, P239, DOI 10.3354/ame030239; Sekar R, 2003, APPL ENVIRON MICROB, V69, P2928, DOI 10.1128/AEm.69.5.2928-2935.2003; SHERR BF, 1989, MAR ECOL PROG SER, V54, P209, DOI 10.3354/meps054209; Simek K, 1997, APPL ENVIRON MICROB, V63, P587, DOI 10.1128/AEM.63.2.587-595.1997; Simek K, 2007, ENVIRON MICROBIOL, V9, P789, DOI 10.1111/j.1462-2920.2006.01201.x; STERNER RW, 1994, LIMNOL OCEANOGR, V39, P535, DOI 10.4319/lo.1994.39.3.0535; Thompson RM, 2007, ECOLOGY, V88, P612, DOI 10.1890/05-1454; Tillmann U, 1998, AQUAT MICROB ECOL, V14, P155, DOI 10.3354/ame014155; Umorin PP, 2009, INLAND WATER BIOL, V2, P1, DOI 10.1134/S1995082909010015; Zeder M, 2009, CYTOM PART A, V75A, P781, DOI 10.1002/cyto.a.20770; Zeder M, 2009, ENVIRON MICROBIOL, V11, P2676, DOI 10.1111/j.1462-2920.2009.01994.x	53	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e24415	10.1371/journal.pone.0024415	http://dx.doi.org/10.1371/journal.pone.0024415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966360	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000295932100003
J	Bally, J; Job, C; Belghazi, M; Job, D				Bally, Julia; Job, Claudette; Belghazi, Maya; Job, Dominique			Metabolic Adaptation in Transplastomic Plants Massively Accumulating Recombinant Proteins	PLOS ONE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE-OXYGENASE; TRANSGENIC TOBACCO; RUBISCO ACTIVASE; PLASTID TRANSFORMATION; ANTISENSE RNA; CHLOROPLASTS; EXPRESSION; PHOTOSYNTHESIS; NUCLEAR; REDUCTION	Background: Recombinant chloroplasts are endowed with an astonishing capacity to accumulate foreign proteins. However, knowledge about the impact on resident proteins of such high levels of recombinant protein accumulation is lacking. Methodology/Principal Findings: Here we used proteomics to characterize tobacco (Nicotiana tabacum) plastid transformants massively accumulating a p-hydroxyphenyl pyruvate dioxygenase (HPPD) or a green fluorescent protein (GFP). While under the conditions used no obvious modifications in plant phenotype could be observed, these proteins accumulated to even higher levels than ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco), the most abundant protein on the planet. This accumulation occurred at the expense of a limited number of leaf proteins including Rubisco. In particular, enzymes involved in CO2 metabolism such as nuclear-encoded plastidial Calvin cycle enzymes and mitochondrial glycine decarboxylase were found to adjust their accumulation level to these novel physiological conditions. Conclusions/Significance: The results document how protein synthetic capacity is limited in plant cells. They may provide new avenues to evaluate possible bottlenecks in recombinant protein technology and to maintain plant fitness in future studies aiming at producing recombinant proteins of interest through chloroplast transformation.	[Bally, Julia; Job, Claudette; Job, Dominique] Ctr Natl Rech Scientif Bayer, CropSci Joint Lab, UMR5240, Lyon, France; [Belghazi, Maya] Ctr Anal Proteomique Marseille, Federatif Rech Jean Roche, Marseille, France	Bayer AG; Bayer CropScience; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Bally, J (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	julia.bally@sydney.edu.au; dominique.job@bayer.com		Bally, Julia/0000-0003-0692-280X				Bally J, 2008, PLANT BIOTECHNOL J, V6, P46, DOI 10.1111/j.1467-7652.2007.00298.x; Bally J, 2009, PLANT PHYSIOL, V150, P1474, DOI 10.1104/pp.109.139816; Bauwe H, 2003, J EXP BOT, V54, P1523, DOI 10.1093/jxb/erg171; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai B, 2010, J PLANT PHYSIOL, V167, P1457, DOI 10.1016/j.jplph.2010.05.004; Catusse J, 2008, P NATL ACAD SCI USA, V105, P10262, DOI 10.1073/pnas.0800585105; Coragliotti AT, 2011, MOL BIOTECHNOL, V48, P60, DOI 10.1007/s12033-010-9348-4; Diaz-Vivancos P, 2008, J EXP BOT, V59, P2147, DOI 10.1093/jxb/ern082; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; FINER JJ, 1992, PLANT CELL REP, V11, P323, DOI 10.1007/BF00233358; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Garcia I, 2000, BIOCHEMISTRY-US, V39, P7501, DOI 10.1021/bi000135h; Garcia-Canas V, 2011, MASS SPECTROM REV, V30, P396, DOI 10.1002/mas.20286; GONTERO B, 1988, EUR J BIOCHEM, V173, P437, DOI 10.1111/j.1432-1033.1988.tb14018.x; Goossens A, 1999, FEBS LETT, V456, P160, DOI 10.1016/S0014-5793(99)00943-6; Han MJ, 2001, J BACTERIOL, V183, P301, DOI 10.1128/JB.183.1.301-308.2001; Harder A, 1999, ELECTROPHORESIS, V20, P826, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<826::AID-ELPS826>3.0.CO;2-A; Herrero M, 2011, MASS SPECTROM REV; Hirel B, 2006, NEW PHYTOL, V169, P445, DOI 10.1111/j.1469-8137.2006.01641.x; HUDSON GS, 1992, PLANT PHYSIOL, V98, P294, DOI 10.1104/pp.98.1.294; Iurina N P, 2008, Genetika, V44, P1445; Kebeish R, 2007, NAT BIOTECHNOL, V25, P593, DOI 10.1038/nbt1299; Leister D, 2005, GENE, V354, P110, DOI 10.1016/j.gene.2005.03.039; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Luo JL, 2009, J PROTEOME RES, V8, P829, DOI 10.1021/pr8002968; Maliga P, 2004, ANNU REV PLANT BIOL, V55, P289, DOI 10.1146/annurev.arplant.55.031903.141633; Mechin Valerie, 2007, V355, P1; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; OECD, 1993, SAF EV FOODS DER MOD; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; PAUL MJ, 1995, PLANT J, V7, P535, DOI 10.1046/j.1365-313X.1995.7040535.x; Pesaresi P, 2007, CURR OPIN PLANT BIOL, V10, P600, DOI 10.1016/j.pbi.2007.07.007; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Prins A, 2008, J EXP BOT, V59, P1935, DOI 10.1093/jxb/ern086; QUICK WP, 1991, PLANTA, V183, P542, DOI 10.1007/BF00194276; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Ricroch AE, 2011, PLANT PHYSIOL, V155, P1752, DOI 10.1104/pp.111.173609; Rokka A, 2001, PLANT J, V25, P463, DOI 10.1046/j.1365-313x.2001.00981.x; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Schiltz S, 2004, PLANT PHYSIOL, V135, P2241, DOI 10.1104/pp.104.041947; Schmidt MA, 2011, PLANT PHYSIOL, V156, P330, DOI 10.1104/pp.111.173807; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; TAYLOR WC, 1989, ANNU REV PLANT PHYS, V40, P211, DOI 10.1146/annurev.pp.40.060189.001235; Vargas-Suarez M, 2004, J EXP BOT, V55, P2533, DOI 10.1093/jxb/erh268; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Wright AF, 2009, TRENDS GENET, V25, P253, DOI 10.1016/j.tig.2009.04.006; Ye GN, 2001, PLANT J, V25, P261, DOI 10.1046/j.1365-313x.2001.00958.x; Zhou YH, 2006, PLANT CELL PHYSIOL, V47, P192, DOI 10.1093/pcp/pci234; ZOUBENKO OV, 1994, NUCLEIC ACIDS RES, V22, P3819, DOI 10.1093/nar/22.19.3819	53	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25289	10.1371/journal.pone.0025289	http://dx.doi.org/10.1371/journal.pone.0025289			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966485	gold, Green Submitted, Green Published			2022-12-25	WOS:000295265100082
J	Chi, F; Wang, L; Zheng, XY; Wu, CH; Jong, A; Sheard, MA; Shi, W; Huang, SH				Chi, Feng; Wang, Lin; Zheng, Xueye; Wu, Chun-Hua; Jong, Ambrose; Sheard, Michael A.; Shi, Wei; Huang, Sheng-He			Meningitic Escherichia coli K1 Penetration and Neutrophil Transmigration Across the Blood-Brain Barrier are Modulated by Alpha7 Nicotinic Receptor	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; ACETYLCHOLINE-RECEPTOR; CEREBROSPINAL-FLUID; ACTIVATION; INVASION; CALCIUM; PERMEABILITY; RECRUITMENT; CYTOSKELETON; STIMULATION	Alpha7 nicotinic acetylcholine receptor (nAChR), an essential regulator of inflammation, is abundantly expressed in hippocampal neurons, which are vulnerable to bacterial meningitis. However, it is unknown whether 7 nAChR contributes to the regulation of these events. In this report, an aggravating role of alpha 7 nAChR in host defense against meningitic E. coli infection was demonstrated by using alpha 7-deficient (alpha 7(-/-)) mouse brain microvascular endothelial cells (BMEC) and animal model systems. As shown in our in vitro and in vivo studies, E. coli K1 invasion and polymorphonuclear neutrophil (PMN) transmigration across the blood-brain barrier (BBB) were significantly reduced in alpha 7(-/-) BMEC and alpha 7(-/-) mice. Stimulation by nicotine was abolished in the alpha 7(-/-) cells and animals. The same blocking effect was achieved by methyllycaconitine (alpha 7 antagonist). The tight junction molecules occludin and ZO-1 were significantly reduced in the brain cortex of wildtype mice infected with E. coli and treated with nicotine, compared to alpha 7(-/-) cells and animals. Decreased neuronal injury in the hippocampal dentate gyrus was observed in alpha 7(-/-) mice with meningitis. Proinflammatory cytokines (IL-1 beta, IL-6, TNF alpha, MCP-1, MIP-1alpha, and RANTES) and adhesion molecules (CD44 and ICAM-1) were significantly reduced in the cerebrospinal fluids of the alpha 7(-/-) mice with E. coli meningitis. Furthermore, alpha 7 nAChR is the major calcium channel for nicotine-and E. coli K1-increased intracellular calcium concentrations of mouse BMEC. Taken together, our data suggest that alpha 7 nAChR plays a detrimental role in the host defense against meningitic infection by modulation of pathogen invasion, PMN recruitment, calcium signaling and neuronal inflammation.	[Chi, Feng; Wang, Lin; Zheng, Xueye; Wu, Chun-Hua; Jong, Ambrose; Sheard, Michael A.; Shi, Wei; Huang, Sheng-He] Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90089 USA; [Wang, Lin] Wuhan Univ, Dept Histol & Embryol, Sch Basic Med Sci, Wuhan 430072, Peoples R China	Children's Hospital Los Angeles; University of Southern California; Wuhan University	Chi, F (corresponding author), Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90089 USA.	shhuang@hsc.usc.edu	Sheard, Michael/J-1374-2019; Chi, Feng/H-5895-2012	Sheard, Michael/0000-0002-4960-7650; 	Public Health Service [R56-AI40635, R01-NS047599]; Saban Research Institute; National Natural Science Foundation of China [81070514]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040635, R01AI040635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047599] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Saban Research Institute; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was financially supported by Public Health Service grants R56-AI40635 (Dr. Huang) and R01-NS047599 (Dr. Jong), a Saban Research Institute Research Career Development Fellowship (RCDF) (Dr. Chi), and a National Natural Science Foundation grant of China 81070514 (Dr. Wang). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruscato TJ, 2002, J PHARM SCI-US, V91, P2525, DOI 10.1002/jps.10256; Aramakis VB, 2000, J NEUROSCI, V20, P6106, DOI 10.1523/JNEUROSCI.20-16-06106.2000; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Beraldo FH, 2010, J BIOL CHEM, V285, P36542, DOI 10.1074/jbc.M110.157263; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Braun JS, 2002, J CLIN INVEST, V109, P19; Bredfeldt R C, 1995, J Am Board Fam Pract, V8, P95; Carman CV, 2009, J CELL SCI, V122, P3025, DOI 10.1242/jcs.047522; CHE X, 2010, BRAIN PATHO IN PRESS; Chen YH, 2002, CELL MICROBIOL, V4, P503, DOI 10.1046/j.1462-5822.2002.00209.x; Chi F, 2011, FUTURE MICROBIOL, V6, P953, DOI 10.2217/FMB.11.65; Chi F, 2010, BIOCHEM J, V427, P79, DOI 10.1042/BJ20091097; Cortes MAM, 2008, INFECT IMMUN, V76, P4129, DOI 10.1128/IAI.00334-08; Cucina A, 2000, J SURG RES, V92, P233, DOI 10.1006/jsre.2000.5894; Du J, 2009, MOL PHARMACEUT, V6, P905, DOI 10.1021/mp800218q; FLEMING JO, 1983, J NEUROIMMUNOL, V4, P129, DOI 10.1016/0165-5728(83)90017-6; Forster C, 2006, J PHYSIOL-LONDON, V573, P413, DOI 10.1113/jphysiol.2006.106385; Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003; Gianinazzi C, 2003, ACTA NEUROPATHOL, V105, P499, DOI 10.1007/s00401-003-0672-7; Giebelen IAJ, 2009, EUR RESPIR J, V33, P375, DOI 10.1183/09031936.00103408; Giebelen IAJ, 2008, J INFECT DIS, V198, P750, DOI 10.1086/590432; Gubbins EJ, 2010, BRAIN RES, V1328, P1, DOI 10.1016/j.brainres.2010.02.083; Hosur V, 2011, MOL PHARMACOL, V79, P167, DOI 10.1124/mol.110.066381; Huang SH, 2000, MICROBES INFECT, V2, P1237, DOI 10.1016/S1286-4579(00)01277-6; Huang SH, 1999, INFECT IMMUN, V67, P2103, DOI 10.1128/IAI.67.5.2103-2109.1999; Huang SH, 2001, CELL MICROBIOL, V3, P277, DOI 10.1046/j.1462-5822.2001.00116.x; JACKSON CJ, 1990, J CELL SCI, V96, P257; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim YV, 2008, CELL TISSUE RES, V332, P427, DOI 10.1007/s00441-008-0598-4; Kolarova A, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-21; Laudenbach V, 2002, FASEB J, V16, P423, DOI 10.1096/fj.01-0532fje; Lee JD, 2006, ACTA TROP, V97, P204, DOI 10.1016/j.actatropica.2005.11.003; Lefort A, 2011, J CLIN MICROBIOL, V49, P777, DOI 10.1128/JCM.01902-10; MAYES RW, 1993, J CLIN PATHOL, V46, P982, DOI 10.1136/jcp.46.11.982; Moreland JG, 2006, AM J PHYSIOL-LUNG C, V290, pL833, DOI 10.1152/ajplung.00333.2005; Moriguchi S, 2009, HIPPOCAMPUS, V19, P844, DOI 10.1002/hipo.20572; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Nhieu GT, 2004, BIOL CELL, V96, P93, DOI 10.1016/j.biocel.2003.10.006; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Ochietti B, 2002, GENE THER, V9, P939, DOI 10.1038/sj.gt.3301716; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Radek KA, 2010, CELL HOST MICROBE, V7, P277, DOI 10.1016/j.chom.2010.03.009; RUEF P, 1991, PEDIATR RES, V29, P128, DOI 10.1203/00006450-199102000-00004; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Sayers NM, 1999, FEMS IMMUNOL MED MIC, V25, P115, DOI 10.1111/j.1574-695X.1999.tb01334.x; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Stins MF, 2001, J NEUROVIROL, V7, P125; Strijbos MH, 2008, BRIT J CANCER, V98, P1731, DOI 10.1038/sj.bjc.6604383; Sukumaran SK, 2003, J BIOL CHEM, V278, P45753, DOI 10.1074/jbc.M307374200; Sukumaran SK, 2003, J INFECT DIS, V188, P1295, DOI 10.1086/379042; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Wang BW, 2006, SYNAPSE, V59, P491, DOI 10.1002/syn.20267; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Yamaguchi H, 2003, INFECT IMMUN, V71, P3645, DOI 10.1128/IAI.71.6.3645-3647.2003; Ye YN, 2004, J PHARMACOL EXP THER, V311, P123, DOI 10.1124/jpet.104.068031; Yong T, 1997, J NEUROIMMUNOL, V80, P158, DOI 10.1016/S0165-5728(97)00151-3; Zen K, 2006, J IMMUNOL METHODS, V309, P86, DOI 10.1016/j.jim.2005.11.014; Zhang XH, 2007, J CEREBR BLOOD F MET, V27, P534, DOI 10.1038/sj.jcbfm.9600368; Zwijnenburg PJG, 2006, INFECT IMMUN, V74, P1445, DOI 10.1128/IAI.74.3.1445-1451.2006	62	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25016	10.1371/journal.pone.0025016	http://dx.doi.org/10.1371/journal.pone.0025016			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966399	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100040
J	Spivey, KA; Chung, I; Banyard, J; Adini, I; Feldman, HA; Zetter, BR				Spivey, K. A.; Chung, I.; Banyard, J.; Adini, I.; Feldman, H. A.; Zetter, B. R.			A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis	ONCOGENE			English	Article						collagen; metastasis; adhesion; anchorage-independence	XIII COLLAGEN; TRANSMEMBRANE PROTEINS; CLAC BINDS; EXPRESSION; CADHERIN; ASSOCIATION; PROMOTES; GROWTH; ATTACHMENT; XVII/BP180	Collagen XXIII is a transmembrane collagen previously shown to be upregulated in metastatic prostate cancer that has been used as a tissue and fluid biomarker for non-small cell lung cancer and prostate cancer. To determine whether collagen XXIII facilitates cancer cell metastasis in vivo and to establish a function for collagen XXIII in cancer progression, collagen XXIII knockdown cells were examined for alterations in in vivo metastasis as well as in vitro cell adhesion. In experimental and spontaneous xenograft models of metastasis, H460 cells expressing collagen XXIII shRNA formed fewer lung metastases than control cells. Loss of collagen XXIII in H460 cells also impaired cell adhesion, anchorage-independent growth and cell seeding to the lung, but did not affect cell proliferation. Corroborating a role for collagen XXIII in cell adhesion, overexpression of collagen XXIII in H1299 cells, which do not express endogenous collagen XXIII, enhanced cell adhesion. Consequent reduction in OB-cadherin, alpha-catenin, gamma-catenin, beta-catenin, vimentin and galectin-3 protein expression was also observed in response to loss of collagen XXIII. This study suggests a potential role for collagen XXIII in mediating metastasis by facilitating cell-cell and cell-matrix adhesion as well as anchorage-independent cell growth. Oncogene (2012) 31, 2362-2372; doi:10.1038/onc.2011.406; published online 3 October 2011	[Spivey, K. A.; Chung, I.; Banyard, J.; Adini, I.; Zetter, B. R.] Childrens Hosp, Karp Family Res Labs, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA; [Feldman, H. A.] Childrens Hosp, Clin Res Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Zetter, BR (corresponding author), Childrens Hosp, Karp Family Res Labs, Dept Surg, Vasc Biol Program, Room 11-125,1 Blackfan Circle, Boston, MA 02115 USA.	Bruce.Zetter@childrens.harvard.edu	Chung, Ivy/C-3804-2012; Feldman, Henry/M-2302-2013		NCI NIH HHS [R01 CA037393, R37 CA037393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037393, R37CA037393] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Banyard J, 2003, J BIOL CHEM, V278, P20989, DOI 10.1074/jbc.M210616200; Banyard J, 2007, CLIN CANCER RES, V13, P2634, DOI 10.1158/1078-0432.CCR-06-2163; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bussemakers MJG, 2000, INT J CANCER, V85, P446, DOI 10.1002/(SICI)1097-0215(20000201)85:3<446::AID-IJC23>3.3.CO;2-2; Chu K, 2008, MOL CANCER RES, V6, P1259, DOI 10.1158/1541-7786.MCR-08-0077; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; Forsell C, 2010, NEUROBIOL AGING, V31, P409, DOI 10.1016/j.neurobiolaging.2008.04.009; Franzke CW, 2009, J BIOL CHEM, V284, P23386, DOI 10.1074/jbc.M109.034090; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; Franzke CW, 2004, J BIOL CHEM, V279, P24521, DOI 10.1074/jbc.M308835200; Franzke CW, 2003, MATRIX BIOL, V22, P299, DOI 10.1016/S0945-053X(03)00051-9; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; Gilles C, 1996, J PATHOL, V180, P175, DOI 10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G; Glinsky VV, 2003, CANCER RES, V63, P3805; Gordon MK, 2005, INVEST OPHTH VIS SCI, V46; Hagg P, 2001, MATRIX BIOL, V19, P727, DOI 10.1016/S0945-053X(00)00119-0; Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kakuyama H, 2005, BIOCHEMISTRY-US, V44, P15602, DOI 10.1021/bi051263e; Khaldoyanidi SK, 2003, J BIOL CHEM, V278, P4127, DOI 10.1074/jbc.M209590200; Kvist AP, 2001, AM J PATHOL, V159, P1581, DOI 10.1016/S0002-9440(10)62542-4; Miles FL, 2008, CLIN EXP METASTAS, V25, P305, DOI 10.1007/s10585-007-9098-2; Mukhopadhyay R, 1999, CLIN EXP METASTAS, V17, P325; NOMURA Y, 1989, CANCER RES, V49, P5288; OKAZAKI M, 1994, J BIOL CHEM, V269, P12092; Orr F W, 2001, Surg Oncol Clin N Am, V10, P357; Osada Y, 2005, J BIOL CHEM, V280, P8596, DOI 10.1074/jbc.M413340200; PIHLAJANIEMI T, 1990, J BIOL CHEM, V265, P16922; Pishvaian MJ, 1999, CANCER RES, V59, P947; Roman J, 2010, AM J RESP CELL MOL, V43, P684, DOI 10.1165/rcmb.2009-0375OC; Schmidmaier R, 2008, CURR MED CHEM, V15, P978, DOI 10.2174/092986708784049667; SIMONNEAU L, 1995, CELL ADHES COMMUN, V3, P115, DOI 10.3109/15419069509081281; Soderberg L, 2005, FEBS J, V272, P2231, DOI 10.1111/j.1742-4658.2005.04647.x; Spivey KA, 2010, CANCER EPIDEM BIOMAR, V19, P1362, DOI 10.1158/1055-9965.EPI-09-1095; Takenaka K, 2000, INT J ONCOL, V17, P1187; Tomita K, 2000, CANCER RES, V60, P3650; Tong Y, 2010, NEUROGENETICS, V11, P41, DOI 10.1007/s10048-009-0201-5; Torimura T, 1999, J HEPATOL, V31, P734, DOI 10.1016/S0168-8278(99)80355-9; Tu HM, 2002, J BIOL CHEM, V277, P23092, DOI 10.1074/jbc.M107583200; Vaisanen MR, 2004, BIOCHEM J, V380, P685, DOI 10.1042/BJ20031974; Vaisanen T, 2005, J PATHOL, V207, P324, DOI 10.1002/path.1836; Veit G, 2007, J BIOL CHEM, V282, P27424, DOI 10.1074/jbc.M703425200; Veit G, 2011, J BIOL CHEM, V286, P27804, DOI 10.1074/jbc.M111.220046; Wewer UM, 1997, AM J PATHOL, V151, P1191; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; WS Rasband, 2010, IMAGEJ, P1997	50	25	27	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	18					2362	2372		10.1038/onc.2011.406	http://dx.doi.org/10.1038/onc.2011.406			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	936SR	21963851	Green Accepted			2022-12-25	WOS:000303610800010
J	Giang, KTN; Zhang, S; Wang, W; Wong, CTT; Ngan, TKN; Tam, JP				Giang Kien Truc Nguyen; Zhang, Sen; Wang, Wei; Wong, Clarence Tsun Ting; Ngan Thi Kim Nguyen; Tam, James P.			Discovery of a Linear Cyclotide from the Bracelet Subfamily and Its Disulfide Mapping by Top-down Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC CYSTINE KNOT; OLDENLANDIA-AFFINIS; KALATA B1; PROTEIN CHARACTERIZATION; CIRCULAR MINIPROTEINS; STRUCTURAL MOTIF; PLANT CYCLOTIDES; PEPTIDES; BIOSYNTHESIS; POLYPEPTIDES	Cyclotides are heat-stable macrocyclic peptides from plants that display a wide range of biological activities. They can be divided into two subfamilies: Mobius or bracelet, based on the presence or absence of a cis-proline residue in loop 5, respectively. Currently, over 150 cyclotides have been discovered, but only four linear variants of the Mobius subfamily have been hitherto isolated. In this study, we report the discovery of two novel cyclotides, hedyotide B1 and hedyotide B2, from the aerial parts of Hedyotis biflora. Hedyotide B1 has a cyclic cystine knot structure typical of cyclotides. Interestingly, hedyotide B2 possesses a linear backbone and is the first linear representative of the bracelet subfamily. Disulfide mapping of hedyotide B2 by a top-down MS/MS approach showed that it shares the same knotted disulfide arrangement as conventional cyclotides. Its unfolding pathway also showed that the penetrating disulfide bond Cys III-VI is the most stable disulfide linkage. Cloning of the gene encoding hedyotide B2 revealed a nonsense mutation that introduces a premature stop codon at the conserved Asn residue position, which is essential for an end-to-end backbone ligation. Biophysical characterization showed that hedyotide B2 was more susceptible to exopeptidase degradation as compared with hedyotide B1. Hedyotide B2 was also inactive against all four tested bacterial strains, whereas hedyotide B1 was bactericidal to Escherichia coli and Streptococcus salivarius at low micromolar concentration. Our results provide a deeper understanding of the structures, functions, and biosynthetic processing of cyclotides and uncyclotides in plants.	[Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	jptam@ntu.edu.sg	Tam, James P/A-2176-2011; Wong, Clarence Tsun Ting/AAH-6159-2020	Tam, James P/0000-0003-4433-198X; Wong, Clarence Tsun Ting/0000-0001-8950-0033; Zhang, Sen/0000-0003-1409-5795	Biomedical Research Council [BMRC09/1/22/19/612]; A*STAR; Ministry of Education in Singapore [ARC21/08]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); A*STAR(Agency for Science Technology & Research (A*STAR)); Ministry of Education in Singapore(Ministry of Education, Singapore)	This work was supported by Biomedical Research Council Grant BMRC09/1/22/19/612, A*STAR, and Grant ARC21/08 from the Academic Research Fund of the Ministry of Education in Singapore.	Barry DG, 2003, BIOCHEMISTRY-US, V42, P6688, DOI 10.1021/bi027323n; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; DAGAR HS, 1991, ECON BOT, V45, P114, DOI 10.1007/BF02860056; Daly NL, 1999, J MOL BIOL, V285, P333, DOI 10.1006/jmbi.1998.2276; Datta P. C., 1969, QUARTERNARY J CRUDE, V9, P1356; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gerlach SL, 2010, J NAT PROD, V73, P1207, DOI 10.1021/np9007365; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Goransson U, 1999, J NAT PROD, V62, P283, DOI 10.1021/np9803878; GRAN L, 1973, LLOYDIA, V36, P207; Gran L, 2000, J ETHNOPHARMACOL, V70, P197, DOI 10.1016/S0378-8741(99)00175-0; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Gupta MK, 1996, HYDROBIOLOGIA, V335, P33, DOI 10.1007/BF00013680; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Ireland DC, 2006, J MOL BIOL, V357, P1522, DOI 10.1016/j.jmb.2006.01.051; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Karehed J, 2008, MOL PHYLOGENET EVOL, V49, P843, DOI 10.1016/j.ympev.2008.09.025; Kelleher NL, 1999, J AM CHEM SOC, V121, P806, DOI 10.1021/ja973655h; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Plan MRR, 2007, CHEMBIOCHEM, V8, P1001, DOI 10.1002/cbic.200700097; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; Reid GE, 2002, J MASS SPECTROM, V37, P663, DOI 10.1002/jms.346; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Sze SK, 2009, ANAL CHEM, V81, P1079, DOI 10.1021/ac802175r; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trabi M, 2004, J NAT PROD, V67, P806, DOI 10.1021/np034068e; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wong CTT, 2011, BIOCHEMISTRY-US, V50, P7275, DOI 10.1021/bi2007004	41	53	53	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44833	44844		10.1074/jbc.M111.290296	http://dx.doi.org/10.1074/jbc.M111.290296			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	21979955	Green Published, hybrid			2022-12-25	WOS:000298645500052
J	Bogema, DR; Scott, NE; Padula, MP; Tacchi, JL; Raymond, BBA; Jenkins, C; Cordwell, SJ; Minion, FC; Walker, MJ; Djordjevic, SP				Bogema, Daniel R.; Scott, Nichollas E.; Padula, Matthew P.; Tacchi, Jessica L.; Raymond, Benjamin B. A.; Jenkins, Cheryl; Cordwell, Stuart J.; Minion, F. Chris; Walker, Mark J.; Djordjevic, Steven P.			Sequence TTKF down arrow QE Defines the Site of Proteolytic Cleavage in Mhp683 Protein, a Novel Glycosaminoglycan and Cilium Adhesin of Mycoplasma hyopneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVED PREDICTION; ORAL IMMUNIZATION; SIGNAL PEPTIDES; BINDING PROTEIN; COILED COILS; IDENTIFICATION; SWINE; ADHERENCE; HEPARIN; ANTIGEN	Mycoplasma hyopneumoniae colonizes the ciliated respiratory epithelium of swine, disrupting mucociliary function and inducing chronic inflammation. P97 and P102 family members are major surface proteins of M. hyopneumoniae and play key roles in colonizing cilia via interactions with glycosaminoglycans and mucin. The p102 paralog, mhp683, and homologs in strains from different geographic origins encode a 135-kDa preprotein (P135) that is cleaved into three fragments identified here as P45(683), P48(683), and P50(683). A peptide sequence (TTKF down arrow QE) was identified surrounding both cleavage sites in Mhp683. N-terminal sequences of P48(683) and P50(683), determined by Edman degradation and mass spectrometry, confirmed cleavage after the phenylalanine residue. A similar proteolytic cleavage site was identified by mass spectrometry in another paralog of the P97/P102 family. Trypsin digestion and surface biotinylation studies showed that P45(683), P48(683), and P50(683) reside on the M. hyopneumoniae cell surface. Binding assays of recombinant proteins F1(683)-F5(683), spanning Mhp683, showed saturable and dose-dependent binding to biotinylated heparin that was inhibited by unlabeled heparin, fucoidan, and mucin. F1(683)-F5(683) also bound porcine epithelial cilia, and antisera to F2(683) and F5(683) significantly inhibited cilium binding by M. hyopneumoniae cells. These data suggest that P45(683), P48(683), and P50(683) each display cilium- and proteoglycan-binding sites. Mhp683 is the first characterized glycosaminoglycan-binding member of the P102 family.	[Bogema, Daniel R.; Jenkins, Cheryl; Djordjevic, Steven P.] Elizabeth Macarthur Agr Inst, NSW Dept Primary Ind, Camden, NSW 2567, Australia; [Bogema, Daniel R.; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Scott, Nichollas E.; Cordwell, Stuart J.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Padula, Matthew P.; Tacchi, Jessica L.; Raymond, Benjamin B. A.; Djordjevic, Steven P.] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Minion, F. Chris] Iowa State Univ, Ames, IA 50011 USA; [Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia	NSW Department of Primary Industries; University of Wollongong; University of Sydney; University of Technology Sydney; Iowa State University; University of Queensland; University of Queensland	Djordjevic, SP (corresponding author), POB 123, Broadway, NSW 2007, Australia.	steven.djordjevic@uts.edu.au	Bogema, Daniel/ABE-8287-2020; Djordjevic, Steven/A-2024-2013; Bogema, Daniel/AAE-2935-2020; Bogema, Daniel/B-4629-2011; Raymond, Benjamin/X-5739-2019; Minion, Chris/A-2955-2015; djordjevic, steven/GNP-4000-2022; Walker, Mark J./F-6940-2011; Jenkins, Cheryl/N-1937-2015; Padula, Matthew P/R-6150-2016	Bogema, Daniel/0000-0001-7013-7326; Djordjevic, Steven/0000-0001-9301-5372; Bogema, Daniel/0000-0001-7013-7326; Bogema, Daniel/0000-0001-7013-7326; Raymond, Benjamin/0000-0003-3610-9289; Minion, Chris/0000-0003-4876-8396; djordjevic, steven/0000-0001-9301-5372; Jenkins, Cheryl/0000-0002-5966-072X; Padula, Matthew P/0000-0002-8283-0643; Walker, Mark/0000-0001-7423-2769; Scott, Nichollas/0000-0003-2556-8316; Cordwell, Stuart/0000-0002-0995-0171	ARC [LP776711]; McGarvie Smith Trust; Australian postgraduate award (Industry)	ARC(Australian Research Council); McGarvie Smith Trust; Australian postgraduate award (Industry)(Australian Government)	This work was supported by ARC-Linkage Grant LP776711 and a grant from the McGarvie Smith Trust (to S. P. D.).; Recipient of an Australian postgraduate award (Industry).	Adams C, 2005, INFECT IMMUN, V73, P7784, DOI 10.1128/IAI.73.11.7784-7787.2005; Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baron MJ, 2007, J BIOL CHEM, V282, P10526, DOI 10.1074/jbc.M608279200; Belloy L, 2003, MICROBIOL-SGM, V149, P185, DOI 10.1099/mic.0.25864-0; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boesen T, 2001, PROTEIN SCI, V10, P2577, DOI 10.1110/ps.ps.31901; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Burnett TA, 2006, MOL MICROBIOL, V60, P669, DOI 10.1111/j.1365-2958.2006.05139.x; Chin J, 1996, J BIOTECHNOL, V44, P13, DOI 10.1016/0168-1656(95)00099-2; Clark L. K., 1993, Swine Health and Production, V1, P10; Cordwell SJ, 2008, PROTEOMICS, V8, P122, DOI 10.1002/pmic.200700561; Courtney HS, 1999, MOL MICROBIOL, V32, P89, DOI 10.1046/j.1365-2958.1999.01328.x; Coutte L, 2003, J EXP MED, V197, P735, DOI 10.1084/jem.20021153; de Castro LA, 2006, VET MICROBIOL, V116, P258, DOI 10.1016/j.vetmic.2006.04.022; DEBEY MC, 1994, INFECT IMMUN, V62, P5312, DOI 10.1128/IAI.62.12.5312-5318.1994; Deutscher AT, 2010, MOL MICROBIOL, V78, P444, DOI 10.1111/j.1365-2958.2010.07345.x; Djordjevic SP, 1997, AUST VET J, V75, P504, DOI 10.1111/j.1751-0813.1997.tb14383.x; Djordjevic SP, 2004, INFECT IMMUN, V72, P2791, DOI 10.1128/IAI.72.5.2791-2802.2004; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; ERLINGER R, 1995, CELL TISSUE RES, V281, P473, DOI 10.1007/BF00417864; Fagan PK, 1997, INFECT IMMUN, V65, P2502, DOI 10.1128/IAI.65.6.2502-2507.1997; Fagan PK, 1996, INFECT IMMUN, V64, P1060, DOI 10.1128/IAI.64.3.1060-1064.1996; Fagan PK, 2001, MICROB PATHOGENESIS, V30, P101, DOI 10.1006/mpat.2000.0412; FISCHETTI VA, 1985, J EXP MED, V161, P1384, DOI 10.1084/jem.161.6.1384; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gonciarz-Swiatek M, 2006, MOL IMMUNOL, V43, P1993, DOI 10.1016/j.molimm.2005.11.012; Haesebrouck F, 2004, VET MICROBIOL, V100, P255, DOI 10.1016/j.vetmic.2004.03.002; Hellstrom JL, 2006, BBA-PROTEINS PROTEOM, V1764, P1735, DOI 10.1016/j.bbapap.2006.08.018; Hsu T, 1998, INFECT IMMUN, V66, P4762, DOI 10.1128/IAI.66.10.4762-4766.1998; Hsu T, 1997, J BACTERIOL, V179, P1317, DOI 10.1128/jb.179.4.1317-1323.1997; Jenkins C, 2006, INFECT IMMUN, V74, P481, DOI 10.1128/IAI.74.1.481-487.2006; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; KELLY C, 1989, FEBS LETT, V258, P127, DOI 10.1016/0014-5793(89)81632-1; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Matic JN, 2009, INFECT IMMUN, V77, P1817, DOI 10.1128/IAI.01301-08; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; MEBUS CA, 1977, AM J VET RES, V38, P1249; Menozzi FD, 2002, MOL MICROBIOL, V43, P1379, DOI 10.1046/j.1365-2958.2002.02841.x; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; Minion FC, 2000, INFECT IMMUN, V68, P3056, DOI 10.1128/IAI.68.5.3056-3060.2000; Moelleken K, 2008, MOL MICROBIOL, V67, P403, DOI 10.1111/j.1365-2958.2007.06050.x; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nunomura K, 2005, MOL CELL PROTEOMICS, V4, P1968, DOI 10.1074/mcp.M500216-MCP200; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Proft T, 1996, GENE, V171, P79, DOI 10.1016/0378-1119(96)00014-5; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; REALINI C, 1994, FEBS LETT, V348, P109, DOI 10.1016/0014-5793(94)00569-9; REALINI C, 1995, J BIOL CHEM, V270, P29664; Scarman AL, 1997, MICROBIOL-SGM, V143, P663, DOI 10.1099/00221287-143-2-663; Scott NE, 2010, PROTEOMICS, V10, P277, DOI 10.1002/pmic.200900440; Scott NE, 2009, J PROTEOME RES, V8, P4654, DOI 10.1021/pr900544x; Seymour LM, 2011, J BIOL CHEM, V286, P10097, DOI 10.1074/jbc.M110.208140; Seymour LM, 2010, J BIOL CHEM, V285, P33971, DOI 10.1074/jbc.M110.104463; SOBEL M, 1992, J BIOL CHEM, V267, P8857; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Szczepanek SM, 2010, INFECT IMMUN, V78, P3475, DOI 10.1128/IAI.00154-10; TAJIMA M, 1982, INFECT IMMUN, V37, P1162, DOI 10.1128/IAI.37.3.1162-1169.1982; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Wilton J, 2009, MOL MICROBIOL, V71, P566, DOI 10.1111/j.1365-2958.2008.06546.x; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; WRIGHT HT, 1991, PROTEIN ENG, V4, P283, DOI 10.1093/protein/4.3.283; Zhang KR, 2006, J PROTEOME RES, V5, P3355, DOI 10.1021/pr060336t; ZHANG QJ, 1994, INFECT IMMUN, V62, P1616, DOI 10.1128/IAI.62.5.1616-1622.1994; ZHANG QJ, 1995, INFECT IMMUN, V63, P1013, DOI 10.1128/IAI.63.3.1013-1019.1995; ZIELINSKI GC, 1990, AM J VET RES, V51, P339; Zimmermann L, 2010, J BACTERIOL, V192, P3773, DOI 10.1128/JB.00253-10	71	42	44	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41217	41229		10.1074/jbc.M111.226084	http://dx.doi.org/10.1074/jbc.M111.226084			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21969369	Green Published, hybrid			2022-12-25	WOS:000298057500010
J	Liu, T; Wan, L; Wu, Y; Chen, JJ; Huang, J				Liu, Ting; Wan, Li; Wu, Yue; Chen, Junjie; Huang, Jun			hSWS1.SWSAP1 Is an Evolutionarily Conserved Complex Required for Efficient Homologous Recombination Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; SACCHAROMYCES-CEREVISIAE; GENOMIC STABILITY; MAMMALIAN-CELLS; PROTEINS; GENES; RAD51; PROMOTE; SCREEN	The Shu complex in yeast plays an important role in the homologous recombination pathway, which is critical for the maintenance of genomic integrity. The identification of human SWS1 (hSWS1) as the homolog of budding yeast Shu2 implicated that the Shu complex is evolutionarily conserved. However, the human counterparts of other components in this complex have not yet been identified and characterized. Here we describe the characterization of a novel human component of this complex, SWSAP1 (hSWS1-associated protein 1)/C19orf39. We show that hSWS1 and SWSAP1 form a stable complex in vivo and in vitro. hSWS1 and SWSAP1 are mutually interdependent for their stability. We further demonstrate that the purified hSWS1.SWSAP1 complex possesses single-stranded DNA-binding activity and DNA-stimulated ATPase activity. Moreover, SWSAP1 interacts with RAD51 and RAD51 paralogs, and depletion of SWSAP1 causes defects in homologous recombination repair. Thus, our results suggest that the human Shu complex (hSWS1.SWSAP1) has an evolutionarily conserved function in homologous recombination.	[Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Liu, Ting; Wan, Li; Wu, Yue; Huang, Jun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Zhejiang University	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org; jhuang@zju.edu.cn	Wan, Li/AFR-0017-2022		National Natural Science Foundation of China [31071243]; Natural Science Foundation of Zhejiang Province [R2110569]; China's Fundamental Research Funds for the Central Universities; Department of Defense [W81XWH-05-1-0470]; Anderson Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [R01CA089239] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); China's Fundamental Research Funds for the Central Universities; Department of Defense(United States Department of Defense); Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Natural Science Foundation of China (Grant 31071243), the Natural Science Foundation of Zhejiang Province (Grant R2110569), and the China's Fundamental Research Funds for the Central Universities (to J. H.).; A recipient of an Era of Hope Scholar award from the Department of Defense (Grant W81XWH-05-1-0470) and a member of the M.D. Anderson Cancer Center (Grant CA016672). To whom correspondence may be addressed. E-mail: jchen8@mdanderson.org.	Ball LG, 2009, MOL MICROBIOL, V73, P89, DOI 10.1111/j.1365-2958.2009.06748.x; Bernstein KA, 2011, MOL BIOL CELL, V22, P1599, DOI 10.1091/mbc.E10-08-0691; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Komori K, 2000, J BIOL CHEM, V275, P33791, DOI 10.1074/jbc.M004556200; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Lukas J, 2004, CELL, V118, P666, DOI 10.1016/j.cell.2004.09.006; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Martin V, 2006, EMBO J, V25, P2564, DOI 10.1038/sj.emboj.7601141; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Sandler SJ, 1996, NUCLEIC ACIDS RES, V24, P2125, DOI 10.1093/nar/24.11.2125; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Shor E, 2005, GENETICS, V169, P1275, DOI 10.1534/genetics.104.036764; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127	23	51	59	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41758	41766		10.1074/jbc.M111.271080	http://dx.doi.org/10.1074/jbc.M111.271080			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965664	hybrid, Green Published			2022-12-25	WOS:000298057500059
J	Wu, W; Sun, XH				Wu, Wei; Sun, Xiao-Hong			A Mechanism Underlying NOTCH-Induced and Ubiquitin-mediated JAK3 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; CYTOKINE SIGNAL-TRANSDUCTION; T-CELL DEVELOPMENT; LYMPHOID DEVELOPMENT; JANUS KINASES; SUPPRESSOR-OF-CYTOKINE-SIGNALING-1 SOCS-1; ACTIVATION LOOP; GAMMA-CHAIN; B-CELLS; FATE	Although NOTCH signaling is well known to regulate lymphopoiesis, Janus kinase 3 (JAK3) also plays a critical role in promoting lymphocyte development. We have previously found that NOTCH signaling leads to the degradation of JAK3 in B lineage cells, suggesting that NOTCH signaling exerts its biological effect on lymphopoiesis through modulating JAK3 levels. Here, we delineate the biochemical mechanisms involved in NOTCH-induced JAK3 ubiquitination and degradation. NOTCH signaling is known to transcriptionally activate the genes encoding ASB2 (ankyrin-repeat SOCS box containing protein 2) and SKP2 (S-phase kinase-associated protein 2). We show that not only NOTCH but also ASB2 and SKP2 can promote the ubiquitination and degradation of JAK3. Both ASB2 and SKP2 can interact with JAK3 through different domains; the FERM and pseudo-kinase domains each had high affinities for ASB2, whereas the kinase domain primarily associated with SKP2. ASB2 and SKP2 previously have been shown to associate with each other to bridge the formation of a non-canonical Cullin1 and Cullin5-containing dimeric E3 ligase complex. Interestingly, the R980W mutant of JAK3 exhibited diminished interaction with SKP2 and resistance to NOTCH or ASB2-induced degradation. Furthermore, dominant-negative mutants of either Cullin1 or Cullin5, which lack the C terminus responsible for recruiting the E2 enzymes, were able to prevent JAK3 degradation induced by both ASB2/SKP2 and NOTCH signaling. Together, these results suggest that JAK3 ubiquitination involves the non-canonical dimeric E3 ligase complex, and the R980W mutant will serve as an excellent tool for investigating the biological significance of NOTCH-mediated JAK3 turnover.	[Wu, Wei; Sun, Xiao-Hong] Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, Oklahoma City, OK 73104 USA; [Wu, Wei; Sun, Xiao-Hong] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Sun, XH (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	sunx@omrf.org			National Institutes of Health [AI56129]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI56129 (to X.-H. S.).	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Allman D, 2002, CELL, V109, pS1, DOI 10.1016/S0092-8674(02)00689-X; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bergamin E, 2006, STRUCTURE, V14, P1285, DOI 10.1016/j.str.2006.06.011; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Callahan R, 2001, J MAMMARY GLAND BIOL, V6, P23, DOI 10.1023/A:1009512414430; Candotti F, 1997, BLOOD, V90, P3996, DOI 10.1182/blood.V90.10.3996; Chatti K, 2004, BIOCHEMISTRY-US, V43, P4272, DOI 10.1021/bi036109b; Cornejo MG, 2009, BLOOD, V113, P2746, DOI 10.1182/blood-2008-06-164368; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Giordanetto F, 2003, PROTEIN ENG, V16, P115, DOI 10.1093/proeng/gzg015; Gurniak CB, 1996, BLOOD, V87, P3151, DOI 10.1182/blood.V87.8.3151.bloodjournal8783151; He YW, 1997, J IMMUNOL, V158, P2592; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Milne CD, 2006, SEMIN IMMUNOL, V18, P20, DOI 10.1016/j.smim.2005.10.003; Moore TA, 1996, J IMMUNOL, V157, P2366; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Nie L, 2008, MOL CELL BIOL, V28, P2078, DOI 10.1128/MCB.00844-07; Nie L, 2011, CELL RES, V21, P754, DOI 10.1038/cr.2010.165; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; O'Shea JJ, 2004, ANN RHEUM DIS, V63, P67, DOI 10.1136/ard.2004.028290; O'Shea JJ, 2004, MOL IMMUNOL, V41, P727, DOI 10.1016/j.molimm.2004.04.014; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Pesu M, 2008, IMMUNOL REV, V223, P132, DOI 10.1111/j.1600-065X.2008.00644.x; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Simpson P, 1998, SEMIN CELL DEV BIOL, V9, P581, DOI 10.1006/scdb.1998.0265; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Thomis DC, 1997, CURR OPIN IMMUNOL, V9, P541, DOI 10.1016/S0952-7915(97)80108-2; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Vainchenker W, 2008, SEMIN CELL DEV BIOL, V19, P385, DOI 10.1016/j.semcdb.2008.07.002; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Waiboci LW, 2007, J IMMUNOL, V178, P5058, DOI 10.4049/jimmunol.178.8.5058; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Yan Q, 2004, J BIOL CHEM, V279, P43019, DOI 10.1074/jbc.M408018200	58	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41153	41162		10.1074/jbc.M111.273755	http://dx.doi.org/10.1074/jbc.M111.273755			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21969365	Green Published, hybrid			2022-12-25	WOS:000298057500004
J	Mellor, KM; Bell, JR; Wendt, IR; Davidoff, AJ; Ritchie, RH; Delbridge, LMD				Mellor, Kimberley M.; Bell, James R.; Wendt, Igor R.; Davidoff, Amy J.; Ritchie, Rebecca H.; Delbridge, Lea M. D.			Fructose Modulates Cardiomyocyte Excitation-Contraction Coupling and Ca2+ Handling In Vitro	PLOS ONE			English	Article							TRANSPORTER; DYSFUNCTION; GLYCOLYSIS; EXPRESSION; GLUT5; GENE; ATP	Background-High dietary fructose has structural and metabolic cardiac impact, but the potential for fructose to exert direct myocardial action is uncertain. Cardiomyocyte functional responsiveness to fructose, and capacity to transport fructose has not been previously demonstrated. Objective:The aim of the present study was to seek evidence of fructos-induced modulation of cardiomyocyte excitation-contraction coupling in an acute, in vitro setting. Methods and Results: The functional effects of fructose on isolated adult rat cardiomyocyte contractility and Ca2+ handling were evaluated under physiological conditions (37 degrees C, 2 mM Ca2+, HEPES buffer, 4 Hz stimulation) using video edge detection and microfluorimetry (Fura2) methods. Compared with control glucose (11 mM) superfusate, 2-deoxyglucose (2 DG, 11 mM) substitution prolonged both the contraction and relaxation phases of the twitch (by 16 and 36% respectively, p<0.05) and this effect was completely abrogated with fructose supplementation (11 mM). Similarly, fructose prevented the Ca2+ transient delay induced by exposure to 2 DG (time to peak Ca2+ transient: 2 DG: 29.0 +/- 2.1 ms vs. glucose: 23.6 +/- 1.1 ms vs. fructose +2 DG: 23.7 +/- 1.0 ms; p<0.05). The presence of the fructose transporter, GLUT5 (Slc2a5) was demonstrated in ventricular cardiomyocytes using real time RT-PCR and this was confirmed by conventional RT-PCR. Conclusion: This is the first demonstration of an acute influence of fructose on cardiomyocyte excitation-contraction coupling. The findings indicate cardiomyocyte capacity to transport and functionally utilize exogenously supplied fructose. This study provides the impetus for future research directed towards characterizing myocardial fructose metabolism and understanding how long term high fructose intake may contribute to modulating cardiac function.	[Mellor, Kimberley M.; Bell, James R.; Delbridge, Lea M. D.] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia; [Ritchie, Rebecca H.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic, Australia; [Wendt, Igor R.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia; [Davidoff, Amy J.] Univ New England, Coll Osteopath Med, Dept Pharmacol, Biddeford, ME USA; [Ritchie, Rebecca H.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; Monash University; University of New England - Maine; Baker Heart and Diabetes Institute	Mellor, KM (corresponding author), Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia.	kimberley.mellor@unimelb.edu.au	Ritchie, Rebecca H/E-7392-2011	Ritchie, Rebecca/0000-0002-8610-0058; Mellor, Kimberley/0000-0002-8443-9365	National Heart Foundation of Australia	National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was supported by the National Heart Foundation of Australia (www.heartfoundation.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG G, 1990, J APPL PHYSIOL, V69, P1244, DOI 10.1152/jappl.1990.69.4.1244; BAIS R, 1985, BIOCHEM J, V230, P53, DOI 10.1042/bj2300053; CASTELLO A, 1995, BIOCHEM J, V309, P271, DOI 10.1042/bj3090271; Chess DJ, 2008, AM J PHYSIOL-HEART C, V295, pH2223, DOI 10.1152/ajpheart.00563.2008; Corpe CP, 2002, BBA-GENE STRUCT EXPR, V1576, P191, DOI 10.1016/S0167-4781(02)00284-1; Davidoff AJ, 2006, CLIN EXP PHARMACOL P, V33, P152, DOI 10.1111/j.1440-1681.2006.04343.x; Delbridge LMD, 2000, CLIN SCI, V98, P401, DOI 10.1042/CS19990230; GIBBS CL, 1979, ANNU REV PHYSIOL, V41, P507, DOI 10.1146/annurev.ph.41.030179.002451; Goldhaber J, 1997, MYOCARDIUM; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALL JL, 1995, J APPL PHYSIOL, V78, P76, DOI 10.1152/jappl.1995.78.1.76; HENRY RR, 1991, ANNU REV NUTR, V11, P21, DOI 10.1146/annurev.nu.11.070191.000321; Kawasaki T, 2002, DIABETES CARE, V25, P353, DOI 10.2337/diacare.25.2.353; Kockskamper J, 2005, J PHYSIOL-LONDON, V564, P697, DOI 10.1113/jphysiol.2004.078782; Laczy B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018417; MAYES PA, 1993, AM J CLIN NUTR, V58, P754; Mellor K, 2010, NUTRITION, V26, P842, DOI 10.1016/j.nut.2009.08.017; Mellor KM, 2011, J MOL CELL CARDIOL, V50, P1035, DOI 10.1016/j.yjmcc.2011.03.002; Mellor KM, 2010, CAN J PHYSIOL PHARM, V88, P525, DOI [10.1139/Y10-005, 10.1139/y10-005]; Mellor KM, 2010, CLIN EXP PHARMACOL P, V37, P222, DOI 10.1111/j.1440-1681.2009.05274.x; Noh HL, 2009, J PHARMACOL EXP THER, V328, P496, DOI 10.1124/jpet.108.136283; PIERCE GN, 1985, J BIOL CHEM, V260, P6862; Ren J, 1997, AM J PHYSIOL-HEART C, V273, pH2876, DOI 10.1152/ajpheart.1997.273.6.H2876; Ren J, 2009, CLIN EXP PHARMACOL P, V36, P141, DOI 10.1111/j.1440-1681.2008.05034.x; Rogers S, 2003, BIOCHEM BIOPH RES CO, V308, P422, DOI 10.1016/S0006-291X(03)01417-7; Schalkwijk CG, 2004, DIABETES-METAB RES, V20, P369, DOI 10.1002/dmrr.488; Scheepers A, 2005, MOL MEMBR BIOL, V22, P339, DOI 10.1080/09687860500166143; Schwanke ML, 2006, DIABETOLOGIA, V49, P1097, DOI 10.1007/s00125-006-0184-9; SHEPHERD PR, 1992, DIABETES, V41, P1360, DOI 10.2337/diabetes.41.10.1360; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; TAVAZZI B, 1992, BASIC RES CARDIOL, V87, P280, DOI 10.1007/BF00804337; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Van Emous JG, 2001, AM J PHYSIOL-HEART C, V280, pH2189, DOI 10.1152/ajpheart.2001.280.5.H2189; WEISS JN, 1993, CARDIOVASC DRUG THER, V7, P499, DOI 10.1007/BF00877614; XU KY, 1995, CIRC RES, V77, P88, DOI 10.1161/01.RES.77.1.88	35	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25204	10.1371/journal.pone.0025204	http://dx.doi.org/10.1371/journal.pone.0025204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980397	Green Submitted, Green Published, gold			2022-12-25	WOS:000295939600015
J	Speed, N; Saunders, C; Davis, AR; Owens, WA; Matthies, HJG; Saadat, S; Kennedy, JP; Vaughan, RA; Neve, RL; Lindsley, CW; Russo, SJ; Daws, LC; Niswender, KD; Galli, A				Speed, Nicole; Saunders, Christine; Davis, Adeola R.; Owens, W. Anthony; Matthies, Heinrich J. G.; Saadat, Sanaz; Kennedy, Jack P.; Vaughan, Roxanne A.; Neve, Rachael L.; Lindsley, Craig W.; Russo, Scott J.; Daws, Lynette C.; Niswender, Kevin D.; Galli, Aurelio			Impaired Striatal Akt Signaling Disrupts Dopamine Homeostasis and Increases Feeding	PLOS ONE			English	Article							HIGH-FAT DIET; NOREPINEPHRINE TRANSPORTER TRAFFICKING; INSULIN-RESISTANCE; DORSAL STRIATUM; INDUCED OBESITY; FOOD REWARD; MICE PRONE; AMPHETAMINE; EXPRESSION; LEPTIN	Background: The prevalence of obesity has increased dramatically worldwide. The obesity epidemic begs for novel concepts and therapeutic targets that cohesively address "food-abuse" disorders. We demonstrate a molecular link between impairment of a central kinase (Akt) involved in insulin signaling induced by exposure to a high-fat (HF) diet and dysregulation of higher order circuitry involved in feeding. Dopamine (DA) rich brain structures, such as striatum, provide motivation stimuli for feeding. In these central circuitries, DA dysfunction is posited to contribute to obesity pathogenesis. We identified a mechanistic link between metabolic dysregulation and the maladaptive behaviors that potentiate weight gain. Insulin, a hormone in the periphery, also acts centrally to regulate both homeostatic and reward-based HF feeding. It regulates DA homeostasis, in part, by controlling a key element in DA clearance, the DA transporter (DAT). Upon HF feeding, nigro-striatal neurons rapidly develop insulin signaling deficiencies, causing increased HF calorie intake. Methodology/Principal Findings: We show that consumption of fat-rich food impairs striatal activation of the insulin-activated signaling kinase, Akt. HF-induced Akt impairment, in turn, reduces DAT cell surface expression and function, thereby decreasing DA homeostasis and amphetamine (AMPH)-induced DA efflux. In addition, HF-mediated dysregulation of Akt signaling impairs DA-related behaviors such as (AMPH)-induced locomotion and increased caloric intake. We restored nigro-striatal Akt phosphorylation using recombinant viral vector expression technology. We observed a rescue of DAT expression in HF fed rats, which was associated with a return of locomotor responses to AMPH and normalization of HF diet-induced hyperphagia. Conclusions/Significance: Acquired disruption of brain insulin action may confer risk for and/or underlie "food-abuse" disorders and the recalcitrance of obesity. This molecular model, thus, explains how even short-term exposure to "the fast food lifestyle" creates a cycle of disordered eating that cements pathological changes in DA signaling leading to weight gain and obesity.	[Davis, Adeola R.; Matthies, Heinrich J. G.; Galli, Aurelio] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Speed, Nicole; Saunders, Christine; Kennedy, Jack P.; Lindsley, Craig W.; Galli, Aurelio] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Galli, Aurelio] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37212 USA; [Owens, W. Anthony; Daws, Lynette C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Vaughan, Roxanne A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA; [Russo, Scott J.] Mt Sinai Med Ctr, Dept Neurosci, New York, NY 10029 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Saadat, Sanaz; Niswender, Kevin D.] Tennessee Valley Healthcare Syst, Nashville, TN USA; [Niswender, Kevin D.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Health San Antonio; University of North Dakota Grand Forks; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Speed, N (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.	aurelio.galli@vanderbilt.edu	Russo, Scott/R-7107-2019; Matthies, Heinrich/B-7284-2017; Matthies, Heinrich/AAD-2375-2019	Russo, Scott/0000-0002-6470-1805; Matthies, Heinrich/0000-0003-3615-7571; Matthies, Heinrich/0000-0003-3615-7571	National Institutes of Health [DA14684, DK085712]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by the National Institutes of Health grants DA14684 given to AG and LCD and by the DK085712 grant given to AG and KDN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Doolen S, 2001, J PHARMACOL EXP THER, V296, P931; Figlewicz DP, 2010, PHARMACOL BIOCHEM BE, V97, P15, DOI 10.1016/j.pbb.2010.03.002; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Gaffaney JD, 2004, MOL PHARMACOL, V65, P692, DOI 10.1124/mol.65.3.692; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; Geiger BM, 2009, NEUROSCIENCE, V159, P1193, DOI 10.1016/j.neuroscience.2009.02.007; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; Gochenauer GE, 2001, J NEUROCHEM, V78, P276, DOI 10.1046/j.1471-4159.2001.00385.x; Grueter BA, 2005, NEUROPSYCHOPHARMACOL, V30, P1302, DOI 10.1038/sj.npp.1300672; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Heusner CL, 2003, BRAIN RES, V980, P266, DOI 10.1016/S0006-8993(03)02986-X; Huang XF, 2005, MOL BRAIN RES, V135, P150, DOI 10.1016/j.molbrainres.2004.12.013; Huang XF, 2006, BEHAV BRAIN RES, V175, P415, DOI 10.1016/j.bbr.2006.08.034; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Konner AC, 2011, CELL METAB, V13, P720, DOI 10.1016/j.cmet.2011.03.021; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Matthies HJG, 2010, J NEUROSCI, V30, P7863, DOI 10.1523/JNEUROSCI.4574-09.2010; Matthies HJG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-65; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Niswender KD, 2003, J HISTOCHEM CYTOCHEM, V51, P275, DOI 10.1177/002215540305100302; Niswender KD, 2011, NEUROPSYCHOPHARMACOL, V36, P359, DOI 10.1038/npp.2010.167; Owens WA, 2005, J NEUROCHEM, V94, P1402, DOI 10.1111/j.1471-4159.2005.03289.x; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Robertson SD, 2010, J NEUROSCI, V30, P11305, DOI 10.1523/JNEUROSCI.0126-10.2010; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Sotak BN, 2005, BRAIN RES, V1061, P88, DOI 10.1016/j.brainres.2005.08.053; Speed NK, 2010, ACS CHEM NEUROSCI, V1, P476, DOI 10.1021/cn100031t; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Taha C, 1999, J MEMBRANE BIOL, V169, P1, DOI 10.1007/PL00005896; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wei Y, 2007, MOL PHARMACOL, V71, P835, DOI 10.1124/mol.106.026351; Williams J, 2007, PLOS BIOL, V5, P2369, DOI 10.1371/journal.pbio.0050274	41	84	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25169	10.1371/journal.pone.0025169	http://dx.doi.org/10.1371/journal.pone.0025169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969871	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900028
J	Yu, QB; Sui, J; Rachakonda, S; He, H; Gruner, W; Pearlson, G; Kiehl, KA; Calhoun, VD				Yu, Qingbao; Sui, Jing; Rachakonda, Srinivas; He, Hao; Gruner, William; Pearlson, Godfrey; Kiehl, Kent A.; Calhoun, Vince D.			Altered Topological Properties of Functional Network Connectivity in Schizophrenia during Resting State: A Small-World Brain Network Study	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; GRAPH-THEORETICAL ANALYSIS; CORTICAL NETWORKS; BLIND SEPARATION; LOW-FREQUENCY; SCALE-FREE; FMRI DATA; MRI DATA; ORGANIZATION; DYSCONNECTIVITY	Aberrant topological properties of small-world human brain networks in patients with schizophrenia (SZ) have been documented in previous neuroimaging studies. Aberrant functional network connectivity (FNC, temporal relationships among independent component time courses) has also been found in SZ by a previous resting state functional magnetic resonance imaging (fMRI) study. However, no study has yet determined if topological properties of FNC are also altered in SZ. In this study, small-world network metrics of FNC during the resting state were examined in both healthy controls (HCs) and SZ subjects. FMRI data were obtained from 19 HCs and 19 SZ. Brain images were decomposed into independent components (ICs) by group independent component analysis (ICA). FNC maps were constructed via a partial correlation analysis of ICA time courses. A set of undirected graphs were built by thresholding the FNC maps and the small-world network metrics of these maps were evaluated. Our results demonstrated significantly altered topological properties of FNC in SZ relative to controls. In addition, topological measures of many ICs involving frontal, parietal, occipital and cerebellar areas were altered in SZ relative to controls. Specifically, topological measures of whole network and specific components in SZ were correlated with scores on the negative symptom scale of the Positive and Negative Symptom Scale (PANSS). These findings suggest that aberrant architecture of small-world brain topology in SZ consists of ICA temporally coherent brain networks.	[Yu, Qingbao; Sui, Jing; Rachakonda, Srinivas; He, Hao; Gruner, William; Kiehl, Kent A.; Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [He, Hao; Gruner, William; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Pearlson, Godfrey; Calhoun, Vince D.] Olin Neuropsychiat Res Ctr, Hartford, CT USA; [Pearlson, Godfrey; Calhoun, Vince D.] Yale Univ, Dept Psychiat, New Haven, CT USA; [Kiehl, Kent A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico; Yale University; University of New Mexico	Yu, QB (corresponding author), Mind Res Network, Albuquerque, NM USA.	qyu@mrn.org; vcalhoun@unm.edu	Calhoun, Vince D./ACN-9399-2022; Yu, Qingbao/I-2244-2013; He, Hao/H-9618-2014; Sui, Jing/B-3455-2018; Kiehl, Kent A./AAK-3290-2020	Calhoun, Vince D./0000-0001-9058-0747; Yu, Qingbao/0000-0003-4166-3102; He, Hao/0000-0002-9382-998X; Sui, Jing/0000-0001-6837-5966; 	NIH [R01 EB000840, R37 MH43775, R01 MH072681-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072681, R37MH043775] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants R01 EB000840 (PI: Calhoun), R37 MH43775 (PI: Pearlson) and R01 MH072681-01 (PI: Kiehl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Adcock RA, 2009, SCHIZOPHRENIA BULL, V35, P1132, DOI 10.1093/schbul/sbp068; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bor J, SCHIZOPHR R IN PRESS; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 1997, SCHIZOPHR RES, V28, P143, DOI 10.1016/S0920-9964(97)00114-X; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Danckert J, 2004, SCHIZOPHR RES, V70, P241, DOI 10.1016/j.schres.2003.12.007; Danielyan A, 2009, PSYCHIAT CLIN N AM, V32, P719, DOI 10.1016/j.psc.2009.08.004; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; Erhardt EB, HUM BRAIN M IN PRESS; First M. B., 2002, STRUCTURED CLIN INTE; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Fisher RA, 1914, BIOMETRIKA, V10, P507; Freire L, 2002, IEEE T MED IMAGING, V21, P470, DOI 10.1109/TMI.2002.1009383; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 2005, AM J PSYCHIAT, V162, P429, DOI 10.1176/appi.ajp.162.3.429; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gillig Paulette Marie, 2010, Psychiatry (Edgmont), V7, P38; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hendler T, 2009, CURR OPIN PSYCHIATR, V22, P300, DOI 10.1097/YCO.0b013e32832a16f0; Honey GD, 2005, BRAIN, V128, P2597, DOI 10.1093/brain/awh632; Hugdahl Kenneth, 2010, Front Hum Neurosci, V4, P4, DOI 10.3389/neuro.09.004.2010; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Iritani S, 2007, NEUROPATHOLOGY, V27, P604, DOI 10.1111/j.1440-1789.2007.00798.x; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Li XB, 2009, CURR OPIN PSYCHIATR, V22, P131, DOI 10.1097/YCO.0b013e328324bc43; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P368, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<368::AID-HBM7>3.0.CO;2-E; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Ongur D, 2010, PSYCHIAT RES-NEUROIM, V183, P59, DOI 10.1016/j.pscychresns.2010.04.008; Palmer BW, 2009, NEUROPSYCHOL REV, V19, P365, DOI 10.1007/s11065-009-9109-y; Park S, 2010, AM J PSYCHIAT, V167, P366, DOI 10.1176/appi.ajp.2010.10010089; Pearlson GD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.037.2009; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sava Simona, 2008, Top Magn Reson Imaging, V19, P71, DOI 10.1097/RMR.0b013e318184187c; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Swanson N, 2011, HUM BRAIN MAPP, V32, P654, DOI 10.1002/hbm.21055; Tan HY, 2006, AM J PSYCHIAT, V163, P1969, DOI 10.1176/appi.ajp.163.11.1969; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Van Snellenberg JX, 2009, PSYCHIAT RES-NEUROIM, V174, P89, DOI 10.1016/j.pscychresns.2009.04.001; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Wang Y, 2009, SCHIZOPHR RES, V114, P64, DOI 10.1016/j.schres.2009.07.009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu QB, 2011, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00007, 10.3389/fnsys.2011.00103]; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029	93	103	107	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25423	10.1371/journal.pone.0025423	http://dx.doi.org/10.1371/journal.pone.0025423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980454	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900064
J	Armata, HL; Shroff, P; Garlick, DE; Penta, K; Tapper, AR; Sluss, HK				Armata, Heather L.; Shroff, Punita; Garlick, David E.; Penta, Krista; Tapper, Andrew R.; Sluss, Hayla K.			Loss of p53 Ser18 and Atm Results in Embryonic Lethality without Cooperation in Tumorigenesis	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA; MUTATIONS; MICE; DEFICIENT; RADIATION; LYMPHOMA; GENE; DEFECTS; PHOSPHORYLATION; SUSCEPTIBILITY	Phosphorylation at murine Serine 18 (human Serine 15) is a critical regulatory process for the tumor suppressor function of p53. p53Ser18 residue is a substrate for ataxia-telangiectasia mutated (ATM) and ATM-related (ATR) protein kinases. Studies of mice with a germ-line mutation that replaces Ser18 with Ala (p53(S18A) mice) have demonstrated that loss of phosphorylation of p53Ser18 leads to the development of tumors, including lymphomas, fibrosarcomas, leukemia and leiomyosarcomas. The predominant lymphoma is B-cell lymphoma, which is in contrast to the lymphomas observed in Atm(-/-) animals. This observation and the fact that multiple kinases phosphorylate p53Ser18 suggest Atm-independent tumor suppressive functions of p53Ser18. Therefore, in order to examine p53Ser18 function in relationship to ATM, we analyzed the lifespan and tumorigenesis of mice with combined mutations in p53Ser18 and Atm. Surprisingly, we observed no cooperation in survival and tumorigenesis in compound p53(S18A) and Atm(-/-) animals. However, we observed embryonic lethality in the compound mutant animals. In addition, the homozygous p53Ser18 mutant allele impacted the weight of Atm(-/-) animals. These studies examine the genetic interaction of p53Ser18 and Atm in vivo. Furthermore, these studies demonstrate a role of p53Ser18 in regulating embryonic survival and motor coordination.	[Armata, Heather L.; Shroff, Punita; Sluss, Hayla K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol, Worcester, MA 01605 USA; [Garlick, David E.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Penta, Krista; Tapper, Andrew R.] Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Armata, HL (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol, Worcester, MA 01605 USA.	hayla.sluss@umassmed.edu			American Cancer Society; Diabetes and Endocrinology Research grant [DK32520]; National Ataxia Foundation; National Institute on Alcohol Abuse and Alcoholism [5R01AA017656]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017656] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Diabetes and Endocrinology Research grant; National Ataxia Foundation; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	PS was funded by an American Cancer Society Fuller Fellow Award. HS is a member of the Universtiy of Massachusetts Diabetes and Endocrinology Research Center (DK32520). Core resources supported by the Diabetes and Endocrinology Research grant DK32520 were also used. This research was supported by a grant from the National Ataxia Foundation to HS and the National Institute on Alcohol Abuse and Alcoholism to AT (Grant 5R01AA017656). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Armata HL, 2007, CANCER RES, V67, P11696, DOI 10.1158/0008-5472.CAN-07-1610; Armata HL, 2010, MOL CELL BIOL, V30, P5787, DOI 10.1128/MCB.00347-10; Bailey SL, 2008, MOL CANCER RES, V6, P1185, DOI 10.1158/1541-7786.MCR-07-2009; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barlow C, 1999, NATURE, V4, P359; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Bullrich F, 1999, CANCER RES, V59, P24; Chao C, 2003, J BIOL CHEM IN PRESS; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kuljis RO, 1997, P NATL ACAD SCI USA, V94, P12688, DOI 10.1073/pnas.94.23.12688; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mao JH, 2008, ONCOGENE, V27, P6596, DOI 10.1038/onc.2008.280; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Reliene R, 2007, J NUTR, V137, p229S, DOI 10.1093/jn/137.1.229S; Schaffner C, 2000, P NATL ACAD SCI USA, V97, P2773, DOI 10.1073/pnas.050400997; Schaffner C, 1999, BLOOD, V94, P748, DOI 10.1182/blood.V94.2.748.414k02_748_753; Sluss HK, 2010, MOL CANCER RES, V8, P216, DOI 10.1158/1541-7786.MCR-09-0324; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; Smilenov LB, 2001, CANCER RES, V61, P5710; Spring K, 2002, NAT GENET, V32, P185, DOI 10.1038/ng958; Spring K, 2001, CANCER RES, V61, P4561; Stankovic T, 2002, LEUKEMIA LYMPHOMA, V43, P1563, DOI 10.1080/1042819021000002884; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; Stilgenbauer S, 1997, NAT MED, V3, P1155, DOI 10.1038/nm1097-1155; Stoppa-Lyonnet D, 1998, BLOOD, V91, P3920, DOI 10.1182/blood.V91.10.3920.3920_3920_3926; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; Taylor AMR, 2005, J CLIN PATHOL, V58, P1009, DOI 10.1136/jcp.2005.026062; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Vorechovsky I, 1997, NAT GENET, V17, P96, DOI 10.1038/ng0997-96; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Worgul BV, 2002, P NATL ACAD SCI USA, V99, P9836, DOI 10.1073/pnas.162349699; Xu Y, 1998, MOL CELL BIOL, V18, P4385, DOI 10.1128/MCB.18.7.4385; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	40	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24813	10.1371/journal.pone.0024813	http://dx.doi.org/10.1371/journal.pone.0024813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980358	Green Published, gold, Green Submitted			2022-12-25	WOS:000295933700009
J	Cook, J; Kleinschmidt, I; Schwabe, C; Nseng, G; Bousema, T; Corran, PH; Riley, EM; Drakeley, CJ				Cook, Jackie; Kleinschmidt, Immo; Schwabe, Christopher; Nseng, Gloria; Bousema, Teun; Corran, Patrick H.; Riley, Eleanor M.; Drakeley, Chris J.			Serological Markers Suggest Heterogeneity of Effectiveness of Malaria Control Interventions on Bioko Island, Equatorial Guinea	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; VECTOR CONTROL; TRANSMISSION; SURVEILLANCE; ELIMINATION; COMBINATION; ANTIBODIES; MORBIDITY; INFECTION; EXPOSURE	Background: In order to control and eliminate malaria, areas of on-going transmission need to be identified and targeted for malaria control interventions. Immediately following intense interventions, malaria transmission can become more heterogeneous if interventions are more successful in some areas than others. Bioko Island, Equatorial Guinea, has been subject to comprehensive malaria control interventions since 2004. This has resulted in substantial reductions in the parasite burden, although this drop has not been uniform across the island. Methods/Principal Findings: In 2008, filter paper blood samples were collected from 7387 people in a cross-sectional study incorporating 18 sentinel sites across Bioko, Equatorial Guinea. Antibodies were measured to P. falciparum Apical Membrane Antigen-1 (AMA-1) by Enzyme Linked Immunosorbent Assay (ELISA). Age-specific seropositivity rates were used to estimate seroconversion rates (SCR). Analysis indicated there had been at least a 60% decline in SCR in four out of five regions on the island. Changes in SCR showed a high degree of congruence with changes in parasite rate (PR) and with regional reductions in all cause child mortality. The mean age adjusted concentration of anti-AMA-1 antibodies was mapped to identify areas where individual antibody responses were higher than expected. This approach confirmed the North West of the island as a major focus of continuing infection and an area where control interventions need to be concentrated or re-evaluated. Conclusion/Interpretation: Both SCR and PR revealed heterogeneity in malaria transmission and demonstrated the variable effectiveness of malaria control measures. This work confirms the utility of serological analysis as an adjunct measure for monitoring transmission. Age-specific seroprevalence based evidence of changes in transmission over time will be of particular value when no baseline data are available. Importantly, SCR data provide additional evidence to link malaria control activities to contemporaneous reductions in all-cause child mortality.	[Cook, Jackie; Bousema, Teun; Corran, Patrick H.; Riley, Eleanor M.; Drakeley, Chris J.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Kleinschmidt, Immo] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Schwabe, Christopher] Med Care Dev Int, Silver Spring, MD USA; [Nseng, Gloria] Minist Hlth & Social Welf, Malabo, Equat Guinea	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Cook, J (corresponding author), London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England.	Chris.Drakeley@lshtm.ac.uk	Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013; Bousema, Teun/N-3574-2014	Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor M/0000-0003-3447-3570; Bousema, Teun/0000-0003-2666-094X	Wellcome Trust [078925]; Marathon Oil Company; Government of Equatorial Guinea; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Marathon Oil Company; Government of Equatorial Guinea; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The malariometric surveys and serological analysis were funded by Marathon Oil and Government of Equatorial Guinea. Addtional funding was provided by by a grant from the Wellcome Trust (078925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported with funds from the Marathon Oil Company. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; BRUCECHWATT LJ, 1975, J TROP MED HYG, V78, P194; BRUCECHWATT LJ, 1973, LANCET, V2, P547; Bukirwa H, 2009, AM J TROP MED HYG, V81, P611, DOI 10.4269/ajtmh.2009.09-0126; Cano J, 2004, J MED ENTOMOL, V41, P158, DOI 10.1603/0022-2585-41.2.158; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; COLLINS WE, 1964, AM J TROP MED HYG, V13, P256, DOI 10.4269/ajtmh.1964.13.256; CORNILLEBROGGER R, 1978, B WORLD HEALTH ORGAN, V56, P579; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; DRAPER CC, 1972, T ROY SOC TROP MED H, V66, P905, DOI 10.1016/0035-9203(72)90126-5; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Kleinschmidt I, 2007, AM J TROP MED HYG, V76, P1027, DOI 10.4269/ajtmh.2007.76.1027; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; Menendez C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-132; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Tseng LF, 2008, AM J TROP MED HYG, V78, P248, DOI 10.4269/ajtmh.2008.78.248; Vega JC, 2007, TROP MED INT HEALTH, V12, P1524, DOI 10.1111/j.1365-3156.2007.01961.x; WILLIAMS BG, 1994, PARASITOL TODAY, V10, P489, DOI 10.1016/0169-4758(94)90163-5; Williams GS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-168; Wilson S, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-67	29	93	94	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25137	10.1371/journal.pone.0025137	http://dx.doi.org/10.1371/journal.pone.0025137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980386	gold, Green Published, Green Accepted			2022-12-25	WOS:000295933700018
J	MacNeil, D; Eliasmith, C				MacNeil, David; Eliasmith, Chris			Fine-Tuning and the Stability of Recurrent Neural Networks	PLOS ONE			English	Article							VESTIBULOOCULAR REFLEX; EYE-MOVEMENTS; CONTINUOUS ATTRACTORS; WORKING-MEMORY; MODEL; INTEGRATOR; PLASTICITY; NEURONS; MECHANISM; DYNAMICS	A central criticism of standard theoretical approaches to constructing stable, recurrent model networks is that the synaptic connection weights need to be finely-tuned. This criticism is severe because proposed rules for learning these weights have been shown to have various limitations to their biological plausibility. Hence it is unlikely that such rules are used to continuously fine-tune the network in vivo. We describe a learning rule that is able to tune synaptic weights in a biologically plausible manner. We demonstrate and test this rule in the context of the oculomotor integrator, showing that only known neural signals are needed to tune the weights. We demonstrate that the rule appropriately accounts for a wide variety of experimental results, and is robust under several kinds of perturbation. Furthermore, we show that the rule is able to achieve stability as good as or better than that provided by the linearly optimal weights often used in recurrent models of the integrator. Finally, we discuss how this rule can be generalized to tune a wide variety of recurrent attractor networks, such as those found in head direction and path integration systems, suggesting that it may be used to tune a wide variety of stable neural systems.	[MacNeil, David; Eliasmith, Chris] Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2L 3G1, Canada	University of Waterloo	MacNeil, D (corresponding author), Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2L 3G1, Canada.	celiasmith@uwaterloo.ca			National Science and Engineering Research Council of Canada (NSERC); NSERC; Canada Research Chair program; Canadian Foundation for Innovation (CFI); Ontario Innovation Trust (OIT)	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Innovation Trust (OIT)	This research was supported by a National Science and Engineering Research Council of Canada (NSERC) Discovery grant, an NSERC Student Research Award (USRA), the Canada Research Chair program, and the Canadian Foundation for Innovation (CFI) and Ontario Innovation Trust (OIT) Leaders Opportunity Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Amit DJ, 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; [Anonymous], 1999, COGNITIVE MAP; [Anonymous], 2003, NEURAL ENG COMPUTATI; Arnold DB, 1997, EXP BRAIN RES, V113, P57, DOI 10.1007/BF02454142; ARNOLD DB, 1991, BIOL CYBERN, V64, P447, DOI 10.1007/BF00202608; ARNOLD DB, 1992, PHILOS T ROY SOC B, V337, P327, DOI 10.1098/rstb.1992.0110; Bekolay T., 2010, CTNTR20101217010; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; COLLEWIJN H, 1977, EXP BRAIN RES, V27, P287; Conklin J, 2005, J COMPUTATIONAL NEUR, V18; De No RL, 1938, J NEUROPHYSIOL, V1, P207; Dell'Osso L, 2008, 070108 OMLAB; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Eliasmith C, 2005, NEURAL COMPUT, V17, P1276, DOI 10.1162/0899766053630332; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Georgopoulos AP, 1986, SCIENCE, V243; Glasser J, 1999, NEUROOPHTHAMALMOLOGY, P327; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Goodridge JP, 2000, J NEUROPHYSIOL, V83, P3402, DOI 10.1152/jn.2000.83.6.3402; Hardie J, 2009, J NEUROSCI, V29, P3233, DOI 10.1523/JNEUROSCI.6000-08.2009; HARRIS LR, 1981, EXP BRAIN RES, V44, P41; Hebb Donald O., 1949, ORG BEHAV; Henneman E, 1981, HDB PHYSL NERVOUS SY, V2; HESS K, 1985, NEURO-OPHTHALMOLOGY, V5, P247, DOI 10.3109/01658108509004937; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Ikezu T, 2008, NEUROIMMUNE PHARM; Jacobs JB, 2004, J VISION, V4, P604, DOI 10.1167/4.7.7; KAPOULA Z, 1989, J NEUROPHYSIOL, V61, P879, DOI 10.1152/jn.1989.61.5.879; KOMPF D, 1987, J NEUROL, V234, P337, DOI 10.1007/BF00314291; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; LASS Y, 1975, BIOL CYBERN, V19, P61, DOI 10.1007/BF00364102; Leigh RJ, 2006, NEUROLOGY EYE MOVEME, P241; LEWIS RF, 1994, J NEUROPHYSIOL, V72, P1028, DOI 10.1152/jn.1994.72.2.1028; Major G, 2004, P NATL ACAD SCI USA, V101, P7739, DOI 10.1073/pnas.0401970101; Major G, 2004, CURRENT OPINION NEUR; McCrea R, 1992, RESPONSES VESTIBULAR, P379; Mensh BD, 2004, VISION RES, V44, P711, DOI 10.1016/j.visres.2003.10.015; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nikitchenko M, 2008, NEURAL COMPUT, V20, P2379, DOI 10.1162/neco.2008.12-06-416; Park J, 2007, J VISION, V7, P142; Porrill J, 2004, P ROY SOC B-BIOL SCI, V271, P789, DOI 10.1098/rspb.2003.2658; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Rao RPN, 2001, NEURAL COMPUT, V13, P2221, DOI 10.1162/089976601750541787; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Seung HS, 2000, J COMPUT NEUROSCI, V9, P171, DOI 10.1023/A:1008971908649; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Seung HS, 1998, NEURAL NETWORKS, V11, P1253, DOI 10.1016/S0893-6080(98)00064-1; Singh R, 2006, J NEUROSCI, V26, P3667, DOI 10.1523/JNEUROSCI.4864-05.2006; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Turaga SC, 2006, COSYNE; Vasilaki E., 2009, PLOS COMPUTATIONAL B, V5; Wang ZI, 2009, VISION RES, V49, P182, DOI 10.1016/j.visres.2008.10.007; WEBER RB, 1972, VISION RES, V12, P467, DOI 10.1016/0042-6989(72)90090-9; WEISSMAN BM, 1989, NEUROLOGY, V39, P534, DOI 10.1212/WNL.39.4.534; Williams R.J., 1995, BACKPROPAGATION THEO, V1, P433; Zhang K, 1996, J NEUROSCI, V16, P2112	62	45	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e22885	10.1371/journal.pone.0022885	http://dx.doi.org/10.1371/journal.pone.0022885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980334	Green Published, gold			2022-12-25	WOS:000295933700002
J	Yan, SJ; Chen, YM; Dong, M; Song, WZ; Belcher, SM; Wang, HS				Yan, Sujuan; Chen, Yamei; Dong, Min; Song, Weizhong; Belcher, Scott M.; Wang, Hong-Sheng			Bisphenol A and 17 beta-Estradiol Promote Arrhythmia in the Female Heart via Alteration of Calcium Handling	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; ISOLATED CARDIAC MYOCYTES; MYOCARDIAL-INFARCTION; MOLECULAR-MECHANISMS; GENDER-DIFFERENCES; CELLULAR BASIS; GUINEA-PIG; CHEMICALS; RAT; CONTRACTION	Background: There is wide-spread human exposure to bisphenol A (BPA), a ubiquitous estrogenic endocrine disruptor that has been implicated as having potentially harmful effects on human heart health. Higher urine BPA concentrations have been shown to be associated with cardiovascular diseases in humans. However, neither the nature nor the mechanism(s) of BPA action on the heart are understood. Methodology/Principal Findings: The rapid (<7 min) effects of BPA and 17 beta-estradiol (E2) in the heart and ventricular myocytes from rodents were investigated in the present study. In isolated ventricular myocytes from young adult females, but not males, physiological concentrations of BPA or E2 (10(-9) M) rapidly induced arrhythmogenic triggered activities. The effects of BPA were particularly pronounced when combined with estradiol. Under conditions of catecholamine stimulation, E2 and BPA promoted ventricular arrhythmias in female, but not male, hearts. The cellular mechanism of the female-specific pro-arrhythmic effects of BPA and E2 were investigated. Exposure to E2 and/or BPA rapidly altered myocyte Ca2+ handling; in particular, estrogens markedly increased sarcoplasmic reticulum (SR) Ca2+ leak, and increased SR Ca2+ load. Ryanodine (10(-7) M) inhibition of SR Ca2+ leak suppressed estrogen-induced triggered activities. The rapid response of female myocytes to estrogens was abolished in an estrogen receptor (ER) beta knockout mouse model. Conclusions/Significance: Physiologically-relevant concentrations of BPA and E2 promote arrhythmias in a female-specific manner in rat hearts; the pro-arrhythmic actions of estrogens are mediated by ER beta-signaling through alterations of myocyte Ca2+ handling, particularly increases in SR Ca2+ leak. Our study provides the first experimental evidence suggesting that exposure to estrogenic endocrine disrupting chemicals and the unique sensitivity of female hearts to estrogens may play a role in arrhythmogenesis in the female heart.	[Yan, Sujuan; Chen, Yamei; Dong, Min; Song, Weizhong; Belcher, Scott M.; Wang, Hong-Sheng] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Yan, SJ (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Jiangxi, Peoples R China.	wanghs@uc.edu		Belcher, Scott/0000-0002-1196-3705	National Institute of Health [R01-ES017262, R21-HL084539, R01-ES05145, RC2 ES018765]; University of Cincinnati Center for Environmental Genetics [P30-ES06096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, RC2ES018765, R01ES017263] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Center for Environmental Genetics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health grants R01-ES017262, R21-HL084539 (HSW), R01-ES05145, RC2 ES018765 (SMB), and University of Cincinnati Center for Environmental Genetics (P30-ES06096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Loza PA, 2008, GENDER MED, V5, pS34, DOI 10.1016/j.genm.2008.03.005; Babiker FA, 2002, CARDIOVASC RES, V53, P709, DOI 10.1016/S0008-6363(01)00526-0; Barakat K, 2000, AM HEART J, V140, P740, DOI 10.1067/mhj.2000.110089; Bers DM, 2005, ANN NY ACAD SCI, V1047, P86, DOI 10.1196/annals.1341.008; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bhupathy P, 2010, WOMENS HEALTH, V6, P77, DOI [10.2217/whe.09.80, 10.2217/WHE.09.80]; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Chung TH, 2004, J MOL CELL CARDIOL, V37, P1013, DOI 10.1016/j.yjmcc.2004.08.003; Czubryt MP, 2006, CAN J PHYSIOL PHARM, V84, P93, DOI 10.1139/Y05-151; Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Du XJ, 2006, PHARMACOL THERAPEUT, V111, P434, DOI 10.1016/j.pharmthera.2005.10.016; Forster C, 2004, P NATL ACAD SCI USA, V101, P14234, DOI 10.1073/pnas.0405571101; Fu XD, 2008, IUBMB LIFE, V60, P502, DOI 10.1002/iub.80; JIANG C, 1992, BRIT J PHARMACOL, V106, P739, DOI 10.1111/j.1476-5381.1992.tb14403.x; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Le HH, 2008, TOXICOL LETT, V176, P149, DOI 10.1016/j.toxlet.2007.11.001; Le HH, 2010, ENDOCRINOLOGY, V151, P5689, DOI 10.1210/en.2010-0710; Levin ER, 2008, AM J PHYSIOL-REG I, V295, pR1425, DOI 10.1152/ajpregu.90605.2008; Marks A. R., 2006, NOVART FDN SYMP, V274, P147; Marks A. R., 2006, NOVART FDN SYMP, V274, P272; Marks Andrew R, 2006, Novartis Found Symp, V274, P132; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Meyer R, 1998, EXP PHYSIOL, V83, P305, DOI 10.1113/expphysiol.1998.sp004115; Nakajima T, 1999, BRIT J PHARMACOL, V127, P429, DOI 10.1038/sj.bjp.0702576; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Rajapakse N, 2001, TOXICOL SCI, V60, P296, DOI 10.1093/toxsci/60.2.296; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Silva E, 2002, ENVIRON SCI TECHNOL, V36, P1751, DOI 10.1021/es0101227; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vom Saal FS, 1998, TOXICOL IND HEALTH, V14, P239, DOI 10.1177/074823379801400115; Wehrens XHT, 2005, ANN NY ACAD SCI, V1047, P366, DOI 10.1196/annals.1341.032; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Wolbrette D, 2002, CLIN CARDIOL, V25, P49, DOI 10.1002/clc.4950250203; Xiao Y, 2011, TOXICOL IN VITRO, V25, P153, DOI 10.1016/j.tiv.2010.10.010; Xing LN, 2010, TOXICOL SCI, V115, P577, DOI 10.1093/toxsci/kfq081; Yap YG, 2005, EUR HEART J, V26, P1385, DOI 10.1093/eurheartj/ehi268; Yuan QQ, 2007, CIRCULATION, V115, P300, DOI 10.1161/CIRCULATIONAHA.106.654699; Zsarnovszky A, 2005, ENDOCRINOLOGY, V146, P5388, DOI 10.1210/en.2005-0565	43	105	109	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25455	10.1371/journal.pone.0025455	http://dx.doi.org/10.1371/journal.pone.0025455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980463	Green Published, Green Submitted, gold			2022-12-25	WOS:000295933700037
J	Houston, MA; Augenlicht, LH; Heerdt, BG				Houston, Michele A.; Augenlicht, Leonard H.; Heerdt, Barbara G.			Intrinsic Mitochondrial Membrane Potential and Associated Tumor Phenotype Are Independent of MUC1 Over-Expression	PLOS ONE			English	Article							COLONIC-CARCINOMA CELLS; CHAIN FATTY-ACIDS; CANCER-CELLS; SURVIVAL RESPONSE; INDUCED APOPTOSIS; RHODACYANINE DYE; OXIDATIVE STRESS; BARTH-SYNDROME; BETA-CATENIN; GROWTH	We have established previously that minor subpopulations of cells with stable differences in their intrinsic mitochondrial membrane potential (Delta psi m) exist within populations of mammary and colonic carcinoma cells and that these differences in Delta psi m are linked to tumorigenic phenotypes consistent with increased probability of participating in tumor progression. However, the mechanism(s) involved in generating and maintaining stable differences in intrinsic Delta psi m and how they are linked to phenotype are unclear. Because the mucin 1 (MUC1) oncoprotein is over-expressed in many cancers, with the cytoplasmic C-terminal fragment (MUC1 C-ter) and its integration into the outer mitochondrial membrane linked to tumorigenic phenotypes similar to those of cells with elevated intrinsic Delta psi m, we investigated whether endogenous differences in MUC1 levels were linked to stable differences in intrinsic Delta psi m and/or to the tumor phenotypes associated with the intrinsic Delta psi m. We report that levels of MUC1 are significantly higher in subpopulations of cells with elevated intrinsic Delta psi m derived from both mammary and colonic carcinoma cell lines. However, using siRNA we found that down-regulation of MUC1 failed to significantly affect either the intrinsic Delta psi m or the tumor phenotypes associated with increased intrinsic Delta psi m. Moreover, whereas pharmacologically mediated disruption of the Delta psi m was accompanied by attenuation of tumor phenotype, it had no impact on MUC1 levels. Therefore, while MUC1 over-expression is associated with subpopulations of cells with elevated intrinsic Delta psi m, it is not directly linked to the generation or maintenance of stable alterations in intrinsic Delta psi m, or to intrinsic Delta psi m associated tumor phenotypes. Since the Delta psi m is the focus of chemotherapeutic strategies, these data have important clinical implications in regard to effectively targeting those cells within a tumor cell population that exhibit stable elevations in intrinsic Delta psi m and are most likely to contribute to tumor progression.	[Houston, Michele A.; Augenlicht, Leonard H.; Heerdt, Barbara G.] Montefiore Med Ctr, Dept Oncol, Albert Einstein Canc Ctr, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Houston, MA (corresponding author), Montefiore Med Ctr, Dept Oncol, Albert Einstein Canc Ctr, 111 E 210Th St, Bronx, NY 10467 USA.	barbara.heerdt@einstein.yu.edu			National Cancer Institute [CA93697]; NATIONAL CANCER INSTITUTE [R01CA093697] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by CA93697 from the National Cancer Institute. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; AZZONE GF, 1984, BIOCHEM SOC T, V12, P414, DOI 10.1042/bst0120414; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Baldus SE, 2004, CLIN CANCER RES, V10, P2790, DOI 10.1158/1078-0432.CCR-03-0163; Barth PG, 1999, J PEDIATR-US, V135, P273, DOI 10.1016/S0022-3476(99)70118-6; Brayman Melissa, 2004, Reprod Biol Endocrinol, V2, P4, DOI 10.1186/1477-7827-2-4; Britten CD, 2000, CLIN CANCER RES, V6, P42; Chaturvedi R, 2005, INT J ONCOL, V26, P1169; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cellbio.4.1.155; CHRISTMAN JE, 1990, GYNECOL ONCOL, V39, P72, DOI 10.1016/0090-8258(90)90402-7; Cullen PJ, 2007, CRIT REV EUKAR GENE, V17, P241, DOI 10.1615/CritRevEukarGeneExpr.v17.i3.50; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; DAIRKEE SH, 1991, BREAST CANCER RES TR, V18, P57, DOI 10.1007/BF01975444; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Fantin VR, 2002, CANCER CELL, V2, P29, DOI 10.1016/S1535-6108(02)00082-X; Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515; Heerdt BG, 2005, CANCER RES, V65, P9861, DOI 10.1158/0008-5472.CAN-05-2444; Heerdt BG, 1998, CANCER RES, V58, P2869; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; Heerdt BG, 2006, CANCER RES, V66, P1591, DOI 10.1158/0008-5472.CAN-05-2717; Heerdt BG, 1999, CANCER RES, V59, P1584; HEERDT BG, 1991, J BIOL CHEM, V266, P19120; Heerdt BG, 2000, CANCER RES, V60, P6704; Hong MY, 2002, CARCINOGENESIS, V23, P1919, DOI 10.1093/carcin/23.11.1919; Horobin RW, 2007, J CONTROL RELEASE, V121, P125, DOI 10.1016/j.jconrel.2007.05.040; Houston Michele A, 2011, Int J Cell Biol, V2011, P978583, DOI 10.1155/2011/978583; Huang L, 2003, CANCER BIOL THER, V2, P702; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Koya K, 1996, CANCER RES, V56, P538; Kufe DW, 2009, CANCER BIOL THER, V8, P1197, DOI 10.4161/cbt.8.13.8844; Liang BC, 2011, INT J MOL MED, V27, P159, DOI 10.3892/ijmm.2010.579; Mariadason JM, 2000, J CELL PHYSIOL, V183, P347, DOI 10.1002/(SICI)1097-4652(200006)183:3<347::AID-JCP7>3.0.CO;2-W; Mariadason JM, 2000, CANCER RES, V60, P4561; MCINTYRE A, 1993, GUT, V34, P386, DOI 10.1136/gut.34.3.386; Medina V, 1998, JPEN-PARENTER ENTER, V22, P14, DOI 10.1177/014860719802200114; MODICANAPOLITANO JS, 1987, CANCER RES, V47, P4361; ModicaNapolitano JS, 1996, CANCER RES, V56, P544; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKAMORI S, 1994, GASTROENTEROLOGY, V106, P353, DOI 10.1016/0016-5085(94)90592-4; Paliwal Rishi, 2007, Current Drug Delivery, V4, P211; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; SCHULZ H, 1985, BIOCH LIPIDS MEMBRAN, P116; SUMMERHAYES IC, 1982, P NATL ACAD SCI-BIOL, V79, P5292, DOI 10.1073/pnas.79.17.5292; Terasaki M, 2007, MOL CELL BIOCHEM, V300, P227, DOI 10.1007/s11010-006-9387-0; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Weissig V., 2000, Current Pharmaceutical Biotechnology, V1, P325, DOI 10.2174/1389201003378870; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Yin L, 2004, J BIOL CHEM, V279, P45721, DOI 10.1074/jbc.M408027200; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200	54	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25207	10.1371/journal.pone.0025207	http://dx.doi.org/10.1371/journal.pone.0025207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966455	Green Submitted, Green Published, gold			2022-12-25	WOS:000295267100028
J	Matter, MS; Hilmenyuk, T; Claus, C; Marone, R; Schurch, C; Tinguely, M; Terracciano, L; Luther, SA; Ochsenbein, AF				Matter, Matthias S.; Hilmenyuk, Tamara; Claus, Christina; Marone, Romina; Schuerch, Christian; Tinguely, Marianne; Terracciano, Luigi; Luther, Sanjiv A.; Ochsenbein, Adrian F.			Destruction of Lymphoid Organ Architecture and Hepatitis Caused by CD4(+) T Cells	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SPLENIC MARGINAL ZONE; B-CELLS; NEUTRALIZING ANTIBODY; IMMUNE-RESPONSES; VIRAL-INFECTION; HIV-INFECTION; MICE; DISEASE; ANTIGEN	Immune responses have the important function of host defense and protection against pathogens. However, the immune response also causes inflammation and host tissue injury, termed immunopathology. For example, hepatitis B and C virus infection in humans cause immunopathological sequel with destruction of liver cells by the host's own immune response. Similarly, after infection with lymphocytic choriomeningitis virus (LCMV) in mice, the adaptive immune response causes liver cell damage, choriomeningitis and destruction of lymphoid organ architecture. The immunopathological sequel during LCMV infection has been attributed to cytotoxic CD8(+) T cells. However, we now show that during LCMV infection CD4(+) T cells selectively induced the destruction of splenic marginal zone and caused liver cell damage with elevated serum alanin-transferase (ALT) levels. The destruction of the splenic marginal zone by CD4(+) T cells included the reduction of marginal zone B cells, marginal zone macrophages and marginal zone metallophilic macrophages. Functionally, this resulted in an impaired production of neutralizing antibodies against LCMV. Furthermore, CD4(+) T cells reduced B cells with an IgM(high) IgD(low) phenotype (transitional stage 1 and 2, marginal zone B cells), whereas other B cell subtypes such as follicular type 1 and 2 and germinal center/memory B cells were not affected. Adoptive transfer of CD4(+) T cells lacking different important effector cytokines and cytolytic pathways such as IFN gamma, TNF alpha, perforin and Fas-FasL interaction did reveal that these cytolytic pathways are redundant in the induction of immunopathological sequel in spleen. In conclusion, our results define an important role of CD4(+) T cells in the induction of immunopathology in liver and spleen. This includes the CD4(+) T cell mediated destruction of the splenic marginal zone with consecutively impaired protective neutralizing antibody responses.	[Matter, Matthias S.; Hilmenyuk, Tamara; Claus, Christina; Schuerch, Christian; Ochsenbein, Adrian F.] Univ Bern, Dept Clin Res, Bern, Switzerland; [Matter, Matthias S.; Terracciano, Luigi] Univ Basel, Dept Pathol, Basel, Switzerland; [Marone, Romina] Univ Basel, Inst Biochem & Genet, Dept Biomed, Basel, Switzerland; [Tinguely, Marianne] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Luther, Sanjiv A.] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Ochsenbein, Adrian F.] Univ Bern, Inselspital, Inst Med Oncol, CH-3010 Bern, Switzerland	University of Bern; University of Basel; University of Basel; University of Zurich; University Zurich Hospital; University of Lausanne; University of Bern; University Hospital of Bern	Matter, MS (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	matterm@uhbs.ch	Terracciano, Luigi M./AAB-5335-2022; Luther, Sanjiv/AAP-6525-2020; Luther, Sanjiv A/B-4380-2016; Schürch, Christian/L-6188-2019; , Sanjiv/B-4380-2016	Terracciano, Luigi M./0000-0002-9393-9660; Luther, Sanjiv/0000-0002-8758-957X; Luther, Sanjiv A/0000-0002-8758-957X; Schürch, Christian/0000-0002-1792-1768; , Sanjiv/0000-0002-0614-561X; Ochsenbein, Adrian/0000-0003-1773-5436; Marone, Romina/0000-0003-1474-1689; Matter, Matthias/0000-0002-2005-5266	Swiss National Science Foundation [632-66020, 117746, 31003A 10488/1, 313630-119347]; Bernische Krebsliga; Werner und Hedy Berger-Janser-Stiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bernische Krebsliga; Werner und Hedy Berger-Janser-Stiftung	This work was supported by the Swiss National Science Foundation (http://www.snf.ch), grant 632-66020; 117746 to Dr. Ochsenbein and grant 31003A 10488/1 to Dr. Luther Oncosuisse (http://www.oncosuisse.ch), the Bernische Krebsliga (http://www.bernischekrebsliga.ch), and the Werner und Hedy Berger-Janser-Stiftung (http://www.krebskrankheiten.ch) to Dr. Ochsenbein. Dr. Schurch is supported by a Swiss MD-PhD scholarship of the Swiss National Science Foundation (313630-119347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Ato M, 2004, J IMMUNOL, V173, P4815, DOI 10.4049/jimmunol.173.8.4815; Attanavanich K, 2004, J IMMUNOL, V172, P803, DOI 10.4049/jimmunol.172.2.803; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Bekiaris V, 2008, J IMMUNOL, V180, P6768, DOI 10.4049/jimmunol.180.10.6768; Belperron AA, 2007, INFECT IMMUN, V75, P3354, DOI 10.1128/IAI.00422-07; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Christensen JP, 1999, P NATL ACAD SCI USA, V96, P5135, DOI 10.1073/pnas.96.9.5135; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Ciurea A, 2001, J EXP MED, V193, P297, DOI 10.1084/jem.193.3.297; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; Frebel H, 2010, EUR J IMMUNOL, V40, P654, DOI 10.1002/eji.200940102; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; GOSSMANN J, 1995, LAB INVEST, V72, P559; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Jellison ER, 2005, J IMMUNOL, V174, P614, DOI 10.4049/jimmunol.174.2.614; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kaplan DE, 2007, GASTROENTEROLOGY, V132, P654, DOI 10.1053/j.gastro.2006.11.044; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Malkiel S, 2009, J IMMUNOL, V182, P498, DOI 10.4049/jimmunol.182.1.498; Matter M, 2006, J EXP MED, V203, P2145, DOI 10.1084/jem.20060651; Matter MS, 2008, AUTOIMMUN REV, V7, P480, DOI 10.1016/j.autrev.2008.03.018; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Muller S, 2002, J VIROL, V76, P2375, DOI 10.1128/JVI.76.5.2375-2383.2002; Nikiforow S, 2003, J VIROL, V77, P12088, DOI 10.1128/JVI.77.22.12088-12104.2003; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Planz O, 2003, NATURE, V426, P474, DOI 10.1038/nature02146; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Su Z, 2001, EUR J IMMUNOL, V31, P947, DOI 10.1002/1521-4141(200103)31:3<947::AID-IMMU947>3.0.CO;2-M; Urban BC, 2005, INFECT IMMUN, V73, P1986, DOI 10.1128/IAI.73.4.1986-1994.2005; van V E, 1985, J HISTOCHEMCYTOCHEM, V33, P40; WALKER DH, 1982, AM J PATHOL, V107, P349; Wilkins BS, 2003, HISTOPATHOLOGY, V42, P173, DOI 10.1046/j.1365-2559.2003.01569.x; ZINKERNAGEL RM, 1986, J EXP MED, V164, P1075, DOI 10.1084/jem.164.4.1075	45	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e24772	10.1371/journal.pone.0024772	http://dx.doi.org/10.1371/journal.pone.0024772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966366	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000295267100008
J	Wong, AL; Shelhamer, M				Wong, Aaron L.; Shelhamer, Mark			Exploring the Fundamental Dynamics of Error-Based Motor Learning Using a Stationary Predictive-Saccade Task	PLOS ONE			English	Article							PROLONGED OPTICAL REVERSAL; VISUAL ERROR; ADAPTIVE-CONTROL; LONG MEMORY; POWER-LAW; ADAPTATION; GAIN; EYE; SEQUENCES; MODEL	The maintenance of movement accuracy uses prior performance errors to correct future motor plans; this motor-learning process ensures that movements remain quick and accurate. The control of predictive saccades, in which anticipatory movements are made to future targets before visual stimulus information becomes available, serves as an ideal paradigm to analyze how the motor system utilizes prior errors to drive movements to a desired goal. Predictive saccades constitute a stationary process (the mean and to a rough approximation the variability of the data do not vary over time, unlike a typical motor adaptation paradigm). This enables us to study inter-trial correlations, both on a trial-by-trial basis and across long blocks of trials. Saccade errors are found to be corrected on a trial-by-trial basis in a direction-specific manner (the next saccade made in the same direction will reflect a correction for errors made on the current saccade). Additionally, there is evidence for a second, modulating process that exhibits long memory. That is, performance information, as measured via inter-trial correlations, is strongly retained across a large number of saccades (about 100 trials). Together, this evidence indicates that the dynamics of motor learning exhibit complexities that must be carefully considered, as they cannot be fully described with current state-space (ARMA) modeling efforts.	[Wong, Aaron L.; Shelhamer, Mark] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Shelhamer, Mark] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	aaron.wong@jhu.edu		Wong, Aaron/0000-0001-7211-0653	National Science Foundation [BCS-0615106]; National Institutes of Health [T32-DC000023, R21 EY019713]; NATIONAL EYE INSTITUTE [R21EY019713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000023] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Science Foundation Grant BCS-0615106 and by the National Institutes of Health Grants T32-DC000023 and R21 EY019713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassingthwaighte J. B., 1994, FRACTAL PHYSL; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; BECKER W, 1973, VISION RES, V13, P1021, DOI 10.1016/0042-6989(73)90141-7; Becker W., 1989, NEUROBIOLOGY SACCADI, P13; Beran J., 1994, STAT LONG MEMORY PRO; Box G. E. P., 1970, Time series analysis, forecasting and control; Chen YQ, 1997, PHYS REV LETT, V79, P4501, DOI 10.1103/PhysRevLett.79.4501; Cheng S, 2006, NEURAL COMPUT, V18, P760, DOI 10.1162/089976606775774651; DAVIES P, 1976, BRAIN RES, V103, P546, DOI 10.1016/0006-8993(76)90453-4; Doornik JA, 2003, COMPUT STAT DATA AN, V42, P333, DOI 10.1016/S0167-9473(02)00212-8; Doornik JA, 2001, INTRO OX VERSION 3 O; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; French AS, 2008, ANN BIOMED ENG, V36, P153, DOI 10.1007/s10439-007-9392-9; Gagnon D, 2002, BRAIN, V125, P123, DOI 10.1093/brain/awf005; Gaymard B, 2001, EUR J NEUROSCI, V14, P554, DOI 10.1046/j.0953-816x.2001.01669.x; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Giraitis L, 2001, J APPL PROBAB, V38, P1033, DOI 10.1017/S0021900200019215; Golla H, 2008, EUR J NEUROSCI, V27, P132, DOI 10.1111/j.1460-9568.2007.05996.x; GONSHOR A, 1976, J PHYSIOL-LONDON, V256, P381, DOI 10.1113/jphysiol.1976.sp011330; Granger C. W. J., 1980, Journal of Time Series Analysis, V1, P15, DOI 10.1111/j.1467-9892.1980.tb00297.x; Hausdorff JM, 1996, PHYS REV E, V54, P2154, DOI 10.1103/PhysRevE.54.2154; HOSKING JRM, 1981, BIOMETRIKA, V68, P165, DOI 10.1093/biomet/68.1.165; Joiner WM, 2005, ANN NY ACAD SCI, V1039, P536, DOI 10.1196/annals.1325.062; Kluzik J, 2008, J NEUROPHYSIOL, V100, P1455, DOI 10.1152/jn.90334.2008; Kording KP, 2007, ADV NEURAL INFORM PR, P745; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lowen SB, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0471754722; Malfait N, 2004, J NEUROSCI, V24, P8084, DOI 10.1523/JNEUROSCI.1742-04.2004; Mandelbrot B. B., 1982, FRACTAL GEOMETRY NAT, DOI DOI 10.1002/ESP3290080415; MANDL G, 1981, BRAIN RES, V209, P35, DOI 10.1016/0006-8993(81)91170-7; Miall RC, 1998, NOVART FDN SYMP, V218, P272; MILLER JM, 1981, J EXP PSYCHOL HUMAN, V7, P356, DOI 10.1037/0096-1523.7.2.356; Morel P, 2011, J NEUROSCI, V31, P10039, DOI 10.1523/JNEUROSCI.0492-11.2011; Nagel M, 2008, EUR NEUROL, V60, P179, DOI 10.1159/000148245; Noto CT, 2001, COGNITIVE BRAIN RES, V12, P301, DOI 10.1016/S0926-6410(01)00062-3; Ooms M, 1999, INFERENCE FORECASTIN; Panouilleres M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017329; Papoulis A, 1984, PROBABILITY RANDOM V; Peng CK, 1995, J ELECTROCARDIOL, V28, P59, DOI 10.1016/S0022-0736(95)80017-4; Rangarajan G, 2000, PHYS REV E, V61, P4991, DOI 10.1103/PhysRevE.61.4991; Roberts S, 2000, PHYS REV E, V62, P2597, DOI 10.1103/PhysRevE.62.2597; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Robinson FR, 2003, J NEUROPHYSIOL, V90, P1235, DOI 10.1152/jn.00656.2002; ROSS SM, 1987, VISION RES, V27, P2177, DOI 10.1016/0042-6989(87)90131-3; Salvucci D.D., 2000, P EYE TRACKING RES A, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; SEMMLOW JL, 1989, J EXP PSYCHOL HUMAN, V15, P249, DOI 10.1037/0096-1523.15.2.249; Shelhamer M, 2005, J NEUROPHYSIOL, V93, P2002, DOI 10.1152/jn.00800.2004; Shelhamer M, 2002, NEUROSCI LETT, V332, P200, DOI 10.1016/S0304-3940(02)00951-5; Shelhamer M, 2007, NONLINEAR DYNAMICS IN PHYSIOLOGY: A STATE-SPACE APPROACH, P1; Shelhamer M, 2003, J NEUROPHYSIOL, V90, P2763, DOI 10.1152/jn.00478.2003; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Srimal R, 2008, J NEUROPHYSIOL, V99, P1554, DOI 10.1152/jn.01024.2007; STARK L, 1962, IRE T HUM FACT ELECT, VHFE3, P52, DOI 10.1109/THFE2.1962.4503342; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Straube A, 2001, NEUROLOGY, V57, P2105, DOI 10.1212/WNL.57.11.2105; Sulzenbruck S, 2009, CONSCIOUS COGN, V18, P145, DOI 10.1016/j.concog.2008.12.001; Takeichi N, 2007, J NEUROPHYSIOL, V97, P4096, DOI 10.1152/jn.01278.2006; Taylor JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002485; Torre K, 2009, HUM MOVEMENT SCI, V28, P297, DOI 10.1016/j.humov.2009.01.001; TREISMAN M, 1984, PSYCHOL REV, V91, P68, DOI 10.1037/0033-295X.91.1.68; Wagenmakers EJ, 2005, J EXP PSYCHOL GEN, V134, P108, DOI 10.1037/0096-3445.134.1.108; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; Wang GD, 2000, PHYS PLASMAS, V7, P1181, DOI 10.1063/1.873927; Wong AL, 2011, J NEUROPHYSIOL, V105, P1130, DOI 10.1152/jn.00394.2010; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; Zambarbieri D, 1987, EYE MOVEMENTS PHYSL, P131; Zarahn E, 2008, J NEUROPHYSIOL, V100, P2537, DOI 10.1152/jn.90529.2008	70	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25225	10.1371/journal.pone.0025225	http://dx.doi.org/10.1371/journal.pone.0025225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825IZ	21966462	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100030
J	Lopez, P; Gonzalez-Rodriguez, I; Gueimonde, M; Margolles, A; Suarez, A				Lopez, Patricia; Gonzalez-Rodriguez, Irene; Gueimonde, Miguel; Margolles, Abelardo; Suarez, Ana			Immune Response to Bifidobacterium bifidum Strains Support Treg/Th17 Plasticity	PLOS ONE			English	Article							REGULATORY T-CELLS; LACTIC-ACID BACTERIA; HUMAN DENDRITIC CELLS; PROINFLAMMATORY IL-17(+); INTESTINAL BACTERIA; SURFACE-MARKERS; T(H)17 CELLS; IN-VIVO; INDUCTION; CYTOKINES	In this work we analyzed the immune activation properties of different Bifidobacterium strains in order to establish their ability as inductors of specific effector (Th) or regulatory (Treg) responses. First, we determined the cytokine pattern induced by 21 Bifidobacterium strains in peripheral blood mononuclear cells (PBMCs). Results showed that four Bifidobacterium bifidum strains showed the highest production of IL-17 as well as a poor secretion of IFN gamma and TNF alpha, suggesting a Th17 profile whereas other Bifidobacterium strains exhibited a Th1-suggestive profile. Given the key role of Th17 subsets in mucosal defence, strains suggestive of Th17 responses and the putative Th1 Bifidobacterium breve BM12/11 were selected to stimulate dendritic cells (DC) to further determine their capability to induce the differentiation of naive CD4(+) lymphocytes toward different Th or Treg cells. All selected strains were able to induce phenotypic DC maturation, but showed differences in cytokine stimulation, DC treated with the putative Th17 strains displaying high IL-1 beta/IL-12 and low IL-12/IL-10 index, whereas BM12/11-DC exhibited the highest IL-12/IL-10 ratio. Differentiation of naive lymphocytes confirmed Th1 polarization by BM12/11. Unexpectedly, any B. bifidum strain showed significant capability for Th17 generation, and they were able to generate functional Treg, thus suggesting differences between in vivo and vitro responses. In fact, activation of memory lymphocytes present in PBMCS with these bacteria, point out the presence in vivo of specific Th17 cells, supporting the plasticity of Treg/Th17 populations and the key role of commensal bacteria in mucosal tolerance and T cell reprogramming when needed.	[Lopez, Patricia; Suarez, Ana] Univ Oviedo, Immunol Area, Dept Funct Biol, Oviedo, Asturias, Spain; [Lopez, Patricia; Gonzalez-Rodriguez, Irene; Gueimonde, Miguel; Margolles, Abelardo] CSIC, IPLA, Dept Microbiol & Biochem Dairy Prod, Villaviciosa, Asturias, Spain	University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA)	Lopez, P (corresponding author), Univ Oviedo, Immunol Area, Dept Funct Biol, Oviedo, Asturias, Spain.	amargolles@ipla.csic.es	López, Patricia/B-8603-2018; Suarez, Ana/F-4492-2015; Margolles, Abelardo/H-3871-2012; Gueimonde, Miguel/A-4239-2010; Gueimonde, Miguel/A-2106-2008	López, Patricia/0000-0002-1843-0653; Suarez, Ana/0000-0002-4452-7539; Margolles, Abelardo/0000-0003-2278-1816; Gueimonde, Miguel/0000-0002-0192-901X	European Union FEDER; Spanish Plan Nacional de I+D [AGL2007-61805, AGL2010-14952]; Consejo Superior de Investigaciones Cientificas (CSIC PIE) [200870I049]	European Union FEDER(European Commission); Spanish Plan Nacional de I+D; Consejo Superior de Investigaciones Cientificas (CSIC PIE)	This work was financed by European Union FEDER funds and the Spanish Plan Nacional de I+D (grants AGL2007-61805 and AGL2010-14952) and by the Consejo Superior de Investigaciones Cientificas (CSIC PIE 200870I049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2008, INT IMMUNOL, V20, P1361, DOI 10.1093/intimm/dxn106; Arboleya S, 2011, INT J FOOD MICROBIOL, V149, P28, DOI 10.1016/j.ijfoodmicro.2010.10.036; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Baba N, 2008, J LEUKOCYTE BIOL, V84, P468, DOI 10.1189/jlb.0108017; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Boirivant M, 2007, CURR OPIN GASTROEN, V23, P679, DOI 10.1097/MOG.0b013e3282f0cffc; Chalova VI, 2008, J ENVIRON SCI HEAL B, V43, P193, DOI 10.1080/03601230701795262; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; de Roock S, 2010, CLIN EXP ALLERGY, V40, P103, DOI 10.1111/j.1365-2222.2009.03344.x; DeSmedt T, 1997, EUR J IMMUNOL, V27, P1229, DOI 10.1002/eji.1830270526; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Erickson KL, 2000, J NUTR, V130, p403S, DOI 10.1093/jn/130.2.403S; Esposito M, 2010, J IMMUNOL, V185, P7467, DOI 10.4049/jimmunol.1001519; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Food and Agriculture Organization of the United nations/World Health Organization (FAO/WHO), 2006, 85 FAOWHO; Frick JS, 2007, INFLAMM BOWEL DIS, V13, P83, DOI 10.1002/ibd.20009; Garrigues C, 2005, AUST J DAIRY TECHNOL, V60, P84; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gionchetti P, 2001, CURR OPIN GASTROEN, V17, P331, DOI 10.1097/00001574-200107000-00006; Guarner F, 2003, GASTROENTEROL HEP S1, V26, P1; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; ISOLAURI E, 1991, PEDIATRICS, V88, P90; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Karim M, 2004, J IMMUNOL, V172, P923, DOI 10.4049/jimmunol.172.2.923; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lopez P, 2010, INT J FOOD MICROBIOL, V138, P157, DOI 10.1016/j.ijfoodmicro.2009.12.023; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Niers LEM, 2005, CLIN EXP ALLERGY, V35, P1481, DOI 10.1111/j.1365-2222.2005.02375.x; O'Mahony D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-63; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Reid G, 2003, J CLIN GASTROENTEROL, V37, P105, DOI 10.1097/00004836-200308000-00004; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rescigno Maria, 2008, J Pediatr Gastroenterol Nutr, V46 Suppl 1, pE17, DOI 10.1097/01.mpg.0000313831.09089.36; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Ruas-Madiedo P, 2008, APPL ENVIRON MICROB, V74, P1936, DOI 10.1128/AEM.02509-07; Sakata S, 2006, MICROBIOL IMMUNOL, V50, P1, DOI 10.1111/j.1348-0421.2006.tb03762.x; Schultz M, 2004, CLIN DIAGN LAB IMMUN, V11, P372, DOI 10.1128/CDLI.11.2.372-378.2004; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Turroni F, 2009, FRONT BIOSCI-LANDMRK, V14, P4673, DOI 10.2741/3559; Valmori D, 2010, P NATL ACAD SCI USA, V107, P19402, DOI 10.1073/pnas.1008247107; Vissers YM, 2010, FEMS IMMUNOL MED MIC, V59, P60, DOI 10.1111/j.1574-695X.2010.00662.x; Westendorf AM, 2010, INT J MED MICROBIOL, V300, P11, DOI 10.1016/j.ijmm.2009.08.009; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	72	89	120	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24776	10.1371/journal.pone.0024776	http://dx.doi.org/10.1371/journal.pone.0024776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966367	Green Published, gold			2022-12-25	WOS:000295265100017
J	Marchini, FK; de Godoy, LMF; Rampazzo, RCP; Pavoni, DP; Probst, CM; Gnad, F; Mann, M; Krieger, MA				Marchini, Fabricio K.; de Godoy, Lyris M. F.; Rampazzo, Rita C. P.; Pavoni, Daniela P.; Probst, Christian M.; Gnad, Florian; Mann, Matthias; Krieger, Marco A.			Profiling the Trypanosoma cruzi Phosphoproteome	PLOS ONE			English	Article							HIGHLY SELECTIVE ENRICHMENT; PROTEIN-KINASES; PHOSPHORYLATED PEPTIDES; MASS-SPECTROMETRY; SEQUENCE-ANALYSIS; TITANIUM-DIOXIDE; FLAGELLAR-LENGTH; LEISHMANIA-MAJOR; CELL-CYCLE; BRUCEI	Protein phosphorylation is a reversible post-translational modification essential for the regulation of several signal transduction pathways and biological processes in the living cell. Therefore, the identification of protein phosphorylation sites is crucial to understand cell signaling control at the molecular level. Based on mass spectrometry, recent studies have reported the large-scale mapping of phosphorylation sites in various eukaryotes and prokaryotes. However, little is known about the impact of phosphorylation in protozoan parasites. To in depth characterize the phosphoproteome of Trypanosoma cruzi, a parasite of the Kinetoplastida class, protein samples from cells at different phases of the metacyclogenesis - differentiation process of the parasites from non-infective epimastigotes to infective metacyclic trypomastigotes - were enriched for phosphopeptides using TiO2 chromatography and analyzed on an LTQ-Orbitrap mass spectrometer. In total, 1,671 proteins were identified, including 753 phosphoproteins, containing a total of 2,572 phosphorylation sites. The distribution of phosphorylated residues was 2,162 (84.1%) on serine, 384 (14.9%) on threonine and 26 (1.0%) on tyrosine. Here, we also report several consensus phosphorylation sequence motifs and as some of these conserved groups have enriched biological functions, we can infer the regulation by protein kinases of this functions. To our knowledge, our phosphoproteome is the most comprehensive dataset identified until now for Kinetoplastida species. Here we also were able to extract biological information and infer groups of sites phosphorylated by the same protein kinase. To make our data accessible to the scientific community, we uploaded our study to the data repositories PHOSIDA, Proteome Commons and TriTrypDB enabling researchers to access information about the phosphorylation sites identified here.	[Marchini, Fabricio K.; de Godoy, Lyris M. F.; Rampazzo, Rita C. P.; Pavoni, Daniela P.; Probst, Christian M.; Krieger, Marco A.] Inst Carios Chagas, Curitiba, Parana, Brazil; [de Godoy, Lyris M. F.; Gnad, Florian; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	Max Planck Society	Marchini, FK (corresponding author), Inst Carios Chagas, Curitiba, Parana, Brazil.	mkrieger@fiocruz.br	Rampazzo, Rita/AAA-4590-2020; Marchini, Fabricio/ABE-4613-2020; Pavoni, Daniela P/L-3302-2014; Publica, Inct Saude/J-9544-2013; P, CM/B-1358-2013; Probst, Christian/B-8678-2009; Marchini, Fabricio K/A-4775-2009; Krieger, Marco/AAE-8611-2020; de Godoy, Lyris/C-4256-2008; Marchini, Fabricio/AAA-1027-2019; Mann, Matthias/A-3454-2013	Rampazzo, Rita/0000-0002-8367-999X; Pavoni, Daniela P/0000-0001-6776-4345; Probst, Christian/0000-0001-9993-6375; Marchini, Fabricio K/0000-0001-5695-2746; Marchini, Fabricio/0000-0001-5695-2746; Mann, Matthias/0000-0003-1292-4799; Krieger, Marco Aurelio/0000-0003-0030-3952; Gnad, Florian/0000-0002-2287-2251	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Oswaldo Cruz (FIOCRUZ); National Council for Scientific and Technological Development (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Oswaldo Cruz (FIOCRUZ); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MAK has a research fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). This work was supported by grant Papes V from Fundacao Oswaldo Cruz (FIOCRUZ) and National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auxiliadora de Sousa M., 1983, Memorias do Instituto Oswaldo Cruz, V78, P317, DOI 10.1590/S0074-02761983000300009; BATISTA JAN, 1994, MOL BIOCHEM PARASIT, V67, P301, DOI 10.1016/0166-6851(94)00133-2; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; CHAPMAN AB, 1994, J BIOL CHEM, V269, P4754; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; D'Orso I, 2003, TRENDS PARASITOL, V19, P151, DOI 10.1016/S1471-4922(03)00035-7; da Cunha JPC, 2005, MOL BIOCHEM PARASIT, V140, P75, DOI 10.1016/j.molbiopara.2004.12.007; Dallagiovanna B, 2005, EXP PARASITOL, V109, P260, DOI 10.1016/j.exppara.2005.01.003; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Erdmann M, 2006, MOL BIOL CELL, V17, P2035, DOI 10.1091/mbc.E05-10-0976; Espinosa JM, 2003, MOL BIOCHEM PARASIT, V131, P35, DOI 10.1016/S0166-6851(03)00187-7; GNAD F, 2009, PROTEOMICS; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gomez EB, 2001, INT J PARASITOL, V31, P1032, DOI 10.1016/S0020-7519(01)00219-3; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Morales MA, 2008, PROTEOMICS, V8, P350, DOI 10.1002/pmic.200700697; Nakayasu ES, 2009, PROTEOMICS, V9, P3489, DOI 10.1002/pmic.200800874; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Nett IRE, 2009, EUKARYOT CELL, V8, P617, DOI 10.1128/EC.00366-08; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; PARSONS M, 1991, MOL BIOCHEM PARASIT, V45, P241, DOI 10.1016/0166-6851(91)90091-J; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Pradel LC, 2006, J CELL SCI, V119, P1852, DOI 10.1242/jcs.02900; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; SCANFF P, 1991, J CHROMATOGR, V539, P425, DOI 10.1016/S0021-9673(01)83951-0; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; TEIXEIRA SMR, 1995, J BIOL CHEM, V270, P22586, DOI 10.1074/jbc.270.38.22586; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Weatherly DB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-255; Wiese M, 2003, EUKARYOT CELL, V2, P769, DOI 10.1128/EC.2.4.769-777.2003; Xu P, 2001, MOL BIOCHEM PARASIT, V112, P39, DOI 10.1016/S0166-6851(00)00341-8	52	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25381	10.1371/journal.pone.0025381	http://dx.doi.org/10.1371/journal.pone.0025381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966514	Green Published, gold			2022-12-25	WOS:000295265100096
J	Laplante, P; Amireault, P; Subang, R; Dieude, M; Levine, JS; Rauch, J				Laplante, Patrick; Amireault, Pascal; Subang, Rebecca; Dieude, Melanie; Levine, Jerrold S.; Rauch, Joyce			Interaction of beta(2)-Glycoprotein I with Lipopolysaccharide Leads to Toll-like Receptor 4 (TLR4)-dependent Activation of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ADP-INDUCED AGGREGATION; ANTIPHOSPHOLIPID ANTIBODIES; ENDOTOXIN CONTAMINATION; MURINE MACROPHAGES; INNATE IMMUNITY; APOPTOTIC CELLS; HUMAN-PLATELETS; TISSUE FACTOR; FACTOR-ALPHA	beta(2)-Glycoprotein I (beta(2)GPI) is an abundant plasma protein that binds to the surface of cells and particles expressing negatively charged lipids, but its physiological role remains unknown. Antibodies to beta(2)GPI are found in patients with anti-phospholipid syndrome, a systemic autoimmune disease associated with vascular thrombosis and pregnancy morbidity. Although it has been suggested that anti-beta(2)GPI antibodies activate endothelial cells and monocytes by signaling through TLR4, it is unclear how anti-beta(2)GPI antibodies and/or beta(2)GPI interact with TLR4. A number of mammalian proteins (termed "endogenous Toll-like receptor (TLR) ligands") have been reported to bind to TLR4, but, in most cases, subsequent studies have shown that LPS interaction with these proteins is responsible for TLR activation. We hypothesized that, like other endogenous TLR ligands, beta(2)GPI interacts specifically with LPS and that this interaction is responsible for apparent TLR4 activation by beta(2)GPI. Here, we show that both LPS and TLR4 are required for beta(2)GPI to bind to and activate macrophages. Untreated beta(2)GPI stimulated TNF-alpha production in TLR4-sufficient (but not TLR4-deficient) macrophages. In contrast, neither polymyxin B-treated nor delipidated beta(2)GPI stimulated TNF-alpha production. Furthermore, beta(2)GPI bound to LPS in a specific and dose-dependent manner. Finally, untreated beta(2)GPI bound to the surface of TLR4-sufficient (but not TLR4-deficient) macrophages. Polymyxin B treatment of beta(2)GPI abolished macrophage binding. Our findings suggest a potential new biological activity for beta(2)GPI as a protein that interacts specifically with LPS and point to the need to evaluate newly discovered endogenous TLR ligands for potential interactions with LPS.	[Laplante, Patrick; Amireault, Pascal; Subang, Rebecca; Dieude, Melanie; Rauch, Joyce] McGill Univ, Dept Med, Div Rheumatol, Res Inst,Hlth Ctr, Montreal, PQ H3G 1A4, Canada; [Levine, Jerrold S.] Univ Illinois, Dept Med, Nephrol Sect, Chicago, IL 60680 USA; [Levine, Jerrold S.] Jesse Brown Vet Affairs Med Ctr, Nephrol Sect, Dept Med, Chicago, IL 60612 USA	McGill University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Rauch, J (corresponding author), Montreal Gen Hosp, Rm A6 148,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	joyce.rauch@mcgill.ca	Amireault, Pascal/ABH-7300-2020; Amireault, Pascal/H-9356-2015	Amireault, Pascal/0000-0002-5562-7586; Dieude, Melanie/0000-0002-9300-4232	Canadian Institutes of Health Research (CIHR) [MOP-67101, MOP-97916]; Institute of Musculoskeletal Health and Arthritis (IMHA); Arthritis Society [MOP-42391]; CIHR/IMHA [MUS-67101]; Research Institute of the McGill University Health Centre; Canada Foundation for Innovation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis (IMHA); Arthritis Society; CIHR/IMHA(Canadian Institutes of Health Research (CIHR)); Research Institute of the McGill University Health Centre; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This was supported in part by operating grants from the Canadian Institutes of Health Research (CIHR) and the Institute of Musculoskeletal Health and Arthritis (IMHA) and by Arthritis Society Grant MOP-42391 (to J. R.), CIHR Grants MOP-67101 and MOP-97916, CIHR/IMHA Fall 2008 Priority Announcement Grant MUS-67101, and a post-doctoral fellowship from the Research Institute of the McGill University Health Centre (to P. L.).; We are grateful to Evan Roter for contribution to experiments related to this study and to Dr. Simone Chevalier for providing access to the fluorescence microscope (funded by the Canada Foundation for Innovation and the Research Institute of the McGill University Health Centre).	Agar C, 2011, BLOOD, V117, P6939, DOI 10.1182/blood-2010-12-325951; Alard JE, 2010, J IMMUNOL, V185, P1550, DOI 10.4049/jimmunol.1000526; Antal-Szalmas P, 2000, EUR J CLIN INVEST, V30, P167; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; DELPAPA N, 1995, CLIN EXP RHEUMATOL, V13, P179; Di Simone N, 2007, ANN NY ACAD SCI, V1108, P505, DOI 10.1196/annals.1422.054; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; GOLDSMITH GH, 1994, BRIT J HAEMATOL, V87, P548, DOI 10.1111/j.1365-2141.1994.tb08311.x; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Lambrianides A, 2010, J IMMUNOL, V184, P6622, DOI 10.4049/jimmunol.0902765; Levine JS, 2006, J IMMUNOL, V177, P6504, DOI 10.4049/jimmunol.177.9.6504; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Lin IC, 2010, FOOD CHEM TOXICOL, V48, P2642, DOI 10.1016/j.fct.2010.06.034; Lutters BCH, 2003, J BIOL CHEM, V278, P33831, DOI 10.1074/jbc.M212655200; Maiti SN, 2008, J BIOL CHEM, V283, P3761, DOI 10.1074/jbc.M704990200; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mulla MJ, 2009, AM J REPROD IMMUNOL, V62, P96, DOI 10.1111/j.1600-0897.2009.00717.x; NIMPF J, 1987, ATHEROSCLEROSIS, V63, P109, DOI 10.1016/0021-9150(87)90110-9; NIMPF J, 1985, THROMB HAEMOSTASIS, V54, P397; NIMPF J, 1986, BIOCHIM BIOPHYS ACTA, V884, P142, DOI 10.1016/0304-4165(86)90237-0; Pierangeli SS, 2007, ANN RHEUM DIS, V66, P1327, DOI 10.1136/ard.2006.065037; Price BE, 1996, J IMMUNOL, V157, P2201; Raschi E, 2003, BLOOD, V101, P3495, DOI 10.1182/blood-2002-08-2349; Rauch J, 2010, LUPUS, V19, P347, DOI 10.1177/0961203310361492; Reed JH, 2009, ARTHRITIS RHEUM-US, V60, P860, DOI 10.1002/art.24361; Romay-Penabad Z, 2011, BLOOD, V117, P1408, DOI 10.1182/blood-2010-07-299099; Romay-Penabad Z, 2009, BLOOD, V114, P3074, DOI 10.1182/blood-2008-11-188698; Sarter K, 2009, BIOCHEM BIOPH RES CO, V379, P155, DOI 10.1016/j.bbrc.2008.12.024; Shi T, 2004, P NATL ACAD SCI USA, V101, P3939, DOI 10.1073/pnas.0400281101; SHI W, 1993, BLOOD, V81, P1255; Sorice M, 2007, ARTHRITIS RHEUM-US, V56, P2687, DOI 10.1002/art.22802; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Turner JJO, 2009, SCAND J IMMUNOL, V69, P329, DOI 10.1111/j.1365-3083.2008.02224.x; Willems GM, 1996, BIOCHEMISTRY-US, V35, P13833, DOI 10.1021/bi960657q; Yang JS, 2006, CLIN VACCINE IMMUNOL, V13, P309, DOI 10.1128/CVI.13.3.309-313.2006; Zhou H, 2011, CLIN EXP IMMUNOL, V163, P189, DOI 10.1111/j.1365-2249.2010.04291.x	39	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42494	42503		10.1074/jbc.M111.230383	http://dx.doi.org/10.1074/jbc.M111.230383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965665	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000298180900057
J	Brown, CR; Mao, CH; Falkovskaia, E; Law, JK; Boeger, H				Brown, Christopher R.; Mao, Changhui; Falkovskaia, Elena; Law, Jason K.; Boeger, Hinrich			In Vivo Role for the Chromatin-remodeling Enzyme SWI/SNF in the Removal of Promoter Nucleosomes by Disassembly Rather Than Sliding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PHO5 PROMOTER; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; POSITIONED NUCLEOSOMES; OCTAMER TRANSFER; HISTONE OCTAMER; HO PROMOTER; SWI-SNF; COMPLEX	Analysis of in vivo chromatin remodeling at the PHO5 promoter of yeast led to the conclusion that remodeling removes nucleosomes from the promoter by disassembly rather than sliding away from the promoter. The catalytic activities required for nucleosome disassembly remain unknown. Transcriptional activation of the yeast PHO8 gene was found to depend on the chromatin-remodeling complex SWI/SNF, whereas activation of PHO5 was not. Here, we show that PHO8 gene circles formed in vivo lose nucleosomes upon PHO8 induction, indicative of nucleosome removal by disassembly. Our quantitative analysis of expression noise and chromatin-remodeling data indicates that the dynamics of continual nucleosome removal and reformation at the activated promoters of PHO5 and PHO8 are closely similar. In contrast to PHO5, however, activator-stimulated transcription of PHO8 appears to be limited mostly to the acceleration of promoter nucleosome disassembly with little or no acceleration of promoter transitions following nucleosome disassembly, accounting for the markedly lower expression level of PHO8.	[Brown, Christopher R.; Mao, Changhui; Falkovskaia, Elena; Law, Jason K.; Boeger, Hinrich] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Boeger, H (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, 1156 High St, Santa Cruz, CA 95064 USA.	hboeger@ucsc.edu		Brown, Christopher/0000-0001-6076-4035	National Institutes of Health [F32GM087867, GM078111]; Pew Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078111, F32GM087867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Research Service Award Grant F32GM087867 from the National Institutes of Health.; Supported by National Institutes of Health Grant GM078111 and the Pew Scholars Program. To whom correspondence should be addressed: Dept. of Molecular, Cell, and Developmental Biology, University of California, 1156 High St., Santa Cruz, CA 95064. Tel.: 831-459-4487; Fax: 831-459-3139; E-mail: hboeger@ucsc.edu.	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; ALMER A, 1986, EMBO J, V5, P2681, DOI 10.1002/j.1460-2075.1986.tb04551.x; Ansari A, 1999, P NATL ACAD SCI USA, V96, P343, DOI 10.1073/pnas.96.2.343; BARBARIC S, 1992, NUCLEIC ACIDS RES, V20, P1031, DOI 10.1093/nar/20.5.1031; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Cote J, 1998, P NATL ACAD SCI USA, V95, P4947, DOI 10.1073/pnas.95.9.4947; Dechassa ML, 2010, MOL CELL, V38, P590, DOI 10.1016/j.molcel.2010.02.040; DEPEW RE, 1975, P NATL ACAD SCI USA, V72, P4275, DOI 10.1073/pnas.72.11.4275; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Ehrensberger AH, 2011, P NATL ACAD SCI USA, V108, P10115, DOI 10.1073/pnas.1101449108; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; FASCHER KD, 1993, J MOL BIOL, V231, P658, DOI 10.1006/jmbi.1993.1317; Fazzio TG, 2003, MOL CELL, V12, P1333, DOI 10.1016/S1097-2765(03)00436-2; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Gaudreau L, 1997, CELL, V89, P55, DOI 10.1016/S0092-8674(00)80182-8; Ge LM, 1997, BIOTECHNIQUES, V22, P28, DOI 10.2144/97221bm03; Gkikopoulos T, 2009, MOL CELL BIOL, V29, P4057, DOI 10.1128/MCB.00400-09; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Griesenbeck J, 2003, MOL CELL BIOL, V23, P9275, DOI 10.1128/MCB.23.24.9275-9282.2003; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; KELLER W, 1975, P NATL ACAD SCI USA, V72, P4876, DOI 10.1073/pnas.72.12.4876; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Lorch Y, 2011, NAT STRUCT MOL BIOL, V18, P881, DOI 10.1038/nsmb.2072; Mao CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017521; Mao CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.83; Munsterkotter M, 2000, J BIOL CHEM, V275, P22678, DOI 10.1074/jbc.M001409200; Neef DW, 2003, MOL CELL BIOL, V23, P3788, DOI 10.1128/MCB.23.11.3788-3797.2003; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Prunell A, 1998, BIOPHYS J, V74, P2531, DOI 10.1016/S0006-3495(98)77961-5; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025	59	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40556	40565		10.1074/jbc.M111.289918	http://dx.doi.org/10.1074/jbc.M111.289918			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21979950	Green Published, hybrid			2022-12-25	WOS:000297315400015
J	Morris, L; Chen, X; Alam, M; Tomaras, G; Zhang, RJ; Marshall, DJ; Chen, B; Parks, R; Foulger, A; Jaeger, F; Donathan, M; Bilska, M; Gray, ES; Karim, SSA; Kepler, TB; Whitesides, J; Montefiori, D; Moody, MA; Liao, HX; Haynes, BF				Morris, Lynn; Chen, Xi; Alam, Munir; Tomaras, Georgia; Zhang, Ruijun; Marshall, Dawn J.; Chen, Bing; Parks, Robert; Foulger, Andrew; Jaeger, Frederick; Donathan, Michele; Bilska, Mira; Gray, Elin S.; Karim, Salim S. Abdool; Kepler, Thomas B.; Whitesides, John; Montefiori, David; Moody, M. Anthony; Liao, Hua-Xin; Haynes, Barton F.			Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; EXTERNAL REGION; SUBTYPE-B; ANTI-GP41 ANTIBODIES; MOLECULAR-FEATURES; GLYCOPROTEIN GP41; ACUTE INFECTION; VACCINE TARGET; ENV CLONES	Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by experimental HIV-1 vaccines. When these antibodies do occur, it is important to be able to isolate and characterize them to provide clues for vaccine design. CAP206 is a South African subtype C HIV-1-infected individual previously shown to have broadly neutralizing plasma antibodies targeting the envelope gp41 distal membrane proximal external region (MPER). We have now used a fluoresceinated peptide tetramer antigen with specific cell sorting to isolate a human neutralizing monoclonal antibody (mAb) against the HIV-1 envelope gp41 MPER. The isolated recombinant mAb, CAP206-CH12, utilized a portion of the distal MPER (HXB2 amino acid residues, 673-680) and neutralized a subset of HIV-1 pseudoviruses sensitive to CAP206 plasma antibodies. Interestingly, this mAb was polyreactive and used the same germ-line variable heavy (V(H)1-69) and variable kappa light chain (V(K)3-20) gene families as the prototype broadly neutralizing anti-MPER mAb, 4E10 (residues 672-680). These data indicate that there are multiple immunogenic targets in the C-terminus of the MPER of HIV-1 gp41 envelope and suggests that gp41 neutralizing epitopes may interact with a restricted set of naive B cells during HIV-1 infection.	[Morris, Lynn; Chen, Xi; Alam, Munir; Tomaras, Georgia; Zhang, Ruijun; Marshall, Dawn J.; Parks, Robert; Foulger, Andrew; Jaeger, Frederick; Donathan, Michele; Bilska, Mira; Kepler, Thomas B.; Whitesides, John; Montefiori, David; Moody, M. Anthony; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27708 USA; [Morris, Lynn; Chen, Xi; Alam, Munir; Tomaras, Georgia; Zhang, Ruijun; Marshall, Dawn J.; Parks, Robert; Foulger, Andrew; Jaeger, Frederick; Donathan, Michele; Bilska, Mira; Kepler, Thomas B.; Whitesides, John; Montefiori, David; Moody, M. Anthony; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Morris, Lynn; Chen, Xi; Alam, Munir; Tomaras, Georgia; Zhang, Ruijun; Marshall, Dawn J.; Parks, Robert; Foulger, Andrew; Jaeger, Frederick; Donathan, Michele; Bilska, Mira; Kepler, Thomas B.; Whitesides, John; Montefiori, David; Moody, M. Anthony; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Sch Med, Dept Surg, Durham, NC USA; [Morris, Lynn; Chen, Xi; Alam, Munir; Tomaras, Georgia; Zhang, Ruijun; Marshall, Dawn J.; Parks, Robert; Foulger, Andrew; Jaeger, Frederick; Donathan, Michele; Bilska, Mira; Kepler, Thomas B.; Whitesides, John; Montefiori, David; Moody, M. Anthony; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Sch Med, Dept Immunol, Durham, NC USA; [Morris, Lynn; Gray, Elin S.] Natl Inst Communicable Dis, Johannesburg, South Africa; [Karim, Salim S. Abdool] Univ KwaZulu Natal, CAPRISA, Durban, South Africa; [Chen, Bing] Harvard Univ, Childrens Hosp, Sch Med, Mol Med Lab, Boston, MA 02115 USA	Duke University; Duke University; Duke University; Duke University; National Institute for Communicable Diseases (NICD); University of Kwazulu Natal; Harvard University; Boston Children's Hospital; Harvard Medical School	Morris, L (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27708 USA.	lynnm@nicd.ac.za	Gray, Elin/V-6707-2019; Abdool Karim, Quarraisha/GVS-1160-2022; Karim, Salim Safurdeen Abdool/N-5947-2013; Morris, Lynn/V-3941-2018; Karim, Salim Abdool/AAE-7118-2019; Moody, M/AAB-6947-2020; Alam, S. Munir/AAC-6711-2019; Zhang, RUIJUN/AAD-6887-2021; Karim, Salim Abdool/P-3117-2019; Tomaras, Georgia/J-5041-2016	Gray, Elin/0000-0002-8613-3570; Abdool Karim, Quarraisha/0000-0002-0985-477X; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Morris, Lynn/0000-0003-3961-7828; Moody, M/0000-0002-3890-5855; Zhang, RUIJUN/0000-0001-6785-9619; Karim, Salim Abdool/0000-0002-4986-2133; Kepler, Thomas/0000-0002-1383-6865	Center for HIV/AIDS Vaccine Immunology (CHAVI), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health [U54-AI057157]; US National Institutes of Health's Comprehensive International Program of Research on AIDS (CIPRA) [AI51794]; Columbia University-Southern African Fogarty AIDS International Training and Research Programme (AITRP) [D43TW00231, CAPRISA 002]; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794, U54AI057157, T32AI007392] Funding Source: NIH RePORTER	Center for HIV/AIDS Vaccine Immunology (CHAVI), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health's Comprehensive International Program of Research on AIDS (CIPRA); Columbia University-Southern African Fogarty AIDS International Training and Research Programme (AITRP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Center for HIV/AIDS Vaccine Immunology (CHAVI) grant U54-AI057157 from the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The authors thank the US National Institutes of Health's Comprehensive International Program of Research on AIDS (CIPRA grant # AI51794) and the Columbia University-Southern African Fogarty AIDS International Training and Research Programme (AITRP grant # D43TW00231) for the research infrastructure and training that made the CAPRISA 002 Acute Infection study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Alam SM, 2004, AIDS RES HUM RETROV, V20, P836, DOI 10.1089/0889222041725181; Blish CA, 2007, AIDS, V21, P693, DOI 10.1097/QAD.0b013e32805e8727; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Gray ES, 2006, PLOS MED, V3, P1023, DOI 10.1371/journal.pmed.0030255; HARRIS EN, 1987, LANCET, V1, P277; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Johnson TA, 1997, J IMMUNOL, V158, P235; Kunert R, 2004, AIDS RES HUM RETROV, V20, P755, DOI 10.1089/0889222041524571; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Perez LG, 2009, J VIROL, V83, P7397, DOI 10.1128/JVI.00656-09; Pietzsch J, 2010, J VIROL, V84, P5032, DOI 10.1128/JVI.00154-10; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Sharma A, 2003, RHEUMATOLOGY, V42, P453, DOI 10.1093/rheumatology/keg161; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Verkoczy L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007215; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Xu HY, 2010, J VIROL, V84, P1076, DOI 10.1128/JVI.02113-09; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	50	120	137	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e23532	10.1371/journal.pone.0023532	http://dx.doi.org/10.1371/journal.pone.0023532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980336	Green Published, gold, Green Submitted			2022-12-25	WOS:000295941300001
J	Fulop, L; Szanda, G; Enyedi, B; Varnai, P; Spat, A				Fueloep, Laszlo; Szanda, Gergoe; Enyedi, Balazs; Varnai, Peter; Spaet, Andras			The Effect of OPA1 on Mitochondrial Ca2+ Signaling	PLOS ONE			English	Article							DYNAMIN-RELATED GTPASE; DOMINANT OPTIC ATROPHY; CYTOCHROME-C; PROTEOLYTIC CLEAVAGE; CALCIUM-UPTAKE; PROTEIN OPA1; FUSION; APOPTOSIS; TRANSPORT; MEMBRANE	The dynamin-related GTPase protein OPA1, localized in the intermembrane space and tethered to the inner membrane of mitochondria, participates in the fusion of these organelles. Its mutation is the most prevalent cause of Autosomal Dominant Optic Atrophy. OPA1 controls the diameter of the junctions between the boundary part of the inner membrane and the membrane of cristae and reduces the diffusibility of cytochrome c through these junctions. We postulated that if significant Ca2+ uptake into the matrix occurs from the lumen of the cristae, reduced expression of OPA1 would increase the access Ca2+ to the transporters in the crista membrane and thus would enhance Ca2+ uptake. In intact H295R adrenocortical and HeLa cells cytosolic Ca2+ signals evoked with K+ and histamine, respectively, were transferred into the mitochondria. The rate and amplitude of mitochandrial [Ca2+] rise (followed with confocal laser scanning microscopy and FRET measurements with fluorescent wide-field microscopy) were increased after knockdown of OPA1, as compared with cells transfected with control RNA or mitofusin1 siRNA. Ca2+ uptake was enhanced despite reduced nlitochondrial membrane potential. In permeablilized cells the rate of Ca2+ uptake by depolarized mitochondria was also increased in OPA1-silenced cells. The participation of Na+/Ca2+ and Ca2+/H+ antiporters in this transport process is indicate by pharmacological data. Altogether, our observations reveal the significance of OPA1 in the control of mitochondrial Ca2+ metabolism.	[Fueloep, Laszlo; Szanda, Gergoe; Enyedi, Balazs; Varnai, Peter; Spaet, Andras] Semmelweis Univ, Hungarian Acad Sci, Fac Med, Dept Physiol, Budapest, Hungary; [Spaet, Andras] Hungarian Acad Sci, Lab Neurobiochem & Mol Physiol, Budapest, Hungary	Hungarian Academy of Sciences; Semmelweis University; Hungarian Academy of Sciences	Fulop, L (corresponding author), Semmelweis Univ, Hungarian Acad Sci, Fac Med, Dept Physiol, Budapest, Hungary.	spat@eok.sote.hu	Enyedi, Balázs/I-9320-2017; Spat, Andras/AAE-9981-2019	Enyedi, Balázs/0000-0001-5713-3785; 	Hungarian Council for Medical Research [ETT 008-09]	Hungarian Council for Medical Research	Hungarian Council for Medical Research (ETT 008-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amutha B, 2004, BIOCHEM J, V381, P19, DOI 10.1042/BJ20040566; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Baricault L, 2007, EXP CELL RES, V313, P3800, DOI 10.1016/j.yexcr.2007.08.008; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BERNARDI P, 1981, J BIOL CHEM, V256, P7187; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; CROMPTON M, 1978, EUR J BIOCHEM, V82, P25, DOI 10.1111/j.1432-1033.1978.tb11993.x; Dayanithi G, 2010, OPHTHALMIC GENET, V31, P53, DOI 10.3109/13816811003698117; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; De Vos KJ, 2007, METHOD CELL BIOL, V80, P627, DOI 10.1016/S0091-679X(06)80030-0; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; JUNG DW, 1995, J BIOL CHEM, V270, P672, DOI 10.1074/jbc.270.2.672; KAPUS A, 1991, FEBS LETT, V282, P61, DOI 10.1016/0014-5793(91)80444-8; Kim B, 2008, J PHYSIOL-LONDON, V586, P1683, DOI 10.1113/jphysiol.2007.148726; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lenaers G, 2009, INT J BIOCHEM CELL B, V41, P1866, DOI 10.1016/j.biocel.2009.04.013; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu X, 2011, CELL DEATH DIFFER; LONCAR D, 1990, J STRUCT BIOL, V105, P133, DOI 10.1016/1047-8477(90)90107-N; Malli R, 2010, FEBS LETT, V584, P1942, DOI 10.1016/j.febslet.2010.01.010; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; Mannella CA, 2000, J BIOENERG BIOMEMBR, V32, P1, DOI 10.1023/A:1005562109678; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; PEROTTI ME, 1983, J HISTOCHEM CYTOCHEM, V31, P351, DOI 10.1177/31.3.6186730; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Schaaf CP, 2011, MOL GENET METAB; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Smets I, 2004, AM J PHYSIOL-RENAL, V286, pF784, DOI 10.1152/ajprenal.00284.2003; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Szanda G, 2010, CELL CALCIUM, V48, P168, DOI 10.1016/j.ceca.2010.08.005; Trenker M, 2008, NAT CELL BIOL, V10, P1237, DOI 10.1038/ncb1108-1237; Twig G, 2010, AM J PHYSIOL-CELL PH, V299, pC477, DOI 10.1152/ajpcell.00427.2009; van der Bliek AM, 2003, DEV CELL, V4, P769, DOI 10.1016/S1534-5807(03)00167-9; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209	72	40	43	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25199	10.1371/journal.pone.0025199	http://dx.doi.org/10.1371/journal.pone.0025199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980395	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600014
J	Yan, TZ; Mo, QH; Cai, R; Chen, X; Zhang, CM; Liu, YH; Chen, YJ; Zhou, WJ; Xiong, F; Xu, XM				Yan, Ti-Zhen; Mo, Qiu-Hua; Cai, Ren; Chen, Xue; Zhang, Cui-Mei; Liu, Yan-Hui; Chen, Ya-Jun; Zhou, Wan-Jun; Xiong, Fu; Xu, Xiang-Min			Reliable Detection of Paternal SNPs within Deletion Breakpoints for Non-Invasive Prenatal Exclusion of Homozygous alpha(0)-Thalassemia in Maternal Plasma	PLOS ONE			English	Article							CELL-FREE DNA; FREE FETAL DNA; NUCLEIC-ACIDS; DIAGNOSIS; THALASSEMIA; POINT; BLOOD; MUTATION; DISEASE; PCR	Reliable detection of large deletions from cell-free fetal DNA (cffDNA) in maternal plasma is challenging, especially when both parents have the same deletion owing to a lack of specific markers for fetal genotyping. In order to evaluate the efficacy of a non-invasive prenatal diagnosis (NIPD) test to exclude alpha-thalassemia major that uses SNPs linked to the normal paternal alpha-globin allele, we established a novel protocol to reliably detect paternal SNPs within the ((_ _SEA)) breakpoints and performed evaluation of the diagnostic potential of the protocol in a total of 67 pregnancies, in whom plasma samples were collected prior to invasive obstetrics procedures in southern China. A group of nine SNPs identified within the deletion breakpoints were scanned to select the informative SNPs in each of the 67 couples DNA by multiplex PCR based mini-sequencing technique. The paternally inherited SNP allele from cffDNA was detected by allele specific real-time PCR. A protocol for reliable detection of paternal SNPs within the ((_ _ SEA)) breakpoints was established and evaluation of the diagnostic potential of the protocol was performed in a total of 67 pregnancies. In 97% of the couples one or more different SNPs within the deletion breakpoint occurred between paternal and maternal alleles. Homozygosity for the ((_ _ SEA)) deletion was accurately excluded in 33 out of 67 (49.3%, 95% CI, 25.4-78.6%) pregnancies through the implementation of the protocol. Protocol was completely concordant with the traditional reference methods, except for two cases that exhibited uncertain results due to sample hemolysis. This method could be used as a routine NIPD test to exclude gross fetal deletions in alpha-thalassemia major, and could further be employed to test for other diseases due to gene deletion.	[Yan, Ti-Zhen; Mo, Qiu-Hua; Chen, Xue; Zhou, Wan-Jun; Xiong, Fu; Xu, Xiang-Min] So Med Univ, Sch Basic Med Sci, Dept Med Genet, Guangzhou, Guangdong, Peoples R China; [Yan, Ti-Zhen; Cai, Ren] Liuzhou Municipal Matern & Child Healthcare Hosp, Ctr Prenatal Diag, Liuzhou, Guangxi, Peoples R China; [Zhang, Cui-Mei] So Med Univ, Affiliated Zhongshan Boai Hosp, Ctr Prenatal Diag, Zhongshan, Guangdong, Peoples R China; [Liu, Yan-Hui] Sun Yat Sen Univ, Affiliated Donghua Hosp, Dept Lab Med, Dongguan, Guangdong, Peoples R China; [Chen, Ya-Jun] Shaoguan Municipal Matern & Child Healthcare Hosp, Ctr Prenatal Diag, Shaoguan, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Sun Yat Sen University	Yan, TZ (corresponding author), So Med Univ, Sch Basic Med Sci, Dept Med Genet, Guangzhou, Guangdong, Peoples R China.	gzxuxm@pub.guangzhou.gd.cn	Yan, Tizhen/AAY-7423-2021		National Natural Science Fund of China (NSFC) [30771192]; National Natural Science Foundation of China (NSFC) [U0632005]; Dongguan Medical Health Institutions [200910515024]	National Natural Science Fund of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Dongguan Medical Health Institutions	This work was funded by a programme grant from the National Natural Science Fund of China (NSFC, No. 30771192), the National Natural Science Foundation of China (NSFC)-Guangdong Joint Fund (NO. U0632005) and the National Key Scientific Research Project of Dongguan Medical Health Institutions (No. 200910515024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amicucci P, 2000, CLIN CHEM, V46, P301; Birch L, 2005, CLIN CHEM, V51, P312, DOI 10.1373/clinchem.2004.042713; Bischoff FZ, 2003, LANCET, V361, P139, DOI 10.1016/S0140-6736(03)12191-5; Chiu RWK, 2002, LANCET, V360, P998, DOI 10.1016/S0140-6736(02)11086-5; Chiu RWK, 2002, CLIN CHEM, V48, P778; Chui DHK, 2005, ANN NY ACAD SCI, V1054, P25, DOI 10.1196/annals.1345.004; Ding CM, 2004, P NATL ACAD SCI USA, V101, P10762, DOI 10.1073/pnas.0403962101; Galbiati S, 2008, HAEMATOLOGICA, V93, P610, DOI 10.3324/haematol.11895; Hahn S, 2002, CLIN OBSTET GYNECOL, V45, P649, DOI 10.1097/00003081-200209000-00008; Ho SSY, 2010, PRENATAL DIAG, V30, P65, DOI 10.1002/pd.2413; Ho SSY, 2007, CLIN CHEM, V53, P173, DOI 10.1373/clinchem.2006.075085; Hung ECW, 2009, J CLIN PATHOL, V62, P308, DOI 10.1136/jcp.2007.048470; JACKSON LG, 1992, NEW ENGL J MED, V327, P594, DOI 10.1056/NEJM199208273270903; Lau ET, 2005, PRENATAL DIAG, V25, P123, DOI 10.1002/pd.1096; Legler Tobias J., 2008, V444, P209, DOI 10.1007/978-1-59745-066-9_16; Li Y, 2005, JAMA-J AM MED ASSOC, V293, P843, DOI 10.1001/jama.293.7.843; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Li Y, 2007, PRENATAL DIAG, V27, P11, DOI 10.1002/pd.1608; Li Y, 2009, FETAL DIAGN THER, V25, P246, DOI 10.1159/000223442; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Nasis O, 2004, CLIN CHEM, V50, P694, DOI 10.1373/clinchem.2003.025981; Simpson JL, 2004, JAMA-J AM MED ASSOC, V291, P1135, DOI 10.1001/jama.291.9.1135; Tungwiwat W, 2006, ANN NY ACAD SCI, V1075, P103, DOI 10.1196/annals.1368.013; Vichinsky Elliott P, 2009, Hematology Am Soc Hematol Educ Program, P35, DOI 10.1182/asheducation-2009.1.35; Weatherall DJ, 2001, THALASSEMIA SYNDROME, P27; Winichagoon P, 2005, INT J HEMATOL, V81, P396, DOI 10.1532/IJH97.A20501; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047; Xiao W, 2000, Zhonghua Xue Ye Xue Za Zhi, V21, P192	30	10	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e24779	10.1371/journal.pone.0024779	http://dx.doi.org/10.1371/journal.pone.0024779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980356	Green Submitted, gold, Green Published			2022-12-25	WOS:000295939600006
J	Liu, YJ; Testa, JS; Philip, R; Block, TM; Mehta, AS				Liu, Yuanjie; Testa, James S.; Philip, Ramila; Block, Timothy M.; Mehta, Anand S.			A Ubiquitin Independent Degradation Pathway Utilized by a Hepatitis B Virus Envelope Protein to Limit Antigen Presentation	PLOS ONE			English	Article							MHC CLASS-I; ENDOPLASMIC-RETICULUM STRESS; PRE-S MUTANTS; PEPTIDE-N-GLYCANASE; HEPATOCELLULAR-CARCINOMA; AAA-ATPASE; MISFOLDED GLYCOPROTEINS; AVIAN HEPADNAVIRUS; PROTEASOME PATHWAY; T-CELLS	Hepatitis B virus envelope glycoproteins Large (L), Middle (M) and Small (S) are targets of the host cellular immune system. The extent to which the host recognizes viral antigens presented by infected cells is believed to play a decisive role in determining if an infection will be resolved or become chronic. As with other antigens, HBV envelope polypeptides must be degraded, presumably by cellular proteasomes, to be presented by the MHC I pathway. We have used M as a model to study this process and determine how ER quality control monitors these foreign polymeric proteins and disposes of them through the ER-associated degradation (ERAD) pathway. Using both wild type and mutant HBV M protein, we found that unlike most ERAD substrates, which require ubiquitination for retrotranslocation and degradation, the HBV M protein, which only contains two lysine residues, can undergo rapid and complete, ubiquitin independent, proteasome dependent degradation. The utilization of this pathway had a functional consequence, since proteins degraded through it, were poorly presented via MHC I. To test the hypothesis that the level of ubiquitination, independent of protein degradation, controls the level of antigen presentation, we inserted two additional lysines into both the wild type and mutant M protein. Amazingly, while the addition of the lysine residues dramatically increased the level of ubiquitination, it did not alter the rate of degradation. However and remarkably, the increased ubiquitination was associated with a dramatic increase in the level of antigen presentation. In conclusion, using the HBV surface protein as a model, we have identified a novel ubiquitin independent degradation pathway and determined that this pathway can have implications for antigen presentation and potentially viral pathogenesis.	[Liu, Yuanjie; Block, Timothy M.; Mehta, Anand S.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA; [Testa, James S.; Philip, Ramila] Immunotope Inc, Doylestown, PA USA	Drexel University	Liu, YJ (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA.	Anand.Mehta@drexelmed.edu			National Cancer Institute (NCI) [R01 CA120206-01]; NCI Early Research Detection Network (EDRN) [UO1 CA084951-06]; National Institute of Allergy and Infectious Diseases (NIAID) [U01AI054763]; NATIONAL CANCER INSTITUTE [U01CA084951, R01CA120206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI054763] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Early Research Detection Network (EDRN); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant R01 CA120206-01 from the National Cancer Institute (NCI), grant UO1 CA084951-06 from the NCI Early Research Detection Network (EDRN), and grant U01AI054763 from the National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe K, 2009, CANCER SCI, V100, P2249, DOI 10.1111/j.1349-7006.2009.01309.x; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Eisenlohr LC, 2007, NAT REV IMMUNOL, V7, P403, DOI 10.1038/nri2077; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Fan YF, 2001, HEPATOLOGY, V33, P277, DOI 10.1053/jhep.2001.21163; Fang ZL, 2008, J GEN VIROL, V89, P2882, DOI 10.1099/vir.0.2008/002824-0; Feldman M, 2009, TRENDS CELL BIOL, V19, P357, DOI 10.1016/j.tcb.2009.05.005; GERLICH WH, 1992, ARCH VIROL, P129; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Golovina TN, 2005, J IMMUNOL, V174, P2763, DOI 10.4049/jimmunol.174.5.2763; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRANT EP, 1995, J IMMUNOL, V155, P3750; Heiligenstein S, 2006, EMBO J, V25, P4717, DOI 10.1038/sj.emboj.7601350; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Huang HP, 2010, PEDIATR RES, V67, P90, DOI 10.1203/PDR.0b013e3181c1b0b7; Huang L, 2011, J IMMUNOL, V186, P1904, DOI 10.4049/jimmunol.1003411; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Kikkert M, 2001, BIOCHEM J, V358, P369, DOI 10.1042/0264-6021:3580369; Kimura Y, 1998, J BIOCHEM-TOKYO, V123, P876; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; LENHOFF RJ, 1994, J VIROL, V68, P4565, DOI 10.1128/JVI.68.7.4565-4571.1994; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Liu YJ, 2007, VIROLOGY, V365, P10, DOI 10.1016/j.virol.2007.03.042; Lord JM, 2003, BIOCHEM SOC T, V31, P1260; MANGOLD CMT, 1993, J VIROL, V67, P4588, DOI 10.1128/JVI.67.8.4588-4597.1993; Mellman I, 2010, CURR OPIN IMMUNOL, V22, P78, DOI 10.1016/j.coi.2010.01.013; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Norton PA, 2010, HEPATOLOGY, V52, P1242, DOI 10.1002/hep.23806; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; Sifers RN, 2009, CELL CYCLE, V8, P4026; Simsek E, 2009, VIROLOGY, V384, P12, DOI 10.1016/j.virol.2008.11.027; Sinnathamby G, 2009, J IMMUNOTHER, V32, P856, DOI 10.1097/CJI.0b013e3181b0b125; SUMMERS J, 1991, J VIROL, V65, P1310, DOI 10.1128/JVI.65.3.1310-1317.1991; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; THUNG SN, 1986, HEPATOLOGY, V6, P1315, DOI 10.1002/hep.1840060615; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Wang JG, 2006, J VIROL, V80, P8541, DOI 10.1128/JVI.00830-06; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yeung P, 2011, J INFECT DIS, V203, P646, DOI 10.1093/infdis/jiq096; Yewdell J, 1999, IMMUNOL REV, V172, P97, DOI 10.1111/j.1600-065X.1999.tb01359.x; Yoshida Y, 2010, BBA-GEN SUBJECTS, V1800, P172, DOI 10.1016/j.bbagen.2009.07.029; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Yuksek K, 2009, J VIROL, V83, P612, DOI 10.1128/JVI.00832-08	65	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24477	10.1371/journal.pone.0024477	http://dx.doi.org/10.1371/journal.pone.0024477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969857	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900008
J	Takamiya, M; Haider, KH; Ashraf, M				Takamiya, Michitaka; Haider, Khawaja H.; Ashraf, Muhammad			Identification and Characterization of a Novel Multipotent Sub-Population of Sca-1(+) Cardiac Progenitor Cells for Myocardial Regeneration	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MAMMALIAN HEART; SMOOTH-MUSCLE; CARDIOVASCULAR REGENERATION; EXPRESSION; POPULATION; DIFFERENTIATION; CARDIOMYOCYTES; GENERATION; LINEAGES	Methods and Results: The cardiac stem/progenitor cells from adult mice were seeded at low density in serum-free medium. The colonies thus obtained were expanded separately and assessed for expression of stem cell antigen-1 (Sca-1). Two colonies each with high Sca-1 (CSH1; 95.9%; CSH2; 90.6%) and low Sca-1 (CSL1; 37.1%; CSL2; 17.4%) expressing cells were selected for further studies. Sca-1(+) cells (98.4%) isolated using Magnetic Cell Sorting System (MACS) from the hearts were used as a control. Although the selected populations were similar in surface marker expression (low in c-kit, CD45, CD34, CD31 and high in CD29), these cells exhibited diverse differentiation potential. Unlike CSH1, CSH2 expressed Nanog, TERT, Bcrp1, Nestin, Musashi1 and Isl-1, and also showed differentiation into osteogenic, chondrogenic, smooth muscle, endothelial and cardiac lineages. MACS sorted cells exhibited similar tendency albeit with relatively weaker differentiation potential. Transplantation of CSH2 cells into infarcted heart showed attenuated infarction size, significantly preserved left ventricular function and anterior wall thickness, and increased capillary density. We also observed direct differentiation of transplanted cells into endothelium and cardiomyocytes. Conclusions: The cardiac stem/progenitor cells isolated by a combined clonal selection and surface marker approach possessed multiple stem cell features important for cardiac regeneration.	[Takamiya, Michitaka; Haider, Khawaja H.; Ashraf, Muhammad] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Takamiya, M (corresponding author), Univ Cincinnati, Dept Pathol, Cincinnati, OH 45221 USA.	muhammad.ashraf@uc.edu	Ashraf, Muhammad/ABB-3463-2021		National Institutes of Health (NIH) [R37-HL074272, HL-080686, HL-087246, HL-087288, HL-089535]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087288, R01HL089535, R01HL080686, R01HL087246, R37HL074272] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) Grants # R37-HL074272, HL-080686, HL-087246 to MA and HL-087288, HL-089535 to KHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Jiang SJ, 2006, CIRC RES, V99, P776, DOI 10.1161/01.RES.0000244687.97719.4f; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; Lai L, 1998, J IMMUNOL, V160, P3861; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leri A, 2001, P NATL ACAD SCI USA, V98, P8626, DOI 10.1073/pnas.151013298; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; McKinney-Freeman SL, 2009, BLOOD, V114, P268, DOI 10.1182/blood-2008-12-193888; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Tateishi K, 2007, J CELL SCI, V120, P1791, DOI 10.1242/jcs.006122; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; WILSON R, 2007, CARDIOVASCULAR REGEN, P77; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yi BA, 2010, J CLIN INVEST, V120, P20, DOI 10.1172/JCI40820	32	55	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25265	10.1371/journal.pone.0025265	http://dx.doi.org/10.1371/journal.pone.0025265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980409	Green Submitted, gold, Green Published			2022-12-25	WOS:000295936900043
J	Kent, R; Bar-Massada, A; Carmel, Y				Kent, Rafi; Bar-Massada, Avi; Carmel, Yohay			Multiscale Analyses of Mammal Species Composition - Environment Relationship in the Contiguous USA	PLOS ONE			English	Article							CANONICAL CORRESPONDENCE-ANALYSIS; LATITUDINAL GRADIENTS; COMMUNITY COMPOSITION; SPATIAL VARIATION; BIODIVERSITY; RICHNESS; DISTRIBUTIONS; PATTERNS; DIVERSITY; SCALE	Relationships between species composition and its environmental determinants are a basic objective of ecology. Such relationships are scale dependent, and predictors of species composition typically include variables such as climate, topographic, historical legacies, land uses, human population levels, and random processes. Our objective was to quantify the effect of environmental determinants on U. S. mammal composition at various spatial scales. We found that climate was the predominant factor affecting species composition, and its relative impact increased in correlation with the increase of the spatial scale. Another factor affecting species composition is land-use-land-cover. Our findings showed that its impact decreased as the spatial scale increased. We provide quantitative indication of highly significant effect of climate and land-use-land-cover variables on mammal composition at multiple scales.	[Kent, Rafi; Carmel, Yohay] Technion Israel Inst Technol, Fac Civil & Environm Engn, Haifa, Israel; [Bar-Massada, Avi] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA	Technion Israel Institute of Technology; University of Wisconsin System; University of Wisconsin Madison	Kent, R (corresponding author), Technion Israel Inst Technol, Fac Civil & Environm Engn, Haifa, Israel.	rkent@technion.ac.il	Carmel, Yohay/G-4362-2011	Carmel, Yohay/0000-0002-5883-0184	Israel Science Foundation [486-2010]	Israel Science Foundation(Israel Science Foundation)	This project was funded by the Israel Science Foundation, www.isf.org.il (grant number 486-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Allen TFH, 1992, UNIFIED ECOLOGY; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Cushman SA, 2002, LANDSCAPE ECOL, V17, P637, DOI 10.1023/A:1021571603605; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ESRI, 1999, ARCVIEW GIS; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; GBIF, 2008, GBIF TRAIN MAN 1 DIG; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Grand J, 2004, BIOL CONSERV, V119, P495, DOI 10.1016/j.biocon.2004.01.012; Grand J, 2003, BIOL CONSERV, V112, P307, DOI 10.1016/S0006-3207(02)00323-3; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; Jones MM, 2008, OECOLOGIA, V155, P593, DOI 10.1007/s00442-007-0923-8; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Kadmon R, 1999, J VEG SCI, V10, P421, DOI 10.2307/3237071; Kent R, 2011, DIVERS DISTRIB, V17, P474, DOI 10.1111/j.1472-4642.2011.00755.x; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Levin SA, 2000, ECOSYSTEMS, V3, P498, DOI 10.1007/s100210000044; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; MacArthur R.H., 1972, pvii; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; May R, 1984, OVERVIEW REAL APPARE, P3; Oksanen J., 2016, R PACKAG; PATRICK R, 1963, ANN NY ACAD SCI, V108, P359, DOI 10.1111/j.1749-6632.1963.tb13389.x; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pyron RA, 2009, GLOBAL ECOL BIOGEOGR, V18, P406, DOI 10.1111/j.1466-8238.2009.00462.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rodriguez J, 2006, J BIOGEOGR, V33, P291, DOI 10.1111/j.1365-2699.2005.01397.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Svenning JC, 2005, J BIOGEOGR, V32, P1019, DOI 10.1111/j.1365-2699.2005.01219.x; Team R. D. C, 2011, R LANG ENV STAT COMP; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Vieira MV, 2009, BIOL CONSERV, V142, P1191, DOI 10.1016/j.biocon.2009.02.006; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wilson RJ, 2004, NATURE, V432, P393, DOI 10.1038/nature03031	41	13	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25440	10.1371/journal.pone.0025440	http://dx.doi.org/10.1371/journal.pone.0025440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980457	Green Submitted, Green Published, gold			2022-12-25	WOS:000295933700034
J	Piveteau, P; Depret, G; Pivato, B; Garmyn, D; Hartmann, A				Piveteau, Pascal; Depret, Geraldine; Pivato, Barbara; Garmyn, Dominique; Hartmann, Alain			Changes in Gene Expression during Adaptation of Listeria monocytogenes to the Soil Environment	PLOS ONE			English	Article							SIGMA-B CONTRIBUTES; EGD-E; VIRULENCE; REGULON; IDENTIFICATION; CONTAMINATION; INTERNALIN; SURVIVAL; GROWTH; CTSR	Listeria monocytogenes is a ubiquitous opportunistic pathogen responsible for listeriosis. In order to study the processes underlying its ability to adapt to the soil environment, whole-genome arrays were used to analyse transcriptome modifications 15 minutes, 30 minutes and 18 h after inoculation of L. monocytogenes EGD-e in soil extracts. Growth was observed within the first day of incubation and large numbers were still detected in soil extract and soil microcosms one year after the start of the experiment. Major transcriptional reprofiling was observed. Nutrient acquisition mechanisms (phosphoenolpyruvate-dependent phosphotransferase systems and ABC transporters) and enzymes involved in catabolism of specific carbohydrates (beta-glucosidases; chitinases) were prevalent. This is consistent with the overrepresentation of the CodY regulon that suggests that in a nutrient depleted environment, L. monocytogenes recruits its extensive repertoire of transporters to acquire a range of substrates for energy production.	[Piveteau, Pascal; Depret, Geraldine; Pivato, Barbara; Garmyn, Dominique; Hartmann, Alain] Univ Bourgogne, UMR 1229, Dijon, France; [Piveteau, Pascal; Depret, Geraldine; Pivato, Barbara; Garmyn, Dominique; Hartmann, Alain] INRA, UMR 1229, F-21034 Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Piveteau, P (corresponding author), Univ Bourgogne, UMR 1229, Dijon, France.	piveteau@u-bourgogne.fr	Hartmann, Alain/B-7862-2018	Hartmann, Alain/0000-0001-6034-5068; Garmyn, Dominique/0000-0003-4693-6026	ANR [SEST 009]	ANR(French National Research Agency (ANR))	This work received the financial support of ANR, project SEST 009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram F, 2008, APPL ENVIRON MICROB, V74, P6848, DOI 10.1128/AEM.00442-08; Aytac SA, 2010, J FOOD AGRIC ENVIRON, V8, P275; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Chan YC, 2007, APPL ENVIRON MICROB, V73, P6484, DOI 10.1128/AEM.00897-07; Chaturongakul S, 2006, APPL ENVIRON MICROB, V72, P5197, DOI 10.1128/AEM.03058-05; Chaturongakul S, 2011, APPL ENVIRON MICROB, V77, P187, DOI 10.1128/AEM.00952-10; Dowe MJ, 1997, J FOOD PROTECT, V60, P1201, DOI 10.4315/0362-028X-60.10.1201; Garcia E, 1996, J FOOD PROTECT, V59, P950, DOI 10.4315/0362-028X-59.9.950; Garner MR, 2006, INFECT IMMUN, V74, P876, DOI 10.1128/IAI.74.2.876-886.2006; Glaser P, 2001, SCIENCE, V294, P849; Gopal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010349; Gorski L, 2011, FOODBORNE PATHOG DIS, V8, P699, DOI 10.1089/fpd.2010.0752; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7967, DOI 10.1128/AEM.01085-07; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7981, DOI 10.1128/AEM.01281-07; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Ledala N, 2010, APPL ENVIRON MICROB, V76, P406, DOI 10.1128/AEM.01389-09; Leisner JJ, 2008, APPL ENVIRON MICROB, V74, P3823, DOI 10.1128/AEM.02701-07; Liu YH, 2008, APPL ENVIRON MICROB, V74, P6859, DOI 10.1128/AEM.00356-08; Lyautey E, 2007, CAN J MICROBIOL, V53, P1158, DOI 10.1139/W07-084; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; McGann P, 2007, APPL ENVIRON MICROB, V73, P2806, DOI 10.1128/AEM.02923-06; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Nadon CA, 2002, INFECT IMMUN, V70, P3948, DOI 10.1128/IAI.70.7.3948-3952.2002; Nightingale KK, 2004, APPL ENVIRON MICROB, V70, P4458, DOI 10.1128/AEM.70.8.4458-4467.2004; Olier M, 2003, INFECT IMMUN, V71, P1217, DOI 10.1128/IAI.71.3.1217-1224.2003; Oliver HF, 2010, APPL ENVIRON MICROB, V76, P4216, DOI 10.1128/AEM.00031-10; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Palumbo JD, 2005, APPL ENVIRON MICROB, V71, P5236, DOI 10.1128/AEM.71.9.5236-5243.2005; PARK SF, 1993, MOL MICROBIOL, V8, P653, DOI 10.1111/j.1365-2958.1993.tb01609.x; Raengpradub S, 2008, APPL ENVIRON MICROB, V74, P158, DOI 10.1128/AEM.00951-07; Rieu A, 2007, APPL ENVIRON MICROB, V73, P6125, DOI 10.1128/AEM.00608-07; Stoll R, 2010, MICROBIOL-SGM, V156, P1069, DOI 10.1099/mic.0.034934-0; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; van der Veen S, 2007, MICROBIOL-SGM, V153, P3593, DOI 10.1099/mic.0.2007/006361-0; VANRENTERGHEM B, 1991, J APPL BACTERIOL, V71, P211; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; WEIS J, 1975, APPL MICROBIOL, V30, P29, DOI 10.1128/AEM.30.1.29-32.1975; WELSHIME.HJ, 1968, J BACTERIOL, V95, P300, DOI 10.1128/JB.95.2.300-303.1968; WELSHIMER HJ, 1960, J BACTERIOL, V80, P316, DOI 10.1128/JB.80.3.316-320.1960; WELSHIMER HJ, 1971, APPL MICROBIOL, V21, P516, DOI 10.1128/AEM.21.3.516-519.1971	45	37	37	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e24881	10.1371/journal.pone.0024881	http://dx.doi.org/10.1371/journal.pone.0024881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966375	Green Published, gold, Green Submitted			2022-12-25	WOS:000295267100012
J	Roehr, CC; Wilitzki, S; Opgen-Rhein, B; Kalache, K; Proquitte, H; Buhrer, C; Schmalisch, G				Roehr, Charles Christoph; Wilitzki, Silke; Opgen-Rhein, Bernd; Kalache, Karim; Proquitte, Hans; Buehrer, Christoph; Schmalisch, Gerd			Early Lung Function Testing in Infants with Aortic Arch Anomalies Identifies Patients at Risk for Airway Obstruction	PLOS ONE			English	Article							VASCULAR RINGS; PLETHYSMOGRAPHIC MEASUREMENTS; COMPRESSION; DIAGNOSIS; VOLUME; SLINGS; LOOPS	Background: Aortic arch anomalies (AAA) are rare cardio-vascular anomalies. Right-sided and double-sided aortic arch anomalies (RAAA, DAAA) are distinguished, both may cause airway obstructions. We studied the degree of airway obstruction in infants with AAA by neonatal lung function testing (LFT). Patients and Methods: 17 patients (10 RAAA and 7 DAAA) with prenatal diagnosis of AAA were investigated. The median (range) post conception age at LFT was 40.3 (36.6-44.1) weeks, median body weight 3400 (2320-4665) g. Measurements included tidal breathing flow-volume loops (TBFVL), airway resistance (R-aw) by bodyplethysmography and the maximal expiratory flow at functional residual capacity (V'maxFRC) by rapid thoracic-abdominal compression (RTC) technique. V'maxFRC was also expressed in Z-scores, based on published gender-, age and height-specific reference values. Results: Abnormal lung function tests were seen in both RAAA and DAAA infants. Compared to RAAA infants, infants with DAAA had significantly more expiratory flow limitations in the TBFVL, (86% vs. 30%, p<0.05) and a significantly increased R-aw (p=0.015). Despite a significant correlation between R-aw and the Z-score of V'maxFRC (r=0.740, p<0.001), there were no statistically significant differences in V'maxFRC and it's Z-scores between RAAA and DAAA infants. 4 (24%) infants (2 RAAA, 2 DAAA) were near or below the 10(th) percentile of V'maxFRC, indicating a high risk for airway obstruction. Conclusion: Both, infants with RAAA and DAAA, are at risk for airway obstruction and early LFT helps to identify and to monitor these infants. This may support the decision for therapeutic interventions before clinical symptoms arise.	[Roehr, Charles Christoph; Wilitzki, Silke; Proquitte, Hans; Buehrer, Christoph; Schmalisch, Gerd] Charite, Dept Neonatol, D-13353 Berlin, Germany; [Opgen-Rhein, Bernd] Charite, Dept Paediat Cardiol, D-13353 Berlin, Germany; [Kalache, Karim] Charite, Dept Obstet & Prenatal Med, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Roehr, CC (corresponding author), Charite, Dept Neonatol, D-13353 Berlin, Germany.	christoph.roehr@charite.de		Roehr, Charles Christoph/0000-0001-7965-4637; Opgen-Rhein, Bernd/0000-0002-4535-4529				Amirav I, 2003, PEDIATR PULM, V35, P62, DOI 10.1002/ppul.10211; Bisgaard H, 2005, CHEST, V128, P355, DOI 10.1378/chest.128.1.355; Bonnard A, J PEDIAT SURG, V38, P539; BURCH M, 1993, ARCH DIS CHILD, V68, P171, DOI 10.1136/adc.68.2.171; Dodge-Khatami A, 2002, CARDIOL YOUNG, V12, P96, DOI 10.1017/S1047951102000239; Eichhorn J, 2004, Z KARDIOL, V93, P201, DOI 10.1007/s00392-004-0026-z; Griffiths AL, 2005, J PAEDIATR CHILD H, V41, P297, DOI 10.1111/j.1440-1754.2005.00615.x; Hernanz-Schulman M, 2005, PEDIATR RADIOL, V35, P961, DOI 10.1007/s00247-005-1529-0; Hoo AF, 2002, AM J RESP CRIT CARE, V165, P1084, DOI 10.1164/ajrccm.165.8.2103035; Humphrey C, 2006, PEDIATRICS, V117, pE903, DOI 10.1542/peds.2005-1674; Leonhardt S, 2010, IEEE T BIO-MED ENG, V57, P1945, DOI 10.1109/TBME.2010.2046168; LOWE GM, 1991, RADIOGRAPHICS, V11, P637, DOI 10.1148/radiographics.11.4.1887119; Ma GQ, 2007, CHINESE MED J-PEKING, V120, P1408, DOI 10.1097/00029330-200708020-00006; MARMON LM, 1984, J PEDIATR SURG, V19, P683, DOI 10.1016/S0022-3468(84)80353-X; McLaren CA, 2008, PAEDIATR RESPIR REV, V9, P85, DOI 10.1016/j.prrv.2007.12.008; Schmalisch G, 2001, MED BIOL ENG COMPUT, V39, P688, DOI 10.1007/BF02345443; Schmalisch G, 2001, EUR RESPIR J, V17, P108, DOI 10.1183/09031936.01.17101080; Schmalisch G, 2005, BMC PEDIATR, V5, P1471; Sly PD, 2000, EUR RESPIR J, V16, P741, DOI 10.1034/j.1399-3003.2000.16d29.x; Stocks J, 2001, EUR RESPIR J, V17, P302, DOI 10.1183/09031936.01.17203020; Stocks J, 2007, PEDIATR PULM, V42, P3, DOI 10.1002/ppul.20520; THOMSON AH, 1990, ARCH DIS CHILD, V65, P171, DOI 10.1136/adc.65.2.171; Turner A, 2005, EUR J PEDIATR, V164, P266, DOI 10.1007/s00431-004-1607-6; Weinberg PM, 2001, HEART DISEASE INFANT, P707; Zidere V, 2006, ULTRASOUND OBST GYN, V28, P876, DOI 10.1002/uog.3841	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e24903	10.1371/journal.pone.0024903	http://dx.doi.org/10.1371/journal.pone.0024903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966379	gold, Green Published, Green Submitted			2022-12-25	WOS:000295267100013
J	Blom, MT; Bardai, A; van Munster, BC; Nieuwland, MI; de Jong, H; van Hoeijen, DA; Spanjaart, AM; de Boer, A; de Rooij, SE; Tan, HL				Blom, Marieke T.; Bardai, Abdennasser; van Munster, Barbara C.; Nieuwland, Mei-Ing; de Jong, Hendrik; van Hoeijen, Daniel A.; Spanjaart, Anne M.; de Boer, Anthonius; de Rooij, Sophia E.; Tan, Hanno L.			Differential Changes in QTc Duration during In-Hospital Haloperidol Use	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; SUDDEN CARDIAC DEATH; TORSADE-DE-POINTES; PROLONGATION; INTERVAL; RISK; REPOLARIZATION; ANTIPSYCHOTICS; ASSOCIATION; CHANNELS	Aims: To evaluate changes in QT duration during low-dose haloperidol use, and determine associations between clinical variables and potentially dangerous QT prolongation. Methods: In a retrospective cohort study in a tertiary university teaching hospital in The Netherlands, all 1788 patients receiving haloperidol between 2005 and 2007 were studied; ninety-seven were suitable for final analysis. Rate-corrected QT duration (QTc) was measured before, during and after haloperidol use. Clinical variables before haloperidol use and at the time of each ECG recording were retrieved from hospital charts. Mixed model analysis was used to estimate changes in QT duration. Risk factors for potentially dangerous QT prolongation were estimated by logistic regression analysis. Results: Patients with normal before-haloperidol QTc duration (male <= 430 ms, female <= 450 ms) had a significant increase in QTc duration of 23 ms during haloperidol use; twenty-three percent of patients rose to abnormal levels (male >= 450 ms, female >= 470 ms). In contrast, a significant decrease occurred in patients with borderline (male 430-450 ms, female 450-470 ms) or abnormal before-haloperidol QTc duration (15 ms and 46 ms, respectively); twenty-three percent of patients in the borderline group, and only 9% of patients in the abnormal group obtained abnormal levels. Potentially dangerous QTc prolongation was independently associated with surgery before haloperidol use (OR(adj) 34.9, p = 0.009) and before-haloperidol QTc duration (OR(adj) 0.94, p = 0.004). Conclusion: QTc duration during haloperidol use changes differentially, increasing in patients with normal before-haloperidol QTc duration, but decreasing in patients with prolonged before-haloperidol QTc duration. Shorter before-haloperidol QTc duration and surgery before haloperidol use predict potentially dangerous QTc prolongation.	[Blom, Marieke T.; Bardai, Abdennasser; Nieuwland, Mei-Ing; de Jong, Hendrik; van Hoeijen, Daniel A.; Spanjaart, Anne M.; Tan, Hanno L.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [van Munster, Barbara C.; de Rooij, Sophia E.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [van Munster, Barbara C.; de Rooij, Sophia E.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med & Geriatr, NL-1105 AZ Amsterdam, Netherlands; [de Boer, Anthonius] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University	Blom, MT (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands.	h.l.tan@amc.nl	, Bardai/AAL-2340-2020	Blom, Marieke Tabo/0000-0002-8088-1105	Netherlands Organization for Scientific Research (NWO) [ZonMW Vici 918.86.616, Mozaiek 017.003.084]; Dutch Medicines Evaluation Board (MEB/CBG)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Medicines Evaluation Board (MEB/CBG)	H.L. Tan was supported by the Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici 918.86.616) and the Dutch Medicines Evaluation Board (MEB/CBG). A. Bardai was supported by the Netherlands Organization for Scientific Research (NWO, grant Mozaiek 017.003.084). Both grants are unrestricted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM PSYCH ASS, APA PRACT GUID APA G; Amin AS, 2008, J CLIN INVEST, V118, P2552, DOI 10.1172/JCI35337; Andrassy G, 2007, ANN NONINVAS ELECTRO, V12, P251, DOI 10.1111/j.1542-474X.2007.00169.x; Brown DW, 2001, J CARDIOVASC RISK, V8, P227, DOI 10.1097/00043798-200108000-00007; Brunton L, PHARM BASIS THERAPEU; Burashnikov A, 2008, CIRC-ARRHYTHMIA ELEC, V1, P202, DOI 10.1161/CIRCEP.107.691931; Committee for Proprietary Medicinal Products, 1997, ASS POT QT INT PROL; de Rooij SE, 2007, J PSYCHOSOM RES, V62, P521, DOI 10.1016/j.jpsychores.2006.11.013; DEBRUIN MLD, 2005, BR J CLIN PHARM, V63, P216; DEKKER JM, 1994, CIRCULATION, V90, P779, DOI 10.1161/01.CIR.90.2.779; Desai M, 2003, PHARMACOGENOMICS J, V3, P105, DOI 10.1038/sj.tpj.6500160; Guo JQ, 2005, HEART RHYTHM, V2, P860, DOI 10.1016/j.hrthm.2005.04.029; HASSABALLA AH, 2003, AM J THER, V10, P58; Hatta K, 2001, J CLIN PSYCHOPHARM, V21, P257, DOI 10.1097/00004714-200106000-00002; Kirchhof P, 2009, J AM COLL CARDIOL, V54, P143, DOI 10.1016/j.jacc.2009.03.043; Mortl D, 2003, J CARDIOVASC PHARM, V41, P870, DOI 10.1097/00005344-200306000-00007; Rasty S, 2004, CHEST, V125, P1821, DOI 10.1378/chest.125.5.1821; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Smits JPP, 2008, EXPERT OPIN PHARMACO, V9, P537, DOI 10.1517/14656566.9.4.537; Stepkovitch K, 2008, J AM GERIATR SOC, V56, P1963, DOI 10.1111/j.1532-5415.2008.01901.x; Stollberger C, 2005, INT CLIN PSYCHOPHARM, V20, P243; Straus SMJM, 2004, ARCH INTERN MED, V164, P1293, DOI 10.1001/archinte.164.12.1293; Straus SMJM, 2005, EUR HEART J, V26, P2007, DOI 10.1093/eurheartj/ehi312; TAN HL, 1995, ANN INTERN MED, V122, P701, DOI 10.7326/0003-4819-122-9-199505010-00009; Wang JX, 2004, J BIOL CHEM, V279, P13289, DOI 10.1074/jbc.C400025200	27	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e23728	10.1371/journal.pone.0023728	http://dx.doi.org/10.1371/journal.pone.0023728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961030	Green Published, gold			2022-12-25	WOS:000295265100002
J	El Guerrab, A; Zegrour, R; Nemlin, CC; Vigier, F; Cayre, A; Penault-Llorca, F; Rossignol, F; Bignon, YJ				El Guerrab, Abderrahim; Zegrour, Rabah; Nemlin, Carine-Christiane; Vigier, Flavie; Cayre, Anne; Penault-Llorca, Frederique; Rossignol, Fabrice; Bignon, Yves-Jean			Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; INDUCIBLE FACTOR-1-ALPHA; GENE-EXPRESSION; MAMMALIAN TARGET; DOWN-REGULATION; CELL-MIGRATION; HIF-ALPHA; TUMOR; CARCINOMA; PROGNOSIS	Background: In solid tumors, such as breast cancer, cells are exposed to hypoxia. Cancer cells adapt their metabolism by activating hypoxia-inducible factors (HIFs) that promote the transcription of genes involved in processes such as cell survival, drug resistance and metastasis. HIF-1 is also induced in an oxygen-independent manner through the activation of epidermal growth factor receptor tyrosine kinase (EGFR-TK). Triple-negative breast cancer (TNBC) is a subtype of invasive breast cancer characterized by negative expression of hormonal and HER2 receptors, and this subtype generally overexpresses EGFR. Sensitivity to three EGFR inhibitors (cetuximab, gefitinib and lapatinib, an HER2/EGFR-TK inhibitor) was evaluated in a metastatic TNBC cell model (MDA-MB-231), and the impact of these drugs on the activity and stability of HIF was assessed. Methodology/Principal Findings: MDA-MB-231 cells were genetically modified to stably express an enhanced green fluorescent protein (EGFP) induced by hypoxia; the Ca9-GFP cell model reports HIF activity, whereas GFP-P564 reports HIF stability. The reporter signal was monitored by flow cytometry. HIF-1 DNA-binding activity, cell migration and viability were also evaluated in response to EGFR inhibitors. Cell fluorescence signals strongly increased under hypoxic conditions (>30-fold). Cetuximab and lapatinib did not affect the signal induced by hypoxia, whereas gefitinib sharply reduced its intensity in both cell models and also diminished HIF-1 alpha levels and HIF-1 DNA-binding activity in MDA-MB-231 cells. This gefitinib feature was associated with its ability to inhibit MDA-MB-231 cell migration and to induce cell mortality in a dose-dependent manner. Cetuximab and lapatinib had no effect on cell migration or cell viability. Conclusion: Resistance to cetuximab and lapatinib and sensitivity to gefitinib were associated with their ability to modulate HIF activity and stability. In conclusion, downregulation of HIF-1 through EGFR signaling seems to be required for the induction of a positive response to EGFR-targeted therapies in TNBC.	[El Guerrab, Abderrahim; Bignon, Yves-Jean] Ctr Jean Perrin, Dept Oncogenet, Clermont Ferrand, France; [El Guerrab, Abderrahim; Zegrour, Rabah; Nemlin, Carine-Christiane; Vigier, Flavie; Rossignol, Fabrice] Ctr Biomed Rech & Valorisat, Fac Med, ADELBIO, Clermont Ferrand, France; [Cayre, Anne; Penault-Llorca, Frederique] Ctr Jean Perrin, Dept Pathol, Clermont Ferrand, France	UNICANCER; Centre Jean Perrin; UNICANCER; Centre Jean Perrin	El Guerrab, A (corresponding author), Ctr Jean Perrin, Dept Oncogenet, Clermont Ferrand, France.	Yves-Jean.BIGNON@cjp.fr	, bignon/Y-3243-2019	CAYRE, Anne/0000-0002-2578-8557	Conseil Regional d'Auvergne	Conseil Regional d'Auvergne(Region Auvergne-Rhone-Alpes)	This work was supported in part by a grant from the "Conseil Regional d'Auvergne.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; DAVIDSON NE, 1987, MOL ENDOCRINOL, V1, P216, DOI 10.1210/mend-1-3-216; FOULKES WD, N ENGL J MED, V363, P1938; Fujiwara S, 2007, INT J ONCOL, V30, P793; Gril B, 2008, JNCI-J NATL CANCER I, V100, P1092, DOI 10.1093/jnci/djn216; Hicks DG, 2006, AM J SURG PATHOL, V30, P1097; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Italiano A, 2007, B CANCER, V94, pF177; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kaluz S, 2002, CANCER RES, V62, P4469; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Le QT, 2004, CANCER METAST REV, V23, P293, DOI 10.1023/B:CANC.0000031768.89246.d7; Li Liyuan, 2010, Open Biol J, V3, P8; Li XQ, 2008, MOL CANCER THER, V7, P1207, DOI 10.1158/1535-7163.MCT-07-2187; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Loncaster JA, 2001, CANCER RES, V61, P6394; Lu Y, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-63; Luwor RB, 2005, ONCOGENE, V24, P4433, DOI 10.1038/sj.onc.1208625; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mendelsohn J, 2002, J CLIN ONCOL, V20, p1S, DOI 10.1200/JCO.2002.07.121; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Price JT, 1999, CANCER RES, V59, P5475; Price JT, 1996, EUR J CANCER, V32A, P1977, DOI 10.1016/0959-8049(96)00207-9; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Subarsky P, 2003, CLIN EXP METASTAS, V20, P237, DOI 10.1023/A:1022939318102; Subarsky P, 2008, CLIN EXP METASTAS, V25, P253, DOI 10.1007/s10585-007-9139-x; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Turner T, 1996, CLIN EXP METASTAS, V14, P409, DOI 10.1007/BF00123400; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wenger RH, 2000, J EXP BIOL, V203, P1253; Wykoff CC, 2000, CANCER RES, V60, P7075; Yu F, 2001, CANCER RES, V61, P4136; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	48	29	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25080	10.1371/journal.pone.0025080	http://dx.doi.org/10.1371/journal.pone.0025080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966417	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100050
J	Glunt, KD; Thomas, MB; Read, AF				Glunt, Katey D.; Thomas, Matthew B.; Read, Andrew F.			The Effects of Age, Exposure History and Malaria Infection on the Susceptibility of Anopheles Mosquitoes to Low Concentrations of Pyrethroid	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; PLASMODIUM-FALCIPARUM; VECTOR CONTROL; SOUTH-AFRICA; MANAGEMENT; GAMBIAE; EVOLUTION; FIELD; NETS; ARABIENSIS	Chemical insecticides are critical components of malaria control programs. Their ability to eliminate huge numbers of mosquitoes allows them to swiftly interrupt disease transmission, but that lethality also imposes immense selection for insecticide resistance. Targeting control at the small portion of the mosquito population actually responsible for transmitting malaria parasites to humans would reduce selection for resistance, yet maintain effective malaria control. Here, we ask whether simply lowering the concentration of the active ingredient in insecticide formulations could preferentially kill mosquitoes infected with malaria and/or those that are potentially infectious, namely, old mosquitoes. Using modified WHO resistance-monitoring assays, we exposed uninfected Anopheles stephensi females to low concentrations of the pyrethroid permethrin at days 4, 8, 12, and 16 days post-emergence and monitored survival for at least 30 days to evaluate the immediate and long-term effects of repeated exposure as mosquitoes aged. We also exposed Plasmodium chabaudi- and P. yoelii-infected An. stephensi females. Permethrin exposure did not consistently increase mosquito susceptibility to subsequent insecticide exposure, though older mosquitoes were more susceptible. A blood meal slightly improved survival after insecticide exposure; malaria infection did not detectably increase insecticide susceptibility. Exposure to low concentrations over successive feeding cycles substantially altered cohort age-structure. Our data suggest the possibility that, where high insecticide coverage can be achieved, low concentration formulations have the capacity to reduce disease transmission without the massive selection for resistance imposed by current practice.	[Glunt, Katey D.; Thomas, Matthew B.; Read, Andrew F.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Glunt, Katey D.; Read, Andrew F.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Thomas, Matthew B.; Read, Andrew F.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Read, Andrew F.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Glunt, KD (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	kdglunt@gmail.com			National Institutes of Health, National Institute of Allergy and Infectious Diseases [R21 AIO88094]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088094] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant number R21 AIO88094 from the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2000, PARASITOLOGY, V120, P329, DOI 10.1017/S0031182099005570; [Anonymous], 1998, WHOCDCMAL98; Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X; Charlwood JD, 1997, B ENTOMOL RES, V87, P445, DOI 10.1017/S0007485300041304; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; CURTIS CF, 1978, ECOL ENTOMOL, V3, P273, DOI 10.1111/j.1365-2311.1978.tb00928.x; Curtis CF, 1998, TROP DOCT, V28, P63, DOI 10.1177/004947559802800129; CURTIS CF, 1985, B ENTOMOL RES, V75, P259, DOI 10.1017/S0007485300014346; DAY JF, 1983, J PARASITOL, V69, P163, DOI 10.2307/3281292; Farenhorst M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012081; Ferguson HM, 2003, PARASITOLOGY, V127, P9, DOI 10.1017/S0031182003003287; Ferguson HM, 2003, EVOLUTION, V57, P2792, DOI 10.1111/j.0014-3820.2003.tb01521.x; Gourley SA, 2011, P ROY SOC A-MATH PHY, V467, P2127, DOI 10.1098/rspa.2010.0413; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hargreaves K, 2003, MED VET ENTOMOL, V17, P417, DOI 10.1111/j.1365-2915.2003.00460.x; Hemingway J, 1997, PESTIC SCI, V51, P375, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;375::AID-PS636&gt;3.0.CO;2-K; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hodjati MH, 1999, B ENTOMOL RES, V89, P329, DOI 10.1017/S0007485399000462; Hougard JM, 2003, B ENTOMOL RES, V93, P491, DOI 10.1079/BER2003261; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Koella JC, 2009, EVOL APPL, V2, P469, DOI 10.1111/j.1752-4571.2009.00072.x; Kolaczinski JH, 2004, J MED ENTOMOL, V41, P930, DOI 10.1603/0022-2585-41.5.930; LINES JD, 1991, MED VET ENTOMOL, V5, P261, DOI 10.1111/j.1365-2915.1991.tb00550.x; LINES JD, 1988, PARASITOL TODAY, V4, pS17, DOI 10.1016/0169-4758(88)90083-X; Matambo TS, 2007, MED VET ENTOMOL, V21, P97, DOI 10.1111/j.1365-2915.2007.00671.x; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Penilla RP, 2007, PESTIC BIOCHEM PHYS, V89, P111, DOI 10.1016/j.pestbp.2007.03.004; Rajatileka S, 2011, T ROY SOC TROP MED H, V105, P247, DOI 10.1016/j.trstmh.2011.01.009; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; ROWLAND M, 1987, PESTIC BIOCHEM PHYS, V28, P239, DOI 10.1016/0048-3575(87)90022-8; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; TABASHNIK BE, 1989, J ECON ENTOMOL, V82, P1263, DOI 10.1093/jee/82.5.1263; Tripet F, 2008, TRENDS PARASITOL, V24, P219, DOI 10.1016/j.pt.2008.02.008; VAUGHAN JA, 1994, J PARASITOL, V80, P674, DOI 10.2307/3283245; WHO, 2006, GUIDELINES TESTING M; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	44	42	42	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24968	10.1371/journal.pone.0024968	http://dx.doi.org/10.1371/journal.pone.0024968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966392	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100036
J	Gotlind, YYC; Raghavan, S; Bland, PW; Hornquist, EH				Gotlind, Yu-Yuan C.; Raghavan, Sukanya; Bland, Paul W.; Hornquist, Elisabeth Hultgren			CD4(+)FoxP3(+) Regulatory T Cells from G alpha i2(-/-) Mice Are Functionally Active In Vitro, but Do Not Prevent Colitis	PLOS ONE			English	Article							G-ALPHA-I2-DEFICIENT MICE; INTESTINAL INFLAMMATION; EPITHELIAL-CELLS; E-CADHERIN; FOXP3; AUTOIMMUNITY; ACTIVATION; INDUCTION; RESPONSES; INTEGRIN	Background: Mice deficient in the inhibitory G protein subunit G alpha i2 spontaneously develop a T helper 1 dominated colitis. We examined whether a defect in CD4(+) FoxP3(+) regulatory T cells (Treg) underpins the pathogenesis of colitis in the G alpha i2(-/-) (G alpha i2-deficient) colitis model. Methodology/Principal Findings: Using flow cytometry, we found that thymus and colonic lamina propria, but not spleen and mesenteric lymph nodes, of colitic G alpha i2(-/-) mice contained increased frequencies of Treg, whereas FoxP3 expression intensity was similar in G alpha i2(-/-) compared to G alpha i2(-/-) or G alpha i2(+/+) wild type (WT) mice. The frequency of CD4(+)FoxP3(+) T cells expressing CD103 was significantly increased in G alpha i2(-/-) compared to WT mice. Treg in colons from WT mice clustered in the T cell areas of colonic lymphoid patches (CLP), with relatively few Treg in the lamina propria, as demonstrated by immunohistochemistry. In G alpha i2(-/-) mice, CLP were not observed but lamina propria Treg were increased in number and frequency within the CD4(+) infiltrate, compared to WT mice. Using an in vitro co-culture system and flow cytometric analysis of cell division we could demonstrate that the in vitro suppressive function of WT and G alpha i2(-/-) CD4(+)FoxP3(+) regulatory T cells (WT-Treg and KO-Treg) was indistinguishable, but that T effector cells (CD4(+)25(-) T cells) from G alpha i2(-/-) mice were less readily suppressed than WT effectors (WT-Teff) by Treg from either source. However, neither WT nor G alpha i2(-/-) Treg was able to suppress colitis induced by adoptive transfer of G alpha i2(-/-) effector T cells (KO-Teff) to RAG2(-/-) recipients. The enhanced inflammatory activity of G alpha i2(-/-) effectors was accompanied by increased expression of an effector/memory T cell phenotype and increased cytokine secretion, especially IL-4, IL-6 and IFN-gamma. Conclusions: There is an increased frequency of G alpha i2(-/-) Treg in the colon, and they demonstrate no endogenous functional defect. However, G alpha i2(-/-) T effector cells are dramatically less susceptible to suppression in vitro, and in vivo, despite increased effective numbers of Treg, they cannot prevent disease.	[Gotlind, Yu-Yuan C.; Raghavan, Sukanya; Bland, Paul W.] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Mucosal Immunol & Vaccine Ctr, Gothenburg, Sweden; [Bland, Paul W.] Univ Bristol, Bristol, Avon, England; [Hornquist, Elisabeth Hultgren] Univ Orebro, Sch Med & Hlth Sci, Orebro, Sweden	University of Gothenburg; University of Bristol; Orebro University	Gotlind, YYC (corresponding author), Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Mucosal Immunol & Vaccine Ctr, Gothenburg, Sweden.				Swedish Research Council [2008-4075]; Swedish Cancer Society [CAN 2008/591]; Sahlgrenska Academy	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Sahlgrenska Academy	Funding for this work was provided by the Swedish Research Council (http://www.vr.se/inenglish) Grant no 2008-4075, The Swedish Cancer Society (http://www.cancerfonden.se/sv/Information-in-English/) Grant no. CAN 2008/591, and the Sahlgrenska Academy (Ph.D. student grant for Y-YG) (http://www.sahlgrenska.gu.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Dalwadi H, 2003, J IMMUNOL, V170, P1707, DOI 10.4049/jimmunol.170.4.1707; Elgbratt K, 2007, IMMUNOLOGY, V122, P199, DOI 10.1111/j.1365-2567.2007.02629.x; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Holtta V, 2008, INFLAMM BOWEL DIS, V14, P1175, DOI 10.1002/ibd.20475; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hornquist CE, 1997, J IMMUNOL, V158, P1068; Huang TT, 2003, INT IMMUNOL, V15, P1359, DOI 10.1093/intimm/dxg135; Hultgren OH, 2006, WORLD J GASTROENTERO, V12, P621, DOI 10.3748/wjg.v12.i4.621; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; KARECLA PI, 1995, EUR J IMMUNOL, V25, P852, DOI 10.1002/eji.1830250333; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Larsson AE, 2006, INFLAMM BOWEL DIS, V12, P478, DOI 10.1097/00054725-200606000-00006; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Leipe J, 2005, ARTHRITIS RES THER, V7, P93, DOI 10.1186/ar1718; Leithauser F, 2006, AM J PATHOL, V168, P1898, DOI 10.2353/ajpath.2006.050228; Mackay IR, 2000, BMJ-BRIT MED J, V321, P93, DOI 10.1136/bmj.321.7253.93; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Ohman L, 2002, GUT, V51, P392, DOI 10.1136/gut.51.3.392; Ohman L, 2000, SCAND J IMMUNOL, V52, P80; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Saha C, 1998, J BIOL CHEM, V273, P21629, DOI 10.1074/jbc.273.34.21629; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Simonetta F, 2010, EUR J IMMUNOL, V40, P2528, DOI 10.1002/eji.201040531; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Zhang YJ, 2005, INT IMMUNOL, V17, P233, DOI 10.1093/intimm/dxh204	39	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25073	10.1371/journal.pone.0025073	http://dx.doi.org/10.1371/journal.pone.0025073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966415	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100048
J	Lohse, I; Reilly, P; Zaugg, K				Lohse, Ines; Reilly, Patrick; Zaugg, Kathrin			The CPT1C 5 ' UTR Contains a Repressing Upstream Open Reading Frame That Is Regulated by Cellular Energy Availability and AMPK	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CARNITINE PALMITOYLTRANSFERASE-I; HYPOTHALAMIC MALONYL-COA; FATTY-ACID-METABOLISM; FOOD-INTAKE; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; BRAIN; HOMEOSTASIS; TRANSLATION	Background: Translational control is utilized as a means of regulating gene expression in many species. In most cases, posttranscriptional regulatory mechanisms play an important role in stress response pathways and can lead to dysfunctional physiology if blocked by mutations. Carnitine Palmitoyltransferase 1 C (CPT1C), the brain-specific member of the CPT 1 family, has previously been shown to be involved in regulating metabolism in situations of energy surplus. Principal Findings: Sequence analysis of the CPT1C mRNA revealed that it contains an upstream open reading frame (uORF) in the 59 UTR of its mRNA. Using CPT1C 5 ' UTR/luciferase constructs, we investigated the role of the uORF in translational regulation. The results presented here show that translation from the CPT1C main open reading frame (mORF) is repressed by the presence of the uORF, that this repression is relieved in response to specific stress stimuli, namely glucose deprivation and palmitate-BSA treatment, and that AMPK inhibition can relieve this uORF-dependent repression. Significance: The fact that the mORF regulation is relieved in response to a specific set of stress stimuli rather than general stress response, hints at an involvement of CPT1C in cellular energy-sensing pathways and provides further evidence for a role of CPT1C in hypothalamic regulation of energy homeostasis.	[Lohse, Ines; Reilly, Patrick; Zaugg, Kathrin] Univ Zurich Hosp, Dept Radiat Oncol, CH-8091 Zurich, Switzerland; [Reilly, Patrick] Natl Canc Ctr Singapore, Dept Cellular & Mol Res, Singapore, Singapore	University of Zurich; University Zurich Hospital; National Cancer Centre Singapore (NCCS)	Lohse, I (corresponding author), Univ Zurich Hosp, Dept Radiat Oncol, CH-8091 Zurich, Switzerland.	kathrin.zaugg@usz.ch			Forschungskredit of the University of Zurich, Oncosuisse [OCS-02009-02-2007]; Olga Mayenfisch Foundation	Forschungskredit of the University of Zurich, Oncosuisse; Olga Mayenfisch Foundation	This work was supported by grants from the Forschungskredit of the University of Zurich, Oncosuisse [OCS-02009-02-2007] and Olga Mayenfisch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Chan AYM, 2005, CAN J PHYSIOL PHARM, V83, P24, DOI 10.1139/Y04-107; Chau-Van C, 2007, ENDOCRINOLOGY, V148, P507, DOI 10.1210/en.2006-1237; Dai Y, 2007, BIOCHEM BIOPH RES CO, V359, P469, DOI 10.1016/j.bbrc.2007.05.161; de Pablo MA, 1999, APOPTOSIS, V4, P81, DOI 10.1023/A:1009694124241; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Gao XF, 2009, DIABETOLOGIA, V52, P912, DOI 10.1007/s00125-009-1284-0; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; He W, 2006, NAT NEUROSCI, V9, P227, DOI 10.1038/nn1626; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Karagounis LG, 2009, INT J BIOCHEM CELL B, V41, P2360, DOI 10.1016/j.biocel.2009.07.004; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lavrentyev EN, 2004, BIOCHEM BIOPH RES CO, V315, P174, DOI 10.1016/j.bbrc.2004.01.040; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; Liu L, 1999, NAT GENET, V21, P128, DOI 10.1038/5082; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; Migrenne S, 2007, DIABETES METAB, V33, P177, DOI 10.1016/j.diabet.2007.01.006; Minokoshi Y, 2008, NUTRITION, V24, P786, DOI 10.1016/j.nut.2008.06.002; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Muhlemann O, 2008, BBA-GENE REGUL MECH, V1779, P538, DOI 10.1016/j.bbagrm.2008.06.012; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Rahmani F, 2009, PLANT PHYSIOL, V150, P1356, DOI 10.1104/pp.109.136036; Ramamurthy S, 2006, J PHYSIOL-LONDON, V574, P85, DOI 10.1113/jphysiol.2006.110122; Sangiao-Alvarellos S, 2010, J NEUROENDOCRINOL, V22, P543, DOI 10.1111/j.1365-2826.2010.01994.x; Scharrer E, 1999, NUTRITION, V15, P704, DOI 10.1016/S0899-9007(99)00125-2; Schluter G, 2000, BIOCHEM BIOPH RES CO, V268, P255, DOI 10.1006/bbrc.2000.2109; Shimokawa T, 2002, P NATL ACAD SCI USA, V99, P66, DOI 10.1073/pnas.012606199; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Spevak CC, 2006, BIOCHEM BIOPH RES CO, V350, P834, DOI 10.1016/j.bbrc.2006.09.128; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; Wen YR, 2009, NAT GENET, V41, P228, DOI 10.1038/ng.276; Wiestner A, 1998, NAT GENET, V18, P49, DOI 10.1038/ng0198-49; Wolfgang MJ, 2008, J NEUROCHEM, V105, P1550, DOI 10.1111/j.1471-4159.2008.05255.x; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Wolfgang MJ, 2006, ANNU REV NUTR, V26, P23, DOI 10.1146/annurev.nutr.25.050304.092532; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221	44	86	87	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e21486	10.1371/journal.pone.0021486	http://dx.doi.org/10.1371/journal.pone.0021486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961029	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000295265100001
J	Vojvodic, S; Jensen, AB; Markussen, B; Eilenberg, J; Boomsma, JJ				Vojvodic, Svjetlana; Jensen, Annette B.; Markussen, Bo; Eilenberg, Jorgen; Boomsma, Jacobus J.			Genetic Variation in Virulence among Chalkbrood Strains Infecting Honeybees	PLOS ONE			English	Article							PAENIBACILLUS-LARVAE; RESISTANCE; DISEASE; DIVERSITY; COLONIES	Ascosphaera apis causes chalkbrood in honeybees, a chronic disease that reduces the number of viable offspring in the nest. Although lethal for larvae, the disease normally has relatively low virulence at the colony level. A recent study showed that there is genetic variation for host susceptibility, but whether Ascosphaera apis strains differ in virulence is unknown. We exploited a recently modified in vitro rearing technique to infect honeybee larvae from three colonies with naturally mated queens under strictly controlled laboratory conditions, using four strains from two distinct A. apis clades. We found that both strain and colony of larval origin affected mortality rates. The strains from one clade caused 12-14% mortality while those from the other clade induced 71-92% mortality. Larvae from one colony showed significantly higher susceptibility to chalkbrood infection than larvae from the other two colonies, confirming the existence of genetic variation in susceptibility across colonies. Our results are consistent with antagonistic coevolution between a specialized fungal pathogen and its host, and suggest that beekeeping industries would benefit from more systematic monitoring of this chronic stress factor of their colonies.	[Vojvodic, Svjetlana; Jensen, Annette B.; Eilenberg, Jorgen] Univ Copenhagen, Ctr Social Evolut, Fac Life Sci, Dept Agr & Ecol, Copenhagen, Denmark; [Markussen, Bo] Univ Copenhagen, Dept Nat Sci & Environm, Fac Life Sci, Copenhagen, Denmark; [Boomsma, Jacobus J.] Univ Copenhagen, Ctr Social Evolut, Dept Biol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Vojvodic, S (corresponding author), Univ Arizona, Canter Insect Sci, Tucson, AZ 85721 USA.	Vojvodic.sv@gmail.com	Jensen, Annette Bruun/AAH-1732-2021; Jensen, Annette B/G-7558-2014; Markussen, Bo/M-2161-2014; Boomsma, Jacobus J/M-2785-2014; Eilenberg, Jorgen/F-7444-2014; Jensen, Annette/E-5478-2013	Jensen, Annette Bruun/0000-0002-2044-2274; Jensen, Annette B/0000-0002-2044-2274; Markussen, Bo/0000-0001-7793-9620; Boomsma, Jacobus J/0000-0002-3598-1609; Eilenberg, Jorgen/0000-0002-9273-5252; Vojvodic Kruse, Svjetlana/0000-0003-0660-6540	Danish National Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	Danish National Research Foundation(Danmarks Grundforskningsfond); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this study was obtained from the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Aupinel Pierrick, 2005, Bulletin of Insectology, V58, P107; Baer B, 1999, NATURE, V397, P151, DOI 10.1038/16451; BEAUVAIS A, 1988, J INVERTEBR PATHOL, V51, P175, DOI 10.1016/0022-2011(88)90079-1; Boomsma J.J., 2005, P139, DOI 10.1079/9780851998121.0139; Brodsgaard CJ, 1998, APIDOLOGIE, V29, P569, DOI 10.1051/apido:19980609; Cole BJ, 1999, SCIENCE, V285, P891, DOI 10.1126/science.285.5429.891; Cremer S, 2009, PHILOS T R SOC B, V364, P129, DOI 10.1098/rstb.2008.0166; Day T, 2004, AM NAT, V163, pE40, DOI 10.1086/382548; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Invernizzi C, 2009, INSECT SOC, V56, P233, DOI 10.1007/s00040-009-0016-2; James RR, 2004, MYCOPATHOLOGIA, V158, P293, DOI 10.1007/s11046-004-2910-5; Jensen AB, 2009, APIDOLOGIE, V40, P524, DOI 10.1051/apido/2009029; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Kalbfleisch J.D., 1980, STAT ANAL FAILURE TI, DOI [10.1002/9781118032985, DOI 10.1002/9781118032985]; Kraaijeveld AR, 2008, HEREDITY, V100, P400, DOI 10.1038/sj.hdy.6801092; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Lively CM, 2010, AM NAT, V175, pE149, DOI 10.1086/652430; Mattila HR, 2010, BEHAV ECOL SOCIOBIOL, V64, P875, DOI 10.1007/s00265-010-0904-5; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; Rauch S, 2009, APPL ENVIRON MICROB, V75, P3344, DOI 10.1128/AEM.02839-08; Reynaldi FJ, 2003, J APICULT RES, V42, P68, DOI 10.1080/00218839.2003.11101096; Schmid-Hempel P., 1998, Parasites in social insects.; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; STEPHEN WP, 1990, APIDOLOGIE, V21, P209, DOI 10.1051/apido:19900306; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Ugelvig LV, 2010, P ROY SOC B-BIOL SCI, V277, P2821, DOI 10.1098/rspb.2010.0644; Vojvodic S, 2011, VET MICROBIOL, V149, P200, DOI 10.1016/j.vetmic.2010.10.001; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301	31	28	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25035	10.1371/journal.pone.0025035	http://dx.doi.org/10.1371/journal.pone.0025035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966406	Green Published, gold			2022-12-25	WOS:000295265100043
J	Fiume, R; Ramazzotti, G; Faenza, I; Piazzi, M; Bavelloni, A; Billi, AM; Cocco, L				Fiume, Roberta; Ramazzotti, Giulia; Faenza, Irene; Piazzi, Manuela; Bavelloni, Alberto; Billi, Anna Maria; Cocco, Lucio			Nuclear PLCs affect insulin secretion by targeting PPAR gamma in pancreatic beta cells	FASEB JOURNAL			English	Article						PLC beta 1; PLC delta 4; phosphoinositides; diabetes	PHOSPHOLIPASE-C ACTIVATION; PROTEIN-KINASE-C; GLUCOSE; PHOSPHOINOSITIDES; RECEPTOR; ISLETS; DIFFERENTIATION; PLC-BETA(1); EXPRESSION; FEEDBACK	Type 2 diabetes is a heterogeneous disorder caused by concomitant impairment of insulin secretion by pancreatic beta cells and of insulin action in peripheral target tissues. Studies with inhibitors and agonists established a role for PLC in the regulation of insulin secretion but did not distinguish between effects due to nuclear or cytoplasmic PLC signaling pathways that act in a distinct fashion. We report that in MIN6 beta cells, PLC beta 1 localized in both nucleus and cytoplasm, PLC delta 4 in the nucleus, and PLC gamma 1 in the cytoplasm. By silencing each isoform, we observed that they all affected glucose-induced insulin release both at basal and high glucose concentrations. To elucidate the molecular basis of PLC regulation, we focused on peroxisome proliferator-activated receptor-gamma (PPAR gamma), a nuclear receptor transcription factor that regulates genes critical to beta-cell maintenance and functions. Silencing of PLC beta 1 and PLC delta 4 resulted in a decrease in the PPAR gamma mRNA level. By means of a PPAR gamma-promoter-luciferase assay, the decrease could be attributed to a PLC action on the PPAR gamma-promoter region. The effect was specifically observed on silencing of the nuclear and not the cytoplasmic PLC. These findings highlight a novel pathway by which nuclear PLCs affect insulin secretion and identify PPAR gamma as a novel molecular target of nuclear PLCs.-Fiume, R., Ramazzotti, G., Faenza, I., Piazzi, M., Bavelloni, A., Billi, A. M., Cocco, L. Nuclear PLCs affect insulin secretion by targeting PPAR gamma in pancreatic beta cells. FASEB J. 26, 203-210 (2012). www.fasebj.org	[Fiume, Roberta; Ramazzotti, Giulia; Faenza, Irene; Piazzi, Manuela; Billi, Anna Maria; Cocco, Lucio] Univ Bologna, Cellular Signaling Lab, Dept Human Anat, Bologna, Italy; [Bavelloni, Alberto] Rizzoli Orthoped Inst, Lab Musculoskeletal Cell Biol, Bologna, Italy	University of Bologna; IRCCS Istituto Ortopedico Rizzoli	Cocco, L (corresponding author), Via Irnerio 48, I-40126 Bologna, Italy.	lucio.cocco@unibo.it	Ramazzotti, Giulia/AAC-4597-2022; Cocco, Lucio/AAI-2206-2020; Piazzi, Manuela/K-2147-2016; Faenza, Irene/AAC-4606-2022; Bavelloni, Alberto/E-5726-2019; RAMAZZOTTI, GIULIA/AGZ-9499-2022; Piazzi, Manuela/AAD-5016-2020	Cocco, Lucio/0000-0002-9206-8277; Piazzi, Manuela/0000-0002-9072-2757; Faenza, Irene/0000-0002-5227-3567; Bavelloni, Alberto/0000-0002-6467-1431; RAMAZZOTTI, GIULIA/0000-0001-9684-714X; Piazzi, Manuela/0000-0002-9072-2757; FIUME, ROBERTA/0000-0001-7757-4000	Italian Ministero dell'Istruzione, dell'Universit a e della Ricerca (MIUR)-Fondo FIRB; Carisbo Foundation, Bologna, Italy	Italian Ministero dell'Istruzione, dell'Universit a e della Ricerca (MIUR)-Fondo FIRB; Carisbo Foundation, Bologna, Italy(Fondazione Carisbo)	The authors thank Dr. Sun Sik Bae (MRC for Ischemic Tissue Regeneration, Pusan National University, Busan, Korea) for the generous gift of the plasmids encoding PPAR-gamma promoter and the PPAR-gamma responsive element (PPRE); and Dr. Susumu Seino (Kobe University, Kobe, Japan) for the generous gift of MIN6m9 cells. This work was supported by Italian Ministero dell'Istruzione, dell'Universit a e della Ricerca (MIUR)-Fondo FIRB and Carisbo Foundation, Bologna, Italy.	Chang TJ, 2009, DIABETOLOGIA, V52, P1112, DOI 10.1007/s00125-009-1337-4; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Faenza I, 2002, BBA-MOL CELL RES, V1589, P305, DOI 10.1016/S0167-4889(02)00192-1; Faenza I, 2007, ENDOCRINOLOGY, V148, P1108, DOI 10.1210/en.2006-1003; Follo MY, 2009, P NATL ACAD SCI USA, V106, P16811, DOI 10.1073/pnas.0907109106; Follo MY, 2009, J CLIN ONCOL, V27, P782, DOI 10.1200/JCO.2008.19.3748; GANESAN S, 1992, J CELL BIOL, V119, P313, DOI 10.1083/jcb.119.2.313; GANESAN S, 1990, P NATL ACAD SCI USA, V87, P9893, DOI 10.1073/pnas.87.24.9893; Gupta D, 2010, DIABETES OBES METAB, V12, P1036, DOI 10.1111/j.1463-1326.2010.01299.x; Kim SP, 2010, BIOCHEM BIOPH RES CO, V399, P55, DOI 10.1016/j.bbrc.2010.07.038; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Leibiger IB, 2010, BIOCHEM BIOPH RES CO, V396, P111, DOI 10.1016/j.bbrc.2010.02.174; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Liu NS, 1996, J BIOL CHEM, V271, P355, DOI 10.1074/jbc.271.1.355; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Nakamichi Y, 2003, BIOCHEM BIOPH RES CO, V306, P832, DOI 10.1016/S0006-291X(03)01045-3; Ramazzotti G, 2008, CELL SIGNAL, V20, P2013, DOI 10.1016/j.cellsig.2008.07.009; Ramazzotti G, 2011, J CELL PHYSIOL, V226, P14, DOI 10.1002/jcp.22334; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; World Health Organization, HLTH TOP DIAB; Yamazaki H, 2006, AM J PHYSIOL-ENDOC M, V290, pE26, DOI 10.1152/ajpendo.00149.2005; Yamazaki H, 2010, J NUTR SCI VITAMINOL, V56, P1, DOI 10.3177/jnsv.56.1; Zawalich WS, 2008, METABOLISM, V57, P290, DOI 10.1016/j.metabol.2007.09.015; Zawalich WS, 2006, METABOLISM, V55, P35, DOI 10.1016/j.metabol.2005.06.023	28	21	25	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					203	210		10.1096/fj.11-186510	http://dx.doi.org/10.1096/fj.11-186510			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21974932				2022-12-25	WOS:000299202200021
J	Ko, IK; Ju, YM; Chen, T; Atala, A; Yoo, JJ; Lee, SJ				Ko, In Kap; Ju, Young Min; Chen, Timothy; Atala, Anthony; Yoo, James J.; Lee, Sang Jin			Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration	FASEB JOURNAL			English	Article						cell-free scaffold; substance P; stromal-derived factor-1 alpha	MUSCLE REGENERATION; HEMATOPOIETIC PROGENITOR; SUBSTANCE-P; BONE-MARROW; MOBILIZATION; RECRUITMENT	Whereas the conventional tissue engineering strategy involves the use of scaffolds combined with appropriate cell types to restore normal functions, the concept of in situ tissue regeneration uses host responses to a target-specific scaffold to mobilize host cells to a site of injury without the need for cell seeding. For this purpose, local delivery of bioactive molecules from scaffolds has been generally used. However, this approach has limited stem cell recruitment into the implants. Thus, we developed a combination of systemic delivery of substance P (SP) and local release of stromal-derived factor-1 alpha (SDF-1 alpha) from an implant. In this study, we examined whether this combined system would significantly enhance recruitment of host stem cells into the implants. Flow cytometry and immunohistochemistry for CD29/CD45, CD146/alpha-smooth muscle actin, and c-kit demonstrated that this system significantly increased the number of stem cell-like cells within the implants when compared with other systems. In vitro culture of the cells that had infiltrated into the scaffolds from the combined system confirmed that host stem cells were recruited into these implants and indicated that they were capable of differentiation into multiple lineages. These results indicate that this combined system may lead to more efficient tissue regeneration.-Ko, I. K., Ju, Y. M., Chen, T., Atala, A., Yoo, J. J., Lee, S. J. Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration. FASEB J. 26, 158 -168 (2012). www.fasebj.org	[Ko, In Kap; Ju, Young Min; Chen, Timothy; Atala, Anthony; Yoo, James J.; Lee, Sang Jin] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA	Wake Forest University	Lee, SJ (corresponding author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	sjlee@wakehealth.edu	Yoo, James J./L-4850-2017; Lee, Sang Jin/S-4056-2019	Lee, Sang Jin/0000-0002-3899-1909; Atala, Anthony/0000-0001-8186-2160	Armed Forces Institute of Regenerative Medicine [X81XWH-08-2-0032]	Armed Forces Institute of Regenerative Medicine	The authors thank Drs. John Jackson and Jennifer Olson for editorial assistance with this manuscript and Dr. Youngsook Son (Kyung Hee University, Seoul, South Korea) for providing valuable information on the CD29 antibody. This study was supported in part by the Armed Forces Institute of Regenerative Medicine (X81XWH-08-2-0032).	An YS, 2011, J CELL PHYSIOL, V226, P1204, DOI 10.1002/jcp.22447; Bladergroen BA, 2009, TISSUE ENG PT A, V15, P1591, DOI 10.1089/ten.tea.2008.0348; Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Hong HS, 2009, NAT MED, V15, P425, DOI 10.1038/nm.1909; Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kim JY, 2010, TISSUE ENG PT A, V16, P3023, DOI 10.1089/ten.TEA.2010.0181; Ko IK, 2010, MOL THER, V18, P1365, DOI 10.1038/mt.2010.54; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Lee SJ, 2008, REJUV RES, V11, P747, DOI 10.1089/rej.2008.0691; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144; Vishalakumar S, 2006, CELL SIGNAL, V18, P422, DOI 10.1016/j.cellsig.2005.05.002; Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	22	68	69	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					158	168		10.1096/fj.11-182998	http://dx.doi.org/10.1096/fj.11-182998			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21965595				2022-12-25	WOS:000299202200017
J	Wang, W; Okeyo, GO; Tao, BL; Hong, JS; Kirk, KL				Wang, Wei; Okeyo, George O.; Tao, Binli; Hong, Jeong S.; Kirk, Kevin L.			Thermally Unstable Gating of the Most Common Cystic Fibrosis Mutant Channel (Delta F508) "RESCUE" BY SUPPRESSOR MUTATIONS IN NUCLEOTIDE BINDING DOMAIN 1 AND BY CONSTITUTIVE MUTATIONS IN THE CYTOSOLIC LOOPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAINS; CFTR CHLORIDE CHANNEL; PHARMACOLOGICAL CHAPERONES; PROCESSING MUTANTS; ABC TRANSPORTER; PLASMA-MEMBRANE; MOLECULAR-BASIS; P-GLYCOPROTEIN; ATP BINDING	Most cystic fibrosis (CF) cases are caused by the Delta F508 mutation in the CF transmembrane conductance regulator (CFTR), which disrupts both the processing and gating of this chloride channel. The cell surface expression of Delta F508-CFTR can be "rescued" by culturing cells at 26-28 degrees C and treating cells with small molecule correctors or intragenic suppressor mutations. Here, we determined whether these various rescue protocols induce a Delta F508-CFTR conformation that is thermally stable in excised membrane patches. We also tested the impact of constitutive cytosolic loop mutations that increase ATP-independent channel activity (K978C and K190C/K978C) on Delta F508-CFTR function. Low temperature-rescued Delta F508-CFTR channels irreversibly inactivated with a time constant of 5-6 min when excised patches were warmed from 22 degrees C to 36.5 degrees C. A panel of CFTR correctors and potentiators that increased Delta F508-CFTR maturation or channel activity failed to prevent this inactivation. Conversely, three suppressor mutations in the first nucleotide binding domain rescued Delta F508-CFTR maturation and stabilized channel activity at 36.5 degrees C. The constitutive loop mutations increased ATP-independent activity of low temperature-rescued Delta F508-CFTR but did not enhance protein maturation. Importantly, the ATP-independent activities of these Delta F508-CFTR constructs were stable at 36.5 degrees C, whereas their ATP-dependent activities were not. Single channel recordings of this thermally stable ATP-independent activity revealed dynamic gating and unitary currents of normal amplitudes. We conclude that: (i) Delta F508-CFTR gating is highly unstable at physiologic temperature; (ii) most rescue protocols do not prevent this thermal instability; and (iii) ATP-independent gating and the pore are spared from Delta F508-induced thermal instability, a finding that may inform alternative treatment strategies.	[Wang, Wei; Okeyo, George O.; Tao, Binli; Kirk, Kevin L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Hong, Jeong S.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Wang, Wei; Okeyo, George O.; Tao, Binli; Hong, Jeong S.; Kirk, Kevin L.] Univ Alabama, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, W (corresponding author), Univ Alabama, Dept Physiol & Biophys, 740 MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	weiwang@uab.edu			National Institutes of Health [R01 DK056796]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK056796.	Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Berger AL, 2005, J BIOL CHEM, V280, P5221, DOI 10.1074/jbc.M412972200; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Hwang TC, 1997, AM J PHYSIOL-CELL PH, V273, pC988, DOI 10.1152/ajpcell.1997.273.3.C988; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2009, BIOCHEMISTRY-US, V48, P9882, DOI 10.1021/bi9004842; Loo TW, 2006, BIOCHEM J, V395, P537, DOI 10.1042/BJ20060013; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mathews CJ, 1998, J MEMBRANE BIOL, V163, P55, DOI 10.1007/s002329900370; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; SMITH JJ, 1994, J CLIN INVEST, V93, P1307, DOI 10.1172/JCI117087; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	60	42	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41937	41948		10.1074/jbc.M111.296061	http://dx.doi.org/10.1074/jbc.M111.296061			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965669	hybrid, Green Published			2022-12-25	WOS:000298180900005
J	Esposito, V; Musi, V; de Chiara, C; Veggi, D; Serruto, D; Scarselli, M; Kelly, G; Pizza, M; Pastore, A				Esposito, Veronica; Musi, Valeria; de Chiara, Cesira; Veggi, Daniele; Serruto, Davide; Scarselli, Maria; Kelly, Geoff; Pizza, Mariagrazia; Pastore, Annalisa			Structure of the C-terminal Domain of Neisseria Heparin Binding Antigen (NHBA), One of the Main Antigens of a Novel Vaccine against Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-H-BINDING; MONOCLONAL-ANTIBODY; PROTECTIVE ANTIGEN; PROTEIN; ASSIGNMENT; GNA1870; SYSTEM	Neisseria heparin binding antigen (NHBA), also known as GNA2132 (genome-derived Neisseria antigen 2132), is a surface-exposed lipoprotein from Neisseria meningitidis that was originally identified by reverse vaccinology. It is one the three main antigens of a multicomponent vaccine against serogroup B meningitis (4CMenB), which has just completed phase III clinical trials in infants. In contrast to the other two main vaccine components, little is known about the origin of the immunogenicity of this antigen, and about its ability to induce a strong cross-bactericidal response in animals and humans. To characterize NHBA in terms of its structural/immunogenic properties, we have analyzed its sequence and identified a C-terminal region that is highly conserved in all strains. We demonstrate experimentally that this region is independently folded, and solved its three-dimensional structure by nuclear magnetic resonance. Notably, we need detergents to observe a single species in solution. The NHBA domain fold consists of an 8-strand beta-barrel that closely resembles the C-terminal domains of N. meningitidis factor H-binding protein and transferrin-binding protein B. This common fold together with more subtle structural similarities suggest a common ancestor for these important antigens and a role of the beta-barrel fold in inducing immunogenicity against N. meningitidis. Our data represent the first step toward understanding the relationship between structural, functional, and immunological properties of this important vaccine component.	[Esposito, Veronica; Musi, Valeria; de Chiara, Cesira; Kelly, Geoff; Pastore, Annalisa] MRC Natl Inst Med Res, London NW7 1AA, England; [Veggi, Daniele; Serruto, Davide; Scarselli, Maria; Pizza, Mariagrazia] Novartis Vaccines & Diagnost, I-53100 Siena, Italy	MRC National Institute for Medical Research; Novartis	Pastore, A (corresponding author), MRC Natl Inst Med Res, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk		de Chiara, Cesira/0000-0002-9766-2515	Medical Research Council [U117584256]; Novartis; MRC [MC_U117584256, MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887, MC_U117584256] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novartis(Novartis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Medical Research Council Grant U117584256.; Supported by a fellowship from Novartis.	Bai XL, 2011, EXPERT OPIN BIOL TH, V11, P969, DOI 10.1517/14712598.2011.585965; Bambini S, 2009, VACCINE, V27, P2794, DOI 10.1016/j.vaccine.2009.02.098; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calmettes C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206102; Cantini F, 2006, J BIOL CHEM, V281, P7220, DOI 10.1074/jbc.M508595200; Cantini F, 2009, J BIOL CHEM, V284, P9022, DOI 10.1074/jbc.C800214200; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Cendron L, 2011, ACTA CRYSTALLOGR F, V67, P531, DOI 10.1107/S1744309111006154; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desvaux M, 2004, CURR ISSUES MOL BIOL, V6, P111; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Esposito V, 2010, BIOMOL NMR ASSIGN, V4, P107, DOI 10.1007/s12104-010-9220-2; FINNE J, 1987, J IMMUNOL, V138, P4402; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P46, DOI 10.1016/S0167-4838(00)00147-3; Folmer RHA, 1997, J BIOMOL NMR, V9, P245, DOI 10.1023/A:1018670623695; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Jacobsson S, 2009, VACCINE, V27, P5755, DOI 10.1016/j.vaccine.2009.07.056; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; Lewis S, 2009, EXPERT REV VACCINES, V8, P729, DOI [10.1586/erv.09.30, 10.1586/ERV.09.30]; Linge JP, 2004, J MAGN RESON, V167, P334, DOI 10.1016/j.jmr.2004.01.010; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Litt DJ, 2004, J INFECT DIS, V190, P1488, DOI 10.1086/424464; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Mascioni A, 2009, J BIOL CHEM, V284, P8729, DOI 10.1074/jbc.M808831200; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Moraes TF, 2009, MOL CELL, V35, P523, DOI 10.1016/j.molcel.2009.06.029; Pace D, 2009, EXPERT REV VACCINES, V8, P529, DOI [10.1586/erv.09.18, 10.1586/ERV.09.18]; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Snape MD, 2011, LANCET, V377, P1809, DOI 10.1016/S0140-6736(11)60762-9; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; Thomas D, 2005, ACTA CRYSTALLOGR D, V61, P112, DOI 10.1107/S0907444904027684; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Vandeputte-Rutten L, 2003, J BIOL CHEM, V278, P24825, DOI 10.1074/jbc.M302803200; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	51	30	34	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41767	41775		10.1074/jbc.M111.289314	http://dx.doi.org/10.1074/jbc.M111.289314			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965688	Green Published, hybrid			2022-12-25	WOS:000298057500060
J	Winkler, DD; Muthurajan, UM; Hieb, AR; Luger, K				Winkler, Duane D.; Muthurajan, Uma M.; Hieb, Aaron R.; Luger, Karolin			Histone Chaperone FACT Coordinates Nucleosome Interaction through Multiple Synergistic Binding Events	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; RECOMBINANT HISTONES; TRANSCRIPT ELONGATION; DNA INTERACTIONS; CORE PARTICLE; CHROMATIN; COMPLEX; PROTEIN	In eukaryotic cells, DNA maintenance requires ordered disassembly and re-assembly of chromatin templates. These processes are highly regulated and require extrinsic factors such as chromatin remodelers and histone chaperones. The histone chaperone FACT (facilitates chromatin transcription) is a large heterodimeric complex with roles in transcription, replication, and repair. FACT promotes and subsequently restricts access to DNA as a result of dynamic nucleosome reorganization. However, until now, there lacked a truly quantitative assessment of the critical contacts mediating FACT function. Here, we demonstrate that FACT binds histones, DNA, and intact nucleosomes at nanomolar concentrations. We also determine roles for the histone tails in free histone and nudeosome binding by FACT. Furthermore, we propose that the conserved acidic C-terminal domain of the FACT subunit Spt16 actively displaces nucleosomal DNA to provide access to the histone octamer. Experiments with tri-nudeosome arrays indicate a possible mode for FACT binding within chromatin. Together, the data reveal that specific FACT subunits synchronize interactions with various target sites on individual nucleosomes to generate a high affinity binding event and promote reorganization.	[Luger, Karolin] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA; Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University; Howard Hughes Medical Institute; Colorado State University	Luger, K (corresponding author), Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA.	Karolin.Luger@colostate.edu		Winkler, Duane D./0000-0003-1045-0323; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331	National Institutes of Health [1P01GM088409]; National Institutes of Health NRSA, NIGMS [F32GM096531]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096531, P01GM088409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NRSA, NIGMS; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P01GM088409 (to K. L.).; Supported by National Institutes of Health NRSA Award F32GM096531 from NIGMS.; Supported by the Howard Hughes Medical Institute.	Andrews AJ, 2008, J BIOL CHEM, V283, P32412, DOI 10.1074/jbc.M805918200; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Evans DRH, 1998, GENETICS, V150, P1393; Formosa T., 2011, BIOCHIM BIO IN PRESS; Formosa T, 2008, MOL BIOSYST, V4, P1085, DOI 10.1039/b812136b; Hammermann M, 2000, BIOPHYS J, V79, P584, DOI 10.1016/S0006-3495(00)76318-1; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Hsieh FK, 2010, EMBO REP, V11, P705, DOI 10.1038/embor.2010.113; Huang JY, 2006, NUCLEIC ACIDS RES, V34, P2398, DOI 10.1093/nar/gkl241; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kelley DE, 1999, CHROMOSOMA, V108, P10, DOI 10.1007/s004120050347; Korolev N, 2007, PROG BIOPHYS MOL BIO, V95, P23, DOI 10.1016/j.pbiomolbio.2006.11.003; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LASKEY RA, 1980, NATURE, V286, P763, DOI 10.1038/286763a0; Li Q., 2011, BIOCHIM BIO IN PRESS; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Loyola A, 2004, METHOD ENZYMOL, V377, P474; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; McCullough L, 2011, GENETICS, V188, P835, DOI 10.1534/genetics.111.128769; Moyle-Heyrman G, 2011, J MOL BIOL, V412, P634, DOI 10.1016/j.jmb.2011.07.032; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; OOHARA I, 1987, J MOL BIOL, V196, P399, DOI 10.1016/0022-2836(87)90700-5; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Philpott A, 2000, SEMIN CELL DEV BIOL, V11, P7, DOI 10.1006/scdb.1999.0346; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Schlesinger MB, 2000, GENETICS, V155, P1593; Shibahara K, 2000, P NATL ACAD SCI USA, V97, P7766, DOI 10.1073/pnas.97.14.7766; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Tsunaka Y, 2009, J BIOL CHEM, V284, P24610, DOI 10.1074/jbc.M109.001958; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; WILHELM FX, 1978, NUCLEIC ACIDS RES, V5, P505, DOI 10.1093/nar/5.2.505; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024	55	110	112	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41883	41892		10.1074/jbc.M111.301465	http://dx.doi.org/10.1074/jbc.M111.301465			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21969370	hybrid, Green Published			2022-12-25	WOS:000298057500070
J	Chen, GP; Howe, AG; Xu, G; Frohlich, O; Klein, JD; Sands, JM				Chen, Guangping; Howe, Ashley G.; Xu, Gang; Froehlich, Otto; Klein, Janet D.; Sands, Jeff M.			Mature N-linked glycans facilitate UT-A1 urea transporter lipid raft compartmentalization	FASEB JOURNAL			English	Article						glycosylation; apical membrane; trafficking; lectin; sucrose gradient centrifugation	MEMBRANE ACCUMULATION; COLLECTING DUCT; CL-COTRANSPORTER; EPITHELIAL-CELLS; APICAL MEMBRANE; RAT-KIDNEY; GLYCOSYLATION; VASOPRESSIN; PHOSPHORYLATION; LOCALIZATION	The UT-A1 urea transporter is a glycoprotein with two different glycosylated forms of 97 and 117 kDa. In this study, we found the 117-kDa UT-A1 preferentially resides in lipid rafts, suggesting that the glycosylation status may interfere with UT-A1 lipid raft trafficking. This was confirmed by a site-directed mutagenesis study in MDCK cells. The nonglycosylated UT-A1 showed reduced localization in lipid rafts. By using sugar-specific binding lectins, we further found that the UT-A1 in nonlipid rafts contained a high amount of mannose, as detected by concanavalin A, while the UT-A1 in lipid rafts was the mature N-acetylglucosamine-containing form, as detected by wheat germ agglutinin. In the inner medulla (IM) of diabetic rats, the more abundant 117-kDa UT-A1 in lipid rafts was the mature glycosylation form, with high amounts of N-acetylglucosamine and sialic acid. In contrast, in the IM of normal rats, the predominant 97-kDa UT-A1 was the form enriched in mannose. Functionally, inhibition of glycosylation by tunicamycin or elimination of the glycosylation sites by mutation significantly reduced UT-A1 activity in oocytes. Taken together, our study reveals a new role of N-linked glycosylation in regulating UT-A1 activity by promoting UT-A1 trafficking into membrane lipid raft subdomains.-Chen, G., Howe, A. G., Xu, G., Frohlich, O., Klein, J. D., Sands, J. M. Mature N-linked glycans facilitate UT-A1 urea transporter lipid raft compartmentalization. FASEB J. 25, 4531-4539 (2011). www.fasebj.org	[Chen, Guangping; Howe, Ashley G.; Xu, Gang; Klein, Janet D.; Sands, Jeff M.] Emory Univ, Sch Med, Div Renal, Dept Med, Atlanta, GA 30322 USA; [Froehlich, Otto; Sands, Jeff M.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University; Emory University	Chen, GP (corresponding author), WMRB Rm 338,1639 Pierce Dr, Atlanta, GA 30322 USA.	gchen3@emory.edu			U.S. National Institutes of Health [R01-DK087838, R21-DK080431, R01-DK41707]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041707, R21DK080431, R01DK087838] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grants R01-DK087838 and R21-DK080431 (to G.C.), and R01-DK41707 (to J.M.S.).	Blount MA, 2008, AM J PHYSIOL-RENAL, V295, pF295, DOI 10.1152/ajprenal.00102.2008; Bradford AD, 2001, AM J PHYSIOL-RENAL, V281, pF133, DOI 10.1152/ajprenal.2001.281.1.F133; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chen G, 2008, AM J PHYSIOL-RENAL, V295, pF1528, DOI 10.1152/ajprenal.90482.2008; Chen GP, 2006, J BIOL CHEM, V281, P27436, DOI 10.1074/jbc.M605525200; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Fattakhova G, 2006, TRAFFIC, V7, P673, DOI 10.1111/j.1600-0854.2006.00423.x; Feng XY, 2009, AM J PHYSIOL-RENAL, V296, pF1514, DOI 10.1152/ajprenal.00068.2009; Fenton RA, 2004, P NATL ACAD SCI USA, V101, P7469, DOI 10.1073/pnas.0401704101; Frohlich O, 2004, AM J PHYSIOL-CELL PH, V286, pC1264, DOI 10.1152/ajpcell.00499.2003; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Hartmann AM, 2009, J NEUROCHEM, V111, P321, DOI 10.1111/j.1471-4159.2009.06343.x; Hendriks G, 2004, J BIOL CHEM, V279, P2975, DOI 10.1074/jbc.M310767200; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Hoover RS, 2003, J AM SOC NEPHROL, V14, P271, DOI 10.1097/01.ASN.0000043903.93452.D0; Huang Haidong, 2010, J Epithel Biol Pharmacol, V3, P34; Huang HD, 2010, AM J PHYSIOL-RENAL, V299, pF1389, DOI 10.1152/ajprenal.00718.2009; Huang P, 2008, BIOCHEM BIOPH RES CO, V365, P82, DOI 10.1016/j.bbrc.2007.10.128; Kanno T, 2010, NEUROCHEM RES, V35, P782, DOI 10.1007/s11064-010-0135-1; Kim D, 2003, AM J PHYSIOL-RENAL, V285, pF303, DOI 10.1152/ajprenal.00438.2002; Klein JD, 2006, J AM SOC NEPHROL, V17, P2680, DOI 10.1681/ASN.2006030246; Klein JD, 2010, AM J PHYSIOL-RENAL, V298, pF935, DOI 10.1152/ajprenal.00682.2009; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Lee TK, 2003, AM J PHYSIOL-GASTR L, V285, pG371, DOI 10.1152/ajpgi.00358.2002; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Marr N, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027355.41663.14; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Nielsen S, 1996, P NATL ACAD SCI USA, V93, P5495, DOI 10.1073/pnas.93.11.5495; Pech V, 2005, AM J PHYSIOL-RENAL, V289, pF531, DOI 10.1152/ajprenal.00125.2005; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; Saldova R, 2011, GLYCOBIOLOGY, V21, P195, DOI 10.1093/glycob/cwq147; Sands JM, 2003, J MEMBRANE BIOL, V191, P149, DOI 10.1007/s00232-002-1053-1; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Xiong YN, 2009, BIOCHEM BIOPH RES CO, V384, P32, DOI 10.1016/j.bbrc.2009.04.044; Zhang C, 2002, AM J PHYSIOL-RENAL, V282, pF85, DOI 10.1152/ajprenal.0054.2001	42	31	36	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4531	4539		10.1096/fj.11-185991	http://dx.doi.org/10.1096/fj.11-185991			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21965602	Green Published			2022-12-25	WOS:000298138100043
J	Payne, CM; Bomble, Y; Taylor, CB; McCabe, C; Himmel, ME; Crowley, MF; Beckham, GT				Payne, Christina M.; Bomble, Yannicki; Taylor, Courtney B.; McCabe, Clare; Himmel, Michael E.; Crowley, Michael F.; Beckham, Gregg T.			Multiple Functions of Aromatic-Carbohydrate Interactions in a Processive Cellulase Examined with Molecular Simulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; CRYSTALLINE CHITIN HYDROLYSIS; FAMILY 18 CHITINASES; SERRATIA-MARCESCENS; CONFORMATIONAL-ANALYSIS; BIOMASS RECALCITRANCE; STEREOCHEMICAL COURSE; HUMICOLA-INSOLENS; BINDING MODULES; MODEL SYSTEM	Proteins employ aromatic residues for carbohydrate binding in a wide range of biological functions. Glycoside hydrolases, which are ubiquitous in nature, typically exhibit tunnels, clefts, or pockets lined with aromatic residues for processing carbohydrates. Mutation of these aromatic residues often results in significant activity differences on insoluble and soluble substrates. However, the thermodynamic basis and molecular level role of these aromatic residues remain unknown. Here, we calculate the relative ligand binding free energy by mutating tryptophans in the Trichoderma reesei family 6 cellulase (Ce16A) to alanine. Removal of aromatic residues near the catalytic site has little impact on the ligand binding free energy, suggesting that aromatic residues immediately upstream of the active site are not directly involved in binding, but play a role in the glucopyranose ring distortion necessary for catalysis. Removal of aromatic residues at the entrance and exit of the Ce16A tunnel, however, dramatically impacts the binding affinity, suggesting that these residues play a role in chain acquisition and product stabilization, respectively. The roles suggested from differences in binding affinity are confirmed by molecular dynamics and normal mode analysis. Surprisingly, our results illustrate that aromatic-carbohydrate interactions vary dramatically depending on the position in the enzyme tunnel. As aromatic-carbohydrate interactions are present in all carbohydrate-active enzymes, these results have implications for understanding protein structure-function relationships in carbohydrate metabolism and recognition, carbon turnover in nature, and protein engineering strategies for biomass utilization. Generally, these results suggest that nature employs aromatic-carbohydrate interactions with a wide range of binding affinities for diverse functions.	[Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Payne, Christina M.; Bomble, Yannicki; Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Taylor, Courtney B.; McCabe, Clare] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [McCabe, Clare] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Vanderbilt University; Vanderbilt University; Colorado School of Mines	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 1617 Cole Blvd, Golden, CO 80401 USA.	Gregg.Beckham@nrel.gov	Payne, Christina/ABE-8330-2020; McCabe, Clare/I-8017-2012; Payne, Christina M/C-7338-2011; crowley, michael F/A-4852-2013	Payne, Christina/0000-0001-5264-0964; McCabe, Clare/0000-0002-8552-9135; Payne, Christina M/0000-0001-5264-0964; crowley, michael F/0000-0001-5163-9398; Bomble, Yannick/0000-0001-7624-8000	Department of Energy Office; National Institute for Computational Sciences Athena cluster under the National Science Foundation [MCB090159]; Department of Energy Office of Energy Efficiency and Renewable Energy [DE-AC36-08GO28308]	Department of Energy Office; National Institute for Computational Sciences Athena cluster under the National Science Foundation; Department of Energy Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	This work was supported by the Department of Energy Office of the Biomass Program.; Computer time was provided by the Texas Advanced Computing Center Ranger cluster and the National Institute for Computational Sciences Athena cluster under the National Science Foundation Teragrid Grant MCB090159 and the National Renewable Energy Laboratory Computational Sciences Center supported by the Department of Energy Office of Energy Efficiency and Renewable Energy under Contract DE-AC36 - 08GO28308. We thank Michelle Kuttel fbr helpful discussions regarding ring parameters, Deanne Sammond Seonah Kim, and Stephen Chmely fir help with figure preparation, and Alex MacKerell for providing updated force field parameters. We also thank Peter Ciesielski, Steve Decker, Mike Resch and Deanne Sammond for helpful discussions and a critical reading of the manuscript. Fig. I was made with PyMOL (78). The glucose ring conformation and hydrogen bonding analyses were performed using VMD (54, 79, 80).	Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2011, J PHYS CHEM B, V115, P4516, DOI 10.1021/jp200912q; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Biarnes X, 2007, J AM CHEM SOC, V129, P10686, DOI 10.1021/ja068411o; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; CLAEYSSENS M, 1990, FEBS LETT, V263, P89, DOI 10.1016/0014-5793(90)80712-R; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 1996, CURR OPIN STRUC BIOL, V6, P679, DOI 10.1016/S0959-440X(96)80036-4; Cross Simon, 2009, J Mol Graph Model, V28, P131, DOI 10.1016/j.jmgm.2009.04.010; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DOWD MK, 1992, CARBOHYD RES, V233, P15, DOI 10.1016/S0008-6215(00)90917-0; Fernandez MD, 2005, J AM CHEM SOC, V127, P7379, DOI 10.1021/ja051020+; Frenkel D., 2000, UNDERSTANDING MOL SI; Gabius HJ, 2004, CHEMBIOCHEM, V5, P740, DOI 10.1002/cbic.200300753; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hill AD, 2007, J CHEM INF MODEL, V47, P1031, DOI 10.1021/ci600492e; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jeoh T, 2007, BIOTECHNOL BIOENG, V98, P112, DOI 10.1002/bit.21408; Jitonnom J, 2011, BIOCHEMISTRY-US, V50, P4697, DOI 10.1021/bi101362g; Katouno F, 2004, J BIOCHEM, V136, P163, DOI 10.1093/jb/mvh105; Kiehna SE, 2007, CHEM COMMUN, P4026, DOI 10.1039/b711431a; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; KNOWLES JKC, 1988, J CHEM SOC CHEM COMM, P1401, DOI 10.1039/c39880001401; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Kuttel M, 2006, J MOL GRAPH MODEL, V25, P380, DOI 10.1016/j.jmgm.2006.02.007; Laughrey ZR, 2008, J AM CHEM SOC, V130, P14625, DOI 10.1021/ja803960x; Laurent N, 2008, CHEM COMMUN, P4400, DOI 10.1039/b806983m; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mertz B, 2007, BIOPOLYMERS, V87, P249, DOI 10.1002/bip.20831; Norberg AL, 2010, THERMOCHIM ACTA, V511, P189, DOI 10.1016/j.tca.2010.08.013; Norberg AL, 2010, FEBS LETT, V584, P4581, DOI 10.1016/j.febslet.2010.10.017; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; Ramirez-Gualito K, 2009, J AM CHEM SOC, V131, P18129, DOI 10.1021/ja903950t; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Screen J, 2007, ANGEW CHEM INT EDIT, V46, P3644, DOI 10.1002/anie.200605116; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Smith EA, 2003, J AM CHEM SOC, V125, P6140, DOI 10.1021/ja034165u; Stern R, 2008, CHEM REV, V108, P5061, DOI 10.1021/cr078240l; STRAATSMA TP, 1991, J CHEM PHYS, V95, P1175, DOI 10.1063/1.461148; Terraneo G, 2007, J AM CHEM SOC, V129, P2890, DOI 10.1021/ja066633g; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; Vandenbussche S, 2008, CHEM-EUR J, V14, P7570, DOI 10.1002/chem.200800247; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Vuong TV, 2009, APPL ENVIRON MICROB, V75, P6655, DOI 10.1128/AEM.01260-09; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Williams SJ, 2001, TRENDS BIOTECHNOL, V19, P356, DOI 10.1016/S0167-7799(01)01699-7; YUI T, 1994, BIOPOLYMERS, V34, P203, DOI 10.1002/bip.360340206; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhong LH, 2009, CARBOHYD RES, V344, P1984, DOI 10.1016/j.carres.2009.07.005; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	80	88	90	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41028	41035		10.1074/jbc.M111.297713	http://dx.doi.org/10.1074/jbc.M111.297713			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965672	hybrid, Green Published			2022-12-25	WOS:000297315400062
J	Vesterlund, M; Zadjali, F; Persson, T; Nielsen, ML; Kessler, BM; Norstedt, G; Flores-Morales, A				Vesterlund, Mattias; Zadjali, Fahad; Persson, Torbjorn; Nielsen, Michael Lund; Kessler, Benedikt M.; Norstedt, Gunnar; Flores-Morales, Amilcar			The SOCS2 Ubiquitin Ligase Complex Regulates Growth Hormone Receptor Levels	PLOS ONE			English	Article							CYTOKINE SIGNALING 2; SUPPRESSOR; BOX; DEGRADATION; ELONGIN; PROTEIN; INHIBITION; RECONSTITUTE; TRANSDUCER; ACTIVATOR	Growth Hormone is essential for the regulation of growth and the homeostatic control of intermediary metabolism. GH actions are mediated by the Growth Hormone Receptor; a member of the cytokine receptor super family that signals chiefly though the JAK2/STAT5 pathway. Target tissue responsiveness to GH is under regulatory control to avoid excessive and off-target effects upon GHR activation. The suppressor of cytokine signalling 2 (SOCS) is a key regulator of GHR sensitivity. This is clearly shown in mice where the SOCS2 gene has been inactivated, which show 30-40% increase in body length, a phenotype that is dependent on endogenous GH secretion. SOCS2 is a GH-stimulated, STAT5b-regulated gene that acts in a negative feedback loop to downregulate GHR signalling. Since the biochemical basis for these actions is poorly understood, we studied the molecular function of SOCS2. We demonstrated that SOCS2 is part of a multimeric complex with intrinsic ubiquitin ligase activity. Mutational analysis shows that the interaction with Elongin B/C controls SOCS2 protein turnover and affects its molecular activity. Increased GHR levels were observed in livers from SOCS2(-/-) mice and in the absence of SOCS2 in in vitro experiments. We showed that SOCS2 regulates cellular GHR level through direct ubiquitination and in a proteasomally dependent manner. We also confirmed the importance of the SOCS-box for the proper function of SOCS2. Finally, we identified two phosphotyrosine residues in the GHR to be responsible for the interaction with SOCS2, but only Y487 to account for the effects of SOCS2. The demonstration that SOCS2 is an ubiquitin ligase for the GHR unveils the molecular basis for its physiological actions.	[Vesterlund, Mattias; Zadjali, Fahad; Norstedt, Gunnar] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Zadjali, Fahad] Sultan Qaboos Univ, Coll Med & Hlth Sci, Muscat, Oman; [Persson, Torbjorn] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Nielsen, Michael Lund; Flores-Morales, Amilcar] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Kessler, Benedikt M.] Univ Oxford, Nuffield Dept Med, Oxford, England	Karolinska Institutet; Sultan Qaboos University; Karolinska Institutet; University of Copenhagen; University of Oxford	Vesterlund, M (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	Amilcar.Flores@cpr.ku.dk	Kessler, Benedikt/AAY-8614-2021; ZADJALI, FAHAD/B-5091-2019; Persson, Torbjörn/K-3229-2012; Vesterlund, Mattias/AAX-8014-2021	Kessler, Benedikt/0000-0002-8160-2446; ZADJALI, FAHAD/0000-0001-5891-4700; Nielsen, Michael/0000-0002-0067-9039; Norstedt, Gunnar/0000-0002-7759-3241; Vesterlund, Mattias/0000-0001-9471-6592	Vetenskapsradet [2009-3738]; Novo Nordisk Foundation Center for Protein Research; Cancerfonden; Biomedical Research Centre (NIHR), Oxford, United Kingdom; Karolinska Institutet; Sultan Qaboos University; MRC [G0501068] Funding Source: UKRI; Medical Research Council [G0501068] Funding Source: researchfish	Vetenskapsradet(Swedish Research Council); Novo Nordisk Foundation Center for Protein Research; Cancerfonden(Swedish Cancer Society); Biomedical Research Centre (NIHR), Oxford, United Kingdom(National Institute for Health Research (NIHR)); Karolinska Institutet(Karolinska Institutet); Sultan Qaboos University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grant 2009-3738 from Vetenskapsradet to Dr. Norstedt, and from grants from the Novo Nordisk Foundation Center for Protein Research, and Cancerfonden to Dr. Flores-Morales. Dr. Kessler is supported by the Biomedical Research Centre (NIHR), Oxford, United Kingdom. Dr. Vesterlund is supported by a fellowship from Karolinska Institutet. Dr. Zadjali is supported by a scholarship from Sultan Qaboos University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2010, J ENDOCRINOL, V206, P249, DOI 10.1677/JOE-10-0045; Babon JJ, 2008, J MOL BIOL, V381, P928, DOI 10.1016/j.jmb.2008.06.038; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Botuyan MV, 1999, P NATL ACAD SCI USA, V96, P9033, DOI 10.1073/pnas.96.16.9033; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Choi YB, 2010, J BIOL CHEM, V285, P7271, DOI 10.1074/jbc.M109.073726; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Deng L, 2007, MOL ENDOCRINOL, V21, P1537, DOI 10.1210/me.2007-0138; Greenhalgh CJ, 2002, MOL ENDOCRINOL, V16, P1394, DOI 10.1210/me.16.6.1394; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hansen JA, 1999, MOL ENDOCRINOL, V13, P1832, DOI 10.1210/me.13.11.1832; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Hu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007178; Johnston JA, 2004, J LEUKOCYTE BIOL, V75, P743, DOI 10.1189/jlb.1003507; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Lee SH, 2010, J IMMUNOL, V185, P917, DOI 10.4049/jimmunol.1000784; Machado FS, 2008, J EXP MED, V205, P1077, DOI 10.1084/jem.20072416; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nakayama K, 2003, P NATL ACAD SCI USA, V100, P8752, DOI 10.1073/pnas.1133216100; Rasche A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-310; Rico-Bautista E, 2005, MOL ENDOCRINOL, V19, P781, DOI 10.1210/me.2004-0040; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Ridderstrale M, 2003, HORM METAB RES, V35, P169, DOI 10.1055/s-2003-39077; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; Sovio U, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000409; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Strous GJ, 2004, CURR TOP MICROBIOL, V286, P81; Tritos NA, 2009, CURR OPIN ENDOCRINOL, V16, P415, DOI 10.1097/MED.0b013e3283319e6d; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Uyttendaele I, 2007, MOL ENDOCRINOL, V21, P2821, DOI 10.1210/me.2006-0541; van den Eijnden MJ, 2007, MOL ENDOCRINOL, V21, P2832, DOI 10.1210/me.2007-0092; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096; Zadjali F, 2011, J BIOL CHEM, V286, P480, DOI 10.1074/jbc.M110.173526; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498	45	52	52	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25358	10.1371/journal.pone.0025358	http://dx.doi.org/10.1371/journal.pone.0025358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980433	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600022
J	Chan, QWT; Mutti, NS; Foster, LJ; Kocher, SD; Amdam, GV; Wolschin, F				Chan, Queenie W. T.; Mutti, Navdeep S.; Foster, Leonard J.; Kocher, Sarah D.; Amdam, Gro V.; Wolschin, Florian			The Worker Honeybee Fat Body Proteome Is Extensively Remodeled Preceding a Major Life-History Transition	PLOS ONE			English	Article							QUANTITATIVE MASS-SPECTROMETRY; INSULIN-RECEPTOR SUBSTRATE-1; COLONY-LEVEL SELECTION; BEE APIS-MELLIFERA; DIVISION-OF-LABOR; JUVENILE-HORMONE; BEHAVIORAL-DEVELOPMENT; GLUCOSE-HOMEOSTASIS; VITELLOGENIN; METABOLISM	Honeybee workers are essentially sterile female helpers that make up the majority of individuals in a colony. Workers display a marked change in physiology when they transition from in-nest tasks to foraging. Recent technological advances have made it possible to unravel the metabolic modifications associated with this transition. Previous studies have revealed extensive remodeling of brain, thorax, and hypopharyngeal gland biochemistry. However, data on changes in the abdomen is scarce. To narrow this gap we investigated the proteomic composition of abdominal tissue in the days typically preceding the onset of foraging in honeybee workers. In order to get a broader representation of possible protein dynamics, we used workers of two genotypes with differences in the age at which they initiate foraging. This approach was combined with RNA interference-mediated downregulation of an insulin/insulin-like signaling component that is central to foraging behavior, the insulin receptor substrate (irs), and with measurements of glucose and lipid levels. Our data provide new insight into the molecular underpinnings of phenotypic plasticity in the honeybee, invoke parallels with vertebrate metabolism, and support an integrated and irs-dependent association of carbohydrate and lipid metabolism with the transition from in-nest tasks to foraging.	[Chan, Queenie W. T.; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Chan, Queenie W. T.; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Mutti, Navdeep S.; Amdam, Gro V.; Wolschin, Florian] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Kocher, Sarah D.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Amdam, Gro V.; Wolschin, Florian] Norwegian Univ Life Sci, Dept Biotechnol Chem & Food Sci, As, Norway	University of British Columbia; University of British Columbia; Arizona State University; Arizona State University-Tempe; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Norwegian University of Life Sciences	Chan, QWT (corresponding author), Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada.	f.wolschin@gmail.com			Alexander-von-Humboldt foundation; Research Council of Norway [180504, 185306, 191699]; National Institute on Aging [P01 AG22500]; Pew Charitable Trust; Natural Sciences and Engineering Research Council (NSERC) of Canada [F09-05648]; Michael Smith Foundation (MSF); Canada Foundation for Innovation; British Columbia Knowledge Development Fund; British Columbia Proteomics Network via the MSF; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	Alexander-von-Humboldt foundation(Alexander von Humboldt Foundation); Research Council of Norway(Research Council of Norway); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pew Charitable Trust; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation (MSF)(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; British Columbia Proteomics Network via the MSF; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	FW was supported by a Feodor-Lynen stipend of the Alexander-von-Humboldt foundation (http://www.humboldt-foundation.de/). GVA was supported by the Research Council of Norway (http://www.forskningsradet.no/) #180504 (to FW), 185306, and 191699, the National Institute on Aging (http://www.nia.nih.gov/), NIA P01 AG22500 (to NM), and the Pew Charitable Trust (http://www.pewtrusts.org/). QWTC has been supported by a PGS-D award from the Natural Sciences and Engineering Research Council (NSERC) of Canada and a Michael Smith Foundation (MSF) Graduate Fellowship. LJF is the Canada Research Chair in Quantitative Proteomics (http://www.chairs-chaires.gc.ca/) and a MSF Scholar (http://www.msfhr.org/). Mass spectrometry infrastructure used in this work is supported by the Canada Foundation for Innovation (http://innovation.ca/en), the British Columbia Knowledge Development Fund and the British Columbia Proteomics Network (http://www.bcproteomicsnetwork.ca/) via the MSF. This work was supported in part by an NSERC (http://www.nserc.gc.ca/index.htm) Discovery Grant #F09-05648 to LJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1998, J CLIN INVEST, V101, P1784, DOI 10.1172/JCI1594; Amdam GV, 2007, AM NAT, V170, P37, DOI 10.1086/518183; Amdam GV, 2005, INSECT SOC, V52, P316, DOI 10.1007/s00040-005-0812-2; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Amdam GV, 2010, EVOLUTION D IN PRESS; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Ayroles JF, 2006, METHOD ENZYMOL, V411, P214, DOI 10.1016/S0076-6879(06)11011-3; BALLARD FJ, 1967, J LIPID RES, V8, P73; BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Bharucha KN, 2009, PEDIATR RES, V65, P132, DOI 10.1203/PDR.0b013e318191fc68; Bitondi MMG, 2006, ARCH INSECT BIOCHEM, V63, P57, DOI 10.1002/arch.20142; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Craparo A, 1997, J BIOL CHEM, V272, P11663; Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001; DEKORT CAD, 1981, ANNU REV ENTOMOL, V26, P1, DOI 10.1146/annurev.en.26.010181.000245; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Elekonich MM, 2005, COMP BIOCHEM PHYS A, V141, P362, DOI 10.1016/j.cbpb.2005.04.014; ENGELMANN F, 1978, INSECT BIOCHEM, V8, P149, DOI 10.1016/0020-1790(78)90066-5; Fahrbach SE, 1996, DEV NEUROSCI-BASEL, V18, P102, DOI 10.1159/000111474; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Feng M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-645; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; FOERSTER EC, 1981, BIOCHEM J, V196, P705, DOI 10.1042/bj1960705; Fritsche L, 2008, CURR MED CHEM, V15, P1316, DOI 10.2174/092986708784534956; Fumeron F, 2006, DIABETES CARE, V29, P2090, DOI 10.2337/dc06-0093; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; HOELLDOBLER B, 1990, ANTS; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; HUANG ZY, 1989, INSECT SOC, V36, P264, DOI 10.1007/BF02224880; Keller I, 2005, BEE WORLD, V86, P3, DOI 10.1080/0005772X.2005.11099641; KETTERER B, 1989, MUTAT RES, V214, P33, DOI 10.1016/0027-5107(89)90195-4; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Kubota M, 2004, BIOSCI BIOTECH BIOCH, V68, P2346, DOI 10.1271/bbb.68.2346; LAW JH, 1989, J BIOL CHEM, V264, P16335; Liu SCH, 1999, J BIOL CHEM, V274, P18093, DOI 10.1074/jbc.274.25.18093; Liu Y, 2009, ARCH INSECT BIOCHEM, V71, P16, DOI 10.1002/arch.20290; Mackert A, 2010, J INSECT PHYSIOL, V56, P1139, DOI 10.1016/j.jinsphys.2010.03.007; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Memon RA, 1995, BIOCHEM MOL BIOL INT, V37, P1079; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P135, DOI 10.1007/BF00170718; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; Pinto LZ, 2000, J INSECT PHYSIOL, V46, P153, DOI 10.1016/S0022-1910(99)00111-0; Piper M. D. W., 2005, DRUG DISCOV TODAY DI, V2, P249; POLICANSKY D, 1982, ANNU REV ECOL SYST, V13, P471, DOI 10.1146/annurev.es.13.110182.002351; Powell AJ, 2000, J MOL BIOL, V303, P311, DOI 10.1006/jmbi.2000.4139; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Roberts SP, 2005, J EXP BIOL, V208, P4193, DOI 10.1242/jeb.01862; Schulz DJ, 2004, ANN ENTOMOL SOC AM, V97, P1313, DOI 10.1603/0013-8746(2004)097[1313:COJHHA]2.0.CO;2; Seed, 2001, PARASITISM DIVERSITY; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Souza JA, 2007, COMP BIOCHEM PHYS A, V147, P993, DOI 10.1016/j.cbpa.2007.03.008; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stow J L, 1995, Curr Opin Nephrol Hypertens, V4, P421, DOI 10.1097/00041552-199509000-00009; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Tchorzewski M, 2002, INT J BIOCHEM CELL B, V34, P911, DOI 10.1016/S1357-2725(02)00012-2; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Ueno T, 2009, ZOOL SCI, V26, P557, DOI 10.2108/zsj.26.557; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Vargas L, 1998, HORM METAB RES, V30, P113, DOI 10.1055/s-2007-978847; Veech RL, 2003, P NATL ACAD SCI USA, V100, P5578, DOI 10.1073/pnas.1132039100; Wang Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000896; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Winston M.L., 1991, BIOL HONEY BEE; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wolschin F, 2009, J EXP BIOL, V212, P4027, DOI 10.1242/jeb.033845; Wolschin F, 2007, ANAL BIOANAL CHEM, V389, P1095, DOI 10.1007/s00216-007-1523-5; Wolschin F, 2011, BIOL LETTERS, V7, P112, DOI 10.1098/rsbl.2010.0463; Woodcroft KJ, 2002, HEPATOLOGY, V35, P263, DOI 10.1053/jhep.2002.30691; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang J, 2006, P NATL ACAD SCI USA, V103, P16212, DOI 10.1073/pnas.0604567103; Zhang SC, 2008, ANAL BIOCHEM, V383, P76, DOI 10.1016/j.ab.2008.07.041	87	33	35	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24794	10.1371/journal.pone.0024794	http://dx.doi.org/10.1371/journal.pone.0024794			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969861	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900012
J	Wang, HL; Zhang, GQ; Wen, YJ; Yang, ST; Xia, XZ; Fu, ZF				Wang, Hualei; Zhang, Guoqing; Wen, Yongjun; Yang, Songtao; Xia, Xianzhu; Fu, Zhen F.			Intracerebral Administration of Recombinant Rabies Virus Expressing GM-CSF Prevents the Development of Rabies after Infection with Street Virus	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; POSTEXPOSURE PROPHYLAXIS; ATTENUATED RABIES; UNITED-STATES; B-CELLS; PERMEABILITY; ANIMALS; VACCINE; INTERFERON	Recently it was found that prior immunization with recombinant rabies virus (RABV) expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) (LBNSE-GM-CSF) resulted in high innate/adaptive immune responses and protection against challenge with virulent RABV (Wen et al., JVI, 2011). In this study, the ability of LBNSE-GM-CSF to prevent animals from developing rabies was investigated in mice after infection with lethal doses of street RABV. It was found that intracerebral administration of LBNSE-GM-CSF protected more mice from developing rabies than sham-treated mice as late as day 5 after infection with street RABV. Intracerebral administration of LBNSE-GM-CSF resulted in significantly higher levels of chemokine/cytokine expression and more infiltration of inflammatory and immune cells into the central nervous system (CNS) than sham-administration or administration with UV-inactivated LBNSE-GM-CSF. Enhancement of blood-brain barrier (BBB) permeability and increases in virus neutralizing antibodies (VNA) were also observed in mice treated with LBNSE-GM-CSF. On the other hand, intracerebral administration with UV-inactivated LBNSE-GM-CSF did not increase protection despite the fact that VNA were induced in the periphery. However, intracerebral administration with chemoattractant protein-1 (MCP-1, also termed CCL2) increased significantly the protective efficacy of UV-inactivated LBNSE-GM-CSF. Together these studies confirm that direct administration of LBNSE-GM-CSF can enhance the innate and adaptive immunity as well as the BBB permeability, thus allowing infiltration of inflammatory cells and other immune effectors enter into the CNS to clear the virus and prevent the development of rabies.	[Wang, Hualei; Zhang, Guoqing; Wen, Yongjun; Fu, Zhen F.] Univ Georgia, Dept Pathol, Athens, GA 30602 USA; [Wang, Hualei; Yang, Songtao; Xia, Xianzhu] Chinese Acad Mil Med Sci, Inst Vet Med, Changchun, Jilin, Peoples R China; [Wang, Hualei] Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China; [Fu, Zhen F.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Fu, Zhen F.] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China	University System of Georgia; University of Georgia; Jilin University; University System of Georgia; University of Georgia; Huazhong Agricultural University	Wang, HL (corresponding author), Univ Georgia, Dept Pathol, Athens, GA 30602 USA.	zhenfu@uga.edu	Wang, Hualei/S-7920-2018; zhang, guoqing/GXG-4800-2022	Wang, Hualei/0000-0001-8008-3878; 	National Institute of Allergy and Infectious Disease [AI-051560]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051560] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported partially by Public Health Service grant AI-051560 from the National Institute of Allergy and Infectious Disease. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MMWR; BARKER CF, 1977, ADV IMMUNOL, V25, P1; Blanton JD, 2010, JAVMA-J AM VET MED A, V237, P646, DOI 10.2460/javma.237.6.646; BROCHIER B, 1991, NATURE, V354, P520, DOI 10.1038/354520a0; Dietzschold B, 2000, J HUMAN VIROL, V3, P50; Dietzschold B, 1998, VACCINE, V16, P1656, DOI 10.1016/S0264-410X(98)00064-4; Faber M, 2009, P NATL ACAD SCI USA, V106, P11300, DOI 10.1073/pnas.0905640106; Fu ZF, 1997, VACCINE, V15, pS20, DOI 10.1016/S0264-410X(96)00312-X; Hanlon CA, 1998, J WILDLIFE DIS, V34, P228, DOI 10.7589/0090-3558-34.2.228; HATTWICK MA, 1972, J AMER MED ASSOC, V222, P44, DOI 10.1001/jama.222.1.44; HEMACHUDHA T, 1988, AM J MED, V84, P673, DOI 10.1016/0002-9343(88)90103-9; Hooper DC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000535; Hosking MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000937; Johnson N, 2006, J GEN VIROL, V87, P2663, DOI 10.1099/vir.0.82024-0; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kuang Y, 2009, VIRUS RES, V144, P18, DOI 10.1016/j.virusres.2009.03.014; Lackay SN, 2008, VET CLIN N AM-SMALL, V38, P851, DOI 10.1016/j.cvsm.2008.03.003; Li XQ, 2005, J VIROL, V79, P10063, DOI 10.1128/JVI.79.15.10063-10068.2005; Merrill JE, 1997, BRAIN BEHAV IMMUN, V11, P245, DOI 10.1006/brbi.1997.0496; Meslin F X, 1994, Curr Top Microbiol Immunol, V187, P1; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Nigg AJ, 2009, PHARMACOTHERAPY, V29, P1182, DOI 10.1592/phco.29.10.1182; Phares TW, 2007, J IMMUNOL, V178, P7334, DOI 10.4049/jimmunol.178.11.7334; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roy A, 2007, J VIROL, V81, P7993, DOI 10.1128/JVI.00710-07; Roy A, 2007, J VIROL, V81, P1110, DOI 10.1128/JVI.01964-06; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Rupprecht CE, 1997, J NEUROVIROL, V3, pS52; Sampath G, 2005, VACCINE, V23, P1102, DOI 10.1016/j.vaccine.2004.08.036; Sarmento L, 2005, J NEUROVIROL, V11, P571, DOI 10.1080/13550280500385310; SCHUMACHER CL, 1993, ONDERSTEPOORT J VET, V60, P459; Smith J. S., 1996, P181; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; Sudarshan M. K., 1999, Journal of Communicable Diseases, V31, P229; Wang ZW, 2005, J VIROL, V79, P12554, DOI 10.1128/JVI.79.19.12554-12565.2005; Wen YJ, 2011, J VIROL, V85, P1634, DOI 10.1128/JVI.01552-10; *WHO, 2010, FACT SHEET 99; Wu XF, 2011, VACCINE, V29, P4195, DOI 10.1016/j.vaccine.2011.03.104; Zhao L, 2010, J VIROL, V84, P9642, DOI 10.1128/JVI.00326-10; Zhao L, 2009, J VIROL, V83, P11808, DOI 10.1128/JVI.01346-09	43	59	64	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25414	10.1371/journal.pone.0025414	http://dx.doi.org/10.1371/journal.pone.0025414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980450	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900062
J	Zhu, WL; Yang, L; Du, ZM				Zhu, Wenliang; Yang, Lei; Du, Zhimin			MicroRNA Regulation and Tissue-Specific Protein Interaction Network	PLOS ONE			English	Article							EXPRESSION; RESOURCE; TARGET	Background: 'Fine-tuning' of protein abundance makes microRNAs (miRNAs) pervasively implicated in human biology. Although targeting many mRNAs endows the power of single miRNA to regulate complex biological processes, its functional roles in a particular tissue will be inevitably restricted because only a subset of its target genes is expressed. Methods: Here, we analyze the characteristics of miRNA regulation upon target genes according to tissue-specific gene expression by constructing tissue-specific protein interaction networks for ten main types of tissues in the human body. Results: Commonly expressed proteins are under more intensive but lower-cost miRNAs control than proteins with the tissue-specific expression. MiRNAs that target more commonly expressed genes usually regulate more tissue-specific genes. This is consistent with the previous finding that tissue-specific proteins tend to be functionally connected with commonly expressed proteins. But to a particular miRNA such a balance is not invariable among different tissues implying diverse tissue regulation modes executed by miRNAs. Conclusion: These results suggest miRNAs that interact with more commonly expressed genes can be expected to play important tissue-specific roles.	[Zhu, Wenliang; Du, Zhimin] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China; [Yang, Lei] Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Du, ZM (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China.	dzm1956@126.com						Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Cui QH, 2007, TRENDS GENET, V23, P372, DOI 10.1016/j.tig.2007.04.003; Cui QH, 2007, BIOCHEM BIOPH RES CO, V352, P733, DOI 10.1016/j.bbrc.2006.11.080; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Gamazon ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013534; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ritchie W, 2010, BIOINFORMATICS, V26, P223, DOI 10.1093/bioinformatics/btp649; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun LL, 2011, DIABETES RES CLIN PR, V91, P94, DOI 10.1016/j.diabres.2010.11.006; Yang BF, 2008, CARDIOVASC RES, V79, P571, DOI 10.1093/cvr/cvn181; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032	26	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25394	10.1371/journal.pone.0025394	http://dx.doi.org/10.1371/journal.pone.0025394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980443	gold, Green Published, Green Submitted			2022-12-25	WOS:000295933700031
J	Azimi, M; Jamali, Y; Mofrad, MRK				Azimi, Mohammad; Jamali, Yousef; Mofrad, Mohammad R. K.			Accounting for Diffusion in Agent Based Models of Reaction-Diffusion Systems with Application to Cytoskeletal Diffusion	PLOS ONE			English	Article							ACTIN-FILAMENTS; ORGANIZATION; LAMELLIPODIUM; SIMULATION; MOTILITY; BIOLOGY; SPACE	Diffusion plays a key role in many biochemical reaction systems seen in nature. Scenarios where diffusion behavior is critical can be seen in the cell and subcellular compartments where molecular crowding limits the interaction between particles. We investigate the application of a computational method for modeling the diffusion of molecules and macromolecules in three-dimensional solutions using agent based modeling. This method allows for realistic modeling of a system of particles with different properties such as size, diffusion coefficients, and affinity as well as the environment properties such as viscosity and geometry. Simulations using these movement probabilities yield behavior that mimics natural diffusion. Using this modeling framework, we simulate the effects of molecular crowding on effective diffusion and have validated the results of our model using Langevin dynamics simulations and note that they are in good agreement with previous experimental data. Furthermore, we investigate an extension of this framework where single discrete cells can contain multiple particles of varying size in an effort to highlight errors that can arise from discretization that lead to the unnatural behavior of particles undergoing diffusion. Subsequently, we explore various algorithms that differ in how they handle the movement of multiple particles per cell and suggest an algorithm that properly accommodates multiple particles of various sizes per cell that can replicate the natural behavior of these particles diffusing. Finally, we use the present modeling framework to investigate the effect of structural geometry on the directionality of diffusion in the cell cytoskeleton with the observation that parallel orientation in the structural geometry of actin filaments of filopodia and the branched structure of lamellipodia can give directionality to diffusion at the filopodia-lamellipodia interface.	[Azimi, Mohammad; Jamali, Yousef; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Azimi, M (corresponding author), Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019; Jamali, Yousef/V-5156-2019	/0000-0001-7004-4859; Jamali, Yousef/0000-0002-5709-3821				Atilgan E, 2005, BIOPHYS J, V89, P3589, DOI 10.1529/biophysj.105.065383; Berry BJL, 2002, P NATL ACAD SCI USA, V99, P7187, DOI 10.1073/pnas.092078899; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bonchev D, 2010, SAR QSAR ENVIRON RES, V21, P77, DOI 10.1080/10629360903568580; Cojoc D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001072; Devillers J, 2010, SAR QSAR ENVIRON RES, V21, P337, DOI 10.1080/10629361003773963; Dobrzynski M, 2007, BIOINFORMATICS, V23, P1969, DOI 10.1093/bioinformatics/btm278; Dong X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009249; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; FICK A, 1995, J MEMBRANE SCI, V100, P33, DOI 10.1016/0376-7388(94)00230-V; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Grima R, 2008, ESSAYS BIOCHEM, V45, P41, DOI 10.1042/BSE0450041; HAN JN, 1993, BIOPHYS J, V65, P1155, DOI 10.1016/S0006-3495(93)81145-7; Haviv L, 2006, P NATL ACAD SCI USA, V103, P4906, DOI 10.1073/pnas.0508269103; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Ihle T, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.020201; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; Miller J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009454; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridgway D, 2006, CURR OPIN BIOTECH, V17, P493, DOI 10.1016/j.copbio.2006.08.004; Rivas German, 2004, EMBO Reports, V5, P23, DOI 10.1038/sj.embor.7400056; Schafer DA, 2004, NATURE, V430, P734, DOI 10.1038/430734a; Schaub S, 2007, J CELL SCI, V120, P1491, DOI 10.1242/jcs.03379; Scheutz M, 2006, J PARALLEL DISTR COM, V66, P1037, DOI 10.1016/j.jpdc.2005.09.004; Small JV, 2008, J MICROSC-OXFORD, V231, P479, DOI 10.1111/j.1365-2818.2008.02060.x; Strating P, 1999, PHYS REV E, V59, P2175, DOI 10.1103/PhysRevE.59.2175; Takahashi K, 2005, FEBS LETT, V579, P1783, DOI 10.1016/j.febslet.2005.01.072; Tesfatsion L, 2006, HANDB ECON, V13, P831; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	35	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25306	10.1371/journal.pone.0025306	http://dx.doi.org/10.1371/journal.pone.0025306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966493	gold, Green Published, Green Submitted			2022-12-25	WOS:000295267100044
J	Manzoni, C; Colombo, L; Bigini, P; Diana, V; Cagnotto, A; Messa, M; Lupi, M; Bonetto, V; Pignataro, M; Airoldi, C; Sironi, E; Williams, A; Salmona, M				Manzoni, Claudia; Colombo, Laura; Bigini, Paolo; Diana, Valentina; Cagnotto, Alfredo; Messa, Massimo; Lupi, Monica; Bonetto, Valentina; Pignataro, Mauro; Airoldi, Cristina; Sironi, Erika; Williams, Alun; Salmona, Mario			The Molecular Assembly of Amyloid A beta Controls Its Neurotoxicity and Binding to Cellular Proteins	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; INTEGRAL MEMBRANE-PROTEINS; ALZHEIMERS-DISEASE; PRION PROTEIN; ACTIVATION; OLIGOMERS; RECEPTOR; BRAIN; PURIFICATION; RENATURATION	Accumulation of beta-sheet-rich peptide (A beta) is strongly associated with Alzheimer's disease, characterized by reduction in synapse density, structural alterations of dendritic spines, modification of synaptic protein expression, loss of long-term potentiation and neuronal cell death. A beta species are potent neurotoxins, however the molecular mechanism responsible for A beta toxicity is still unknown. Numerous mechanisms of toxicity were proposed, although there is no agreement about their relative importance in disease pathogenesis. Here, the toxicity of A beta 1-40 and A beta 1-42 monomers, oligomers or fibrils, was evaluated using the N2a cell line. A structure-function relationship between peptide aggregation state and toxic properties was established. Moreover, we demonstrated that A beta toxic species cross the plasma membrane, accumulate in cells and bind to a variety of internal proteins, especially on the cytoskeleton and in the endoplasmatic reticulum (ER). Based on these data we suggest that numerous proteins act as A beta receptors in N2a cells, triggering a multi factorial toxicity.	[Manzoni, Claudia; Colombo, Laura; Bigini, Paolo; Diana, Valentina; Cagnotto, Alfredo; Messa, Massimo; Bonetto, Valentina; Pignataro, Mauro; Salmona, Mario] Mario Negri Inst Pharmacol Res, Dept Mol Biochem & Pharmacol, Milan, Italy; [Lupi, Monica] Mario Negri Inst Pharmacol Res, Dept Oncol, Milan, Italy; [Bonetto, Valentina; Pignataro, Mauro] Dulbecco Telethon Inst, Milan, Italy; [Airoldi, Cristina; Sironi, Erika] Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy; [Williams, Alun] Univ Cambridge, Dept Vet Med, Cambridge, England	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Milano-Bicocca; University of Cambridge	Manzoni, C (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, London, England.	mario.salmona@marionegri.it	Bonetto, Valentina/ABB-6383-2020; salmona, mario/ABI-4066-2020; colombo, laura/AAA-6716-2020; Cagnotto, Alfredo/AAB-3083-2020; Airoldi, Cristina/A-6521-2010; Bonetto, Valentina/I-4694-2018; salmona, mario/AAA-7116-2020; Bigini, Paolo/AAB-2901-2020; manzoni, claudia/F-4831-2014; Lupi, Monica/AAH-5704-2019	Bonetto, Valentina/0000-0003-0456-2054; colombo, laura/0000-0002-3243-0270; Cagnotto, Alfredo/0000-0002-1390-8240; Airoldi, Cristina/0000-0002-3670-6262; Bonetto, Valentina/0000-0003-0456-2054; salmona, mario/0000-0002-9098-9873; Bigini, Paolo/0000-0002-0239-9532; Manzoni, Claudia/0000-0001-5367-4023; Lupi, Monica/0000-0002-9835-7870	Banca IntesaSanPaolo; Fondazione Cariplo; Fondazione Telethon Funding Source: Custom	Banca IntesaSanPaolo; Fondazione Cariplo(Fondazione Cariplo); Fondazione Telethon(Fondazione Telethon)	Banca IntesaSanPaolo and Fondazione Cariplo Proget NOBEL-GUARD provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi C, 2011, ORG BIOMOL CHEM, V9, P463, DOI 10.1039/c0ob00303d; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Bamberger ME, 2003, J NEUROSCI, V23, P2665; BIRK HW, 1987, ANAL BIOCHEM, V164, P12, DOI 10.1016/0003-2697(87)90360-5; Cappai R, 2008, NEUROCHEM RES, V33, P526, DOI 10.1007/s11064-007-9469-8; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Foldi Istvan, 2011, J Neurochem, V117, P691, DOI 10.1111/j.1471-4159.2011.07238.x; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Guillemin I, 2005, PROTEOMICS, V5, P35, DOI 10.1002/pmic.200400892; Hartinger J, 1996, ANAL BIOCHEM, V240, P126, DOI 10.1006/abio.1996.0339; KLINZ FJ, 1994, EUR J BIOCHEM, V225, P99, DOI 10.1111/j.1432-1033.1994.00099.x; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; LaDu MJ, 2000, J BIOL CHEM, V275, P33974, DOI 10.1074/jbc.M000602200; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; MACFARLANE DE, 1989, ANAL BIOCHEM, V176, P457, DOI 10.1016/0003-2697(89)90342-4; Manzoni C, 2009, AMYLOID, V16, P71, DOI 10.1080/13506120902879848; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Origlia N, 2008, J NEUROSCI, V28, P3521, DOI 10.1523/JNEUROSCI.0204-08.2008; Ray I, 1998, NEUROCHEM RES, V23, P1277, DOI 10.1023/A:1020744216699; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; SALEHZADA T, 1991, ANAL BIOCHEM, V196, P410, DOI 10.1016/0003-2697(91)90486-D; Schindler J, 2006, J NEURAL TRANSM, V113, P995, DOI 10.1007/s00702-006-0508-4; Srivastava RAK, 2002, J NEUROL SCI, V196, P45, DOI 10.1016/S0022-510X(02)00026-6; Strom A, 2006, PROTEOMICS, V6, P26, DOI 10.1002/pmic.200500066; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x	30	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e24909	10.1371/journal.pone.0024909	http://dx.doi.org/10.1371/journal.pone.0024909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966382	Green Published, gold			2022-12-25	WOS:000295267100015
J	Fadool, DA; Tucker, K; Pedarzani, P				Fadool, Debra Ann; Tucker, Kristal; Pedarzani, Paola			Mitral Cells of the Olfactory Bulb Perform Metabolic Sensing and Are Disrupted by Obesity at the Level of the Kv1.3 Ion Channel	PLOS ONE			English	Article							INSULIN SENSITIVITY; TASTE SENSITIVITY; BRAIN INSULIN; K+ CHANNELS; MODULATION; EXPRESSION; PROTEINS; DELETION; MICE; GENE	Sixty-five percent of Americans are over-weight. While the neuroendocrine controls of energy homeostasis are well known, how sensory systems respond to and are impacted by obesity is scantily understood. The main accepted function of the olfactory system is to provide an internal depiction of our external chemical environment, starting from the detection of chemosensory cues. We hypothesized that the system additionally functions to encode internal chemistry via the detection of chemicals that are important indicators of metabolic state. We here uncovered that the olfactory bulb (OB) subserves as an internal sensor of metabolism via insulin-induced modulation of the potassium channel Kv1.3. Using an adult slice preparation of the olfactory bulb, we found that evoked neural activity in Kv1.3-expressing mitral cells is enhanced following acute insulin application. Insulin mediated changes in mitral cell excitability are predominantly due to the modulation of Kv1.3 channels as evidenced by the lack of effect in slices from Kv1.3-null mice. Moreover, a selective Kv1.3 peptide blocker (ShK186) inhibits more than 80% of the outward current in parallel voltage-clamp studies, whereby insulin significantly decreases the peak current magnitude without altering the kinetics of inactivation or deactivation. Mice that were chronically administered insulin using intranasal delivery approaches exhibited either an elevation in basal firing frequency or fired a single cluster of action potentials. Following chronic administration of the hormone, mitral cells were inhibited by application of acute insulin rather than excited. Mice made obese through a diet of similar to 32% fat exhibited prominent changes in mitral cell action potential shape and clustering behavior, whereby the subsequent response to acute insulin stimulation was either attenuated or completely absent. Our results implicate an inappropriate neural function of olfactory sensors following exposure to chronic levels of the hormone insulin (diabetes) or increased body weight (obesity).	[Fadool, Debra Ann; Tucker, Kristal] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; [Fadool, Debra Ann] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Fadool, Debra Ann] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Pedarzani, Paola] UCL, Res Dept Neurosci Physiol & Pharmacol, London, England	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of London; University College London	Fadool, DA (corresponding author), Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA.	dfadool@bio.fsu.edu			US National Institutes of Health (NIH) from the National Institutes of Deaf and Communications Disorders (NIDCD) [R01 DC003387, F31 DC010097, T32 DC00044]; Tallahassee Memorial Hospital/Robinson Foundation; Florida State University; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E0020585]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC010097, T32DC000044, R01DC003387] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) from the National Institutes of Deaf and Communications Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Tallahassee Memorial Hospital/Robinson Foundation; Florida State University; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the US National Institutes of Health (NIH) [R01 DC003387, F31 DC010097, and T32 DC00044] from the National Institutes of Deaf and Communications Disorders (NIDCD), the Tallahassee Memorial Hospital/Robinson Foundation, and a Sabbatical Award from The Florida State University. Work in the laboratory of Dr. Pedarzani was supported by the Biotechnology and Biological Sciences Research Council (BBSRC, grant BB/E0020585). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axel R, 2005, ANGEW CHEM INT EDIT, V44, P6110, DOI 10.1002/anie.200501726; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Biju KC, 2008, J COMP NEUROL, V506, P161, DOI 10.1002/cne.21540; Burnham MP, 2006, AM J PHYSIOL-HEART C, V290, pH1520, DOI 10.1152/ajpheart.00827.2005; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Choi BH, 2010, ACTA PHARMACOL SIN, V31, P1031, DOI 10.1038/aps.2010.133; Colley BS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-8; Cook KK, 2002, J BIOL CHEM, V277, P13268, DOI 10.1074/jbc.M108898200; Elson AET, 2010, FASEB J, V24, P3960, DOI 10.1096/fj.10-158105; Fadool DA, 2004, NEURON, V41, P389, DOI 10.1016/S0896-6273(03)00844-4; Fadool DA, 1998, J NEUROSCI, V18, P6126; Fadool DA, 2000, J NEUROPHYSIOL, V83, P2332, DOI 10.1152/jn.2000.83.4.2332; Fan LH, 2009, NUTRITION, V25, P359, DOI 10.1016/j.nut.2008.09.005; Fan LH, 2009, BIOMED PHARMACOTHER, V63, P165, DOI 10.1016/j.biopha.2008.01.005; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FOURNIER L, 1992, J MEMBRANE BIOL, V129, P267; Getchell TV, 2006, PHYSIOL BEHAV, V87, P848, DOI 10.1016/j.physbeh.2005.11.016; Gilbertson TA, 2005, PHYSIOL BEHAV, V86, P681, DOI 10.1016/j.physbeh.2005.08.057; Gilbertson TA, 2010, TASTE TEXTURE POST I, P83; Guthoff M, 2009, DIABETES-METAB RES, V25, P523, DOI 10.1002/dmrr.979; Junek S, 2010, NEURON, V67, P872, DOI 10.1016/j.neuron.2010.08.005; Jyotaki M, 2010, ENDOCR J, V57, P467, DOI 10.1507/endocrj.K10E-095; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; KUES WA, 1992, EUR J NEUROSCI, V4, P1296, DOI 10.1111/j.1460-9568.1992.tb00155.x; Lacroix MC, 2008, J NEUROENDOCRINOL, V20, P1176, DOI 10.1111/j.1365-2826.2008.01777.x; Marks DR, 2007, J NEUROCHEM, V103, P1608, DOI 10.1111/j.1471-4159.2007.04870.x; Marks DR, 2009, J NEUROSCI, V29, P6734, DOI 10.1523/JNEUROSCI.1350-09.2009; Martin B, 2009, TRENDS ENDOCRIN MET, V20, P163, DOI 10.1016/j.tem.2009.01.006; PAGER J, 1972, PHYSIOL BEHAV, V9, P573, DOI 10.1016/0031-9384(72)90014-5; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI [10.1056/NEJMoa031314, DOI 10.1056/NEJMOA031314]; Pittman DW, 2008, CHEM SENSES, V33, P449, DOI 10.1093/chemse/bjn012; Prud'homme MJ, 2009, NEUROSCIENCE, V162, P1287, DOI 10.1016/j.neuroscience.2009.05.043; Savigner A, 2009, J NEUROPHYSIOL, V101, P2898, DOI 10.1152/jn.91169.2008; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Straub SV, 2011, AM J PHYSIOL-ENDOC M, V301, pE380, DOI 10.1152/ajpendo.00076.2011; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Tschritter O, 2006, J CLIN ENDOCR METAB, V91, P654, DOI 10.1210/jc.2005-0725; Tucker K, 2008, INT J OBESITY, V32, P1222, DOI 10.1038/ijo.2008.77; Tucker K, 2010, RESULTS PROBL CELL D, V52, P147, DOI 10.1007/978-3-642-14426-4_12; Xu JC, 2004, P NATL ACAD SCI USA, V101, P3112, DOI 10.1073/pnas.0308450100; Xu JC, 2003, HUM MOL GENET, V12, P551, DOI 10.1093/hmg/ddg049; Yee KK, 2011, P NATL ACAD SCI USA, V108, P5431, DOI 10.1073/pnas.1100495108; Yeomans MR, 2006, PHYSIOL BEHAV, V89, P10, DOI [10.1016/j.physbeh.2006.04.010, 10.1016/j.physbeh.2006.01.029]	44	65	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24921	10.1371/journal.pone.0024921	http://dx.doi.org/10.1371/journal.pone.0024921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966386	gold, Green Published			2022-12-25	WOS:000295265100031
J	Liao, WWP; Arthur, JW				Liao, Webber W. P.; Arthur, Jonathan W.			Predicting Peptide Binding Affinities to MHC Molecules Using a Modified Semi-Empirical Scoring Function	PLOS ONE			English	Article							T-CELL-RECEPTOR; MYELIN BASIC-PROTEIN; CLASS-II MOLECULE; MULTIPLE-SCLEROSIS; CRYSTAL-STRUCTURE; VACCINE DESIGN; CROSS-REACTIVITY; STRUCTURAL BASIS; ATOM CONTACTS; HLA-DR	The Major Histocompatibility Complex (MHC) plays an important role in the human immune system. The MHC is involved in the antigen presentation system assisting T cells to identify foreign or pathogenic proteins. However, an MHC molecule binding a self-peptide may incorrectly trigger an immune response and cause an autoimmune disease, such as multiple sclerosis. Understanding the molecular mechanism of this process will greatly assist in determining the aetiology of various diseases and in the design of effective drugs. In the present study, we have used the Fresno semi-empirical scoring function and modify the approach to the prediction of peptide-MHC binding by using open-source and public domain software. We apply the method to HLA class II alleles DR15, DR1, and DR4, and the HLA class I allele HLA A2. Our analysis shows that using a large set of binding data and multiple crystal structures improves the predictive capability of the method. The performance of the method is also shown to be correlated to the structural similarity of the crystal structures used. We have exposed some of the obstacles faced by structure-based prediction methods and proposed possible solutions to those obstacles. It is envisaged that these obstacles need to be addressed before the performance of structure-based methods can be on par with the sequence-based methods.	[Liao, Webber W. P.; Arthur, Jonathan W.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Arthur, Jonathan W.] Childrens Med Res Inst, Sydney, NSW, Australia	University of Sydney; Children's Medical Research Institute - Australia; University of Sydney	Liao, WWP (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.	jarthur@cmri.org.au	Arthur, Jonathan/A-5367-2009	Arthur, Jonathan/0000-0003-3615-7352	Australian Government, Department of Innovation, Industry, Science, and Research	Australian Government, Department of Innovation, Industry, Science, and Research(Australian GovernmentDepartment of Industry, Innovation and Science)	WWPL receives an Australian Postgraduate Award from the Australian Government, Department of Innovation, Industry, Science, and Research (http://www.innovation.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldulaijan S, 2010, J MOL GRAPH MODEL, V29, P240, DOI 10.1016/j.jmgm.2010.05.010; ALTUVIA Y, 1995, J MOL BIOL, V249, P244, DOI 10.1006/jmbi.1995.0293; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blythe MJ, 2002, BIOINFORMATICS, V18, P434, DOI 10.1093/bioinformatics/18.3.434; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Borbulevych OY, 2005, J IMMUNOL, V174, P4812, DOI 10.4049/jimmunol.174.8.4812; Bordner AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014383; Bordner AJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-41; Bouvier M, 1998, PROTEINS, V33, P97, DOI 10.1002/(SICI)1097-0134(19981001)33:1<97::AID-PROT9>3.0.CO;2-I; Celie PHN, 2009, J AM CHEM SOC, V131, P12298, DOI 10.1021/ja9037559; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dimitrov I, 2010, EUR J MED CHEM, V45, P236, DOI 10.1016/j.ejmech.2009.09.049; Dionne SO, 2003, CANCER IMMUNOL IMMUN, V52, P199, DOI 10.1007/s00262-002-0358-3; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hattotuwagama Channa K., 2007, V409, P227, DOI 10.1007/978-1-60327-118-9_16; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kumar N, 2007, NUCLEIC ACIDS RES, V35, pW549, DOI 10.1093/nar/gkm266; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Lata Sneh, 2007, V409, P201, DOI 10.1007/978-1-60327-118-9_14; Levin MC, 2002, NAT MED, V8, P509, DOI 10.1038/nm0502-509; Li ZL, 2007, SCI CHINA SER C, V50, P706, DOI 10.1007/s11427-007-0080-7; LIAO WW, 2011, AUTOIMMUNIT IN PRESS; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Lundegaard Claus, 2010, Immunome Res, V6 Suppl 2, pS3, DOI 10.1186/1745-7580-6-S2-S3; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; McSparron H, 2003, J CHEM INF COMP SCI, V43, P1276, DOI 10.1021/ci030461e; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; R Development Core Team, 2009, R FDN STAT COMP; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rognan D, 1999, J MED CHEM, V42, P4650, DOI 10.1021/jm9910775; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Schiewe AJ, 2007, J MOL GRAPH MODEL, V26, P667, DOI 10.1016/j.jmgm.2007.03.017; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Solache A, 1999, J IMMUNOL, V163, P5512; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Texier C, 2000, J IMMUNOL, V164, P3177, DOI 10.4049/jimmunol.164.6.3177; vanElsas A, 1996, EUR J IMMUNOL, V26, P1683, DOI 10.1002/eji.1830260803; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Webb AI, 2004, J BIOL CHEM, V279, P23438, DOI 10.1074/jbc.M314066200; Westall FC, 2006, J CLIN MICROBIOL, V44, P2099, DOI 10.1128/JCM.02532-05; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Wilson CC, 2003, J IMMUNOL, V171, P5611, DOI 10.4049/jimmunol.171.10.5611; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Zeng G, 2002, CANCER RES, V62, P3630	61	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25055	10.1371/journal.pone.0025055	http://dx.doi.org/10.1371/journal.pone.0025055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966412	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100046
J	Marengo, EB; de Moraes, LV; Melo, RL; Balan, A; Fernandes, BL; Tambourgi, DV; Rizzo, LV; Sant'Anna, OA				Marengo, Eliana B.; de Moraes, Luciana V.; Melo, Robson L.; Balan, Andrea; Fernandes, Beatriz L.; Tambourgi, Denise V.; Rizzo, Luiz Vicente; Sant'Anna, Osvaldo Augusto			A Mycobacterium leprae Hsp65 Mutant as a Candidate for Mitigating Lupus Aggravation in Mice	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SERUM-SOLUBLE HEAT-SHOCK-PROTEIN-60; CRYSTAL-STRUCTURE; AUTOIMMUNE ARTHRITIS; CHAPERONIN COMPLEX; PEPTIDE THERAPY; DENDRITIC CELLS; ATHEROSCLEROSIS; IDENTIFICATION; ANTIBODIES	Hsp60 is an abundant and highly conserved family of intracellular molecules. Increased levels of this family of proteins have been observed in the extracellular compartment in chronic inflammation. Administration of M. leprae Hsp65 [WT] in [NZBxNZW]F(1) mice accelerates the Systemic Lupus Erythematosus [SLE] progression whereas the point mutated K(409)A Hsp65 protein delays the disease. Here, the biological effects of M. leprae Hsp65 Leader pep and K(409)A pep synthetic peptides, which cover residues 352-371, are presented. Peptides had immunomodulatory effects similar to that observed with their respective proteins on survival and the combined administration of K(409)A+Leader pep or K(409)A pep+WT showed that the mutant forms were able to inhibit the deleterious effect of WT on mortality, indicating the neutralizing potential of the mutant molecules in SLE progression. Molecular modeling showed that replacing Lysine by Alanine affects the electrostatic potential of the 352-371 region. The number of interactions observed for WT is much higher than for Hsp65 K(409)A and mouse Hsp60. The immunomodulatory effects of the point-mutated protein and peptide occurred regardless of the catalytic activity. These findings may be related to the lack of effect on survival when F(1) mice were inoculated with Hsp60 or K(409)A pep. Our findings indicate the use of point-mutated Hsp65 molecules, such as the K(409)A protein and its corresponding peptide, that may minimize or delay the onset of SLE, representing a new approach to the treatment of autoimmune diseases.	[Marengo, Eliana B.; Rizzo, Luiz Vicente] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [de Moraes, Luciana V.] Inst Gulbenkian Ciencias, Lab Doencas Genet, Oeiras, Portugal; [Melo, Robson L.; Fernandes, Beatriz L.] Inst Butantan, Ctr Toxinol Aplicada CAT CEPID, Sao Paulo, Brazil; [Balan, Andrea] Ctr Pesquisa Energia & Mat, LNBio, Campinas, SP, Brazil; [Tambourgi, Denise V.; Sant'Anna, Osvaldo Augusto] Inst Butantan, Lab Imunoquim, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Instituto Gulbenkian de Ciencia; Instituto Butantan; Instituto Butantan	Marengo, EB (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, Brazil.	gbrazil@usp.br	Melo, Robson/B-5798-2013; Balan, Andrea/D-1891-2014; de Moraes, Luciana/M-1619-2013; Tambourgi, Denise/H-7114-2016; Rizzo, Luiz Vicente/B-4458-2009	Balan, Andrea/0000-0001-6199-3198; de Moraes, Luciana/0000-0001-6605-5547; Tambourgi, Denise/0000-0003-1896-9074; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); National Council for Research and Development (CNPq-Brazil); CNPq; ABTlus Associacao Brasileira de Tecnologia de Luz Sincrotron	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Research and Development (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ABTlus Associacao Brasileira de Tecnologia de Luz Sincrotron	This work was supported by funding from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and National Council for Research and Development (CNPq-Brazil) - INCTTOX Program. EBM is the recipient of an FAPESP fellowship. LVM is the recipient of Fundacao para Ciencia e Tecnologia, Portugal. AB is supported by CNPq and ABTlus Associacao Brasileira de Tecnologia de Luz Sincrotron. DVT, LVR, and OAS are researchers at CNPq-Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti JR, 2005, J AM ACAD DERMATOL, V52, P702, DOI 10.1016/j.jaad.2004.09.025; Atherton E., 1990, SOLID PHASE PEPTIDE; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Biozzi G, 1979, Curr Top Microbiol Immunol, V85, P31; Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; Chaudhry C, 2004, J MOL BIOL, V342, P229, DOI 10.1016/j.jmb.2004.07.015; Chen W, 1999, J IMMUNOL, V162, P3212; DELANO WL, 1998, PYMOL MOL GRAPHICH S; DUDANI AK, 1989, INFECT IMMUN, V57, P2786, DOI 10.1128/IAI.57.9.2786-2793.1989; Durai M, 2004, J IMMUNOL, V173, P181, DOI 10.4049/jimmunol.173.1.181; ELIAS D, 1994, LANCET, V343, P704, DOI 10.1016/S0140-6736(94)91582-2; Elias D, 1997, DIABETES, V46, P758, DOI 10.2337/diabetes.46.5.758; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flohe SB, 2003, J IMMUNOL, V170, P2340, DOI 10.4049/jimmunol.170.5.2340; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GEORGOPOULOS C, 1992, TRENDS BIOCHEM SCI, V17, P295, DOI 10.1016/0968-0004(92)90439-G; GILES AR, 1987, THROMB HAEMOSTASIS, V58, P1078; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Habich C, 2006, FEBS LETT, V580, P115, DOI 10.1016/j.febslet.2005.11.060; Kilmartin B, 2004, EUR J IMMUNOL, V34, P2041, DOI 10.1002/eji.200425108; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luna E, 2007, CELL STRESS CHAPERON, V12, P112, DOI 10.1379/CSC-209R.1; Marengo EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007912; Marengo EB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003025; Marques MAM, 1998, INFECT IMMUN, V66, P2625, DOI 10.1128/IAI.66.6.2625-2631.1998; Martiniuk Frank, 2007, J Drugs Dermatol, V6, P268; MITCHELL HK, 1985, P NATL ACAD SCI USA, V82, P4969, DOI 10.1073/pnas.82.15.4969; Moudgil KD, 2008, TRENDS IMMUNOL, V29, P412, DOI 10.1016/j.it.2008.06.003; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; PARADA CA, MICROB PATHOG; Paul AGA, 2000, J IMMUNOL, V165, P7270, DOI 10.4049/jimmunol.165.12.7270; Perschinka H, 2003, ARTERIOSCL THROM VAS, V23, P1060, DOI 10.1161/01.ATV.0000071701.62486.49; Phipps PA, 2003, EUR J IMMUNOL, V33, P224, DOI 10.1002/immu.200390025; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Portaro FCV, 2002, BIOCHEMISTRY-US, V41, P7400, DOI 10.1021/bi011999l; Prohaszka Z, 1999, INT IMMUNOL, V11, P1363, DOI 10.1093/intimm/11.9.1363; Qamra R, 2004, J BACTERIOL, V186, P8105, DOI 10.1128/jb.186.23.8105-8113.2004; Qamra R, 2004, J MOL BIOL, V342, P605, DOI 10.1016/j.jmb.2004.07.066; Rajaiah R, 2009, AUTOIMMUN REV, V8, P388, DOI 10.1016/j.autrev.2008.12.004; Saito K, 2005, EXP CELL RES, V310, P229, DOI 10.1016/j.yexcr.2005.07.014; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANTANNA OA, 1985, IMMUNOGENETICS, V22, P131, DOI 10.1007/BF00563510; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shimamura T, 2004, STRUCTURE, V12, P1471, DOI 10.1016/j.str.2004.05.020; Tsuruta LR, 2006, ANAL BIOCHEM, V353, P174, DOI 10.1016/j.ab.2006.03.018; Xiao QZ, 2005, STROKE, V36, P2571, DOI 10.1161/01.STR.0000189632.98944.ab; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zanin-Zhorov A, 2005, J IMMUNOL, V174, P3227, DOI 10.4049/jimmunol.174.6.3227; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	55	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24093	10.1371/journal.pone.0024093	http://dx.doi.org/10.1371/journal.pone.0024093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961033	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100005
J	Srinivasan, M; Janardhanam, S				Srinivasan, Mythily; Janardhanam, Srihari			Novel p65 Binding Glucocorticoid-induced Leucine Zipper Peptide Suppresses Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELL-ACTIVATION; TRANSACTIVATION DOMAIN; PROTEIN-STRUCTURE; INDUCED GENE; II HELIX; GILZ; TRANSCRIPTION; COACTIVATORS; RECOGNITION	Multiple sclerosis (MS) is a neurological disease characterized by inflammatory demyelination in the brain and spinal cord. The immune-mediated inflammation involves well orchestrated intermolecular interactions that exhibit rapid binding kinetics. The binding interfaces of transient interactions frequently include proline residues that favor an extended conformation for molecular recognition. Linear interface peptides are excellent lead inhibitors of specific protein-protein interactions because only small segments of the interface contribute to the binding. Glucocorticoid-induced leucine zipper (GILZ), a recently identified molecule exhibits potent anti-inflammatory properties. Mechanistically, a prolinerich segment in the carboxyl terminus of GILZ physically binds the p65 subunit of nuclear factor-kappa B and inhibits the transactivation of inflammatory cytokines. Integrating knowledge derived from the mechanism of action of GILZ with in silico structure prediction identified an immunomodulatory peptide, the GILZ-P. Treatment with GILZ-P exhibited therapeutic efficacy in experimental autoimmune encephalomyelitis, a model for human MS.	[Srinivasan, Mythily; Janardhanam, Srihari] Indiana Univ Purdue Univ, Sch Dent, Dept Oral Pathol Med & Radiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Srinivasan, M (corresponding author), 1121 W Michigan St, Indianapolis, IN 46202 USA.	mysriniv@iupui.edu	Janardhanam, Srihari/H-7429-2013					Asamitsu K, 2003, J BIOL CHEM, V278, P26879, DOI 10.1074/jbc.M211831200; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Beaulieu E, 2011, NAT REV RHEUMATOL, V7, P340, DOI 10.1038/nrrheum.2011.59; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bhattacharyya R, 2003, J MOL BIOL, V331, P925, DOI 10.1016/S0022-2836(03)00759-9; Bochicchio B, 2002, CHIRALITY, V14, P782, DOI 10.1002/chir.10153; Calzado MA, 2007, CURR MED CHEM, V14, P367, DOI 10.2174/092986707779941113; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cannarile L, 2001, CELL DEATH DIFFER, V8, P201, DOI 10.1038/sj.cdd.4400798; Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024; Chandra BR, 2004, PROTEIN ENG DES SEL, V17, P175, DOI 10.1093/protein/gzh024; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Delfino DV, 2006, INT IMMUNOPHARMACOL, V6, P1126, DOI 10.1016/j.intimp.2006.02.001; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Dudhgaonkar SP, 2009, J IMMUNOL, V183, P7505, DOI 10.4049/jimmunol.0902056; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Gros E, 2006, BBA-BIOMEMBRANES, V1758, P384, DOI 10.1016/j.bbamem.2006.02.006; Heinrich L, 2010, J IMMUNOL METHODS, V352, P13, DOI 10.1016/j.jim.2009.10.002; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Martino G. A., 1999, BASIC IMMUNOLOGY IMM, V1, P185; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; O'Shea JM, 2008, BIOCHEM SOC T, V36, P603, DOI 10.1042/BST0360603; Pande V, 2005, CURR MED CHEM, V12, P357, DOI 10.2174/0929867053363180; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saladin PM, 2009, IDRUGS, V12, P779; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; Seidel G, 1997, J BIOL CHEM, V272, P30918, DOI 10.1074/jbc.272.49.30918; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; Srinivasan M, 2005, J BIOL CHEM, V280, P10149, DOI 10.1074/jbc.M409521200; Srinivasan M, 2001, J IMMUNOL, V167, P578, DOI 10.4049/jimmunol.167.1.578; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Tanaka K, 2001, JPN J CANCER RES, V92, P959, DOI 10.1111/j.1349-7006.2001.tb01187.x; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Vanderlugt CL, 1998, IMMUNOL REV, V164, P63, DOI 10.1111/j.1600-065X.1998.tb01208.x; Weber MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016009; Zimecki M, 2008, ADV EXP MED BIOL, V606, P241, DOI 10.1007/978-0-387-74087-4_9	46	49	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44799	44810		10.1074/jbc.M111.279257	http://dx.doi.org/10.1074/jbc.M111.279257			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	21965677	Green Published, hybrid			2022-12-25	WOS:000298645500049
J	Hickok, JR; Sahni, S; Mikhed, Y; Bonini, MG; Thomas, DD				Hickok, Jason R.; Sahni, Sumit; Mikhed, Yuliya; Bonini, Marcelo G.; Thomas, Douglas D.			Nitric Oxide Suppresses Tumor Cell Migration through N-Myc Downstream-regulated Gene-1 (NDRG1) Expression ROLE OF CHELATABLE IRON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE BREAST-CANCER; METASTASIS SUPPRESSOR; INDUCIBLE FACTOR-1-ALPHA; POOR-PROGNOSIS; DIFFERENTIATION; TARGET; GROWTH; DRG-1; CHELATORS; PROTEINS	N-Myc downstream-regulated gene 1 (NDRG1) is a ubiquitous cellular protein that is up-regulated under a multitude of stress and growth-regulatory conditions. Although the exact cellular functions of this protein have not been elucidated, mutations in this gene or aberrant expression of this protein have been linked to both tumor suppressive and oncogenic phenotypes. Previous reports have demonstrated that NDRG1 is strongly up-regulated by chemical iron chelators and hypoxia, yet its regulation by the free radical nitric oxide ((NO)-N-center dot) has never been demonstrated. Herein, we examine the chemical biology that confers NDRG1 responsiveness at the mRNA and protein levels to (NO)-N-center dot. We demonstrate that the interaction of (NO)-N-center dot with the chelatable iron pool (CIP) and the appearance of dinitrosyliron complexes (DNIC) are key determinants. Using HCC 1806 triple negative breast cancer cells, we find that NDRG1 is up-regulated by physiological (NO)-N-center dot concentrations in a dose- and time-dependant manner. Tumor cell migration was suppressed by NDRG1 expression and we excluded the involvement of HIF-1 alpha, sGC, N-Myc, and c-Myc as upstream regulatory targets of (NO)-N-center dot. Augmenting the chelatable iron pool abolished (NO)-N-center dot-mediated NDRG1 expression and the associated phenotypic effects. These data, in summary, reveal a link between (NO)-N-center dot, chelatable iron, and regulation of NDRG1 expression and signaling in tumor cells.	[Thomas, Douglas D.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA; [Bonini, Marcelo G.] Univ Illinois, Dept Med & Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Thomas, DD (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, 833 S Wood St,MC 781, Chicago, IL 60612 USA.	ddthomas@uic.edu		Sahni, Sumit/0000-0002-2900-8845; Thomas, Douglas/0000-0003-1252-0786	National Institutes of Health from the National Cancer Institute [K22CA113315]; American Cancer Society; University of Illinois at Chicago, Cancer Center; NATIONAL CANCER INSTITUTE [K22CA113315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094175] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); University of Illinois at Chicago, Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant K22CA113315 from the National Cancer Institute, grants from the American Cancer Society, and the University of Illinois at Chicago, Cancer Center.	Akiba J, 2008, ONCOL REP, V20, P1329, DOI 10.3892/or_00000148; Ando T, 2006, DIS ESOPHAGUS, V19, P454, DOI 10.1111/j.1442-2050.2006.00618.x; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; BOUTON C, 2003, SCI STKE, pPE17; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; Chowdhury R, 2011, J MOL BIOL, V410, P268, DOI 10.1016/j.jmb.2011.04.075; Chua MS, 2007, MODERN PATHOL, V20, P76, DOI 10.1038/modpathol.3800711; Costa M, 2005, MUTAT RES-FUND MOL M, V592, P79, DOI 10.1016/j.mrfmmm.2005.06.008; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Doi K, 1996, CANCER-AM CANCER SOC, V77, P1598, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1598::AID-CNCR3>3.0.CO;2-A; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Griffith M., 2007, DATABASE MRNA EXPRES; Guang RJ, 2000, CANCER RES, V60, P749; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Hickok JR, 2010, CURR PHARM DESIGN, V16, P381, DOI 10.2174/138161210790232149; Hwang J, 2011, J BIOL CHEM, V286, P12450, DOI 10.1074/jbc.M110.170803; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kurdistani SK, 1998, CANCER RES, V58, P4439; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Li J, 2003, MOL CELL BIOCHEM, V250, P91, DOI 10.1023/A:1024918328162; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; Masuda K, 2003, INT J CANCER, V105, P803, DOI 10.1002/ijc.11152; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Mocellin S, 2007, MED RES REV, V27, P317, DOI 10.1002/med.20092; Nishio S, 2008, CANCER LETT, V264, P36, DOI 10.1016/j.canlet.2008.01.020; Petrat F, 2002, BIOL CHEM, V383, P489, DOI 10.1515/BC.2002.051; Petrat F, 2001, BIOCHEM J, V356, P61, DOI 10.1042/0264-6021:3560061; Pieper GM, 2003, P NATL ACAD SCI USA, V100, P3125, DOI 10.1073/pnas.0636938100; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rutherford MN, 2001, LEUKEMIA, V15, P362, DOI 10.1038/sj.leu.2402059; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Salnikow K, 2003, CANCER RES, V63, P3524; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Schwab M, 2004, CANCER LETT, V204, P179, DOI 10.1016/S0304-3835(03)00454-3; Shah MA, 2005, CLIN CANCER RES, V11, P3296, DOI 10.1158/1078-0432.CCR-04-2417; Shaw E, 2002, PROTEINS, V47, P163, DOI 10.1002/prot.10083; Stein S, 2004, J BIOL CHEM, V279, P48930, DOI 10.1074/jbc.M400386200; Stys A, 2011, J BIOL CHEM, V286, P22846, DOI 10.1074/jbc.M111.231902; Sun BQ, 2009, J NEURO-ONCOL, V94, P213, DOI 10.1007/s11060-009-9859-7; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; Thomas DD, 2003, ANTIOXID REDOX SIGN, V5, P307, DOI 10.1089/152308603322110887; Thomas DD, 2002, METHOD ENZYMOL, V359, P84; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; vanBelzen N, 1997, LAB INVEST, V77, P85; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wistuba II, 1998, CLIN CANCER RES, V4, P2931; Xu X, 2008, MOL PHARMACOL, V73, P833, DOI 10.1124/mol.107.041335; Yan XR, 2008, CANCER LETT, V262, P133, DOI 10.1016/j.canlet.2007.12.010; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016	59	59	60	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41413	41424		10.1074/jbc.M111.287052	http://dx.doi.org/10.1074/jbc.M111.287052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21976667	hybrid, Green Published			2022-12-25	WOS:000298057500028
J	Pickens, LB; Sawaya, MR; Rasool, H; Pashkov, I; Yeates, TO; Tang, Y				Pickens, Lauren B.; Sawaya, Michael R.; Rasool, Huma; Pashkov, Inna; Yeates, Todd O.; Tang, Yi			Structural and Biochemical Characterization of the Salicylyl-acyltranferase SsfX3 from a Tetracycline Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; COLI THIOESTERASE-I; GENE-CLUSTER; CATALYTIC TRIAD; ACTIVE-SITE; PROTEASE-I; ANTITUMOR-ACTIVITY; FAMILY; IDENTIFICATION; ENZYME	SsfX3 is a GDSL, family acyltransferase that transfers salicylate to the C-4 hydroxyl of a tetracycline intermediate in the penultimate step during biosynthesis of the anticancer natural product ST2575. The C-4 salicylate takes the place of the more common C-4 dimethylamine functionality, making SsfX3 the first acyltransferase identified to act on a tetracycline substrate. The crystal structure of SsfX3 was determined at 2.5 angstrom, revealing two distinct domains as follows: an N-terminal beta-sandwich domain that resembles a carbohydrate-binding module, and a C-terminal catalytic domain that contains the atypical alpha/beta-hydrolase fold found in the GDSL, hydrolase family of enzymes. The active site lies at one end of a large open binding pocket, which is spatially defined by structural elements from both the N- and C-terminal domains. Mutational analysis in the putative substrate binding pocket identified residues from both domains that are important for binding the acyl donor and acceptor. Furthermore, removal of the N-terminal carbohydrate-binding module-like domain rendered the stand-alone alp-hydrolase domain inactive. The additional noncatalytic module is therefore proposed to be required to define the binding pocket and provide sufficient interactions with the spatially extended tetracyclic substrate. SsfX3 was also demonstrated to accept a variety of non-native acyl groups. This relaxed substrate specificity toward the acyl donor allowed the chemoenzymatic biosynthesis of C-4-modified analogs of the immediate precursor to the bioactive SF2575; these were used to assay the structure activity relationships at the C-4 position.	[Pickens, Lauren B.; Rasool, Huma; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Pashkov, Inna; Yeates, Todd O.; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Yeates, Todd O.; Tang, Yi] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Tang, Y (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.	yitang@ucla.edu		Yeates, Todd/0000-0001-5709-9839	National Institutes of Health from NCRR [RR-15301]; United States Department of Energy [W-31-109-ENG-38]; National Science Foundation [0545860, 1033070]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; Directorate For Engineering [1033070] Funding Source: National Science Foundation	National Institutes of Health from NCRR; United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank Dr. Duilio Cascio, the staff of the Advanced Light Source beamline 8.2.1, and the staff of the Advanced Photon Source, Northeastern Collaborative Access Team (NECAT) beamline 24-ID-C for assistance with data collection, The NECAT beamline is supported by National Institutes of Health Award RR-15301 from NCRR. Use of the Advanced Photon Source is supported by the United States Department of Energy, (Vice of Basic Energy Sciences under Contract W-31-109-ENG-38.; This work was supported by National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) Grants 0545860 and 1033070 (to V. T.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Asler IL, 2010, CHEMBIOCHEM, V11, P2158, DOI 10.1002/cbic.201000398; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bricogne G, 2009, BUSTER VERSION 2 8 0; Chang RC, 1996, BIOCHEM BIOPH RES CO, V221, P477, DOI 10.1006/bbrc.1996.0620; CHO HS, 1993, J BIOL CHEM, V268, P9238; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Funabashi M, 2010, CHEMBIOCHEM, V11, P184, DOI 10.1002/cbic.200900665; Ghatge MS, 2009, APPL ENVIRON MICROB, V75, P3469, DOI 10.1128/AEM.02590-08; HATSU M, 1992, J ANTIBIOT, V45, P320, DOI 10.7164/antibiotics.45.320; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HORIGUCHI T, 1994, J ANTIBIOT, V47, P545, DOI 10.7164/antibiotics.47.545; Huang YT, 2001, J MOL BIOL, V307, P1075, DOI 10.1006/jmbi.2001.4539; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARASAWA K, 1991, J BIOCHEM, V109, P288; Karasawa K, 1999, J BIOCHEM-TOKYO, V126, P445, DOI 10.1093/oxfordjournals.jbchem.a022470; Kaysser L, 2010, CHEMBIOCHEM, V11, P191, DOI 10.1002/cbic.200900637; Kaysser L, 2009, J BIOL CHEM, V284, P14987, DOI 10.1074/jbc.M901258200; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; Kruger RG, 2005, CHEM BIOL, V12, P131, DOI 10.1016/j.chembiol.2004.12.005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; Li TL, 2004, CHEM BIOL, V11, P107, DOI 10.1016/j.chembiol.2004.01.001; Lo YC, 2000, ACTA CRYSTALLOGR D, V56, P756, DOI 10.1107/S0907444900004339; Lo YC, 2003, J MOL BIOL, V330, P539, DOI 10.1016/S0022-2836(03)00637-5; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Menendez N, 2004, CHEM BIOL, V11, P21, DOI 10.1016/j.chembiol.2003.12.011; Menendez N, 2007, MICROBIOL-SGM, V153, P3061, DOI 10.1099/mic.0.2007/007922-0; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Montanier C, 2009, PLOS BIOL, V7, P687, DOI 10.1371/journal.pbio.1000071; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Moss SJ, 2002, J AM CHEM SOC, V124, P6544, DOI 10.1021/ja020214b; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Olano C, 2010, NAT PROD REP, V27, P571, DOI 10.1039/b911956f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACAUD M, 1971, EUR J BIOCHEM, V23, P435, DOI 10.1111/j.1432-1033.1971.tb01638.x; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pickens LB, 2009, J AM CHEM SOC, V131, P17677, DOI 10.1021/ja907852c; ROBERTSON DL, 1994, J BIOL CHEM, V269, P2146; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sheldrick G.M, 2001, International Tables for Macromolecular Crystallography, P333; Smith AJT, 2008, J AM CHEM SOC, V130, P15361, DOI 10.1021/ja803213p; Tyukhtenko SI, 2002, FEBS LETT, V528, P203, DOI 10.1016/S0014-5793(02)03308-2; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; WEI YY, 1995, NAT STRUCT BIOL, V2, P218, DOI 10.1038/nsb0395-218; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xie XK, 2006, CHEM BIOL, V13, P1161, DOI 10.1016/j.chembiol.2006.09.008; Xie XK, 2009, J AM CHEM SOC, V131, P8388, DOI 10.1021/ja903203g	60	10	10	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41539	41551		10.1074/jbc.M111.299859	http://dx.doi.org/10.1074/jbc.M111.299859			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965680	Green Published, hybrid			2022-12-25	WOS:000298057500040
J	Jung, MS; Park, JH; Ryu, YS; Choi, SH; Yoon, SH; Kwen, MY; Oh, JY; Song, WJ; Chung, SH				Jung, Min-Su; Park, Jung-Hwa; Ryu, Young Shin; Choi, Sun-Hee; Yoon, Song-Hee; Kwen, Mi-Yang; Oh, Ji Youn; Song, Woo-Joo; Chung, Sul-Hee			Regulation of RCAN1 Protein Activity by Dyrk1A Protein-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION; CALCINEURIN PHOSPHATASE-ACTIVITY; DOWN-SYNDROME; ALZHEIMERS-DISEASE; FUNCTIONAL-LINK; HUMAN HOMOLOG; TAU-PROTEIN; STRIATED-MUSCLES; OXIDATIVE STRESS; T-CELLS	Two genes on chromosome 21, namely dual specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) and regulator of calcineurin 1 (RCAN1), have been implicated in some of the phenotypic characteristics of Downsyndrome, including the early onset of Alzheimer disease. Although a link between Dyrk1A and RCAN1 and the nuclear factor of activated T cells (NFAT) pathway has been reported, it remains unclear whether Dyrk1A directly interacts with RCAN1. In the present study, Dyrk1A is shown to directly interact with and phosphorylate RCAN1 at Ser(112) and Thr(192) residues. Dyrk1A-mediated phosphorylation of RCAN1 at Ser(112) primes the protein for the GSK3 beta-mediated phosphorylation of Ser(108). Phosphorylation of RCAN1 at Thr(192) by Dyrk1A enhances the ability of RCAN1 to inhibit the phosphatase activity of calcineurin (Caln), leading to reduced NFAT transcriptional activity and enhanced Tau phosphorylation. These effects are mediated by the enhanced binding of RCAN1 to Caln and its extended half-life caused by Dyrk1A-mediated phosphorylation. Furthermore, an increased expression of phospho-Thr(192)-RCAN1 was observed in the brains of transgenic mice overexpressing the Dyrk1A protein. These results suggest a direct link between Dyrk1A and RCAN1 in the Caln-NFAT signaling and Tau hyperphosphorylation pathways, supporting the notion that the synergistic interaction between the chromosome 21 genes RCAN1 and Dyrk1A is associated with a variety of pathological features associated with DS.	[Jung, Min-Su; Park, Jung-Hwa; Ryu, Young Shin; Choi, Sun-Hee; Yoon, Song-Hee; Kwen, Mi-Yang; Oh, Ji Youn; Song, Woo-Joo; Chung, Sul-Hee] Inje Univ, Grad Program Neurosci, Inst Brain Sci & Technol, Res Grp 1, Pusan 614735, South Korea	Inje University	Song, WJ (corresponding author), Inje Univ, Grad Program Neurosci, Inst Brain Sci & Technol, Res Grp 1, 633-146 Gaegeum,2 Dong, Pusan 614735, South Korea.	wjsong@inje.ac.kr; sulchung@inje.ac.kr			Korea Healthcare Technology RD Project; Ministry of Health, Welfare, and Family Affairs, Republic of Korea [A092004, A080227]; National Research Foundation of Korea; Ministry of Education, Science, and Technology [2009-0073210, 2009-0067388, 2011-0014085, 2011-0023401]	Korea Healthcare Technology RD Project; Ministry of Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Korea Healthcare Technology R&D Project and Ministry of Health, Welfare, and Family Affairs, Republic of Korea, Grants A092004 and A080227. This work was also supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (Grants 2009-0073210, 2009-0067388, 2011-0014085, and 2011-0023401).	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Abdul Hafiz Mohmmad, 2010, Mol Cell Pharmacol, V2, P7; Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Aubareda A, 2006, CELL SIGNAL, V18, P1430, DOI 10.1016/j.cellsig.2005.11.006; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Chan B, 2005, P NATL ACAD SCI USA, V102, P13075, DOI 10.1073/pnas.0503846102; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Cook CN, 2005, J ALZHEIMERS DIS, V8, P63; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; de la Luna S, 2006, TRENDS MOL MED, V12, P451, DOI 10.1016/j.molmed.2006.08.001; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Ferrer I, 2005, NEUROBIOL DIS, V20, P392, DOI 10.1016/j.nbd.2005.03.020; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Garver TD, 1999, MOL PHARMACOL, V55, P632; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Lee J, 2008, J BIOL CHEM, V283, P3392, DOI 10.1074/jbc.M706707200; Liu QH, 2009, NAT CELL BIOL, V11, P154, DOI 10.1038/ncb1823; Martinez-Martineza S, 2009, P NATL ACAD SCI USA, V106, P6117, DOI 10.1073/pnas.0812544106; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Mulero MC, 2009, J BIOL CHEM, V284, P9394, DOI 10.1074/jbc.M805889200; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Pfister SC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-24; Poppek D, 2006, BIOCHEM J, V400, P511, DOI 10.1042/BJ20060463; Porta S, 2007, HUM MOL GENET, V16, P1039, DOI 10.1093/hmg/ddm049; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Ryu YS, 2010, J NEUROCHEM, V115, P574, DOI 10.1111/j.1471-4159.2010.06769.x; Sagoo JK, 1996, BIOCHEM J, V320, P879, DOI 10.1042/bj3200879; Shindoh N, 1996, BIOCHEM BIOPH RES CO, V225, P92, DOI 10.1006/bbrc.1996.1135; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Wegiel J, 2011, FEBS J, V278, P236, DOI 10.1111/j.1742-4658.2010.07955.x; Wegiel J, 2011, J NEUROPATH EXP NEUR, V70, P36, DOI 10.1097/NEN.0b013e318202bfa1; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Zeitelhofer M, 2007, NAT PROTOC, V2, P1692, DOI 10.1038/nprot.2007.226	55	60	61	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40401	40412		10.1074/jbc.M111.253971	http://dx.doi.org/10.1074/jbc.M111.253971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965663	Green Published, hybrid			2022-12-25	WOS:000296925700071
J	Hsieh, JY; Chen, MC; Hung, HC				Hsieh, Ju-Yi; Chen, Meng-Chun; Hung, Hui-Chih			Determinants of Nucleotide-Binding Selectivity of Malic Enzyme	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; FUNCTIONAL ROLES; CRYSTAL-STRUCTURE; CDNA CLONING; ATP; PURIFICATION; EXPRESSION; MECHANISM; SITE; INHIBITION	Malic enzymes have high cofactor selectivity. An isoform-specific distribution of residues 314, 346, 347 and 362 implies that they may play key roles in determining the cofactor specificity. Currently, Glu314, Ser346, Lys347 and Lys362 in human c-NADP-ME were changed to the corresponding residues of human m-NAD(P)-ME (Glu, Lys, Tyr and Gln, respectively) or Ascaris suum m-NAD-ME (Ala, Ile, Asp and His, respectively). Kinetic data demonstrated that the S346K/K347Y/K362Q c-NADP-ME was transformed into a debilitated NAD(+)-utilizing enzyme, as shown by a severe decrease in catalytic efficiency using NADP(+) as the cofactor without a significant increase in catalysis using NAD(+) as the cofactor. However, the S346K/K347Y/K362H enzyme displayed an enhanced value for k(cat,NAD), suggesting that His at residue 362 may be more beneficial than Gln for NAD(+) binding. Furthermore, the S3461/K347D/K362H mutant had a very large K-m,K-NADP value compared to other mutants, suggesting that this mutant exclusively utilizes NAD(+) as its cofactor. Since the S346K/K347Y/K362Q, S346K1K347Y/K362H and S346I/K347D/K362H c-NADP-ME mutants did not show significant reductions in their K-m,K-NAD values, the E314A mutation was then introduced into these triple mutants. Comparison of the kinetic parameters of each triple-quadruple mutant pair (for example, S346K/K347Y/K362Q versus E314A/S346K/K347Y/K362Q) revealed that all of the K-m values for NAD(+) and NADP(+) of the quadruple mutants were significantly decreased, while either k(cat,NAD) or k(cat,NADP) was substantially increased. By adding the E314A mutation to these triple mutant enzymes, the E314A/S346K/K347Y/K362Q, E314A/S346K/K347Y/K362H and E314A/S3461/K347D/K362H c-NADP-ME variants are no longer debilitated but become mainly NAD utilizing enzymes by a considerable increase in catalysis using NAD(+) as the cofactor. These results suggest that abolishing the repulsive effect of Glu314 in these quadruple mutants increases the binding affinity of NAD(+) Here, we demonstrate that a series of E314A-containing c-NADP-ME quadruple mutants have been changed to NAD(+)-Utilizing enzymes by abrogating NADP(+) binding and increasing NAD(+) binding.	[Hsieh, Ju-Yi; Chen, Meng-Chun; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Hsieh, JY (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/G-4485-2013; Hung, Hui-Chih/L-8061-2019	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council, ROC [NSC-99-2113-M-005-010]; Ministry of Education, Taiwan	National Science Council, ROC(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by the National Science Council, ROC (NSC-99-2113-M-005-010) and the Ministry of Education, Taiwan, R.O.C. under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas DF, 2008, BIOCHEMISTRY-US, V47, P2539, DOI 10.1021/bi702261m; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; BAKER PJ, 1987, J MOL BIOL, V193, P233, DOI 10.1016/0022-2836(87)90643-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG GG, 1991, EUR J BIOCHEM, V202, P681, DOI 10.1111/j.1432-1033.1991.tb16423.x; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Coleman DE, 2002, BIOCHEMISTRY-US, V41, P6928, DOI 10.1021/bi0255120; Frenkel R, 1975, Curr Top Cell Regul, V9, P157; FRENKEL R, 1972, BIOCHEM BIOPH RES CO, V47, P931, DOI 10.1016/0006-291X(72)90582-7; Goodridge AG, 1996, PROG NUCLEIC ACID RE, V52, P89, DOI 10.1016/S0079-6603(08)60965-4; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hsieh JY, 2008, FEBS J, V275, P5383, DOI 10.1111/j.1742-4658.2008.06668.x; Hsieh JY, 2006, J BIOL CHEM, V281, P23237, DOI 10.1074/jbc.M603451200; Hsieh JY, 2009, J BIOL CHEM, V284, P4536, DOI 10.1074/jbc.M807008200; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; Hsu WC, 2004, BIOCHEMISTRY-US, V43, P7382, DOI 10.1021/bi049600r; Hung HC, 2005, BIOCHEM J, V392, P39, DOI 10.1042/BJ20050641; Hung HC, 2005, BIOCHEMISTRY-US, V44, P12737, DOI 10.1021/bi050510b; Karsten WE, 2005, BIOCHEMISTRY-US, V44, P3626, DOI 10.1021/bi047826o; KIICK DM, 1986, BIOCHEMISTRY-US, V25, P227, DOI 10.1021/bi00349a032; Kuo CC, 2000, BIOCHEM BIOPH RES CO, V270, P821, DOI 10.1006/bbrc.2000.2502; LOEBER G, 1994, BIOCHEM J, V304, P687, DOI 10.1042/bj3040687; LOEBER G, 1994, FEBS LETT, V344, P181, DOI 10.1016/0014-5793(94)00386-6; LOEBER G, 1991, J BIOL CHEM, V266, P3016; MANDELLA RD, 1975, J BIOL CHEM, V250, P5877; MCKEEHAN WL, 1982, J CELL PHYSIOL, V110, P142, DOI 10.1002/jcp.1041100206; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; SAUER LA, 1973, FEBS LETT, V33, P251, DOI 10.1016/0014-5793(73)80205-4; Tao X, 2003, STRUCTURE, V11, P1141, DOI 10.1016/S0969-2126(03)00168-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu YW, 1999, STRUCT FOLD DES, V7, P877, DOI 10.1016/S0969-2126(99)80115-4; Yang ZR, 2000, BIOCHEM BIOPH RES CO, V274, P440, DOI 10.1006/bbrc.2000.3163; Yang ZR, 2000, NAT STRUCT BIOL, V7, P251; Yang ZR, 2002, PROTEIN SCI, V11, P332, DOI 10.1110/ps.38002; Yang ZR, 2002, STRUCTURE, V10, P951, DOI 10.1016/S0969-2126(02)00788-8	36	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25312	10.1371/journal.pone.0025312	http://dx.doi.org/10.1371/journal.pone.0025312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980421	Green Published, gold			2022-12-25	WOS:000295939600018
J	Zeng, T; Gao, HY; Yu, P; He, H; Ouyang, XM; Deng, LJ; Zhang, Y				Zeng, Tao; Gao, Hongyi; Yu, Pei; He, Heng; Ouyang, Xiaoming; Deng, Lijuan; Zhang, Yan			Up-Regulation of Kin17 Is Essential for Proliferation of Breast Cancer	PLOS ONE			English	Article							DNA-DAMAGE; RNA-BINDING; COMET ASSAY; CYCLIN D1; PROTEIN; REPAIR; EXPRESSION; COMPLEX; MARKERS; LINES	Background: Kin17 is ubiquitously expressed at low levels in human tissue and participates in DNA replication, DNA repair and cell cycle control. Breast cancer cells are characterized by enabling replicative immortality and accumulated DNA damage. However, whether kin17 contributes to breast carcinogenesis remains unknown. Methodology/Principal Findings: In this study, we show for the first time that kin17 is an important molecule related to breast cancer. Our results show that kin17 expression was markedly increased in clinical breast tumors and was associated with tumor grade, Ki-67 expression, p53 mutation status and progesterone receptor expression, which were assessed in a clinicopathologic characteristics review. Knockdown of kin17 inhibited DNA replication and repair, blocked cell cycle progression and inhibited anchorage-independent growth, while increasing sensitivity to chemotherapy in breast cancer cells. Moreover, kin17 silencing decreased EGF-stimulated cell growth. Furthermore, overexpression of kin17 promoted DNA replication and cell proliferation in MCF-10A. Conclusions/Significance:Our findings indicate that up-regulation of kin17 is strongly associated with cellular proliferation, DNA replication, DNA damage response and breast cancer development. The increased level of kin17 was not only a consequence of immortalization but also associated with tumorigenesis. Therefore, kin17 could be a novel therapeutic target for inhibiting cell growth in breast cancer.	[Zeng, Tao; Yu, Pei; He, Heng; Deng, Lijuan; Zhang, Yan] Sun Yat Sen Univ, Sch Life Sci, Minist Educ, State Key Lab Biocontrol,Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Hongyi] Guangdong Women & Childrens Hosp & Hlth Inst, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Ouyang, Xiaoming] Guangzhou Med Univ, Affiliated Hosp 2, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University	Zeng, T (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Minist Educ, State Key Lab Biocontrol,Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China.	zhang39@mail.sysu.edu.cn	Gao, Hongyi/AAE-3460-2020	Zeng, Tao/0000-0001-8896-0361	Guangdong Planning Project of Science and Technology [2008B030301342, 2009B030803037]	Guangdong Planning Project of Science and Technology	This work was supported by the Guangdong Planning Project of Science and Technology (No. 2008B030301342 and No. 2009B030803037) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Biard DSF, 1997, RADIAT RES, V147, P442, DOI 10.2307/3579501; Biard DSF, 2002, J BIOL CHEM, V277, P19156, DOI 10.1074/jbc.M200321200; Boccardo F, 2007, LANCET, V369, P533, DOI 10.1016/S0140-6736(07)60201-3; Bosch A, 2010, CANCER TREAT REV, V36, P206, DOI 10.1016/j.ctrv.2009.12.002; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Montero JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005565; Chen ZJ, 2010, MUTAT RES-GEN TOX EN, V695, P16, DOI 10.1016/j.mrgentox.2009.10.001; Collins Andrew R, 2004, Mol Biotechnol, V26, P249; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Ewen ME, 2004, TRENDS MOL MED, V10, P158, DOI 10.1016/j.molmed.2004.02.005; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hussain SA, 2007, BIODRUGS, V21, P215, DOI 10.2165/00063030-200721040-00002; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kannouche P, 2000, CARCINOGENESIS, V21, P1701, DOI 10.1093/carcin/21.9.1701; Kannouche P, 1998, CARCINOGENESIS, V19, P781, DOI 10.1093/carcin/19.5.781; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kobayashi S, 2006, CANCER RES, V66, P11389, DOI 10.1158/0008-5472.CAN-06-2318; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; le Maire A, 2006, J MOL BIOL, V364, P764, DOI 10.1016/j.jmb.2006.09.033; Lu Jing, 2009, Cancer Res, V69, P4951, DOI 10.1158/0008-5472.CAN-09-0099; Maslon MM, 2010, TRENDS CELL BIOL, V20, P542, DOI 10.1016/j.tcb.2010.06.005; Masson C, 2003, P NATL ACAD SCI USA, V100, P616, DOI 10.1073/pnas.0236176100; MAZIN A, 1994, MOL GEN GENET, V244, P435, DOI 10.1007/BF00286696; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Miccoli L, 2005, MOL CELL BIOL, V25, P3814, DOI 10.1128/MCB.25.9.3814-3830.2005; Miccoli L, 2002, CANCER RES, V62, P5425; Milanezi F, 2008, EXPERT REV MOL DIAGN, V8, P417, DOI 10.1586/14737159.8.4.417; Pinon-Lataillade G, 2004, J CELL SCI, V117, P3691, DOI 10.1242/jcs.01226; Price JT, 1999, CANCER RES, V59, P5475; Reddy TK, 2008, PHYTOTHER RES, V22, P1188, DOI 10.1002/ptr.2428; Salti GI, 2000, ANTICANCER RES, V20, P3189; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Venkatesha VA, 2010, TOXICOL LETT, V196, P110, DOI 10.1016/j.toxlet.2010.04.005	39	23	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25343	10.1371/journal.pone.0025343	http://dx.doi.org/10.1371/journal.pone.0025343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980430	gold, Green Published, Green Submitted			2022-12-25	WOS:000295939600021
J	Petrovan, SO; Ward, AI; Wheeler, P				Petrovan, Silviu O.; Ward, Alastair I.; Wheeler, Philip			Detectability Counts when Assessing Populations for Biodiversity Targets	PLOS ONE			English	Article							HARES LEPUS-EUROPAEUS; BROWN HARES; ABUNDANCE; CONSERVATION; LANDSCAPE; FARMLAND; BRITAIN; DESIGN	Efficient, practical and accurate estimates of population parameters are a necessary basis for effective conservation action to meet biodiversity targets. The brown hare is representative of many European farmland species: historically widespread and abundant but having undergone rapid declines as a result of agricultural intensification. As a priority species in the UK Biodiversity Action Plan, it has national targets for population increase that are part of wider national environmental indicators. Previous research has indicated that brown hare declines have been greatest in pastural landscapes and that gains might be made by focussing conservation effort there. We therefore used hares in pastural landscapes to examine how basic changes in survey methodology can affect the precision of population density estimates and related these to national targets for biodiversity conservation in the UK. Line transects for hares carried out at night resulted in higher numbers of detections, had better-fitting detection functions and provided more robust density estimates with lower effort than those during the day, due primarily to the increased probability of detection of hares at night and the nature of hare responses to the observer. Hare spring densities varied widely within a single region, with a pooled mean of 20.6 hares km 22, significantly higher than the reported national average of hares in pastures of 3.3 hares km(-2). The high number of encounters allowed us to resolve hare densities at site, season and year scales. We demonstrate how survey conduct can impact on data quantity and quality with implications for setting and monitoring biodiversity targets. Our case study of the brown hare provides evidence that for wildlife species with low detectability, large scale volunteer-based monitoring programmes, either species specific or generalist, might be more successfully and efficiently carried out by a small number of trained personnel able to employ methods that maximise detectability.	[Petrovan, Silviu O.; Wheeler, Philip] Univ Hull, Ctr Environm & Marine Sci, Scarborough, N Yorkshire, England; [Petrovan, Silviu O.; Ward, Alastair I.] Food & Environm Res Agcy, York, N Yorkshire, England	University of Hull; Food & Environment Research Agency	Petrovan, SO (corresponding author), Univ Hull, Ctr Environm & Marine Sci, Scarborough Campus, Scarborough, N Yorkshire, England.	s.petrovan@hull.ac.uk	Ward, Alastair/J-5616-2014; Petrovan, Silviu/AAZ-9299-2021; Petrovan, Silviu/ADM-9976-2022	Petrovan, Silviu/0000-0002-3984-2403; Petrovan, Silviu/0000-0002-3984-2403; Wheeler, Philip/0000-0002-2056-6605; Ward, Alastair/0000-0002-3305-3323	University of Hull, United Kingdom	University of Hull, United Kingdom	The sole funder of this work was the University of Hull, United Kingdom, through a research studentship to SP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES RFW, 1985, J ZOOL, V206, P273, DOI 10.1111/j.1469-7998.1985.tb05653.x; Battersby, 2005, UK MAMMALS SPECIES S; BROWNE SJ, 2003, ARABLE STEWARDSHIP I; Buckland S.T., 2001, pi; Cowan D., 2004, OVERVIEW CURRENT STA; Fewster RM, 2009, BIOMETRICS, V65, P225, DOI 10.1111/j.1541-0420.2008.01018.x; Field SA, 2007, AUSTRAL ECOL, V32, P485, DOI 10.1111/j.1442-9993.2007.01715.x; Heydon MJ, 2000, J ZOOL, V251, P253, DOI 10.1111/j.1469-7998.2000.tb00608.x; HOLLEY AJF, 2001, MAMM BIOL, V66, P1; Hutchings MR, 1995, J ZOOL, V237, P663, DOI 10.1111/j.1469-7998.1995.tb05023.x; Hutchings MR, 1996, CURRENT STATUS BROWN; Jackson AL, 2008, BIOL CONSERV, V141, P2932, DOI 10.1016/j.biocon.2008.09.002; Jensen C., 2017, VELFAERD; Langbein J, 1999, MAMMAL REV, V29, P93, DOI 10.1046/j.1365-2907.1999.00040.x; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Marboutin E, 1995, J APPL ECOL, V32, P809, DOI 10.2307/2404820; Marques TA, 2010, BIOMETRICS, V66, P1247, DOI 10.1111/j.1541-0420.2009.01381.x; McLaren G. W., 1997, Gibier Faune Sauvage, V14, P335; MONAGHAN P, 1985, ANIM BEHAV, V33, P993, DOI 10.1016/S0003-3472(85)80033-6; Newey S, 2003, WILDLIFE BIOL, V9, P185, DOI 10.2981/wlb.2003.049; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Petrovan SO, 2011, EUR J WILDLIFE RES, V57, P27, DOI 10.1007/s10344-010-0394-9; Reid N, 2007, IRISH WILDLIFE MANUA, V30; Reid N, 2007, J APPL ECOL, V44, P1200, DOI 10.1111/j.1365-2664.2007.01336.x; Reynolds JC, 2010, EUR J WILDLIFE RES, V56, P541, DOI 10.1007/s10344-009-0355-3; Risely K., 2009, 537 BTO; Sauer J.R., 2008, N AM BREEDING BIRD S; Smith RK, 2005, MAMMAL REV, V35, P1, DOI 10.1111/j.1365-2907.2005.00057.x; Smith RK, 2004, J APPL ECOL, V41, P1092, DOI 10.1111/j.0021-8901.2004.00976.x; TAPPER S, 1984, MAMMAL REV, V14, P57, DOI 10.1111/j.1365-2907.1984.tb00339.x; TAPPER SC, 1986, J APPL ECOL, V23, P39, DOI 10.2307/2403079; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; *UK BAP, 1995, BIOD UK ACT PLAN; van Swaay CAM, 2008, BIODIVERS CONSERV, V17, P3455, DOI 10.1007/s10531-008-9491-4; Vaughan N, 2003, J APPL ECOL, V40, P163, DOI 10.1046/j.1365-2664.2003.00784.x	35	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24206	10.1371/journal.pone.0024206	http://dx.doi.org/10.1371/journal.pone.0024206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980343	Green Published, Green Submitted, gold			2022-12-25	WOS:000295933700004
J	Roy, SK; Chen, QH; Fu, JS; Shankar, S; Srivastava, RK				Roy, Sanjit K.; Chen, Qinghe; Fu, Junsheng; Shankar, Sharmila; Srivastava, Rakesh K.			Resveratrol Inhibits Growth of Orthotopic Pancreatic Tumors through Activation of FOXO Transcription Factors	PLOS ONE			English	Article							CELL-SURVIVAL; KINASE; ANGIOGENESIS; CANCER; AKT; SULFORAPHANE; POLYPHENOLS; MECHANISMS; PATHWAY; GENES	Background: The forkhead transcription factors of the O class (FOXO) play a direct role in cellular proliferation, oxidative stress response, and tumorigenesis. The objectives of this study were to examine whether FOXOs regulate antitumor activities of resveratrol in pancreatic cancer cells in vitro and in vivo. Methodology/Principal Findings: Pancreatic cancer cell lines were treated with resveratrol. Cell viability, colony formation, apoptosis and cell cycle were measured by XTT, soft agar, TUNEL and flow cytometry assays, respectively. FOXO nuclear translocation, DNA binding and transcriptional activities were measured by fluorescence technique, gelshift and luciferase assay, respectively. Mice were orthotopically implanted with PANC1 cells and orally gavaged with resveratrol. The components of PI3K and ERK pathways, FOXOs and their target gene expressions were measured by the Western blot analysis. Resveratrol inhibited cell viability and colony formations, and induced apoptosis through caspase-3 activation in four pancreatic cancer cell lines (PANC-1, MIA PaCa-2, Hs766T, and AsPC-1). Resveratrol induced cell cycle arrest by up-regulating the expression of p21/CIP1, p27/KIP1 and inhibiting the expression of cyclin D1. Resveratrol induced apoptosis by up-regulating Bim and activating caspase-3. Resveratrol inhibited phosphorylation of FOXOs, and enhanced their nuclear translocation, FOXO-DNA binding and transcriptional activities. The inhibition of PI3K/AKT and MEK/ERK pathways induced FOXO transcriptional activity and apoptosis. Furthermore, deletion of FOXO genes abrogated resveratrol-induced cell cycle arrest and apoptosis. Finally, resveratrol-treated mice showed significant inhibition in tumor growth which was associated with reduced phosphorylation of ERK, PI3K, AKT, FOXO1 and FOXO3a, and induction of apoptosis and FOXO target genes. Conclusions: These data suggest that inhibition of ERK and AKT pathways act together to activate FOXO transcription factors which are involved in resveratrol-mediated pancreatic tumor growth suppression.	[Roy, Sanjit K.; Chen, Qinghe; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut & Med, Ctr Canc, Kansas City, KS 66103 USA; [Fu, Junsheng; Shankar, Sharmila] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Ctr Canc, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Roy, SK (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut & Med, Ctr Canc, Kansas City, KS 66103 USA.	rsrivastava@kumc.edu						Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; BOKOCH GM, 1993, FASEB J, V7, P750, DOI 10.1096/fasebj.7.9.8330683; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cappellini A, 2003, LEUKEMIA, V17, P2157, DOI 10.1038/sj.leu.2403111; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Daitoku H, 2007, J BIOCHEM, V141, P769, DOI 10.1093/jb/mvm104; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davis R, 2009, ONCOL REP, V22, P1473, DOI 10.3892/or_00000589; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Boer VCJ, 2006, MECH AGEING DEV, V127, P618, DOI 10.1016/j.mad.2006.02.007; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gold E B, 1998, Surg Oncol Clin N Am, V7, P67; Han J, 1999, NAT CELL BIOL, V1, pE39, DOI 10.1038/10032; Harikumar Kuzhuvelil B, 2010, Int J Cancer, V127, P257, DOI 10.1002/ijc.25041; Hruban RH, 2001, J GASTROINTEST SURG, V5, P583, DOI 10.1016/S1091-255X(01)80099-8; Hutzen B, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-24; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kallifatidis G, 2008, GUT; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Li DH, 2001, CANCER J, V7, P259; LUBINUS M, 1994, J BIOL CHEM, V269, P9822; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; McKenna S, 2003, ONCOLOGIST, V8, P149, DOI 10.1634/theoncologist.8-2-149; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Shankar S, 2008, CLIN CANCER RES, V14, P1; Shankar Sharmila, 2008, J Mol Signal, V3, P7, DOI 10.1186/1750-2187-3-7; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4881, DOI 10.2741/2435; Shankar S, 2008, FRONT BIOSCI-LANDMRK, V13, P440, DOI 10.2741/2691; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4839, DOI 10.2741/2432; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; Srivastava RK, 2010, MOL CELL BIOCHEM, V337, P201, DOI 10.1007/s11010-009-0300-5; Srivastava Rakesh K., 2000, Molecular Cell Biology Research Communications, V4, P67, DOI 10.1006/mcbr.2001.0265; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167	44	102	107	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25166	10.1371/journal.pone.0025166	http://dx.doi.org/10.1371/journal.pone.0025166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980390	Green Published, Green Submitted, gold			2022-12-25	WOS:000295933700019
J	Midkiff, J; Borochoff-Porte, N; White, D; Johnson, DI				Midkiff, John; Borochoff-Porte, Nathan; White, Dylan; Johnson, Douglas I.			Small Molecule Inhibitors of the Candida albicans Budded-to-Hyphal Transition Act through Multiple Signaling Pathways	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; FILAMENTOUS GROWTH; GENE-EXPRESSION; FATTY-ACIDS; KINASE; MORPHOGENESIS; ACTIVATION; VIRULENCE; EFG1; TRANSDUCTION	The ability of the pathogenic yeast Candida albicans to interconvert between budded and hyphal growth states, herein termed the budded-to-hyphal transition (BHT), is important for C. albicans development and virulence. The BHT is under the control of multiple cell signaling pathways that respond to external stimuli, including nutrient availability, high temperature, and pH. Previous studies identified 21 small molecules that could inhibit the C. albicans BHT in response to carbon limitation in Spider media. However, the studies herein show that the BHT inhibitors had varying efficacies in other hyphal-inducing media, reflecting their varying abilities to block signaling pathways associated with the different media. Chemical epistasis analyses suggest that most, but not all, of the BHT inhibitors were acting through either the Efg1 or Cph1 signaling pathways. Notably, the BHT inhibitor clozapine, a FDA-approved drug used to treat atypical schizophrenia by inhibiting G-protein-coupled dopamine receptors in the brain, and several of its functional analogs were shown to act at the level of the Gpr1 G-protein-coupled receptor. These studies are the first step in determining the target and mechanism of action of these BHT inhibitors, which may have therapeutic anti-fungal utility in the future.	[Midkiff, John; Borochoff-Porte, Nathan; White, Dylan; Johnson, Douglas I.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont	Midkiff, J (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	Douglas.Johnson@uvm.edu			Vermont Experiment Station [VT-H01308]	Vermont Experiment Station	This research was supported by USDA-Hatch grant VT-H01308 from the Vermont Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem MAS, 2005, J MED MICROBIOL, V54, P1001, DOI 10.1099/jmm.0.46172-0; Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Barrington RE, 1998, MOL CELL BIOL, V18, P85, DOI 10.1128/MCB.18.1.85; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Biswas S, 2003, MICROBIOL-SGM, V149, P2597, DOI 10.1099/mic.0.26215-0; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Bockmuhl DP, 2001, GENETICS, V157, P1523; Braun BR, 2000, GENETICS, V155, P57; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Brown Alistair J. P., 2002, P87; Brown Alistair J. P., 2002, P95; CHIOU CY, 1975, BRIT J PHARMACOL, V53, P279, DOI 10.1111/j.1476-5381.1975.tb07359.x; CHO H, 1991, J MED CHEM, V34, P1503, DOI 10.1021/jm00108a039; Cottier F, 2009, FEMS MICROBIOL LETT, V295, P1, DOI 10.1111/j.1574-6968.2009.01564.x; COX DA, 1993, J CARDIOVASC PHARM, V21, P595, DOI 10.1097/00005344-199304000-00013; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Davis-Hanna A, 2008, MOL MICROBIOL, V67, P47, DOI 10.1111/j.1365-2958.2007.06013.x; DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Han TL, 2011, FUNGAL GENET BIOL, V48, P747, DOI 10.1016/j.fgb.2011.04.002; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; INAGAKI M, 1986, MOL PHARMACOL, V29, P577; Kadosh D, 2001, MOL CELL BIOL, V21, P2496, DOI 10.1128/MCB.21.7.2496-2505.2001; KAWAMOTO S, 1984, BIOCHEM BIOPH RES CO, V125, P258, DOI 10.1016/S0006-291X(84)80362-9; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kohler JR, 1996, P NATL ACAD SCI USA, V93, P13223, DOI 10.1073/pnas.93.23.13223; Kumamoto CA, 2008, CURR OPIN MICROBIOL, V11, P325, DOI 10.1016/j.mib.2008.05.008; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Lane S, 2001, MOL CELL BIOL, V21, P6418, DOI 10.1128/MCB.21.19.6418-6428.2001; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Maccarrone M, 2000, EUR J BIOCHEM, V267, P5078, DOI 10.1046/j.1432-1327.2000.01564.x; Maidan MM, 2005, BIOCHEM SOC T, V33, P291, DOI 10.1042/BST0330291; Maidan MM, 2005, MOL BIOL CELL, V16, P1971, DOI 10.1091/mbc.E04-09-0780; Miwa T, 2004, EUKARYOT CELL, V3, P919, DOI 10.1128/EC.3.4.919-931.2004; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Noverr MC, 2003, CLIN MICROBIOL REV, V16, P517, DOI 10.1128/CMR.16.3.517-533.2003; Sanchez-Martinez C, 2002, EUKARYOT CELL, V1, P865, DOI 10.1128/EC.1.6.865-874.2002; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Schweizer A, 2000, MOL MICROBIOL, V38, P435, DOI 10.1046/j.1365-2958.2000.02132.x; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Sharkey LL, 1999, J BACTERIOL, V181, P5273, DOI 10.1128/JB.181.17.5273-5279.1999; Sherman F., 1986, METHODS YEAST GENETI; Singh A, 2011, CELL MICROBIOL, V13, P177, DOI 10.1111/j.1462-5822.2010.01550.x; Singh P, 2001, INFECT IMMUN, V69, P7898, DOI 10.1128/IAI.69.12.7898-7903.2001; Sonneborn A, 2000, MOL MICROBIOL, V35, P386, DOI 10.1046/j.1365-2958.2000.01705.x; Staab JF, 2003, MICROBIOL-SGM, V149, P2977, DOI 10.1099/mic.0.26445-0; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Takami M, 2000, AM J PHYSIOL-CELL PH, V278, pC646, DOI 10.1152/ajpcell.2000.278.4.C646; Toenjes KA, 2005, ANTIMICROB AGENTS CH, V49, P963, DOI 10.1128/AAC.49.3.963-972.2005; Toenjes KA, 2009, J MED MICROBIOL, V58, P779, DOI 10.1099/jmm.0.006841-0; VERCESI AE, 1993, J BIOL CHEM, V268, P8564; Warnock David W, 2007, Nihon Ishinkin Gakkai Zasshi, V48, P1, DOI 10.3314/jjmm.48.1; YECIES LD, 1979, J IMMUNOL, V122, P2083	66	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25395	10.1371/journal.pone.0025395	http://dx.doi.org/10.1371/journal.pone.0025395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966518	gold, Green Submitted, Green Published			2022-12-25	WOS:000295932100037
J	Singh, B; Bhat, NK; Bhat, HK				Singh, Bhupendra; Bhat, Nimee K.; Bhat, Hari K.			Partial Inhibition of Estrogen-Induced Mammary Carcinogenesis in Rats by Tamoxifen: Balance between Oxidant Stress and Estrogen Responsiveness	PLOS ONE			English	Article							FEMALE ACI RATS; DNA-FRAGMENTATION-FACTOR; CONTAINING MONOOXYGENASE FMO; HUMAN LIVER-MICROSOMES; DUCTAL BREAST-CANCER; OXIDATIVE STRESS; ANTIESTROGEN RESISTANCE; RECEPTOR MODULATORS; CATECHOL QUINONES; SYRIAN-HAMSTERS	Epidemiological and experimental evidences strongly support the role of estrogens in breast tumor development. Both estrogen receptor (ER)-dependent and ER-independent mechanisms are implicated in estrogen-induced breast carcinogenesis. Tamoxifen, a selective estrogen receptor modulator is widely used as chemoprotectant in human breast cancer. It binds to ERs and interferes with normal binding of estrogen to ERs. In the present study, we examined the effect of long-term tamoxifen treatment in the prevention of estrogen-induced breast cancer. Female ACI rats were treated with 17 beta-estradiol (E2), tamoxifen or with a combination of E2 and tamoxifen for eight months. Tissue levels of oxidative stress markers 8-iso-Prostane F-2 alpha (8-isoPGF(2 alpha)), superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase, and oxidative DNA damage marker 8-hydroxydeoxyguanosine (8-OHdG) were quantified in the mammary tissues of all the treatment groups and compared with age-matched controls. Levels of tamoxifen metabolizing enzymes cytochrome P450s as well as estrogen responsive genes were also quantified. At necropsy, breast tumors were detected in 44% of rats co-treated with tamoxifen+E2. No tumors were detected in the sham or tamoxifen only treatment groups whereas in the E2 only treatment group, the tumor incidence was 82%. Co-treatment with tamoxifen decreased GPx and catalase levels; did not completely inhibit E2-mediated oxidative DNA damage and estrogen-responsive genes monoamine oxygenase B1 (MaoB1) and cell death inducing DFF45 like effector C (Cidec) but differentially affected the levels of tamoxifen metabolizing enzymes. In summary, our studies suggest that although tamoxifen treatment inhibits estrogen-induced breast tumor development and increases the latency of tumor development, it does not completely abrogate breast tumor development in a rat model of estrogen-induced breast cancer. The inability of tamoxifen to completely inhibit E2-induced breast carcinogenesis may be because of increased estrogen-mediated oxidant burden.	[Singh, Bhupendra; Bhat, Nimee K.; Bhat, Hari K.] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Singh, B (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA.	bhath@umkc.edu	Singh, Bhupendra/E-7691-2013		National Institutes of Health [CA 109551]; NATIONAL CANCER INSTITUTE [R01CA109551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant CA 109551 to HKB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnerlov C, 2001, ANAL CELL PATHOL, V23, P21, DOI 10.1155/2001/430674; Bhat HK, 2004, J STEROID BIOCHEM, V92, P391, DOI 10.1016/j.jsbmb.2004.07.009; Bhat HK, 2003, P NATL ACAD SCI USA, V100, P3913, DOI 10.1073/pnas.0437929100; BHAT HK, 1993, CANCER RES, V53, P5447; Boocock DJ, 2002, CARCINOGENESIS, V23, P1897, DOI 10.1093/carcin/23.11.1897; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CARTHEW P, 1995, CANCER RES, V55, P544; Cavalieri EL, 2004, ANN NY ACAD SCI, V1028, P247, DOI 10.1196/annals.1322.029; Cavalieri E, 2006, ANN NY ACAD SCI, V1089, P286, DOI 10.1196/annals.1386.042; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Clark AS, 2002, MOL CANCER THER, V1, P707; Clarke M, 1998, LANCET, V351, P1451; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; CRESPI CL, 1991, CHEM RES TOXICOL, V4, P566, DOI 10.1021/tx00023a013; Dehal SS, 1997, CANCER RES, V57, P3402; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; HAN XL, 1992, CANCER RES, V52, P1360; HAN XL, 1994, CARCINOGENESIS, V15, P997, DOI 10.1093/carcin/15.5.997; Harvell DME, 2000, P NATL ACAD SCI USA, V97, P2779, DOI 10.1073/pnas.050569097; Hu Y, 2003, XENOBIOTICA, V33, P141, DOI 10.1080/0049825021000042733; Huang X, 2001, FREE RADICAL BIO MED, V31, P1341, DOI 10.1016/S0891-5849(01)00681-5; *IARC, 1999, IARC MON EV CARC RIS, V72, P474; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Kariagina Anastasia, 2010, Hormones & Cancer, V1, P229, DOI 10.1007/s12672-010-0048-0; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Krueger SK, 2006, DRUG METAB REV, V38, P139, DOI 10.1080/03602530600569919; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; Li JJ, 2002, MOL CARCINOGEN, V33, P56, DOI 10.1002/mc.10022; Li JJ, 2004, P NATL ACAD SCI USA, V101, P18123, DOI 10.1073/pnas.0408273101; LI JJ, 1987, FED PROC, V46, P1858; Li SA, 2002, J ENDOCRINOL, V175, P297, DOI 10.1677/joe.0.1750297; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; LIEHR JG, 1986, J STEROID BIOCHEM, V24, P353, DOI 10.1016/0022-4731(86)90080-4; LIEHR JG, 1990, FREE RADICAL BIO MED, V8, P415, DOI 10.1016/0891-5849(90)90108-U; LIM CK, 1994, CARCINOGENESIS, V15, P589, DOI 10.1093/carcin/15.4.589; Lundholm L, 2008, J ENDOCRINOL, V196, P547, DOI 10.1677/JOE-07-0277; Makris A, 1997, BREAST CANCER RES TR, V44, P65, DOI 10.1023/A:1005717924761; MARKLUND S, 1980, ACTA PHYSIOL SCAND, P19; Mense SM, 2008, TOXICOL APPL PHARM, V232, P78, DOI 10.1016/j.taap.2008.06.007; Mense SM, 2009, CARCINOGENESIS, V30, P1202, DOI 10.1093/carcin/bgp093; Mobley JA, 2004, CARCINOGENESIS, V25, P3, DOI 10.1093/carcin/bgg175; Montano MM, 2007, ONCOGENE, V26, P3587, DOI 10.1038/sj.onc.1210144; Mukherjee S, 2005, J BIOL CHEM, V280, P17617, DOI 10.1074/jbc.M502278200; Parte P, 2005, DRUG METAB DISPOS, V33, P1446, DOI 10.1124/dmd.104.000802; Patel MM, 2004, J BIOCHEM MOL TOXIC, V18, P37, DOI 10.1002/jbt.20005; Pedram A, 2002, J BIOL CHEM, V277, P50768, DOI 10.1074/jbc.M210106200; PHILLIPS DH, 1994, CANCER RES, V54, P5518; Riggins RB, 2005, VITAM HORM, V71, P201, DOI 10.1016/S0083-6729(05)71007-4; Riggins RB, 2008, CANCER RES, V68, P8908, DOI 10.1158/0008-5472.CAN-08-2669; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; SEOUD MAF, 1993, OBSTET GYNECOL, V82, P165; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Shull JD, 1997, CARCINOGENESIS, V18, P1595, DOI 10.1093/carcin/18.8.1595; Singh B, 2010, TOXICOL APPL PHARM, V247, P83, DOI 10.1016/j.taap.2010.06.011; Singh B, 2009, J BIOCHEM MOL TOXIC, V23, P202, DOI 10.1002/jbt.20281; STYLES JA, 1994, CARCINOGENESIS, V15, P5, DOI 10.1093/carcin/15.1.5; Umemoto A, 2000, CARCINOGENESIS, V21, P1737, DOI 10.1093/carcin/21.9.1737; Vitseva O, 2005, J PHARMACOL EXP THER, V312, P1144, DOI 10.1124/jpet.104.076315; von Mach-Szczypinski J, 2009, METABOLISM, V58, P867, DOI 10.1016/j.metabol.2009.02.011; Weroha SJ, 2006, CARCINOGENESIS, V27, P491, DOI 10.1093/carcin/bgi278; WILSON AJ, 1985, WORLD J SURG, V9, P756, DOI 10.1007/BF01655191; Yager J D, 2000, J Natl Cancer Inst Monogr, P67; Zhang ZP, 2006, MOL ENDOCRINOL, V20, P1547, DOI 10.1210/me.2005-0252	68	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25125	10.1371/journal.pone.0025125	http://dx.doi.org/10.1371/journal.pone.0025125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966433	gold, Green Published, Green Submitted			2022-12-25	WOS:000295932100019
J	Meshki, J; Douglas, SD; Hu, MY; Leeman, SE; Tuluc, F				Meshki, John; Douglas, Steven D.; Hu, Mingyue; Leeman, Susan E.; Tuluc, Florin			Substance P Induces Rapid and Transient Membrane Blebbing in U373MG Cells in a p21-Activated Kinase-Dependent Manner	PLOS ONE			English	Article							NEUROKININ-1 RECEPTOR; TACHYKININ RECEPTOR; PAK; NEUROPEPTIDES; INFLAMMATION; ACTIVATION; EXPRESSION; DISORDERS; MECHANISM; GEF-H1	U373MG astrocytoma cells endogenously express the full-length neurokinin 1 receptor (NK1R). Substance P (SP), the natural ligand for NK1R, triggers rapid and transient membrane blebbing and we report that these morphological changes have different dynamics and intracellular signaling as compared to the changes that we have previously described in HEK293-NK1R cells. In both cell lines, the SP-induced morphological changes are Gq-independent, and they require the Rho, Rho-associated coiled-coil kinase (ROCK) signaling pathway. Using confocal microscopy we have demonstrated that tubulin is phosphorylated subsequent to cell stimulation with SP and that tubulin accumulates inside the blebs. Colchicine, a tubulin polymerization inhibitor, blocked SP-induced blebbing in U373MG but not in HEK293-NK1R cells. Although p21-activated kinase (PAK) is expressed in both cell lines, SP induced rapid phosphorylation of PAK in U373MG, but failed to phosphorylate PAK in HEK293-NK1R cells. The cell-permeable Rho inhibitor C3 transferase inhibited SP-induced PAK phosphorylation, but the ROCK inhibitor Y27632 had no effect on PAK phosphorylation, suggesting that Rho activates PAK in a ROCK-independent manner. Our study demonstrates that SP triggers rapid changes in cell morphology mediated by distinct intracellular signaling mechanisms in U373MG versus HEK293-NK1R cells.	[Meshki, John; Douglas, Steven D.; Hu, Mingyue; Tuluc, Florin] Childrens Hosp Philadelphia, Res Inst, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Douglas, Steven D.; Tuluc, Florin] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Tuluc, Florin] Childrens Hosp Philadelphia, Res Inst, Flow Cytometry Core Lab, Philadelphia, PA 19104 USA; [Leeman, Susan E.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Boston University	Meshki, J (corresponding author), Childrens Hosp Philadelphia, Res Inst, Div Allergy & Immunol, Philadelphia, PA 19104 USA.	tuluc@email.chop.edu	Tuluc, Petronel/C-2527-2011	Leeman, Susan/0000-0002-0951-5364; Douglas, Steven/0000-0002-3748-3603	National Institutes of Health [U01MH090325, R01-MH049981, P01-MH076388]; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH076388, U01MH090325, R01MH049981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants U01MH090325, R01-MH049981 and P01-MH076388 (to SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Bahri S, 2010, DEVELOPMENT, V137, P2023, DOI 10.1242/dev.045088; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bost KL, 2004, FRONT BIOSCI-LANDMRK, V9, P3331, DOI 10.2741/1484; Brain SD, 1997, IMMUNOPHARMACOLOGY, V37, P133, DOI 10.1016/S0162-3109(97)00055-6; Chahl LA, 2006, CURR DRUG TARGETS, V7, P993, DOI 10.2174/138945006778019309; CHANG MM, 1970, J BIOL CHEM, V245, P4784; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Ebner K, 2006, AMINO ACIDS, V31, P251, DOI 10.1007/s00726-006-0335-9; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; FONG TM, 1992, MOL PHARMACOL, V41, P24; Goode T, 2000, CLIN DIAGN LAB IMMUN, V7, P371, DOI 10.1128/CDLI.7.3.371-376.2000; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEUILLET E, 1993, J NEUROCHEM, V60, P868, DOI 10.1111/j.1471-4159.1993.tb03231.x; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Huebert RC, 2010, HEPATOLOGY, V52, P238, DOI 10.1002/hep.23628; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; KAGE R, 1993, J NEUROCHEM, V60, P347, DOI 10.1111/j.1471-4159.1993.tb05857.x; Kramer MS, 1998, SCIENCE, V281, P1640, DOI 10.1126/science.281.5383.1640; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Lai JP, 2006, P NATL ACAD SCI USA, V103, P7771, DOI 10.1073/pnas.0602563103; Lai JP, 2008, P NATL ACAD SCI USA, V105, P12605, DOI 10.1073/pnas.0806632105; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; LANIYONU A, 1988, FEBS LETT, V240, P186, DOI 10.1016/0014-5793(88)80365-X; Meshki J, 2009, J BIOL CHEM, V284, P9280, DOI 10.1074/jbc.M808825200; NICOLL RA, 1980, ANNU REV NEUROSCI, V3, P227, DOI 10.1146/annurev.ne.03.030180.001303; OBLAS B, 1990, BIOCHEM BIOPH RES CO, V166, P978, DOI 10.1016/0006-291X(90)90907-5; Palma C, 2006, CURR DRUG TARGETS, V7, P1043, DOI 10.2174/138945006778019282; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Rosenkranz MA, 2007, PSYCHOL BULL, V133, P1007, DOI 10.1037/0033-2909.133.6.1007; Satake H, 2006, CURR DRUG TARGETS, V7, P963, DOI 10.2174/138945006778019273; Svensson A, 2005, J IMMUNOL, V175, P6802, DOI 10.4049/jimmunol.175.10.6802; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Thorley JA, 2010, PROTOPLASMA, V244, P15, DOI 10.1007/s00709-010-0152-6; Tuluc F, 2009, TRENDS IMMUNOL, V30, P271, DOI 10.1016/j.it.2009.03.006; Vadlamudi RK, 2005, MOL CELL BIOL, V25, P3726, DOI 10.1128/MCB.25.9.3726-3736.2005; Walter BN, 1998, J BIOL CHEM, V273, P28733, DOI 10.1074/jbc.273.44.28733; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	47	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25332	10.1371/journal.pone.0025332	http://dx.doi.org/10.1371/journal.pone.0025332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966499	Green Published, gold, Green Submitted			2022-12-25	WOS:000295267100045
J	Molina-Lopez, RA; Casal, J; Darwich, L				Molina-Lopez, Rafael A.; Casal, Jordi; Darwich, Laila			Causes of Morbidity in Wild Raptor Populations Admitted at a Wildlife Rehabilitation Centre in Spain from 1995-2007: A Long Term Retrospective Study	PLOS ONE			English	Article							MORTALITY; OWLS; ADMISSIONS; VIRGINIA; BIRDS	Background: Morbidity studies complement the understanding of hazards to raptors by identifying natural or anthropogenic factors. Descriptive epidemiological studies of wildlife have become an important source of information about hazards to wildlife populations. On the other hand, data referenced to the overall wild population could provide a more accurate assessment of the potential impact of the morbidity/mortality causes in populations of wild birds. Methodology/Principal Findings: The present study described the morbidity causes of hospitalized wild raptors and their incidence in the wild populations, through a long term retrospective study conducted at a wildlife rehabilitation centre of Catalonia (1995-2007). Importantly, Seasonal Cumulative Incidences (SCI) were calculated considering estimations of the wild population in the region and trend analyses were applied among the different years. A total of 7021 birds were analysed: 7 species of Strigiformes (n = 3521) and 23 of Falconiformes (n = 3500). The main causes of morbidity were trauma (49.5%), mostly in the Falconiformes, and orphaned/young birds (32.2%) mainly in the Strigiformes. During wintering periods, the largest morbidity incidence was observed in Accipiter gentillis due to gunshot wounds and in Tyto alba due to vehicle trauma. Within the breeding season, Falco tinnunculus (orphaned/young category) and Bubo bubo (electrocution and metabolic disorders) represented the most affected species. Cases due to orphaned/young, infectious/parasitic diseases, electrocution and unknown trauma tended to increase among years. By contrast, cases by undetermined cause, vehicle trauma and captivity decreased throughout the study period. Interestingly, gunshot injuries remained constant during the study period. Conclusions/Significance: Frequencies of morbidity causes calculated as the proportion of each cause referred to the total number of admitted cases, allowed a qualitative assessment of hazards for the studied populations. However, cumulative incidences based on estimated wild raptor population provided a more accurate approach to the potential ecological impact of the morbidity causes in the wild populations.	[Molina-Lopez, Rafael A.] Ctr Fauna Salvatge Torreferrussa, Catalan Wildlife Serv, Forestal Catalana, Spain; [Molina-Lopez, Rafael A.; Casal, Jordi; Darwich, Laila] Univ Autonoma Barcelona, Fac Vet, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Casal, Jordi; Darwich, Laila] Campus Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim, UAB IRTA, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA	Molina-Lopez, RA (corresponding author), Ctr Fauna Salvatge Torreferrussa, Catalan Wildlife Serv, Forestal Catalana, Spain.		Casal, Jordi/F-3020-2016; Darwich, Laila/F-5330-2016	Casal, Jordi/0000-0002-6909-9366; Darwich, Laila/0000-0001-9027-9452; Molina Lopez, Rafael/0000-0002-9043-2346	Catalan Wildlife-Service and Forestal Catalana	Catalan Wildlife-Service and Forestal Catalana	The study has been supported by the Catalan Wildlife-Service and Forestal Catalana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker K, 1993, IDENTIFICATION GUIDE; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Burfield IJ, 2008, AMBIO, V37, P401, DOI 10.1579/0044-7447(2008)37[401:TCSATO]2.0.CO;2; Deem SL, 1998, J ZOO WILDLIFE MED, V29, P160; [Direccion General para la Biodiversidad Ministerio de Medio Ambiente], 2006, CAT NAC ESP AM 1990; Frias Oscar, 1999, Ardeola, V46, P23; Gonzalez LM, 2007, ORYX, V41, P495, DOI 10.1017/S0030605307414119; Guzman Jose, 1998, Ardeola, V45, P161; Harris MC, 2007, J ZOO WILDLIFE MED, V38, P62, DOI 10.1638/05-099.1; HERNANDEZ M, 1988, Journal of Raptor Research, V22, P81; Kelly A, 2006, J RAPTOR RES, V40, P231, DOI 10.3356/0892-1016(2006)40[231:ADAOFE]2.0.CO;2; Komnenou AT, 2005, J ZOO WILDLIFE MED, V36, P222, DOI 10.1638/04-061.1; Kovacs A, 2008, AMBIO, V37, P408, DOI 10.1579/0044-7447(2008)37[408:EMFRAO]2.0.CO;2; Manosa S, 2001, BIODIVERS CONSERV, V10, P1997, DOI 10.1023/A:1013129709701; MANOSA S, 2002, CONFLICT GAME UNPUB; Martinez Climent Jose Antonio, 2001, Biota (Race), V2, P163; Martinez JA, 2004, ARDEOLA, V51, P303; Martinez JA, 2006, BIRD CONSERV INT, V16, P265, DOI 10.1017/S0959270906000402; Morishita TY, 1998, J AVIAN MED SURG, V12, P78; Naldo JL, 2004, J AVIAN MED SURG, V18, P229, DOI 10.1647/2002-013; Newton I., 2002, P217, DOI 10.1002/9780470752319.ch14; Newton I, 1999, J ZOOL, V248, P139, DOI 10.1111/j.1469-7998.1999.tb01190.x; Real J, 2001, BIRD STUDY, V48, P221, DOI 10.1080/00063650109461221; Rodriguez B, 2010, J RAPTOR RES, V44, P30, DOI 10.3356/JRR-09-40.1; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sleeman Jonathan M., 2008, P97; Tinto A, 2010, J WILDLIFE MANAGE, V74, P1852, DOI 10.2193/2009-521; Wendell MD, 2002, J WILDLIFE DIS, V38, P101, DOI 10.7589/0090-3558-38.1.101	28	77	80	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e24603	10.1371/journal.pone.0024603	http://dx.doi.org/10.1371/journal.pone.0024603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966362	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100005
J	Singer, E; Emerson, D; Webb, EA; Barco, RA; Kuenen, JG; Nelson, WC; Chan, CS; Comolli, LR; Ferriera, S; Johnson, J; Heidelberg, JF; Edwards, KJ				singer, Esther; Emerson, David; Webb, Eric A.; Barco, Roman A.; Kuenen, J. Gijs; Nelson, William C.; Chan, Clara S.; Comolli, Luis R.; Ferriera, Steve; Johnson, Justin; Heidelberg, John F.; Edwards, Katrina J.			Mariprofundus ferrooxydans PV-1 the First Genome of a Marine Fe(II) Oxidizing Zetaproteobacterium	PLOS ONE			English	Article							CHEMOLITHOTROPH THIOBACILLUS-NEAPOLITANUS; GREEN-SULFUR BACTERIUM; DE-FUCA RIDGE; HYDROTHERMAL VENTS; ACIDITHIOBACILLUS-FERROOXIDANS; FERROUS IRON; INTRACELLULAR POLYGLUCOSE; MICROBIAL GENOMES; ELECTRON-TRANSFER; PURPLE BACTERIA	Mariprofundus ferrooxydans PV-1 has provided the first genome of the recently discovered Zetaproteobacteria subdivision. Genome analysis reveals a complete TCA cycle, the ability to fix CO2, carbon-storage proteins and a sugar phosphotransferase system (PTS). The latter could facilitate the transport of carbohydrates across the cell membrane and possibly aid in stalk formation, a matrix composed of exopolymers and/or exopolysaccharides, which is used to store oxidized iron minerals outside the cell. Two-component signal transduction system genes, including histidine kinases, GGDEF domain genes, and response regulators containing CheY-like receivers, are abundant and widely distributed across the genome. Most of these are located in close proximity to genes required for cell division, phosphate uptake and transport, exopolymer and heavy metal secretion, flagellar biosynthesis and pilus assembly suggesting that these functions are highly regulated. Similar to many other motile, microaerophilic bacteria, genes encoding aerotaxis as well as antioxidant functionality (e.g., superoxide dismutases and peroxidases) are predicted to sense and respond to oxygen gradients, as would be required to maintain cellular redox balance in the specialized habitat where M. ferrooxydans resides. Comparative genomics with other Fe(II) oxidizing bacteria residing in freshwater and marine environments revealed similar content, synteny, and amino acid similarity of coding sequences potentially involved in Fe( II) oxidation, signal transduction and response regulation, oxygen sensation and detoxification, and heavy metal resistance. This study has provided novel insights into the molecular nature of Zetaproteobacteria.	[singer, Esther; Edwards, Katrina J.] Univ So Calif, Geomicrobiol Grp, Dept Earth Sci, Los Angeles, CA 90095 USA; [Emerson, David] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA; [Webb, Eric A.; Barco, Roman A.; Nelson, William C.; Heidelberg, John F.; Edwards, Katrina J.] Univ So Calif, Dept Biol Sci, Marine Environm Biol Sect, Los Angeles, CA 90089 USA; [Kuenen, J. Gijs] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands; [Chan, Clara S.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Comolli, Luis R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Ferriera, Steve; Johnson, Justin] J Craig Venter Inst, San Diego, CA USA	University of Southern California; Bigelow Laboratory for Ocean Sciences; University of Southern California; Delft University of Technology; Woods Hole Oceanographic Institution; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; J. Craig Venter Institute	Singer, E (corresponding author), Univ So Calif, Geomicrobiol Grp, Dept Earth Sci, Los Angeles, CA 90095 USA.	kje@usc.edu	Chan, Clara S/B-6420-2011; Nelson, William C/E-9263-2016; Comolli, Luis Raul/C-5907-2017	Chan, Clara S/0000-0003-1810-4994; Nelson, William C/0000-0002-1873-3929; Singer, Esther/0000-0002-3126-2199; Comolli, Luis Raul/0000-0002-9313-6550; Heidelberg, John/0000-0003-0673-3224	NSF; Gordon and Betty Moore Foundation; College of Letters, Arts, and Sciences at the University of Southern California; NASA Astrobiology Institute; Office of Science, Basic Energy Sciences, Division of Materials Science of the United States Department of Energy [DE-AC02-05CH11231]	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); College of Letters, Arts, and Sciences at the University of Southern California; NASA Astrobiology Institute; Office of Science, Basic Energy Sciences, Division of Materials Science of the United States Department of Energy(United States Department of Energy (DOE))	Funding has been provided by the NSF Microbial Observatories Program (KJE, DE), NSF's Science and Technology Program, by the Gordon and Betty Moore Foundation (KJE), the College of Letters, Arts, and Sciences at the University of Southern California (KJE), and by the NASA Astrobiology Institute (KJE, DE). Advanced Light Source analyses at the Lawrence Berkeley National Lab are supported by the Office of Science, Basic Energy Sciences, Division of Materials Science of the United States Department of Energy (DE-AC02-05CH11231). This is the Center for Dark Energy Biosphere Investigations contribution #110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; BEUDEKER RF, 1981, ARCH MICROBIOL, V129, P221, DOI 10.1007/BF00425255; BEUDEKER RF, 1981, FEMS MICROBIOL LETT, V12, P337; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Chang C.-C., 2010, P 2010 INT JOINT C N, P1, DOI DOI 10.1109/ICC.2010.5502361; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Comolli LR, 2006, J MICROSC-OXFORD, V223, P40, DOI 10.1111/j.1365-2818.2006.01597.x; Croal LR, 2007, J BACTERIOL, V189, P1774, DOI 10.1128/JB.01395-06; Croal LR, 2004, ANNU REV GENET, V38, P175, DOI 10.1146/annurev.genet.38.072902.091138; Davis R, 2005, AGU FALL M SAN FRANC; Dhillon A, 2003, APPL ENVIRON MICROB, V69, P2765, DOI 10.1128/AEM.69.5.2765-2772.2003; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; Drummond AJ, 2010, GENEIOUS; Druschel GK, 2008, GEOCHIM COSMOCHIM AC, V72, P3358, DOI 10.1016/j.gca.2008.04.035; Eder W, 2001, APPL ENVIRON MICROB, V67, P3077, DOI 10.1128/AEM.67.7.3077-3085.2001; Edwards KJ, 2011, ISME J; EHRENREICH A, 1994, APPL ENVIRON MICROB, V60, P4517, DOI 10.1128/AEM.60.12.4517-4526.1994; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Elbehti A, 2000, J BACTERIOL, V182, P3602, DOI 10.1128/JB.182.12.3602-3606.2000; Emerson D, 2005, METHOD ENZYMOL, V397, P112, DOI 10.1016/S0076-6879(05)97006-7; Emerson D, 1997, APPL ENVIRON MICROB, V63, P4784, DOI 10.1128/AEM.63.12.4784-4792.1997; Emerson D, 2002, APPL ENVIRON MICROB, V68, P3085, DOI 10.1128/AEM.68.6.3085-3093.2002; Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667; Emerson D, 2010, OCEANOGRAPHY, V23, P148, DOI 10.5670/oceanog.2010.67; Forget NL, 2010, GEOBIOLOGY, V8, P417, DOI 10.1111/j.1472-4669.2010.00247.x; FRANCIS RT, 1984, ANAL BIOCHEM, V136, P509, DOI 10.1016/0003-2697(84)90253-7; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Glazer BT, 2009, GEOMICROBIOL J, V26, P606, DOI 10.1080/01490450903263392; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; GOMMERS PJF, 1988, ARCH MICROBIOL, V150, P117, DOI 10.1007/BF00425150; GORBY YA, 1991, APPL ENVIRON MICROB, V57, P867, DOI 10.1128/AEM.57.3.867-870.1991; Gottschalk G., 1986, BACTERIAL METABOLISM; GUAY R, 1977, BIOTECHNOL BIOENG, V19, P727, DOI 10.1002/bit.260190509; Haber F, 1932, NATURWISSENSCHAFTEN, V20, P948, DOI 10.1007/BF01504715; Heising S, 1999, ARCH MICROBIOL, V172, P116, DOI 10.1007/s002030050748; Hernandez JM, 1996, J BACTERIOL, V178, P347, DOI 10.1128/jb.178.2.347-356.1996; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; Jiao Y, 2007, J BACTERIOL, V189, P1765, DOI 10.1128/JB.00776-06; Kappler A, 2004, GEOCHIM COSMOCHIM AC, V68, P1217, DOI 10.1016/j.gca.2003.09.006; Kato S, 2009, ENVIRON MICROBIOL, V11, P3210, DOI 10.1111/j.1462-2920.2009.02031.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kennedy CB, 2003, GEOMICROBIOL J, V20, P199, DOI 10.1080/01490450303873; Kulajta C, 2006, J MOL BIOL, V355, P989, DOI 10.1016/j.jmb.2005.11.039; LANDER E S, 1988, Genomics, V2, P231; LAZAROFF N, 1982, APPL ENVIRON MICROB, V43, P924, DOI 10.1128/AEM.43.4.924-938.1982; Li XZ, 2009, J BACTERIOL, V191, P2675, DOI 10.1128/JB.01814-08; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Mahmoud KK, 2005, J MICROBIOL METH, V61, P33, DOI 10.1016/j.mimet.2004.10.022; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; McBeth JM, 2011, APPL ENVIRON MICROB, V77, P1405, DOI 10.1128/AEM.02095-10; MCFADDEN BA, 1973, BACTERIOL REV, V37, P289, DOI 10.1128/MMBR.37.3.289-319.1973; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Omata T, 1999, P NATL ACAD SCI USA, V96, P13571, DOI 10.1073/pnas.96.23.13571; OREN A, 1979, ARCH MICROBIOL, V122, P77, DOI 10.1007/BF00408049; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Rassa AC, 2009, GEOMICROBIOL J, V26, P623, DOI 10.1080/01490450903263350; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Scott KM, 2006, PLOS BIOL, V4, P2196, DOI 10.1371/journal.pbio.0040383; Shi L, 2008, J BACTERIOLOGY; Shi LA, 2009, ENV MICROBIOL REP, V1, P220, DOI 10.1111/j.1758-2229.2009.00035.x; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Staudigel H, 2006, P NATL ACAD SCI USA, V103, P6448, DOI 10.1073/pnas.0600830103; Straub K, 2001, FEMS MICROBIOLOGY EC; TABITA FR, 1995, ADV PHOTOSYNTH, V2, P885; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Toner BM, 2009, GEOCHIM COSMOCHIM AC, V73, P388, DOI 10.1016/j.gca.2008.09.035; Weber KA, 2006, APPL ENVIRON MICROB, V72, P686, DOI 10.1128/AEM.72.1.686-694.2006; WIDDEL F, 1993, NATURE, V362, P834, DOI 10.1038/362834a0; Yanyushin MF, 2005, BIOCHEMISTRY-US, V44, P10037, DOI 10.1021/bi047267l; Yarzabal A, 2002, FEMS MICROBIOL LETT, V209, P189, DOI 10.1016/S0378-1097(02)00514-1; Yarzabal A, 2002, J BACTERIOL, V184, P313, DOI 10.1128/JB.184.1.313-317.2002; Zufferey R, 1996, J BIOL CHEM, V271, P9114, DOI 10.1074/jbc.271.15.9114	76	104	107	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25386	10.1371/journal.pone.0025386	http://dx.doi.org/10.1371/journal.pone.0025386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966516	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100053
J	Drwal, MN; Agama, K; Wakelin, LPG; Pommier, Y; Griffith, R				Drwal, Malgorzata N.; Agama, Keli; Wakelin, Laurence P. G.; Pommier, Yves; Griffith, Renate			Exploring DNA Topoisomerase I Ligand Space in Search of Novel Anticancer Agents	PLOS ONE			English	Article							PLANT ANTITUMOR AGENTS; CAMPTOTHECIN RESISTANCE; DRUG DISCOVERY; INHIBITORS; NORINDENOISOQUINOLINE; DERIVATIVES; MECHANISM; DESIGN; ORIENTATION; FLAVONOIDS	DNA topoisomerase I (Top1) is over-expressed in tumour cells and is an important target in cancer chemotherapy. It relaxes DNA torsional strain generated during DNA processing by introducing transient single-strand breaks and allowing the broken strand to rotate around the intermediate Top1 -DNA covalent complex. This complex can be trapped by a group of anticancer agents interacting with the DNA bases and the enzyme at the cleavage site, preventing further topoisomerase activity. Here we have identified novel Top1 inhibitors as potential anticancer agents by using a combination of structure- and ligand-based molecular modelling methods. Pharmacophore models have been developed based on the molecular characteristics of derivatives of the alkaloid camptothecin (CPT), which represent potent antitumour agents and the main group of Top1 inhibitors. The models generated were used for in silico screening of the National Cancer Institute (NCI, USA) compound database, leading to the identification of a set of structurally diverse molecules. The strategy is validated by the observation that amongst these molecules are several known Top1 inhibitors and agents cytotoxic against human tumour cell lines. The potential of the untested hits to inhibit Top1 activity was further evaluated by docking into the binding site of a Top1 -DNA complex, resulting in a selection of 10 compounds for biological testing. Limited by the compound availability, 7 compounds have been tested in vitro for their Top1 inhibitory activity, 5 of which display mild to moderate Top1 inhibition. A further compound, found by similarity search to the active compounds, also shows mild activity. Although the tested compounds display only low in vitro antitumour activity, our approach has been successful in the identification of structurally novel Top1 inhibitors worthy of further investigation as potential anticancer agents.	[Drwal, Malgorzata N.; Wakelin, Laurence P. G.; Griffith, Renate] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia; [Agama, Keli; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	University of New South Wales Sydney; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Drwal, MN (corresponding author), Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia.	r.griffith@unsw.edu.au	Drwal, Malgorzata/B-6461-2015; Griffith, Renate/A-3584-2015	Griffith, Renate/0000-0001-7739-5686	University of New South Wales; National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC006161] Funding Source: NIH RePORTER	University of New South Wales; National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for the computer-aided design work was provided by internal University of New South Wales funding (Faculty grant to RG, scholarship to MD). The biological assays were supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andricopulo AD, 2009, CURR TOP MED CHEM, V9, P771, DOI 10.2174/156802609789207127; Bailly C, 2003, CRIT REV ONCOL HEMAT, V45, P91, DOI 10.1016/S1040-8428(02)00090-2; Brangi M, 1999, CANCER RES, V59, P5938; Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007; CREAVEN PJ, 1973, CANCER CHEMOTH REP 1, V57, P175; Dexheimer TS, 2008, NAT PROTOC, V3, P1736, DOI 10.1038/nprot.2008.174; Dong G, 2010, J MED CHEM; Gao QZ, 2010, CURR COMPUT-AID DRUG, V6, P37, DOI 10.2174/157340910790980151; GOTTLIEB JA, 1970, CANCER CHEMOTH REP 1, V54, P461; Hein M., 2010, DRUG DISCOV TODAY-TE, V7, pe229, DOI [10.1016/j.ddtec.2010.12.003, DOI 10.1016/J.DDTEC.2010.12.003]; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Ioanoviciu A, 2005, J MED CHEM, V48, P4803, DOI 10.1021/jm050076b; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KIKUCHI Y, 1991, CHEM PHARM BULL, V39, P1466, DOI 10.1248/cpb.39.1466; Kiselev E, 2010, J MED CHEM, V53, P8716, DOI 10.1021/jm101048k; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; LACKEY K, 1995, J MED CHEM, V38, P906, DOI 10.1021/jm00006a008; Lackey K, 1996, J MED CHEM, V39, P713, DOI 10.1021/jm950507y; Lansiaux A, 2007, MOL PHARMACOL, V72, P311, DOI 10.1124/mol.107.034637; Li HS., 2000, PRINCIPLES TECHNIQUE; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lloyd DG, 2006, DRUG DISCOV TODAY, V11, P149, DOI 10.1016/S1359-6446(05)03688-3; LUZZIO MJ, 1995, J MED CHEM, V38, P395, DOI 10.1021/jm00003a001; Marchand C, 2006, MOL CANCER THER, V5, P287, DOI 10.1158/1535-7163.MCT-05-0456; Meng LH, 2003, CURR TOP MED CHEM, V3, P305; Oprea TI, 2002, J COMPUT AID MOL DES, V16, P325, DOI 10.1023/A:1020877402759; Plewczynski D, 2011, J COMPUT CHEM, V32, P742, DOI 10.1002/jcc.21643; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Pommier Y, 2009, MOL CANCER THER, V8, P1008, DOI 10.1158/1535-7163.MCT-08-0706; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Song YL, 2008, J PHYS CHEM B, V112, P9484, DOI 10.1021/jp8005603; Song YL, 2010, J MED CHEM, V53, P1979, DOI 10.1021/jm901649x; Staker BL, 2005, J MED CHEM, V48, P2336, DOI 10.1021/jm049146p; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Talevi A, 2009, CURR COMPUT-AID DRUG, V5, P23, DOI 10.2174/157340909787580854; UEHLING DE, 1995, J MED CHEM, V38, P1106, DOI 10.1021/jm00007a008; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; WALL ME, 1993, J MED CHEM, V36, P2689, DOI 10.1021/jm00070a013; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Webb MR, 2004, BIOCHEM J, V384, P527, DOI 10.1042/BJ20040474; WILLETT P, 1986, QUANT STRUCT-ACT REL, V5, P18, DOI 10.1002/qsar.19860050105; Wolber G, 2008, DRUG DISCOV TODAY, V13, P23, DOI 10.1016/j.drudis.2007.09.007; Yang SY, 2010, DRUG DISCOV TODAY, V15, P444, DOI 10.1016/j.drudis.2010.03.013; Zhang XW, 1999, ANTI-CANCER DRUG, V10, P569, DOI 10.1097/00001813-199907000-00009	47	31	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25150	10.1371/journal.pone.0025150	http://dx.doi.org/10.1371/journal.pone.0025150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966440	gold, Green Submitted, Green Published			2022-12-25	WOS:000295265100068
J	Garcia-Arnandis, I; Guillen, MI; Gomar, F; Castejon, MA; Alcaraz, MJ				Garcia-Arnandis, Isabel; Isabel Guillen, Maria; Gomar, Francisco; Angel Castejon, Miguel; Jose Alcaraz, Maria			Control of Cell Migration and Inflammatory Mediators Production by CORM-2 in Osteoarthritic Synoviocytes	PLOS ONE			English	Article							NF-KAPPA-B; MONOXIDE-RELEASING MOLECULES; FIBROBLAST-LIKE SYNOVIOCYTES; COLONIC EPITHELIAL-CELLS; ADENOVIRAL GENE-TRANSFER; GROUP BOX 1; C-X-C; MATRIX METALLOPROTEINASES; SYNOVIAL FIBROBLASTS; RHEUMATOID-ARTHRITIS	Background: Osteoarthritis (OA) is the most widespread degenerative joint disease. Inflamed synovial cells contribute to the release of inflammatory and catabolic mediators during OA leading to destruction of articular tissues. We have shown previously that CO-releasing molecules exert anti-inflammatory effects in animal models and OA chondrocytes. We have studied the ability of CORM-2 to modify the migration of human OA synoviocytes and the production of chemokines and other mediators sustaining inflammatory and catabolic processes in the OA joint. Methodology/Principal Findings: OA synoviocytes were stimulated with interleukin(IL)-1 beta in the absence or presence of CORM-2. Migration assay was performed using transwell chambers. Gene expression was analyzed by quantitative PCR and protein expression by Western Blot and ELISA. CORM-2 reduced the proliferation and migration of OA synoviocytes, the expression of IL-8, CCL2, CCL20, matrix metalloproteinase(MMP)-1 and MMP-3, and the production of oxidative stress. We found that CORM-2 reduced the phosphorylation of extracellular signal-regulated kinase1/2, c-Jun N-terminal kinase1/2 and to a lesser extent p38. Our results also showed that CORM-2 significantly decreased the activation of nuclear factor-kappa B and activator protein-1 regulating the transcription of chemokines and MMPs in OA synoviocytes. Conclusion/Significance: A number of synoviocyte functions relevant in OA synovitis and articular degradation can be down-regulated by CORM-2. These results support the interest of this class of agents for the development of novel therapeutic strategies in inflammatory and degenerative conditions.	[Garcia-Arnandis, Isabel; Isabel Guillen, Maria; Jose Alcaraz, Maria] Univ Valencia, Dept Pharmacol, Valencia, Spain; [Garcia-Arnandis, Isabel; Isabel Guillen, Maria; Jose Alcaraz, Maria] Univ Valencia, IDM, Valencia, Spain; [Isabel Guillen, Maria] Cardenal Herrera CEU Univ, Dept Chem Biochem & Mol Biol, Valencia, Spain; [Gomar, Francisco] Univ Valencia, Sch Med, Dept Surg, Valencia, Spain; [Angel Castejon, Miguel] De la Ribera Univ Hosp, Dept Orthopaed Surg & Traumatol, Valencia, Spain	University of Valencia; University of Valencia; Universidad CEU Cardenal Herrera; University of Valencia	Garcia-Arnandis, I (corresponding author), Univ Valencia, Dept Pharmacol, Valencia, Spain.	maria.j.alcaraz@uv.es	Alcaraz, Maria Jose/D-8195-2018	Gomar-Sancho, Francisco/0000-0001-7672-1291	Spanish Ministery of Science and Innovation, ISCIII, FEDER [SAF2010-22048, RETICEF RD06/0013/2001]; Generalitat Valenciana [Prometeo2010-047]	Spanish Ministery of Science and Innovation, ISCIII, FEDER(Instituto de Salud Carlos III); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work has been supported by research grants SAF2010-22048 and RETICEF RD06/0013/2001 (Spanish Ministery of Science and Innovation, ISCIII, FEDER), and Prometeo2010-047 (Generalitat Valenciana). IGA was supported by a fellowship from Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; Alcaraz MJ, 2003, CURR PHARM DESIGN, V9, P2541, DOI 10.2174/1381612033453749; Amos N, 2006, RHEUMATOLOGY, V45, P1201, DOI 10.1093/rheumatology/kel078; ATHANASOU NA, 1988, J PATHOL, V155, P133, DOI 10.1002/path.1711550210; Barchowsky A, 2000, CYTOKINE, V12, P1469, DOI 10.1006/cyto.2000.0743; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099; Bondeson J, 2007, J RHEUMATOL, V34, P523; Borzi RM, 2000, ARTHRITIS RHEUM, V43, P1734, DOI 10.1002/1529-0131(200008)43:8<1734::AID-ANR9>3.0.CO;2-B; Brauchle M, 2000, EXP CELL RES, V258, P135, DOI 10.1006/excr.2000.4913; Bruhl H, 2008, RHEUMATOLOGY, V47, P1771, DOI 10.1093/rheumatology/ken383; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Chevalier X, 1997, BIOMED PHARMACOTHER, V51, P58, DOI 10.1016/S0753-3322(97)87727-X; DIBATTISTA JA, 1995, J RHEUMATOL, V22, P123; Ferrandiz ML, 2008, ANN RHEUM DIS, V67, P1211, DOI 10.1136/ard.2007.082412; Firestein GS, 1999, ARTHRITIS RHEUM-US, V42, P609, DOI 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I; Fuchs S, 2004, OSTEOARTHR CARTILAGE, V12, P409, DOI 10.1016/j.joca.2004.02.005; Garcia-Arnandis I, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3124; Garcia-Arnandis I, 2010, RHEUMATOLOGY, V49, P854, DOI 10.1093/rheumatology/kep463; Guillen MI, 2008, RHEUMATOLOGY, V47, P1323, DOI 10.1093/rheumatology/ken264; Hadjigogos K, 2003, PANMINERVA MED, V45, P7; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Hayashida K, 2001, ARTHRITIS RES, V3, P118, DOI 10.1186/ar149; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Honorati MC, 2002, OSTEOARTHR CARTILAGE, V10, P799, DOI 10.1053/joca.2002.0829; Inoue H, 2001, INFLAMM RES, V50, P65; Kasai K, 2000, AM J PHYSIOL-CELL PH, V279, pC1859, DOI 10.1152/ajpcell.2000.279.6.C1859; Kawashiri SY, 2009, J RHEUMATOL, V36, P2397, DOI 10.3899/jrheum.090132; Kim MS, 2006, J CELL BIOCHEM, V97, P512, DOI 10.1002/jcb.20649; Kwon JH, 2002, GUT, V51, P818, DOI 10.1136/gut.51.6.818; Megias J, 2008, J PHARMACOL EXP THER, V325, P56, DOI 10.1124/jpet.107.134650; Mietz H, 2003, INVEST OPHTH VIS SCI, V44, P5182, DOI 10.1167/iovs.02-0462; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clim.2004.12.009; Morita Y, 1998, ANN RHEUM DIS, V57, P122, DOI 10.1136/ard.57.2.122; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Muhlbauer M, 2004, AM J PHYSIOL-GASTR L, V286, pG1000, DOI 10.1152/ajpgi.00338.2003; OKADA Y, 1987, J RHEUMATOL, V14, P41; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; RATHANASWAMI P, 1993, ARTHRITIS RHEUM, V36, P1295, DOI 10.1002/art.1780360914; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Schedel J, 2004, SCAND J IMMUNOL, V60, P514, DOI 10.1111/j.0300-9475.2004.01507.x; Schneider N, 2005, BIOCHEM BIOPH RES CO, V334, P669, DOI 10.1016/j.bbrc.2005.06.147; Tolboom TCA, 2002, ANN RHEUM DIS, V61, P975, DOI 10.1136/ard.61.11.975; UNEMORI EN, 1993, J BIOL CHEM, V268, P1338; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401	46	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24591	10.1371/journal.pone.0024591	http://dx.doi.org/10.1371/journal.pone.0024591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961038	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100011
J	Guillem, K; Peoples, LL				Guillem, Karine; Peoples, Laura L.			Acute Effects of Nicotine Amplify Accumbal Neural Responses during Nicotine-Taking Behavior and Nicotine-Paired Environmental Cues	PLOS ONE			English	Article							SELF-ADMINISTRATION BEHAVIOR; CONDITIONED APPROACH TASK; MPEP DECREASED NICOTINE; NUCLEUS-ACCUMBENS; CIGARETTE-SMOKING; D-AMPHETAMINE; NONCONTINGENT NICOTINE; INDUCED REINSTATEMENT; INTRAVENOUS NICOTINE; 2ND-ORDER SCHEDULES	Nicotine self-administration (SA) is maintained by several variables, including the reinforcing properties of nicotine-paired cues and the nicotine-induced amplification of those cue properties. The nucleus accumbens (NAc) is implicated in mediating the influence of these variables, though the underlying neurophysiological mechanisms are not yet understood. In the present study, Long-Evans rats were trained to self-administer nicotine. During SA sessions each press of a lever was followed by an intravenous infusion of nicotine (30 mu g/kg) paired with a combined light-tone cue. Extracellular recordings of single-neuron activity showed that 20% of neurons exhibited a phasic change in firing during the nicotine-directed operant, the light-tone cue, or both. The phasic change in firing for 98% of neurons was an increase. Sixty-two percent of NAc neurons additionally or alternatively showed a sustained decrease in average firing during the SA session relative to a presession baseline period. These session decreases in firing were significantly less prevalent in a group of neurons that were activated during either the operant or the cue than in a group of neurons that were nonresponsive during those events (referred to as task-activated and task-nonactivated neurons, respectively). Moreover, the session decrease in firing was dose-dependent for only the task-nonactivated neurons. The data of the present investigation provide supportive correlational evidence for two hypotheses: (1) excitatory neurophysiological mechanisms mediate the NAc role in cue-maintenance of nicotine SA, and (2) a differential nicotine-induced inhibition of task-activated and task-nonactivated neurons mediates the NAc role in nicotine-induced amplification of cue effects on nicotine SA.	[Guillem, Karine] Univ Bordeaux, Inst Malad Neurodegenerat, Bordeaux, France; [Guillem, Karine] CNRS, Inst Malad Neurodegenerat, Bordeaux, France; [Peoples, Laura L.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Peoples, Laura L.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); University of Pennsylvania; Drexel University	Guillem, K (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, Bordeaux, France.	karine.guillem@u-bordeaux2.fr; laura.peoples@drexelmed.edu	Guillem, Karine/D-8705-2014	Guillem, Karine/0000-0002-9623-3698	American Cancer Society [IRG-78-002-29]; National Institute on Drug Abuse [CA/DA84718, R01DA026942-01]; NATIONAL CANCER INSTITUTE [P50CA084718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026942] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research was funded by American Cancer Society Institutional Grant IRG-78-002-29 and National Institute on Drug Abuse CA/DA84718 and R01DA026942-01. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfour DJK, 2004, NICOTINE TOB RES, V6, P899, DOI 10.1080/14622200412331324965; Bespalov AY, 2005, NEUROPHARMACOLOGY, V49, P167, DOI 10.1016/j.neuropharm.2005.06.007; Brunzell DH, 2010, NEUROPSYCHOPHARMACOL, V35, P665, DOI 10.1038/npp.2009.171; Brunzell DH, 2009, NEUROPSYCHOPHARMACOL, V34, P1993, DOI 10.1038/npp.2009.11; Caggiula AR, 2001, PHARMACOL BIOCHEM BE, V70, P515, DOI 10.1016/S0091-3057(01)00676-1; Caggiula AR, 2002, PSYCHOPHARMACOLOGY, V163, P230, DOI 10.1007/s00213-002-1156-5; Carelli RM, 1997, PHARMACOL BIOCHEM BE, V57, P495, DOI 10.1016/S0091-3057(96)00442-X; Carelli RM, 2000, SYNAPSE, V35, P238, DOI 10.1002/(SICI)1098-2396(20000301)35:3<238::AID-SYN10>3.0.CO;2-Y; CARELLI RM, 1994, J NEUROSCI, V14, P7735; Chang JY, 1998, J NEUROSCI, V18, P3098; Chaudhri N, 2006, PSYCHOPHARMACOLOGY, V184, P353, DOI 10.1007/s00213-005-0178-1; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; de Rover M, 2002, EUR J NEUROSCI, V16, P2279, DOI 10.1046/j.1460-9568.2002.02289.x; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Di Ciano P, 2005, EUR J PHARMACOL, V526, P186, DOI 10.1016/j.ejphar.2005.09.024; Donny EC, 1995, PSYCHOPHARMACOLOGY, V122, P390, DOI 10.1007/BF02246272; Donny EC, 2003, PSYCHOPHARMACOLOGY, V169, P68, DOI 10.1007/s00213-003-1473-3; Dravolina OA, 2007, NEUROPHARMACOLOGY, V52, P263, DOI 10.1016/j.neuropharm.2006.07.023; Franklin TR, 2007, NEUROPSYCHOPHARMACOL, V32, P2301, DOI 10.1038/sj.npp.1301371; GOLDBERG SR, 1981, SCIENCE, V214, P573; Guillem K, 2005, J NEUROSCI, V25, P8593, DOI 10.1523/JNEUROSCI.2139-05.2005; Guillem K, 2010, 66824 SOC NEUR; Guillem K, 2010, J NEUROSCI, V30, P276, DOI 10.1523/JNEUROSCI.2820-09.2010; Hall J, 2001, EUR J NEUROSCI, V13, P1984, DOI 10.1046/j.0953-816x.2001.01577.x; HENNINGFIELD JE, 1983, PHARMACOL BIOCHEM BE, V19, P887, DOI 10.1016/0091-3057(83)90099-0; Hollander JA, 2005, NEUROPSYCHOPHARMACOL, V30, P1464, DOI 10.1038/sj.npp.1300748; Hollander JA, 2007, J NEUROSCI, V27, P3535, DOI 10.1523/JNEUROSCI.3667-06.2007; Janak PH, 1999, BRAIN RES, V817, P172, DOI 10.1016/S0006-8993(98)01245-1; Jones JL, 2008, SYNAPSE, V62, P219, DOI 10.1002/syn.20486; JONGENRELO AL, 1994, EUR J NEUROSCI, V6, P1255, DOI 10.1111/j.1460-9568.1994.tb00315.x; Kenny PJ, 2003, ANN NY ACAD SCI, V1003, P415, DOI 10.1196/annals.1300.040; Kravitz AV, 2006, SYNAPSE, V60, P420, DOI 10.1002/syn.20311; Lazev AB, 1999, EXP CLIN PSYCHOPHARM, V7, P56, DOI 10.1037/1064-1297.7.1.56; Lecca D, 2006, PSYCHOPHARMACOLOGY, V184, P435, DOI 10.1007/s00213-005-0280-4; LeSage MG, 2004, PHARMACOL BIOCHEM BE, V79, P507, DOI 10.1016/j.pbb.2004.09.002; Lex A, 2008, LEARN MEMORY, V15, P483, DOI 10.1101/lm.978708; Liechti ME, 2007, J NEUROSCI, V27, P9077, DOI 10.1523/JNEUROSCI.1766-07.2007; Nicola SM, 2004, J NEUROPHYSIOL, V91, P1866, DOI 10.1152/jn.00658.2003; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nicola SM, 2000, J NEUROSCI, V20, P5526, DOI 10.1523/JNEUROSCI.20-14-05526.2000; O'Donnell P, 2003, EUR J NEUROSCI, V17, P429, DOI 10.1046/j.1460-9568.2003.02463.x; Olausson P, 2004, PSYCHOPHARMACOLOGY, V173, P98, DOI 10.1007/s00213-003-1702-9; Olausson P, 2004, PSYCHOPHARMACOLOGY, V171, P173, DOI 10.1007/s00213-003-1575-y; Palmatier M, 2006, PSYCHOPHARMACOLOGY, V184, P391, DOI 10.1007/s00213-005-0183-4; Palmatier MI, 2008, NEUROPHARMACOLOGY, V55, P1425, DOI 10.1016/j.neuropharm.2008.09.002; Palmatier MI, 2007, PSYCHOPHARMACOLOGY, V195, P235, DOI 10.1007/s00213-007-0897-6; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Paterson NE, 2003, PSYCHOPHARMACOLOGY, V167, P257, DOI 10.1007/s00213-003-1432-z; Paterson NE, 2005, PSYCHOPHARMACOLOGY, V179, P255, DOI 10.1007/s00213-004-2070-9; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PAYNE TJ, 1991, ADDICT BEHAV, V16, P467, DOI 10.1016/0306-4603(91)90054-L; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Peoples LL, 2007, NEUROPSYCHOPHARMACOL, V32, P1141, DOI 10.1038/sj.npp.1301203; Peoples LL, 2010, FRONT NEUROSCI, P27; Peoples LL, 2004, J NEUROPHYSIOL, V91, P314, DOI 10.1152/jn.00638.2003; Peoples LL, 2003, J NEUROPHYSIOL, V90, P993, DOI 10.1152/jn.00849.2002; Peoples LL, 1996, J NEUROSCI, V16, P3459; Peoples LL, 1997, BRAIN RES, V757, P280, DOI 10.1016/S0006-8993(97)00299-0; Peoples LL, 1998, NEUROSCIENCE, V86, P13, DOI 10.1016/S0306-4522(98)00116-X; Peoples LL, 1999, BASAL GANGLIA, VVI, P547; Peoples LL, 1994, NATL I DRUG ABUSE RE, VII, P326; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Reid MS, 2000, SYNAPSE, V35, P129, DOI 10.1002/(SICI)1098-2396(200002)35:2<129::AID-SYN5>3.0.CO;2-D; Robinson DL, 2008, EUR J NEUROSCI, V28, P1887, DOI 10.1111/j.1460-9568.2008.06464.x; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Rose JE, 2006, PSYCHOPHARMACOLOGY, V184, P274, DOI 10.1007/s00213-005-0250-x; Rose JE, 2003, PHARMACOL BIOCHEM BE, V76, P243, DOI 10.1016/j.pbb.2003.07.002; Rose JE, 1997, PSYCHOPHARMACOLOGY, V130, P28, DOI 10.1007/s002130050209; Spina L, 2006, PSYCHOPHARMACOLOGY, V184, P447, DOI 10.1007/s00213-005-0211-4; Taha SA, 2005, J NEUROSCI, V25, P1193, DOI 10.1523/JNEUROSCI.3975-04.2005; TAYLOR JR, 1986, PSYCHOPHARMACOLOGY, V90, P390; TAYLOR JR, 1984, PSYCHOPHARMACOLOGY, V84, P405, DOI 10.1007/BF00555222; Tessari M, 2004, EUR J PHARMACOL, V499, P121, DOI 10.1016/j.ejphar.2004.07.056; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Uzwiak AJ, 1997, BRAIN RES, V767, P363, DOI 10.1016/S0006-8993(97)00752-X; Wan X, 2008, J NEUROSCI, V28, P7501, DOI 10.1523/JNEUROSCI.1071-08.2008; Wan X, 2006, J NEUROPHYSIOL, V96, P652, DOI 10.1152/jn.00068.2006; Wilson DIG, 2004, PSYCHOPHARMACOLOGY, V174, P430, DOI 10.1007/s00213-004-1867-x; WOLTERINK G, 1993, PSYCHOPHARMACOLOGY, V110, P355, DOI 10.1007/BF02251293; Wyvell CL, 2000, J NEUROSCI, V20, P8122	81	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24049	10.1371/journal.pone.0024049	http://dx.doi.org/10.1371/journal.pone.0024049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961032	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100004
J	Lei, X; Ostwald, D; Hu, JH; Qiu, C; Porcaro, C; Bagshaw, AP; Yao, DZ				Lei, Xu; Ostwald, Dirk; Hu, Jiehui; Qiu, Chuan; Porcaro, Camillo; Bagshaw, Andrew P.; Yao, Dezhong			Multimodal Functional Network Connectivity: An EEG-fMRI Fusion in Network Space	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; DEFAULT MODE NETWORK; GRANGER CAUSALITY; HUMAN BRAIN; EEG/FMRI ANALYSIS; ALPHA-RHYTHM; SCHIZOPHRENIA; MRI; OSCILLATIONS; FRAMEWORK	EEG and fMRI recordings measure the functional activity of multiple coherent networks distributed in the cerebral cortex. Identifying network interaction from the complementary neuroelectric and hemodynamic signals may help to explain the complex relationships between different brain regions. In this paper, multimodal functional network connectivity (mFNC) is proposed for the fusion of EEG and fMRI in network space. First, functional networks (FNs) are extracted using spatial independent component analysis (ICA) in each modality separately. Then the interactions among FNs in each modality are explored by Granger causality analysis (GCA). Finally, fMRI FNs are matched to EEG FNs in the spatial domain using network-based source imaging (NESOI). Investigations of both synthetic and real data demonstrate that mFNC has the potential to reveal the underlying neural networks of each modality separately and in their combination. With mFNC, comprehensive relationships among FNs might be unveiled for the deep exploration of neural activities and metabolic responses in a specific task or neurological state.	[Lei, Xu; Hu, Jiehui; Qiu, Chuan; Yao, Dezhong] Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Lei, Xu] Southwest Univ, Key Lab Cognit & Personal, Minist Educ, Chongqing, Peoples R China; [Lei, Xu] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Ostwald, Dirk; Porcaro, Camillo; Bagshaw, Andrew P.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Ostwald, Dirk] Charite, Dept Neurol, Berlin, Germany; [Ostwald, Dirk] Charite, Bermstein Ctr Computat Neurosci, Berlin, Germany; [Porcaro, Camillo] Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Electronic Science & Technology of China; Southwest University - China; Southwest University - China; University of Birmingham; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Newcastle University - UK	Lei, X (corresponding author), Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.	dyao@uestc.edu.cn	Porcaro, Camillo/K-7864-2016; Jovicich, Jorge/D-2293-2010	Porcaro, Camillo/0000-0003-4847-163X; Bagshaw, Andrew/0000-0001-6217-1292; Lei, Xu/0000-0003-2271-1287; Ostwald, Dirk/0000-0002-3530-1845; Yao, Dezhong/0000-0002-8042-879X	973 project [2011CB707803]; National Nature Science Foundation of China [60736029]; 863 Project [2009AA02Z301]; PCSIRT; UK Engineering and Physical Sciences Research Council [EP/F023057/1]; EPSRC [EP/F023057/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F023057/1] Funding Source: researchfish	973 project(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This project was funded by grants from the 973 project 2011CB707803, the National Nature Science Foundation of China #60736029, the 863 Project 2009AA02Z301 and the PCSIRT project. This work was also supported by grant number EP/F023057/1 from the UK Engineering and Physical Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Beisteiner R, 1997, EUR J NEUROSCI, V9, P1072, DOI 10.1111/j.1460-9568.1997.tb01457.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bressler SL., 2006, HDB TIME SERIES ANAL; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Calhoun VD, 2006, IEEE ENG MED BIOL, V25, P79, DOI 10.1109/MEMB.2006.1607672; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Chen ACN, 2008, NEUROIMAGE, V41, P561, DOI 10.1016/j.neuroimage.2007.12.064; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Daunizeau J, 2007, NEUROIMAGE, V36, P69, DOI 10.1016/j.neuroimage.2007.01.044; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Demirci O, 2009, NEUROIMAGE, V46, P419, DOI 10.1016/j.neuroimage.2009.02.014; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Eichele T, 2009, INT J PSYCHOPHYSIOL, V73, P53, DOI 10.1016/j.ijpsycho.2008.12.018; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 1996, CEREB CORTEX, V6, P156, DOI 10.1093/cercor/6.2.156; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Haykin S., 2002, ADAPTIVE FILTER THEO; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Lei X, 2011, HUM BRAIN MAPP, V32, P1141, DOI 10.1002/hbm.21098; Lei X, 2010, NEUROIMAGE, V52, P1123, DOI 10.1016/j.neuroimage.2010.01.024; Luessi M, 2011, NEUROIMAGE, V55, P113, DOI 10.1016/j.neuroimage.2010.11.037; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marinazzo D, 2010, NEUROIMAGE; Martinez-Montes E, 2004, NEUROIMAGE, V22, P1023, DOI 10.1016/j.neuroimage.2004.03.038; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; Ostwald D, 2010, NEUROIMAGE, V49, P498, DOI 10.1016/j.neuroimage.2009.07.038; Ou W, 2010, NEUROIMAGE; Phillips C, 2005, NEUROIMAGE, V24, P997, DOI 10.1016/j.neuroimage.2004.10.030; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Sackett DL, 2001, CAN MED ASSOC J, V165, P1226; Scheeringa R, 2011, NEURON, V69, P572, DOI 10.1016/j.neuron.2010.11.044; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Trujillo-Barreto NJ, 2001, INT J BIOELECTROMAGN, V3, P1; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; Valdes-Sosa PA, 2009, HUM BRAIN MAPP, V30, P2701, DOI 10.1002/hbm.20704; Valdes-Sosa PA, 2009, HUM BRAIN MAPP, V30, P1898, DOI 10.1002/hbm.20784; Yao DZ, 2000, IEEE T BIO-MED ENG, V47, P964, DOI 10.1109/10.846691; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	52	36	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24642	10.1371/journal.pone.0024642	http://dx.doi.org/10.1371/journal.pone.0024642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961040	Green Submitted, gold, Green Published			2022-12-25	WOS:000295265100013
J	Major, T; Menon, J; Auyeung, G; Soldner, F; Hockemeyer, D; Jaenisch, R; Tabar, V				Major, Tamara; Menon, Jayanthi; Auyeung, Gordon; Soldner, Frank; Hockemeyer, Dirk; Jaenisch, Rudolf; Tabar, Viviane			Transgene Excision Has No Impact on In Vivo Integration of Human iPS Derived Neural Precursors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ADULT MAMMALIAN BRAIN; REPROGRAMMING FACTORS; DIFFERENTIATION PROPENSITY; HUMAN FIBROBLASTS; SOMATIC-CELLS; RAT-BRAIN; HUMAN ES; GENERATION; INDUCTION	The derivation of induced human pluripotent stem cells (hiPS) has generated significant enthusiasm particularly for the prospects of cell-based therapy. But there are concerns about the suitability of iPS cells for in vivo applications due in part to the introduction of potentially oncogenic transcription factors via viral vectors. Recently developed lentiviral vectors allow the excision of viral reprogramming factors and the development of transgene-free iPS lines. However it is unclear if reprogramming strategy has an impact on the differentiation potential and the in vivo behavior of hiPS progeny. Here we subject viral factor-free, c-myc-free and conventionally reprogrammed four-factor human iPS lines to a further challenge, by analyzing their differentiation potential along the 3 neural lineages and over extended periods of time in vitro, as well as by interrogating their ability to respond to local environmental cues by grafting into the striatum. We demonstrate similar and efficient differentiation into neurons, astrocytes and oligodendrocytes among all hiPS and human ES line controls. Upon intracranial grafting in the normal rat (Sprague Dawley), precursors derived from all hiPS lines exhibited good survival and response to environmental cues by integrating into the subventricular zone, acquiring phenotypes typical of type A, B or C cells and migrating along the rostral migratory stream into the olfactory bulb. There was no teratoma or other tumor formation 12 weeks after grafting in any of the 26 animals used in the study. Thus neither factor excision nor persistence of c-myc impact the behavior of hiPS lines in vivo.	[Major, Tamara; Menon, Jayanthi; Auyeung, Gordon; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, New York, NY 10021 USA; [Major, Tamara; Menon, Jayanthi; Auyeung, Gordon; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Soldner, Frank; Hockemeyer, Dirk; Jaenisch, Rudolf] MIT, Whitehead Inst, Cambridge, MA 02139 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Major, T (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, 1275 York Ave, New York, NY 10021 USA.	tabarv@mskcc.org		Hockemeyer, Dirk/0000-0002-5598-5092; Major, Tamara/0000-0003-1383-3418	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NINDS); NYSTEM; Starr Foundation	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NYSTEM; Starr Foundation	VT received funding from National Institutes of Health/National Institute of Neurological Disorders and Stroke (NINDS) and NYSTEM; TM received support from the Starr Foundation (Tri-Institutional Starr Stem Cell Scholars Fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2009, STEM CELLS, V27, P3053, DOI 10.1002/stem.242; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Desponts C, 2010, METHODS MOL BIOL, V636, P207, DOI 10.1007/978-1-60761-691-7_13; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Ramos-Mejia V, 2010, CELL RES, V20, P1092, DOI 10.1038/cr.2010.125; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201	42	14	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24687	10.1371/journal.pone.0024687	http://dx.doi.org/10.1371/journal.pone.0024687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961042	gold, Green Submitted, Green Published			2022-12-25	WOS:000295265100015
J	Marathe, A; Lewis, B; Barrett, C; Chen, JZ; Marathe, M; Eubank, S; Ma, YF				Marathe, Achla; Lewis, Bryan; Barrett, Christopher; Chen, Jiangzhuo; Marathe, Madhav; Eubank, Stephen; Ma, Yifei			Comparing Effectiveness of Top-Down and Bottom-Up Strategies in Containing Influenza	PLOS ONE			English	Article								This research compares the performance of bottom-up, self-motivated behavioral interventions with top-down interventions targeted at controlling an "Influenza-like-illness''. Both types of interventions use a variant of the ring strategy. In the first case, when the fraction of a person's direct contacts who are diagnosed exceeds a threshold, that person decides to seek prophylaxis, e. g. vaccine or antivirals; in the second case, we consider two intervention protocols, denoted Block and School: when a fraction of people who are diagnosed in a Census Block (resp., School) exceeds the threshold, prophylax the entire Block (resp., School). Results show that the bottom-up strategy outperforms the top-down strategies under our parameter settings. Even in situations where the Block strategy reduces the overall attack rate well, it incurs a much higher cost. These findings lend credence to the notion that if people used antivirals effectively, making them available quickly on demand to private citizens could be a very effective way to control an outbreak.	[Marathe, Achla; Lewis, Bryan; Barrett, Christopher; Chen, Jiangzhuo; Marathe, Madhav; Eubank, Stephen; Ma, Yifei] Virginia Tech, Network Dynam & Simulat Sci Lab, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Marathe, Achla] Virginia Tech, Dept Agr & Appl Econ, Blacksburg, VA USA; [Barrett, Christopher; Marathe, Madhav] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Eubank, Stephen] Virginia Tech, Dept Phys, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Marathe, A (corresponding author), Virginia Tech, Network Dynam & Simulat Sci Lab, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	amarathe@vbi.vt.edu	Eubank, Stephen/AAD-5089-2021; Eubank, Stephen/D-7497-2011	Chen, Jiangzhuo/0000-0002-2729-3881; Eubank, Stephen/0000-0002-7177-309X	National Science Foundation [CNS-0626964, SES-0729441, OCI-0904844, CNS-0831633, CNS-0845700, CNS-1011769, OCI-1032677]; Defense Threat Reduction Agency [HDTRA1-0901-0017, HDTRA1-07-C-0113]; Department of Energy [DE-SC0003957]; United States Naval Surface Warfare Center [N00178-09-D-3017 DEL ORDER 13]; National Institutes of Health [2U01GM070694-7]; National Institute of Allergy and Infectious Disease & National Institute of Health [HHSN272201000056C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070694] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Department of Energy(United States Department of Energy (DOE)); United States Naval Surface Warfare Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease & National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been partially supported by National Science Foundation Networking Technology and Systems Grant CNS-0626964, National Science Foundation Human and Social Dynamics Grant SES-0729441, National Science Foundation Accelerating Discovery in Science and Engineering Through PetaScale Simulations and Analysis Grant OCI-0904844, National Science Foundation Networking Technology and Systems Grant CNS-0831633, National Science Foundation Research Experiences for Undergraduates Supplement Grant CNS-0845700, National Science Foundation Network Science and Engineering Grant CNS-1011769, National Science Foundation Software Development for Cyberinfrastructure Grant OCI-1032677, Defense Threat Reduction Agency Research & Development Grant HDTRA1-0901-0017, Defense Threat Reduction Agency Comprehensive National Incident Management System Grant HDTRA1-07-C-0113, Department of Energy Grant DE-SC0003957, United States Naval Surface Warfare Center Grant N00178-09-D-3017 DEL ORDER 13, National Institutes of Health Models of Infectious Disease Agent Study project 2U01GM070694-7 and National Institute of Allergy and Infectious Disease & National Institute of Health project HHSN272201000056C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey NTJ, 1975, MATH THEORY INFECT D; Balicer RD, 2005, EMERGING INFECT DIS, P11; Barrett C., 2001, LAUR001725; Barrett C.L., 2008, SC 2008 P 2008 ACMIE, P1, DOI DOI 10.1109/SC.2008.5214892; Barrett C, 2010, AI MAG, V31, P75, DOI 10.1609/aimag.v31i1.2283; Beckman RJ, 1996, TRANSPORT RES A-POL, V30, P415, DOI 10.1016/0965-8564(96)00004-3; Bisset K., 2009, DOE SCIDAC MAG, V66, P36; Bisset KR, 2009, ICS'09: PROCEEDINGS OF THE 2009 ACM SIGARCH INTERNATIONAL CONFERENCE ON SUPERCOMPUTING, P430, DOI 10.1145/1542275.1542336; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson N, 2005, NATURE; KUZNETSOV YA, 1994, J MATH BIOL, V32, P109, DOI 10.1007/BF00163027; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Murray J., 2002, BIOMATHEMATICS, V19	13	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25149	10.1371/journal.pone.0025149	http://dx.doi.org/10.1371/journal.pone.0025149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966439	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100067
J	Jaiswal, R; Gong, J; Sambasivam, S; Combes, V; Mathys, JM; Davey, R; Grau, GER; Bebawy, M				Jaiswal, Ritu; Gong, Joyce; Sambasivam, Shwetha; Combes, Valery; Mathys, Jean-Marie; Davey, Ross; Grau, Georges E. R.; Bebawy, Mary			Microparticle-associated nucleic acids mediate trait dominance in cancer	FASEB JOURNAL			English	Article						multidrug resistance; P-glycoprotein; multidrug resistance-associated protein 1; intercellular transfer	P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; BREAST-CANCER; IN-VITRO; DIAGNOSTIC BIOMARKERS; CROSS-RESISTANCE; DRUG-RESISTANCE; TUMOR-CELLS; EXPRESSION; MICROVESICLES	Drug resistance is a major cause of cancer treatment failure, with multidrug resistance (MDR) being the most serious, whereby cancer cells display cross-resistance to structurally and functionally unrelated drugs. MDR is caused by overexpression of the efflux transporters P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1). These transporters act to maintain sublethal intracellular drug concentrations within the cancer cell, making the population treatment unresponsive. Recently, we discovered a novel nongenetic basis to MDR whereby microparticles (MPs) transfer P-gp intercellularly from MDR donor cells to drug-sensitive recipient cells. MPs isolated from MDR leukemia and breast cancer cells were cocultured with their drug-sensitive counterparts. P-gp transfer was assessed by direct immunolabeling, and acquired transcripts and regulatory microRNAs by quantitative real-time PCR. We show that MDR MPs incorporate nucleic acids; MPs change recipient cells' transcriptional environment to reflect donor MDR phenotype, and distinct pathways exist among cancers of different origin that may be dependent on donor cells' ABCB1 overexpression. We demonstrate that this pathway exists for both hematological and nonhematological malignancies. By conferring MDR and "retemplating" the transcriptional landscape of recipient cells, MPs provide a novel pathway, having implications in the dissemination and acquisition of deleterious traits in clinical oncology.-Jaiswal, R., Gong, J., Sambasivam, S., Combes, V., Mathys, J.-M., Davey, R., Grau, G. E. R., Bebawy, M. Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB J. 26, 420-429 (2012). www.fasebj.org	[Jaiswal, Ritu; Gong, Joyce; Sambasivam, Shwetha; Bebawy, Mary] Univ Technol Sydney, Sch Pharm, Grad Sch Hlth, Sydney, NSW 2007, Australia; [Jaiswal, Ritu; Gong, Joyce; Combes, Valery; Grau, Georges E. R.] Univ Sydney, Vasc Immunol Unit, Sydney Med Sch, Sydney, NSW 2006, Australia; [Jaiswal, Ritu; Gong, Joyce; Combes, Valery; Grau, Georges E. R.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Mathys, Jean-Marie] Royal Prince Alfred Hosp, Dept Mol & Clin Genet, Camperdown, NSW 2050, Australia; [Davey, Ross] Kolling Inst, Bill Walsh Canc Res Labs, St Leonards, NSW, Australia	University of Technology Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Kolling Institute of Medical Research	Bebawy, M (corresponding author), Univ Technol Sydney, Sch Pharm, Grad Sch Hlth, Level 5,Bldg 4,POB 123, Sydney, NSW 2007, Australia.	georges.grau@sydney.edu.au; mary.bebawy@uts.edu.au	Grau, Georges/AGR-7139-2022	Grau, Georges/0000-0002-0442-0462; Bebawy, Mary/0000-0003-2606-921X; Jaiswal, Ritu/0000-0002-8691-1352; Combes, Valery/0000-0003-2178-3596	New South Wales Cancer Council [571016]; National Health and Medical Research Council [1007613]	New South Wales Cancer Council(Cancer Council New South Wales); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank the following funding bodies for supporting this work: New South Wales Cancer Council (571016) and National Health and Medical Research Council (1007613) for research grants (to M. B., G. E. R. G., and V. C.).	Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Bebawy M, 1999, ANAL BIOCHEM, V268, P270, DOI 10.1006/abio.1998.3087; Bebawy M, 2001, BRIT J CANCER, V85, P1998, DOI 10.1054/bjoc.2001.2184; Bebawy M, 2009, LEUKEMIA, V23, P1643, DOI 10.1038/leu.2009.76; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; BIEDLER JL, 1970, CANCER RES, V30, P1174; Camussi G, 2011, AM J CANCER RES, V1, P98; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Distler JHW, 2006, AUTOIMMUNITY, V39, P683, DOI 10.1080/08916930601061538; Donmez Y, 2011, CANCER CHEMOTH PHARM, V67, P823, DOI 10.1007/s00280-010-1385-y; Freyssinet JM, 2003, J THROMB HAEMOST, V1, P1655, DOI 10.1046/j.1538-7836.2003.00309.x; GOASGUEN JE, 1993, BLOOD, V81, P2394; Gong J, 2012, CANCER TREAT REV, V38, P226, DOI 10.1016/j.ctrv.2011.06.005; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Lane JD, 2005, J CELL SCI, V118, P4059, DOI 10.1242/jcs.02529; Lee G, 2004, PHARM RES-DORDR, V21, P1313, DOI 10.1023/B:PHAM.0000036905.82914.8e; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang ZX, 2010, BIOCHEM PHARMACOL, V79, P817, DOI 10.1016/j.bcp.2009.10.017; LINN SC, 1995, ANN ONCOL, V6, P679, DOI 10.1093/oxfordjournals.annonc.a059284; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Longo-Sorbello GSA, 2001, HAEMATOLOGICA, V86, P121; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mi Y, 2007, BRIT J CANCER, V97, P934, DOI 10.1038/sj.bjc.6603985; Munoz M, 2007, IUBMB LIFE, V59, P752, DOI 10.1080/15216540701736285; Nooter K, 1997, LANCET, V349, P1885, DOI 10.1016/S0140-6736(05)63876-7; Oerlemans R, 2006, ARTHRITIS RHEUM-US, V54, P557, DOI 10.1002/art.21569; Reich CF, 2009, EXP CELL RES, V315, P760, DOI 10.1016/j.yexcr.2008.12.014; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Schiller M, 2008, CELL DEATH DIFFER, V15, P183, DOI 10.1038/sj.cdd.4402239; Shi HC, 2008, CANCER INVEST, V26, P344, DOI 10.1080/07357900701788072; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smalley DM, 2007, THROMB HAEMOSTASIS, V97, P67, DOI 10.1160/TH06-02-0066; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tesselaar MET, 2009, J THROMB HAEMOST, V7, P1421, DOI 10.1111/j.1538-7836.2009.03504.x; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	44	91	92	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					420	429		10.1096/fj.11-186817	http://dx.doi.org/10.1096/fj.11-186817			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21965597				2022-12-25	WOS:000299202200041
J	Bhalla, K; Hwang, BJ; Choi, JH; Dewi, R; Ou, LH; Mclenithan, J; Twaddel, W; Pozharski, E; Stock, J; Girnum, GD				Bhalla, Kavita; Hwang, Bor Jang; Choi, Jang Hyun; Dewi, Ruby; Ou, Lihui; Mclenithan, John; Twaddel, William; Pozharski, Edwin; Stock, Jeffry; Girnum, Geoffrey D.			N-Acetylfarnesylcysteine Is a Novel Class of Peroxisome Proliferator-activated Receptor gamma Ligand with Partial and Full Agonist Activity in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; ADIPOSE-TISSUE MACROPHAGES; TYPE-2 DIABETES-MELLITUS; PPAR-GAMMA; INSULIN-RESISTANCE; ADIPOCYTE DIFFERENTIATION; FATTY-ACIDS; METABOLIC DISEASE; GENE-EXPRESSION; BINDING DOMAIN	The thiazolidedione (TZD) class of drugs is clinically approved for the treatment of type 2 diabetes. The therapeutic actions of TZDs are mediated via activation of peroxisome proliferator-activated receptor gamma (PPAR gamma). Despite their widespread use, concern exists regarding the safety of currently used TZDs. This has prompted the development of selective PPAR gamma modulators (SPPARMs), compounds that promote glucose homeostasis but with reduced side effects due to partial PPAR gamma agonism. However, this also results in partial agonism with respect to PPAR gamma target genes promoting glucose homeostasis. Using a gene expression-based screening approach we identified N-acetylfarnesylcysteine (AFC) as both a full and partial agonist depending on the PPAR gamma target gene (differential SPPARM). AFC activated PPAR gamma as effectively as rosiglitazone with regard to Adrp, Angpt14, and AdipoQ, but was a partial agonist of aP2, a PPAR gamma target gene associated with increased adiposity. Induction of adipogenesis by AFC was also attenuated compared with rosiglitazone. Reporter, ligand binding assays, and dynamic modeling demonstrate that AFC binds and activates PPAR gamma in a unique manner compared with other PPAR gamma ligands. Importantly, treatment of mice with AFC improved glucose tolerance similar to rosiglitazone, but AFC did not promote weight gain to the same extent. Finally, AFC had effects on adipose tissue remodeling similar to those of rosiglitazone and had enhanced antiinflammatory effects. In conclusion, we describe a new approach for the identification of differential SPPARMs and have identified AFC as a novel class of PPAR gamma ligand with both full and partial agonist activity in vitro and in vivo.	[Bhalla, Kavita; Dewi, Ruby; Ou, Lihui; Girnum, Geoffrey D.] Harvard Univ, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Boston, MA 02215 USA; [Hwang, Bor Jang; Girnum, Geoffrey D.] Harvard Univ, Sch Med, Dept Biochem & Mol Biol, Boston, MA 02215 USA; [Choi, Jang Hyun] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Mclenithan, John] Univ Maryland, Sch Med, Dept Endocrinol, Baltimore, MD 21201 USA; [Twaddel, William] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Pozharski, Edwin] Univ Maryland, Sch Med, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Stock, Jeffry] Princeton Univ, Dept Mol Biol, Princeton, NJ 08554 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Princeton University	Girnum, GD (corresponding author), Univ Maryland Greenebaum Canc Ctr, Dept Biochem & Mol Biol, 655 W Baltimore St,BRB Rm 10-039, Baltimore, MD 21201 USA.	ggirnun@som.umaryland.edu	Pozharski, Edwin/AAM-7692-2020	Pozharski, Edwin/0000-0001-7012-5376	National Institutes of Health [K01DK064685]; Maryland Cigarette Restitution Fund; University of Maryland Nutrition Obesity Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK064685, P30DK072488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Cigarette Restitution Fund; University of Maryland Nutrition Obesity Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported, in whole or in part, by National Institutes of Health Grant K01DK064685. This work was also supported by Maryland Cigarette Restitution Fund and a pilot grant from the University of Maryland Nutrition Obesity Research Center (to G.D.G).	Acton JJ, 2005, BIOORG MED CHEM LETT, V15, P357, DOI 10.1016/j.bmcl.2004.10.068; Anghel SI, 2007, CELL RES, V17, P486, DOI 10.1038/cr.2007.48; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Balint B. L., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P33; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Camp HS, 1997, J BIOL CHEM, V272, P10811; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; Einstein M, 2008, MOL PHARMACOL, V73, P62, DOI 10.1124/mol.107.041202; Elbrecht A, 1999, J BIOL CHEM, V274, P7913, DOI 10.1074/jbc.274.12.7913; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; Gordon JS, 2008, J INVEST DERMATOL, V128, P643, DOI 10.1038/sj.jid.5701061; Gregoire FM, 2009, MOL ENDOCRINOL, V23, P975, DOI 10.1210/me.2008-0473; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kolak M, 2007, J CLIN ENDOCR METAB, V92, P720, DOI 10.1210/jc.2006-1465; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Marathe C, 2009, J LIPID RES, V50, P214, DOI 10.1194/jlr.M800189-JLR200; Mizuno CS, 2008, CURR MED CHEM, V15, P61; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Moore GBT, 2001, BIOCHEM BIOPH RES CO, V286, P735, DOI 10.1006/bbrc.2001.5460; Motani A, 2009, J MOL BIOL, V386, P1301, DOI 10.1016/j.jmb.2009.01.025; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Phillips SA, 2005, OBES RES, V13, P1321, DOI 10.1038/oby.2005.160; Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; Rangwala Shamina M, 2002, Sci STKE, V2002, ppe9, DOI 10.1126/stke.2002.121.pe9; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Schwartz AV, 2008, PPAR RES, V2008, DOI 10.1155/2008/297893; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Shearer BG, 2007, BBA-MOL CELL BIOL L, V1771, P1082, DOI 10.1016/j.bbalip.2007.05.005; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Targett-Adams P, 2005, BBA-GENE STRUCT EXPR, V1728, P95, DOI 10.1016/j.bbaexp.2005.01.017; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; VOLKER C, 1991, J BIOL CHEM, V266, P21515; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Walkey CJ, 2008, J BIOL CHEM, V283, P24290, DOI 10.1074/jbc.C800139200; Watkins PB, 1998, NEW ENGL J MED, V338, P916, DOI 10.1056/NEJM199803263381314; Wellen KE, 2004, ENDOCRINOLOGY, V145, P2214, DOI 10.1210/en.2003-1580; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000	75	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41626	41635		10.1074/jbc.M111.257915	http://dx.doi.org/10.1074/jbc.M111.257915			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21979952	Green Published, hybrid			2022-12-25	WOS:000298057500047
J	Ruangsri, S; Lin, A; Mulpuri, Y; Lee, K; Spigelman, I; Nishimura, I				Ruangsri, Supanigar; Lin, Audrey; Mulpuri, Yatendra; Lee, Kyung; Spigelman, Igor; Nishimura, Ichiro			Relationship of Axonal Voltage-gated Sodium Channel 1.8 (NaV1.8) mRNA Accumulation to Sciatic Nerve Injury-induced Painful Neuropathy in Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED SELECTIVE KNOCKDOWN; PERIPHERAL NEUROPATHY; EXPRESSION; NA(V)1.8; NEURONS; TRANSPORT; SNS/PN3; PROTEIN; MODEL; IMMUNOREACTIVITY	Painful peripheral neuropathy is a significant clinical problem; however, its pathological mechanism and effective treatments remain elusive. Increased peripheral expression of tetro-dotoxin-resistant voltage-gated sodium channel 1.8 (NaV1.8) has been shown to associate with chronic pain symptoms in humans and experimental animals. Sciatic nerve entrapment (SNE) injury was used to develop neuropathic pain symptoms in rats, resulting in increased NaV1.8 mRNA in the injured nerve but not in dorsal root ganglia (DRG). To study the role of NaV1.8 mRNA in the pathogenesis of SNE-induced painful neuropathy, NaV1.8 shRNA vector was delivered by subcutaneous injection of cationized gelatin/plasmid DNA polyplex into the rat hindpaw and its subsequent retrograde transport via sciatic nerve to DRG. This in vivo NaV1.8 shRNA treatment reversibly and repeatedly attenuated the SNE-induced pain symptoms, an effect that became apparent following a distinct lag period of 3-4 days and lasted for 4-6 days before returning to pretreatment levels. Surprisingly, apparent knockdown of NaV1.8 mRNA occurred only in the injured nerve, not in the DRG, during the pain alleviation period. Levels of heteronuclear NaV1.8 RNA were unaffected by SNE or shRNA treatments, suggesting that transcription of the Scn10a gene encoding NaV1.8 was unchanged. Based on these data, we postulate that increased axonal mRNA transport results in accumulation of functional NaV1.8 protein in the injured nerve and the development of painful neuropathy symptoms. Thus, targeted delivery of agents that interfere with axonal NaV1.8 mRNA may represent effective neuropathic pain treatments.	[Ruangsri, Supanigar; Lin, Audrey; Lee, Kyung; Nishimura, Ichiro] Univ Calif Los Angeles, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90095 USA; [Ruangsri, Supanigar; Mulpuri, Yatendra; Spigelman, Igor; Nishimura, Ichiro] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90095 USA; [Spigelman, Igor] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Ruangsri, Supanigar] Khon Kaen Univ, Fac Dent, Khon Kaen 40002, Thailand	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Khon Kaen University	Nishimura, I (corresponding author), UCLA Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Box 951668,CHS B3-087, Los Angeles, CA 90095 USA.	inishimura@dentistry.ucla.edu	Mulpuri, Yatendra/V-5481-2019	Mulpuri, Yatendra/0000-0003-1764-119X	National Institutes of Health Grants [NS049137, DA023163]; Royal Thai Government, Thailand; UCLA School; NCRR [C06 RR014529]; UCLA School of Dentistry; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS049137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023163] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Thai Government, Thailand; UCLA School; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UCLA School of Dentistry; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS049137 and DA023163. This work was also supported by a Royal Thai Government scholarship from Thailand, a UCLA School of Dentistry seed grant, and Research Facilities Improvement Program Grant C06 RR014529 from NCRR, National Institutes of Health.; We thank Prof. Yasuhiko Tabata (Institute for Frontier Medical Science, Kyoto University, Japan) for providing cationized gelatin nanoparticles, Dr. Emmanuelle Faure-Kuma (Vector Core, UCLA) for lentivirus production, Dr. Mathew Schibler (California NanoSystems Institute and Brain Research Institute microscopy core facility, UCLA) for confocal laser scanning micrography, Mari-ane Cilluffo (Brain Research Institute microscopy core facility) for immunohistochemistry consultation, and (Daniela Markovic of Department of Biomathematics), and David Geffen (School of Medicine at UCLA) for statistical consultation. We also thank Prof. David Wong (Associate Dean of Research, UCLA School of Dentistry) for generous funding support for statistical consultations.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Bailey AL, 2006, NEUROSCIENCE, V138, P675, DOI 10.1016/j.neuroscience.2005.11.051; Baron R, 2009, PAIN, V146, P34, DOI 10.1016/j.pain.2009.06.001; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Black JA, 2008, ANN NEUROL, V64, P644, DOI 10.1002/ana.21527; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Coward K, 2000, PAIN, V85, P41, DOI 10.1016/S0304-3959(99)00251-1; Delaney A, 2009, NEUROTHERAPEUTICS, V6, P630, DOI 10.1016/j.nurt.2009.07.005; Dib-Hajj SD, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-37; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Dong XW, 2007, NEUROSCIENCE, V146, P812, DOI 10.1016/j.neuroscience.2007.01.054; England JD, 1996, NEUROLOGY, V47, P272, DOI 10.1212/WNL.47.1.272; Frieboes LR, 2010, J ORTHOP RES, V28, P753, DOI 10.1002/jor.21047; Fukuoka T, 2008, J COMP NEUROL, V510, P188, DOI 10.1002/cne.21786; Gardner E.P., 2000, PRINCIPLES NEURAL SC, P430; Gilron I, 2006, CAN MED ASSOC J, V175, P265, DOI 10.1503/cmaj.060146; Gold MS, 2003, J NEUROSCI, V23, P158; Gupta R, 2006, EXP NEUROL, V200, P418, DOI 10.1016/j.expneurol.2006.02.134; Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006; Hoffman EM, 2010, J HISTOCHEM CYTOCHEM, V58, P329, DOI 10.1369/jhc.2009.954008; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KAJANDER KC, 1992, J NEUROPHYSIOL, V68, P734, DOI 10.1152/jn.1992.68.3.734; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kretschmer T, 2002, J NEUROSURG, V97, P1424, DOI 10.3171/jns.2002.97.6.1424; Kretschmer T, 2002, ACTA NEUROCHIR, V144, P803, DOI 10.1007/s00701-002-0970-1; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Lai J, 2004, ANNU REV PHARMACOL, V44, P371, DOI 10.1146/annurev.pharmtox.44.101802.121627; Liu JM, 2006, J NEUROSCI, V26, P5204, DOI 10.1523/JNEUROSCI.4917-05.2006; Loser P, 1998, J VIROL, V72, P180; Matsuka Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-66; MATZNER O, 1994, J NEUROPHYSIOL, V72, P349, DOI 10.1152/jn.1994.72.1.349; Mikami M, 2005, ANESTHESIOLOGY, V103, P828, DOI 10.1097/00000542-200510000-00022; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Mosconi T, 1996, PAIN, V64, P37, DOI 10.1016/0304-3959(95)00077-1; Murashov AK, 2007, FASEB J, V21, P656, DOI 10.1096/fj.06-6155com; Novakovic SD, 1998, J NEUROSCI, V18, P2174; Pitcher GM, 1999, PAIN, V83, P37, DOI 10.1016/S0304-3959(99)00085-8; Pitcher GM, 2008, EXP NEUROL, V214, P219, DOI 10.1016/j.expneurol.2008.08.003; Puigdellivol-Sanchez A, 2002, J NEUROSCI METH, V115, P115, DOI 10.1016/S0165-0270(01)00532-5; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Shembalkar PK, 2001, EUR J PAIN, V5, P319, DOI 10.1053/eujp.2001.0251; Siqueira SRDT, 2009, NEUROSCIENCE, V164, P573, DOI 10.1016/j.neuroscience.2009.08.037; Taylor Rod S, 2006, Pain Pract, V6, P22, DOI 10.1111/j.1533-2500.2006.00054.x; Thakor D, 2007, MOL THER, V15, P2124, DOI 10.1038/sj.mt.6300256; Thakor DK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-14; Tomishima MJ, 2001, TRAFFIC, V2, P429, DOI 10.1034/j.1600-0854.2001.020701.x; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; WAXMAN SG, 1999, PAIN S, V6, P133; Yiangou Y, 2000, FEBS LETT, V467, P249, DOI 10.1016/S0014-5793(00)01166-2; Zhang XF, 2004, BRAIN RES, V1009, P147, DOI 10.1016/j.brainres.2004.02.057; Zhao J, 2010, J NEUROSCI, V30, P10860, DOI 10.1523/JNEUROSCI.1980-10.2010	60	28	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39836	39847		10.1074/jbc.M111.261701	http://dx.doi.org/10.1074/jbc.M111.261701			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965668	Green Published, hybrid			2022-12-25	WOS:000296925700018
J	Paul, AG; Sharma-Walia, N; Chandran, B				Paul, Arun George; Sharma-Walia, Neelam; Chandran, Bala			Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; KAPOSIS-SARCOMA; CYCLOOXYGENASE-2 COX-2; GROWTH-FACTOR; CANCER-CELLS; IN-VITRO; APOPTOSIS; EXPRESSION; INDUCTION; INFECTION	The significance of inflammation in KSHV biology and tumorigenesis prompted us to examine the role of COX-2 in primary effusion lymphoma (PEL), an aggressive AIDS-linked KSHV-associated non-Hodgkin's lymphoma (NHL) using nimesulide, a well-known COX-2 specific NSAID. We demonstrate that (1) nimesulide is efficacious in inducing proliferation arrest in PEL (KSHV+/EBV-; BCBL-1 and BC-3, KSHV+/EBV+; JSC-1), EBV-infected (KSHV-/EBV+; Raji) and non-infected (KSHV-/EBV-; Akata, Loukes, Ramos, BJAB) high malignancy human Burkitt's lymphoma (BL) as well as KSHV-/EBV+ lymphoblastoid (LCL) cell lines; (2) nimesulide is selectively toxic to KSHV infected endothelial cells (TIVE-LTC) compared to TIVE and primary endothelial cells (HMVEC-d); (3) nimesulide reduced KSHV latent gene expression, disrupted p53-LANA-1 protein complexes, and activated the p53/p21 tumor-suppressor pathway; (4) COX-2 inhibition down-regulated cell survival kinases (p-Akt and p-GSK-3b), an angiogenic factor (VEGF-C), PEL defining genes (syndecan-1, aquaporin-3, and vitamin-D3 receptor) and cell cycle proteins such as cyclins E/A and cdc25C; (5) nimesulide induced sustained cell death and G1 arrest in BCBL-1 cells; (6) nimesulide substantially reduced the colony forming capacity of BCBL-1 cells. Overall, our studies provide a comprehensive molecular framework linking COX-2 with PEL pathogenesis and identify the chemotherapeutic potential of nimesulide in treating PEL.	[Paul, Arun George; Sharma-Walia, Neelam; Chandran, Bala] Rosalind Franklin Univ Med & Sci, HM Bligh Canc Res Labs, Dept Microbiol & Immunol, Chicago Med Sch, N Chicago, IL USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Paul, AG (corresponding author), Rosalind Franklin Univ Med & Sci, HM Bligh Canc Res Labs, Dept Microbiol & Immunol, Chicago Med Sch, N Chicago, IL USA.	neelam.sharma-walia@rosalindfranklin.edu		Paul, Arun/0000-0002-4643-2568	Public Health Service [CA128560]; RFUMS H. M. Bligh Cancer Research Fund;  [G2009101428];  [CA 099925]; NATIONAL CANCER INSTITUTE [R01CA099925, R21CA128560] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); RFUMS H. M. Bligh Cancer Research Fund; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by Sigma Xi Grant-in-aid grant G2009101428 to AGP, Public Health Service grant CA128560 to NSW, and CA 099925 and RFUMS H. M. Bligh Cancer Research Fund to B. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2004, LEUKEMIA, V18, P1699, DOI 10.1038/sj.leu.2403460; Aoki M, 2001, TUMOR BIOL, V22, P239, DOI 10.1159/000050622; Bakhle YS, 2001, BRIT J PHARMACOL, V134, P1137, DOI 10.1038/sj.bjp.0704365; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Bernard MP, 2008, CURR PHARM DESIGN, V14, P2051, DOI 10.2174/138161208785294654; Bhatt AP, 2010, BLOOD, V115, P4455, DOI 10.1182/blood-2009-10-251082; Blumenthal RD, 2001, CLIN CANCER RES, V7, P3178; Campbell FC, 2010, BIOCHEM PHARMACOL, V79, P1, DOI 10.1016/j.bcp.2009.09.005; Carbone A, 2009, BLOOD, V113, P1213, DOI 10.1182/blood-2008-09-180315; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen WG, 2010, J VIROL, V84, P3898, DOI 10.1128/JVI.01321-09; Curreli F, 2005, J CLIN INVEST, V115, P642, DOI 10.1172/JCI200523334; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; DAVIS R, 1994, DRUGS, V48, P431, DOI 10.2165/00003495-199448030-00008; de Groot DJA, 2007, BRIT J CANCER, V97, P1077, DOI 10.1038/sj.bjc.6604010; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Guasparri I, 2006, EMBO REP, V7, P114, DOI 10.1038/sj.embor.7400580; Halfdanarson TR, 2006, ANN ONCOL, V17, P1849, DOI 10.1093/annonc/mdl139; Hocqueloux L, 2001, AIDS, V15, P280, DOI 10.1097/00002030-200101260-00023; Hull MA, 2005, EUR J CANCER, V41, P1854, DOI 10.1016/j.ejca.2005.04.013; Jenner RG, 2003, P NATL ACAD SCI USA, V100, P10399, DOI 10.1073/pnas.1630810100; Jones MK, 1999, NAT MED, V5, P1418; Kardosh A, 2005, CANCER BIOL THER, V4, P571, DOI 10.4161/cbt.4.5.1699; Klass CM, 2005, CURR OPIN ONCOL, V17, P447, DOI 10.1097/01.cco.0000172823.01190.6c; Klein U, 2003, BLOOD, V101, P4115, DOI 10.1182/blood-2002-10-3090; Kobayashi M, 2005, EUR J HAEMATOL, V75, P212, DOI 10.1111/j.1600-0609.2005.00498.x; Ladetto M, 2005, BLOOD, V105, P4784, DOI 10.1182/blood-2004-11-4201; Li JY, 2003, WORLD J GASTROENTERO, V9, P915; Liu JF, 2009, CANCER INVEST, V27, P17, DOI 10.1080/07357900801992913; Luppi M, 2005, LEUKEMIA, V19, P473, DOI 10.1038/sj.leu.2403646; Naranatt PP, 2004, CANCER RES, V64, P72, DOI 10.1158/0008-5472.CAN-03-2767; Nun TK, 2007, MOL CANCER THER, V6, P2360, DOI 10.1158/1535-7163.MCT-07-0108; Paul AG, 2010, CANCER RES, V70, P3697, DOI 10.1158/0008-5472.CAN-09-3934; Renard Jean-Francois, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P233, DOI 10.2174/187152006776930855; Sadagopan S, 2007, J VIROL, V81, P3949, DOI 10.1128/JVI.02333-06; Saini AK, 2009, NUTR HOSP, V24, P717, DOI 10.3305/nh.2009.24.6.4557; Sarek G, 2007, J CLIN INVEST, V117, P1019, DOI 10.1172/JCI30945; Sharma-Walia N, 2006, J VIROL, V80, P6534, DOI 10.1128/JVI.00231-06; SHARMAWALIA N, 2010, PLOS PATHOG, V0006; Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092; Sinha-Datta U, 2008, APOPTOSIS, V13, P33, DOI 10.1007/s10495-007-0148-7; Su B, 2009, BIOORG MED CHEM LETT, V19, P6733, DOI 10.1016/j.bmcl.2009.09.109; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Toomey NL, 2001, ONCOGENE, V20, P7029, DOI 10.1038/sj.onc.1204895; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wen KW, 2010, CANCER LETT, V289, P140, DOI 10.1016/j.canlet.2009.07.004; Wun T, 2004, LEUKEMIA RES, V28, P179, DOI 10.1016/S0145-2126(03)00183-8; Zha S, 2004, CANCER LETT, V215, P1, DOI 10.1016/j.canlet.2004.06.014	53	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24379	10.1371/journal.pone.0024379	http://dx.doi.org/10.1371/journal.pone.0024379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980345	gold, Green Published, Green Submitted			2022-12-25	WOS:000295941300005
J	Wu, XH; Chen, S; He, YZ; Rhodes, SD; Mohammad, KS; Li, XH; Yang, XL; Jiang, L; Nalepa, G; Snider, P; Robling, AG; Clapp, DW; Conway, SJ; Guise, TA; Yang, FC				Wu, Xiaohua; Chen, Shi; He, Yongzheng; Rhodes, Steven D.; Mohammad, Khalid S.; Li, Xiaohong; Yang, Xianlin; Jiang, Li; Nalepa, Grzegorz; Snider, Paige; Robling, Alexander G.; Clapp, D. Wade; Conway, Simon J.; Guise, Theresa A.; Yang, Feng-Chun			The Haploinsufficient Hematopoietic Microenvironment Is Critical to the Pathological Fracture Repair in Murine Models of Neurofibromatosis Type 1	PLOS ONE			English	Article							NF1 TUMOR-SUPPRESSOR; BONE-MINERAL-DENSITY; STEM-CELL NICHE; TIBIAL PSEUDOARTHROSIS; SPINAL DEFORMITIES; SKELETAL TISSUES; MICE; GENE; IDENTIFICATION; OSTEOBLAST	Germline mutations in the NF1 tumor suppressor gene cause neurofibromatosis type 1 (NF1), a complex genetic disorder with a high predisposition of numerous skeletal dysplasias including short stature, osteoporosis, kyphoscoliosis, and facture non-union (pseudoarthrosis). We have developed rnurine models that phenocopy many of the skeletal dysplasias observed in NF1 patients, including reduced bone mass and fracture non-union. We also show that the development of these skeletal manifestations requires an Nf1 haploinsufficient background in addition to nullizygous loss of Nf1 in mesenchymal stem/progenitor cells (MSCs) and/or their progenies. This is replicated in two animal models of NF1, PeriCre(+);Nf1(flox/-) and Col2.3Cre(+);Nf1(flox/-) mice. Adoptive transfer experiments demonstrate a critical role of the Nf1(+/-) marrow microenvironment in the impaired fracture healing in both models and adoptive transfer of WT bone marrow cells improves fracture healing in these mice. To our knowledge, this is the first demonstration of a non-cell autonomous mechanism in non-malignant NF1 manifestations. Collectively, these data provide evidence of a combinatory effect between nullizygous loss Nf1 in osteoblast progenitors and haploinsufficiency in hematoietic cells in the develpment of non-malignant NF1 manifestations.	[Wu, Xiaohua; Chen, Shi; He, Yongzheng; Li, Xiaohong; Yang, Xianlin; Jiang, Li; Nalepa, Grzegorz; Snider, Paige; Clapp, D. Wade; Conway, Simon J.; Yang, Feng-Chun] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Wu, Xiaohua; Chen, Shi; He, Yongzheng; Rhodes, Steven D.; Li, Xiaohong; Yang, Xianlin; Jiang, Li; Nalepa, Grzegorz; Snider, Paige; Clapp, D. Wade; Conway, Simon J.; Yang, Feng-Chun] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA; [Mohammad, Khalid S.; Guise, Theresa A.] Indiana Univ Sch Med, Dept Internal Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wu, XH (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	fyang@iupui.edu	Mohammad, Khalid/AAE-9569-2022; Mohammad, Khalid/AFE-4205-2022	Lab, Nalepa/0000-0002-7560-1906; Nalepa, Grzegorz/0000-0002-5779-9103	Department of Defense (DOD) [NF043032, NF073112]; March of Dimes [YF08-246]; National Institute of Neurological Disorders and Stroke [NS052606]; Indiana Clinical and Translational Sciences Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS052606] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); March of Dimes(March of Dimes); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Indiana Clinical and Translational Sciences Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Department of Defense (DOD) grant no. NF043032 to FCY and grant no. NF073112 to FCY; March of Dimes grant no. YF08-246 to FCY; National Institute of Neurological Disorders and Stroke grant no. NS052606 to WC, SJC and FCY; and the Indiana Clinical and Translational Sciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2001, J IMMUNOL, V166, P552, DOI 10.4049/jimmunol.166.1.552; Atit RP, 1999, J INVEST DERMATOL, V112, P835, DOI 10.1046/j.1523-1747.1999.00609.x; Atit RP, 2000, J INVEST DERMATOL, V114, P1093, DOI 10.1046/j.1523-1747.2000.00994.x; Bajenaru ML, 2003, CANCER RES, V63, P8573; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Cecchini MG, 1997, MOL REPROD DEV, V46, P75; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; CRAWFORD AH, 1986, J PEDIATR ORTHOPED, V6, P72, DOI 10.1097/01241398-198601000-00015; CRAWFORD AH, 1989, CLIN ORTHOP RELAT R, P29; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Daginakatte GC, 2007, HUM MOL GENET, V16, P1098, DOI 10.1093/hmg/ddm059; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Heuze Y, 2002, Rev Stomatol Chir Maxillofac, V103, P105; Illes T, 2001, OSTEOPOROSIS INT, V12, P823, DOI 10.1007/s001980170032; Ingram DA, 2000, J EXP MED, V191, P181, DOI 10.1084/jem.191.1.181; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Jacques C, 2005, J NEURORADIOLOGY, V32, P180, DOI 10.1016/S0150-9861(05)83136-0; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Kolanczyk M, 2007, HUM MOL GENET, V16, P874, DOI 10.1093/hmg/ddm032; Komatsu DE, 2010, J ORTHOP RES, V28, P928, DOI 10.1002/jor.21078; Kruzynska-Frejtag A, 2004, DEV DYNAM, V229, P857, DOI 10.1002/dvdy.10453; Kuorilehto T, 2004, J BONE MINER RES, V19, P983, DOI 10.1359/JBMR.040130; Kuorilehto T, 2005, OSTEOPOROSIS INT, V16, P928, DOI 10.1007/s00198-004-1801-4; Kuorilehto T, 2006, PATHOL RES PRACT, V202, P687, DOI 10.1016/j.prp.2006.03.006; Lammert M, 2005, OSTEOPOROSIS INT, V16, P1161, DOI 10.1007/s00198-005-1940-2; Lindsley A, 2007, DEV BIOL, V307, P340, DOI 10.1016/j.ydbio.2007.04.041; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; MARQUES P, 1951, J Radiol Electrol Arch Electr Medicale, V32, P608; Munugalavadla V, 2008, MOL CELL BIOL, V28, P7182, DOI 10.1128/MCB.00920-08; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Rasmussen SA, 2000, GENE CHROMOSOME CANC, V28, P425, DOI 10.1002/1098-2264(200008)28:4<425::AID-GCC8>3.0.CO;2-E; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rutkowski JL, 2000, HUM MOL GENET, V9, P1059, DOI 10.1093/hmg/9.7.1059; Sawada S, 1996, NAT GENET, V14, P110, DOI 10.1038/ng0996-110; Sbihi A, 1980, Maroc Med, V2, P393; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Simmons GW, 2011, J NEUROPATH EXP NEUR, V70, P51, DOI 10.1097/NEN.0b013e3182032d37; Stevenson DA, 2006, AM J HUM GENET, V79, P143, DOI 10.1086/504441; Stevenson DA, 1999, AM J MED GENET, V84, P413, DOI 10.1002/(SICI)1096-8628(19990611)84:5<413::AID-AJMG5>3.0.CO;2-1; Stevenson DA, 2007, J PEDIATR-US, V150, P83, DOI 10.1016/j.jpeds.2006.10.048; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Wang W, 2010, J BONE MINER RES; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Warden SJ, 2009, BONE, V44, P485, DOI 10.1016/j.bone.2008.11.007; Wu XH, 2006, HUM MOL GENET, V15, P2837, DOI 10.1093/hmg/ddl208; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yang FC, 2003, J CLIN INVEST, V112, P1851, DOI 10.1172/JCI200319195; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Yang FC, 2006, J CLIN INVEST, V116, P2880, DOI 10.1172/JCI29092; Yu X, 2005, BONE; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang W, 2011, BONE; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	58	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e24917	10.1371/journal.pone.0024917	http://dx.doi.org/10.1371/journal.pone.0024917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980365	Green Submitted, Green Published, gold			2022-12-25	WOS:000295939600009
J	Garvin, MR; Bielawski, JP; Gharrett, AJ				Garvin, Michael R.; Bielawski, Joseph P.; Gharrett, Anthony J.			Positive Darwinian Selection in the Piston That Powers Proton Pumps in Complex I of the Mitochondria of Pacific Salmon	PLOS ONE			English	Article							MOLECULAR ADAPTATION; ADAPTIVE SELECTION; NATURAL-SELECTION; DNA; EVOLUTION; MTDNA; ONCORHYNCHUS; HUMANS; SUBSTITUTION; MODELS	The mechanism of oxidative phosphorylation is well understood, but evolution of the proteins involved is not. We combined phylogenetic, genomic, and structural biology analyses to examine the evolution of twelve mitochondrial encoded proteins of closely related, yet phenotypically diverse, Pacific salmon. Two separate analyses identified the same seven positively selected sites in ND5. A strong signal was also detected at three sites of ND2. An energetic coupling analysis revealed several structures in the ND5 protein that may have co-evolved with the selected sites. These data implicate Complex I, specifically the piston arm of ND5 where it connects the proton pumps, as important in the evolution of Pacific salmon. Lastly, the lineage to Chinook experienced rapid evolution at the piston arm.	[Garvin, Michael R.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Div Fisheries, Juneau, AK USA; [Bielawski, Joseph P.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Gharrett, Anthony J.] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada	University of Alaska System; University of Alaska Fairbanks; Dalhousie University; Dalhousie University	Garvin, MR (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Div Fisheries, Juneau, AK USA.	mrgarvin@alaska.edu		Garvin, Michael/0000-0002-2204-7569; Bielawski, Joseph/0000-0002-1621-1772	Arctic-Yukon-Kuskokwim-Sustainable-Salmon-Initiative; Alaska Sustainable Salmon Fund	Arctic-Yukon-Kuskokwim-Sustainable-Salmon-Initiative; Alaska Sustainable Salmon Fund	M. Garvin's PhD thesis is being supported by the Arctic-Yukon-Kuskokwim-Sustainable-Salmon-Initiative (www.aykssi.org) and the Alaska Sustainable Salmon Fund (www.akssf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barrowclough GF, 2009, MOL ECOL, V18, P2934, DOI 10.1111/j.1365-294X.2009.04271.x; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Behnke RJ, 2002, TROUT SALMON N AM; Bielawski JP, 2005, LIKELIHOOD METHODS D; BLIER PU, 1993, J EXP BIOL, V176, P145; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Efremov R.G., 2011, NATURE; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FRIEDBERG EC, 2005, DNA REPAIR MUTATGENE; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Garvin MR, 2010, GENOME, V53, P501, DOI [10.1139/G10-026, 10.1139/g10-026]; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Glemet H, 1998, MOL ECOL, V7, P1655, DOI 10.1046/j.1365-294x.1998.00494.x; GLEMET HC, 1997, MITOCHONDRIAL DNA IN; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Hendry A. P., 2004, EVOLUTION ILLUMINATE; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Khan SM, 2007, AM J PHYSIOL-CELL PH, V292, pC658, DOI 10.1152/ajpcell.00224.2006; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lio P, 2005, GENE, V345, P55, DOI 10.1016/j.gene.2004.11.033; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lodish H, 2000, MOL CELL BIOL; Mathews C.K., 2000, BIOCHEMISTRY-US; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; MCCUSKER MR, 2010, MOL ECOLOGY; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nachman MW, 1996, GENETICS, V142, P953; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Ohnishi T, 2010, FEBS LETT, V584, P4131, DOI 10.1016/j.febslet.2010.08.039; Pabijan M, 2008, J MOL EVOL, V67, P246, DOI 10.1007/s00239-008-9123-3; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; STEARLEY RF, 1993, T AM FISH SOC, V122, P1, DOI 10.1577/1548-8659(1993)122<0001:POTPTA>2.3.CO;2; Steimle S, 2011, BIOCHEMISTRY-US, V50, P3386, DOI 10.1021/bi200264q; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; SWOFFORD DL, 1996, MOL SYSTEMATICS, V2, P407; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; THOMAS WK, 1986, CAN J ZOOL, V64, P1058, DOI 10.1139/z86-158; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; UTTER FM, 1994, CONSERV BIOL, V8, P864, DOI 10.1046/j.1523-1739.1994.08030863-2.x; Wise CA, 1998, GENETICS, V148, P409; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zink RM, 2005, P ROY SOC B-BIOL SCI, V272, P71, DOI 10.1098/rspb.2004.2908; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	76	78	80	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24127	10.1371/journal.pone.0024127	http://dx.doi.org/10.1371/journal.pone.0024127			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969854	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900005
J	Mereuta, L; Asandei, A; Luchian, T				Mereuta, Loredana; Asandei, Alina; Luchian, Tudor			Meet Me on the Other Side: Trans-Bilayer Modulation of a Model Voltage-Gated Ion Channel Activity by Membrane Electrostatics Asymmetry	PLOS ONE			English	Article							HP(2-20) ANTIMICROBIAL PEPTIDE; LIPID-MEMBRANES; BIOLOGICAL-MEMBRANES; GRAMICIDIN CHANNEL; ALAMETHICIN; CONDUCTANCE; PHOSPHOLIPIDS; PROBABILITY; PHLORETIN; BEHAVIOR	While it is accepted that biomembrane asymmetry is generated by proteins and phospholipids distribution, little is known about how electric changes manifested in a monolayer influence functional properties of proteins localized on the opposite leaflet. Herein we used single-molecule electrophysiology and investigated how asymmetric changes in the electrostatics of an artificial lipid membrane monolayer, generated oppositely from where alamethicin - a model voltage-gated ion channel was added, altered peptide activity. We found that phlorizin, a membrane dipole potential lowering amphiphile, augmented alamethicin activity and transport features, whereas the opposite occurred with RH-421, which enhances the monolayer dipole potential. Further, the monolayer surface potential was decreased via adsorption of sodium dodecyl sulfate, and demonstrated that vectorial modification of it also affected the alamethicin activity in a predictive manner. A new paradigm is suggested according to which asymmetric changes in the monolayer dipole and surface potential extend their effects spatially by altering the intramembrane potential, whose gradient is sensed by distantly located peptides.	[Mereuta, Loredana; Asandei, Alina; Luchian, Tudor] Alexandru I Cuza Univ, Dept Phys, Lab Mol Biophys & Med Phys, Iasi, Romania	Alexandru Ioan Cuza University	Luchian, T (corresponding author), Alexandru I Cuza Univ, Dept Phys, Lab Mol Biophys & Med Phys, Iasi, Romania.	luchian@uaic.ro	Asandei, Alina/ABA-2912-2021	Luchian, Tudor/0000-0002-9388-7266	 [POSDRU/89/1.5/S/49944];  [POSDRU/89/1.5/S/63663]	; 	The authors' acknowledge the financial support offered by post-doctoral grants POSDRU/89/1.5/S/49944 (Development of the innovation capacity and growth of the research impact through post-doctoral programs) and POSDRU/89/1.5/S/63663 (Communicating Science). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen O S, 1999, Methods Enzymol, V294, P208; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Apetrei A, 2009, BBA-GEN SUBJECTS, V1790, P809, DOI 10.1016/j.bbagen.2009.04.002; Asawakarn T, 2001, J BIOL CHEM, V276, P38457, DOI 10.1074/jbc.M103269200; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezrukov SM, 2000, CURR OPIN COLLOID IN, V5, P237, DOI 10.1016/S1359-0294(00)00061-3; Bezrukov SM, 1998, FARADAY DISCUSS, V111, P173; Bjelkmar P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000289; CAFISO DS, 1994, ANNU REV BIOPH BIOM, V23, P141, DOI 10.1146/annurev.bb.23.060194.001041; CEVC G, 1990, BIOCHIM BIOPHYS ACTA, V1031, P311, DOI 10.1016/0304-4157(90)90015-5; Cladera J, 1998, BIOPHYS J, V74, P2434, DOI 10.1016/S0006-3495(98)77951-2; Cladera J, 1999, J BIOL CHEM, V274, P29951, DOI 10.1074/jbc.274.42.29951; Duclohier H, 2001, J MEMBRANE BIOL, V184, P1, DOI 10.1007/s00232-001-0077-2; Duffin RL, 2003, LANGMUIR, V19, P1439, DOI 10.1021/la025892q; FLEWELLING RF, 1986, BIOPHYS J, V49, P541, DOI 10.1016/S0006-3495(86)83664-5; FRANKLIN JC, 1993, BIOPHYS J, V65, P289, DOI 10.1016/S0006-3495(93)81051-8; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P4629, DOI 10.1021/jp8001993; Gurtovenko AA, 2007, J AM CHEM SOC, V129, P5358, DOI 10.1021/ja070949m; HALL JE, 1984, BIOPHYS J, V45, P233, DOI 10.1016/S0006-3495(84)84151-X; Jackson M. B., 2006, MOL CELLULAR BIOPHYS; KELLER SL, 1993, BIOPHYS J, V65, P23, DOI 10.1016/S0006-3495(93)81040-3; Lewis JR, 1999, BIOCHEMISTRY-US, V38, P5932, DOI 10.1021/bi9828167; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Luchian T, 2006, LANGMUIR, V22, P8452, DOI 10.1021/la0613777; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Lundbaek JA, 1999, BIOPHYS J, V76, P889, DOI 10.1016/S0006-3495(99)77252-8; Lundbaek JA, 2010, P NATL ACAD SCI USA, V107, P15427, DOI 10.1073/pnas.1007455107; Maggio B, 1999, J LIPID RES, V40, P930; Malkov DY, 1996, BBA-BIOMEMBRANES, V1278, P197, DOI 10.1016/0005-2736(95)00197-2; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; Mereuta L, 2008, BIOCHEM BIOPH RES CO, V373, P467, DOI 10.1016/j.bbrc.2008.04.046; Mereuta L, 2009, J BIOENERG BIOMEMBR, V41, P79, DOI 10.1007/s10863-009-9204-z; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; O'Shea P, 2005, PHILOS T R SOC A, V363, P575, DOI 10.1098/rsta.2004.1509; Ostroumova OS, 2008, LANGMUIR, V24, P2987, DOI 10.1021/la800206v; Ostroumova OS, 2010, LANGMUIR, V26, P15092, DOI 10.1021/la102691y; Petrache HI, 2006, P NATL ACAD SCI USA, V103, P7982, DOI 10.1073/pnas.0509967103; Pohl P, 1997, BBA-BIOMEMBRANES, V1323, P163, DOI 10.1016/S0005-2736(96)00185-X; Raychaudhuri P, 2011, BIOCHEMISTRY-US, V50, P1599, DOI 10.1021/bi1012386; Rokitskaya TI, 2002, BIOPHYS J, V82, P865, DOI 10.1016/S0006-3495(02)75448-9; SANSOM MSP, 1991, EUR BIOPHYS J, V20, P229, DOI 10.1007/BF00183460; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Sudbrack TP, 2011, J PHYS CHEM B, V115, P269, DOI 10.1021/jp108653e; Tan AM, 2002, BIOPHYS J, V83, P1547, DOI 10.1016/S0006-3495(02)73924-6; Tour O, 1998, BIOPHYS J, V74, P1767, DOI 10.1016/S0006-3495(98)77887-7; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200; Wiese A, 1996, BIOPHYS J, V70, P321, DOI 10.1016/S0006-3495(96)79573-5; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	51	17	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25276	10.1371/journal.pone.0025276	http://dx.doi.org/10.1371/journal.pone.0025276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980414	Green Published, Green Submitted, gold			2022-12-25	WOS:000295933700024
J	Subathra, M; Qureshi, A; Luberto, C				Subathra, Marimuthu; Qureshi, Asfia; Luberto, Chiara			Sphingomyelin Synthases Regulate Protein Trafficking and Secretion	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; D-MEDIATED PHOSPHORYLATION; CERAMIDE TRANSFER PROTEIN; CYSTEINE-RICH DOMAIN/; KINASE-C-MU; PLASMA-MEMBRANE; GLUCOSE-HOMEOSTASIS; INSULIN-SECRETION; MOLECULAR-CLONING; PHOSPHOLIPASE-C	Sphingomyelin synthases (SMS1 and 2) represent a class of enzymes that transfer a phosphocholine moiety from phosphatidylcholine onto ceramide thus producing sphingomyelin and diacylglycerol (DAG). SMS1 localizes at the Golgi while SMS2 localizes both at the Golgi and the plasma membrane. Previous studies from our laboratory showed that modulation of SMS1 and, to a lesser extent, of SMS2 affected the formation of DAG at the Golgi apparatus. As a consequence, down-regulation of SMS1 and SMS2 reduced the localization of the DAG-binding protein, protein kinase D (PKD), to the Golgi. Since PKD recruitment to the Golgi has been implicated in cellular secretion through the trans golgi network (TGN), the effect of down-regulation of SMSs on TGN-to-plasma membrane trafficking was studied. Down regulation of either SMS1 or SMS2 significantly retarded trafficking of the reporter protein vesicular stomatitis virus G protein tagged with GFP (VSVG-GFP) from the TGN to the cell surface. Inhibition of SMSs also induced tubular protrusions from the trans Golgi network reminiscent of inhibited TGN membrane fission. Since a recent study demonstrated the requirement of PKD activity for insulin secretion in beta cells, we tested the function of SMS in this model. Inhibition of SMS significantly reduced insulin secretion in rat INS-1 cells. Taken together these results provide the first direct evidence that both enzymes (SMS1 and 2) are capable of regulating TGN-mediated protein trafficking and secretion, functions that are compatible with PKD being a down-stream target for SMSs in the Golgi.	[Subathra, Marimuthu; Qureshi, Asfia; Luberto, Chiara] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Subathra, M (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	luberto@musc.edu			Hollings Cancer Center/Medical University of South Carolina Department of Defense [GC-3319-05-4498CM]; Nation Institutes of Health (NIH), National Center for Research Resources [P20 RR-017677]; American Cancer Society [IRG 97-219-08]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER	Hollings Cancer Center/Medical University of South Carolina Department of Defense; Nation Institutes of Health (NIH), National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by a Hollings Cancer Center/Medical University of South Carolina Department of Defense grant "Translational Research on Cancer Control and Related Therapy" (Subcontract GC-3319-05-4498CM), by the Nation Institutes of Health (NIH) Grant # P20 RR-017677 from the National Center for Research Resources, and by Grant # IRG 97-219-08 from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. John R. Raymond for the use of the velocity 3 software (obtained through the Department of Veterans Affairs Shared Equipment and Research Enhancement Award Program Grants to the Ralph H. Johnson VA Medical Center) and Drs. Aleksander Baldys and Jolanta Katarzyna Idkowiak- Baldys for their help with the 3D analysis of the images. We are grateful to Mrs. Katherine Robinson for the precious guidance in handling of INS- 1 cells and insulin measurements. We are deeply grateful to Dr. Paola Giussani (University of Milan, Italy) for the siRNA transfection protocol for INS- 1 cells. We thank Dr. Julie Chao for the use of the Gamma Counter. We are very appreciative of Drs. Yusuf Hannun, Lina Obeid and Maurizio Del Poeta for their enthusiastic support and critical discussion. We thank the Cell and Molecular Imaging Core at the Hollings Cancer Center (Medical University of South Carolina) for assistance with imaging analysis.	Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chen J, 2008, BIOCHEM J, V411, P333, DOI 10.1042/BJ20071334; Anel AMD, 2007, BIOCHEM J, V406, P157, DOI 10.1042/BJ20070359; Ding T, 2008, J LIPID RES, V49, P376, DOI 10.1194/jlr.M700401-JLR200; DIRINGER H, 1972, BIOCHEM BIOPH RES CO, V47, P1345, DOI 10.1016/0006-291X(72)90220-3; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; HAN S, 2010, CELL RES; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haselton AT, 2010, AGING-US, V2, P523, DOI 10.18632/aging.100185; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Huwiler A, 2009, PHARMACOL THERAPEUT, V124, P96, DOI 10.1016/j.pharmthera.2009.06.008; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Jin ZX, 2008, INT IMMUNOL, V20, P1427, DOI 10.1093/intimm/dxn100; Lafont E, 2010, CELL DEATH DIFFER, V17, P642, DOI 10.1038/cdd.2009.130; LEFRANCOIS L, 1982, VIROLOGY, V121, P168, DOI 10.1016/0042-6822(82)90126-X; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Li ZQ, 2007, BBA-MOL CELL BIOL L, V1771, P1186, DOI 10.1016/j.bbalip.2007.05.007; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Meng AM, 2004, EXP CELL RES, V292, P385, DOI 10.1016/j.yexcr.2003.10.001; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Qureshi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015587; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Rey O, 2001, BIOCHEM BIOPH RES CO, V287, P21, DOI 10.1006/bbrc.2001.5530; Schultz A, 2004, J BIOL CHEM, V279, P31750, DOI 10.1074/jbc.M313017200; Separovic D, 2008, EXP CELL RES, V314, P1860, DOI 10.1016/j.yexcr.2008.02.008; Separovic D, 2007, BIOCHEM BIOPH RES CO, V358, P196, DOI 10.1016/j.bbrc.2007.04.095; Speight P, 2005, TRAFFIC, V6, P858, DOI 10.1111/j.1600-0854.2005.00321.x; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tani M, 2009, BIOCHEM BIOPH RES CO, V381, P328, DOI 10.1016/j.bbrc.2009.02.063; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; Toker A, 2005, EMBO REP, V6, P310, DOI 10.1038/sj.embor.7400378; Toomre D, 1999, J CELL SCI, V112, P21; ULLMAN MD, 1974, J BIOL CHEM, V249, P1506; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; van der Luit AH, 2007, BIOCHEM J, V401, P541, DOI 10.1042/BJ20061178; Villani M, 2008, BIOCHEM J, V414, P31, DOI 10.1042/BJ20071240; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	60	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e23644	10.1371/journal.pone.0023644	http://dx.doi.org/10.1371/journal.pone.0023644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980337	Green Submitted, gold, Green Published			2022-12-25	WOS:000295933700003
J	Ansaldi, D; Hod, EA; Stellari, F; Kim, JB; Lim, E; Roskey, M; Francis, KP; Singh, R; Zhang, N				Ansaldi, Dan; Hod, Eldad A.; Stellari, Fabio; Kim, Jae-Beom; Lim, Ed; Roskey, Mark; Francis, Kevin P.; Singh, Rajendra; Zhang, Ning			Imaging Pulmonary NF-kappaB Activation and Therapeutic Effects of MLN120B and TDZD-8	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TUMOR-NECROSIS-FACTOR; ACUTE LUNG INJURY; B ACTIVATION; GENE-EXPRESSION; IN-VIVO; DNA COMPLEXES; INFLAMMATION; MICE; LIPOPOLYSACCHARIDE	NF-kappa B activation is a critical signaling event in the inflammatory response and has been implicated in a number of pathological lung diseases. To enable the assessment of NF-kappa B activity in the lungs, we transfected a luciferase based NF-kappa B reporter into the lungs of mice or into Raw264.7 cells in culture. The transfected mice showed specific luciferase expression in the pulmonary tissues. Using these mouse models, we studied the kinetics of NF-kappa B activation following exposure to lipopolysaccharide (LPS). The Raw264.7 cells expressed a dose-dependent increase in luciferase following exposure to LPS and the NF-kappa B reporter mice expressed luciferase in the lungs following LPS challenge, establishing that bioluminescence imaging provides adequate sensitivity for tracking the NF-kappa B activation pathway. Interventions affecting the NF-kappa B pathway are promising clinical therapeutics, thus we further examined the effect of IKK-2 inhibition by MLN120B and glycogen synthase kinase 3 beta inhibition by TDZD-8 on NF-kappa B activation. Pre-treatment with either MLN120B or TDZD-8 attenuated NF-kappa B activation in the pulmonary tissues, which was accompanied with suppression of pro-inflammatory chemokine MIP-1 beta and induction of anti-inflammatory cytokine IL-10. In summary, we have established an imaging based approach for non-invasive and longitudinal assessment of NF-kappa B activation and regulation during acute lung injury. This approach will potentiate further studies on NF-kappa B regulation under various inflammatory conditions.	[Ansaldi, Dan; Kim, Jae-Beom; Lim, Ed; Roskey, Mark; Francis, Kevin P.; Singh, Rajendra; Zhang, Ning] Caliper Life Sci, Alameda, CA USA; [Hod, Eldad A.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY USA; [Stellari, Fabio] Chiesi Grp, Vivo Pulm Pharmacol Dept, Parma, Italy	Columbia University; Chiesi Pharmaceuticals Inc	Ansaldi, D (corresponding author), Caliper Life Sci, Alameda, CA USA.	ning.zhang@caliperls.com	Hamblin, Michael R/H-2758-2019; Hamblin, Mike/AAB-2511-2022	Hamblin, Michael R/0000-0001-6431-4605; 	Caliper Life Sciences	Caliper Life Sciences	This research project was funded by Caliper Life Sciences, who, through the employment of Dan Ansaldi, Jae-Beom Kim, Ed Lim, Mark Roskey, Kevin P. Francis, Raj Singh amd Ning Zhang were involved in the conceiving, designing and performing of the experiments and the analyzing of the data.	Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Blackwell TS, 2000, AM J RESP CRIT CARE, V162, P1095, DOI 10.1164/ajrccm.162.3.9906129; Bless NM, 2000, J IMMUNOL, V164, P2650, DOI 10.4049/jimmunol.164.5.2650; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Charokopos N, 2009, CURR MED CHEM, V16, P867, DOI 10.2174/092986709787549280; Cuzzocrea S, 2006, BRIT J PHARMACOL, V149, P687, DOI 10.1038/sj.bjp.0706902; Cuzzocrea S, 2002, EUR CYTOKINE NETW, V13, P285; Densmore Charles L., 2006, Current Drug Delivery, V3, P55, DOI 10.2174/156720106775197547; Dugo L, 2005, CRIT CARE MED, V33, P1903, DOI 10.1097/01.CCM.0000178350.21839.44; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Geraets L, 2009, BIOCHEM BIOPH RES CO, V382, P598, DOI 10.1016/j.bbrc.2009.03.071; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ginger RS, 2000, EMBO J, V19, P5483, DOI 10.1093/emboj/19.20.5483; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hubbard AK, 2002, AM J PHYSIOL-LUNG C, V282, pL968, DOI 10.1152/ajplung.00327.2001; Izmailova ES, 2007, ARTHRITIS RHEUM-US, V56, P117, DOI 10.1002/art.22303; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kline JN, 1999, AM J RESP CRIT CARE, V160, P297, DOI 10.1164/ajrccm.160.1.9808144; Koay MA, 2002, AM J PHYSIOL-LUNG C, V283, pL1247, DOI 10.1152/ajplung.00036.2002; Lesina E, 2010, J CONTROL RELEASE, V143, P243, DOI 10.1016/j.jconrel.2010.01.003; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Mizuno T, 2009, J CONTROL RELEASE, V134, P149, DOI 10.1016/j.jconrel.2008.11.018; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Van Wauwe J, 2003, DRUG NEWS PERSPECT, V16, P557, DOI 10.1358/dnp.2003.16.9.829337; Vernooy JHJ, 2002, AM J RESP CELL MOL, V26, P152, DOI 10.1165/ajrcmb.26.1.4652; Vernooy JHJ, 2001, AM J RESP CELL MOL, V24, P569, DOI 10.1165/ajrcmb.24.5.4156; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; WORTHEN GS, 1996, MECH NEUTROPHIL MEDI, P99; Yao HW, 2009, CURR OPIN PHARMACOL, V9, P375, DOI 10.1016/j.coph.2009.06.009; Yew NS, 2005, ADV GENET, V53, P189, DOI 10.1016/S0065-2660(05)53007-4; Zhang N, 2003, J IMMUNOL, V170, P6307, DOI 10.4049/jimmunol.170.12.6307	41	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25093	10.1371/journal.pone.0025093	http://dx.doi.org/10.1371/journal.pone.0025093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966423	Green Published, gold			2022-12-25	WOS:000295265100055
J	Gonzalez, NH; Felsner, G; Schramm, FD; Klingl, A; Maier, UG; Bolte, K				Gonzalez, Nicola H.; Felsner, Gregor; Schramm, Frederic D.; Klingl, Andreas; Maier, Uwe-G.; Bolte, Kathrin			A Single Peroxisomal Targeting Signal Mediates Matrix Protein Import in Diatoms	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PHAEODACTYLUM-TRICORNUTUM; MEMBRANE-PROTEINS; CARBOXY-TERMINUS; RECEPTOR; ARABIDOPSIS; EVOLUTION; THIOLASE; PLASTIDS; PATHWAY	Peroxisomes are single membrane bound compartments. They are thought to be present in almost all eukaryotic cells, although the bulk of our knowledge about peroxisomes has been generated from only a handful of model organisms. Peroxisomal matrix proteins are synthesized cytosolically and posttranslationally imported into the peroxisomal matrix. The import is generally thought to be mediated by two different targeting signals. These are respectively recognized by the two import receptor proteins Pex5 and Pex7, which facilitate transport across the peroxisomal membrane. Here, we show the first in vivo localization studies of peroxisomes in a representative organism of the ecologically relevant group of diatoms using fluorescence and transmission electron microscopy. By expression of various homologous and heterologous fusion proteins we demonstrate that targeting of Phaeodactylum tricornutum peroxisomal matrix proteins is mediated only by PTS1 targeting signals, also for proteins that are in other systems imported via a PTS2 mode of action. Additional in silico analyses suggest this surprising finding may also apply to further diatoms. Our data suggest that loss of the PTS2 peroxisomal import signal is not reserved to Caenorhabditis elegans as a single exception, but has also occurred in evolutionary divergent organisms. Obviously, targeting switching from PTS2 to PTS1 across different major eukaryotic groups might have occurred for different reasons. Thus, our findings question the widespread assumption that import of peroxisomal matrix proteins is generally mediated by two different targeting signals. Our results implicate that there apparently must have been an event causing the loss of one targeting signal even in the group of diatoms. Different possibilities are discussed that indicate multiple reasons for the detected targeting switching from PTS2 to PTS1.	[Gonzalez, Nicola H.; Felsner, Gregor; Schramm, Frederic D.; Maier, Uwe-G.; Bolte, Kathrin] Univ Marburg, Cell Biol Lab, Marburg, Germany; [Klingl, Andreas; Maier, Uwe-G.] LOEWE Zent Synthet Mikrobiol SynMikro, Marburg, Germany	Philipps University Marburg	Gonzalez, NH (corresponding author), Univ Marburg, Cell Biol Lab, Marburg, Germany.	kathrin.bolte@biologie.uni-marburg.de	Klingl, Andreas/K-6675-2014	Schramm, Frederic Dominique/0000-0003-1858-7770; Klingl, Andreas/0000-0001-8414-8317	German Research Foundation [SFB593]; LOEWE program of the State of Hessen (Germany)	German Research Foundation(German Research Foundation (DFG)); LOEWE program of the State of Hessen (Germany)	The authors' work is supported by the German Research Foundation (SFB593) and the LOEWE program of the State of Hessen (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bolte K, 2011, BIOESSAYS, V33, P368, DOI 10.1002/bies.201100007; Bolte K, 2009, J EUKARYOT MICROBIOL, V56, P9, DOI 10.1111/j.1550-7408.2008.00370.x; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; Carrie C, 2007, PLANT MOL BIOL, V63, P97, DOI 10.1007/s11103-006-9075-1; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Gabaldon T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-8; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Hempel F, 2007, BIOL CHEM, V388, P899, DOI 10.1515/BC.2007.119; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Junglas B, 2008, ARCH MICROBIOL, V190, P395, DOI 10.1007/s00203-008-0402-6; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; Klingl A, 2011, ARCH MICROBIOL; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsumoto N, 2003, NAT CELL BIOL, V5, P454, DOI 10.1038/ncb982; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Motley AM, 2000, EMBO REP, V1, P40, DOI 10.1093/embo-reports/kvd010; MULLER M, 1973, J HISTOCHEM CYTOCHEM, V21, P955; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Peterhansel C, 2011, PLANT PHYSIOL, V155, P49, DOI 10.1104/pp.110.165019; PHILIPPI ML, 1975, ARCH MICROBIOL, V103, P127, DOI 10.1007/BF00436339; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Purdue PE, 1998, J CELL BIOL, V143, P1859; Rachel R, 2010, METHOD CELL BIOL, V96, P47, DOI 10.1016/S0091-679X(10)96003-2; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Rucktaschel R, 2010, BIOCHIM BIOPHYS ACTA, V1808, P892; Sambrook J., 2002, MOL CLONING LAB MANU; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; Schluter A, 2006, MOL BIOL EVOL, V23, P838, DOI 10.1093/molbev/msj103; Schrader M, 2008, HISTOCHEM CELL BIOL, V129, P421, DOI 10.1007/s00418-008-0396-9; Shinozaki A, 2009, PROTOPLASMA, V235, P57, DOI 10.1007/s00709-009-0031-1; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; STELLY N, 1975, J HISTOCHEM CYTOCHEM, V23, P686, DOI 10.1177/23.9.170331; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; Titorenko VI, 1998, J CELL BIOL, V142, P403, DOI 10.1083/jcb.142.2.403; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; WINKLER U, 1995, PLANTA, V195, P403; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65	60	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25316	10.1371/journal.pone.0025316	http://dx.doi.org/10.1371/journal.pone.0025316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966495	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100086
J	Rohling, JHT; Vanderleest, HT; Michel, S; Vansteensel, MJ; Meijer, JH				Rohling, Jos H. T.; Vanderleest, Henk Tjebbe; Michel, Stephan; Vansteensel, Mariska J.; Meijer, Johanna H.			Phase Resetting of the Mammalian Circadian Clock Relies on a Rapid Shift of a Small Population of Pacemaker Neurons	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; ELECTRICAL-ACTIVITY; IMMUNOREACTIVE NEURONS; GENE-EXPRESSION; OSCILLATORS; CELLS; LIGHT; PER1; SYNCHRONIZATION; HETEROGENEITY	The circadian pacemaker of the suprachiasmatic nuclei (SCN) contains a major pacemaker for 24 h rhythms that is synchronized to the external light-dark cycle. In response to a shift in the external cycle, neurons of the SCN resynchronize with different pace. We performed electrical activity recordings of the SCN of rats in vitro following a 6 hour delay of the light-dark cycle and observed a bimodal electrical activity pattern with a shifted and an unshifted component. The shifted component was relatively narrow as compared to the unshifted component (2.2 h and 5.7 h, respectively). Curve fitting and simulations predicted that less than 30% of the neurons contribute to the shifted component and that their phase distribution is small. This prediction was confirmed by electrophysiological recordings of neuronal subpopulations. Only 25% of the neurons exhibited an immediate shift in the phase of the electrical activity rhythms, and the phases of the shifted subpopulations appeared significantly more synchronized as compared to the phases of the unshifted subpopulations (p<0.05). We also performed electrical activity recordings of the SCN following a 9 hour advance of the light-dark cycle. The phase advances induced a large desynchrony among the neurons, but consistent with the delays, only 19% of the neurons peaked at the mid of the new light phase. The data suggest that resetting of the central circadian pacemaker to both delays and advances is brought about by an initial shift of a relatively small group of neurons that becomes highly synchronized following a shift in the external cycle. The high degree of synchronization of the shifted neurons may add to the ability of this group to reset the pacemaker. The large desynchronization observed following advances may contribute to the relative difficulty of the circadian system to respond to advanced light cycles.	[Rohling, Jos H. T.; Vanderleest, Henk Tjebbe; Michel, Stephan; Meijer, Johanna H.] Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, Leiden, Netherlands; [Vansteensel, Mariska J.] Univ Med Ctr Utrecht, Sect Brain Funct & Plast, Dept Neurol & Neurosurg, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	Rohling, JHT (corresponding author), Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, Leiden, Netherlands.	J.H.Meijer@lumc.nl	Rohling, Jos/AAC-3516-2022; Michel, Stephan/ABC-4211-2021; Vansteensel, Mariska/K-8015-2019	Vansteensel, Mariska/0000-0002-9252-5116; Rohling, Jos H T/0000-0001-5721-2715	Netherlands Organization for Scientific Research (NWO) [805.47.212]; EU	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EU(European Commission)	This research was supported by Netherlands Organization for Scientific Research (NWO), program grant nr 805.47.212 "From Molecule to Cell" (http://www.nwo.nl/nwohome.nsf/pages/NWOP_5BQDBD_Eng), and by "Entrainment of the circadian clock" - EUCLOCK program of the EU (http://www.euclock.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida R, 2002, MOL PHARMACOL, V61, P26, DOI 10.1124/mol.61.1.26; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Antle MC, 2009, REV ENDOCR METAB DIS, V10, P279, DOI 10.1007/s11154-009-9116-6; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Brown TM, 2009, J BIOL RHYTHM, V24, P44, DOI 10.1177/0748730408327918; CARD JP, 1981, J NEUROSCI, V1, P1289; Colwell CS, 2005, NAT NEUROSCI, V8, P10, DOI 10.1038/nn0105-10; de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Engelund A, 2010, CELL TISSUE RES, V340, P243, DOI 10.1007/s00441-010-0950-3; Gamble KL, 2007, J NEUROSCI, V27, P12078, DOI 10.1523/JNEUROSCI.1109-07.2007; GROOS GA, 1980, J COMP PHYSIOL, V135, P349, DOI 10.1007/BF00657651; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; IBATA Y, 1989, NEUROSCI LETT, V97, P1, DOI 10.1016/0304-3940(89)90129-8; Kawamoto K, 2003, J NEUROSCI RES, V74, P852, DOI 10.1002/jnr.10751; Kiss J, 2008, EUR J NEUROSCI, V28, P1760, DOI 10.1111/j.1460-9568.2008.06463.x; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; MEIJER JH, 1986, BRAIN RES, V382, P109, DOI 10.1016/0006-8993(86)90117-4; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Nagano M, 2003, J NEUROSCI, V23, P6141; Nakamura W, 2005, J NEUROSCI, V25, P5481, DOI 10.1523/JNEUROSCI.0889-05.2005; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rohling J, 2006, J PHYSIOL-PARIS, V100, P261, DOI 10.1016/j.jphysparis.2007.05.005; Romijn HJ, 1997, EUR J NEUROSCI, V9, P2613, DOI 10.1111/j.1460-9568.1997.tb01691.x; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Sharma L, 2007, J R SOC PROMO HEALTH, V127, P268, DOI 10.1177/1466424006064305; van Esseveldt LKE, 2000, BRAIN RES REV, V33, P34, DOI 10.1016/S0165-0173(00)00025-4; van Oosterhout F, 2008, ANN NEUROL, V64, P315, DOI 10.1002/ana.21418; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; Vansteensel MJ, 2003, CURR BIOL, V13, P1538, DOI 10.1016/S0960-9822(03)00560-8; Watanabe K, 2000, BRAIN RES, V877, P361, DOI 10.1016/S0006-8993(00)02724-4; Waterhouse J, 2007, LANCET, V369, P1117, DOI 10.1016/S0140-6736(07)60529-7; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Winfree T., 2000, GEOMETRY BIOL TIME; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan L, 1999, NEUROSCIENCE, V94, P141, DOI 10.1016/S0306-4522(99)00223-7; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x	41	49	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25437	10.1371/journal.pone.0025437	http://dx.doi.org/10.1371/journal.pone.0025437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966529	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100098
J	Wang, J; Chen, LL; Li, Y; Guan, XY				Wang, Jian; Chen, Leilei; Li, Yan; Guan, Xin-Yuan			Overexpression of Cathepsin Z Contributes to Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma	PLOS ONE			English	Article							BREAST-CANCER; EXPRESSION; PLAYS; PROGRESSION; GENES	The aim of this study was to characterize the oncogenic function and mechanism of Cathepsin Z (CTSZ) at 20q13.3, a frequently amplified region in hepatocellular carcinoma (HCC). Real-time PCR were used to compare CTSZ expression between paired HCC tumor and non-tumor specimens. CTSZ gene was stably transfected into HCC line QGY-7703 cells and its role in tumorigenicity and cell motility was characterized by soft agar, wound-healing, transwell invasion and cell adhesion assay, and tumor xenograft mouse model. Western blot analysis was used to study expression of proteins associated with epithelial-mesenchymal transition (EMT). Upregulation of CTSZ was detected in 59/137 (43%) of primary HCCs, which was significantly associated with advanced clinical stage (P = 0.000). Functional study found that CTSZ could increase colony formation in soft agar and promote cell motility. Further study found that the metastatic effect of CTSZ was associated with its role in inducing epithelial-mesenchymal transition (EMT) by upregulating mesenchymal markers (fibronectin and vimentin) and downregulating epithelial markers (E-cadherin and alpha-catenin). In addition, CTSZ could also upregulate proteins associated with extracellular matrix remodeling such as MMP2, MMP3 and MMP9. Taken together, our data suggested that CTSZ was a candidate oncogene within the 20q13 amplicon and it played an important role in HCC metastasis.	[Wang, Jian; Chen, Leilei; Guan, Xin-Yuan] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Li, Yan; Guan, Xin-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou, Peoples R China	University of Hong Kong; Sun Yat Sen University	Wang, J (corresponding author), Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China.	xyguan@hku.hk	Guan, Xin-Yuan/A-3639-2009; /A-3639-2009	Guan, Xin-Yuan/0000-0002-4485-6017; /0000-0003-1874-9805; Chen, Polly Leilei/0000-0002-1987-3878	Research Grant Council (RGC) [HKUST 2/06C, HKU 7656/07M, HKU5/CRF/08]; Major State Basic Research Program of China [2006CB910104]; Sun Yat-Sen University [85000-3171311]	Research Grant Council (RGC)(Hong Kong Research Grants Council); Major State Basic Research Program of China(National Basic Research Program of China); Sun Yat-Sen University	This work was funded by the Research Grant Council (RGC) Central Allocation (HKUST 2/06C), RGC Competitive Earmarked Research Grant (HKU 7656/07M), RGC Collaborative Research Fund (HKU5/CRF/08), the Major State Basic Research Program of China (2006CB910104), and Sun Yat-Sen University "Hundred Talents Program'' (85000-3171311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Crawley JJ, 2002, GENOME BIOL, V3; Egeblad M, 2001, SURG ONCOL CLIN N AM, V10, P417; Glondu M, 2002, ONCOGENE, V21, P5127, DOI 10.1038/sj.onc.1205657; Guan XY, 2000, GENE CHROMOSOME CANC, V29, P110; Hidaka S, 2000, CLIN CANCER RES, V6, P2712; Hua J, 1996, CANCER RES, V56, P5279; Husmann K, 2008, MOL CARCINOGEN, V47, P66, DOI 10.1002/mc.20362; Kraus S, 2011, EUR J CELL BIOL, V90, P678, DOI 10.1016/j.ejcb.2011.03.008; Krueger S, 2005, J PATHOL, V207, P32, DOI 10.1002/path.1820; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Murashige M, 1996, JPN J CLIN ONCOL, V26, P303, DOI 10.1093/oxfordjournals.jjco.a023237; Ohri SS, 2008, INT J ONCOL, V32, P491; Pang RWC, 2007, ONCOLOGY-BASEL, V72, P30, DOI 10.1159/000111705; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Ratovitski T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185348; Rumpler G, 2003, EXP DERMATOL, V12, P761, DOI 10.1111/j.0906-6705.2003.00082.x; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Wong N, 1999, AM J PATHOL, V154, P37, DOI 10.1016/S0002-9440(10)65248-0; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	26	64	67	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24967	10.1371/journal.pone.0024967	http://dx.doi.org/10.1371/journal.pone.0024967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966391	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100035
J	Torchia, EC; Caulin, C; Acin, S; Terzian, T; Kubick, BJ; Box, NF; Roop, DR				Torchia, E. C.; Caulin, C.; Acin, S.; Terzian, T.; Kubick, B. J.; Box, N. F.; Roop, D. R.			Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma	ONCOGENE			English	Article						Aurora Kinase A; genomic instability; Myc; p53; SCC; tumor progression	LI-FRAUMENI-SYNDROME; PSORALEN-PLUS-ULTRAVIOLET; SQUAMOUS-CELL CARCINOMAS; C-MYC; CHROMOSOMAL INSTABILITY; GENE-EXPRESSION; PHARMACOLOGICAL ACTIVATION; PSORIASIS PATIENTS; COLORECTAL-CANCER; LUNG-CANCER	Clinical observations, as well as data obtained from the analysis of genetically engineered mouse models, firmly established the gain-of-function (GOF) properties of certain p53 mutations. However, little is known about the underlying mechanisms. We have used two independent microarray platforms to perform a comprehensive and global analysis of tumors arising in a model of metastatic skin cancer progression, which compares the consequences of a GOF p53R(172H) mutant vs p53 deficiency. DNA profiling revealed a higher level of genomic instability in GOF vs loss-of-function (LOF) p53 squamous cell carcinomas (SCCs). Moreover, GOF p53 SCCs showed preferential amplification of Myc with a corresponding increase in its expression and deregulation of Aurora Kinase A. Fluorescent in situ hybridization confirmed amplification of Myc in primary GOF p53 SCCs and its retention in metastatic tumors. We also identified by RNA profiling distinct gene expression profiles in GOF p53 tumors, which included enriched integrin and Rho signaling, independent of tumor stage. Thus, the progression of GOF p53 papillomas to carcinoma was marked by the acquisition of epithelial-to-mesenchymal transition and metastatic signatures. In contrast, LOF p53 tumors showed enrichment of genes associated with cancer proliferation and chromosomal instability. Collectively, these observations suggest that genomic instability has a prominent role in the early stages of GOF p53 tumor progression (that is, papillomas), whereas it is implicated at a later stage in LOF p53 tumors (that is, SCCs). This model will allow us to identify specific targets in mutant p53 SCCs, which may lead to the development of new therapeutic agents for the treatment of metastatic SCCs. Oncogene (2012) 31, 2680-2690; doi:10.1038/onc.2011.441; published online 3 October 2011	[Torchia, E. C.; Terzian, T.; Kubick, B. J.; Box, N. F.; Roop, D. R.] Univ Colorado, Dept Dermatol, Aurora, CO 80045 USA; [Torchia, E. C.; Terzian, T.; Kubick, B. J.; Box, N. F.; Roop, D. R.] Univ Colorado, Ctr Regenerat Med & Stem Cell Biol, Aurora, CO 80045 USA; [Caulin, C.; Acin, S.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; UTMD Anderson Cancer Center	Roop, DR (corresponding author), Univ Colorado, Dept Dermatol, Anschutz Med Campus,POB 6511, Aurora, CO 80045 USA.	Dennis.Roop@UCDenver.edu	Acin, Sergio/S-5185-2017; Box, Neil/F-3591-2010	Acin, Sergio/0000-0001-7335-2865; Box, Neil/0000-0002-3486-0346	NIH [DE015344, CA52607, CA105491]; National Institute of Cancer, USA; NATIONAL CANCER INSTITUTE [R01CA052607, U01CA105491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015344] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Cancer, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Grant Support: NIH grants: DE015344 (CC), CA52607 and CA105491 (DRR). We acknowledge Dr Lisa White and Laura Liles for their assistance with microarray experiments; Dr Leila Garcia for her assistance with the FISH experiments and Dr Ariefdjohan for the reading of the manuscript. This work was funded by grants from the National Institute of Cancer, USA.	Bickers DR, 2006, J AM ACAD DERMATOL, V55, P490, DOI 10.1016/j.jaad.2006.05.048; Bin Cho K, 2010, CANCER LETT, V293, P230, DOI 10.1016/j.canlet.2010.01.013; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Boelens MC, 2009, LUNG CANCER, V66, P372, DOI 10.1016/j.lungcan.2009.02.017; Bougeard G, 2008, J MED GENET, V45, P535, DOI 10.1136/jmg.2008.057570; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Caulin C, 2007, J CLIN INVEST, V117, P1893, DOI 10.1172/JCI31721; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Cheok CF, 2010, CELL DEATH DIFFER, V17, P1486, DOI 10.1038/cdd.2010.18; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Daya-Grosjean L, 2005, MUTAT RES-FUND MOL M, V571, P43, DOI 10.1016/j.mrfmmm.2004.11.013; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Denys H, 2009, CURR PHARM DESIGN, V15, P1373, DOI 10.2174/138161209787846711; Doyle B, 2010, J PATHOL, V222, P129, DOI 10.1002/path.2748; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HAUGHEY BH, 1992, AM J OTOLARYNG, V13, P168, DOI 10.1016/0196-0709(92)90117-C; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Karthigeyan D, 2011, MED RES REV, V31, P757, DOI 10.1002/med.20203; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; KOZMA L, 1994, CANCER LETT, V81, P165, DOI 10.1016/0304-3835(94)90198-8; Kreimer-Erlacher H, 2003, J INVEST DERMATOL, V120, P676, DOI 10.1046/j.1523-1747.2003.12085.x; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lim SK, 2007, BIOCHEM J, V403, P119, DOI 10.1042/BJ20061272; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Mizuarai S, 2006, CANCER RES, V66, P6319, DOI 10.1158/0008-5472.CAN-05-4629; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Ozakyol A, 2006, HEPATO-GASTROENTEROL, V53, P192; Paterson IC, 1996, ORAL ONCOL, V32B, P150, DOI 10.1016/0964-1955(95)00065-8; PIERCEALL WE, 1991, MOL CARCINOGEN, V4, P196, DOI 10.1002/mc.2940040306; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Ramos DM, 2002, MATRIX BIOL, V21, P297, DOI 10.1016/S0945-053X(02)00002-1; Rao CV, 2009, CARCINOGENESIS, V30, P1469, DOI 10.1093/carcin/bgp081; Rounbehler RJ, 2001, ONCOGENE, V20, P5341, DOI 10.1038/sj.onc.1204691; Saha MN, 2010, J CLIN PATHOL, V63, P204, DOI 10.1136/jcp.2009.070961; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Sauer L, 2010, ONCOGENE, V29, P2628, DOI 10.1038/onc.2010.24; Shen H, 2011, CURR PHARM DESIGN, V17, P560, DOI 10.2174/138161211795222603; Shi J, 2009, BIOORG MED CHEM LETT, V19, P6038, DOI 10.1016/j.bmcl.2009.09.044; SPENCER JM, 1995, ARCH DERMATOL, V131, P796, DOI 10.1001/archderm.131.7.796; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUN Y, 1993, P NATL ACAD SCI USA, V90, P2827, DOI 10.1073/pnas.90.7.2827; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Torchia EC, 2009, CANCER RES, V69, P7207, DOI 10.1158/0008-5472.CAN-09-1059; van der Meel R, 2011, DRUG DISCOV TODAY, V16, P219, DOI 10.1016/j.drudis.2011.01.005; Wang XJ, 1998, MOL CARCINOGEN, V23, P185, DOI 10.1002/(SICI)1098-2744(199811)23:3<185::AID-MC7>3.0.CO;2-5; Wolf P, 2004, J INVEST DERMATOL, V122, P190, DOI 10.1046/j.0022-202X.2004.22118.x; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Yakut T, 2003, LUNG, V181, P245, DOI 10.1007/s00408-003-1026-x; Yang SB, 2010, EXP MOL MED, V42, P759, DOI 10.3858/emm.2010.42.11.077; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493	71	23	24	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	21					2680	2690		10.1038/onc.2011.441	http://dx.doi.org/10.1038/onc.2011.441			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	948SS	21963848	Green Accepted			2022-12-25	WOS:000304523500007
J	Herman, AB; Savage, VM; West, GB				Herman, Alexander B.; Savage, Van M.; West, Geoffrey B.			A Quantitative Theory of Solid Tumor Growth, Metabolic Rate and Vascularization	PLOS ONE			English	Article							BLOOD-FLOW; FRACTAL CHARACTERISTICS; GEOMETRIC RESISTANCE; GENERAL-MODEL; SCALING LAWS; ARCHITECTURE; PATTERNS; VASCULATURE; EVOLUTION; DYNAMICS	The relationships between cellular, structural and dynamical properties tumors have traditionally been studied separately. Here, we construct a quantitative, predictive theory of solid tumor growth, metabolic ate, vascularization and necrosis that the relationships between these properties. To accomplish this, we develop a comprehensive theory that the interface and integration of the tumor vascular network and resource supply with the cardiovascular system of Our theory enables a quantitative understanding of how cells, tissues, and vascular networks act together across pie scales by building on recent theoretical advances in modeling both healthy vasculature and the detailed processes angiogenesis and tumor growth. The theory explicitly relates tumor vascularization and growth to metabolic rate, and extensive predictions four or properties, inclucling growth rates, metabolic rates, degree of necrosis, blood flow rates and vessel sizes. Besides these quantitative predictions, we explain how growth rates depend on capillary density and metabolic rate and why similar tumors grow slower and occur less frequently in larger animals, shedding light on Peto's paradox. Various implications for potential therapeutic strategies and further research are discussed.	[Herman, Alexander B.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Savage, Van M.] Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90024 USA; [Herman, Alexander B.; Savage, Van M.; West, Geoffrey B.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Herman, Alexander B.; Savage, Van M.; West, Geoffrey B.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; The Santa Fe Institute; United States Department of Energy (DOE); Los Alamos National Laboratory	Herman, AB (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	alexander.herman@ucsf.edu			National Science Foundation [PHY 0750037, PHY-0946635]; Thaw Charitable Trust; Zwan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; Division Of Physics [0750037] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Thaw Charitable Trust; Zwan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Foundation Award #PHY 0750037, NSF Grant #PHY-0946635, the Thaw Charitable Trust and the Zwan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031; BAKER GM, 1990, GROWTH DEVELOP AGING, V54, P85; BASSUKAS ID, 1993, NATURWISSENSCHAFTEN, V80, P366, DOI 10.1007/BF01138793; BAXTER LT, 1995, CANCER RES, V55, P4611; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; BRUNTON GF, 1978, CELL TISSUE KINET, V11, P161, DOI 10.1111/j.1365-2184.1978.tb00884.x; Castorina P, 2009, CANCER RES, V69, P8507, DOI 10.1158/0008-5472.CAN-09-0653; Caulin AF, 2011, TRENDS ECOL EVOL, V26, P175, DOI 10.1016/j.tree.2011.01.002; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Chaplain MAJ, 2000, J NEURO-ONCOL, V50, P37, DOI 10.1023/A:1006446020377; Craciunescu OI, 1999, J BIOMECH ENG-T ASME, V121, P480, DOI 10.1115/1.2835076; DeGregori J, 2011, CANCER RES, V71, P3739, DOI 10.1158/0008-5472.CAN-11-0342; Friebores B, 2006, CANCER RES, V66, P1597; Gatenby RA, 2003, NATURE, V421, P321, DOI 10.1038/421321a; Gazit Y, 1997, MICROCIRCULATION-LON, V4, P395, DOI 10.3109/10739689709146803; Gevertz J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051910; Gevertz JL, 2006, J THEOR BIOL, V243, P517, DOI 10.1016/j.jtbi.2006.07.002; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Guiot C, 2003, J THEOR BIOL, V225, P147, DOI 10.1016/S0022-5193(03)00221-2; Guiot C, 2006, J THEOR BIOL, V240, P459, DOI 10.1016/j.jtbi.2005.10.006; GULLINO PM, 1964, CANCER RES, V24, P1727; GULLINO PM, 1961, J NATL CANCER I, V27, P1465; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hilmas DE, 1973, CANCER, V33, P103; HORI K, 1991, JPN J CANCER RES, V82, P109, DOI 10.1111/j.1349-7006.1991.tb01753.x; Huo YL, 2006, AM J PHYSIOL-HEART C, V291, pH1074, DOI 10.1152/ajpheart.00200.2006; Jain RK, 1996, SCIENCE, V271, P1079, DOI 10.1126/science.271.5252.1079; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kallinowsk F, 1984, CANCER RES, V49, P3759; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Kassab GS, 2006, AM J PHYSIOL-HEART C, V290, pH894, DOI 10.1152/ajpheart.00579.2005; Less JR, 1997, MICROCIRCULATION-LON, V4, P25, DOI 10.3109/10739689709148315; LESS JR, 1991, CANCER RES, V51, P265; Leu AJ, 2000, CANCER RES, V60, P4324; LYNG H, 1992, CANCER RES, V52, P584; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Rejniak KA, 2011, WIRES SYST BIOL MED, V3, P115, DOI 10.1002/wsbm.102; Rogers W, 1967, THESIS U MINNESOTA; Sabo E, 2001, CLIN CANCER RES, V7, P533; Savage VM, 2010, P NATL ACAD SCI USA, V107, P22722, DOI 10.1073/pnas.1012194108; Savage VM, 2007, P NATL ACAD SCI USA, V104, P4718, DOI 10.1073/pnas.0611235104; Savage VM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000171; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SEVICK EM, 1989, CANCER RES, V49, P3506; SKEHAN P, 1986, GROWTH, V50, P496; SPENCER RP, 1970, YALE J BIOL MED, V43, P22; Spencer SL, 2006, PLOS COMPUT BIOL, V2, P939, DOI 10.1371/journal.pcbi.0020108; STEEL GG, 1980, CELL TISSUE KINET, V13, P451, DOI 10.1111/j.1365-2184.1980.tb00485.x; Steel GG, 1977, GROWTH KINETICS TUMO; Tannock I, 1998, BASIC SCI ONCOLOGY; van Leeuwen IMM, 2003, BRIT J CANCER, V89, P2254, DOI 10.1038/sj.bjc.6601394; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; Zamir M, 2000, SFI S SCI C, P129; Zimmer C, MERE EXISTENCE WHALE	57	59	59	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e22973	10.1371/journal.pone.0022973	http://dx.doi.org/10.1371/journal.pone.0022973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980335	Green Submitted, gold, Green Published			2022-12-25	WOS:000295939600001
J	Sangsuriya, P; Senapin, S; Huang, WP; Lo, CF; Flegel, TW				Sangsuriya, Pakkakul; Senapin, Saengchan; Huang, Wei-Pang; Lo, Chu-Fang; Flegel, Timothy W.			Co-Interactive DNA-Binding between a Novel, Immunophilin-Like Shrimp Protein and VP15 Nucleocapsid Protein of White Spot Syndrome Virus	PLOS ONE			English	Article							VIRAL-PROTEINS; IDENTIFICATION; GENE; WSSV; GLYCOSYLATION; LOCALIZATION; SEQUENCE; RECEPTOR; FK-506; FKBPS	White spot syndrome virus (WSSV) is one of the most serious pathogens of penaeid shrimp. Although its genome has been completely characterized, the functions of most of its putative proteins are not yet known. It has been suggested that the major nucleocapsid protein VP15 is involved in packaging of the WSSV genome during virion formation. However, little is known in its relationship with shrimp host cells. Using the yeast two-hybrid approach to screen a shrimp lymphoid organ (LO) cDNA library for proteins that might interact with VP15, a protein named PmFKBP46 was identified. It had high sequence similarity to a 46 kDa-immunophilin called FKBP46 from the lepidopteran Spodoptera frugiperda (the fall armyworm). The full length PmFKBP46 consisted of a 1,257-nucleotide open reading frame with a deduced amino acid sequence of 418 residues containing a putative FKBP-PPlase domain in the C-terminal region. Results from a GST pull-down assay and histological co-localization revealed that VP15 physically interacted with PmFKBP46 and that both proteins shared the same subcellular location in the nucleus. An electrophoretic mobility shift assay indicated that PmFKBP46 possessed DNA-binding activity and functionally co-interacted with VP15 in DNA binding. The overall results suggested that host PmFKBP46 might be involved in genome packaging by viral VP15 during virion assembly.	[Sangsuriya, Pakkakul; Flegel, Timothy W.] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Senapin, Saengchan] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Huang, Wei-Pang; Lo, Chu-Fang] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Academia Sinica - Taiwan; National Taiwan University	Sangsuriya, P (corresponding author), Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand.	sctwf@mahidol.ac.th	Senapin, Saengchan/F-1323-2011; Lo, Chu-Fang/G-3088-2014	Senapin, Saengchan/0000-0002-5599-4343; Lo, Chu-Fang/0000-0001-5136-8129; Sangsuriya, Pakkakul/0000-0001-5978-7977; HUANG, WEI-PANG/0000-0001-8410-6555; Flegel, Timothy W./0000-0002-1913-213X; Sangsuriya, Panpanga/0000-0002-5522-0620	Mahidol University; Taiwan National Science Council; Thailand Research Fund [PHD/0231/2548]	Mahidol University; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by research grants from Mahidol University and a Taiwan National Science Council grant. P.S. has been supported by a Royal Golden Jubilee Ph.D. program (PHD/0231/2548) from the Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALNEMRI ES, 1994, J BIOL CHEM, V269, P30828; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; BIERER BE, 1990, SCIENCE, V250, P556, DOI 10.1126/science.1700475; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Breiman A, 2002, TRANSGENIC RES, V11, P321, DOI 10.1023/A:1016331814412; Cantin R, 2005, J VIROL, V79, P6577, DOI 10.1128/JVI.79.11.6577-6587.2005; Chen KY, 2009, FISH SHELLFISH IMMUN, V27, P460, DOI 10.1016/j.fsi.2009.06.018; Chen LL, 2007, DIS AQUAT ORGAN, V74, P171, DOI 10.3354/dao074171; Chen LL, 2002, VIROLOGY, V301, P136, DOI 10.1006/viro.2002.1536; Flegel TW, 2011, MAR BIOTECHNOL, V13, P587, DOI 10.1007/s10126-010-9287-x; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; GALAT A, 1992, BIOCHEMISTRY-US, V31, P2427, DOI 10.1021/bi00123a031; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gollan PJ, 2010, PLANT MOL BIOL, V72, P1, DOI 10.1007/s11103-009-9547-1; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Huang CH, 2002, MOL CELL PROTEOMICS, V1, P223, DOI 10.1074/mcp.M100035-MCP200; Kang CB, 2005, BIOCHEM BIOPH RES CO, V337, P30, DOI 10.1016/j.bbrc.2005.09.023; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kuzuhara T, 2004, NAT STRUCT MOL BIOL, V11, P275, DOI 10.1038/nsmb733; Leu JH, 2009, CURR TOP MICROBIOL, V328, P197; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Li Li-juan, 2009, Virologica Sinica, V24, P71, DOI 10.1007/s12250-009-3013-8; Liang Y, 2005, DIS AQUAT ORGAN, V66, P81, DOI 10.3354/dao066081; Lightner D.V, 1996, HDB SHRIMP PATHOLOGY; Liu YJ, 2010, VIROLOGY, V408, P197, DOI 10.1016/j.virol.2010.09.008; Lu LQ, 2004, FEBS LETT, V577, P141, DOI 10.1016/j.febslet.2004.08.087; Nyanguile O, 1997, P NATL ACAD SCI USA, V94, P13402, DOI 10.1073/pnas.94.25.13402; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; RIVIERE S, 1993, FEBS LETT, V315, P247, DOI 10.1016/0014-5793(93)81173-W; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; SIEKIERKA JJ, 1989, J IMMUNOL, V143, P1580; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Somarelli JA, 2007, ARCH INSECT BIOCHEM, V65, P195, DOI 10.1002/arch.20177; Sriphaijit T, 2007, DEV COMP IMMUNOL, V31, P1145, DOI 10.1016/j.dci.2007.03.005; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Tonganunt M, 2009, FISH SHELLFISH IMMUN, V26, P509, DOI 10.1016/j.fsi.2009.02.002; Tsai JM, 2006, J VIROL, V80, P3021, DOI 10.1128/JVI.80.6.3021-3029.2006; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; van Hulten MCW, 2002, J GEN VIROL, V83, P257, DOI 10.1099/0022-1317-83-1-257; Vlak J.M., 2005, VIRUS TAXONOMY, P187; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Wang ZL, 2005, J VIROL, V79, P8764, DOI 10.1128/JVI.79.14.8764-8772.2005; Witteveldt J, 2005, ARCH VIROL, V150, P1121, DOI 10.1007/s00705-004-0483-8; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Yang WM, 2001, EMBO J, V20, P4814, DOI 10.1093/emboj/20.17.4814; YANG WM, 1995, J BIOL CHEM, V270, P15187, DOI 10.1074/jbc.270.25.15187; Yao YL, 2011, CURR OPIN PHARMACOL, V11, P301, DOI 10.1016/j.coph.2011.03.005; Zhang XB, 2001, VIRUS RES, V79, P137, DOI 10.1016/S0168-1702(01)00340-9	52	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25420	10.1371/journal.pone.0025420	http://dx.doi.org/10.1371/journal.pone.0025420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980453	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600025
J	Pradel, A; Tafforeau, P; Maisey, JG; Janvier, P				Pradel, Alan; Tafforeau, Paul; Maisey, John G.; Janvier, Philippe			A New Paleozoic Symmoriiformes (Chondrichthyes) from the Late Carboniferous of Kansas (USA) and Cladistic Analysis of Early Chondrichthyans	PLOS ONE			English	Article							BEAR GULCH LIMESTONE; ELEPHANT SHARK; BRAINCASE; MICROTOMOGRAPHY; INIOPTERYGIA; PHYLOGENY; EVOLUTION; INSIGHTS; MONTANA; SKULL	Background: The relationships of cartilaginous fishes are discussed in the light of well preserved three-dimensional Paleozoic specimens. There is no consensus to date on the interrelationship of Paleozoic chondrichthyans, although three main phylogenetic hypotheses exist in the current literature: 1. the Paleozoic shark-like chondrichthyans, such as the Symmoriiformes, are grouped along with the modern sharks (neoselachians) into a clade which is sister group of holocephalans; 2. the Symmoriiformes are related to holocephalans, whereas the other Paleozoic shark-like chondrichthyans are related to neoselachians; 3. many Paleozoic shark-like chondrichthyans, such as the Symmoriiformes, are stem chondrichthyans, whereas stem and crown holocephalans are sister group to the stem and crown neoselachians in a crown-chondrichthyan clade. This third hypothesis was proposed recently, based mainly on dental characters. Methodology/Principal Findings: On the basis of two well preserved chondrichthyan neurocrania from the Late Carboniferous of Kansas, USA, we describe here a new species of Symmoriiformes, Kawichthys moodiei gen. et sp. nov., which was investigated by means of computerized X-ray synchrotron microtomography. We present a new phylogenetic analysis based on neurocranial characters, which supports the third hypothesis and corroborates the hypothesis that crown-group chondrichthyans (Holocephali+Neoselachii) form a tightly-knit group within the chondrichthyan total group, by providing additional, non dental characters. Conclusions/Significance: Our results highlight the importance of new well preserved Paleozoic fossils and new techniques of observation, and suggest that a new look at the synapomorphies of the crown-group chondrichthyans would be worthwhile in terms of understanding the adaptive significance of phylogenetically important characters.	[Pradel, Alan; Maisey, John G.] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Janvier, Philippe] Museum Natl Hist Nat, CNRS, Ctr Rech Paleobiodivers & Paleoenvironm CRP2, UMR 7207,Dept Hist Terre, Paris, France	American Museum of Natural History (AMNH); European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Pradel, A (corresponding author), Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA.	apradel@amnh.org	Janvier, Philippe/Q-5268-2019	Tafforeau, Paul/0000-0002-5962-1683				Allis E. P., 1914, Anatomischer Anzeiger, V46; Coates MI, 2001, SYST ASSOC SPEC VOL, V61, P241; Coates MI, 2001, J VERTEBR PALEONTOL, V21, P438, DOI 10.1671/0272-4634(2001)021[0438:ANSCFT]2.0.CO;2; Coates MI, 1998, T ROY SOC EDIN-EARTH, V89, P63, DOI 10.1017/S026359330000701X; Coates MI, 2007, PALAEONTOLOGY, V50, P1421, DOI 10.1111/j.1475-4983.2007.00719.x; COLE FJ, 1896, T ROY SOC EDINBURGH, V38, P49; de Beer G., 1937, DEV VERTEBRATE SKULL; de Beer GR, 1934, PHILOS T ROY SOC B, V224, P287; DICK J R F, 1978, Transactions of the Royal Society of Edinburgh, V70, P63; Didier DA, 1995, AM MUS NOVIT, V3119, P1; Duffin CJ, 1996, NEUES JB GEOLOGIE PA, V1996, P232; Fritsch A., 1880, FAUNA GASKOHLE KALKS, V1, P93, DOI [10.5962/bhl.title.14775, DOI 10.5962/BHL.TITLE.14775]; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Ginter M, 2004, ACTA PALAEONTOL POL, V49, P409; Ginter M., 2004, RECENT ADV ORIGIN EA, P473; Ginter M, 2010, HDB PALEOICHTHYOLO V, V3D; Ginter M., 2005, ICHTHYOLITH ISSUES S, V8, P11; GOLOBOFF PA, TREE ANAL USING NEW; Grogan ED, 2000, J MORPHOL, V243, P219, DOI 10.1002/(SICI)1097-4687(200003)243:3<219::AID-JMOR1>3.0.CO;2-1; Grogan ED, 2009, ACTA ZOOL-STOCKHOLM, V90, P134, DOI 10.1111/j.1463-6395.2008.00371.x; Holmgren Nils, 1940, ACTA ZOOL [STOCKHOLM], V21, P51; Inoue JG, 2010, MOL BIOL EVOL, V27, P2576, DOI 10.1093/molbev/msq147; Janvier P., 1996, EARLY VERTEBRATES; Klug S, 2010, ZOOL SCR, V39, P37, DOI 10.1111/j.1463-6409.2009.00399.x; Labiche JC, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2783112; Lane JA, 2010, AM MUS NOVIT, P1, DOI 10.1206/681.1; Larsson TA, 2009, GENOMICS, V93, P254, DOI 10.1016/j.ygeno.2008.10.001; Lisney TJ, 2010, REV FISH BIOL FISHER, V20, P571, DOI 10.1007/s11160-010-9162-x; Long John A., 1995, Records of the Western Australian Museum, V17, P287; Lund R., 1977, Annals of Carnegie Museum, V46, P195; Lund R., 1986, Journal of Vertebrate Paleontology, V6, P12; Lund R, 1997, REV FISH BIOL FISHER, V7, P65, DOI 10.1023/A:1018471324332; Lund R., 1985, Journal of Vertebrate Paleontology, V5, P1; Maddison WP, 2004, MESQUIT MODULAR SYST; Mader H., 1986, Goettinger Arbeiten zur Geologie und Palaeontologie, P1; Maisey J.G., 1986, American Museum Novitates, P1; MAISEY J G, 1985, American Museum Novitates, P1; MAISEY J G, 1983, American Museum Novitates, P1; Maisey J.G., 2004, RECENT ADV ORIGIN EA, P139; Maisey JG, 2005, B AM MUS NAT HIST, P1; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P702, DOI 10.1671/0272-4634(2001)021[0702:APCBFT]2.0.CO;2; Maisey JG, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)429<0001:MOTBIT>2.0.CO;2; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Maisey J, 2009, ACTA ZOOL-STOCKHOLM, V90, P109, DOI 10.1111/j.1463-6395.2008.00330.x; Maisey JG, 2007, B AM MUS NAT HIST, P4; Maisey JG, 2011, PALAEONTOLOGY, V54, P417, DOI 10.1111/j.1475-4983.2011.01035.x; Maisey JG, 2010, CR PALEVOL, V9, P289, DOI 10.1016/j.crpv.2010.07.021; Maisey JG, 2009, J VERTEBR PALEONTOL, V29, P14, DOI 10.1671/039.029.0130; Marinelli W, 1959, VERGLEICHENDE ANAT 2, P179; Moy-Thomas J.A., 1936, GEOL MAG, V73, P488, DOI [10.1017/S0016756800095212, DOI 10.1017/S0016756800095212]; Nixon KC, 2002, WINCLADIA VERSION 1; Oelofsen B.W., 1986, P107; ORVIG T, 1972, Zoologica Scripta, V1, P139, DOI 10.1111/j.1463-6409.1972.tb00672.x; PATTERSO.C, 1965, PHILOS T ROY SOC B, V249, P101, DOI 10.1098/rstb.1965.0010; Pradel A, 2010, GEODIVERSITAS, V32, P595, DOI 10.5252/g2010n4a2; Pradel A, 2010, CR PALEVOL, V9, P377, DOI 10.1016/j.crpv.2010.07.015; Pradel A, 2009, P NATL ACAD SCI USA, V106, P5224, DOI 10.1073/pnas.0807047106; Ravi V, 2009, P NATL ACAD SCI USA, V106, P16327, DOI 10.1073/pnas.0907914106; Schaeffer B., 1967, P3; Schaeffer B., 1981, B AM MUS NAT HIST, V169, P3; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Williams M.E., 1985, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V190, P83; Woodward A.S., 1889, CATALOGUE FOSSIL F 1, P1; Woodward AS, 1919, ZOOL SOC P, V13, P231; Yu WP, 2008, P NATL ACAD SCI USA, V105, P3819, DOI 10.1073/pnas.0800398105; Zangere R., 1976, Palaeontographica Abt A, V154, P107; ZANGERL R, 1973, Fieldiana Geology Memoirs, V6, P1; ZANGERL R, 1990, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V213, P115; ZANGERL R, 1981, HDB PALEOICHTHYOLO A, V3; Zangerl R, 1997, US FIELDIANA GEOL, V35, P1	71	48	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24938	10.1371/journal.pone.0024938	http://dx.doi.org/10.1371/journal.pone.0024938			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980367	Green Published, Green Submitted, gold			2022-12-25	WOS:000295933700012
J	Valdez, CD; Davis, JN; Odeh, HM; Layfield, TL; Cousineau, CS; Berton, TR; Johnson, DG; Wojno, KJ; Day, ML				Valdez, Conrad David; Davis, Joanne N.; Odeh, Hana M.; Layfield, Tristan L.; Cousineau, Craig S.; Berton, Thomas R.; Johnson, David G.; Wojno, Kirk J.; Day, Mark L.			Repression of Androgen Receptor Transcription through the E2F1/DNMT1 Axis	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; EPITHELIAL-CELL LINE; HEAT-SHOCK-PROTEIN; CHIP-SEQ DATA; DNA METHYLATION; GENE-EXPRESSION; DEREGULATED EXPRESSION; E2F1 ACTIVATION; BINDING-SITES; CYCLE ARREST	Although androgen receptor (AR) function has been extensively studied, regulation of the AR gene itself has been much less characterized. In this study, we observed a dramatic reduction in the expression of androgen receptor mRNA and protein in hyperproliferative prostate epithelium of keratin 5 promoter driven E2F1 transgenic mice. To confirm an inhibitory function for E2F1 on AR transcription, we showed that E2F1 inhibited the transcription of endogenous AR mRNA, subsequent AR protein, and AR promoter activity in both human and mouse epithelial cells. E2F1 also inhibited androgen-stimulated activation of two AR target gene promoters. To elucidate the molecular mechanism of E2F-mediated inhibition of AR, we evaluated the effects of two functional E2F1 mutants on AR promoter activity and found that the transactivation domain appears to mediate E2F1 repression of the AR promoter. Because DNMT1 is a functional intermediate of E2F1 we examined DNMT1 function in AR repression. Repression of endogenous AR in normal human prostate epithelial cells was relieved by DNMT1 shRNA knock down. DNMT1 was shown to be physically associated within the AR minimal promoter located 22 bps from the transcription start site; however, methylation remained unchanged at the promoter regardless of DNMT1 expression. Taken together, our results suggest that DNMT1 operates either as a functional intermediary or in cooperation with E2F1 inhibiting AR gene expression in a methylation independent manner.	[Valdez, Conrad David; Davis, Joanne N.; Odeh, Hana M.; Layfield, Tristan L.; Cousineau, Craig S.; Wojno, Kirk J.; Day, Mark L.] Univ Michigan, Dept Urol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Berton, Thomas R.; Johnson, David G.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX USA	University of Michigan System; University of Michigan; University of Texas System; UTMD Anderson Cancer Center	Valdez, CD (corresponding author), Univ Michigan, Dept Urol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	mday@umich.edu		Johnson, David/0000-0002-6223-1790	National Institutes of Health [R01 DK-056137, R01 DK-066610]; Department of Defense; American Cancer Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056137, R01DK066610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Institutes of Health grants (R01 DK-056137 and R01 DK-066610) (to MLD), Department of Defense prostate cancer training grant (to CDV), and the American Cancer Society Clyde-Dixon Postdoctoral Fellowship (to JND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Boily G, 2004, BRIT J CANCER, V90, P1606, DOI 10.1038/sj.bjc.6601716; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; CUNHA GR, 1992, J ANDROL, V13, P465; Davis JN, 2006, CANCER RES, V66, P11897, DOI 10.1158/0008-5472.CAN-06-2497; Day KC, 2002, J BIOL CHEM, V277, P44475, DOI 10.1074/jbc.M205361200; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; FABER PW, 1991, J BIOL CHEM, V266, P10743; FABER PW, 1993, J BIOL CHEM, V268, P9296; Fry CJ, 1999, J BIOL CHEM, V274, P15883, DOI 10.1074/jbc.274.22.15883; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Heinlein CA, 1999, J BIOL CHEM, V274, P16147, DOI 10.1074/jbc.274.23.16147; Hobisch A, 1996, PROSTATE, V28, P129; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Isaacs JT, 2008, PROSTATE, V68, P1025, DOI 10.1002/pros.20763; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Jarrard DF, 1998, CANCER RES, V58, P5310; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; Johnson DG, 2000, MOL CARCINOGEN, V27, P151, DOI 10.1002/(SICI)1098-2744(200003)27:3<151::AID-MC1>3.0.CO;2-C; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Keller ET, 1996, FRONT BIOSCI, V1, pd59, DOI DOI 10.2741/A116; Kinoshita H, 2000, CANCER RES, V60, P3623; Koziczak M, 2000, MOL CELL BIOL, V20, P2014, DOI 10.1128/MCB.20.6.2014-2022.2000; KUMAR MV, 1994, NUCLEIC ACIDS RES, V22, P3693, DOI 10.1093/nar/22.18.3693; Lin XH, 2003, CANCER RES, V63, P498; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Mann DJ, 1996, CURR BIOL, V6, P474, DOI 10.1016/S0960-9822(02)00515-8; Marker PC, 2008, DIFFERENTIATION, V76, P736, DOI 10.1111/j.1432-0436.2008.00297.x; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Milutinovic S, 2004, J BIOL CHEM, V279, P27915, DOI 10.1074/jbc.M312823200; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Pearson A, 1997, ONCOGENE, V15, P2643, DOI 10.1038/sj.onc.1201451; Pierce AM, 1998, ONCOGENE, V16, P1267, DOI 10.1038/sj.onc.1201666; Pierce AM, 1999, MOL CELL BIOL, V19, P6408; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Seelan RS, 2002, NEOPLASIA, V4, P195, DOI 10.1038/sj.neo.7900237; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; SENSIBAR JA, 1995, MICROSC RES TECHNIQ, V30, P342, DOI 10.1002/jemt.1070300409; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Sobel RE, 2006, IN VITRO CELL DEV-AN, V42, P33; SONG CS, 1995, ANN NY ACAD SCI, V761, P97, DOI 10.1111/j.1749-6632.1995.tb31372.x; Song CS, 1999, MOL ENDOCRINOL, V13, P1487, DOI 10.1210/me.13.9.1487; Stanelle J, 2002, NUCLEIC ACIDS RES, V30, P1859, DOI 10.1093/nar/30.8.1859; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400; TAKEDA H, 1991, BIOCHEM BIOPH RES CO, V177, P488, DOI 10.1016/0006-291X(91)92010-H; TAM CW, 2011, J PINEAL RES; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; TILLEY WD, 1990, J BIOL CHEM, V265, P13776; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Waltregny D, 2001, MOL ENDOCRINOL, V15, P765, DOI 10.1210/me.15.5.765; Wang A, 2000, J BIOL CHEM, V275, P4532, DOI 10.1074/jbc.275.6.4532; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Wu ZL, 2009, INT J BIOCHEM CELL B, V41, P2389, DOI 10.1016/j.biocel.2009.06.004; Yakabe S, 2008, GENES GENET SYST, V83, P199, DOI 10.1266/ggs.83.199; Yan L, 2003, CANCER BIOL THER, V2, P552, DOI 10.4161/cbt.2.5.469; Yeh Shuyuan, 1999, Keio Journal of Medicine, V48, P87; Yu S, 2009, BIOCHEM BIOPH RES CO, V382, P756, DOI 10.1016/j.bbrc.2009.03.110; YUAN SX, 1993, CANCER RES, V53, P1304; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	83	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25187	10.1371/journal.pone.0025187	http://dx.doi.org/10.1371/journal.pone.0025187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966451	gold, Green Published, Green Submitted			2022-12-25	WOS:000295932100022
J	Huang, SH; Hsiao, CD; Lin, DS; Chow, CY; Chang, CJ; Liau, I				Huang, Shih-Hao; Hsiao, Chung-Der; Lin, Dar-Shong; Chow, Cho-Yen; Chang, Chia-Jen; Liau, Ian			Imaging of Zebrafish In Vivo with Second-Harmonic Generation Reveals Shortened Sarcomeres Associated with Myopathy Induced by Statin	PLOS ONE			English	Article							SKELETAL-MUSCLE; MOLECULAR-BASIS; DISEASE; COLLAGEN; DAMAGE; CELLS; FLUORESCENCE; MICROSCOPY; TOXICITY; MODELS	We employed second-harmonic generation (SHG) imaging and the zebrafish model to investigate the myopathy caused by statin in vivo with emphasis on the altered microstructures of the muscle sarcomere, the fundamental contractile element of muscles. This approach derives an advantage of SHG imaging to observe the striated skeletal muscle of living zebrafish based on signals produced mainly from the thick myosin filament of sarcomeres without employing exogenous labels, and eliminates concern about the distortion of muscle structures caused by sample preparation in conventional histological examination. The treatment with statin caused a significantly shortened sarcomere relative to an untreated control (1.73 +/- 0.09 mu m vs 1.91 +/- 0.08 mu m, P<0.05) while the morphological integrity of the muscle fibers remained largely intact. Mechanistic tests indicated that this microstructural disorder was associated with the biosynthetic pathway of cholesterol, or, specifically, with the impaired production of mevalonate by statins. This microstructural disorder exhibited a strong dependence on both the dosage and the duration of treatment, indicating a possibility to assess the severity of muscle injury according to the altered length of the sarcomeres. In contrast to a conventional assessment of muscle injury using clinical biomarkers in blood, such as creatine kinase that is released from only disrupted myocytes, the ability to determine microstructural modification of sarcomeres allows diagnosis of muscle injury before an onset of conventional clinical symptoms. In light of the increasing prevalence of the incidence of muscle injuries caused by new therapies, our work consolidates the combined use of the zebrafish and SHG imaging as an effective and sensitive means to evaluate the safety profile of new therapeutic targets in vivo.	[Huang, Shih-Hao; Chow, Cho-Yen; Chang, Chia-Jen; Liau, Ian] Natl Chiao Tung Univ, Inst Mol Sci, Dept Appl Chem, Hsinchu, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Ctr Nanotechnol, Chungli, Taiwan; [Lin, Dar-Shong] Mackay Mem Hosp, Taipei, Taiwan	National Yang Ming Chiao Tung University; Chung Yuan Christian University; Chung Yuan Christian University; Mackay Memorial Hospital	Huang, SH (corresponding author), Natl Chiao Tung Univ, Inst Mol Sci, Dept Appl Chem, Hsinchu, Taiwan.	ianliau@mail.nctu.edu.tw	Hsiao, Chung-Der/W-4535-2019	Hsiao, Chung-Der/0000-0002-6398-8672	National Science Council; MOE-ATU program of Taiwan; National Chiao Tung University [MMH99-5]; Mackay Memorial Hospital [MMH-CT9904]	National Science Council(Ministry of Science and Technology, Taiwan); MOE-ATU program of Taiwan(Ministry of Education, Taiwan); National Chiao Tung University; Mackay Memorial Hospital	This work was supported by the National Science Council and the MOE-ATU program of Taiwan, the National Chiao Tung University (MMH99-5), and Mackay Memorial Hospital (MMH-CT9904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett DI, 2003, HUM MOL GENET, V12, pR265, DOI 10.1093/hmg/ddg279; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Bub G, 2010, AM J PHYSIOL-HEART C, V298, pH1616, DOI 10.1152/ajpheart.00481.2009; Buettner C, 2008, PHARMACOGENOMICS, V9, P1133, DOI 10.2217/14622416.9.8.1133; Campagnola PJ, 1999, BIOPHYS J, V77, P3341, DOI 10.1016/S0006-3495(99)77165-1; Cao PR, 2009, FASEB J, V23, P2844, DOI 10.1096/fj.08-128843; Chow ESH, 2003, TOXICOL SCI, V73, P149, DOI 10.1093/toxsci/kfg046; Choy JS, 2005, ANN BIOMED ENG, V33, P1027, DOI 10.1007/s10439-005-4854-4; Draeger A, 2006, J PATHOL, V210, P94, DOI 10.1002/path.2018; Fu Y, 2007, BIOPHYS J, V92, P3251, DOI 10.1529/biophysj.106.089011; Gunst JJ, 1998, CLIN CHEM, V44, P939; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Hedenmalm K, 2010, PHARMACOEPIDEM DR S, V19, P223, DOI 10.1002/pds.1895; Hirata H, 2009, EXPERT OPIN DRUG DIS, V4, P507, DOI 10.1517/17460440902835483; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jhan JW, 2008, OPT EXPRESS, V16, P16431, DOI 10.1364/OE.16.016431; KAHN P, 1994, SCIENCE, V264, P904, DOI 10.1126/science.8178149; Kirkpatrick ND, 2007, AM J PHYSIOL-HEART C, V292, pH3198, DOI 10.1152/ajpheart.01234.2006; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Ludman A, 2009, PHARMACOL THERAPEUT, V122, P30, DOI 10.1016/j.pharmthera.2009.01.002; Mohaupt MG, 2009, CAN MED ASSOC J, V181, pE11, DOI 10.1503/cmaj.081785; Mohler W, 2003, METHODS, V29, P97, DOI 10.1016/S1046-2023(02)00292-X; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Plotnikov SV, 2006, BIOPHYS J, V90, P693, DOI 10.1529/biophysj.105.071555; Psilodimitrakopoulos S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3059627; Recher G, 2009, OPT EXPRESS, V17, P19763, DOI 10.1364/OE.17.019763; Rosenson RS, 2004, AM J MED, V116, P408, DOI 10.1016/j.amjmed.2003.10.033; Rubinstein AL, 2003, CURR OPIN DRUG DI DE, V6, P218; Sanger JW, 2009, CELL MOTIL CYTOSKEL, V66, P556, DOI 10.1002/cm.20365; Schaller RD, 2002, J PHYS CHEM B, V106, P5143, DOI 10.1021/jp0144653; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; So PTC, 1998, OPT EXPRESS, V3, P339, DOI 10.1364/OE.3.000339; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Strupler M, 2007, OPT EXPRESS, V15, P4054, DOI 10.1364/OE.15.004054; Tan HY, 2006, INVEST OPHTH VIS SCI, V47, P5251, DOI 10.1167/iovs.06-0386; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Thorpe JL, 2004, DEV CELL, V6, P295, DOI 10.1016/S1534-5807(04)00032-2; Vaklavas C, 2009, ATHEROSCLEROSIS, V202, P18, DOI 10.1016/j.atherosclerosis.2008.05.021; Wallace SJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3027970; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Wu YM, 2009, ANAL CHEM, V81, P1496, DOI 10.1021/ac8026838; Yeh AT, 2008, TISSUE ENG PART B-RE, V14, P119, DOI 10.1089/teb.2007.0284; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	49	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e24764	10.1371/journal.pone.0024764	http://dx.doi.org/10.1371/journal.pone.0024764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966365	Green Submitted, gold, Green Published			2022-12-25	WOS:000295267100007
J	Liu, ML; Rogers, L; Cheng, QY; Shao, YZ; Fernandez-Beros, ME; Hirschhorn, JN; Lyon, HN; Gajdos, ZKZ; Vedantam, S; Gregersen, P; Seldin, MF; Bleck, B; Ramasamy, A; Hartikainen, AL; Jarvelin, MR; Kuokkanen, M; Laitinen, T; Eriksson, J; Lehtimaki, T; Raitakari, OT; Reibman, J				Liu, Mengling; Rogers, Linda; Cheng, Qinyi; Shao, Yongzhao; Fernandez-Beros, Maria Elena; Hirschhorn, Joel N.; Lyon, Helen N.; Gajdos, Zofia K. Z.; Vedantam, Sailaja; Gregersen, Peter; Seldin, Michael F.; Bleck, Bertram; Ramasamy, Adaikalavan; Hartikainen, Anna-Liisa; Jarvelin, Marjo-Riitta; Kuokkanen, Mikko; Laitinen, Tarja; Eriksson, Johan; Lehtimaki, Terho; Raitakari, Olli T.; Reibman, Joan			Genetic Variants of TSLP and Asthma in an Admixed Urban Population	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; MEDIATED ALLERGIC INFLAMMATION; DENDRITIC CELL MATURATION; GENOME-WIDE ASSOCIATION; EPITHELIAL-CELLS; OX40 LIGAND; AIRWAY INFLAMMATION; IMMUNE-RESPONSES; DNA MARKERS; ANCESTRY	Background: Thymic stromal lymphopoietin (TSLP), an IL7-like cytokine produced by bronchial epithelial cells is upregulated in asthma and induces dendritic cell maturation supporting a Th2 response. Environmental pollutants, including tobacco smoke and diesel exhaust particles upregulate TSLP suggesting that TSLP may be an interface between environmental pollution and immune responses in asthma. Since asthma is prevalent in urban communities, variants in the TSLP gene may be important in asthma susceptibility in these populations. Objectives: To determine whether genetic variants in TSLP are associated with asthma in an urban admixed population. Methodology and Main Results: Ten tag-SNPs in the TSLP gene were analyzed for association with asthma using 387 clinically diagnosed asthmatic cases and 212 healthy controls from an urban admixed population. One SNP (rs1898671) showed nominally significant association with asthma (odds ratio (OR) = 1.50; 95% confidence interval (95% CI): 1.09-2.05, p = 0.01) after adjusting for age, BMI, income, education and population stratification. Association results were consistent using two different approaches to adjust for population stratification. When stratified by smoking status, the same SNP showed a significantly increased risk associated with asthma in ex-smokers (OR = 2.00, 95% CI: 1.04-3.83, p = 0.04) but not significant in never-smokers (OR = 1.34; 95% CI: 0.93-1.94, p = 0.11). Haplotype-specific score test indicated that an elevated risk for asthma was associated with a specific haplotype of TSLP involving SNP rs1898671 (OR = 1.58, 95% CI: 1.10-2.27, p = 0.01). Association of this SNP with asthma was confirmed in an independent large population-based cohort consortium study (OR = 1.15, 95% CI: 1.07-1.23, p = 0.0003) and the results stratified by smoking status were also validated (ex-smokers: OR = 1.21, 95% CI: 1.08-1.34, p = 0.003; never-smokers: OR = 1.06, 95% CI: 0.94-1.17, p = 0.33). Conclusions: Genetic variants in TSLP may contribute to asthma susceptibility in admixed urban populations with a gene and environment interaction.	[Liu, Mengling; Cheng, Qinyi; Shao, Yongzhao; Reibman, Joan] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA; [Rogers, Linda; Fernandez-Beros, Maria Elena; Bleck, Bertram; Reibman, Joan] NYU, Dept Med, Sch Med, New York, NY 10016 USA; [Hirschhorn, Joel N.; Gajdos, Zofia K. Z.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Hirschhorn, Joel N.; Lyon, Helen N.; Gajdos, Zofia K. Z.; Vedantam, Sailaja] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.; Lyon, Helen N.; Gajdos, Zofia K. Z.; Vedantam, Sailaja] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Hirschhorn, Joel N.; Lyon, Helen N.; Gajdos, Zofia K. Z.; Vedantam, Sailaja] MIT, Cambridge, MA 02139 USA; [Gregersen, Peter] Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA; [Seldin, Michael F.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Kuokkanen, Mikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Oulu, Finland; [Laitinen, Tarja] Turku Univ Hosp, Dept Pulm Dis & Clin Allergol, FIN-20520 Turku, Finland; [Eriksson, Johan] Finland Helsinki Univ, Natl Inst Hlth & Welf, Finland Dept Gen Practice & Primary Hlth Care, Cent Hosp,Unit Gen Practice,Univ Helsinki, Helsinki, Finland; [Eriksson, Johan] Finland Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan] Finland Vasa Cent Hosp, Vaasa, Finland; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, FIN-33101 Tampere, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Tampere, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [Hirschhorn, Joel N.; Lyon, Helen N.; Gajdos, Zofia K. Z.; Vedantam, Sailaja] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA	New York University; New York University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Northwell Health; University of California System; University of California Davis; University of Oulu; Imperial College London; Finland National Institute for Health & Welfare; University of Turku; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Vaasa Central Hospital; Tampere University; Tampere University; Tampere University Hospital; University of Turku; University of Turku; Harvard University; Boston Children's Hospital	Liu, ML (corresponding author), NYU, Dept Environm Med, Sch Med, 550 1St Ave, New York, NY 10016 USA.	joan.reibman@nyumc.org	Raitakari, Olli/AAQ-7389-2021; Lehtimäki, Terho/AAD-1094-2022; Ramasamy, Adaikalavan/G-2632-2010; Kuokkanen, Mikko/M-8247-2016	Lehtimäki, Terho/0000-0002-2555-4427; Ramasamy, Adaikalavan/0000-0002-7598-2892; Kuokkanen, Mikko/0000-0003-4375-9327; Reibman, Joan/0000-0001-7878-1511; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Eriksson, Johan/0000-0002-2516-2060; Liu, Mengling/0000-0001-9758-8522	Colton Family Foundation; National Institutes of Health [M01RR00096, RO1ES10187]; NIEHS [ES00260]; Stony-Wold Herbert Fund; American Asthma Foundation [07-0282]; National Heart, Lung and Blood Institute [N01-HC-25195]; Affymetrix, Inc [N02-HL-6-4278]; Department of Medicine at Boston University School of Medicine; Boston Medical Center; Academy of Finland [104781, 1114194, 120315, 129398, 117941, 126925, 121584, 124282]; Center of Excellence in Complex Disease Genetics; Oulu University Hospital, Biocenter Oulu, University of Oulu, Finland; European Commission QLG1-CT-2000-01643; NHLBI [5R01HL087679-02, 1RL1MH083268-01]; ENGAGE project [HEALTH-F4-2007-201413]; Medical Research Council [G0500539]; Biocentrum Helsinki; Samfundet Folkhalsan; Finnish Diabetes Research Foundation; Finska Lakaresallskapet; Finnish Foundation for Cardiovascular Research; Foundation of the Finnish Anti-Tuberculosis and Allergy Associations; Yrjo Jahnsson Foundation; Foundation Liv och Halsa; Social Insurance Institution of Finland, Kuopio, Tampere; Turku University Hospital [9L054, 9M048]; Emil Aaltonen Foundaton (TLehtimaki); Tampere Tuberculosis Foundation; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation; Medical Research Council [G0801056B] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278, R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, R01ES010187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER	Colton Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Stony-Wold Herbert Fund; American Asthma Foundation; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix, Inc; Department of Medicine at Boston University School of Medicine; Boston Medical Center; Academy of Finland(Academy of Finland); Center of Excellence in Complex Disease Genetics(Academy of Finland); Oulu University Hospital, Biocenter Oulu, University of Oulu, Finland; European Commission QLG1-CT-2000-01643(European Commission); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ENGAGE project(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biocentrum Helsinki; Samfundet Folkhalsan; Finnish Diabetes Research Foundation; Finska Lakaresallskapet; Finnish Foundation for Cardiovascular Research; Foundation of the Finnish Anti-Tuberculosis and Allergy Associations; Yrjo Jahnsson Foundation; Foundation Liv och Halsa; Social Insurance Institution of Finland, Kuopio, Tampere; Turku University Hospital; Emil Aaltonen Foundaton (TLehtimaki); Tampere Tuberculosis Foundation; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Financial support for the NYUBAR study was received from the Colton Family Foundation; National Institutes of Health M01RR00096, RO1ES10187, NIEHS center grant (ES00260); Stony-Wold Herbert Fund. Financial support the FH study for was provided by the American Asthma Foundation (grant 07-0282). The research on the Framingham Heart Study cohort was conducted using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the NIH and Boston University School of Medicine based on analyses by Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. Financial support for NFBC66 was received from the Academy of Finland (project grants 104781, 1114194, 120315 and Center of Excellence in Complex Disease Genetics), Oulu University Hospital, Biocenter Oulu, University of Oulu, Finland, the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), ENGAGE project and grant agreement HEALTH-F4-2007-201413, and the Medical Research Council (studentship grant G0500539). The DNA extractions, sample quality controls, biobank up-keeping and aliquotting was performed in the National Institute for Health and Welfare, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. Financial support for the HBC, H2000 and Finrisk studies was received from the Academy of Finland, Samfundet Folkhalsan, Finnish Diabetes Research Foundation, Finska Lakaresallskapet, Finnish Foundation for Cardiovascular Research, Foundation of the Finnish Anti-Tuberculosis and Allergy Associations, Yrjo Jahnsson Foundation, and Foundation Liv och Halsa. The Young Finns Study has been financially supported by the Academy of Finland (grants 129398, 117941, 126925, 121584, and 124282), the Social Insurance Institution of Finland, Kuopio, Tampere and Turku University Hospital Medical Funds (grants 9L054 and 9M048), Emil Aaltonen Foundaton (TLehtimaki), Tampere Tuberculosis Foundation (TLehtimaki and MK), Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research and Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bleck B, 2008, J CLIN IMMUNOL, V28, P147, DOI 10.1007/s10875-007-9149-0; Bleck B, 2010, J IMMUNOL, V185, P6636, DOI 10.4049/jimmunol.1000719; Caulfield T, 2009, GENOME MED, V1, DOI 10.1186/gm8; Collins-Schramm HE, 2004, HUM GENET, V114, P263, DOI 10.1007/s00439-003-1058-6; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Enright PL, 1999, CHEST, V116, P603, DOI 10.1378/chest.116.3.603; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; He JQ, 2009, J ALLERGY CLIN IMMUN, V124, P222, DOI 10.1016/j.jaci.2009.04.018; Hunninghake GM, 2008, AM J RESP CRIT CARE, V177, P830, DOI 10.1164/rccm.200711-1697OC; Hunninghake GM, 2006, AM J RESP CRIT CARE, V173, P143, DOI 10.1164/rccm.200508-1232SO; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Liu YJ, 2007, J ALLERGY CLIN IMMUN, V120, P238, DOI 10.1016/j.jaci.2007.06.004; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Meyers DA, 2001, GENET EPIDEMIOL, V21, pS4, DOI 10.1002/gepi.2001.21.s1.s4; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nakamura Y, 2008, J ALLERGY CLIN IMMUN, V122, P1208, DOI 10.1016/j.jaci.2008.09.022; Nguyen Khoa D, 2010, Allergy Asthma Clin Immunol, V6, P4, DOI 10.1186/1710-1492-6-4; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Quentmeier H, 2001, LEUKEMIA, V15, P1286, DOI 10.1038/sj.leu.2402175; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Saxon A, 2005, NAT IMMUNOL, V6, P223, DOI 10.1038/ni0305-223; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Shriver MD, 1997, AM J HUM GENET, V60, P957; Smelter DF, 2010, J IMMUNOL, V185, P3035, DOI 10.4049/jimmunol.1000252; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Valzasina B, 2005, BLOOD, V105, P2845, DOI 10.1182/blood-2004-07-2959; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Widen E, 2010, AM J HUM GENET, V86, P773, DOI 10.1016/j.ajhg.2010.03.010; Yang N, 2005, HUM GENET, V118, P382, DOI 10.1007/s00439-005-0012-1; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	45	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25099	10.1371/journal.pone.0025099	http://dx.doi.org/10.1371/journal.pone.0025099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966427	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100058
J	Silver, KL; Conroy, AL; Leke, RGF; Leke, RJI; Gwanmesia, P; Molyneux, ME; Wallace, DT; Rogerson, SJ; Kain, KC				Silver, Karlee L.; Conroy, Andrea L.; Leke, Rose G. F.; Leke, Robert J. I.; Gwanmesia, Philomina; Molyneux, Malcolm E.; Wallace, Diane Taylor; Rogerson, Stephen J.; Kain, Kevin C.			Circulating Soluble Endoglin Levels in Pregnant Women in Cameroon and Malawi-Associations with Placental Malaria and Fetal Growth Restriction	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; PLASMODIUM-FALCIPARUM MALARIA; NECROSIS-FACTOR-ALPHA; SUB-SAHARAN AFRICA; TGF-BETA; GESTATIONAL-AGE; ENDOTHELIAL-CELLS; IMMUNE-RESPONSES; PRETERM DELIVERY; PREECLAMPSIA	Placental infections with Plasmodium falciparum are associated with fetal growth restriction resulting in low birth weight (LBW). The mechanisms that mediate these effects have yet to be completely described; however, they are likely to involve inflammatory processes and dysregulation of angiogenesis. Soluble endoglin (sEng), a soluble receptor of transforming growth factor (TGF)-beta previously associated with preeclampsia in pregnant women and with severe malaria in children, regulates the immune system and influences angiogenesis. We hypothesized that sEng may play a role in development of LBW associated with placental malaria (PM). Plasma levels of sEng were measured in women (i) followed prospectively throughout pregnancy in Cameroon (n = 52), and (ii) in a case-control study at delivery in Malawi (n = 479). The relationships between sEng levels and gravidity, peripheral and placental parasitemia, gestational age, and adverse outcomes of PM including maternal anemia and LBW were determined. In the longitudinal cohort from Cameroon, 28 of 52 women (54%) experienced at least one malaria infection during pregnancy. In Malawi we enrolled two aparasitemic gravidity-matched controls for every case with PM. sEng levels varied over the course of gestation and were significantly higher in early and late gestation as compared to delivery (P<0.006 and P<0.0001, respectively). Circulating sEng levels were higher in primigravidae than multigravidae from both Cameroon and Malawi, irrespective of malarial infection status (p<0.046 and p<0.001, respectively). Peripheral parasitemia in Cameroonian women and PM in Malawian women were each associated with elevated sEng levels following correction for gestational age and gravidity (p=0.006 and p=0.033, respectively). Increased sEng was also associated with the delivery of LBW infants in primigravid Malawian women (p=0.017); the association was with fetal growth restriction (p=0.003) but not pre-term delivery (p=0.286). Increased circulating maternal sEng levels are associated with P. falciparum infection in pregnancy and with fetal growth restriction in primigravidae with PM.	[Silver, Karlee L.; Conroy, Andrea L.; Kain, Kevin C.] Univ Toronto, Toronto Gen Hosp, Sandra A Rotman Labs, McLaughlin Rotman Ctr Global Hlth,Univ Hlth Netwo, Toronto, ON M5G 1L7, Canada; [Conroy, Andrea L.; Kain, Kevin C.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L7, Canada; [Leke, Rose G. F.; Leke, Robert J. I.; Gwanmesia, Philomina] Univ Yaounde, Fac Med & Biomed Res, Yaounde, Cameroon; [Molyneux, Malcolm E.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Malawi, Coll Med, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [Wallace, Diane Taylor] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Wallace, Diane Taylor] Univ Hawaii, John A Burns Sch Med, Dept Trop Med, Honolulu, HI 96822 USA; [Rogerson, Stephen J.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Kain, Kevin C.] Univ Toronto, Trop Dis Unit, Div Infect Dis, Dept Med, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Yaounde I; University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; Georgetown University; University of Hawaii System; Royal Melbourne Hospital; University of Melbourne; University of Toronto	Silver, KL (corresponding author), Univ Toronto, Toronto Gen Hosp, Sandra A Rotman Labs, McLaughlin Rotman Ctr Global Hlth,Univ Hlth Netwo, Toronto, ON M5G 1L7, Canada.	kevin.kain@uhn.on.ca	Conroy, Andrea/ABC-5715-2020; Conroy, Andrea/AAA-8356-2020	Conroy, Andrea/0000-0002-5328-6511; Conroy, Andrea/0000-0002-5328-6511; Kain, Kevin/0000-0001-6068-1272; Rogerson, Stephen/0000-0003-4287-1982	Canadian Institutes of Health Research (CIHR) [MOP-13721, MOP-115160]; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [5UO1AI43888]; MITACS Elevate Postdoctoral Fellowship; Wellcome Trust [063215]; CIHR Canada Research Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071160, U01AI043888] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MITACS Elevate Postdoctoral Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); CIHR Canada Research Chair(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Canadian Institutes of Health Research (CIHR) grant (MOP-13721 and MOP-115160 (KCK)), and a CIHR Team Grant in Malaria (KCK). Recruitment of Cameroon study population was supported by a National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) grant (5UO1AI43888 (DWT)). KLS is supported by a MITACS Elevate Postdoctoral Fellowship, ALC is supported by a CIHR Doctoral Scholarship, SJR is funded by a Wellcome Trust Senior Research Fellowship (063215), KCK is supported as a CIHR Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ET, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-39; Abrams ET, 2004, AM J REPROD IMMUNOL, V52, P174, DOI 10.1111/j.1600-0897.2004.00186.x; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Caniggia I, 1997, ENDOCRINOLOGY, V138, P4977, DOI 10.1210/en.138.11.4977; Chaiworapongsa T, 2010, ULTRASOUND OBST GYN, V35, P155, DOI 10.1002/uog.7491; Chaiyaroj SC, 2004, ACTA TROP, V89, P319, DOI 10.1016/j.actatropica.2003.10.010; Cho SK, 2001, BLOOD, V98, P3635, DOI 10.1182/blood.V98.13.3635; Dekker G A, 1998, Obstet Gynecol Surv, V53, P377, DOI 10.1097/00006254-199806000-00023; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Dietmann A, 2009, J INFECT DIS, V200, P1842, DOI 10.1086/648476; Duffy PE, 2007, PARASITOLOGY, V134, P1877, DOI 10.1017/S0031182007000170; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Fried M, 1998, J IMMUNOL, V160, P2523; GOUGOS A, 1988, J IMMUNOL, V141, P1925; GOUGOS A, 1992, INT IMMUNOL, V4, P83, DOI 10.1093/intimm/4.1.83; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; GRAHAM CH, 1991, J CELL PHYSIOL, V148, P228, DOI 10.1002/jcp.1041480207; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Guyatt HL, 2001, T ROY SOC TROP MED H, V95, P569, DOI 10.1016/S0035-9203(01)90082-3; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Kidanto HL, 2009, SAMJ S AFR MED J, V99, P98; Kongnyuy Eugene J, 2008, BMC Womens Health, V8, P19, DOI 10.1186/1472-6874-8-19; Kwiek JJ, 2008, MALAWI MED J, V20, P80, DOI 10.4314/mmj.v20i3.10965; Landis SH, 2009, ULTRASOUND OBST GYN, V34, P379, DOI 10.1002/uog.6357; LASTRES P, 1992, EUR J IMMUNOL, V22, P393, DOI 10.1002/eji.1830220216; Leke RFG, 2010, AM J TROP MED HYG, V83, P996, DOI 10.4269/ajtmh.2010.10-0249; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li C, 2003, INFECT IMMUN, V71, P4850, DOI 10.1128/IAI.71.9.4850-4856.2003; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; MacDorman M F, 1999, Natl Vital Stat Rep, V47, P1; Manga L., 1992, Memoires de la Societe Royale Belge d'Entomologie, V35, P155; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Moody JL, 2007, STEM CELLS, V25, P2809, DOI 10.1634/stemcells.2006-0602; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Omer FM, 1998, J EXP MED, V188, P39, DOI 10.1084/jem.188.1.39; Omer FM, 2003, J IMMUNOL, V171, P5430, DOI 10.4049/jimmunol.171.10.5430; Perkins DJ, 2000, J INFECT DIS, V182, P988, DOI 10.1086/315762; PIJNENBORG R, 1981, PLACENTA, V2, P303, DOI 10.1016/S0143-4004(81)80027-6; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rogerson SJ, 2007, AM J TROP MED HYG, V77, P14; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Silver KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009481; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; TURNER M, 1990, Cytokine, V2, P211, DOI 10.1016/1043-4666(90)90018-O; Velasco-Loyden G, 2004, J BIOL CHEM, V279, P7721, DOI 10.1074/jbc.M306499200; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; WISEMAN DM, 1988, BIOCHEM BIOPH RES CO, V157, P793, DOI 10.1016/S0006-291X(88)80319-X; Wolf M, 2005, AM J OBSTET GYNECOL, V193, P16, DOI 10.1016/j.ajog.2005.03.016	56	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24985	10.1371/journal.pone.0024985	http://dx.doi.org/10.1371/journal.pone.0024985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966395	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100037
J	Wakayama, Y; Miura, K; Sabe, H; Mochizuki, N				Wakayama, Yuki; Miura, Koichi; Sabe, Hisataka; Mochizuki, Naoki			EphrinA1-EphA2 Signal Induces Compaction and Polarization of Madin-Darby Canine Kidney Cells by Inactivating Ezrin through Negative Regulation of RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR TYROSINE KINASE; ERM PROTEINS; EZRIN/RADIXIN/MOESIN PROTEINS; DOWNSTREAM EFFECTOR; RAC1 ACTIVATION; EPH RECEPTORS; MORPHOGENESIS; ADHESION; PHOSPHORYLATION	The epithelial cells exhibit either a columnar or a flat shape dependent on extracellular stimuli or the cell-cell adhesion. Membrane-anchored ephrinA stimulates EphA receptor tyrosine kinases as a ligand in a cell-cell contact-dependent manner. The mechanism through which ephrinA1/EphA2 signal regulates the cell morphology remains elusive. We demonstrate here that ephrinA1/EphA2 signal induces compaction and enhanced polarization (columnar change) of Madin-Darby canine kidney epithelial cells by regulating Ezrin, a linker that connects plasma membrane and actin cytoskeleton. Activation of EphA2 resulted in RhoA inactivation through p190RhoGAP-A and subsequent dephosphorylation of Ezrin on Thr-567 phosphorylated by Rho kinase. Consistently, the cells expressing an active mutant of Ezrin in which Thr-567 was replaced with Asp did not change their shape in response to ephrinA1. Furthermore, depletion of Ezrin led to compaction and enhanced polarization without ephrinA1 stimulation, suggesting the role for active Ezrin in keeping the flat cell shape. Ezrin localized to apical domain irrespective of ephrinA1 stimulation, whereas phosphorylated Ezrin on the apical domain was reduced by ephrinA1 stimulation. Collectively, ephrinA1/EphA2 signal negatively regulates Ezrin and promotes the alteration of cell shape, from flat to columnar shape.	[Wakayama, Yuki; Miura, Koichi; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, Suita, Osaka 5658565, Japan; [Sabe, Hisataka] Hokkaido Univ, Grad Sch Med, Dept Mol Biol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	National Cerebral & Cardiovascular Center - Japan; Hokkaido University	Miura, K (corresponding author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	miurako@ri.ncvc.go.jp; nmochizu@ri.ncvc.go.jp	Sabe, Hisataka/A-4066-2012; Sabe, Hisataka/GPF-4385-2022		Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour, and Welfare of Japan; Takeda Science Foundation; Mitsubishi Foundation; AstraZeneca	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; AstraZeneca(AstraZeneca)	This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture of Japan (to N. M.); the Ministry of Health, Labour, and Welfare of Japan (to N. M.); Takeda Science Foundation (to N. M.); the Mitsubishi Foundation (to N. M.); and an AstraZeneca Research Grant (to N. M.).	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Dard N, 2004, DEV BIOL, V271, P87, DOI 10.1016/j.ydbio.2004.03.024; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kondo T, 1997, J CELL BIOL, V139, P749, DOI 10.1083/jcb.139.3.749; Koss M, 2006, J IMMUNOL, V176, P1218, DOI 10.4049/jimmunol.176.2.1218; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Miura K, 2009, MOL BIOL CELL, V20, P1949, DOI 10.1091/mbc.E08-06-0549; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589, DOI 10.1681/ASN.V1281589; PANDEY A, 1994, J BIOL CHEM, V269, P30154; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Stein E, 1997, TRENDS CARDIOVAS MED, V7, P329, DOI 10.1016/S1050-1738(97)00095-9; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Yonemura S, 2002, J CELL SCI, V115, P2569; Zantek ND, 1999, CELL GROWTH DIFFER, V10, P629; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200	42	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44243	44253		10.1074/jbc.M111.267047	http://dx.doi.org/10.1074/jbc.M111.267047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21979959	hybrid, Green Published			2022-12-25	WOS:000298402300064
J	Towne, JE; Renshaw, BR; Douangpanya, J; Lipsky, BP; Shen, M; Gabel, CA; Sims, JE				Towne, Jennifer E.; Renshaw, Blair R.; Douangpanya, Jason; Lipsky, Brian P.; Shen, Min; Gabel, Christopher A.; Sims, John E.			Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36 alpha, IL-36 beta, and IL-36 gamma) or Antagonist (IL-36Ra) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERALIZED PUSTULAR PSORIASIS; NF-KAPPA-B; FAMILY; MEMBERS; RECEPTOR; ACTIVATION; IDENTIFICATION; PROTEINS; SUBUNIT; CLONING	IL-36 alpha, IL-36 beta, and IL-36 gamma (formerly IL-1F6, IL-1F8, and IL-1F9) are IL-1 family members that signal through the IL-1 receptor family members IL-1Rrp2 (IL-1RL2) and IL-1RAcP. IL-36Ra (formerly IL-1F5) has been reported to antagonize IL-36 gamma. However, our previous attempts to demonstrate IL-36Ra antagonism were unsuccessful. Here, we demonstrate that IL-36Ra antagonist activity is dependent upon removal of its N-terminal methionine. IL-36Ra starting at Val-2 is fully active and capable of inhibiting not only IL-36 gamma but also IL-36 alpha and IL-36 beta. Val-2 of IL-36Ra lies 9 amino acids N-terminal to an A-X-Asp motif conserved in all IL-1 family members. In further experiments, we show that truncation of IL-36 alpha, IL-36 beta, and IL-36 gamma to this same point increased their specific activity by similar to 10(3)-10(4)-fold (from EC50 1 mu g/ml to EC50 1 ng/ml). Inhibition of truncated IL-36 beta activity required similar to 10(2)-10(3)-fold excess IL-36Ra, similar to the ratio required for IL-1Ra to inhibit IL-1 beta. Chimeric receptor experiments demonstrated that the extracellular (but not cytoplasmic) domain of IL-1Rrp2 or IL-1R1 is required for inhibition by their respective natural antagonists. IL-36Ra bound to IL-1Rrp2, and pretreatment of IL-1Rrp2-expressing cells with IL-36Ra prevented IL-36 beta-mediated co-immunoprecipitation of IL-1Rrp2 with IL-1RAcP. Taken together, these results suggest that the mechanism of IL-36Ra antagonism is analogous to that of IL-1Ra, such that IL-36Ra binds to IL-1Rrp2 and prevents IL-1RAcP recruitment and the formation of a functional signaling complex. In addition, truncation of IL-36 alpha, IL-36 beta, and IL-36 gamma dramatically enhances their activity, suggesting that post-translational processing is required for full activity.	[Shen, Min] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA; [Towne, Jennifer E.; Renshaw, Blair R.; Douangpanya, Jason; Lipsky, Brian P.; Gabel, Christopher A.; Sims, John E.] Amgen Inc, Dept Inflammat Res, Seattle, WA 98119 USA	Amgen; Amgen	Towne, JE (corresponding author), Amgen Inc, Dept Prot Sci, 1201 Amgen Court W, Seattle, WA 98119 USA.	townej@amgen.com		Sims, John/0000-0002-5667-9185				Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; Born TL, 2000, J BIOL CHEM, V275, P29946, DOI 10.1074/jbc.M004077200; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973; Dunn E, 2001, TRENDS IMMUNOL, V22, P533, DOI 10.1016/S1471-4906(01)02034-8; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Martin U, 2009, J IMMUNOL, V183, P4021, DOI 10.4049/jimmunol.0803301; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200	20	238	278	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42594	42602		10.1074/jbc.M111.267922	http://dx.doi.org/10.1074/jbc.M111.267922			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965679	Green Published, hybrid			2022-12-25	WOS:000298180900067
J	Lucas, N; Cho, W				Lucas, Nathan; Cho, Wonhwa			Phosphatidylserine Binding Is Essential for Plasma Membrane Recruitment and Signaling Function of 3-Phosphoinositide-dependent Kinase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PROTEIN-KINASE; C-ALPHA; DIFFERENTIAL ROLES; 3T3-L1 ADIPOCYTES; PH DOMAIN; ACTIVATION; PDK1; TRANSLOCATION; LOCALIZATION	3-Phosphoinositide-dependent kinase-1 (PDK1) is a ubiquitously expressed serine/threonine kinase that functions downstream of phosphoinositide 3-kinase. Although binding of 3'-phosphoinositides, phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,4-bisphosphate, to the pleckstrin homology (PH) domain of PDK1 is known to be essential for its interaction with and activation of downstream kinases, the mechanism by which PDK1 is recruited to the plasma membrane remains controversial. Our surface plasmon resonance analysis of the PDK1 PH domain and selected mutants shows that the PH domain specifically binds phosphatidylserine using a site that is separate from the canonical phosphoinositide-binding site. Further cell studies show that this specific phosphatidylserine binding is important for the plasma membrane localization and signaling function of PDK1.	[Lucas, Nathan; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cho, W (corresponding author), Univ Illinois, Dept Chem, M-C 111,845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu			National Institutes of Health [GM68849]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68849.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bayascas JR, 2008, CELL CYCLE, V7, P2978, DOI 10.4161/cc.7.19.6810; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CHO W, 2006, SCI STKE, pPE7, DOI DOI 10.1126/STKE.3212006PE7; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Garza LA, 2000, J BIOL CHEM, V275, P2560, DOI 10.1074/jbc.275.4.2560; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Knight JD, 2009, BIOPHYS J, V96, P566, DOI 10.1016/j.bpj.2008.10.020; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Manna D, 2007, J BIOL CHEM, V282, P32093, DOI 10.1074/jbc.M703517200; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Sanchez-Bautista S, 2006, J MOL BIOL, V362, P901, DOI 10.1016/j.jmb.2006.07.093; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Whiteman EL, 2003, ENDOCRINOLOGY, V144, P3811, DOI 10.1210/en.2003-0480; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	39	37	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41265	41272		10.1074/jbc.M111.300806	http://dx.doi.org/10.1074/jbc.M111.300806			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21971045	hybrid, Green Published			2022-12-25	WOS:000298057500014
J	Qi, DF; Huang, SP; Miao, RD; She, ZG; Quinn, T; Chang, YZ; Liu, JG; Fan, DP; Chen, YE; Fu, MG				Qi, Dongfei; Huang, Shengping; Miao, Ruidong; She, Zhi-Gang; Quinn, Tim; Chang, Yingzi; Liu, Jianguo; Fan, Daping; Chen, Y. Eugene; Fu, Mingui			Monocyte Chemotactic Protein-induced Protein 1 (MCPIP1) Suppresses Stress Granule Formation and Determines Apoptosis under Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; BODIES; TRANSLATION; SITES; CELLS; IDENTIFICATION; ACTIVATION; EXPRESSION; MODULATORS; REVEALS	It is unclear how stress granule (SG) formation and cellular apoptosis are coordinately regulated. MCPIP1 (monocyte chemotactic protein-induced protein 1), also known as Zc3h12a, is a critical regulator of the inflammatory response and immune homeostasis. However, the role of MCPIP1 in stress response remains unknown. Here, we report that overexpression of MCPIP1 inhibited the assembly of SGs in response to various stresses. Conversely, MCPIP1-deficient splenocytes developed more SGs even without stress. On the other hand, overexpression of MCPIP1 sensitized RAW 264.7 cells to apoptosis under stress, whereas MCPIP1-deficient cells were resistant to stress-induced apoptosis. Mutagenesis study showed that the ability of MCPIP1 to repress SG formation is dependent on its deubiquitinating activity. Consistently, MCPIP1 negatively regulated stress-induced phosphorylation of eIF2 alpha and thus released stress-induced inhibition of protein translation. However, MCPIP1 also inhibited 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced SG formation, which was reported to be independent of eIF2 alpha phosphorylation. Taken together, these results suggest that MCPIP1 coordinates SG formation and apoptosis during cellular stress and may play a critical role in immune homeostasis and resolution of macrophage inflammation.	[Qi, Dongfei; Huang, Shengping; Miao, Ruidong; Quinn, Tim; Fu, Mingui] Univ Missouri, Sch Med, Shock Trauma Res Ctr, Kansas City, MO 64108 USA; [Qi, Dongfei; Huang, Shengping; Miao, Ruidong; Quinn, Tim; Fu, Mingui] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [She, Zhi-Gang] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92037 USA; [Chang, Yingzi] AT Still Univ Hlth Sci, Dept Pharmacol, Kirksville, MO 63501 USA; [Liu, Jianguo] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63104 USA; [Fan, Daping] Univ S Carolina, Dept Cell Biol & Anat, Columbia, SC 29209 USA; [Chen, Y. Eugene] Univ Michigan, Med Ctr, Ctr Cardiovasc, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Sanford Burnham Prebys Medical Discovery Institute; A.T. Still University of Health Sciences; Saint Louis University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Michigan System; University of Michigan	Fu, MG (corresponding author), Univ Missouri, Sch Med, Shock Trauma Res Ctr, Kansas City, MO 64108 USA.	fum@umkc.edu	Qi, Dongfei/L-9548-2015; Qi, Dongfei/M-1050-2015	Qi, Dongfei/0000-0001-9104-978X; Qi, Dongfei/0000-0001-9104-978X	National Institutes of Health [HL-098794, CA-137126, AR-055353, HL-106325, RR-016434, HL-092421, HL-068878, HL-89544]; American Heart Association; NATIONAL CANCER INSTITUTE [K22CA137126] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092421, R01HL089544, R01HL068878, R21HL106325, R21HL098794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-098794 (to M. F.), CA-137126 and AR-055353 (to L.), HL-106325 and RR-016434 (to D. F.), and HL-092421, HL-068878, and HL-89544 (to Y. E. C.). This work was also supported by an American Heart Association beginning grant-in-aid award (to M. F.).	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cande C, 2004, J CELL SCI, V117, P4461, DOI 10.1242/jcs.01356; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chang WL, 2009, NUCLEIC ACIDS RES, V37, P6600, DOI 10.1093/nar/gkp717; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rossi JJ, 2005, NAT CELL BIOL, V7, P643, DOI 10.1038/ncb0705-643; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Serman A, 2007, NUCLEIC ACIDS RES, V35, P4715, DOI 10.1093/nar/gkm491; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tsai NP, 2010, CELL SIGNAL, V22, P668, DOI 10.1016/j.cellsig.2009.12.001; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	33	40	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41692	41700		10.1074/jbc.M111.276006	http://dx.doi.org/10.1074/jbc.M111.276006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21971051	Green Published, hybrid			2022-12-25	WOS:000298057500053
J	Shapira, S; Kazanov, D; Weisblatt, S; Starr, A; Arber, N; Kraus, S				Shapira, Shiran; Kazanov, Dina; Weisblatt, Samuel; Starr, Alex; Arber, Nadir; Kraus, Sarah			The CD24 Protein Inducible Expression System Is an Ideal Tool to Explore the Potential of CD24 as an Oncogene and a Target for Immunotherapy in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLLED GENE-EXPRESSION; CELL-PROLIFERATION; B-CELLS; TETRACYCLINE; CANCER; APOPTOSIS; INTERNALIZATION; CARCINOGENESIS; PRECURSORS; ADHESION	CD24 is a cell surface, heavily glycosylated glycosylphosphatidylinositol-anchored mucin-like protein that is overexpressed in various human malignancies. To accurately analyze CD24 function and dissect its biological role in a defined genetic background, it is critical to tightly regulate its expression and be able to turn it on/off in a restricted environment and at a specific time, rho tetracycline-induced expression system is most promising as it exhibits such regulation, lack of pleiotropic effects, and high and rapid induction levels. To evaluate the oncogenic and immunotherapeutic potential of CD24 by applying the Tet-On system, the human CD24 gene was cloned downstream to two tetracycline operator sequences, resulting in pCDNA4/TO-CD24, which was then transfected into tetracycline (Tet) repressor-expressing cells (293T-REx), allowing tight on/off regulation, thereby resulting in a very low background or leaky CD24 expression. Selected clones were chosen for further studies and characterized in vitro and in vivo, and several treatment modalities were examined. In addition, the role of CD24 in promoting cell proliferation and tumor growth was studied. The tetracycline-dependent system was successfully implemented. Tetracycline treatment induced CD24 expression in a dose- and time-dependent fashion, which was abrogated following treatment with anti-CD24 monoclonal antibodies (mAbs). CD24-induced expression led to an increased proliferation rate that was inhibited by mAb treatment. In vivo, significantly larger tumors were developed in tetracycline-fed mice. The CD24 Tet-On system is a good model to unravel the role and underlying CD24 pathogenesis in vivo. This valuable tool allows the successful study of novel treatment options, whose effectiveness depends on the CD24 expression level. This set of experiments supports CD24 oncogenic properties.	[Shapira, Shiran; Kazanov, Dina; Weisblatt, Samuel; Arber, Nadir; Kraus, Sarah] Tel Aviv Med Ctr & Sch Med, Tel Aviv Sourasky Med Ctr, Integrated Canc Prevent Ctr, IL-64239 Tel Aviv, Israel; [Starr, Alex] Tel Aviv Sourasky Med Ctr, Lung & Allergy Inst, IL-64239 Tel Aviv, Israel; [Starr, Alex] Tel Aviv Univ, Dept Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Shapira, Shiran; Weisblatt, Samuel; Arber, Nadir; Kraus, Sarah] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Arber, N (corresponding author), Tel Aviv Med Ctr & Sch Med, Tel Aviv Sourasky Med Ctr, Integrated Canc Prevent Ctr, 3-3rd Fl,Arison Med Tower,6 Weizmann St, IL-64239 Tel Aviv, Israel.	nadir@tasmc.health.gov.il		Arber, Nadir/0000-0001-5283-6991; Starr, Alexander/0000-0002-9329-3740	Deutsches Krebsforschungszentrum (DFKZ); Israel Ministry of Science and Technology (MOST)	Deutsches Krebsforschungszentrum (DFKZ); Israel Ministry of Science and Technology (MOST)	This work was supported in part by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DFKZ) and the Israel Ministry of Science and Technology (MOST).	Aiba A, 2007, NEUROSCI RES, V58, P113, DOI 10.1016/j.neures.2007.01.009; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Chappel MS, 1996, J EXP MED, V184, P1639, DOI 10.1084/jem.184.5.1639; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Kim HJ, 2007, CANCER LETT, V258, P98, DOI 10.1016/j.canlet.2007.08.025; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Li O, 2004, J EXP MED, V200, P1083, DOI 10.1084/jem.20040779; Lim SC, 2005, PATHOL RES PRACT, V201, P479, DOI 10.1016/j.prp.2005.05.004; Matzke AJM, 2003, PLANT MOL BIOL REP, V21, P9, DOI 10.1007/BF02773392; Mazor Y, 2007, J IMMUNOL METHODS, V321, P41, DOI 10.1016/j.jim.2007.01.008; MUCCI D, 1995, INFECT IMMUN, V63, P2912, DOI 10.1128/IAI.63.8.2912-2918.1995; Nieoullon V, 2005, MOL CELL NEUROSCI, V28, P462, DOI 10.1016/j.mcn.2004.10.007; Nieoullon V, 2007, CELL TISSUE RES, V329, P457, DOI 10.1007/s00441-007-0395-5; Nizard P, 2001, PROTEIN ENG, V14, P439, DOI 10.1093/protein/14.6.439; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Petry IB, 2010, CLIN CANCER RES, V16, P451, DOI 10.1158/1078-0432.CCR-09-1617; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Sagiv E, 2006, BIOMED PHARMACOTHER, V60, P280, DOI 10.1016/j.biopha.2006.06.006; Sagiv E, 2008, CANCER RES, V68, P2803, DOI 10.1158/0008-5472.CAN-07-6463; Sagiv E, 2006, GASTROENTEROLOGY, V131, P630, DOI 10.1053/j.gastro.2006.04.028; Sagiv Eyal, 2008, Expert Rev Gastroenterol Hepatol, V2, P125, DOI 10.1586/17474124.2.1.125; Shapira S, 2011, GASTROENTEROLOGY, V140, P935, DOI 10.1053/j.gastro.2010.12.004; Stebbins MJ, 2001, P NATL ACAD SCI USA, V98, P10775, DOI 10.1073/pnas.121186498; Suzuki T, 2001, J IMMUNOL, V166, P5567, DOI 10.4049/jimmunol.166.9.5567; Taguchi T, 2003, J IMMUNOL, V170, P252, DOI 10.4049/jimmunol.170.1.252; Wang WF, 2010, CANCER SCI, V101, P112, DOI 10.1111/j.1349-7006.2009.01370.x; WEINMANN P, 1994, PLANT J, V5, P559, DOI 10.1046/j.1365-313X.1994.5040559.x; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; Yin DX, 1996, ANAL BIOCHEM, V235, P195, DOI 10.1006/abio.1996.0112	30	10	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40548	40555		10.1074/jbc.M111.286534	http://dx.doi.org/10.1074/jbc.M111.286534			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21976680	Green Published, hybrid			2022-12-25	WOS:000297315400014
J	Venkov, C; Plieth, D; Ni, T; Karmaker, A; Bian, AH; George, AL; Neilson, EG				Venkov, Christo; Plieth, David; Ni, Terri; Karmaker, Amitava; Bian, Aihua; George, Alfred L., Jr.; Neilson, Eric G.			Transcriptional Networks in Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; GROWTH-FACTOR-BETA; CONFERS RESISTANCE; TGF-BETA; EXPRESSION; FIBROSIS; DISEASE; CANCER; KIDNEY; QUANTIFICATION	Backround: Epithelial-mesenchymal transition (EMT) changes polarized epithelial cells into migratory phenotypes associated with loss of cell-cell adhesion molecules and cytoskeletal rearrangements. This form of plasticity is seen in mesodermal development, fibroblast formation, and cancer metastasis. Methods and Findings: Here we identify prominent transcriptional networks active during three time points of this transitional process, as epithelial cells become fibroblasts. DNA microarray in cultured epithelia undergoing EMT, validated in vivo, were used to detect various patterns of gene expression. In particular, the promoter sequences of differentially expressed genes and their transcription factors were analyzed to identify potential binding sites and partners. The four most frequent cis-regulatory elements (CREs) in up-regulated genes were SRY, FTS-1, Evi-1, and GC-Box, and RNA inhibition of the four transcription factors, Atf2, Klf10, Sox11, and SP1, most frequently binding these CREs, establish their importance in the initiation and propagation of EMT. Oligonucleotides that block the most frequent CREs restrain EMT at early and intermediate stages through apoptosis of the cells. Conclusions: Our results identify new transcriptional interactions with high frequency CREs that modulate the stability of cellular plasticity, and may serve as targets for modulating these transitional states in fibroblasts.	[Venkov, Christo; Plieth, David; Ni, Terri; George, Alfred L., Jr.; Neilson, Eric G.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Neilson, Eric G.] Vanderbilt Univ, Sch Med, Dept Cell Biol, Nashville, TN 37212 USA; [Bian, Aihua] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Karmaker, Amitava] Univ Wisconsin Stout, Menomonie, WI USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Wisconsin System; University of Wisconsin Stout	Venkov, C (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	eric.neilson@vanderbilt.edu			National Institutes of Health [DK-46282]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK-46282. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Cutroneo KR, 2007, WOUND REPAIR REGEN, V15, pS54, DOI 10.1111/j.1524-475X.2007.00226.x; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Defrance M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-396; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; GOTEA V, 2010, GENOME RES; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Iwano Masayuki, 2010, Front Biosci (Schol Ed), V2, P229; Johnsen SA, 2002, ONCOGENE, V21, P5783, DOI 10.1038/sj.onc.1205681; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KIM SJ, 1992, NATURE, V358, P331, DOI 10.1038/358331a0; Kubo A, 2010, DEVELOPMENT, V137, P1613, DOI 10.1242/dev.046789; Kuhn H, 2001, ANTISENSE NUCLEIC A, V11, P149, DOI 10.1089/108729001300338672; Le Bechec A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-67; Leung-Hagesteijn C, 2005, MOL CELL BIOL, V25, P3648, DOI 10.1128/MCB.25.9.3648-3657.2005; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lok CN, 2008, J CELL BIOCHEM, V103, P1066, DOI 10.1002/jcb.21477; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Morishita R, 1998, CIRC RES, V82, P1023, DOI 10.1161/01.RES.82.10.1023; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nawshad A, 2007, J CELL SCI, V120, P1646, DOI 10.1242/jcs.003129; Neilson EG, 2006, NAT CLIN PRACT NEPHR, V2, P101, DOI 10.1038/ncpneph0093; Ni TT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-505; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Penolazzi L, 2003, BIOCHEM PHARMACOL, V66, P1189, DOI 10.1016/S0006-2952(03)00470-2; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Plisov SY, 2000, GENESIS, V27, P22, DOI 10.1002/1526-968X(200005)27:1<22::AID-GENE40>3.3.CO;2-M; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; PRYOR JL, 1992, ANAL BIOCHEM, V202, P100, DOI 10.1016/0003-2697(92)90213-Q; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Robson EJD, 2006, DIFFERENTIATION, V74, P254, DOI 10.1111/j.1432-0436.2006.00075.x; Ross KR, 2007, CELL SIGNAL, V19, P923, DOI 10.1016/j.cellsig.2006.11.008; Shoval O, 2010, CELL, V143, P326, DOI 10.1016/j.cell.2010.09.050; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Subramaniam M, 2010, BIOFACTORS, V36, P8, DOI 10.1002/biof.67; Subramanian SV, 2004, MOL BIOL CELL, V15, P4532, DOI 10.1091/mbc.E04-04-0348; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Tomita Naruya, 2007, Clin Exp Nephrol, V11, P7, DOI 10.1007/s10157-007-0459-6; Uhl JD, 2010, DEV BIOL, V343, P154, DOI 10.1016/j.ydbio.2010.04.004; Valdes F, 2002, MOL CANCER RES, V1, P68; Vavouri T, 2009, BIOESSAYS, V31, P727, DOI 10.1002/bies.200900014; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Weinberg RA, 2008, NAT CELL BIOL, V10, P1021, DOI 10.1038/ncb0908-1021; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Xue CS, 2003, CANCER RES, V63, P3386; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang XH, 2005, AM J PHYSIOL-RENAL, V288, pF16, DOI 10.1152/ajprenal.00318.2003	71	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25354	10.1371/journal.pone.0025354	http://dx.doi.org/10.1371/journal.pone.0025354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980432	Green Submitted, gold, Green Published			2022-12-25	WOS:000295941300025
J	Proppe, DS; Sturdy, CB; St Clair, CC				Proppe, Darren S.; Sturdy, Christopher B.; St Clair, Colleen Cassady			Flexibility in Animal Signals Facilitates Adaptation to Rapidly Changing Environments	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; SONG STRUCTURE; URBAN NOISE; GREAT TITS; BIRDS; CALLS; MECHANISM; CONTESTS; BEHAVIOR; QUALITY	Charles Darwin posited that secondary sexual characteristics result from competition to attract mates. In male songbirds, specialized vocalizations represent secondary sexual characteristics of particular importance because females prefer songs at specific frequencies, amplitudes, and duration. For birds living in human-dominated landscapes, historic selection for song characteristics that convey fitness may compete with novel selective pressures from anthropogenic noise. Here we show that black-capped chickadees (Poecile atricapillus) use shorter, higher-frequency songs when traffic noise is high, and longer, lower-frequency songs when noise abates. We suggest that chickadees balance opposing selective pressures by use low-frequency songs to preserve vocal characteristics of dominance that repel competitors and attract females, and high frequency songs to increase song transmission when their environment is noisy. The remarkable vocal flexibility exhibited by chickadees may be one reason that they thrive in urban environments, and such flexibility may also support subsequent genetic adaptation to an increasingly urbanized world.	[Proppe, Darren S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Sturdy, Christopher B.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [St Clair, Colleen Cassady] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Proppe, DS (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	dproppe@montreat.edu	St. Clair, Colleen Cassady/A-2953-2016; Sturdy, Christopher B/A-4407-2009	St. Clair, Colleen Cassady/0000-0002-3378-795X; Sturdy, Christopher/0000-0003-2721-3770; Proppe, Darren/0000-0001-7741-6504	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; University of Alberta; Alberta Ingenuity Fund; Alberta Sport, Recreation, Parks, and Wildlife Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); University of Alberta(University of Alberta); Alberta Ingenuity Fund; Alberta Sport, Recreation, Parks, and Wildlife Foundation	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (CBS and CCS), the Canada Foundation for Innovation (CBS and CCS), partner funding from the University of Alberta (CBS), Alberta Ingenuity Fund (CBS) and the Alberta Sport, Recreation, Parks, and Wildlife Foundation (DSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan R, 2001, J COMP PHYSIOL A, V187, P255, DOI 10.1007/s003590100197; Brumm H, 2011, BEHAV ECOL, V22, P310, DOI 10.1093/beheco/arq205; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Caro SP, 2010, BEHAV ECOL, V21, P562, DOI 10.1093/beheco/arq022; Christie PJ, 2004, BEHAV ECOL SOCIOBIOL, V55, P341, DOI 10.1007/s00265-003-0711-3; Christie PJ, 2004, BEHAVIOUR, V141, P101, DOI 10.1163/156853904772746628; Darwin C., 1981, DESCENT MAN SELECTIO; Foote JR, 2008, BEHAV ECOL, V19, P1192, DOI 10.1093/beheco/arn087; Franz M, 2003, J EXP BIOL, V206, P967, DOI 10.1242/jeb.00196; Hall DW, 2000, EVOLUTION, V54, P1862, DOI 10.1111/j.0014-3820.2000.tb01233.x; Hoeschele M, 2010, ANIM BEHAV, V79, P657, DOI 10.1016/j.anbehav.2009.12.015; Hof D, 2010, ANIM BEHAV, V80, P821, DOI 10.1016/j.anbehav.2010.07.017; HORN AG, 1992, AUK, V109, P847; Horn AG, 1992, FREQUENCY VARIATION; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Mennill DJ, 2004, ANIM BEHAV, V67, P441, DOI 10.1016/j.anbehav.2003.04.010; Mockford EJ, 2009, P ROY SOC B-BIOL SCI, V276, P2979, DOI 10.1098/rspb.2009.0586; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; Proppe DS, 2009, J EXP BIOL, V212, P3016, DOI 10.1242/jeb.031724; Proppe DS, 2010, EFFECT ANTHROPOGENIC; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; RATCLIFFE L, 1985, CONDOR, V87, P555, DOI 10.2307/1367963; Reijnen R, 2006, ENVIRONM POLLUT SER, V10, P255, DOI 10.1007/1-4020-4504-2_12; Sharbaugh SM, 2001, PHYSIOL BIOCHEM ZOOL, V74, P568, DOI 10.1086/322170; Slabbekoom H, 2004, J ACOUST SOC AM, V116, P3727, DOI 10.1121/1.1811121; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; Smith S.M., 1991, BLACK CAPPED CHICKAD; Weisman R, 1990, CONDOR, V92, P188; Wiley R. H., 1982, ACOUSTIC COMMUNICATI, P131, DOI DOI 10.1016/B978-0-08-092416-8.50014-0; Zahavi A, 1999, HANDICAP PRINCIPLE M	33	21	21	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25413	10.1371/journal.pone.0025413	http://dx.doi.org/10.1371/journal.pone.0025413			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980449	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900061
J	Valcarcel, B; Wurtz, P; al Basatena, NKS; Tukiainen, T; Kangas, AJ; Soininen, P; Jarvelin, MR; Ala-Korpela, M; Ebbels, TM; de Iorio, M				Valcarcel, Beatriz; Wurtz, Peter; al Basatena, Nafisa-Katrin Seich; Tukiainen, Taru; Kangas, Antti J.; Soininen, Pasi; Jarvelin, Marjo-Riitta; Ala-Korpela, Mika; Ebbels, Timothy M.; de Iorio, Maria			A Differential Network Approach to Exploring Differences between Biological States: An Application to Prediabetes	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; VLDL	Background: Variations in the pattern of molecular associations are observed during disease development. The comprehensive analysis of molecular association patterns and their changes in relation to different physiological conditions can yield insight into the biological basis of disease-specific phenotype variation. Methodology: Here, we introduce a formal statistical method for the differential analysis of molecular associations via network representation. We illustrate our approach with extensive data on lipoprotein subclasses measured by NMR spectroscopy in 4,406 individuals with normal fasting glucose, and 531 subjects with impaired fasting glucose (prediabetes). We estimate the pair-wise association between measures using shrinkage estimates of partial correlations and build the differential network based on this measure of association. We explore the topological properties of the inferred network to gain insight into important metabolic differences between individuals with normal fasting glucose and prediabetes. Conclusions/Significance: Differential networks provide new insights characterizing differences in biological states. Based on conventional statistical methods, few differences in concentration levels of lipoprotein subclasses were found between individuals with normal fasting glucose and individuals with prediabetes. By performing the differential analysis of networks, several characteristic changes in lipoprotein metabolism known to be related to diabetic dyslipidemias were identified. The results demonstrate the applicability of the new approach to identify key molecular changes inaccessible to standard approaches.	[Valcarcel, Beatriz; al Basatena, Nafisa-Katrin Seich] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England; [Wurtz, Peter; Tukiainen, Taru; Kangas, Antti J.; Soininen, Pasi; Ala-Korpela, Mika] Univ Oulu, Inst Clin Med, Oulu, Finland; [Wurtz, Peter; Tukiainen, Taru; Kangas, Antti J.; Soininen, Pasi; Jarvelin, Marjo-Riitta; Ala-Korpela, Mika] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Soininen, Pasi; Ala-Korpela, Mika] Univ Eastern Finland, Dept Biosci, NMR Metabon Lab, Kuopio, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Wellbeing, Dept Child & Adolescent Hlth, Oulu, Finland; [Jarvelin, Marjo-Riitta] Inst Hlth Sci, Oulu, Finland; [Ala-Korpela, Mika] Univ Oulu, Dept Internal Med, Clin Res Ctr, SF-90220 Oulu, Finland; [Ebbels, Timothy M.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	Imperial College London; University of Oulu; University of Oulu; University of Eastern Finland; University of Oulu; Imperial College London	Valcarcel, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England.	t.ebbels@imperial.ac.uk; m.deiorio@imperial.ac.uk	Ebbels, Tim/ABB-2627-2021; Soininen, Pasi/B-9716-2008	Ebbels, Tim/0000-0002-3372-8423; Ala-Korpela, Mika/0000-0001-5905-1206; De Iorio, Maria/0000-0003-3109-0478; Wurtz, Peter/0000-0002-5832-0221; Kangas, Antti/0000-0001-7492-1732; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Tukiainen, Taru/0000-0002-5404-8398	Biotechnology and Biological Sciences Research Council [BB/E20372/1]; Academy of Finland [137870, 129429, 104781, 120315, 1114194, 129269 (SALVE), 139900S]; Finnish Cardiovascular Research Foundation; Jenny and Antti Wihuri Foundation; Instrumentarium Science Foundation; University Hospital Oulu, Biocenter, University of Oulu, Finland; Medical Research Council (PrevMetSyn), UK; ENGAGE project [HEALTH-F4-2007-201413]; BBSRC [BB/E020372/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E020372/1] Funding Source: researchfish; Medical Research Council [G0801056B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Academy of Finland(Academy of Finland); Finnish Cardiovascular Research Foundation; Jenny and Antti Wihuri Foundation; Instrumentarium Science Foundation; University Hospital Oulu, Biocenter, University of Oulu, Finland; Medical Research Council (PrevMetSyn), UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ENGAGE project(General Electric); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by: Biotechnology and Biological Sciences Research Council (Grant Ref. BB/E20372/1); Academy of Finland (grant number 137870); Responding to Public Health Challenges Research Programme of the Academy of Finland (grant number 129429); The Finnish Cardiovascular Research Foundation; The Jenny and Antti Wihuri Foundation; Academy of Finland and the Instrumentarium Science Foundation; The Academy of Finland (project grants 104781, 120315, 1114194, 129269 (SALVE), 139900S); University Hospital Oulu, Biocenter, University of Oulu, Finland; The Medical Research Council (PrevMetSyn), UK and the ENGAGE project and grant agreement HEALTH-F4-2007-201413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bertram HC, 2009, METABOLISM, V58, P1039, DOI 10.1016/j.metabol.2009.03.011; Camacho D, 2005, METABOLOMICS, V1, P53, DOI 10.1007/s11306-005-1107-3; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; de Silva E, 2005, J R SOC INTERFACE, V2, P419, DOI 10.1098/rsif.2005.0067; Festa A, 2005, CIRCULATION, V111, P3465, DOI 10.1161/CIRCULATIONAHA.104.512079; Fuite J, 2008, GENOMICS, V92, P393, DOI 10.1016/j.ygeno.2008.08.008; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gill R, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-427, 10.1186/1471-2105-11-95]; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Hodge AM, 2009, DIABETES RES CLIN PR, V83, P132, DOI 10.1016/j.diabres.2008.11.007; Inouye M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.93; Kumpula LS, 2008, CHEM PHYS LIPIDS, V155, P57, DOI 10.1016/j.chemphyslip.2008.06.003; Ledoit 0., 2003, J EMPIR FINANC, V10, P603, DOI [10.1016/S0927-5398(03)00007-0, DOI 10.1016/S0927-5398(03)00007-0]; Mora S, 2010, DIABETES, V59, P1153, DOI 10.2337/db09-1114; Niemi J, 2009, ANN MED, V41, P451, DOI 10.1080/07853890902893392; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Ursem R, 2008, EUPHYTICA, V161, P181, DOI 10.1007/s10681-008-9672-y; Vehtari A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S8; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; World Health Organization, 2003, WHONMHMN031	30	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24702	10.1371/journal.pone.0024702	http://dx.doi.org/10.1371/journal.pone.0024702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980352	Green Published, gold, Green Submitted			2022-12-25	WOS:000295933700007
J	Wang, QL; Zhang, M; Liang, B; Shirwany, N; Zhu, Y; Zou, MH				Wang, Qilong; Zhang, Miao; Liang, Bin; Shirwany, Najeeb; Zhu, Yi; Zou, Ming-Hui			Activation of AMP-Activated Protein Kinase Is Required for Berberine-Induced Reduction of Atherosclerosis in Mice: The Role of Uncoupling Protein 2	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; TRADITIONAL CHINESE MEDICINE; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; INSULIN SENSITIVITY; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; IN-VIVO; MITOCHONDRIAL BIOGENESIS; HYDROGEN-PEROXIDE	Aims: Berberine, a botanical alkaloid purified from Coptidis rhizoma, is reported to activate the AMP-activated protein kinase (AMPK). Whether AMPK is required for the protective effects of berberine in cardiovascular diseases remains unknown. This study was designed to determine whether AMPK is required for berberine-induced reduction of oxidative stress and atherosclerosis in vivo. Methods: ApoE (ApoE(-/-)) mice and ApoE(-/-)/AMPK alpha 2(-/-) mice that were fed Western diets were treated with berberine for 8 weeks. Atherosclerotic aortic lesions, expression of uncoupling protein 2 (UCP2), and markers of oxidative stress were evaluated in isolated aortas. Results: In ApoE(-/-) mice, chronic administration of berberine significantly reduced aortic lesions, markedly reduced oxidative stress and expression of adhesion molecules in aorta, and significantly increased UCP2 levels. In contrast, in ApoE(-/-)/AMPK alpha 2(-/-) mice, berberine had little effect on those endpoints. In cultured human umbilical vein endothelial cells (HUVECs), berberine significantly increased UCP2 mRNA and protein expression in an AMPK-dependent manner. Transfection of HUVECs with nuclear respiratory factor 1 (NRF1)-specific siRNA attenuated berberine-induced expression of UCP2, whereas transfection with control siRNA did not. Finally, berberine promoted mitochondrial biogenesis that contributed to up-regulation of UCP2 expression. Conclusion: We conclude that berberine reduces oxidative stress and vascular inflammation, and suppresses atherogenesis via a mechanism that includes stimulation of AMPK-dependent UCP2 expression.	[Wang, Qilong; Zhang, Miao; Liang, Bin; Shirwany, Najeeb; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK 73190 USA; [Zhu, Yi] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Peking University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Wang, QL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK 73190 USA.	ming-hui-zou@ouhsc.edu	wang, qilong/O-1962-2013	wang, qilong/0000-0002-4375-991X	National Institutes of Health; American Diabetes Association; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health, American Diabetes Association, and American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arayne MS, 2007, PAK J PHARM SCI, V20, P83; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Beall C, 2010, BIOCHEM J, V429, P323, DOI 10.1042/BJ20100231; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Cheng Z, 2006, BBA-GEN SUBJECTS, V1760, P1682, DOI 10.1016/j.bbagen.2006.09.007; Cho BJ, 2005, MOL CELLS, V20, P429; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Cicero AEG, 2007, ARZNEIMITTELFORSCH, V57, P26; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; DONG Y, 2002, CIRCULATION, V121, P792; Duval C, 2002, BIOCHEM CELL BIOL, V80, P757, DOI 10.1139/O02-158; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Fulop P, 2006, HEPATOLOGY, V44, P592, DOI 10.1002/hep.21310; Gauthier MS, 2011, BIOCHEM BIOPH RES CO, V404, P382, DOI 10.1016/j.bbrc.2010.11.127; Guo Y, 2008, CHINESE MED J-PEKING, V121, P1197, DOI 10.1097/00029330-200807010-00009; Han YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015420; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Horimoto M, 2004, HEPATOLOGY, V39, P386, DOI 10.1002/hep.20047; Jelenik T, 2010, DIABETES, V59, P2737, DOI 10.2337/db09-1716; Jo SH, 2006, J IMMUNOL, V177, P3737, DOI 10.4049/jimmunol.177.6.3737; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Liang KW, 2006, BIOCHEM PHARMACOL, V71, P806, DOI 10.1016/j.bcp.2005.12.028; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Moukdar F, 2009, J LIPID RES, V50, P59, DOI 10.1194/jlr.M800273-JLR200; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Palanivel R, 2008, J ENDOCRINOL, V199, P389, DOI 10.1677/JOE-08-0336; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Ruzicka M, 2005, INT J BIOCHEM CELL B, V37, P809, DOI 10.1016/j.biocel.2004.10.016; Serafim TL, 2008, CANCER CHEMOTH PHARM, V61, P1007, DOI 10.1007/s00280-007-0558-9; Shirwany NA, 2010, ACTA PHARMACOL SIN, V31, P1075, DOI 10.1038/aps.2010.139; Tsai JS, 2010, J CELL BIOCHEM, V110, P1410, DOI 10.1002/jcb.22657; Uotani S, 2006, BIOCHEM BIOPH RES CO, V351, P171, DOI 10.1016/j.bbrc.2006.10.015; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Vieira O, 2000, FASEB J, V14, P532, DOI 10.1096/fasebj.14.3.532; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wang HY, 2009, SPECTROCHIM ACTA A, V73, P682, DOI 10.1016/j.saa.2009.03.017; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Wang YQ, 2009, CARDIOVASC RES, V82, P484, DOI 10.1093/cvr/cvp078; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; WUTHRICH RP, 1990, AM J PATHOL, V136, P441; Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610; Ye JM, 2006, DIABETES, V55, P2797, DOI 10.2337/db05-1315; Yin HQ, 2008, J ETHNOPHARMACOL, V118, P133, DOI 10.1016/j.jep.2008.03.022; Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330; Yu L, 2010, NEUROSCIENCE, V169, P23, DOI 10.1016/j.neuroscience.2010.04.063; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253	63	102	111	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25436	10.1371/journal.pone.0025436	http://dx.doi.org/10.1371/journal.pone.0025436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980456	Green Published, Green Submitted, gold			2022-12-25	WOS:000295933700033
J	Wang, W; Lv, L; Pan, K; Zhang, Y; Zhao, JJ; Chen, JG; Chen, YB; Li, YQ; Wang, QJ; He, J; Chen, SP; Zhou, ZW; Xia, JC				Wang, Wei; Lv, Lin; Pan, Ke; Zhang, Yu; Zhao, Jing-jing; Chen, Ju-gao; Chen, Yi-bing; Li, Yong-qiang; Wang, Qi-jin; He, Jia; Chen, Shi-ping; Zhou, Zhi-wei; Xia, Jian-chuan			Reduced Expression of Transcription Factor AP-2 alpha Is Associated with Gastric Adenocarcinoma Prognosis	PLOS ONE			English	Article							FACTOR AP-2; GENE-EXPRESSION; PROSTATE-CANCER; SURVIVAL; IDENTIFICATION; METASTASIS; CARCINOMA; PROFILE; GROWTH	Background: This study aims to investigate the expression and prognostic significance of activator protein 2 alpha (AP-2 alpha) in gastric adenocarcinoma. Methodology/Principal Findings: AP-2 alpha expression was analyzed using real-time quantitative PCR (RT-qPCR), western blotting, and immunohistochemical staining methods on tissue samples from a consecutive series of 481 gastric adenocarcinoma patients who underwent resections between 2003 and 2006. The relationship between AP-2 alpha expression, clinicopathological factors, and patient survival was investigated. RT-qPCR results showed that the expression of AP-2 alpha mRNA was reduced in tumor tissue samples, compared with expression in matched adjacent non-tumor tissue samples (P = 0.009); this finding was confirmed by western blotting analysis (P = 0.012). Immunohistochemical staining data indicated that AP-2 alpha expression was significantly decreased in 196 of 481 (40.7%) gastric adenocarcinoma cases; reduced AP-2 alpha expression was also observed in patients with poorly differentiated tumors (P = 0.001) and total gastric carcinomas (P = 0.002), as well as in patients who underwent palliative tumor resection (P = 0.004). Additionally, reduced expression of AP-2 alpha was more commonly observed in tumors that were staged as T4a/b (P = 0.018), N3 (P = 0.006), and M1 (P = 0.008). Kaplan-Meier survival curves revealed that reduced expression of AP-2 alpha was associated with poor prognosis in gastric adenocarcinoma patients (P<0.001). Multivariate Cox analysis identified AP-2 alpha expression as an independent prognostic factor for overall survival (HR = 1.512, 95% CI = 1.127-2.029, P = 0.006). Conclusions/Significance: Our data suggest that AP-2 alpha plays an important role in tumor progression and that reduced AP-2 alpha expression independently predicts an unfavorable prognosis in gastric adenocarcinoma patients.	[Wang, Wei; Lv, Lin; Pan, Ke; Zhang, Yu; Zhao, Jing-jing; Chen, Ju-gao; Chen, Yi-bing; Li, Yong-qiang; Wang, Qi-jin; He, Jia; Chen, Shi-ping; Zhou, Zhi-wei; Xia, Jian-chuan] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wei; Lv, Lin; Pan, Ke; Zhang, Yu; Zhao, Jing-jing; Chen, Ju-gao; Chen, Yi-bing; Li, Yong-qiang; Wang, Qi-jin; He, Jia; Chen, Shi-ping; Zhou, Zhi-wei; Xia, Jian-chuan] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wei; Zhou, Zhi-wei] Sun Yat Sen Univ, Dept Gastr & Pancreat Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yu] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wang, W (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	zhouzhw@sysucc.org.cn; xiajch@mail.sysu.edu.cn			National Natural Science Foundation of China [30973398]; Science and Technology Projects of Guangdong Province [2008B030301103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Projects of Guangdong Province	This work was supported by National Natural Science Foundation of China Grant 30973398 and the Science and Technology Projects of Guangdong Province (2008B030301103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2010, NCCN CLIN PRACTICE G, V2; Anttila MA, 2000, BRIT J CANCER, V82, P1974; Bar-Eli M, 1999, CANCER METAST REV, V18, P377, DOI 10.1023/A:1006377309524; Chen CN, 2005, J CLIN ONCOL, V23, P7286, DOI 10.1200/JCO.2004.00.2253; Douglas DB, 2004, CANCER RES, V64, P1611, DOI 10.1158/0008-5472.CAN-0318-2; Gee JMW, 1999, J PATHOL, V189, P514, DOI 10.1002/(SICI)1096-9896(199912)189:4<514::AID-PATH463>3.0.CO;2-9; Heimberger AB, 2005, CLIN CANCER RES, V11, P267; Hippo Y, 2002, CANCER RES, V62, P233; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karjalainen JM, 1998, J CLIN ONCOL, V16, P3584, DOI 10.1200/JCO.1998.16.11.3584; Lee HS, 2007, CLIN CANCER RES, V13, P4154, DOI 10.1158/1078-0432.CCR-07-0173; Lipponen P, 2000, EUR UROL, V37, P573, DOI 10.1159/000020195; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Pellikainen J, 2002, CLIN CANCER RES, V8, P3487; Ropponen KM, 2001, J CLIN PATHOL, V54, P533, DOI 10.1136/jcp.54.7.533; Ropponen KM, 1999, BRIT J CANCER, V81, P133, DOI 10.1038/sj.bjc.6690662; Ruiz M, 2004, CANCER RES, V64, P631, DOI 10.1158/0008-5472.CAN-03-2751; Yasui Wataru, 2005, Gastric Cancer, V8, P86, DOI 10.1007/s10120-005-0320-0; Yasui W, 2009, PATHOL INT, V59, P121, DOI 10.1111/j.1440-1827.2009.02329.x	22	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e24897	10.1371/journal.pone.0024897	http://dx.doi.org/10.1371/journal.pone.0024897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966377	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100006
J	Scoma, HD; Humby, M; Yadav, G; Zhang, QJ; Fogerty, J; Besharse, JC				Scoma, Heather Dehlin; Humby, Monica; Yadav, Geetha; Zhang, Qingjiong; Fogerty, Joseph; Besharse, Joseph C.			The De-Ubiquitinylating Enzyme, USP2, Is Associated with the Circadian Clockwork and Regulates Its Sensitivity to Light	PLOS ONE			English	Article							GENE-EXPRESSION; DEUBIQUITINATING ENZYMES; DEGRADATION; TRANSCRIPTION; ACTIVATION; COACTIVATOR; PHYSIOLOGY; TURNOVER; PROTEIN; BMAL1	We have identified a novel component of the circadian clock that regulates its sensitivity to light at the evening light to dark transition. USP2 (Ubiquitin Specific Protease 2), which de-ubiquitinylates and stabilizes target proteins, is rhythmically expressed in multiple tissues including the SCN. We have developed a knockout model of USP2 and found that exposure to low irradiance light at ZT12 increases phase delays of USP2(-/-) mice compared to wildtype. We additionally show that USP2b is in a complex with several clock components and regulates the stability and turnover of BMAL1, which in turn alters the expression of several CLOCK/BMAL1 controlled genes. Rhythmic expression of USP2 in the SCN and other tissues offers a new level of control of the clock machinery through de-ubiqutinylation and suggests a role for USP2 during circadian adaptation to environmental day length changes.	[Scoma, Heather Dehlin; Humby, Monica; Yadav, Geetha; Zhang, Qingjiong; Fogerty, Joseph; Besharse, Joseph C.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Scoma, HD (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	jbeshars@mcw.edu	Zhang, Qingjiong/AAR-6331-2021	Zhang, Qingjiong/0000-0001-7508-848X; Fogerty, Joseph/0000-0003-0028-1861	NIH [EY02414, EY03222, P30-EY01931, T32-EY014537]; NATIONAL EYE INSTITUTE [T32EY014537, R01EY002414, P30EY001931, R01EY003222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was supported by NIH research grants EY02414 (JCB) and EY03222 (JCB) and by NIH Core Grant for Vision Research P30-EY01931. HDS and JF were supported by training grant NIH T32-EY014537. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2006, MOL BIOL CELL, V17, P555, DOI 10.1091/mbc.E05-05-0396; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hurst WJ, 2002, BIOCHEM BIOPH RES CO, V298, P133, DOI 10.1016/S0006-291X(02)02346-X; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Kita Y, 2002, PHARMACOGENETICS, V12, P55, DOI 10.1097/00008571-200201000-00008; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kondratov RV, 2007, CURR TOP DEV BIOL, V78, P173, DOI 10.1016/S0070-2153(06)78005-X; Lall GS, 2010, NEURON, V66, P417, DOI 10.1016/j.neuron.2010.04.037; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Liu S, 2007, CHRONOBIOL INT, V24, P793, DOI 10.1080/07420520701672556; Lonard DM, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe16; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Park KC, 2002, P NATL ACAD SCI USA, V99, P9733, DOI 10.1073/pnas.152011799; Parviz F, 2002, GENESIS, V32, P130, DOI 10.1002/gene.10058; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeffer M, 2009, J NEUROSCI, V29, P6114, DOI 10.1523/JNEUROSCI.0275-09.2009; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Sehgal A, 2008, NEURON, V57, P8, DOI 10.1016/j.neuron.2007.12.018; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Tischkau SA, 2005, METHOD ENZYMOL, V393, P593, DOI 10.1016/S0076-6879(05)93031-0; Verrey F, 2008, KIDNEY INT, V73, P691, DOI 10.1038/sj.ki.5002737; von Gall C, 2003, EUR J NEUROSCI, V18, P125, DOI 10.1046/j.1460-9568.2003.02735.x; Wu M, 2000, GENE DEV, V14, P301; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995	40	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25382	10.1371/journal.pone.0025382	http://dx.doi.org/10.1371/journal.pone.0025382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966515	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100052
J	Jarome, TJ; Werner, CT; Kwapis, JL; Helmstetter, FJ				Jarome, Timothy J.; Werner, Craig T.; Kwapis, Janine L.; Helmstetter, Fred J.			Activity Dependent Protein Degradation Is Critical for the Formation and Stability of Fear Memory in the Amygdala	PLOS ONE			English	Article							TRANSLATIONAL CONTROL; MESSENGER-RNA; UBIQUITIN; PROTEASOME; RECONSOLIDATION; CONSOLIDATION; ACQUISITION; EXPRESSION; PLASTICITY; CIRCUITS	Protein degradation through the ubiquitin-proteasome system [UPS] plays a critical role in some forms of synaptic plasticity. However, its role in memory formation in the amygdala, a site critical for the formation of fear memories, currently remains unknown. Here we provide the first evidence that protein degradation through the UPS is critically engaged at amygdala synapses during memory formation and retrieval. Fear conditioning results in NMDA-dependent increases in degradation-specific polyubiquitination in the amygdala, targeting proteins involved in translational control and synaptic structure and blocking the degradation of these proteins significantly impairs long-term memory. Furthermore, retrieval of fear memory results in a second wave of NMDA-dependent polyubiquitination that targets proteins involved in translational silencing and synaptic structure and is critical for memory updating following recall. These results indicate that UPS-mediated protein degradation is a major regulator of synaptic plasticity necessary for the formation and stability of long-term memories at amygdala synapses.	[Jarome, Timothy J.; Werner, Craig T.; Kwapis, Janine L.; Helmstetter, Fred J.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Jarome, TJ (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	fjh@uwm.edu		Werner, Craig/0000-0001-8387-777X; Helmstetter, Fred/0000-0003-3413-2418; Kwapis, Janine/0000-0002-2349-8601	National Institutes of Health (NIH) [R01-MH069558, F31-MH088125]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069558, F31MH088125] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (NIH) grants R01-MH069558 (Dr. Helmstetter) and F31-MH088125 (Dr. Jarome). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artinian J, 2008, EUR J NEUROSCI, V27, P3009, DOI 10.1111/j.1460-9568.2008.06262.x; Bailey DJ, 1999, BEHAV NEUROSCI, V113, P276, DOI 10.1037/0735-7044.113.2.276; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Layfield R, 2001, PROTEOMICS, V1, P773, DOI 10.1002/1615-9861(200106)1:6<773::AID-PROT773>3.0.CO;2-0; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Mamiya N, 2009, J NEUROSCI, V29, P402, DOI 10.1523/JNEUROSCI.4639-08.2009; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ostroff LE, 2010, P NATL ACAD SCI USA, V107, P9418, DOI 10.1073/pnas.0913384107; Parsons RG, 2006, EUR J NEUROSCI, V23, P1853, DOI 10.1111/j.1460-9568.2006.04723.x; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rinetti GV, 2010, J NEUROSCI, V30, P3157, DOI 10.1523/JNEUROSCI.3712-09.2010; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Wang SH, 2009, NAT NEUROSCI, V12, P905, DOI 10.1038/nn.2350	42	133	135	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24349	10.1371/journal.pone.0024349	http://dx.doi.org/10.1371/journal.pone.0024349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961035	gold, Green Published			2022-12-25	WOS:000295265100008
J	Rossi, S; Toigo, C; Hars, J; Pol, F; Hamann, JL; Depner, K; Le Potier, MF				Rossi, Sophie; Toigo, Carole; Hars, Jean; Pol, Francoise; Hamann, Jean-Luc; Depner, Klaus; Le Potier, Marie-Frederique			New Insights on the Management of Wildlife Diseases Using Multi-State Recapture Models: The Case of Classical Swine Fever in Wild Boar	PLOS ONE			English	Article							ORAL IMMUNIZATION; LONG-TERM; PERSISTENCE; VACCINATION; CSF; EPIDEMIOLOGY; DIAGNOSIS; SURVIVAL; ANIMALS; BAITS	Background: The understanding of host-parasite systems in wildlife is of increasing interest in relation to the risk of emerging diseases in livestock and humans. In this respect, many efforts have been dedicated to controlling classical swine fever (CSF) in the European Wild Boar. But CSF eradication has not always been achieved even though vaccination has been implemented at a large-scale. Piglets have been assumed to be the main cause of CSF persistence in the wild since they appeared to be more often infected and less often immune than older animals. However, this assumption emerged from laboratory trials or cross-sectional surveys based on the hunting bags. Methodology/Principal Findings: In the present paper we conducted a capture-mark-recapture study in free-ranging wild boar piglets that experienced both CSF infection and vaccination under natural conditions. We used multi-state capture recapture models to estimate the immunization and infection rates, and their variations according to the periods with or without vaccination. According to the model prediction, 80% of the infected piglets did not survive more than two weeks, while the other 20% quickly recovered. The probability of becoming immune did not increase significantly during the summer vaccination sessions, and the proportion of immune piglets was not higher after the autumn vaccination. Conclusions/Significance: Given the high lethality of CSF in piglets highlighted in our study, we consider unlikely that piglets could maintain the chain of CSF virus transmission. Our study also revealed the low efficacy of vaccination in piglets in summer and autumn, possibly due to the low palatability of baits to that age class, but also to the competition between baits and alternative food sources. Based on this new information, we discuss the prospects for the improvement of CSF control and the interest of the capture-recapture approach for improving the understanding of wildlife diseases.	[Rossi, Sophie; Hars, Jean] Off Natl Chasse & Faune Sauvage, Unite Sanit Faune, Gap, France; [Toigo, Carole] Off Natl Chasse & Faune Sauvage, CNERA Faune Montagne, Gieres, France; [Pol, Francoise; Le Potier, Marie-Frederique] French Agcy Food Envionmental & Occupat Hlth & Sa, Lab Natl Reference Pestes Porcines, Ploufragan, France; [Hamann, Jean-Luc] Off Natl Chasse & Faune Sauvage, CNERA Cervides Sanglier, Petite Pierre, France; [Depner, Klaus] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany	Friedrich Loeffler Institute	Rossi, S (corresponding author), Off Natl Chasse & Faune Sauvage, Unite Sanit Faune, Gap, France.	sophie.rossi@oncfs.gouv.fr		Pol, Francoise/0000-0003-1696-8959	French Ministry of Agriculture	French Ministry of Agriculture	This study has been funded by the French Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artois M, 2002, REV SCI TECH OIE, V21, P287, DOI 10.20506/rst.21.2.1332; Ballesteros C, 2009, RES VET SCI, V86, P388, DOI 10.1016/j.rvsc.2008.09.003; Bonenfant C, 2002, ECOGRAPHY, V25, P446, DOI 10.1034/j.1600-0587.2002.250407.x; Brauer A, 2006, EUR J WILDLIFE RES, V52, P271, DOI 10.1007/s10344-006-0048-0; Burnham K. P., 1998, MODEL SELECTION INFE; Choquet R, 2005, MSURGE 1 7 USERS MAN; CHOQUET R, 2005, UCARE 2 2 USERS MANU; Conn PB, 2009, J APPL ECOL, V46, P486, DOI 10.1111/j.1365-2664.2008.01597.x; Depner K.R, 2000, DTSCH TIERARZTL WSCH, V107, P41; Depner K, 2007, VET MICROBIOL, V121, P338, DOI 10.1016/j.vetmic.2006.12.027; Depner KR, 1995, VET REC, V140, P506; Dewulf J, 2004, J VIROL METHODS, V119, P137, DOI 10.1016/j.jviromet.2004.03.010; EFSA, 2008, ANN EFSA J, V932, P1; Fritzemeier J, 2000, VET MICROBIOL, V77, P29, DOI 10.1016/S0378-1135(00)00254-6; GAILLARD JM, 1992, OECOLOGIA, V90, P167, DOI 10.1007/BF00317173; Guberti V, 1998, P M MEAS CONTR CLASS, P54; Hars J., 2004, Game & Wildlife Science, V21, P513; Hebeisen C., 2007, POPULATION SIZE DENS; HONE J, 1992, EPIDEMIOL INFECT, V108, P377, DOI 10.1017/S0950268800049840; HUGGETT AS, 1951, J PHYSIOL-LONDON, V114, P306, DOI 10.1113/jphysiol.1951.sp004622; Jennelle CS, 2007, ECOL APPL, V17, P154, DOI 10.1890/1051-0761(2007)017[0154:SDPADP]2.0.CO;2; Jullien JM, 1988, B MENSUEL OFFICE NAT, V122, P28; Kaden V, 2006, J VET MED B, V53, P455, DOI 10.1111/j.1439-0450.2006.00993.x; Kaden V, 2004, DEUT TIERARZTL WOCH, V111, P63; Kaden V, 2002, BERL MUNCH TIERARZTL, V115, P179; Kern B, 1999, J VET MED B, V46, P63, DOI 10.1046/j.1439-0450.1999.00214.x; KLEIN F, 2004, GESTION SANGLIER PIS; Klein F., 1984, S INT SANGL TOUL, P58; Kramer-Schadt S, 2007, MAMMAL REV, V37, P1, DOI 10.1111/j.1365-2907.2007.00097.x; Kramer-Schadt S, 2009, OIKOS, V118, P199, DOI 10.1111/j.1600-0706.2008.16582.x; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; Laddomada A, 2000, VET MICROBIOL, V73, P121, DOI 10.1016/S0378-1135(00)00139-5; Le Dimna M, 2008, J VIROL METHODS, V147, P136, DOI 10.1016/j.jviromet.2007.08.013; Le Potier M. F., 2006, DIS SWINE, V9th, P309; Lebreton JD, 2002, J APPL STAT, V29, P353, DOI 10.1080/02664760120108638; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Louguet Y, 2005, B EPIDEMIOLOGIQUE AG, V19, P3; Moennig V, 2003, VET J, V165, P11, DOI 10.1016/S1090-0233(02)00112-0; Muller T, 2005, J VET MED B, V52, P432, DOI 10.1111/j.1439-0450.2005.00896.x; Oli MK, 2006, ECOL MODEL, V198, P183, DOI 10.1016/j.ecolmodel.2006.04.007; Pol F, 2008, VET REC, V162, P811, DOI 10.1136/vr.162.25.811; Pradel R, 2003, BIOMETRICS, V59, P43, DOI 10.1111/1541-0420.00006; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Rossi S, 2005, EPIDEMIOL INFECT, V133, P559, DOI 10.1017/S0950268804003553; Rossi S, 2005, VET RES, V36, P27, DOI 10.1051/vetres:2004050; Rossi S, 2010, VET MICROBIOL, V142, P99, DOI 10.1016/j.vetmic.2009.09.050; Rossi S, 2006, B ACAD VET FRANCE, V159, P389; Rossi S, 2008, P EWDA S ROV 5 9 OCT; Ruiz-Fons F, 2008, VET J, V176, P158, DOI 10.1016/j.tvjl.2007.02.017; Toigo C, 2008, J WILDLIFE MANAGE, V72, P1532, DOI 10.2193/2007-378; von Ruden S, 2008, VET MICROBIOL, V132, P29, DOI 10.1016/j.vetmic.2008.04.022	51	24	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24257	10.1371/journal.pone.0024257	http://dx.doi.org/10.1371/journal.pone.0024257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21977225	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100007
J	Yukiura, H; Hama, K; Nakanaga, K; Tanaka, M; Asaoka, Y; Okudaira, S; Arima, N; Inoue, A; Hashimoto, T; Arai, H; Kawahara, A; Nishina, H; Aoki, J				Yukiura, Hiroshi; Hama, Kotaro; Nakanaga, Keita; Tanaka, Masayuki; Asaoka, Yoichi; Okudaira, Shinichi; Arima, Naoaki; Inoue, Asuka; Hashimoto, Takafumi; Arai, Hiroyuki; Kawahara, Atsuo; Nishina, Hiroshi; Aoki, Junken			Autotaxin Regulates Vascular Development via Multiple Lysophosphatidic Acid (LPA) Receptors in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTILITY-STIMULATING PROTEIN; LYSOPHOSPHOLIPASE-D; IDENTIFICATION; ENZYME; BLOOD; MORPHOGENESIS; ANGIOGENESIS; P2Y5/LPA(6); REVEALS; EMBRYOS	Autotaxin (ATX) is a multifunctional ecto-type phosphodiesterase that converts lysophospholipids, such as lysophosphatidylcholine, to lysophosphatidic acid (LPA) by its lysophospholipase D activity. LPA is a lipid mediator with diverse biological functions, most of which are mediated by G protein-coupled receptors specific to LPA (LPA(1-6)). Recent studies on ATX knock-out mice revealed that ATX has an essential role in embryonic blood vessel formation. However, the underlying molecular mechanisms remain to be solved. A data base search revealed that ATX and LPA receptors are conserved in wide range of vertebrates from fishes to mammals. Here we analyzed zebrafish ATX (zATX) and LPA receptors both biochemically and functionally. zATX, like mammalian ATX, showed lysophospholipase D activity to produce LPA. In addition, all zebrafish LPA receptors except for LPA(5)a and LPA(5)b were found to respond to LPA. Knockdown of zATX in zebrafish embryos by injecting morpholino antisense oligonucleotides (MOs) specific to zATX caused abnormal blood vessel formation, which has not been observed in other morphant embryos or mutants with vascular defects reported previously. In ATX morphant embryos, the segmental arteries sprouted normally from the dorsal aorta but stalled in midcourse, resulting in aberrant vascular connection around the horizontal myoseptum. Similar vascular defects were not observed in embryos in which each single LPA receptor was attenuated by using MOs. Interestingly, similar vascular defects were observed when both LPA(1) and LPA(4) functions were attenuated by using MOs and/or a selective LPA receptor antagonist, Ki16425. These results demonstrate that the ATX-LPA-LPAR axis is a critical regulator of embryonic vascular development that is conserved in vertebrates.	[Yukiura, Hiroshi; Hama, Kotaro; Nakanaga, Keita; Tanaka, Masayuki; Okudaira, Shinichi; Arima, Naoaki; Inoue, Asuka; Hashimoto, Takafumi; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Tanaka, Masayuki; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Asaoka, Yoichi; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Kawahara, Atsuo] Riken Quantitat Biol Ctr, Lab Cardiovasc Mol Dynam, Suita, Osaka 5650874, Japan; [Aoki, Junken] Tohoku Univ, Grad Sch Med, Ctr Metab Dis, Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University; University of Tokyo; Tokyo Medical & Dental University (TMDU); RIKEN; Tohoku University	Aoki, J (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	jaoki@m.tohoku.ac.jp		Aoki, Junken/0000-0001-9435-1896	National Institute of Biomedical Innovation [09-11]; Ministry of Education [MPB3]; CREST (Japan Science and Technology Corporation), Science, Sports, and Culture of Japan [22116004, 21770131]; Grants-in-Aid for Scientific Research [23227004, 23790071] Funding Source: KAKEN	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education; CREST (Japan Science and Technology Corporation), Science, Sports, and Culture of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by grants from the National Institute of Biomedical Innovation (Grant Number: 09-11), the National Project on Protein Structural and Functional Analyses, from the Ministry of Education (Grant Number: MPB3), CREST (Japan Science and Technology Corporation), Science, Sports, and Culture of Japan (to J. A. (KAKENHI #22116004) and K. H. (#21770131)).	Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Baldessari D, 2008, PHARMACOL THERAPEUT, V118, P206, DOI 10.1016/j.pharmthera.2008.02.010; Clair T, 2003, CANCER RES, V63, P5446; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035; Ferry G, 2007, FEBS LETT, V581, P3572, DOI 10.1016/j.febslet.2007.06.064; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimura T, 2011, CARDIOVASC RES, V92, P149, DOI 10.1093/cvr/cvr154; Kishimoto T, 2003, CLIN CHIM ACTA, V333, P59, DOI 10.1016/S0009-8981(03)00165-7; Koike S, 2009, J BIOL CHEM, V284, P33561, DOI 10.1074/jbc.M109.012716; Lee SJ, 2008, FASEB J, V22, P3706, DOI 10.1096/fj.08-106088; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; MURATA J, 1994, J BIOL CHEM, V269, P30479; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Sumida H, 2010, BLOOD, V116, P5060, DOI 10.1182/blood-2010-03-272443; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Tsuda S, 2006, J BIOL CHEM, V281, P26081, DOI 10.1074/jbc.M602925200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505	39	71	72	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43972	43983		10.1074/jbc.M111.301093	http://dx.doi.org/10.1074/jbc.M111.301093			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21971049	hybrid, Green Published			2022-12-25	WOS:000298402300038
J	Lu, JH; Ellsworth, JL; Hamacher, N; Oak, SW; Sun, PD				Lu, Jinghua; Ellsworth, Jeff L.; Hamacher, Nels; Oak, Si Won; Sun, Peter D.			Crystal Structure of Fc gamma Receptor I and Its Implication in High Affinity gamma-Immunoglobulin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IGG; MOLECULAR-BASIS; COMPLEX; RECOGNITION; FRAGMENT; DOMAINS; RIII; IIB	Fc gamma receptors (Fc gamma Rs) play critical roles in humoral and cellular immune responses through interactions with the Fc region of immunoglobulin G (IgG). Among them, Fc gamma RI is the only high affinity receptor for IgG and thus is a potential target for immunotherapy. Here we report the first crystal structure of an Fc gamma RI with all three extracellular Ig-like domains (designated as D1, D2, and D3). The structure shows that, first, Fc gamma RI has an acute D1-D2 hinge angle similar to that of Fc epsilon RI but much smaller than those observed in the low affinity Fc gamma receptors. Second, the D3 domain of Fc gamma RI is positioned away from the putative IgG binding site on the receptor and is thus unlikely to make direct contacts with Fc. Third, the replacement of Fc gamma RIII FG-loop ((171)LVGSKNV(177)) with that of Fc gamma RI ((171)MGKHRY(176)) resulted in a 15-fold increase in IgG, binding affinity, whereas a valine insertion in the Fc gamma RI FG-loop ((171)MVGKHRY(177)) abolished the affinity enhancement. Thus, the Fc gamma RI FG-loop with its conserved one-residue deletion is critical to the high affinity IgG binding. The structural results support Fc gamma RI binding to IgG in a similar mode as its low affinity counterparts. Taken together, our study suggests a molecular mechanism for the high affinity IgG recognition by Fc gamma RI and provides a structural basis for understanding its physiological function and its therapeutic implication in treating autoimmune diseases.	[Lu, Jinghua; Oak, Si Won; Sun, Peter D.] NIAID, Struct Immunol Sect, Lab Immunogenet, NIH, Rockville, MD USA; [Hamacher, Nels] ZymoGenetics, Dept BioProc Dev, Seattle, WA 98102 USA; [Ellsworth, Jeff L.] ZymoGenetics, Dept Immunol, Seattle, WA 98102 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Zymogenet Inc.; Zymogenet Inc.	Sun, PD (corresponding author), 12441 Parklawn Dr, Rockville, MD 20852 USA.	psun@niaid.nih.gov	lu, jinghua/G-5872-2012	Oak, Allen/0000-0003-2837-6846	National Institutes of Health (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000853] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health intramural research funding (NIAID).	Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ellsworth JL, 2008, J IMMUNOL, V180, P580, DOI 10.4049/jimmunol.180.1.580; Ellsworth JL, 2009, J IMMUNOL, V182, P7272, DOI 10.4049/jimmunol.0803497; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feige MJ, 2009, J MOL BIOL, V391, P599, DOI 10.1016/j.jmb.2009.06.048; FRIDMAN WH, 1991, FASEB J, V5, P2684, DOI 10.1096/fasebj.5.12.1916092; Galon J, 1997, EUR J IMMUNOL, V27, P1928, DOI 10.1002/eji.1830270816; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; HULETT MD, 1993, EUR J IMMUNOL, V23, P640, DOI 10.1002/eji.1830230310; Hulett MD, 1998, MOL IMMUNOL, V35, P989, DOI 10.1016/S0161-5890(98)00069-8; HULETT MD, 1991, J IMMUNOL, V147, P1863; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kleinau S, 2000, J EXP MED, V191, P1611, DOI 10.1084/jem.191.9.1611; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Powell MS, 1999, IMMUNOL LETT, V68, P17, DOI 10.1016/S0165-2478(99)00025-5; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Ravetch JV, 2002, J CLIN INVEST, V110, P1759, DOI 10.1172/JCI200217349; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 2001, J MOL BIOL, V309, P737, DOI 10.1006/jmbi.2001.4670; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; Tamm A, 1997, Int Rev Immunol, V16, P57, DOI 10.3109/08830189709045703; UNKELESS JC, 1988, ANNU REV IMMUNOL, V6, P251, DOI 10.1146/annurev.iy.06.040188.001343; van de Velde NC, 2006, SPRINGER SEMIN IMMUN, V28, P329, DOI 10.1007/s00281-006-0056-x; van de Winkel JGJ, 2010, IMMUNOL LETT, V128, P4, DOI 10.1016/j.imlet.2009.09.005; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187; Zhang YH, 2000, IMMUNITY, V13, P387, DOI 10.1016/S1074-7613(00)00038-8	45	59	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40608	40613		10.1074/jbc.M111.257550	http://dx.doi.org/10.1074/jbc.M111.257550			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965667	Green Published, hybrid			2022-12-25	WOS:000297315400021
J	Kataoka, K; Fujihashi, K; Terao, Y; Gilbert, RS; Sekine, S; Kobayashi, R; Fukuyama, Y; Kawabata, S; Fujihashi, K				Kataoka, Kosuke; Fujihashi, Keiko; Terao, Yutaka; Gilbert, Rebekah S.; Sekine, Shinichi; Kobayashi, Ryoki; Fukuyama, Yoshiko; Kawabata, Shigetada; Fujihashi, Kohtaro			Oral-Nasopharyngeal Dendritic Cells Mediate T Cell-Independent IgA Class Switching on B-1 B Cells	PLOS ONE			English	Article							MUCOSAL IMMUNE-SYSTEM; FLT3 LIGAND CDNA; CHOLERA-TOXIN; LAMINA PROPRIA; LYMPHOID-TISSUE; TH2 CELLS; GUT; ADJUVANT; RESPONSES; EXPRESSION	Native cholera toxin (nCT) as a nasal adjuvant was shown to elicit increased levels of T-independent S-IgA antibody (Ab) responses through IL-5- IL-5 receptor interactions between CD4(+) T cells and IgA(+) B-1 B cells in murine submandibular glands (SMGs) and nasal passages (NPs). Here, we further investigate whether oral-nasopharyngeal dendritic cells (DCs) play a central role in the induction of B-1 B cell IgA class switch recombination (CSR) for the enhancement of T cell-independent (TI) mucosal S-IgA Ab responses. High expression levels of activation-induced cytidine deaminase, I alpha-C mu circulation transcripts and I mu-C alpha transcripts were seen on B-1 B cells purified from SMGs and NPs of both TCR beta(-/-) mice and wild-type mice given nasal trinitrophenyl (TNP)-LPS plus nCT, than in the same tissues of mice given nCT or TNP-LPS alone. Further, DCs from SMGs, NPs and NALT of mice given nasal TNP-LPS plus nCT expressed significantly higher levels of a proliferation-inducing ligand (APRIL) than those in mice given TNP-LPS or nCT alone, whereas the B-1 B cells in SMGs and NPs showed elevated levels of transmembrane activator and calcium modulator cyclophilin ligand interactor (TACI) expression. Interestingly, high frequencies of IgA(+) B-1 B cells were induced when peritoneal IgA(-) IgM(+) B cells were stimulated with mucosal DCs from mice given nasal TNP-LPS plus nCT. Taken together, these findings show nasal nCT plays a key role in the enhancement of mucosal DC-mediated TI IgA CSR by B-1 B cells through their interactions with APRIL and TACI.	[Kataoka, Kosuke] Univ Tokushima Grad Sch, Inst Hlth Biosci, Dept Prevent Dent, Tokushima, Japan; [Kataoka, Kosuke; Fujihashi, Keiko; Gilbert, Rebekah S.; Kobayashi, Ryoki; Fukuyama, Yoshiko; Fujihashi, Kohtaro] Univ Alabama Birmingham, Immunobiol Vaccine Ctr, Dept Pediat Dent, Birmingham, AL USA; [Kataoka, Kosuke; Fujihashi, Keiko; Gilbert, Rebekah S.; Kobayashi, Ryoki; Fukuyama, Yoshiko; Fujihashi, Kohtaro] Univ Alabama Birmingham, Dept Microbiol, Immunobiol Vaccine Ctr, Birmingham, AL 35294 USA; [Terao, Yutaka; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Osaka, Japan; [Sekine, Shinichi] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Osaka, Japan	Tokushima University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Osaka University; Osaka University	Kataoka, K (corresponding author), Univ Tokushima Grad Sch, Inst Hlth Biosci, Dept Prevent Dent, Tokushima, Japan.	kohtarof@uab.edu	KATAOKA, KOSUKE/AAD-7003-2022; Sekine, Shinichi/AGT-1514-2022	Sekine, Shinichi/0000-0003-4160-5578; Kobayashi, Ryoki/0000-0002-7909-8981; Terao, Yutaka/0000-0002-4450-5583	National Institutes of Health (NIH) [DE 12242, AG 025873]; Ministry of Education, Culture, Sports, Science and Technology of Japan [B-23390481, C-19592403, 22659383]; Fujii-Otsuka Foundation for International Research; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE012242, R01DE012242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025873] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fujii-Otsuka Foundation for International Research; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by National Institutes of Health (NIH) grants DE 12242 and AG 025873 to Dr. Fujihashi, as well as by Grants-in-Aid (B-23390481, C-19592403, Challenging Exploratory Research 22659383) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Scholarship of the Fujii-Otsuka Foundation for International Research to Dr. Kataoka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone F, 2009, MUCOSAL IMMUNOL, V2, P495, DOI 10.1038/mi.2009.106; Boyaka PN, 1999, J IMMUNOL, V162, P122; Bracci L, 2008, EXPERT REV VACCINES, V7, P373, DOI 10.1586/14760584.7.3.373; Brandt LE, 2009, P NATL ACAD SCI USA, V106, P5773; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P267, DOI 10.1016/S0167-5699(99)01468-1; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Fukuiwa T, 2008, VACCINE, V26, P4849, DOI 10.1016/j.vaccine.2008.06.091; Hagiwara Y, 2006, J IMMUNOL, V177, P3045, DOI 10.4049/jimmunol.177.5.3045; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hiroi T, 1999, J IMMUNOL, V162, P821; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; KANTOR AB, 1991, IMMUNOL TODAY, V12, P389, DOI 10.1016/0167-5699(91)90136-H; Kataoka K, 2004, J IMMUNOL, V172, P3612, DOI 10.4049/jimmunol.172.6.3612; Kataoka K, 2007, J IMMUNOL, V178, P6058, DOI 10.4049/jimmunol.178.10.6058; Kataoka K, 2009, EXPERT REV VACCINES, V8, P1183, DOI [10.1586/erv.09.80, 10.1586/ERV.09.80]; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Kroese F G, 1996, Semin Immunol, V8, P11, DOI 10.1006/smim.1996.0003; KROESE FGM, 1993, INT IMMUNOL, V5, P1317, DOI 10.1093/intimm/5.10.1317; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Lillard JW, 2003, BLOOD, V101, P807, DOI 10.1182/blood-2002-07-2305; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2002, NAT IMMUNOL, V3, P798, DOI 10.1038/ni0902-798; MARINARO M, 1995, J IMMUNOL, V155, P4621; Mestecky J, 2003, FUNDAMENTAL IMMUNOLO, P965; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111; MURAKAMI M, 1995, IMMUNOL TODAY, V16, P534, DOI 10.1016/0167-5699(95)80047-6; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Savage DC, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P19, DOI 10.1016/B978-012491543-5/50006-1; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Sekine S, 2008, J IMMUNOL, V180, P8126, DOI 10.4049/jimmunol.180.12.8126; Shikina T, 2004, J IMMUNOL, V172, P6259, DOI 10.4049/jimmunol.172.10.6259; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8	44	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25396	10.1371/journal.pone.0025396	http://dx.doi.org/10.1371/journal.pone.0025396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980444	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600023
J	Kormelink, TG; Pardo, A; Knipping, K; Buendia-Roldan, I; Garcia-de-Alba, C; Blokhuis, BR; Selman, M; Redegeld, FA				Kormelink, Tom Groot; Pardo, Annie; Knipping, Karen; Buendia-Roldan, Ivette; Garcia-de-Alba, Carolina; Blokhuis, Bart R.; Selman, Moises; Redegeld, Frank A.			Immunoglobulin Free Light Chains Are Increased in Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; FIBROBLAST-GROWTH-FACTOR; MAST-CELL TRYPTASE; FARMERS LUNG; TISSUE; PATHOGENESIS; SUBACUTE; SERUM; DNA	Background: Idiopathic pulmonary fibrosis (IPF), a devastating lung disorder of unknown aetiology, and chronic hypersensitivity pneumonitis (HP), a disease provoked by an immunopathologic reaction to inhaled antigens, are two common interstitial lung diseases with uncertain pathogenic mechanisms. Previously, we have shown in other upper and lower airway diseases that immunoglobulin free light chains (FLCs) are increased and may be involved in initiating a local inflammation. In this study we explored if such a mechanism may also apply to HP and IPF. Methods: In this study we examined the presence of FLC in serum and BAL fluid from 21 IPF and 22 HP patients and controls. IgG, IgE and tryptase concentrations were measured in BAL fluid only. The presence of FLCs, plasma cells, B cells and mast cells in lung tissue of 3 HP and 3 IPF patients and 1 control was analyzed using immunohistochemistry. Results: FLC concentrations in serum and BAL fluid were increased in IPF and HP patients as compared to control subjects. IgG concentrations were only increased in HP patients, whereas IgE concentrations were comparable to controls in both patient groups. FLC-positive cells, B cells, plasma cells, and large numbers of activated mast cells were all detected in the lungs of HP and IPF patients, not in control lung. Conclusion: These results show that FLC concentrations are increased in serum and BAL fluid of IPF and HP patients and that FLCs are present within affected lung tissue. This suggests that FLCs may be involved in mediating pathology in both diseases.	[Kormelink, Tom Groot; Knipping, Karen; Blokhuis, Bart R.; Redegeld, Frank A.] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol & Pathophysiol, Utrecht, Netherlands; [Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Sci, Mexico City 04510, DF, Mexico; [Knipping, Karen] Ctr Specialised Nutr, Wageningen, Netherlands; [Buendia-Roldan, Ivette; Garcia-de-Alba, Carolina; Selman, Moises] Inst Nacl Enfermedades Respiratorias Ismael Cosio, Mexico City, DF, Mexico	Utrecht University; Universidad Nacional Autonoma de Mexico	Kormelink, TG (corresponding author), Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol & Pathophysiol, Utrecht, Netherlands.	f.a.m.redegeld@uu.nl	Garcia-de-Alba, Carolina/AAJ-3924-2021; Redegeld, Frank A/O-6534-2016	Garcia-de-Alba, Carolina/0000-0001-9774-445X; Redegeld, Frank A/0000-0001-8830-7960; Buendia, Ivette/0000-0002-8230-0749				Akashi T, 2009, AM J CLIN PATHOL, V131, P405, DOI 10.1309/AJCPNWX4SLZRP9SW; Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; Araya J, 2010, ANNU REV PATHOL-MECH, V5, P77, DOI 10.1146/annurev.pathol.4.110807.092217; Barrera L, 2008, AM J RESP CRIT CARE, V177, P44, DOI 10.1164/rccm.200701-093OC; BJERMER L, 1988, ARCH INTERN MED, V148, P1362, DOI 10.1001/archinte.148.6.1362; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Churg A, 2006, AM J SURG PATHOL, V30, P201, DOI 10.1097/01.pas.0000184806.38037.3c; Cohen G, 2002, NEPHROL DIAL TRANSPL, V17, P879, DOI 10.1093/ndt/17.5.879; DRENT M, 1993, THORAX, V48, P835, DOI 10.1136/thx.48.8.835; Fink JN, 2005, AM J RESP CRIT CARE, V171, P792, DOI 10.1164/rccm.200409-1205WS; Galli SJ, 2008, J DERMATOL SCI, V49, P7, DOI 10.1016/j.jdermsci.2007.09.009; Gotway MB, 2007, THORAX, V62, P546, DOI 10.1136/thx.2004.040022; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; HUNT LW, 1992, MAYO CLIN PROC, V67, P941, DOI 10.1016/S0025-6196(12)60924-0; Inoue Y, 1996, AM J PATHOL, V149, P2037; Inoue Y, 2002, AM J RESP CRIT CARE, V166, P765, DOI 10.1164/rccm.2010014; ISHIDA T, 1995, INTERNAL MED, V34, P357, DOI 10.2169/internalmedicine.34.357; Katzenstein ALA, 2008, HUM PATHOL, V39, P1275, DOI 10.1016/j.humpath.2008.05.009; Kormelink TG, 2010, ANN RHEUM DIS, V69, P2137, DOI 10.1136/ard.2009.126441; Kraneveld AD, 2005, P NATL ACAD SCI USA, V102, P1578, DOI 10.1073/pnas.0406808102; Matsumori A, 2010, CIRC RES, V106, P1533, DOI 10.1161/CIRCRESAHA.110.218438; McSharry C, 2003, CLIN EXP ALLERGY, V33, P159, DOI 10.1046/j.1365-2222.2003.01603.x; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; PESCI A, 1991, CHEST, V100, P1197, DOI 10.1378/chest.100.5.1197; PESCI A, 1993, CHEST, V103, P989, DOI 10.1378/chest.103.4.989; Powe DG, 2010, J ALLERGY CLIN IMMUN, V125, P139, DOI 10.1016/j.jaci.2009.07.025; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Redegeld FA, 2002, NAT MED, V8, P694, DOI 10.1038/nm722; Rijnierse A, 2010, J IMMUNOL, V185, P653, DOI 10.4049/jimmunol.0901129; Selman M, 2004, CLIN CHEST MED, V25, P531, DOI 10.1016/j.ccm.2004.04.001; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2010, MURRAY NADELS TXB RE, P1356, DOI DOI 10.1016/B978-1-4160-4710-0.00057-2; SOLER P, 1987, THORAX, V42, P565, DOI 10.1136/thx.42.8.565; SOLLING K, 1977, SCAND J CLIN LAB INV, V37, P21; Stewart JP, 1999, AM J RESP CRIT CARE, V159, P1336, DOI 10.1164/ajrccm.159.4.9807077; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; Vannella KM, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-2; WALLS AF, 1991, CLIN SCI, V81, P183, DOI 10.1042/cs0810183; Wolff F, 2007, CLIN BIOCHEM, V40, P351, DOI 10.1016/j.clinbiochem.2006.11.011	42	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25392	10.1371/journal.pone.0025392	http://dx.doi.org/10.1371/journal.pone.0025392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980441	gold, Green Submitted, Green Published			2022-12-25	WOS:000295936900058
J	Bourseau-Guilmain, E; Griveau, A; Benoit, JP; Garcion, E				Bourseau-Guilmain, Erika; Griveau, Audrey; Benoit, Jean-Pierre; Garcion, Emmanuel			The Importance of the Stem Cell Marker Prominin-1/CD133 in the Uptake of Transferrin and in Iron Metabolism in Human Colon Cancer Caco-2 Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE PROTRUSIONS; BLOOD-BRAIN-BARRIER; HEMATOPOIETIC STEM; SIGNALING PATHWAY; EPITHELIAL-CELLS; RETINAL DEGENERATION; RESPONSIVE ELEMENTS; 3T3-L1 ADIPOCYTES; OXIDATIVE STRESS; BINDING PROTEIN	As the pentaspan stem cell marker CD133 was shown to bind cholesterol and to localize in plasma membrane protrusions, we investigated a possible function for CD133 in endocytosis. Using the CD133 siRNA knockdown strategy and non-differentiated human colon cancer Caco-2 cells that constitutively over-expressed CD133, we provide for the first time direct evidence for a role of CD133 in the intracellular accumulation of fluorescently labeled extracellular compounds. Assessed using AC133 monoclonal antibody, CD133 knockdown was shown to improve Alexa488-transferrin (Tf) uptake in Caco-2 cells but had no impact on FITC-dextran or FITC-cholera-toxin. Absence of effect of the CD133 knockdown on Tf recycling established a role for CD133 in inhibiting Tf endocytosis rather than in stimulating Tf exocytosis. Use of previously identified inhibitors of known endocytic pathways and the positive impact of CD133 knockdown on cellular uptake of clathrin-endocytosed synthetic lipid nanocapsules supported that CD133 impact on endocytosis was primarily ascribed to the clathrin pathway. Also, cholesterol extraction with methyl-beta-cyclodextrine up regulated Tf uptake at greater intensity in the CD133(high) situation than in the CD133(low) situation, thus suggesting a role for cholesterol in the inhibitory effect of CD133 on endocytosis. Interestingly, cell treatment with the AC133 antibody down regulated Tf uptake, thus demonstrating that direct extracellular binding to CD133 could affect endocytosis. Moreover, flow cytometry and confocal microscopy established that down regulation of CD133 improved the accessibility to the TfR from the extracellular space, providing a mechanism by which CD133 inhibited Tf uptake. As Tf is involved in supplying iron to the cell, effects of iron supplementation and deprivation on CD133/AC133 expression were investigated. Both demonstrated a dose-dependent down regulation here discussed to the light of transcriptional and post-transciptional effects. Taken together, these data extend our knowledge of the function of CD133 and underline the interest of further exploring the CD133-Tf-iron network.	[Bourseau-Guilmain, Erika; Griveau, Audrey; Benoit, Jean-Pierre; Garcion, Emmanuel] Univ Angers, Lab Ingn Vectorisat Particulaire, INSERM, UMR S 646, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Bourseau-Guilmain, E (corresponding author), Univ Angers, Lab Ingn Vectorisat Particulaire, INSERM, UMR S 646, Angers, France.	emmanuel.garcion@univ-angers.fr	GARCION, Emmanuel/K-5417-2015; Benoit, Jean-Pierre/K-4387-2015	GARCION, Emmanuel/0000-0003-0887-272X; BENOIT, Jean-Pierre/0000-0002-6178-7199; GRIVEAU, Audrey/0000-0002-5928-6328	Institut National de la Sante et de la Recherche Medicale; Canceropole Grand-Ouest; "La Ligue Contre le Cancer" through an "Equipe Labellisee"	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Canceropole Grand-Ouest; "La Ligue Contre le Cancer" through an "Equipe Labellisee"	This work was supported by the "Institut National de la Sante et de la Recherche Medicale", the "Axe Cellules Souches et Cancer" at the "Canceropole Grand-Ouest" and by "La Ligue Contre le Cancer" through an "Equipe Labellisee 2007" grant. Erika Bourseau was initially a PhD fellow with the "Conseil General de Maine-et-Loire" and then a PhD fellow with the "Comite Departemental de Maine-et-Loire de La Ligue Contre le Cancer". Audrey Griveau was a PhD fellow with the "Conseil General de Maine-et-Loire". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Bedrine-Ferran H, 2004, GENOMICS, V83, P772, DOI 10.1016/j.ygeno.2003.11.014; Bhatt L, 2010, FEBS J, V277, P3219, DOI 10.1111/j.1742-4658.2010.07727.x; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Campillos M, 2010, NUCLEIC ACIDS RES, V38, pW360, DOI 10.1093/nar/gkq371; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Chang J, 2009, INT J PHARMACEUT, V379, P285, DOI 10.1016/j.ijpharm.2009.04.035; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Cmejla R, 2006, BIOCHEM BIOPH RES CO, V341, P158, DOI 10.1016/j.bbrc.2005.12.155; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Corbeil D, 1998, BLOOD, V91, P2625, DOI 10.1182/blood.V91.7.2625.2625_2625_2626; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Corbeil D, 2010, FEBS LETT, V584, P1659, DOI 10.1016/j.febslet.2010.01.050; DAVIS RJ, 1986, J BIOL CHEM, V261, P8708; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Eckard J, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-28; Enns CA, 2001, TRAFFIC, V2, P167, DOI 10.1034/j.1600-0854.2001.020303.x; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; Garcion E, 2001, DEVELOPMENT, V128, P2485; Garcion E, 2006, MOL CANCER THER, V5, P1710, DOI 10.1158/1535-7163.MCT-06-0289; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; He WL, 2008, J ZHEJIANG UNIV-SC B, V9, P707, DOI 10.1631/jzus.B0820023; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; HENTZE MW, 1987, P NATL ACAD SCI USA, V84, P6730, DOI 10.1073/pnas.84.19.6730; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; INMAN RS, 1993, J BIOL CHEM, V268, P8521; Jacolot S, 2008, BLOOD CELL MOL DIS, V41, P100, DOI 10.1016/j.bcmd.2008.01.006; Jiang DL, 2009, BIOCHEMISTRY-US, V48, P7939, DOI 10.1021/bi900907a; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; King FW, 2009, STEM CELLS DEV, V18, P1441, DOI 10.1089/scd.2009.0012; Knowles HJ, 2006, CANCER RES, V66, P2600, DOI 10.1158/0008-5472.CAN-05-2351; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lin E, 2001, J BIOL CHEM, V276, P27685, DOI 10.1074/jbc.M100941200; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Martini LA, 2002, J NUTR, V132, P693, DOI 10.1093/jn/132.4.693; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Mastroberardino PG, 2009, NEUROBIOL DIS, V34, P417, DOI 10.1016/j.nbd.2009.02.009; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mole DR, 2010, ANTIOXID REDOX SIGN, V12, P445, DOI 10.1089/ars.2009.2790; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; NUNEZ MT, 1982, BIOCHEMISTRY-US, V21, P4139, DOI 10.1021/bi00260a034; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Paillard A, 2010, BIOMATERIALS, V31, P7542, DOI 10.1016/j.biomaterials.2010.06.024; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Roger E, 2009, J CONTROL RELEASE, V140, P174, DOI 10.1016/j.jconrel.2009.08.010; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Stehling O, 2009, METHOD ENZYMOL, V456, P209, DOI 10.1016/S0076-6879(08)04412-1; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Taieb N, 2009, CANCER LETT, V278, P164, DOI 10.1016/j.canlet.2009.01.013; TANNER LI, 1989, J CELL BIOL, V108, P1537, DOI 10.1083/jcb.108.4.1537; TEICHMANN R, 1990, J CLIN INVEST, V86, P2145, DOI 10.1172/JCI114953; THEIL EC, 1994, BIOCHEM J, V304, P1; Torgersen ML, 2001, J CELL SCI, V114, P3737; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WARBURG O, 1956, SCIENCE, V124, P269; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Woo KJ, 2006, BIOCHEM BIOPH RES CO, V343, P8, DOI 10.1016/j.bbrc.2006.02.116; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Yang C, 2007, BIOCHEMISTRY-MOSCOW+, V72, P854, DOI 10.1134/S000629790708007X; Yang ZB, 2005, J BIOL CHEM, V280, P654, DOI 10.1074/jbc.M408486200; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zhang ZH, 2003, EUR J PHARMACOL, V467, P41, DOI 10.1016/S0014-2999(03)01597-8; Zhu L, 2006, J AGR FOOD CHEM, V54, P7924, DOI 10.1021/jf061036z	87	54	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25515	10.1371/journal.pone.0025515	http://dx.doi.org/10.1371/journal.pone.0025515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966538	gold, Green Published, Green Submitted			2022-12-25	WOS:000295932100046
J	Wei, Q; Sun, ZH; He, XC; Tan, T; Lu, B; Guo, XY; Su, B; Ji, WZ				Wei, Qiang; Sun, Zhenghua; He, Xiechao; Tan, Tao; Lu, Bin; Guo, Xiangyu; Su, Bing; Ji, Weizhi			Derivation of Rhesus Monkey Parthenogenetic Embryonic Stem Cells and Its MicroRNA Signature	PLOS ONE			English	Article							NUCLEAR TRANSFER; X-INACTIVATION; EXPRESSION PATTERNS; SOMATIC-CELLS; LINES; GENE; PLURIPOTENCY; BLASTOCYSTS; DISCOVERY; CANCER	Parthenogenetic embryonic stem cells are considered as a promising resource for regeneration medicine and powerful tools for developmental biology. A lot of studies have revealed that embryonic stem cells have distinct microRNA expression pattern and these microRNAs play important roles in self-renewal and pluripotency of embryonic stem cells. However, few studies concern about microRNA expression pattern in parthenogenetic embryonic stem cells, especially in non-human primate-the ideal model species for human, largely due to the limited rhesus monkey parthenogenetic embryonic stem cells (rpESCs) available and lack of systematic analysis of the basics of rpESCs. Here, we derived two novel rpESCs lines and characterized their microRNA signature by Solexa deep sequencing. These two novel rpESCs shared many properties with other primate ESCs, including expression of pluripotent markers, capacity to generate derivatives representative of all three germ layers in vivo and in vitro, maintaining of euploid karyotype even after long culture. Additionally, lack of some paternally expressed imprinted genes and identity of Single-nucleotide Polymorphism (SNP) compare to their oocyte donors support their parthenogenesis origin. By characterizing their microRNA signature, we identified 91 novel microRNAs, except those are also detected in other primate ESCs. Moreover, these two novel rpESCs display a unique microRNA signature, comparing to their biparental counterpart ESCs. Then we analyzed X chromosome status in these two novel rpESCs; results suggested that one of them possesses two active X chromosomes, the other possesses only one active X chromosome liking biparental female embryonic stem cells. Taken together, our novel rpESCs provide a new alternative to existing rhesus monkey embryonic stem cells, microRNA information expands rhesus monkey microRNA data and may help understanding microRNA roles in pluripotency and parthenogenesis.	[Wei, Qiang; He, Xiechao; Tan, Tao; Lu, Bin; Guo, Xiangyu; Ji, Weizhi] Chinese Acad Sci, Kunming Inst Zool, Dept Reprod & Dev, Kunming, Peoples R China; [Sun, Zhenghua; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Wei, Qiang; Sun, Zhenghua; Tan, Tao; Lu, Bin; Guo, Xiangyu; Su, Bing; Ji, Weizhi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wei, Q (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Dept Reprod & Dev, Kunming, Peoples R China.	weiqaix@hotmail.com; sub@mail.kiz.ac.cn; wji@mail.kiz.ac.cn		Ji, Weizhi/0000-0003-2550-4224; tan, tao/0000-0002-7589-602X	National 973 project of China [2007CB947701]	National 973 project of China(National Basic Research Program of China)	This study was supported by grants from the National 973 project of China (2007CB947701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; BARROSODELJESUS A, 2011, FASEB J; Brevini TAL, 2009, STEM CELL REV REP, V5, P340, DOI 10.1007/s12015-009-9086-9; Bruck T, 2011, STEM CELL RES, V6, P187, DOI 10.1016/j.scr.2010.12.001; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Dighe V, 2008, STEM CELLS, V26, P756, DOI 10.1634/stemcells.2007-0869; Dvash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011330; Dvash T, 2009, EPIGENETICS-US, V4, P19, DOI 10.4161/epi.4.1.7438; FENG M, 2011, ONCOGENE; Gong C, 2011, J BIOL CHEM; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Krutovskikh VA, 2010, BIOESSAYS, V32, P894, DOI 10.1002/bies.201000040; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Leeb M, 2010, HEREDITY, V105, P64, DOI 10.1038/hdy.2009.181; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mai QY, 2007, CELL RES, V17, P1008, DOI 10.1038/cr.2007.102; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; McKiernan SH, 2000, HUM REPROD, V15, P157, DOI 10.1093/humrep/15.1.157; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Mitalipov SM, 2002, BIOL REPROD, V66, P1367, DOI 10.1095/biolreprod66.5.1367; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; Niu YY, 2010, P NATL ACAD SCI USA, V107, P17663, DOI 10.1073/pnas.1006563107; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; Revazova ES, 2008, CLONING STEM CELLS, V10, P11, DOI 10.1089/clo.2007.0063; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Shruti K, 2011, BIOCH BIOPHYS RES CO; Sparman M, 2009, STEM CELLS, V27, P1255, DOI 10.1002/stem.60; Sritanaudomchai H, 2010, HUM REPROD, V25, P1927, DOI 10.1093/humrep/deq144; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Sun ZH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-276; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tiscornia G, 2010, GENE DEV, V24, P2732, DOI 10.1101/gad.1982910; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wolf DP, 2008, REGEN MED, V3, P129, DOI 10.2217/17460751.3.2.129; Yang S, 2007, THERIOGENOLOGY, V67, P1194, DOI 10.1016/j.theriogenology.2006.10.021	55	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25052	10.1371/journal.pone.0025052	http://dx.doi.org/10.1371/journal.pone.0025052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966410	Green Submitted, Green Published, gold			2022-12-25	WOS:000295932100015
J	Chou, WY; Pai, TW; Jiang, TY; Chou, WI; Tang, CY; Chang, MDT				Chou, Wei-Yao; Pai, Tun-Wen; Jiang, Ting-Ying; Chou, Wei-I; Tang, Chuan-Yi; Chang, Margaret Dah-Tsyr			Hydrophilic Aromatic Residue and in silico Structure for Carbohydrate Binding Module	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTEIN-STRUCTURE PREDICTION; LIGAND-BINDING; CELLULOSE-BINDING; RECOGNITION; DOMAIN; GLUCOAMYLASE; CYCLODEXTRIN; RESOLUTION; CATALYSIS	Carbohydrate binding modules (CBMs) are found in polysaccharide-targeting enzymes and increase catalytic efficiency. Because only a relatively small number of CBM structures have been solved, computational modeling represents an alternative approach in conjunction with experimental assessment of CBM functionality and ligand-binding properties. An accurate target-template sequence alignment is the crucial step during homology modeling. However, low sequence identities between target/template sequences can be a major bottleneck. We therefore incorporated the predicted hydrophilic aromatic residues (HARs) and secondary structure elements into our feature-incorporated alignment (FIA) algorithm to increase CBM alignment accuracy. An alignment performance comparison for FIA and six others was made, and the greatest average sequence identities and similarities were achieved by FIA. In addition, structure models were built for 817 representative CBMs. Our models possessed the smallest average surface-potential z scores. Besides, a large true positive value for liagnd-binding aromatic residue prediction was obtained by HAR identification. Finally, the pre-simulated CBM structures have been deposited in the Database of Simulated CBM structures (DS-CBMs). The web service is publicly available at http://dscbm.life.nthu.edu.tw/ and http://dscbm.cs.ntou.edu.tw/.	[Chou, Wei-Yao; Tang, Chuan-Yi] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Chou, Wei-Yao; Jiang, Ting-Ying; Chou, Wei-I; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Chou, Wei-Yao; Jiang, Ting-Ying; Chou, Wei-I; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Pai, Tun-Wen] Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Keelung, Taiwan; [Pai, Tun-Wen] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Keelung, Taiwan; [Chou, Wei-I] Simpson Biotech Co Ltd, Tao Yuan, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Taiwan Ocean University; National Taiwan Ocean University	Chou, WY (corresponding author), Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan.	lscmdt@life.nthu.edu.tw			National Science Council, R.O.C. [NSC100-2628-B-007-003-MY3, NSC100-2627-B-019-006, NSC98-2221-E-019-031-MY2, NSC99-2627-B-126-001, NSC98-2917-I-007-105]; Toward world-class university; Simpson Biotech Corporation [100A0157V7]; Ju-Chen Shen Tsing Hua Fellowship	National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan); Toward world-class university; Simpson Biotech Corporation; Ju-Chen Shen Tsing Hua Fellowship	This work was funded by National Science Council, R.O.C. grant numbers NSC100-2628-B-007-003-MY3 to Margaret Dah-Tsyr Chang; NSC100-2627-B-019-006 and NSC98-2221-E-019-031-MY2 to Tun-Wen Pai; NSC99-2627-B-126-001 to Chuan-Yi Tang; and NSC98-2917-I-007-105 to Wei-Yao Chou. This work was also supported by Toward world-class university project to NTHU, Simpson Biotech Corporation grant number 100A0157V7 to Margaret Dah-Tsyr Chang, and Ju-Chen Shen Tsing Hua Fellowship to Ting-Ying Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; Boraston AB, 2006, J BIOL CHEM, V281, P587, DOI 10.1074/jbc.M509958200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; Chou WI, 2006, BIOCHEM J, V396, P469, DOI 10.1042/BJ20051982; Chou WY, 2010, BIOINFORMATICS, V26, P1022, DOI 10.1093/bioinformatics/btq084; Christiansen C, 2009, FEBS J, V276, P5006, DOI 10.1111/j.1742-4658.2009.07221.x; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; GILKES NR, 1988, J BIOL CHEM, V263, P10401; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Harata K, 1996, ACTA CRYSTALLOGR D, V52, P1136, DOI 10.1107/S0907444996008438; Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; JONES D, 1993, J COMPUT AID MOL DES, V7, P439, DOI 10.1007/BF02337560; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; LIU T, 2011, COMB CHEM HIGH THROU; Lo HF, 2004, CURR MICROBIOL, V48, P280, DOI 10.1007/s00284-003-4198-y; Mitsuoka K, 2011, MICRON, V42, P100, DOI 10.1016/j.micron.2010.08.006; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oliveira OV, 2009, J MOL RECOGNIT, V22, P38, DOI 10.1002/jmr.925; Paldi T, 2003, BIOCHEM J, V372, P905, DOI 10.1042/BJ20021527; Parker MW, 2003, J BIOL PHYS, V29, P341, DOI 10.1023/A:1027310719146; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Pires VMR, 2004, J BIOL CHEM, V279, P21560, DOI 10.1074/jbc.M401599200; Shani N, 2011, J IMMUNOL, V186, P1240, DOI 10.4049/jimmunol.1000640; Shin J, 2008, EXPERT REV PROTEOMIC, V5, P589, DOI 10.1586/14789450.5.4.589; Sorimachi K, 1997, STRUCTURE, V5, P647, DOI 10.1016/S0969-2126(97)00220-7; Subramanian AR, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-6; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5; Tung JY, 2008, BIOCHEM J, V416, P27, DOI 10.1042/BJ20080580; Uitdehaag JCM, 1999, J BIOL CHEM, V274, P34868, DOI 10.1074/jbc.274.49.34868; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; Watson JN, 2004, FEBS LETT, V577, P265, DOI 10.1016/j.febslet.2004.10.016; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290	49	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24814	10.1371/journal.pone.0024814	http://dx.doi.org/10.1371/journal.pone.0024814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966371	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100022
J	Jaworowska, E; Trubicka, J; Lener, MR; Masojc, B; Zlowocka-Perlowska, E; Mckay, JD; Renard, H; Oszutowska, D; Wokolorczyk, D; Lubinski, J; Grodzki, T; Serwatowski, P; Nej-Wolosiak, K; Toloczko-Grabarek, A; Sikorski, A; Slojewski, M; Jakubowska, A; Cybulski, C; Lubinski, J; Scott, RJ				Jaworowska, Ewa; Trubicka, Joanna; Lener, Marcin R.; Masojc, Bartlomiej; Zlowocka-Perlowska, Elzbieta; Mckay, James D.; Renard, Helene; Oszutowska, Dorota; Wokolorczyk, Dominika; Lubinski, Jakub; Grodzki, Tomasz; Serwatowski, Piotr; Nej-Wolosiak, Katarzyna; Toloczko-Grabarek, Aleksandra; Sikorski, Andrzej; Slojewski, Marcin; Jakubowska, Anna; Cybulski, Cezary; Lubinski, Jan; Scott, Rodney J.			Smoking Related Cancers and Loci at Chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish Population	PLOS ONE			English	Article							FAMILIAL LUNG-CANCER; SUSCEPTIBILITY LOCUS; NICOTINE DEPENDENCE; GENOME-WIDE; SEQUENCE VARIANTS; GENETIC-VARIATION; CANDIDATE GENE; MULTIPLE LOCI; RISK; ASSOCIATION	Genetic factors associated with the risk of smoking related cancers have until recently remained elusive. Since the publication of a genome-wide association study (GWAS) on lung cancer new genetic loci have been identified that appear to be associated with disease risk. In this replication study we genotyped 14 single nucleotide polymorphisms (SNPs) located at the 5p12.3-p15.33, 6p21.3-p22.1, 6q23-q27 and 15q25.1 loci in 874 lung, 450 bladder, 418 laryngeal cancer cases and cancer-free controls, matched by year of birth and sex to the cases. Our results revealed that loci in the chromosome region 15q25.1 (rs16969968[A], rs8034191[G]) and 5p15 (rs402710[T]) are associated with lung cancer risk in the Polish population (smoking status adjusted OR = 1.45, 1.35, 0.77; p <= 0.0001, 0.0005, 0.002; 95% CI 1.23-1.72, 1.14-1.59, 0.66-0.91 respectively). None of the other regions analyzed herein were implicated in the risk of lung, bladder or laryngeal cancer. This study supports previous findings on lung cancer but fails to show association of SNPs located in 15q25.1 and 5p15 region with other smoking related cancers like bladder and laryngeal cancer.	[Jaworowska, Ewa; Lubinski, Jakub] Pomeranian Med Univ, Dept Otolaryngol & Laryngol Oncol, Szczecin, Poland; [Trubicka, Joanna; Lener, Marcin R.; Masojc, Bartlomiej; Zlowocka-Perlowska, Elzbieta; Oszutowska, Dorota; Wokolorczyk, Dominika; Nej-Wolosiak, Katarzyna; Toloczko-Grabarek, Aleksandra; Jakubowska, Anna; Cybulski, Cezary; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathomorphol, Szczecin, Poland; [Masojc, Bartlomiej] Western Pomeranian Oncol Ctr, Dept Radiotherapy, Szczecin, Poland; [Mckay, James D.; Renard, Helene] Int Agcy Res Canc, Dept Genet Epidemiol, F-69372 Lyon, France; [Grodzki, Tomasz; Serwatowski, Piotr] Reg Hosp Lung Dis, Szczecin, Poland; [Sikorski, Andrzej; Slojewski, Marcin] Pomeranian Med Univ, Dept Urol & Urol Oncol, Szczecin, Poland; [Scott, Rodney J.] Univ Newcastle, Discipline Med Genet, Newcastle, NSW 2300, Australia; [Scott, Rodney J.] Hunter Med Res Inst, Newcastle, NSW, Australia	Pomeranian Medical University; Pomeranian Medical University; World Health Organization; International Agency for Research on Cancer (IARC); Pomeranian Medical University; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Jaworowska, E (corresponding author), Pomeranian Med Univ, Dept Otolaryngol & Laryngol Oncol, Szczecin, Poland.	bmasojc@gmail.com	Jakubowska, Anna/O-8050-2014; Scott, Rodney J/B-2827-2013; Oszutowska-Mazurek, Dorota/D-2000-2017; Trubicka, Joanna/R-1215-2018; Jaworowska, Ewa/B-1211-2015; Slojewski, Marcin/P-6992-2014; Zlowocka-Perlowska, Elzbieta/W-9862-2018	Jakubowska, Anna/0000-0002-5650-0501; Scott, Rodney J/0000-0001-7724-3404; Oszutowska-Mazurek, Dorota/0000-0001-6403-4160; Trubicka, Joanna/0000-0002-9848-3674; Jaworowska, Ewa/0000-0001-9050-5042; Slojewski, Marcin/0000-0003-2943-629X; Zlowocka-Perlowska, Elzbieta/0000-0002-5143-6387; Lubinski, Jan/0000-0003-2931-3003; Slojewski, Marcin/0000-0003-3679-7325	European Community [MTKD-CT-2004-510114]; Polish Ministry of Science and Higher Education	European Community(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by European Community program "Marie- Curie Host Fellowships for the Transfer of Knowledge'', nr MTKD-CT-2004-510114. B. M. receives a "Scholarship for Young Scientists'' from Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Chen D, 2011, CANCER EPIDEM BIOMAR, V20, P658, DOI 10.1158/1055-9965.EPI-10-1008; Fang SY, 2010, CANCER EPIDEM BIOMAR, V19, P3157, DOI 10.1158/1055-9965.EPI-10-0792; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gago-Dominguez M, 2011, CARCINOGENESIS, V32, P197, DOI 10.1093/carcin/bgq233; Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jin GF, 2009, CARCINOGENESIS, V30, P987, DOI 10.1093/carcin/bgp090; KRAIS AM, 2011, CARCINOGENESIS; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; Liu PY, 2010, CANCER EPIDEM BIOMAR, V19, P517, DOI 10.1158/1055-9965.EPI-09-0791; Matakidou A, 2005, BRIT J CANCER, V93, P825, DOI 10.1038/sj.bjc.6602769; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Savage SA, 2005, HUM MUTAT, V26, P343, DOI 10.1002/humu.20226; Sherry ST, 1999, GENOME RES, V9, P677; Shiraishi K, 2009, CARCINOGENESIS, V30, P65, DOI 10.1093/carcin/bgn257; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Wang JC, 2009, MOL PSYCHIATR, V14, P501, DOI 10.1038/mp.2008.42; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201; Wang YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019085; Wang YF, 2010, CARCINOGENESIS, V31, P234, DOI 10.1093/carcin/bgp287; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335; Young RP, 2008, EUR RESPIR J, V32, P1158, DOI 10.1183/09031936.00093908; Zoli M, 2002, J NEUROSCI, V22, P8785	42	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25057	10.1371/journal.pone.0025057	http://dx.doi.org/10.1371/journal.pone.0025057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966413	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100047
J	Sharma, S; Mells, JE; Fu, PP; Saxena, NK; Anania, FA				Sharma, Shvetank; Mells, Jamie E.; Fu, Ping P.; Saxena, Neeraj K.; Anania, Frank A.			GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GLUCAGON-LIKE PEPTIDE-1; RECEPTOR DOWN-REGULATION; PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; INDUCED AUTOPHAGY; ACTIVATION; APOPTOSIS; LIPOTOXICITY; MECHANISMS	Background: Nonalcoholic fatty liver disease (NAFLD) is a known outcome of hepatosteatosis. Free fatty acids (FFA) induce the unfolded protein response (UPR) or endoplasmic reticulum (ER) stress that may induce apoptosis. Recent data indicate ER stress to be a major player in the progression of fatty liver to more aggressive lesions. Autophagy on the other hand has been demonstrated to be protective against ER stress-induced cell death. We hypothesized that exendin-4 (GLP-1 analog) treatment of fat loaded hepatocytes can reduce steatosis by autophagy which leads to reduced ER stress-related hepatocyte apoptosis. Methodology/Principal Findings: Primary human hepatocytes were loaded with saturated, cis- and trans-unsaturated fatty acids (palmitic, oleic and elaidic acid respectively). Steatosis, induced with all three fatty acids, was significantly resolved after exendin-4 treatment. Exendin-4 sustained levels of GRP78 expression in fat-loaded cells when compared to untreated fat-loaded cells alone. In contrast, CHOP (C/EBP homologous protein); the penultimate protein that leads to ER stress-related cell death was significantly decreased by exendin-4 in hepatocytes loaded with fatty acids. Finally, exendin-4 in fat loaded hepatocytes clearly promoted gene products associated with macroautophagy as measured by enhanced production of both Beclin-1 and LC3B-II, markers for autophagy; and visualized by transmission electron microscopy (TEM). Similar observations were made in mouse liver lysates after mice were fed with high fat high fructose diet and treated with a long acting GLP-1 receptor agonist, liraglutide. Conclusions/Significance: GLP-1 proteins appear to protect hepatocytes from fatty acid-related death by prohibition of a dysfunctional ER stress response; and reduce fatty acid accumulation, by activation of both macro-and chaperone-mediated autophagy. These findings provide a novel role for GLP-1 proteins in halting the progression of more aggressive lesions from underlying steatosis in humans afflicted with NAFLD.	[Sharma, Shvetank; Mells, Jamie E.; Fu, Ping P.; Saxena, Neeraj K.; Anania, Frank A.] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA	Emory University	Sharma, S (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	fanania@emory.edu			National Institutes of Health [RO1DK062092, RO1DK075397, R24DK064399, R03DK089130, K01DK077137]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062092, R03DK089130, R01DK075397, K01DK077137, R24DK064399] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The study was supported by funding from National Institutes of Health grants RO1DK062092, RO1DK075397, R24DK064399, R03DK089130 and K01DK077137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Bandyopadhyay U, 2010, MOL CELL, V39, P535, DOI 10.1016/j.molcel.2010.08.004; Banhegyi G, 2007, ANN NY ACAD SCI, V1113, P58, DOI 10.1196/annals.1391.007; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; BODEN G, 1994, J CLIN ENDOCR METAB, V78, P657, DOI 10.1210/jc.78.3.657; Bregenbolt S, 2005, BIOCHEM BIOPH RES CO, V330, P577, DOI 10.1016/j.bbrc.2005.03.013; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Centis E, 2010, DIGEST DIS, V28, P267, DOI 10.1159/000282101; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Cusi K, 2009, CLIN LIVER DIS, V13, P545, DOI 10.1016/j.cld.2009.07.009; Czaja MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC973, DOI 10.1152/ajpcell.00527.2009; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Dragunow M, 2007, J BIOMOL SCREEN, V12, P999, DOI 10.1177/1087057107306502; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; GARVEY WT, 1986, DIABETES, V35, P258, DOI 10.2337/diabetes.35.3.258; Gault VA, 2003, DIABETOLOGIA, V46, P222, DOI 10.1007/s00125-002-1028-x; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Handy JA, 2010, J CELL BIOCHEM, V110, P1195, DOI 10.1002/jcb.22634; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Holst JJ, 2004, HORM METAB RES, V36, P747, DOI 10.1055/s-2004-826158; Huett A, 2010, CURR OPIN GASTROEN, V26, P302, DOI 10.1097/MOG.0b013e32833ae2ed; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kim DS, 2010, IMMUNOPHARM IMMUNOT, V32, P251, DOI 10.3109/08923970903252220; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Peyot ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006221; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Rask E, 2001, DIABETES CARE, V24, P1640, DOI 10.2337/diacare.24.9.1640; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sharma D, 2010, HEPATOLOGY, V52, P1713, DOI 10.1002/hep.23892; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Swanlund JM, 2010, AUTOPHAGY, V6, P270, DOI 10.4161/auto.6.2.10439; Tetri LH, 2008, AM J PHYSIOL-GASTR L, V295, pG987, DOI 10.1152/ajpgi.90272.2008; Tsunekawa S, 2007, J ENDOCRINOL, V193, P65, DOI 10.1677/JOE-06-0148; VENKATESAN N, 1995, METABOLISM, V44, P75, DOI 10.1016/0026-0495(95)90292-9; Wei Y, 2007, MOL CELL BIOCHEM, V303, P105, DOI 10.1007/s11010-007-9461-2; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Winzell MS, 2004, HORM METAB RES, V36, P795, DOI 10.1055/s-2004-826166; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhou LJ, 2009, MOL PHARMACOL, V76, P596, DOI 10.1124/mol.109.057067	50	174	196	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25269	10.1371/journal.pone.0025269	http://dx.doi.org/10.1371/journal.pone.0025269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957486	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100046
J	Koeberle, A; Shindou, H; Harayama, T; Yuki, K; Shimizu, T				Koeberle, Andreas; Shindou, Hideo; Harayama, Takeshi; Yuki, Koichi; Shimizu, Takao			Polyunsaturated fatty acids are incorporated into maturating male mouse germ cells by lysophosphatidic acid acyltransferase 3	FASEB JOURNAL			English	Article						lipidomics; phospholipids; spermatocytes	LIPID-COMPOSITION; LONG-CHAIN; ACYL-COA; LYSOPHOSPHOLIPID ACYLTRANSFERASE; RAT TESTES; TESTICULAR LIPIDS; SERTOLI-CELLS; METABOLISM; MICE; IDENTIFICATION	Long-chain polyunsaturated fatty acids (PUFAs) accumulate in mammalian testis during puberty and are essential for fertility. To investigate whether lysophospholipid acyltransferases determine the PUFA composition of testicular phospholipids during pubertal development, we compared their mRNA expression, in vitro activity, and specificity with the lipidomic profile of major phospholipids. The accumulation of PUFAs in phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine correlated with an induced lysophosphatidic acid acyltransferase (LPAAT)3 mRNA expression, increased microsomal LPAAT3 activity, and shift of LPAAT specificity to PUFA-coenzyme A. LPAAT3 was induced during germ cell maturation, as shown by immunofluorescence microscopy. Accordingly, differentiation of mouse GC-2spd(ts) spermatocytes into spermatides up-regulated LPAAT3 mRNA, increased the amount of polyunsaturated phospholipids, and shifted the specificity for the incorporation of deuterium-labeled docosahexaenoic acid toward phosphatidylcholine and phosphatidylethanolamine. Stable knockdown of LPAAT3 in GC-2spd(ts) cells significantly decreased microsomal LPAAT3 activity, reduced levels of polyunsaturated phosphatidylethanolamine species, and impaired cell proliferation/survival during geneticin selection. We conclude that the induction of LPAAT3 during germ cell development critically contributes to the accumulation of PUFAs in testicular phospholipids, thereby possibly affecting sperm cell production.-Koeberle, A., Shindou, H., Harayama, T., Yuki, K., Shimizu, T. Polyunsaturated fatty acids are incorporated into maturating male mouse germ cells by lysophosphatidic acid acyltransferase 3. FASEB J. 26, 169-180 (2012). www.fasebj.org	[Shimizu, Takao] Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Shimizu, T (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan.	tshimizu@m.u-tokyo.ac.jp	Koeberle, Andreas/ABB-2356-2020; Harayama, Takeshi/AAD-8852-2022; Shimizu, Takao/AAV-7052-2021	Koeberle, Andreas/0000-0001-6269-5088; Harayama, Takeshi/0000-0003-2255-4197; 	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Society for Promotion of Sciences; Center for NanoBio Integration at the University of Tokyo; Ministry of Health and Labor; MEXT; Uehara Memorial Foundation; Cell Science Research Foundation; Japan Society for the Promotion of Science; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for NanoBio Integration at the University of Tokyo; Ministry of Health and Labor; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to T. S.) and a Global COE Program (The University of Tokyo) from the Japan Society for Promotion of Sciences (to T. S.). T. S. and H. S. were supported by the Center for NanoBio Integration at the University of Tokyo. H. S. was supported by Health and Labor Sciences research grants (Research on Allergic Disease and Immunology) from the Ministry of Health and Labor, a Grant-in-Aid for Young Scientists (B) from MEXT, and grants from the Uehara Memorial Foundation and the Cell Science Research Foundation. T. H. was supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists. A. K. received a stipend from Takeda Science Foundation.	AHLUWALIA B, 1966, LIPIDS, V1, P197, DOI 10.1007/BF02531872; BECKMAN JK, 1980, LIPIDS, V15, P389, DOI 10.1007/BF02534061; BECKMAN JK, 1979, LIPIDS, V14, P262, DOI 10.1007/BF02533912; BIERI JG, 1965, COMP BIOCHEM PHYSIOL, V15, P275, DOI 10.1016/0010-406X(65)90131-3; BLANK ML, 1985, BIOCHIM BIOPHYS ACTA, V833, P366, DOI 10.1016/0005-2760(85)90092-X; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cao JS, 2008, J BIOL CHEM, V283, P19049, DOI 10.1074/jbc.M800364200; CONIGLIO JG, 1975, BIOL REPROD, V12, P255, DOI 10.1095/biolreprod12.2.255; DAVIS JT, 1966, BIOCHEM J, V98, P342, DOI 10.1042/bj0980342; DIX JA, 1990, BIOCHEMISTRY-US, V29, P1949, DOI 10.1021/bi00459a041; Furland NE, 2007, BIOL REPROD, V77, P181, DOI 10.1095/biolreprod.106.056556; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; HOFMANN MC, 1994, P NATL ACAD SCI USA, V91, P5533, DOI 10.1073/pnas.91.12.5533; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Huyghe S, 2006, ENDOCRINOLOGY, V147, P2228, DOI 10.1210/en.2005-1571; Jain S, 2009, J LIPID RES, V50, P1563, DOI 10.1194/jlr.M800398-JLR200; JOHNSON LA, 1975, J ANIM SCI, V40, P108, DOI 10.2527/jas1975.401108x; Kazachkov M, 2008, LIPIDS, V43, P895, DOI 10.1007/s11745-008-3233-y; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Kume K, 1997, BIOCHEM BIOPH RES CO, V237, P663, DOI 10.1006/bbrc.1997.7214; LACY D, 1962, BRIT MED BULL, V18, P205, DOI 10.1093/oxfordjournals.bmb.a069979; Lin DS, 2004, J LIPID RES, V45, P529, DOI 10.1194/jlr.M300374-JLR200; LYNCH KM, 1951, ENDOCRINOLOGY, V49, P8, DOI 10.1210/endo-49-1-8; Moreno RD, 2006, MOL REPROD DEV, V73, P1430, DOI 10.1002/mrd.20581; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NISSEN HP, 1983, ANDROLOGIA, V15, P264; Oresti GM, 2010, J LIPID RES, V51, P2909, DOI 10.1194/jlr.M006429; Retterstol K, 2001, LIPIDS, V36, P601, DOI 10.1007/s11745-001-0763-z; Retterstol K, 2001, REPRODUCTION, V121, P881, DOI 10.1530/reprod/121.6.881; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; Saether T, 2003, BIOL REPROD, V69, P117, DOI 10.1095/biolreprod.102.014035; Schmidt JA, 2009, J CELL BIOL, V186, P211, DOI 10.1083/jcb.200904147; SEBOKOVA E, 1988, AM J PHYSIOL, V255, pE442, DOI 10.1152/ajpendo.1988.255.4.E442; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wathes DC, 2007, BIOL REPROD, V77, P190, DOI 10.1095/biolreprod.107.060558; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200; Ye XQ, 2008, BIOL REPROD, V79, P328, DOI 10.1095/biolreprod.108.068783; Yuki K, 2009, J LIPID RES, V50, P860, DOI 10.1194/jlr.M800468-JLR200; Zanetti SR, 2007, CANCER RES, V67, P6973, DOI 10.1158/0008-5472.CAN-07-0376; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	46	42	43	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					169	180		10.1096/fj.11-184879	http://dx.doi.org/10.1096/fj.11-184879			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21968070				2022-12-25	WOS:000299202200018
J	Boersma, YL; Chao, G; Steiner, D; Wittrup, KD; Pluckthun, A				Boersma, Ykelien L.; Chao, Ginger; Steiner, Daniel; Wittrup, K. Dane; Plueckthun, Andreas			Bispecific Designed Ankyrin Repeat Proteins (DARPins) Targeting Epidermal Growth Factor Receptor Inhibit A431 Cell Proliferation and Receptor Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITOR; YEAST SURFACE DISPLAY; MONOCLONAL-ANTIBODIES; IN-VITRO; AUTOPHOSPHORYLATION SITES; ERBB RECEPTORS; EXTRACELLULAR DOMAIN; THERAPEUTIC TARGETS; PERSISTENT ACTIVITY; STRUCTURAL BASIS	The EGF receptor (EGFR) has been implicated in the development and progression of many tumors. Although monoclonal antibodies directed against EGFR have been approved for the treatment of cancer in combination with chemotherapy, there are limitations in their clinical efficacy, necessitating the search for robust targeting molecules that can be equipped with new effector functions or show a new mechanism of action. Designed ankyrin repeat proteins (DARPins) may provide the targeting component for such novel reagents. Previously, four DARPins were selected against EGFR with (sub)nanomolar affinity. As any targeting module should preferably be able to inhibit EGFR-mediated signaling, their effect on A431 cells overexpressing EGFR was examined: three of them were shown to inhibit proliferation by inducing G(1) arrest, as seen for the Food and Drug Administration-approved antibody cetuximab To understand this inhibitory mechanism, we mapped the epitopes of the DARPins using yeast surface display. The epitopes for the biologically active DARPins overlapped with the EGF-binding site, whereas the fourth DARPin bound to a different domain, explaining the lack of a biological effect. To optimize the biological activity of the DARPins, we combined two DARPins binding to different epitopes with a flexible linker or with a leucine zipper, leading to a homodimer. The latter DARPin was able to reduce surface EGFR by inhibiting receptor recycling, leading to a dramatic decrease in cell viability. These results indicate that multispecific EGFR-specific DARPins are superior to cetuximab and may form the basis of new opportunities in tumor targeting and tumor therapy.	[Boersma, Ykelien L.; Steiner, Daniel; Plueckthun, Andreas] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Chao, Ginger; Wittrup, K. Dane] MIT, Dept Chem Engn & Bioengn, Cambridge, MA 02139 USA	University of Zurich; Massachusetts Institute of Technology (MIT)	Pluckthun, A (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	plueckthun@bioc.uzh.ch	Plückthun, Andreas/C-2746-2009	Plückthun, Andreas/0000-0003-4191-5306	National Institutes of Health [CA96504]; Dutch Organization for Scientific Research (NWO) [680-50-0704, OCS-02128-08-2007]; NATIONAL CANCER INSTITUTE [R01CA096504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA96504 (to G. C. and K. D. W.). This work was also supported by Dutch Organization for Scientific Research (NWO) Rubicon Postdoctoral Grant 680-50-0704 (to V L B.) and Oncosuisse Grant OCS-02128-08-2007 (to A. P.).	Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Boersma Y. L., 2011, CURR OPIN BIOTECH, DOI [10.1016/j.copbio.2011.06.004, DOI 10.1016/TCOPBIO.2011.06.004]; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Clayton AHA, 2007, BIOCHEMISTRY-US, V46, P4589, DOI 10.1021/bi700002b; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Dassonville O, 2007, CRIT REV ONCOL HEMAT, V62, P53, DOI 10.1016/j.critrevonc.2006.12.008; DECKER SJ, 1993, J BIOL CHEM, V268, P9176; FAN Z, 1993, CANCER RES, V53, P4322; FAN Z, 1994, J BIOL CHEM, V269, P27595; FAN Z, 1993, J BIOL CHEM, V268, P21073; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Friedlander E, 2008, IMMUNOL LETT, V116, P126, DOI 10.1016/j.imlet.2007.12.001; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Garrett TPJ, 2009, P NATL ACAD SCI USA, V106, P5082, DOI 10.1073/pnas.0811559106; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GILL GN, 1984, J BIOL CHEM, V259, P7755; GOTOH N, 1994, P NATL ACAD SCI USA, V91, P167, DOI 10.1073/pnas.91.1.167; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hildebrandt Bert, 2007, V176, P135; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hong KW, 2010, J BIOTECHNOL, V145, P84, DOI 10.1016/j.jbiotec.2009.09.023; Huang SM, 2000, CLIN CANCER RES, V6, P2166; Huber T, 2007, J STRUCT BIOL, V159, P206, DOI 10.1016/j.jsb.2007.01.013; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Janmaat ML, 2003, CLIN CANCER RES, V9, P2316; Jaramillo ML, 2006, EXP CELL RES, V312, P2778, DOI 10.1016/j.yexcr.2006.05.008; Kamat V, 2008, CANCER BIOL THER, V7, P726, DOI 10.4161/cbt.7.5.6097; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; Kawe M, 2006, J BIOL CHEM, V281, P40252, DOI 10.1074/jbc.M602506200; Kim YS, 2006, PROTEINS, V62, P1026, DOI 10.1002/prot.20618; Li S, 2008, STRUCTURE, V16, P216, DOI 10.1016/j.str.2007.11.009; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lofblom J, 2011, CURR OPIN BIOTECH, V22, P843, DOI 10.1016/j.copbio.2011.06.002; Maegawa M, 2009, CANCER SCI, V100, P552, DOI 10.1111/j.1349-7006.2008.01071.x; Martin-Killias P, 2011, CLIN CANCER RES, V17, P100, DOI 10.1158/1078-0432.CCR-10-1303; Meira DD, 2009, EUR J CANCER, V45, P1265, DOI 10.1016/j.ejca.2008.12.012; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Mendelsohn J, 2002, J CLIN ONCOL, V20, p1S, DOI 10.1200/JCO.2002.07.121; Miqueli AD, 2007, HYBRIDOMA, V26, P423, DOI 10.1089/hyb.2007.0516; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; PARKER PJ, 1984, J BIOL CHEM, V259, P9906; Patel D, 2009, INT J ONCOL, V34, P25, DOI 10.3892/ijo_00000125; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Raben D, 2005, CLIN CANCER RES, V11, P795; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Roovers RC, 2011, INT J CANCER, V129, P2013, DOI 10.1002/ijc.26145; Sato J D, 1983, Mol Biol Med, V1, P511; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Schmitz KR, 2009, EXP CELL RES, V315, P659, DOI 10.1016/j.yexcr.2008.10.008; Sergina NV, 2007, TRENDS MOL MED, V13, P527, DOI 10.1016/j.molmed.2007.10.002; Spangler JB, 2010, P NATL ACAD SCI USA, V107, P13252, DOI 10.1073/pnas.0913476107; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Winkler J, 2009, MOL CANCER THER, V8, P2674, DOI 10.1158/1535-7163.MCT-09-0402; XU FG, 1993, INT J CANCER, V53, P401, DOI 10.1002/ijc.2910530310; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zahnd C, 2006, J BIOL CHEM, V281, P35167, DOI 10.1074/jbc.M602547200; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	68	71	80	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41273	41285		10.1074/jbc.M111.293266	http://dx.doi.org/10.1074/jbc.M111.293266			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21979953	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000298057500015
J	Smith, SE; Granell, S; Salcedo-Sicilia, L; Baldini, G; Egea, G; Teckman, JH; Baldini, G				Smith, Steven E.; Granell, Susana; Salcedo-Sicilia, Laia; Baldini, Giovanna; Egea, Gustavo; Teckman, Jeff H.; Baldini, Giulia			Activating Transcription Factor 6 Limits Intracellular Accumulation of Mutant alpha(1)-Antitrypsin Z and Mitochondrial Damage in Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ALPHA-1-ANTITRYPSIN Z; INCLUSION-BODIES; LIVER-DISEASE; MANNOSIDASE I; ER STRESS; DEGRADATION; AUTOPHAGY; DEFICIENCY	alpha(1)-Antitrypsin is a serine protease inhibitor secreted by hepatocytes. A variant of alpha(1)-antitrypsin with an E342K (Z) mutation (ATZ) has propensity to form polymers, is retained in the endoplasmic reticulum (ER), is degraded by both ER-associated degradation and autophagy, and causes hepatocyte loss. Constant features in hepatocytes of PiZZ individuals and in PiZ transgenic mice expressing ATZ are the formation of membrane-limited globular inclusions containing ATZ and mitochondrial damage. Expression of ATZ in the liver does not induce the unfolded protein response (UPR), a protective mechanism aimed to maintain ER homeostasis in the face of an increased load of proteins. Here we found that in hepatoma cells the ER E3 ligase HRD1 functioned to degrade most of the ATZ before globular inclusions are formed. Activation of the activating transcription factor 6 (ATF6) branch of the UPR by expression of spliced ATF6(1-373) decreased intracellular accumulation of ATZ and the formation of globular inclusions by a pathway that required HRD1 and the proteasome. Expression of ATF6(1- 373) in ATZ-expressing hepatoma cells did not induce autophagy and increased the level of the proapoptotic factor CCAAT/enhancer-binding protein (C/EBP) homologous protein (CHOP) but did not lead to apoptotic DNA fragmentation. Expression of ATF6(1-373) did not cause inhibition of protein synthesis and prevented mitochondrial damage induced by ATZ expression. It was concluded that activation of the ATE6 pathway of the UPR limits ATZ-dependent cell toxicity by selectively promoting ER-associated degradation of ATZ and is thereby a potential target to prevent hepatocyte loss in addition to autophagy-enhancing drugs.	[Smith, Steven E.; Granell, Susana; Baldini, Giulia] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Salcedo-Sicilia, Laia; Egea, Gustavo] Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Fac Med, Inst Invest Biomediquens August Pi I Sunyer IDIBA, E-08036 Barcelona, Spain; [Baldini, Giovanna] Univ Trieste, Dipartimento Univ Clin Sci Med Chirurg & Salute, I-34138 Trieste, Italy; [Teckman, Jeff H.] St Louis Univ, Sch Med, Dept Pediat, St Louis, MO 63104 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Trieste; Saint Louis University	Baldini, G (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Slot 516,4301 W Markham, Little Rock, AR 72205 USA.	gbaldini@uams.edu	Egea, Gustavo/I-2394-2014; granell, susana/H-2734-2012	Egea, Gustavo/0000-0001-5242-150X; Teckman, Jeffrey/0000-0002-4870-2621	National Institutes of Health from the National Center for Research Resources [UL1RR029884]; Alpha-1 Foundation; Secretaria de Estado de Universidades Del Ministerio de Educacion y Ciencia, Spain; Ministerio de Innovacion y Ciencia, Spain [BEU2009-07186]; Arkansas Tobacco Settlement; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Alpha-1 Foundation; Secretaria de Estado de Universidades Del Ministerio de Educacion y Ciencia, Spain(Spanish Government); Ministerio de Innovacion y Ciencia, Spain; Arkansas Tobacco Settlement; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant UL1RR029884 from the National Center for Research Resources (to the University of Arkansas for Medical Sciences Translational Research Institute). This work was also supported by a grant from the Alpha-1 Foundation, the Arkansas Tobacco Settlement (to Giulia Baldini), a postdoctoral grant from the Secretaria de Estado de Universidades Del Ministerio de Educacion y Ciencia, Spain (to S. G.), and Grant BEU2009-07186 from the Ministerio de Innovacion y Ciencia, Spain (to G. E.).	An JK, 2005, HEPATOLOGY, V41, P160, DOI 10.1002/hep.20508; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Bobrovnikova-Marjon E, 2007, DEV CELL, V13, P322, DOI 10.1016/j.devcel.2007.08.006; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Egawa N, 2011, J BIOL CHEM, V286, P7947, DOI 10.1074/jbc.M110.156430; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Granell S, 2008, MOL BIOL CELL, V19, P572, DOI 10.1091/mbc.E07-06-0587; Granell S, 2008, AUTOPHAGY, V4, P375, DOI 10.4161/auto.5605; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kaushal S, 2010, EXP BIOL MED, V235, P700, DOI 10.1258/ebm.2010.009297; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; LE A, 1990, J BIOL CHEM, V265, P14001; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Pan SJ, 2009, HEPATOLOGY, V50, P275, DOI 10.1002/hep.22974; Perlmutter DH, 2011, ANNU REV MED, V62, P333, DOI 10.1146/annurev-med-042409-151920; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Teckman JH, 2007, SEMIN LIVER DIS, V27, P274, DOI 10.1055/s-2007-985072; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 2004, AM J PHYSIOL-GASTR L, V286, pG851, DOI 10.1152/ajpgi.00175.2003; Teckman JH, 1996, J BIOL CHEM, V271, P13215, DOI 10.1074/jbc.271.22.13215; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V278, pG39, DOI 10.1152/ajpgi.2000.278.1.G39; Teckman JH, 2001, J BIOL CHEM, V276, P44865, DOI 10.1074/jbc.M103703200; Termine DJ, 2009, J CELL SCI, V122, P976, DOI 10.1242/jcs.037291; Wang Y, 2000, J BIOL CHEM, V275, P27013; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ying Z, 2011, J BIOL CHEM, V286, P20835, DOI 10.1074/jbc.M110.200808; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	44	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41563	41577		10.1074/jbc.M111.280073	http://dx.doi.org/10.1074/jbc.M111.280073			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21976666	Green Published, hybrid			2022-12-25	WOS:000298057500042
J	Zhang, J; Petit, CM; King, DS; Lee, AL				Zhang, Jun; Petit, Chad M.; King, David S.; Lee, Andrew L.			Phosphorylation of a PDZ Domain Extension Modulates Binding Affinity and Interdomain Interactions in Postsynaptic Density-95 (PSD-95) Protein, a Membrane-associated Guanylate Kinase (MAGUK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; SCAFFOLDING PROTEINS; SYNAPTIC PLASTICITY; COMPLEX; RECEPTOR; IDENTIFICATION; AUTOINHIBITION; DYNAMICS; LIGAND; SITES	Postsynaptic density-95 is a multidomain scaffolding protein that recruits glutamate receptors to postsynaptic sites and facilitates signal processing and connection to the cytoskeleton. It is the leading member of the membrane-associated guanylate kinase family of proteins, which are defined by the PSD-95/Discs large/ZO-1 (PDZ)-Src homology 3 (SH3)-guanylate kinase domain sequence. We used NMR to show that phosphorylation of conserved tyrosine 397, which occurs in vivo and is located in an atypical helical extension (alpha 3), initiates a rapid equilibrium of docked and undocked conformations. Undocking reduced ligand binding affinity allosterically and weakened the interaction of PDZ3 with SH3 even though these domains are separated by a similar to 25-residue linker. Additional phosphorylation at two linker sites further disrupted the interaction, implicating alpha 3 and the linker in tuning interdomain communication. These experiments revealed a novel mode of regulation by a detachable PDZ element and offer a first glimpse at the dynamic interaction of PDZ and SH3-guanylate kinase domains in membrane-associated guanylate kinases.	[Lee, Andrew L.] Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Zhang, Jun; Petit, Chad M.; Lee, Andrew L.] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA; [King, David S.] Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA; [King, David S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lee, AL (corresponding author), Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Beard Hall,CB 7568, Chapel Hill, NC 27599 USA.	drewlee@unc.edu	Zhang, Jun/R-1502-2016; Lee, Andrew/GVU-2817-2022	Zhang, Jun/0000-0002-5842-7424; 	National Science Foundation [MCB-0344354]; University of North Carolina; Eshelman School of Pharmacy	National Science Foundation(National Science Foundation (NSF)); University of North Carolina; Eshelman School of Pharmacy	This work was supported by National Science Foundation Grant MCB-0344354 (to A. L L.) and bridge funding provided by the University of North Carolina and the Eshelman School of Pharmacy.	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; An YF, 2005, APPL MICROBIOL BIOT, V68, P774, DOI 10.1007/s00253-005-1948-8; Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P15400, DOI 10.1021/bi9814991; Brenman JE, 1998, J NEUROSCI, V18, P8805; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gardoni F, 2009, NEUROSCIENCE, V158, P324, DOI 10.1016/j.neuroscience.2008.07.068; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kalia LV, 2003, NEUROPHARMACOLOGY, V45, P720, DOI 10.1016/S0028-3908(03)00313-7; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Korkin D, 2006, PLOS COMPUT BIOL, V2, P1365, DOI 10.1371/journal.pcbi.0020153; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Lin DH, 2002, J BIOMOL NMR, V23, P317, DOI 10.1023/A:1020225206644; Liu W, 2011, CELL, V145, P1088, DOI 10.1016/j.cell.2011.05.015; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Massari S, 2005, J BIOL CHEM, V280, P7388, DOI 10.1074/jbc.M412668200; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pan LF, 2009, P NATL ACAD SCI USA, V106, P5575, DOI 10.1073/pnas.0901819106; Parker LL, 2003, J BIOL CHEM, V278, P21576, DOI 10.1074/jbc.M210973200; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Popovic Matija, 2011, J Mol Recognit, V24, P245, DOI 10.1002/jmr.1042; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Sapienza PJ, 2010, CURR OPIN PHARMACOL, V10, P723, DOI 10.1016/j.coph.2010.09.006; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; SPRANG SR, 1988, NATURE, V336, P215, DOI 10.1038/336215a0; Stein ELA, 2010, J NEUROCHEM, V113, P42, DOI 10.1111/j.1471-4159.2009.06529.x; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Tyler RC, 2010, BIOCHEMISTRY-US, V49, P951, DOI 10.1021/bi9017335; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yan J, 2010, P NATL ACAD SCI USA, V107, P4040, DOI 10.1073/pnas.0911385107; Zhang MJ, 2003, ACCOUNTS CHEM RES, V36, P530, DOI 10.1021/ar020210b	60	53	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41776	41785		10.1074/jbc.M111.272583	http://dx.doi.org/10.1074/jbc.M111.272583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965656	hybrid, Green Published			2022-12-25	WOS:000298057500061
J	Freitas, MO; Francisco, T; Rodrigues, TA; Alencastre, IS; Pinto, MP; Grou, CP; Carvalho, AF; Fransen, M; Sa-Miranda, C; Azevedo, JE				Freitas, Marta O.; Francisco, Tania; Rodrigues, Tony A.; Alencastre, Ines S.; Pinto, Manuel P.; Grou, Claudia P.; Carvalho, Andreia F.; Fransen, Marc; Sa-Miranda, Clara; Azevedo, Jorge E.			PEX5 Protein Binds Monomeric Catalase Blocking Its Tetrarnerization and Releases It upon Binding the N-terminal Domain of PEX14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL TARGETING SIGNAL; RAT-LIVER PEROXISOMES; IMPORT RECEPTOR PEX5P; SACCHAROMYCES-CEREVISIAE; PTS1 RECEPTOR; MEMBRANE-PROTEIN; CYCLING RECEPTOR; QUATERNARY STRUCTURE; CONSERVED CYSTEINE; YEAST PEX14P	Newly synthesized peroxisomal matrix proteins are targeted to the organelle by PEX5. PEX5 has a dual role in this process. First, it acts as a soluble receptor recognizing these proteins in the cytosol. Subsequently, at the peroxisomal docking/translocation machinery, PEX5 promotes their translocation across the organelle membrane. Despite significant advances made in recent years, several aspects of this pathway remain unclear. Two important ones regard the formation and disruption of the PEX5-cargo protein interaction in the cytosol and at the docking/translocation machinery, respectively. Here, we provide data on the interaction of PEX5 with catalase, a homotetrameric enzyme in its native state. We found that PEX5 interacts with monomeric catalase yielding a stable protein complex; no such complex was detected with tetrameric catalase. Binding of PEX5 to monomeric catalase potently inhibits its tetramerization, a property that depends on domains present in both the N- and C-terminal halves of PEX5. Interestingly, the PEX5-catalase interaction is disrupted by the N-terminal domain of PEX14, a component of the docking/translocation machinery. One or two of the seven PEX14-binding diaromatic motifs present in the N-terminal half of PEX5 are probably involved in this phenomenon. These results suggest the following: 1) catalase domain(s) involved in the interaction with PEX5 are no longer accessible upon tetramerization of the enzyme; 2) the catalase-binding interface in PEX5 is not restricted to its C-terminal peroxisomal targeting sequence type 1-binding domain and also involves PEX5 N-terminal domain(s); and 3) PEX14 participates in the cargo protein release step.	[Freitas, Marta O.; Francisco, Tania; Rodrigues, Tony A.; Alencastre, Ines S.; Pinto, Manuel P.; Grou, Claudia P.; Carvalho, Andreia F.; Sa-Miranda, Clara; Azevedo, Jorge E.] Univ Porto, Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; [Freitas, Marta O.; Francisco, Tania; Rodrigues, Tony A.; Alencastre, Ines S.; Azevedo, Jorge E.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4009003 Oporto, Portugal; [Fransen, Marc] Katholieke Univ Leuven, Dept Mol Celbiol, B-3000 Louvain, Belgium	Universidade do Porto; Universidade do Porto; KU Leuven	Azevedo, JE (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	sá Miranda, Maria Clara/K-3920-2013; Grou, Claudia P/K-5472-2013; Francisco, Tânia FAG/K-5545-2013; Francisco, Tânia/AAK-9920-2020; Freitas, Marta/J-8699-2013; Carvalho, Andreia/J-9013-2015; Fransen, Marc/ADL-0723-2022; Azevedo, Jorge E/A-4113-2008; Fransen, Marc/C-6262-2008; Pinto, Manuel/K-6425-2013; Rodrigues, Tony A. Q./K-1141-2014	sá Miranda, Maria Clara/0000-0003-0123-5525; Grou, Claudia P/0000-0001-5197-2270; Francisco, Tânia FAG/0000-0003-3571-5164; Francisco, Tânia/0000-0003-3571-5164; Freitas, Marta/0000-0001-5779-2289; Carvalho, Andreia/0000-0001-8781-5680; Azevedo, Jorge E/0000-0001-7714-5302; Fransen, Marc/0000-0001-9284-1197; Pinto, Manuel/0000-0001-9778-2093; Rodrigues, Tony A. Q./0000-0003-2311-8258; Alencastre, Ines/0000-0002-5591-5596	Fundacao para a Ciencia e Tecnologia, Portugal; Fundo Europeu de Desenvolvimento Regional through COMPETE; Programa Operacional Factores de Cornpetitividade, Portugal [PEst-C/SAU/LA0002/2011, PTDC/BIA-BCM/64771/2006]; European Union [LSHGCT-2004-512018]; Fundacao para a Ciencia e Tecnologia; Programa Operacional Potencial Human do OREN; Fund Social Europeu; Programa Ciencia; Programa Operacional Potencial Humane do QREN; Tipologia [4.2]; Promocao do Emprego Cientifico; Fundo Social Europeu; Ministerio da Ciencia, Tecnologia e Ensino Superior	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundo Europeu de Desenvolvimento Regional through COMPETE; Programa Operacional Factores de Cornpetitividade, Portugal; European Union(European Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Human do OREN; Fund Social Europeu; Programa Ciencia(Spanish Government); Programa Operacional Potencial Humane do QREN; Tipologia; Promocao do Emprego Cientifico; Fundo Social Europeu; Ministerio da Ciencia, Tecnologia e Ensino Superior	This work was supported in part by Fundacao para a Ciencia e Tecnologia, Portugal, and Fundo Europeu de Desenvolvimento Regional through COMPETE, Programa Operacional Factores de Cornpetitividade in the context of QREN, Portugal, Grants PEst-C/SAU/LA0002/2011 and PTDC/BIA-BCM/64771/2006, and by the European Union VI Framework Program Grant LSHGCT-2004-512018, Peroxisomes in Health and Disease.; Supported by Fundacao para a Ciencia e Tecnologia, Programa Operacional Potencial Human do OREN, and Fund Social Europeu.; Supported by Programa Ciencia, funded by Programa Operacional Potencial Humane do QREN, Tipologia 4.2, Promocao do Emprego Cientifico, by Fundo Social Europeu and by national funds from Ministerio da Ciencia, Tecnologia e Ensino Superior.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Azevedo JE, 2006, BBA-MOL CELL RES, V1763, P1574, DOI 10.1016/j.bbamcr.2006.09.002; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; BRUL S, 1988, BIOCHEM BIOPH RES CO, V152, P1083, DOI 10.1016/S0006-291X(88)80395-4; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; Faber KN, 2002, BBA-MOL CELL RES, V1591, P157, DOI 10.1016/S0167-4889(02)00274-4; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Ghosh D, 2010, J AM CHEM SOC, V132, P3973, DOI 10.1021/ja9109049; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; Gould SJ, 2002, NAT REV MOL CELL BIO, V3, P382, DOI 10.1038/nrm807; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 1999, ANAL BIOCHEM, V274, P270, DOI 10.1006/abio.1999.4281; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Islinger M, 2009, TRAFFIC, V10, P1711, DOI 10.1111/j.1600-0854.2009.00966.x; Koepke JI, 2007, TRAFFIC, V8, P1590, DOI 10.1111/j.1600-0854.2007.00633.x; KRAGLER F, 1993, J CELL BIOL, V120, P665, DOI 10.1083/jcb.120.3.665; Lanyon-Hogg T, 2010, BIOL CELL, V102, P245, DOI 10.1042/BC20090159; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; LAZAROW PB, 1982, ANN NY ACAD SCI, V386, P285, DOI 10.1111/j.1749-6632.1982.tb21423.x; LAZAROW PB, 1973, J CELL BIOL, V59, P491, DOI 10.1083/jcb.59.2.491; LAZAROW PB, 1973, J CELL BIOL, V59, P507, DOI 10.1083/jcb.59.2.507; Lee MS, 1997, PLANT CELL, V9, P185, DOI 10.1105/tpc.9.2.185; LEIGHTON F, 1969, J CELL BIOL, V41, P521, DOI 10.1083/jcb.41.2.521; LEIGHTON F, 1975, J CELL BIOL, V67, P281, DOI 10.1083/jcb.67.2.281; Leiper JM, 1996, J CELL BIOL, V135, P939, DOI 10.1083/jcb.135.4.939; Leon S, 2006, BBA-MOL CELL RES, V1763, P1552, DOI 10.1016/j.bbamcr.2006.08.037; Luo B, 2008, J MOL BIOL, V380, P31, DOI 10.1016/j.jmb.2008.04.064; Ma C, 2009, MOL BIOL CELL, V20, P3680, DOI 10.1091/mbc.E09-01-0037; Ma C, 2009, IUBMB LIFE, V61, P713, DOI 10.1002/iub.196; Madrid KP, 2004, MOL CELL BIOL, V24, P7331, DOI 10.1128/MCB.24.17.7331-7344.2004; Mate MJ, 1999, J MOL BIOL, V286, P135, DOI 10.1006/jmbi.1998.2453; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; MIDDELKOOP E, 1991, FEBS LETT, V279, P79, DOI 10.1016/0014-5793(91)80255-2; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; MIYAZAWA S, 1987, J BIOL CHEM, V262, P8131; Mullen RT, 1997, PLANT J, V12, P313, DOI 10.1046/j.1365-313X.1997.12020313.x; MURTHY MRN, 1981, J MOL BIOL, V152, P465, DOI 10.1016/0022-2836(81)90254-0; Niederhoff K, 2005, J BIOL CHEM, V280, P35571, DOI 10.1074/jbc.M502460200; Nilsen T, 2004, J BIOL CHEM, V279, P4794, DOI 10.1074/jbc.M309653200; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Oliveira MEM, 2002, BBA-BIOMEMBRANES, V1567, P13, DOI 10.1016/S0005-2736(02)00635-1; Oshima Y, 2008, PLANT CELL PHYSIOL, V49, P671, DOI 10.1093/pcp/pcn038; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Palosaari P. M, 1990, BIOL CHEM, V265, P2446; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Ple S, 2010, J BACTERIOL, V192, P3801, DOI 10.1128/JB.00117-10; POOLE B, 1969, J CELL BIOL, V41, P536, DOI 10.1083/jcb.41.2.536; Purdue PE, 1996, ANN NY ACAD SCI, V804, P775, DOI 10.1111/j.1749-6632.1996.tb18699.x; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Sacksteder KA, 2000, ANNU REV GENET, V34, P623, DOI 10.1146/annurev.genet.34.1.623; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; SCANDALIOS JG, 1965, P NATL ACAD SCI USA, V53, P1035, DOI 10.1073/pnas.53.5.1035; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schluter A, 2006, MOL BIOL EVOL, V23, P838, DOI 10.1093/molbev/msj103; Shiozawa K, 2009, J BIOL CHEM, V284, P25334, DOI 10.1074/jbc.M109.002311; Stanley WA, 2006, BBA-MOL CELL RES, V1763, P1592, DOI 10.1016/j.bbamcr.2006.10.015; Stewart MQ, 2001, J CELL SCI, V114, P2863; SULLIVAN DT, 1985, J BIOL CHEM, V260, P4345; Tanaka N, 2008, STRUCTURE, V16, P388, DOI 10.1016/j.str.2007.12.022; Trelease RN, 1996, EUR J CELL BIOL, V71, P248; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Will GK, 1999, MOL CELL BIOL, V19, P2265; Williams C, 2005, FEBS LETT, V579, P3416, DOI 10.1016/j.febslet.2005.05.011; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Williams C, 2006, BBA-MOL CELL RES, V1763, P1585, DOI 10.1016/j.bbamcr.2006.09.007; Wolf J, 2010, FEBS J, V277, P3268, DOI 10.1111/j.1742-4658.2010.07739.x; Zamocky M, 1999, PROG BIOPHYS MOL BIO, V72, P19, DOI 10.1016/S0079-6107(98)00058-3	88	64	64	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40509	40519		10.1074/jbc.M111.287201	http://dx.doi.org/10.1074/jbc.M111.287201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21976670	hybrid, Green Published			2022-12-25	WOS:000297315400010
J	Jesse, M; Mazzucco, R; Dieckmann, U; Heesterbeek, H; Metz, JAJ				Jesse, Marieke; Mazzucco, Rupert; Dieckmann, Ulf; Heesterbeek, Hans; Metz, Johan A. J.			Invasion and Persistence of Infectious Agents in Fragmented Host Populations	PLOS ONE			English	Article							STRUCTURED POPULATIONS; HABITAT FRAGMENTATION; METAPOPULATION MODELS; DISEASE DYNAMICS; EPIDEMIC SPREAD; MOUTH-DISEASE; WATER VOLE; TRANSMISSION; HOUSEHOLDS; FITNESS	One of the important questions in understanding infectious diseases and their prevention and control is how infectious agents can invade and become endemic in a host population. A ubiquitous feature of natural populations is that they are spatially fragmented, resulting in relatively homogeneous local populations inhabiting patches connected by the migration of hosts. Such fragmented population structures are studied extensively with metapopulation models. Being able to define and calculate an indicator for the success of invasion and persistence of an infectious agent is essential for obtaining general qualitative insights into infection dynamics, for the comparison of prevention and control scenarios, and for quantitative insights into specific systems. For homogeneous populations, the basic reproduction ratio R(0) plays this role. For metapopulations, defining such an 'invasion indicator' is not straightforward. Some indicators have been defined for specific situations, e. g., the household reproduction number R(*). However, these existing indicators often fail to account for host demography and especially host migration. Here we show how to calculate a more broadly applicable indicator R(m) for the invasion and persistence of infectious agents in a host metapopulation of equally connected patches, for a wide range of possible epidemiological models. A strong feature of our method is that it explicitly accounts for host demography and host migration. Using a simple compartmental system as an example, we illustrate how Rm can be calculated and expressed in terms of the key determinants of epidemiological dynamics.	[Jesse, Marieke; Heesterbeek, Hans] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Mazzucco, Rupert; Dieckmann, Ulf; Metz, Johan A. J.] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; [Metz, Johan A. J.] Inst Biol, Leiden, Netherlands; [Metz, Johan A. J.] Math Inst, Leiden, Netherlands	Utrecht University; International Institute for Applied Systems Analysis (IIASA)	Jesse, M (corresponding author), Univ Utrecht, Fac Vet Med, Utrecht, Netherlands.	m.jesse@uu.nl	Dieckmann, Ulf/E-1424-2011	Dieckmann, Ulf/0000-0001-7089-0393; Mazzucco, Rupert/0000-0002-7608-0196; Heesterbeek, Hans/0000-0001-8537-6418	Chair Modelisation Mathematique et biodiversite VEOLIA-Ecole Polytechnique-MNHN-F.X; Netherlands Organisation for Scientific Research (NWO) [918.56.620]; European Commission; European Science Foundation; Austrian Science Fund; Austrian Ministry of Science and Research; Vienna Science and Technology Fund	Chair Modelisation Mathematique et biodiversite VEOLIA-Ecole Polytechnique-MNHN-F.X; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation(European Science Foundation (ESF)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry of Science and Research; Vienna Science and Technology Fund	This research benefited from the support of the Chair Modelisation Mathematique et biodiversite VEOLIA-Ecole Polytechnique-MNHN-F.X to JAJM. The research carried out by MJ and HH is supported by The Netherlands Organisation for Scientific Research (NWO grant 918.56.620). UD gratefully acknowledges financial support by the European Commission, the European Science Foundation, the Austrian Science Fund, the Austrian Ministry of Science and Research, and the Vienna Science and Technology Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball F, 1999, MATH BIOSCI, V156, P41, DOI 10.1016/S0025-5564(98)10060-3; Ball F, 1997, ANN APPL PROBAB, V7, P46; Ball F, 2010, MATH BIOSCI, V224, P53, DOI 10.1016/j.mbs.2009.12.003; BECKER NG, 1995, MATH BIOSCI, V127, P207, DOI 10.1016/0025-5564(94)00055-5; CHESSON PL, 1984, Z WAHRSCHEINLICHKEIT, V66, P97, DOI 10.1007/BF00532798; Coops NC, 2010, FOREST ECOL MANAG, V259, P2355, DOI 10.1016/j.foreco.2010.03.008; Cross PC, 2007, J R SOC INTERFACE, V4, P315, DOI 10.1098/rsif.2006.0185; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis S, 2008, NATURE, V454, P634, DOI 10.1038/nature07053; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Fulford GR, 2002, THEOR POPUL BIOL, V61, P15, DOI 10.1006/tpbi.2001.1553; Gaona P, 1998, ECOL MONOGR, V68, P349, DOI 10.1890/0012-9615(1998)068[0349:DAVOAM]2.0.CO;2; Goldstein E, 2009, MATH BIOSCI, V221, P11, DOI 10.1016/j.mbs.2009.06.002; Gourbiere S, 2002, J THEOR BIOL, V217, P351, DOI 10.1006/jtbi.2002.3033; Grenfell B T, 1995, Stat Methods Med Res, V4, P160, DOI 10.1177/096228029500400205; Gyllenberg M, 2001, J MATH BIOL, V43, P545, DOI 10.1007/s002850100113; Hall IM, 2007, EPIDEMIOL INFECT, V135, P1133, DOI 10.1017/S0950268806007783; Hanski I, 1996, AM NAT, V147, P527, DOI 10.1086/285864; Hanski I., 1999, METAPOPULATION ECOLO; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; House T, 2009, EPIDEMIOL INFECT, V137, P654, DOI 10.1017/S0950268808001416; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kinezaki N, 2010, THEOR POPUL BIOL, V78, P298, DOI 10.1016/j.tpb.2010.09.002; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Laine AL, 2006, J ECOL, V94, P217, DOI 10.1111/j.1365-2745.2005.01075.x; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Le Menach A, 2005, VET RES, V36, P699, DOI 10.1051/vetres:2005025; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Li TA, 2010, LANDSCAPE ECOL, V25, P839, DOI 10.1007/s10980-010-9461-6; Massol F, 2009, THEOR POPUL BIOL, V75, P183, DOI 10.1016/j.tpb.2009.02.005; Metz JAJ, 2001, P ROY SOC B-BIOL SCI, V268, P499, DOI 10.1098/rspb.2000.1373; Olsson GE, 2010, VECTOR-BORNE ZOONOT, V10, P549, DOI 10.1089/vbz.2009.0138; Ostfeld RS, INFECT DIS ECOLOGY E; Parvinen K, 2008, THEOR POPUL BIOL, V73, P517, DOI 10.1016/j.tpb.2008.01.002; Pellis L, 2009, J R SOC INTERFACE, V6, P979, DOI 10.1098/rsif.2008.0493; Phillips BL, 2010, ECOLOGY, V91, P872, DOI 10.1890/09-0530.1; Ross JV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009666; Rushton SP, 2000, J APPL ECOL, V37, P475, DOI 10.1046/j.1365-2664.2000.00504.x; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; Telfer S, 2001, OIKOS, V95, P31, DOI 10.1034/j.1600-0706.2001.950104.x; Volkova VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011185; Weisser WW, 1997, J THEOR BIOL, V189, P413, DOI 10.1006/jtbi.1997.0529	47	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24006	10.1371/journal.pone.0024006	http://dx.doi.org/10.1371/journal.pone.0024006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980339	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000295941300002
J	Town, L; McGlinn, E; Davidson, TL; Browne, CM; Chawengsaksophak, K; Koopman, P; Richman, JM; Wicking, C				Town, Liam; McGlinn, Edwina; Davidson, Tara-Lynne; Browne, Catherine M.; Chawengsaksophak, Kallayanee; Koopman, Peter; Richman, Joy M.; Wicking, Carol			Tmem26 Is Dynamically Expressed during Palate and Limb Development but Is Not Required for Embryonic Survival	PLOS ONE			English	Article							EXHIBIT CLEFT-PALATE; CRANIOFACIAL DEVELOPMENT; VERTEBRATE LIMB; MICE; GENE; GLI3; CHONDROGENESIS; OSTEOGENESIS; TOPOLOGY; SEGMENTS	The Tmem26 gene encodes a novel protein that we have previously shown to be regulated by hedgehog signalling in the mouse limb. We now report that Tmem26 expression is spatially and temporally restricted in other regions of the mouse embryo, most notably the facial primordia. In particular, Tmem26 expression in the mesenchyme of the maxillary and nasal prominences is coincident with fusion of the primary palate. In the secondary palate, Tmem26 is expressed in the palatal shelves during their growth and fusion but is downregualted once fusion is complete. Expression was also detected at the midline of the expanding mandible and at the tips of the eyelids as they migrate across the cornea. Given the spatio-temporally restricted expression of Tmen26, we sought to uncover a functional role in embryonic development through targeted gene inactivation in the mouse. However, ubiquitous inactivation of Tmem26 led to no overt phenotype in the resulting embryos or adult mice, suggesting that TMEM26 function is dispensable for embryonic survival.	[Town, Liam; McGlinn, Edwina; Davidson, Tara-Lynne; Browne, Catherine M.; Chawengsaksophak, Kallayanee; Koopman, Peter; Wicking, Carol] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Richman, Joy M.] Univ British Columbia, Inst Life Sci, Dept Oral Hlth Sci, Vancouver, BC V5Z 1M9, Canada	University of Queensland; University of British Columbia	Town, L (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	c.wicking@imb.uq.edu.au	Richman, Joy M./C-3111-2018; Richman, Joy/AAD-9445-2020; Koopman, Peter A/C-9416-2009; Chawengsaksophak, Kallayanee/G-4427-2014; Wicking, Carol/J-1814-2014	Richman, Joy M./0000-0002-1409-8163; Richman, Joy/0000-0002-1409-8163; Koopman, Peter A/0000-0001-6939-0914; Chawengsaksophak, Kallayanee/0000-0001-9401-2122; Wicking, Carol/0000-0002-7225-3803; McGlinn, Edwina/0000-0002-1829-986X	Australian National Health and Medical Research Council (NHMRC) [401683]; Australian Postgraduate Award; Killam Research Fellowship; IMB	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Killam Research Fellowship; IMB	This work was supported by an Australian National Health and Medical Research Council (NHMRC) project grant (#401683). CW is an NHMRC Senior Research Fellow. EM was the recipient of an Australian Postgraduate Award, and LT was a recipient of an NHMRC Dora Lush Postgraduate Research Scholarship. JR was funded by a Killam Research Fellowship and an IMB visitor award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bancroft JD, 1990, THEORY PRACTICE HIST, Vxiv, P726; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Dixon J, 2004, DEV DYNAM, V229, P907, DOI 10.1002/dvdy.20004; Fowles LF, 2003, GENESIS, V35, P73, DOI 10.1002/gene.10165; Hogan B, 1994, MANIPULATING MOUSE E; Huang X, 2008, DEV DYNAM, V237, P3079, DOI 10.1002/dvdy.21714; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; JONES MC, 1988, CLEFT PALATE J, V25, P16; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Pauws E, 2009, HUM MOL GENET, V18, P4171, DOI 10.1093/hmg/ddp368; Rachman H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000029; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sambrook J, 2001, MOL CLONING LAB MANU; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Schutte BC, 1999, HUM MOL GENET, V8, P1853, DOI 10.1093/hmg/8.10.1853; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411	28	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25228	10.1371/journal.pone.0025228	http://dx.doi.org/10.1371/journal.pone.0025228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980401	gold, Green Published, Green Submitted			2022-12-25	WOS:000295939600016
J	Sigoillot, FD; Huckins, JF; Li, FH; Zhou, XB; Wong, STC; King, RW				Sigoillot, Frederic D.; Huckins, Jeremy F.; Li, Fuhai; Zhou, Xiaobo; Wong, Stephen T. C.; King, Randall W.			A Time-Series Method for Automated Measurement of Changes in Mitotic and Interphase Duration from Time-Lapse Movies	PLOS ONE			English	Article							MAMMALIAN-CELLS; FLUORESCENCE MICROSCOPY; PHASE IDENTIFICATION; ANTIMITOTIC DRUGS; DNA-DAMAGE; SEGMENTATION; CLASSIFICATION; DYNAMICS; SYSTEM	Background: Automated time-lapse microscopy can visualize proliferation of large numbers of individual cells, enabling accurate measurement of the frequency of cell division and the duration of interphase and mitosis. However, extraction of quantitative information by manual inspection of time-lapse movies is too time-consuming to be useful for analysis of large experiments. Methodology/Principal Findings: Here we present an automated time-series approach that can measure changes in the duration of mitosis and interphase in individual cells expressing fluorescent histone 2B. The approach requires analysis of only 2 features, nuclear area and average intensity. Compared to supervised learning approaches, this method reduces processing time and does not require generation of training data sets. We demonstrate that this method is as sensitive as manual analysis in identifying small changes in interphase or mitotic duration induced by drug or siRNA treatment. Conclusions/Significance: This approach should facilitate automated analysis of high-throughput time-lapse data sets to identify small molecules or gene products that influence timing of cell division.	[Sigoillot, Frederic D.; Huckins, Jeremy F.; King, Randall W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Li, Fuhai; Wong, Stephen T. C.] Weill Cornell Med Coll, Methodist Hosp, Res Inst, Dept Syst Med & Bioengn, Houston, TX USA; [Zhou, Xiaobo] Weill Cornell Med Coll, Methodist Hosp, Res Inst, Dept Translat Imaging, Houston, TX USA	Harvard University; Harvard Medical School; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Sigoillot, FD (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	randy_king@hms.harvard.edu	Huckins, Jeremy/AAI-7446-2020	Huckins, Jeremy/0000-0003-0106-7808; Sigoillot, Frederic/0000-0002-8695-4838	NIH [GM66492]; Lynch Foundation; National Library of Medicine [R01LM008696]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066492, R01GM066492] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM008696] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lynch Foundation; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants GM66492 from the NIH http://www.nih.gov/ and the Lynch Foundation http://www.thelynchfoundation.org/ to R.W.K. and a grant from National Library of Medicine http://www.nlm.nih.gov/ to S.W. (R01LM008696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XW, 2006, IEEE T BIO-MED ENG, V53, P762, DOI 10.1109/TBME.2006.870201; Davis PJ, 2007, J MICROSC-OXFORD, V228, P296, DOI 10.1111/j.1365-2818.2007.01847.x; Debeir O, 2008, EXP CELL RES, V314, P2985, DOI 10.1016/j.yexcr.2008.06.010; DEWITH A, 1995, J PHOTOCH PHOTOBIO B, V30, P71, DOI 10.1016/1011-1344(95)07151-Q; Dixit R, 2003, PLANT J, V36, P280, DOI 10.1046/j.1365-313X.2003.01868.x; Gambe AE, 2007, CYTOM PART A, V71A, P286, DOI 10.1002/cyto.a.20378; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Godley BF, 2005, J BIOL CHEM, V280, P21061, DOI 10.1074/jbc.M502194200; GUPTA RS, 1985, JNCI-J NATL CANCER I, V74, P159; Harder N, 2008, METHOD CELL BIOL, V85, P539, DOI 10.1016/S0091-679X(08)85023-6; Harder N, 2009, GENOME RES, V19, P2113, DOI 10.1101/gr.092494.109; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Jones JT, 2004, NAT BIOTECHNOL, V22, P306, DOI 10.1038/nbt941; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105; Li F, 2010, IEEE T MED IMAGING; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Nath SK, 2006, LECT NOTES COMPUT SC, V4190, P101; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Vogel C, 2007, CANCER RES, V67, P339, DOI 10.1158/0008-5472.CAN-06-2548; Wang M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-32; Wang M, 2008, BIOINFORMATICS, V24, P94, DOI 10.1093/bioinformatics/btm530; Yan PK, 2008, IEEE T INF TECHNOL B, V12, P109, DOI 10.1109/TITB.2007.898006	26	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25511	10.1371/journal.pone.0025511	http://dx.doi.org/10.1371/journal.pone.0025511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966537	gold, Green Published, Green Submitted			2022-12-25	WOS:000295932100045
J	Hayman, DTS; Wang, LF; Barr, J; Baker, KS; Suu-Ire, R; Broder, CC; Cunningham, AA; Wood, JLN				Hayman, David T. S.; Wang, Lin-Fa; Barr, Jennifer; Baker, Kate S.; Suu-Ire, Richard; Broder, Christopher C.; Cunningham, Andrew A.; Wood, James L. N.			Antibodies to Henipavirus or Henipa-Like Viruses in Domestic Pigs in Ghana, West Africa	PLOS ONE			English	Article							NIPAH-VIRUS; FRUIT BATS; HENDRA VIRUS; MORBILLIVIRUS; TRANSMISSION; ENCEPHALITIS; INFECTION; HORSES; CATS	Henipaviruses, Hendra virus (HeV) and Nipah virus (NiV), have Pteropid bats as their known natural reservoirs. Antibodies against henipaviruses have been found in Eidolon helvum, an old world fruit bat species, and henipavirus-like nucleic acid has been detected in faecal samples from E. helvum in Ghana. The initial outbreak of NiV in Malaysia led to over 265 human encephalitis cases, including 105 deaths, with infected pigs acting as amplifier hosts for NiV during the outbreak. We detected non-neutralizing antibodies against viruses of the genus Henipavirus in approximately 5% of pig sera (N = 97) tested in Ghana, but not in a small sample of other domestic species sampled under a E. helvum roost. Although we did not detect neutralizing antibody, our results suggest prior exposure of the Ghana pig population to henipavirus(es). Because a wide diversity of henipavirus-like nucleic acid sequences have been found in Ghanaian E. helvum, we hypothesise that these pigs might have been infected by henipavirus(es) sufficiently divergent enough from HeVor NiV to produce cross-reactive, but not cross-neutralizing antibodies to HeV or NiV.	[Hayman, David T. S.; Baker, Kate S.; Wood, James L. N.] Univ Cambridge, Cambridge Infect Dis Consortium, Cambridge, England; [Hayman, David T. S.; Baker, Kate S.; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Hayman, David T. S.] Anim Hlth & Vet Labs Agcy, Weybridge, Surrey, England; [Hayman, David T. S.] Colorado State Univ, Ft Collins, CO 80523 USA; [Wang, Lin-Fa; Barr, Jennifer] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Suu-Ire, Richard] Ghana Forestry Commiss, Wildlife Div, Accra, Ghana; [Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	University of Cambridge; Zoological Society of London; Veterinary Laboratories Agency; Colorado State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Uniformed Services University of the Health Sciences - USA	Hayman, DTS (corresponding author), Univ Cambridge, Cambridge Infect Dis Consortium, Cambridge, England.	dtsh2@cam.ac.uk	Barr, Jennifer A/H-9254-2013; wang, lin/GSE-3040-2022; Baker, Kate/P-2087-2016; Wood, James/A-1626-2008; Cunningham, Andrew A/E-7536-2010; Broder, Christopher/E-1169-2013	Baker, Kate/0000-0001-5850-1949; Wood, James/0000-0002-0258-3188; Wang, Lin-Fa/0000-0003-2752-0535; Hayman, David/0000-0003-0087-3015; Barr, Jennifer/0000-0001-5266-9142	Wellcome Trust [VT0105]; Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health (NIH); NIH [AI077995]; MRC [G0902430] Funding Source: UKRI; Medical Research Council [G0902430] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077995] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the The Wellcome Trust (to DTSH, KSB), Defra grant VT0105, the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and Fogarty International Center, National Institutes of Health (NIH), and NIH grant AI077995. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chen JM, 2006, J VIROL METHODS, V136, P273, DOI 10.1016/j.jviromet.2006.05.003; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hayman DTS, 2008, EMERG INFECT DIS, V14, P926, DOI 10.3201/eid1406.071421; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Li Y, 2008, EMERG INFECT DIS, V14, P1974, DOI 10.3201/eid1412.080359; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Middleton DJ, 2002, J COMP PATHOL, V126, P124, DOI 10.1053/jcpa.2001.0532; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; PULLIAM JR, 2011, J R SOC INT IN PRESS; Tamungang SA, 2008, AFR J ECOL, V46, P230, DOI 10.1111/j.1365-2028.2007.00825.x; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; PROMED PRO AH EDR HE	19	54	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25256	10.1371/journal.pone.0025256	http://dx.doi.org/10.1371/journal.pone.0025256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966471	gold, Green Submitted, Green Published			2022-12-25	WOS:000295265100076
J	Savinova, OV; Liu, YH; Aasen, GA; Mao, K; Weltman, NY; Nedich, BL; Liang, QR; Gerdes, AM				Savinova, Olga V.; Liu, Yingheng; Aasen, Garth A.; Mao, Kai; Weltman, Nathan Y.; Nedich, Brett L.; Liang, Qiangrong; Gerdes, A. Martin			Thyroid Hormone Promotes Remodeling of Coronary Resistance Vessels	PLOS ONE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; FIBROBLAST-GROWTH-FACTOR; MYOCARDIAL BLOOD-FLOW; HEART-FAILURE; ARTERIOLAR GROWTH; CARDIAC-FUNCTION; TIE2 RECEPTOR; CELL-SURFACE; ANGIOGENESIS; ANGIOPOIETIN-1	Low thyroid hormone (TH) function has been linked to impaired coronary blood flow, reduced density of small arterioles, and heart failure. Nonetheless, little is known about the mechanisms by which THs regulate coronary microvascular remodeling. The current study examined the initial cellular events associated with coronary remodeling induced by triiodothyronine (T3) in hypothyroid rats. Rats with established hypothyroidism, eight weeks after surgical thyroidectomy (TX), were treated with T3 for 36 or 72 hours. The early effects of T3 treatment on coronary microvasculature were examined morphometrically. Gene expression changes in the heart were assessed by quantitative PCR Array. Hypothyroidism resulted in arteriolar atrophy in the left ventricle. T3 treatment rapidly induced small arteriolar muscularization and, within 72 hours, restored arteriolar density to control levels. Total length of the capillary network was not affected by TX or T3 treatment. T3 treatment resulted in the coordinate regulation of Angiopoietin 1 and 2 expression. The response of Angiopoietins was consistent with vessel enlargement. In addition to the well known effects of THs on vasoreactivity, these results suggest that THs may affect function of small resistance arteries by phenotypic remodeling of vascular smooth muscle cells (VSMC).	[Savinova, Olga V.; Liu, Yingheng; Aasen, Garth A.; Mao, Kai; Weltman, Nathan Y.; Nedich, Brett L.; Liang, Qiangrong; Gerdes, A. Martin] Sanford Res Univ S Dakota, Cardiovasc Hlth Res Ctr, Sioux Falls, SD USA	Sanford Health	Savinova, OV (corresponding author), Sanford Res Univ S Dakota, Cardiovasc Hlth Res Ctr, Sioux Falls, SD USA.	agerdes@nyit.edu			National Center for Research Resources (NCRR) [P20RR017662-06A1, RO1 HL093160-01A1]; National Institutes of Health (NIH); NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017662] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093160] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Center for Research Resources (NCRR) Grant P20RR017662-06A1 and RO1 HL093160-01A1 (A. M. G.) from the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR TH, 1994, AM J PHYSIOL, V266, pH1434; Asvold BO, 2008, ARCH INTERN MED, V168, P855, DOI 10.1001/archinte.168.8.855; Asvold BO, 2007, EUR J ENDOCRINOL, V156, P181, DOI 10.1530/eje.1.02333; Davis FB, 2004, CIRC RES, V94, P1500, DOI 10.1161/01.RES.0000130784.90237.4a; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DEESCOBAR GM, 1994, ENDOCRINOLOGY, V134, P2410; Gerdes AM, 2010, CIRCULATION, V122, P385, DOI 10.1161/CIRCULATIONAHA.109.917922; Henderson KK, 2009, CIRC-HEART FAIL, V2, P243, DOI 10.1161/CIRCHEARTFAILURE.108.810747; HERON MI, 1995, J MOL CELL CARDIOL, V27, P1393, DOI 10.1006/jmcc.1995.0132; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Khalife WI, 2005, AM J PHYSIOL-HEART C, V289, pH2409, DOI 10.1152/ajpheart.00483.2005; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Lei L, 2004, CIRCULATION, V110, P796, DOI 10.1161/01.CIR.0000138933.85923.36; LIU Y, 2009, AM J PHYSL HEART CIR; Liu YH, 2008, AM J PHYSIOL-HEART C, V294, pH2137, DOI 10.1152/ajpheart.01379.2007; Liu YH, 2010, VASC PHARMACOL, V52, P146, DOI 10.1016/j.vph.2009.10.003; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mousa SA, 2006, ENDOCRINOLOGY, V147, P1602, DOI 10.1210/en.2005-1390; Neglia D, 2002, CIRCULATION, V105, P186, DOI 10.1161/hc0202.102119; Pantos C, 2008, BASIC RES CARDIOL, V103, P308, DOI 10.1007/s00395-008-0697-0; PRICE RJ, 1994, CIRC RES, V75, P520, DOI 10.1161/01.RES.75.3.520; Roura S, 2009, NAT REV CARDIOL, V6, P590, DOI 10.1038/nrcardio.2009.130; Shyu KG, 1998, CIRCULATION, V98, P2081, DOI 10.1161/01.CIR.98.19.2081; Stolen KQ, 2004, AM J CARDIOL, V93, P64, DOI 10.1016/j.amjcard.2003.08.074; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tang YD, 2005, CIRCULATION, V112, P3122, DOI 10.1161/CIRCULATIONAHA.105.572883; Thomas TA, 2005, AM J PHYSIOL-HEART C, V288, pH2118, DOI 10.1152/ajpheart.01000.2004; Thurston G, 2005, DEVELOPMENT, V132, P3317, DOI 10.1242/dev.01888; Tomanek RJ, 1998, CIRC RES, V82, P587, DOI 10.1161/01.RES.82.5.587; Tomanek RJ, 1998, J MOL CELL CARDIOL, V30, P923, DOI 10.1006/jmcc.1998.0671; Tomanek RJ, 1998, ANAT RECORD, V251, P44; VANGRONINGEN JP, 1991, ANAT EMBRYOL, V184, P65; Wang XG, 2003, AM J PHYSIOL-HEART C, V284, pH613, DOI 10.1152/ajpheart.00449.2002; Zheng W, 2004, AM J PHYSIOL-HEART C, V286, pH1994, DOI 10.1152/ajpheart.00991.2003	34	36	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25054	10.1371/journal.pone.0025054	http://dx.doi.org/10.1371/journal.pone.0025054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966411	Green Submitted, gold, Green Published			2022-12-25	WOS:000295265100045
J	Ding, H; Yan, CZ; Shi, HL; Zhao, YS; Chang, SY; Yu, P; Wu, WS; Zhao, CY; Chang, YZ; Duan, XL				Ding, Hui; Yan, Cai-Zhen; Shi, Honglian; Zhao, Ya-Shuo; Chang, Shi-Yang; Yu, Peng; Wu, Wen-Shuang; Zhao, Chen-Yang; Chang, Yan-Zhong; Duan, Xiang-Lin			Hepcidin Is Involved in Iron Regulation in the Ischemic Brain	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PEPTIDE HEPCIDIN; EXPRESSION; PROTEIN; FERROPORTIN; PROTECTION; BINDING; INJURY; INFLAMMATION; METABOLISM	Oxidative stress plays an important role in neuronal injuries caused by cerebral ischemia. It is well established that free iron increases significantly during ischemia and is responsible for oxidative damage in the brain. However, the mechanism of this ischemia-induced increase in iron is not completely understood. In this report, the middle cerebral artery occlusion (MCAO) rat model was performed and the mechanism of iron accumulation in cerebral ischemia-reperfusion was studied. The expression of L-ferritin was significantly increased in the cerebral cortex, hippocampus, and striatum on the ischemic side, whereas H-ferritin was reduced in the striatum and increased in the cerebral cortex and hippocampus. The expression level of the iron-export protein ferroportin1 (FPN1) significantly decreased, while the expression of transferrin receptor 1 (TfR1) was increased. In order to elucidate the mechanisms of FPN1 regulation, we studied the expression of the key regulator of FPN1, hepcidin. We observed that the hepcidin level was significantly elevated in the ischemic side of the brain. Knockdown hepcidin repressed the increasing of L-ferritin and decreasing of FPN1 invoked by ischemia-reperfusion. The results indicate that hepcidin is an important contributor to iron overload in cerebral ischemia. Furthermore, our results demonstrated that the levels of hypoxia-inducible factor-1 alpha (HIF-1 alpha) were significantly higher in the cerebral cortex, hippocampus and striatum on the ischemic side; therefore, the HIF-1 alpha-mediated TfR1 expression may be another contributor to the iron overload in the ischemia-reperfusion brain.	[Ding, Hui; Yan, Cai-Zhen; Zhao, Ya-Shuo; Chang, Shi-Yang; Yu, Peng; Wu, Wen-Shuang; Zhao, Chen-Yang; Chang, Yan-Zhong; Duan, Xiang-Lin] Hebei Normal Univ, Lab Mol Iron Metab, Coll Life Sci, Shijiazhuang, Peoples R China; [Yan, Cai-Zhen] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China; [Shi, Honglian] Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA	Hebei Normal University; Hebei Medical University; University of Kansas	Ding, H (corresponding author), Hebei Normal Univ, Lab Mol Iron Metab, Coll Life Sci, Shijiazhuang, Peoples R China.	frankyzchang@yahoo.com.hk; xlduan0311@163.com	Chang, Yan-Zhong/AAB-5676-2020; YU, Peng/GRJ-4129-2022	Chang, Yan-Zhong/0000-0002-6386-9649; Zhao, Yashuo/0000-0002-5793-5574	National Natural Science Foundation of China [30930036, 10979025, 30871260]; Natural Science Foundation for Distinguished Young Scholar of Hebei Province [C2010002032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Distinguished Young Scholar of Hebei Province	Contract grant sponsor: National Natural Science Foundation of China; Contract grant number: 30930036, 10979025, 30871260. Contract grant sponsor: Natural Science Foundation for Distinguished Young Scholar of Hebei Province; Contract grant number: C2010002032. The funders had no role in study design, data collection and anslysis, decision to publish, ro preparation of the manuscript.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Aki HS, 2009, BRAIN RES, V1292, P180, DOI 10.1016/j.brainres.2009.07.054; Amantea D, 2010, BRAIN RES, V1313, P259, DOI 10.1016/j.brainres.2009.12.017; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Chang YZ, 2005, J CELL PHYSIOL, V204, P623, DOI 10.1002/jcp.20321; Chen YM, 2005, NEUROCHEM INT, V47, P507, DOI 10.1016/j.neuint.2005.06.004; Chevion M, 2008, J MOL CELL CARDIOL, V45, P839, DOI 10.1016/j.yjmcc.2008.08.011; Chi SI, 2000, NEUROSCIENCE, V100, P475, DOI 10.1016/S0306-4522(00)00317-1; Darshan D, 2009, BIOMETALS, V22, P77, DOI 10.1007/s10534-008-9187-y; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; De Domenico I, 2009, P NATL ACAD SCI USA, V106, P3800, DOI 10.1073/pnas.0900453106; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Du F, 2011, GLIA, V59, P936, DOI 10.1002/glia.21166; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Hamrick SEG, 2005, NEUROSCI LETT, V379, P96, DOI 10.1016/j.neulet.2004.12.080; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; Jia J, 2009, LIFE SCI, V84, P505, DOI 10.1016/j.lfs.2009.01.015; Ke Y, 2007, PROG NEUROBIOL, V83, P149, DOI 10.1016/j.pneurobio.2007.07.009; Li L, 2009, J CLIN NEUROSCI, V16, P1466, DOI 10.1016/j.jocn.2009.01.020; Lipscomb DC, 1998, STROKE, V29, P487, DOI 10.1161/01.STR.29.2.487; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MABJEESH NJ, 2003, CANCER CELL, V3, P13; Mao YY, 2010, J CEREBR BLOOD F MET, V30, P1044, DOI 10.1038/jcbfm.2009.283; MAO Z, 2005, J ZHEJIANG U SCI, V7; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Mu DZ, 2005, EXP NEUROL, V195, P407, DOI 10.1016/j.expneurol.2005.06.001; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Namura S, 1998, J NEUROSCI, V18, P3659; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Obolensky A, 2008, FREE RADICAL BIO MED, V44, P1286, DOI 10.1016/j.freeradbiomed.2007.10.060; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peeters-Scholte C, 2002, STROKE, V33, P2304, DOI 10.1161/01.STR.0000028343.25901.09; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Qian ZM, 1998, BRAIN RES REV, V27, P257, DOI 10.1016/S0165-0173(98)00012-5; Qian ZM, 2001, TRENDS MOL MED, V7, P103, DOI 10.1016/S1471-4914(00)01910-9; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Shi HL, 2007, FRONT BIOSCI-LANDMRK, V12, P1318, DOI 10.2741/2150; SOROND FA, 2000, ANTIOXIDANTS REDOX S, V2, P16; Tacchini L, 2008, J BIOL CHEM, V283, P20674, DOI 10.1074/jbc.M800365200; TANG WH, 2008, FREE RADICAL BIO MED, V45, P9; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Viatte L, 2005, BLOOD, V105, P4861, DOI 10.1182/blood-2004-12-4608; Wang SM, 2010, CELL MOL LIFE SCI, V67, P123, DOI 10.1007/s00018-009-0167-3; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yang L, 2011, CELL PHYSIOL BIOCHEM, V27, P23, DOI 10.1159/000325202; Zhang AS, 2009, J BIOL CHEM, V284, P711, DOI 10.1074/jbc.R800017200	50	93	103	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25324	10.1371/journal.pone.0025324	http://dx.doi.org/10.1371/journal.pone.0025324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957487	gold, Green Published, Green Submitted			2022-12-25	WOS:000295262100047
J	Few, AP; Nanou, E; Scheuer, T; Catterall, WA				Few, Alexandra P.; Nanou, Evanthia; Scheuer, Todd; Catterall, William A.			Molecular Determinants of Ca(v)2.1 Channel Regulation by Calcium-binding Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERM SYNAPTIC PLASTICITY; VISININ-LIKE PROTEIN-2; CA2+ CHANNELS; CA2+-BINDING PROTEINS; P/Q; CALMODULIN; FACILITATION; INACTIVATION; DEPRESSION; MODULATION	Presynaptic Ca(v)2.1 channels, which conduct P/Q-type Ca2+ currents, initiate synaptic transmission at most synapses in the central nervous system. Regulation of Ca(v)2.1 channels by CaM contributes significantly to short term facilitation and rapid depression of synaptic transmission. Short term synaptic plasticity is diverse in form and function at different synapses, yet CaMis ubiquitously expressed. Differential regulation of Ca(v)2.1 channels by CaM-like Ca2+ sensor (CaS) proteins differentially affects short term synaptic facilitation and rapid synaptic depression in transfected sympathetic neuron synapses. Here, we define the molecular determinants for differential regulation of Ca(v)2.1 channels by the CaS protein calcium-binding protein- 1 (CaBP1) by analysis of chimeras in which the unique structural domains of CaBP1 are inserted into CaM. Our results show that the N-terminal domain, including its myristoylation site, and the second EF-hand, which is inactive in Ca2+ binding, are the key molecular determinants of differential regulation of Ca(v)2.1 channels by CaBP1. These findings give insight into the molecular code by which CaS proteins differentially regulate Ca(v)2.1 channel function and provide diversity of form and function of short term synaptic plasticity.	[Few, Alexandra P.; Nanou, Evanthia; Scheuer, Todd; Catterall, William A.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@uw.edu			National Institutes of Health [R01 NS22625, F31 MH078345]; Swedish Research Council [524-2010-913]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH078345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS22625 (to W. A. C.) and Predoctoral Fellowship F31 MH078345 (to A. P. F.). This work was also supported by Swedish Research Council Postdoctoral Fellowship 524-2010-913 (to E. N.).	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Haeseleer F, 2002, ADV EXP MED BIOL, V514, P303; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Inchauspe CG, 2004, J NEUROSCI, V24, P10379, DOI 10.1523/JNEUROSCI.2104-04.2004; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu JH, 2007, CURR OPIN NEUROBIOL, V17, P352, DOI 10.1016/j.conb.2007.04.005; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	24	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41917	41923		10.1074/jbc.M111.292417	http://dx.doi.org/10.1074/jbc.M111.292417			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965686	hybrid, Green Published			2022-12-25	WOS:000298180900003
J	Finlay-Schultz, J; Canastar, A; Short, M; El Gazzar, M; Coughlan, C; Leonard, S				Finlay-Schultz, Jessica; Canastar, Andrew; Short, Margaret; El Gazzar, Mohamed; Coughlan, Christina; Leonard, Sherry			Transcriptional Repression of the alpha 7 Nicotinic Acetylcholine Receptor Subunit Gene (CHRNA7) by Activating Protein-2 alpha (AP-2 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; FACTOR AP-2; DNA-BINDING; FUNCTIONAL-CHARACTERIZATION; LINKAGE ANALYSIS; CARCINOMA-CELLS; FRONTAL-CORTEX; RETINOIC ACID; FACTOR EGR-1; SCHIZOPHRENIA	The CHRNA7 gene, which encodes the alpha 7 nicotinic acetylcholine receptor (alpha 7*nAChR), has been implicated as a candidate gene in schizophrenia. Expression of the alpha 7*nAChR mRNA and protein are reduced in multiple regions of post-mortem brain from patients diagnosed with schizophrenia. Transcriptional regulation may therefore be an important mechanism for the regulation of this gene. A 230-bp proximal promoter fragment, necessary for transcription in cultured neuroblastoma cells, was used to study a putative AP-2 alpha binding site. Mutation of the site indicates that AP-2 alpha plays a negative role in regulating CHRNA7 transcription. This was confirmed through knockdown and overexpression of AP-2 alpha. Electrophoretic mobility shift assays (EMSAs) identified positive DNA-protein interaction at this same site, and supershift assays indicate that the complex includes AP-2 alpha. The interaction was confirmed in cells using chromatin immunoprecipitation (ChIP). DNA methylation was discovered as an anomalous mechanism for CHRNA7 regulation in one cell line. These studies suggest a role for AP-2 alpha regulation of CHRNA7 mRNA expression in multiple tissues during development.	[Finlay-Schultz, Jessica; Canastar, Andrew; El Gazzar, Mohamed; Leonard, Sherry] Univ Colorado Denver, Dept Psychiat, Aurora, CO 80045 USA; [Finlay-Schultz, Jessica] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Leonard, Sherry] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Coughlan, Christina] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Short, Margaret; Leonard, Sherry] Denver Vet Affairs Med Ctr, Denver, CO 80220 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Leonard, S (corresponding author), Univ Colorado Denver, Dept Psychiat, Mail Stop 8344,POB 6511,Anschutz Med Campus, Aurora, CO 80045 USA.	Sherry.Leonard@ucdenver.edu		Finlay-Schultz, Jessica/0000-0002-7855-9870	National Institutes of Health [DA009457, MH081177]; Veterans Affairs Medical Research Service Merit Review; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Medical Research Service Merit Review; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA009457 and MH081177 and a Veterans Affairs Medical Research Service Merit Review (to S. L.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Baskin F, 1997, NEUROSCIENCE, V76, P821; Bazinet RP, 2005, PSYCHOPHARMACOLOGY, V182, P180, DOI 10.1007/s00213-005-0059-7; BIEDLER JL, 1978, CANCER RES, V38, P3751; BOSHER JM, 1995, P NATL ACAD SCI USA, V92, P744, DOI 10.1073/pnas.92.3.744; Carrasco-Serrano C, 1998, J BIOL CHEM, V273, P20021, DOI 10.1074/jbc.273.32.20021; Carrasco-Serrano C, 2000, J NEUROCHEM, V74, P932, DOI 10.1046/j.1471-4159.2000.0740932.x; Cheng C, 2002, INT J BIOCHEM CELL B, V34, P78, DOI 10.1016/S1357-2725(01)00098-X; Citrome L, 2009, J CLIN PSYCHIAT, V70, P932, DOI 10.4088/JCP.09ac05289; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; Court J, 1999, J NEUROCHEM, V73, P1590, DOI 10.1046/j.1471-4159.1999.0731590.x; Criado M, 1997, J NEUROSCI, V17, P6554; DAVIES AF, 1995, HUM MOL GENET, V4, P121; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Fornasari D, 1997, MOL PHARMACOL, V51, P250, DOI 10.1124/mol.51.2.250; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Fu XW, 2009, AM J RESP CELL MOL, V41, P93, DOI 10.1165/rcmb.2008-0352OC; Garcia MA, 2000, J MOL BIOL, V301, P807, DOI 10.1006/jmbi.2000.4019; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; GERZANICH V, 1994, MOL PHARMACOL, V45, P212; GETMAN DK, 1995, J BIOL CHEM, V270, P23511, DOI 10.1074/jbc.270.40.23511; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HERMANN R, 1991, FEBS LETT, V281, P191, DOI 10.1016/0014-5793(91)80391-F; Houy E, 2004, MOL PSYCHIATR, V9, P320, DOI 10.1038/sj.mp.4001443; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.0.CO;2-W; Kawanishi Y, 2000, J HUM GENET, V45, P24, DOI 10.1007/s100380050005; Kumari V, 2005, NEUROSCI BIOBEHAV R, V29, P1021, DOI 10.1016/j.neubiorev.2005.02.006; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Leonard S, 2001, Nicotine Tob Res, V3, P203; Leonard S, 2001, PHARMACOL BIOCHEM BE, V70, P561, DOI 10.1016/S0091-3057(01)00677-3; Leonard Sherry, 2007, J Dual Diagn, V3, P43, DOI 10.1300/J374v03n03_05; Liu CM, 2001, AM J MED GENET, V105, P658, DOI 10.1002/ajmg.1547; LUSCHER B, 1989, GENE DEV, V3, P1507, DOI 10.1101/gad.3.10.1507; Marutle A, 2001, J CHEM NEUROANAT, V22, P115, DOI 10.1016/S0891-0618(01)00117-X; Mexal S, 2010, J MOL NEUROSCI, V40, P185, DOI 10.1007/s12031-009-9233-4; Mitchell DL, 2010, EXP CELL RES, V316, P194, DOI 10.1016/j.yexcr.2009.08.008; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Mohibullah N, 1999, NUCLEIC ACIDS RES, V27, P2760, DOI 10.1093/nar/27.13.2760; MOSER M, 1995, DEVELOPMENT, V121, P2779; Nagavarapu U, 2001, J BIOL CHEM, V276, P16749, DOI 10.1074/jbc.M009712200; Olavesen MG, 1997, GENOMICS, V46, P303, DOI 10.1006/geno.1997.5032; OuladAbdelghani M, 1996, EXP CELL RES, V225, P338, DOI 10.1006/excr.1996.0184; Pfisterer P, 2002, J BIOL CHEM, V277, P6637, DOI 10.1074/jbc.M108578200; Rao Jagadeesh S, 2009, Curr Mol Pharmacol, V2, P207; Rao JS, 2005, NEUROPSYCHOPHARMACOL, V30, P2006, DOI 10.1038/sj.npp.1300740; Reynolds PR, 2005, J BIOL CHEM, V280, P32548, DOI 10.1074/jbc.M502231200; Schulte JH, 2008, CANCER LETT, V271, P56, DOI 10.1016/j.canlet.2008.05.039; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Sharma G, 2008, CURR MED CHEM, V15, P2921, DOI 10.2174/092986708786848703; Shinawi M, 2009, NAT GENET, V41, P1269, DOI 10.1038/ng.481; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; Stober G, 2000, AM J HUM GENET, V67, P1201, DOI 10.1086/321183; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Sun XJ, 2009, CANCER RES, V69, P6445, DOI 10.1158/0008-5472.CAN-09-1001; Terzano S, 2000, J BIOL CHEM, V275, P41495, DOI 10.1074/jbc.M006197200; Tregellas JR, 2011, BIOL PSYCHIAT, V69, P7, DOI 10.1016/j.biopsych.2010.07.004; Tsuang DW, 2001, AM J MED GENET, V105, P662, DOI 10.1002/ajmg.1550.abs; Wankhade S, 2000, J BIOL CHEM, V275, P29701, DOI 10.1074/jbc.M000931200; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xu JZ, 2001, AM J MED GENET, V105, P669, DOI 10.1002/ajmg.1549; YANG XD, 1995, J BIOL CHEM, V270, P8514, DOI 10.1074/jbc.270.15.8514; Zhao F, 2001, J BIOL CHEM, V276, P40755, DOI 10.1074/jbc.M106284200; Zheng Y, 2007, AM J RESP CELL MOL, V37, P681, DOI 10.1165/rcmb.2007-0051OC; Zink M, 2010, CURR OPIN PSYCHIATR, V23, P103, DOI 10.1097/YCO.0b013e3283366427	75	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42123	42132		10.1074/jbc.M111.276014	http://dx.doi.org/10.1074/jbc.M111.276014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21979958	hybrid, Green Published			2022-12-25	WOS:000298180900023
J	Tajima, H; Imada, K; Sakuma, M; Hattori, F; Nara, T; Kamo, N; Homma, M; Kawagishi, I				Tajima, Hirotaka; Imada, Katsumi; Sakuma, Mayuko; Hattori, Fumiyuki; Nara, Toshifumi; Kamo, Naoki; Homma, Michio; Kawagishi, Ikuro			Ligand Specificity Determined by Differentially Arranged Common Ligand-binding Residues in Bacterial Amino Acid Chemoreceptors Tsr and Tar	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI TSR; ASPARTATE RECEPTOR; SULFHYDRYL MODIFICATION; 3-DIMENSIONAL STRUCTURE; SIGNAL-TRANSDUCTION; SERINE RECEPTOR; CHEMOTAXIS; DOMAIN; SITE; MUTANTS	Escherichia coli has closely related amino acid chemoreceptors with distinct ligand specificity, Tar for L-aspartate and Tsr for L-serine. Crystallography of the ligand-binding domain of Tar identified the residues interacting with aspartate, most of which are conserved in Tsr. However, swapping of the nonconserved residues between Tsr and Tar did not change ligand specificity. Analyses with chimeric receptors led us to hypothesize that distinct three-dimensional arrangements of the conserved ligand-binding residues are responsible for ligand specificity. To test this hypothesis, the structures of the apo- and serine-binding forms of the ligand-binding domain of Tsr were determined at 1.95 and 2.5 angstrom resolutions, respectively. Some of the Tsr residues are arranged differently from the corresponding aspartate-binding residues of Tar to form a high affinity serine-binding pocket. The ligand-binding pocket of Tsr was surrounded by negatively charged residues, which presumably exclude negatively charged aspartate molecules. We propose that all these Tsr- and Tar-specific features contribute to specific recognition of serine and aspartate with the arrangement of the side chain of residue 68 (Asn in Tsr and Ser in Tar) being the most critical.	[Imada, Katsumi] Osaka Univ, Dept Macromol Sci, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Tajima, Hirotaka; Sakuma, Mayuko; Hattori, Fumiyuki; Homma, Michio] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Tajima, Hirotaka; Kawagishi, Ikuro] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 1848584, Japan; [Tajima, Hirotaka; Kawagishi, Ikuro] Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo 1848584, Japan; [Imada, Katsumi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Nara, Toshifumi; Kamo, Naoki] Matsuyama Univ, Coll Pharmaceut Sci, Matsuyama, Ehime 7908578, Japan	Osaka University; Nagoya University; Hosei University; Hosei University; Osaka University	Imada, K (corresponding author), Osaka Univ, Dept Macromol Sci, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan.	kimada@chem.sci.osaka-u.ac.jp; ikurok@hosei.ac.jp		Imada, Katsumi/0000-0003-1342-8885	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research and the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K. I. and I. K.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; BOWIE JU, 1995, ACTA CRYSTALLOGR D, V51, P145, DOI 10.1107/S0907444994010498; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chi YI, 1997, FEBS LETT, V414, P327, DOI 10.1016/S0014-5793(97)01027-2; CLARKE S, 1979, J BIOL CHEM, V254, P9695; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; GARDINA P, 1992, J BACTERIOL, V174, P1528, DOI 10.1128/jb.174.5.1528-1536.1992; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; GOMI S, 1993, J BIOCHEM-TOKYO, V113, P208, DOI 10.1093/oxfordjournals.jbchem.a124027; GOMI S, 1994, OLFACTION TASTE, V9, P210; HEDBLOM ML, 1983, J BACTERIOL, V155, P1463, DOI 10.1128/JB.155.3.1463-1466.1983; HEDBLOM ML, 1980, J BACTERIOL, V144, P1048, DOI 10.1128/JB.144.3.1048-1060.1980; IWAMA T, 1995, J BACTERIOL, V177, P2218, DOI 10.1128/jb.177.8.2218-2221.1995; Iwama T, 1997, J BIOL CHEM, V272, P13810, DOI 10.1074/jbc.272.21.13810; JEFFERY CJ, 1993, PROTEIN SCI, V2, P559; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEE L, 1990, J BACTERIOL, V172, P377, DOI 10.1128/JB.172.1.377-382.1990; LEE L, 1988, J BACTERIOL, V170, P4769, DOI 10.1128/jb.170.10.4769-4774.1988; LEE L, 1990, THESIS NAGOYA U JAPA; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025; LYNCH BA, 1992, FEBS LETT, V307, P3, DOI 10.1016/0014-5793(92)80891-J; MACAB RM, 1987, ESCHERICHIA COLI SAL, P732; MELTON T, 1978, J BACTERIOL, V133, P708, DOI 10.1128/JB.133.2.708-716.1978; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; MILLIGAN DL, 1988, J BIOL CHEM, V263, P6268; MILLIGAN DL, 1993, J BIOL CHEM, V268, P19991; MOWBRAY SL, 1990, J BIOL CHEM, V265, P15638; SCOTT WG, 1993, J MOL BIOL, V232, P555, DOI 10.1006/jmbi.1993.1411; STOCK JB, 1996, ESCHERICHIA COLI SAL, V2, P1103; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; TATSUNO I, 1994, MOL MICROBIOL, V14, P755, DOI 10.1111/j.1365-2958.1994.tb01312.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; WOLFE AJ, 1987, J BACTERIOL, V169, P1878, DOI 10.1128/jb.169.5.1878-1885.1987; WOLFF C, 1988, J BACTERIOL, V170, P4509, DOI 10.1128/jb.170.10.4509-4515.1988; YEH JI, 1993, J BIOL CHEM, V268, P9787; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507	41	43	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42200	42210		10.1074/jbc.M111.221887	http://dx.doi.org/10.1074/jbc.M111.221887			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21979954	hybrid, Green Published			2022-12-25	WOS:000298180900030
J	Diana, D; Basile, A; De Rosa, L; Di Stasi, R; Auriemma, S; Arra, C; Pedone, C; Turco, MC; Fattorusso, R; D'Andrea, LD				Diana, Donatella; Basile, Anna; De Rosa, Lucia; Di Stasi, Rossella; Auriemma, Sara; Arra, Claudio; Pedone, Carlo; Turco, Maria Caterina; Fattorusso, Roberto; D'Andrea, Luca Domenico			beta-Hairpin Peptide That Targets Vascular Endothelial Growth Factor (VEGF) Receptors DESIGN, NMR CHARACTERIZATION, AND BIOLOGICAL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; STRUCTURAL DETERMINANTS; CRYSTAL-STRUCTURE; IN-VIVO; ANGIOGENESIS; STABILITY; FLT-1; DOMAIN; MODEL; STABILIZATION	VEGF receptors have been the target of intense research aimed to develop molecules able to inhibit or stimulate angiogenesis. Based on the x-ray structure of the complex placental growth factor-VEGF receptor 1,2, we designed a VEGF receptor-binding peptide reproducing the placental growth factor beta-hairpin region Gln(87)-Val(100) that is involved in receptor recognition. A conformational analysis showed that the designed peptide adopts the expected fold in pure water. Moreover, a combination of NMR interaction analysis and cell binding studies were used to demonstrate that the peptide targets VEGF receptors. The VEGF receptor 1(D2)-interacting residues were characterized at the molecular level, and they correspond to the residues recognizing the placental growth factor sequence Gln(87)-Val(100). Finally, the peptide biological activity was characterized in vitro and in vivo, and it showed a VEGF-like behavior. Indeed, the peptide activated VEGF-dependent intracellular pathways, induced endothelial cell proliferation and rescue from apoptosis, and promoted angiogenesis in vivo. This compound is one of the few peptides known with proangiogenic activity, which makes it a candidate for the development of a novel peptide-based drug for medical applications in therapeutic angiogenesis.	[D'Andrea, Luca Domenico] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy; [Basile, Anna; Turco, Maria Caterina] Univ Salerno, Dipartimento Sci Farmaceut & Biomed, I-84084 Salerno, Italy; [Auriemma, Sara; Pedone, Carlo] Univ Naples Federico II, Dipartimento Sci Biol, I-80134 Naples, Italy; [Arra, Claudio] Ist Nazl Tumori Fdn G Pascale, I-80131 Naples, Italy; [Fattorusso, Roberto] Univ Naples 2, Dipartimento Sci Ambientali, I-81100 Caserta, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Salerno; University of Naples Federico II; IRCCS Fondazione Pascale; Universita della Campania Vanvitelli	D'Andrea, LD (corresponding author), CNR, Ist Biostrutture & Bioimmagini, Via Mezzocannone 16, I-80134 Naples, Italy.	ldandrea@unina.it	TURCO, Maria Caterina/AAC-5282-2022	TURCO, Maria Caterina/0000-0002-7835-359X; Basile, Anna/0000-0002-4523-8202; Fattorusso, Roberto/0000-0002-3539-5343; Arra, Claudio/0000-0003-3162-2091; D'ANDREA, LUCA DOMENICO/0000-0002-2589-216X	Diagnostica e Farmaceutica Molecolari scarl; Ministero dell'Istruzione, dell'Universita e della Ricerca [PRIN2008-200875WHMR, FIRB2008-RBRN07BMCT]; Programma Operativo Nazionale (PON) Ricerca e Competitivita [PON01_02388]	Diagnostica e Farmaceutica Molecolari scarl; Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Programma Operativo Nazionale (PON) Ricerca e Competitivita	This work was supported by Diagnostica e Farmaceutica Molecolari scarl and the Ministero dell'Istruzione, dell'Universita e della Ricerca (Grant PRIN2008-200875WHMR, Grant FIRB2008-RBRN07BMCT, Programma Operativo Nazionale (PON) Ricerca e Competitivita 2007-2013, and Grant PON01_02388).	Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Blanco F, 1998, CURR OPIN STRUC BIOL, V8, P107, DOI 10.1016/S0959-440X(98)80017-1; BLANCO FJ, 1994, BIOCHEMISTRY-US, V33, P6004, DOI 10.1021/bi00185a041; Cao YH, 1996, J BIOL CHEM, V271, P3154, DOI 10.1074/jbc.271.6.3154; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; D'Andrea LD, 2005, P NATL ACAD SCI USA, V102, P14215, DOI 10.1073/pnas.0505047102; D'Andrea LD, 2009, CURR PHARM DESIGN, V15, P2414, DOI 10.2174/138161209788682235; De Falco S, 2002, TRENDS CARDIOVAS MED, V12, P241, DOI 10.1016/S1050-1738(02)00168-8; Di Stasi R, 2010, BIOPOLYMERS, V94, P800, DOI 10.1002/bip.21448; Diana D, 2008, CHEM-EUR J, V14, P4164, DOI 10.1002/chem.200800180; Diana D, 2010, CHEM-EUR J, V16, P5400, DOI 10.1002/chem.200903428; Dudar GK, 2008, AM J PHYSIOL-GASTR L, V295, pG374, DOI 10.1152/ajpgi.90325.2008; Eidenschink L, 2009, PROTEINS, V75, P308, DOI 10.1002/prot.22240; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Gautier B, 2010, J MED CHEM, V53, P4428, DOI 10.1021/jm1002167; Goddard T. D., 2001, SPARKY VERSION 3; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Garcia-Aranda MI, 2011, BIOORGAN MED CHEM, V19, P1978, DOI 10.1016/j.bmc.2011.01.056; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; Maynard AJ, 1998, J AM CHEM SOC, V120, P1996, DOI 10.1021/ja9726769; Mirassou Y, 2009, CHEMBIOCHEM, V10, P902, DOI 10.1002/cbic.200800834; MORRIS KF, 1992, J AM CHEM SOC, V114, P3139, DOI 10.1021/ja00034a071; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PARK JE, 1994, J BIOL CHEM, V269, P25646; Pastor MT, 2005, CHEMBIOCHEM, V6, P1753, DOI 10.1002/cbic.200500178; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Russell SJ, 2003, J AM CHEM SOC, V125, P388, DOI 10.1021/ja028075l; Santiveri CM, 2010, BIOPOLYMERS, V94, P779, DOI 10.1002/bip.21436; Santulli G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-41; Soro S, 2008, BLOOD, V111, P3479, DOI 10.1182/blood-2007-03-077537; Starovasnik MA, 1999, J MOL BIOL, V293, P531, DOI 10.1006/jmbi.1999.3134; Vicari D, 2011, J BIOL CHEM, V286, P13612, DOI 10.1074/jbc.M110.216812; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang Y, 2010, P NATL ACAD SCI USA, V107, P1906, DOI 10.1073/pnas.0914052107; Yao SG, 2000, J BIOMOL NMR, V16, P109, DOI 10.1023/A:1008382624724; Yilmaz A, 2003, BIOCHEM BIOPH RES CO, V306, P730, DOI 10.1016/S0006-291X(03)01064-7; Ziche M, 1997, LAB INVEST, V76, P517; Zilberberg L, 2003, J BIOL CHEM, V278, P35564, DOI 10.1074/jbc.M304435200	52	32	33	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41680	41691		10.1074/jbc.M111.257402	http://dx.doi.org/10.1074/jbc.M111.257402			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21969375	Green Published, hybrid			2022-12-25	WOS:000298057500052
J	Maki, K; Inoue, T; Onaka, A; Hashizunne, H; Sonnete, N; Kobayashi, Y; Murakami, S; Shigaki, C; Takahashi, TS; Masukata, H; Nakagawa, T				Maki, Kentaro; Inoue, Takahiro; Onaka, Atsushi; Hashizunne, Hiroko; Sonnete, Naoko; Kobayashi, Yuko; Murakami, Shigefunni; Shigaki, Chikako; Takahashi, Tatsuro S.; Masukata, Hisao; Nakagawa, Takuro			Abundance of Prereplicative Complexes (Pre-RCs) Facilitates Recombinational Repair under Replication Stress in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; MEIER-GORLIN SYNDROME; DOUBLE-STRAND BREAKS; ORIGIN RECOGNITION COMPLEX; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; S-PHASE; RAD51-MEDIATED RECOMBINATION	Mcm2-7 complexes are loaded onto chromatin with the aid of Cdt1 and Cdc18/Cdc6 and form prereplicative complexes (pre-RCs) at multiple sites on each chromosome. Pre-RCs are essential for DNA replication and surviving replication stress. However, the mechanism by which pre-RCs contribute to surviving replication stress is largely unknown. Here, we isolated the fission yeast mcm6-S1 mutant that was hypersensitive to methyl methanesulfonate (MMS) and camptothecin (CPT), both of which cause forks to collapse. The mcm6-S1 mutation impaired the interaction with Cdt1 and decreased the binding of minichromosome maintenance (MCM) proteins to replication origins. Overexpression of Cdt1 restored MCM binding and suppressed the sensitivity to MMS and CPT, suggesting that the Cdt1-Mcm6 interaction is important for the assembly of pre-RCs and the repair of collapsed forks. MMS-induced Chk1 phosphorylation and Rad22/Rad52 focus formation occurred normally, whereas cells containing Rhp54/Rad54 foci, which are involved in DNA strand exchange and dissociation of the joint molecules, were increased. Remarkably. G, phase extension through deletion of an S phase cyclin, Cig2, as well as Cdt1 overexpression restored pre-RC assembly and suppressed Rhp54 accumulation. A cdc18 mutation also caused hypersensitivity to MMS and CPT and accumulation of Rhp54 foci. These data suggest that an abundance of pre-RCs facilitates a late step in the recombinational repair of collapsed forks in the following S phase.	[Maki, Kentaro; Inoue, Takahiro; Onaka, Atsushi; Hashizunne, Hiroko; Sonnete, Naoko; Kobayashi, Yuko; Murakami, Shigefunni; Shigaki, Chikako; Takahashi, Tatsuro S.; Masukata, Hisao; Nakagawa, Takuro] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan; [Maki, Kentaro; Murakami, Shigefunni; Masukata, Hisao] Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 5600043, Japan	Osaka University; Osaka University	Nakagawa, T (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	takuro4@bio.sci.osaka-u.ac.jp	Takahashi, Tatsuro/F-4669-2016; Takahashi, Tatsuro/AAD-9936-2020; Nakagawa, Takuro/A-1367-2017	Takahashi, Tatsuro/0000-0002-1947-7680; Takahashi, Tatsuro/0000-0002-1947-7680; Nakagawa, Takuro/0000-0003-3455-8224; Onaka, Atsushi/0000-0001-7765-5812	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for scientific research on innovative areas from the Ministry of Education, Culture, Sports, Science and Technology (to T. N.) and a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (to T. N.).	Alfa C, 1993, EXPT FISSION YEAST L; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Chen SY, 2011, GENE DEV, V25, P363, DOI 10.1101/gad.2011511; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; Coulon S, 2006, MOL BIOL CELL, V17, P2081, DOI 10.1091/mbc.E05-11-1006; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Doksani Y, 2009, CELL, V137, P247, DOI 10.1016/j.cell.2009.02.016; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; Groth P, 2010, J MOL BIOL, V402, P70, DOI 10.1016/j.jmb.2010.07.010; Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Jallepalli PV, 1998, P NATL ACAD SCI USA, V95, P8159, DOI 10.1073/pnas.95.14.8159; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Kurokawa Y, 2008, PLOS BIOL, V6, P836, DOI 10.1371/journal.pbio.0060088; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Mondesert O, 1996, MOL CELL BIOL, V16, P1527; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Murayama Y, 2008, NATURE, V451, P1018, DOI 10.1038/nature06609; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nitani N, 2008, P NATL ACAD SCI USA, V105, P12973, DOI 10.1073/pnas.0805307105; Nitani N, 2006, GENETICS, V174, P155, DOI 10.1534/genetics.106.060053; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Okuno Y, 1999, MOL CELL BIOL, V19, P6699; Orr SJ, 2010, ONCOGENE, V29, P3803, DOI 10.1038/onc.2010.138; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rhind N, 2000, J CELL SCI, V113, P3889; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; SLATER ML, 1973, J BACTERIOL, V113, P263, DOI 10.1128/JB.113.1.263-270.1973; Takahashi T, 2003, EMBO J, V22, P964, DOI 10.1093/emboj/cdg079; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wei Z, 2010, J BIOL CHEM, V285, P12469, DOI 10.1074/jbc.C109.094599; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200; Zafar F., 2011, FUNDAMENTAL ASPECTS, P65; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	78	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41701	41710		10.1074/jbc.M111.285619	http://dx.doi.org/10.1074/jbc.M111.285619			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21971174	Green Published, hybrid			2022-12-25	WOS:000298057500054
J	Labeed, FH; Lu, JT; Mulhall, HJ; Marchenko, SA; Hoettges, KF; Estrada, LC; Lee, AP; Hughes, MP; Flanagan, LA				Labeed, Fatima H.; Lu, Jente; Mulhall, Hayley J.; Marchenko, Steve A.; Hoettges, Kai F.; Estrada, Laura C.; Lee, Abraham P.; Hughes, Michael P.; Flanagan, Lisa A.			Biophysical Characteristics Reveal Neural Stem Cell Differentiation Potential	PLOS ONE			English	Article							PROGENITOR CELLS; DIELECTRIC-PROPERTIES; SUBVENTRICULAR ZONE; RADIAL GLIA; REACTIVE ASTROCYTES; GROWTH-FACTORS; CANCER-CELLS; MEMBRANE; SEPARATION; NEURONS	Background: Distinguishing human neural stem/progenitor cell (huNSPC) populations that will predominantly generate neurons from those that produce glia is currently hampered by a lack of sufficient cell type-specific surface markers predictive of fate potential. This limits investigation of lineage-biased progenitors and their potential use as therapeutic agents. A live-cell biophysical and label-free measure of fate potential would solve this problem by obviating the need for specific cell surface markers. Methodology/Principal Findings: We used dielectrophoresis (DEP) to analyze the biophysical, specifically electrophysiological, properties of cortical human and mouse NSPCs that vary in differentiation potential. Our data demonstrate that the electrophysiological property membrane capacitance inversely correlates with the neurogenic potential of NSPCs. Furthermore, as huNSPCs are continually passaged they decrease neuron generation and increase membrane capacitance, confirming that this parameter dynamically predicts and negatively correlates with neurogenic potential. In contrast, differences in membrane conductance between NSPCs do not consistently correlate with the ability of the cells to generate neurons. DEP crossover frequency, which is a quantitative measure of cell behavior in DEP, directly correlates with neuron generation of NSPCs, indicating a potential mechanism to separate stem cells biased to particular differentiated cell fates. Conclusions/Significance: We show here that whole cell membrane capacitance, but not membrane conductance, reflects and predicts the neurogenic potential of human and mouse NSPCs. Stem cell biophysical characteristics therefore provide a completely novel and quantitative measure of stem cell fate potential and a label-free means to identify neuron- or glial-biased progenitors.	[Labeed, Fatima H.; Mulhall, Hayley J.; Hoettges, Kai F.; Hughes, Michael P.] Univ Surrey, Ctr Biomed Engn, Guildford GU2 5XH, Surrey, England; [Lu, Jente; Flanagan, Lisa A.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Lu, Jente; Estrada, Laura C.; Lee, Abraham P.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Marchenko, Steve A.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA; [Estrada, Laura C.] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA USA	University of Surrey; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Labeed, FH (corresponding author), Univ Surrey, Ctr Biomed Engn, Guildford GU2 5XH, Surrey, England.	lflanaga@uci.edu	Lu, Jente/F-4189-2011; Hoettges, Kai/F-1613-2013; Hughes, Michael/H-6996-2016; Lee, Abraham/E-7401-2011	Lu, Jente/0000-0001-6951-290X; Hughes, Michael/0000-0001-7385-5876; Labeed, Fatima/0000-0002-0092-257X; Lee, Abraham/0000-0001-8378-6616	Roman Reed Spinal Cord Injury Research Fund of California; UK Foreign and Commonwealth Office Collaboration; SETsquared UK-US Science Bridge for Applied Collaborative Research; California Institute for Regenerative Medicine [RT1-01074, TG2-01152]; NIH [P41-RR003155, AG23583]; Engineering and Physical Sciences Research Council [EP/I500936/1] Funding Source: researchfish; EPSRC [EP/I500936/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG023583] Funding Source: NIH RePORTER	Roman Reed Spinal Cord Injury Research Fund of California; UK Foreign and Commonwealth Office Collaboration; SETsquared UK-US Science Bridge for Applied Collaborative Research; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded in part by the Roman Reed Spinal Cord Injury Research Fund of California (http://www.reeve.uci.edu/roman-reed-research-grants.html), the UK Foreign and Commonwealth Office Collaboration Development Award (http://ukinusa.fco.gov.uk/en/news/?view=News&id=22705563), the SETsquared UK-US Science Bridge for Applied Collaborative Research (http://www.setsquared.co.uk/), the California Institute for Regenerative Medicine RT1-01074 and TG2-01152 (http://www.cirm.ca.gov/), and grants NIH P41-RR003155 (http://www.ncrr.nih.gov/) and NIH AG23583 (http://www.nia.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare L, 2003, BIOTECHNOL BIOENG, V82, P474, DOI 10.1002/bit.10590; BECKER FF, 1995, P NATL ACAD SCI USA, V92, P860, DOI 10.1073/pnas.92.3.860; BECKER FF, 1994, J PHYS D APPL PHYS, V27, P2659, DOI 10.1088/0022-3727/27/12/030; Broche LM, 2005, PHYS MED BIOL, V50, P2267, DOI 10.1088/0031-9155/50/10/006; Cai JL, 2004, J NEUROCHEM, V88, P212, DOI 10.1046/j.1471-4159.2003.02184.x; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Chin S, 2006, INT J NANOMED, V1, P333; Clowry G, 2010, J ANAT, V217, P276, DOI 10.1111/j.1469-7580.2010.01281.x; Desai SP, 2009, LANGMUIR, V25, P3867, DOI 10.1021/la803330c; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Duncan L, 2008, PHYS MED BIOL, V53, pN1, DOI 10.1088/0031-9155/53/2/N01; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Flanagan LA, 2008, STEM CELLS, V26, P656, DOI 10.1634/stemcells.2007-0810; Gascoyne PRC, 1997, IEEE T IND APPL, V33, P670, DOI 10.1109/28.585856; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; GHEORGHIU E, 1993, PHYS MED BIOL, V38, P979, DOI 10.1088/0031-9155/38/7/008; GROVE EA, 1993, DEVELOPMENT, V117, P553; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hoettges KF, 2008, ANAL CHEM, V80, P2063, DOI 10.1021/ac702083g; Howard B, 2006, GLIA, V53, P57, DOI 10.1002/glia.20259; IRIMAJIRI A, 1979, J THEOR BIOL, V78, P251, DOI 10.1016/0022-5193(79)90268-6; Labeed FH, 2006, BBA-GEN SUBJECTS, V1760, P922, DOI 10.1016/j.bbagen.2006.01.018; LEVISON SW, 1993, DEVELOPMENT, V119, P611; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; Maric D, 2003, J NEUROSCI, V23, P240; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Mo ZC, 2007, J NEUROSCI, V27, P4132, DOI 10.1523/JNEUROSCI.0111-07.2007; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Patel P, 2008, ENZYME MICROB TECH, V43, P463, DOI 10.1016/j.enzmictec.2008.09.005; Pethig R, 1997, TRENDS BIOTECHNOL, V15, P426, DOI 10.1016/S0167-7799(97)01096-2; Pethig R, 2002, ELECTROPHORESIS, V23, P2057, DOI 10.1002/1522-2683(200207)23:13<2057::AID-ELPS2057>3.0.CO;2-X; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Pohl H., 1978, DIELECTROPHORESIS; Prasad S, 2004, J NEUROSCI METH, V135, P79, DOI 10.1016/j.jneumeth.2003.12.007; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rao MS, 1997, DEV BIOL, V188, P48, DOI 10.1006/dbio.1997.8597; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sah DWY, 1997, J NEUROBIOL, V32, P95, DOI 10.1002/(SICI)1097-4695(199701)32:1<95::AID-NEU9>3.0.CO;2-9; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Smith DO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001604; Stoneman M, 2007, BIOELECTROCHEMISTRY, V70, P542, DOI 10.1016/j.bioelechem.2006.12.008; Suzuki M, 2006, EUR J NEUROSCI, V24, P645, DOI 10.1111/j.1460-9568.2006.04957.x; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Wang XJ, 1999, BBA-GEN SUBJECTS, V1426, P53, DOI 10.1016/S0304-4165(98)00122-6; Wang XJ, 2002, BBA-BIOMEMBRANES, V1564, P412, DOI 10.1016/S0005-2736(02)00495-9; Wegner F, 2009, J NEUROCHEM, V111, P204, DOI 10.1111/j.1471-4159.2009.06315.x; Yanagisawa M, 2004, GENES CELLS, V9, P801, DOI 10.1111/j.1365-2443.2004.00764.x; Yang J, 1999, BIOPHYS J, V76, P3307, DOI 10.1016/S0006-3495(99)77483-7; Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044	56	60	62	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25458	10.1371/journal.pone.0025458	http://dx.doi.org/10.1371/journal.pone.0025458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980464	Green Published, gold			2022-12-25	WOS:000295941300034
J	Rosen, S; Wise, RJS; Chadha, S; Conway, EJ; Scott, SK				Rosen, Stuart; Wise, Richard J. S.; Chadha, Shabneet; Conway, Eleanor-Jayne; Scott, Sophie K.			Hemispheric Asymmetries in Speech Perception: Sense, Nonsense and Modulations	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; TEMPORAL ENVELOPE; HUMAN BRAIN; CUES; LATERALIZATION; SENSITIVITY; ACTIVATION; AMPLITUDE; POSITION; FEATURES	Background: The well-established left hemisphere specialisation for language processing has long been claimed to be based on a low-level auditory specialization for specific acoustic features in speech, particularly regarding 'rapid temporal processing'. Methodology: A novel analysis/synthesis technique was used to construct a variety of sounds based on simple sentences which could be manipulated in spectro-temporal complexity, and whether they were intelligible or not. All sounds consisted of two noise-excited spectral prominences (based on the lower two formants in the original speech) which could be static or varying in frequency and/or amplitude independently. Dynamically varying both acoustic features based on the same sentence led to intelligible speech but when either or both acoustic features were static, the stimuli were not intelligible. Using the frequency dynamics from one sentence with the amplitude dynamics of another led to unintelligible sounds of comparable spectro-temporal complexity to the intelligible ones. Positron emission tomography (PET) was used to compare which brain regions were active when participants listened to the different sounds. Conclusions: Neural activity to spectral and amplitude modulations sufficient to support speech intelligibility (without actually being intelligible) was seen bilaterally, with a right temporal lobe dominance. A left dominant response was seen only to intelligible sounds. It thus appears that the left hemisphere specialisation for speech is based on the linguistic properties of utterances, not on particular acoustic features.	[Rosen, Stuart; Chadha, Shabneet; Conway, Eleanor-Jayne] UCL, Univ Coll London Speech Hearing & Phonet Sci, Div Psychol & Language Sci, London, England; [Wise, Richard J. S.] Univ London Imperial Coll Sci Technol & Med, Div Neurosci & Mental Hlth, London, England; [Scott, Sophie K.] UCL, Univ Coll London Inst Cognit Neurosci, Div Psychol & Language Sci, London, England	University of London; University College London; Imperial College London; University of London; University College London	Rosen, S (corresponding author), UCL, Univ Coll London Speech Hearing & Phonet Sci, Div Psychol & Language Sci, London, England.	stuart@phon.ucl.ac.uk	Scott, Sophie K/A-1843-2010; Rosen, Stuart/A-7875-2008; Rosen, Stuart/A-7875-2008	Scott, Sophie K/0000-0001-7510-6297; Rosen, Stuart/0000-0002-9376-2148; Rosen, Stuart/0000-0002-4893-8669	Wellcome Trust [WT074414MA]; MRC [MC_U120064975] Funding Source: UKRI; Medical Research Council [MC_U120064975] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	S. K. S. is funded by Grant No. WT074414MA from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bench J., 1979, SPEECH HEARING TESTS; Best CT, 1999, PSYCHOL SCI, V10, P65, DOI 10.1111/1467-9280.00108; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; DORMAN MF, 1980, J PHONETICS, V8, P397, DOI 10.1016/S0095-4470(19)31496-2; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; EFRON R, 1963, BRAIN, V86, P403, DOI 10.1093/brain/86.3.403; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Harms MP, 2002, J NEUROPHYSIOL, V88, P1433, DOI 10.1152/jn.2002.88.3.1433; Hart HC, 2003, CEREB CORTEX, V13, P773, DOI 10.1093/cercor/13.7.773; Langers DRM, 2003, NEUROIMAGE, V20, P265, DOI 10.1016/S1053-8119(03)00258-1; Obleser J, 2008, J NEUROSCI, V28, P8116, DOI 10.1523/JNEUROSCI.1290-08.2008; Overath T, 2008, J NEUROSCI, V28, P13268, DOI 10.1523/JNEUROSCI.4596-08.2008; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; REMEZ RE, 1981, SCIENCE, V212, P947, DOI 10.1126/science.7233191; Rosen S, 2007, DEVELOPMENTAL SCI, V10, P165, DOI 10.1111/j.1467-7687.2007.00550.x; Schonwiesner M, 2005, EUR J NEUROSCI, V22, P1521, DOI 10.1111/j.1460-9568.2005.04315.x; Scott SK, 2004, J ACOUST SOC AM, V115, P813, DOI 10.1121/1.1639336; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Sharp DJ, 2004, CEREB CORTEX, V14, P1, DOI 10.1093/cercor/bhg086; Thivard L, 2000, NEUROREPORT, V11, P2969, DOI 10.1097/00001756-200009110-00028; Warren JD, 2005, NEUROIMAGE, V24, P1052, DOI 10.1016/j.neuroimage.2004.10.031; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	32	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24672	10.1371/journal.pone.0024672	http://dx.doi.org/10.1371/journal.pone.0024672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980349	Green Published, Green Submitted, gold			2022-12-25	WOS:000295941300007
J	Sabari, J; Lax, D; Connors, D; Brotman, I; Mindrebo, E; Butler, C; Entersz, I; Jia, DX; Foty, RA				Sabari, Joshua; Lax, Daniel; Connors, Daniel; Brotman, Ian; Mindrebo, Eric; Butler, Christine; Entersz, Ildiko; Jia, Dongxuan; Foty, Ramsey A.			Fibronectin Matrix Assembly Suppresses Dispersal of Glioblastoma Cells	PLOS ONE			English	Article							HUMAN FIBROSARCOMA CELLS; EXTRACELLULAR-MATRIX; GENETIC ALTERATIONS; INVASION; GLIOMAS; COHESION; ADHESION; PROLIFERATION; EXPRESSION; CADHERIN	Glioblastoma (GBM), the most aggressive and most common form of primary brain tumor, has a median survival of 12-15 months. Surgical excision, radiation and chemotherapy are rarely curative since tumor cells broadly disperse within the brain. Preventing dispersal could be of therapeutic benefit. Previous studies have reported that increased cell-cell cohesion can markedly reduce invasion by discouraging cell detachment from the tumor mass. We have previously reported that alpha 5 beta 1 integrin-fibronectin interaction is a powerful mediator of indirect cell-cell cohesion and that the process of fibronectin matrix assembly (FNMA) is crucial to establishing strong bonds between cells in 3D tumor-like spheroids. Here, we explore a potential role for FNMA in preventing dispersal of GBM cells from a tumor-like mass. Using a series of GBM-derived cell lines we developed an in vitro assay to measure the dispersal velocity of aggregates on a solid substrate. Despite their similar pathologic grade, aggregates from these lines spread at markedly different rates. Spreading velocity is inversely proportional to capacity for FNMA and restoring FNMA in GBM cells markedly reduces spreading velocity by keeping cells more connected. Blocking FNMA using the 70 KDa fibronectin fragment in FNMA-restored cells rescues spreading velocity, establishing a functional role for FNMA in mediating dispersal. Collectively, the data support a functional causation between restoration of FNMA and decreased dispersal velocity. This is a first demonstration that FNMA can play a suppressive role in GBM dispersal.	[Sabari, Joshua; Lax, Daniel; Connors, Daniel; Brotman, Ian; Mindrebo, Eric; Butler, Christine; Entersz, Ildiko; Jia, Dongxuan; Foty, Ramsey A.] UMDNJ Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sabari, J (corresponding author), UMDNJ Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA.	fotyra@umdnj.edu			National Institutes of Health/National Cancer Institute [R01CA118755]; NATIONAL CANCER INSTITUTE [R01CA118755] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by grant R01CA118755 from the National Institutes of Health/National Cancer Institute to RAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandes AA, 2008, CRIT REV ONCOL HEMAT, V67, P139, DOI 10.1016/j.critrevonc.2008.02.005; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; Caicedo-Carvajal CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011830; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; CIFARELLI CP, 2010, J NEUROSURG; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; de Gennes P. G, 1994, SOFT INTERFACES; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Fehlauer F, 2007, ONCOL REP, V17, P941; Foty RA, 2004, INT J DEV BIOL, V48, P397, DOI 10.1387/ijdb.041810rf; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Foty RA, 1997, CANCER RES, V57, P5033; FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298; Foty RA, 1998, CANCER RES, V58, P3586; George J, 2010, INT J BIOCHEM CELL B, V42, P1164, DOI 10.1016/j.biocel.2010.04.002; Hagemann Carsten, 2010, BMC Res Notes, V3, P293, DOI 10.1186/1756-0500-3-293; Hamel W, 2000, ACTA NEUROCHIR, V142, P113, DOI 10.1007/s007010050015; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hegedus B, 2006, BIOPHYS J, V91, P2708, DOI 10.1529/biophysj.105.077834; Jang HS, 2010, NEUROCHEM RES, V35, P1796, DOI 10.1007/s11064-010-0246-8; Knupfer MM, 1997, KLIN PADIATR, V209, P271, DOI 10.1055/s-2008-1043961; Kogiku M, 2008, J CLIN NEUROSCI, V15, P1198, DOI 10.1016/j.jocn.2007.11.012; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Li RH, 2010, ONCOL REP, V23, P1553, DOI 10.3892/or_00000795; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MCKEOWNLONGO PJ, 1987, J CELL BIOL, V104, P601, DOI 10.1083/jcb.104.3.601; NAGANE M, 2001, CANC LETT, V162, P17; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Riemenschneider MJ, 2010, TARGET ONCOL, V5, P161, DOI 10.1007/s11523-010-0153-6; Robinson EE, 2003, J CELL SCI, V116, P377, DOI 10.1242/jcs.00231; Robinson EE, 2004, MOL BIOL CELL, V12, P12; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Smith JS, 2000, FRONT BIOSCI-LANDMRK, V5, pD213, DOI 10.2741/Smith; Tabatabai G, 2010, TARGET ONCOL, V5, P175, DOI 10.1007/s11523-010-0156-3; Varga I, 2010, CENT EUR NEUROSURG, V71, P173, DOI 10.1055/s-0030-1249698; Winters BS, 2006, MOL BIOL CELL, V17, P3386, DOI 10.1091/mbc.E05-09-0849; Winters BS, 2005, INT J CANCER, V114, P371, DOI 10.1002/ijc.20722; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; YUAN L, 2010, J NEUROONCOL	46	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24810	10.1371/journal.pone.0024810	http://dx.doi.org/10.1371/journal.pone.0024810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980357	Green Published, gold			2022-12-25	WOS:000295941300010
J	Avinun, R; Israel, S; Shalev, I; Gritsenko, I; Bornstein, G; Ebstein, RP; Knafo, A				Avinun, Reut; Israel, Salomon; Shalev, Idan; Gritsenko, Inga; Bornstein, Gary; Ebstein, Richard P.; Knafo, Ariel			AVPR1A Variant Associated with Preschoolers' Lower Altruistic Behavior	PLOS ONE			English	Article							PROMOTER REGION; PROSOCIAL BEHAVIOR; GENETIC-VARIATION; VASOPRESSIN; POLYMORPHISMS; MICROSATELLITE; SUSCEPTIBILITY; HERITABILITY; CHILDHOOD	The genetic origins of altruism, defined here as a costly act aimed to benefit non-kin individuals, have not been examined in young children. However, previous findings concerning adults pointed at the arginine vasopressin receptor 1A (AVPR1A) gene as a possible candidate. AVPR1A has been associated with a range of behaviors including aggressive, affiliative and altruistic phenotypes, and recently a specific allele (327 bp) of one of its promoter region polymorphisms (RS3) has been singled out in particular. We modeled altruistic behavior in preschoolers using a laboratory-based economic paradigm, a modified dictator game (DG), and tested for association between DG allocations and the RS3 "target allele." Using both population and family-based analyses we show a significant link between lower allocations and the RS3 "target allele," associating it, for the first time, with a lower proclivity toward altruistic behavior in children. This finding helps further the understanding of the intricate mechanisms underlying early altruistic behavior.	[Avinun, Reut; Shalev, Idan] Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel; [Israel, Salomon; Bornstein, Gary; Ebstein, Richard P.; Knafo, Ariel] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; [Gritsenko, Inga] S Herzog Mem Hosp, Jerusalem, Israel; [Bornstein, Gary] Ctr Study Rational & Interact Decis Theory, Jerusalem, Israel; [Ebstein, Richard P.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Herzog Medical Center; National University of Singapore	Avinun, R (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel.	msarielk@huji.ac.il	Shalev, Idan/H-1943-2011; Knafo-Noam, Ariel/E-8067-2011	Knafo-Noam, Ariel/0000-0003-0613-1960; Israel, Salomon/0000-0003-3629-2466; Avinun, Reut/0000-0002-3281-1268; Ebstein, Richard/0000-0002-3626-541X	Israel Science Foundation [31/06]; Notre Dame Science of Generosity Project; National Institute for Psychobiology in Israel	Israel Science Foundation(Israel Science Foundation); Notre Dame Science of Generosity Project; National Institute for Psychobiology in Israel	The longitudinal Israeli study of twins is supported by grant No. 31/06 from the Israel Science Foundation to the last author and by a grant from the Notre Dame Science of Generosity Project. Genotyping was supported by a grant from the National Institute for Psychobiology in Israel to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachner-Melman R, 2005, MOL PSYCHIATR, V10, P333, DOI 10.1038/sj.mp.4001635; Bachner-Melman R, 2004, INT J EAT DISORDER, V36, P451, DOI 10.1002/eat.20049; Bachner-Melman R., 2005, J INDIVID DIFFER, V26, P2, DOI DOI 10.1027/1614-0001.26.1.2; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Ben-Ner A, 2004, J ECON PSYCHOL, V25, P581, DOI 10.1016/S0167-4870(03)00065-5; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Camerer CF, 2003, TRENDS COGN SCI, V7, P225, DOI 10.1016/S1364-6613(03)00094-9; Caprara GV, 2000, PSYCHOL SCI, V11, P302, DOI 10.1111/1467-9280.00260; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; DiLalla LF, 2009, DEV PSYCHOBIOL, V51, P451, DOI 10.1002/dev.20384; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Gummerum M, 2009, J EC PSYCHOL; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Knafo A, 2006, TWIN RES HUM GENET, V9, P791, DOI 10.1375/twin.9.6.791; Knafo A, 2006, DEV PSYCHOL, V42, P771, DOI 10.1037/0012-1649.42.5.771; Knafo A, 2011, DEV PSYCHOPATHOL, V23, P53, DOI 10.1017/S0954579410000647; Knafo A, 2009, ANN NY ACAD SCI, V1167, P103, DOI 10.1111/j.1749-6632.2009.04540.x; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Levin R, 2009, PSYCHONEUROENDOCRINO, V34, P901, DOI 10.1016/j.psyneuen.2008.12.014; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Meyer-Lindenberg A, 2009, MOL PSYCHIATR, V14, P968, DOI 10.1038/mp.2008.54; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Oakley BA, PATHOLOGICAL ALTRUIS; Reuter M, 2011, SOC COGN AFFECT NEUR, V6, P662, DOI 10.1093/scan/nsq083; RUSHTON JP, 1986, J PERS SOC PSYCHOL, V50, P1192, DOI 10.1037/0022-3514.50.6.1192; Skuse DH, 2009, TRENDS COGN SCI, V13, P27, DOI 10.1016/j.tics.2008.09.007; Smith A., 1984, THEORY MORAL SENTIME; Thibonnier M, 2000, J MOL CELL CARDIOL, V32, P557, DOI 10.1006/jmcc.2000.1108; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Wassink TH, 2004, MOL PSYCHIATR, V9, P968, DOI 10.1038/sj.mp.4001503; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529	44	51	56	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25274	10.1371/journal.pone.0025274	http://dx.doi.org/10.1371/journal.pone.0025274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980412	gold, Green Published			2022-12-25	WOS:000295936900045
J	Gentile, LB; Piva, B; Diaz, BL				Gentile, Luciana B.; Piva, Bruno; Diaz, Bruno L.			Hypertonic Stress Induces VEGF Production in Human Colon Cancer Cell Line Caco-2: Inhibitory Role of Autocrine PGE(2)	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR-KAPPA-B; FACTOR EXPRESSION; IN-VIVO; CYCLOOXYGENASE-2 EXPRESSION; TUMOR ANGIOGENESIS; COLORECTAL-CANCER; DESCENDING COLON; GENE-EXPRESSION; UP-REGULATION	Vascular Endothelial Growth Factor (VEGF) is a major regulator of angiogenesis. VEGF expression is up regulated in response to micro-environmental cues related to poor blood supply such as hypoxia. However, regulation of VEGF expression in cancer cells is not limited to the stress response due to increased volume of the tumor mass. Lipid mediators in particular arachidonic acid-derived prostaglandin (PG)E-2 are regulators of VEGF expression and angiogenesis in colon cancer. In addition, increased osmolarity that is generated during colonic water absorption and feces consolidation seems to activate colon cancer cells and promote PGE(2) generation. Such physiological stimulation may provide signaling for cancer promotion. Here we investigated the effect of exposure to a hypertonic medium, to emulate colonic environment, on VEGF production by colon cancer cells. The role of concomitant PGE(2) generation and MAPK activation was addressed by specific pharmacological inhibition. Human colon cancer cell line Caco-2 exposed to a hypertonic environment responded with marked VEGF and PGE(2) production. VEGF production was inhibited by selective inhibitors of ERK 1/2 and p38 MAPK pathways. To address the regulatory role of PGE(2) on VEGF production, Caco-2 cells were treated with cPLA(2) (ATK) and COX-2 (NS-398) inhibitors, that completely block PGE(2) generation. The Caco-2 cells were also treated with a non selective PGE(2) receptor antagonist. Each treatment significantly increased the hypertonic stress-induced VEGF production. Moreover, addition of PGE(2) or selective EP2 receptor agonist to activated Caco-2 cells inhibited VEGF production. The autocrine inhibitory role for PGE(2) appears to be selective to hypertonic environment since VEGF production induced by exposure to CoCl2 was decreased by inhibition of concomitant PGE(2) generation. Our results indicated that hypertonicity stimulates VEGF production in colon cancer cell lines. Also PGE(2) plays an inhibitory role on VEGF production by Caco-2 cells exposed to hyperosmotic stress through EP2 activation.	[Gentile, Luciana B.] Inst Nacl Canc, Div Biol Celular, Rio De Janeiro, Brazil; [Gentile, Luciana B.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Posgrad Ciencias Morfol, Rio De Janeiro, Brazil; [Piva, Bruno; Diaz, Bruno L.] Univ Fed Rio de Janeiro, Inst Biofis, Programa Imunobiol, Rio De Janeiro, Brazil	National Cancer Institute (Inca); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Gentile, LB (corresponding author), Inst Nacl Canc, Div Biol Celular, Rio De Janeiro, Brazil.	bldiaz@biof.ufrj.br	Gentile, Luciana/B-7151-2014; Diaz, Bruno L./A-5673-2009	Gentile, Luciana/0000-0002-5248-5789; Diaz, Bruno L./0000-0001-8393-3823	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil); Ministry of Health (Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Ministry of Health (Brazil)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil) (to BLD) and a Ministry of Health (Brazil) PhD fellowship (to LBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Bermont L, 2000, INT J CANCER, V85, P117, DOI 10.1002/(SICI)1097-0215(20000101)85:1<117::AID-IJC21>3.3.CO;2-O; Bobrovnikova-Marjon EV, 2004, CANCER RES, V64, P4858, DOI 10.1158/0008-5472.CAN-04-0682; Brown NS, 2005, BRIT J CANCER, V92, P1696, DOI 10.1038/sj.bjc.6602522; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Chapple KS, 2002, J PATHOL, V198, P435, DOI 10.1002/path.1223; Chulada PC, 2000, CANCER RES, V60, P4705; Cianchi F, 2001, GASTROENTEROLOGY, V121, P1339, DOI 10.1053/gast.2001.29691; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; DAngelo G, 1997, J CELL BIOCHEM, V67, P353, DOI 10.1002/(SICI)1097-4644(19971201)67:3<353::AID-JCB7>3.3.CO;2-2; Feng WG, 2002, CELL RES, V12, P331, DOI 10.1038/sj.cr.7290135; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Fukuda R, 2003, CANCER RES, V63, P2330; Gentile LB, 2010, PROSTAG LEUKOTR ESS, V82, P131, DOI 10.1016/j.plefa.2009.11.005; Grader-Beck T, 2003, BLOOD, V101, P998, DOI 10.1182/blood-2002-06-1665; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; IJICHI A, 1995, GLIA, V14, P87, DOI 10.1002/glia.440140203; Jurek D, 2004, FASEB J, V18, P97, DOI 10.1096/fj.04-2111fje; Ko HM, 2002, CANCER RES, V62, P1809; Kuroki M, 1996, J CLIN INVEST, V98, P1667, DOI 10.1172/JCI118962; Leahy KM, 2002, CANCER RES, V62, P625; Litz J, 2006, MOL CANCER THER, V5, P1415, DOI 10.1158/1535-7163.MCT-05-0503; Liu XH, 1999, CLIN EXP METASTAS, V17, P687, DOI 10.1023/A:1006728119549; Mezentsev A, 2002, J BIOL CHEM, V277, P18670, DOI 10.1074/jbc.M201143200; Moreira LS, 2009, BBA-MOL CELL BIOL L, V1791, P156, DOI 10.1016/j.bbalip.2009.01.003; NAFTALIN RJ, 1994, PHYSIOL RES, V43, P65; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Newcomb EW, 2006, INT J ONCOL, V28, P1121; Okita NT, 2009, JPN J CLIN ONCOL, V39, P595, DOI 10.1093/jjco/hyp066; Poulios E, 2006, ANTICANCER RES, V26, P2165; POWELL DW, 1995, J CLIN INVEST, V96, P2102, DOI 10.1172/JCI118261; Rao M, 2004, INT J COLORECTAL DIS, V19, P1, DOI 10.1007/s00384-003-0511-2; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; Shoji Y, 2004, GUT, V53, P1151, DOI 10.1136/gut.2003.028787; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; TAKAHASHI Y, 1995, CANCER RES, V55, P3964; Takeda H, 2003, CANCER RES, V63, P4872; Thiagarajah JR, 2001, AM J PHYSIOL-CELL PH, V281, pC1898, DOI 10.1152/ajpcell.2001.281.6.C1898; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Zhong H, 2004, INT J CANCER, V112, P585, DOI 10.1002/ijc.20438	45	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25193	10.1371/journal.pone.0025193	http://dx.doi.org/10.1371/journal.pone.0025193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980393	Green Submitted, gold, Green Published			2022-12-25	WOS:000295936900031
J	Kim, HS; Cross, GAM				Kim, Hee-Sook; Cross, George A. M.			Identification of Trypanosoma brucei RMI1/BLAP75 Homologue and Its Roles in Antigenic Variation	PLOS ONE			English	Article							BREAK-INDUCED REPLICATION; TOPOISOMERASE-III-ALPHA; SACCHAROMYCES-CEREVISIAE; GENOME STABILITY; DNA-REPLICATION; RECQ HELICASE; ESSENTIAL COMPONENT; EXPRESSION SITES; SYNDROME PROTEIN; BLOOM HELICASE	At any time, each cell of the protozoan parasite Trypanosoma brucei expresses a single species of its major antigenic protein, the variant surface glycoprotein (VSG), from a repertoire of >2,000 VSG genes and pseudogenes. The potential to express different VSGs by transcription and recombination allows the parasite to escape the antibody-mediated host immune response, a mechanism known as antigenic variation. The active VSG is transcribed from a sub-telomeric polycistronic unit called the expression site (ES), whose promoter is 40-60 kb upstream of the VSG. While the mechanisms that initiate recombination remain unclear, the resolution phase of these reactions results in the recombinational replacement of the expressed VSG with a donor from one of three distinct chromosomal locations; sub-telomeric loci on the 11 essential chromosomes, on minichromosomes, or at telomere-distal loci. Depending on the type of recombinational replacement (single or double crossover, duplicative gene conversion, etc), several DNA-repair pathways have been thought to play a role. Here we show that VSG recombination relies on at least two distinct DNA-repair pathways, one of which requires RMI1-TOPO3 alpha to suppress recombination and one that is dependent on RAD51 and RMI1. These genetic interactions suggest that both RAD51-dependent and RAD51-independent recombination pathways operate in antigenic switching and that trypanosomes differentially utilize recombination factors for VSG switching, depending on currently unknown parameters within the ES.	[Kim, Hee-Sook; Cross, George A. M.] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA	Rockefeller University	Kim, HS (corresponding author), Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA.	george.cross@rockefeller.edu	Cross, George/B-7444-2011	Cross, George/0000-0003-1374-6955	Rockefeller University; National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) [R01AI021729]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021729] Funding Source: NIH RePORTER	Rockefeller University; National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Rockefeller University Women in Science fellowship to HK and by grant no. R01AI021729 from the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitcheson N, 2005, MOL MICROBIOL, V57, P1608, DOI 10.1111/j.1365-2958.2005.04795.x; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; BERNARDS A, 1986, J MOL BIOL, V190, P1, DOI 10.1016/0022-2836(86)90070-7; Bernstein KA, 2009, EMBO J, V28, P915, DOI 10.1038/emboj.2009.28; Boothroyd CE, 2009, NATURE, V459, P278, DOI 10.1038/nature07982; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chelysheva L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000309; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; Conway C, 2002, MOL MICROBIOL, V45, P1687, DOI 10.1046/j.1365-2958.2002.03122.x; CROSS GAM, 2002, MOL MED, P89; Cross M, 1998, MOL CELL BIOL, V18, P198, DOI 10.1128/MCB.18.1.198; DALGAARD JZ, 2004, SCI STKE, pRE17; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Hartung F, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000285; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; Hoadley KA, 2010, STRUCTURE, V18, P1149, DOI 10.1016/j.str.2010.06.009; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Kim HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000992; Kratz E, 2002, TRENDS GENET, V18, P29, DOI 10.1016/S0168-9525(01)02579-3; Le S, 1999, GENETICS, V152, P143; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Machado CR, 2006, MUTAT RES-REV MUTAT, V612, P40, DOI 10.1016/j.mrrev.2005.05.001; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Mankouri HW, 2006, MOL BIOL CELL, V17, P4473, DOI 10.1091/mbc.E06-06-0516; Marrero VA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001007; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Neff NF, 1999, MOL BIOL CELL, V10, P665, DOI 10.1091/mbc.10.3.665; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; PAYS E, 1985, NATURE, V316, P562, DOI 10.1038/316562a0; Raynard S, 2008, J BIOL CHEM, V283, P15701, DOI 10.1074/jbc.M802127200; Rudenko G, 1996, MOL BIOCHEM PARASIT, V80, P65, DOI 10.1016/0166-6851(96)02669-2; Scahill MD, 2008, MOL BIOCHEM PARASIT, V157, P73, DOI 10.1016/j.molbiopara.2007.10.003; Seki Masayuki, 2006, Subcell Biochem, V40, P49; Seki M, 2006, MOL CELL BIOL, V26, P6299, DOI 10.1128/MCB.00702-06; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shor E, 2002, GENETICS, V162, P647; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(05)00094-8; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wang F, 2010, STRUCTURE, V18, P1159, DOI 10.1016/j.str.2010.06.008; Watt PM, 1996, GENETICS, V144, P935; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	64	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25313	10.1371/journal.pone.0025313	http://dx.doi.org/10.1371/journal.pone.0025313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980422	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900050
J	Roffman, JL; Nitenson, AZ; Agam, Y; Isom, M; Friedman, JS; Dyckman, KA; Brohawn, DG; Smoller, JW; Goff, DC; Manoach, DS				Roffman, Joshua L.; Nitenson, Adam Z.; Agam, Yigal; Isom, Marlisa; Friedman, Jesse S.; Dyckman, Kara A.; Brohawn, David G.; Smoller, Jordan W.; Goff, Donald C.; Manoach, Dara S.			A Hypomethylating Variant of MTHFR, 677C > T, Blunts the Neural Response to Errors in Patients with Schizophrenia and Healthy Individuals	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; METHYLENETETRAHYDROFOLATE REDUCTASE; ANTERIOR CINGULATE; EXECUTIVE FUNCTION; DNA-METHYLATION; COMMON MUTATION; POLYMORPHISMS; PERFORMANCE; DISORDERS; NEURONS	Background: Responding to errors is a critical first step in learning from mistakes, a process that is abnormal in schizophrenia. To gain insight into the neural and molecular mechanisms of error processing, we used functional MRI to examine effects of a genetic variant in methylenetetrahydrofolate reductase (MTHFR 677C>T, rs1801133) that increases risk for schizophrenia and that has been specifically associated with increased perseverative errors among patients. MTHFR is a key regulator of the intracellular one-carbon milieu, including DNA methylation, and each copy of the 677T allele reduces MTHFR activity by 35%. Methodology/Principal Findings: Using an antisaccade paradigm, we found that the 677T allele induces a dose-dependent blunting of dorsal anterior cingulate cortex (dACC) activation in response to errors, a pattern that was identical in healthy individuals and patients with schizophrenia. Further, the normal relationship between dACC activation and error rate was disrupted among carriers of the 677T allele. Conclusions/Significance: These findings implicate an epigenetic mechanism in the neural response to errors, and provide insight into normal cognitive variation through a schizophrenia risk gene.	[Roffman, Joshua L.] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; Harvard Univ, Sch Med, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University	Roffman, JL (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA.	jroffman@partners.org	Roffman, Joshua/G-8228-2012	Roffman, Joshua/0000-0003-4073-532X	National Institute of Mental Health [5R01MH067720]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067720] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This paper was funded by the National Institute of Mental Health (5R01MH067720) to DSM. and a Howard Hughes Medical Institute Physician-Scientist Early Career Award to JLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.3.CO;2-X; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; First MB, 2002, STRUCTURED CLIN INTE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gilbody S, 2007, AM J EPIDEMIOL, V165, P1, DOI 10.1093/aje/kwj347; Graff J, 2009, EUR J NEUROSCI, V30, P1, DOI 10.1111/j.1460-9568.2009.06787.x; Hill M, 2011, SCHIZOPHR RES, V127, P41, DOI 10.1016/j.schres.2010.12.006; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Imamura K, 2007, NEUROREPORT, V18, P1319, DOI 10.1097/WNR.0b013e3282aaa0b4; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Levav-Rabkin T, 2011, BEHAV BRAIN RES, V216, P505, DOI 10.1016/j.bbr.2010.08.031; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; PEERBOOMS OL, 2010, BRAIN BEHAV IN PRESS; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Polli FE, 2008, BRAIN, V131, P971, DOI 10.1093/brain/awm307; Roffman JL, 2006, HARVARD REV PSYCHIAT, V14, P78, DOI 10.1080/10673220600642945; Roffman JL, 2008, P NATL ACAD SCI USA, V105, P17573, DOI 10.1073/pnas.0803727105; Roffman JL, 2008, AM J MED GENET B, V147B, P990, DOI 10.1002/ajmg.b.30684; Roffman JL, 2008, BIOL PSYCHIAT, V63, P42, DOI 10.1016/j.biopsych.2006.12.017; Roffman JL, 2007, SCHIZOPHR RES, V92, P181, DOI 10.1016/j.schres.2007.01.003; Roffman JL, 2011, BRAIN IMAGING BEHAV, V5, P65, DOI 10.1007/s11682-010-9111-2; Tan HY, 2007, CEREB CORTEX, V17, pI171, DOI [10.1093/cercor/bhm069, 10.1093/cercor/hhm069]; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; ZHU Q, 2011, SCAND J GAS IN PRESS	35	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25253	10.1371/journal.pone.0025253	http://dx.doi.org/10.1371/journal.pone.0025253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980405	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900040
J	Cutfield, SW; Derraik, JGB; Reed, PW; Hofman, PL; Jefferies, C; Cutfield, WS				Cutfield, Samuel W.; Derraik, Jose G. B.; Reed, Peter W.; Hofman, Paul L.; Jefferies, Craig; Cutfield, Wayne S.			Early Markers of Glycaemic Control in Children with Type 1 Diabetes Mellitus	PLOS ONE			English	Article							METABOLIC-CONTROL; NEW-ZEALAND; SOCIOECONOMIC-STATUS; PARTIAL REMISSION; RISK-FACTORS; ADOLESCENTS; INSULIN; FAMILY; ETHNICITY; ADHERENCE	Background: Type 1 diabetes mellitus (T1DM) may lead to severe long-term health consequences. In a longitudinal study, we aimed to identify factors present at diagnosis and 6 months later that were associated with glycosylated haemoglobin (HbA(1c)) levels at 24 months after T1DM diagnosis, so that diabetic children at risk of poor glycaemic control may be identified. Methods: 229 children,15 years of age diagnosed with T1DM in the Auckland region were studied. Data collected at diagnosis were: age, sex, weight, height, ethnicity, family living arrangement, socio-economic status (SES), T1DM antibody titre, venous pH and bicarbonate. At 6 and 24 months after diagnosis we collected data on weight, height, HbA(1c) level, and Results: Factors at diagnosis that were associated with higher HbA(1c) levels at 6 months: female sex (p<0.05), lower SES (p<0.01), non-European ethnicity (p<0.01) and younger age (p<0.05). At 24 months, higher HbA1c was associated with lower SES (p<0.001), Pacific Island ethnicity (p<0.001), not living with both biological parents (p<0.05), and greater BMI SDS (p<0.05). A regression equation to predict HbA(1c) at 24 months was consequently developed. Conclusions: Deterioration in glycaemic control shortly after diagnosis in diabetic children is particularly marked in Pacific Island children and in those not living with both biological parents. Clinicians need to be aware of factors associated with poor glycaemic control beyond the remission phase, so that more effective measures can be implemented shortly after diagnosis to prevent deterioration in diabetes control.	[Cutfield, Samuel W.; Derraik, Jose G. B.; Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Reed, Peter W.; Jefferies, Craig] Auckland Dist Hlth Board, Starship Childrens Hosp, Auckland, New Zealand; [Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand	University of Auckland; Auckland District Health Board; Starship Children's Hospital; University of Auckland	Cutfield, SW (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Jefferies, craig/ABA-1921-2021; Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Jefferies, Craig/0000-0002-0541-6094				Abdul-Rasoul M, 2006, PEDIATR DIABETES, V7, P101, DOI 10.1111/j.1399-543X.2006.00155.x; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Anderson BJ, 2002, DIABETIC MED, V19, P635, DOI 10.1046/j.1464-5491.2002.00752.x; AUSLANDER W F, 1990, Health and Social Work, V15, P133; Auslander WF, 1997, DIABETES CARE, V20, P1569, DOI 10.2337/diacare.20.10.1569; BAKER L, 1967, J PEDIATR-US, V71, P825, DOI 10.1016/S0022-3476(67)80007-6; Bober E, 2001, J PEDIATR ENDOCR MET, V14, P435; Cameron FJ, 2008, DIABETIC MED, V25, P463, DOI 10.1111/j.1464-5491.2008.02399.x; Campbell-Stokes PL, 2005, DIABETOLOGIA, V48, P643, DOI 10.1007/s00125-005-1697-3; Carter PJ, 2008, DIABETOLOGIA, V51, P1835, DOI 10.1007/s00125-008-1106-9; Chalew SA, 2000, J DIABETES COMPLICAT, V14, P71, DOI 10.1016/S1056-8727(00)00072-6; Chase HP, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00034.x; Davis CL, 2001, J PEDIATR PSYCHOL, V26, P123, DOI 10.1093/jpepsy/26.2.123; Delamater AM, 1999, DIABETES CARE, V22, P700, DOI 10.2337/diacare.22.5.700; DELAMATER AM, 1991, DIABETES CARE, V14, P20, DOI 10.2337/diacare.14.1.20; Delderfield M, 2005, SDS INDIVIDUAL CALCU; Dost A, 2007, EXP CLIN ENDOCR DIAB, V115, P33, DOI 10.1055/s-2007-948214; Douglas NM, 2007, J PAEDIATR CHILD H, V43, P173, DOI 10.1111/j.1440-1754.2007.01038.x; ELLIOTT RB, 1992, PEDIAT AD E, V21, P66; Frey MA, 2007, PEDIATR DIABETES, V8, P220, DOI 10.1111/j.1399-5448.2007.00260.x; Gallegos-Macias Angela R, 2003, Pediatr Diabetes, V4, P19, DOI 10.1034/j.1399-5448.2003.00020.x; Gerstl EM, 2008, EUR J PEDIATR, V167, P447, DOI 10.1007/s00431-007-0586-9; Hardy D, 2011, CANCER-AM CANCER SOC, V117, P1506, DOI 10.1002/cncr.25669; Hoey H, 2001, DIABETES CARE, V24, P1923, DOI 10.2337/diacare.24.11.1923; Hoffman RP, 2000, PEDIATR RES, V48, P384, DOI 10.1203/00006450-200009000-00022; Kaufman FR, 1999, PEDIATRICS, V103, P948, DOI 10.1542/peds.103.5.948; Kington RS, 1997, AM J PUBLIC HEALTH, V87, P805, DOI 10.2105/AJPH.87.5.805; KNIP M, 1982, ACTA DIABETOL LAT, V19, P243, DOI 10.1007/BF02624684; Lee Rachel, 2010, Hawaii Med J, V69, P28; MIROUZE J, 1978, DIABETOLOGIA, V14, P223, DOI 10.1007/BF01219420; Mortensen HB, 2010, PEDIATR DIABETES, V11, P218, DOI 10.1111/j.1399-5448.2009.00566.x; Muhammad J, 1999, ARCH DIS CHILD, V80, P367, DOI 10.1136/adc.80.4.367; New Zealand Health Information Service, 2010, DOM COD TABL; New Zealand. Ministry of Social Development, 2010, SOC REP; Overstreet S, 1997, DIABETIC MED, V14, P153, DOI 10.1002/(SICI)1096-9136(199702)14:2<153::AID-DIA318>3.0.CO;2-K; Povlsen L, 2005, J ADV NURS, V50, P576, DOI 10.1111/j.1365-2648.2005.03443.x; Salmond C, 2002, NZDEP2001 INDEX DEPR; Salmond C., 2007, NZDEP2006 INDEX DEPR; SHAH SC, 1989, NEW ENGL J MED, V320, P550, DOI 10.1056/NEJM198903023200902; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186; Simmons D, 2004, DIABETES CARE, V27, P3002, DOI 10.2337/diacare.27.12.3002; Sopoaga F, 2010, J PRIM HEALTH CARE, V2, P105, DOI 10.1071/HC10105; Springer D, 2006, J PEDIATR-US, V149, P227, DOI 10.1016/j.jpeds.2006.03.052; Statistics New Zealand, 2006, 2006 CENS DAT QUICKS; Sundborn G, 2010, NZ MED J, V123, P4036; Swift EE, 2006, ANN BEHAV MED, V32, P39, DOI 10.1207/s15324796abm3201_5; Thompson SJ, 2001, DIABETES CARE, V24, P234, DOI 10.2337/diacare.24.2.234; Tomlin Andrew, 2006, N Z Med J, V119, pU2004; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Tyrrell VJ, 2001, INT J OBESITY, V25, P164, DOI 10.1038/sj.ijo.0801532; Viswanathan V, 2011, DIABETES RES CLIN PR, V92, P65, DOI 10.1016/j.diabres.2010.12.032; Williams DR, 1999, ANN NY ACAD SCI, V896, P173, DOI 10.1111/j.1749-6632.1999.tb08114.x; Wolfsdorf J, 2009, PEDIATR DIABETES, V10, P118, DOI 10.1111/j.1399-5448.2009.00569.x	54	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25251	10.1371/journal.pone.0025251	http://dx.doi.org/10.1371/journal.pone.0025251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966469	gold, Green Submitted, Green Published			2022-12-25	WOS:000295932100029
J	Hudson, NJ; Gu, Q; Nagaraj, SH; Ding, YS; Dalrymple, BP; Reverter, A				Hudson, Nicholas J.; Gu, Quan; Nagaraj, Shivashankar H.; Ding, Yong-Sheng; Dalrymple, Brian P.; Reverter, Antonio			Eukaryotic Evolutionary Transitions Are Associated with Extreme Codon Bias in Functionally-Related Proteins	PLOS ONE			English	Article							SYNONYMOUS CODON; USAGE BIAS; ADAPTATION INDEX; GENE-EXPRESSION; TRANSFER-RNAS; QUANTIFICATION; FAMILY; SITES	Codon bias in the genome of an organism influences its phenome by changing the speed and efficiency of mRNA translation and hence protein abundance. We hypothesized that differences in codon bias, either between-species differences in orthologous genes, or within-species differences between genes, may play an evolutionary role. To explore this hypothesis, we compared the genome-wide codon bias in six species that occupy vital positions in the Eukaryotic Tree of Life. We acquired the entire protein coding sequences for these organisms, computed the codon bias for all genes in each organism and explored the output for relationships between codon bias and protein function, both within-and between-lineages. We discovered five notable coordinated patterns, with extreme codon bias most pronounced in traits considered highly characteristic of a given lineage. Firstly, the Homo sapiens genome had stronger codon bias for DNA-binding transcription factors than the Saccharomyces cerevisiae genome, whereas the opposite was true for ribosomal proteins - perhaps underscoring transcriptional regulation in the origin of complexity. Secondly, both mammalian species examined possessed extreme codon bias in genes relating to hair - a tissue unique to mammals. Thirdly, Arabidopsis thaliana showed extreme codon bias in genes implicated in cell wall formation and chloroplast function - which are unique to plants. Fourthly, Gallus gallus possessed strong codon bias in a subset of genes encoding mitochondrial proteins perhaps reflecting the enhanced bioenergetic efficiency in birds that co-evolved with flight. And lastly, the G. gallus genome had extreme codon bias for the Ciliary Neurotrophic Factor - which may help to explain their spontaneous recovery from deafness. We propose that extreme codon bias in groups of genes that encode functionally related proteins has a pathway-level energetic explanation.	[Hudson, Nicholas J.; Gu, Quan; Nagaraj, Shivashankar H.; Dalrymple, Brian P.; Reverter, Antonio] CSIRO Livestock Ind, Brisbane, Qld, Australia; [Gu, Quan; Ding, Yong-Sheng] Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Donghua University	Hudson, NJ (corresponding author), CSIRO Livestock Ind, Brisbane, Qld, Australia.	nick.hudson@csiro.au	Reverter, Antonio/C-9699-2013; Hudson, Nick/AAF-5644-2020; Dalrymple, Brian P/F-8721-2010; Hudson, Nick/C-1201-2008; Hudson, Nicholas J/D-1606-2011	Reverter, Antonio/0000-0002-4681-9404; Hudson, Nick/0000-0002-3549-9396; Dalrymple, Brian P/0000-0003-3891-5233; Hudson, Nicholas J/0000-0002-3549-9396; Gu, Quan/0000-0002-1201-6734	National Nature Science Foundation of China [60975059, 60775052]; Ministry of Education of China [20090075110002]; Shanghai Committee of Science and Technology [10JC1400200, 10DZ0506500, 09JC1400900]; CSIRO; CSIRO Transformational Biology Capability Platform and Food Futures Flagship	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Transformational Biology Capability Platform and Food Futures Flagship	This work was supported by the National Nature Science Foundation of China (No. 60975059, 60775052), Specialized Research Fund for the Doctoral Program of Higher Education from Ministry of Education of China (No. 20090075110002), Project of the Shanghai Committee of Science and Technology (Nos. 10JC1400200, 10DZ0506500, 09JC1400900). Shivashankar H. Nagaraj is grateful to CSIRO for the award of an OCE Post-Doctoral Fellowship. The financial support of the CSIRO Transformational Biology Capability Platform and Food Futures Flagship is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg OG, 1999, J MOL EVOL, V48, P398, DOI 10.1007/PL00006484; Bracewell RN, 2000, FOURIER TRANSFORM IT; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Carlini DB, 2001, GENETICS, V159, P623; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Cutter AD, 2006, MOL BIOL EVOL, V23, P2303, DOI 10.1093/molbev/msl097; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Gregory TR, 2002, GENETICA, V115, P131, DOI 10.1023/A:1016032400147; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; Hsu YC, 2010, J BIOL CHEM, V285, P13885, DOI 10.1074/jbc.M109.081463; Hurst LD, 2011, NATURE, V471, P582, DOI 10.1038/471582a; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Itzkovitz S, 2010, GENOME RES, V20, P1582, DOI 10.1101/gr.105072.110; Lane N., 2002, OXYGEN MOL MADE WORL; Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200; Maderson PFA, 2003, EXP DERMATOL, V12, P233, DOI 10.1034/j.1600-0625.2003.00069.x; McInerney JO, 1998, BIOINFORMATICS, V14, P372, DOI 10.1093/bioinformatics/14.4.372; McPherson JD, 2004, PROPOSAL SEQUENCE GE; Pennisi E, 2010, SCIENCE, V329, P128, DOI 10.1126/science.329.5988.128-a; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; PINCUS SM, 1994, METHOD ENZYMOL, V240, P68; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Powell JR, 1997, P NATL ACAD SCI USA, V94, P7784, DOI 10.1073/pnas.94.15.7784; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Roux B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S12; Sau Keya, 2007, Journal of Microbiology Immunology and Infection, V40, P24; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shinohara T, 2002, P NATL ACAD SCI USA, V99, P1657, DOI 10.1073/pnas.032677999; Supek F, 2004, BIOINFORMATICS, V20, P2329, DOI 10.1093/bioinformatics/bth238; Takahashi A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-214; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan X, 2003, INTELLIGENT ENG SYST, P1101; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Wu DD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-241; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Zhang F, SCIENCE, V329, P1534	43	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25457	10.1371/journal.pone.0025457	http://dx.doi.org/10.1371/journal.pone.0025457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966531	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000295267100062
J	Jost, S; Quillay, H; Reardon, J; Peterson, E; Simmons, RP; Parry, BA; Bryant, NNP; Binder, WD; Altfeld, M				Jost, Stephanie; Quillay, Heloise; Reardon, Jeff; Peterson, Eric; Simmons, Rachel P.; Parry, Blair A.; Bryant, Nancy N. P.; Binder, William D.; Altfeld, Marcus			Changes in Cytokine Levels and NK Cell Activation Associated with Influenza	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; VIRUS-INFECTED CELLS; HUMORAL IMMUNITY; HIV-1 INFECTION; DENDRITIC CELLS; RECOGNITION; PATHOGENESIS; RESPONSES; MICE; H5N1	Several studies have highlighted the important role played by murine natural killer (NK) cells in the control of influenza infection. However, human NK cell responses in acute influenza infection, including infection with the 2009 pandemic H1N1 influenza virus, are poorly documented. Here, we examined changes in NK cell phenotype and function and plasma cytokine levels associated with influenza infection and vaccination. We show that absolute numbers of peripheral blood NK cells, and particularly those of CD56(bright) NK cells, decreased upon acute influenza infection while this NK cell subset expanded following intramuscular influenza vaccination. NK cells exposed to influenza antigens were activated, with higher proportions of NK cells expressing CD69 in study subjects infected with seasonal influenza strains. Vaccination led to increased levels of CD25+ NK cells, and notably CD56(bright) CD25+ NK cells, whereas decreased amounts of this subset were present in the peripheral blood of influenza infected individuals, and predominantly in study subjects infected with the 2009 pandemic H1N1 influenza virus. Finally, acute influenza infection was associated with low plasma concentrations of inflammatory cytokines, including IFN-gamma, MIP-1 beta, IL-2 and IL-15, and high levels of the anti-inflammatory cytokines IL-10 and IL-1ra. Altogether, these data suggest a role for the CD56(bright) NK cell subset in the response to influenza, potentially involving their recruitment to infected tissues and a local production and/or uptake of inflammatory cytokines.	[Jost, Stephanie; Quillay, Heloise; Reardon, Jeff; Peterson, Eric; Simmons, Rachel P.; Altfeld, Marcus] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ragon Inst Massachusetts Gen Hosp,Massachusetts I, Boston, MA 02215 USA; [Parry, Blair A.; Binder, William D.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Bryant, Nancy N. P.] Massachusetts Gen Hosp, Massachusetts Gen Hosp Med Walk Clin, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Jost, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ragon Inst Massachusetts Gen Hosp,Massachusetts I, Boston, MA 02215 USA.	maltfeld@partners.org	Altfeld, Marcus/AAE-7306-2019	Altfeld, Marcus/0000-0001-5972-2997; Simmons, Rachel/0000-0003-2498-7965	Doris Duke Charitable Foundation; Philip T. and Susan M. Ragon Foundation; Swiss National Science Foundation [PBELP3-122872]; Massachusetts General Hospital Executive Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Philip T. and Susan M. Ragon Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Massachusetts General Hospital Executive Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Doris Duke Charitable Foundation (MA; http://www.ddcf.org/) and the Philip T. and Susan M. Ragon Foundation (MA; http://www.ragoninstitute.org). SJ was supported by the Swiss National Science Foundation (PBELP3-122872; http://www.snf.ch) and the Massachusetts General Hospital Executive Committee on Research Fund for Medical Discovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achdout H, 2003, J IMMUNOL, V171, P915, DOI 10.4049/jimmunol.171.2.915; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Alter G, 2007, J INFECT DIS, V195, P1452, DOI 10.1086/513878; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Biron CA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000816; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Bjorkstrom NK, 2010, J EXP MED; CALIGIURI MA, 1990, J EXP MED, V171, P1509, DOI 10.1084/jem.171.5.1509; Centers for Disease Control and Prevention website, 2009, MMWR MORB MORT WEEKL; Chen RF, 2006, MICROBES INFECT, V8, P122, DOI 10.1016/j.micinf.2005.06.007; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Denney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010675; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Dong L, 2000, J INFECT DIS, V182, P391, DOI 10.1086/315727; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; Du N, 2010, J VIROL, V84, P7822, DOI 10.1128/JVI.00069-10; ENNIS FA, 1981, LANCET, V2, P891; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Guo HL, 2009, IMMUNOL CELL BIOL, V87, P579, DOI 10.1038/icb.2009.60; He XS, 2004, J CLIN INVEST, V114, P1812, DOI 10.1172/JCI200422797; Heltzer ML, 2009, J LEUKOCYTE BIOL, V85, P1036, DOI 10.1189/jlb.1108710; Ho JW, 2008, J VIROL, V82, P2028, DOI 10.1128/JVI.02065-07; Jost S, 2010, IMMUNOLOGY; Kaiser L, 2001, J MED VIROL, V64, P262, DOI 10.1002/jmv.1045; Kos FJ, 1996, CELL IMMUNOL, V173, P1, DOI 10.1006/cimm.1996.0245; Kuijpers TW, 2008, BLOOD, V112, P914, DOI 10.1182/blood-2008-05-157354; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Liu BX, 2004, J GEN VIROL, V85, P423, DOI 10.1099/vir.0.19596-0; Long BR, 2008, CLIN VACCINE IMMUNOL, V15, P120, DOI 10.1128/CVI.00357-07; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mao HW, 2009, J VIROL, V83, P9215, DOI 10.1128/JVI.00805-09; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Nogusa S, 2008, MECH AGEING DEV, V129, P223, DOI 10.1016/j.mad.2008.01.003; Owen RE, 2007, J VIROL, V81, P11170, DOI 10.1128/JVI.01217-07; REYNOLDS CW, 1981, J IMMUNOL, V127, P282; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Sanchez-Cordon PJ, 2005, VET PATHOL, V42, P477, DOI 10.1354/vp.42-4-477; Scalera NM, 2009, POSTGRAD MED, V121, P43, DOI 10.3810/pgm.2009.09.2051; Siren J, 2004, J GEN VIROL, V85, P2357, DOI 10.1099/vir.0.80105-0; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stein-Streilein J, 1988, Reg Immunol, V1, P100; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; STEINSTREILEIN J, 1983, J IMMUNOL, V131, P2699; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Sun K, 2010, J VIROL, V84, P5007, DOI 10.1128/JVI.02408-09; Swiergiel AH, 1997, BRAIN RES, V776, P96, DOI 10.1016/S0006-8993(97)01009-3; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; World Health Organization, SEAS INFL FACT SHEET	61	48	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25060	10.1371/journal.pone.0025060	http://dx.doi.org/10.1371/journal.pone.0025060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966414	gold, Green Published, Green Submitted			2022-12-25	WOS:000295267100019
J	Szabo, V; Muskotal, A; Toth, B; Mihovilovic, MD; Vonderviszt, F				Szabo, Veronika; Muskotal, Adel; Toth, Balazs; Mihovilovic, Marko D.; Vonderviszt, Ferenc			Construction of a Xylanase A Variant Capable of Polymerization	PLOS ONE			English	Article							BIOENGINEERED FLAGELLA; BACTERIAL FLAGELLA; FILAMENT FORMATION; TERMINAL REGIONS; NANOTUBES; DISPLAY; PROTEIN	The aim of our work is to furnish enzymes with polymerization ability by creating fusion constructs with the polymerizable protein, flagellin, the main component of bacterial flagellar filaments. The D3 domain of flagellin, exposed on the surface of flagellar filaments, is formed by the hypervariable central portion of the polypeptide chain. D3 is not essential for filament formation. The concept in this project is to replace the D3 domain with suitable monomeric enzymes without adversely affecting polymerization ability, and to assemble these chimeric flagellins into tubular nanostructures. To test the feasibility of this approach, xylanase A (XynA) from B. subtilis was chosen as a model enzyme for insertion into the central part of flagellin. With the help of genetic engineering, a fusion construct was created in which the D3 domain was replaced by XynA. The flagellin-XynA chimera exhibited catalytic activity as well as polymerization ability. These results demonstrate that polymerization ability can be introduced into various proteins, and building blocks for rationally designed assembly of filamentous nanostructures can be created.	[Szabo, Veronika; Muskotal, Adel; Toth, Balazs; Vonderviszt, Ferenc] Univ Pannonia, Bionanosyst Lab, Fac Informat Technol, Res Inst Chem & Proc Engn, Veszprem, Hungary; [Toth, Balazs] Hungarian Acad Sci, Agr Res Inst, H-2462 Martonvasar, Hungary; [Mihovilovic, Marko D.] Vienna Univ Technol, Inst Appl Synthet Chem, A-1040 Vienna, Austria; [Vonderviszt, Ferenc] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary	University of Pannonia; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Technische Universitat Wien; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Szabo, V (corresponding author), Univ Pannonia, Bionanosyst Lab, Fac Informat Technol, Res Inst Chem & Proc Engn, Veszprem, Hungary.	von007@almos.vein.hu	Toth, Balazs/B-4252-2012; Vonderviszt, Ferenc/GLR-5618-2022	Vonderviszt, Ferenc/0000-0002-6498-8172; Mihovilovic, Marko D./0000-0002-5438-8368	Hungarian Scientific Research Fund (OTKA) [NK77978]; National Development Agency [CK77819, TAMOP-4.2.2/B-10/1-2010-0025]; Hungarian Academy of Sciences	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	The support of the Hungarian Scientific Research Fund (OTKA grant NK77978) and the National Development Agency (grants CK77819 and TAMOP-4.2.2/B-10/1-2010-0025) is gratefully acknowledged. BT was supported by the Bolyai Fellowship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Ezaki S, 1998, J FERMENT BIOENG, V86, P500, DOI 10.1016/S0922-338X(98)80159-1; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ge J, 2009, BIOCHEM ENG J, V44, P53, DOI 10.1016/j.bej.2009.01.002; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Kim JB, 2008, TRENDS BIOTECHNOL, V26, P639, DOI 10.1016/j.tibtech.2008.07.009; Kumara MT, 2007, BIOMACROMOLECULES, V8, P3718, DOI 10.1021/bm7005449; Kumara MT, 2007, J NANOSCI NANOTECHNO, V7, P2260, DOI 10.1166/jnn.2007.641; Kumara MT, 2007, J PHYS CHEM C, V111, P5276, DOI 10.1021/jp067479n; MimoriKiyosue Y, 1997, J MOL BIOL, V270, P222, DOI 10.1006/jmbi.1997.1111; MimoriKiyosue Y, 1996, P NATL ACAD SCI USA, V93, P15108, DOI 10.1073/pnas.93.26.15108; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Murakami MT, 2005, FEBS LETT, V579, P6505, DOI 10.1016/j.febslet.2005.10.039; Muskotal A, 2010, J MOL BIOL, V403, P607, DOI 10.1016/j.jmb.2010.09.024; Saijo-Hamano Y, 2000, J STRUCT BIOL, V132, P142, DOI 10.1006/jsbi.2000.4311; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Stocker B A, 1994, Int Rev Immunol, V11, P167, DOI 10.3109/08830189409061724; VONDERVISZT F, 1991, J MOL BIOL, V221, P1461, DOI 10.1016/0022-2836(91)90946-4; VONDERVISZT F, 1989, J MOL BIOL, V209, P127, DOI 10.1016/0022-2836(89)90176-9; Vonderviszt F., 2008, FIBROUS PROTEINS, P58; Westerlund-Wikstrom B, 2000, INT J MED MICROBIOL, V290, P223; Woods RD, 2007, NANO LETT, V7, P1809, DOI 10.1021/nl0702968; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	26	13	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25388	10.1371/journal.pone.0025388	http://dx.doi.org/10.1371/journal.pone.0025388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966517	Green Submitted, gold, Green Published			2022-12-25	WOS:000295267100054
J	Tamaki, H; Wright, CL; Li, XZ; Lin, QY; Hwang, CC; Wang, SP; Thimmapuram, J; Kamagata, Y; Liu, WT				Tamaki, Hideyuki; Wright, Chris L.; Li, Xiangzhen; Lin, Qiaoyan; Hwang, Chiachi; Wang, Shiping; Thimmapuram, Jyothi; Kamagata, Yoichi; Liu, Wen-Tso			Analysis of 16S rRNA Amplicon Sequencing Options on the Roche/454 Next-Generation Titanium Sequencing Platform	PLOS ONE			English	Article							SPECIES RICHNESS; RARE BIOSPHERE; GENE; COMMUNITY; FRAGMENTS; TAXONOMY; PCR	Background: 16S rRNA gene pyrosequencing approach has revolutionized studies in microbial ecology. While primer selection and short read length can affect the resulting microbial community profile, little is known about the influence of pyrosequencing methods on the sequencing throughput and the outcome of microbial community analyses. The aim of this study is to compare differences in output, ease, and cost among three different amplicon pyrosequencing methods for the Roche/454 Titanium platform Methodology/Principal Findings: The following three pyrosequencing methods for 16S rRNA genes were selected in this study: Method-1 (standard method) is the recommended method for bi-directional sequencing using the LIB-A kit; Method-2 is a new option designed in this study for unidirectional sequencing with the LIB-A kit; and Method-3 uses the LIB-L kit for unidirectional sequencing. In our comparison among these three methods using 10 different environmental samples, Method-2 and Method-3 produced 1.5-1.6 times more useable reads than the standard method (Method-1), after quality-based trimming, and did not compromise the outcome of microbial community analyses. Specifically, Method-3 is the most cost-effective unidirectional amplicon sequencing method as it provided the most reads and required the least effort in consumables management. Conclusions: Our findings clearly demonstrated that alternative pyrosequencing methods for 16S rRNA genes could drastically affect sequencing output (e. g. number of reads before and after trimming) but have little effect on the outcomes of microbial community analysis. This finding is important for both researchers and sequencing facilities utilizing 16S rRNA gene pyrosequencing for microbial ecological studies.	[Tamaki, Hideyuki; Li, Xiangzhen; Lin, Qiaoyan; Hwang, Chiachi; Liu, Wen-Tso] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [Tamaki, Hideyuki; Kamagata, Yoichi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Wright, Chris L.; Thimmapuram, Jyothi] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Roy J Carver Biotechnol Ctr, Urbana, IL USA; [Lin, Qiaoyan; Wang, Shiping] Chinese Acad Sci, Key Lab Adaptat & Evolut Plateau Biota, Haibei Alpine Meadow Ecosyst Res Stn, NW Inst Plateau Biol, Xining, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; National Institute of Advanced Industrial Science & Technology (AIST); University of Illinois System; University of Illinois Urbana-Champaign; Chinese Academy of Sciences	Tamaki, H (corresponding author), Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA.	wtliu@illinois.edu	Tamaki, Hideyuki/M-9863-2016; Liu, Wen-Tso/C-8788-2011; Tamaki, Hideyuki/C-9414-2009; Lin, Qiaoyan/H-1164-2011	Liu, Wen-Tso/0000-0002-8700-9803; 	University of Illinois; Grants-in-Aid for Scientific Research [23657069] Funding Source: KAKEN	University of Illinois; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a start-up account for WTL from the University of Illinois. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Hamp TJ, 2009, APPL ENVIRON MICROB, V75, P3263, DOI 10.1128/AEM.01931-08; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lykidis A, 2011, ISME J, V5, P122, DOI 10.1038/ismej.2010.125; Palatinszky M, 2011, J MICROBIOL METH, V85, P131, DOI 10.1016/j.mimet.2011.02.007; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09	17	167	184	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25263	10.1371/journal.pone.0025263	http://dx.doi.org/10.1371/journal.pone.0025263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966473	Green Submitted, Green Published, gold			2022-12-25	WOS:000295267100034
J	Delivopoulos, E; Murray, AF				Delivopoulos, Evangelos; Murray, Alan F.			Controlled Adhesion and Growth of Long Term Glial and Neuronal Cultures on Parylene-C	PLOS ONE			English	Article							POLYETHYLENE-GLYCOL; NEUROTROPHIC FACTOR; CELL-PROLIFERATION; NEURAL-NETWORKS; ASTROCYTES; PATTERNS; SURVIVAL; RELEASE; DENSITY; BDNF	This paper explores the long term development of networks of glia and neurons on patterns of Parylene-C on a SiO2 substrate. We harvested glia and neurons from the Sprague-Dawley (P1-P7) rat hippocampus and utilized an established cell patterning technique in order to investigate cellular migration, over the course of 3 weeks. This work demonstrates that uncontrolled glial mitosis gradually disrupts cellular patterns that are established early during culture. This effect is not attributed to a loss of protein from the Parylene-C surface, as nitrogen levels on the substrate remain stable over 3 weeks. The inclusion of the anti-mitotic cytarabine (Ara-C) in the culture medium moderates glial division and thus, adequately preserves initial glial and neuronal conformity to underlying patterns. Neuronal apoptosis, often associated with the use of Ara-C, is mitigated by the addition of brain derived neurotrophic factor (BDNF). We believe that with the right combination of glial inhibitors and neuronal promoters, the Parylene-C based cell patterning method can generate structured, active neural networks that can be sustained and investigated over extended periods of time. To our knowledge this is the first report on the concurrent application of Ara-C and BDNF on patterned cell cultures.	[Delivopoulos, Evangelos] Univ Cambridge, Dept Engn, Nanosci Ctr, Cambridge CB2 1PZ, Cambs, England; [Murray, Alan F.] Univ Edinburgh, Sch Engn & Elect, Inst Integrated Micro & Nano Syst, Edinburgh, Midlothian, Scotland	University of Cambridge; University of Edinburgh	Delivopoulos, E (corresponding author), Univ Cambridge, Dept Engn, Nanosci Ctr, Cambridge CB2 1PZ, Cambs, England.	ed369@cam.ac.uk			Engineering and Physical Sciences Research Council (EPSRC) [EP/G005508/1]; EPSRC [EP/H011242/1, EP/G005508/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G005508/1, EP/H011242/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Engineering and Physical Sciences Research Council (EPSRC), grant reference: EP/G005508/1 (http://gow.epsrc.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNEY ER, 1981, DEV BIOL, V83, P301, DOI 10.1016/0012-1606(81)90476-0; Aguado F, 2002, J NEUROSCI, V22, P9430; Ahlemeyer B, 2003, NEUROCHEM INT, V42, P567, DOI 10.1016/S0197-0186(02)00164-X; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bartrup JT, 1997, NEUROREPORT, V8, P3791, DOI 10.1097/00001756-199712010-00027; Boehler MD, 2007, NEURON GLIA BIOL, V3, P127, DOI 10.1017/S1740925X07000440; Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4; Branch DW, 2000, IEEE T BIO-MED ENG, V47, P290, DOI 10.1109/10.827289; Brewer GJ, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/014001; Chang JC, 2000, BIOMED MICRODEVICES, V2, P245, DOI 10.1023/A:1009946920296; Delivopoulos E, 2010, J BIOMED MATER RES A, V94A, P47, DOI 10.1002/jbm.a.32662; Delivopoulos E, 2009, BIOMATERIALS, V30, P2048, DOI 10.1016/j.biomaterials.2008.12.049; Depboylu C, 2007, NEURODEGENER DIS, V4, P218, DOI 10.1159/000101846; Franks W, 2007, BIOSENS BIOELECTRON, V22, P1426, DOI 10.1016/j.bios.2006.06.031; Frimat JP, 2010, LAB CHIP, V10, P701, DOI 10.1039/b922193j; Hardelauf H, 2011, LAB CHIP, V11, P2763, DOI 10.1039/c1lc20257j; HATTEN ME, 1987, J CELL BIOL, V104, P1353, DOI 10.1083/jcb.104.5.1353; Jun SB, 2008, J NEURAL ENG, V5, P203, DOI 10.1088/1741-2560/5/2/011; Jun SB, 2007, J NEUROSCI METH, V160, P317, DOI 10.1016/j.jneumeth.2006.09.009; Leeds P, 2005, NEUROCHEM INT, V46, P61, DOI 10.1016/j.neuint.2004.07.001; Millet LJ, 2010, LAB CHIP, V10, P1525, DOI 10.1039/c001552k; Musick K, 2009, LAB CHIP, V9, P2036, DOI 10.1039/b820596e; Nam Y, 2004, IEE Proc Nanobiotechnol, V151, P109, DOI 10.1049/ip-nbt:20040706; Nam Y, 2005, I IEEE EMBS C NEUR E, P325; Nam Y, 2007, J BIOMAT SCI-POLYM E, V18, P1091, DOI 10.1163/156856207781494430; Nam Y, 2006, BIOSENS BIOELECTRON, V22, P589, DOI 10.1016/j.bios.2006.01.027; Negishi T, 2003, J NEUROSCI METH, V131, P133, DOI 10.1016/j.jneumeth.2003.08.006; Pinzon-Duarte G, 2004, EUR J NEUROSCI, V19, P1475, DOI 10.1111/j.1460-9568.2004.03252.x; Rhodes KE, 2003, NEUROSCIENCE, V120, P41, DOI 10.1016/S0306-4522(03)00285-9; Sakai R, 2005, J NEURAL TRANSM, V112, P1005, DOI 10.1007/s00702-004-0246-4; Schmidt EM, 1995, J NEUROSCI METH, V62, P89, DOI 10.1016/0165-0270(95)00060-7; SHARMA A, 2010, APPL PHYS LETT, V96; Takeuchi S, 2005, LAB CHIP, V5, P519, DOI 10.1039/b417497f; Tooker A, 2005, IEEE ENG MED BIOL, V24, P30, DOI 10.1109/MEMB.2005.1549727; Unsworth CF, 2010, J NEUROSCI METH, V194, P154, DOI 10.1016/j.jneumeth.2010.09.022; Unsworth CP, 2011, BIOMATERIALS, V32, P6541, DOI 10.1016/j.biomaterials.2011.05.041; Unsworth CR, 2011, BIOMATERIALS, V32, P2566, DOI 10.1016/j.biomaterials.2010.12.017; WALLACE TL, 1989, J NEUROSCI, V9, P115; Wheeler BC, 2010, P IEEE, V98, P398, DOI 10.1109/JPROC.2009.2039029; Wright D, 2007, LAB CHIP, V7, P1272, DOI 10.1039/b706081e; Yu MR, 2011, ACS NANO, V5, P2447, DOI 10.1021/nn103618d; Zeng HC, 2007, J NEUROSCI METH, V165, P72, DOI 10.1016/j.jneumeth.2007.05.027; Zheng HP, 2004, LANGMUIR, V20, P7215, DOI 10.1021/la049856y	43	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25411	10.1371/journal.pone.0025411	http://dx.doi.org/10.1371/journal.pone.0025411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966523	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000295265100097
J	He, YZ; Staser, K; Rhodes, SD; Liu, YL; Wu, XH; Park, SJ; Yuan, J; Yang, XL; Li, XH; Jiang, L; Chen, S; Yang, FC				He, Yongzheng; Staser, Karl; Rhodes, Steven D.; Liu, Yaling; Wu, Xiaohua; Park, Su-Jung; Yuan, Jin; Yang, Xianlin; Li, Xiaohong; Jiang, Li; Chen, Shi; Yang, Feng-Chun			Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive Activity	PLOS ONE			English	Article							RECEPTOR ACTIVATOR; P85-ALPHA SUBUNIT; PMMA-INDUCTION; KINASE; LIGAND; PATHWAY; RAS; PHOSPHORYLATION; PATHOGENESIS; MATURATION	The extracellular signal-regulated kinases (ERK1 and 2) are widely-expressed and they modulate proliferation, survival, differentiation, and protein synthesis in multiple cell lineages. Altered ERK1/2 signaling is found in several genetic diseases with skeletal phenotypes, including Noonan syndrome, Neurofibromatosis type 1, and Cardio-facio-cutaneous syndrome, suggesting that MEK-ERK signals regulate human skeletal development. Here, we examine the consequence of Erk1 and Erk2 disruption in multiple functions of osteoclasts, specialized macrophage/monocyte lineage-derived cells that resorb bone. We demonstrate that Erk1 positively regulates osteoclast development and bone resorptive activity, as genetic disruption of Erk1 reduced osteoclast progenitor cell numbers, compromised pit formation, and diminished M-CSF-mediated adhesion and migration. Moreover, WT mice reconstituted long-term with Erk1(-/-) bone marrow mononuclear cells (BMMNCs) demonstrated increased bone mineral density as compared to recipients transplanted with WT and Erk2(-/-) BMMNCs, implicating marrow autonomous, Erk1-dependent osteoclast function. These data demonstrate Erk1 plays an important role in osteoclast functions while providing rationale for the development of Erk1-specific inhibitors for experimental investigation and/or therapeutic modulation of aberrant osteoclast function.	[He, Yongzheng; Staser, Karl; Liu, Yaling; Wu, Xiaohua; Park, Su-Jung; Yuan, Jin; Yang, Xianlin; Li, Xiaohong; Jiang, Li; Chen, Shi; Yang, Feng-Chun] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46204 USA; [He, Yongzheng; Staser, Karl; Rhodes, Steven D.; Liu, Yaling; Wu, Xiaohua; Park, Su-Jung; Yuan, Jin; Yang, Xianlin; Li, Xiaohong; Jiang, Li; Chen, Shi; Yang, Feng-Chun] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA; [Rhodes, Steven D.; Yang, Feng-Chun] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	He, YZ (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46204 USA.	fyang@iupui.edu			Department of Defense [NF043032, NF073112]; National Institutes of Health [T32 CA111198]; NCCR [5TL1RR025759-03]; NATIONAL CANCER INSTITUTE [T32CA111198] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025759] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCR(Swiss National Science Foundation (SNSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the Department of Defense (http://www.defense.gov/) NF043032 (FCY) and NF073112 (FCY). KS was additionally supported by a pre-doctoral training grant from the National Institutes of Health (http://www.nih.gov/) Grant T32 CA111198. SR is a Pre-Doctoral Trainee of Indiana CTSI (Career Development Award from NCCR 5TL1RR025759-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2003, J ORTHOPAED RES, V21, P1041, DOI 10.1016/S0736-0266(03)00081-0; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; AUBIN JE, 1992, J BONE MINER RES, V7, P365; Bates ME, 2010, J IMMUNOL, V184, P7125, DOI 10.4049/jimmunol.0900634; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Bourcier C, 2006, CANCER RES, V66, P2700, DOI 10.1158/0008-5472.CAN-05-3129; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bradley Elizabeth W., 2008, V455, P19, DOI 10.1007/978-1-59745-104-8_2; Chambers TJ, 2000, J PATHOL, V192, P4; Chellaiah MA, 2003, CALCIFIED TISSUE INT, V72, P197, DOI 10.1007/s00223-002-1025-6; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; Datta HK, 2008, J CLIN PATHOL, V61, P577, DOI 10.1136/jcp.2007.048868; Fiil BK, 2009, CURR OPIN PLANT BIOL, V12, P615, DOI 10.1016/j.pbi.2009.07.017; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; Kim HH, 2003, EXP CELL RES, V289, P368, DOI 10.1016/S0014-4827(03)00288-X; Kinoshita T, 2008, BIOCHEM BIOPH RES CO, V377, P1123, DOI 10.1016/j.bbrc.2008.10.127; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Munugalavadla V, 2005, BLOOD, V106, P103, DOI 10.1182/blood-2004-10-4041; Munugalavadla V, 2008, MOL CELL BIOL, V28, P7182, DOI 10.1128/MCB.00920-08; Newbern J, 2008, P NATL ACAD SCI USA, V105, P17115, DOI 10.1073/pnas.0805239105; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Seibel Markus J, 2005, Clin Biochem Rev, V26, P97; Shaul YD, 2009, GENE DEV, V23, P1779, DOI 10.1101/gad.523909; STEVENSON D, CLIN GENET; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; TUMURKHUU M, PEDIAT INT, V52, P557; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wu XH, 2006, HUM MOL GENET, V15, P2837, DOI 10.1093/hmg/ddl208; Yamanaka Y, 2006, J ORTHOP RES, V24, P1349, DOI 10.1002/jor.20199; Yan JC, 2008, HUM MOL GENET, V17, P936, DOI 10.1093/hmg/ddm366; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Yang FC, 2006, J CLIN INVEST, V116, P2880, DOI 10.1172/JCI29092; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yasuda T, 2008, IMMUNITY, V28, P499, DOI 10.1016/j.immuni.2008.02.015; Yip KHM, 2006, AM J PATHOL, V169, P503, DOI 10.2353/ajpath.2006.050960	46	88	90	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24780	10.1371/journal.pone.0024780	http://dx.doi.org/10.1371/journal.pone.0024780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961044	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100018
J	Kitayama, M; Ueno, M; Itakura, T; Yamashita, T				Kitayama, Mari; Ueno, Masaki; Itakura, Toru; Yamashita, Toshihide			Activated Microglia Inhibit Axonal Growth through RGMa	PLOS ONE			English	Article							SPINAL-CORD-INJURY; REPULSIVE GUIDANCE MOLECULE; CNS INJURY; MINOCYCLINE; REGENERATION; MACROPHAGES; RECOVERY; EXPRESSION; DEATH; DIEBACK	By causing damage to neural networks, spinal cord injuries (SCI) often result in severe motor and sensory dysfunction. Functional recovery requires axonal regrowth and regeneration of neural network, processes that are quite limited in the adult central nervous system (CNS). Previous work has shown that SCI lesions contain an accumulation of activated microglia, which can have multiple pathophysiological influences. Here, we show that activated microglia inhibit axonal growth via repulsive guidance molecule a (RGMa). We found that microglia activated by lipopolysaccharide (LPS) inhibited neurite outgrowth and induced growth cone collapse of cortical neurons in vitro-a pattern that was only observed when there was direct contact between microglia and neurons. After microglia were activated by LPS, they increased expression of RGMa; however, treatment with RGMa-neutralizing antibodies or transfection of RGMa siRNA attenuated the inhibitory effects of microglia on axonal outgrowth. Furthermore, minocycline, an inhibitor of microglial activation, attenuated the effects of microglia and RGMa expression. Finally, we examined whether these in vitro patterns could also be observed in vivo. Indeed, in a mouse SCI model, minocycline treatment reduced the accumulation of microglia and decreased RGMa expression after SCI, leading to reduced dieback in injured corticospinal tracts. These results suggest that activated microglia play a major role in inhibiting axon regeneration via RGMa in the injured CNS.	[Kitayama, Mari; Ueno, Masaki; Yamashita, Toshihide] Osaka Univ, Dept Mol Neurosci, Grad Sch Med, Osaka, Japan; [Kitayama, Mari; Itakura, Toru] Wakayama Med Univ, Dept Neurol Surg, Wakayama, Japan; [Ueno, Masaki; Yamashita, Toshihide] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Ueno, Masaki; Yamashita, Toshihide] Japan Sci & Technol Agcy JST, Tokyo, Japan	Osaka University; Wakayama Medical University; Osaka University; Japan Science & Technology Agency (JST)	Kitayama, M (corresponding author), Osaka Univ, Dept Mol Neurosci, Grad Sch Med, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Ueno, Masaki/J-1216-2019	Ueno, Masaki/0000-0003-1484-9921; Yamashita, Toshihide/0000-0003-4559-7018	Japan Society for the Promotion of Science; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by a Grant-in-Aid for Young Scientists (S) from Japan Society for the Promotion of Science and by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Festoff BW, 2006, J NEUROCHEM, V97, P1314, DOI 10.1111/j.1471-4159.2006.03799.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Herrmann JE, 2010, EXP NEUROL, V223, P582, DOI 10.1016/j.expneurol.2010.02.005; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lee JHT, 2010, EXP NEUROL, V225, P219, DOI 10.1016/j.expneurol.2010.06.018; Lee SM, 2004, J NEUROCHEM, V91, P568, DOI 10.1111/j.1471-4159.2004.02780.x; Liu YB, 2008, J NEUROSCI, V28, P8376, DOI 10.1523/JNEUROSCI.1939-08.2008; Longbrake EE, 2007, J NEUROCHEM, V102, P1083, DOI 10.1111/j.1471-4159.2007.04617.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Prewitt CMF, 1997, EXP NEUROL, V148, P433, DOI 10.1006/exnr.1997.6694; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Silver J, 2010, NEURON, V66, P619, DOI 10.1016/j.neuron.2010.05.028; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Ueno Masaki, 2008, Biologics, V2, P253; Wehrle R, 2005, EUR J NEUROSCI, V22, P2134, DOI 10.1111/j.1460-9568.2005.04419.x; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; Yamashita T, 2007, CURR OPIN NEUROBIOL, V17, P29, DOI 10.1016/j.conb.2006.12.001; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007	35	87	96	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25234	10.1371/journal.pone.0025234	http://dx.doi.org/10.1371/journal.pone.0025234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957482	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100042
J	Radulescu, AE; Shields, D				Radulescu, Andreea E.; Shields, Dennis			Clathrin is required for postmitotic Golgi reassembly	FASEB JOURNAL			English	Article						mitosis; remodeling; spindle poles; centrosome	VESICLE-TETHERING PROTEIN; CELL-FREE SYSTEM; PLASMA-MEMBRANE; MITOTIC SPINDLE; APPARATUS; CYTOKINESIS; MITOSIS; ORGANIZATION; INHERITANCE; BIOGENESIS	During the G2-M transition, the highly organized Golgi apparatus undergoes reversible fragmentation through unstacking of the cisternal ribbon and disassembly into radially dispersed vesicles and tubules. These Golgi-derived fragments redistribute randomly within the cytoplasm, partition stochastically, and in telophase coalesce to generate a functionally and structurally intact Golgi complex. Here we identified a novel step in postmitotic Golgi reassembly that requires the clathrin heavy chain (CHC). We used siRNA-mediated CHC knockdown, biochemistry, and morphological analysis and showed that the spindle-and spindle pole-associated clathrin pools are membrane-bound and required for postmitotic Golgi reassembly. The results presented here show that clathrin remains associated with the spindle poles throughout mitosis and that this clathrin pool is distinct from the previously characterized spindle-associated population. We suggest that clathrin may provide a template for postmitotic Golgi reassembly and cisternal remodeling. In absence of the CHC, the Golgi apparatus remained disconnected and disordered and failed to regain its characteristic perinuclear, lace-like morphology. Our findings build on previous independent reports that clathrin is required for Golgi reassembly following disruption with pharmacological agents and for mitotic chromosome congression.-Radulescu, A. E., Shields, D. Clathrin is required for postmitotic Golgi reassembly. FASEB J. 26, 129-136 (2012). www.fasebj.org	[Radulescu, Andreea E.; Shields, Dennis] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Shields, Dennis] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Radulescu, AE (corresponding author), 1300 Morris Pk Ave,Chanin 505, Bronx, NY 10461 USA.	aradulescu@ucsd.edu			U.S. National Institutes of Health [DK21860]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021860, R37DK021860] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This article is dedicated to the memory of Dr. Dennis Shields (1948-2008). The authors thank Drs. Silvia Corvera (University of Massachusetts Medical School, Worcester, MA, USA), Yanzhuang Wang (University of Michigan, Ann Arbor, MI, USA), and Sylvie Urbe (University of Liverpool, School of Biomedical Sciences, Liverpool, UK) for very generous gifts of antibodies and Dr. James Keen (Thomas Jefferson University, Philadelphia, PA, USA) for the CLCdsRed plasmid. The authors thank Dr. Shaeri Mukherjee for helpful suggestions with the manuscript. This work was supported by U.S. National Institutes of Health grant DK21860 to D.S.	Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Blomberg-Wirschell M, 1998, METHOD ENZYMOL, V298, P228, DOI 10.1016/S0076-6879(98)98022-3; Booth D. G., EMBO J, V30, P906; Borlido J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003115; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; CORTHESYTHEULAZ I, 1992, J CELL BIOL, V118, P1333, DOI 10.1083/jcb.118.6.1333; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Gerald NJ, 2001, CELL MOTIL CYTOSKEL, V48, P213, DOI 10.1002/1097-0169(200103)48:3<213::AID-CM1010>3.0.CO;2-V; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Jiang S, 2006, MOL BIOL CELL, V17, P4105, DOI 10.1091/mbc.E05-12-1112; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; KURIYAMA R, 1984, J CELL SCI, V66, P265; Lehtonen S, 2008, MOL BIOL CELL, V19, P2949, DOI 10.1091/mbc.E07-05-0521; Liu ZH, 2009, J CELL BIOL, V186, P473, DOI 10.1083/jcb.200902071; Lowe M, 1998, TRENDS CELL BIOL, V8, P40, DOI 10.1016/S0962-8924(97)01189-6; Lowe M, 2007, NAT REV MOL CELL BIO, V8, P429, DOI 10.1038/nrm2179; MARO B, 1985, J EMBRYOL EXP MORPH, V90, P287; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Misteli T, 1996, FEBS LETT, V389, P66, DOI 10.1016/0014-5793(96)00518-2; Morita E., P NATL ACAD SCI US, V107, P12889; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; Puri S, 2004, J CELL SCI, V117, P451, DOI 10.1242/jcs.00863; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; Radulescu AE, 2007, MOL BIOL CELL, V18, P94, DOI 10.1091/mbc.E06-06-0532; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Seemann J, 2002, SCIENCE, V295, P848, DOI 10.1126/science.1068064; Shimizu H, 2009, J CELL SCI, V122, P3145, DOI 10.1242/jcs.052795; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Warner AK, 2006, TRAFFIC, V7, P205, DOI 10.1111/j.1600-0854.2005.00377.x; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	42	7	7	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					129	136		10.1096/fj.10-167684	http://dx.doi.org/10.1096/fj.10-167684			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21965600	Green Published			2022-12-25	WOS:000299202200014
J	Szabo, ER; Cservenak, M; Dobolyi, A				Szabo, Eva Rebeka; Cservenak, Melinda; Dobolyi, Arpad			Amylin is a novel neuropeptide with potential maternal functions in the rat	FASEB JOURNAL			English	Article						preoptic area; hypothalamus; postpartum mother; peptide expression	MEDIAL PREOPTIC AREA; AMYLOID POLYPEPTIDE AMYLIN; GENE-RELATED PEPTIDE; TUBEROINFUNDIBULAR PEPTIDE; STRIA TERMINALIS; BRAIN-REGIONS; BED NUCLEUS; 39 RESIDUES; C-FOS; BEHAVIOR	Amylin, a 37-aa pancreatic peptide, was found to be expressed in the preoptic area of mother rats in our recent microarray study. Here, we report a marked increase in amylin expression around parturition and show that amylin mRNA level remains elevated as long as the pups are not removed from the dams. Amylin expression is also induced in maternally behaving (sensitized) nonlactating but not in nonsensitized nulliparous females or in females that did not become maternal despite the sensitization procedure. Immunohistochemistry verified the increased amylin peptide expression in maternally behaving rats and demonstrated the same expression pattern of amylin as in situ hybridization histochemistry. Ovariectomy had no effect on the activation of amylin neurons, suggesting sexual steroid-independent mechanisms. In subsequent functional experiments, mothers were separated from their pups for 22 h. On return of the pups, neuronal activation was found in the mother's preoptic area, with a distribution pattern similar to amylin-expressing neurons. Subsequent double labeling revealed that 86-93% of amylin neurons were activated by pup exposure. The results implicate amylin in the control of maternal adaptations, possibly exerting its actions on maternal behaviors via amylin receptors present in brain regions to which preoptic neurons project.-Szabo, E. R., Cservenak, M., Dobolyi, A. Amylin is a novel neuropeptide with potential maternal functions in the rat. FASEB J. 26, 272-281 (2012). www.fasebj.org	Semmelweis Univ, Neuromorphol & Neuroendocrine Res Lab, Dept Anat Histol & Embryol, H-1094 Budapest, Hungary; Hungarian Acad Sci, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences	Dobolyi, A (corresponding author), Semmelweis Univ, Neuromorphol Lab, Dept Anat Histol & Embryol, Tuzolto U 58, H-1094 Budapest, Hungary.	dobolyi@ana.sote.hu	Dobolyi, Arpad/AAE-5913-2020; Cservenak, Melinda/AAF-3072-2020	Cservenak, Melinda/0000-0002-6899-9944	Hungarian Academy of Sciences; NFM-OTKA [NNF2 85612, NKTH-OTKA K67646, OTKA K100319, NKTH TECH_09_A1]	Hungarian Academy of Sciences(Hungarian Academy of Sciences); NFM-OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	Grant support was provided by the Bolyai Janos Fellowship grant from the Hungarian Academy of Sciences, as well as NFM-OTKA NNF2 85612, NKTH-OTKA K67646, OTKA K100319, and NKTH TECH_09_A1 grants. The authors thank Prof. Miklos Palkovits for critically reading the manuscript and Eva Renner for help in the combination of in situ hybridization and immunocytochemistry procedures. The authors also appreciate the technical assistance of Nikolett Hanak and Szilvia Deak. American Journal Experts is acknowledged for English editing. The authors declare no conflicts of interest.	Augustine RA, 2008, J PHYSIOL-LONDON, V586, P387, DOI 10.1113/jphysiol.2007.146316; Becskei C, 2004, BRAIN RES, V1030, P221, DOI 10.1016/j.brainres.2004.10.012; Bosch OJ, 2010, J NEUROENDOCRINOL, V22, P420, DOI 10.1111/j.1365-2826.2010.01984.x; Bosch OJ, 2008, P NATL ACAD SCI USA, V105, P17139, DOI 10.1073/pnas.0807412105; Burbach JPH, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P3055; Carter C S, 2001, Prog Brain Res, V133, P241; Coolen LM, 1998, J COMP NEUROL, V397, P421, DOI 10.1002/(SICI)1096-9861(19980803)397:3<421::AID-CNE8>3.0.CO;2-4; Cservenak M, 2010, ENDOCRINOLOGY, V151, P5830, DOI 10.1210/en.2010-0767; Dobolyi A, 2005, J COMP NEUROL, V489, P92, DOI 10.1002/cne.20618; Dobolyi A, 2011, J NEUROENDOCRINOL, V23, P1002, DOI 10.1111/j.1365-2826.2011.02127.x; Dobolyi A, 2002, P NATL ACAD SCI USA, V99, P1651, DOI 10.1073/pnas.042416199; Dobolyi A, 2008, J COMP NEUROL, V507, P1393, DOI 10.1002/cne.21621; Dobolyi A, 2009, J NEUROCHEM, V111, P1490, DOI 10.1111/j.1471-4159.2009.06422.x; FLEMING AS, 1974, J COMP PHYSIOL PSYCH, V86, P957, DOI 10.1037/h0036414; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Gebre-Medhin S, 1998, MOL BRAIN RES, V63, P180, DOI 10.1016/S0169-328X(98)00269-1; GRAY P, 1984, BEHAV NEUROSCI, V98, P703, DOI 10.1037/0735-7044.98.4.703; Hay DL, 2004, BIOCHEM SOC T, V32, P865, DOI 10.1042/BST0320865; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Kinsley CH, 2008, J NEUROENDOCRINOL, V20, P515, DOI 10.1111/j.1365-2826.2008.01667.x; Knobil E., 2006, KNOBIL NEILLS PHYSL, V2; Lamming G. E., 1994, MARSHALLS PHYSL REPR, V3; LEFFERT JD, 1989, P NATL ACAD SCI USA, V86, P3127, DOI 10.1073/pnas.86.9.3127; Leng G, 2008, CURR OPIN PHARMACOL, V8, P731, DOI 10.1016/j.coph.2008.07.001; Li C, 1999, NEUROSCIENCE, V94, P117, DOI 10.1016/S0306-4522(99)00236-5; Lin SH, 1998, BRAIN RES, V787, P226, DOI 10.1016/S0006-8993(97)01484-4; Lonstein JS, 1998, NEUROSCIENCE, V82, P267; Lutz TA, 2001, INT J OBESITY, V25, P1005, DOI 10.1038/sj.ijo.0801664; Lutz TA, 2006, PHYSIOL BEHAV, V89, P465, DOI 10.1016/j.physbeh.2006.04.001; Mallikarjun PK, 2005, J R SOC PROMO HEALTH, V125, P221, DOI 10.1177/146642400512500514; McNeilly AS, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2511; MULDER H, 1995, J NEUROSCI, V15, P7625; Numan M, 1997, J NEUROENDOCRINOL, V9, P369, DOI 10.1046/j.1365-2826.1997.t01-1-00597.x; NUMAN M, 1986, ANN NY ACAD SCI, V474, P226, DOI 10.1111/j.1749-6632.1986.tb28014.x; Numan M, 1997, ANN NY ACAD SCI, V807, P101, DOI 10.1111/j.1749-6632.1997.tb51915.x; Numan M., 2003, HORM BR BEHAV; Numan M, 2010, BEHAV NEUROSCI, V124, P715, DOI 10.1037/a0021548; Potes CS, 2010, PHYSIOL BEHAV, V100, P511, DOI 10.1016/j.physbeh.2010.03.001; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; ROSENBLATT JS, 1967, SCIENCE, V156, P1512, DOI 10.1126/science.156.3781.1512; Rushing PA, 2001, ENDOCRINOLOGY, V142, P5035, DOI 10.1210/en.142.11.5035; SEXTON PM, 1994, NEUROSCIENCE, V62, P553, DOI 10.1016/0306-4522(94)90388-3; SHEWARD WJ, 1994, NEUROSCI LETT, V181, P31, DOI 10.1016/0304-3940(94)90553-3; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; SIMERLY RB, 1988, J COMP NEUROL, V270, P209, DOI 10.1002/cne.902700205; Smith MS, 2002, FRONT NEUROENDOCRIN, V23, P225, DOI 10.1016/S0091-3022(02)00002-X; Stack EC, 2000, BEHAV NEUROSCI, V114, P609, DOI 10.1037/0735-7044.114.3.609; Tohyama M., 1998, ATLAS NEUROACTIVE SU; Wayneforth H, 1992, EXPT SURG TECHNIQUES; Wimalawansa SJ, 1997, CRIT REV NEUROBIOL, V11, P167, DOI 10.1615/CritRevNeurobiol.v11.i2-3.40; Woodside B, 2007, PHYSIOL BEHAV, V91, P375, DOI 10.1016/j.physbeh.2007.04.015; Young Andrew, 2005, Adv Pharmacol, V52, P19, DOI 10.1016/S1054-3589(05)52002-7	52	38	38	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					272	281		10.1096/fj.11-191841	http://dx.doi.org/10.1096/fj.11-191841			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21965599				2022-12-25	WOS:000299202200028
J	Cong, L; Pakala, SB; Ohshiro, K; Li, DQ; Kumar, R				Cong, Lin; Pakala, Suresh B.; Ohshiro, Kazufumi; Li, Da-Qiang; Kumar, Rakesh			SUMOylation and SUMO-interacting Motif (SIM) of Metastasis Tumor Antigen 1 (MTA1) Synergistically Regulate Its Transcriptional Repressor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; TRANSACTIVATION FUNCTIONS; E3 LIGASE; PROTEIN; CANCER; PROLIFERATION; RECOGNITION; ASSOCIATION; CONJUGATION; STABILITY	Metastasis tumor antigen 1 (MTA1), a component of the Mi-2 center dot nucleosome remodeling and deacetylase complex, plays a crucial role in gene transcription, but the mechanism involved remains largely unknown. Here, we report that MTA1 is a substrate for small ubiquitin-related modifier 2/3 (SUMO2/3) in vivo. Protein inhibitor of activated STAT (PIAS) proteins enhance SUMOylation of MTA1 and may participate in para-log-selective SUMOylation, whereas sentrin/SUMO-specific protease 1 (SENP1) and 2 may act as deSUMOylation enzymes for MTA1. Moreover, MTA1 contains a functional SUMO-interacting motif (SIM) at its C terminus, and SIM is required for the efficient SUMOylation of MTA1. SUMO conjugation on Lys-509, which is located within the SUMO consensus site, together with SIM synergistically regulates the co-repressor activity of MTA1 on PS2 transcription, probably by recruiting HDAC2 onto the PS2 promoter. Interestingly, MTA1 may upregulate the expression of SUMO2 via interaction with RNA polymerase II and SP1 at the SUMO2 promoter. These findings not only provide novel mechanistic insights into the regulation of the transcriptional repressor function of MTA1 by SUMOylation and SIM but also uncover a potential function of MTA1 in modulating the SUMOylation pathway.	[Cong, Lin; Pakala, Suresh B.; Ohshiro, Kazufumi; Li, Da-Qiang; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Kumar, Rakesh] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India	George Washington University; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Kumar, R (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803; Pakala, Suresh Babu/0000-0002-5679-4837	National Institutes of Health [CA98823, CA98823-S1]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 and CA98823-S1 (to R. K.).	Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Buache E, 2011, ONCOGENE, V30, P3261, DOI 10.1038/onc.2011.41; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Han Y, 2010, J BIOL CHEM, V285, P12906, DOI 10.1074/jbc.M109.071431; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mishra SK, 2003, J BIOL CHEM, V278, P19209, DOI 10.1074/jbc.M301968200; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Ohshiro K, 2010, EMBO REP, V11, P691, DOI 10.1038/embor.2010.99; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saether T, 2011, ONCOGENE, V30, P212, DOI 10.1038/onc.2010.397; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Talukder AH, 2003, J BIOL CHEM, V278, P11676, DOI 10.1074/jbc.M209570200; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Toh Y, 1997, INT J CANCER, V74, P459, DOI 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.3.CO;2-H; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	37	25	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43793	43808		10.1074/jbc.M111.267237	http://dx.doi.org/10.1074/jbc.M111.267237			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21965678	Green Published, hybrid			2022-12-25	WOS:000298402300022
J	David, Y; Ternette, N; Edelmann, MJ; Ziv, T; Gayer, B; Sertchook, R; Dadon, Y; Kessler, BM; Navon, A				David, Yael; Ternette, Nicola; Edelmann, Mariola J.; Ziv, Tamar; Gayer, Batya; Sertchook, Rotem; Dadon, Yakir; Kessler, Benedikt M.; Navon, Ami			E3 Ligases Determine Ubiquitination Site and Conjugate Type by Enforcing Specificity on E2 Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAIN; NUCLEAR EXPORT; RING DOMAIN; STRUCTURAL BASIS; PROTEIN LIGASE; MEDIATED DEGRADATION; P53-BINDING PROTEIN; P53 STABILITY; TARGET P53; C-TERMINUS	Ubiquitin-conjugating enzymes (E2s) have a dominant role in determining which of the seven lysine residues of ubiquitin is used for polyubiquitination. Here we show that tethering of a substrate to an E2 enzyme in the absence of an E3 ubiquitin ligase is sufficient to promote its ubiquitination, whereas the type of the ubiquitin conjugates and the identity of the target lysine on the substrate are promiscuous. In contrast, when an E3 enzyme is introduced, a clear decision between mono-and polyubiquitination is made, and the conjugation type as well as the identity of the target lysine residue on the substrate becomes highly specific. These features of the E3 can be further regulated by auxiliary factors as exemplified by MDMX (Murine Double Minute X). In fact, we show that this interactor reconfigures MDM2-dependent ubiquitination of p53. Based on several model systems, we propose that although interaction with an E2 is sufficient to promote substrate ubiquitination the E3 molds the reaction into a specific, physiologically relevant protein modification.	[David, Yael; Gayer, Batya; Dadon, Yakir; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Ternette, Nicola; Edelmann, Mariola J.; Kessler, Benedikt M.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7BN, England; [Sertchook, Rotem] Weizmann Inst Sci, Fac Biochem, IL-76100 Rehovot, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Smoler Prote Ctr, IL-31096 Haifa, Israel	Weizmann Institute of Science; University of Oxford; Weizmann Institute of Science; Technion Israel Institute of Technology	Navon, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	ami.navon@weizmann.ac.il	Kessler, Benedikt/AAY-8614-2021	Kessler, Benedikt/0000-0002-8160-2446; Ziv, Tamar/0000-0003-4299-7454; Ternette, Nicola/0000-0002-9283-0743; Edelmann, Mariola/0000-0003-0459-7716	Israel Science Foundation (ISF); Minerva Foundation (Germany); German-Israeli Foundation for Scientific Research and Development (GIF); MRC [G0501068] Funding Source: UKRI; Medical Research Council [G0501068] Funding Source: researchfish	Israel Science Foundation (ISF)(Israel Science Foundation); Minerva Foundation (Germany); German-Israeli Foundation for Scientific Research and Development (GIF)(German-Israeli Foundation for Scientific Research and Development); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Israel Science Foundation (ISF), the Minerva Foundation (Germany), the German-Israeli Foundation for Scientific Research and Development (GIF), and a special donation from Rolando Uziel.	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; BUSCH H, 1981, MOL CELL BIOCHEM, V40, P173; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Chan WM, 2006, MOL CANCER RES, V4, P15, DOI 10.1158/1541-7786.MCR-05-0097; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; HAAS A, 1990, J BIOL CHEM, V265, P21664; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HERSHKO A, 1981, J BIOL CHEM, V256, P1525; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; KINTER M, 2000, PROTEIN SEQUENCING I, P147, DOI DOI 10.1002/0471721980; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laine A, 2006, MOL CELL BIOL, V26, P8901, DOI 10.1128/MCB.01156-06; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Lewis MJ, 2006, J BIOMOL NMR, V34, P89, DOI 10.1007/s10858-005-5583-6; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009	63	47	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44104	44115		10.1074/jbc.M111.234559	http://dx.doi.org/10.1074/jbc.M111.234559			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21965653	hybrid, Green Published			2022-12-25	WOS:000298402300051
J	Boncela, J; Przygodzka, P; Papiewska-Pajak, I; Wyroba, E; Cierniewski, CS				Boncela, Joanna; Przygodzka, Patrycja; Papiewska-Pajak, Izabela; Wyroba, Elzbieta; Cierniewski, Czeslaw S.			Association of Plasminogen Activator Inhibitor Type 2 (PAI-2) with Proteasome within Endothelial Cells Activated with Inflammatory Stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ALPHA-INDUCED APOPTOSIS; PCR-RFLP DETECTION; CROSS-LINKING; SERPIN; PROTECTION; DISEASE; TISSUE; POLYMORPHISM; IL-1-BETA	Quiescent endothelial cells contain low concentrations of plasminogen activator inhibitor type 2 (PAI-2). However, its synthesis can be rapidly stimulated by a variety of inflammatory mediators. In this study, we provide evidence that PAI-2 interacts with proteasome and affects its activity in endothelial cells. To ensure that the PAI-2.proteasome complex is formed in vivo, both proteins were coimmunoprecipitated from endothelial cells and identified with specific antibodies. The specificity of this interaction was evidenced after (a) transfection of HeLa cells with pCMV-PAI-2 and coimmunoprecipitation of both proteins with anti-PAI-2 antibodies and (b) silencing of the PAI-2 gene using specific small interfering RNA (siRNA). Subsequently, cellular distribution of the PAI-2.proteasome complexes was established by immunogold staining and electron microscopy analyses. As judged by confocal microscopy, both proteins appeared in a diffuse cytosolic pattern, but they also could be found in a dense perinuclear and nuclear location. PAI-2 was not polyubiquitinated, suggesting that it bound to proteasome not as the substrate but rather as its inhibitor. Consistently, increased PAI-2 expression (a) abrogated degradation of degron analyzed after cotransfection of HeLa cells with pCMV-PAI-2 and pd2EGFP-N1, (b) prevented degradation of p53, as evidenced both by confocal microscopy and Western immunoblotting, and (c) inhibited proteasome cleavage of specific fluorogenic substrate. This suggests that PAI-2, in endothelial cells induced with inflammatory stimuli, can inhibit proteasome and thus tilt the balance favoring proapoptotic signaling.	[Papiewska-Pajak, Izabela; Cierniewski, Czeslaw S.] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; [Boncela, Joanna; Przygodzka, Patrycja; Cierniewski, Czeslaw S.] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Wyroba, Elzbieta] Polish Acad Sci, Nencki Inst Expt Biol, PL-02093 Warsaw, Poland	Medical University Lodz; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Cierniewski, CS (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.	czeslaw.cierniewski@umed.lodz.pl	Wyroba, Elzbieta/R-7525-2016; Boncela, Joanna/AAU-4481-2020; Wyroba, Elzbieta/P-4434-2019	Boncela, Joanna/0000-0001-8419-7012; Papiewska-Pajak, Izabela/0000-0001-6116-3418; Przygodzka, Patrycja/0000-0001-7529-8815	Polish Ministry of Science and Higher Education [N 301 3386 33, N301 4392 38]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Polish Ministry of Science and Higher Education Projects N 301 3386 33 (to J. B.) and N301 4392 38 (to C. S. C.).	Antalis TM, 1998, J EXP MED, V187, P1799, DOI 10.1084/jem.187.11.1799; Arcangeletti C, 1997, J STRUCT BIOL, V119, P35, DOI 10.1006/jsbi.1997.3871; BELIN D, 1989, EMBO J, V8, P3287, DOI 10.1002/j.1460-2075.1989.tb08489.x; Boncela J, 2011, J BIOL CHEM, V286, P6820, DOI 10.1074/jbc.M110.173781; Buyru N, 2003, CLIN APPL THROMB-HEM, V9, P333, DOI 10.1177/107602960300900409; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Dickinson JL, 1998, CELL DEATH DIFFER, V5, P163, DOI 10.1038/sj.cdd.4400324; Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686; Duval Helene, 2003, Angiogenesis, V6, P171, DOI 10.1023/B:AGEN.0000021390.09275.bc; Fan J, 2004, ACTA BIOCH BIOPH SIN, V36, P42, DOI 10.1093/abbs/36.1.42; Fish RJ, 2006, EXP CELL RES, V312, P350, DOI 10.1016/j.yexcr.2005.11.003; Foy CA, 1997, THROMB HAEMOSTASIS, V77, P955; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; GENTON C, 1987, J CELL BIOL, V104, P705, DOI 10.1083/jcb.104.3.705; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Heda GD, 2008, J AM PODIAT MED ASSN, V98, P345, DOI 10.7547/0980345; Jensen PH, 1996, J BIOL CHEM, V271, P26892, DOI 10.1074/jbc.271.43.26892; JENSEN PH, 1994, J BIOL CHEM, V269, P15394; Kardesler L, 2008, CLIN BIOCHEM, V41, P863, DOI 10.1016/j.clinbiochem.2008.04.013; Kasyapa CS, 2006, BLOOD, V107, P3693, DOI 10.1182/blood-2005-04-1505; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; Lijnen HR, 2007, J THROMB HAEMOST, V5, P2259, DOI 10.1111/j.1538-7836.2007.02735.x; Lobov S, 2004, J MOL BIOL, V344, P1359, DOI 10.1016/j.jmb.2004.10.010; Lobov S, 2008, THROMB HAEMOSTASIS, V100, P319, DOI 10.1160/TH08-02-0119; Macaluso M, 2006, CELL DEATH DIFFER, V13, P1515, DOI 10.1038/sj.cdd.4401835; Manders P, 2004, CANCER RES, V64, P659, DOI 10.1158/0008-5472.CAN-03-1820; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; Ohkuchi A, 2001, AM J REPROD IMMUNOL, V46, P252, DOI 10.1034/j.1600-0897.2001.d01-10.x; Palafox-Sanchez CA, 2009, CLIN APPL THROMB-HEM, V15, P233, DOI 10.1177/1076029607308868; Ritchie H, 2000, EXP CELL RES, V260, P20, DOI 10.1006/excr.2000.4957; Saito S, 2007, MOL ASPECTS MED, V28, P192, DOI 10.1016/j.mam.2007.02.006; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Vazquez-Del Mercado M, 2007, SCAND J RHEUMATOL, V36, P206, DOI 10.1080/03009740601089648; Wojcik C, 2002, J CELL MOL MED, V6, P25, DOI 10.1111/j.1582-4934.2002.tb00309.x; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Yu H, 2002, BLOOD, V99, P2810, DOI 10.1182/blood.V99.8.2810; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhang YQ, 2003, ACTA BIOCH BIOPH SIN, V35, P661	39	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43164	43171		10.1074/jbc.M111.245647	http://dx.doi.org/10.1074/jbc.M111.245647			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21976669	hybrid, Green Published			2022-12-25	WOS:000298351300037
J	Mayberry, LK; Allen, ML; Nitka, KR; Campbell, L; Murphy, PA; Browning, KS				Mayberry, Laura K.; Allen, M. Leah; Nitka, Kelley R.; Campbell, Lara; Murphy, Patricia A.; Browning, Karen S.			Plant Cap-binding Complexes Eukaryotic Initiation Factors eIF4F and eIFISO4F MOLECULAR SPECIFICITY OF SUBUNIT BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS INITIATION; TRANSLATION INITIATION; WHEAT-GERM; ARABIDOPSIS-THALIANA; ISOZYME FORM; ELONGATION-FACTORS; MESSENGER-RNA; FACTOR 4B; PURIFICATION; EXPRESSION	The initiation of translation in eukaryotes requires a suite of eIFs that include the cap-binding complex, eIF4F. eIF4F is comprised of the subunits eIF4G and eIF4E and often the helicase, eIF4A. The eIF4G subunit serves as an assembly point for other initiation factors, whereas eIF4E binds to the 7-methyl guanosine cap of mRNA. Plants have an isozyme form of eIF4F (eIFiso4F) with comparable subunits, eIFiso4E and eIFiso4G. Plant eIF4A is very loosely associated with the plant cap-binding complexes. The specificity of interaction of the individual subunits of the two complexes was previously unknown. To address this issue, mixed complexes (eIF4E-eIFiso4G or eIFiso4E-eIF4G) were expressed and purified from Escherichia coli for biochemical analysis. The activity of the mixed complexes in in vitro translation assays correlated with the large subunit of the respective correct complex. These results suggest that the eIF4G or eIFiso4G subunits influence translational efficiency more than the cap-binding subunits. The translation assays also showed varying responses of the mRNA templates to eIF4F or eIFiso4F, suggesting that some level of mRNA discrimination is possible. The dissociation constants for the correct complexes have K-D values in the subnanomolar range, whereas the mixed complexes were found to have K-D values in the similar to 10 nM range. Displacement assays showed that the correct binding partner readily displaces the incorrect binding partner in a manner consistent with the difference in K-D values. These results show molecular specificity for the formation of plant eIF4F and eIFiso4F complexes and suggest a role in mRNA discrimination during initiation of translation.	[Browning, Karen S.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Browning, KS (corresponding author), Univ Texas Austin, Dept Chem & Biochem, 1 Univ Stn A5300, Austin, TX 78712 USA.	kbrowning@mail.utexas.edu			National Science Foundation [MCB1052530, MCB0745146]; Direct For Biological Sciences [1052530] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB1052530 and MCB0745146 (to K. S. B.).	ALLEN ML, 1992, J BIOL CHEM, V267, P23232; Bellsolell L, 2006, STRUCTURE, V14, P913, DOI 10.1016/j.str.2006.03.012; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; BROWNING KS, 1990, J BIOL CHEM, V265, P17967; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Clarkson BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009114; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Freire MA, 2000, PLANT MOL BIOL, V44, P129, DOI 10.1023/A:1006494628892; Freire MA, 2005, GENE, V345, P271, DOI 10.1016/j.gene.2004.11.030; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Korneeva NL, 2000, J BIOL CHEM, V275, P41369, DOI 10.1074/jbc.M007525200; LAUER SJ, 1985, BIOCHEMISTRY-US, V24, P2928, DOI 10.1021/bi00333a017; LAX S, 1985, P NATL ACAD SCI USA, V82, P330, DOI 10.1073/pnas.82.2.330; LAX SR, 1986, METHOD ENZYMOL, V118, P109; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Lellis AD, 2010, PLANT MOL BIOL, V74, P249, DOI 10.1007/s11103-010-9670-z; Livingstone M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/021001; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Marintchev A, 2005, BIOCHEMISTRY-US, V44, P12265, DOI 10.1021/bi051271v; MATHEWS MB, 2007, COLD SPRING HARB MON, V48, P1; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; Mayberry LK, 2009, PLANT PHYSIOL, V150, P1844, DOI 10.1104/pp.109.138438; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Metz AM, 1999, BIOCHEM BIOPH RES CO, V266, P314, DOI 10.1006/bbrc.1999.1814; METZ AM, 1992, NUCLEIC ACIDS RES, V20, P4096, DOI 10.1093/nar/20.15.4096; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Park EH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-68; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Serino Giovanna, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4683; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; VANHEERDEN A, 1994, J BIOL CHEM, V269, P17454	40	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42566	42574		10.1074/jbc.M111.280099	http://dx.doi.org/10.1074/jbc.M111.280099			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965660	Green Published, hybrid			2022-12-25	WOS:000298180900064
J	Epis, MR; Barker, A; Giles, KM; Beveridge, DJ; Leedman, PJ				Epis, Michael R.; Barker, Andrew; Giles, Keith M.; Beveridge, Dianne J.; Leedman, Peter J.			The RNA-binding Protein HuR Opposes the Repression of ERBB-2 Gene Expression by MicroRNA miR-331-3p in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELAV-LIKE PROTEIN; MESSENGER-RNA; CYCLOOXYGENASE-2 EXPRESSION; POLY(C)-BINDING PROTEIN; 3'-UNTRANSLATED REGION; COX-2 EXPRESSION; OVEREXPRESSION; PROLIFERATION; CARCINOMA; TRASTUZUMAB	ERBB-2 overexpression is associated with the development and progression of cancer and mediates its resistance to therapy. It has been suggested that post-transcriptional mechanisms control the overexpression of ERBB-2 in prostate cancer (PCa). We recently demonstrated that the 3'-untranslated region (3'-UTR) of ERBB-2 mRNA contains two specific target sites for binding of the microRNA miR-331-3p and that miR-331-3p represses ERBB-2 expression and signaling in PCa cells. Here we investigate a U-rich element situated in close proximity to the distal miR-331-3p target site in the ERBB-2 3'-UTR. Specific binding of HuR to this U-rich element promotes ERBB-2 expression in PCa cells. We show that HuR antagonizes the repressive action of miR-331-3p on its distal ERBB-2 3'-UTR target site. These results support a model in which the interplay between RNA-binding proteins and microRNAs controls the post-transcriptional regulation of gene expression and suggest that both HuR and miR-3:31-3p participate in the overexpression of ERBB-2 observed in some PCas.	[Epis, Michael R.; Barker, Andrew; Giles, Keith M.; Beveridge, Dianne J.; Leedman, Peter J.] Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6000, Australia; [Epis, Michael R.; Barker, Andrew; Giles, Keith M.; Beveridge, Dianne J.; Leedman, Peter J.] Univ Western Australia, Med Res Ctr, Royal Perth Hosp, Perth, WA 6000, Australia; [Leedman, Peter J.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6008, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Leedman, PJ (corresponding author), Western Australian Inst Med Res, Lab Canc Med, Level 6,MRF Bldg,Rear 50 Murray St, Perth, WA 6000, Australia.	peterl@waimr.uwa.edu.au	Leedman, Peter J/O-4044-2014; Barker, Andrew/A-4289-2013; Jackson, Benjamin L/C-4297-2012		National Health and Medical Research Council of Australia; Prostate Cancer Foundation of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Prostate Cancer Foundation of Australia	This work was supported by the National Health and Medical Research Council of Australia and the Prostate Cancer Foundation of Australia.	Abdelmohsen K, 2010, CELL CYCLE, V9, P1354, DOI 10.4161/cc.9.7.11164; Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Australian Institute of Heakh and Welfare, 2010, CANC AUSTR OV CANC S, V60; Barbisan F, 2009, EUR UROL, V56, P105, DOI 10.1016/j.eururo.2008.04.043; Barnabas N, 2011, PROSTATE, V71, P857, DOI 10.1002/pros.21302; Barreau C, 2006, BIOCHIMIE, V88, P515, DOI 10.1016/j.biochi.2005.10.011; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bubendorf L, 1999, CANCER RES, V59, P803; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cho NP, 2007, J ORAL PATHOL MED, V36, P297, DOI 10.1111/j.1600-0714.2007.00526.x; Cho NH, 2006, CANCER LETT, V232, P170, DOI 10.1016/j.canlet.2005.02.026; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; De Silanes IL, 2004, GENE EXPRESSION, V12, P49, DOI 10.3727/000000004783992215; Denkert C, 2004, CANCER RES, V64, P189, DOI 10.1158/0008-5472.CAN-03-1987; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Epis MR, 2009, J BIOL CHEM, V284, P24696, DOI 10.1074/jbc.M109.030098; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gandellini P, 2010, DISCOV MED, V9, P212; Giles KM, 2011, METHODS MOL BIOL, V676, P147, DOI 10.1007/978-1-60761-863-8_11; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hostetter C, 2008, CANCER BIOL THER, V7, P1498, DOI 10.4161/cbt.7.9.6490; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kang MJ, 2008, GASTROENTEROLOGY, V135, P2030, DOI 10.1053/j.gastro.2008.08.009; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Ketting RF, 2007, CELL, V131, P1226, DOI 10.1016/j.cell.2007.12.004; Legrier ME, 2007, BRIT J CANCER, V96, P269, DOI 10.1038/sj.bjc.6603553; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Q, 2011, AM J PATHOL, V179, P46, DOI 10.1016/j.ajpath.2011.03.008; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mehta A, 2006, GENE DEV, V20, P939, DOI 10.1101/gad.1388706; Minner S, 2010, CLIN CANCER RES, V16, P1553, DOI 10.1158/1078-0432.CCR-09-2546; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Niesporek S, 2008, INT J ONCOL, V32, P341; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Scott GK, 2008, MOL CANCER RES, V6, P1250, DOI 10.1158/1541-7786.MCR-07-2110; Neto AS, 2010, J UROLOGY, V184, P842, DOI 10.1016/j.juro.2010.04.077; Shaw G, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-3; Small EJ, 2001, SEMIN ONCOL, V28, P71, DOI 10.1053/sonc.2001.26908; Sridhar SS, 2010, AM J CLIN ONCOL-CANC, V33, P609, DOI 10.1097/COC.0b013e3181beac33; Stavridi F, 2010, CANCER TREAT REV, V36, P122, DOI 10.1016/j.ctrv.2009.06.001; Sully G, 2004, BIOCHEM J, V377, P629, DOI 10.1042/BJ20031484; Thomson AM, 1999, BIOTECHNIQUES, V27, P1032, DOI 10.2144/99275rr03; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Xu F, 2010, J CELL BIOCHEM, V111, P727, DOI 10.1002/jcb.22762; Xu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015519; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Yap TA, 2011, NAT REV CLIN ONCOL, V8, P597, DOI 10.1038/nrclinonc.2011.117; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Ziada A, 2004, PROSTATE, V60, P332, DOI 10.1002/pros.20065	69	78	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41442	41454		10.1074/jbc.M111.301481	http://dx.doi.org/10.1074/jbc.M111.301481			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21971048	Green Published, hybrid			2022-12-25	WOS:000298057500031
J	Chen, JJ; Tsu, CA; Gavin, JM; Milhollen, MA; Bruzzese, FJ; Mallender, WD; Sintchak, MD; Bump, NJ; Yang, XF; Ma, JY; Loke, HK; Xu, Q; Li, P; Bence, NF; Brownell, JE; Dick, LR				Chen, Jesse J.; Tsu, Christopher A.; Gavin, James M.; Milhollen, Michael A.; Bruzzese, Frank J.; Mallender, William D.; Sintchak, Michael D.; Bump, Nancy J.; Yang, Xiaofeng; Ma, Jingya; Loke, Huay-Keng; Xu, Qing; Li, Ping; Bence, Neil F.; Brownell, James E.; Dick, Lawrence R.			Mechanistic Studies of Substrate-assisted Inhibition of Ubiquitin-activating Enzyme by Adenosine Sulfamate Analogues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEDD8-ACTIVATING ENZYME; PROTEIN-ACTIVATION; PROTEASOME SYSTEM; CELL LYMPHOMA; SUMO E1; CANCER; INSIGHTS; NEDD8; CONJUGATION; DISEASES	Ubiquitin-activating enzyme (UAE or E1) activates ubiquitin via an adenylate intermediate and catalyzes its transfer to a ubiquitin-conjugating enzyme (E2). MLN4924 is an adenosine sulfamate analogue that was identified as a selective, mechanism-based inhibitor of NEDD8-activating enzyme (NAE), another E1 enzyme, by forming a NEDD8-MLN4924 adduct that tightly binds at the active site of NAE, a novel mechanism termed substrate-assisted inhibition (Brownell, J. E., Sintchak, M. D., Gavin, J. M., Liao, H., Bruzzese, F. J., Bump, N. J., Soucy, T. A., Milhollen, M. A., Yang, X., Burkhardt, A. L., Ma, J., Loke, H. K, Lingaraj, T., Wu, D., Hamman, K. B., Spelman, J. J., Cullis, C. A., Langston, S. P., Vyskocil, S., Sells, T. B., Mallender, W. D., Visiers, I., Li, P., Claiborne, C. F., Rolfe, M., Bolen, J. B., and Dick, L. R. (2010) Mol. Cell 37, 102-111). In the present study, substrate-assisted inhibition of human UAL (Ube1) by another adenosine sulfamate analogue, 5'-O-sulfamoyl-N-6-[(1S)-2,3-dihydro-1H-inden-1-yl] -adenosine (Compound I), a nonselective E1 inhibitor, was characterized. Compound I inhibited UAE-dependent ATP-PP1 exchange activity, caused loss of UAE thioester, and inhibited E1-E2 transthiolation in a dose-dependent manner. Mechanistic studies on Compound I and its purified ubiquitin adduct demonstrate that the proposed substrate-assisted inhibition via covalent adduct formation is entirely consistent with the three-step ubiquitin activation process and that the adduct is formed via nucleophilic attack of UAL thioester by the sulfamate group of Compound I after completion of step 2. Kinetic and affinity analysis of Compound I, MLN4924, and their purified ubiquitin adducts suggest that both the rate of adduct formation and the affinity between the adduct and E1 contribute to the overall potency. Because all Lis are thought to use a similar mechanism to activate their cognate ubiquitin-like proteins, the substrate-assisted inhibition by adenosine sulfamate analogues represents a promising strategy to develop potent and selective E1 inhibitors that can modulate diverse biological pathways.	[Chen, Jesse J.; Tsu, Christopher A.; Gavin, James M.; Milhollen, Michael A.; Bruzzese, Frank J.; Mallender, William D.; Sintchak, Michael D.; Bump, Nancy J.; Yang, Xiaofeng; Ma, Jingya; Loke, Huay-Keng; Xu, Qing; Li, Ping; Bence, Neil F.; Brownell, James E.; Dick, Lawrence R.] Millennium Pharmaceut Inc, Discovery, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Chen, JJ (corresponding author), 40 Landsdowne St, Cambridge, MA 02139 USA.	jesse.chen@mpi.com	Dick, Lawrence/ABA-8831-2021	Dick, Larry/0000-0002-6880-0405				Bacik JP, 2010, J BIOL CHEM, V285, P20273, DOI 10.1074/jbc.M110.102921; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bruzzese FJ, 2009, ANAL BIOCHEM, V394, P24, DOI 10.1016/j.ab.2009.07.011; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kane RC, 2007, CLIN CANCER RES, V13, P5291, DOI 10.1158/1078-0432.CCR-07-0871; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Soucy TA, 2009, CLIN CANCER RES, V15, P3912, DOI 10.1158/1078-0432.CCR-09-0343; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; Tokgoz Z, 2006, J BIOL CHEM, V281, P14729, DOI 10.1074/jbc.M513562200; Valero E, 2000, BIOCHEM J, V350, P237, DOI 10.1042/0264-6021:3500237; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456	32	66	70	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40867	40877		10.1074/jbc.M111.279984	http://dx.doi.org/10.1074/jbc.M111.279984			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969368	Green Published, hybrid			2022-12-25	WOS:000297315400047
J	Lei, JT; Mazumdar, T; Martinez-Moczygemba, M				Lei, Jonathan T.; Mazumdar, Tuhina; Martinez-Moczygemba, Margarita			Three Lysine Residues in the Common beta Chain of the Interleukin-5 Receptor Are Required for Janus Kinase (JAK)-dependent Receptor Ubiquitination, Endocytosis, and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR TRAFFICKING; ERYTHROPOIETIN RECEPTOR; INDUCED INTERNALIZATION; JUXTAMEMBRANE DOMAIN; CYTOKINE RECEPTORS; ALPHA-CHAIN; IL-5; TRANSPORTER; DEGRADATION; REVEALS	Eosinophils are multifunctional leukocytes implicated in the pathogenesis of numerous inflammatory diseases including allergic asthma and hypereosinophilic syndrome. Eosinophil physiology is critically dependent on IL-5 and the IL-5 receptor (IL-5R), composed of a ligand binding alpha chain (IL-5R alpha), and a common beta chain, beta c. Previously, we demonstrated that the beta c cytoplasmic tail is ubiquitinated and degraded by proteasomes following IL-5 stimulation. However, a complete understanding of the role of beta c ubiquitination in IL-5R biology is currently lacking. By using a well established, stably transduced HEK293 cell model system, we show here that in the absence of ubiquitination, beta c subcellular localization, IL-5-induced endocytosis, turnover, and IL-5R signaling were significantly impaired. Whereas ubiquitinated IL-5Rs internalized into trafficking endosomes for their degradation, ubiquitination-deficient IL-5Rs accumulated on the cell surface and displayed blunted signaling even after IL-5 stimulation. Importantly, we identified a cluster of three membrane-proximal beta c lysine residues (Lys(457), Lys(461), and Lys(467)) whose presence was required for both JAK1/2 binding to beta c and receptor ubiquitination. These findings establish that JAK kinase binding to beta c requires the presence of three critical beta c lysine residues, and this binding event is essential for receptor ubiquitination, endocytosis, and signaling.	[Martinez-Moczygemba, Margarita] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, Coll Med, Houston, TX 77030 USA; [Lei, Jonathan T.; Mazumdar, Tuhina; Martinez-Moczygemba, Margarita] Texas A&M Hlth Sci Ctr, Clin Sci & Translat Res Inst, Coll Med, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Martinez-Moczygemba, M (corresponding author), 2121 W Holcombe Blvd,Suite 805, Houston, TX 77030 USA.	mmoczygemba@medicine.tamhsc.edu		Lei, Jonathan/0000-0002-0209-8051	National Institutes of Health from NIAID [AI063178]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063178] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI063178 from the NIAID (to M. M.-M.).	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Asquith KL, 2008, J IMMUNOL, V180, P1199, DOI 10.4049/jimmunol.180.2.1199; Blanchard C, 2009, ADV IMMUNOL, V101, P81, DOI 10.1016/S0065-2776(08)01003-1; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Boyle K, 2009, CELL SIGNAL, V21, P394, DOI 10.1016/j.cellsig.2008.11.002; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; de Pablo Y, 2008, J NEUROCHEM, V104, P124, DOI 10.1111/j.1471-4159.2007.05027.x; dos Santos CMA, 2001, J BIOL CHEM, V276, P10839, DOI 10.1074/jbc.M003635200; Fernandez-Sanchez E, 2009, J BIOL CHEM, V284, P19482, DOI 10.1074/jbc.M109.005165; Finger EC, 2008, J BIOL CHEM, V283, P34808, DOI 10.1074/jbc.M804741200; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gonzalez-Gonzalez IM, 2008, GLIA, V56, P963, DOI 10.1002/glia.20670; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Greiser JS, 2002, J BIOL CHEM, V277, P26959, DOI 10.1074/jbc.M204113200; Haan C, 2002, BIOCHEM J, V361, P105, DOI 10.1042/0264-6021:3610105; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; He K, 2005, ENDOCRINOLOGY, V146, P4755, DOI 10.1210/en.2005-0514; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Kouro T, 1996, INT IMMUNOL, V8, P237, DOI 10.1093/intimm/8.2.237; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Lei JT, 2008, J LEUKOCYTE BIOL, V84, P499, DOI 10.1189/jlb.1207828; Liu LY, 2002, J IMMUNOL, V169, P6459, DOI 10.4049/jimmunol.169.11.6459; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Martinez-Moczygemba M, 2001, J CLIN INVEST, V108, P1797, DOI 10.1172/JCI200113877; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; Meenhuis A, 2009, BIOCHEM J, V417, P737, DOI 10.1042/BJ20081153; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; Ogata N, 1998, BLOOD, V91, P2264, DOI 10.1182/blood.V91.7.2264.2264_2264_2271; Okuda K, 1999, ANN NY ACAD SCI, V872, P305, DOI 10.1111/j.1749-6632.1999.tb08474.x; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Pelletier S, 2006, MOL CELL BIOL, V26, P8527, DOI 10.1128/MCB.01035-06; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; van Kerkhof P, 2001, J BIOL CHEM, V276, P3778, DOI 10.1074/jbc.M007326200; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Yan H, 1996, MOL CELL BIOL, V16, P2074	61	13	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40091	40103		10.1074/jbc.M111.273482	http://dx.doi.org/10.1074/jbc.M111.273482			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965659	hybrid, Green Published			2022-12-25	WOS:000296925700042
J	Newmeyer, T; Tecimer, SN; Jaworsky, D; Chihrin, S; Gough, K; Rachlis, A; Martin, J; Mohammed, S; Loutfy, MR				Newmeyer, Trent; Tecimer, Sandy N.; Jaworsky, Denise; Chihrin, Steven; Gough, Kevin; Rachlis, Anita; Martin, James; Mohammed, Saira; Loutfy, Mona R.			Case Series of Fertility Treatment in HIV-Discordant Couples (Male Positive, Female Negative): The Ontario Experience	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; INTENTIONS; WOMEN; PREGNANCY; DESIRES; INDIVIDUALS; PEOPLE; MEN; DECISION; SERVICES	The success of combination antiretroviral therapies for the treatment of human immunodeficiency virus (HIV) has resulted in prolonged life expectancy (over 40 years from diagnosis) and an improved quality of life for people living with HIV. The risk of vertical HIV transmission during pregnancy has been reduced to less than 1%. As a result of these breakthroughs and as many of these individuals are of reproductive age, fertility issues are becoming increasingly important for this population. One population in which conception planning and reduction of horizontal HIV transmission warrants further research is HIV-discordant couples where the male partner is HIV-positive and the female partner is HIV-negative. Sperm washing is a technique carried out in a fertility clinic that separates HIV from the seminal fluid. Although sperm washing followed by intrauterine insemination significantly reduces the risk of horizontal HIV transmission, there has been limited access to the procedure in North America. Furthermore, little is known about the conception decision-making experiences of HIV-discordant couples who might benefit from sperm washing. Chart reviews and semi-structured interviews were completed with 12 HIV-discordant couples in Ontario, Canada. Couples were recruited through HIV clinics and one fertility clinic that offered sperm washing. Participants identified a number of factors that affected their decision-making around pregnancy planning. Access to sperm washing and other fertility services was an issue (cost, travel and few clinics). Participants identified a lack of information on the procedure (availability, safety). Sources of support (social networks, healthcare providers) were unevenly distributed, especially among those who did not disclose their HIV status to friends and family. Finally, the stigmatisation of HIV continues to have a negative affect on HIV-discordant couples and their intentions to conceive. Access to sperm washing and fertility service is significantly limited for this population and is accompanied with a number of challenges.	[Newmeyer, Trent] Brock Univ, St Catharines, ON L2S 3A1, Canada; [Tecimer, Sandy N.; Jaworsky, Denise; Mohammed, Saira; Loutfy, Mona R.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Tecimer, Sandy N.; Jaworsky, Denise; Gough, Kevin; Rachlis, Anita; Loutfy, Mona R.] Univ Toronto, Toronto, ON, Canada; [Chihrin, Steven] Univ Western Ontario, London, ON, Canada; [Gough, Kevin; Loutfy, Mona R.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Rachlis, Anita] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Martin, James] So Ontario Fertil Technol, London, ON, Canada	Brock University; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Newmeyer, T (corresponding author), Brock Univ, St Catharines, ON L2S 3A1, Canada.	trent.newmeyer@brocku.ca			Women's College Research Institute, Toronto, Ontario	Women's College Research Institute, Toronto, Ontario	The Women and HIV Research Program, Women's College Research Institute, Toronto, Ontario provided financial support for the transcriptions in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braverman A, 2010, FERTIL STERIL, V94, P11, DOI 10.1016/j.fertnstert.2010.01.077; Bujan L, 2007, AIDS, V21, P1909, DOI 10.1097/QAD.0b013e3282703879; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Gruskin S, 2008, AM J PUBLIC HEALTH, V98, P1746, DOI 10.2105/AJPH.2008.137232; Gruskin S, 2007, REPROD HEALTH MATTER, V15, P4, DOI 10.1016/S0968-8080(07)29028-7; Kanniappan S, 2008, AIDS CARE, V20, P625, DOI 10.1080/09540120701660361; Klein J, 2003, OBSTET GYNECOL, V101, P987, DOI 10.1016/S0029-7844(03)00012-7; Ko NY, 2005, J MIDWIFERY WOM HEAL, V50, P23, DOI 10.1016/j.jmwh.2004.08.003; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Loutfy MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007925; Lurie M, 2008, JAIDS-J ACQ IMM DEF, V47, P484, DOI 10.1097/QAI.0b013e3181648de8; Margolese S, 2010, 18 INT AIDS C VIENN; Margolese S, 2011, 1 INT WORKSH HIV WOM; Myer L, 2006, AIDS CARE, V18, P772, DOI 10.1080/09540120500409283; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Oosterhoff P, 2008, CULT HEALTH SEX, V10, P403, DOI 10.1080/13691050801915192; Paiva V, 2003, REPROD HEALTH MATTER, V11, P91, DOI 10.1016/S0968-8080(03)02293-6; Panozzo L, 2003, SWISS MED WKLY, V133, P124; *PUBL HLTH AG CAN, 2009, HIV AIDS CAN SEL SUR; Scott S, J AM PHARM ASS, V49, P462; SEMPRINI AE, 1992, LANCET, V340, P1317, DOI 10.1016/0140-6736(92)92495-2; Sherr L, 2004, HIV MED, V5, P258, DOI 10.1111/j.1468-1293.2004.00218.x; Siegel K, 2001, PSYCHOL WOMEN QUART, V25, P112, DOI 10.1111/1471-6402.00013; Sunderam S, 2008, REPROD HEALTH MATTER, V16, P211, DOI 10.1016/S0968-8080(08)31342-1; Tecimer Sandy N, 2011, Open AIDS J, V5, P37, DOI 10.2174/1874613601105010037; VanDevanter N, 1999, AIDS CARE, V11, P181, DOI 10.1080/09540129948072; Vernazza P, 2008, B MED SUISSES, V89, P165; Yudin MH, 2011, J OBSTET GYNAECOL CA, V33, P269, DOI 10.1016/S1701-2163(16)34829-0; Yudin MH, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-7; Yudin MH, 2011, 20 CAN ASS HIV RES C	33	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24853	10.1371/journal.pone.0024853	http://dx.doi.org/10.1371/journal.pone.0024853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834CT	21969863	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900014
J	Comte, J; del Giorgio, PA				Comte, Jerome; del Giorgio, Paul A.			Composition Influences the Pathway but not the Outcome of the Metabolic Response of Bacterioplankton to Resource Shifts	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; BACTERIAL COMMUNITIES; PRODUCTIVITY; BIODIVERSITY; TEMPERATURE; REDUNDANCY; DIVERSITY; MORTALITY; SALINITY; DYNAMICS	Bacterioplankton community metabolism is central to the functioning of aquatic ecosystems, and strongly reactive to changes in the environment, yet the processes underlying this response remain unclear. Here we explore the role that community composition plays in shaping the bacterial metabolic response to resource gradients that occur along aquatic ecotones in a complex watershed in Quebec. Our results show that the response is mediated by complex shifts in community structure, and structural equation analysis confirmed two main pathways, one involving adjustments in the level of activity of existing phylotypes, and the other the replacement of the dominant phylotypes. These contrasting response pathways were not determined by the type or the intensity of the gradients involved, as we had hypothesized, but rather it would appear that some compositional configurations may be intrinsically more plastic than others. Our results suggest that community composition determines this overall level of community plasticity, but that composition itself may be driven by factors independent of the environmental gradients themselves, such that the response of bacterial communities to a given type of gradient may alternate between the adjustment and replacement pathways. We conclude that community composition influences the pathways of response in these bacterial communities, but not the metabolic outcome itself, which is driven by the environment, and which can be attained through multiple alternative configurations.	[Comte, Jerome; del Giorgio, Paul A.] Univ Quebec, Dept Sci Biol, GRIL, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	Comte, J (corresponding author), Univ Quebec, Dept Sci Biol, GRIL, CP 8888, Montreal, PQ H3C 3P8, Canada.	comte.jerome@courrier.uqam.ca	del Giorgio, Paul/AAD-1315-2019	del Giorgio, Paul/0000-0003-1866-8159; Comte, Jerome/0000-0002-7936-4290	National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/Index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL AA, 2001, SCIENCE, V12, P221; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Alonso-Saez L, 2007, AQUAT MICROB ECOL, V46, P43, DOI 10.3354/ame046043; [Anonymous], 2002, CAUSE CORRELATION BI; Apple JK, 2008, J COASTAL RES, P59, DOI 10.2112/SI55-005.1; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bertilsson S, 2007, ISME J, V1, P532, DOI 10.1038/ismej.2007.64; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Button DK, 2004, APPL ENVIRON MICROB, V70, P5511, DOI 10.1128/AEM.70.9.5511-5521.2004; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Comte J, 2010, ECOLOGY, V91, P1466, DOI 10.1890/09-0848.1; Comte J, 2009, ENVIRON MICROBIOL, V11, P1704, DOI 10.1111/j.1462-2920.2009.01897.x; Corno G, 2008, ENVIRON MICROBIOL, V10, P2857, DOI 10.1111/j.1462-2920.2008.01713.x; Cotner JB, 2002, ECOSYSTEMS, V5, P105, DOI 10.1007/s10021-001-0059-3; del Giorgio P. A., 2008, MICROBIAL ECOLOGY OC, P243, DOI DOI 10.1002/9780470281840.CH8; del Giorgio PA, 2002, LIMNOL OCEANOGR, V47, P471, DOI 10.4319/lo.2002.47.2.0471; Ducklow H, 2008, AQUAT MICROB ECOL, V53, P13, DOI 10.3354/ame01220; Fernandez A, 1999, APPL ENVIRON MICROB, V65, P3697; Findlay SEG, 2003, LIMNOL OCEANOGR, V48, P1608, DOI 10.4319/lo.2003.48.4.1608; Fisher MM, 2000, MICROBIAL ECOL, V40, P125, DOI 10.1007/s002480000049; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Giller PS, 2004, OIKOS, V104, P423, DOI 10.1111/j.0030-1299.2004.13253.x; Judd KE, 2006, ECOLOGY, V87, P2068, DOI 10.1890/0012-9658(2006)87[2068:VIDOMC]2.0.CO;2; Kirchman DL, 2004, AQUAT MICROB ECOL, V35, P243, DOI 10.3354/ame035243; Kritzberg ES, 2006, FEMS MICROBIOL ECOL, V56, P406, DOI 10.1111/j.1574-6941.2006.00084.x; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Langenheder S, 2006, APPL ENVIRON MICROB, V72, P212, DOI 10.1128/AEM.72.1.212-220.2006; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; Lennon JT, 2008, ECOLOGY, V89, P1001, DOI 10.1890/07-1380.1; Longnecker K, 2005, APPL ENVIRON MICROB, V71, P7737, DOI 10.1128/AEM.71.12.7737-7749.2005; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Meyer AF, 2004, APPL ENVIRON MICROB, V70, P483, DOI 10.1128/AEM.70.1.483-489.2004; Mills AL, 2003, 2003012509 SAE INT; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Nelson CE, 2009, ISME J, V3, P13, DOI 10.1038/ismej.2008.81; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schimel JP, 1998, GLOBAL CHANGE BIOL, V4, P745, DOI 10.1046/j.1365-2486.1998.00195.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vrede K, 2005, MICROB ECOL, V49, P245, DOI 10.1007/s00248-004-0259-4; Weinbauer MG, 2004, ENVIRON MICROBIOL, V6, P1, DOI 10.1046/j.1462-2920.2003.00539.x; Wohl DL, 2004, ECOLOGY, V85, P1534, DOI 10.1890/03-3050; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	49	52	53	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25266	10.1371/journal.pone.0025266	http://dx.doi.org/10.1371/journal.pone.0025266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980410	Green Published, Green Submitted, gold			2022-12-25	WOS:000295933700023
J	Soichot, M; Hennart, B; Al Saabi, A; Leloire, A; Froguel, P; Levy-Marchal, C; Poulain-Godefroy, O; Allorge, D				Soichot, Marion; Hennart, Benjamin; Al Saabi, Alaa; Leloire, Audrey; Froguel, Philippe; Levy-Marchal, Claire; Poulain-Godefroy, Odile; Allorge, Delphine			Identification of a Variable Number of Tandem Repeats Polymorphism and Characterization of LEF-1 Response Elements in the Promoter of the IDO1 Gene	PLOS ONE			English	Article							SERUM KYNURENINE/TRYPTOPHAN RATIO; INDOLEAMINE 2,3-DIOXYGENASE GENE; ALLOGENEIC FETAL REJECTION; INTERFERON-GAMMA; IFN-GAMMA; TRYPTOPHAN CATABOLITES; IMMUNE TOLERANCE; DENDRITIC CELLS; EXPRESSION; DIOXYGENASE	Background: Indoleamine 2,3-dioxygenase (IDO) catalyzes the first and rate-limiting step of the kynurenine pathway that is an important component of immunomodulatory and neuromodulatory processes. The IDO1 gene is highly inducible by IFN-gamma and TNF-alpha through interaction with cis-acting regulatory elements of the promoter region. Accordingly, functional polymorphisms in the IDO1 promoter could partly explain the interindividual variability in IDO expression that has been previously documented. Methodology/Principal Findings: A PCR-sequencing strategy, applied to DNA samples from healthy Caucasians, allowed us to identify a VNTR polymorphism in the IDO1 promoter, which correlates significantly with serum tryptophan concentration, controlled partially by IDO activity, in female subjects, but not in males. Although this VNTR does not appear to affect basal or cytokine-induced promoter activity in gene reporter assays, it contains novel cis-acting elements. Three putative LEF-1 binding sites, one being located within the VNTR repeat motif, were predicted in silico and confirmed by chromatin immunoprecipitation. Overexpression of LEF-1 in luciferase assays confirmed an interaction between LEF-1 and the predicted transcription factor binding sites, and modification of the LEF-1 core sequence within the VNTR repeat motif, by site-directed mutagenesis, resulted in an increase in promoter activity. Conclusions/Significance: The identification of a VNTR in the IDO1 promoter revealed a cis-acting element interacting with the most downstream factor of the Wnt signaling pathway, suggesting novel mechanisms of regulation of IDO1 expression. These data offer new insights, and suggest further studies, into the role of IDO in various pathological conditions, particularly in cancer where IDO and the Wnt pathway are strongly dysregulated.	[Soichot, Marion; Hennart, Benjamin; Al Saabi, Alaa; Allorge, Delphine] Univ Lille Nord France, UDSL, Fac Med Lille, Equipe Accueil 4483, Lille, France; [Leloire, Audrey; Froguel, Philippe; Poulain-Godefroy, Odile] Univ Lille 2, Inst Pasteur, CNRS Inst Biol 8199, Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England; [Levy-Marchal, Claire] Hop Robert Debre, CIC EC 05, Inst Natl Sante & Rech Med, F-75019 Paris, France	Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Soichot, M (corresponding author), Univ Lille Nord France, UDSL, Fac Med Lille, Equipe Accueil 4483, Lille, France.	dallorge@univ-lille2.fr	FROGUEL, Philippe/O-6799-2017; Poulain-Godefroy, Odile/AAF-5474-2021	FROGUEL, Philippe/0000-0003-2972-0784; POULAIN-GODEFROY, Odile/0000-0001-8805-9450; allorge, delphine/0000-0003-2356-3319; HENNART, Benjamin/0000-0003-0302-6049	Universite Lille-Nord de France; Centre Hospitalier et Universitaire de Lille; Conseil Regional Nord-Pas de Calais; CHRU de Lille; MRC [G0700342] Funding Source: UKRI; Medical Research Council [G0700342] Funding Source: researchfish	Universite Lille-Nord de France; Centre Hospitalier et Universitaire de Lille; Conseil Regional Nord-Pas de Calais(Region Hauts-de-France); CHRU de Lille; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Universite Lille-Nord de France, the Centre Hospitalier et Universitaire de Lille and the Conseil Regional Nord-Pas de Calais. This work is part of a research program of the Pole Interdisciplinaire sur les Conduites Addictives (PIRCad). Marion Soichot is co-funded by the CHRU de Lille and the Conseil Regional Nord-Pas de Calais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-159; Arefayene M, 2009, PHARMACOGENET GENOM, V19, P464, DOI 10.1097/FPC.0b013e32832c005a; Bonaccorso S, 2002, J CLIN PSYCHOPHARM, V22, P86, DOI 10.1097/00004714-200202000-00014; Bouatia-Naji N, 2009, EUR J ENDOCRINOL, V160, P557, DOI 10.1530/EJE-08-0794; Carretti N, 2005, HUM REPROD, V20, P1548, DOI 10.1093/humrep/deh795; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chon SY, 1996, J BIOL CHEM, V271, P17247, DOI 10.1074/jbc.271.29.17247; Corm S, 2009, LEUKEMIA RES, V33, P490, DOI 10.1016/j.leukres.2008.06.014; Hebenstreit D, 2008, J BIOL CHEM, V283, P22490, DOI 10.1074/jbc.M804096200; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Huttunen R, 2010, SHOCK, V33, P149, DOI 10.1097/SHK.0b013e3181ad3195; Jaquet D, 2004, HORM RES, V62, P92, DOI 10.1159/000079709; Kato A, 2010, HEMODIAL INT, V14, P418, DOI 10.1111/j.1542-4758.2010.00464.x; Kawaguchi R, 2008, J REPROD IMMUNOL, V77, P117, DOI 10.1016/j.jri.2007.08.003; Konan KV, 1996, J BIOL CHEM, V271, P19140, DOI 10.1074/jbc.271.32.19140; Lesch KP, 2005, PROG NEURO-PSYCHOPH, V29, P1062, DOI 10.1016/j.pnpbp.2005.03.012; Logters TT, 2009, SHOCK, V32, P29, DOI 10.1097/SHK.0b013e31819714fa; Macchiarulo A, 2009, AMINO ACIDS, V37, P219, DOI 10.1007/s00726-008-0137-3; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Muller AJ, 2005, EXPERT OPIN THER TAR, V9, P831, DOI 10.1517/14728222.9.4.831; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Murray MF, 2007, CURR DRUG METAB, V8, P197, DOI 10.2174/138920007780362509; Myint AM, 2009, METAB BRAIN DIS, V24, P55, DOI 10.1007/s11011-008-9114-5; Nemeth H, 2006, J NEURAL TRANSM-SUPP, P285; Nemeth Hajnalka, 2007, Central Nervous System Agents in Medicinal Chemistry, V7, P45, DOI 10.2174/187152407780059240; Nishizawa H, 2007, AM J REPROD IMMUNOL, V58, P11, DOI 10.1111/j.1600-0897.2007.00484.x; Nishizawa H, 2010, AM J REPROD IMMUNOL, V64, P68, DOI 10.1111/j.1600-0897.2010.00820.x; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Orabona C, 2011, METHODS MOL BIOL, V677, P269, DOI 10.1007/978-1-60761-869-0_19; Oxenkrug G, 2011, J NEURAL TRANSM, V118, P271, DOI 10.1007/s00702-010-0525-1; Oxenkrug GF, 2007, ANN NY ACAD SCI, V1122, P35, DOI 10.1196/annals.1403.003; Oxenkrug GF, 2011, J NEURAL TRANSM, V118, P75, DOI 10.1007/s00702-010-0475-7; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Pertovaara M, 2007, CLIN EXP IMMUNOL, V148, P106, DOI 10.1111/j.1365-2249.2007.03325.x; Prendergast GC, 2008, ONCOGENE, V27, P3889, DOI 10.1038/onc.2008.35; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Raitala A, 2005, SCAND J IMMUNOL, V61, P387, DOI 10.1111/j.1365-3083.2005.01586.x; Robinson CM, 2005, J INTERF CYTOK RES, V25, P20, DOI 10.1089/jir.2005.25.20; Robinson CM, 2003, J INTERF CYTOK RES, V23, P413, DOI 10.1089/107999003322277829; Robinson CM, 2006, CYTOKINE, V35, P53, DOI 10.1016/j.cyto.2006.07.007; Schefold JC, 2009, NEPHROL DIAL TRANSPL, V24, P1901, DOI 10.1093/ndt/gfn739; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Suzuki Y, 2010, LUNG CANCER, V67, P361, DOI 10.1016/j.lungcan.2009.05.001; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; TAKIKAWA O, 1988, J BIOL CHEM, V263, P2041; Ueno A, 2007, DIABETES, V56, P1686, DOI 10.2337/db06-1727; Vonica A, 2000, DEV BIOL, V217, P230, DOI 10.1006/dbio.1999.9551; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Zhu BT, 2010, INT J MOL MED, V25, P831, DOI 10.3892/ijmm_00000411; Zhu WH, 2007, MULT SCLER J, V13, P33, DOI 10.1177/1352458506071171	55	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25470	10.1371/journal.pone.0025470	http://dx.doi.org/10.1371/journal.pone.0025470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980470	Green Published, gold, Green Submitted			2022-12-25	WOS:000295933700039
J	Hua, XY; Chason, KD; Patel, JY; Naselsky, WC; Tilley, SL				Hua, Xiaoyang; Chason, Kelly D.; Patel, Janki Y.; Naselsky, Warren C.; Tilley, Stephen L.			IL-4 Amplifies the Pro-Inflammatory Effect of Adenosine in Human Mast Cells by Changing Expression Levels of Adenosine Receptors	PLOS ONE			English	Article							DEPENDENT HISTAMINE-RELEASE; A(3) RECEPTOR; AIRWAY INFLAMMATION; INHALED ADENOSINE; GENE ABLATION; A(2B); ACTIVATION; DEGRANULATION; MICE; IGE	Adenosine inhalation produces immediate bronchoconstriction in asthmatics but not in normal subjects. The bronchospastic effect of adenosine is largely mediated through adenosine-induced mast cell activation, the mechanism of which is poorly understood due to limitations in culturing human primary mast cells. Here, we show that human umbilical cord blood -derived mast cells incubated with the Th2 cytokine IL-4 develop increased sensitivity to adenosine. Potentiation of anti-IgE- induced and calcium ionophore/PMA-induced degranulation was augmented in mast cells cultured with IL-4, and this effect was reduced or abolished by pre-treatment with A(2B) siRNA and selective A(2B) receptor antagonists, respectively. IL-4 incubation resulted in the increased expression of A(2B) and reduced expression of A(2A) adenosine receptors on human mast cells. These results suggest that Th2 cytokines in the asthmatic lung may alter adenosine receptor expression on airway mast cells to promote increased responsiveness to adenosine.	[Hua, Xiaoyang; Chason, Kelly D.; Patel, Janki Y.; Naselsky, Warren C.; Tilley, Stephen L.] Univ N Carolina, Div Pulm & Crit Care Med, Dept Med, Chapel Hill, NC 27515 USA; [Hua, Xiaoyang; Chason, Kelly D.; Patel, Janki Y.; Naselsky, Warren C.; Tilley, Stephen L.] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA; [Hua, Xiaoyang] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Otolaryngol, Wuhan 430074, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Huazhong University of Science & Technology	Hua, XY (corresponding author), Univ N Carolina, Div Pulm & Crit Care Med, Dept Med, Chapel Hill, NC 27515 USA.	stephen_tilley@med.unc.edu	Hua, Xiaoyang/T-5252-2019	Hua, Xiaoyang/0000-0001-6414-7712	National Institutes of Health [HL071802, U19AI077437]; North Carolina Translational and Clinical Sciences (NC TraCS) Institute [50KR20926]; Natural Science Foundation of China [30700933]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Translational and Clinical Sciences (NC TraCS) Institute; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was made possible by funding from the National Institutes of Health grants HL071802 (SLT), U19AI077437 (D.B. Peden), the North Carolina Translational and Clinical Sciences (NC TraCS) Institute grant 50KR20926 (XH), and the Natural Science Foundation of China grant 30700933 (XH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auchampach JA, 1997, MOL PHARMACOL, V52, P846, DOI 10.1124/mol.52.5.846; Bradding P, 2005, CHEM IMMUNOL ALLERGY, V87, P163, DOI 10.1159/000087643; CHURCH MK, 1987, BRIT J PHARMACOL, V90, P421, DOI 10.1111/j.1476-5381.1987.tb08972.x; Cohen MV, BR J PHARM, V159, P1595; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Csoma Z, 2005, EUR RESPIR J, V25, P873, DOI 10.1183/09031936.05.00110204; CUSHLEY MJ, 1983, BRIT J CLIN PHARMACO, V15, P161, DOI 10.1111/j.1365-2125.1983.tb01481.x; DRIVER AG, 1993, AM REV RESPIR DIS, V148, P91, DOI 10.1164/ajrccm/148.1.91; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Fenster MS, 2000, MICROCIRCULATION, V7, P129, DOI 10.1038/sj.mn.7300101; Feoktistov I, 2003, CIRC RES, V92, P485, DOI 10.1161/01.RES.0000061572.10929.2D; FEOKTISTOV I, 1995, J CLIN INVEST, V96, P1979, DOI 10.1172/JCI118245; Forsythe P, 1999, CLIN SCI, V96, P349, DOI 10.1042/CS19980228; Forsythe P, 1999, INFLAMM RES, V48, P301, DOI 10.1007/s000110050464; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Hua X, 2008, J ALLERGY CLIN IMMUN, V121, pS111, DOI 10.1016/j.jaci.2007.12.443; Hua XY, 2008, J ALLERGY CLIN IMMUN, V122, P107, DOI 10.1016/j.jaci.2008.03.026; Hua XY, 2007, J EXP MED, V204, P117, DOI 10.1084/jem.20061372; HUGHES PJ, 1984, BIOCHEM PHARMACOL, V33, P3847, DOI 10.1016/0006-2952(84)90050-9; Knight D, 1997, J LEUKOCYTE BIOL, V62, P465, DOI 10.1002/jlb.62.4.465; Nguyen MT, 2002, J IMMUNOL, V169, P4586, DOI 10.4049/jimmunol.169.8.4586; NILSSON G, 1994, SCAND J IMMUNOL, V39, P489, DOI 10.1111/j.1365-3083.1994.tb03404.x; PEACHELL PT, 1988, AM REV RESPIR DIS, V138, P1143, DOI 10.1164/ajrccm/138.5.1143; PEACHELL PT, 1991, J PHARMACOL EXP THER, V256, P717; PHILLIPS GD, 1989, CLIN EXP ALLERGY, V19, P405, DOI 10.1111/j.1365-2222.1989.tb02406.x; PHILLIPS GD, 1989, EUR RESPIR J, V2, P210; Rork TH, 2008, AM J PHYSIOL-HEART C, V295, pH1825, DOI 10.1152/ajpheart.495.2008; Ryzhov S, 2008, J IMMUNOL, V180, P7212, DOI 10.4049/jimmunol.180.11.7212; Ryzhov S, 2008, J PHARMACOL EXP THER, V324, P694, DOI 10.1124/jpet.107.131540; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; Suzuki H, 1998, BIOCHEM BIOPH RES CO, V242, P697, DOI 10.1006/bbrc.1997.8040; Theoharides TC, 2006, STEM CELL REV, V2, P143; Tilley SL, 2003, J IMMUNOL, V171, P331, DOI 10.4049/jimmunol.171.1.331; Tilley SL, 2000, J CLIN INVEST, V105, P361, DOI 10.1172/JCI8253; Versluis M, 2008, INT IMMUNOPHARMACOL, V8, P866, DOI 10.1016/j.intimp.2008.02.001; Wang XS, 2006, J IMMUNOL METHODS, V309, P69, DOI 10.1016/j.jim.2005.11.012; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Yip K H, 2009, Inflamm Res, V58 Suppl 1, P17, DOI 10.1007/s00011-009-0647-9; Young HWJ, 2004, J IMMUNOL, V173, P1380, DOI 10.4049/jimmunol.173.2.1380; Zhong H, 2003, J IMMUNOL, V171, P338, DOI 10.4049/jimmunol.171.1.338; Zhou Y, 2009, J IMMUNOL, V182, P8037, DOI 10.4049/jimmunol.0900515	42	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e24947	10.1371/journal.pone.0024947	http://dx.doi.org/10.1371/journal.pone.0024947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966389	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100008
J	Rieker, C; Dev, KK; Lehnhoff, K; Barbieri, S; Ksiazek, I; Kauffmann, S; Danner, S; Schell, H; Boden, C; Ruegg, MA; Kahle, PJ; van der Putten, H; Shimshek, DR				Rieker, Claus; Dev, Kumlesh K.; Lehnhoff, Katja; Barbieri, Samuel; Ksiazek, Iwona; Kauffmann, Sabine; Danner, Simone; Schell, Heinrich; Boden, Cindy; Ruegg, Markus A.; Kahle, Philipp J.; van der Putten, Herman; Shimshek, Derya R.			Neuropathology in Mice Expressing Mouse Alpha-Synuclein	PLOS ONE			English	Article							IMMOBILIZED PH GRADIENTS; LEWY BODY DISEASE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SUBCELLULAR-LOCALIZATION; PROTEINASE K; BODIES; BRAIN; MODEL; INSOLUBILITY	alpha-Synuclein (alpha SN) in human is tightly linked both neuropathologically and genetically to Parkinson's disease (PD) and related disorders. Disease-causing properties in vivo of the wildtype mouse ortholog (m alpha SN), which carries a threonine at position 53 like the A53T human mutant version that is genetically linked to PD, were never reported. To this end we generated mouse lines that express m alpha SN in central neurons at levels reaching up to six-fold compared to endogenous m alpha SN. Unlike transgenic mice expressing human wildtype or mutant forms of alpha SN, these m alpha SN transgenic mice showed pronounced ubiquitin immunopathology in spinal cord and brainstem. Isoelectric separation of m alpha SN species revealed multiple isoforms including two Ser129-phosphorylated species in the most severely affected brain regions. Neuronal Ser129-phosphorylated alpha SN occured in granular and small fibrillar aggregates and pathological staining patterns in neurites occasionally revealed a striking ladder of small alternating segments staining either for Ser129-phosphorylated alpha SN or ubiquitin but not both. Axonal degeneration in long white matter tracts of the spinal cord, with breakdown of myelin sheaths and degeneration of neuromuscular junctions with loss of integrity of the presynaptic neurofilament network in m alpha SN transgenic mice, was similar to what we have reported for mice expressing human alpha SN wildtype or mutant forms. In hippocampal neurons, the m alpha SN protein accumulated and was phosphorylated but these neurons showed no ubiquitin immunopathology. In contrast to the early-onset motor abnormalities and muscle weakness observed in mice expressing human alpha SN, m alpha SN transgenic mice displayed only end-stage phenotypic alterations that manifested alongside with neuropathology. Altogether these findings show that increased levels of wildtype m alpha SN does not induce early-onset behavior changes, but drives end-stage pathophysiological changes in murine neurons that are strikingly similar to those evoked by expression of human wildtype or mutant forms.	[Rieker, Claus; Lehnhoff, Katja; Barbieri, Samuel; Kauffmann, Sabine; Danner, Simone; van der Putten, Herman; Shimshek, Derya R.] Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland; [Dev, Kumlesh K.] Trinity Coll Dublin, Sch Med, Dept Physiol, Dublin, Ireland; [Ksiazek, Iwona; Ruegg, Markus A.] Univ Basel, Neurobiol Biozentrum, Basel, Switzerland; [Schell, Heinrich; Boden, Cindy; Kahle, Philipp J.] Univ Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany; [Schell, Heinrich; Boden, Cindy; Kahle, Philipp J.] Univ Tubingen, German Ctr Neurodegenerat Dis, Tubingen, Germany	Novartis; Trinity College Dublin; University of Basel; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Rieker, C (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland.	derya.shimshek@novartis.com	Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Shimshek, Derya/0000-0001-8602-7850; Dev, Kumlesh/0000-0003-4274-9119	Novartis Pharma AG	Novartis Pharma AG	The study was funded by Novartis Pharma AG, who, through the employment of Claus Rieker, Katja Lehnhoff, Samuel Barbieri, Sabine Kauffmann, Simone Danner Herman van der Putten and Derya Shimshek, had a role in conceiving, designing and performing the experiments and analyzing the data.	Braak H, 1996, J NEURAL TRANSM, V103, P455, DOI 10.1007/BF01276421; Braak H, 2000, NERVENARZT, V71, P459, DOI 10.1007/s001150050607; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P1, DOI 10.1016/S0028-3908(02)00337-4; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gomez-Tortosa E, 2000, ACTA NEUROPATHOL, V99, P352, DOI 10.1007/s004010051135; Gomez-Tortosa E, 2000, ANN NY ACAD SCI, V920, P9; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Klein RL, 2002, HUM GENE THER, V13, P605, DOI 10.1089/10430340252837206; Lee FKM, 2009, J NEUROCHEM, V110, P208, DOI 10.1111/j.1471-4159.2009.06124.x; Luthi A, 1997, J NEUROSCI, V17, P4688; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McLean PJ, 2000, J NEURAL TRANSM-SUPP, P53; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Rabilloud T, 1997, ELECTROPHORESIS, V18, P307, DOI 10.1002/elps.1150180303; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takahashi N, 2002, BBA-PROTEINS PROTEOM, V1601, P110, DOI 10.1016/S1570-9639(02)00435-1; Takeda A, 1998, LAB INVEST, V78, P1169; Towbin H, 2001, ELECTROPHORESIS, V22, P1887, DOI 10.1002/1522-2683(200106)22:10<1887::AID-ELPS1887>3.0.CO;2-Q; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Wakabayashi K, 1997, ACTA NEUROPATHOL, V93, P7, DOI 10.1007/s004010050576; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n	33	35	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e24834	10.1371/journal.pone.0024834	http://dx.doi.org/10.1371/journal.pone.0024834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966373	Green Accepted, gold, Green Published			2022-12-25	WOS:000295932100005
J	Rocklin, D; Tomasini, JA; Culioli, JM; Pelletier, D; Mouillot, D				Rocklin, Delphine; Tomasini, Jean-Antoine; Culioli, Jean-Michel; Pelletier, Dominique; Mouillot, David			Spearfishing Regulation Benefits Artisanal Fisheries: The ReGS Indicator and Its Application to a Multiple-Use Mediterranean Marine Protected Area	PLOS ONE			English	Article							FISH COMMUNITY; SOFT-BOTTOM; RESERVES; COASTAL; MANAGEMENT; SPILLOVER; SIZE; IMPACTS; HABITAT; TRAITS	The development of fishing efficiency coupled with an increase of fishing effort led to the overexploitation of numerous natural marine resources. In addition to this commercial pressure, the impact of recreational activities on fish assemblages remains barely known. Here we examined the impact of spearfishing limitation on resources in a marine protected area (MPA) and the benefit it provides for the local artisanal fishery through the use of a novel indicator. We analysed trends in the fish assemblage composition using artisanal fisheries data collected in the Bonifacio Strait Natural Reserve (BSNR), a Mediterranean MPA where the spearfishing activity has been forbidden over 15% of its area. Fish species were pooled into three response groups according to their target level by spearfishing. We developed the new flexible ReGS indicator reflecting shifts in species assemblages according to the relative abundance of each response group facing external pressure. The catch per unit effort (CPUE) increased by ca. 60% in the BSNR between 2000 and 2007, while the MPA was established in 1999. The gain of CPUE strongly depended on the considered response group: for the highly targeted group, the CPUE doubled while the CPUE of the untargeted group increased by only 15.5%. The ReGS value significantly increased from 0.31 to 0.45 (on a scale between 0 and 1) in the general perimeter of this MPA while it has reached a threshold of 0.43, considered as a reference point, in the area protected from spearfishing since 1982. Our results demonstrated that limiting recreational fishing by appropriate zoning in multiple-use MPAs represents a real benefit for artisanal fisheries. More generally we showed how our new indicator may reveal a wide range of impacts on coastal ecosystems such as global change or habitat degradation.	[Rocklin, Delphine; Tomasini, Jean-Antoine; Mouillot, David] Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, UMR CNRS IRD IFREMER UM2 5119, Montpellier, France; [Rocklin, Delphine; Pelletier, Dominique] IFREMER, Lab Biol Halieut, Dept Sci & Technol Halieut, Plouzane, France; [Culioli, Jean-Michel] Off Environm Corse, Corte, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ifremer	Rocklin, D (corresponding author), Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, UMR CNRS IRD IFREMER UM2 5119, Montpellier, France.	delphine.rocklin@gmail.com	Rocklin, Delphine/G-6359-2012; Pelletier, Dominique/A-1649-2011	Rocklin, Delphine/0000-0003-4442-0704; Pelletier, Dominique/0000-0003-2420-1942	PAMPA Pacific Area Movements Priority Agency; French Research Institute for Exploitation of the Sea; l'Office de l'Environnement de la Corse; ANR	PAMPA Pacific Area Movements Priority Agency; French Research Institute for Exploitation of the Sea; l'Office de l'Environnement de la Corse(Region Corse); ANR(French National Research Agency (ANR))	This work was partially funded by a LITEAU III project (PAMPA Pacific Area Movements Priority Agency), as well as by two ANR programmes (GAIUS and AMPHORE) to study the effects of Marine Protected Areas. DR was supported, during her PhD, by a scholarship from IFREMER (French Research Institute for Exploitation of the Sea) and l'Office de l'Environnement de la Corse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; BAUCHOT ML, 1980, GUIDE POISSONS MARIN; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Blanchard JL, 2005, ICES J MAR SCI, V62, P405, DOI 10.1016/j.icesjms.2005.01.006; Boersma PD, 1999, ECOL ECON, V31, P287, DOI 10.1016/S0921-8009(99)00085-3; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Bowman AW, 2003, COMPUT STAT DATA AN, V42, P545, DOI 10.1016/S0167-9473(02)00118-4; Chen Y, 1999, CAN J FISH AQUAT SCI, V56, P1525, DOI 10.1139/cjfas-56-9-1525; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; Claudet J, 2004, AQUAT LIVING RESOUR, V17, P129, DOI 10.1051/alr:2004017; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; Dauvin JC, 2007, MAR POLLUT BULL, V55, P271, DOI 10.1016/j.marpolbul.2006.08.017; Denny CM, 2004, BIOL CONSERV, V116, P119, DOI 10.1016/S0006-3207(03)00183-6; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; European Union, 2004, FISH EUR MED GUAR SU; FAO, 2020, STAT WORLD FISH AQ, DOI 10.4060/ca9229-n; Forcada A, 2009, MAR ECOL PROG SER, V379, P197, DOI 10.3354/meps07892; Fox J, 2002, COX PROPORTIONAL HAZ; Garcia-Charton JA, 2000, ENVIRON CONSERV, V27, P159, DOI 10.1017/S0376892900000199; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gomez S, 2006, COAST MANAGE, V34, P217, DOI 10.1080/08920750500531389; Goni R, 2008, MAR ECOL PROG SER, V366, P159, DOI 10.3354/meps07532; Goni R, 2006, MAR ECOL PROG SER, V308, P207, DOI 10.3354/meps308207; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Hutchings JA, 2005, CAN J FISH AQUAT SCI, V62, P824, DOI 10.1139/F05-081; Hutchings JA, 2009, EVOL APPL, V2, P324, DOI 10.1111/j.1752-4571.2009.00085.x; Islam MS, 2004, MAR POLLUT BULL, V48, P624, DOI 10.1016/j.marpolbul.2003.12.004; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 2005, FISH FISH, V6, P212, DOI 10.1111/j.1467-2979.2005.00189.x; Jouvenel JY, 2001, AQUAT CONSERV, V11, P1, DOI 10.1002/aqc.424; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; Kendall MS, 2004, AQUAT CONSERV, V14, P113, DOI 10.1002/aqc.601; Lasram FB, 2010, GLOBAL CHANGE BIOL, V16, P3233, DOI 10.1111/j.1365-2486.2010.02224.x; Lasram FB, 2009, MAR ECOL PROG SER, V376, P253, DOI 10.3354/meps07786; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lloret J, 2008, FISH RES, V94, P84, DOI 10.1016/j.fishres.2008.07.002; Lloret J, 2008, FISH RES, V91, P252, DOI 10.1016/j.fishres.2007.12.002; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Mistri M, 2008, MAR POLLUT BULL, V56, P587, DOI 10.1016/j.marpolbul.2007.12.002; Morales-Nin B, 2005, ICES J MAR SCI, V62, P727, DOI 10.1016/j.icesjms.2005.01.022; Mouillot D, 2008, BIOL CONSERV, V141, P1569, DOI 10.1016/j.biocon.2008.04.002; Mouillot D, 2006, AQUAT CONSERV, V16, P469, DOI 10.1002/aqc.769; Mouillot D, 2005, OECOLOGIA, V145, P345, DOI 10.1007/s00442-005-0151-z; Mouillot D, 2002, ENVIRON CONSERV, V29, P385, DOI 10.1017/S0376892902000267; MURAWSKI SA, 2003, AM FISH SOC SEA GRAN, P167; Murrell P., 2005, R GRAPHICS; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; National Research Council, 2006, REV RECR FISH SURV M; Ormerod SJ, 2003, J APPL ECOL, V40, P204, DOI 10.1046/j.1365-2664.2003.00824.x; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pelletier D, 2005, AQUAT LIVING RESOUR, V18, P15, DOI 10.1051/alr:2005011; Pelletier D, 2008, CAN J FISH AQUAT SCI, V65, P765, DOI 10.1139/F08-026; Perez-Ruzafa A, 2008, J NAT CONSERV, V16, P234, DOI 10.1016/j.jnc.2008.09.003; Pinnegar JK, 2004, ECOL MODEL, V172, P249, DOI 10.1016/j.ecolmodel.2003.09.010; Pitcher T.J., 2002, RECREATIONAL FISHERI, P53; Pitchford JW, 2007, ECOL MODEL, V207, P286, DOI 10.1016/j.ecolmodel.2007.05.006; Pluquet F, 2006, EVOLUTION RECENTE SE; Preuss B, 2009, ICES J MAR SCI, V66, P170, DOI 10.1093/icesjms/fsn204; Punt AE, 2008, AM FISH S S, V49, P1343; Roberts C.M., 1991, Reviews in Fish Biology and Fisheries, V1, P65, DOI 10.1007/BF00042662; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Rochet MJ, 1998, ICES J MAR SCI, V55, P371, DOI 10.1006/jmsc.1997.0324; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Sainsbury K, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P343, DOI 10.1079/9780851996332.0343; Seytre C, 2009, ICES J MAR SCI, V66, P180, DOI 10.1093/icesjms/fsn196; Shears NT, 2002, OECOLOGIA, V28, P312; Shin YJ, 2004, CAN J FISH AQUAT SCI, V61, P414, DOI 10.1139/F03-154; Stelzenmuller V, 2007, BIOL CONSERV, V136, P571, DOI 10.1016/j.biocon.2007.01.002; Stobart B, 2009, MAR ECOL PROG SER, V384, P47, DOI 10.3354/meps08007; Tetreault I, 2007, ECOL APPL, V17, P2251, DOI 10.1890/06-0161.1; Tuya FC, 2000, ICES J MAR SCI, V57, P1218, DOI 10.1006/jmsc.2000.0808; Venables WN, 2009, INTRO R; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; Whitehead P.J.P., 1986, FISHES NE ATLANTIC M; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zeller D, 2008, FISH RES, V91, P88, DOI 10.1016/j.fishres.2007.11.010	86	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e23820	10.1371/journal.pone.0023820	http://dx.doi.org/10.1371/journal.pone.0023820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966357	Green Published, gold			2022-12-25	WOS:000295267100003
J	Han, CSA; Lu, Y; Wei, Y; Liu, Y; He, RQ				Han, Chanshuai; Lu, Yang; Wei, Yan; Liu, Ying; He, Rongqiao			D-Ribose Induces Cellular Protein Glycation and Impairs Mouse Spatial Cognition	PLOS ONE			English	Article							GLYCOSYLATION END-PRODUCTS; D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ALZHEIMERS-DISEASE; ASTROCYTES; APOPTOSIS; RECEPTOR; ALBUMIN; NEURONS; GLUCOSE	Background: D-Ribose, an important reducing monosaccharide, is highly active in the glycation of proteins, and results in the rapid production of advanced glycation end products (AGEs) in vitro. However, whether D-ribose participates in glycation and leads to production of AGEs in vivo still requires investigation. Methodology/Principal Findings: Here we treated cultured cells and mice with D-ribose and D-glucose to compare ribosylation and glucosylation for production of AGEs. Treatment with D-ribose decreased cell viability and induced more AGE accumulation in cells. C57BL/6J mice intraperitoneally injected with D-ribose for 30 days showed high blood levels of glycated proteins and AGEs. Administration of high doses D-ribose also accelerated AGE formation in the mouse brain and induced impairment of spatial learning and memory ability according to the performance in Morris water maze test. Conclusions/Significance: These data demonstrate that D-ribose but not D-glucose reacts rapidly with proteins and produces significant amounts of AGEs in both cultured cells and the mouse brain, leading to accumulation of AGEs which may impair mouse spatial cognition.	[Han, Chanshuai; Lu, Yang; Wei, Yan; Liu, Ying; He, Rongqiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [He, Rongqiao] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Han, Chanshuai] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Lu, Yang] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Han, CSA (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	herq@sun5.ibp.ac.cn	Liu, Ying/D-8933-2013; han, chanshuai/GXG-6801-2022	Liu, Ying/0000-0003-0802-3832; 	973-Project [2010CB912303, 2006CB500703]; Natural Scientific Foundation of China NSFC [30970695, CAS-KSCX2-YW-R-119, KSCX2-YW-R-256]; QCAS [GJHZ1131]; Beijing Natural Science Foundation	973-Project(National Basic Research Program of China); Natural Scientific Foundation of China NSFC(National Natural Science Foundation of China (NSFC)); QCAS; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from the 973-Project (2010CB912303; 2006CB500703), the Natural Scientific Foundation of China NSFC 30970695, 30970695, CAS-KSCX2-YW-R-119, KSCX2-YW-R-256, QCAS Biotechnology Fund (GJHZ1131) and by Beijing Natural Science Foundation (Ribosylation of intracellular protein and the mechanism of cell death). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW WF, 1967, ACTA PHYSIOL SCAND, V70, P168, DOI 10.1111/j.1748-1716.1967.tb03612.x; BARTELS H, 1971, CLIN CHIM ACTA, V32, P81, DOI 10.1016/0009-8981(71)90467-0; Bergmeyer H U, 1976, Clin Chim Acta, V70, pF19, DOI 10.1016/0009-8981(76)90437-X; BERGMEYER HU, 1986, J CLIN CHEM CLIN BIO, V24, P481; BIEDLER JL, 1978, CANCER RES, V38, P3751; BONDAR RJL, 1974, CLIN CHEM, V20, P586; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BROOM AD, 1964, BIOCHEMISTRY-US, V3, P494, DOI 10.1021/bi00892a005; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669; Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009052; Chen L, 2009, CELL MOL LIFE SCI, V66, P2559, DOI 10.1007/s00018-009-0058-7; Cloos PAC, 2002, MATRIX BIOL, V21, P39, DOI 10.1016/S0945-053X(01)00188-3; DAY JF, 1979, J BIOL CHEM, V254, P595; GARLICK RL, 1983, J BIOL CHEM, V258, P6142; Gebhart B, 2004, PHARMACOTHERAPY, V24, P1646, DOI 10.1592/phco.24.16.1646.50957; HARVEY SC, 1986, J AM CHEM SOC, V108, P6128, DOI 10.1021/ja00280a004; HE RQ, 1995, BIOCHEM J, V309, P133, DOI 10.1042/bj3090133; HE RQ, 1995, BBA-PROTEIN STRUCT M, V1253, P47, DOI 10.1016/0167-4838(95)00145-K; HEINZEL SS, 1988, J VIROL, V62, P3738, DOI 10.1128/JVI.62.10.3738-3746.1988; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; KELLER PJ, 1988, BIOCHEMISTRY-US, V27, P1117, DOI 10.1021/bi00404a006; Li YP, 1996, BRAIN RES, V738, P196, DOI 10.1016/S0006-8993(96)00733-0; LYONS TJ, 1991, DIABETES, V40, P1010, DOI 10.2337/diabetes.40.8.1010; MAUSER M, 1985, CIRC RES, V56, P220, DOI 10.1161/01.RES.56.2.220; Mayo L, 2007, CELL DEATH DIFFER, V14, P183, DOI 10.1038/sj.cdd.4401989; Miyata T, 1999, KIDNEY INT, V55, P389, DOI 10.1046/j.1523-1755.1999.00302.x; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MUNCH G, 2003, ADV RES NEURODEGENER; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Pertynska-Marczewska M, 2004, CYTOKINE, V28, P35, DOI 10.1016/j.cyto.2004.06.006; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; PLIML W, 1992, LANCET, V340, P507, DOI 10.1016/0140-6736(92)91709-H; Sasaki N, 2001, BRAIN RES, V888, P256, DOI 10.1016/S0006-8993(00)03075-4; Sasaki N, 1998, AM J PATHOL, V153, P1149, DOI 10.1016/S0002-9440(10)65659-3; Takeda A, 1998, ACTA NEUROPATHOL, V95, P555, DOI 10.1007/s004010050839; Takeuchi M, 2000, J NEUROPATH EXP NEUR, V59, P1094, DOI 10.1093/jnen/59.12.1094; TANAKA S, 1988, J MOL BIOL, V203, P495, DOI 10.1016/0022-2836(88)90015-0; Teitelbaum JE, 2006, J ALTERN COMPLEM MED, V12, P857, DOI 10.1089/acm.2006.12.857; Viviani GL, 2008, METABOLISM, V57, P163, DOI 10.1016/j.metabol.2007.08.020; VLASSARA H, 1992, P NATL ACAD SCI USA, V89, P12043, DOI 10.1073/pnas.89.24.12043; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Wei Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-10; Weng D, 2007, TOXICOLOGY, V232, P15, DOI 10.1016/j.tox.2006.12.010; Woltjer RL, 2003, J ALZHEIMERS DIS, V5, P467, DOI 10.3233/JAD-2003-5607; Woodside JV, 1998, AM J CLIN NUTR, V67, P858, DOI 10.1093/ajcn/67.5.858; Yang K, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-66	48	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24623	10.1371/journal.pone.0024623	http://dx.doi.org/10.1371/journal.pone.0024623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21966363	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800074
J	Chattergoon, NN; Giraud, GD; Louey, S; Stork, P; Fowden, AL; Thornburg, KL				Chattergoon, Natasha N.; Giraud, George D.; Louey, Samantha; Stork, Philip; Fowden, Abigail L.; Thornburg, Kent L.			Thyroid hormone drives fetal cardiomyocyte maturation	FASEB JOURNAL			English	Article						proliferation; sheep fetus; p21	SIGNAL-REGULATED KINASE; CELL-CYCLE ACTIVITY; INTRAUTERINE GROWTH RESTRICTION; ATRIAL-NATRIURETIC-FACTOR; ACTIVATED PROTEIN-KINASE; CARDIAC-MUSCLE-CELLS; MEK-ERK PATHWAY; SARCOPLASMIC-RETICULUM; POSTNATAL-DEVELOPMENT; SHEEP CARDIOMYOCYTES	Tri-iodo-L-thyronine (T-3) suppresses the proliferation of near-term serum-stimulated fetal ovine cardiomyocytes in vitro. Thus, we hypothesized that T-3 is a major stimulant of cardiomyocyte maturation in vivo. We studied 3 groups of sheep fetuses on gestational days 125-130 (term similar to 145 d): a T-3-infusion group, to mimic fetal term levels (plasma T-3 levels increased from similar to 0.1 to similar to 1.0 ng/ml; t(1/2) similar to 24 h); a thyroidectomized group, to produce low thyroid hormone levels; and a vehicle-infusion group, to serve as intact controls. At 130 d of gestation, sections of left ventricular freewall were harvested, and the remaining myocardium was enzymatically dissociated. Proteins involved in cell cycle regulation (p21, cyclin D1), proliferation (ERK), and hypertrophy (mTOR) were measured in left ventricular tissue. Evidence that elevated T-3 augmented the maturation rate of cardiomyocytes included 14% increased width, 31% increase in binucleation, 39% reduction in proliferation, 150% reduction in cyclin D1 protein, and 500% increase in p21 protein. Increased expression of phospho-mTOR, ANP, and SERCA2a also suggests that T-3 promotes maturation and hypertrophy of fetal cardiomyocytes. Thyroidectomized fetuses had reduced cell cycle activity and binucleation. These findings support the hypothesis that T-3 is a prime driver of prenatal cardiomyocyte maturation.-Chattergoon, N. N., Giraud, G. D., Louey, S., Stork, P., Fowden, A. L., Thornburg, K. L. Thyroid hormone drives fetal cardiomyocyte maturation FASEB J. 26, 397-408 (2012). www.fasebj.org	[Chattergoon, Natasha N.; Giraud, George D.; Louey, Samantha; Thornburg, Kent L.] Oregon Hlth & Sci Univ, Heart Res Ctr, Portland, OR 97239 USA; [Giraud, George D.; Thornburg, Kent L.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA; [Giraud, George D.; Louey, Samantha; Thornburg, Kent L.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Stork, Philip] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Giraud, George D.] Portland VA Med Ctr, Portland, OR USA; [Fowden, Abigail L.] Univ Cambridge, Physiol Lab, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; University of Cambridge	Thornburg, KL (corresponding author), Oregon Hlth & Sci Univ, Heart Res Ctr, 3303 SW Bond Ave,CH15H, Portland, OR 97239 USA.	thornbur@ohsu.edu	Louey, Samantha/A-1381-2009	Louey, Samantha/0000-0002-2628-0085	U.S. National Institute of Child Health and Human Development [P01 HD 34430]; National Heart, Lung, and Blood Institute (NHLBI) [R21 HL093617, T32HL094294]; National Institutes of Health [R01 HL102763]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD034430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102763, T32HL094294, R21HL093617] Funding Source: NIH RePORTER	U.S. National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Mr. Robert Webber and Ms. Loni Socha for excellent technical assistance. The authors appreciate support from the M. Lowell Edwards Endowment. This study was supported by funds from U.S. National Institute of Child Health and Human Development grant P01 HD 34430, National Heart, Lung, and Blood Institute (NHLBI) grant R21 HL093617, and National Institutes of Health grant R01 HL102763. N.N.C. was supported by NHLBI training grant T32HL094294.	ANVERSA P, 1978, LAB INVEST, V38, P597; ANVERSA P, 1980, CIRC RES, V46, P495, DOI 10.1161/01.RES.46.4.495; Barbera A, 2000, AM J PHYSIOL-REG I, V279, pR1157, DOI 10.1152/ajpregu.2000.279.4.R1157; Barker DJP, 2010, EUR J HEART FAIL, V12, P819, DOI 10.1093/eurjhf/hfq069; BECKS GP, 1991, MED CLIN N AM, V75, P121, DOI 10.1016/S0025-7125(16)30475-8; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Boluyt MO, 2004, CARDIOVASC DRUG THER, V18, P257, DOI 10.1023/B:CARD.0000041245.61136.56; Bottazzi ME, 1999, J CELL BIOL, V146, P1255, DOI 10.1083/jcb.146.6.1255; BREALL JA, 1984, J CLIN INVEST, V73, P1418, DOI 10.1172/JCI111346; Brown DD, 2007, DEV BIOL, V306, P20, DOI 10.1016/j.ydbio.2007.03.021; Bubb KJ, 2007, J PHYSIOL-LONDON, V578, P871, DOI 10.1113/jphysiol.2006.121160; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Burrell JH, 2003, ANAT REC PART A, V274A, P952, DOI 10.1002/ar.a.10110; BURROW GN, 1994, NEW ENGL J MED, V331, P1072; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; CASTRO R, 1988, Pediatric Research, V23, p274A; Cernohorsky J, 1998, AM J PHYSIOL-HEART C, V275, pH264, DOI 10.1152/ajpheart.1998.275.1.H264; Chan S, 2003, J CLIN ENDOCR METAB, V88, P4488, DOI 10.1210/jc.2003-030228; Chan SY, 2006, J ENDOCRINOL, V189, P465, DOI 10.1677/joe.1.06582; Chan SY, 2009, NAT CLIN PRACT ENDOC, V5, P45, DOI 10.1038/ncpendmet1026; Chang FM, 2002, CELL CYCLE, V1, P220, DOI 10.4161/cc.1.3.128; Chattergoon NN, 2007, J ENDOCRINOL, V192, pR1, DOI 10.1677/JOE-06-0114; Chen CH, 2011, NEUROTOX RES, V20, P15, DOI 10.1007/s12640-010-9214-y; Chen D, 1999, J IMMUNOL, V163, P5796; CHEUNG CY, 1987, AM J PHYSIOL, V252, pE279, DOI 10.1152/ajpendo.1987.252.2.E279; CHEUNG CY, 1993, AM J OBSTET GYNECOL, V169, P1345, DOI 10.1016/0002-9378(93)90303-Z; Ching GW, 1996, HEART, V75, P363, DOI 10.1136/hrt.75.4.363; CHOPRA IJ, 1978, ENDOCRINOLOGY, V103, P393, DOI 10.1210/endo-103-2-393; Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Davis PJ, 2002, THYROID, V12, P459, DOI 10.1089/105072502760143827; DILLMANN WH, 1985, MED CLIN N AM, V69, P849, DOI 10.1016/S0025-7125(16)30993-2; Dillmann WH, 2002, THYROID, V12, P447, DOI 10.1089/105072502760143809; Fisher DA, 1997, CLIN OBSTET GYNECOL, V40, P16, DOI 10.1097/00003081-199703000-00005; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; Forhead AJ, 2003, J PHYSIOL-LONDON, V548, P941, DOI 10.1113/jphysiol.2002.035816; Forhead AJ, 2002, J ENDOCRINOL, V173, P143, DOI 10.1677/joe.0.1730143; Forhead AJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE80, DOI 10.1152/ajpendo.00284.2001; Forhead AJ, 2006, ENDOCRINOLOGY, V147, P5988, DOI 10.1210/en.2006-0712; Gardner DG, 2003, TRENDS ENDOCRIN MET, V14, P411, DOI 10.1016/S1043-2760(03)00113-9; Gezmish O, 2010, REPROD SCI, V17, P168, DOI 10.1177/1933719109349536; Giraud GD, 2006, ENDOCRINOLOGY, V147, P3643, DOI 10.1210/en.2006-0061; Glinoer D, 2000, THYROID, V10, P871, DOI 10.1089/thy.2000.10.871; Goldenthal MJ, 2005, J MOL CELL CARDIOL, V39, P319, DOI 10.1016/j.yjmcc.2005.03.016; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Higuchi R, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e57; HIRAKOW R, 1980, ACTA ANAT, V108, P144; HOPKINS PS, 1972, J ENDOCRINOL, V54, P55, DOI 10.1677/joe.0.0540055; Hume R, 2004, J CLIN ENDOCR METAB, V89, P4097, DOI 10.1210/jc.2004-0573; Jonker SS, 2007, J APPL PHYSIOL, V102, P1130, DOI 10.1152/japplphysiol.00937.2006; Jonker SS, 2007, AM J PHYSIOL-REG I, V292, pR913, DOI 10.1152/ajpregu.00484.2006; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Kawa MP, 2010, EUR J ENDOCRINOL, V162, P295, DOI 10.1530/EJE-09-0875; Kawamura Y, 2010, CIRC J, V74, P1442, DOI 10.1253/circj.CJ-09-0793; Kenessey A, 2006, J BIOL CHEM, V281, P20666, DOI 10.1074/jbc.M512671200; Knowles JW, 2001, J CLIN INVEST, V107, P975, DOI 10.1172/JCI11273; Kuzman JA, 2005, J MOL CELL CARDIOL, V39, P841, DOI 10.1016/j.yjmcc.2005.07.019; Kuzman JA, 2005, J MOL CELL CARDIOL, V39, P251, DOI 10.1016/j.yjmcc.2005.03.020; Li GH, 2004, AM J PHYSIOL-HEART C, V286, pH1712, DOI 10.1152/ajpheart.00898.2003; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; Louey S, 2007, J PHYSIOL-LONDON, V580, P639, DOI 10.1113/jphysiol.2006.122200; Macchia PE, 2000, MOL MED TODAY, V6, P36, DOI 10.1016/S1357-4310(99)01620-2; Moriscot AS, 1997, ENDOCRINOLOGY, V138, P26, DOI 10.1210/en.138.1.26; Muslin AJ, 2005, TRENDS CARDIOVAS MED, V15, P225, DOI 10.1016/j.tcm.2005.06.008; Niswander KR, 1972, COLLABORATIVE PERINA, P246; O'Tierney PF, 2010, J PHYSIOL-LONDON, V588, P2879, DOI 10.1113/jphysiol.2010.191098; O'Tierney PF, 2010, AM J PHYSIOL-REG I, V299, pR573, DOI 10.1152/ajpregu.00754.2009; OPPENHEIMER JH, 1978, CLIN ENDOCRINOL META, V7, P145, DOI 10.1016/S0300-595X(78)80040-1; PINSON CW, 1991, CIRC RES, V68, P947, DOI 10.1161/01.RES.68.4.947; POLK DH, 1995, REPROD FERT DEVELOP, V7, P469, DOI 10.1071/RD9950469; Radetti G, 2002, Minerva Pediatr, V54, P383; RAKUSAN K, 1984, GROWTH HEART HLTH DI, P25; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Schaub MC, 1997, J MOL MED, V75, P901, DOI 10.1007/s001090050182; SCHELLENBERG JC, 1987, J PERINAT MED, V15, P447, DOI 10.1515/jpme.1987.15.5.447; Seely BL, 1994, MATERNAL FETAL MED P, P979; SMOLICH JJ, 1989, AM J PHYSIOL, V257, pH1, DOI 10.1152/ajpheart.1989.257.1.H1; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Sundgren NC, 2003, AM J PHYSIOL-REG I, V285, pR1481, DOI 10.1152/ajpregu.00232.2003; Sundgren NC, 2003, J PHYSIOL-LONDON, V548, P881, DOI 10.1113/jphysiol.2003.038778; Thaler S, 2009, CANCER RES, V69, P1748, DOI 10.1158/0008-5472.CAN-08-1377; Thomas TA, 2005, AM J PHYSIOL-HEART C, V288, pH2118, DOI 10.1152/ajpheart.01000.2004; THORBURN A, 1994, BIOCHEM BIOPH RES CO, V205, P1417, DOI 10.1006/bbrc.1994.2823; Thornburg K. L., 2009, FETAL MED; Thornburg K, 2011, PROG BIOPHYS MOL BIO, V106, P289, DOI 10.1016/j.pbiomolbio.2010.11.010; Ueyama T, 2000, J MOL CELL CARDIOL, V32, P947, DOI 10.1006/jmcc.2000.1135; van Tuyl M, 2004, DEV BIOL, V272, P104, DOI 10.1016/j.ydbio.2004.03.042; Wang LJ, 2001, J BIOL CHEM, V276, P32670, DOI 10.1074/jbc.M102776200; Wang MY, 1998, P NATL ACAD SCI USA, V95, P714, DOI 10.1073/pnas.95.2.714	91	107	110	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					397	408		10.1096/fj.10-179895	http://dx.doi.org/10.1096/fj.10-179895			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21974928	Green Published			2022-12-25	WOS:000299202200039
J	Hedrich, CM; Rauen, T; Tsokos, GC				Hedrich, Christian M.; Rauen, Thomas; Tsokos, George C.			cAMP-responsive Element Modulator (CREM)alpha Protein Signaling Mediates Epigenetic Remodeling of the Human Interleukin-2 Gene IMPLICATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSES IL-2 PRODUCTION; CD4(+) T-CELLS; DNA METHYLATION; EXPRESSION; LYMPHOCYTES; PROMOTER; BINDING; ALPHA; AUTOIMMUNITY; ACTIVATION	IL-2 is a key cytokine during proliferation and activation of T lymphocytes and functions as an auto-and paracrine growth factor. Regardless of activating effects on T lymphocytes, the absence of IL-2 has been linked to the development of autoimmune pathology in mice and humans. Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease and characterized by dysregulation of lymphocyte function, transcription factor and cytokine expression, and antigen presentation. Reduced IL-2 expression is a hallmark of SLETlymphocytes and results in decreased numbers of regulatory T lymphocytes which play an important role in preventing autoimmunity. Reduced IL-2 expression was linked to overproduction of the transcription regulatory factor cAMP-responsive element modulator (CREM)alpha in SLE T lymphocytes and subsequent CREM alpha binding to a CRE site within the IL2 promoter (-180 CRE). In this study, we demonstrate the involvement of CREM alpha-mediated IL2 silencing inTlymphocytes from SLE patients through a gene-wide histone deacetylase 1-directed deacetylation of histone H3K18 and DNA methyltransferase 3a-directed cytosine phosphate guanosine (CpG)-DNA hypermethylation. For the first time, we provide direct evidence that CREM alpha mediates silencing of the IL2 gene in SLE T cells though histone deacetylation and CpG-DNA methylation.	[Hedrich, Christian M.; Rauen, Thomas; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Rheumatol, Boston, MA 02115 USA; [Rauen, Thomas] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, D-52074 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University	Hedrich, CM (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Rheumatol, Boston, MA 02115 USA.	chedrich@bidmc.harvard.edu; gtsokos@bidmc.harvard.edu	Hedrich, Christian/AAW-3958-2020; tsokos, george C/O-3360-2013; Hedrich, Christian/AAD-6855-2019	tsokos, george C/0000-0001-9589-2360; Hedrich, Christian/0000-0002-1295-6179	National Institutes of Health [R01 AI42269, R01 AI49954, R01 AI85567]; Deutsche Forschungsgemeinschaft [RA1927-1/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269, R01AI049954, R01AI085567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI42269, R01 AI49954, and R01 AI85567 (to G. C. T.). This work was also supported by Deutsche Forschungsgemeinschaft Research Fellowship RA1927-1/1 (to T. R.).	Adachi S, 2005, NUCLEIC ACIDS RES, V33, P3200, DOI 10.1093/nar/gki637; ALCOCERVARELA J, 1982, J CLIN INVEST, V69, P1388, DOI 10.1172/JCI110579; Bailey J, 2005, J MOL ENDOCRINOL, V34, P1, DOI 10.1677/jme.1.01594; Balada E, 2008, IMMUNOLOGY, V124, P339, DOI 10.1111/j.1365-2567.2007.02771.x; Brenner C, 2007, DEV CELL, V12, P843, DOI 10.1016/j.devcel.2007.05.011; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Crispin JC, 2010, CURR OPIN RHEUMATOL, V22, P499, DOI 10.1097/BOR.0b013e32833c62b0; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; DEFAUCAL P, 1984, ANN INST PASTEUR IMM, VD135, P161, DOI 10.1016/S0769-2625(84)81108-3; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Hedrich CM, 2010, MOL IMMUNOL, V48, P73, DOI 10.1016/j.molimm.2010.09.009; Hedrich CM, 2010, IMMUNOL RES, V47, P185, DOI 10.1007/s12026-009-8150-5; HEDRICH CM, 2011, TRENDS MOL IN PRESS; Hewagama A, 2009, J AUTOIMMUN, V33, P3, DOI 10.1016/j.jaut.2009.03.007; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; ISHIDA H, 1987, J IMMUNOL, V139, P1070; Januchowski R, 2008, CLIN RHEUMATOL, V27, P21, DOI 10.1007/s10067-007-0644-8; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Kovacs B, 1996, CLIN EXP RHEUMATOL, V14, P695; Lei W, 2009, SCAND J RHEUMATOL, V38, P369, DOI 10.1080/03009740902758875; Lieberman LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/740619; LINKERISRAELI M, 1983, J IMMUNOL, V130, P2651; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Mosca M, 2006, CLIN EXP RHEUMATOL, V24, pS100; Nambiar MP, 2002, J CELL BIOCHEM, V85, P459, DOI 10.1002/jcb.10160; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; Renaudineau Yves, 2011, Keio Journal of Medicine, V60, P10; Solomou EE, 2001, J IMMUNOL, V166, P5665, DOI 10.4049/jimmunol.166.9.5665; Strickland FM, 2008, AUTOIMMUNITY, V41, P278, DOI 10.1080/08916930802024616; Sullivan KE, 2007, CLIN IMMUNOL, V123, P74, DOI 10.1016/j.clim.2006.12.008; Sunahori K, 2011, J IMMUNOL, V186, P4508, DOI 10.4049/jimmunol.1000340; Sunahori K, 2009, J IMMUNOL, V182, P1500, DOI 10.4049/jimmunol.182.3.1500; Tenbrock K, 2003, J IMMUNOL, V170, P2971, DOI 10.4049/jimmunol.170.6.2971; Tenbrock K, 2006, J IMMUNOL, V177, P6159, DOI 10.4049/jimmunol.177.9.6159; Wang GS, 2009, LUPUS, V18, P1037, DOI 10.1177/0961203309106181; WIGFALL DR, 1988, CLIN IMMUNOL IMMUNOP, V47, P354, DOI 10.1016/S0090-1229(88)80012-6; Xu LT, 2004, NAT MED, V10, P411, DOI 10.1038/nm1005; Zhao M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3214; Zhao M, 2010, J AUTOIMMUN, V35, P58, DOI 10.1016/j.jaut.2010.02.002; ZHOU Y, 2011, LUPUS IN PRESS	42	64	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43429	43436		10.1074/jbc.M111.299339	http://dx.doi.org/10.1074/jbc.M111.299339			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21976679	hybrid, Green Published			2022-12-25	WOS:000298351300062
J	Jin, Y; Wang, C; Liu, XQ; Mu, WB; Chen, ZJ; Yu, DS; Wang, AX; Dai, Y; Zhou, XF				Jin, Yi; Wang, Cheng; Liu, Xiqiang; Mu, Wenbo; Chen, Zujian; Yu, Dongsheng; Wang, Anxun; Dai, Yang; Zhou, Xiaofeng			Molecular Characterization of the MicroRNA-138-Fos-like Antigen 1 (FOSL1) Regulatory Module in Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; MESSENGER-RNAS; CANCER-CELLS; LUNG-CANCER; MICRORNA; EXPRESSION; TONGUE; HEAD; ABUNDANCE; MIR-138	MicroRNA-138 is one of the most frequently down-regulated microRNAs in cancer. We recently identified 51 candidate targets of microRNA-138 (Jiang, L., Dai, Y., Liu, X., Wang, C., Wang, A., Chen, Z., Heidbreder, C. E., Kolokythas, A., and Zhou, X. (2011) Hum. Genet. 129, 189-197). Among these candidates, Fos-like antigen 1 (FOSL1) is a member of Fos gene family and is a known proto-oncogene. In this study, we first confirmed the microRNA-138-mediated down-regulation of FOSL1 in squamous cell carcinoma cell lines. We then demonstrated the effect of this microRNA-138-FOSL1 regulatory module on downstream genes (homolog of Snail 2 (Snai2) expression and the Snai2-mediated repression of E-cadherin expression), as well as its contributions to tumorigenesis. The microRNA-138-directed recruitment of FOSL1 mRNA to the RNAi-induced silencing complex was confirmed by a ribonucleoprotein-immunoprecipitation assay. Three canonical and three high affinity non-canonical microRNA-138 (miR-138) targeting sites were identified on the FOSL1 mRNA: one in the 5'-UTR, three overlapping sites in the coding sequences, and two overlapping sites in the 3'-UTR. The direct targeting of miR-138 to these sites was confirmed using luciferase reporter gene assays. In summary, we describe an important microRNA regulatory module, which may play an important role in cancer initiation and progression. Our results also provide evidence that microRNAs target both canonical and non-canonical targeting sites located in all areas of the mRNA molecule (e. g. 5'-UTR, coding sequences, and 3'-UTR).	[Zhou, Xiaofeng] Univ Illinois, Dept Periodont, Coll Dent, Chicago, IL 60612 USA; [Jin, Yi; Wang, Cheng; Liu, Xiqiang; Chen, Zujian; Yu, Dongsheng; Wang, Anxun; Zhou, Xiaofeng] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Mu, Wenbo; Dai, Yang] Univ Illinois, Dept Bioengn, Coll Engn, Chicago, IL 60612 USA; [Dai, Yang] Univ Illinois, Univ Illinois Chicago UIC Canc Ctr, Chicago, IL 60612 USA; [Wang, Cheng; Liu, Xiqiang; Yu, Dongsheng] Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Guanghua Sch, Guangzhou 510055, Guangdong, Peoples R China; [Wang, Cheng; Liu, Xiqiang; Yu, Dongsheng] Sun Yat Sen Univ, Res Inst Stomatol, Guangzhou 510055, Guangdong, Peoples R China; [Wang, Anxun] Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Affiliated Hosp 1, Guangzhou 510055, Guangdong, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhou, XF (corresponding author), Univ Illinois, Dept Periodont, Coll Dent, 801 S Paulina St,Room 530C, Chicago, IL 60612 USA.	xfzhou@uic.edu			National Institutes of Health Grant Public Health Service [CA135992, CA139596, DE014847]; UIC Center for Clinical and Translational Science (CCTS) [UL1RR029879]; National Institutes of Health [DE018381]; NATIONAL CANCER INSTITUTE [R03CA135992, R01CA139596] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K22DE014847] Funding Source: NIH RePORTER	National Institutes of Health Grant Public Health Service; UIC Center for Clinical and Translational Science (CCTS); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant Public Health Service Grants CA135992, CA139596, and DE014847 (to X. Z.). This work was also supported by supplementary funding from the UIC Center for Clinical and Translational Science (CCTS) (Grant UL1RR029879).; Supported by National Institutes of Health T32 Training Grant DE018381.	Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hogg RP, 2002, EUR J CANCER, V38, P1585, DOI 10.1016/S0959-8049(01)00422-1; Jiang L, 2011, HUM GENET, V129, P189, DOI 10.1007/s00439-010-0915-3; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Jiang L, 2010, INT J CANCER, V127, P505, DOI 10.1002/ijc.25320; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Liao JM, 2011, J BIOL CHEM, V286, P33901, DOI 10.1074/jbc.M111.262030; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Liu XQ, 2009, CANCER LETT, V286, P217, DOI 10.1016/j.canlet.2009.05.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x; Moretti F, 2010, RNA, V16, P2493, DOI 10.1261/rna.2384610; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Piccinin S, 1998, BRIT J CANCER, V78, P1147, DOI 10.1038/bjc.1998.644; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Wang C, 2012, INT J CANCER, V130, P2249, DOI 10.1002/ijc.26226; Wang Q, 2011, EXP LUNG RES, V37, P427, DOI 10.3109/01902148.2011.584263; Wang X, 1999, INT J ONCOL, V14, P557; Wang YM, 2011, MOL CANCER RES, V9, P1100, DOI 10.1158/1541-7786.MCR-11-0007; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yip L, 2011, ANN SURG ONCOL, V18, P2035, DOI 10.1245/s10434-011-1733-0; Zhao XH, 2010, LEUKEMIA RES, V34, P1078, DOI 10.1016/j.leukres.2009.10.002; Zhou XF, 2006, NEOPLASIA, V8, P925, DOI 10.1593/neo.06430	32	47	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40104	40109		10.1074/jbc.C111.296707	http://dx.doi.org/10.1074/jbc.C111.296707			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21969367	Green Published, hybrid			2022-12-25	WOS:000296925700043
J	Olmedillas, H; Gonzalez-Aguero, A; Moreno, LA; Casajus, JA; Vicente-Rodriguez, G				Olmedillas, Hugo; Gonzalez-Agueero, Alejandro; Moreno, Luis A.; Casajus, Jose A.; Vicente-Rodriguez, German			Bone Related Health Status in Adolescent Cyclists	PLOS ONE			English	Article							MINERAL DENSITY; PHYSICAL-ACTIVITY; MASTER CYCLISTS; MUSCLE MASS; EXERCISE; ACQUISITION; GROWTH; WOMEN; GIRLS; RISK	Purpose: To describe bone status and analyse bone mass in adolescent cyclists. Methods: Male road cyclists (n = 22) who had been training for a minimum of 2 years and a maximum of 7 years with a volume of 10 h/w, were compared to age-matched controls (n = 22) involved in recreational sports activities. Subjects were divided in 2 groups based on age: adolescents under 17 yrs (cyclists, n = 11; controls, n = 13) and over 17 yrs (cyclists, n = 11; controls, n = 9). Peak oxygen uptake (VO(2)max) was measured on a cycloergometer. Whole body, lumbar spine, and hip bone mineral content (BMC), density (BMD) and bone area were assessed using dual x-ray absorptiometry (DXA). Volumetric BMD (vBMD) and bone mineral apparent density (BMAD) were also estimated. Results: The BMC of cyclists was lower for the whole body, pelvis, femoral neck and legs; BMD for the pelvis, hip, legs and whole body and legs bone area was lower but higher in the hip area (all, P <= 0.05) after adjusting by lean mass and height. The BMC of young cyclists was 10% lower in the leg and 8% higher in the hip area than young controls (P <= 0.05). The BMC of cyclists over 17 yrs was 26.5%, 15.8% and 14.4% lower BMC at the pelvis, femoral neck and legs respectively while the BMD was 8.9% to 24.5% lower for the whole body, pelvis, total hip, trochanter, intertrochanter, femoral neck and legs and 17.1% lower the vBMD at the femoral neck (all P <= 0.05). Grouped by age interaction was found in both pelvis and hip BMC and BMD and in femoral neck vBMD (all P <= 0.05). Conclusion: Cycling performed throughout adolescence may negatively affect bone health, then compromising the acquisition of peak bone mass.	[Olmedillas, Hugo; Gonzalez-Agueero, Alejandro; Moreno, Luis A.; Casajus, Jose A.; Vicente-Rodriguez, German] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Olmedillas, Hugo; Gonzalez-Agueero, Alejandro; Casajus, Jose A.; Vicente-Rodriguez, German] Univ Zaragoza, Dept Psychiat & Nursing, Fac Hlth & Sport Sci FCSD, Huesca, Spain; [Moreno, Luis A.] Univ Zaragoza, Sch Hlth Sci EUCS, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; University of Zaragoza	Olmedillas, H (corresponding author), Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain.	hugo.olmedillas@gmail.com	Moreno, Luis/S-1780-2019; Olmedillas, Hugo/F-4809-2015; Vicente-Rodriguez, German/J-9846-2016	Moreno, Luis/0000-0003-0454-653X; Olmedillas, Hugo/0000-0003-4625-2759; Vicente-Rodriguez, German/0000-0002-4303-4097; Casajus Mallen, Jose Antonio/0000-0002-7215-6931; Gonzalez-Aguero, Alex/0000-0002-1132-5906	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III [DPS2008-06999]; Presidencia del Gobierno de Espana, Consejo Superior de Deportes [21/UPB20/10]	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Presidencia del Gobierno de Espana, Consejo Superior de Deportes	This work has been funded by Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III (DPS2008-06999) and Presidencia del Gobierno de Espana, Consejo Superior de Deportes (21/UPB20/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrach LK, 1999, J CLIN ENDOCR METAB, V84, P4702, DOI 10.1210/jc.84.12.4702; BASSEY EJ, 1995, BONE, V16, P469; Beghin L, 2008, INT J OBESITY, V32, pS12, DOI 10.1038/ijo.2008.179; Calbet JAL, 2001, MED SCI SPORT EXER, V33, P1682, DOI 10.1097/00005768-200110000-00011; de Geus B, 2008, SCAND J MED SCI SPOR, V18, P498, DOI 10.1111/j.1600-0838.2007.00729.x; Dorado C, 2002, J SPORT SCI, V20, P591, DOI 10.1080/026404102320183149; Ducher G, 2009, MED SCI SPORT EXER, V41, P1975, DOI 10.1249/MSS.0b013e3181af2764; Duncan CS, 2002, MED SCI SPORT EXER, V34, P286, DOI 10.1097/00005768-200202000-00017; Duncan CS, 2002, MED SCI SPORT EXER, V34, P673, DOI 10.1097/00005768-200204000-00018; Gass M, 2006, AM J MED, V119, p3S, DOI 10.1016/j.amjmed.2005.12.017; GOULET GC, 2011, CALCIF TISSUE INT; Gravholt CH, 2002, J CLIN ENDOCR METAB, V87, P2798, DOI 10.1210/jc.87.6.2798; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; KATZMAN DK, 1991, J CLIN ENDOCR METAB, V73, P1332, DOI 10.1210/jcem-73-6-1332; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Lauritzen JB, 1996, BONE, V18, pS65, DOI 10.1016/8756-3282(95)00382-7; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Medelli J, 2009, J CLIN DENSITOM, V12, P28, DOI 10.1016/j.jocd.2008.07.057; Morel J, 2001, OSTEOPOROSIS INT, V12, P152, DOI 10.1007/s001980170148; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nevill AM, 2004, J SPORT SCI, V22, P645, DOI 10.1080/02640410310001655769; Nichols JF, 2003, OSTEOPOROSIS INT, V14, P644, DOI 10.1007/s00198-003-1418-z; NICHOLS JF, 2010, J STRENGTH COND RES; Rector RS, 2008, METABOLISM, V57, P226, DOI 10.1016/j.metabol.2007.09.005; RICO H, 1993, BONE, V14, P93, DOI 10.1016/8756-3282(93)90233-Z; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Sanchis-Moysi J, 2010, EUR J APPL PHYSIOL, V110, P83, DOI 10.1007/s00421-010-1470-2; SLEMENDA CW, 1994, J PEDIATR-US, V125, P201, DOI 10.1016/S0022-3476(94)70193-8; Vicente-Rodriguez G, 2007, INT J SPORTS MED, V28, P386, DOI 10.1055/s-2006-924397; Vicente-Rodriguez G, 2005, BRIT J SPORT MED, V39, P611, DOI 10.1136/bjsm.2004.014431; Vicente-Rodriguez G, 2004, BONE, V35, P1208, DOI 10.1016/j.bone.2004.06.012; Vicente-Rodriguez G, 2006, SPORTS MED, V36, P561, DOI 10.2165/00007256-200636070-00002; Warner SE, 2002, BONE, V30, P281, DOI 10.1016/S8756-3282(01)00704-9; Wilks DC, 2009, MED SCI SPORT EXER, V41, P566, DOI 10.1249/MSS.0b013e31818a0ec8	34	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24841	10.1371/journal.pone.0024841	http://dx.doi.org/10.1371/journal.pone.0024841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980360	Green Published, gold			2022-12-25	WOS:000295941300011
J	Glaser, R; Andridge, R; Yang, EV; Shana'ah, AY; Di Gregorio, M; Chen, M; Johnson, SL; De Renne, LA; Lambert, DR; Jewell, SD; Bechtel, MA; Hearne, DW; Herron, JB; Kiecolt-Glaser, JK				Glaser, Ronald; Andridge, Rebecca; Yang, Eric V.; Shana'ah, Arwa Y.; Di Gregorio, Michael; Chen, Min; Johnson, Sheri L.; De Renne, Lawrence A.; Lambert, David R.; Jewell, Scott D.; Bechtel, Mark A.; Hearne, Dean W.; Herron, Joel Bain; Kiecolt-Glaser, Janice K.			Tumor Site Immune Markers Associated with Risk for Subsequent Basal Cell Carcinomas	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; ULTRAVIOLET-RADIATION; REGRESSION; MELANOMA; HISTORY; SUN	Background: Basal cell carcinoma (BCC) tumors are the most common skin cancer and are highly immunogenic. Objective:The goal of this study was to assess how immune-cell related gene expression in an initial BCC tumor biopsy was related to the appearance of subsequent BCC tumors. Materials and Methods: Levels of mRNA for CD3 epsilon; (a T-cell receptor marker), CD25 (the alpha chain of the interleukin (IL)-2 receptor expressed on activated T-cells and B-cells), CD68 (a marker for monocytes/macrophages), the cell surface glycoprotein intercellular adhesion molecule-1 (ICAM-1), the cytokine interferon-7 (IFN-gamma) and the anti-inflammatory cytokine IL-10 were measured in BCC tumor biopsies from 138 patients using real-time PCR. Results:The median follow-up was 26.6 months, and 61% of subjects were free of new BCCs two years post-initial biopsy. Patients with low CD3 epsilon CD25, CD68, and ICAM-1 mRNA levels had significantly shorter times before new tumors were detected (p = 0.03, p = 0.02, p = 0.003, and p = 0.08, respectively). Furthermore, older age diminished the association of mRNA levels with the appearance of subsequent tumors. Conclusions: Our results show that levels of CDR, CD25, CD68, and ICAM-1 mRNA in BCC biopsies may predict risk for new BCC tumors.	[Glaser, Ronald; Yang, Eric V.; Di Gregorio, Michael; Chen, Min; Kiecolt-Glaser, Janice K.] Ohio State Univ Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA; [Glaser, Ronald; Yang, Eric V.] Ohio State Univ Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH USA; [Glaser, Ronald; Lambert, David R.; Bechtel, Mark A.; Hearne, Dean W.; Herron, Joel Bain] Ohio State Univ Med Ctr, Dept Internal Med, Columbus, OH USA; [Glaser, Ronald; Yang, Eric V.] Ohio State Univ Med Ctr, Ctr Comprehens Canc, Columbus, OH USA; [Andridge, Rebecca] Ohio State Univ Coll Publ Hlth, Div Biostat, Columbus, OH USA; [Yang, Eric V.] Ohio State Univ Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH USA; [Shana'ah, Arwa Y.; De Renne, Lawrence A.; Jewell, Scott D.] Ohio State Univ Med Ctr, Dept Pathol, Columbus, OH USA; [Johnson, Sheri L.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Lambert, David R.; Bechtel, Mark A.; Hearne, Dean W.; Herron, Joel Bain] Ohio State Univ Med Ctr, Div Dermatol, Columbus, OH USA; [Kiecolt-Glaser, Janice K.] Ohio State Univ Med Ctr, Dept Psychiat, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California Berkeley; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Glaser, R (corresponding author), Ohio State Univ Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA.	Ronald.glaser@osumc.edu	Andridge, Rebecca Roberts/C-8457-2012; Kiecolt-Glaser, Janice K/A-3236-2009; Glaser, Ronald/E-3124-2011; Johnson, Sheri/D-8712-2014	Andridge, Rebecca Roberts/0000-0001-9991-9647; Kiecolt-Glaser, Janice K/0000-0003-4900-9578; Johnson, Sheri/0000-0002-9945-4816	National Cancer Institute [CA100243]; The Gilbert and Kathryn Mitchell Endowment; Ohio State University Comprehensive Cancer Center [CA16058]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA100243] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Gilbert and Kathryn Mitchell Endowment; Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by a grant from the National Cancer Institute CA100243 (RG), The Gilbert and Kathryn Mitchell Endowment (RG), and in part by the Ohio State University Comprehensive Cancer Center, CA16058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2010, CANC FACTS FIG 2010; Barnes EA, 2005, ONCOGENE, V24, P902, DOI 10.1038/sj.onc.1208240; Cantwell MM, 2009, BRIT J CANCER, V100, P174, DOI 10.1038/sj.bjc.6604842; Carlson JA, 2002, J CUTAN PATHOL, V29, P268, DOI 10.1034/j.1600-0560.2002.290502.x; De Giorgi V, 2009, INT J DERMATOL, V48, P312, DOI 10.1111/j.1365-4632.2009.03916.x; Domingo DS, 2008, ADV EXP MED BIOL, V624, P187, DOI 10.1007/978-0-387-77574-6_15; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Fortina AB, 2004, ARCH DERMATOL, V140, P1079, DOI 10.1001/archderm.140.9.1079; Goppner D, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/650258; HALLIDAY GM, 1995, WORLD J SURG, V19, P352, DOI 10.1007/BF00299157; HUNT MJ, 1994, BRIT J DERMATOL, V130, P1, DOI 10.1111/j.1365-2133.1994.tb06873.x; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Kahn HS, 1998, JAMA-J AM MED ASSOC, V280, P910, DOI 10.1001/jama.280.10.910; Kaur P, 2006, AM J DERMATOPATH, V28, P293, DOI 10.1097/00000372-200608000-00002; Kiiski V, 2010, ARCH DERMATOL, V146, P848, DOI 10.1001/archdermatol.2010.155; KIM J, 1995, J IMMUNOL, V155, P2240; KRICKER A, 1994, CANCER CAUSE CONTROL, V5, P367, DOI 10.1007/BF01804988; KRIPKE ML, 1994, CANCER RES, V54, P6102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcil I, 2000, ARCH DERMATOL, V136, P1524, DOI 10.1001/archderm.136.12.1524; Nugent Z, 2005, CANCER EPIDEM BIOMAR, V14, P2584, DOI 10.1158/1055-9965.EPI-05-0379; Paul J, 2011, AM J DERMATOPATH, V33, P152, DOI 10.1097/DAD.0b013e3181ef2d65; Rama I, 2010, NAT REV NEPHROL, V6, P511, DOI 10.1038/nrneph.2010.102; Rieger UM, 2009, TUMORI, V95, P258; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Rosenberg CA, 2004, CANCER, V100, P130, DOI 10.1002/cncr.11874; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Schwarz A, 2004, J IMMUNOL, V172, P1036, DOI 10.4049/jimmunol.172.2.1036; Schwarz T, 1999, ALLERGY, V54, P1252, DOI 10.1034/j.1398-9995.1999.00105.x; Slominski A, 2007, J CLIN INVEST, V117, P3166, DOI 10.1172/JCI33508; Tessari G, 2010, ARCH DERMATOL, V146, P294, DOI 10.1001/archdermatol.2009.377; Uitto Jouni, 2008, J Drugs Dermatol, V7, ps12; Urosevic M, 2003, ARCH DERMATOL, V139, P1325, DOI 10.1001/archderm.139.10.1325; Wisgerhof HC, 2010, TRANSPLANTATION, V89, P1231, DOI 10.1097/TP.0b013e3181d84cdc; Wong DA, 2000, BRIT J DERMATOL, V143, P91, DOI 10.1046/j.1365-2133.2000.03596.x	35	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25160	10.1371/journal.pone.0025160	http://dx.doi.org/10.1371/journal.pone.0025160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980389	Green Published, gold			2022-12-25	WOS:000295939600013
J	Pati, S; Gerber, MH; Menge, TD; Wataha, KA; Zhao, YH; Baumgartner, JA; Zhao, J; Letourneau, PA; Huby, MP; Baer, LA; Salsbury, JR; Kozar, RA; Wade, CE; Walker, PA; Dash, PK; Cox, CS; Doursout, MF; Holcomb, JB				Pati, Shibani; Gerber, Michael H.; Menge, Tyler D.; Wataha, Kathryn A.; Zhao, Yuhai; Baumgartner, John Adam; Zhao, Jing; Letourneau, Phillip A.; Huby, Maria P.; Baer, Lisa A.; Salsbury, John R.; Kozar, Rosemary A.; Wade, Charles E.; Walker, Peter A.; Dash, Pramod K.; Cox, Charles S., Jr.; Doursout, Marie-Francoise; Holcomb, John B.			Bone Marrow Derived Mesenchymal Stem Cells Inhibit Inflammation and Preserve Vascular Endothelial Integrity in the Lungs after Hemorrhagic Shock	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; STROMAL CELLS; ADHERENS JUNCTIONS; KAPOSIS-SARCOMA; GROWTH-FACTORS; VE-CADHERIN; INJURY; PERMEABILITY; DISEASE; SEPSIS	Hemorrhagic shock (HS) and trauma is currently the leading cause of death in young adults worldwide. Morbidity and mortality after HS and trauma is often the result of multi-organ failure such as acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), conditions with few therapeutic options. Bone marrow derived mesenchymal stem cells (MSCs) are a multipotent stem cell population that has shown therapeutic promise in numerous pre-clinical and clinical models of disease. In this paper, in vitro studies with pulmonary endothelial cells (PECs) reveal that conditioned media (CM) from MSCs and MSC-PEC co-cultures inhibits PEC permeability by preserving adherens junctions (VE-cadherin and beta-catenin). Leukocyte adhesion and adhesion molecule expression (VCAM-1 and ICAM-1) are inhibited in PECs treated with CM from MSC-PEC co-cultures. Further support for the modulatory effects of MSCs on pulmonary endothelial function and inflammation is demonstrated in our in vivo studies on HS in the rat. In a rat "fixed volume" model of mild HS, we show that MSCs administered IV potently inhibit systemic levels of inflammatory cytokines and chemokines in the serum of treated animals. In vivo MSCs also inhibit pulmonary endothelial permeability and lung edema with concurrent preservation of the vascular endothelial barrier proteins: VE-cadherin, Claudin-1, and Occludin-1. Leukocyte infiltrates (CD68 and MPO positive cells) are also decreased in lungs with MSC treatment. Taken together, these data suggest that MSCs, acting directly and through soluble factors, are potent stabilizers of the vascular endothelium and inflammation. These data are the first to demonstrate the therapeutic potential of MSCs in HS and have implications for the potential use of MSCs as a cellular therapy in HS-induced lung injury.	[Pati, Shibani; Gerber, Michael H.; Menge, Tyler D.; Wataha, Kathryn A.; Zhao, Yuhai; Baumgartner, John Adam; Letourneau, Phillip A.; Huby, Maria P.; Baer, Lisa A.; Salsbury, John R.; Kozar, Rosemary A.; Wade, Charles E.; Holcomb, John B.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA; [Pati, Shibani; Gerber, Michael H.; Menge, Tyler D.; Wataha, Kathryn A.; Zhao, Yuhai; Baumgartner, John Adam; Letourneau, Phillip A.; Huby, Maria P.; Baer, Lisa A.; Salsbury, John R.; Kozar, Rosemary A.; Wade, Charles E.; Holcomb, John B.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX USA; [Dash, Pramod K.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX USA; [Zhao, Jing; Walker, Peter A.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX USA; [Doursout, Marie-Francoise] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Pati, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA.	shibani.pati@uth.tmc.edu		Dash, Pramod/0000-0001-6746-1002; holcomb, john/0000-0001-8312-9157	Mission Connect: The Institute for Rehabilitation and Research; National Institutes of Health [T32GM008792-11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008792] Funding Source: NIH RePORTER	Mission Connect: The Institute for Rehabilitation and Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from Mission Connect: The Institute for Rehabilitation and Research and the National Institutes of Health T32GM008792-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aird WC, 2003, CRIT CARE MED, V31, pS221, DOI 10.1097/01.CCM.0000057847.32590.C1; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Ball SG, 2007, J CELL MOL MED, V11, P1012, DOI 10.1111/j.1582-4934.2007.00120.x; Ball SG, 2007, INT J BIOCHEM CELL B, V39, P379, DOI 10.1016/j.biocel.2006.09.005; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cinel I, 2007, CURR OPIN INFECT DIS, V20, P345, DOI 10.1097/QCO.0b013e32818be70a; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; DIAZFLORES L, 1991, HISTOL HISTOPATHOL, V6, P269; Fang XH, 2010, J BIOL CHEM, V285, P26211, DOI 10.1074/jbc.M110.119917; Fein AM, 2000, CRIT CARE CLIN, V16, P289, DOI 10.1016/S0749-0704(05)70111-1; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; FLECK A, 1985, LANCET, V1, P781; GROTZ MRW, 1995, SHOCK, V3, P362; Guidot DM, 2006, AM J PHYSIOL-LUNG C, V291, pL301, DOI 10.1152/ajplung.00153.2006; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Kamouchi M, 2010, CELL MOL NEUROBIOL; Kerkar S, 2001, J TRAUMA, V51, P440, DOI 10.1097/00005373-200109000-00003; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Lampugnani MG, 2007, THROMB RES, V120, pS1, DOI 10.1016/S0049-3848(07)70124-X; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lee CC, 2005, SHOCK, V24, P177, DOI 10.1097/01.shk.0000171870.42900.15; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Matthay MA, 2010, CHEST, V138, P965, DOI 10.1378/chest.10-0518; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Pati S, 2001, J VIROL, V75, P8660, DOI 10.1128/JVI.75.18.8660-8673.2001; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Qian H, 2008, INT J MOL MED, V22, P325, DOI 10.3892/ijmm_00000026; Rocco TR, 2001, ANN SURG, V233, P414, DOI 10.1097/00000658-200103000-00017; SIMS DE, 1991, CAN J CARDIOL, V7, P431; SINCLAIR DG, 1994, CHEST, V106, P535, DOI 10.1378/chest.106.2.535; Sondeen JL, 2007, SHOCK, V28, P426, DOI 10.1097/shk.0b013e31804a5791; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7	47	108	118	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25171	10.1371/journal.pone.0025171	http://dx.doi.org/10.1371/journal.pone.0025171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980392	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900029
J	Nijwening, JH; Geutjes, EJ; Bernards, R; Beijersbergen, RL				Nijwening, Jeroen H.; Geutjes, Ernst-Jan; Bernards, Rene; Beijersbergen, Roderick L.			The Histone Demethylase Jarid1b (Kdm5b) Is a Novel Component of the Rb Pathway and Associates with E2f-Target Genes in MEFs during Senescence	PLOS ONE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; TRANSCRIPTIONAL REPRESSION; INK4A-ARF LOCUS; HETEROCHROMATIN FORMATION; EMBRYONIC FIBROBLASTS; EPIGENETIC CONTROL; JMJD3 CONTRIBUTES; MELANOMA-CELLS	Senescence is a robust cell cycle arrest controlled by the p53 and Rb pathways that acts as an important barrier to tumorigenesis. Senescence is associated with profound alterations in gene expression, including stable suppression of E2f-target genes by heterochromatin formation. Some of these changes in chromatin composition are orchestrated by Rb. In complex with E2f, Rb recruits chromatin modifying enzymes to E2f target genes, leading to their transcriptional repression. To identify novel chromatin remodeling enzymes that specifically function in the Rb pathway, we used a functional genetic screening model for bypass of senescence in murine cells. We identified the H3K4-demethylase Jarid1b as novel component of the Rb pathway in this screening model. We find that depletion of Jarid1b phenocopies knockdown of Rb1 and that Jarid1b associates with E2f-target genes during cellular senescence. These results suggest a role for Jarid1b in Rb-mediated repression of cell cycle genes during senescence.	[Nijwening, Jeroen H.; Geutjes, Ernst-Jan; Bernards, Rene; Beijersbergen, Roderick L.] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands	Netherlands Cancer Institute	Nijwening, JH (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands.	r.beijersbergen@nki.nl		Bernards, Rene/0000-0001-8677-3423; Beijersbergen, Roderick/0000-0003-0116-4130	Top Institute Pharma [T3-105]	Top Institute Pharma	This work has been supported by Top Institute Pharma (project T3-105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Epping MT, 2011, NAT CELL BIOL, V13, P102, DOI 10.1038/ncb2142; Ferreira R, 2001, ONCOGENE, V20, P3128, DOI 10.1038/sj.onc.1204337; Halaban R, 2005, CANCER METAST REV, V24, P339, DOI 10.1007/s10555-005-1582-z; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Roesch A, 2005, MODERN PATHOL, V18, P1249, DOI 10.1038/modpathol.3800413; Roesch A, 2006, J INVEST DERMATOL, V126, P1850, DOI 10.1038/sj.jid.5700324; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Talluri S, 2010, MOL CELL BIOL, V30, P948, DOI 10.1128/MCB.01168-09; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Vogt T, 1999, LAB INVEST, V79, P1615; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001	54	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25235	10.1371/journal.pone.0025235	http://dx.doi.org/10.1371/journal.pone.0025235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980403	gold, Green Published, Green Submitted			2022-12-25	WOS:000295933700022
J	Tse, H; To, KKW; Wen, X; Chen, HL; Chan, KH; Tsoi, HW; Li, IWS; Yuen, KY				Tse, Herman; To, Kelvin K. W.; Wen, Xi; Chen, Honglin; Chan, Kwok-Hung; Tsoi, Hoi-Wah; Li, Iris W. S.; Yuen, Kwok-Yung			Clinical and Virological Factors Associated with Viremia in Pandemic Influenza A/H1N1/2009 Virus Infection	PLOS ONE			English	Article							H1N1 2009; DISEASE; HEMAGGLUTININ; CONCURRENT	Background: Positive detection of viral RNA in blood and other non-respiratory specimens occurs in severe human influenza A/H5N1 viral infection but is not known to occur commonly in seasonal human influenza infection. Recently, viral RNA was detected in the blood of patients suffering from severe pandemic influenza A/H1N1/2009 viral infection, although the significance of viremia had not been previously studied. Our study aims to explore the clinical and virological factors associated with pandemic influenza A/H1N1/2009 viremia and to determine its clinical significance. Methodology/Principal Findings: Clinical data of patients admitted to hospitals in Hong Kong between May 2009 and April 2010 and tested positive for pandemic influenza A/H1N1/2009 was collected. Viral RNA was detected by reverse-transcription polymerase chain reactions (RT-PCR) targeting the matrix (M) and HA genes of pandemic influenza A/H1N1/2009 virus from the following specimens: nasopharyngeal aspirate (NPA), endotracheal aspirate (ETA), blood, stool and rectal swab. Stool and/or rectal swab was obtained only if the patient complained of any gastrointestinal symptoms. A total of 139 patients were included in the study, with viral RNA being detected in the blood of 14 patients by RT-PCR. The occurrence of viremia was strongly associated with a severe clinical presentation and a higher mortality rate, although the latter association was not statistically significant. D222G/N quasispecies were observed in 90% of the blood samples. Conclusion: Presence of pandemic influenza A/H1N1/2009 viremia is an indicator of disease severity and strongly associated with D222G/N mutation in the viral hemagglutinin protein.	[Tse, Herman; To, Kelvin K. W.; Chen, Honglin; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Wen, Xi; Tsoi, Hoi-Wah] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok-Hung; Li, Iris W. S.] Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Tse, H (corresponding author), Univ Hong Kong, Carol Yu Ctr Infect, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk	Chan, Kwok Hung/ABD-5399-2021; Chen, Honglin/C-4224-2009; To, Kelvin/AAV-7007-2020	Chen, Honglin/0000-0001-5108-8338; To, Kelvin/0000-0002-1921-5824; Wen, Xi/0000-0002-7103-9936; Yuen, Kwok-yung/0000-0002-2083-1552	Providence Foundation Limited; University Grants Council; Food and Health Bureau of the Hong Kong SAR Government	Providence Foundation Limited; University Grants Council; Food and Health Bureau of the Hong Kong SAR Government	We gratefully acknowledge funding support from the Providence Foundation Limited in memory of the late Dr Lui Hac Minh, the University Grants Council, and the Research Fund for the Control of Infectious Diseases (RFCID) of the Food and Health Bureau of the Hong Kong SAR Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*CDCP, 2007, 100705 CDCP; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Gordon CL, 2010, CLIN INFECT DIS, V50, P672, DOI 10.1086/650462; HERZBERG K, 1961, Z HYG INFEKTIONSKR, V147, P382, DOI 10.1007/BF02152067; Hung IFN, 2010, CLIN INFECT DIS, V51, P274, DOI 10.1086/653940; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kilander A, 2010, EURO SURVEILL, V15; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Likos AM, 2007, TRANSFUSION, V47, P1080, DOI 10.1111/j.1537-2995.2007.01264.x; Mak GC, 2010, EURO SURVEILL, V15; MILLER RR, 2010, EURO SURVEILL, V15; MINUSE E, 1962, J LAB CLIN MED, V59, P1016; NAFICY K, 1963, NEW ENGL J MED, V269, P964, DOI 10.1056/NEJM196310312691807; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Oughton M, 2011, DIAGN MICR INFEC DIS, V70, P213, DOI 10.1016/j.diagmicrobio.2010.12.013; Poliakova T G, 1970, Vopr Virusol, V15, P724; Rouphael NG, 2007, LANCET INFECT DIS, V7, P814, DOI 10.1016/S1473-3099(07)70290-6; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stanley E D, 1966, Trans Assoc Am Physicians, V79, P376; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; To KKW, 2010, POSTGRAD MED J, V86, P515, DOI 10.1136/pgmj.2009.096206; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tsuruoka H, 1997, Nihon Rinsho, V55, P2714; VANHOLDER R, 1993, J AM SOC NEPHROL, V3, P1541; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P21	27	55	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e22534	10.1371/journal.pone.0022534	http://dx.doi.org/10.1371/journal.pone.0022534			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980333	gold, Green Published			2022-12-25	WOS:000295933700001
J	Zhou, P; Cowled, C; Marsh, GA; Shi, ZL; Wang, LF; Baker, ML				Zhou, Peng; Cowled, Chris; Marsh, Glenn A.; Shi, Zhengli; Wang, Lin-Fa; Baker, Michelle L.			Type III IFN Receptor Expression and Functional Characterisation in the Pteropid Bat, Pteropus alecto	PLOS ONE			English	Article							IL-10 RECEPTOR-2; CYTOKINE; INTERLEUKIN-22; INTERFERONS; ALIGNMENT; IMMUNITY; COMPLEX; FAMILY; CELLS; CHAIN	Bats are rich reservoir hosts for a variety of viruses, many of which are capable of spillover to other susceptible mammals with lethal consequences. The ability of bats to remain asymptomatic to viral infection may be due to the rapid control of viral replication very early in the immune response through innate antiviral mechanisms. Type I and III interferons (IFNs) represent the first line of defence against viral infection in mammals, with both families of IFNs present in pteropid bats. To obtain further insight into the type III IFN system in bats, we describe the characterization of the type III IFN receptor (IFN lambda R) in the black flying fox, P. alecto with the characterization of IFN lambda R1 and IL10R2 genes that make up the type III IFN receptor complex. The bat IFN lambda R complex has a wide tissue distribution and at the cellular level, both epithelial and immune cells are responsive to IFN-lambda treatment. Furthermore, we demonstrate that the bat IFN lambda R1 chain acts as a functional receptor. To our knowledge, this report represents the first description of an IFN receptor in any species of bat. The responsiveness of bat cells to IFN-lambda support a role for the type III IFN system by epithelial and immune cells in bats.	[Zhou, Peng; Cowled, Chris; Marsh, Glenn A.; Wang, Lin-Fa; Baker, Michelle L.] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Zhou, Peng; Shi, Zhengli] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Wang, Lin-Fa] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Baker, Michelle L.] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of Melbourne; University of New Mexico	Zhou, P (corresponding author), CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia.	Michelle.Baker@csiro.au	Marsh, Glenn A/A-5418-2013; Cowled, Christopher JE/H-5308-2013; Baker, Michelle L/C-9694-2013; Zhou, Peng/I-8578-2015; wang, lin/GSE-3040-2022; Baker, Michelle/AAX-9171-2020; Shi, Zheng-Li/A-1013-2013	Marsh, Glenn A/0000-0002-3469-1837; Cowled, Christopher JE/0000-0002-1969-9371; Baker, Michelle L/0000-0002-7993-9971; Zhou, Peng/0000-0003-1938-8255; Baker, Michelle/0000-0002-7993-9971; Shi, Zheng-Li/0000-0001-8089-163X; Wang, Lin-Fa/0000-0003-2752-0535	Commonwealth Scientific and Industrial Research Organisation; National Institutes of Health of the National Center for Research Resources [P20RR018754]; Chinese Academy of Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER	Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); National Institutes of Health of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Commonwealth Scientific and Industrial Research Organisation Chief Executive Officer Science Leaders award to L-F.W, a grant from the National Institutes of Health (grant no. P20RR018754) from the Institutional Development Award (IDeA) programme of the National Center for Research Resources to M. L. B., and a Scholarship from the Chinese Academy of Sciences to P.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Ank N, 2009, BIOFACTORS, V35, P82, DOI 10.1002/biof.19; Baker ML, 2010, IMMUNOGENETICS, V62, P173, DOI 10.1007/s00251-010-0425-4; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cowled C, 2011, DEV COMP IMMUNOL, V35, P7, DOI 10.1016/j.dci.2010.07.006; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Langer JA, 2004, CYTOKINE GROWTH F R, V15, P33, DOI 10.1016/j.cytogfr.2003.10.001; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Li J, 2004, INT IMMUNOPHARMACOL, V4, P693, DOI 10.1016/j.intimp.2004.01.010; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Qi ZT, 2010, J IMMUNOL, V184, P5038, DOI 10.4049/jimmunol.0903374; Sheikh F, 2004, J IMMUNOL, V172, P2006, DOI 10.4049/jimmunol.172.4.2006; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Witte K, 2009, GENES IMMUN, V10, P702, DOI 10.1038/gene.2009.72; Witte K, 2010, CYTOKINE GROWTH F R, V21, P237, DOI 10.1016/j.cytogfr.2010.04.002; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Zhou P, 2011, J IMMUNOL, V186, P3138, DOI 10.4049/jimmunol.1003115	25	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25385	10.1371/journal.pone.0025385	http://dx.doi.org/10.1371/journal.pone.0025385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980438	gold, Green Published			2022-12-25	WOS:000295933700029
J	Fidanboylu, M; Griffiths, LA; Flatters, SJL				Fidanboylu, Mehmet; Griffiths, Lisa A.; Flatters, Sarah J. L.			Global Inhibition of Reactive Oxygen Species (ROS) Inhibits Paclitaxel-Induced Painful Peripheral Neuropathy	PLOS ONE			English	Article							DORSAL-HORN NEURONS; ACETYL-L-CARNITINE; RADICAL SCAVENGER; LANGERHANS CELLS; DOUBLE-BLIND; RATS; HYPERALGESIA; TAXOL; SUPEROXIDE; TRIAL	Paclitaxel (Taxol (R)) is a widely used chemotherapeutic agent that has a major dose limiting side-effect of painful peripheral neuropathy. Currently there is no effective therapy for the prevention or treatment of chemotherapy-induced painful peripheral neuropathies. Evidence for mitochondrial dysfunction during paclitaxel-induced pain was previously indicated with the presence of swollen and vacuolated neuronal mitochondria. As mitochondria are a major source of reactive oxygen species (ROS), the aim of this study was to examine whether pharmacological inhibition of ROS could reverse established paclitaxel-induced pain or prevent the development of paclitaxel-induced pain. Using a rat model of paclitaxel-induced pain (intraperitoneal 2 mg/kg paclitaxel on days 0, 2, 4 & 6), the effects of a non-specific ROS scavenger, N-tert-Butyl-alpha-phenylnitrone (PBN) and a superoxide selective scavenger, 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPOL) were compared. Systemic 100 mg/kg PBN administration markedly inhibited established paclitaxel-induced mechanical hypersensitivity to von Frey 8 g and 15 g stimulation and cold hypersensitivity to plantar acetone application. Daily systemic administration of 50 mg/kg PBN (days -1 to 13) completely prevented mechanical hypersensitivity to von Frey 4 g and 8 g stimulation and significantly attenuated mechanical hypersensitivity to von Frey 15 g. Systemic 100 mg/kg TEMPOL had no effect on established paclitaxel-induced mechanical or cold hypersensitivity. High dose (250 mg/kg) systemic TEMPOL significantly inhibited mechanical hypersensitivity to von Frey 8 g & 15 g, but to a lesser extent than PBN. Daily systemic administration of 100 mg/kg TEMPOL (day -1 to 12) did not affect the development of paclitaxel-induced mechanical hypersensitivity. These data suggest that ROS play a causal role in the development and maintenance of paclitaxel-induced pain, but such effects cannot be attributed to superoxide radicals alone.	[Fidanboylu, Mehmet] Kings Coll London, Ctr Integrat Biomed, Inst Pharmaceut Sci, Wolfson Ctr Age Related Dis, London WC2R 2LS, England	University of London; King's College London	Fidanboylu, M (corresponding author), Kings Coll London, Ctr Integrat Biomed, Inst Pharmaceut Sci, Wolfson Ctr Age Related Dis, London WC2R 2LS, England.	sarah.flatters@kcl.ac.uk		Griffiths, Lisa/0000-0002-3676-1560; Flatters, Sarah Jane Louise/0000-0001-7129-3670	Capacity Building Award in Integrative Mammalian Biology; Biotechnology and Biological Sciences Research Council (BBSRC); British Pharmacological Society (BPS); Higher Education Funding Council for England (HEFCE); Medical Research Council (MRC); Scottish Funding Council (SFC); Department for Innovation, Universities and Skills (DIUS); Wellcome Trust; BBSRC [BB/E527098/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E527098/1] Funding Source: researchfish	Capacity Building Award in Integrative Mammalian Biology; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Pharmacological Society (BPS); Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council (SFC); Department for Innovation, Universities and Skills (DIUS); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SJLF is an Academic Fellow and MF and LAG are postgraduate students in the Centre for Integrative Biomedicine. Their positions and these studies are supported by a Capacity Building Award in Integrative Mammalian Biology funded by the Biotechnology and Biological Sciences Research Council (BBSRC), British Pharmacological Society (BPS) Integrative Pharmacology Fund, Higher Education Funding Council for England (HEFCE), Medical Research Council (MRC), Scottish Funding Council (SFC) and the Department for Innovation, Universities and Skills (DIUS). These studies are also partly funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley W, 1998, J CLIN ONCOL, V16, P153, DOI 10.1200/JCO.1998.16.1.153; Authier N, 2000, BRAIN RES, V887, P239, DOI 10.1016/S0006-8993(00)02910-3; Boyette-Davis J, 2011, PAIN, V152, P308, DOI 10.1016/j.pain.2010.10.030; Campana WM, 1998, NEUROTOXICOLOGY, V19, P237; Cata JP, 2008, BRAIN RES, V1229, P100, DOI 10.1016/j.brainres.2008.07.001; Cavaletti G, 1997, NEUROTOXICOLOGY, V18, P137; CAVALETTI G, 1995, EXP NEUROL, V133, P64, DOI 10.1006/exnr.1995.1008; Cliffer KD, 1998, ANN NEUROL, V43, P46, DOI 10.1002/ana.410430111; Dougherty PM, 2004, PAIN, V109, P132, DOI 10.1016/j.pain.2004.01.021; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Flatters SJL, 2006, NEUROSCI LETT, V397, P219, DOI 10.1016/j.neulet.2005.12.013; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; Forsyth PA, 1997, J NEURO-ONCOL, V35, P47, DOI 10.1023/A:1005805907311; Gao X, 2007, PAIN, V131, P262, DOI 10.1016/j.pain.2007.01.011; Jin HW, 2008, EXP NEUROL, V210, P229, DOI 10.1016/j.expneurol.2007.11.001; Jordan MA, 2007, CURR CANCER DRUG TAR, V7, P730, DOI 10.2174/156800907783220417; Kautio AL, 2008, J PAIN SYMPTOM MANAG, V35, P31, DOI 10.1016/j.jpainsymman.2007.02.043; Kautio AL, 2009, ANTICANCER RES, V29, P2601; Khalil Z, 1999, PAIN, V79, P31, DOI 10.1016/S0304-3959(98)00143-2; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kim HK, 2010, ANESTHESIOLOGY, V112, P432, DOI 10.1097/ALN.0b013e3181ca31bd; Kim HK, 2004, PAIN, V111, P116, DOI 10.1016/j.pain.2004.06.008; Lee I, 2007, PAIN, V133, P9, DOI 10.1016/j.pain.2007.01.035; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; Park ES, 2006, NEUROSCI LETT, V391, P108, DOI 10.1016/j.neulet.2005.08.055; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; POSTMA TJ, 1995, ANN ONCOL, V6, P489, DOI 10.1093/oxfordjournals.annonc.a059220; Rao RD, 2008, CANCER, V112, P2802, DOI 10.1002/cncr.23482; Rao RD, 2007, CANCER-AM CANCER SOC, V110, P2110, DOI 10.1002/cncr.23008; Rosenfeld J, 1997, EXP NEUROL, V147, P37, DOI 10.1006/exnr.1997.6604; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; Schwartz E.S., 2008, PAIN; Schwartz ES, 2009, J NEUROSCI, V29, P159, DOI 10.1523/JNEUROSCI.3792-08.2009; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Tal M, 1996, NEUROREPORT, V7, P1382, DOI 10.1097/00001756-199605310-00010; Tanabe M, 2009, NEUROPHARMACOLOGY, V56, P702, DOI 10.1016/j.neuropharm.2008.12.003; vandenBent MJ, 1997, MUSCLE NERVE, V20, P750; Wagner R, 1998, PAIN, V77, P173, DOI 10.1016/S0304-3959(98)00091-8; Wang J, 2008, NEUROSCI LETT, V439, P216, DOI 10.1016/j.neulet.2008.05.018; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	42	102	106	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25212	10.1371/journal.pone.0025212	http://dx.doi.org/10.1371/journal.pone.0025212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966458	Green Published, Green Submitted, gold			2022-12-25	WOS:000295932100026
J	Thibodeau, V; Lajoie, J; Labbe, AC; Zannou, MD; Fowke, KR; Alary, M; Poudrier, J; Roger, M				Thibodeau, Valerie; Lajoie, Julie; Labbe, Annie-Claude; Zannou, Marcel D.; Fowke, Keith R.; Alary, Michel; Poudrier, Johanne; Roger, Michel			High Level of Soluble HLA-G in the Female Genital Tract of Beninese Commercial Sex Workers Is Associated with HIV-1 Infection	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; LEUKOCYTE ANTIGEN-G; CLASS-I; BACTERIAL VAGINOSIS; T-CELLS; AFRICAN WOMEN; G GENOTYPE; NK CELLS; ACQUISITION; EXPRESSION	Background: Most HIV infections are transmitted across mucosal epithelium. Understanding the role of innate and specific mucosal immunity in susceptibility or protection against HIV infection, as well as the effect of HIV infection on mucosal immunity, are of fundamental importance. HLA-G is a powerful modulator of the immune response. The aim of this study was to investigate whether soluble HLA-G (sHLA-G) expression in the female genital tract is associated with HIV-1 infection. Methods and Findings: Genital levels of sHLA-G were determined in 52 HIV-1-uninfected and 44 antiretroviral naive HIV-1-infected female commercial sex workers (CSWs), as well as 71 HIV-1-uninfected non-CSW women at low risk of exposure, recruited in Cotonou, Benin. HIV-1-infected CSWs had higher genital levels of sHLA-G compared with those in both the HIV-1-uninfected CSW (P = 0.009) and non-CSW groups (P = 0.0006). The presence of bacterial vaginosis (P = 0.008), and HLA-G*01:01:02 genotype (P = 0.002) were associated with higher genital levels of sHLA-G in the HIV-1-infected CSWs, whereas the HLA-G*01: 04: 04 genotype was also associated with higher genital level of sHLA-G in the overall population (P = 0.038). When adjustment was made for all significant variables, the increased expression of sHLA-G in the genital mucosa remained significantly associated with both HIV-1 infection (P = 0.02) and bacterial vaginosis (P = 0.03). Conclusion: This study demonstrates that high level of sHLA-G in the genital mucosa is independently associated with both HIV-1 infection and bacterial vaginosis.	[Thibodeau, Valerie; Poudrier, Johanne; Roger, Michel] CRCHUM, Immunogenet Lab, Montreal, PQ, Canada; [Thibodeau, Valerie; Labbe, Annie-Claude; Poudrier, Johanne; Roger, Michel] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Lajoie, Julie; Fowke, Keith R.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Labbe, Annie-Claude] Hop Maison Neuve Rosemont, Dept Med Microbiol, Montreal, PQ H1T 2M4, Canada; [Zannou, Marcel D.] Univ Abomey Calavi, Natl Ctr, Hosp Univ Hubert K Maga, Cotonou, Benin; [Alary, Michel] Affilie Univ Quebec, Unite Rech Sante Populat, Ctr Hosp, Quebec City, PQ, Canada; [Alary, Michel] Univ Laval, Quebec City, PQ, Canada; [Alary, Michel] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada	Universite de Montreal; Universite de Montreal; University of Manitoba; Universite de Montreal; University of Abomey Calavi; Laval University; Laval University; Laval University	Thibodeau, V (corresponding author), CRCHUM, Immunogenet Lab, Montreal, PQ, Canada.	michel.roger.chum@ssss.gouv.qc.ca		Lajoie, Julie/0000-0003-0262-8005; Fowke, Keith/0000-0001-8227-6649	Canadian Institutes of Health Research (CIHR) [HOP-79213]; Reseau SIDA from the Fonds de la Recherche en Sante du Quebec (FRSQ); FRSQ	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Reseau SIDA from the Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by grant HOP-79213 from the Canadian Institutes of Health Research (CIHR) and by the Reseau SIDA from the Fonds de la Recherche en Sante du Quebec (FRSQ) to MR. JL holds a Student Research award from the CIHR. MR is recipient of a Research Scholar award from the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Cabello A, 2003, HUM IMMUNOL, V64, P1045, DOI 10.1016/j.humimm.2003.08.353; Cohen CR, 1999, AIDS, V13, P327, DOI 10.1097/00002030-199902250-00004; Fabris A, 2009, AIDS, V23, P177, DOI 10.1097/QAD.0b013e32832027bf; Ferguson R, 2011, HUM IMMUNOL, V72, P337, DOI 10.1016/j.humimm.2011.01.010; Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Gumbi PP, 2008, J VIROL, V82, P8529, DOI 10.1128/JVI.00183-08; Hackmon R, 2004, FETAL DIAGN THER, V19, P404, DOI 10.1159/000078992; Haynes BF, 2008, IMMUNITY, V28, P10, DOI 10.1016/j.immuni.2007.12.005; Hel Z, 2006, TRENDS IMMUNOL, V27, P274, DOI 10.1016/j.it.2006.04.007; Huang JH, 2010, J VIROL, V84, P10784, DOI 10.1128/JVI.01292-10; Hviid TVF, 2004, IMMUNOGENETICS, V56, P135, DOI 10.1007/s00251-004-0673-2; Hviid TVF, 2004, TISSUE ANTIGENS, V64, P66, DOI 10.1111/j.1399-0039.2004.00239.x; ISHITANI A, 1992, P NATL ACAD SCI USA, V89, P3947, DOI 10.1073/pnas.89.9.3947; Kanai T, 2001, MOL HUM REPROD, V7, P195, DOI 10.1093/molehr/7.2.195; Lajoie J, 2008, MUCOSAL IMMUNOL, V1, P309, DOI 10.1038/mi.2008.18; Lajoie J, 2006, J INFECT DIS, V193, P298, DOI 10.1086/498877; Lajoie J, 2010, J CLIN IMMUNOL, V30, P90, DOI 10.1007/s10875-009-9343-3; Lajoie J, 2010, HUM IMMUNOL, V71, P182, DOI 10.1016/j.humimm.2009.11.007; Lajoie J, 2009, AIDS, V23, P1437, DOI 10.1097/QAD.0b013e32832d0825; Le Gal FA, 1999, INT IMMUNOL, V11, P1351, DOI 10.1093/intimm/11.8.1351; Le Rond S, 2006, J IMMUNOL, V176, P3266, DOI 10.4049/jimmunol.176.5.3266; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106; Liang S, 2008, P NATL ACAD SCI USA, V105, P8357, DOI 10.1073/pnas.0803341105; Lila N, 2001, P NATL ACAD SCI USA, V98, P12150, DOI 10.1073/pnas.201407398; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Matte C, 2004, AIDS, V18, P427, DOI 10.1097/00002030-200402200-00008; McIntire RH, 2004, J LEUKOCYTE BIOL, V76, P1220, DOI 10.1189/jlb.0604337; Mirmonsef P, 2011, AM J REPROD IMMUNOL, V65, P190, DOI 10.1111/j.1600-0897.2010.00943.x; Moreau P, 1999, INT IMMUNOL, V11, P803, DOI 10.1093/intimm/11.5.803; Morel E, 2008, J IMMUNOL, V181, P2368, DOI 10.4049/jimmunol.181.4.2368; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Park GM, 2004, BIOCHEM BIOPH RES CO, V313, P606, DOI 10.1016/j.bbrc.2003.11.153; Pistoia V, 2007, SEMIN CANCER BIOL, V17, P469, DOI 10.1016/j.semcancer.2007.07.004; Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x; Riteau B, 2001, INT IMMUNOL, V13, P193, DOI 10.1093/intimm/13.2.193; Rivero A, 2007, HUM IMMUNOL, V68, P303, DOI 10.1016/j.humimm.2006.10.014; Rudstein-Svetlicky N, 2007, TISSUE ANTIGENS, V69, P140, DOI 10.1111/j.1399-0039.2006.763_4.x; Segat L, 2010, AIDS, V24, P1961, DOI 10.1097/QAD.0b013e32833c3324; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; UNAIDS, 2010, UNAIDS REP GLOB AIDS; van der Meer A, 2007, MOL HUM REPROD, V13, P123, DOI 10.1093/molehr/gal100; Yasodhara P, 2006, J REPROD IMMUNOL, V70, P133, DOI 10.1016/j.jri.2005.11.001; Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059	46	23	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25185	10.1371/journal.pone.0025185	http://dx.doi.org/10.1371/journal.pone.0025185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966450	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100026
J	Janiszewski, PM; Ross, R; Despres, JP; Lemieux, I; Orlando, G; Carli, F; Bagni, P; Menozzi, M; Zona, S; Guaraldi, G				Janiszewski, Peter M.; Ross, Robert; Despres, Jean-Pierre; Lemieux, Isabelle; Orlando, Gabriella; Carli, Federica; Bagni, Pietro; Menozzi, Marianna; Zona, Stefano; Guaraldi, Giovanni			Hypertriglyceridemia and Waist Circumference Predict Cardiovascular Risk among HIV Patients: A Cross-Sectional Study	PLOS ONE			English	Article							ATHEROGENIC METABOLIC TRIAD; CORONARY-ARTERY-DISEASE; BODY-MASS INDEX; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; FAT ACCUMULATION; INSULIN; MEN; LIPODYSTROPHY; OBESITY	Background: Although half of HIV-infected patients develop lipodystrophy and metabolic complications, there exists no simple clinical screening tool to discern the high from the low-risk HIV-infected patient. Thus, we evaluated the associations between waist circumference (WC) combined with triglyceride (TG) levels and the severity of lipodystrophy and cardiovascular risk among HIV-infected men and women. Methods: 1481 HIV-infected men and 841 HIV-infected women were recruited between 2005 and 2009 at the metabolic clinic of the University of Modena and Reggio Emilia in Italy. Within each gender, patients were categorized into 4 groups according to WC and TG levels. Total and regional fat and fat-free mass were assessed by duel-energy x-ray absorptiometry, and visceral adipose tissue (VAT) and abdominal subcutaneous AT (SAT) were quantified by computed tomography. Various cardiovascular risk factors were assessed in clinic after an overnight fast. Results: The high TG/high WC men had the most VAT (208.0 +/- 94.4 cm(2)), as well as the highest prevalence of metabolic syndrome (42.2%) and type-2 diabetes (16.2%), and the highest Framingham risk score (10.3 +/- 6.5) in comparison to other groups (p<0.05 for all). High TG/high WC women also had elevated VAT (150.0 +/- 97.9 cm(2)) and a higher prevalence of metabolic syndrome (53.3%), hypertension (30.5%) and type-2 diabetes (12.0%), and Framingham risk score(2.9 +/- 2.8) by comparison to low TG/low WC women (p<0.05 for all). Conclusions: A simple tool combining WC and TG levels can discriminate high-from low-risk HIV-infected patients.	[Janiszewski, Peter M.; Ross, Robert] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Ross, Robert] Queens Univ, Div Endocrinol & Metab, Sch Med, Kingston, ON, Canada; [Despres, Jean-Pierre; Lemieux, Isabelle] Hop Laval, Res Ctr, Quebec Heart Inst, Quebec City, PQ, Canada; [Orlando, Gabriella; Carli, Federica; Bagni, Pietro; Menozzi, Marianna; Zona, Stefano; Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Metab Clin, Infect & Trop Dis Unit, Dept Med, Modena, Italy	Queens University - Canada; Queens University - Canada; Laval University; Universita di Modena e Reggio Emilia	Janiszewski, PM (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	rossr@queensu.ca	Guaraldi, Giovanni/J-9467-2018; Orlando, Gabriella/K-3954-2018	Orlando, Gabriella/0000-0002-4590-9045; Janiszewski, Peter/0000-0003-1051-9474; Guaraldi, Giovanni/0000-0002-5724-3914; Zona, Stefano/0000-0003-3451-2744	Canadian Institutes of Health Research; Heart and Stroke foundation of Ontario; Marks Work Warehouse; Sanofi-Aventis; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Merck; Pfizer; Boehringer-Ingelheim; Theratechnologies; Tibotec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke foundation of Ontario(Heart & Stroke Foundation of Ontario); Marks Work Warehouse; Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); Boehringer-Ingelheim(Boehringer Ingelheim); Theratechnologies; Tibotec	Dr. Ross receives honoraria for lectures from scientific, educational and lay groups; receives research funding from Canadian Institutes of Health Research, Heart and Stroke foundation of Ontario, Marks Work Warehouse and Sanofi-Aventis; is a member of the Canadian Sugar Institute Advisory Board. Dr. Guaraldi has received research grants from Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Boehringer-Ingelheim, Theratechnologies and Tibotec. He has received honoraria as speaker and/or advisor from Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Theratechnologies, and Tibotec. Drs. Janiszewski and Zona have no conflicts to declare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	Arsenault BJ, 2010, CAN MED ASSOC J, V182, P1427, DOI 10.1503/cmaj.091276; Blackburn P, 2008, DIABETES CARE, V31, P170, DOI 10.2337/dc07-0272; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Fujimoto WY, 1999, DIABETES CARE, V22, P1808, DOI 10.2337/diacare.22.11.1808; Gan SK, 2002, DIABETES, V51, P3163, DOI 10.2337/diabetes.51.11.3163; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Guaraldi G, 2010, ATHEROSCLEROSIS, V208, P222, DOI 10.1016/j.atherosclerosis.2009.06.011; Janiszewski PM, 2008, DIABETOLOGIA, V51, P1475, DOI 10.1007/s00125-008-1058-0; Janiszewski PM, 2007, DIABETES CARE, V30, P3105, DOI 10.2337/dc07-0945; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Joy T, 2008, JAIDS-J ACQ IMM DEF, V47, P174, DOI 10.1097/QAI.0b013e31815b0792; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Lichtenstein KA, 2001, AIDS, V15, P1389, DOI 10.1097/00002030-200107270-00008; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; Miller J, 2003, HIV Med, V4, P293; Miller KD, 1998, LANCET, V351, P871, DOI 10.1016/S0140-6736(97)11518-5; POULIOT MC, 1992, DIABETES, V41, P826, DOI 10.2337/diabetes.41.7.826; Sam S, 2009, DIABETES CARE, V32, P1916, DOI 10.2337/dc09-0412; Sutinen J, 2002, AIDS, V16, P2183, DOI 10.1097/00002030-200211080-00011; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190	23	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25032	10.1371/journal.pone.0025032	http://dx.doi.org/10.1371/journal.pone.0025032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966404	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100042
J	Zhang, W; Coldefy, AS; Hubbard, SR; Burden, SJ				Zhang, Wei; Coldefy, Anne-Sophie; Hubbard, Stevan R.; Burden, Steven J.			Agrin Binds to the N-terminal Region of Lrp4 Protein and Stimulates Association between Lrp4 and the First Immunoglobulin-like Domain in Muscle-specific Kinase (MuSK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; NERVE GROWTH-FACTOR; NEUROMUSCULAR-JUNCTION; LDL-RECEPTOR; CRYSTAL-STRUCTURE; COMPLEX; DOK-7; WNT; MEDIATE; TRKA	Neuromuscular synapse formation depends upon coordinated interactions between motor neurons and muscle fibers, leading to the formation of a highly specialized postsynaptic membrane and a highly differentiated nerve terminal. Synapse formation begins as motor axons approach muscles that are prepatterned in the prospective synaptic region in a manner that depends upon Lrp4, a member of the LDL receptor family, and muscle-specific kinase (MuSK), a receptor tyrosine kinase. Motor axons supply Agrin, which binds Lrp4 and stimulates further MuSK phosphorylation, stabilizing nascent synapses. How Agrin binds Lrp4 and stimulates MuSK kinase activity is poorly understood. Here, we demonstrate that Agrin binds to the N-terminal region of Lrp4, including a subset of the LDLa repeats and the first of four beta-propeller domains, which promotes association between Lrp4 and MuSK and stimulates MuSK kinase activity. In addition, we show that Agrin stimulates the formation of a functional complex between I.rp4 and MuSK on the surface of myotubes in the absence of the transmembrane and intracellular domains of Lrp4. Further, we demonstrate that the first Ig-like domain in MuSK, which shares homology with the NGF-binding region in Tropomyosin Receptor Kinase (TrKA), is required for MuSK to bind Lrp4. These findings suggest that Lrp4 is a cis-acting ligand for MUSK, whereas Agrin functions as an allosteric and paracrine regulator to promote association between Lrp4 and MuSK.	[Zhang, Wei; Coldefy, Anne-Sophie; Burden, Steven J.] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA; [Hubbard, Stevan R.] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Struct Biol Program, New York, NY 10016 USA	New York University; New York University	Burden, SJ (corresponding author), 540 1st Ave, New York, NY 10016 USA.	burden@saturn.med.nyu.edu		Hubbard, Stevan/0000-0002-2707-9383; Burden, Steven/0000-0002-3550-6891	National Institutes of Health [NS36193, NS53414]; Association Francaise contre les Myopathies; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036193, R01NS053414, R01NS036193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS36193 (to S. J. B.) and NS53414 (to S. R. H.) and a postdoctoral fellowship from the Association Francaise contre les Myopathies (to A. S. C.).	Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Burden SJ, 2011, CELL, V144, P826, DOI 10.1016/j.cell.2011.02.037; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Cheng HJ, 2000, METH MOL B, V124, P313; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Farrugia ME, 2010, CURR OPIN NEUROL, V23, P489, DOI 10.1097/WCO.0b013e32833cc968; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Ibanez C. F., 2010, COMMUN, V396, P24; JENNINGS CGB, 1993, P NATL ACAD SCI USA, V90, P2895, DOI 10.1073/pnas.90.7.2895; Johnson EB, 2006, GENOMICS, V88, P600, DOI 10.1016/j.ygeno.2006.08.005; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li Y, 2010, AM J HUM GENET, V86, P696, DOI 10.1016/j.ajhg.2010.03.004; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Ohazama A, 2010, AM J MED GENET A, V152A, P2974, DOI 10.1002/ajmg.a.33372; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schlee S, 2006, NAT CHEM BIOL, V2, P636, DOI 10.1038/nchembio823; Stiegler AL, 2006, J MOL BIOL, V364, P424, DOI 10.1016/j.jmb.2006.09.019; Stiegler AL, 2009, J MOL BIOL, V393, P1, DOI 10.1016/j.jmb.2009.07.091; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; WOODRUFF ML, 1987, J CELL BIOL, V104, P939, DOI 10.1083/jcb.104.4.939; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	42	96	106	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40624	40630		10.1074/jbc.M111.279307	http://dx.doi.org/10.1074/jbc.M111.279307			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969364	Green Published, hybrid			2022-12-25	WOS:000297315400023
J	Li, JH; Deng, M; Wei, Q; Liu, T; Tong, XM; Ye, X				Li, Junhui; Deng, Min; Wei, Qian; Liu, Ting; Tong, Xiaomei; Ye, Xin			Phosphorylation of MCM3 Protein by Cyclin E/Cyclin-dependent Kinase 2 (Cdk2) Regulates Its Function in Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION ORIGINS; XENOPUS EGG EXTRACTS; MINICHROMOSOME MAINTENANCE PROTEINS; S-PHASE; CHECKPOINT KINASES; BUDDING YEAST; COMPLEX; ATR; CHK1; IDENTIFICATION	MCM2-7 proteins form a stable heterohexamer with DNA helicase activity functioning in the DNA replication of eukaryotic cells. The MCM2-7 complex is loaded onto chromatin in a cell cycle-dependent manner. The phosphorylation of MCM2-7 proteins contributes to the formation of the MCM2-7 complex. However, the regulation of specific MCM phosphorylation still needs to be elucidated. In this study, we demonstrate that MCM3 is a substrate of cyclin E/Cdk2 and can be phosphorylated by cyclin E/Cdk2 at Thr-722. We find that the MCM3 T722A mutant binds chromatin much less efficiently when compared with wild type MCM3, suggesting that this phosphorylation site is involved in MCM3 loading onto chromatin. Interestingly, overexpression of MCM3, but not MCM3 T722A mutant, inhibits the S phase entry, whereas it does not affect the exit from mitosis. Knockdown of MCM3 does not affect S phase entry and progression, indicating that a small fraction of MCM3 is sufficient for normal S phase completion. These results suggest that excess accumulation of MCM3 protein onto chromatin may inhibit DNA replication. Other studies indicate that excess of MCM3 up-regulates the phosphorylation of CHK1 Ser-345 and CDK2 Thr-14. These data reveal that the phosphorylation of MCM3 contributes to its function in controlling the S phase checkpoint of cell cycle in addition to the regulation of formation of the MCM2-7 complex.	[Li, Junhui; Deng, Min; Wei, Qian; Liu, Ting; Tong, Xiaomei; Ye, Xin] Chinese Acad Sci, Ctr Mol Immunol, Chinese Acad Sci Key Lab Pathogen Microbiol & Imm, Inst Microbiol, Beijing 100101, Peoples R China; [Li, Junhui; Deng, Min; Wei, Qian; Liu, Ting] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Ctr Mol Immunol, Chinese Acad Sci Key Lab Pathogen Microbiol & Imm, Inst Microbiol, 1 Beichen W Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn			National Natural Science Foundation of China [30871238]; Ministry of Science and Technology of China [2009ZX10004-101, 2008ZX10002-009, 2011CB504705, 2012CB519003]; Chinese Academy of Sciences [KSCX2-EW-J-6];  [81021003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); 	This work was supported by National Natural Science Foundation of China Grant 30871238, The Ministry of Science and Technology of China Grants 2009ZX10004-101, 2008ZX10002-009, 2011CB504705, 2012CB519003, and Chinese Academy of Sciences Innovation Projects KSCX2-EW-J-6.; A principal investigator of the Innovative Research Group of the National Natural Science Foundation of China (81021003). To whom correspondence should be addressed: Center for Molecular Immunology, Chinese Academy of Science Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 1 Beichen West Rd., Chaoyang District, Beijing 100101, China. Tel.: 86-10-64807508; Fax: 86-10-64807513; E-mail: yex@im.ac.cn.	Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Early A, 2004, PHILOS T R SOC B, V359, P31, DOI 10.1098/rstb.2003.1362; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Hendrickson M, 1996, P NATL ACAD SCI USA, V93, P12223, DOI 10.1073/pnas.93.22.12223; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ishimi Y, 2003, J BIOL CHEM, V278, P24644, DOI 10.1074/jbc.M213252200; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Laezza C, 2006, FEBS LETT, V580, P6076, DOI 10.1016/j.febslet.2006.09.074; Lin DI, 2008, P NATL ACAD SCI USA, V105, P8079, DOI 10.1073/pnas.0800077105; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Meister P, 2007, EMBO J, V26, P1315, DOI 10.1038/sj.emboj.7601538; Namiki Y, 2006, P NATL ACAD SCI USA, V103, P580, DOI 10.1073/pnas.0510223103; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shechter D, 2004, P NATL ACAD SCI USA, V101, P10845, DOI 10.1073/pnas.0404143101; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shi YL, 2007, J BIOL CHEM, V282, P9236, DOI 10.1074/jbc.M609256200; Snyder M, 2009, J BIOL CHEM, V284, P13466, DOI 10.1074/jbc.M809471200; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Sun JY, 2010, ACTA BIOCH BIOPH SIN, V42, P433, DOI 10.1093/abbs/gmq048; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Yim H, 2010, P NATL ACAD SCI USA, V107, P19742, DOI 10.1073/pnas.1013557107	38	34	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39776	39785		10.1074/jbc.M111.226464	http://dx.doi.org/10.1074/jbc.M111.226464			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965652	Green Published, hybrid			2022-12-25	WOS:000296925700011
J	Bhat, AA; Mahajan, G; Mehta, A				Bhat, Ajaz Ahmad; Mahajan, Gaurang; Mehta, Anita			Learning with a Network of Competing Synapses	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; MODELS; ADAPTATION; TIMESCALES	Competition between synapses arises in some forms of correlation-based plasticity. Here we propose a game theory-inspired model of synaptic interactions whose dynamics is driven by competition between synapses in their weak and strong states, which are characterized by different timescales. The learning of inputs and memory are meaningfully definable in an effective description of networked synaptic populations. We study, numerically and analytically, the dynamic responses of the effective system to various signal types, particularly with reference to an existing empirical motor adaptation model. The dependence of the system-level behavior on the synaptic parameters, and the signal strength, is brought out in a clear manner, thus illuminating issues such as those of optimal performance, and the functional role of multiple timescales.	[Bhat, Ajaz Ahmad; Mahajan, Gaurang; Mehta, Anita] SN Bose Natl Ctr Basic Sci, Kolkata 700064, W Bengal, India; [Mehta, Anita] CEA Saclay, Inst Phys Thor, F-91191 Gif Sur Yvette, France	Department of Science & Technology (India); SN Bose National Centre for Basic Science (SNBNCBS); CEA; UDICE-French Research Universities; Universite Paris Saclay	Bhat, AA (corresponding author), SN Bose Natl Ctr Basic Sci, Kolkata 700064, W Bengal, India.	anita@bose.res.in		Mahajan, Gaurang/0000-0002-6583-6269; Bhat, Ajaz/0000-0002-6992-8224	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was funded by the Department of Science and Technology, Government of India, under the project "Cognitive Science Initiative." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ACKLEY DH, 1985, COGNITIVE SCI, V9, P147; Babadi B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000961; Baldassi C, 2007, P NATL ACAD SCI USA, V104, P11079, DOI 10.1073/pnas.0700324104; Barrett AB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000230; Bhat AA, 2011, ARXIV11050523; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BOGARTZ RS, 1990, J EXP PSYCHOL LEARN, V16, P138, DOI 10.1037/0278-7393.16.1.138; Bromberg-Martin ES, 2010, NEURON, V67, P499, DOI 10.1016/j.neuron.2010.06.031; Camalet S, 2000, P NATL ACAD SCI USA, V97, P3183, DOI 10.1073/pnas.97.7.3183; Camerer CF, 2003, TRENDS COGN SCI, V7, P225, DOI 10.1016/S1364-6613(03)00094-9; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Dayan P., 2001, THEORETICAL NEUROSCI; de Arcangelis L, 2010, P NATL ACAD SCI USA, V107, P3977, DOI 10.1073/pnas.0912289107; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Fairhall AL, 2000, P NIPS, P124; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; GARDNER E, 1988, J PHYS A-MATH GEN, V21, P271, DOI 10.1088/0305-4470/21/1/031; Gerstner W., 2002, SPIKING NEURON MODEL; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Leibold C, 2008, CEREB CORTEX, V18, P67, DOI 10.1093/cercor/bhm037; Mahajan G, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/48008; Mehta A, 1999, PHYS REV E, V60, P5218, DOI 10.1103/PhysRevE.60.5218; Mehta A, 2011, JSTAT IN PRESS; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Yamashita Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000220; Yu YG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108103	40	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25048	10.1371/journal.pone.0025048	http://dx.doi.org/10.1371/journal.pone.0025048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980377	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900020
J	Biyani, N; Mandal, S; Seth, C; Saint, M; Natarajan, K; Ghosh, I; Madhubala, R				Biyani, Neha; Mandal, Swati; Seth, Chandan; Saint, Malika; Natarajan, Krishnamurthy; Ghosh, Indira; Madhubala, Rentala			Characterization of Leishmania donovani Aquaporins Shows Presence of Subcellular Aquaporins Similar to Tonoplast Intrinsic Proteins of Plants	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS EXPRESSION; PLASMODIUM-FALCIPARUM; CRYSTAL-STRUCTURE; WATER CHANNELS; DRUG UPTAKE; AQUAGLYCEROPORIN; GLYCEROL; PREDICTION; MEMBRANE	Leishmania donovani, a protozoan parasite, resides in the macrophages of the mammalian host. The aquaporin family of proteins form important components of the parasite-host interface. The parasite-host interface could be a potential target for chemotherapy. Analysis of L. major and L. infantum genomes showed the presence of five aquaporins (AQPs) annotated as AQP9 (230aa), AQP putative (294aa), AQP-like protein (279aa), AQP1 (314aa) and AQP-like protein (596aa). We report here the structural modeling, localization and functional characterization of the AQPs from L. donovani. LdAQP1, LdAQP9, LdAQP2860 and LdAQP2870 have the canonical NPA-NPA motifs, whereas LdAQP putative has a non-canonical NPM-NPA motif. In the carboxyl terminal to the second NPA box of all AQPs except AQP1, a valine/alanine residue was found instead of the arginine. In that respect these four AQPs are similar to tonoplast intrinsic proteins in plants, which are localized to intracellular organelles. Confocal microscopy of L. donovani expressing GFP-tagged AQPs showed an intracellular localization of LdAQP9 and LdAQP2870. Real-time PCR assays showed expression of all aquaporins except LdAQP2860, whose level was undetectable. Three-dimensional homology modeling of the AQPs showed that LdAQP1 structure bears greater topological similarity to the aquaglyceroporin than to aquaporin of E. coli. The pore of LdAQP1 was very different from the rest in shape and size. The cavity of LdAQP2860 was highly irregular and undefined in geometry. For functional characterization, four AQP proteins were heterologously expressed in yeast. In the fps1 Delta yeast cells, which lacked the key aquaglyceroporin, LdAQP1 alone displayed an osmosensitive phenotype indicating glycerol transport activity. However, expression of LdAQP1 and LdAQP putative in a yeast gpd1 Delta strain, deleted for glycerol production, conferred osmosensitive phenotype indicating water transport activity or aquaporin function. Our analysis for the first time shows the presence of subcellular aquaporins and provides structural and functional characterization of aquaporins in Leishmania donovani.	[Biyani, Neha; Saint, Malika; Natarajan, Krishnamurthy] Jawaharlal Nehru Univ, Sch Life Sci, Lab Eukaryot Gene Regulat, New Delhi 110067, India; [Seth, Chandan; Ghosh, Indira] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Biyani, N (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Lab Eukaryot Gene Regulat, New Delhi 110067, India.	madhubala@mail.jnu.ac.in	biyani, neha/AAN-1860-2020; ghosh, indira/H-5008-2019	madhubala, rentala/0000-0002-0034-399X; Saint, Malika/0000-0001-7509-0619; Seth Nanda, Chandan/0000-0002-3955-8808	Department of Biotechnology, India; Department of Science and Technology, India; Council of Scientific and Industrial Research, India; University Grants Commission, Government of India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India)	This work is supported by a grant from the Department of Biotechnology, India to Rentala Madhubala. Rentala Madhubala is a JC Bose National Fellow supported by the Department of Science and Technology, India. Neha Biyani is supported by a Senior Research Fellowship from the Council of Scientific and Industrial Research, India, and Swati Mandal is supported by a fellowship from the University Grants Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Alconada A, 1996, EMBO J, V15, P6096, DOI 10.1002/j.1460-2075.1996.tb00998.x; Amiry-Moghaddam M, 2005, FASEB J, V19, P1459, DOI 10.1096/fj.04-3515com; [Anonymous], EMBOSS HMOMENT; Bates PA, 2001, PROTEINS, P39; Beitz E, 2005, BIOL CELL, V97, P373, DOI 10.1042/BC20040095; Bhattacharjee Hiranmoy, 2009, Handb Exp Pharmacol, P309, DOI 10.1007/978-3-540-79885-9_16; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Figarella K, 2007, MOL MICROBIOL, V65, P1006, DOI 10.1111/j.1365-2958.2007.05845.x; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Gourbal B, 2004, J BIOL CHEM, V279, P31010, DOI 10.1074/jbc.M403959200; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Ishibashi K, 2006, BBA-BIOMEMBRANES, V1758, P989, DOI 10.1016/j.bbamem.2006.02.024; Ishikawa Y, 2006, BBA-BIOMEMBRANES, V1758, P1053, DOI 10.1016/j.bbamem.2006.03.026; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jiang JS, 2006, J BIOL CHEM, V281, P454, DOI 10.1074/jbc.M508926200; Kirk K, 2004, ACTA TROP, V89, P285, DOI 10.1016/j.actatropica.2003.10.002; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Ma S, 2004, PLANT J, V40, P845, DOI 10.1111/j.1365-313X.2004.02265.x; Maharjan M, 2008, AM J TROP MED HYG, V79, P69, DOI 10.4269/ajtmh.2008.79.69; Mandal S, 2010, J ANTIMICROB CHEMOTH, V65, P496, DOI 10.1093/jac/dkp468; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Newby ZER, 2008, NAT STRUCT MOL BIOL, V15, P619, DOI 10.1038/nsmb.1431; Oliveira EMM, 2005, FEMS YEAST RES, V5, P605, DOI 10.1016/j.femsyr.2004.11.011; Oliveira R, 2003, BBA-BIOMEMBRANES, V1613, P57, DOI 10.1016/S0005-2736(03)00138-X; Pellegrini-Calace M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000440; Pettersson N, 2006, CURR GENET, V50, P247, DOI 10.1007/s00294-006-0092-z; Pitt WR, 2001, BIOINFORMATICS, V17, P729, DOI 10.1093/bioinformatics/17.8.729; Prudent S, 2005, FEBS LETT, V579, P3872, DOI 10.1016/j.febslet.2005.05.076; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; Roy G, 2000, MOL BIOCHEM PARASIT, V110, P195, DOI 10.1016/S0166-6851(00)00270-X; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schrodinger L., PYMOL MOL GRAPHICS S; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Uzcategui NL, 2004, J BIOL CHEM, V279, P42669, DOI 10.1074/jbc.M404518200; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; Weig AR, 2000, FEBS LETT, V481, P293, DOI 10.1016/S0014-5793(00)02027-5; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wiwanitkit V, 2008, INDIAN J MED MICROBI, V26, P246, DOI 10.4103/0255-0857.42036	53	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24820	10.1371/journal.pone.0024820	http://dx.doi.org/10.1371/journal.pone.0024820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969862	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900013
J	Pradhan, AK; Das Mohapatra, A; Nayak, KB; Chakraborty, S				Pradhan, Anjan Kumar; Das Mohapatra, Alok; Nayak, Kasturi Bala; Chakraborty, Soumen			Acetylation of the Proto-Oncogene EVI1 Abrogates Bcl-xL Promoter Binding and Induces Apoptosis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; CELL-DEATH; MYELODYSPLASTIC SYNDROMES; TRANSCRIPTION FACTORS; CARDIAC MYOCYTES; GENE-EXPRESSION; DNA-BINDING; BCL-X(L); DEACETYLASE; INDUCTION	EVI1 (Ecotropic Viral Integration site I), which was originally identified as a myeloid transforming gene by means of retroviral insertional mutagenesis in mouse leukemia, encodes a nuclear DNA binding zinc finger protein. The presence of zinc fingers that are able to bind to specific sequences of DNA suggests that EVI1 is a transcriptional regulator; however, except a few, target genes of EVI1 are poorly functionally identified thus far. In this study we provide evidence that EVI1 directly induces the expression of Bcl-xL through the first set of zinc finger and thereby inhibits apoptosis. ChIP analysis showed that EVI1 binds to the Bcl-xL promoter in HT-29 cells, a colon carcinoma cell line, which expresses EVI1. The observation is also supported by the fact that EVI1 siRNA treated HT-29 cells, shows a down regulation of Bcl-xL expression and that over expression of EVI1 results in the induction of the Bcl-xL reporter construct. A set of EVI1 positive chronic myeloid leukemia (CML) samples also showed higher Bcl-xL expression with respect to EVI1 negative samples. Interestingly, co-expression of EVI1 with wild type, but not with dominant-negative form of PCAF, abolishes the effect of EVI1 on Bcl-xL, indicating that acetylation of EVI1 abrogates its ability not only to bind Bcl-xL promoter but also alleviate Bcl-xL activity. Finally we have shown that EVI1 expression regulates apoptosis in HT-29 cells, which is abrogated when HT-29 cells are transfected with EVI1 siRNA or PCAF. The result for the first time shows a direct pathway by which EVI1 can protect cells from apoptosis and also demonstrates that the pathway can be reversed when EVI1 is acetylated.	[Pradhan, Anjan Kumar; Nayak, Kasturi Bala; Chakraborty, Soumen] Inst Life Sci, Dept Gene Funct & Regulat, Bhubaneswar, Orissa, India; [Das Mohapatra, Alok] Inst Life Sci, Dept Infect Dis Biol, Bhubaneswar, Orissa, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Pradhan, AK (corresponding author), Inst Life Sci, Dept Gene Funct & Regulat, Bhubaneswar, Orissa, India.	soumen_ils@yahoo.co.in	Pradhan, Anjan K/O-2555-2014	DAS MOHAPATRA, ALOK/0000-0001-6189-9118	Department of Science and Technology (DST) [SR/SO/BB-13/2006]; Council of Scientific and Industrial Research, India; Indian Council of Medical Research, India; Department of Science and Technology, India	Department of Science and Technology (DST)(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported by a grant-in-aid from the Department of Science and Technology (DST) to SC (Grant No. SR/SO/BB-13/2006) and also partly by the Institutional core grant. AKP is supported by a fellowship from the Council of Scientific and Industrial Research, India. ADM is supported by fellowship from the Indian Council of Medical Research, India. KBN was supported by fellowship from Department of Science and Technology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2000, CANCER RES, V60, P6101; BARTHOLOMEW C, 1994, ONCOGENE, V9, P939; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buonamici S, 2005, J BIOL CHEM, V280, P428, DOI 10.1074/jbc.M410836200; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Caillaud A, 2002, J BIOL CHEM, V277, P49417, DOI 10.1074/jbc.M207484200; Chakraborty S, 2001, J BIOL CHEM, V276, P44936, DOI 10.1074/jbc.M106733200; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen N, 2009, J BIOL CHEM, V284, P10004, DOI 10.1074/jbc.M805997200; CherbonnelLasserre C, 1996, ONCOGENE, V13, P1489; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DREYFUS F, 1995, LEUKEMIA, V9, P203; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fujio Y, 1997, J CLIN INVEST, V99, P2898, DOI 10.1172/JCI119484; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Konrad TA, 2009, J LEUKOCYTE BIOL, V86, P813, DOI 10.1189/jlb.0109042; Kuo YY, 2007, MOL CELL BIOL, V27, P4261, DOI 10.1128/MCB.02212-06; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Laricchia-Robbio L, 2006, MOL CELL BIOL, V26, P7658, DOI 10.1128/MCB.00363-06; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; MORISHITA K, 1990, ONCOGENE, V5, P963; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Ogawa S, 1996, LEUKEMIA, V10, P788; OHYASHIKI JH, 1995, BLOOD, V85, P3713, DOI 10.1182/blood.V85.12.3713.bloodjournal85123713; Qiu Y, 2008, BIOCHEMISTRY-US, V47, P3697, DOI 10.1021/bi702524v; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Ravindra KC, 2009, J BIOL CHEM, V284, P24453, DOI 10.1074/jbc.M109.023861; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Roy P, 2010, FEBS J, V277, P441, DOI 10.1111/j.1742-4658.2009.07496.x; RUSSELL M, 1994, BLOOD, V84, P1243, DOI 10.1182/blood.V84.4.1243.bloodjournal8441243; Sevilla L, 1999, MOL CELL BIOL, V19, P2624; Shimabe M, 2009, ONCOGENE, V28, P4364, DOI 10.1038/onc.2009.288; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Valks DM, 2003, J BIOL CHEM, V278, P25542, DOI 10.1074/jbc.M303760200; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Yang Y, 2009, NEOPLASIA, V11, P313, DOI 10.1593/neo.81358; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679	42	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25370	10.1371/journal.pone.0025370	http://dx.doi.org/10.1371/journal.pone.0025370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980434	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900055
J	Wallace, BP; DiMatteo, AD; Bolten, AB; Chaloupka, MY; Hutchinson, BJ; Abreu-Grobois, FA; Mortimer, JA; Seminoff, JA; Amorocho, D; Bjorndal, KA; Bourjea, J; Bowen, BW; Duenas, RB; Casale, P; Choudhury, BC; Costa, A; Dutton, PH; Fallabrino, A; Finkbeiner, EM; Girard, A; Girondot, M; Hamann, M; Hurley, BJ; Lopez-Mendilaharsu, M; Marcovaldi, MA; Musick, JA; Nel, R; Pilcher, NJ; Troeng, S; Witherington, B; Mast, RB				Wallace, Bryan P.; DiMatteo, Andrew D.; Bolten, Alan B.; Chaloupka, Milani Y.; Hutchinson, Brian J.; Abreu-Grobois, F. Alberto; Mortimer, Jeanne A.; Seminoff, Jeffrey A.; Amorocho, Diego; Bjorndal, Karen A.; Bourjea, Jerome; Bowen, Brian W.; Briseno Duenas, Raquel; Casale, Paolo; Choudhury, B. C.; Costa, Alice; Dutton, Peter H.; Fallabrino, Alejandro; Finkbeiner, Elena M.; Girard, Alexandre; Girondot, Marc; Hamann, Mark; Hurley, Brendan J.; Lopez-Mendilaharsu, Milagros; Angela Marcovaldi, Maria; Musick, John A.; Nel, Ronel; Pilcher, Nicolas J.; Troeng, Sebastian; Witherington, Blair; Mast, Roderic B.			Global Conservation Priorities for Marine Turtles	PLOS ONE			English	Article							LEATHERBACK TURTLE; SEA-TURTLES; POPULATION; MANAGEMENT; PACIFIC; RECOVERY	Where conservation resources are limited and conservation targets are diverse, robust yet flexible priority-setting frameworks are vital. Priority-setting is especially important for geographically widespread species with distinct populations subject to multiple threats that operate on different spatial and temporal scales. Marine turtles are widely distributed and exhibit intra-specific variations in population sizes and trends, as well as reproduction and morphology. However, current global extinction risk assessment frameworks do not assess conservation status of spatially and biologically distinct marine turtle Regional Management Units (RMUs), and thus do not capture variations in population trends, impacts of threats, or necessary conservation actions across individual populations. To address this issue, we developed a new assessment framework that allowed us to evaluate, compare and organize marine turtle RMUs according to status and threats criteria. Because conservation priorities can vary widely (i.e. from avoiding imminent extinction to maintaining long-term monitoring efforts) we developed a "conservation priorities portfolio" system using categories of paired risk and threats scores for all RMUs (n = 58). We performed these assessments and rankings globally, by species, by ocean basin, and by recognized geopolitical bodies to identify patterns in risk, threats, and data gaps at different scales. This process resulted in characterization of risk and threats to all marine turtle RMUs, including identification of the world's 11 most endangered marine turtle RMUs based on highest risk and threats scores. This system also highlighted important gaps in available information that is crucial for accurate conservation assessments. Overall, this priority-setting framework can provide guidance for research and conservation priorities at multiple relevant scales, and should serve as a model for conservation status assessments and priority-setting for widespread, long-lived taxa.	[Wallace, Bryan P.; DiMatteo, Andrew D.; Bolten, Alan B.; Chaloupka, Milani Y.; Hutchinson, Brian J.; Abreu-Grobois, F. Alberto; Mortimer, Jeanne A.; Seminoff, Jeffrey A.; Amorocho, Diego; Bjorndal, Karen A.; Bourjea, Jerome; Bowen, Brian W.; Briseno Duenas, Raquel; Casale, Paolo; Choudhury, B. C.; Costa, Alice; Dutton, Peter H.; Fallabrino, Alejandro; Finkbeiner, Elena M.; Girard, Alexandre; Girondot, Marc; Hamann, Mark; Hurley, Brendan J.; Lopez-Mendilaharsu, Milagros; Angela Marcovaldi, Maria; Musick, John A.; Nel, Ronel; Pilcher, Nicolas J.; Troeng, Sebastian; Witherington, Blair; Mast, Roderic B.] Burning Issues Working Grp, IUCN SSC Marine Turtle Specialist Grp, Arlington, VA USA; [Wallace, Bryan P.; Hutchinson, Brian J.; Hurley, Brendan J.; Mast, Roderic B.] Conservat Int, Global Marine Div, Arlington, VA USA; [Wallace, Bryan P.; Finkbeiner, Elena M.] Duke Univ, Div Marine Sci & Conservat, Beaufort, NC USA; [DiMatteo, Andrew D.] Duke Univ, Marine Geospatial Ecol Lab, Durham, NC USA; [Bolten, Alan B.; Bjorndal, Karen A.] Univ Florida, Archie Carr Ctr Sea Turtle Res, Gainesville, FL USA; [Bolten, Alan B.; Mortimer, Jeanne A.; Bjorndal, Karen A.] Univ Florida, Dept Biol, Gainesville, FL USA; [Chaloupka, Milani Y.] Univ Queensland, Ecol Modelling Serv Pty Ltd, Brisbane, Qld, Australia; [Abreu-Grobois, F. Alberto] Univ Nacl Autonoma Mexico, Unidad Acad Mazatlan, Inst Ciencias Mar & Limnol, Mazatlan, Sinaloa, Mexico; [Mortimer, Jeanne A.] Isl Conservat Soc, Victoria, Mahe, Seychelles; [Amorocho, Diego] NOAA, Natl Marine Fisheries Serv, Marine Turtle Ecol & Assessment Program, SW Fisheries Sci Ctr, La Jolla, CA USA; [Amorocho, Diego] Ctr Invest Medio Ambiente & Desarrollo, Cali, Colombia; [Bourjea, Jerome] IFREMER, Lab Ressources Halieut, Ile De La Reunion, France; [Bowen, Brian W.] Hawaii Inst Marine Biol, Kaneohe, HI USA; [Briseno Duenas, Raquel] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Banco Informac Tortugas Marinas BITMAR, Unidad Mazatlan, Mazatlan, Sinaloa, Mexico; [Casale, Paolo] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Casale, Paolo] World Wildlife Fund Italy, WWF Mediterranean Turtle Programme, Rome, Italy; [Choudhury, B. C.] Wildlife Inst India, Dept Endangered Species Management, Dehra Dun, Uttarakhand, India; [Costa, Alice] World Wildlife Fund Mozamb, Maputo, Mozambique; [Dutton, Peter H.] Natl Ocean & Atmospher Adm, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Fallabrino, Alejandro] Karumbe, Montevideo, Uruguay; [Girard, Alexandre] Assoc RENATURA, Albens, France; [Girard, Alexandre] Assoc RENATURA, Pointe Noire, Rep Congo; [Girondot, Marc] Univ Paris 11, Lab Ecol Syst & Evolut, Orsay, France; [Hamann, Mark] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld, Australia; [Lopez-Mendilaharsu, Milagros; Angela Marcovaldi, Maria] Fundacao Pro Tamar, Projeto Tamar ICMBio, Salvador, BA, Brazil; Univ Estado Rio de Janeiro, Dept Ecol, Inst Biol, BR-20550011 Rio De Janeiro, Brazil; [Musick, John A.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; [Nel, Ronel] Nelson Mandela Metropolitan Univ, Sch Environm Sci, Summerstrand Campus, South Africa; [Pilcher, Nicolas J.] Marine Res Fdn, Sabah, Malaysia; [Troeng, Sebastian] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; [Troeng, Sebastian] Sea Turtle Conservancy, Sci Advisory Comm, Gainesville, FL USA; [Witherington, Blair] Florida Fish & Wildlife Conservat Commiss, Melbourne Beach, FL USA	Conservation International; Duke University; Duke University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Queensland; Universidad Nacional Autonoma de Mexico; National Oceanic Atmospheric Admin (NOAA) - USA; Ifremer; Universidad Nacional Autonoma de Mexico; Sapienza University Rome; Wildlife Institute of India; National Oceanic Atmospheric Admin (NOAA) - USA; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; James Cook University; Universidade do Estado do Rio de Janeiro; William & Mary; Virginia Institute of Marine Science; Nelson Mandela University; Lund University; Florida Fish & Wildlife Conservation Commission	Wallace, BP (corresponding author), Burning Issues Working Grp, IUCN SSC Marine Turtle Specialist Grp, Arlington, VA USA.	b.wallace@conservation.org	Grobois, Alberto Abreu/A-3560-2017; Girondot, Marc/A-7663-2010	Grobois, Alberto Abreu/0000-0002-7350-757X; Bjorndal, Karen/0000-0002-6286-1901; Bolten, Alan/0000-0002-4834-2742; Mortimer, Jeanne A./0000-0001-6318-2890; Girondot, Marc/0000-0001-6645-8530; Bourjea, Jerome/0000-0001-7149-3648; Girard, Alexandre/0000-0002-2973-5137; Hamann, Mark/0000-0003-4588-7955; CASALE, PAOLO/0000-0003-2534-6158	National Fish and Wildlife Foundation; Offield Family Foundation; Ecological Modelling Services, Pty Ltd	National Fish and Wildlife Foundation; Offield Family Foundation; Ecological Modelling Services, Pty Ltd	This study was funded by the National Fish and Wildlife Foundation and the Offield Family Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MYC is employed by a commercial company (Ecological Modelling Services, Pty Ltd) that provides ecological modeling services, and his involvement in all aspects of this study was partially supported by this company. However, this support in no way biased his contributions to all aspects of this study, the overall process or resulting products generated by this study.	Abreu-Grobois FA, 2007, IUCN RED LIST STATUS; Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bolten A.B., 2003, LOGGERHEAD SEA TURTL, P63; Boyd C, 2008, CONSERV LETT, V1, P37, DOI 10.1111/j.1755-263X.2008.00002.x; C?lix M., 2018, EUROPEAN RED LIST SA; Casale P, SEA TURTLES MEDITERR; Chaloupka M, 2008, MAR BIOL, V154, P887, DOI 10.1007/s00227-008-0981-4; Chaloupka M, 2008, GLOBAL ECOL BIOGEOGR, V17, P297, DOI 10.1111/j.1466-8238.2007.00367.x; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; Donlan CJ, 2010, CONSERV BIOL, V24, P1586, DOI 10.1111/j.1523-1739.2010.01541.x; Ehrhart L.M., 2003, LOGGERHEAD SEA TURTL, P157; Fowler SL, 2005, SHARKS RAYS CHIMAERA; Freeman Milton M. R., 2008, Endangered Species Research, V6, P173, DOI 10.3354/esr00102; Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x; Gaos AR, 2010, ORYX, V44, P595, DOI 10.1017/S0030605310000773; Godfrey Matthew H., 2008, Endangered Species Research, V6, P155, DOI 10.3354/esr00071; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Lauret-Stepler M., 2007, Endangered Species Research, V3, P217, DOI 10.3354/esr003217; Limpus Colin J., 2003, Memoirs of the Queensland Museum, V49, P349; Margaritoulis D., 2003, LOGGERHEAD SEA TURTL, P175; Marsh H, 2007, CONSERV BIOL, V21, P387, DOI 10.1111/j.1523-1739.2006.00589.x; Mast R., 2005, MARINE TURTLE NEWSLE, V110, P13; Mast Roderic B., 2009, Marine Turtle Newsletter, P17; Merkhofer M.W., 2012, DECISION SCI SOCIAL, V2; Meylan Anne B., 1999, Chelonian Conservation and Biology, V3, P200; Monzon-Arguello C, 2010, J BIOGEOGR, V37, P1752, DOI 10.1111/j.1365-2699.2010.02326.x; Mortimer JA, 2008, TURTLE SPECIALIST GR; National Research Council (NRC), 2010, ASS SEA TURTL STAT T; Nel R, 2008, SEA TURTLES KWAZULU; Tomillo PS, 2007, CHELONIAN CONSERV BI, V6, P54; Martinez LS, 2007, CHELONIAN CONSERV BI, V6, P70, DOI 10.2744/1071-8443(2007)6[70:CABOTL]2.0.CO;2; SEMINOFF J, 2004, GLOBAL STATUS ASSESS; Seminoff JA, 2008, J EXP MAR BIOL ECOL, V356, P52, DOI 10.1016/j.jembe.2007.12.007; Shanker K, 2008, MARINE TURTLES INDIA; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Turtle Expert Working Group, 2007, NMFSSEFSC555 NOAA; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Wallace Bryan P., 2009, Endangered Species Research, V7, P11, DOI 10.3354/esr00177; Witt MJ, 2011, P ROY SOC B-BIOL SCI, V278, P2338, DOI 10.1098/rspb.2010.2467	43	327	350	2	190	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24510	10.1371/journal.pone.0024510	http://dx.doi.org/10.1371/journal.pone.0024510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969858	Green Published, Green Accepted, gold			2022-12-25	WOS:000295936900009
J	Zhu, XZ; Zhang, JT; Ma, KP				Zhu, Xunzhi; Zhang, Jintun; Ma, Keping			Soil Biota Reduce Allelopathic Effects of the Invasive Eupatorium adenophorum	PLOS ONE			English	Article							CENTAUREA-MACULOSA; ALLELOCHEMICAL (+/-)-CATECHIN; ROOT EXUDATE; WEAPONS; FACILITATE; COMMUNITY; MECHANISM; SUCCESS; FUNGI	Allelopathy has been hypothesized to play a role in exotic plant invasions, and study of this process can improve our understanding of how direct and indirect plant interactions influence plant community organization and ecosystem functioning. However, allelopathic effects can be highly conditional. For example allelopathic effects demonstrated in vivo can be difficult to demonstrate in field soils. Here we tested phytotoxicity of Eupatorium adenophorum (croftonweed), one of the most destructive exotic species in China, to a native plant species Brassica rapa both in sand and in native soil. Our results suggested that natural soils from different invaded habitats alleviated or eliminated the efficacy of potential allelochemicals relative to sand cultures. When that soil is sterilized, the allelopathic effects returned; suggesting that soil biota were responsible for the reduced phytotoxicity in natural soils. Neither of the two allelopathic compounds (9-Oxo-10,11-dehydroageraphorone and 9b-Hydroxyageraphorone) of E. adenophorum could be found in natural soils infested by the invader, and when those compounds were added to the soils as leachates, they showed substantial degradation after 24 hours in natural soils but not in sand. Our findings emphasize that soil biota can reduce the allelopathic effects of invaders on other plants, and therefore can reduce community invasibility. These results also suggest that soil biota may have stronger or weaker effects on allelopathic interactions depending on how allelochemicals are delivered.	[Zhu, Xunzhi; Ma, Keping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhang, Jintun] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Beijing Normal University	Zhu, XZ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	kpma@ibcas.ac.cn		Zhang, Jin-tun/0000-0002-3163-6808	Chinese Academy of Sciences [KSCX1-SW-13-03]	Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was financially supported with the Knowledge Innovation Project of Chinese Academy of Sciences (KSCX1-SW-13-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2000, PERSPECT PLANT ECOL, V3, P52, DOI DOI 10.1078/1433-8319-00004; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Barto EK, 2009, CHEMOSPHERE, V76, P71, DOI 10.1016/j.chemosphere.2009.02.020; BARUAH NC, 1994, J CHEM ECOL, V20, P1885, DOI 10.1007/BF02066230; Bertin C, 2009, J CHEM ECOL, V35, P1288, DOI 10.1007/s10886-009-9707-4; Blair AC, 2005, ECOL LETT, V8, P1039, DOI 10.1111/j.1461-0248.2005.00805.x; Blair AC, 2006, J CHEM ECOL, V32, P2327, DOI 10.1007/s10886-006-9168-y; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Callaway RM, 2003, ECOLOGY, V84, P129, DOI 10.1890/0012-9658(2003)084[0129:SFATEO]2.0.CO;2; Cui QG, 2009, WEED RES, V49, P201, DOI 10.1111/j.1365-3180.2008.00679.x; D'Antonio CM, 2004, WEED TECHNOL, V18, P1572, DOI 10.1614/0890-037X(2004)018[1572:ERITAP]2.0.CO;2; Duke SO, 2009, J CHEM ECOL, V35, P141, DOI 10.1007/s10886-008-9587-z; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Gimsing AL, 2009, CHEMOSPHERE, V76, P1041, DOI 10.1016/j.chemosphere.2009.04.048; He WM, 2009, OECOLOGIA, V159, P803, DOI 10.1007/s00442-008-1234-4; Inderjit, 2003, PLANT SOIL, V256, P1, DOI 10.1023/A:1026242418333; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; Inderjit, 2000, J CHEM ECOL, V26, P2111, DOI 10.1023/A:1005516431969; Kaur H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004700; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Lu Ping, 2005, Acta Phytoecologica Sinica, V29, P1029; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Perry LG, 2007, J CHEM ECOL, V33, P2337, DOI 10.1007/s10886-007-9383-1; Pollock JL, 2009, J ECOL, V97, P1234, DOI 10.1111/j.1365-2745.2009.01553.x; Reinhart KO, 2004, ECOL APPL, V14, P1737, DOI 10.1890/03-5204; SONG QS, 2000, ACTA PHYTOECOL SIN, V24, P362; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; TRIPATHI R S, 1981, Proceedings of the Indian National Science Academy Part B Biological Sciences, V47, P458; Vivanco JM, 2004, ECOL LETT, V7, P285, DOI 10.1111/j.1461-0248.2004.00576.x; [王俊峰 WANG JunFeng], 2006, [生态学报, Acta Ecologica Sinica], V26, P1809; Yang GQ, 2006, ALLELOPATHY J, V18, P237; Yang GQ, 2008, ALLELOPATHY J, V21, P253; Yu XJ, 2006, WEED RES, V46, P319, DOI 10.1111/j.1365-3180.2006.00501.x; Yu XingJun, 2004, Acta Phytoecologica Sinica, V28, P773; Yu XJ, 2005, CHINESE SCI BULL, V50, P1105, DOI 10.1360/04WC0280; ZHANG XY, 2005, THESIS CHINESE ACAD; Zhang ZY, 2010, J APPL MICROBIOL, V108, P1839, DOI 10.1111/j.1365-2672.2009.04589.x; [郑丽 ZHENG Li], 2005, [生态学报, Acta Ecologica Sinica], V25, P2782	41	18	24	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25393	10.1371/journal.pone.0025393	http://dx.doi.org/10.1371/journal.pone.0025393			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980442	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900059
J	Shephard, F; Adenle, AA; Jacobson, LA; Szewczyk, NJ				Shephard, Freya; Adenle, Ademola A.; Jacobson, Lewis A.; Szewczyk, Nathaniel J.			Identification and Functional Clustering of Genes Regulating Muscle Protein Degradation from amongst the Known C. elegans Muscle Mutants	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MOLECULAR-MECHANISMS; HOMEOSTASIS; GENETICS; CELLS; RESISTANCE; EXERCISE; RNA	Loss of muscle mass via protein degradation is an important clinical problem but we know little of how muscle protein degradation is regulated genetically. To gain insight our labs developed C. elegans into a model for understanding the regulation of muscle protein degradation. Past studies uncovered novel functional roles for genes affecting muscle and/or involved in signalling in other cells or tissues. Here we examine most of the genes previously identified as the sites of mutations affecting muscle for novel roles in regulating degradation. We evaluate genomic (RNAi knockdown) approaches and combine them with our established genetic (mutant) and pharmacologic (drugs) approaches to examine these 159 genes. We find that RNAi usually recapitulates both organismal and sub-cellular mutant phenotypes but RNAi, unlike mutants, can frequently be used acutely to study gene function solely in differentiated muscle. In the majority of cases where RNAi does not produce organismal level phenotypes, sub-cellular defects can be detected; disrupted proteostasis is most commonly observed. We identify 48 genes in which mutation or RNAi knockdown causes excessive protein degradation; myofibrillar and/or mitochondrial morphologies are also disrupted in 19 of these 48 cases. These 48 genes appear to act via at least three sub-networks to control bulk degradation of protein in muscle cytosol. Attachment to the extracellular matrix regulates degradation via unidentified proteases and affects myofibrillar and mitochondrial morphology. Growth factor imbalance and calcium overload promote lysosome based degradation whereas calcium deficit promotes proteasome based degradation, in both cases myofibrillar and mitochondrial morphologies are largely unaffected. Our results provide a framework for effectively using RNAi to identify and functionally cluster novel regulators of degradation. This clustering allows prioritization of candidate genes/pathways for future mechanistic studies.	[Shephard, Freya; Adenle, Ademola A.; Szewczyk, Nathaniel J.] Univ Nottingham, Royal Derby Hosp, Sch Grad Entry Med & Hlth, Derby, England; [Jacobson, Lewis A.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Nottingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shephard, F (corresponding author), Univ Nottingham, Royal Derby Hosp, Sch Grad Entry Med & Hlth, Derby, England.	nate@alumni.cmu.edu		Szewczyk, Nathaniel/0000-0003-4425-9746	United States National Institutes of Health (NIH) National Institute for Arthritis and Musculoskeletal and Skin Diseases [AR-054342]; US National Science Foundation [MCB-0542355]; US NIH National Center for Research Resources; US NIH National Human Genome Research Institute; British Medical Research Council; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054342] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH) National Institute for Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US National Science Foundation(National Science Foundation (NSF)); US NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US NIH National Human Genome Research Institute; British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the United States National Institutes of Health (NIH) National Institute for Arthritis and Musculoskeletal and Skin Diseases (AR-054342). Strains used for comparative analysis that were not specifically made for this work were constructed by past members of the Jacobson lab and funded by the US National Science Foundation (MCB-0542355). Almost all of the mutant alleles utilized in this work were obtained from the Caenorhabditis Genetics Center, which is funded by the US NIH National Center for Research Resources. All Bioinformatic work was conducted utilizing WormBase [27], which is funded by the US NIH National Human Genome Research Institute and the British Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P1084, DOI 10.1016/j.biocel.2004.10.003; AVERY L, 1993, GENETICS, V133, P897; Avery L, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-69; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BRENNER S, 1974, GENETICS, V77, P71; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Chen NS, 2005, NUCLEIC ACIDS RES, V33, pD383, DOI 10.1093/nar/gki066; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fostel JL, 2003, BIOCHEM BIOPH RES CO, V312, P173, DOI 10.1016/j.bbrc.2003.09.248; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lecroisey C, 2007, J MUSCLE RES CELL M, V28, P79, DOI 10.1007/s10974-007-9104-y; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Ong DST, 2010, NAT CHEM BIOL, V6, P424, DOI 10.1038/nchembio.368; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Plenefisch JD, 2000, DEVELOPMENT, V127, P1197; REINER DJ, 1995, GENETICS, V141, P961; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schafer William R, 2005, WormBook, P1; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Szewczyk NJ, 2007, EMBO J, V26, P935, DOI 10.1038/sj.emboj.7601540; Szewczyk NJ, 2005, INT J BIOCHEM CELL B, V37, P1997, DOI 10.1016/j.biocel.2005.02.020; Szewczyk NJ, 2000, J CELL SCI, V113, P2003; Szewczyk NJ, 2003, EMBO J, V22, P5058, DOI 10.1093/emboj/cdg472; Szewczyk NJ, 2002, MOL CELL BIOL, V22, P4181, DOI 10.1128/MCB.22.12.4181-4188.2002; THOMAS JH, 1990, GENETICS, V124, P855; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Zdinak LA, 1997, J CELL BIOCHEM, V67, P143, DOI 10.1002/(SICI)1097-4644(19971001)67:1<143::AID-JCB15>3.3.CO;2-F	42	24	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24686	10.1371/journal.pone.0024686	http://dx.doi.org/10.1371/journal.pone.0024686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980350	Green Published, Green Accepted, gold			2022-12-25	WOS:000295933700006
J	Hresko, RC; Hruz, PW				Hresko, Richard C.; Hruz, Paul W.			HIV Protease Inhibitors Act as Competitive Inhibitors of the Cytoplasmic Glucose Binding Site of GLUTs with Differing Affinities for GLUT1 and GLUT4	PLOS ONE			English	Article							INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; SKELETAL-MUSCLE; IN-VITRO; TRANSPORTER; INFECTION; CELLS; LOPINAVIR/RITONAVIR; SENSITIVITY; TIPRANAVIR	The clinical use of several first generation HIV protease inhibitors (PIs) is associated with the development of insulin resistance. Indinavir has been shown to act as a potent reversible noncompetitive inhibitor of zero-trans glucose influx via direct interaction with the insulin responsive facilitative glucose transporter GLUT4. Newer drugs within this class have differing effects on insulin sensitivity in treated patients. GLUTs are known to contain two distinct glucose-binding sites that are located on opposite sides of the lipid bilayer. To determine whether interference with the cytoplasmic glucose binding site is responsible for differential effects of PIs on glucose transport, intact intracellular membrane vesicles containing GLUT1 and GLUT4, which have an inverted transporter orientation relative to the plasma membrane, were isolated from 3T3-L1 adipocytes. The binding of biotinylated ATB-BMPA, a membrane impermeable bis-mannose containing photolabel, was determined in the presence of indinavir, ritonavir, atazanavir, tipranavir, and cytochalasin b. Zero-trans 2-deoxyglucose transport was measured in both 3T3-L1 fibroblasts and primary rat adipocytes acutely exposed to these compounds. PI inhibition of glucose transport correlated strongly with the PI inhibition of ATB-BMPA/transporter binding. At therapeutically relevant concentrations, ritonavir was not selective for GLUT4 over GLUT1. Indinavir was found to act as a competitive inhibitor of the cytoplasmic glucose binding site of GLUT4 with a K-I of 8.2 mu M. These data establish biotinylated ATB-BMPA as an effective probe to quantify accessibility of the endofacial glucose-binding site in GLUTs and reveal that the ability of PIs to block this site differs among drugs within this class. This provides mechanistic insight into the basis for the clinical variation in drug-related metabolic toxicity.	[Hresko, Richard C.; Hruz, Paul W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Hruz, Paul W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Hresko, RC (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	hruz_p@kids.wustl.edu		Hruz, Paul/0000-0002-1478-3355	National Institutes of Health [DK064572, HL092798]; March of Dimes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the National Institutes of Health (DK064572 and HL092798) and from the March of Dimes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; CLARK AE, 1990, BIOCHEM J, V269, P615, DOI 10.1042/bj2690615; Copeland R. A., 2005, EVALUATION ENZYME IN; Grinspoon Steven K, 2005, Am J Med, V118 Suppl 2, p23S; Hertel J, 2004, J BIOL CHEM, V279, P55147, DOI 10.1074/jbc.M410826200; Hruz PW, 2006, JAIDS-J ACQ IMM DEF, V43, P624, DOI 10.1097/01.qai.0000245883.66509.b4; Hruz PW, 2011, BEST PRACT RES CL EN, V25, P459, DOI 10.1016/j.beem.2010.10.017; Hruz PW, 2008, CURR OPIN HIV AIDS, V3, P660, DOI 10.1097/COH.0b013e3283139134; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Kalla Vyas A, 2010, J BIOL CHEM; Koumanov F, 1998, BIOCHEM J, V330, P1209, DOI 10.1042/bj3301209; LANGE K, 1990, FEBS LETT, V261, P459, DOI 10.1016/0014-5793(90)80615-P; LOWE AG, 1989, BIOCHEM SOC T, V17, P435, DOI 10.1042/bst0170435; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; Murata H, 2002, AIDS, V16, P859, DOI 10.1097/00002030-200204120-00005; Nolte LA, 2001, DIABETES, V50, P1397, DOI 10.2337/diabetes.50.6.1397; Noor MA, 2004, AIDS, V18, P2137, DOI 10.1097/00002030-200411050-00005; Noor MA, 2006, AIDS, V20, P1813, DOI 10.1097/01.aids.0000244200.11006.55; Orman JS, 2008, DRUGS, V68, P1435, DOI 10.2165/00003495-200868100-00006; Owen Andrew, 2004, J HIV Ther, V9, P97; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Rudich A, 2003, DIABETOLOGIA, V46, P649, DOI 10.1007/s00125-003-1080-1; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Tan QY, 2005, JAIDS-J ACQ IMM DEF, V40, P398, DOI 10.1097/01.qai.0000176654.97392.c7; TORDJMAN KM, 1989, P NATL ACAD SCI USA, V86, P7761, DOI 10.1073/pnas.86.20.7761; Vyas AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017178; Wang S, 2002, ANTIVIR THER, V7, pL6; Weber T. M., 1988, INSULIN RECEPTORS B, P171	31	60	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25237	10.1371/journal.pone.0025237	http://dx.doi.org/10.1371/journal.pone.0025237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966466	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100032
J	Coleman, JJ; Ghosh, S; Okoli, I; Mylonakis, E				Coleman, Jeffrey J.; Ghosh, Suman; Okoli, Ikechukwu; Mylonakis, Eleftherios			Antifungal Activity of Microbial Secondary Metabolites	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; CYTOCHROME BC(1) COMPLEX; ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; CAENORHABDITIS-ELEGANS; GLIOTOXIN PRODUCTION; FUSARIUM-OXYSPORUM; ILICICOLIN-H; IN-VITRO; IDENTIFICATION	Secondary metabolites are well known for their ability to impede other microorganisms. Reanalysis of a screen of natural products using the Caenorhabditis elegans-Candida albicans infection model identified twelve microbial secondary metabolites capable of conferring an increase in survival to infected nematodes. In this screen, the two compound treatments conferring the highest survival rates were members of the epipolythiodioxopiperazine (ETP) family of fungal secondary metabolites, acetylgliotoxin and a derivative of hyalodendrin. The abundance of fungal secondary metabolites indentified in this screen prompted further studies investigating the interaction between opportunistic pathogenic fungi and Aspergillus fumigatus, because of the ability of the fungus to produce a plethora of secondary metabolites, including the well studied ETP gliotoxin. We found that cell-free supernatant of A. fumigatus was able to inhibit the growth of Candida albicans through the production of a secreted product. Comparative studies between a wild-type and an A. fumigatus Delta gliP strain unable to synthesize gliotoxin demonstrate that this secondary metabolite is the major factor responsible for the inhibition. Although toxic to organisms, gliotoxin conferred an increase in survival to C. albicans-infected C. elegans in a dose dependent manner. As A. fumigatus produces gliotoxin in vivo, we propose that in addition to being a virulence factor, gliotoxin may also provide an advantage to A. fumigatus when infecting a host that harbors other opportunistic fungi.	[Coleman, Jeffrey J.; Ghosh, Suman; Okoli, Ikechukwu; Mylonakis, Eleftherios] Massachusetts Gen Hosp, Harvard Med Sch, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Coleman, JJ (corresponding author), Massachusetts Gen Hosp, Harvard Med Sch, Div Infect Dis, Boston, MA 02114 USA.	emylonakis@partners.org	Ghosh, Suman/F-3453-2013; Coleman, Jeffrey J/E-2981-2015	Coleman, Jeffrey/0000-0001-8579-1996	National Institutes of Health [AI075286, AI070569, AI07061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075286, T32AI007061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health trough, an R01 award (AI075286), and an R21 award (AI070569) to EM, and a T32 (AI07061) to JJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo PH, 2003, J BIOL CHEM, V278, P46549, DOI 10.1074/jbc.M304825200; Berry EA, 2010, BBA-BIOENERGETICS, V1797, P360, DOI 10.1016/j.bbabio.2009.12.003; BOELAERT JR, 1993, J CLIN INVEST, V91, P1979, DOI 10.1172/JCI116419; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Coleman JJ, 2010, ACS CHEM BIOL, V5, P321, DOI 10.1021/cb900243b; Coleman JJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000486; DUKSIN D, 1982, J BIOL CHEM, V257, P3105; EICHNER RD, 1988, J BIOL CHEM, V263, P3772; ELBEIN AD, 1981, TRENDS BIOCHEM SCI, V6, P219, DOI 10.1016/0968-0004(81)90080-3; FREEMAN GG, 1948, NATURE, V162, P30, DOI 10.1038/162030a0; FREEMAN GG, 1949, J GEN MICROBIOL, V3, P60, DOI 10.1099/00221287-3-1-60; Frisvad JC, 2009, MED MYCOL, V47, pS53, DOI 10.1080/13693780802307720; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Gardiner DM, 2005, FUNGAL GENET BIOL, V42, P257, DOI 10.1016/j.fgb.2004.12.001; Gardiner DM, 2005, MICROBIOL-SGM, V151, P1021, DOI 10.1099/mic.0.27847-0; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; Groll AH, 1996, J INFECTION, V33, P23, DOI 10.1016/S0163-4453(96)92700-0; Gutierrez-Cirlos EB, 2004, J BIOL CHEM, V279, P8708, DOI 10.1074/jbc.M311805200; Ibrahim AS, 2008, CURR OPIN INFECT DIS, V21, P620, DOI 10.1097/QCO.0b013e3283165fd1; Jayasinghe L, 2006, J NAT PROD, V69, P439, DOI 10.1021/np050487v; Jestoi M, 2008, CRIT REV FOOD SCI, V48, P21, DOI 10.1080/10408390601062021; Johnson JR, 1943, J AM CHEM SOC, V65, P2005, DOI 10.1021/ja01250a051; KAMOGASHIRA T, 1988, AGR BIOL CHEM TOKYO, V52, P859; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kim B, 1999, CAN J BOT, V77, P850, DOI 10.1139/cjb-77-6-850; KONETSCHNYRAPP S, 1992, J AM CHEM SOC, V114, P2224, DOI 10.1021/ja00032a043; Kupfahl C, 2008, INT J MED MICROBIOL, V298, P319, DOI 10.1016/j.ijmm.2007.04.006; Kupfahl C, 2007, FEMS YEAST RES, V7, P986, DOI 10.1111/j.1567-1364.2007.00256.x; Kwon-Chung KJ, 2009, MED MYCOL, V47, pS97, DOI 10.1080/13693780802056012; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee KZ, 2010, VIRULENCE, V1, P113, DOI 10.4161/viru.1.3.10974; Lewis RE, 2005, J CLIN MICROBIOL, V43, P6120, DOI 10.1128/JCM.43.12.6120-6122.2005; Lewis RE, 2005, INFECT IMMUN, V73, P635, DOI 10.1128/IAI.73.1.635-637.2005; Lionakis MS, 2010, VIRULENCE, V1, P488, DOI 10.4161/viru.1.6.13311; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; MATSUMOTO M, 1976, TETRAHEDRON LETT, P3827; National Committee for Clinical Laboratory Standards, 1995, M27A NAT COMM CLIN L; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Nieminen SM, 2002, APPL ENVIRON MICROB, V68, P4871, DOI 10.1128/AEM.68.10.4871-4875.2002; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; Patron NJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-174; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Pukkila-Worley R, 2010, VIRULENCE, V1, P111, DOI 10.4161/viru.1.3.11746; REILLY HC, 1945, J BACTERIOL, V49, P585, DOI 10.1128/JB.49.6.585-594.1945; ROHR J, 1992, NAT PROD REP, V9, P103, DOI 10.1039/np9920900103; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000952; SHAH DT, 1991, MYCOPATHOLOGIA, V116, P203, DOI 10.1007/BF00436836; Spikes S, 2008, J INFECT DIS, V197, P479, DOI 10.1086/525044; STILLWELL MA, 1974, CAN J MICROBIOL, V20, P759, DOI 10.1139/m74-116; TAMURA G, 1968, J ANTIBIOT, V21, P539, DOI 10.7164/antibiotics.21.539; WINKELMANN G, 1992, MYCOL RES, V96, P529, DOI 10.1016/S0953-7562(09)80976-3; ZOCHER R, 1982, BIOCHEMISTRY-US, V21, P43, DOI 10.1021/bi00530a008	52	49	55	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25321	10.1371/journal.pone.0025321	http://dx.doi.org/10.1371/journal.pone.0025321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966496	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100087
J	Hong, PY; Croix, JA; Greenberg, E; Gaskins, HR; Mackie, RI				Hong, Pei-Ying; Croix, Jennifer A.; Greenberg, Eugene; Gaskins, H. Rex; Mackie, Roderick I.			Pyrosequencing-Based Analysis of the Mucosal Microbiota in Healthy Individuals Reveals Ubiquitous Bacterial Groups and Micro-Heterogeneity	PLOS ONE			English	Article							HUMAN GASTROINTESTINAL-TRACT; MOLECULAR CHARACTERIZATION; MUCIN DEGRADATION; DIVERSITY; BACTEROIDES; ADHERENT; DIET	This study used 16S rRNA-based pyrosequencing to examine the microbial community that is closely associated with the colonic mucosa of five healthy individuals. Spatial heterogeneity in microbiota was measured at right colon, left colon and rectum, and between biopsy duplicates spaced 1 cm apart. The data demonstrate that mucosal-associated microbiota is comprised of Firmicutes (50.9%+/- 21.3%), Bacteroidetes (40.2%+/- 23.8%) and Proteobacteria (8.6% +/- 64.7%), and that interindividual differences were apparent. Among the genera, Bacteroides, Leuconostoc and Weissella were present at high abundance (4.6% to 41.2%) in more than 90% of the studied biopsy samples. Lactococcus, Streptococcus, Acidovorax, Acinetobacter, Blautia, Faecalibacterium, Veillonella, and several unclassified bacterial groups were also ubiquitously present at an abundance <7.0% of total microbial community. With the exception of one individual, the mucosal-associated microbiota was relatively homogeneous along the colon (average 61% Bray-Curtis similarity). However, micro-heterogeneity was observed in biopsy duplicates within defined colonic sites for three of the individuals. A weak but significant Mantel correlation of 0.13 was observed between the abundance of acidomucins and mucosal-associated microbiota (P-value = 0.04), indicating that the localized biochemical differences may contribute in part to the micro-heterogeneity. This study provided a detailed insight to the baseline mucosal microbiota along the colon, and revealed the existence of microheterogeneity within defined colonic sites for certain individuals.	[Hong, Pei-Ying; Croix, Jennifer A.; Gaskins, H. Rex; Mackie, Roderick I.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Gaskins, H. Rex] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Croix, Jennifer A.; Gaskins, H. Rex; Mackie, Roderick I.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Gaskins, H. Rex; Mackie, Roderick I.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Greenberg, Eugene] Carle Fdn Hosp, Inst Digest Hlth, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Hong, PY (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	r-mackie@illinois.edu	Hong, Peiying/A-4813-2009	Hong, Peiying/0000-0002-4474-6600; Gaskins, H. Rex/0000-0002-1249-535X	United States Department of Agriculture - National Research Initiative [1-489318-231000-191100]; University of Illinois at Urbana-Champaign-Carle Foundation Hospital [C7074]	United States Department of Agriculture - National Research Initiative(United States Department of Agriculture (USDA)); University of Illinois at Urbana-Champaign-Carle Foundation Hospital	This study was supported in part by funds from United States Department of Agriculture - National Research Initiative (1-489318-231000-191100) to RM, and from a joint University of Illinois at Urbana-Champaign-Carle Foundation Hospital Grant (Translational Research Program #C7074) to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN A, 1982, ADV EXP MED BIOL, V144, P115; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BJORKROTH J, 2006, GENERA LEUCONOSTOC O; Chen J, 2008, P NATL ACAD SCI USA, V105, P15235, DOI 10.1073/pnas.0806990105; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; CROIX JA, 2011, PLOS ONE IN PRESS; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Deplancke B, 2000, APPL ENVIRON MICROB, V66, P2166, DOI 10.1128/AEM.66.5.2166-2174.2000; Durban A, 2011, MICROB ECOL, V61, P123, DOI 10.1007/s00248-010-9738-y; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Green GL, 2006, J APPL MICROBIOL, V100, P460, DOI 10.1111/j.1365-2672.2005.02783.x; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; HOSKINS LC, 1985, J CLIN INVEST, V75, P944, DOI 10.1172/JCI111795; HOSKINS LC, 1993, EUR J GASTROEN HEPAT, V5, P205, DOI 10.1097/00042737-199304000-00004; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Lepage P, 2005, INFLAMM BOWEL DIS, V11, P473, DOI 10.1097/01.MIB.0000159662.62651.06; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Montagne L, 2004, NUTR REV, V62, P105, DOI [10.1301/nr.2004.mar.105-114, 10.1111/j.1753-4887.2004.tb00031.x]; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P789, DOI 10.1111/j.1462-2920.2007.01503.x; SHAH HN, 1993, CLIN INFECT DIS, V16, pS160, DOI 10.1093/clinids/16.Supplement_4.S160; SHEAHAN DG, 1976, AM J ANAT, V146, P103, DOI 10.1002/aja.1001460202; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; TURCK D, 1993, PEDIATR RES, V33, P564, DOI 10.1203/00006450-199306000-00005; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Willis CL, 1996, ANAEROBE, V2, P117, DOI 10.1006/anae.1996.0015; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zhang ML, 2007, J CLIN MICROBIOL, V45, P496, DOI 10.1128/JCM.01720-06	38	79	82	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25042	10.1371/journal.pone.0025042	http://dx.doi.org/10.1371/journal.pone.0025042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966408	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100044
J	Kumita, JR; Helmfors, L; Williams, J; Luheshi, LM; Menzer, L; Dumoulin, M; Lomas, DA; Crowther, DC; Dobson, CM; Brorsson, AC				Kumita, Janet R.; Helmfors, Linda; Williams, Jocy; Luheshi, Leila M.; Menzer, Linda; Dumoulin, Mireille; Lomas, David A.; Crowther, Damian C.; Dobson, Christopher M.; Brorsson, Ann-Christin			Disease-related amyloidogenic variants of human lysozyme trigger the unfolded protein response and disturb eye development in Drosophila melanogaster	FASEB JOURNAL			English	Article						quality control system; ER stress; xbp1-EGFP	HEREDITARY RENAL AMYLOIDOSIS; ENDOPLASMIC-RETICULUM STRESS; CAMELID ANTIBODY FRAGMENT; ALZHEIMERS-DISEASE; GENE-EXPRESSION; FOLDING PROCESS; MODEL; DEGENERATION; STABILITY; FIBRILS	We have created a Drosophila model of lysozyme amyloidosis to investigate the in vivo behavior of disease-associated variants. To achieve this objective, wild-type (WT) protein and the amyloidogenic variants F57I and D67H were expressed in Drosophila melanogaster using the UAS-gal4 system and both the ubiquitous and retinal expression drivers Act5C-gal4 and gmr-gal4. The nontransgenic w(1118) Drosophila line was used as a control throughout. We utilized ELISA experiments to probe lysozyme protein levels, scanning electron microscopy for eye phenotype classification, and immunohistochemistry to detect the unfolded protein response (UPR) activation. We observed that expressing the destabilized F57I and D67H lysozymes triggers UPR activation, resulting in degradation of these variants, whereas the WT lysozyme is secreted into the fly hemolymph. Indeed, the level of WT was up to 17 times more abundant than the variant proteins. In addition, the F57I variant gave rise to a significant disruption of the eye development, and this correlated to pronounced UPR activation. These results support the concept that the onset of familial amyloid disease is linked to an inability of the UPR to degrade completely the amyloidogenic lysozymes prior to secretion, resulting in secretion of these destabilized variants, thereby leading to deposition and associated organ damage.-Kumita, J. R., Helmfors, L., Williams, J., Luheshi, L. M., Menzer, L., Dumoulin, M., Lomas, D. A., Crowther, D. C., Dobson, C. M., Brorsson, A.-C. Disease-related amyloidogenic variants of human lysozyme trigger the unfolded protein response and disturb eye development in Drosophila melanogaster. FASEB J. 26, 192-202 (2012). www.fasebj.org	[Helmfors, Linda; Brorsson, Ann-Christin] Linkoping Univ, Dept Phys Chem & Biol, Div Mol Biotechnol, SE-58183 Linkoping, Sweden; [Kumita, Janet R.; Luheshi, Leila M.; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Williams, Jocy] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Crowther, Damian C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Menzer, Linda; Dumoulin, Mireille] Univ Liege, Lab Enzymol & Prot Folding, Ctr Prot Engn, Inst Chem B6c, Liege, Belgium; [Lomas, David A.; Crowther, Damian C.] Cambridge Inst Med Res, Cambridge, England	Linkoping University; University of Cambridge; University of Cambridge; University of Cambridge; University of Liege; University of Cambridge	Brorsson, AC (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Div Mol Biotechnol, SE-58183 Linkoping, Sweden.	anki@ifm.liu.se	Kumita, Janet/AAO-5254-2021		Swedish Research Council; Biotechnology and Biological Sciences Research Council [BB/E019927/1, BBH0038431]; Wellcome Trust; Leverhulme Trust; European Commission [LSHM-CT-2006-037525/EURAMY]; Medical Research Council [G0700990]; VINNOVA; BBSRC [BB/H003843/1] Funding Source: UKRI; MRC [G0700990, G0901786, MC_G1000734] Funding Source: UKRI; Alzheimers Research UK [ART-SRF2010-2] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/H003843/1] Funding Source: researchfish; Medical Research Council [G0901786, MC_G1000734] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Leverhulme Trust(Leverhulme Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); VINNOVA(Vinnova); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Prof. Bengt-Harald Jonsson for valuable discussions and Mildred Otieno for technical assistance. This work was supported in part by the Swedish Research Council (A.-C.B.) and in part by a grant from the Biotechnology and Biological Sciences Research Council (BB/E019927/1 to C. M. D. and J.R.K.; and BBH0038431 to C. M. D., D. C. C., and D. A. L.), the Wellcome and Leverhulme Trusts (to C. M. D.), and the European Commission (project LSHM-CT-2006-037525/EURAMY to C. M. D. and M. D.). D. C. C. and L. M. L. were supported by the Medical Research Council (G0700990). L. H. is enrolled in the multidisciplinary graduate school Forum Scientium at Linkoping University and in the VINNOVA-supported program AgoraLink. M. D. is a Research Associate of the Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (Belgium), and D. C. C. is an Alzheimer's Research UK Senior Research Fellow.	Berg I, 2009, NEURODEGENER DIS, V6, P127, DOI 10.1159/000213761; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768; Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t; Chamberlain AK, 2001, PROTEIN SCI, V10, P2525, DOI 10.1110/ps.ps.28101; Chan PH, 2008, BIOCHEMISTRY-US, V47, P11041, DOI 10.1021/bi8005797; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Dumoulin M, 2006, ACCOUNTS CHEM RES, V39, P603, DOI 10.1021/ar050070g; Esposito G, 2003, J BIOL CHEM, V278, P25910, DOI 10.1074/jbc.M211000200; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Frare E, 2009, J MOL BIOL, V387, P17, DOI 10.1016/j.jmb.2009.01.049; Funahashi J, 1996, J BIOCHEM, V120, P1216; FYRBERG EA, 1983, CELL, V33, P115, DOI 10.1016/0092-8674(83)90340-9; Gillmore JD, 1999, NEPHROL DIAL TRANSPL, V14, P2639, DOI 10.1093/ndt/14.11.2639; Green C, 2000, GENETICS, V156, P1117; HAEZEBROUCK P, 1995, J MOL BIOL, V246, P382, DOI 10.1006/jmbi.1994.0093; Hagan CL, 2010, PROTEIN ENG DES SEL, V23, P499, DOI 10.1093/protein/gzq023; Hirota-Nakaoka N, 2003, J BIOCHEM, V134, P159, DOI 10.1093/jb/mvg124; HOOKE SD, 1994, BIOCHEMISTRY-US, V33, P5867, DOI 10.1021/bi00185a026; HOOKE SD, 1995, J AM CHEM SOC, V117, P7548, DOI 10.1021/ja00133a030; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Johnson RJK, 2005, J MOL BIOL, V352, P823, DOI 10.1016/j.jmb.2005.07.040; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; Kumita JR, 2006, FEBS J, V273, P711, DOI 10.1111/j.1742-4658.2005.05099.x; Lee YC, 2002, ANAL BIOCHEM, V310, P223, DOI 10.1016/S0003-2697(02)00320-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; Oberstein A, 2005, NAT METHODS, V2, P583, DOI 10.1038/NMETH775; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Pokrzywa M, 2007, EUR J NEUROSCI, V26, P913, DOI 10.1111/j.1460-9568.2007.05728.x; PORSTMANN B, 1989, CLIN BIOCHEM, V22, P349, DOI 10.1016/S0009-9120(89)80031-1; Rocken Christoph, 2006, Hum Mutat, V27, P119, DOI 10.1002/humu.9393; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Takano K, 2001, EUR J BIOCHEM, V268, P155, DOI 10.1046/j.1432-1327.2001.01863.x; Valleix S, 2002, KIDNEY INT, V61, P907, DOI 10.1046/j.1523-1755.2002.00205.x; Wain R, 2005, J MOL BIOL, V351, P662, DOI 10.1016/j.jmb.2005.06.035; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Whyteside G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022692; Yazaki M, 2003, KIDNEY INT, V63, P1652, DOI 10.1046/j.1523-1755.2003.00904.x; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	53	14	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					192	202		10.1096/fj.11-185983	http://dx.doi.org/10.1096/fj.11-185983			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21965601	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000299202200020
J	Komissarov, AA; Florova, G; Idell, S				Komissarov, Andrey A.; Florova, Galina; Idell, Steven			Effects of Extracellular DNA on Plasminogen Activation and Fibrinolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; CELL-FREE DNA; DEEP-VEIN THROMBOSIS; FREE PLASMA DNA; RESPIRATORY-DISTRESS-SYNDROME; ACUTE MYOCARDIAL-INFARCTION; FLOW FLUORESCENCE KINETICS; DETERMINING REGION 3; ALPHA-HELIX-F; PLEURAL EFFUSIONS	The increased levels of extracellular DNA found in a number of disorders involving dysregulation of the fibrinolytic system may affect interactions between fibrinolytic enzymes and inhibitors. Double-stranded (ds) DNA and oligonucleotides bind tissue-(tPA) and urokinase (uPA)-type plasminogen activators, plasmin, and plasminogen with submicromolar affinity. The binding of enzymes to DNA was detected by EMSA, steady-state, and stopped-flow fluorimetry. The interaction of dsDNA/oligonucleotides with tPA and uPA includes a fast bimolecular step, followed by two monomolecular steps, likely indicating slow conformational changes in the enzyme. DNA (0.1-5.0 mu g/ml), but not RNA, potentiates the activation of Glu- and Lys-plasminogen by tPA and uPA by 480-and 70-fold and 10.7- and 17-fold, respectively, via a template mechanism similar to that known for fibrin. However, unlike fibrin, dsDNA/oligonucleotides moderately affect the reaction between plasmin and alpha(2)-antiplasmin and accelerate the inactivation of tPA and two chain uPA by plasminogen activator inhibitor-1 (PAI-1), which is potentiated by vitronectin. dsDNA (0.1-1.0 mu g/ml) does not affect the rate of fibrinolysis by plasmin but increases by 4 -5-fold the rate of fibrinolysis by Glu-plasminogen/plasminogen activator. The presence of alpha(2)-antiplasmin abolishes the potentiation of fibrinolysis by dsDNA. At higher concentrations (1.0-20 mu g/ml), dsDNA competes for plasmin with fibrin and decreases the rate of fibrinolysis. dsDNA/oligonucleotides incorporated into a fibrin film also inhibit fibrinolysis. Thus, extracellular DNA at physiological concentrations may potentiate fibrinolysis by stimulating fibrin-independent plasminogen activation. Conversely, DNA could inhibit fibrinolysis by increasing the susceptibility of fibrinolytic enzymes to serpins.	[Komissarov, Andrey A.; Florova, Galina; Idell, Steven] Univ Texas Hlth Sci Ctr Tyler, Texas Lung Injury Inst, Tyler, TX 75708 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Komissarov, AA (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Texas Lung Injury Inst, 11937 US Highway 271, Tyler, TX 75708 USA.	andrey.komissarov@uthct.edu		Komissarov, Andrey/0000-0003-4346-8888	NHLBI [PO-1 076406, P50 HL107186-02]; Texas Lung Injury Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL107186] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Texas Lung Injury Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO-1 076406 and P50 HL107186-02 from NHLBI. This work was also supported by the Texas Lung Injury Institute.	Albers GW, 2008, CHEST, V133, p630S, DOI 10.1378/chest.08-0720; Aleman C, 2003, CLIN SCI, V105, P601, DOI 10.1042/CS20030115; Allport LE, 2008, J CLIN NEUROSCI, V15, P917, DOI 10.1016/j.jocn.2007.03.026; ANDRADEGORDON P, 1986, BIOCHEMISTRY-US, V25, P4033, DOI 10.1021/bi00362a007; ANONICK PK, 1991, BIOCHEM J, V275, P53, DOI 10.1042/bj2750053; Benlloch S, 2006, CLIN LUNG CANCER, V8, P140, DOI 10.3816/CLC.2006.n.043; Bouros D, 2007, PULM PHARMACOL THER, V20, P616, DOI 10.1016/j.pupt.2006.08.001; Chan MHM, 2003, CLIN CHEM, V49, P740, DOI 10.1373/49.5.740; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; CHRISTENSEN S, 1995, BIOCHEM J, V305, P97, DOI 10.1042/bj3050097; Christensen U, 1996, FEBS LETT, V387, P58, DOI 10.1016/0014-5793(96)00429-2; CHRISTENSEN U, 1978, BIOCHEM J, V175, P635, DOI 10.1042/bj1750635; CHRISTENSEN U, 1977, BIOCHEM J, V163, P389, DOI 10.1042/bj1630389; DAWSON S, 1992, ATHEROSCLEROSIS, V95, P105, DOI 10.1016/0021-9150(92)90014-8; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; Duboscq C, 1997, THROMB HAEMOSTASIS, V77, P1090; FEARS R, 1985, BIOCHEM J, V229, P555, DOI 10.1042/bj2290555; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; GALLIMORE MJ, 1980, THROMB RES, V18, P601, DOI 10.1016/0049-3848(80)90214-5; GANDO S, 1995, CRIT CARE MED, V23, P1835, DOI 10.1097/00003246-199511000-00009; Gebbink MFBG, 2009, FEBS LETT, V583, P2691, DOI 10.1016/j.febslet.2009.06.013; GRIMAUDO V, 1992, THROMB HAEMOSTASIS, V67, P397; Hack CE, 2001, SEMIN THROMB HEMOST, V27, P633, DOI 10.1055/s-2001-18867; Haj MA, 1998, INTENS CARE MED, V24, P258, DOI 10.1007/s001340050561; HARDAWAY RM, 1990, CRIT CARE MED, V18, P1413, DOI 10.1097/00003246-199012000-00021; HARDAWAY RM, 1994, ADV THER, V11, P43; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Held C, 1997, CIRCULATION, V95, P2380, DOI 10.1161/01.CIR.95.10.2380; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2183; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; Iba T, 2005, SHOCK, V23, P25, DOI 10.1097/01.shk.0000144422.32647.b6; IDELL S, 1991, AM REV RESPIR DIS, V144, P187, DOI 10.1164/ajrccm/144.1.187; Idell S, 2005, CLIN PULM MED, V12, P184; Iglesias D, 2005, EUR RESPIR J, V25, P104, DOI 10.1183/09031936.04.00010504; Ioannidou-Papayannaki E, 2000, ACTA CARDIOL, V55, P247, DOI 10.2143/AC.55.4.2005747; Johansson L, 2000, STROKE, V31, P26, DOI 10.1161/01.STR.31.1.26; Johnsen LB, 1998, BIOCHEMISTRY-US, V37, P12631, DOI 10.1021/bi9806697; Kim HS, 2006, CARDIOVASC INTER RAD, V29, P1003, DOI 10.1007/s00270-005-0341-4; Kolev K., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P341, DOI 10.2174/156801605774322337; Kolev K, 2003, BLOOD, V101, P4380, DOI 10.1182/blood-2002-10-3227; Komissarov AA, 2005, J BIOL CHEM, V280, P1482, DOI 10.1074/jbc.M408608200; Komissarov AA, 2002, J BIOL CHEM, V277, P43858, DOI 10.1074/jbc.M204110200; Komissarov AA, 1999, BIOCHEMISTRY-US, V38, P14631, DOI 10.1021/bi991347l; Komissarov AA, 1997, J BIOL CHEM, V272, P26864, DOI 10.1074/jbc.272.43.26864; Komissarov AA, 1996, J BIOL CHEM, V271, P12241, DOI 10.1074/jbc.271.21.12241; Komissarov AA, 2007, J BIOL CHEM, V282, P26306, DOI 10.1074/jbc.M702089200; Komissarov AA, 2009, AM J PHYSIOL-LUNG C, V297, pL568, DOI 10.1152/ajplung.00066.2009; KVASSMAN JO, 1995, FIBRINOLYSIS, V9, P215, DOI 10.1016/S0268-9499(08)80062-8; Kvassman JO, 1998, BIOCHEMISTRY-US, V37, P15491, DOI 10.1021/bi9814787; Lam NYL, 2006, RESUSCITATION, V68, P71, DOI 10.1016/j.resuscitation.2005.05.021; Liang JF, 2000, THROMB RES, V97, P349, DOI 10.1016/S0049-3848(99)00188-7; Lo YMD, 2000, CLIN CHEM, V46, P319; Lo YMD, 2001, ANN NY ACAD SCI, V945, P1; Longstaff C, 2011, BLOOD, V117, P661, DOI 10.1182/blood-2010-06-290338; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Mavrommatis AC, 2001, INTENS CARE MED, V27, P1853, DOI 10.1007/s00134-001-1139-8; Merkle DL, 1996, BLOOD COAGUL FIBRIN, V7, P650, DOI 10.1097/00001721-199609000-00011; NIEUWENHUIZEN W, 1988, EUR J BIOCHEM, V174, P163, DOI 10.1111/j.1432-1033.1988.tb14077.x; Nordenhem A, 2005, THROMB RES, V116, P223, DOI 10.1016/j.thromres.2004.12.007; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; PAQUES EP, 1986, THROMB RES, V42, P797, DOI 10.1016/0049-3848(86)90116-7; Parikh S, 2008, J VASC INTERV RADIOL, V19, P521, DOI 10.1016/j.jvir.2007.11.023; PARISE P, 1993, BLOOD COAGUL FIBRIN, V4, P721, DOI 10.1097/00001721-199304050-00008; PEDERSEN OD, 1994, CORONARY ARTERY DIS, V5, P617, DOI 10.1097/00019501-199407000-00010; PHILIPJOET F, 1995, EUR RESPIR J, V8, P1352, DOI 10.1183/09031936.95.08081352; PREISSNER KT, 1990, J BIOL CHEM, V265, P18490; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; Raaphorst J, 2001, THROMB HAEMOSTASIS, V86, P543, DOI 10.1055/s-0037-1616084; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Samson AL, 2009, BLOOD, V114, P1937, DOI 10.1182/blood-2009-02-203448; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Saukkonen K, 2007, INTENS CARE MED, V33, P1624, DOI 10.1007/s00134-007-0686-z; Sen P, 2011, J THROMB HAEMOST, V9, P531, DOI 10.1111/j.1538-7836.2010.04167.x; SHORE JD, 1995, J BIOL CHEM, V270, P5395, DOI 10.1074/jbc.270.10.5395; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; Thelwell C, 2007, J THROMB HAEMOST, V5, P804, DOI 10.1111/j.1538-7836.2007.02422.x; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Tomasini B R, 1991, Prog Hemost Thromb, V10, P269; TORBET J, 1986, BIOCHEMISTRY-US, V25, P5309, DOI 10.1021/bi00366a048; Uzuelli JA, 2009, CLIN CHIM ACTA, V409, P112, DOI 10.1016/j.cca.2009.09.011; VARGO JS, 1990, CHEST, V97, P63, DOI 10.1378/chest.97.1.63; Watanabe R, 2001, CLIN APPL THROMB-HEM, V7, P229, DOI 10.1177/107602960100700309; WEITZ JI, 1991, THROMB HAEMOSTASIS, V65, P541; Wijeratne S, 2004, ANN NY ACAD SCI, V1022, P232, DOI 10.1196/annals.1318.036; Wiman B, 1999, SCAND J CLIN LAB INV, V59, P23; WIMAN B, 1978, EUR J BIOCHEM, V84, P573, DOI 10.1111/j.1432-1033.1978.tb12200.x; WU JH, 1995, THROMB HAEMOSTASIS, V74, P711; Wu TL, 2002, CLIN CHIM ACTA, V321, P77, DOI 10.1016/S0009-8981(02)00091-8; ZAMARRON C, 1984, J BIOL CHEM, V259, P2080; Zeerleder S, 2005, CHEST, V128, P2864, DOI 10.1378/chest.128.4.2864; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943; Zhu ZW, 2006, CHEST, V129, P1577, DOI 10.1378/chest.129.6.1577	95	43	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41949	41962		10.1074/jbc.M111.301218	http://dx.doi.org/10.1074/jbc.M111.301218			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21976662	hybrid, Green Published			2022-12-25	WOS:000298180900006
J	Vaz, SH; Jorgensen, TN; Cristovao-Ferreira, S; Duflot, S; Ribeiro, JA; Gether, U; Sebastiao, AM				Vaz, Sandra H.; Jorgensen, Trine N.; Cristovao-Ferreira, Sofia; Duflot, Sylvie; Ribeiro, Joaquim A.; Gether, Ulrik; Sebastiao, Ana M.			Brain-derived Neurotrophic Factor (BDNF) Enhances GABA Transport by Modulating the Trafficking of GABA Transporter-1 (GAT-1) from the Plasma Membrane of Rat Cortical Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC-ACID; ADENOSINE A(2A) RECEPTORS; PROTEIN-KINASE-C; SYNAPTIC-TRANSMISSION; LENTIVIRAL VECTOR; SIGNAL-TRANSDUCTION; NEUROTRANSMITTER TRANSPORTERS; TYROSINE PHOSPHORYLATION; SELECTIVE INHIBITOR; SURFACE EXPRESSION	The gamma-aminobutyric acid (GABA) transporters (GATs) are located in the plasma membrane of neurons and astrocytes and are responsible for termination of GABAergic transmission. It has previously been shown that brain derived neurotrophic factor (BDNF) modulates GAT-1-mediated GABA transport in nerve terminals and neuronal cultures. We now report that BDNF enhances GAT-1-mediated GABA transport in cultured astrocytes, an effect mostly due to an increase in the V-max kinetic constant. This action involves the truncated form of the TrkB receptor (TrkB-t) coupled to a non-classic PLC-gamma/PKC-delta and ERK/MAPIK pathway and requires active adenosine A(2A) receptors. Transport through GAT-3 is not affected by BDNF. To elucidate if BDNF affects trafficking of GAT-1 in astrocytes, we generated and infected astrocytes with a functional mutant of the rat GAT-1 (rGAT-1) in which the hemagglutinin (HA) epitope was incorporated into the second extracellular loop. An increase in plasma membrane of HA-rGAT-1 as well as of rGAT-1 was observed when both HA-GAT-1-transduced astrocytes and rGAT-1-overexpressing astrocytes were treated with BDNF. The effect of BDNF results from inhibition of dynamin/dathrin-dependent constitutive internalization of GAT-1 rather than from facilitation of the monensin-sensitive recycling of GAT-1 molecules back to the plasma membrane. We therefore conclude that BDNF enhances the time span of GAT-1 molecules at the plasma membrane of astrocytes. BDNF may thus play an active role in the clearance of GABA from synaptic and extrasynaptic sites and in this way influence neuronal excitability.	[Vaz, Sandra H.; Cristovao-Ferreira, Sofia; Duflot, Sylvie; Ribeiro, Joaquim A.; Sebastiao, Ana M.] Univ Lisbon, Inst Farmacol & Neurociencias, Fac Med, P-1649028 Lisbon, Portugal; [Vaz, Sandra H.; Cristovao-Ferreira, Sofia; Duflot, Sylvie; Ribeiro, Joaquim A.; Sebastiao, Ana M.] Univ Lisbon, Unit Neurosci, Inst Mol Med, P-1649028 Lisbon, Portugal; [Jorgensen, Trine N.; Gether, Ulrik] Univ Copenhagen, Dept Pharmacol & Neurosci, Mol Neuropharmacol Grp, Panum Inst, DK-2200 Copenhagen, Denmark	Universidade de Lisboa; Universidade de Lisboa; University of Copenhagen	Sebastiao, AM (corresponding author), Univ Lisbon, Inst Farmacol & Neurociencias, Fac Med, Av Prof Egas Moniz,Edificio Egas Moniz,Piso 1B, P-1649028 Lisbon, Portugal.	anaseb@fm.ul.pt	Vaz, Sandra H./L-7393-2015	Vaz, Sandra H./0000-0003-4258-9397; Gether, Ulrik/0000-0002-0020-3807; Ribeiro, Joaquim/0000-0002-9330-3507; Sebastiao, Ana M/0000-0001-9030-6115; Cristovao Ferreira, Ana Sofia/0000-0003-0606-8017	Fundacao para a Ciencia ea Tecnologia [SFRH/BD/227989/2006, SFRH/BD/38099/2007]	Fundacao para a Ciencia ea Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by Fundacao para a Ciencia ea Tecnologia Grants SFRH/BD/227989/2006 (to S. H. V.) and SFRH/BD/38099/2007 (to S. C. F.).	Assaife-Lopes N, 2010, J NEUROSCI, V30, P8468, DOI 10.1523/JNEUROSCI.5695-09.2010; AWAD JA, 1983, J BIOL CHEM, V258, P2960; Baxter GT, 1997, J NEUROSCI, V17, P2683; Beckman ML, 1999, J NEUROSCI, V19; Bergami M, 2008, J CELL BIOL, V183, P213, DOI 10.1083/jcb.200806137; Biber K, 1997, J NEUROSCI, V17, P4956; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; BORDEN LA, 1994, EUR J PHARM-MOLEC PH, V269, P219, DOI 10.1016/0922-4106(94)90089-2; BORDEN LA, 1994, RECEPTOR CHANNEL, V2, P207; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Cristovao-Ferreira S, 2009, J NEUROCHEM, V109, P336, DOI 10.1111/j.1471-4159.2009.05963.x; Deken SL, 2003, J NEUROSCI, V23, P1563; DING JB, 1995, J BIOL CHEM, V270, P11684, DOI 10.1074/jbc.270.19.11684; Diogenes MJ, 2007, HIPPOCAMPUS, V17, P577, DOI 10.1002/hipo.20294; Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004; Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Fontinha BM, 2008, NEUROPHARMACOLOGY, V54, P924, DOI 10.1016/j.neuropharm.2008.01.011; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Haapasalo A, 2002, J BIOL CHEM, V277, P43160, DOI 10.1074/jbc.M205202200; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; JARVIS MF, 1989, J PHARMACOL EXP THER, V251, P888; Jiang M, 2009, J NEUROSCI, V29, P8063, DOI 10.1523/JNEUROSCI.6139-08.2009; Johansen JL, 2005, MOL BIOTECHNOL, V29, P47, DOI 10.1385/MB:29:1:47; Kirmse K, 2009, SYNAPSE, V63, P921, DOI 10.1002/syn.20675; Law RM, 2000, J BIOL CHEM, V275, P23986, DOI 10.1074/jbc.M910283199; Lee TS, 2006, ACTA NEUROPATHOL, V111, P351, DOI 10.1007/s00401-005-0017-9; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ohira K, 2007, EUR J NEUROSCI, V25, P406, DOI 10.1111/j.1460-9568.2007.05282.x; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Pousinha PA, 2006, NEUROSCI LETT, V404, P143, DOI 10.1016/j.neulet.2006.05.036; Pyne NJ, 2011, TRENDS PHARMACOL SCI, V32, P443, DOI 10.1016/j.tips.2011.04.002; Quick MW, 2004, J BIOL CHEM, V279, P15961, DOI 10.1074/jbc.M306924200; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Schousboe A, 2004, EUR J PHARMACOL, V500, P281, DOI 10.1016/j.ejphar.2004.07.032; Schousboe A, 2004, NEUROCHEM INT, V45, P521, DOI 10.1016/j.neuint.2003.11.001; Sebastiao A. M., 2010, BIOCHIM BIOPHYS ACTA, V1808, P1340; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Tanaka T, 1997, J NEUROSCI, V17, P2959; TAPLEY P, 1992, ONCOGENE, V7, P371; Tebano MT, 2008, J NEUROCHEM, V104, P279, DOI 10.1111/j.1471-4159.2007.05046.x; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Vaz SH, 2008, BRAIN RES, V1219, P19, DOI 10.1016/j.brainres.2008.04.008; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Wardle RA, 2003, J NEUROSCI, V23, P8722; Whitworth TL, 2001, J BIOL CHEM, V276, P42932, DOI 10.1074/jbc.M107638200; WOOD JD, 1986, J NEUROCHEM, V46, P739, DOI 10.1111/j.1471-4159.1986.tb13034.x; Zocchi C, 1996, J PHARMACOL EXP THER, V276, P398; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	64	47	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40464	40476		10.1074/jbc.M111.232009	http://dx.doi.org/10.1074/jbc.M111.232009			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969376	hybrid, Green Published			2022-12-25	WOS:000297315400006
J	Chen, CH; Sarbassov, DD				Chen, Chien-Hung; Sarbassov, Dos D.			The mTOR (Mammalian Target of Rapamycin) Kinase Maintains Integrity of mTOR Complex 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; MOTIF PHOSPHORYLATION; S6 KINASE-1; CELL-GROWTH; RICTOR; AKT; ACTIVATION; RAPTOR; SITE	In higher eukaryotes, growth factors promote anabolic processes and stimulate cell growth, proliferation, and survival by activation of the phosphoinositide 3-kinase (PI3K)/Akt pathway. Deregulation of PI3K/Akt signaling is linked to human diseases, including cancer and metabolic disorders. The PI3K-dependent signaling kinase complex mTORC2(mammalian target of rapamycin complex 2) has been defined as the regulatory Ser-473 kinase of Akt. The regulation of mTORC2 remains very poorly characterized. We have reconstituted mTORC2 by its assembly in vitro or by co-expression its four essential components (rictor, SIN1, mTOR, mLST8). We show that the functional mTOR kinase domain is required for the mTORC2 activity as the Ser-473 kinase of Akt. We also found that mTOR by phosphorylation of SIN1 prevents its lysosomal degradation. Thus, the kinase domain of mTOR is required for the functional activity of mTORC2, and it controls integrity of mTORC2 by maintaining the protein stability of SIN1.	[Chen, Chien-Hung; Sarbassov, Dos D.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, Chien-Hung; Sarbassov, Dos D.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Sarbassov, DD (corresponding author), 1515 Holcombe Blvd, Houston, TX 77030 USA.	dsarbass@mdanderson.org	Sarbassov, Dos/AAS-4950-2020	Sarbassov, Dos/0000-0002-6848-1133	National Institutes of Health [CA133522]; NATIONAL CANCER INSTITUTE [R01CA133522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA133522 (to D. D. S.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Boulbes D, 2010, MOL CANCER RES, V8, P896, DOI 10.1158/1541-7786.MCR-09-0409; Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pearce LR, 2011, BIOCHEM J, V436, P169, DOI 10.1042/BJ20102103; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	40	33	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40386	40394		10.1074/jbc.M111.282590	http://dx.doi.org/10.1074/jbc.M111.282590			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965657	Green Published, hybrid			2022-12-25	WOS:000296925700069
J	Luzzati, F; De Marchis, S; Parlato, R; Gribaudo, S; Schutz, G; Fasolo, A; Peretto, P				Luzzati, Federico; De Marchis, Silvia; Parlato, Rosanna; Gribaudo, Simona; Schuetz, Guenther; Fasolo, Aldo; Peretto, Paolo			New Striatal Neurons in a Mouse Model of Progressive Striatal Degeneration Are Generated in both the Subventricular Zone and the Striatal Parenchyma	PLOS ONE			English	Article							NEURAL STEM-CELLS; ISCHEMIC BRAIN-INJURY; PROGENITOR CELLS; ADULT BRAIN; FOREBRAIN NEUROGENESIS; QUANTITATIVE-ANALYSIS; DIFFERENTIATION; MIGRATION; INTERNEURONS; MULTIPOTENT	Acute striatal lesions increase proliferation in the subventricular zone (SVZ) and induce migration of SVZ neuroblasts to the striatum. However, the potential of these cells to replace acutely degenerated neurons is controversial. The possible contribution of parenchymal progenitors to striatal lesion-induced neurogenesis has been poorly explored. Here, we present a detailed investigation of neurogenesis in the striatum of a mouse model showing slow progressive neurodegeneration of striatal neurons, the Creb1(Camkcre4) Crem(-/-) mutant mice (CBCM). By using BrdU time course analyses, intraventricular injections of a cell tracker and 3D reconstructions we showed that neurodegeneration in CBCM mice stimulates the migration of SVZ neuroblasts to the striatum without altering SVZ proliferation. SVZ-neuroblasts migrate as chains through the callosal striatal border and then enter within the striatal parenchyma as individual cells. In addition, a population of clustered neuroblasts showing high turnover rates were observed in the mutant striatum that had not migrated from the SVZ. Clustered neuroblasts might originate within the striatum itself because they are specifically associated with parenchymal proliferating cells showing features of intermediate neuronal progenitors such as clustering, expression of EGF receptor and multiple glial (SOX2, SOX9, BLBP) and neuronal (Dlx, Sp8, and to some extent DCX) markers. Newborn striatal neurons had a short lifespan and did not replace projection neurons nor expressed sets of transcription factors involved in their specification. The differentiation failure of endogenous neuroblasts likely occurred cell autonomously because transplanted wild type embryonic precursors correctly differentiated into striatal projection neurons. Thus, we propose that under progressive degeneration, neither SVZ derived nor intra-striatal generated neurons have the potential to differentiate into striatal projection neurons.	[Luzzati, Federico; De Marchis, Silvia; Gribaudo, Simona; Fasolo, Aldo; Peretto, Paolo] Univ Turin, Dept Anim & Human Biol, Turin, Italy; [Luzzati, Federico; Peretto, Paolo] Cavalieri Ottolenghi Fdn, Inst Sci, Orbassano, Italy; [Parlato, Rosanna; Schuetz, Guenther] German Canc Res Ctr, Heidelberg, Germany	University of Turin; Helmholtz Association; German Cancer Research Center (DKFZ)	Luzzati, F (corresponding author), Univ Turin, Dept Anim & Human Biol, Turin, Italy.	paolo.peretto@unito.it	De+Marchis, Silvia/ABH-8872-2020; Parlato, Rosanna/G-8768-2015; Parlato, Rosanna/AAH-4429-2020	Parlato, Rosanna/0000-0001-6682-9645; Gribaudo, Simona/0000-0002-9361-3855; de marchis, silvia/0000-0002-8096-7670; Peretto, Paolo Marcello/0000-0001-9747-6379; LUZZATI, FEDERICO/0000-0003-0648-9989	Compagnia di San Paolo [NEUROTRANSPLANT 2004.2019]; Universita di Torino; PRIN 2007; Regione Piemonte - Ricerca Sanitaria Finalizzata	Compagnia di San Paolo(Compagnia di San Paolo); Universita di Torino; PRIN 2007(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Regione Piemonte - Ricerca Sanitaria Finalizzata(Regione Piemonte)	Support was contributed by Compagnia di San Paolo (NEUROTRANSPLANT 2004.2019); Universita di Torino 2007; PRIN 2007; Regione Piemonte - Ricerca Sanitaria Finalizzata (2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Batista CMC, 2006, J NEUROSCI, V26, P10452, DOI 10.1523/JNEUROSCI.2850-06.2006; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Carletti B, 2004, J NEUROCYTOL, V33, P309, DOI 10.1023/B:NEUR.0000044192.20397.7e; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Collin T, 2005, EXP NEUROL, V195, P71, DOI 10.1016/j.expneurol.2005.03.017; Cong SY, 2005, MOL CELL NEUROSCI, V30, P560, DOI 10.1016/j.mcn.2005.10.015; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; De Marchis S, 2001, J NEUROBIOL, V49, P326, DOI 10.1002/neu.10012; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Eriksson C, 2003, EXP NEUROL, V184, P615, DOI 10.1016/S0014-4886(03)00271-1; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Gordon RJ, 2007, NEUROSCIENCE, V146, P1704, DOI 10.1016/j.neuroscience.2007.03.011; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Jiang HB, 2006, NEUROBIOL DIS, V23, P543, DOI 10.1016/j.nbd.2006.04.011; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Liu F, 2009, J NEUROSCI, V29, P5075, DOI 10.1523/JNEUROSCI.0201-09.2009; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Luzzati F, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00070; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Marin O, 2000, J NEUROSCI, V20, P6063; Mason HA, 2005, DEVELOPMENT, V132, P4247, DOI 10.1242/dev.02008; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Palmer TD, 1999, J NEUROSCI, V19, P8487; PANGANIBAN G, 1995, SCIENCE, V270, P1363, DOI 10.1126/science.270.5240.1363; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Wei B, 2011, EUR J NEUROSCI, V33, P819, DOI 10.1111/j.1460-9568.2010.07570.x; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Zhang RL, 2009, J CEREBR BLOOD F MET, V29, P1240, DOI 10.1038/jcbfm.2009.55; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007	54	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25088	10.1371/journal.pone.0025088	http://dx.doi.org/10.1371/journal.pone.0025088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980380	Green Published, gold, Green Submitted			2022-12-25	WOS:000295941300018
J	Yamaguchi, J; Mizoguchi, T; Fujiwara, H				Yamaguchi, Junichi; Mizoguchi, Takayuki; Fujiwara, Haruhiko			siRNAs Induce Efficient RNAi Response in Bombyx mori Embryos	PLOS ONE			English	Article							GENETIC INTERFERENCE; PROLEG DEVELOPMENT; MAMMALIAN-CELLS; SILKWORM; DROSOPHILA; SELECTION; DESIGN	Short interference RNA (siRNA) is widely used in mammalian cells. In insects, however, reports concerning the suitablility of siRNA in vivo is very limited compared with that of long dsRNA, which is thought to be more effective. There is insufficient information on the essential rules of siRNA design in insects, as very few siRNAs have been tested in this context. To establish an effective method of gene silencing using siRNA in vivo in insects, we determined the effects of siRNA on seven target genes. We designed siRNAs according to a new guideline and injected them into eggs of Bombyx mori. At the mRNA level, the expression of most of these genes was successfully silenced, down to less than half the constitutive level, which in some cases led to the development of distinctive phenotypes. In addition, we observed stronger effect of siRNA both on the mRNA level and the phenotype than that of long dsRNA under comparable conditions. These results indicate that direct injection of siRNA is an effective reverse-genetics tool for the analysis of embryogenesis in vivo in insects.	[Yamaguchi, Junichi; Mizoguchi, Takayuki; Fujiwara, Haruhiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan	University of Tokyo	Yamaguchi, J (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan.	haruh@k.u-tokyo.ac.jp			Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN);  [22128005]	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); 	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (22128005) of Japan and the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) to HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clemons A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016730; COULTER DE, 1988, GENE DEV, V2, P1812, DOI 10.1101/gad.2.12b.1812; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gong LA, 2011, PEST MANAG SCI, V67, P514, DOI 10.1002/ps.2086; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; KRAFT R, 1994, P NATL ACAD SCI USA, V91, P6634, DOI 10.1073/pnas.91.14.6634; Kumar M, 2009, J INSECT PHYSIOL, V55, P273, DOI 10.1016/j.jinsphys.2008.12.005; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Luo KQ, 2004, BIOCHEM BIOPH RES CO, V318, P303, DOI 10.1016/j.bbrc.2004.04.027; Martin BL, 2009, CURR BIOL, V19, pR215, DOI 10.1016/j.cub.2009.01.052; Masumoto M, 2009, DEV GENES EVOL, V219, P437, DOI 10.1007/s00427-009-0305-9; NAGY L, 1994, DEV BIOL, V165, P137, DOI 10.1006/dbio.1994.1241; Nakao H, 2010, J EXP ZOOL PART B, V314B, P224, DOI 10.1002/jez.b.21328; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Svoboda P, 2000, DEVELOPMENT, V127, P4147; TAKESUE S, 1980, J EMBRYOL EXP MORPH, V60, P117; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Tamura Toshiki, 2007, Journal of Insect Biotechnology and Sericology, V76, P155; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tomita S, 2009, DEV BIOL, V328, P403, DOI 10.1016/j.ydbio.2009.01.040; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Xiang H, 2011, ARCH INSECT BIOCHEM, V76, P1, DOI 10.1002/arch.20393; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366	27	49	52	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25469	10.1371/journal.pone.0025469	http://dx.doi.org/10.1371/journal.pone.0025469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980469	gold, Green Submitted, Green Published			2022-12-25	WOS:000295941300035
J	Brannstrom, K; Ohman, A; Olofsson, A				Brannstrom, Kristoffer; Ohman, Anders; Olofsson, Anders			A beta Peptide Fibrillar Architectures Controlled by Conformational Constraints of the Monomer	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; SOLUTION NMR-SPECTROSCOPY; ALZHEIMERS-DISEASE; HYDROGEN/DEUTERIUM EXCHANGE; SOLVENT PROTECTION; KINETIC-ANALYSIS; AGGREGATION; MICE; MUTAGENESIS; FORM	Anomalous self-assembly of the A beta peptide into fibrillar amyloid deposits strongly correlated with the development of Alzheimer's disease. A beta fibril extension follows a template guided "dock and lock" mechanism where polymerisation is catalysed by the fibrillar ends. Using surface plasmon resonance (SPR) and quenched hydrogen-deuterium exchange NMR (H/D-exchange NMR), we have analysed the fibrillar structure and polymerisation properties of both the highly aggregation prone A beta 1-40 Glu22Gly (A beta(40Arc)) and wild type A beta 1-40 (A beta(40WT)). The solvent protection patterns from H/D exchange experiments suggest very similar structures of the fibrillar forms. However, through cross-seeding experiments monitored by SPR, we found that the monomeric form of A beta(40WT) is significantly impaired to acquire the fibrillar architecture of A beta(40Arc). A detailed characterisation demonstrated that A beta(40WT) has a restricted ability to dock and isomerise with high binding affinity onto A beta(40Arc) fibrils. These results have general implications for the process of fibril assembly, where the rate of polymerisation, and consequently the architecture of the formed fibrils, is restricted by conformational constraints of the monomers. Interestingly, we also found that the kinetic rate of fibril formation rather than the thermodynamically lowest energy state determines the overall fibrillar structure.	[Brannstrom, Kristoffer; Olofsson, Anders] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Ohman, Anders] Umea Univ, Dept Chem, Umea, Sweden	Umea University; Umea University	Brannstrom, K (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	anders.ohman@chem.umu.se; anders.olofsson@medchem.umu.se	Brännström, Kristoffer/AAC-1204-2020; Brännström, Kristoffer/D-3648-2009		J.C. Kempe Foundation; Swedish Research Council; O.E. och Edla Johanssons vetenskapliga stiftelse; FAMY; Medical Faculty of Umea University	J.C. Kempe Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); O.E. och Edla Johanssons vetenskapliga stiftelse; FAMY; Medical Faculty of Umea University	This work was supported by J.C. Kempe Foundation, the Swedish Research Council, O.E. och Edla Johanssons vetenskapliga stiftelse, FAMY and the Medical Faculty of Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MI, 2005, NEUROTOX RES, V7, P17, DOI 10.1007/BF03033773; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Codita A, 2010, BEHAV BRAIN RES, V215, P83, DOI 10.1016/j.bbr.2010.06.034; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13489, DOI 10.1021/bi020369w; Hu WP, 2006, J NEUROSCI METH, V154, P190, DOI 10.1016/j.jneumeth.2005.12.016; Ippel JH, 2002, P NATL ACAD SCI USA, V99, P8648, DOI 10.1073/pnas.132098999; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; Lord A, 2009, FEBS J, V276, P995, DOI 10.1111/j.1742-4658.2008.06836.x; Mercy L, 2008, NEUROLOGY, V71, P1496, DOI 10.1212/01.wnl.0000334277.16896.fa; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; OLOFSSON A, 2007, BIOCH J; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Olofsson A, 2009, FEBS J, V276, P4051, DOI 10.1111/j.1742-4658.2009.07113.x; Olofsson A, 2009, ANAL BIOCHEM, V385, P374, DOI 10.1016/j.ab.2008.10.034; Peralvarez-Marin A, 2009, BIOPHYS J, V97, P277, DOI 10.1016/j.bpj.2009.04.017; Philipson O, 2009, NEUROBIOL AGING, V30, P1393, DOI 10.1016/j.neurobiolaging.2007.11.022; Ryu J, 2008, ANAL CHEM, V80, P2400, DOI 10.1021/ac7019514; Sahlin C, 2007, J NEUROCHEM, V101, P854, DOI 10.1111/j.1471-4159.2006.04443.x; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Whalen BM, 2005, NEUROBIOL DIS, V20, P254, DOI 10.1016/j.nbd.2005.03.007; Williams AD, 2006, J MOL BIOL, V357, P1283, DOI 10.1016/j.jmb.2006.01.041; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x	30	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25157	10.1371/journal.pone.0025157	http://dx.doi.org/10.1371/journal.pone.0025157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980388	Green Submitted, Green Published, gold			2022-12-25	WOS:000295939600012
J	Caruso, V; Chen, H; Morris, MJ				Caruso, Vanni; Chen, Hui; Morris, Margaret J.			Early Hypothalamic FTO Overexpression in Response to Maternal Obesity - Potential Contribution to Postweaning Hyperphagia	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; BODY-MASS INDEX; CHILDHOOD OBESITY; MITOCHONDRIAL DYSFUNCTION; APPETITE REGULATORS; ADULT OBESITY; ENERGY-INTAKE; FOOD-INTAKE; CHILDREN; VARIANTS	Background: Intrauterine and postnatal overnutrition program hyperphagia, adiposity and glucose intolerance in offspring. Single-nucleotide polymorphisms (SNPs) of the fat mass and obesity associated (FTO) gene have been linked to increased risk of obesity. FTO is highly expressed in hypothalamic regions critical for energy balance and hyperphagic phenotypes were linked with FTO SNPs. As nutrition during fetal development can influence the expression of genes involved in metabolic function, we investigated the impact of maternal obesity on FTO. Methods: Female Sprague Dawley rats were exposed to chow or high fat diet (HFD) for 5 weeks before mating, throughout gestation and lactation. On postnatal day 1 (PND1), some litters were adjusted to 3 pups (vs. 12 control) to induce postnatal overnutrition. At PND20, rats were weaned onto chow or HFD for 15 weeks. FTO mRNA expression in the hypothalamus and liver, as well as hepatic markers of lipid metabolism were measured. Results: At weaning, hypothalamic FTO mRNA expression was increased significantly in offspring of obese mothers and FTO was correlated with both visceral and epididymal fat mass (P<0.05); body weight approached significance (P = 0.07). Hepatic FTO and Fatty Acid Synthase mRNA expression were decreased by maternal obesity. At 18 weeks, FTO mRNA expression did not differ between groups; however body weight was significantly correlated with hypothalamic FTO. Postnatal HFD feeding significantly reduced hepatic Carnitine Palmitoyltransferase-1a but did not affect the expression of other hepatic markers investigated. FTO was not affected by chronic HFD feeding. Significance: Maternal obesity significantly impacted FTO expression in both hypothalamus and liver at weaning. Early overexpression of hypothalamic FTO correlated with increased adiposity and later food intake of siblings exposed to HFD suggesting upregulation of FTO may contribute to subsequent hyperphagia, in line with some human data. No effect of maternal obesity was observed on FTO in adulthood.	[Caruso, Vanni; Chen, Hui; Morris, Margaret J.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia; [Chen, Hui] Univ Technol Sydney, Fac Sci, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia	University of New South Wales Sydney; University of Technology Sydney	Caruso, V (corresponding author), Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia.	m.morris@unsw.edu.au	Morris, Margaret J/J-4285-2013; Chen, Hui/R-6137-2019; Chen, Hui/D-2005-2014	Chen, Hui/0000-0001-6883-3752; Chen, Hui/0000-0001-6883-3752; Caruso, Vanni/0000-0002-0523-6149; Morris, Margaret/0000-0003-2285-5117	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by project funding from the National Health and Medical Research Council of Australia to Margaret J Morris.	Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Bayol SA, 2010, ENDOCRINOLOGY, V151, P1451, DOI 10.1210/en.2009-1192; Bouchard C, 2008, OBESITY, V16, pS5, DOI 10.1038/oby.2008.528; Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006259; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Fang HY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-136; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; Jacobsson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020158; Keller MP, 2010, ANNU REV NUTR, V30, P341, DOI 10.1146/annurev.nutr.012809.104747; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Mitchell GA, 2009, INT J OBESITY, V33, pS41, DOI 10.1038/ijo.2009.16; Morris MJ, 2009, INT J OBESITY, V33, P115, DOI 10.1038/ijo.2008.213; Morris Margaret J, 2009, Expert Rev Endocrinol Metab, V4, P625, DOI 10.1586/eem.09.45; Oben JA, J HEPATOLOGY, V52, P913; Oken E, 2009, OBSTET GYN CLIN N AM, V36, P361, DOI 10.1016/j.ogc.2009.03.007; Okuda M, 2011, PEDIAT DIABETES; Poritsanos NJ, 2010, BIOCHEM BIOPH RES CO, V400, P713, DOI 10.1016/j.bbrc.2010.08.133; Rutters F, 2011, J CLIN ENDOCR METAB, V96, pE939, DOI 10.1210/jc.2010-2413; Ryu MH, 2005, NUTRITION, V21, P537, DOI 10.1016/j.nut.2004.08.015; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Skiba-Cassy S, 2007, COMP BIOCHEM PHYS B, V147, P278, DOI 10.1016/j.cbpb.2007.01.007; Soncini M, 1995, J BIOL CHEM, V270, P30339, DOI 10.1074/jbc.270.51.30339; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Sul HS, 1998, PROG NUCLEIC ACID RE, V60, P317, DOI 10.1016/S0079-6603(08)60896-X; THUMELIN S, 1994, BIOCHEM J, V300, P583, DOI 10.1042/bj3000583; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zabena C, 2009, OBES SURG, V19, P87, DOI 10.1007/s11695-008-9727-0; Zhang JH, 2001, FASEB J, V15, P1261, DOI 10.1096/fj.00-0717fje	53	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25261	10.1371/journal.pone.0025261	http://dx.doi.org/10.1371/journal.pone.0025261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980407	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900042
J	Corsi, DJ; Finlay, JE; Subramanian, SV				Corsi, Daniel J.; Finlay, Jocelyn E.; Subramanian, S. V.			Global Burden of Double Malnutrition: Has Anyone Seen It?	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION TRANSITION; SOCIOECONOMIC-STATUS; RISK-FACTORS; OVERWEIGHT; WOMEN; UNDERNUTRITION; OBESITY; OVERNUTRITION; UNDERWEIGHT	Background: Low-to middle-income countries (LMICs) are believed to be characterized by the coexistence of underweight and overweight. It has also been posited that such coexistence is appearing among the low socioeconomic status (SES) groups. Methods: We conducted a cross-sectional analysis of nationally representative samples of 451321 women aged 20-49 years drawn from 57 Demographic and Health Surveys conducted between 1994 and 2008. Body Mass Index (BMI in kg/m(2)), was used to define underweight and overweight following conventional cut-points. Covariates included age, household wealth, education, and residence. We estimated multinomial multilevel models to assess the extent to which underweight (BMI<18.5 kg/m(2)) and overweight (BMI >= 25.0 kg/m(2)) correlate at the country-level, and at the neighborhood-level within each country. Results: In age-adjusted models, there was a strong negative correlation between likelihood of being underweight and overweight at country- (r = -0.79, p<0.001), and at the neighborhood-level within countries (r = -0.51, P<0.001). Negative correlations ranging from -0.11 to -0.90 were observed in 46 of the 57 countries at the neighborhood-level and 29/57 were statistically significant (p <= 0.05). Similar negative correlations were observed in analyses restricted to low SES groups. Finally, the negative correlations across countries, and within-countries, appeared to be stable over time in a sub-set of 36 countries. Conclusion: The explicitly negative correlations between prevalence of underweight and overweight at the country-level and at neighborhood-level suggest that the hypothesized coexistence of underweight and overweight has not yet occurred in a substantial manner in a majority of LMICs.	[Corsi, Daniel J.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Corsi, Daniel J.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Finlay, Jocelyn E.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	McMaster University; Population Health Research Institute; McMaster University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Corsi, DJ (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.	svsubram@hsph.harvard.edu	Finlay, Jocelyn/AAS-9588-2021; Corsi, Daniel J/S-4689-2018	Finlay, Jocelyn/0000-0002-3077-5515; Corsi, Daniel J/0000-0001-7063-3354	Macro International Inc. (Washington, DC)	Macro International Inc. (Washington, DC)	The authors acknowledge the support of Macro International Inc. (Washington, DC) for providing access to the various Demographic and Health Surveys.	Ackerson LK, 2008, ECON HUM BIOL, V6, P264, DOI 10.1016/j.ehb.2008.05.002; [Anonymous], 2008, DEMOGRAPHIC HLTH RES; Browne W., 2009, MCMC ESTIMATION MLWI; Corsi DJ, 2011, J NUTR, V141, P631, DOI 10.3945/jn.110.131599; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Garrett James L., 2005, Food and Nutrition Bulletin, V26, P209; Goldstein H., 2003, MULTILEVEL STAT MODE; Griffiths P, 2005, EUR J CLIN NUTR, V59, P1217, DOI 10.1038/sj.ejcn.1602228; Griffiths PL, 2001, J NUTR, V131, P2692, DOI 10.1093/jn/131.10.2692; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Ha DTP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-62; Kapoor SK, 2002, J EPIDEMIOL COMMUN H, V56, P804, DOI 10.1136/jech.56.11.804; Kennedy G., 2006, DOUBLE BURDEN MALNUT; Lukito Widjaja, 2006, Asia Pac J Clin Nutr, V15 Suppl, P21; Macro International Inc, 1996, 6 DHS 3 MACR INT INC; *MEASURE DHS, 2009, DEM HLTH SURV; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Monteiro CA, 2002, PUBLIC HEALTH NUTR, V5, P105, DOI 10.1079/PHN2001281; *ORC MACR, 2006, 2 ORC MACR MEASURE D; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Popkin BM, 2003, DEV POLICY REV, V21, P581, DOI DOI 10.1111/J.1467-8659.2003.00225.X; Pullum TW, 2008, ASSESSMENT QUALITY D; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Reddy KS, 1998, CIRCULATION, V97, P596; Rutstein SO, 2003, GUIDE DHS STAT; Rutstein SO, 2004, DHS WEALTH ASSET IND; Shafique S, 2007, INT J EPIDEMIOL, V36, P449, DOI 10.1093/ije/dyl306; Shukla HC, 2002, J EPIDEMIOL COMMUN H, V56, P876, DOI 10.1136/jech.56.11.876; Steyn K, 1998, E AFR MED J, V75, P35; Subramanian SV, 2007, J EPIDEMIOL COMMUN H, V61, P802, DOI 10.1136/jech.2006.053801; Subramanian SV, 2006, AM J CLIN NUTR, V84, P633, DOI 10.1093/ajcn/84.3.633; Subramanian S. V., 2003, Neighborhoods and health, P65; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Subramanian SV, 2009, AM J CLIN NUTR, V90, P369, DOI 10.3945/ajcn.2009.27487; Subramanian SV, 2004, SOC SCI MED, V58, P1961, DOI 10.1016/S0277-9536(03)00415-5; Usfar AA, 2010, OBES REV, V11, P924, DOI 10.1111/j.1467-789X.2010.00814.x; VAESSEN M, 1996, DEMOGRAPHIC EVALUATI; van der Sande MAB, 2001, AM J PUBLIC HEALTH, V91, P1641, DOI 10.2105/AJPH.91.10.1641; Wang H, 2007, INT J OBESITY, V31, P272, DOI 10.1038/sj.ijo.0803416; WHO, 2004, LANCET, V363, P902; WHO/FAO, 2002, REP JOINT WHO FAO EX; Wirth M., 2006, MONITORING HLTH EQUI; World Bank, 2009, WORLD DEV IND; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	47	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25120	10.1371/journal.pone.0025120	http://dx.doi.org/10.1371/journal.pone.0025120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834CT	21980384	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900025
J	Donze, A; Fanchon, E; Gattepaille, LM; Maler, O; Tracqui, P				Donze, Alexandre; Fanchon, Eric; Gattepaille, Lucie Martine; Maler, Oded; Tracqui, Philippe			Robustness Analysis and Behavior Discrimination in Enzymatic Reaction Networks	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; MODEL CHECKING	Characterizing the behavior and robustness of enzymatic networks with numerous variables and unknown parameter values is a major challenge in biology, especially when some enzymes have counter-intuitive properties or switch-like behavior between activation and inhibition. In this paper, we propose new methodological and tool-supported contributions, based on the intuitive formalism of temporal logic, to express in a rigorous manner arbitrarily complex dynamical properties. Our multi-step analysis allows efficient sampling of the parameter space in order to define feasible regions in which the model exhibits imposed or experimentally observed behaviors. In a first step, an algorithmic methodology involving sensitivity analysis is conducted to determine bifurcation thresholds for a limited number of model parameters or initial conditions. In a second step, this boundary detection is supplemented by a global robustness analysis, based on quasi-Monte Carlo approach that takes into account all model parameters. We apply this method to a well-documented enzymatic reaction network describing collagen proteolysis by matrix metalloproteinase MMP2 and membrane type 1 metalloproteinase (MT1-MMP) in the presence of tissue inhibitor of metalloproteinase TIMP2. For this model, our method provides an extended analysis and quantification of network robustness toward paradoxical TIMP2 switching activity between activation or inhibition of MMP2 production. Further implication of our approach is illustrated by demonstrating and analyzing the possible existence of oscillatory behaviors when considering an extended open configuration of the enzymatic network. Notably, we construct bifurcation diagrams that specify key parameters values controlling the co-existence of stable steady and non-steady oscillatory proteolytic dynamics.	[Donze, Alexandre; Maler, Oded] UJF Grenoble 1, CNRS, Lab VERIMAG, UMR 5104, Gieres, France; [Fanchon, Eric; Gattepaille, Lucie Martine; Tracqui, Philippe] UJF Grenoble 1, CNRS, Lab TIMC IMAG, UMR 5525,DyCTiM Team,Fac Med Grenoble, Grenoble, France; [Fanchon, Eric; Gattepaille, Lucie Martine; Tracqui, Philippe] UJF Grenoble 1, CNRS, Lab TIMC IMAG, UMR 5525,BCM Team,Fac Med Grenoble, Grenoble, France; [Fanchon, Eric; Gattepaille, Lucie Martine; Tracqui, Philippe] In3S, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Donze, A (corresponding author), UJF Grenoble 1, CNRS, Lab VERIMAG, UMR 5104, Gieres, France.	Alexandre.Donze@imag.fr; Philippe.Tracqui@imag.fr	Gattepaille, Lucie/V-3229-2019	Donze, Alexandre/0000-0002-1138-5458	IXXI (Institut Rhone-Alpin des Systemes Complexes); Syne2Arti ANR	IXXI (Institut Rhone-Alpin des Systemes Complexes)(Region Auvergne-Rhone-Alpes); Syne2Arti ANR(French National Research Agency (ANR))	This work is supported by a grant from IXXI (Institut Rhone-Alpin des Systemes Complexes, http://www.ixxi.fr/) and the Syne2Arti ANR Grant (http://www.agence-nationale-recherche.fr/programmes-de-recherche/projets-selectionnes/programme-conception-et-simulation-2010/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alur R, 1996, J ACM, V43, P116, DOI 10.1145/227595.227602; Antoniotti M, 2003, CELL BIOCHEM BIOPHYS, V38, P271, DOI 10.1385/CBB:38:3:271; Baier C, 2008, PRINCIPLES OF MODEL CHECKING, P1; Batt G, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P370; Chabrier N, 2003, LECT NOTES COMPUT SC, V2602, P149; Chaves M, 2006, IEE P SYST BIOL, V153, P154, DOI 10.1049/ip-syb:20050079; Coelho PMBM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000319; Cook B, 2011, LECT NOTES COMPUT SC, V6538, P134, DOI 10.1007/978-3-642-18275-4_11; Dang T, 2009, LECT N BIOINFORMAT, V5688, P126, DOI 10.1007/978-3-642-03845-7_9; Dayarian A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000256; Donze A, 2010, LECT NOTES COMPUT SC, V6246, P92, DOI 10.1007/978-3-642-15297-9_9; Donze A, 2010, LECT NOTES COMPUT SC, V6174, P167, DOI 10.1007/978-3-642-14295-6_17; Donze A, 2010, J COMPUT BIOL, V17, P325, DOI 10.1089/cmb.2009.0172; Fages F, 2009, LECT NOTES COMPUT SC, V5732, P319, DOI 10.1007/978-3-642-04244-7_26; Fainekos GE, 2009, THEOR COMPUT SCI, V410, P4262, DOI 10.1016/j.tcs.2009.06.021; Faure H, 2009, ACM T MODEL COMPUT S, V19, DOI 10.1145/1596519.1596520; Fisher J, 2006, PROCEEDINGS OF THE 2006 WINTER SIMULATION CONFERENCE, VOLS 1-5, P1675, DOI 10.1109/WSC.2006.322942; Gattepaille Lucie Martine EF, 2009, CELLML MODEL COLLAGE; Gingras D, 2010, BBA-MOL CELL RES, V1803, P142, DOI 10.1016/j.bbamcr.2009.04.011; Gruel J, 2009, BMC RES NOTES; GUNAWARDENA J, 2009, ELEMENTS COMPUTATION; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hafner M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000534; Hahn T, 2005, COMPUT PHYS COMMUN, V168, P78, DOI 10.1016/j.cpc.2005.01.010; Karagiannis ED, 2004, J BIOL CHEM, V279, P39105, DOI 10.1074/jbc.M403627200; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; Kiparissides A, 2009, IND ENG CHEM RES, V48, P7168, DOI 10.1021/ie900139x; Kleinberg S, 2009, QUEUE, V7, P40; KOYMANS R, 1990, REAL-TIME SYST, V2, P255, DOI 10.1007/BF01995674; Kugler H, 2010, J R SOC INTERFACE, V7, P1015, DOI 10.1098/rsif.2009.0457; Lafleur MA, 2002, J CELL SCI, V115, P3427; Maler O, 2008, LECT NOTES COMPUT SC, V4800, P475, DOI 10.1007/978-3-540-78127-1_26; Manna Z., 1991, TEMPORAL LOGIC REACT; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Niederreiter H., 1992, RANDOM NUMBER GENERA; Pnueli A., 1977, 18th Annual Symposium on Foundations of Computer Science, P46, DOI 10.1109/SFCS.1977.32; Rizk A, 2009, BIOINFORMATICS, V25, pI169, DOI 10.1093/bioinformatics/btp200; Rizk A, 2008, LECT N BIOINFORMAT, V5307, P251, DOI 10.1007/978-3-540-88562-7_19; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; Sobol IM, 2010, COMPUT PHYS COMMUN, V181, P1212, DOI 10.1016/j.cpc.2010.03.006; Stephanou A, 2007, MICROVASC RES, V73, P182, DOI 10.1016/j.mvr.2006.12.002; Voit E. O., 2000, COMPUTATIONAL ANAL B	42	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24246	10.1371/journal.pone.0024246	http://dx.doi.org/10.1371/journal.pone.0024246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980344	gold, Green Published, Green Submitted			2022-12-25	WOS:000295933700005
J	Borcherding, DC; Hugo, ER; Idelman, G; De Silva, A; Richtand, NW; Loftus, J; Ben-Jonathan, N				Borcherding, Dana C.; Hugo, Eric R.; Idelman, Gila; De Silva, Anuradha; Richtand, Nathan W.; Loftus, Jean; Ben-Jonathan, Nira			Dopamine Receptors in Human Adipocytes: Expression and Functions	PLOS ONE			English	Article							BETA-ADRENERGIC REGULATION; ADIPOSE-TISSUE; METACHROMATIC LEUKODYSTROPHY; ARYLSULFATASE-A; WEIGHT-GAIN; IN-VIVO; PROLACTIN; RELEASE; SECRETION; BINDING	Introduction: Dopamine (DA) binds to five receptors (DAR), classified by their ability to increase (D1R-like) or decrease (D2R-like) cAMP. In humans, most DA circulates as dopamine sulfate (DA-S), which can be de-conjugated to bioactive DA by arylsulfatase A (ARSA). The objective was to examine expression of DAR and ARSA in human adipose tissue and determine whether DA regulates prolactin (PRL) and adipokine expression and release. Methods: DAR were analyzed by RT-PCR and Western blotting in explants, primary adipocytes and two human adipocyte cell lines, LS14 and SW872. ARSA expression and activity were determined by qPCR and enzymatic assay. PRL expression and release were determined by luciferase reporter and Nb2 bioassay. Analysis of cAMP, cGMP, leptin, adiponectin and interleukin 6 (IL-6) was done by ELISA. Activation of MAPK and PI3 kinase/Akt was determined by Western blotting. Results: DAR are variably expressed at the mRNA and protein levels in adipose tissue and adipocytes during adipogenesis. ARSA activity in adipocyte increases after differentiation. DA at nM concentrations suppresses cAMP, stimulates cGMP, and activates MAPK in adipocytes. Acting via D2R-like receptors, DA and DA-S inhibit PRL gene expression and release. Acting via D1R/D5R receptors, DA suppresses leptin and stimulates adiponectin and IL-6 release. Conclusions: This is the first report that human adipocytes express functional DAR and ARSA, suggesting a regulatory role for peripheral DA in adipose functions. We speculate that the propensity of some DAR-activating antipsychotics to increase weight and alter metabolic homeostasis is due, in part, to their direct action on adipose tissue.	[Borcherding, Dana C.; Hugo, Eric R.; Idelman, Gila; De Silva, Anuradha; Richtand, Nathan W.; Ben-Jonathan, Nira] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA; [Loftus, Jean] Christ Hosp, Cincinnati, OH 45219 USA	University System of Ohio; University of Cincinnati; Christ Hospital - Ohio	Borcherding, DC (corresponding author), Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA.	Nira.Ben-Jonathan@uc.edu	Hugo, Eric/ADA-3523-2022	Hugo, Eric/0000-0002-2990-6362; Borcherding, Dana/0000-0002-8849-2139	National Institutes of Health [S012212, CA096613]; Department of Defense [BC05725]; Susan G. Komen Breast Cancer Foundation [BCRT87406]; Elsa U. Pardee foundation; National Research Service Award (NRSA) [F31 DK761852]; NATIONAL CANCER INSTITUTE [R01CA096613, Z01BC005725, T32CA117846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Elsa U. Pardee foundation; National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants S012212 and CA096613, Department of Defense BC05725, Susan G. Komen Breast Cancer Foundation grant BCRT87406, and a grant from the Elsa U. Pardee foundation (to NBJ), and a National Research Service Award (NRSA) predoctoral fellowship F31 DK761852 (to DCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Basu S, 2004, CANCER RES, V64, P5551, DOI 10.1158/0008-5472.CAN-04-1600; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; BENJONATHAN N, 1985, ENDOCR REV, V6, P564, DOI 10.1210/edrv-6-4-564; BENJONATHAN N, 1980, J CLIN ENDOCR METAB, V51, P1019; Biffi A, 2008, CLIN GENET, V74, P349, DOI 10.1111/j.1399-0004.2008.01058.x; Brandebourg T, 2007, DIABETES OBES METAB, V9, P464, DOI 10.1111/j.1463-1326.2006.00671.x; CHANG PL, 1981, ANAL BIOCHEM, V117, P382, DOI 10.1016/0003-2697(81)90795-8; Chen J, 2004, J BIOL CHEM, V279, P39317, DOI 10.1074/jbc.M403891200; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Dajani R, 1999, J BIOL CHEM, V274, P37862, DOI 10.1074/jbc.274.53.37862; Dalla Valle L, 2006, J ENDOCRINOL, V190, P129, DOI 10.1677/joe.1.06811; Dixon TM, 2001, J BIOL CHEM, V276, P722, DOI 10.1074/jbc.M008440200; Eisenhofer G, 1999, CLIN EXP PHARMACOL P, V26, pS41; Eldrup E, 2004, DAN MED BULL, V51, P34; Fain JN, 2000, METABOLISM, V49, P804, DOI 10.1053/meta.2000.6244; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Ghosh D, 2007, CELL MOL LIFE SCI, V64, P2013, DOI 10.1007/s00018-007-7175-y; Gieselmann V, 2008, ACTA PAEDIATR, V97, P15, DOI 10.1111/j.1651-2227.2008.00648.x; GOLANDER A, 1979, J CLIN ENDOCR METAB, V49, P787, DOI 10.1210/jcem-49-5-787; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; Goossens GH, 2008, DIABETES OBES METAB, V10, P1029, DOI 10.1111/j.1463-1326.2008.00856.x; GUEST SJ, 1990, J BIOL CHEM, V265, P5370; Hugo ER, 2006, ENDOCRINOLOGY, V147, P306, DOI 10.1210/en.2005-0989; Hugo ER, 2008, J CLIN ENDOCR METAB, V93, P4006, DOI 10.1210/jc.2008-1172; LaPensee CR, 2008, ENDOCRINOLOGY, V149, P5415, DOI 10.1210/en.2008-0549; Lee MY, 2006, J CELL PHYSIOL, V208, P399, DOI 10.1002/jcp.20674; Maayan L, 2010, NEUROPSYCHOPHARMACOL, V35, P1520, DOI 10.1038/npp.2010.21; Matzner U, 2009, J BIOL CHEM, V284, P9372, DOI 10.1074/jbc.M809457200; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Mignini F, 2000, J AUTON PHARMACOL, V20, P325, DOI 10.1046/j.1365-2680.2000.00198.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mohamed-Ali V, 2001, J CLIN ENDOCR METAB, V86, P5864, DOI 10.1210/jc.86.12.5864; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; NISOLI E, 1992, J PHARMACOL EXP THER, V263, P823; Path G, 2001, J CLIN ENDOCR METAB, V86, P2281, DOI 10.1210/jc.86.5.2281; Pivonello R, 2007, EUR J ENDOCRINOL, V156, pS13, DOI 10.1530/eje.1.02353; Regis S, 2002, HUM GENET, V110, P351, DOI 10.1007/s00439-002-0701-y; Ricci A, 1997, NEUROSCI LETT, V229, P130, DOI 10.1016/S0304-3940(97)00413-8; Ricci A, 1999, J NEUROIMMUNOL, V96, P234, DOI 10.1016/S0165-5728(99)00042-9; Richtand NM, 2007, NEUROPSYCHOPHARMACOL, V32, P1715, DOI 10.1038/sj.npp.1301305; Rondinone CM, 2006, ENDOCRINE, V29, P81, DOI 10.1385/ENDO:29:1:81; Shetty S, 2009, TRENDS PHARMACOL SCI, V30, P234, DOI 10.1016/j.tips.2009.02.004; Sidhu A, 2000, INT J DEV NEUROSCI, V18, P669, DOI 10.1016/S0736-5748(00)00033-2; STROBEL G, 1990, BIOCHEM INT, V20, P343; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Than A, 2011, MOL CELL ENDOCRINOL, V332, P261, DOI 10.1016/j.mce.2010.11.002; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Zeigerer A, 2008, EXP CELL RES, V314, P2249, DOI 10.1016/j.yexcr.2008.04.003; Zimmermann U, 2003, J PSYCHIATR RES, V37, P193, DOI 10.1016/S0022-3956(03)00018-9; Zinger M, 2003, J CLIN ENDOCR METAB, V88, P689, DOI 10.1210/jc.2002-021255	55	67	70	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25537	10.1371/journal.pone.0025537	http://dx.doi.org/10.1371/journal.pone.0025537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966540	Green Submitted, Green Published, gold			2022-12-25	WOS:000295932100048
J	Liu, Q; Fan, JJ; Niu, C; Wang, DC; Wang, JP; Wang, X; Villaruz, AE; Li, M; Otto, M; Gao, Q				Liu, Qian; Fan, Jiajia; Niu, Chen; Wang, Decheng; Wang, Jianping; Wang, Xing; Villaruz, Amer E.; Li, Min; Otto, Michael; Gao, Qian			The Eukaryotic-Type Serine/Threonine Protein Kinase Stk Is Required for Biofilm Formation and Virulence in Staphylococcus epidermidis	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; SERINE THREONINE KINASE; SER/THR KINASE; STREPTOCOCCUS-PNEUMONIAE; BINDING PROTEIN; GENE; IDENTIFICATION; AUREUS; PHOSPHATASE; PHOSPHORYLATION	Background: Serine/threonine kinases are involved in gene regulation and signal transduction in prokaryotes and eukaryotes. Here, we investigated the role of the serine/threonine kinase Stk in the opportunistic pathogen Staphylococcus epidermidis. Methodology/Principal Findings: We constructed an isogenic stk mutant of a biofilm-forming clinical S. epidermidis isolate. Presence of stk was important for biofilm formation in vitro and virulence in a murine subcutaneous foreign body infection model. Furthermore, the stk mutant exhibited phenotypes indicating an impact of stk on metabolic pathways. Using different constructs for the genetic complementation of the stk mutant strain with full-length Stk or specific Stk domains, we determined that the Stk intracellular kinase domain is important for biofilm formation and regulation of purine metabolism. Site-specific inactivation of the Stk kinase domain led to defective biofilm formation, in further support of the notion that the kinase activity of Stk regulates biofilm formation of S. epidermidis. According to immunological detection of the biofilm exopolysaccharide PIA and real-time PCR of the PIA biosynthesis genes, the impact of stk on biofilm formation is mediated, at least in part, by a strong influence on PIA expression. Conclusions: Our study identifies Stk as an important regulator of biofilm formation and virulence of S. epidermidis, with additional involvement in purine metabolism and the bacterial stress response.	[Liu, Qian; Fan, Jiajia; Niu, Chen; Wang, Decheng; Wang, Jianping; Wang, Xing; Gao, Qian] Fudan Univ, Key Lab Med Mol Virol, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Liu, Qian; Fan, Jiajia; Niu, Chen; Wang, Decheng; Wang, Jianping; Wang, Xing; Gao, Qian] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Villaruz, Amer E.; Otto, Michael] NIAID, NIH, Bethesda, MD 20892 USA; [Li, Min] Fudan Univ, Dept Lab Med, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fudan University	Liu, Q (corresponding author), Fudan Univ, Key Lab Med Mol Virol, Inst Biomed Sci, Shanghai 200433, Peoples R China.	qgao99@yahoo.com	WANG, DECHENG/AGO-5098-2022	WANG, DECHENG/0000-0002-1742-7460; Otto, Michael/0000-0002-2222-4115	National Natural Science Foundation of China [30670108, J0730860]; National Institute of Allergy and Infectious Diseases, The National Institutes of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001080] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Allergy and Infectious Diseases, The National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Natural Science Foundation of China 30670108 and J0730860, and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, The National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGUSTIN J, 1990, FEMS MICROBIOL LETT, V66, P203, DOI 10.1016/0378-1097(90)90283-V; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002; COZZONE AJ, 1993, J CELL BIOCHEM, V51, P7, DOI 10.1002/jcb.240510103; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Dias R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-121; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Fey PD, 2010, CURR OPIN MICROBIOL, V13, P610, DOI 10.1016/j.mib.2010.09.007; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Fujimoto K, 2001, CHEM-BIOL INTERACT, V130, P825, DOI 10.1016/S0009-2797(00)00238-6; Gopalaswamy R, 2008, FEMS MICROBIOL LETT, V278, P121, DOI 10.1111/j.1574-6968.2007.00989.x; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Hussain H, 2006, J BACTERIOL, V188, P1628, DOI 10.1128/JB.188.4.1628-1632.2006; Hussain M, 1997, INFECT IMMUN, V65, P519, DOI 10.1128/IAI.65.2.519-524.1997; Ji YD, 1999, J BACTERIOL, V181, P6585, DOI 10.1128/JB.181.21.6585-6590.1999; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; Knobloch JKM, 2003, APPL ENVIRON MICROB, V69, P5812, DOI 10.1128/AEM.69.10.5812-5818.2003; Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Liebeke M, 2010, CHEM BIOL, V17, P820, DOI 10.1016/j.chembiol.2010.06.012; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; Mack D, 2000, INFECT IMMUN, V68, P3799, DOI 10.1128/IAI.68.7.3799-3807.2000; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Novakova L, 2005, FEBS J, V272, P1243, DOI 10.1111/j.1742-4658.2005.04560.x; Novakova L, 2010, J BACTERIOL; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pei L, 2001, MICROB PATHOGENESIS, V31, P185, DOI 10.1006/mpat.2001.0462; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Perez J, 2006, BIOCHEM BIOPH RES CO, V348, P6, DOI 10.1016/j.bbrc.2006.06.164; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rajagopal L, 2005, MOL MICROBIOL, V56, P1329, DOI 10.1111/j.1365-2958.2005.04620.x; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005; Rupp ME, 1999, INFECT IMMUN, V67, P2656, DOI 10.1128/IAI.67.5.2656-2659.1999; Saskova L, 2007, J BACTERIOL, V189, P4168, DOI 10.1128/JB.01616-06; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Tamber S, 2010, INFECT IMMUN, V78, P3637, DOI 10.1128/IAI.00296-10; Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239; Wang CZ, 2007, MICROBES INFECT, V9, P1376, DOI 10.1016/j.micinf.2007.06.012; Wang CZ, 2010, FEMS IMMUNOL MED MIC, V59, P152, DOI 10.1111/j.1574-695X.2010.00673.x; Wang L, 2008, J INFECT DIS, V197, P1254, DOI 10.1086/586714; Wang X, 2010, INFECT IMMUN, V79, P1007; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002; Xu L, 2006, INFECT IMMUN, V74, P488, DOI 10.1128/IAI.74.1.488-496.2006; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3	64	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25380	10.1371/journal.pone.0025380	http://dx.doi.org/10.1371/journal.pone.0025380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966513	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100051
J	Qiu, L; Dhe-Paganon, S				Qiu, Liyan; Dhe-Paganon, Sirano			Oligomeric Structure of the MALT1 Tandem Ig-Like Domains	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; UBIQUITIN LIGASE; BCL10; ACTIVATION; LYMPHOMA; DEATH; APOPTOSIS; PROTEINS; CORE; GENE	Background: Mucosa-associated lymphoid tissue 1 (MALT1) plays an important role in the adaptive immune program. During TCR- or BCR-induced NF-kappa B activation, MALT1 serves to mediate the activation of the IKK (I kappa B kinase) complex, which subsequently regulates the activation of NF-kappa B. Aggregation of MALT1 is important for E3 ligase activation and NF-kappa B signaling. Principal Findings: Unlike the isolated CARD or paracaspase domains, which behave as monomers, the tandem Ig-like domains of MALT1 exists as a mixture of dimer and tetramer in solution. High-resolution structures reveals a protein-protein interface that is stabilized by a buried surface area of 1256 angstrom(2) and contains numerous hydrogen and salt bonds. In conjunction with a second interface, these interactions may represent the basis of MALT1 oligomerization. Conclusions: The crystal structure of the tandem Ig-like domains reveals the oligomerization potential of MALT1 and a potential intermediate in the activation of the adaptive inflammatory pathway.	[Qiu, Liyan; Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Qiu, Liyan; Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto	Qiu, L (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	sirano.dhepaganon@utoronto.ca			Canadian Institutes for Health Research [1097737]; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation; Swedish Foundation for Strategic Research; Wellcome Trust; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Leanne Wybenga-Groot and Masato Akutsu for purifying and crystallizing proteins, John R. Walker for collecting X-ray data, solving and refining structures, Christine Butler-Cole and Yanjun Li for cloning constructs, and Matthieu Schapira for formatting the manuscript. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kawadler H, 2008, MOL CELL, V31, P415, DOI 10.1016/j.molcel.2008.06.008; Kohl A, 2004, CR BIOL, V327, P1077, DOI 10.1016/j.crvi.2004.08.006; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langel FD, 2008, J BIOL CHEM, V283, P32419, DOI 10.1074/jbc.M800670200; LESK AM, 1982, J MOL BIOL, V160, P325, DOI 10.1016/0022-2836(82)90179-6; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; McAllister-Lucas LM, 2008, NAT IMMUNOL, V9, P231, DOI 10.1038/ni0308-231; Minor W, 2002, ACTA PHYS POL A, V101, P613, DOI 10.12693/APhysPolA.101.613; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; PFUHL M, 1995, STRUCTURE, V3, P391, DOI 10.1016/S0969-2126(01)00170-8; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thieblemont C, 1997, J CLIN ONCOL, V15, P1624, DOI 10.1200/JCO.1997.15.4.1624; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9	28	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e23220	10.1371/journal.pone.0023220	http://dx.doi.org/10.1371/journal.pone.0023220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966355	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100001
J	Roney, KE; O'Connor, BP; Wen, H; Holl, EK; Guthrie, EH; Davis, BK; Jones, SW; Jha, S; Sharek, L; Garcia-Mata, R; Bear, JE; Ting, JPY				Roney, Kelly E.; O'Connor, Brian P.; Wen, Haitao; Holl, Eda K.; Guthrie, Elizabeth H.; Davis, Beckley K.; Jones, Stephen W.; Jha, Sushmita; Sharek, Lisa; Garcia-Mata, Rafael; Bear, James E.; Ting, Jenny P. -Y.			Plexin-B2 Negatively Regulates Macrophage Motility, Rac, and Cdc42 Activation	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; CELL-SURFACE MOLECULE; RECEPTOR PLEXIN-B1; DENDRITIC CELLS; RHO-GTPASES; ACTIVE RAC; SEMAPHORIN RECEPTORS; IMMUNE-RESPONSES; PDZ-RHOGEF; IN-VIVO	Plexins are cell surface receptors widely studied in the nervous system, where they mediate migration and morphogenesis though the Rho family of small GTPases. More recently, plexins have been implicated in immune processes including cell-cell interaction, immune activation, migration, and cytokine production. Plexin-B2 facilitates ligand induced cell guidance and migration in the nervous system, and induces cytoskeletal changes in overexpression assays through RhoGTPase. The function of Plexin-B2 in the immune system is unknown. This report shows that Plexin-B2 is highly expressed on cells of the innate immune system in the mouse, including macrophages, conventional dendritic cells, and plasmacytoid dendritic cells. However, Plexin-B2 does not appear to regulate the production of proinflammatory cytokines, phagocytosis of a variety of targets, or directional migration towards chemoattractants or extracellular matrix in mouse macrophages. Instead, Plxnb2(-/-) macrophages have greater cellular motility than wild type in the unstimulated state that is accompanied by more active, GTP-bound Rac and Cdc42. Additionally, Plxnb2(-/-) macrophages demonstrate faster in vitro wound closure activity. Studies have shown that a closely related family member, Plexin-B1, binds to active Rac and sequesters it from downstream signaling. The interaction of Plexin-B2 with Rac has only been previously confirmed in yeast and bacterial overexpression assays. The data presented here show that Plexin-B2 functions in mouse macrophages as a negative regulator of the GTPases Rac and Cdc42 and as a negative regulator of basal cell motility and wound healing.	[Roney, Kelly E.; Wen, Haitao; Holl, Eda K.; Davis, Beckley K.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA; [Roney, Kelly E.; Wen, Haitao; Holl, Eda K.; Guthrie, Elizabeth H.; Jones, Stephen W.; Jha, Sushmita; Bear, James E.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [O'Connor, Brian P.; Bear, James E.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Integrated Dept Immunol, Denver, CO USA; [Jones, Stephen W.; Sharek, Lisa; Garcia-Mata, Rafael] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Jewish Health; University of North Carolina; University of North Carolina Chapel Hill	Roney, KE (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA.	panyun@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; Jha, Sushmita/I-8867-2019	Jha, Sushmita/0000-0003-2336-5064; Garcia-Mata, Rafael/0000-0002-7116-4411	NIH [AI29564]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI029564, R01AI029564, R37AI029564] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH grant AI29564 (J.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Kheir W, 2005, J CELL SCI, V118, P5369, DOI 10.1242/jcs.02638; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Aurandt J, 2006, BIOCHEM J, V394, P459, DOI 10.1042/BJ20051123; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Bouguet-Bonnet S, 2008, J MOL BIOL, V377, P1474, DOI 10.1016/j.jmb.2008.01.081; Campana L, 2009, J LEUKOCYTE BIOL, V86, P609, DOI 10.1189/jlb.0908576; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Deaglio S, 2004, BLOOD; Deng SH, 2007, J NEUROSCI, V27, P6333, DOI 10.1523/JNEUROSCI.5381-06.2007; Driessens MHE, 2002, FEBS LETT, V529, P168, DOI 10.1016/S0014-5793(02)03323-9; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eun SY, 2006, J IMMUNOL, V177, P4271, DOI 10.4049/jimmunol.177.7.4271; Fenteany G, 2004, CURR OPIN HEMATOL, V11, P15, DOI 10.1097/00062752-200401000-00004; Friedel RH, 2007, J NEUROSCI, V27, P3921, DOI 10.1523/JNEUROSCI.4710-06.2007; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Roman JJG, 2008, TRANSL RES, V151, P134, DOI 10.1016/j.trsl.2007.12.003; Granziero L, 2003, BLOOD, V101, P1962, DOI 10.1182/blood-2002-05-1339; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; Harduf H, 2007, FERTIL STERIL, V87, P1419, DOI 10.1016/j.fertnstert.2006.11.141; Harduf H, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-14; Hartwig C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-53; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hirotani M, 2002, BIOCHEM BIOPH RES CO, V297, P32, DOI 10.1016/S0006-291X(02)02122-8; Hirschberg A, 2010, MOL CELL BIOL, V30, P764, DOI 10.1128/MCB.01458-09; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Hota PK, 2009, PROTEIN SCI, V18, P1060, DOI 10.1002/pro.116; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Ji JD, 2009, HUM IMMUNOL, V70, P211, DOI 10.1016/j.humimm.2009.01.026; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kumanogoh A, 2005, INT IMMUNOL, V17, P1277, DOI 10.1093/intimm/dxh307; Li M, 2009, IMMUNOLOGY, V128, P114, DOI 10.1111/j.1365-2567.2009.03098.x; Li XH, 2010, J BIOL CHEM, V285, P32436, DOI 10.1074/jbc.M110.120451; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Maier V, 2011, MOL CELL NEUROSCI, V46, P419, DOI 10.1016/j.mcn.2010.11.005; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; Masuda K, 2004, GENES CELLS, V9, P821, DOI 10.1111/j.1365-2443.2004.00766.x; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Neufeld G, 2007, ADV EXP MED BIOL, V600, P118; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; O'Connor BP, 2008, P NATL ACAD SCI USA, V105, P13015, DOI 10.1073/pnas.0803386105; O'Connor BP, 2008, IMMUNOL RES, V41, P217, DOI 10.1007/s12026-008-8026-0; OHTA K, 1992, NEURON, V9, P151, DOI 10.1016/0896-6273(92)90230-B; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Okuno T, 2010, J IMMUNOL, V184, P1499, DOI 10.4049/jimmunol.0903302; Pan GQ, 2009, WORLD J GASTROENTERO, V15, P2800, DOI 10.3748/wjg.15.2800; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Park H, 2009, MOL BIOL CELL, V20, P4500, DOI 10.1091/mbc.E09-03-0230; Perala N, 2011, DIFFERENTIATION, V81, P81, DOI 10.1016/j.diff.2010.10.001; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Regev A, 2005, FERTIL STERIL, V84, P1210, DOI 10.1016/j.fertnstert.2005.05.011; Saito Y, 2009, EMBO REP, V10, P614, DOI 10.1038/embor.2009.63; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Serini G, 2009, ANGIOGENESIS, V12, P187, DOI 10.1007/s10456-009-9138-4; Stevens L, 2010, J INVEST DERMATOL, V130, P1636, DOI 10.1038/jid.2010.13; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885; Takamatsu H, 2010, CELL MOL IMMUNOL, V7, P83, DOI 10.1038/cmi.2009.111; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Vemula S, 2010, BLOOD, V116, P4103, DOI 10.1182/blood-2010-01-262790; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Waimey KE, 2006, NEUROSCIENTIST, V12, P398, DOI 10.1177/1073858406292631; Watarai H, 2008, P NATL ACAD SCI USA, V105, P2993, DOI 10.1073/pnas.0710351105; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Wong OGW, 2007, P NATL ACAD SCI USA, V104, P19040, DOI 10.1073/pnas.0702544104; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yu D, 2008, IMMUNOL CELL BIOL, V86, P3, DOI 10.1038/sj.icb.7100123; Yukawa K, 2010, INT J MOL MED, V25, P225, DOI 10.3892/ijmm_00000334; Zielonka M, 2010, EXP CELL RES	78	32	36	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e24795	10.1371/journal.pone.0024795	http://dx.doi.org/10.1371/journal.pone.0024795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966369	Green Published, gold			2022-12-25	WOS:000295267100009
J	Belser, JA; Jayaraman, A; Raman, R; Pappas, C; Zeng, H; Cox, NJ; Katz, JM; Sasisekharan, R; Tumpey, TM				Belser, Jessica A.; Jayaraman, Akila; Raman, Rahul; Pappas, Claudia; Zeng, Hui; Cox, Nancy J.; Katz, Jacqueline M.; Sasisekharan, Ram; Tumpey, Terrence M.			Effect of D222G Mutation in the Hemagglutinin Protein on Receptor Binding, Pathogenesis and Transmissibility of the 2009 Pandemic H1N1 Influenza Virus	PLOS ONE			English	Article							SINGLE-AMINO-ACID; A VIRUS; CELL TROPISM; IN-VITRO; VIRULENCE; SUBSTITUTION; REPLICATION; INFECTION; DETERMINANT; SPECIFICITY	Influenza viruses isolated during the 2009 H1N1 pandemic generally lack known molecular determinants of virulence associated with previous pandemic and highly pathogenic avian influenza viruses. The frequency of the amino acid substitution D222G in the hemagglutinin (HA) of 2009 H1N1 viruses isolated from severe but not mild human cases represents the first molecular marker associated with enhanced disease. To assess the relative contribution of this substitution in virus pathogenesis, transmission, and tropism, we introduced D222G by reverse genetics in the wild-type HA of the 2009 H1N1 virus, A/California/04/09 (CA/04). A dose-dependent glycan array analysis with the D222G virus showed a modest reduction in the binding avidity to human-like (alpha 2-6 sialylated glycan) receptors and an increase in the binding to avian-like (alpha 2-3 sialylated glycan) receptors in comparison with wild-type virus. In the ferret pathogenesis model, the D222G mutant virus was found to be similar to wild-type CA/04 virus with respect to lethargy, weight loss and replication efficiency in the upper and lower respiratory tract. Moreover, based on viral detection, the respiratory droplet transmission properties of these two viruses were found to be similar. The D222G virus failed to productively infect mice inoculated by the ocular route, but exhibited greater viral replication and weight loss than wild-type CA/04 virus in mice inoculated by the intranasal route. In a more relevant human cell model, D222G virus replicated with delayed kinetics compared with wild-type virus but to higher titer in human bronchial epithelial cells. These findings suggest that although the D222G mutation does not influence virus transmission, it may be considered a molecular marker for enhanced replication in certain cell types.	[Belser, Jessica A.; Pappas, Claudia; Zeng, Hui; Cox, Nancy J.; Katz, Jacqueline M.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Jayaraman, Akila; Raman, Rahul; Sasisekharan, Ram] MIT, Harvard MIT Div Hlth Sci & Technol, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART)	Belser, JA (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	tft9@cdc.gov			Centers for Disease Control and Prevention; National Institutes of Health [R37 GM057073-13]; Singapore-MIT Alliance for Research and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT Alliance for Research and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The source of funding for this work was the Centers for Disease Control and Prevention. This work was funded in part by a merit award to RS (R37 GM057073-13) from the National Institutes of Health and the Singapore-MIT Alliance for Research and Technology. The authors acknowledge the Consortium for Functional Glycomics for providing the glycan standards. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldanti F, 2011, CLIN MICROBIOL INFEC, V17, P1166, DOI 10.1111/j.1469-0691.2010.03403.x; Belser JA, 2011, J VIROL, V85, P1563, DOI 10.1128/JVI.02231-10; Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09; Belser JA, 2009, J VIROL, V83, P7075, DOI 10.1128/JVI.00535-09; Centers for Disease Control and Prevention, 2010, 2009 H1N1 FLU INT SI; Chan KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013757; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Chan PKS, 2011, J CLIN VIROL, V50, P320, DOI 10.1016/j.jcv.2011.01.013; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dubnov-Raz G, 2011, PEDIATR INT, V53, P426, DOI 10.1111/j.1442-200X.2010.03271.x; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Lopez-Prats MJ, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/423672; Kilander A, 2010, EURO SURVEILL, V15; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Mak GC, 2010, EURO SURVEILL, V15; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Puzelli S., 2010, EURO SURVEILL, V15, P19696; Skarbinski J, 2011, CLIN INFECT DIS, V52, pS50, DOI 10.1093/cid/ciq021; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Takemae N, 2010, J GEN VIROL, V91, P938, DOI 10.1099/vir.0.016691-0; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; WHO, 2009, PREL REV D222G AM AC; Xu LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-325; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zheng BJ, 2010, EXP BIOL MED, V235, P981, DOI 10.1258/ebm.2010.010071	49	61	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25091	10.1371/journal.pone.0025091	http://dx.doi.org/10.1371/journal.pone.0025091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966421	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100053
J	Johnson, KL; Kibble, NAJ; Bacic, A; Schultz, CJ				Johnson, Kim L.; Kibble, Natalie A. J.; Bacic, Antony; Schultz, Carolyn J.			A Fasciclin-Like Arabinogalactan-Protein (FLA) Mutant of Arabidopsis thaliana, fla1, Shows Defects in Shoot Regeneration	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; GENE FAMILY; MEDIATED TRANSFORMATION; REVERSE GENETICS; GENOME-WIDE; ROOT; EXPRESSION; MUTATIONS; IDENTIFICATION; PERICYCLE	Background: The fasciclin-like arabinogalactan-proteins (FLAs) are an enigmatic class of 21 members within the larger family of arabinogalactan-proteins (AGPs) in Arabidopsis thaliana. Located at the cell surface, in the cell wall/plasma membrane, they are implicated in many developmental roles yet their function remains largely undefined. Fasciclin (FAS) domains are putative cell-adhesion domains found in extracellular matrix proteins of organisms from all kingdoms, but the juxtaposition of FAS domains with highly glycosylated AGP domains is unique to plants. Recent studies have started to elucidate the role of FLAs in Arabidopsis development. FLAs containing a single FAS domain are important for the integrity and elasticity of the plant cell wall matrix (FLA11 and FLA12) and FLA3 is involved in microspore development. FLA4/SOS5 with two FAS domains and two AGP domains has a role in maintaining proper cell expansion under salt stressed conditions. The role of other FLAs remains to be uncovered. Method/Principal Findings: Here we describe the characterisation of a T-DNA insertion mutant in the FLA1 gene (At5g55730). Under standard growth conditions fla1-1 mutants have no obvious phenotype. Based on gene expression studies, a putative role for FLA1 in callus induction was investigated and revealed that fla1-1 has a reduced ability to regenerate shoots in an in vitro shoot-induction assay. Analysis of FLA1p:GUS reporter lines show that FLA1 is expressed in several tissues including stomata, trichomes, the vasculature of leaves, the primary root tip and in lateral roots near the junction of the primary root. Conclusion: The results of the developmental expression of FLA1 and characterisation of the fla1 mutant support a role for FLA1 in the early events of lateral root development and shoot development in tissue culture, prior to cell-type specification.	[Johnson, Kim L.; Bacic, Antony] Univ Melbourne, Sch Bot, ARC Ctr Excellence Plant Cell Walls & Plant Cell, Melbourne, Vic, Australia; [Kibble, Natalie A. J.] Univ Adelaide, ARC Ctr Excellence Plant Cell Walls, Waite Res Inst, Glen Osmond, SA, Australia; [Kibble, Natalie A. J.; Schultz, Carolyn J.] Univ Adelaide, Sch Agr & Wine, Waite Res Inst, Glen Osmond, SA, Australia	University of Melbourne; University of Adelaide; University of Adelaide	Johnson, KL (corresponding author), John Innes Ctr, Colney Lane, Norwich, Norfolk, England.	carolyn.schultz@adelaide.edu.au	Johnson, Kim/AAB-5696-2022	Johnson, Kim/0000-0001-6917-7742; Bacic, Tony/0000-0001-7483-8605	Australian Research Council [DP034545]; University of Melbourne	Australian Research Council(Australian Research Council); University of Melbourne(University of Melbourne)	This work was funded by Australian Research Council grant (DP034545 to CJS and AB), and University of Melbourne, Albert Shimmins writing-up award (KLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Atta R, 2009, PLANT J, V57, P626, DOI 10.1111/j.1365-313X.2008.03715.x; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041; Bouche N, 2001, CURR OPIN PLANT BIOL, V4, P111, DOI 10.1016/S1369-5266(00)00145-X; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Buechel S, 2010, EUR J CELL BIOL, V89, P279, DOI 10.1016/j.ejcb.2009.11.016; Candela M, 2001, IN VITRO CELL DEV-PL, V37, P638, DOI 10.1007/s11627-001-0111-1; Cary A, 2001, PLANTA, V213, P700, DOI 10.1007/s004250100565; Cary AJ, 2002, PLANT J, V32, P867, DOI 10.1046/j.1365-313X.2002.01479.x; Casero PJ, 1998, PLANTA, V204, P252, DOI 10.1007/s004250050254; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Che P, 2002, PLANT CELL, V14, P2771, DOI 10.1105/tpc.006668; Che P, 2007, PLANTA, V226, P1183, DOI 10.1007/s00425-007-0565-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clout NJ, 2003, STRUCTURE, V11, P197, DOI 10.1016/S0969-2126(03)00002-9; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Feraru E, 2011, CURR BIOL, V21, P338, DOI 10.1016/j.cub.2011.01.036; Fischer U, 2004, CURR OPIN PLANT BIOL, V7, P670, DOI 10.1016/j.pbi.2004.09.007; Gaspar Y, 2001, PLANT MOL BIOL, V47, P161, DOI 10.1023/A:1010683432529; Gaspar YM, 2004, PLANT PHYSIOL, V135, P2162, DOI 10.1104/pp.104.045542; Gens JS, 2000, PROTOPLASMA, V212, P115, DOI 10.1007/BF01279353; Harwood A, 2004, CURR OPIN CELL BIOL, V16, P470, DOI 10.1016/j.ceb.2004.07.011; HUBER O, 1994, EMBO J, V13, P4212, DOI 10.1002/j.1460-2075.1994.tb06741.x; Iwase A, 2011, CURR BIOL, V21, P508, DOI 10.1016/j.cub.2011.02.020; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; Johnson KL, 2003, PLANT PHYSIOL, V133, P1911, DOI 10.1104/pp.103.031237; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; KNOX JP, 1995, FASEB J, V9, P1004, DOI 10.1096/fasebj.9.11.7544308; Lalanne E, 2004, PLANT CELL, V16, P229, DOI 10.1105/tpc.014407; Li J, 2010, PLANT J, V64, P482, DOI 10.1111/j.1365-313X.2010.04344.x; Liu TB, 2009, J ZHEJIANG UNIV-SC B, V10, P434, DOI 10.1631/jzus.B0920017; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Majewska-Sawka A, 2000, PLANT PHYSIOL, V122, P3, DOI 10.1104/pp.122.1.3; Matsuo N, 2011, PLANT SCI, V181, P39, DOI 10.1016/j.plantsci.2011.03.007; McCabe PF, 1997, PLANT CELL, V9, P2225, DOI 10.1105/tpc.9.12.2225; MCKINNEY EC, 1995, PLANT J, V8, P613, DOI 10.1046/j.1365-313X.1995.8040613.x; Meissner RC, 1999, PLANT CELL, V11, P1827, DOI 10.1105/tpc.11.10.1827; Motose H, 2004, NATURE, V429, P873, DOI 10.1038/nature02613; Nam J, 1999, MOL GEN GENET, V261, P429, DOI 10.1007/s004380050985; PENNELL RI, 1995, PHILOS T R SOC B, V350, P87, DOI 10.1098/rstb.1995.0142; PENNELL RI, 1991, PLANT CELL, V3, P1317, DOI 10.1105/tpc.3.12.1317; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Pickard BG, 2005, FUNCT PLANT BIOL, V32, P863, DOI 10.1071/FP05045; Schultz CJ, 1997, PLANT MOL BIOL, V35, P833, DOI 10.1023/A:1005816520060; Schultz CJ, 2002, PLANT PHYSIOL, V129, P1448, DOI 10.1104/pp.003459; Schultz CJ, 2000, PLANT CELL, V12, P1751, DOI 10.1105/tpc.12.9.1751; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Serpe MD, 1999, ADV BOT RES, V30, P207; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; van Hengel AJ, 2003, PLANT J, V36, P256, DOI 10.1046/j.1365-313X.2003.01874.x; Van Vactor D, 1998, CURR OPIN NEUROBIOL, V8, P80, DOI 10.1016/S0959-4388(98)80011-1; Winkler RG, 1998, PLANT PHYSIOL, V118, P743, DOI 10.1104/pp.118.3.743	59	51	57	7	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25154	10.1371/journal.pone.0025154	http://dx.doi.org/10.1371/journal.pone.0025154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966441	gold, Green Published			2022-12-25	WOS:000295265100069
J	Orlandi, C; La Via, L; Bonini, D; Mora, C; Russo, I; Barbon, A; Barlati, S				Orlandi, Cesare; La Via, Luca; Bonini, Daniela; Mora, Cristina; Russo, Isabella; Barbon, Alessandro; Barlati, Sergio			AMPA Receptor Regulation at the mRNA and Protein Level in Rat Primary Cortical Cultures	PLOS ONE			English	Article							GLUTAMATE-OPERATED CHANNELS; HIPPOCAMPAL-NEURONS; KINETIC-PROPERTIES; MOLECULAR DETERMINANT; RETINOIC ACID; GLUR2; TRAFFICKING; EXPRESSION; FLOP; TRANSLATION	Ionotropic glutamate alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors are the major mediators of fast synaptic neurotransmission. In this work, we used primary cortical cultures from rats as a model system to study AMPA receptor regulation during in vitro cell maturation and after synaptic activity modifications. The levels of AMPA receptor mRNA and protein, along with the alternative splicing and RNA editing of the AMPA receptor subunit (GluR1-4) mRNAs, were analyzed in immature (DIV5) and mature (DIV26) rat neuronal cultures. We observed an increase in the expression of all four AMPA receptor subunits during in vitro neuronal maturation. This finding might be due to the formation of new synapses between neurons during the development of a complex neuronal network. We also analyzed the effects of stimulation (KCl and glutamate) and inhibition (APV/TTX) on rat mature neuronal cultures (DIV26): stimulation with KCl led to an overall down-regulation of GluR1 and GluR3 AMPA receptor subunits and an up-regulation of the GluR2 subunit. Similarly, glutamate treatment induced a significant down-regulation of GluR1 together with an up-regulation of GluR2. In contrast, the chronic blockade of neuronal activity that resulted from APV/TTX treatment up-regulated GluR1 and GluR3 with a parallel down-regulation of GluR2 and GluR4. RNA editing at the R/G site increased during neuronal cell maturation for all AMPA receptors (from 8-39% at DIV5 to 28-67% at DIV26). Unexpectedly, all the treatments tested induced a marked reduction (ranging from -9% to -52%) of R/G editing levels in mature neurons, primarily for the mRNA flip variant. In summary, we showed that cultured rat cortical neurons are able to vary the stoichiometric ratios of the AMPA receptor subunits and to control post-transcriptional processes to adapt fast synaptic transmission under different environmental conditions.	[Orlandi, Cesare] Univ Brescia, Div Biol & Genet, Dept Biomed Sci & Biotechnol, Brescia, Italy; Univ Brescia, Natl Inst Neurosci, Brescia, Italy	University of Brescia; University of Brescia	Orlandi, C (corresponding author), Univ Brescia, Div Biol & Genet, Dept Biomed Sci & Biotechnol, Brescia, Italy.	barlati@med.unibs.it	Orlandi, Cesare/AAK-3180-2020; Russo, Isabella/AAB-4882-2020; Barbon, Alessandro/E-7037-2010; Mora, Cristina/K-1222-2018; Orlandi, Cesare/O-4332-2015	Orlandi, Cesare/0000-0002-4992-9350; Russo, Isabella/0000-0002-6151-2451; Barbon, Alessandro/0000-0002-1127-7764; Mora, Cristina/0000-0003-3896-7893; 	MIUR [2007YYL5J9]; Ricerca Finalizzata Min Sal. Conv. [42]	MIUR(Ministry of Education, Universities and Research (MIUR)); Ricerca Finalizzata Min Sal. Conv.	This work was supported by grants from MIUR (PRIN 2007YYL5J9) and by Ricerca Finalizzata 2007 Min Sal. Conv. N<SUP>o</SUP> 42. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaneya Y, 2007, EUR J NEUROSCI, V25, P1641, DOI 10.1111/j.1460-9568.2007.05388.x; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Bai XT, 2003, J NEUROCYTOL, V32, P71, DOI 10.1023/A:1027380315902; Barbon A, 2003, MOL BRAIN RES, V117, P168, DOI 10.1016/S0169-328X(03)00317-6; Barbon A, 2010, J NEUROCHEM, V114, P397, DOI 10.1111/j.1471-4159.2010.06767.x; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Ben Fredj N, 2004, J CELL SCI, V117, P1079, DOI 10.1242/jcs.00927; Black MD, 2005, PSYCHOPHARMACOLOGY, V179, P154, DOI 10.1007/s00213-004-2065-6; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DeLima AD, 1997, J COMP NEUROL, V382, P230, DOI 10.1002/(SICI)1096-9861(19970602)382:2<230::AID-CNE7>3.0.CO;2-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Goslin K., 1991, CULTURING NERVE CELL, P251; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Grosskreutz J, 2003, EUR J NEUROSCI, V17, P1173, DOI 10.1046/j.1460-9568.2003.02531.x; Ha JS, 2009, BRAIN RES, V1273, P138, DOI 10.1016/j.brainres.2009.03.050; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Howes JF, 2007, NEUROTHERAPEUTICS, V4, P126, DOI 10.1016/j.nurt.2006.11.001; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; KHATEB A, 1995, J PHYSIOL-LONDON, V487, P623, DOI 10.1113/jphysiol.1995.sp020905; King AE, 2006, J COMP NEUROL, V498, P277, DOI 10.1002/cne.21053; Koike M, 2000, J NEUROSCI, V20, P2166; Krampfl K, 2002, EUR J NEUROSCI, V15, P51, DOI 10.1046/j.0953-816x.2001.01841.x; KRIEGSTEIN AR, 1983, J NEUROSCI, V3, P1634; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Maghsoodi B, 2008, P NATL ACAD SCI USA, V105, P16015, DOI 10.1073/pnas.0804801105; Mahajan SS, 2011, NEUROSCIENCE; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marenco S, 2006, CNS DRUGS, V20, P173, DOI 10.2165/00023210-200620030-00001; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Myers SJ, 2004, J NEUROSCI, V24, P3489, DOI 10.1523/JNEUROSCI.4127-03.2004; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; O'Neill MJ, 2004, CNS NEUROL DISORD-DR, V3, P181, DOI 10.2174/1568007043337508; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pei WM, 2009, BIOCHEMISTRY-US, V48, P3767, DOI 10.1021/bi8015907; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Qian YS, 2011, EUR J PHARMACOL, V651, P59, DOI 10.1016/j.ejphar.2010.10.095; Rao A, 1998, J NEUROSCI, V18, P1217; Ryman K, 2007, RNA, V13, P1071, DOI 10.1261/rna.404407; Schoft VK, 2007, NUCLEIC ACIDS RES, V35, P3723, DOI 10.1093/nar/gkm314; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Sergeeva OA, 2007, CELL MOL NEUROBIOL, V27, P669, DOI 10.1007/s10571-007-9153-1; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Sohya K, 2007, NEUROSCIENCE, V145, P232, DOI 10.1016/j.neuroscience.2006.11.045; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Van den Bosch L, 2006, BBA-MOL BASIS DIS, V1762, P1068, DOI 10.1016/j.bbadis.2006.05.002; Zhang DW, 2009, J NEUROSCI, V29, P4498, DOI 10.1523/JNEUROSCI.6094-08.2009	63	28	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25350	10.1371/journal.pone.0025350	http://dx.doi.org/10.1371/journal.pone.0025350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966506	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100094
J	Paltto, H; Nordberg, A; Norden, B; Snall, T				Paltto, Heidi; Nordberg, Anna; Norden, Bjorn; Snall, Tord			Development of Secondary Woodland in Oak Wood Pastures Reduces the Richness of Rare Epiphytic Lichens	PLOS ONE			English	Article							COLONIZATION-EXTINCTION DYNAMICS; RED-LISTED LICHENS; FRAXINUS-EXCELSIOR; SPECIES RICHNESS; POLLARDED TRUNKS; POPULUS-TREMULA; TREE; CONSERVATION; FOREST; QUERCUS	Wooded pastures with ancient trees were formerly abundant throughout Europe, but during the last century, grazing has largely been abandoned often resulting in dense forests. Ancient trees constitute habitat for many declining and threatened species, but the effects of secondary woodland on the biodiversity associated with these trees are largely unknown. We tested for difference in species richness, occurrence, and abundance of a set of nationally and regionally red-listed epiphytic lichens between ancient oaks located in secondary woodland and ancient oaks located in open conditions. We refined the test of the effect of secondary woodland by also including other explanatory variables. Species occurrence and abundance were modelled jointly using overdispersed zero-inflated Poisson models. The richness of the red-listed lichens on ancient oaks in secondary woodland was half of that compared with oaks growing in open conditions. The species-level analyses revealed that this was mainly the result of lower occupancy of two of the study species. The tree-level abundance of one species was also lower in secondary woodland. Potential explanations for this pattern are that the study lichens are adapted to desiccating conditions enhancing their population persistence by low competition or that open, windy conditions enhance their colonisation rate. This means that the development of secondary woodland is a threat to red-listed epiphytic lichens. We therefore suggest that woody vegetation is cleared and grazing resumed in abandoned oak pastures. Importantly, this will also benefit the vitality of the oaks.	[Paltto, Heidi; Snall, Tord] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Nordberg, Anna; Norden, Bjorn] Gothenburg Univ, Dept Plant & Environm Sci, Gothenburg, Sweden	Swedish University of Agricultural Sciences; University of Gothenburg	Paltto, H (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	heidi.paltto@slu.se	nordberg, agneta/ABD-2479-2021; Nordén, Björn/B-4956-2012	Nordén, Björn/0000-0002-2739-9774	Swedish Research Council FORMAS [2008-1311, 2005-933]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	The Swedish Research Council FORMAS: Heidi Paltto grant number 2008-1311, Tord Snall grant number 2005-933. Minor grants to Heidi Paltto: Marie Claire Cronstedts stiftelse (the foundation of M. C. Cronstedt). Helge Ax:son Johnsons stiftelse (the foundation of H. AX:son Johnson) http://www.haxsonj.se/. Erik och Ebba Larssons samt Thure Rignells stiftelse "Tranemalastiftelsen" (The foundation of E. and E. Larsson and T. Rignell - "Tranemala-foundation'') http://www.tranemala.org/.Stiftelsen Lars Hiertas minne (the foundation for the memory of L. Hierta) http://www.larshiertasminne.se/. Karen och Axel Binnings stipendiefond (the foundation of K. and A. Binning) www.kva.se. Stiftelsen Hierta-Retzius fond for vetenskaplig forskning (the foundation of Hierta-Retzius for scientific research) www.kva.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Armstrong RA, 2007, SYMBIOSIS, V43, P1; Arup U., 1997, SKYDDSVARDA LAVAR SY; Barkman J.J., 1958, BRYOLOGIST; BATES JW, 1992, J ECOL, V80, P163, DOI 10.2307/2261073; Benson S, 2002, BRYOLOGIST, V105, P673, DOI 10.1639/0007-2745(2002)105[0673:LCAGSI]2.0.CO;2; Brudvig LA, 2009, J APPL ECOL, V46, P231, DOI 10.1111/j.1365-2664.2008.01590.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butler L, 2000, ANN ENTOMOL SOC AM, V93, P500, DOI 10.1603/0013-8746(2000)093[0500:OOLOSH]2.0.CO;2; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Carlsson A, 2007, GASTEKAR VACKEFUROR; Caruso A, 2010, OIKOS, V119, P1947, DOI 10.1111/j.1600-0706.2010.18713.x; County Administration Board of Ostergotland [Lansstyrelsen Ostergotland], 2006, 200613 COUNTR ADM BO; County Administration Board of Ostergotland [Lansstyrelsen Ostergotland], 2009, 200813 COUNTR ADM BO; Edman M, 2008, J APPL ECOL, V45, P26, DOI 10.1111/j.1365-2664.2007.01354.x; Ek T, 2001, 20011 COUNTR ADM BOA; Ek T, 2005, 200516 COUNTR ADM OS; Eliasson P, 2006, 5617 SWED ENV PROT A; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Franc N, 2008, BIOL CONSERV, V141, P2310, DOI 10.1016/j.biocon.2008.06.023; Fritz O, 2008, BIOL CONSERV, V141, P655, DOI 10.1016/j.biocon.2007.12.006; Fritz O, 2009, BRYOLOGIST, V112, P488, DOI 10.1639/0007-2745-112.3.488; Gibbons P, 2008, CONSERV BIOL, V22, P1309, DOI 10.1111/j.1523-1739.2008.00997.x; Gotmark F, 2005, FOREST ECOL MANAG, V214, P124, DOI 10.1016/j.foreco.2005.03.052; Gotmark F, 2007, BIOL CONSERV, V140, P349, DOI 10.1016/j.biocon.2007.08.018; GUSTAFSSON L, 1995, J APPL ECOL, V32, P412, DOI 10.2307/2405107; HALLINGBACK T, 1995, LICHENS SWEDEN THEIR; Hanski I., 1999, METAPOPULATION ECOLO; Hedenas H, 2003, ECOL APPL, V13, P1124, DOI 10.1890/1051-0761(2003)13[1124:ROELOP]2.0.CO;2; Johansson V, 2009, ANN BOT FENN, V46, P496, DOI 10.5735/085.046.0602; JOHN E, 1995, BRYOLOGIST, V98, P29, DOI 10.2307/3243637; Kiviniemi K, 1999, OIKOS, V86, P241, DOI 10.2307/3546442; Lindquist B, 1939, BYGD NATUR, V1, P357; Lobel S, 2006, ECOGRAPHY, V29, P169, DOI 10.1111/j.2006.0906-7590.04348.x; Lohmus A, 2010, BIOL CONSERV, V143, P891, DOI 10.1016/j.biocon.2009.12.036; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; McCullagh P, 1989, GEN LINEAR MODELS; Merrifield K, 2000, BRYOLOGIST, V103, P720, DOI 10.1639/0007-2745(2000)103[0720:BOIQGT]2.0.CO;2; Moe B, 2000, PLANT ECOL, V151, P143, DOI 10.1023/A:1026585911823; Moe B, 1997, PLANT ECOL, V129, P157, DOI 10.1023/A:1009720132726; Muir PS, 2006, ECOL APPL, V16, P1207, DOI 10.1890/1051-0761(2006)016[1207:IOOROG]2.0.CO;2; Norden B, 2008, CAN J FOREST RES, V38, P1807, DOI 10.1139/X08-031; Okland B, 2008, BIODIVERS CONSERV, V17, P2599, DOI 10.1007/s10531-008-9325-4; Olff H, 1999, PLANT BIOLOGY, V1, P127, DOI 10.1111/j.1438-8677.1999.tb00236.x; Paltto H, 2008, FOREST ECOL MANAG, V256, P536, DOI 10.1016/j.foreco.2008.04.045; Paltto H, 2010, CONSERV BIOL, V24, P758, DOI 10.1111/j.1523-1739.2009.01423.x; Pasinelli G, 2000, BIOL CONSERV, V93, P227, DOI 10.1016/S0006-3207(99)00137-8; Peterken G. F, 1993, WOODLAND CONSERVATIO; Ranius T, 2000, J INSECT CONSERV, V4, P23, DOI 10.1023/A:1009682722905; Ranius T, 2000, BIOL CONSERV, V95, P85, DOI 10.1016/S0006-3207(00)00007-0; Ranius T, 2008, BIODIVERS CONSERV, V17, P2371, DOI 10.1007/s10531-008-9387-3; Ranius T, 2008, J VEG SCI, V19, P653, DOI 10.3170/2008-8-18433; Rosas CA, 2008, J VEG SCI, V19, P769, DOI 10.3170/2008-8-18447; Rose F., 1974, BRIT OAK ITS HIST NA, P250; Ruczynski I, 2008, J MAMMAL, V89, P942, DOI 10.1644/07-MAMM-A-134.1; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; SEPA and SFA (Swedish Forestry Agency), 2005, NAT STRAT FORM PROT; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; Snall T, 2004, ECOGRAPHY, V27, P757, DOI 10.1111/j.0906-7590.2004.04026.x; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Thor G., 2010, 2010 RED LIST SWEDIS, P285; Thor G, 2010, BIODIVERS CONSERV, V19, P2307, DOI 10.1007/s10531-010-9843-8; Vera F. W. M., 2002, GRAZING ECOLOGY FORE; Wirth V, 1995, FLECHTEN BADEN WURTT, V1; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur Alain F., 2009, P1; [No title captured]	67	48	50	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24675	10.1371/journal.pone.0024675	http://dx.doi.org/10.1371/journal.pone.0024675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961041	Green Submitted, gold, Green Published			2022-12-25	WOS:000295265100014
J	Hara-Chikuma, M; Sugiyama, Y; Kabashima, K; Sohara, E; Uchida, S; Sasaki, S; Inoue, S; Miyachi, Y				Hara-Chikuma, Mariko; Sugiyama, Yoshinori; Kabashima, Kenji; Sohara, Eisei; Uchida, Shinichi; Sasaki, Sei; Inoue, Shintaro; Miyachi, Yoshiki			Involvement of aquaporin-7 in the cutaneous primary immune response through modulation of antigen uptake and migration in dendritic cells	FASEB JOURNAL			English	Article						macropinocytosis; phagocytosis; chemotaxis	LANGERHANS CELLS; CONTACT HYPERSENSITIVITY; GENE DISRUPTION; DOWN-REGULATION; WATER CHANNEL; LYMPH-NODES; MACROPINOCYTOSIS; EXPRESSION; GLYCEROL; PROLIFERATION	Dendritic cells (DCs) have the ability to present antigen and play a critical role in the induction of the acquired immune response. Skin DCs uptake antigen and subsequently migrate to regional draining lymph nodes (LNs), where they activate naive T cells. Here we show that the water/glycerol channel protein aquaporin 7 (AQP7) is expressed on epidermal and dermal DCs and involved in the initiation of primary immune responses. AQP7-deficient DCs showed a decreased cellular uptake of low-molecular-mass compounds (fluorescein isothiocyanate and Lucifer yellow) and high-molecular-mass substances (ovalbumin and dextran), suggesting that AQP7 is involved in antigen uptake. AQP7-deficient DCs also exhibited reduced chemokine-dependent cell migration in comparison to wild-type DCs. Consistent with these in vitro results, AQP7-deficient mice demonstrated a reduced accumulation of antigen-retaining DCs in the LNs after antigen application to the skin, which could be attributed to decreased antigen uptake and migration. Coincidentally, AQP7-deficient mice had impaired antigen-induced sensitization in a contact hypersensitivity model. These observations suggested that AQP7 in skin DCs is primarily involved in antigen uptake and in the subsequent migration of DCs and is responsible for antigen presentation and the promotion of downstream immune responses.-Hara-Chikuma, M., Sugiyama, Y., Kabashima, K., Sohara, E., Uchida, S., Sasaki, S., Inoue, S., Miyachi, Y. Involvement of aquaporin-7 in the cutaneous primary immune response through modulation of antigen uptake and migration in dendritic cells. FASEB J. 26, 211-218 (2012). www.fasebj.org	[Hara-Chikuma, Mariko] Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Dept Dermatol,Sakyo Ku, Kyoto 6068501, Japan; [Hara-Chikuma, Mariko; Sugiyama, Yoshinori; Inoue, Shintaro] Kanebo Cosmet Inc, Innovat Beauty Sci Lab, Odawara, Kanagawa, Japan; [Sohara, Eisei; Uchida, Shinichi; Sasaki, Sei] Tokyo Med & Dent Univ, Dept Nephrol, Tokyo, Japan	Kyoto University; Kanebo Cosmetics Inc.; Tokyo Medical & Dental University (TMDU)	Hara-Chikuma, M (corresponding author), Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Dept Dermatol,Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	haramari@kuhp.kyoto-u.ac.jp	Inoue, Shintaro/AAR-6767-2021; Uchida, Shinichi/D-1111-2013; Kabashima, Kenji/G-2521-2014	Inoue, Shintaro/0000-0002-4996-5693; Kabashima, Kenji/0000-0002-0773-0554	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Maiko Yusa and Kiiko Kumagai for mouse breeding, Dr. Yoshinori Fujiyoshi and Akiko Kamegawa for help with water transport measurement, and Dr. Shunsuke Chikuma for critical reading of the manuscript. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; CARBREY JM, 2009, HDB EXP PHARM, V190, P3, DOI DOI 10.1007/978-3-540-79885-9_; de Baey A, 2000, J EXP MED, V191, P743, DOI 10.1084/jem.191.4.743; Dieu-Nosjean MC, 1999, J LEUKOCYTE BIOL, V66, P252, DOI 10.1002/jlb.66.2.252; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Hara-Chikuma M, 2008, J MOL MED-JMM, V86, P221, DOI 10.1007/s00109-007-0272-4; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Honda T, 2010, J ALLERGY CLIN IMMUN, V125, P1154, DOI 10.1016/j.jaci.2009.12.005; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; Kuriyama H, 1997, BIOCHEM BIOPH RES CO, V241, P53, DOI 10.1006/bbrc.1997.7769; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Martin SF, 2004, INT ARCH ALLERGY IMM, V134, P186, DOI 10.1159/000078765; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Moon C, 2004, AM J HEMATOL, V75, P128, DOI 10.1002/ajh.10476; Noordegraaf M, 2010, J INVEST DERMATOL, V130, P2752, DOI 10.1038/jid.2010.223; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Oliva R, 2010, P NATL ACAD SCI USA, V107, P4135, DOI 10.1073/pnas.0910632107; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Sohara E, 2005, AM J PHYSIOL-RENAL, V289, pF1195, DOI 10.1152/ajprenal.00133.2005; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Verkman AS, 2008, SEMIN NEPHROL, V28, P217, DOI 10.1016/j.semnephrol.2008.03.004; Verkman AS, 2009, J EXP BIOL, V212, P1707, DOI 10.1242/jeb.024125; Wang GF, 2008, CLIN EXP IMMUNOL, V153, P410, DOI 10.1111/j.1365-2249.2008.03702.x; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Yang BX, 2006, FEBS LETT, V580, P6679, DOI 10.1016/j.febslet.2006.11.025	36	30	31	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					211	218		10.1096/fj.11-186627	http://dx.doi.org/10.1096/fj.11-186627			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21968069				2022-12-25	WOS:000299202200022
J	Nassar, D; Droitcourt, C; Mathieu-d'Argent, E; Kim, MJ; Khosrotehrani, K; Aractingi, S				Nassar, Dany; Droitcourt, Catherine; Mathieu-d'Argent, Emmanuelle; Kim, Min Ji; Khosrotehrani, Kiarash; Aractingi, Selim			Fetal progenitor cells naturally transferred through pregnancy participate in inflammation and angiogenesis during wound healing	FASEB JOURNAL			English	Article						microchimerism; skin; VEGFa	MESENCHYMAL STEM-CELLS; MARROW-DERIVED CELLS; BONE-MARROW; MATERNAL TISSUE; BLOOD; SKIN; MICROCHIMERISM; CONTRIBUTE; ORIGIN; REPAIR	The phenotype and fate of fetal microchimeric cells transfered into the maternal circulation during pregnancy are not well described. Since progenitors from distal sites mobilize during wound healing, we analyzed the recruitment and plasticity of fetal progenitors into maternal wounds. Wounds were generated on normal and bleomycin-induced fibrotic skin of parous or pregnant wild-type females with fluorescent GFP(+) fetuses. Analyses were performed on skin and blood specimens through PCR, immunohistochemistry, and flow cytometry. Controls consisted of parous and pregnant females without wounds and virgin females with wounds. Fetal cells were detected in all skin specimens of parous mice as long as healing was not achieved. During early stages of wound healing, fetal cells expressed mainly leukocyte markers, while in later phases endothelial markers prevailed. Fetally derived vessels connected to maternal circulation were also found, demonstrating the transfer of fetal endothelial progenitor cells. Wounding mobilized fetal CD34(+) ckit(-) cells into the blood during pregnancy. Most of this population was CD11b(-)VEGFR2(-). Another part was CD11b(+) with a fraction expressing VEGFR2. VEGFa-spiked Matrigel plugs partially mimicked this fetal progenitor recruitment and mobilization into the blood. In summary, fetal cells that mobilize in response to wounding are mainly progenitor cells and participate in angiogenesis and inflammation.-Nassar, D., Droitcourt, C., Mathieu-d'Argent, E., Kim, M. J., Khosrotehrani, K., Aractingi, S. Fetal progenitor cells naturally transferred through pregnancy participate in inflammation and angiogenesis during wound healing. FASEB J. 26, 149-157 (2012). www.fasebj.org	[Nassar, Dany; Droitcourt, Catherine; Mathieu-d'Argent, Emmanuelle; Kim, Min Ji; Khosrotehrani, Kiarash; Aractingi, Selim] Univ Paris 06, UMR 938, F-75012 Paris, France; [Nassar, Dany; Droitcourt, Catherine; Mathieu-d'Argent, Emmanuelle; Kim, Min Ji; Khosrotehrani, Kiarash; Aractingi, Selim] St Antoine Res Ctr, U938, Inst Natl Sante & Rech Med INSERM, Paris, France; [Khosrotehrani, Kiarash] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Aractingi, Selim] Hop Tenon, AP HP, Dept Dermatol, F-75970 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Queensland; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Nassar, D (corresponding author), Univ Paris 06, INSERM, UMR S 938, Ctr Rech St Antoine,Lab Cellules Souches Foetales, 27 Rue Chaligny, F-75012 Paris, France.	dany.nassar@inserm.fr	kim, minji/GRX-9996-2022; Khosrotehrani, Kiarash/M-8025-2015	Khosrotehrani, Kiarash/0000-0002-6406-4076; kim, Min Ji/0000-0002-1403-9331; Aractingi, Selim/0000-0002-7766-2673; Nassar, Dany/0000-0001-6780-0721	Pierre et Marie Curie University Paris 6; Societe Francaise de Dermatologie; ANR; Fondation Rene Touraine; STEM-Pole Ile-de-France; National Health and Medical Research Council [569822]	Pierre et Marie Curie University Paris 6; Societe Francaise de Dermatologie; ANR(French National Research Agency (ANR)); Fondation Rene Touraine; STEM-Pole Ile-de-France; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Pierre et Marie Curie University Paris 6, the Societe Francaise de Dermatologie, and the ANR PHYSIO2007 funding. D.N. was supported by the Fondation Rene Touraine and STEM-Pole Ile-de-France. K. K. was supported by National Health and Medical Research Council project grant 569822. The authors thank Philippe Fontange (Plateforme d'Imagerie IFR65, Hopital Tenon) for providing technical support and access to confocal microscopy, and Anne-Marie Faussat (Plateforme de Cytometrie IFR65, Saint-Antoine Research Centre). The authors thank Edwige Roy for important advice on flow cytometry and Elke Seppanen for proofreading the manuscript. Author contributions: D.N.: collection and assembly of data, data analysis and interpretation, and manuscript writing; C. D.: collection and assembly of data; E. M.-D.: collection and assembly of data; M.J.K.: collection and assembly of data; K. K.: conception and design, data analysis and interpretation, manuscript writing, final approval of manuscript; S. A.: conception and design, data analysis and interpretation, manuscript writing, final approval of manuscript. The authors declare no conflicts of interest.	Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Awad O, 2005, STEM CELLS, V23, P575, DOI 10.1634/stemcells.2004-0185; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Droitcourt C, 2008, J EUR ACAD DERMATOL, V22, P1256, DOI 10.1111/j.1468-3083.2008.02602.x; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Goolsby J, 2003, P NATL ACAD SCI USA, V100, P14926, DOI 10.1073/pnas.2434383100; Hildbrand P, 2004, BLOOD, V104, P2010, DOI 10.1182/blood-2003-12-4219; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hristov M, 2009, CYTOM PART A, V75A, P848, DOI 10.1002/cyto.a.20772; Huu SN, 2007, P NATL ACAD SCI USA, V104, P1871, DOI 10.1073/pnas.0606490104; Huu SN, 2009, AM J PATHOL, V174, P630, DOI 10.2353/ajpath.2009.080566; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Khosrotehrani K, 2007, HUM REPROD, V22, P654, DOI 10.1093/humrep/del426; Khosrotehrani K, 2005, J CELL SCI, V118, P1559, DOI 10.1242/jcs.02332; Khosrotehrani K, 2005, J REPROD IMMUNOL, V66, P1, DOI 10.1016/j.jri.2005.02.001; Khosrotehrani K, 2004, HUM REPROD, V19, P2460, DOI 10.1093/humrep/deh445; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Khosrotehrani K, 2008, J IMMUNOL, V180, P889, DOI 10.4049/jimmunol.180.2.889; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; Parant O, 2009, LAB INVEST, V89, P915, DOI 10.1038/labinvest.2009.55; Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Streit M, 2000, EMBO J, V19, P3272, DOI 10.1093/emboj/19.13.3272; Tan XW, 2005, STEM CELLS, V23, P1443, DOI 10.1634/stemcells.2004-0169; Tepper OM, 2010, DIABETES, V59, P1974, DOI 10.2337/db09-0185; Wang Y, 2004, BIOCHEM BIOPH RES CO, V325, P961, DOI 10.1016/j.bbrc.2004.10.105; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635	33	39	42	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					149	157		10.1096/fj.11-180695	http://dx.doi.org/10.1096/fj.11-180695			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21974929				2022-12-25	WOS:000299202200016
J	Liu, LJ; Sanosaka, M; Lei, S; Bestwick, ML; Frey, JH; Surovtseva, YV; Shadel, GS; Cooper, MP				Liu, Lijun; Sanosaka, Masato; Lei, Shi; Bestwick, Megan L.; Frey, Joseph H., Jr.; Surovtseva, Yulia V.; Shadel, Gerald S.; Cooper, Marcus P.			LRP130 Protein Remodels Mitochondria and Stimulates Fatty Acid Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-A; RICH PENTATRICOPEPTIDE-REPEAT; C-OXIDASE DEFICIENCY; MESSENGER-RNA; GENE-EXPRESSION; COMPLEX-I; ATP TURNOVER; FACTORS B1; NUCLEAR; DNA	Impaired oxidative phosphorylation (OXPHOS) is implicated in several metabolic disorders. Even though mitochondrial DNA encodes several subunits critical for OXPHOS, the metabolic consequence of activating mitochondrial transcription remains unclear. We show here that LRP130, a protein involved in Leigh syndrome, increases hepatic beta-fatty acid oxidation. Using convergent genetic and biochemical approaches, we demonstrate LRP130 complexes with the mitochondrial RNA polymerase to activate mitochondrial transcription. Activation of mitochondrial transcription is associated with increased OXPHOS activity, increased supercomplexes, and denser cristae, independent of mitochondrial biogenesis. Consistent with increased oxidative phosphorylation, ATP levels are increased in both cells and mouse liver, whereas coupled respiration is increased in cells. We propose activation of mitochondrial transcription remodels mitochondria and enhances oxidative metabolism.	[Liu, Lijun; Sanosaka, Masato; Lei, Shi; Frey, Joseph H., Jr.; Cooper, Marcus P.] Univ Massachusetts, Sch Med, Div Cardiovasc Med, Worcester, MA 01605 USA; [Bestwick, Megan L.; Surovtseva, Yulia V.; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Bestwick, Megan L.; Surovtseva, Yulia V.; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	University of Massachusetts System; University of Massachusetts Worcester; Yale University; Yale University	Cooper, MP (corresponding author), Univ Massachusetts, Sch Med, Div Cardiovasc Med, 381 Plantat St,Biotech 5,Ste 200, Worcester, MA 01605 USA.	marcus.cooper@umassmed.edu		Bestwick, Megan/0000-0003-3670-5507	National Institutes of Health [K08DK071017, R03DK081564, R01DK089185, R01HL059655]; James Hudson Brown-Alexander Brown Coxe Fellowship; NIDDK [DK32520]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089185, R03DK081564, K08DK071017, P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James Hudson Brown-Alexander Brown Coxe Fellowship; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08DK071017, R03DK081564, and R01DK089185 (to M. P. C.) and R01HL059655 (to G. S. S.). This work was also supported by a James Hudson Brown-Alexander Brown Coxe Fellowship (to Y. V. S.).; Core resources were supported by National Institutes of Health Diabetes Endocrinology Research Center Grant DK32520 from NIDDK	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Ainscow EK, 1999, EUR J BIOCHEM, V266, P737, DOI 10.1046/j.1432-1327.1999.00856.x; ALLEN JF, 1993, J THEOR BIOL, V165, P609, DOI 10.1006/jtbi.1993.1210; Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Cooper MP, 2008, J BIOL CHEM, V283, P31960, DOI 10.1074/jbc.M805431200; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Cotney J, 2009, HUM MOL GENET, V18, P2670, DOI 10.1093/hmg/ddp208; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; Duborjal H, 2002, GENOME RES, V12, P1901, DOI 10.1101/gr.194102; Duggan AT, 2011, J EXP BIOL, V214, P1880, DOI 10.1242/jeb.053322; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Enriquez JA, 1996, EUR J BIOCHEM, V237, P601, DOI 10.1111/j.1432-1033.1996.0601p.x; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; FISHER RP, 1985, J BIOL CHEM, V260, P1330; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Garbian Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009985; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Giege P, 2005, PLANT CELL, V17, P1497, DOI 10.1105/tpc.104.030254; Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400; HAFNER RP, 1990, EUR J BIOCHEM, V188, P313, DOI 10.1111/j.1432-1033.1990.tb15405.x; HAYASHI J, 1990, BIOCHEM BIOPH RES CO, V167, P216, DOI 10.1016/0006-291X(90)91753-F; Hokari M, 2010, NEUROPATHOLOGY, V30, P401, DOI 10.1111/j.1440-1789.2009.01086.x; Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835; Inoue K, 1997, BIOCHEM BIOPH RES CO, V239, P257, DOI 10.1006/bbrc.1997.7446; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Labialle S, 2004, NUCLEIC ACIDS RES, V32, P3864, DOI 10.1093/nar/gkh722; Lenaz G, 2010, ANTIOXID REDOX SIGN, V12, P961, DOI 10.1089/ars.2009.2704; Liang HY, 2007, ANN NY ACAD SCI, V1100, P264, DOI 10.1196/annals.1395.028; LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; Martinez-Azorin F, 2008, J NEUROCHEM, V105, P165, DOI 10.1111/j.1471-4159.2007.05122.x; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Montoya J, 1997, MOL CELL BIOCHEM, V174, P227, DOI 10.1023/A:1006812625445; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; MORIN C, 1993, AM J HUM GENET, V53, P488; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Rimoin David, 2006, PRINCIPLES PRACTICE; Rodeheffer MS, 2001, J BIOL CHEM, V276, P8616, DOI 10.1074/jbc.M009901200; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Shadel GS, 2008, AM J PATHOL, V172, P1445, DOI 10.2353/ajpath.2008.071163; Shutt TE, 2010, P NATL ACAD SCI USA, V107, P12133, DOI 10.1073/pnas.0910581107; Soboll S, 1998, EUR J BIOCHEM, V254, P194, DOI 10.1046/j.1432-1327.1998.2540194.x; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Sondheimer N, 2010, BIOCHEMISTRY-US, V49, P7467, DOI 10.1021/bi1008479; Spurway TD, 1997, BIOCHEM J, V323, P119, DOI 10.1042/bj3230119; Sterky FH, 2010, BIOCHEM BIOPH RES CO, V398, P759, DOI 10.1016/j.bbrc.2010.07.019; Sunny NE, 2010, AM J PHYSIOL-ENDOC M, V298, pE1226, DOI 10.1152/ajpendo.00033.2010; Tavares-Carreon F, 2008, J BIOL CHEM, V283, P1472, DOI 10.1074/jbc.M708437200; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Topisirovic I, 2009, EMBO J, V28, P1087, DOI 10.1038/emboj.2009.53; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Tsuchiya N, 2004, BIOCHEM BIOPH RES CO, V317, P736, DOI 10.1016/j.bbrc.2004.03.103; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Xu F., 2011, BIOCHEM IN PRESS; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469	82	37	37	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41253	41264		10.1074/jbc.M111.276121	http://dx.doi.org/10.1074/jbc.M111.276121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21971050	Green Published, hybrid			2022-12-25	WOS:000298057500013
J	Luthra, A; Zhu, GY; Desrosiers, DC; Eggers, CH; Mulay, V; Anand, A; McArthur, FA; Romano, FB; Caimano, MJ; Heuck, AP; Malkowski, MG; Radolf, JD				Luthra, Amit; Zhu, Guangyu; Desrosiers, Daniel C.; Eggers, Christian H.; Mulay, Vishwaroop; Anand, Arvind; McArthur, Fiona A.; Romano, Fabian B.; Caimano, Melissa J.; Heuck, Alejandro P.; Malkowski, Michael G.; Radolf, Justin D.			The Transition from Closed to Open Conformation of Treponema pallidum Outer Membrane-associated Lipoprotein TP0453 Involves Membrane Sensing and Integration by Two Amphipathic Helices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORRELIA-BURGDORFERI; MYCOBACTERIUM-TUBERCULOSIS; SYPHILIS SPIROCHETE; PHYSICAL-PROPERTIES; ESCHERICHIA-COLI; PROTEIN; SURFACE; REFINEMENT; LOCALIZATION; PHAGOCYTOSIS	The molecular architecture and composition of the outer membrane (OM) of Treponema pallidum (Tp), the noncultivable agent of venereal syphilis, differ considerably from those of typical Gram-negative bacteria. Several years ago we described TP0453, the only lipoprotein associated with the inner leaflet of the Tp OM. Whereas polypeptides of other treponemal lipoproteins are hydrophilic, non-lipidated TP0453 can integrate into membranes, a property attributed to its multiple amphipathic helices (AHs). Furthermore, membrane integration of the TP0453 polypeptide was found to increase membrane permeability, suggesting the molecule functions in a porin-like manner. To better understand the mechanism of membrane integration of TP0453 and its physiological role in Tp OM biogenesis, we solved its crystal structure and used mutagenesis to identify membrane insertion elements. The crystal structure of TP0453 consists of an alpha/beta/alpha-fold and includes five stably folded AHs. In high concentrations of detergent, TP0453 transitions from a closed to open conformation by lateral movement of two groups of AHs, exposing a large hydrophobic cavity. Triton X-114 phase partitioning, liposome floatation assay, and bis-1-anilino-8-naphthalenesulfonate binding revealed that two adjacent AHs are critical for membrane sensing/integration. Using terbium-dipicolinic acid complex-loaded large unilamellar vesicles, we found that TP0453 increased efflux of fluorophore only at acidic pH. Gel filtration and cross-linking experiments demonstrated that one AH critical for membrane sensing/insertion also forms a dimeric interface. Based on structural dynamics and comparison with Mycobacterium tuberculosis lipoproteins LprG and LppX, we propose that TP0453 functions as a carrier of lipids, glycolipids, and/or derivatives during OM biogenesis.	[Luthra, Amit; Mulay, Vishwaroop; Anand, Arvind; McArthur, Fiona A.; Caimano, Melissa J.; Radolf, Justin D.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA; [Radolf, Justin D.] Univ Connecticut, Ctr Hlth, Dept Pediat, Farmington, CT 06030 USA; [Radolf, Justin D.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Radolf, Justin D.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA; [Zhu, Guangyu; Malkowski, Michael G.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Zhu, Guangyu; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Desrosiers, Daniel C.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; [Eggers, Christian H.] Quinnipiac Univ, Dept Biomed Sci, Hamden, CT 06518 USA; [Heuck, Alejandro P.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Romano, Fabian B.; Heuck, Alejandro P.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Yale University; Quinnipiac University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Radolf, JD (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA.	JRadolf@up.uchc.edu	Malkowski, Michael G/G-4939-2011; Caimano, Melissa J./AAR-6578-2020; Caimano, Melissa J./AAQ-7573-2021; Zhu, Guangyu/F-6279-2011; Romano-Chernac, Fabian B./K-9396-2019	Malkowski, Michael G/0000-0003-1025-0014; Zhu, Guangyu/0000-0003-4228-135X; Malkowski, Michael/0000-0002-1203-7463	Public Health Service [AI-26756, RG-71111-N]; National Institutes of Health [GM074899, GM094611, GM094597]; National Institutes of Health National Research Service [T32 GM08515]; Notional Science Foundation under National Science Foundation [DMR-0225180]; National Center for Research Resources National Institutes of Health [RR-01646]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health; National Center for Research Resources; Biomedical Technology Program; NIGMS; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI026756, R37AI026756, R01AI026756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597, U54GM074899, T32GM008515, U54GM094611] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notional Science Foundation under National Science Foundation; National Center for Research Resources National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service Grants AI-26756 (to J. D. R.) and RG-71111-N (to A. P. H.). This work was also supported, in whole or in part, by National Institutes of Health Grants GM074899, GM094611, and GM094597 (NIGMS Protein Structure Initiative to the High throughput screening laboratory at the Hauptman Woodward Institute).; Supported in part by National Institutes of Health National Research Service Award T32 GM08515.; This work was based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the Notional Science Foundation under National Science Foundation Award DMR-0225180 using the Macromolecular Diffraction at CHESS (Mac CHESS,) facility, which is supported by National Center for Research Resources National Institutes of Health Award RR-01646. Portions of this research were also carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the NIGMS. We acknowledge the excellent technical assistance of Morgan LeDoyt and thank Star Dunham-Ems and V.Kuruthihalli (University of Connecticut Health Center) for valuable discussions,	BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; Brunner J, 1996, TRENDS CELL BIOL, V6, P154, DOI 10.1016/0962-8924(96)40001-0; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; Cameron CE, 2006, PATHOGENIC TREPONEMA : MOLECULAR AND CELLULAR BIOLOGY, P237; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Cox DL, 2010, INFECT IMMUN, V78, P5178, DOI 10.1128/IAI.00834-10; Cox DL, 2001, MICROBIOL-SGM, V147, P1161, DOI 10.1099/00221287-147-5-1161; COX DL, 1994, METHOD ENZYMOL, V236, P390; Dasanayake D, 2011, MOL MICROBIOL, V81, P734, DOI 10.1111/j.1365-2958.2011.07727.x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Desrosiers DC, 2011, MOL MICROBIOL, V80, P1496, DOI 10.1111/j.1365-2958.2011.07662.x; Drage MG, 2010, NAT STRUCT MOL BIOL, V17, P1088, DOI 10.1038/nsmb.1869; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARRIS FJ, 1978, J AM CHEM SOC, V100, P4469, DOI 10.1021/ja00482a026; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Hazlett KRO, 2005, J BACTERIOL, V187, P6499, DOI 10.1128/JB.187.18.6499-6508.2005; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOPE MJ, 1986, CHEM PHYS LIPIDS, V40, P89, DOI 10.1016/0009-3084(86)90065-4; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; JONES JD, 1995, INFECT IMMUN, V63, P2424, DOI 10.1128/IAI.63.7.2424-2434.1995; Koszelak-Rosenblum M, 2009, PROTEIN SCI, V18, P1828, DOI 10.1002/pro.193; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; LUKEHART SA, 1978, J IMMUNOL, V121, P2014; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore MW, 2007, INFECT IMMUN, V75, P2046, DOI 10.1128/IAI.01666-06; Moreira JN, 1996, J MATER SCI-MATER M, V7, P301, DOI 10.1007/BF00058571; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narita S, 2004, ARCH MICROBIOL, V182, P1, DOI 10.1007/s00203-004-0682-4; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RADOLF JD, 1995, INFECT IMMUN, V63, P4244, DOI 10.1128/IAI.63.11.4244-4252.1995; RADOLF JD, 1995, MOL MICROBIOL, V16, P1067, DOI 10.1111/j.1365-2958.1995.tb02332.x; ROSEVEAR P, 1980, BIOCHEMISTRY-US, V19, P4108, DOI 10.1021/bi00558a032; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shevchenko DV, 1999, INFECT IMMUN, V67, P2266, DOI 10.1128/IAI.67.5.2266-2276.1999; Smoot AL, 2001, BIOCHEMISTRY-US, V40, P4484, DOI 10.1021/bi001822b; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Steinkellner G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-32; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; WALKER EM, 1989, J BACTERIOL, V171, P5005, DOI 10.1128/jb.171.9.5005-5011.1989; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635	56	22	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41656	41668		10.1074/jbc.M111.305284	http://dx.doi.org/10.1074/jbc.M111.305284			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965687	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000298057500050
J	Zhang, Q; Chen, L; Helfand, BT; Jang, TL; Sharma, V; Kozlowski, J; Kuzel, TM; Zhu, LJ; Yang, XJ; Javonovic, B; Guo, YL; Lonning, S; Harper, J; Teicher, BA; Brendler, C; Yu, NW; Catalona, WJ; Lee, C				Zhang, Qiang; Chen, Lin; Helfand, Brian T.; Jang, Thomas L.; Sharma, Vidit; Kozlowski, James; Kuzel, Timothy Michael; Zhu, Lihua J.; Yang, Ximing J.; Javonovic, Borko; Guo, Yinglu; Lonning, Scott; Harper, Jay; Teicher, Beverly A.; Brendler, Charles; Yu, Nengwang; Catalona, William J.; Lee, Chung			TGF-beta Regulates DNA Methyltransferase Expression in Prostate Cancer, Correlates with Aggressive Capabilities, and Predicts Disease Recurrence	PLOS ONE			English	Article							CD8(+) T-CELLS; GROWTH-FACTOR; PROTEIN EXPRESSION; METHYLATION; TUMOR; INHIBITION; PATHWAY; PROLIFERATION; MECHANISM; ERK	Background: DNA methyltransferase (DNMT) is one of the major factors mediating the methylation of cancer related genes such as TGF-beta receptors (T beta Rs). This in turn may result in a loss of sensitivity to physiologic levels of TGF-beta in aggressive prostate cancer (CaP). The specific mechanisms of DNMT's role in CaP remain undetermined. In this study, we describe the mechanism of TGF-beta-mediated DNMT in CaP and its association with clinical outcomes following radical prostatectomy. Methodology/Principal Findings: We used human CaP cell lines with varying degrees of invasive capability to describe how TGF-beta mediates the expression of DNMT in CaP, and its effects on methylation status of TGF-beta receptors and the invasive capability of CaP in vitro and in vivo. Furthermore, we determined the association between DNMT expression and clinical outcome after radical prostatectomy. We found that more aggressive CaP cells had significantly higher TGF-b levels, increased expression of DNMT, but reduced T beta Rs when compared to benign prostate cells and less aggressive prostate cancer cells. Blockade of TGF-beta signaling or ERK activation (p-ERK) was associated with a dramatic decrease in the expression of DNMT, which results in a coincident increase in the expression of T beta Rs. Blockade of either TGF-beta signaling or DNMT dramatically decreased the invasive capabilities of CaP. Inhibition of TGF-beta in an TRAMP-C2 CaP model in C57BL/6 mice using 1D11 was associated with downregulation of DNMTs and p-ERK and impairment in tumor growth. Finally, independent of Gleason grade, increased DNMT1 expression was associated with biochemical recurrence following surgical treatment for prostate cancer. Conclusions and Significance: Our findings demonstrate that CaP derived TGF-beta may induce the expression of DNMTs in CaP which is associated with methylation of its receptors and the aggressive potential of CaP. In addition, DNMTs is an independent predictor for disease recurrence after prostatectomy, and may have clinical implications for CaP prognostication and therapy.	[Zhang, Qiang; Chen, Lin; Helfand, Brian T.; Sharma, Vidit; Kozlowski, James; Yu, Nengwang; Catalona, William J.; Lee, Chung] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Zhang, Qiang; Kozlowski, James; Yang, Ximing J.; Javonovic, Borko; Catalona, William J.; Lee, Chung] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Jang, Thomas L.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA; [Kuzel, Timothy Michael] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Zhu, Lihua J.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Boston, MA 02125 USA; [Yang, Ximing J.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Javonovic, Borko] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Guo, Yinglu] Peking Univ, Inst Urol, Dept Urol, Hosp 1, Beijing 100871, Peoples R China; [Lonning, Scott; Harper, Jay; Teicher, Beverly A.] Genzyme Corp, Framingham, MA 01701 USA; [Brendler, Charles] Northshore Univ Heathsyst, Dept Surg, Evanston, IL USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Northwestern University; Feinberg School of Medicine; University of Massachusetts System; University of Massachusetts Boston; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Peking University; Sanofi-Aventis; Genzyme Corporation; NorthShore University Health System	Zhang, Q (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	q-zhang2@northwestern.edu			National Cancer Institute, NIH [2 P50CA090386-06A2]; National Cancer Institute [U01 CA152738]; American Cancer Society, Illinois [08-22]; Department of Defense [W81XWH-09-1-0311]; Portes Center/Institute of Medicine of Chicago; American Cancer Society [ACS-IRG 93-037-12]; Genzyme Corporation; Northshore University Healthsystem; NATIONAL CANCER INSTITUTE [U01CA152738, P50CA090386] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society, Illinois(American Cancer Society); Department of Defense(United States Department of Defense); Portes Center/Institute of Medicine of Chicago; American Cancer Society(American Cancer Society); Genzyme Corporation(Sanofi-AventisGenzyme Corporation); Northshore University Healthsystem; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by Grant Number 2 P50CA090386-06A2 from the National Cancer Institute, NIH, as well as grants from the National Cancer Institute (U01 CA152738), American Cancer Society, Illinois (#08-22), Department of Defense (W81XWH-09-1-0311), Portes Center/Institute of Medicine of Chicago (QZ), American Cancer Society Institutional Research Grant (ACS-IRG 93-037-12), a grant from the Genzyme Corporation, a grant from Northshore University Healthsystem, and a gift from Mr. Fred L. Turner. Through the employment of SL, JH and BT, Genzyme Corporation's role included: providing reagents, offering suggestions of experimental design and help with the preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Attwood John, 2004, Methods Mol Biol, V287, P273; Bacolla A, 1999, J BIOL CHEM, V274, P33011, DOI 10.1074/jbc.274.46.33011; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bender CM, 1998, CANCER RES, V58, P95; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Chan MF, 2000, CURR TOP MICROBIOL, V249, P75; Chen MF, 2010, J MOL MED, V88, P953, DOI 10.1007/s00109-010-0640-3; Deng C, 2003, ARTHRITIS RHEUM, V48, P746, DOI 10.1002/art.10833; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Fandy TE, 2009, CURR MED CHEM, V16, P2075, DOI 10.2174/092986709788612738; Ghoshal K, 2007, DRUG TODAY, V43, P395, DOI 10.1358/dot.2007.43.6.1062666; Giehl K, 2000, ONCOGENE, V19, P4531, DOI 10.1038/sj.onc.1203806; Gowher H, 2004, CANCER BIOL THER, V3, P1062, DOI 10.4161/cbt.3.11.1308; Grizzle WE, 1998, METH MOLEC MED, V14, P143; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kim IY, 1996, CANCER RES, V56, P44; KOZLOWSKI JM, 1991, INNOVATIONS UROLOGIC, P13; KOZLOWSKI JM, 1988, TUMOR PROGR METASTAS, P189; LEE C, 1993, CANCER METAST REV, V12, P21, DOI 10.1007/BF00689787; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; LIN C, 2010, 101 AM UR ASS ANN M; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Lu QJ, 2005, J IMMUNOL, V174, P6212, DOI 10.4049/jimmunol.174.10.6212; Lu R, 2007, J BIOL CHEM, V282, P12249, DOI 10.1074/jbc.M608525200; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; Perry K, 2008, UROLOGY, V72, P225, DOI 10.1016/j.urology.2007.11.091; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Saito Y, 2003, INT J CANCER, V105, P527, DOI 10.1002/ijc.11127; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Serganova I, 2009, FASEB J, V23, P2662, DOI 10.1096/fj.08-126920; Sintich SM, 1999, ENDOCRINOLOGY, V140, P3411, DOI 10.1210/en.140.8.3411; Steg A, 2007, DIAGN MOL PATHOL, V16, P229, DOI 10.1097/PDM.0b013e31811edc7e; WU JC, 1987, J BIOL CHEM, V262, P4778; Xing J, 2008, BRIT J CANCER, V98, P1716, DOI 10.1038/sj.bjc.6604343; Yu NF, 2008, CURR MED CHEM, V15, P1350, DOI 10.2174/092986708784567653; Zhang Q, 2005, MOL ENDOCRINOL, V19, P2390, DOI 10.1210/me.2005-0096; Zhang Q, 2005, CANCER RES, V65, P1761, DOI 10.1158/0008-5472.CAN-04-3169; ZHANG Q, 2011, 102 AM ASS CANC RES; Zhang Q, 2006, MOL CANCER THER, V5, P1733, DOI 10.1158/1535-7163.MCT-06-0109; Zhang Q, 2009, CLIN CANCER RES, V15, P3557, DOI 10.1158/1078-0432.CCR-08-1656; Zhou W, 2003, ENDOCRINOLOGY, V144, P4280, DOI 10.1210/en.2003-0554	49	59	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25168	10.1371/journal.pone.0025168	http://dx.doi.org/10.1371/journal.pone.0025168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980391	Green Published, gold			2022-12-25	WOS:000295941300021
J	Nawata, H; Kashino, G; Tano, K; Daino, K; Shimada, Y; Kugoh, H; Oshimura, M; Watanabe, M				Nawata, Hisakatsu; Kashino, Genro; Tano, Keizo; Daino, Kazuhiro; Shimada, Yoshiya; Kugoh, Hiroyuki; Oshimura, Mitsuo; Watanabe, Masami			Dysregulation of Gene Expression in the Artificial Human Trisomy Cells of Chromosome 8 Associated with Transformed Cell Phenotypes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; DNA METHYLATION; WILMS-TUMORS; TSLC1 GENE; LIFE-SPAN; WT1 GENE; ABERRATIONS; ANEUPLOIDY; IMMORTALIZATION; ARCHITECTURE	A change in chromosome number, known as aneuploidy is a common characteristic of cancer. Aneuploidy disrupts gene expression in human cancer cells and immortalized human epithelial cells, but not in normal human cells. However, the relationship between aneuploidy and cancer remains unclear. To study the effects of aneuploidy in normal human cells, we generated artificial cells of human primary fibroblast having three chromosome 8 (trisomy 8 cells) by using microcell- mediated chromosome transfer technique. In addition to decreased proliferation, the trisomy 8 cells lost contact inhibition and reproliferated after exhibiting senescence-like characteristics that are typical of transformed cells. Furthermore, the trisomy 8 cells exhibited chromosome instability, and the overall gene expression profile based on microarray analyses was significantly different from that of diploid human primary fibroblasts. Our data suggest that aneuploidy, even a single chromosome gain, can be introduced into normal human cells and causes, in some cases a partial cancer phenotype due to a disruption in overall gene expression.	[Nawata, Hisakatsu; Tano, Keizo; Watanabe, Masami] Kyoto Univ, Inst Res Reactor, Radiat Biol Lab, Osaka 59004, Japan; [Kashino, Genro] Oita Univ, Sch Med, Adv Mol Imaging Ctr, Oita 87011, Japan; [Daino, Kazuhiro; Shimada, Yoshiya] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Expt Radiobiol Childrens Hlth Res Grp, Chiba 260, Japan; [Kugoh, Hiroyuki; Oshimura, Mitsuo] Tottori Univ, Grad Sch Med Sci, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Tottori 680, Japan	Kyoto University; Oita University; National Institutes for Quantum Science & Technology; Tottori University	Nawata, H (corresponding author), Kyoto Univ, Inst Res Reactor, Radiat Biol Lab, Osaka 59004, Japan.	msm@rri.kyoto-u.ac.jp	Nawata, Hisakatsu/F-5351-2011		Ministry of Education, Culture, Sports, Science and Technology of Japan [21310036]; Nuclear Safety Commission of Japan; Central Research Institute of Electric Power Industry; Grants-in-Aid for Scientific Research [22501012] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nuclear Safety Commission of Japan; Central Research Institute of Electric Power Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21310036) and for The Nuclear Safety Research Enhancement Actions from the Nuclear Safety Commission of Japan. A grant from the Central Research Institute of Electric Power Industry also supported part of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGAR EM, 1995, HUM MUTAT, V5, P221, DOI 10.1002/humu.1380050306; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boffetta P, 2007, AM J EPIDEMIOL, V165, P36, DOI 10.1093/aje/kwj367; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; COPPES MJ, 1993, FASEB J, V7, P886, DOI 10.1096/fasebj.7.10.8393819; Doherty AMO, 2003, MAMM GENOME, V14, P583, DOI 10.1007/s00335-003-4002-0; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; FLETCHER JA, 1995, CANCER GENET CYTOGEN, V79, P139, DOI 10.1016/0165-4608(94)00134-W; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fukami T, 2003, INT J CANCER, V107, P53, DOI 10.1002/ijc.11348; Ganmore I, 2009, HUM MOL GENET, V18, pR84, DOI 10.1093/hmg/ddp084; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Goto A, 2005, CANCER SCI, V96, P480, DOI 10.1111/j.1349-7006.2005.00075.x; HABER DA, 1993, SCIENCE, V262, P2057, DOI 10.1126/science.8266105; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heller G, 2006, ONCOGENE, V25, P959, DOI 10.1038/sj.onc.1209115; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Ito T, 2003, CANCER RES, V63, P6320; Kodama S, 2001, RADIAT RES, V155, P254, DOI 10.1667/0033-7587(2001)155[0254:CCDSLG]2.0.CO;2; Kugoh H, 1999, DNA Res, V6, P165, DOI 10.1093/dnares/6.3.165; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Little M, 1997, HUM MUTAT, V9, P209, DOI 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2; Loeb DM, 2002, INT J HEMATOL, V76, P117, DOI 10.1007/BF02982573; Mao XL, 2004, ONCOGENE, V23, P5632, DOI 10.1038/sj.onc.1207756; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; PERUCHO M, 1981, CELL, V27, P467, DOI 10.1016/0092-8674(81)90388-3; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; RAUSCHER FJ, 1993, FASEB J, V7, P896, DOI 10.1096/fasebj.7.10.8393820; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sakurai-Yageta M, 2009, BIOCHEM BIOPH RES CO, V390, P977, DOI 10.1016/j.bbrc.2009.10.088; SANKARY S, 1993, CANCER GENET CYTOGEN, V65, P152, DOI 10.1016/0165-4608(93)90225-B; SCHOFIELD DE, 1994, AM J SURG PATHOL, V18, P14, DOI 10.1097/00000478-199401000-00002; SCHOFIELD DE, 1993, AM J PATHOL, V143, P714; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; Shimizu K, 2007, BIOCHEM BIOPH RES CO, V353, P522, DOI 10.1016/j.bbrc.2006.12.048; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; SOLOMON E, 1991, SCIENCE, V254, P1153, DOI 10.1126/science.1957167; Sugiyama H, 2010, JPN J CLIN ONCOL, V40, P377, DOI 10.1093/jjco/hyp194; Suzuki M, 1998, J RADIAT RES, V39, P203, DOI 10.1269/jrr.39.203; Tsujiuchi T, 2007, CANCER SCI, V98, P943, DOI 10.1111/j.1349-7006.2007.00480.x; Upender MB, 2004, CANCER RES, V64, P6941, DOI 10.1158/0008-5472.CAN-04-0474; Virtaneva K, 2001, P NATL ACAD SCI USA, V98, P1124, DOI 10.1073/pnas.98.3.1124; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Yang Z, 1998, J RADIAT RES, V39, P35, DOI 10.1269/jrr.39.35	52	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25319	10.1371/journal.pone.0025319	http://dx.doi.org/10.1371/journal.pone.0025319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980425	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600019
J	Iwasaki, H; Kawamoto, A; Tjwa, M; Horii, M; Hayashi, S; Oyamada, A; Matsumoto, T; Suehiro, S; Carmeliet, P; Asahara, T				Iwasaki, Hiroto; Kawamoto, Atsuhiko; Tjwa, Marc; Horii, Miki; Hayashi, Saeko; Oyamada, Akira; Matsumoto, Tomoyuki; Suehiro, Shigefumi; Carmeliet, Peter; Asahara, Takayuki			PlGF Repairs Myocardial Ischemia through Mechanisms of Angiogenesis, Cardioprotection and Recruitment of Myo-Angiogenic Competent Marrow Progenitors	PLOS ONE			English	Article							PLACENTAL GROWTH-FACTOR; GENE-TRANSFER; FACTOR-I; DOUBLE-BLIND; EXPRESSION; CELLS; REVASCULARIZATION; HEART; VEGF; IMPROVEMENT	Rationale: Despite preclinical success in regenerating and revascularizing the infarcted heart using angiogenic growth factors or bone marrow (BM) cells, recent clinical trials have revealed less benefit from these therapies than expected. Objective: We explored the therapeutic potential of myocardial gene therapy of placental growth factor (PlGF), a VEGF-related angiogenic growth factor, with progenitor-mobilizing activity. Methods and Results: Myocardial PlGF gene therapy improves cardiac performance after myocardial infarction, by inducing cardiac repair and reparative myoangiogenesis, via upregulation of paracrine anti-apoptotic and angiogenic factors. In addition, PlGF therapy stimulated Sca-1(+)/Lin(-) (SL) BM progenitor proliferation, enhanced their mobilization into peripheral blood, and promoted their recruitment into the peri-infarct borders. Moreover, PlGF enhanced endothelial progenitor colony formation of BM-derived SL cells, and induced a phenotypic switch of BM-SL cells, recruited in the infarct, to the endothelial, smooth muscle and cardiomyocyte lineage. Conclusions: Such pleiotropic effects of PlGF on cardiac repair and regeneration offer novel opportunities in the treatment of ischemic heart disease.	[Iwasaki, Hiroto; Kawamoto, Atsuhiko; Horii, Miki; Hayashi, Saeko; Oyamada, Akira; Matsumoto, Tomoyuki; Asahara, Takayuki] RIKEN, Ctr Dev Biol, Inst Biomed Res & Innovat, Kobe, Hyogo, Japan; [Iwasaki, Hiroto; Suehiro, Shigefumi] Osaka City Univ, Dept Cardiovasc Surg, Grad Sch Med, Osaka 558, Japan; [Tjwa, Marc; Carmeliet, Peter] Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, Louvain, Belgium; [Tjwa, Marc; Carmeliet, Peter] VIB, Dept Transgene Technol & Gene Therapy, Louvain, Belgium; [Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa 25911, Japan	Institute for Biomedical Research & Innovation (IBRI); RIKEN; Osaka Metropolitan University; KU Leuven; Flanders Institute for Biotechnology (VIB); Tokai University	Iwasaki, H (corresponding author), RIKEN, Ctr Dev Biol, Inst Biomed Res & Innovat, Kobe, Hyogo, Japan.	kawamoto@fbri.org; asa777@is.icc.u-tokai.ac.jp	Carmeliet, Peter/AAQ-5140-2020	Carmeliet, Peter/0000-0001-7961-1821; Kawamoto, Atsuhiko/0000-0002-2733-8015; Matsumoto, Tomoyuki/0000-0003-4587-0029	Japanese Ministry of Health, Labour and Welfare [H14-trans-001, H17-trans-002]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) [G.0121.02]; Belgian Science Policy [IAP-P5/02]; Concerted Research Activities, Belgium [GOA2001/09, GOA2006/11]	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Belgian Science Policy(Belgian Federal Science Policy Office); Concerted Research Activities, Belgium	This work was supported by a Health and Labour Sciences Research Grant (H14-trans-001, H17-trans-002) from the Japanese Ministry of Health, Labour and Welfare and by grants from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO G.0121.02), the Belgian Science Policy (project no. IAP-P5/02), from the Concerted Research Activities, Belgium (grants #GOA2001/09 and GOA2006/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini A, 2002, CANCER RES, V62, P2749; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3; Cianfarani F, 2006, AM J PATHOL, V169, P1167, DOI 10.2353/ajpath.2006.051314; Dallabrida SM, 2005, CIRC RES, V96, DOI 10.1161/01.RES.0000158285.57191.60; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Fukuhara S, 2004, CELL TRANSPLANT, V13, P741, DOI 10.3727/000000004783983486; Horio T, 2005, REGUL PEPTIDES, V124, P65, DOI 10.1016/j.regpep.2004.06.029; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Iwama H, 2006, J AM COLL CARDIOL, V47, P1559, DOI 10.1016/j.jacc.2005.11.064; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kidoguchi K, 2006, STROKE, V37, P1856, DOI 10.1161/01.STR.0000226904.96059.a6; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Lenderink T, 2006, J AM COLL CARDIOL, V47, P307, DOI 10.1016/j.jacc.2005.08.063; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; Losordo DW, 2002, CIRCULATION, V105, P2012, DOI 10.1161/01.CIR.0000015982.70785.B7; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Mehrhof FB, 2001, CIRCULATION, V104, P2088, DOI 10.1161/hc4201.097133; Ninomiya M, 2003, GENE THER, V10, P1152, DOI 10.1038/sj.gt.3301984; Odorisio T, 2006, J DERMATOL SCI, V41, P11, DOI 10.1016/j.jdermsci.2005.08.008; Roy H, 2005, HUM GENE THER, V16, P1422, DOI 10.1089/hum.2005.16.1422; Szukiewicz D, 2005, GYNECOL OBSTET INVES, V59, P102, DOI 10.1159/000082622; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Wei SC, 2005, GUT, V54, P666, DOI 10.1136/gut.2004.050831	31	48	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24872	10.1371/journal.pone.0024872	http://dx.doi.org/10.1371/journal.pone.0024872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969865	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900016
J	Liu, MY; Liu, WY; Luo, J; Liu, YL; Zhu, Y; Berman, H; Wu, JG				Liu, Michelle Y.; Liu, Weiyong; Luo, Jun; Liu, Yingle; Zhu, Yang; Berman, Hillary; Wu, Jianguo			Characterization of an Outbreak of Hand, Foot, and Mouth Disease in Nanchang, China in 2010	PLOS ONE			English	Article							ENTEROVIRUS 71 INFECTION; MOLECULAR EPIDEMIOLOGY; RECOMBINATION; TAIWAN; CIRCULATION; PREVALENCE; CHILDREN; JAPAN	Recent outbreaks of human enterovirus 71 (EV71) infection and EV71-associated hand, foot, and mouth disease (HFMD) in China have affected millions and potentially lead to life-threatening complications in newborns. Furthermore, these outbreaks represent a significant global public health issue in the world. Understanding the epidemiology of HFMD and EV71 infection and their transmission patterns in China is essential for controlling outbreaks. However, no studies on the outbreaks of HFMD and EV71 infection in China during 2010 have been reported. In this report, we carried out an epidemiological analysis to study an outbreak of HFMD and EV71 infection in 2010 in the city of Nanchang in the Jiangxi province of People's Republic of China. From April 7 to May 11, 2010, a total of 109 HFMD cases were reported, and in this report the HFMD cases were studied by both epidemiological and laboratory analyses. The epidemiological study indicates that children aged younger than 8 years old represented more than 90% of the reported cases, with the age group of 1-3 years containing the highest number of cases. Laboratory studies detected a high prevalence of EV71 amongst the cases in our study, suggesting EV71 as a common enterovirus found in HFMD cases in Nanchang. Phylogenetic analysis of the sequence of the VP1 region of four EV71 isolates indicated that the Nanchang strains belong to the C4 subgenotype commonly found in China during outbreaks in 2008 but contain distinct variations from these strains. Our study for the first time characterizes the epidemiology of HFMD and EV71 infection in China in 2010 and furthermore, provides the first direct evidence of the genotype of EV71 circulating in Nanchang, China. Our study should facilitate the development of public health measures for the control and prevention of HFMD and EV71 infection in at-risk individuals in China.	[Liu, Michelle Y.; Liu, Weiyong; Luo, Jun; Liu, Yingle; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Michelle Y.; Liu, Weiyong; Luo, Jun; Liu, Yingle; Wu, Jianguo] Wuhan Univ, Zhongnan Hosp, Chinese French Liver Dis Res Inst, Wuhan 430072, Peoples R China; [Zhu, Yang] Jiangsu Affynigen Biotechnol Inc, Taizhou Inst Virol, Taizhou, Jiangsu, Peoples R China; [Berman, Hillary] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Liu, Weiyong; Liu, Yingle; Wu, Jianguo] Wuhan E Lake High Technol Dev Zone, Wuhan Inst Biotechnol, Wuhan, Peoples R China	Wuhan University; Wuhan University; University of California System; University of California Berkeley	Liu, MY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	jwu@whu.edu.cn		Wu, Jianguo/0000-0002-8326-2895	National Mega Project on Major Infectious Diseases Prevention [2008ZX10002-009, 2008ZX10204, 2009ZX10004-207]; National Mega Project on Major Drug Development [2009ZX09301-014, 2011ZX09401-302]; National Science Foundation of China [30730001, 30872491, 81030031]; Major State Basic Research Development Program [2007CB512803, 2009CB522506, 2011CB504800]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0745]; Chinese Ministry of Education [204114208]; Department of Science and Technology of Hubei Province [2005ABC003]; Fundamental Research Funds for the Central Universities [1102001]; Specialized Research Fund for the Doctoral Program of Higher Education [20090141110033]	National Mega Project on Major Infectious Diseases Prevention; National Mega Project on Major Drug Development; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chinese Ministry of Education(Ministry of Education, China); Department of Science and Technology of Hubei Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by research grants from the National Mega Project on Major Infectious Diseases Prevention (2008ZX10002-009, 2008ZX10204, and 2009ZX10004-207), the National Mega Project on Major Drug Development (2009ZX09301-014 and 2011ZX09401-302), the National Science Foundation of China (30730001 30872491, and 81030031), the Major State Basic Research Development Program (2007CB512803, 2009CB522506, and 2011CB504800), the Program for Changjiang Scholars and Innovative Research Team in University (IRT0745), the Key Project of the Chinese Ministry of Education (204114208), the Department of Science and Technology of Hubei Province (2005ABC003), Fundamental Research Funds for the Central Universities (1102001), and the Specialized Research Fund for the Doctoral Program of Higher Education (20090141110033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chen CH, 2008, J APPL MICROBIOL, V104, P817, DOI 10.1111/j.1365-2672.2007.03598.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Hsu BM, 2008, FEMS IMMUNOL MED MIC, V52, P253, DOI 10.1111/j.1574-695X.2008.00379.x; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Komatsu H, 1999, PEDIATR NEUROL, V20, P17, DOI 10.1016/S0887-8994(98)00087-3; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Mao L. X., 2010, J CLIN VIRO IN PRESS; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Oberste MS, 2004, J VIROL, V78, P2948, DOI 10.1128/JVI.78.6.2948-2955.2004; Oprisan G, 2002, J GEN VIROL, V83, P2193, DOI 10.1099/0022-1317-83-9-2193; Ortner B, 2009, J MED VIROL, V81, P317, DOI 10.1002/jmv.21374; Pallansch, 2007, FIELDS VIROLOGY, P839; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Witso E, 2007, VIRUS RES, V123, P19, DOI 10.1016/j.virusres.2006.07.015; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	35	63	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25287	10.1371/journal.pone.0025287	http://dx.doi.org/10.1371/journal.pone.0025287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980416	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900047
J	Wang, DP; Calla, B; Vimolmangkang, S; Wu, X; Korban, SS; Huber, SC; Clough, SJ; Zhao, YF				Wang, Dongping; Calla, Bernarda; Vimolmangkang, Sornkanok; Wu, Xia; Korban, Schuyler S.; Huber, Steven C.; Clough, Steven J.; Zhao, Youfu			The Orphan Gene ybjN Conveys Pleiotropic Effects on Multicellular Behavior and Survival of Escherichia coli	PLOS ONE			English	Article							ANTIGEN-43-MEDIATED AUTOAGGREGATION; BIOFILM FORMATION; RCS PHOSPHORELAY; PERSISTER CELLS; ACID RESISTANCE; EXPRESSION; TOLERANCE; GENOMES; K-12; OVEREXPRESSION	YbjN, encoding an enterobacteria-specific protein, is a multicopy suppressor of temperature sensitivity in the ts9 mutant strain of Escherichia coli. In this study, we further explored the role(s) of ybjN. First, we demonstrated that the ybjN transcript was about 10-fold lower in the ts9 strain compared to that of E. coli strain BW25113 (BW). Introduction of multiple copies of ybjN in the ts9 strain resulted in over-expression of ybjN by about 10-fold as compared to that of BW. These results suggested that temperature sensitivity of the ts9 mutant of E. coli may be related to expression levels of ybjN. Characterization of E. coli ybjN mutant revealed that ybjN mutation resulted in pleiotropic phenotypes, including increased motility, fimbriation (auto-aggregation), exopolysaccharide production, and biofilm formation. In contrast, over-expression of ybjN (in terms of multiple copies) resulted in reduced motility, fimbriation, exopolysaccharide production, biofilm formation and acid resistance. In addition, our results indicate that a ybjN-homolog gene from Erwinia amylovora, a plant enterobacterial pathogen, is functionally conserved with that of E. coli, suggesting similar evolution of the YbjN family proteins in enterobacteria. A microarray study revealed that the expression level of ybjN was inversely correlated with the expression of flagellar, fimbrial and acid resistance genes. Over-expression of ybjN significantly down-regulated genes involved in citric acid cycle, glycolysis, the glyoxylate shunt, oxidative phosphorylation, amino acid and nucleotide metabolism. Furthermore, over-expression of ybjN up-regulated toxin-antitoxin modules, the SOS response pathway, cold shock and starvation induced transporter genes. Collectively, these results suggest that YbjN may play important roles in regulating bacterial multicellular behavior, metabolism, and survival under stress conditions in E. coli. These results also suggest that ybjN over-expression-related temperature rescue of the ts9 mutant may be due to down-regulation of metabolic activity and activation of stress response genes in the ts9 mutant.	[Wang, Dongping; Calla, Bernarda; Clough, Steven J.; Zhao, Youfu] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Vimolmangkang, Sornkanok; Korban, Schuyler S.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Wu, Xia; Huber, Steven C.; Zhao, Youfu] Univ Illinois, Program Physiol & Mol Plant Biol, Urbana, IL 61801 USA; [Huber, Steven C.; Clough, Steven J.] ARS, USDA, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Wang, DP (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	zhao888@illinois.edu	Wu, Xia/J-8690-2014; Wang, Dongping/L-2124-2013	Wu, Xia/0000-0002-0024-4481; 	USDA National Institute of Food and Agriculture [2010-65110-20497]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This project was supported by the Agriculture and Food Research Initiative Competitive Grants Program Grant no. 2010-65110-20497 from the USDA National Institute of Food and Agriculture (Dr. Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; Binnewies Tim T., 2006, Functional & Integrative Genomics, V6, P165, DOI 10.1007/s10142-006-0027-2; Bore E, 2007, MICROBIOL-SGM, V153, P935, DOI 10.1099/mic.0.29288-0; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chen XN, 2006, BIOCHEM BIOPH RES CO, V345, P834, DOI 10.1016/j.bbrc.2006.04.101; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Daubin V, 2004, GENOME RES, V14, P1036, DOI 10.1101/gr.2231904; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; FLAKS JG, 1966, COLD SPRING HARB SYM, V31, P623, DOI 10.1101/SQB.1966.031.01.081; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Frazier ME, 2003, SCIENCE, V300, P290, DOI 10.1126/science.1084566; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; Galperin MY, 2001, COMPAR FUNCT GENOM, V2, P14, DOI 10.1002/cfg.66; Hasman H, 1999, J BACTERIOL, V181, P4834, DOI 10.1128/JB.181.16.4834-4841.1999; Hayashi S, 2003, J BIOSCI BIOENG, V95, P379, DOI 10.1263/jbb.95.379; Itou J, 2009, BIOSCI BIOTECH BIOCH, V73, P870, DOI 10.1271/bbb.80795; Kasari V, 2010, J BACTERIOL, V192, P2908, DOI 10.1128/JB.01266-09; Keeney D, 2008, J ANTIMICROB CHEMOTH, V61, P46, DOI 10.1093/jac/dkm397; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Krin E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-273; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Narra HP, 2008, PROTEOMICS, V8, P4772, DOI 10.1002/pmic.200800061; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Sambrook J, 2001, MOL CLONING LAB MANU; Sayed AK, 2007, MICROBIOL-SGM, V153, P2584, DOI 10.1099/mic.0.2007/007005-0; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Thomas GH, 1999, BIOINFORMATICS, V15, P860, DOI 10.1093/bioinformatics/15.10.860; Ulett GC, 2006, MICROBIOL-SGM, V152, P2101, DOI 10.1099/mic.0.28607-0; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wang DP, 2011, PHYTOPATHOLOGY, V101, P710, DOI 10.1094/PHYTO-09-10-0258; Wang DP, 2010, PHYTOPATHOLOGY, V100, P192, DOI 10.1094/PHYTO-100-2-0192; Wang DP, 2009, MOL PLANT PATHOL, V10, P277, DOI 10.1111/j.1364-3703.2008.00531.x; Whitworth DE, 2008, TRENDS MICROBIOL, V16, P512, DOI 10.1016/j.tim.2008.08.001; Zhao YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-245	51	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25293	10.1371/journal.pone.0025293	http://dx.doi.org/10.1371/journal.pone.0025293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980417	gold, Green Published, Green Submitted			2022-12-25	WOS:000295933700025
J	Chan, LK; Ko, FCF; Sze, KMF; Ng, IOL; Yam, JWP				Chan, Lo-Kong; Ko, Frankie Chi Fat; Sze, Karen Man-Fong; Ng, Irene Oi-Lin; Yam, Judy Wai Ping			Nuclear-Targeted Deleted in Liver Cancer 1 (DLC1) Is Less Efficient in Exerting Its Tumor Suppressive Activity Both In Vitro and In Vivo	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; GTPASE-ACTIVATING PROTEIN; CELL-PROLIFERATION; DOWN-REGULATION; RHOA GTPASE; GENE; EXPRESSION; GROWTH; APOPTOSIS; TUMORIGENICITY	Background: Deleted in liver cancer 1 (DLC1) serves as an important RhoGTPase activating protein (RhoGAP) protein that terminates active RhoA signaling in human cancers. Increasing evidence has demonstrated that the tumor suppressive activity of DLC1 depends not only on RhoGAP activity, but also relies on proper focal adhesion localization through its interaction with tensin family proteins. Recently, there are reports showing that DLC1 can also be found in the nucleus; however, the existence and the relative tumor suppressive activity of nuclear DLC1 have never been clearly addressed. Methodology and Principal Findings: We herein provide new evidence that DLC1 protein, which predominantly associated with focal adhesions and localized in cytosol, dynamically shuttled between cytoplasm and nucleus. Treatment of cells with nuclear export blocker, Leptomycin B (LMB), retained DLC1 in the nucleus. To understand the nuclear entry of DLC1, we identified amino acids 600-700 of DLC1 as a novel region that is important for its nuclear localization. The tumor suppressive activity of nuclear DLC1 was directly assessed by employing a nuclear localization signal (NLS) fusion variant of DLC1 (NLS-DLC1) with preferential nuclear localization. In SMMC-7721 HCC cells, expression of NLS-DLC1 failed to suppress colony formation and actin stress fiber formation in vitro. The abrogated tumor suppressive activity of nuclear DLC1 was demonstrated for the first time in vivo by subcutaneously injecting p53(-/-) RasV12 hepatoblasts with stable NLS-DLC1 expression in nude mice. The injected hepatoblasts with NLS-DLC1 expression effectively formed tumors when compared with the non-nuclear targeted DLC1. Conclusions/Significance: Our study identified a novel region responsible for the nuclear entry of DLC1 and demonstrated the functional difference of DLC1 in different cellular compartments both in vitro and in vivo.	[Chan, Lo-Kong; Ko, Frankie Chi Fat; Sze, Karen Man-Fong; Ng, Irene Oi-Lin; Yam, Judy Wai Ping] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Chan, Lo-Kong; Ko, Frankie Chi Fat; Sze, Karen Man-Fong; Ng, Irene Oi-Lin; Yam, Judy Wai Ping] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Chan, Lo-Kong; Ko, Frankie Chi Fat; Ng, Irene Oi-Lin; Yam, Judy Wai Ping] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, LK (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	iolng@hku.hk; judyyam@pathology.hku.hk	Ko, Frankie Chi Fat/AAZ-8112-2021; Ko, Frankie Chi Fat/C-4759-2009; Kong, Chan Lo/AAI-9300-2020; Yam, Judy Wai Ping/C-4454-2009	Ko, Frankie Chi Fat/0000-0002-0393-9668; Ko, Frankie Chi Fat/0000-0002-0393-9668; Kong, Chan Lo/0000-0003-3082-1013; Yam, Judy Wai Ping/0000-0002-5637-121X; Ng, Irene Oi-lin/0000-0001-7532-2029	Hong Kong Research Grants Council [HKU7798/07M, HKU 1/06C, HKU 7/CRG/09]; Outstanding Young Researcher Award	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Outstanding Young Researcher Award	This work was supported by the Hong Kong Research Grants Council (HKU7798/07M), Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C and HKU 7/CRG/09) and Outstanding Young Researcher Award (to J.W.P. Yam). I.O.L. Ng is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005572; Dubash AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017380; Erlmann P, 2009, MOL BIOL CELL, V20, P4400, DOI 10.1091/mbc.E09-03-0247; Feng MH, 2011, MOL BIOL REP, V38, P1915, DOI 10.1007/s11033-010-0311-z; Guan M, 2006, CLIN CANCER RES, V12, P1412, DOI 10.1158/1078-0432.CCR-05-1906; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Hers I, 2006, J BIOL CHEM, V281, P4762, DOI 10.1074/jbc.M511008200; Jang BC, 2004, BIOCHEM PHARMACOL, V68, P263, DOI 10.1016/j.bcp.2004.03.007; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Kawai K, 2009, GENES CELLS, V14, P227, DOI 10.1111/j.1365-2443.2008.01265.x; Kim TY, 2007, BIOCHEM BIOPH RES CO, V355, P72, DOI 10.1016/j.bbrc.2007.01.121; Kim TY, 2003, ONCOGENE, V22, P3943, DOI 10.1038/sj.onc.1206573; Ko FCF, 2010, GASTROENTEROLOGY, V139, P1397, DOI 10.1053/j.gastro.2010.06.051; Liao YC, 2008, CANCER RES, V68, P7718, DOI 10.1158/0008-5472.CAN-08-2042; Ng IOL, 2000, CANCER RES, V60, P6581; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Ullmannova V, 2006, INT J ONCOL, V29, P1127; Wong CM, 2003, CANCER RES, V63, P7646; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498; Yuan BZ, 2007, EXP CELL RES, V313, P3868, DOI 10.1016/j.yexcr.2007.08.009; Yuan BZ, 1998, CANCER RES, V58, P2196; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; Zhou X, 2008, INT J ONCOL, V32, P1285; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246	29	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25547	10.1371/journal.pone.0025547	http://dx.doi.org/10.1371/journal.pone.0025547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966542	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100050
J	Favia, AD; Masetti, M; Recanatini, M; Cavalli, A				Favia, Angelo D.; Masetti, Matteo; Recanatini, Maurizio; Cavalli, Andrea			Substrate Binding Process and Mechanistic Functioning of Type 1 11 beta-Hydroxysteroid Dehydrogenase from Enhanced Sampling Methods	PLOS ONE			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; MOLECULAR-DYNAMICS; COENZYME SPECIFICITY; CRYSTAL-STRUCTURE; FREE-ENERGIES; FORCE-FIELD; INHIBITORS; ENZYMES; COMPLEX; DISCOVERY	In humans, type 1 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD-1) plays a key role in the regulation of the glucocorticoids balance by converting the inactive hormone cortisone into cortisol. Numerous functional aspects of 11 beta-HSD-1 have been understood thanks to the availability at the Worldwide Protein Data Bank of a number of X-ray structures of the enzyme either alone or in complex with inhibitors, and to several experimental data. However at present, a complete description of the dynamic behaviour of 11 beta-HSD-1 upon substrate binding is missing. To this aim we firstly docked cortisone into the catalytic site of 11 beta-HSD-1 (both wild type and Y177A mutant), and then we used steered molecular dynamics and metadynamics to simulate its undocking. This methodology helped shedding light at molecular level on the complex relationship between the enzyme and its natural substrate. In particular, the work highlights a) the reason behind the functional dimerisation of 11 beta-HSD-1, b) the key role of Y177 in the cortisone binding event, c) the fine tuning of the active site degree of solvation, and d) the role of the S228-P237 loop in ligand recognition.	[Favia, Angelo D.; Cavalli, Andrea] Ist Italiano Tecnol, Drug Discovery & Dev Dept, Genoa, Italy; [Masetti, Matteo; Recanatini, Maurizio; Cavalli, Andrea] Univ Bologna, Dipartimento Sci Farmaceut, I-40126 Bologna, Italy	Istituto Italiano di Tecnologia - IIT; University of Bologna	Favia, AD (corresponding author), Ist Italiano Tecnol, Drug Discovery & Dev Dept, Genoa, Italy.	angelo.favia@iit.it	Recanatini, Maurizio/AAU-3319-2021; Recanatini, Maurizio/GXH-1338-2022	Recanatini, Maurizio/0000-0002-0039-0518; Masetti, Matteo/0000-0002-3757-7802; CAVALLI, ANDREA/0000-0002-6370-1176	European Community [228398]	European Community(European Commission)	This work was partly carried out under the HPC-EUROPA2 project (project number 228398), with the support of the European Community - Research Infrastructure Action of the FP7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mezei M, 1986, Ann N Y Acad Sci, V482, P1, DOI 10.1111/j.1749-6632.1986.tb20933.x; [Anonymous], MAESTR VERS 8 5; [Anonymous], GLID VERS 5 0; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bostrom J, 2006, J MED CHEM, V49, P6716, DOI 10.1021/jm060167o; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Bussi G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090601; Cieplak P, 2001, J COMPUT CHEM, V22, P1048, DOI 10.1002/jcc.1065; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; Daggett V, 2000, CURR OPIN STRUC BIOL, V10, P160, DOI 10.1016/S0959-440X(00)00062-2; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8; Favia A.D., COMPUTATION IN PRESS; Favia AD, 2008, J MOL BIOL, V375, P855, DOI 10.1016/j.jmb.2007.10.065; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fowler PW, 2007, BIOCHEMISTRY-US, V46, P3108, DOI 10.1021/bi602455n; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Frisch M., 2016, GAUSSIAN 16 REVISION; Gervasio FL, 2005, J AM CHEM SOC, V127, P2600, DOI 10.1021/ja0445950; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holmberg N, 1999, PROTEIN ENG, V12, P851, DOI 10.1093/protein/12.10.851; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hosfield DJ, 2005, J BIOL CHEM, V280, P4639, DOI 10.1074/jbc.M411104200; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iannuzzi M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238302; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Julian LD, 2008, J MED CHEM, V51, P3953, DOI 10.1021/jm800310g; Kaminski GA, 2002, J COMPUT CHEM, V23, P1515, DOI 10.1002/jcc.10125; KEARSLEY SK, 1989, ACTA CRYSTALLOGR A, V45, P208, DOI 10.1107/S0108767388010128; Kim KW, 2007, FEBS LETT, V581, P995, DOI 10.1016/j.febslet.2007.01.075; Kim KW, 2006, BBA-PROTEINS PROTEOM, V1764, P824, DOI 10.1016/j.bbapap.2006.02.008; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Limongelli V, 2010, P NATL ACAD SCI USA, V107, P5411, DOI 10.1073/pnas.0913377107; Maser E, 2002, BIOCHEMISTRY-US, V41, P2459, DOI 10.1021/bi015803t; Masetti M, 2009, J PHYS CHEM B, V113, P4807, DOI 10.1021/jp803936q; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Ogg D, 2005, J BIOL CHEM, V280, P3789, DOI 10.1074/jbc.M412463200; Oppermann UCT, 2001, CHEM-BIOL INTERACT, V130, P699, DOI 10.1016/S0009-2797(00)00301-X; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Procacci P, 1997, J COMPUT CHEM, V18, P1848, DOI 10.1002/(SICI)1096-987X(19971130)18:15<1848::AID-JCC2>3.0.CO;2-O; Provasi D, 2009, BIOCHEMISTRY-US, V48, P10020, DOI 10.1021/bi901494n; Ren PY, 2002, J COMPUT CHEM, V23, P1497, DOI 10.1002/jcc.10127; Rew Y, 2009, BIOORG MED CHEM LETT, V19, P1797, DOI 10.1016/j.bmcl.2009.01.058; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Tu H, 2008, BIOORGAN MED CHEM, V16, P8922, DOI 10.1016/j.bmc.2008.08.065; Walker EA, 2001, J BIOL CHEM, V276, P21343, DOI 10.1074/jbc.M011142200; Wan ZK, 2009, J MED CHEM, V52, P5449, DOI 10.1021/jm900639u; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xie WS, 2007, J CHEM THEORY COMPUT, V3, P1878, DOI 10.1021/ct700146x	61	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25375	10.1371/journal.pone.0025375	http://dx.doi.org/10.1371/journal.pone.0025375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966510	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100049
J	Ibrahim, MM; Fjaere, E; Lock, EJ; Naville, D; Amlund, H; Meugnier, E; Battistoni, BL; Froyland, L; Madsen, L; Jessen, N; Lund, S; Vidal, H; Ruzzin, J				Ibrahim, Mohammad Madani; Fjaere, Even; Lock, Erik-Jan; Naville, Danielle; Amlund, Heidi; Meugnier, Emmanuelle; Battistoni, Brigitte Le Magueresse; Froyland, Livar; Madsen, Lise; Jessen, Niels; Lund, Sten; Vidal, Hubert; Ruzzin, Jerome			Chronic Consumption of Farmed Salmon Containing Persistent Organic Pollutants Causes Insulin Resistance and Obesity in Mice	PLOS ONE			English	Article							FISH-OIL SUPPLEMENTATION; POLYUNSATURATED FATTY-ACIDS; DIETARY COD PROTEIN; GLUCOSE-TOLERANCE; SKELETAL-MUSCLE; BLOOD-PRESSURE; SERUM-LIPIDS; RISK; OMEGA-3-FATTY-ACIDS; SENSITIVITY	Background: Dietary interventions are critical in the prevention of metabolic diseases. Yet, the effects of fatty fish consumption on type 2 diabetes remain unclear. The aim of this study was to investigate whether a diet containing farmed salmon prevents or contributes to insulin resistance in mice. Methodology/Principal Findings: Adult male C57BL/6J mice were fed control diet (C), a very high-fat diet without or with farmed Atlantic salmon fillet (VHF and VHF/S, respectively), and Western diet without or with farmed Atlantic salmon fillet (WD and WD/S, respectively). Other mice were fed VHF containing farmed salmon fillet with reduced concentrations of persistent organic pollutants (VHF/S-POPs). We assessed body weight gain, fat mass, insulin sensitivity, glucose tolerance, ex vivo muscle glucose uptake, performed histology and immunohistochemistry analysis, and investigated gene and protein expression. In comparison with animals fed VHF and WD, consumption of both VHF/S and WD/S exaggerated insulin resistance, visceral obesity, and glucose intolerance. In addition, the ability of insulin to stimulate Akt phosphorylation and muscle glucose uptake was impaired in mice fed farmed salmon. Relative to VHF/S-fed mice, animals fed VHF/S-POPs had less body burdens of POPs, accumulated less visceral fat, and had reduced mRNA levels of TNF alpha as well as macrophage infiltration in adipose tissue. VHF/S-POPs-fed mice further exhibited better insulin sensitivity and glucose tolerance than mice fed VHF/S. Conclusions/Significance: Our data indicate that intake of farmed salmon fillet contributes to several metabolic disorders linked to type 2 diabetes and obesity, and suggest a role of POPs in these deleterious effects. Overall, these findings may participate to improve nutritional strategies for the prevention and therapy of insulin resistance.	[Ibrahim, Mohammad Madani; Fjaere, Even; Lock, Erik-Jan; Amlund, Heidi; Froyland, Livar; Madsen, Lise; Ruzzin, Jerome] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Ibrahim, Mohammad Madani] Univ Bergen, Inst Biomed, Bergen, Norway; [Fjaere, Even; Madsen, Lise] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Naville, Danielle; Meugnier, Emmanuelle; Battistoni, Brigitte Le Magueresse; Vidal, Hubert] Univ Lyon 1, INSERM, INRA, CarMeN Lab,U 1060,U 1235, Oullins, France; [Jessen, Niels] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus, Denmark; [Lund, Sten] Aarhus Univ Hosp, Dept Internal Med & Diabet, DK-8000 Aarhus, Denmark; [Lund, Sten] Aarhus Univ Hosp, Inst Expt Clin Res, DK-8000 Aarhus, Denmark; [Ruzzin, Jerome] Univ Bergen, Dept Biol, Bergen, Norway	University of Bergen; University of Copenhagen; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Aarhus University; Aarhus University; Aarhus University; University of Bergen	Ibrahim, MM (corresponding author), Natl Inst Nutr & Seafood Res, Bergen, Norway.	jerome.ruzzin@bio.uib.no	Le Magueresse-Battistoni, Brigitte/AAZ-5601-2021; Lock, Erik-Jan/B-7523-2012; Ruzzin, Jerome/AAA-5826-2020; Ruzzin, Jérôme/U-1688-2017; Naville, Danielle/N-1200-2017; Jessen, Niels/E-1731-2011; Le Magueresse-Battistoni, Brigitte/M-6927-2017; Vidal, Hubert/M-6674-2017; Lock, Erik-Jan/AAM-9766-2020; Madsen, Lise/C-6246-2012; Lock, Erik-Jan/F-3115-2012	Le Magueresse-Battistoni, Brigitte/0000-0002-7247-4403; Ruzzin, Jérôme/0000-0003-3676-8145; Naville, Danielle/0000-0003-2615-6161; Le Magueresse-Battistoni, Brigitte/0000-0002-7247-4403; Vidal, Hubert/0000-0002-9467-0317; Madsen, Lise/0000-0003-4468-1947; Lund, Sten/0000-0002-3805-6267; Lock, Erik-Jan/0000-0002-8157-5249; meugnier, emmanuelle/0000-0002-2291-7691; Amlund, Heidi/0000-0002-2471-3676; Jessen, Niels/0000-0001-5613-7274	Research Council of Norway [184783, 204473, 185567]; Danish Council for Strategic Research [2101-08-0053]	Research Council of Norway(Research Council of Norway); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by grants from the Research Council of Norway (no. 184783 and 204473 to J.R. and 185567 for M.M.I.). E.F. and L.M. were supported by a grant from the Danish Council for Strategic Research (no. 2101-08-0053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Berntssen MHG, 2010, CHEMOSPHERE, V81, P242, DOI 10.1016/j.chemosphere.2010.06.031; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; BORKMAN M, 1989, DIABETES, V38, P1314, DOI 10.2337/diabetes.38.10.1314; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Carpenter David O., 2008, Reviews on Environmental Health, V23, P59; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Djousse L, 2011, AM J CLIN NUTR, V93, P143, DOI 10.3945/ajcn.110.005603; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; ERITSLAND J, 1994, SCAND J CLIN LAB INV, V54, P273, DOI 10.3109/00365519409087522; FASCHING P, 1991, DIABETES, V40, P583, DOI 10.2337/diabetes.40.5.583; FESKENS EJM, 1995, DIABETES CARE, V18, P1104, DOI 10.2337/diacare.18.8.1104; Fisher BE, 1999, ENVIRON HEALTH PERSP, V107, pA18, DOI 10.2307/3434279; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Giacco R, 2007, NUTR METAB CARDIOVAS, V17, P572, DOI 10.1016/j.numecd.2006.06.006; GLAUBER H, 1988, ANN INTERN MED, V108, P663, DOI 10.7326/0003-4819-108-5-663; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; HENDRA TJ, 1990, DIABETES CARE, V13, P821, DOI 10.2337/diacare.13.8.821; Hites RA, 2004, SCIENCE, V303, P226, DOI 10.1126/science.1091447; Jessen N, 2008, HORM METAB RES, V40, P269, DOI 10.1055/s-2007-1022546; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Laaksonen DE, 2002, DIABETIC MED, V19, P456, DOI 10.1046/j.1464-5491.2002.00707.x; Lavigne C, 2001, AM J PHYSIOL-ENDOC M, V281, pE62, DOI 10.1152/ajpendo.2001.281.1.E62; Lee DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022360; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lee DH, 2010, ENVIRON HEALTH PERSP, V118, P1235, DOI 10.1289/ehp.0901480; Li QQ, 2006, J TOXICOL ENV HEAL A, V69, P1927, DOI 10.1080/15287390600751306; LIM S, 2009, PLOS ONE, V4; Lordo RA, 1996, AM J PUBLIC HEALTH, V86, P1253, DOI 10.2105/AJPH.86.9.1253; Mann JI, 2002, LANCET, V360, P783, DOI 10.1016/S0140-6736(02)09901-4; Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528; Mostad IL, 2006, AM J CLIN NUTR, V84, P540, DOI 10.1093/ajcn/84.3.540; OECD/EU, 2010, HLTH GLANC EUR 2010; Ouellet V, 2007, DIABETES CARE, V30, P2816, DOI 10.2337/dc07-0273; Pilon G, 2011, METABOLISM, V60, P1122, DOI 10.1016/j.metabol.2010.12.005; Ruzzin J, 2007, ANN NUTR METAB, V51, P347; Ruzzin J, 2005, DIABETOLOGIA, V48, P2119, DOI 10.1007/s00125-005-1886-0; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; TOFT I, 1995, ANN INTERN MED, V123, P911, DOI 10.7326/0003-4819-123-12-199512150-00003; Torstensen BE, 2008, AQUACULTURE, V285, P193, DOI 10.1016/j.aquaculture.2008.08.025; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; van Woudenbergh GJ, 2009, DIABETES CARE, V32, P2021, DOI 10.2337/dc09-1042; VESSBY B, 1992, DIABETIC MED, V9, P126, DOI 10.1111/j.1464-5491.1992.tb01748.x; *WHO, 2005, CHRON DIS VIT INV; Woodman RJ, 2002, AM J CLIN NUTR, V76, P1007, DOI 10.1093/ajcn/76.5.1007	50	115	119	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25170	10.1371/journal.pone.0025170	http://dx.doi.org/10.1371/journal.pone.0025170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966444	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000295267100022
J	Schlafer, S; Raarup, MK; Meyer, RL; Sutherland, DS; Dige, I; Nyengaard, JR; Nyvad, B				Schlafer, Sebastian; Raarup, Merete K.; Meyer, Rikke L.; Sutherland, Duncan S.; Dige, Irene; Nyengaard, Jens R.; Nyvad, Bente			pH Landscapes in a Novel Five-Species Model of Early Dental Biofilm	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; ACTINOMYCES-NAESLUNDII; ORAL STREPTOCOCCI; ARTIFICIAL MOUTH; ROOT SURFACES; MOLECULAR ANALYSIS; TOOTH SURFACES; CARIES; PLAQUE; ENAMEL	Background: Despite continued preventive efforts, dental caries remains the most common disease of man. Organic acids produced by microorganisms in dental plaque play a crucial role for the development of carious lesions. During early stages of the pathogenetic process, repeated pH drops induce changes in microbial composition and favour the establishment of an increasingly acidogenic and aciduric microflora. The complex structure of dental biofilms, allowing for a multitude of different ecological environments in close proximity, remains largely unexplored. In this study, we designed a laboratory biofilm model that mimics the bacterial community present during early acidogenic stages of the caries process. We then performed a time-resolved microscopic analysis of the extracellular pH landscape at the interface between bacterial biofilm and underlying substrate. Methodology/Principal Findings: Strains of Streptococcus oralis, Streptococcus sanguinis, Streptococcus mitis, Streptococcus downei and Actinomyces naeslundii were employed in the model. Biofilms were grown in flow channels that allowed for direct microscopic analysis of the biofilms in situ. The architecture and composition of the biofilms were analysed using fluorescence in situ hybridization and confocal laser scanning microscopy. Both biofilm structure and composition were highly reproducible and showed similarity to in-vivo-grown dental plaque. We employed the pH-sensitive ratiometric probe C-SNARF-4 to perform real-time microscopic analyses of the biofilm pH in response to salivary solutions containing glucose. Anaerobic glycolysis in the model biofilms created a mildly acidic environment. Decrease in pH in different areas of the biofilms varied, and distinct extracellular pH-microenvironments were conserved over several hours. Conclusions/Significance: The designed biofilm model represents a promising tool to determine the effect of potential therapeutic agents on biofilm growth, composition and extracellular pH. Ratiometric pH analysis using C-SNARF-4 gives detailed insight into the pH landscape of living biofilms and contributes to our general understanding of metabolic processes in in-vivo-grown bacterial biofilms.	[Schlafer, Sebastian; Meyer, Rikke L.; Sutherland, Duncan S.] Aarhus Univ, iNANO Interdisciplinary Nanosci Ctr, Fac Sci, Aarhus, Denmark; [Schlafer, Sebastian; Dige, Irene; Nyvad, Bente] Aarhus Univ, Dept Dent Pathol Operat Dent & Endodont, Sch Dent, Fac Hlth Sci, Aarhus, Denmark; [Raarup, Merete K.; Nyengaard, Jens R.] Aarhus Univ, Stereol & Elect Microscopy Res Lab, Ctr Stochast Geometry & Adv Bioimaging, Aarhus, Denmark; [Meyer, Rikke L.] Aarhus Univ, Dept Biol Sci, Fac Sci, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Schlafer, S (corresponding author), Aarhus Univ, iNANO Interdisciplinary Nanosci Ctr, Fac Sci, Aarhus, Denmark.	sebastian.schlafer@hotmail.de	Meyer, Rikke Louise/AAB-5377-2021; Sutherland, Duncan S/E-4385-2010; Schlafer, Sebastian/I-8788-2018	Meyer, Rikke Louise/0000-0002-6485-5134; Sutherland, Duncan S/0000-0002-5045-9915; Dige, Irene/0000-0003-0095-179X; Schlafer, Sebastian/0000-0003-2463-1926; Nyvad, Bente/0000-0002-9545-0447	Danish National Advanced Technology Foundation; Villum Foundation; Villum Fonden [00008721] Funding Source: researchfish	Danish National Advanced Technology Foundation; Villum Foundation(Villum Fonden); Villum Fonden(Villum Fonden)	This work was funded by the Danish National Advanced Technology Foundation through the ProSURF platform project (Protein-Based Functionalisation of Surfaces). The Centre for Stochastic Geometry and Advanced Bioimaging is supported by Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AamdalScheie A, 1996, J DENT RES, V75, P1901, DOI 10.1177/00220345960750111301; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Babaahmady KG, 1997, ARCH ORAL BIOL, V42, P101, DOI 10.1016/S0003-9969(96)00116-1; BOUE D, 1987, J DENT RES, V66, P23, DOI 10.1177/00220345870660010501; BOYAR RM, 1989, J DENT RES, V68, P1734, DOI 10.1177/00220345890680120301; BRADSHAW DJ, 1989, J DENT RES, V68, P1298, DOI 10.1177/00220345890680090101; Bradshawa DJ, 2002, CARIES RES, V36, P81, DOI 10.1159/000057864; BROWN LR, 1976, MICROBIAL ASPECTS DE, P275; CHESTNUTT IG, 1994, ARCH ORAL BIOL, V39, P589, DOI 10.1016/0003-9969(94)90134-1; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; DAWES C, 1989, J DENT RES, V68, P1479, DOI 10.1177/00220345890680110201; Dawes Colin, 2003, J Can Dent Assoc, V69, P722; de los Rios A, 2003, ENVIRON MICROBIOL, V5, P231; de Soet JJ, 2000, CARIES RES, V34, P486, DOI 10.1159/000016628; DEJONG MH, 1984, APPL ENVIRON MICROB, V47, P901, DOI 10.1128/AEM.47.5.901-904.1984; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; Exterkate RAM, 2010, CARIES RES, V44, P372, DOI 10.1159/000316541; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hunter RC, 2005, APPL ENVIRON MICROB, V71, P2501, DOI 10.1128/AEM.71.5.2501-2510.2005; Kara D, 2006, EUR J ORAL SCI, V114, P58, DOI 10.1111/j.1600-0722.2006.00262.x; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; Lima JPM, 2009, EUR J ORAL SCI, V117, P568, DOI 10.1111/j.1600-0722.2009.00662.x; LISTGARTEN MA, 1975, J PERIODONTOL, V46, P10, DOI 10.1902/jop.1975.46.1.10; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Lynch RJM, 2006, CARIES RES, V40, P142, DOI 10.1159/000091061; MACPHERSON LMD, 1991, CARIES RES, V25, P58, DOI 10.1159/000261343; Magitot E, 1878, TREATISE DENT CARIES; MARSH PD, 1989, J DENT RES, V68, P1151, DOI 10.1177/00220345890680070301; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001; Periasamy S, 2009, INFECT IMMUN, V77, P3542, DOI 10.1128/IAI.00345-09; PERRONS CJ, 1990, J DENT RES, V69, P483, DOI 10.1177/00220345900690021301; PIGMAN W, 1952, J DENT RES, V31, P627, DOI 10.1177/00220345520310050501; Ramberg P, 2003, J CLIN PERIODONTOL, V30, P990, DOI 10.1034/j.1600-051X.2003.00419.x; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; RUSSELL C, 1975, APPL MICROBIOL, V29, P141, DOI 10.1128/AEM.29.2.141-144.1975; SANSONE C, 1993, J DENT RES, V72, P508, DOI 10.1177/00220345930720020701; Schlafer S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-66; SEKSEK O, 1991, ANAL BIOCHEM, V193, P49, DOI 10.1016/0003-2697(91)90042-R; Shapiro S, 2002, CARIES RES, V36, P93, DOI 10.1159/000057866; Shen S, 2004, J DENT, V32, P667, DOI 10.1016/j.jdent.2004.07.002; Shu M, 2000, ARCH ORAL BIOL, V45, P27, DOI 10.1016/S0003-9969(99)00111-9; Sissons C H, 1997, Adv Dent Res, V11, P110; SISSONS CH, 1992, ARCH ORAL BIOL, V37, P913, DOI 10.1016/0003-9969(92)90062-D; Steinberg D, 2001, J ANTIMICROB CHEMOTH, V48, P241, DOI 10.1093/jac/48.2.241; Svensater G, 2003, CARIES RES, V37, P395, DOI 10.1159/000073390; Takahashi N, 1996, ORAL MICROBIOL IMMUN, V11, P193, DOI 10.1111/j.1399-302X.1996.tb00357.x; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Tang G, 2003, J DENT, V31, P161, DOI 10.1016/S0300-5712(03)00009-5; THEILADE E, 1982, J PERIODONTAL RES, V17, P12, DOI 10.1111/j.1600-0765.1982.tb01127.x; van Ruyven FOJ, 2000, J DENT RES, V79, P778, DOI 10.1177/00220345000790021201; Vecer J, 2001, PHOTOCHEM PHOTOBIOL, V74, P8, DOI 10.1562/0031-8655(2001)074<0008:FBOTPS>2.0.CO;2; von Ohle C, 2010, APPL ENVIRON MICROB, V76, P2326, DOI 10.1128/AEM.02090-09; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205	59	39	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25299	10.1371/journal.pone.0025299	http://dx.doi.org/10.1371/journal.pone.0025299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966490	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100042
J	Buntgen, U; Raible, CC; Frank, D; Helama, S; Cunningham, L; Hofer, D; Nievergelt, D; Verstege, A; Timonen, M; Stenseth, NC; Esper, J				Buentgen, Ulf; Raible, Christoph C.; Frank, David; Helama, Samuli; Cunningham, Laura; Hofer, Dominik; Nievergelt, Daniel; Verstege, Anne; Timonen, Mauri; Stenseth, Nils Chr.; Esper, Jan			Causes and Consequences of Past and Projected Scandinavian Summer Temperatures, 500-2100 AD	PLOS ONE			English	Article							TREE-RING WIDTH; NORTH-ATLANTIC; CLIMATE-CHANGE; DENSITY DATA; VARIABILITY; RECONSTRUCTION; OSCILLATION; CIRCULATION; SENSITIVITY; SIMULATIONS	Tree rings dominate millennium-long temperature reconstructions and many records originate from Scandinavia, an area for which the relative roles of external forcing and internal variation on climatic changes are, however, not yet fully understood. Here we compile 1,179 series of maximum latewood density measurements from 25 conifer sites in northern Scandinavia, establish a suite of 36 subset chronologies, and analyse their climate signal. A new reconstruction for the 1483-2006 period correlates at 0.80 with June-August temperatures back to 1860. Summer cooling during the early 17th century and peak warming in the 1930s translate into a decadal amplitude of 2.9 degrees C, which agrees with existing Scandinavian tree-ring proxies. Climate model simulations reveal similar amounts of mid to low frequency variability, suggesting that internal ocean-atmosphere feedbacks likely influenced Scandinavian temperatures more than external forcing. Projected 21st century warming under the SRES A2 scenario would, however, exceed the reconstructed temperature envelope of the past 1,500 years.	[Buentgen, Ulf; Frank, David; Nievergelt, Daniel; Verstege, Anne] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Buentgen, Ulf; Raible, Christoph C.; Frank, David; Hofer, Dominik] Oeschger Ctr Climate Change Res, Bern, Switzerland; [Raible, Christoph C.; Hofer, Dominik] Univ Bern, Inst Phys, Bern, Switzerland; [Helama, Samuli] Univ Lapland, Arctic Ctr, Rovaniemi, Finland; [Cunningham, Laura] Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland; [Timonen, Mauri] Finnish Forest Res Inst, Rovaniemi, Finland; [Stenseth, Nils Chr.] Univ Oslo, Ctr Ecol & Evolutionary Synth CEES, Blindern, Norway; [Esper, Jan] Johannes Gutenberg Univ Mainz, Dept Geog, Mainz, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; University of Bern; University of Lapland; University of St Andrews; Natural Resources Institute Finland (Luke); University of Oslo; Johannes Gutenberg University of Mainz	Buntgen, U (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.	buentgen@wsl.ch	Raible, Christoph/M-8309-2016; Nievergelt, Daniel/J-7156-2012; buentgen, ulf/J-6952-2013; Stenseth, Nils Chr./G-5212-2016; Frank, David/C-7764-2013; Esper, Jan/O-3127-2018	Raible, Christoph/0000-0003-0176-0602; Nievergelt, Daniel/0000-0003-0402-9348; Stenseth, Nils Chr./0000-0002-1591-5399; Esper, Jan/0000-0003-3919-014X; Frank, David/0000-0001-5463-5640; Cunningham, Laura Kay/0000-0001-6591-4610	Swiss Federal Research Institute WSL	Swiss Federal Research Institute WSL	Funding was provided by the Swiss Federal Research Institute WSL (www.wsl.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battipaglia G, 2010, GLOBAL PLANET CHANGE, V72, P182, DOI 10.1016/j.gloplacha.2010.02.004; Briffa KR, 2002, HOLOCENE, V12, P759, DOI 10.1191/0959683602hl588rp; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Buntgen U, 2008, GLOBAL CHANGE BIOL, V14, P2443, DOI 10.1111/j.1365-2486.2008.01640.x; Buntgen U, 2010, TREES-STRUCT FUNCT, V24, P261, DOI 10.1007/s00468-009-0396-y; Buntgen U, 2006, J CLIMATE, V19, P5606, DOI 10.1175/JCLI3917.1; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; D'Arrigo R, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006352; D'Arrigo RD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017250; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; DURBIN J, 1951, BIOMETRIKA, V38, P159, DOI 10.1093/biomet/38.1-2.159; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Eschbach W., 1995, Dendrochronologia, V13, P155; Esper J, 2005, QUATERNARY SCI REV, V24, P2164, DOI 10.1016/j.quascirev.2005.07.001; Esper J, 2003, TREE-RING RES, V59, P81; Esper J, 2010, GLOBAL CHANGE BIOL, V16, P386, DOI 10.1111/j.1365-2486.2009.01913.x; Fischer EM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027992; Frank D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030571; Frank D, 2010, WIRES CLIM CHANGE, V1, P507, DOI 10.1002/wcc.53; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; Grudd H, 2008, CLIM DYNAM, V31, P843, DOI 10.1007/s00382-007-0358-2; Hegerl GC, 2006, NATURE, V440, P1029, DOI 10.1038/nature04679; Helama S, 2007, MAR ENVIRON RES, V63, P185, DOI 10.1016/j.marenvres.2006.08.003; Helama S, 2011, J ARCHAEOL SCI, V38, P452, DOI 10.1016/j.jas.2010.09.029; Helama S, 2009, J QUATERNARY SCI, V24, P450, DOI 10.1002/jqs.1291; Hofer D, 2011, CLIM PAST, V7, P133, DOI 10.5194/cp-7-133-2011; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Jones PD, 1997, J CLIMATE, V10, P2548, DOI 10.1175/1520-0442(1997)010<2548:ESEILS>2.0.CO;2; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Kaufman DS, 2009, SCIENCE, V325, P1236, DOI 10.1126/science.1173983; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Keenlyside NS, 2008, NATURE, V453, P84, DOI 10.1038/nature06921; Klingbjer P, 2003, INT J CLIMATOL, V23, P1465, DOI 10.1002/joc.946; Kristensen DK, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000960; Luterbacher J, 2002, CLIM DYNAM, V18, P545, DOI 10.1007/s00382-001-0196-6; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Raible CC, 2005, J CLIMATE, V18, P3968, DOI 10.1175/JCLI3511.1; Raible CC, 2001, CLIM DYNAM, V18, P321, DOI 10.1007/s003820100176; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Schone BR, 2003, GEOLOGY, V31, P1037, DOI 10.1130/G20013.1; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Yoshimori M, 2005, J CLIMATE, V18, P4253, DOI 10.1175/JCLI3537.1; Yoshimori M, 2010, CLIM DYNAM, V34, P101, DOI 10.1007/s00382-009-0540-9; Zorita E, 2010, CLIMATIC CHANGE, V101, P143, DOI 10.1007/s10584-010-9824-7	47	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25133	10.1371/journal.pone.0025133	http://dx.doi.org/10.1371/journal.pone.0025133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966436	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100064
J	Clemente-Postigo, M; Queipo-Ortuno, MI; Fernandez-Garcia, D; Gomez-Huelgas, R; Tinahones, FJ; Cardona, F				Clemente-Postigo, Mercedes; Isabel Queipo-Ortuno, Maria; Fernandez-Garcia, Diego; Gomez-Huelgas, Ricardo; Tinahones, Francisco J.; Cardona, Fernando			Adipose Tissue Gene Expression of Factors Related to Lipid Processing in Obesity	PLOS ONE			English	Article							ACYLATION-STIMULATING PROTEIN; LIPOPROTEIN-LIPASE ACTIVITY; MESSENGER-RNA EXPRESSION; INSULIN RESISTANCE; RECEPTOR; ADIPOCYTES; GLUCOSE; BINDING; INFLAMMATION; HOMEOSTASIS	Background: Adipose tissue lipid storage and processing capacity can be a key factor for obesity-related metabolic disorders such as insulin resistance and diabetes. Lipid uptake is the first step to adipose tissue lipid storage. The aim of this study was to analyze the gene expression of factors involved in lipid uptake and processing in subcutaneous (SAT) and visceral (VAT) adipose tissue according to body mass index (BMI) and the degree of insulin resistance (IR). Methods and Principal Findings: VLDL receptor (VLDLR), lipoprotein lipase (LPL), acylation stimulating protein (ASP), LDL receptor-related protein 1 (LRP1) and fatty acid binding protein 4 (FABP4) gene expression was measured in VAT and SAT from 28 morbidly obese patients with Type 2 Diabetes Mellitus (T2DM) or high IR, 10 morbidly obese patients with low IR, 10 obese patients with low IR and 12 lean healthy controls. LPL, FABP4, LRP1 and ASP expression in VAT was higher in lean controls. In SAT, LPL and FABP4 expression were also higher in lean controls. BMI, plasma insulin levels and HOMA-IR correlated negatively with LPL expression in both VAT and SAT as well as with FABP4 expression in VAT. FABP4 gene expression in SAT correlated inversely with BMI and HOMA-IR. However, multiple regression analysis showed that BMI was the main variable contributing to LPL and FABP4 gene expression in both VAT and SAT. Conclusions: Morbidly obese patients have a lower gene expression of factors related with lipid uptake and processing in comparison with healthy lean persons.	[Clemente-Postigo, Mercedes; Isabel Queipo-Ortuno, Maria; Cardona, Fernando] Hosp Virgen Victoria, Fdn IMABIS, Lab Invest Biomed, Malaga, Spain; [Isabel Queipo-Ortuno, Maria; Fernandez-Garcia, Diego; Gomez-Huelgas, Ricardo; Tinahones, Francisco J.; Cardona, Fernando] CIBER Fisiopat Obesidad & Nutr, Malaga, Spain; [Fernandez-Garcia, Diego; Tinahones, Francisco J.] Hosp Univ Virgen Victoria, Serv Endocrinol & Nutr, Malaga, Spain; [Gomez-Huelgas, Ricardo] Hosp Reg Carlos, Serv Med Interna, Malaga, Spain	FIMABIS; Hospital Virgen de la Victoria; Hospital Virgen de la Victoria	Clemente-Postigo, M (corresponding author), Hosp Virgen Victoria, Fdn IMABIS, Lab Invest Biomed, Malaga, Spain.	fernandocardonadiaz@gmail.com	Cardona, Fernando/H-6022-2015; Gomez-Huelgas, Ricardo/ABF-5100-2021; Tinahones, Francisco José/AAB-2882-2020; Clemente-Postigo, Mercedes/AAA-1102-2020; Cardona, Fernando/AAG-7835-2019; Ortuño, María Isabel Queipo/AAC-1238-2021	Cardona, Fernando/0000-0003-4460-6824; Gomez-Huelgas, Ricardo/0000-0002-9909-3555; Cardona, Fernando/0000-0003-4460-6824; Clemente-Postigo, Mercedes/0000-0002-4146-6662; QUEIPO ORTUNO, MARIA ISABEL/0000-0002-2867-0845; Tinahones, Francisco J/0000-0001-6871-4403	"Centros de Investigacion en Red'' [CIBER] [CB06/03/0018]; Instituto de Salud Carlos III Madrid, Spain [CP07/0095, PI081655, PS09/00997]; Instituto de Salud Carlos III; Servicio Andaluz de Salud [PI325/2008]; Education Ministry, Madrid, Spain [AP2009-4537]	"Centros de Investigacion en Red'' [CIBER]; Instituto de Salud Carlos III Madrid, Spain(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Servicio Andaluz de Salud; Education Ministry, Madrid, Spain	This research group belongs to the "Centros de Investigacion en Red'' [CIBER, CB06/03/0018] of the "Instituto de Salud Carlos III''. This work was supported in part by a grant from the Instituto de Salud Carlos III [CP07/0095, PI081655 and PS09/00997] Madrid, Spain, the Servicio Andaluz de Salud [PI325/2008], and author MCP is a recipient of a grant (FPU) from the Education Ministry, Madrid, Spain [AP2009-4537]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbarroja N, 2010, BIOCHEM J, V430, P141, DOI 10.1042/BJ20100285; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; Cianflone K, 1999, SEMIN CELL DEV BIOL, V10, P31, DOI 10.1006/scdb.1998.0272; Crawford DC, 2008, J LIPID RES, V49, P588, DOI 10.1194/jlr.M700409-JLR200; DESCAMPS O, 1993, J BIOL CHEM, V268, P974; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Faraj M, 2004, J LIPID RES, V45, P657, DOI 10.1194/jlr.M300299-JLR200; Fisher RM, 2001, DIABETOLOGIA, V44, P1268, DOI 10.1007/s001250100643; FRIED SK, 1993, J CLIN INVEST, V92, P2191, DOI 10.1172/JCI116821; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Gabrielsson BG, 2003, OBES RES, V11, P699, DOI 10.1038/oby.2003.100; Garcia-Fuentes E, 2010, OBESITY, V18, P952, DOI 10.1038/oby.2009.314; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; KERN PA, 1987, DIABETES, V36, P1238, DOI 10.2337/diabetes.36.11.1238; Koistinen HA, 2001, ARTERIOSCL THROM VAS, V21, P1034, DOI 10.1161/01.ATV.21.6.1034; KOWAL RC, 1990, J BIOL CHEM, V265, P10771; MacLaren RE, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-3; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Mahley RW, 1999, J LIPID RES, V40, P1; Makowski L, 2004, J NUTR, V134, p2464S, DOI 10.1093/jn/134.9.2464S; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Neville MJ, 2011, OBESITY, V19, P888, DOI 10.1038/oby.2010.257; Panarotto D, 2000, METABOLISM, V49, P1224, DOI 10.1053/meta.2000.8624; Poulain-Godefroy O, 2008, AM J PHYSIOL-REG I, V295, pR1, DOI 10.1152/ajpregu.00926.2007; Reaven Gerald, 2005, Diab Vasc Dis Res, V2, P105, DOI 10.3132/dvdr.2005.017; Ruge T, 2006, EUR J CLIN INVEST, V36, P16, DOI 10.1111/j.1365-2362.2006.01584.x; SEMENKOVICH CF, 1989, J BIOL CHEM, V264, P9030; Tacken PJ, 2001, CURR OPIN LIPIDOL, V12, P275, DOI 10.1097/00041433-200106000-00006; Tinahones FJ, 2010, OBES SURG, V20, P1559, DOI 10.1007/s11695-010-0194-z; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Van Hermelen V, 1999, J BIOL CHEM, V274, P18243, DOI 10.1074/jbc.274.26.18243; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Voshol PJ, 2009, BBA-MOL CELL BIOL L, V1791, P479, DOI 10.1016/j.bbalip.2008.12.015; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Xia ZN, 2003, METABOLISM, V52, P1360, DOI 10.1016/S0026-0495(03)00254-3; Yang Y, 2006, INT J OBESITY, V30, P439, DOI 10.1038/sj.ijo.0803173	40	74	74	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24783	10.1371/journal.pone.0024783	http://dx.doi.org/10.1371/journal.pone.0024783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966368	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100019
J	Kumar, N; Taneja, KK; Kalra, V; Behari, M; Aneja, S; Bansal, SK				Kumar, Neeraj; Taneja, Krishna Kant; Kalra, Veena; Behari, Madhuri; Aneja, Satinder; Bansal, Surendra Kumar			Genomic Profiling Identifies Novel Mutations and SNPs in ABCD1 Gene: A Molecular, Biochemical and Clinical Analysis of X-ALD Cases in India	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; LINKED ADRENOLEUKODYSTROPHY; MONOZYGOTIC TWINS; FAMILY; CELLS; HETEROGENEITY; DISORDERS; PLASMA	X-linked adrenoleukodystrophy (X-ALD) affects the nervous system white matter and adrenal cortex secondary to mutations in the ABCD1 gene that encode the peroxisomal membrane protein. We conducted a genomic and protein expression study of susceptibility gene with its clinical and biochemical analysis. To the best of our knowledge this is the first preliminary comprehensive study in Indian population that identified novel mutations and SNPs in a relatively large group. We screened 17 Indian indigenous X-linked adrenoleukodystrophy cases and 70 controls for mutations and SNPs in the exonic regions (including flanking regions) of ABCD1 gene by direct sequencing with ABI automated sequencer along with Western blot analysis of its endogenous protein, ALDP, levels in peripheral blood mononuclear cells. Single germ line mutation was identified in each index case in ABCD1 gene. We detected 4 novel mutations (2 missense and 2 deletion/insertion) and 3 novel single nucleotide polymorphisms. We observed a variable protein expression in different patients. These findings were further extended to biochemical and clinical observations as it occurs with great clinical expression variability. This is the first major study in this population that presents a different molecular genetic spectrum as compared to Caucasian population due to geographical distributions of ethnicity of patients. It enhances our knowledge of the causative mutations of X-ALD that grants holistic base to develop effective medicine against X-ALD.	[Kumar, Neeraj; Bansal, Surendra Kumar] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Biochem, Delhi 110007, India; [Taneja, Krishna Kant] Inst Genom & Integrat Biol, Funct Genom Unit, Delhi, India; [Kalra, Veena] All India Inst Med Sci, Dept Pediat, New Delhi, India; [Behari, Madhuri] All India Inst Med Sci, Dept Neurol, New Delhi, India; [Aneja, Satinder] Univ Delhi, Dept Pediat, Lady Hardinge Med Coll, Delhi 110007, India; [Aneja, Satinder] Univ Delhi, Associated Kalawati Balsaran Children Hosp, Delhi 110007, India	University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Lady Hardinge Medical College & Hospital; University of Delhi; University of Delhi	Kumar, N (corresponding author), Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Biochem, Delhi 110007, India.	bansalsurendrak@yahoo.com	Kumar, Neeraj/J-3768-2015	Kumar, Neeraj/0000-0003-1411-4079; Kumar, Neeraj/0000-0002-0906-4559	Council of Scientific and Industrial Research (CSIR)	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Council of Scientific and Industrial Research (CSIR). www.csir.res.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SV, 2009, INDIAN J PEDIATR, V76, P1045, DOI 10.1007/s12098-009-0220-0; BERGER J, 1994, BIOCHEM BIOPH RES CO, V205, P1638, DOI 10.1006/bbrc.1994.2855; Bezman L, 2001, ANN NEUROL, V49, P512, DOI 10.1002/ana.101; Boehm CD, 1999, MOL GENET METAB, V66, P128, DOI 10.1006/mgme.1998.2779; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Coll MJ, 2005, CLIN GENET, V67, P418, DOI 10.1111/j.1399-0004.2005.00423.x; Dubey P, 2005, J PEDIATR-US, V146, P528, DOI 10.1016/j.jpeds.2004.10.067; Eichler EE, 1997, HUM MOL GENET, V6, P991, DOI 10.1093/hmg/6.7.991; Ferrer I, 2010, BRAIN PATHOL, V20, P817, DOI 10.1111/j.1750-3639.2010.00390.x; Gosalakkal J, 2010, NEUROL INDIA, V58, P109, DOI 10.4103/0028-3886.60418; IGARASHI M, 1976, J NEUROCHEM, V26, P851, DOI 10.1111/j.1471-4159.1976.tb04462.x; Ito M, 2001, J NEUROPATH EXP NEUR, V60, P1004, DOI 10.1093/jnen/60.10.1004; Kemp K, 2010, REGEN MED, V5, P425, DOI [10.2217/rme.10.10, 10.2217/RME.10.10]; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Korenke GC, 1996, ANN NEUROL, V40, P254, DOI 10.1002/ana.410400221; Kumar N, 2008, PEDIATR NEUROL, V39, P289, DOI 10.1016/j.pediatrneurol.2008.07.006; Kumar N, 2010, J GENET, V89, P473, DOI 10.1007/s12041-010-0067-1; Kumar Neeraj, 2009, Hum Genet, V126, P344; Lachtermacher MBR, 2000, HUM MUTAT, V15, P348; LIGTENBERG MJL, 1995, AM J HUM GENET, V56, P44; MAESTRI NE, 1992, AM J MED GENET, V44, P576, DOI 10.1002/ajmg.1320440509; Maniatis T, SAMBROOK J MOL CLONI; McGuinness MC, 1997, J NEUROIMMUNOL, V75, P174, DOI 10.1016/S0165-5728(97)00020-9; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Moser HW, 2007, NAT CLIN PRACT NEURO, V3, P140, DOI 10.1038/ncpneuro0421; Moser HW, 2005, ARCH NEUROL-CHICAGO, V62, P1073, DOI 10.1001/archneur.62.7.1073; Moser HW, 1996, ANN NY ACAD SCI, V804, P427, DOI 10.1111/j.1749-6632.1996.tb18634.x; MOSER HW, 1981, NEUROLOGY, V31, P1241, DOI 10.1212/WNL.31.10.1241; MOSER HW, 1995, J NEUROPATH EXP NEUR, V54, P740, DOI 10.1097/00005072-199509000-00017; Moser HW, 2002, METAB MOL BASES INHE, P3257; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Pan H, 2005, PEDIATR NEUROL, V33, P114, DOI 10.1016/j.pediatrneurol.2005.03.006; Ping Li-li, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P66; POWERS JM, 1992, J NEUROPATH EXP NEUR, V51, P630, DOI 10.1097/00005072-199211000-00007; Shukla P, 2009, J CHILD NEUROL, V24, P857, DOI 10.1177/0883073808330764; Soardi FC, 2010, ARQ BRAS ENDOCRINOL, V54, P738, DOI 10.1590/S0004-27302010000800013; SOBUE G, 1994, ANN NEUROL, V36, P912, DOI 10.1002/ana.410360617; Suzuki Y, 2005, BRAIN DEV-JPN, V27, P353, DOI 10.1016/j.braindev.2004.09.008; Valadares ER, 2011, GENET MOL RES, V10, P65, DOI 10.4238/vol10-1gmr975; Valianpour F, 2003, MOL GENET METAB, V79, P189, DOI 10.1016/S1096-7192(03)00098-2	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25094	10.1371/journal.pone.0025094	http://dx.doi.org/10.1371/journal.pone.0025094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966424	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100056
J	Quille, ML; Carat, S; Quemener-Redon, S; Hirchaud, E; Baron, D; Benech, C; Guihot, J; Placet, M; Mignen, O; Ferec, C; Houlgatte, R; Friocourt, G				Quille, Marie-Lise; Carat, Solenne; Quemener-Redon, Sylvia; Hirchaud, Edouard; Baron, Daniel; Benech, Caroline; Guihot, Jeanne; Placet, Morgane; Mignen, Olivier; Ferec, Claude; Houlgatte, Remi; Friocourt, Gaelle			High-Throughput Analysis of Promoter Occupancy Reveals New Targets for Arx, a Gene Mutated in Mental Retardation and Interneuronopathies	PLOS ONE			English	Article							HOMEOBOX GENE; INTELLECTUAL DISABILITY; POLYALANINE EXPANSION; NEURONAL MIGRATION; ABNORMAL GENITALIA; INFANTILE SPASMS; EXPRESSION; TELENCEPHALON; FOREBRAIN; MUTATIONS	Genetic investigations of X-linked intellectual disabilities have implicated the ARX (Aristaless-related homeobox) gene in a wide spectrum of disorders extending from phenotypes characterised by severe neuronal migration defects such as lissencephaly, to mild or moderate forms of mental retardation without apparent brain abnormalities but with associated features of dystonia and epilepsy. Analysis of Arx spatio-temporal localisation profile in mouse revealed expression in telencephalic structures, mainly restricted to populations of GABAergic neurons at all stages of development. Furthermore, studies of the effects of ARX loss of function in humans and animal models revealed varying defects, suggesting multiple roles of this gene during brain development. However, to date, little is known about how ARX functions as a transcription factor and the nature of its targets. To better understand its role, we combined chromatin immunoprecipitation and mRNA expression with microarray analysis and identified a total of 1006 gene promoters bound by Arx in transfected neuroblastoma (N2a) cells and in mouse embryonic brain. Approximately 24% of Arx-bound genes were found to show expression changes following Arx overexpression or knock-down. Several of the Arx target genes we identified are known to be important for a variety of functions in brain development and some of them suggest new functions for Arx. Overall, these results identified multiple new candidate targets for Arx and should help to better understand the pathophysiological mechanisms of intellectual disability and epilepsy associated with ARX mutations.	[Quille, Marie-Lise; Quemener-Redon, Sylvia; Benech, Caroline; Guihot, Jeanne; Placet, Morgane; Mignen, Olivier; Ferec, Claude; Friocourt, Gaelle] INSERM, U613, Brest, France; [Quille, Marie-Lise; Quemener-Redon, Sylvia; Benech, Caroline; Guihot, Jeanne; Placet, Morgane; Mignen, Olivier; Ferec, Claude; Friocourt, Gaelle] Brest Univ, Fac Med & Sci Sante, Brest, France; [Quille, Marie-Lise; Quemener-Redon, Sylvia; Benech, Caroline; Guihot, Jeanne; Placet, Morgane; Mignen, Olivier; Ferec, Claude; Friocourt, Gaelle] Brest Univ Hosp, Lab Mol Genet & Histocompatibil, Brest, France; [Carat, Solenne; Hirchaud, Edouard; Baron, Daniel; Houlgatte, Remi] Univ Nantes, INSERM, Inst Thorax, U915, Nantes, France; [Benech, Caroline; Ferec, Claude] Etab Francais Sang EFS Bretagne, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Quille, ML (corresponding author), INSERM, U613, Brest, France.	gaelle.friocourt@univ-brest.fr	Dumont, Solenne/L-3023-2015; MIGNEN, Olivier/M-3258-2019; Ferec, Claude/ABG-9699-2020; Houlgatte, Remi/P-3020-2017; Friocourt-Masse, Gaelle/M-8916-2017	Dumont, Solenne/0000-0003-3237-7382; MIGNEN, Olivier/0000-0001-7913-6119; Ferec, Claude/0000-0002-2325-0710; Friocourt, Gaelle/0000-0001-6681-7644; REDON, Sylvia/0000-0001-7310-1142	la Fondation Jerome Lejeune; le Fonds Europeen de Developpement Regional; INSERM; le Ministere de la Recherche; Association Gaetan Saleun	la Fondation Jerome Lejeune; le Fonds Europeen de Developpement Regional; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); le Ministere de la Recherche(Ministry of Research, France); Association Gaetan Saleun	This work was supported by la Fondation Jerome Lejeune (http://www.fondationlejeune.org/), le Fonds Europeen de Developpement Regional (http://www.feder.public.lu/) and INSERM (http://www.inserm.fr/). MLQ was supported by le Ministere de la Recherche (http://www.enseignementsup-recherche.gouv.fr/) and the Association Gaetan Saleun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baron D, 2007, IRBM, V28, P210; Baron D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-357; Baron D, 2011, BIOINFORMATICS, V27, P725, DOI 10.1093/bioinformatics/btq710; Baron D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-113; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Biressi S, 2008, CELL DEATH DIFFER, V15, P94, DOI 10.1038/sj.cdd.4402230; Carat Solenne, 2010, Journal of Bioinformatics and Computational Biology, V8, P485, DOI 10.1142/S0219720010004689; Colasante G, 2009, DEV BIOL, V334, P59, DOI 10.1016/j.ydbio.2009.07.014; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Colombo E, 2004, DEV DYNAM, V231, P631, DOI 10.1002/dvdy.20164; Colombo E, 2007, J NEUROSCI, V27, P4786, DOI 10.1523/JNEUROSCI.0417-07.2007; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friocourt G, 2006, EUR J NEUROSCI, V23, P869, DOI 10.1111/j.1460-9568.2006.04629.x; Friocourt G, 2008, J NEUROSCI, V28, P5794, DOI 10.1523/JNEUROSCI.1067-08.2008; Fullenkamp AN, 2008, BIOCHEM BIOPH RES CO, V377, P73, DOI 10.1016/j.bbrc.2008.09.116; Fulp CT, 2008, HUM MOL GENET, V17, P3740, DOI 10.1093/hmg/ddn271; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Guerrini R, 2007, NEUROLOGY, V69, P427, DOI 10.1212/01.wnl.0000266594.16202.c1; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kato M, 2003, NEUROLOGY, V61, P267, DOI 10.1212/01.WNL.0000068012.69928.92; Kato M, 2007, AM J HUM GENET, V81, P361, DOI 10.1086/518903; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Lamirault G, 2010, J CELL MOL MED, V14, P1443, DOI 10.1111/j.1582-4934.2009.00913.x; Marcorelles P, 2010, ACTA NEUROPATHOL, V120, P503, DOI 10.1007/s00401-010-0692-z; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; McKenzie O, 2007, NEUROSCIENCE, V146, P236, DOI 10.1016/j.neuroscience.2007.01.038; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Okazaki S, 2008, ACTA NEUROPATHOL, V116, P453, DOI 10.1007/s00401-008-0382-2; Poirier K, 2004, MOL BRAIN RES, V122, P35, DOI 10.1016/j.molbrainres.2003.11.021; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Scheffer IE, 2002, NEUROLOGY, V59, P348, DOI 10.1212/WNL.59.3.348; Seufert DW, 2005, DEV DYNAM, V232, P313, DOI 10.1002/dvdy.20234; Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	44	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25181	10.1371/journal.pone.0025181	http://dx.doi.org/10.1371/journal.pone.0025181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966449	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100071
J	Ueta, M; Sotozono, C; Yokoi, N; Inatomi, T; Kinoshita, S				Ueta, Mayumi; Sotozono, Chie; Yokoi, Norihiko; Inatomi, Tsutomu; Kinoshita, Shigeru			Prostaglandin E Receptor Subtype EP3 Expression in Human Conjunctival Epithelium and Its Changes in Various Ocular Surface Disorders	PLOS ONE			English	Article								Background: In our earlier genome-wide association study on Stevens-Johnson Syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), we found that in Japanese patients with these severe ocular surface complications there was an association with prostaglandin E receptor 3 (EP3) gene (PTGER3) polymorphisms. We also reported that EP3 is dominantly expressed in the ocular surface-, especially the conjunctival epithelium, and suggested that EP3 in the conjunctival epithelium may down-regulate ocular surface inflammation. In the current study we investigated the expression of EP3 protein in the conjunctiva of patients with various ocular surface diseases such as SJS/TEN, chemical eye burns, Mooren's ulcers, and ocular cicatricial pemphigoid (OCP). Methodology/Principal Findings: Conjunctival tissues were obtained from patients undergoing surgical reconstruction of the ocular surface due to SJS/TEN, chemical eye burns, and OCP, and from patients with Mooren's ulcers treated by resection of the inflammatory conjunctiva. The controls were nearly normal human conjunctival tissues acquired at surgery for conjunctivochalasis. We performed immunohistological analysis of the EP3 protein and evaluated the immunohistological staining of EP3 protein in the conjunctival epithelium of patients with ocular surface diseases. EP3 was expressed in the conjunctival epithelium of patients with chemical eye burns and Mooren's ulcer and in normal human conjunctival epithelium. However, it was markedly down-regulated in the conjunctival epithelium of SJS/TEN and OCP patients. Conclusions: We posit an association between the down-regulation of EP3 in conjunctival epithelium and the pathogenesis and pathology of SJS/TEN and OCP, and suggest a common mechanism(s) in the pathology of these diseases. The examination of EP3 protein expression in conjunctival epithelium may aid in the differential diagnosis of various ocular surface diseases.	[Ueta, Mayumi; Sotozono, Chie; Yokoi, Norihiko; Inatomi, Tsutomu; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Ueta, Mayumi] Doshisha Univ, Res Ctr Inflammat & Regenerat Med, Fac Life & Med Sci, Kyoto 602, Japan	Kyoto Prefectural University of Medicine; Doshisha University	Ueta, M (corresponding author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan.	mueta@koto.kpu-m.ac.jp			Japanese Ministry of Health, Labour and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology; CREST from JST; Kyoto Foundation for the Promotion of Medical Science; Kyoto Prefectural University of Medicine	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST from JST(Core Research for Evolutional Science and Technology (CREST)); Kyoto Foundation for the Promotion of Medical Science(Kyoto Foundation for the Promotion of Medical Science); Kyoto Prefectural University of Medicine	This work was supported in part by grants-in-aid for scientific research from the Japanese Ministry of Health, Labour and Welfare, the Japanese Ministry of Education, Culture, Sports, Science and Technology, CREST from JST, a research grant from the Kyoto Foundation for the Promotion of Medical Science, and the Intramural Research Fund of Kyoto Prefectural University of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Honda T, 2009, J ALLERGY CLIN IMMUN, V124, P809, DOI 10.1016/j.jaci.2009.04.029; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Matsuoka T, 2007, THESCIENTIFICWORLDJO, V7, P1329, DOI 10.1100/tsw.2007.182; Razzaque MS, 2003, INVEST OPHTH VIS SCI, V44, P1998, DOI 10.1167/iovs.02-0967; Sotozono C, 2009, OPHTHALMOLOGY, V116, P685, DOI 10.1016/j.ophtha.2008.12.048; Ueta M, 2011, BRIT J OPHTHALMOL, V95, P859, DOI 10.1136/bjo.2010.199679; Ueta M, 2010, J ALLERGY CLIN IMMUN, V126, P1218, DOI 10.1016/j.jaci.2010.08.007; Ueta M, 2009, J ALLERGY CLIN IMMUN, V123, P466, DOI 10.1016/j.jaci.2008.09.044	8	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25209	10.1371/journal.pone.0025209	http://dx.doi.org/10.1371/journal.pone.0025209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966456	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100072
J	Yang, X; Kume, S; Tanaka, Y; Isshiki, K; Araki, S; Chin-Kanasaki, M; Sugimoto, T; Koya, D; Haneda, M; Sugaya, T; Li, DT; Han, P; Nishio, Y; Kashiwagi, A; Maegawa, H; Uzu, T				Yang, Xu; Kume, Shinji; Tanaka, Yuki; Isshiki, Keiji; Araki, Shin-ichi; Chin-Kanasaki, Masami; Sugimoto, Toshiro; Koya, Daisuke; Haneda, Masakazu; Sugaya, Takeshi; Li, Detian; Han, Ping; Nishio, Yoshihiko; Kashiwagi, Atsunori; Maegawa, Hiroshi; Uzu, Takashi			GW501516, a PPAR delta Agonist, Ameliorates Tubulointerstitial Inflammation in Proteinuric Kidney Disease via Inhibition of TAK1-NF kappa B Pathway in Mice	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; PROXIMAL TUBULAR CELLS; HIGH-FAT DIET; RENAL INJURY; INSULIN SENSITIVITY; METABOLIC SYNDROME; MCP-1 EXPRESSION; BETA-OXIDATION; KAPPA-B; ALBUMIN	Peroxisome proliferator-activated receptors (PPARs) are a nuclear receptor family of ligand-inducible transcription factors, which have three different isoforms: PPAR alpha, delta and gamma. It has been demonstrated that PPAR alpha and gamma agonists have renoprotective effects in proteinuric kidney diseases; however, the role of PPAR delta agonists in kidney diseases remains unclear. Thus, we examined the renoprotective effect of GW501516, a PPAR delta agonist, in a protein-overload mouse nephropathy model and identified its molecular mechanism. Mice fed with a control diet or GW501516-containing diet were intraperitoneally injected with free fatty acid (FFA)-bound albumin or PBS(-). In the control group, protein overload caused tubular damages, macrophage infiltration and increased mRNA expression of MCP-1 and TNF alpha. These effects were prevented by GW501516 treatment. In proteinuric kidney diseases, excess exposure of proximal tubular cells to albumin, FFA bound to albumin or cytokines such as TNF alpha is detrimental. In vitro studies using cultured proximal tubular cells showed that GW501516 attenuated both TNF alpha- and FFA (palmitate)-induced, but not albumin-induced, MCP-1 expression via direct inhibition of the TGF-beta activated kinase 1 (TAK1)-NF kappa B pathway, a common downstream signaling pathway to TNF alpha receptor and toll-like receptor-4. In conclusion, we demonstrate that GW501516 has an anti-inflammatory effect in renal tubular cells and may serve as a therapeutic candidate to attenuate tubulointerstitial lesions in proteinuric kidney diseases.	[Yang, Xu; Kume, Shinji; Tanaka, Yuki; Isshiki, Keiji; Araki, Shin-ichi; Chin-Kanasaki, Masami; Sugimoto, Toshiro; Nishio, Yoshihiko; Kashiwagi, Atsunori; Maegawa, Hiroshi; Uzu, Takashi] Shiga Univ Med Sci, Dept Med, Shiga, Japan; [Yang, Xu; Li, Detian; Han, Ping] China Med Univ, Dept Med, Shengjing Hosp, Shenyang, Liaoning, Peoples R China; [Koya, Daisuke] Kanazawa Med Univ, Div Endocrinol & Metab, Kanazawa, Ishikawa, Japan; [Haneda, Masakazu] Asahikawa Med Coll, Dept Med, Asahikawa, Hokkaido 078, Japan; [Sugaya, Takeshi] St Marianna Univ, Sch Med, Kawasaki Ku, Kanagawa, Japan	Shiga University of Medical Science; China Medical University; Kanazawa Medical University; Asahikawa Medical College; Saint Marianna University	Yang, X (corresponding author), Shiga Univ Med Sci, Dept Med, Shiga, Japan.	takuzu@belle.shiga-med.ac.jp	Koya, Daisuke/J-3257-2014; Kashiwagi, Atsunori/H-8712-2019	Maegawa, Hiroshi/0000-0002-4611-8149	Shiga Medical Science Association for International Corporation	Shiga Medical Science Association for International Corporation	This work was supported with funds granted to XY by the Shiga Medical Science Association for International Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Bahlmann FH, 2004, CIRCULATION, V110, P1006, DOI 10.1161/01.CIR.0000139335.04152.F3; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Barish GD, 2008, P NATL ACAD SCI USA, V105, P4271, DOI 10.1073/pnas.0711875105; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Burton C, 1996, AM J KIDNEY DIS, V27, P765, DOI 10.1016/S0272-6386(96)90512-0; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Drumm K, 2002, CELL PHYSIOL BIOCHEM, V12, P187, DOI 10.1159/000066278; Duan SZ, 2009, CURR OPIN NEPHROL HY, V18, P128, DOI 10.1097/MNH.0b013e328325803b; Fan YB, 2008, ARTERIOSCL THROM VAS, V28, P315, DOI 10.1161/ATVBAHA.107.149815; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Guan YF, 2001, KIDNEY INT, V60, P14, DOI 10.1046/j.1523-1755.2001.00766.x; Ishikado A, 2009, ATHEROSCLEROSIS, V205, P404, DOI 10.1016/j.atherosclerosis.2009.01.010; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Isshiki K, 2000, DIABETES, V49, P1022, DOI 10.2337/diabetes.49.6.1022; Kamijo A, 2002, KIDNEY INT, V62, P1628, DOI 10.1046/j.1523-1755.2002.00618.x; Kamijo Y, 2007, J AM SOC NEPHROL, V18, P3089, DOI 10.1681/ASN.2007020238; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Kume S, 2008, PPAR RES, V2008, DOI 10.1155/2008/879523; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Letavernier E, 2005, J AM SOC NEPHROL, V16, P2395, DOI 10.1681/ASN.2004090802; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Piqueras L, 2009, J LEUKOCYTE BIOL, V86, P115, DOI [10.1189/jlb.0508284, 10.1189/JLB.0508284]; Sarafidis PA, 2006, KIDNEY INT, V70, P1223, DOI 10.1038/sj.ki.5001620; Shimizu H, 2003, J AM SOC NEPHROL, V14, P1496, DOI 10.1097/01.ASN.0000069223.98703.8E; Shin SJ, 2009, HYPERTENS RES, V32, P835, DOI 10.1038/hr.2009.107; Soumura M, 2010, BIOCH BIOPHYS RES CO; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Takaya K, 2003, AM J PHYSIOL-RENAL, V284, pF1037, DOI 10.1152/ajprenal.00230.2002; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; THOMAS ME, 1993, AM J NEPHROL, V13, P385, DOI 10.1159/000168653; Zoja C, 1998, KIDNEY INT, V53, P1608, DOI 10.1046/j.1523-1755.1998.00905.x; Zoja C, 2009, FRONT BIOSCI-LANDMRK, V14, P1815, DOI 10.2741/3343	44	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25271	10.1371/journal.pone.0025271	http://dx.doi.org/10.1371/journal.pone.0025271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966476	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100078
J	Xiao, YP; Kavanau, C; Bertin, L; Kaplan, E				Xiao, Youping; Kavanau, Chistopher; Bertin, Lauren; Kaplan, Ehud			The Biological Basis of a Universal Constraint on Color Naming: Cone Contrasts and the Two-Way Categorization of Colors	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; STRIATE CORTEX; MACAQUE MONKEY; CHROMATIC MECHANISMS; QUANTITATIVE ASPECTS; SYSTEM; HUE; WAVELENGTH; ADAPTATION	Many studies have provided evidence for the existence of universal constraints on color categorization or naming in various languages, but the biological basis of these constraints is unknown. A recent study of the pattern of color categorization across numerous languages has suggested that these patterns tend to avoid straddling a region in color space at or near the border between the English composite categories of "warm" and "cool". This fault line in color space represents a fundamental constraint on color naming. Here we report that the two-way categorization along the fault line is correlated with the sign of the L- versus M-cone contrast of a stimulus color. Moreover, we found that the sign of the L-M cone contrast also accounted for the two-way clustering of the spatially distributed neural responses in small regions of the macaque primary visual cortex, visualized with optical imaging. These small regions correspond to the hue maps, where our previous study found a spatially organized representation of stimulus hue. Altogether, these results establish a direct link between a universal constraint on color naming and the cone-specific information that is represented in the primate early visual system.	[Xiao, Youping; Kavanau, Chistopher; Kaplan, Ehud] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Xiao, Youping; Kavanau, Chistopher; Kaplan, Ehud] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Bertin, Lauren] Bennington Coll, Bennington, VT USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Xiao, YP (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	Youping.Xiao@mssm.edu		Lauwereyns, Jan/0000-0003-0551-2550; Bertin, Lauren/0000-0002-4261-089X; Xiao, Youping/0000-0003-3954-3443	National Institutes of Health (NIH) [EY016371, EY12867, GM71558, EY01867]; Fight For Sight; NATIONAL EYE INSTITUTE [R01EY012867, R01EY016371, P30EY001867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fight For Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (NIH) grants EY016371, EY12867, GM71558 and core grant EY01867, and a grant from Fight For Sight to Y.X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Baronchelli A, 2010, P NATL ACAD SCI USA, V107, P2403, DOI 10.1073/pnas.0908533107; Berlin B., 1969, BASIC COLOR TERMS TH; BOYNTON RM, 1987, COLOR RES APPL, V12, P94, DOI 10.1002/col.5080120209; CHAPARRO A, 1995, VISION RES, V35, P3103, DOI 10.1016/0042-6989(95)00069-C; Claeskens G, 2008, J MACHINE LEARNING R, V9, P18; Conway BR, 2010, J NEUROSCI, V30, P14955, DOI 10.1523/JNEUROSCI.4348-10.2010; Cottaris NP, 1998, NATURE, V395, P896, DOI 10.1038/27666; Davidoff J, 1999, NATURE, V398, P203, DOI 10.1038/18335; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DeValois RL, 1997, VISION RES, V37, P885, DOI 10.1016/S0042-6989(96)00234-9; DEVALOIS RL, 1964, SCIENCE, V146, P1184, DOI 10.1126/science.146.3648.1184; DEVALOIS RL, 1965, COLD SPRING HARB SYM, V30, P567, DOI 10.1101/SQB.1965.030.01.055; DEVALOIS RL, 1966, J OPT SOC AM, V56, P966, DOI 10.1364/JOSA.56.000966; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; Goethe Johann Wolfgang, 1982, THEORY COLOURS; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hanazawa A, 2000, EUR J NEUROSCI, V12, P1753, DOI 10.1046/j.1460-9568.2000.00041.x; Hering, 1878, LEHR LICHTS; HURVICH LM, 1956, J OPT SOC AM, V46, P416, DOI 10.1364/JOSA.46.000416; JAMESON D, 1956, J OPT SOC AM, V46, P405, DOI 10.1364/JOSA.46.000405; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; Johnson EN, 2004, J NEUROPHYSIOL; Kay P, 2003, P NATL ACAD SCI USA, V100, P9085, DOI 10.1073/pnas.1532837100; Kay P, COLOR CATEGORIES THO, P21; Komarova NI, 2008, J THEOR BIOL, V253, P680, DOI 10.1016/j.jtbi.2008.03.030; Landisman CE, 2002, J NEUROPHYSIOL, V87, P3126, DOI 10.1152/jn.2002.87.6.3126; LENNIE P, 1990, J NEUROSCI, V10, P649; Lindsey DT, 2006, P NATL ACAD SCI USA, V103, P16608, DOI 10.1073/pnas.0607708103; Lindsey DT, 2002, PSYCHOL SCI, V13, P506, DOI 10.1111/1467-9280.00489; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Lu HD, 2008, CEREB CORTEX, V18, P516, DOI 10.1093/cercor/bhm081; Regier T, 2005, P NATL ACAD SCI USA, V102, P8386, DOI 10.1073/pnas.0503281102; Regier T, 2007, P NATL ACAD SCI USA, V104, P1436, DOI 10.1073/pnas.0610341104; Regier T, 2009, TRENDS COGN SCI, V13, P439, DOI 10.1016/j.tics.2009.07.001; Roberson D, 2005, COGNITIVE PSYCHOL, V50, P378, DOI 10.1016/j.cogpsych.2004.10.001; Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369; Schwarz G, 1978, ANN STAT, V6, P4; SEBER GAF, 1984, MULTIVARIATE OBSERVA; SPATH H, 1985, CLUSTER DISSECTION A; Steels L, 2005, BEHAV BRAIN SCI, V28, P469, DOI 10.1017/S0140525X05000087; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Stockman A, 2008, J VISION, V8, DOI 10.1167/8.16.1; Vapnik V., 1998, STAT LEARNING THEORY; Wachtler T, 2003, NEURON, V37, P681, DOI 10.1016/S0896-6273(03)00035-7; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; Wyszecki G, 1982, COLOR SCI, Vsecond; Xiao Y, 2008, IMPROVED MAPPING INF; Xiao YP, 2007, NEUROIMAGE, V35, P771, DOI 10.1016/j.neuroimage.2006.11.059; Yendrikhovskij SN, 2001, J IMAGING SCI TECHN, V45, P409; Yoshioka T, 1996, BEHAV BRAIN RES, V76, P51, DOI 10.1016/0166-4328(95)00183-2	53	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24994	10.1371/journal.pone.0024994	http://dx.doi.org/10.1371/journal.pone.0024994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21977226	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100030
J	Huang, QJ; Lan, FH; Zheng, ZY; Xie, FL; Han, JY; Dong, LH; Xie, YC; Zheng, F				Huang, Qiaojia; Lan, Fenghua; Zheng, Zhiyong; Xie, Feilai; Han, Junyong; Dong, Lihong; Xie, Yanchuan; Zheng, Feng			Akt2 Kinase Suppresses Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH)-mediated Apoptosis in Ovarian Cancer Cells via Phosphorylating GAPDH at Threonine 237 and Decreasing Its Nuclear Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; PROTEIN; BREAST; ACTIVATION; TARGET; DEATH; PROLIFERATION; MIGRATION; SURVIVAL; AKT/PKB	Protein kinase B (Akt) plays important roles in regulation of cell growth and survival, but while many aspects of its mechanism of action are known, there are potentially additional regulatory events that remain to be discovered. Here we detected a 36-kDa protein that was co-immunoprecipitated with protein kinase B beta (Akt2) in OVCAR-3 ovarian cancer cells. The protein was identified to be glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by MALDI-TOF/TOF MS, and the interaction of Akt2 and GAPDH was verified by reverse immunoprecipitation. Our further study showed that Akt2 may suppress GAPDH-mediated apoptosis in ovarian cancer cells. Overexpression of GAPDH increased ovarian cancer cell apoptosis induced by H2O2, which was inhibited by Akt2 overexpression and restored by the PI3K/Akt inhibitor wortmannin or Akt2 siRNA. Akt2 phosphorylated Thr-237 of GAPDH and decreased its nuclear translocation, an essential step for GAPDH-mediated apoptosis. The interaction between Akt2 and GAPDH may be important in ovarian cancer as immunohistochemical analysis of 10 normal and 30 cancerous ovarian tissues revealed that decreased nuclear expression of GAPDH correlated with activation (phosphorylation) of Akt2. In conclusion, our study suggests that activated Akt2 may increase ovarian cancer cell survival via inhibition of GAPDH-induced apoptosis. This effect of Akt2 is partly mediated by its phosphorylation of GAPDH at Thr-237, which results in the inhibition of GAPDH nuclear translocation.	[Huang, Qiaojia; Lan, Fenghua; Han, Junyong; Dong, Lihong; Xie, Yanchuan] Dongfang Hosp, Fuzhou Gen Hosp, Dept Expt Med, Fuzhou 350025, Fujian Province, Peoples R China; [Zheng, Feng] Dongfang Hosp, Fuzhou Gen Hosp, Dept Nephrol, Fuzhou 350025, Fujian Province, Peoples R China; [Zheng, Zhiyong; Xie, Feilai] Dongfang Hosp, Fuzhou Gen Hosp, Dept Pathol, Fuzhou 350025, Fujian Province, Peoples R China		Huang, QJ (corresponding author), Dongfang Hosp, Fuzhou Gen Hosp, Dept Expt Med, 156 N Xi Er Huan Rd, Fuzhou 350025, Fujian Province, Peoples R China.	huangqj100@126.com			Medical Scientific Research Foundation of Nanjing Command [08MA100]; Natural Science Foundation of Fujian Province [2009J01181]; Fuzhou General Hospital Special Foundation [2004037]	Medical Scientific Research Foundation of Nanjing Command; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Fuzhou General Hospital Special Foundation	This work was supported by the Medical Scientific Research Foundation of Nanjing Command Grant 08MA100, Natural Science Foundation of Fujian Province Grant 2009J01181, and Fuzhou General Hospital Special Foundation Grant 2004037.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Arboleda MJ, 2003, CANCER RES, V63, P196; Baba T, 2010, FEBS LETT, V584, P2796, DOI 10.1016/j.febslet.2010.05.015; Chau NM, 2004, BREAST CANCER RES, V6, P55, DOI 10.1186/bcr739; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Dastoor Z, 2001, J CELL SCI, V114, P1643; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Du ZX, 2007, ENDOCRINOLOGY, V148, P4352, DOI 10.1210/en.2006-1511; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Harada N, 2007, J BIOL CHEM, V282, P22651, DOI 10.1074/jbc.M610724200; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Huang QJ, 2008, J CANCER RES CLIN, V134, P1219, DOI 10.1007/s00432-008-0398-y; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jiang K, 2000, MOL CELL BIOL, V20, P139, DOI 10.1128/MCB.20.1.139-148.2000; Kallergi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2149; Kwon HJ, 2010, EXP MOL MED, V42, P254, DOI 10.3858/emm.2010.42.4.025; Li XY, 2006, TOXICOL MECH METHOD, V16, P1, DOI 10.1080/15376520500191797; Mackey AM, 2008, CELL DEATH DIFFER, V15, P1291, DOI 10.1038/cdd.2008.43; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Noske A, 2007, CANCER LETT, V246, P190, DOI 10.1016/j.canlet.2006.02.018; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Pecorari L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-58; Qin SF, 2003, BIOCHEMISTRY-US, V42, P2995, DOI 10.1021/bi0205911; Sadidi M, 2009, BIOCHIMIE, V91, P577, DOI 10.1016/j.biochi.2009.01.010; Sahin O, 2007, P NATL ACAD SCI USA, V104, P6579, DOI 10.1073/pnas.0606827104; Schmitz HD, 2001, EUR J CELL BIOL, V80, P419, DOI 10.1078/0171-9335-00174; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Villafuerte BC, 2004, J BIOL CHEM, V279, P36650, DOI 10.1074/jbc.M404349200; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yoon SO, 2001, FASEB J, V15, P111, DOI 10.1096/fj.01-0398fje; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	40	68	74	4	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42211	42220		10.1074/jbc.M111.296905	http://dx.doi.org/10.1074/jbc.M111.296905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21979951	Green Published, hybrid			2022-12-25	WOS:000298180900031
J	Paschall, CO; Thompson, JA; Marzahn, MR; Chiraniya, A; Hayner, JN; O'Donnell, M; Robbins, AH; McKenna, R; Bloom, LB				Paschall, Christopher O.; Thompson, Jennifer A.; Marzahn, Melissa R.; Chiraniya, Ankita; Hayner, Jaclyn N.; O'Donnell, Mike; Robbins, Arthur H.; McKenna, Robert; Bloom, Linda B.			The Escherichia coli Clamp Loader Can Actively Pry Open the beta-Sliding Clamp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; CELL NUCLEAR ANTIGEN; REPLICATION-FACTOR-C; ONE HOLOENZYME PARTICLE; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; DELTA-SUBUNIT; GAMMA-COMPLEX; MACHINE	Clamp loaders load ring-shaped sliding clamps onto DNA. Once loaded onto DNA, sliding clamps bind to DNA polymerases to increase the processivity of DNA synthesis. To load clamps onto DNA, an open clamp loader-clamp complex must form. An unresolved question is whether clamp loaders capture clamps that have transiently opened or whether clamp loaders bind closed clamps and actively open clamps. A simple fluorescence-based clamp opening assay was developed to address this question and to determine how ATP binding contributes to clamp opening. A direct comparison of real time binding and opening reactions revealed that the Escherichia coli alpha complex binds beta first and then opens the clamp. Mutation of conserved "arginine fingers" in the alpha complex that interact with bound ATP decreased clamp opening activity showing that arginine fingers make an important contribution to the ATP-induced conformational changes that allow the clamp loader to pry open the clamp.	[Paschall, Christopher O.; Thompson, Jennifer A.; Marzahn, Melissa R.; Chiraniya, Ankita; Hayner, Jaclyn N.; Robbins, Arthur H.; McKenna, Robert; Bloom, Linda B.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [O'Donnell, Mike] Howard Hughes Med Inst, New York, NY 10021 USA; [O'Donnell, Mike] Rockefeller Univ, New York, NY 10021 USA	State University System of Florida; University of Florida; Howard Hughes Medical Institute; Rockefeller University	Bloom, LB (corresponding author), Univ Florida, Dept Biochem & Mol Biol, 1600 SW Archer Rd,JHMHC R3-234, Gainesville, FL 32610 USA.	lbloom@ufl.edu	Bloom, Linda B/F-3684-2014	O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [GM055596, GM082849, GM038839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082849, R37GM038839, R01GM055596, R01GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM055596 and GM082849 (to L.B.B.) and GM038839 (to M.O.D.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alley SC, 2000, BIOCHEMISTRY-US, V39, P3076, DOI 10.1021/bi992377r; Alley SC, 1999, BIOCHEMISTRY-US, V38, P7696, DOI 10.1021/bi9827971; Anderson SG, 2009, BIOCHEMISTRY-US, V48, P8516, DOI 10.1021/bi900912a; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; DONG ZM, 1993, J BIOL CHEM, V268, P11758; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Johnson A, 2006, J BIOL CHEM, V281, P35531, DOI 10.1074/jbc.M606090200; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leu FP, 2000, J BIOL CHEM, V275, P34609, DOI 10.1074/jbc.M005495200; Leu FP, 2001, J BIOL CHEM, V276, P47185, DOI 10.1074/jbc.M106780200; MAKI S, 1988, J BIOL CHEM, V263, P6547; Millar D, 2004, BIOCHEMISTRY-US, V43, P12723, DOI 10.1021/bi048349c; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; O'Donnell M, 2006, CURR OPIN STRUC BIOL, V16, P35, DOI 10.1016/j.sbi.2005.12.004; Oakley AJ, 2003, ACTA CRYSTALLOGR D, V59, P1192, DOI 10.1107/S0907444903009958; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Snyder AK, 2004, J BIOL CHEM, V279, P4386, DOI 10.1074/jbc.M310430200; Stewart J, 2001, J BIOL CHEM, V276, P19182, DOI 10.1074/jbc.M100592200; Thompson JA, 2009, J BIOL CHEM, V284, P32147, DOI 10.1074/jbc.M109.045997; Trakselis MA, 2001, P NATL ACAD SCI USA, V98, P8368, DOI 10.1073/pnas.111006698; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103; Zhuang ZH, 2006, BIOCHEMISTRY-US, V45, P7976, DOI 10.1021/bi0601205	41	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42704	42714		10.1074/jbc.M111.268169	http://dx.doi.org/10.1074/jbc.M111.268169			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21971175	Green Published, hybrid			2022-12-25	WOS:000298180900077
J	Weitz-Schmidt, G; Schurpf, T; Springer, TA				Weitz-Schmidt, Gabriele; Schuerpf, Thomas; Springer, Timothy A.			The C-Terminal alpha I Domain Linker as a Critical Structural Element in the Conformational Activation of alpha I Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; ADHESION MOLECULE-1 ICAM-1; BETA-PROPELLER DOMAIN; ALLOSTERIC SITE; CELL-ADHESION; SUBUNIT; ANTIBODIES; BINDING; LFA-1; ALPHA-L-BETA-2	The activation of alpha/beta heterodimeric integrins is the result of highly coordinated rearrangements within both subunits. The molecular interactions between the two subunits, however, remain to be characterized. In this study, we use the integrin alpha(L)beta(2) to investigate the functional role of the C-linker polypeptide that connects the C-terminal end of the inserted (I) domain with the beta-propeller domain on the alpha subunit and is located at the interface with the beta I domain of the alpha chain. We demonstrate that shortening of the C-linker by eight or more amino acids results in constitutively active alpha(L)beta(2) in which the alpha I domain is no longer responsive to the regulation by the beta I domain. Despite this intersubunit uncoupling, both I domains remain individually sensitive to intrasubunit conformational changes induced by allosteric modulators. Interestingly, the length and not the sequence of the C-linker appears to be critical for its functionality in alpha/beta intersubunit communication. Using two monoclonal antibodies (R7.1 and CBRLFA-1/1) we further demonstrate that shortening of the C-linker results in the gradual loss of combinational epitopes that require both the alpha I and beta-propeller domains for full reactivity. Taken together, our findings highlight the role of the C-linker as a spring-like element that allows relaxation of the alpha I domain in the resting state and controlled tension of the alpha I domain during activation, exerted by the beta chain.	[Weitz-Schmidt, Gabriele] Univ Basel, PharmaCtr, CH-4056 Basel, Switzerland; [Weitz-Schmidt, Gabriele; Schuerpf, Thomas; Springer, Timothy A.] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Weitz-Schmidt, Gabriele; Schuerpf, Thomas; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Basel; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Weitz-Schmidt, G (corresponding author), Univ Basel, PharmaCtr, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	gabriele.weitz-schmidt@unibas.ch; springer@idi.harvard.edu	Schürpf, Thomas/E-7380-2012	Schurpf, Thomas/0000-0003-3023-1136	National Institutes of Health [CA31798]; NATIONAL CANCER INSTITUTE [R01CA031798, R37CA031798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA31798.	ARGENBRIGHT LW, 1991, J LEUKOCYTE BIOL, V49, P253, DOI 10.1002/jlb.49.3.253; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; FOTOUHI N, 1999, Patent No. 0021920; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Huang CC, 2000, J BIOL CHEM, V275, P21514, DOI 10.1074/jbc.M002286200; HUANG CC, 1995, J BIOL CHEM, V270, P19008, DOI 10.1074/jbc.270.32.19008; Huang CC, 1997, P NATL ACAD SCI USA, V94, P3162, DOI 10.1073/pnas.94.7.3162; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Kelly TA, 1999, J IMMUNOL, V163, P5173; Lu CF, 2004, J IMMUNOL, V173, P3972, DOI 10.4049/jimmunol.173.6.3972; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398; Lu CF, 1998, J BIOL CHEM, V273, P15138, DOI 10.1074/jbc.273.24.15138; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Lupher ML, 2001, J IMMUNOL, V167, P1431, DOI 10.4049/jimmunol.167.3.1431; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Smagghe BJ, 2010, J BIOL CHEM, V285, P32954, DOI 10.1074/jbc.M110.145177; Song G, 2006, J BIOL CHEM, V281, P5042, DOI 10.1074/jbc.M510454200; Weetall M, 2001, ANAL BIOCHEM, V293, P277, DOI 10.1006/abio.2001.5140; Weitz-Schmidt G, 2004, J BIOL CHEM, V279, P46764, DOI 10.1074/jbc.M407951200; Welzenbach K, 2002, J BIOL CHEM, V277, P10590, DOI 10.1074/jbc.M110521200; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Yalamanchili P, 2000, J BIOL CHEM, V275, P21877, DOI 10.1074/jbc.M908868199; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101	36	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42115	42122		10.1074/jbc.M111.282830	http://dx.doi.org/10.1074/jbc.M111.282830			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965670	Green Published, hybrid			2022-12-25	WOS:000298180900022
J	Chantret, I; Kodali, VP; Lahmouich, C; Harvey, DJ; Moore, SEH				Chantret, Isabelle; Kodali, Vidya P.; Lahmouich, Chaimaa; Harvey, David J.; Moore, Stuart E. H.			Endoplasmic Reticulum-associated Degradation (ERAD) and Free Oligosaccharide Generation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-N-GLYCANASE; MISFOLDED GLYCOPROTEINS; LINKED GLYCANS; NEGATIVE-IONS; HUMAN OS-9; YEAST; PROTEIN; MANNOSIDASE; GLYCOSYLATION; PATHWAY	In Saccharomyces cerevisiae, proteins with misfolded lumenal, membrane, and cytoplasmic domains are cleared from the endoplasmic reticulum (ER) by ER-associated degradation (ERAD)-L, -M, and -C, respectively. ERAD-L is N-glycan-dependent and is characterized by ER mannosidase (Mns1p) and ER mannosidase-like protein (Mnl1p), which generate Man(7)GlcNAc(2) (d1) N-glycans with non-reducing alpha 1,6-mannosyl residues. Glycoproteins bearing this motif bind Yos9p and are dislocated into the cytoplasm and then deglycosylated by peptide N-glycanase (Png1p) to yield free oligosaccharides (fOS). Here, we examined yeast fOS metabolism as a function of cell growth in order to obtain quantitative and mechanistic insights into ERAD. We demonstrate that both Png1p-dependent generation of Man(7-10)GlcNAc(2) fOS and vacuolar a-mannosidase (Ams1p)-dependent fOS demannosylation to yield Man(1)GlcNAc(2) are strikingly up-regulated during post-diauxic growth which occurs when the culture medium is depleted of glucose. Gene deletions in the ams1 Delta background revealed that, as anticipated, Mns1p and Mnl1p are required for efficient generation of the Man(7)GlcNAc(2) (d1) fOS, but for the first time, we demonstrate that small amounts of this fOS are generated in an Mnl1p-independent, Mns1p-dependent pathway and that a Man,GlcNAc., fOS that is known to bind Yos9p is generated in an Mnl1p-dependent, Mns1p-independent manner. This latter observation adds mechanistic insight into a recently described Mnl1p-dependent, Mns1p-independent ERAD pathway. Finally, we show that 50% of fOS generation is independent of ERAD-L, and because our data indicate that ERAD-M and ERAD-C contribute little to fOS levels, other important processes underlie fOS generation in S. cerevisiae.	[Moore, Stuart E. H.] Univ Paris 07, INSERM, U773, Fac Med Xavier Bichat,CRB3, F-75018 Paris, France; [Chantret, Isabelle; Kodali, Vidya P.; Lahmouich, Chaimaa; Moore, Stuart E. H.] Univ Paris 07, Paris, France; [Harvey, David J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Oxford	Moore, SEH (corresponding author), Univ Paris 07, INSERM, U773, Fac Med Xavier Bichat,CRB3, 16 Rue Henri Huchard, F-75018 Paris, France.	stuart.moore@inserm.fr	Kodali, Dr. Vidya Prabhakar/ABE-7646-2021; Moore, Stuart/AAF-3920-2021; Harvey, David/A-5579-2013; CHANTRET, Isabelle/AAF-7134-2021	Moore, Stuart/0000-0002-1020-2242; CHANTRET, Isabelle/0000-0002-0896-1274; Harvey, David/0000-0003-0544-771X	Mizutani Foundation; GIS-Institut des Maladies Rares/INSERM; French CDG Research Network, EUROGLY-CANET [LSHM-CT-2005-512131]; La Fondation pour la Recherche Medicale; INSERM	Mizutani Foundation; GIS-Institut des Maladies Rares/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); French CDG Research Network, EUROGLY-CANET; La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the Mizutani Foundation, the GIS-Institut des Maladies Rares/INSERM-funded French CDG Research Network, EUROGLY-CANET (LSHM-CT-2005-512131), La Fondation pour la Recherche Medicale, and institutional funding from INSERM.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.1042/BJ20030384; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Chantret I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011734; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Davidson GS, 2011, MOL BIOL CELL, V22, P988, DOI 10.1091/mbc.E10-06-0499; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P622, DOI 10.1016/j.jasms.2005.01.004; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P631, DOI 10.1016/j.jasms.2005.01.005; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; Herscovics A, 2002, GLYCOBIOLOGY, V12, p14G; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hosomi A, 2010, J BIOL CHEM, V285, P24324, DOI 10.1074/jbc.M109.095919; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Kawaguchi S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015532; KENNEDY LD, 1983, ANAL BIOCHEM, V128, P465, DOI 10.1016/0003-2697(83)90402-5; Kostova Z, 2009, J CELL SCI, V122, P1374, DOI 10.1242/jcs.044255; Mikami K, 2010, GLYCOBIOLOGY, V20, P310, DOI 10.1093/glycob/cwp175; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Moore SEH, 1999, TRENDS CELL BIOL, V9, P441, DOI 10.1016/S0962-8924(99)01648-7; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; NAKANISHISHINDO Y, 1993, J BIOL CHEM, V268, P26338; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; OPHEIM DJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P121, DOI 10.1016/0005-2744(78)90110-9; Peric D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011675; Petracek ME, 2002, METHOD ENZYMOL, V350, P445, DOI 10.1016/S0076-6879(02)50978-2; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Reiss G, 1996, GLYCOBIOLOGY, V6, P493, DOI 10.1093/glycob/6.5.493; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Suzuki T, 1998, J BIOL CHEM, V273, P21526, DOI 10.1074/jbc.273.34.21526; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; YIP CL, 1994, P NATL ACAD SCI USA, V91, P2723, DOI 10.1073/pnas.91.7.2723	47	22	23	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41786	41800		10.1074/jbc.M111.251371	http://dx.doi.org/10.1074/jbc.M111.251371			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21979948	Green Published, hybrid			2022-12-25	WOS:000298057500062
J	King, JG; Vernick, KD; Hillyer, JF				King, Jonas G.; Vernick, Kenneth D.; Hillyer, Julian F.			Members of the Salivary Gland Surface Protein (SGS) Family Are Major Immunogenic Components of Mosquito Saliva	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT FEMALE MOSQUITO; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; MONOCLONAL-ANTIBODIES; MEMBRANE-PROTEINS; MALARIA PARASITES; GENE-EXPRESSION; HUMAN IGE; INSIGHT; IDENTIFICATION	Mosquitoes transmit Plasmodium and certain arboviruses during blood feeding, when they are injected along with saliva. Mosquito saliva interferes with the host's hemostasis and inflammation response and influences the transmission success of some pathogens. One family of mosquito salivary gland proteins, named SGS, is composed of large bacterial-type proteins that in Aedes aegypti were implicated as receptors for Plasmodium on the basal salivary gland surface. Here, we characterize the biology of two SGSs in the malaria mosquito, Anopheles gambiae, and demonstrate their involvement in blood feeding. Western blots and RT-PCR showed that Sgs4 and Sgs5 are produced exclusively in female salivary glands, that expression increases with age and after blood feeding, and that protein levels fluctuate in a circadian manner. Immunohistochemistry showed that SGSs are present in the acinar cells of the distal lateral lobes and in the salivary ducts of the proximal lobes. PAGE, Western blots, bite blots, and immunization via mosquito bites showed that SGSs are highly immunogenic and form major components of mosquito saliva. Last, Western and bioinformatic analyses suggest that SGSs are secreted via a non-classical pathway that involves cleavage into a 300-kDa soluble fragment and a smaller membrane-bound fragment. Combined, these data strongly suggest that SGSs play an important role in blood feeding. Together with their role in malaria transmission, we propose that SGSs could be used as markers of human exposure to mosquito bites and in the development of disease control strategies.	[King, Jonas G.; Hillyer, Julian F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [King, Jonas G.; Hillyer, Julian F.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37235 USA; [Vernick, Kenneth D.] Inst Pasteur, Dept Parasitol & Mycol, F-75015 Paris, France	Vanderbilt University; Vanderbilt University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Hillyer, JF (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B 35-1634, Nashville, TN 37235 USA.	julian.hillyer@vanderbilt.edu		Hillyer, Julian/0000-0002-3178-0201; King, Jonas/0000-0003-2270-4212	Vanderbilt University	Vanderbilt University	This work was supported by a Vanderbilt University Discovery Grant (to J. F. H.).	Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Arca B, 2007, INSECT BIOCHEM MOLEC, V37, P107, DOI 10.1016/j.ibmb.2006.10.007; Barreau C, 1999, INSECT BIOCHEM MOLEC, V29, P515, DOI 10.1016/S0965-1748(99)00025-9; BILLINGSLEY PF, 1991, T ROY SOC TROP MED H, V85, P450, DOI 10.1016/0035-9203(91)90215-K; Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069; BOORMAN J, 1987, MED VET ENTOMOL, V1, P211, DOI 10.1111/j.1365-2915.1987.tb00346.x; Bowen MF, 1996, CIBA F SYMP, V200, P197; Brennan JDG, 2000, P NATL ACAD SCI USA, V97, P13859, DOI 10.1073/pnas.250472597; BRUMMERKORVENKONTIO H, 1994, J ALLERGY CLIN IMMUN, V93, P551, DOI 10.1016/S0091-6749(94)70066-4; Calvo E, 2010, J MED ENTOMOL, V47, P376, DOI 10.1603/ME09226; Castellanos-Serra L, 2006, NAT PROTOC, V1, P1544, DOI 10.1038/nprot.2006.233; Chen YL, 1998, INT ARCH ALLERGY IMM, V116, P269, DOI 10.1159/000023955; Cornelie S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-75; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06; Dowling AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015693; Drame PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015596; Francischetti IMB, 2002, J EXP BIOL, V205, P2429; Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265; Harlow E., 1988, ANTIBODIES LAB MANUA; Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; JAMES AA, 1991, MOL BIOCHEM PARASIT, V44, P245, DOI 10.1016/0166-6851(91)90010-4; Jariyapan N, 2010, PARASITOL RES, V107, P509, DOI 10.1007/s00436-010-1883-1; Jeon SH, 2001, INT ARCH ALLERGY IMM, V126, P206, DOI 10.1159/000049515; Juhn J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-1; Kebaier C, 2010, INFECT IMMUN, V78, P545, DOI 10.1128/IAI.00807-09; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Klasson L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-33; Korochkina S, 2006, CELL MICROBIOL, V8, P163, DOI 10.1111/j.1462-5822.2005.00611.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malafronte Rdos S., 2003, INSECT BIOCHEM MOLEC, V33, P63; Mans B. J., 2011, TOXINS HEMOSTASIS, P21; Minet AD, 1999, J CELL SCI, V112, P2019; Moreira CK, 2001, J MED ENTOMOL, V38, P763, DOI 10.1603/0022-2585-38.5.763; Morris RV, 2001, J IMMUNOL, V167, P5226, DOI 10.4049/jimmunol.167.9.5226; Okulate MA, 2007, INSECT MOL BIOL, V16, P711, DOI 10.1111/j.1365-2583.2007.00765.x; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Owhashi M, 2001, PARASITOL RES, V87, P376, DOI 10.1007/s004360000355; Peng ZK, 1998, J ALLERGY CLIN IMMUN, V101, P498, DOI 10.1016/S0091-6749(98)70357-4; PENNEYS NS, 1989, ARCH DERMATOL, V125, P219, DOI 10.1001/archderm.125.2.219; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; RACIOPPI JV, 1987, INSECT BIOCHEM, V17, P503, DOI 10.1016/0020-1790(87)90010-2; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reddy V, 2008, J MOL NEUROSCI, V36, P241, DOI 10.1007/s12031-008-9079-1; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Sasse J., 2009, CURR PROTOC MOL BIOL; Saunders D. S., 2002, INSECT CLOCKS, P9; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Siriyasatien Padet, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P64; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Vaughan JA, 1999, INFECT IMMUN, V67, P4285, DOI 10.1128/IAI.67.8.4285-4289.1999; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004; Wasserman HA, 2004, PARASITE IMMUNOL, V26, P295, DOI 10.1111/j.0141-9838.2004.00712.x; *WHO, 1996, WEEKLY EPIDEMIOLOGIC, V71, P17; Youderian P, 2007, GENETICS, V177, P557, DOI 10.1534/genetics.107.076182	60	29	29	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40824	40834		10.1074/jbc.M111.280552	http://dx.doi.org/10.1074/jbc.M111.280552			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965675	Green Published, hybrid			2022-12-25	WOS:000297315400043
J	Grigorian, A; Araujo, L; Naidu, NN; Place, DJ; Choudhury, B; Demetriou, M				Grigorian, Ani; Araujo, Lindsey; Naidu, Nandita N.; Place, Dylan J.; Choudhury, Biswa; Demetriou, Michael			N-Acetylglucosamine Inhibits T-helper 1 (Th1)/T-helper 17 (Th17) Cell Responses and Treats Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACEBO-CONTROLLED TRIAL; INTERLEUKIN-7 RECEPTOR; SURFACE ORGANIZATION; MULTIPLE-SCLEROSIS; ORAL FINGOLIMOD; GLUCOSAMINE; ACTIVATION; CYTOKINE; GLYCOSYLATION; TOXICITY	Current treatments and emerging oral therapies for multiple sclerosis (MS) are limited by effectiveness, cost, and/or toxicity. Genetic and environmental factors that alter the branching of Asn (N)-linked glycans result in T cell hyperactivity, promote spontaneous inflammatory demyelination and neurodegeneration in mice, and converge to regulate the risk of MS. The sugar N-acetylglucosamine (GlcNAc) enhances N-glycan branching and inhibits T cell activity and adoptive transfer experimental autoimmune encephalomyelitis (EAE). Here, we report that oral GlcNAc inhibits T-helper 1 (Th1) and T-helper 17 (Th17) responses and attenuates the clinical severity of myelin oligodendrocyte glycoprotein (MOG)-induced EAE when administered after disease onset. Oral GlcNAc increased expression of branched N-glycans in T cells in vivo as shown by high pH anion exchange chromatography, MALDI-TOF mass spectroscopy and FACS analysis with the plant lectin L-phytohemagglutinin. Initiating oral GlcNAc treatment on the second day of clinical disease inhibited MOG-induced EAE as well as secretion of interferon-gamma, tumor necrosis factor-alpha, interleukin-17, and interleukin-22. In the more severe 2D2 T cell receptor transgenic EAE model, oral GlcNAc initiated after disease onset also inhibits clinical disease, except for those with rapid lethal progression. These data suggest that oral GlcNAc may provide an inexpensive and nontoxic oral therapeutic agent for MS that directly targets an underlying molecular mechanism causal of disease.	[Demetriou, Michael] Univ Calif Irvine, Dept Neurol, Multiple Sclerosis Res Ctr, Inst Immunol, Irvine, CA 92697 USA; [Araujo, Lindsey; Demetriou, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Naidu, Nandita N.; Choudhury, Biswa] Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Diego	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol, Multiple Sclerosis Res Ctr, Inst Immunol, 250 Sprague Hall, Irvine, CA 92697 USA.	mdemetri@uci.edu		Badin, Dylan/0000-0002-5038-2823; Demetriou, Michael/0000-0002-2224-7798	National Institutes of Health through the NIAID [R01AI053331, R01AI082266, F32AI081456]; Collaborative Multiple Sclerosis Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053331, R01AI082266, F32AI081456] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Collaborative Multiple Sclerosis Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI053331 and R01AI082266 (to M. D.) and F32AI081456 (to A. G.) through the NIAID. This work was also supported by a Collaborative Multiple Sclerosis Research Center award (to M. D.).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Broschat KO, 2002, J BIOL CHEM, V277, P14764, DOI 10.1074/jbc.M201056200; Brynedal B, 2010, J NEUROIMMUNOL, V220, P120, DOI 10.1016/j.jneuroim.2010.01.003; Chen HL, 2009, J BIOL CHEM, V284, P32454, DOI 10.1074/jbc.M109.023630; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; EBERS GC, 1986, NEW ENGL J MED, V315, P1638, DOI 10.1056/NEJM198612253152603; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grigorian A, 2010, METHOD ENZYMOL, V480, P245, DOI 10.1016/S0076-6879(10)80012-6; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee KY, 2004, FOOD CHEM TOXICOL, V42, P687, DOI 10.1016/j.fct.2003.12.005; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; LEVIN RM, 1961, J LAB CLIN MED, V58, P927; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Ma LL, 2002, J BIOL CHEM, V277, P39343, DOI 10.1074/jbc.M204924200; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Motran CC, 2008, EUR J IMMUNOL, V38, P3015, DOI 10.1002/eji.200838295; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Salvatore S, 2000, ALIMENT PHARM THER, V14, P1567, DOI 10.1046/j.1365-2036.2000.00883.x; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; SHOJI A, 1999, CHITIN CHITOSAN RES, V5, P34; Takahashi M, 2009, FOOD CHEM TOXICOL, V47, P462, DOI 10.1016/j.fct.2008.12.002; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wolosker H, 1998, FASEB J, V12, P91, DOI 10.1096/fasebj.12.1.91; Ye ZY, 2004, GLYCOBIOLOGY, V14, P547, DOI 10.1093/glycob/cwh069; Zhang GX, 2005, J IMMUNOL, V175, P7202, DOI 10.4049/jimmunol.175.11.7202; Zhang J, 2003, J CELL BIOCHEM, V88, P932, DOI 10.1002/jcb.10444; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	44	74	81	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40133	40141		10.1074/jbc.M111.277814	http://dx.doi.org/10.1074/jbc.M111.277814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965673	Green Published, hybrid			2022-12-25	WOS:000296925700046
J	Faumont, S; Rondeau, G; Thiele, TR; Lawton, KJ; McCormick, KE; Sottile, M; Griesbeck, O; Heckscher, ES; Roberts, WM; Doe, CQ; Lockery, SR				Faumont, Serge; Rondeau, Gary; Thiele, Tod R.; Lawton, Kristy J.; McCormick, Kathryn E.; Sottile, Matthew; Griesbeck, Oliver; Heckscher, Ellie S.; Roberts, William M.; Doe, Chris Q.; Lockery, Shawn R.			An Image-Free Opto-Mechanical System for Creating Virtual Environments and Imaging Neuronal Activity in Freely Moving Caenorhabditis elegans	PLOS ONE			English	Article							NEURAL ACTIVITY; IN-VIVO; INDICATORS; LOCOMOTION; BEHAVIOR; CHANNEL; MOTONEURONS; EXPRESSION; DROSOPHILA; RECEPTOR	Non-invasive recording in untethered animals is arguably the ultimate step in the analysis of neuronal function, but such recordings remain elusive. To address this problem, we devised a system that tracks neuron-sized fluorescent targets in real time. The system can be used to create virtual environments by optogenetic activation of sensory neurons, or to image activity in identified neurons at high magnification. By recording activity in neurons of freely moving C. elegans, we tested the long-standing hypothesis that forward and reverse locomotion are generated by distinct neuronal circuits. Surprisingly, we found motor neurons that are active during both types of locomotion, suggesting a new model of locomotion control in C. elegans. These results emphasize the importance of recording neuronal activity in freely moving animals and significantly expand the potential of imaging techniques by providing a mean to stabilize fluorescent targets.	[Faumont, Serge; Heckscher, Ellie S.; Doe, Chris Q.] Univ Oregon, Inst Neurosci, Howard Hughes Med Inst, Inst Mol Biol, Eugene, OR 97403 USA; [Rondeau, Gary] Appl Sci Instrumentat, Eugene, OR USA; [Thiele, Tod R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lawton, Kristy J.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Sottile, Matthew] Galois Inc, Portland, OR USA; [Griesbeck, Oliver] Max Planck Inst Neurobiol, Martinsried, Germany	Howard Hughes Medical Institute; University of Oregon; University of California System; University of California San Francisco; Cornell University; Max Planck Society	Faumont, S (corresponding author), Univ Oregon, Inst Neurosci, Howard Hughes Med Inst, Inst Mol Biol, Eugene, OR 97403 USA.	shawn@chinook.uoregon.edu	Sottile, Matthew/J-1386-2019	Sottile, Matthew/0000-0001-7436-5246; Thiele, Tod/0000-0003-2628-8359; Roberts, William/0000-0001-9762-4255; Griesbeck, Oliver/0000-0001-5883-5594	National Institutes of Health (NIH) [MH051383-13]; NIH National Center for Research Resources; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051383, R29MH051383, R21MH112105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from the National Institutes of Health (NIH) grant MH051383-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Gal Haspel for help in identifying motoneurons. Some strains were provided by the C. elegans Genetic Center, which is supported by the NIH National Center for Research Resources.	BARGMANN CI, 1990, COLD SH Q B, V55, P529; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; BRENNER S, 1974, GENETICS, V77, P71; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; CULOTTI JG, 1978, GENETICS, V90, P243; Goodman MB, 2005, WORMBOOK, DOI [10.1895/wormbook.1.7.1, DOI 10.1895/W0RMBOOK.1.7.1]; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Haspel G, 2010, J NEUROSCI, V30, P11151, DOI 10.1523/JNEUROSCI.2244-10.2010; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lockery SR, 2008, J NEUROPHYSIOL, V99, P3136, DOI 10.1152/jn.91327.2007; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Marder E, 2005, CURR BIOL, V15, pR685, DOI 10.1016/j.cub.2005.08.022; Mullins OJ, 2011, PROG NEUROBIOL, V93, P244, DOI 10.1016/j.pneurobio.2010.11.001; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Naumann EA, 2010, NAT NEUROSCI, V13, P513, DOI 10.1038/nn.2518; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schregardus DS, 2006, J NEUROSCI METH, V155, P62, DOI 10.1016/j.jneumeth.2005.12.028; Stiernagle Theresa, 2006, WormBook, P1; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1992, NATURE, V355, P838, DOI 10.1038/355838a0	35	82	86	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24666	10.1371/journal.pone.0024666	http://dx.doi.org/10.1371/journal.pone.0024666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969859	Green Published, gold			2022-12-25	WOS:000295936900010
J	Jarjour, AA; Durko, M; Luk, TL; Marcal, N; Shekarabi, M; Kennedy, TE				Jarjour, Andrew A.; Durko, Margaret; Luk, Tamarah L.; Marcal, Nathalie; Shekarabi, Masoud; Kennedy, Timothy E.			Autocrine Netrin Function Inhibits Glioma Cell Motility and Promotes Focal Adhesion Formation	PLOS ONE			English	Article							GROWTH-CONE ATTRACTION; COLORECTAL-CANCER DCC; SPINAL-CORD; AXON GUIDANCE; TYROSINE PHOSPHORYLATION; FILOPODIA FORMATION; BRAIN-TUMORS; RECEPTOR DCC; C-ELEGANS; EXPRESSION	Deregulation of mechanisms that control cell motility plays a key role in tumor progression by promoting tumor cell dissemination. Secreted netrins and their receptors, Deleted in Colorectal Cancer (DCC), neogenin, and the UNC5 homologues, regulate cell and axon migration, cell adhesion, and tissue morphogenesis. Netrin and netrin receptor expression have previously been shown to be disrupted in invasive tumors, including glioblastoma. We determined that the human glioblastoma cell lines U87, U343, and U373 all express neogenin, UNC5 homologues, and netrin-1 or netrin-3, but only U87 cells express DCC. Using transfilter migration assays, we demonstrate DCC-dependent chemoattractant migration of U87 cells up a gradient of netrin-1. In contrast, U343 and U373 cells, which do not express DCC, were neither attracted nor repelled. Ectopic expression of DCC by U343 and U373 cells resulted in these cells becoming competent to respond to a gradient of netrin-1 as a chemoattractant, and also slowed their rate of spontaneous migration. Here, in addition to netrins' well-characterized chemotropic activity, we demonstrate an autocrine function for netrin-1 and netrin-3 in U87 and U373 cells that slows migration. We provide evidence that netrins promote the maturation of focal complexes, structures associated with cell movement, into focal adhesions. Consistent with this, netrin, DCC, and UNC5 homologues were associated with focal adhesions, but not focal complexes. Disrupting netrin or DCC function did not alter cell proliferation or survival. Our findings provide evidence that DCC can slow cell migration, and that neogenin and UNC5 homologues are not sufficient to substitute for DCC function in these cells. Furthermore, we identify a role for netrins as autocrine inhibitors of cell motility that promote focal adhesion formation. These findings suggest that disruption of netrin signalling may disable a mechanism that normally restrains inappropriate cell migration.	[Jarjour, Andrew A.; Durko, Margaret; Luk, Tamarah L.; Marcal, Nathalie; Shekarabi, Masoud; Kennedy, Timothy E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Jarjour, AA (corresponding author), Univ Edinburgh, Scottish Ctr Regenerat Med, Edinburgh Ctr Multiple Sclerosis Res, Edinburgh, Midlothian, Scotland.	timothy.kennedy@mcgill.ca		Jarjour, Andrew/0000-0002-1550-1778	Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Biochem Pharma Inc.	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Biochem Pharma Inc.	This work was supported by grants from the Canadian Institutes of Health Research, the Multiple Sclerosis Society of Canada, and Biochem Pharma Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KA, 2006, CURR OPIN NEUROBIOL, V16, P529, DOI 10.1016/j.conb.2006.08.002; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Ekstrand BC, 1995, ONCOGENE, V11, P2393; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Flores C, 2005, MOL PSYCHIATR, V10, P606, DOI 10.1038/sj.mp.4001607; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; GORDONWEEKS PR, 1992, EXP PHYSIOL, V77, P681, DOI 10.1113/expphysiol.1992.sp003634; Guillamo JS, 2001, J NEURO-ONCOL, V52, P205, DOI 10.1023/A:1010620420241; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hinck L, 2004, DEV CELL, V7, P783, DOI 10.1016/j.devcel.2004.11.002; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; HUNTER DD, 1992, J COMP NEUROL, V323, P238, DOI 10.1002/cne.903230208; Jarjour AA, 2003, J NEUROSCI, V23, P3735; Jarjour AA, 2008, J NEUROSCI, V28, P11003, DOI 10.1523/JNEUROSCI.3285-08.2008; Kaufmann S, 2009, CELL ONCOL, V31, P415, DOI 10.3233/CLO-2009-0491; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kennedy TE, 2006, J NEUROSCI, V26, P8866, DOI 10.1523/JNEUROSCI.5191-05.2006; KLINGELHUTZ AJ, 1995, ONCOGENE, V10, P1581; Knott JCA, 1998, INT J CANCER, V75, P864, DOI 10.1002/(SICI)1097-0215(19980316)75:6<864::AID-IJC8>3.0.CO;2-T; Koed K, 2005, CANCER RES, V65, P34; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Li WQ, 2006, J CELL SCI, V119, P47, DOI 10.1242/jcs.02697; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu Y, 2004, CURR BIOL, V14, P897, DOI 10.1016/j.cub.2004.05.020; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Manitt C, 2001, J NEUROSCI, V21, P3911, DOI 10.1523/JNEUROSCI.21-11-03911.2001; Manitt C, 2002, PROG BRAIN RES, V137, P425; Manitt C, 2004, J NEUROSCI RES, V77, P690, DOI 10.1002/jnr.20199; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mehlen P, 2003, BIOL CELL, V95, P425, DOI 10.1016/S0248-4900(03)00072-8; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Meyerhardt JA, 1999, CELL GROWTH DIFFER, V10, P35; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; NARAYANAN R, 1992, ONCOGENE, V7, P553; NISTER M, 1987, CANCER RES, V47, P4953; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Rajasekharan S, 2010, J NEUROCHEM, V113, P1589, DOI 10.1111/j.1471-4159.2010.06717.x; Rajasekharan S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-239; Rajasekharan S, 2009, DEVELOPMENT, V136, P415, DOI 10.1242/dev.018234; Rasband W., 2006, IMAGEJ; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; ReyesMugica M, 1997, CANCER RES, V57, P382; Rodrigues S, 2007, ONCOGENE, V26, P5615, DOI 10.1038/sj.onc.1210347; Shatzmiller RA, 2008, NEUROSCIENCE, V157, P621, DOI 10.1016/j.neuroscience.2008.09.031; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Sieg DJ, 1999, J CELL SCI, V112, P2677; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Tong JF, 2001, J BIOL CHEM, V276, P40917, DOI 10.1074/jbc.M103872200; Tsai HH, 2006, J NEUROSCI, V26, P1913, DOI 10.1523/JNEUROSCI.3571-05.2006; Tsai HH, 2003, DEVELOPMENT, V130, P2095, DOI 10.1242/dev.00424; Tysnes BB, 1997, INVAS METAST, V17, P270; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; von Bulow C, 2001, J PATHOL, V193, P367, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH810>3.0.CO;2-1; Wang H, 1999, J NEUROSCI, V19, P4938; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; YIP JW, 1992, DEV BRAIN RES, V68, P23, DOI 10.1016/0165-3806(92)90244-Q; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792	69	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25408	10.1371/journal.pone.0025408	http://dx.doi.org/10.1371/journal.pone.0025408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980448	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900060
J	Nakaoka, H; Cui, T; Tajima, A; Oka, A; Mitsunaga, S; Kashiwase, K; Homma, Y; Sato, S; Suzuki, Y; Inoko, H; Inoue, I				Nakaoka, Hirofumi; Cui, Tailin; Tajima, Atsushi; Oka, Akira; Mitsunaga, Shigeki; Kashiwase, Koichi; Homma, Yasuhiko; Sato, Shinji; Suzuki, Yasuo; Inoko, Hidetoshi; Inoue, Ituro			A Systems Genetics Approach Provides a Bridge from Discovered Genetic Variants to Biological Pathways in Rheumatoid Arthritis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SEVERE COMBINED IMMUNODEFICIENCY; JAPANESE POPULATION; LUPUS-ERYTHEMATOSUS; SUSCEPTIBILITY GENES; EUROPEAN POPULATIONS; COMMON DISEASE; RISK LOCUS; REVEALS ASSOCIATION; AUTOIMMUNE-DISEASES	Genome-wide association studies (GWAS) have yielded novel genetic loci underlying common diseases. We propose a systems genetics approach to utilize these discoveries for better understanding of the genetic architecture of rheumatoid arthritis (RA). Current evidence of genetic associations with RA was sought through PubMed and the NHGRI GWAS catalog. The associations of 15 single nucleotide polymorphisms and HLA-DRB1 alleles were confirmed in 1,287 cases and 1,500 controls of Japanese subjects. Among these, HLA-DRB1 alleles and eight SNPs showed significant associations and all but one of the variants had the same direction of effect as identified in the previous studies, indicating that the genetic risk factors underlying RA are shared across populations. By receiver operating characteristic curve analysis, the area under the curve (AUC) for the genetic risk score based on the selected variants was 68.4%. For seropositive RA patients only, the AUC improved to 70.9%, indicating good but suboptimal predictive ability. A simulation study shows that more than 200 additional loci with similar effect size as recent GWAS findings or 20 rare variants with intermediate effects are needed to achieve AUC = 80.0%. We performed the random walk with restart (RWR) algorithm to prioritize genes for future mapping studies. The performance of the algorithm was confirmed by leave-one-out cross-validation. The RWR algorithm pointed to ZAP70 in the first rank, in which mutation causes RA-like autoimmune arthritis in mice. By applying the hierarchical clustering method to a subnetwork comprising RA-associated genes and top-ranked genes by the RWR, we found three functional modules relevant to RA etiology: "leukocyte activation and differentiation", "pattern-recognition receptor signaling pathway", and "chemokines and their receptors". These results suggest that the systems genetics approach is useful to find directions of future mapping strategies to illuminate biological pathways.	[Nakaoka, Hirofumi; Inoue, Ituro] Natl Inst Genet, Dept Integrated Genet, Div Human Genet, Shizuoka, Japan; [Cui, Tailin; Tajima, Atsushi; Oka, Akira; Mitsunaga, Shigeki; Inoko, Hidetoshi; Inoue, Ituro] Tokai Univ, Sch Med, Div Mol Life Sci, Kanagawa 2591100, Japan; [Tajima, Atsushi] Univ Tokusima, Grad Sch, Inst Hlth Biosci, Dept Human Genet & Publ Hlth, Tokushima, Japan; [Kashiwase, Koichi] Japanese Red Cross Tokyo Blood Ctr, Dept Lab, Koto Ku, Tokyo, Japan; [Homma, Yasuhiko] Tokai Univ, Sch Med, Dept Clin Hlth Sci, Kanagawa 2591100, Japan; [Sato, Shinji; Suzuki, Yasuo] Tokai Univ, Sch Med, Div Rheumatol, Dept Internal Med, Kanagawa 2591100, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tokai University; Tokai University; Tokai University	Nakaoka, H (corresponding author), Natl Inst Genet, Dept Integrated Genet, Div Human Genet, Shizuoka, Japan.	itinoue@lab.nig.ac.jp	Sato, Shinji/V-7271-2019; Tajima, Atsushi/C-1053-2008; Sato, Shinji/AAN-8803-2020	Tajima, Atsushi/0000-0001-6808-5491; Nakaoka, Hirofumi/0000-0002-8454-1159	Japanese Ministry of Health, Labor, and Welfare; Grants-in-Aid for Scientific Research [23510242, 22510213, 23133507, 19101008] Funding Source: KAKEN	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Japanese Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Barnetche T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2379; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Barton A, 2009, HUM MOL GENET, V18, P2518, DOI 10.1093/hmg/ddp177; Begovich AB, 2007, ARTHRITIS RHEUM, V56, P3168, DOI 10.1002/art.22857; Burr ML, 2010, ANN RHEUM DIS, V69, P666, DOI 10.1136/ard.2009.111294; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Daha NA, 2009, ARTHRITIS RHEUM-US, V60, P1255, DOI 10.1002/art.24503; Delgado-Vega AM, 2007, AUTOIMMUN REV, V6, P402, DOI 10.1016/j.autrev.2006.11.004; Dieguez-Gonzalez R, 2008, ARTHRITIS RHEUM-US, V58, P1264, DOI 10.1002/art.23426; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Eleftherohorinou H, 2011, HUM MOL GENET, V20, P3494, DOI 10.1093/hmg/ddr248; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Freudenberg J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/art.30235; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Gulcher J, 2010, EUR J CLIN INVEST, V40, P56, DOI 10.1111/j.1365-2362.2009.02233.x; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Han SW, 2009, J RHEUMATOL, V36, P693, DOI 10.3899/jrheum.081054; Han SZ, 2005, HUM GENET, V118, P123, DOI 10.1007/s00439-005-0033-9; Harrison P, 2008, RHEUMATOLOGY, V47, P1768, DOI 10.1093/rheumatology/ken374; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ioannidis JPA, 2002, SEMIN ARTHRITIS RHEU, V31, P361, DOI 10.1053/sarh.2002.31725; Iwamoto T, 2006, RHEUMATOLOGY, V45, P804, DOI 10.1093/rheumatology/kel023; Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Janssens ACJW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000420; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Ji JD, 2010, MOL BIOL REP, V37, P141, DOI 10.1007/s11033-009-9553-z; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Jun KR, 2007, J KOREAN MED SCI, V22, P973, DOI 10.3346/jkms.2007.22.6.973; Kenny EM, 2011, DNA RES, V18, P31, DOI 10.1093/dnares/dsq029; Khoury MJ, 2010, AM J EPIDEMIOL, V172, P517, DOI 10.1093/aje/kwq211; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Kochi Y, 2009, J AUTOIMMUN, V32, P158, DOI 10.1016/j.jaut.2009.02.020; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Koike A, 2009, J HUM GENET, V54, P543, DOI 10.1038/jhg.2009.68; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Lee YH, 2008, J RHEUMATOL, V35, P2129, DOI 10.3899/jrheum.080186; Lee YH, 2007, RHEUMATOL INT, V27, P827, DOI 10.1007/s00296-007-0320-y; Lee YH, 2007, J RHEUMATOL, V34, P43; Lee YH, 2010, RHEUMATOL INT, V30, P947, DOI 10.1007/s00296-009-1082-5; Lee YH, 2010, RHEUMATOL INT, V30, P661, DOI 10.1007/s00296-009-1051-z; Lee YH, 2009, J RHEUMATOL, V36, P12, DOI 10.3899/jrheum.080450; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lei C, 2005, EUR J HUM GENET, V13, P823, DOI 10.1038/sj.ejhg.5201423; Lindner E, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-33; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lu Q, 2008, AM J HUM GENET, V82, P641, DOI 10.1016/j.ajhg.2007.12.025; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2009, GENOME MED, V1, DOI 10.1186/gm66; Nadeau JH, 2011, SCIENCE, V331, P1015, DOI 10.1126/science.1203869; Nakaoka H, 2009, J HUM GENET, V54, P615, DOI 10.1038/jhg.2009.95; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Okada Y, 2008, J RHEUMATOL, V35, P1723; Orozco G, 2008, ARTHRITIS RHEUM-US, V58, P1974, DOI 10.1002/art.23549; Orozco G, 2010, ANN RHEUM DIS, V69, P813, DOI 10.1136/ard.2009.109579; Orozco G, 2010, EXPERT REV CLIN IMMU, V6, P61, DOI 10.1586/ECI.09.72; Patsopoulos NA, 2010, ANN RHEUM DIS, V69, P561, DOI 10.1136/ard.2009.109447; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Plant D, 2009, ANN RHEUM DIS, V68, P1373, DOI 10.1136/ard.2008.103572; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Plenge RM, 2009, CURR OPIN RHEUMATOL, V21, P262, DOI 10.1097/BOR.0b013e32832a2e2d; Prahalad S, 2006, GENES IMMUN, V7, P264, DOI 10.1038/sj.gene.6364298; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ransohoff DF, 2010, EUR J CLIN INVEST, V40, P64, DOI 10.1111/j.1365-2362.2009.02232.x; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Shen HW, 2009, PHYSICA A, V388, P1706, DOI 10.1016/j.physa.2008.12.021; Shimane K, 2010, ARTHRITIS RHEUM-US, V62, P574, DOI 10.1002/art.27190; Slatkin M, 2008, GENETICS, V179, P2253, DOI 10.1534/genetics.107.077719; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Suarez-Gestal M, 2009, ARTHRITIS RHEUM-US, V60, P2558, DOI 10.1002/art.24748; Surolia I, 2010, NATURE, V466, P243, DOI 10.1038/nature09115; Takata Y, 2008, J HUM GENET, V53, P163, DOI 10.1007/s10038-007-0232-4; Tamiya G, 2005, HUM MOL GENET, V14, P2305, DOI 10.1093/hmg/ddi234; Terao C, 2011, HUM MOL GENET, V20, P2680, DOI 10.1093/hmg/ddr161; van der Helm-van Mil AHM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2384; van der Woude D, 2010, ARTHRITIS RHEUM-US, V62, P1236, DOI 10.1002/art.27366; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wheeler J, 2007, ANTIVIR THER, V12, P233; WILLIAMS RC, 1995, HUM IMMUNOL, V42, P90, DOI 10.1016/0198-8859(94)00079-6; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang QH, 2003, AM J HUM GENET, V72, P636, DOI 10.1086/367923; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	109	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25389	10.1371/journal.pone.0025389	http://dx.doi.org/10.1371/journal.pone.0025389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980439	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900057
J	Sgroi, A; Gonelle-Gispert, C; Morel, P; Baertschiger, RM; Niclauss, N; Mentha, G; Majno, P; Serre-Beinier, V; Buhler, L				Sgroi, Antonino; Gonelle-Gispert, Carmen; Morel, Philippe; Baertschiger, Reto Marc; Niclauss, Nadja; Mentha, Gilles; Majno, Pietro; Serre-Beinier, Veronique; Buhler, Leo			Interleukin-1 Receptor Antagonist Modulates the Early Phase of Liver Regeneration after Partial Hepatectomy in Mice	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; HEPATOCYTE GROWTH-FACTOR; HEPATIC ISCHEMIA-REPERFUSION; CELL-CYCLE PROGRESSION; INFLAMMATORY RESPONSE; MESSENGER-RNA; UP-REGULATION; FAILURE; IL-1; CYTOKINES	Background: Cytokine administration is a potential therapy for acute liver failure by reducing inflammatory responses and favour hepatocyte regeneration. The aim of this study was to evaluate the role of interleukin-1 receptor antagonist (IL-1ra) during liver regeneration and to study the effect of a recombinant human IL-1ra on liver regeneration. Methods: We performed 70%-hepatectomy in wild type (WT) mice, IL-1ra knock-out (KO) mice and in WT mice treated by anakinra. We analyzed liver regeneration at regular intervals by measuring the blood levels of cytokines, the hepatocyte proliferation by bromodeoxyuridin (BrdU) incorporation, proliferating cell nuclear antigen (PCNA) and Cyclin D1 expression. The effect of anakinra on hepatocyte proliferation was also tested in vitro using human hepatocytes. Results: At 24h and at 48h after hepatectomy, IL-1ra KO mice had significantly higher levels of pro-inflammatory cytokines (IL-6, IL-1 beta and MCP-1) and a reduced and delayed hepatocyte proliferation measured by BrdU incorporation, PCNA and Cyclin D1 protein levels, when compared to WT mice. IGFBP-1 and C/EBP beta expression was significantly decreased in IL-1ra KO compared to WT mice. WT mice treated with anakinra showed significantly decreased levels of IL-6 and significantly higher hepatocyte proliferation at 24h compared to untreated WT mice. In vitro, primary human hepatocytes treated with anakinra showed significantly higher proliferation at 24h compared to hepatocytes without treatment. Conclusion: IL1ra modulates the early phase of liver regeneration by decreasing the inflammatory stress and accelerating the entry of hepatocytes in proliferation. IL1ra might be a therapeutic target to improve hepatocyte proliferation.	[Sgroi, Antonino; Gonelle-Gispert, Carmen; Morel, Philippe; Baertschiger, Reto Marc; Serre-Beinier, Veronique; Buhler, Leo] Univ Hosp Geneva, Dept Surg, Surg Res Unit, Geneva, Switzerland; [Sgroi, Antonino; Gonelle-Gispert, Carmen; Morel, Philippe; Baertschiger, Reto Marc; Serre-Beinier, Veronique; Buhler, Leo] Univ Geneva, Geneva, Switzerland	University of Geneva; University of Geneva	Sgroi, A (corresponding author), Univ Hosp Geneva, Dept Surg, Surg Res Unit, Geneva, Switzerland.	leo.buhler@hcuge.ch	Baertschiger, Reto/AAA-3299-2021; Serre-Beinier, Véronique/T-8064-2019	Baertschiger, Reto/0000-0002-6284-1994; Serre-Beinier, Véronique/0000-0002-6016-1645; Buhler, Leo/0000-0002-9461-8498	Swiss National Science Foundation [323500-115048/1, 3100A0-109888]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by MD-PhD scholarship No. 323500-115048/1 from the Swiss National Science Foundation to A. S., research Grant No. 3100A0-109888 from the Swiss National Science Foundation to L. B. and C. G. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Albrecht JH, 1999, CELL GROWTH DIFFER, V10, P397; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Assy N, 1997, J HEPATOL, V26, P945, DOI 10.1016/S0168-8278(97)80266-8; Bellido T, 1998, J BIOL CHEM, V273, P21137, DOI 10.1074/jbc.273.33.21137; BOERMEESTER MA, 1995, HEPATOLOGY, V22, P1499, DOI 10.1016/0270-9139(95)90158-2; Boulton R, 1997, HEPATOLOGY, V26, P49; BROWN Z, 1992, KIDNEY INT, V42, P95, DOI 10.1038/ki.1992.266; Burger D, 2006, BEST PRACT RES CL RH, V20, P879, DOI 10.1016/j.berh.2006.06.004; Cosgrove BD, 2008, HEPATOLOGY, V48, P276, DOI 10.1002/hep.22335; Dewberry RM, 2008, FEBS LETT, V582, P886, DOI 10.1016/j.febslet.2008.02.021; FISCHER E, 1991, AM J PHYSIOL, V261, pR442, DOI 10.1152/ajpregu.1991.261.2.R442; Fox IJ, 2004, J HEPATOL, V40, P878, DOI 10.1016/j.jhep.2004.04.009; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Gabay C, 2001, EUR J IMMUNOL, V31, P490, DOI 10.1002/1521-4141(200102)31:2<490::AID-IMMU490>3.0.CO;2-H; Galun E, 2002, BBA-MOL CELL RES, V1592, P345, DOI 10.1016/S0167-4889(02)00326-9; Gramantieri L, 1999, CLIN EXP IMMUNOL, V115, P515; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Harada H, 2002, TRANSPLANTATION, V74, P1434, DOI 10.1097/00007890-200211270-00016; Hirsch E, 1996, P NATL ACAD SCI USA, V93, P11008, DOI 10.1073/pnas.93.20.11008; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Leifeld L, 2003, J PATHOL, V199, P335, DOI 10.1002/path.1298; Lentsch AB, 1998, HEPATOLOGY, V27, P507, DOI 10.1002/hep.510270226; Leu JI, 2003, MOL CELL BIOL, V23, P1251, DOI 10.1128/MCB.23.4.1251-1259.2003; Lieu HT, 2006, HEPATOLOGY, V44, P1452, DOI 10.1002/hep.21434; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; MARRA F, 1993, J CLIN INVEST, V92, P1674, DOI 10.1172/JCI116753; Massberg S, 2003, THROMB RES, V110, P187, DOI 10.1016/S0049-3848(03)00342-6; Masuhara M, 1996, HEPATOLOGY, V24, P323; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Molnar C, 2004, EUR CYTOKINE NETW, V15, P303; Ogiso T, 2007, J HEPATOL, V47, P816, DOI 10.1016/j.jhep.2007.06.017; Ostapowicz G, 2000, J GASTROEN HEPATOL, V15, P480, DOI 10.1046/j.1440-1746.2000.02074.x; Pahlavan PS, 2006, J SURG RES, V134, P238, DOI 10.1016/j.jss.2005.12.011; Schilsky ML, 2009, CLIN CHEST MED, V30, P71, DOI 10.1016/j.ccm.2008.10.001; SEKIYAMA KD, 1994, CLIN EXP IMMUNOL, V98, P71; Shinoda M, 2007, J SURG RES, V137, P130, DOI 10.1016/j.jss.2006.08.009; Shinoda M, 2006, TISSUE ENG, V12, P1313, DOI 10.1089/ten.2006.12.1313; SHIOTA G, 1995, HEPATOLOGY, V21, P106, DOI 10.1002/hep.1840210119; Shito M, 1997, TRANSPLANTATION, V63, P143, DOI 10.1097/00007890-199701150-00026; STANDIFORD TJ, 1991, J BIOL CHEM, V266, P9912; Straatsburg IH, 1996, J PATHOL, V179, P100, DOI 10.1002/(SICI)1096-9896(199605)179:1<100::AID-PATH532>3.0.CO;2-W; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340; Tellez N, 2005, GENE THER, V12, P120, DOI 10.1038/sj.gt.3302351; Valatas V, 2004, BRIT J PHARMACOL, V141, P477, DOI 10.1038/sj.bjp.0705633; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; VILLIGER PM, 1992, J CLIN INVEST, V90, P488, DOI 10.1172/JCI115885; Wang ZQ, 1998, HEPATOLOGY, V28, P430, DOI 10.1002/hep.510280221; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Wilson HL, 2004, J IMMUNOL, V173, P1202, DOI 10.4049/jimmunol.173.2.1202; Wustefeld T, 2000, HEPATOLOGY, V32, P514, DOI 10.1053/jhep.2000.16604; Xu Y, 1996, GASTROENTEROLOGY, V110, P1870, DOI 10.1053/gast.1996.v110.pm8964413	56	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25442	10.1371/journal.pone.0025442	http://dx.doi.org/10.1371/journal.pone.0025442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980458	Green Submitted, Green Published, gold			2022-12-25	WOS:000295933700035
J	Markegard, E; Trager, E; Yang, CWO; Zhang, WG; Weiss, A; Roose, JP				Markegard, Evan; Trager, Evan; Yang, Chih-wen Ou; Zhang, Weiguo; Weiss, Arthur; Roose, Jeroen P.			Basal LAT-diacylglycerol-RasGRP1 Signals in T Cells Maintain TCR alpha Gene Expression	PLOS ONE			English	Article							ANTIGEN RECEPTOR; RAS ACTIVATION; B-CELLS; LAT; LYMPHOCYTES; MUTATION; SELF; IMMUNOGLOBULIN; SENSITIVITY; ABLATION	In contrast to the well-characterized T cell receptor (TCR) signaling pathways that induce genes that drive T cell development or polarization of naive CD4 T cells into the diverse T(H)1, T(H)2, T(H)17 and T(reg) lineages, it is unclear what signals maintain specific gene expression in mature resting T cells. Resting T cells residing in peripheral lymphoid organs exhibit low-level constitutive signaling. Whereas tonic signals in B cells are known to be critical for survival, the roles of tonic signals in peripheral T cells are unknown. Here we demonstrate that constitutive signals in Jurkat T cell lines are transduced via the adapter molecule LAT and the Ras exchange factor RasGRP1 to maintain expression of TCR alpha mRNA and surface expression of the TCR/CD3 complex. Independent approaches of reducing basal activity through the LAT-diacylglycerol-RasGRP pathway led to reduced constitutive Ras-MEK-ERK signals and decreased TCR alpha mRNA and surface TCR expression in Jurkat cells. However, loss of TCR expression takes several days in these cell line experiments. In agreement with these in vitro approaches, inducible deletion of Lat in vivo results in reduced TCR alpha mRNA-and surface TCR-expression in a delayed temporal manner as well. Lastly, we demonstrate that loss of basal LAT-RasGRP signals appears to lead to silencing or repression of TCR alpha transcription. We postulate that basal LAT-diacylglycerol-RasGRP signals fulfill a regulatory function in peripheral T lymphocytes by maintaining proper gene expression programs.	[Markegard, Evan; Trager, Evan; Roose, Jeroen P.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Yang, Chih-wen Ou; Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Weiss, Arthur] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Markegard, E (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	jeroen.roose@ucsf.edu		Roose, Jeroen/0000-0003-4746-2811	National Institutes of Health-National Cancer Institute [K01CA113367]; Arthritis Foundation; NIH [AI048674, AI056156]; NATIONAL CANCER INSTITUTE [K01CA113367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048674, R56AI048674, R01AI056156, R56AI056156] Funding Source: NIH RePORTER	National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Arthritis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Institutes of Health-National Cancer Institute (K01CA113367 and ARRA supplement) and Arthritis Foundation (JPR) and the NIH (grants AI048674 and AI056156 for WZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Bhandoola A, 2002, IMMUNITY, V17, P425, DOI 10.1016/S1074-7613(02)00417-X; Brownlie R, 2009, IMMUNITY, V31, P174, DOI 10.1016/j.immuni.2009.08.002; Chu Peter, 2003, J Biol, V2, P21, DOI 10.1186/1475-4924-2-21; Chuck MI, 2010, J IMMUNOL, V184, P2476, DOI 10.4049/jimmunol.0902876; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; FIFE BT, 2009, NAT IMMUNOL; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; GOLDSMITH MA, 1987, P NATL ACAD SCI USA, V84, P6879, DOI 10.1073/pnas.84.19.6879; Hogquist KA, 2003, CURR BIOL, V13, pR239, DOI 10.1016/S0960-9822(03)00161-1; Keren Z, 2004, J BIOL CHEM, V279, P13418, DOI 10.1074/jbc.M311970200; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lin J, 2001, J CELL SCI, V114, P243; LINDSTEN T, 1988, J IMMUNOL, V141, P1769; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Roose JP, 2003, PLOS BIOL, V1, P271, DOI 10.1371/journal.pbio.0000053; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Shen SD, 2009, J IMMUNOL, V182, P5596, DOI 10.4049/jimmunol.0803170; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Tomlinson MG, 2000, IMMUNOL TODAY, V21, P584, DOI 10.1016/S0167-5699(00)01716-3; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Vazquez BN, 2009, J IMMUNOL, V183, P6513, DOI 10.4049/jimmunol.0900839; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wilson CB, 2006, CURR OPIN IMMUNOL, V18, P143, DOI 10.1016/j.coi.2006.01.013; YOSHIKAI Y, 1984, NATURE, V312, P521, DOI 10.1038/312521a0; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	44	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25540	10.1371/journal.pone.0025540	http://dx.doi.org/10.1371/journal.pone.0025540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966541	gold, Green Published			2022-12-25	WOS:000295932100049
J	O'Brien, VA; Brown, CR				O'Brien, Valerie A.; Brown, Charles R.			Group Size and Nest Spacing Affect Buggy Creek Virus (Togaviridae: Alphavirus) Infection in Nestling House Sparrows	PLOS ONE			English	Article							FORT-MORGAN VIRUS; WEST-NILE-VIRUS; SWALLOW BUGS; CLIFF SWALLOWS; PARASITE TRANSMISSION; AVIAN DIVERSITY; GREAT-PLAINS; ARBOVIRUS; COLONIALITY; HOST	The transmission of parasites and pathogens among vertebrates often depends on host population size, host species diversity, and the extent of crowding among potential hosts, but little is known about how these variables apply to most vector-borne pathogens such as the arboviruses (arthropod-borne viruses). Buggy Creek virus (BCRV; Togaviridae: Alphavirus) is an RNA arbovirus transmitted by the swallow bug (Oeciacus vicarius) to the cliff swallow (Petrochelidon pyrrhonota) and the introduced house sparrow (Passer domesticus) that has recently invaded swallow nesting colonies. The virus has little impact on cliff swallows, but house sparrows are seriously affected by BCRV. For house sparrows occupying swallow nesting colonies in western Nebraska, USA, the prevalence of BCRV in nestling sparrows increased with sparrow colony size at a site but decreased with the number of cliff swallows present. If one nestling in a nest was infected with the virus, there was a greater likelihood that one or more of its nest-mates would also be infected than nestlings chosen at random. The closer a nest was to another nest containing infected nestlings, the greater the likelihood that some of the nestlings in the focal nest would be BCRV-positive. These results illustrate that BCRV represents a cost of coloniality for a vertebrate host (the house sparrow), perhaps the first such demonstration for an arbovirus, and that virus infection is spatially clustered within nests and within colonies. The decreased incidence of BCRV in sparrows as cliff swallows at a site increased reflects the "dilution effect," in which virus transmission is reduced when a vector switches to feeding on a less competent vertebrate host.	[O'Brien, Valerie A.; Brown, Charles R.] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA	University of Tulsa	O'Brien, VA (corresponding author), Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA.	charles-brown@utulsa.edu			National Institutes of Health (NIH) [AI057569]; National Science Foundation (NSF) [DEB-0514824]; American Ornithologists' Union; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057569] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); American Ornithologists' Union; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (NIH) (AI057569), National Science Foundation (NSF) (DEB-0514824), and the American Ornithologists' Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; ANDERSON R M, 1991; Anderson TR., 2006, BIOL UBIQUITOUS HOUS; Brault AC, 2009, J MED ENTOMOL, V46, P1203, DOI 10.1603/033.046.0531; Brown C. R., 1996, COLONIALITY CLIFF SW; Brown CR, 2008, MOL ECOL, V17, P2164, DOI 10.1111/j.1365-294X.2008.03747.x; Brown CR, 2007, VECTOR-BORNE ZOONOT, V7, P304, DOI 10.1089/vbz.2006.0646; Brown CR, 2010, J MED ENTOMOL, V47, P436, DOI 10.1603/ME09288; Brown CR, 2010, VECTOR-BORNE ZOONOT, V10, P355, DOI 10.1089/vbz.2009.0031; Brown CR, 2009, ECOLOGY, V90, P3168, DOI 10.1890/08-1731.1; BROWN CR, 1986, ECOLOGY, V67, P1206, DOI 10.2307/1938676; Brown CR, 2004, ECOLOGY, V85, P1619, DOI 10.1890/03-0206; Brown CR, 2002, J MED ENTOMOL, V39, P115, DOI 10.1603/0022-2585-39.1.115; Brown CR, 2001, CURR ORNITHOL, V16, P1; Brown CR, 2001, P ROY SOC B-BIOL SCI, V268, P1833, DOI 10.1098/rspb.2001.1749; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CALISHER CH, 1980, AM J TROP MED HYG, V29, P1428, DOI 10.4269/ajtmh.1980.29.1428; Carver S, 2011, OECOLOGIA, V166, P713, DOI 10.1007/s00442-010-1882-z; Cecere MC, 1997, MED VET ENTOMOL, V11, P383, DOI 10.1111/j.1365-2915.1997.tb00426.x; Cohen J., 2003, APPL MULTIPLE REGRES; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; de Jong M, 1995, EPIDEMIC MODELS THEI, P84; DIETZ K, 1988, PARASITOL TODAY, V4, P91, DOI 10.1016/0169-4758(88)90034-8; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Godfrey SS, 2009, BEHAV ECOL SOCIOBIOL, V63, P1045, DOI 10.1007/s00265-009-0730-9; HESS AD, 1970, AM J TROP MED HYG, V19, P327, DOI 10.4269/ajtmh.1970.19.327; Hodgson JC, 2001, J MED ENTOMOL, V38, P59, DOI 10.1603/0022-2585-38.1.59; HOOGLAND JL, 1979, BEHAVIOUR, V69, P1, DOI 10.1163/156853979X00377; HOPLA CE, 1993, J MED ENTOMOL, V30, P267, DOI 10.1093/jmedent/30.1.267; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; Hudson PJ, 1995, PARASITOLOGY, V111, pS49, DOI 10.1017/S0031182000075818; Huyvaert KP, 2008, J WILDLIFE DIS, V44, P331, DOI 10.7589/0090-3558-44.2.331; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Komar N, 1997, THESIS HARVARD U SCH; Kosciuch KL, 2004, AUK, V121, P257, DOI 10.1642/0004-8038(2004)121[0257:EOCVCS]2.0.CO;2; Lowther P.E., 2006, BIRDS N AM; MCGILLIVRAY WB, 1980, AUK, V97, P396; Moller A.P., 1990, NATO ASI Series Series G Ecological Sciences, V24, P269; Moore AT, 2007, J MED ENTOMOL, V44, P42, DOI 10.1603/0022-2585(2007)44[42:ECOBCV]2.0.CO;2; Nunn C, 2005, BEHAV ECOL SOCIOBIOL, V59, P30, DOI 10.1007/s00265-005-0005-z; O'Brien VA, 2011, P ROY SOC B-BIOL SCI, V278, P239, DOI 10.1098/rspb.2010.1098; O'Brien VA, 2010, AM J TROP MED HYG, V82, P937, DOI 10.4269/ajtmh.2010.09-0515; O'Brien VA, 2010, J WILDLIFE DIS, V46, P23, DOI 10.7589/0090-3558-46.1.23; O'Brien VA, 2008, WILSON J ORNITHOL, V120, P910, DOI 10.1676/08-028.1; OBRIEN VA, 2009, THESIS U TULSA TULSA; Padhi A, 2008, J GEN VIROL, V89, P2122, DOI 10.1099/vir.0.2008/001719-0; Pfeffer M, 2006, APPL ENVIRON MICROB, V72, P6886, DOI 10.1128/AEM.00868-06; POULIN R, 1991, CONDOR, V93, P418, DOI 10.2307/1368958; POULIN R, 1991, OECOLOGIA, V86, P390, DOI 10.1007/BF00317606; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Rannala B.H., 1995, DEMOGRAPHY GENETIC S; REISEN W K, 1990, Bulletin of the Society for Vector Ecology, V15, P11; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Royall R., 1997, STAT EVIDENCE LIKELI; RUSH WA, 1980, ANN ENTOMOL SOC AM, V73, P315, DOI 10.1093/aesa/73.3.315; RUSH WA, 1981, J MED ENTOMOL, V18, P425, DOI 10.1093/jmedent/18.5.425; SAS Institute, 2008, SAS STAT US GUID; Schmid-Hempel P., 1998, Parasites in social insects.; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; SCOTT TW, 1984, AM J TROP MED HYG, V33, P981, DOI 10.4269/ajtmh.1984.33.981; SHIELDS WM, 1987, ECOLOGY, V68, P1373, DOI 10.2307/1939221; SMITH G C, 1978, Journal of the Washington Academy of Sciences, V68, P23; STONER DAYTON, 1939, WILSON BULL, V51, P221; SUMMERSSMITH D, 1963, HOUSE SPARROW; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Telfer S, 2005, PARASITOLOGY, V130, P661, DOI 10.1017/S0031182005007250; Usinger RL, 1966, MONOGRAPH CIMICIDAE; Weaver SC, 1997, J VIROL, V71, P613, DOI 10.1128/JVI.71.1.613-623.1997; [No title captured]	77	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25521	10.1371/journal.pone.0025521	http://dx.doi.org/10.1371/journal.pone.0025521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966539	gold, Green Published			2022-12-25	WOS:000295932100047
J	Zhu, HL; Meng, SR; Fan, JB; Chen, J; Liang, Y				Zhu, Hai-Li; Meng, Sheng-Rong; Fan, Jun-Bao; Chen, Jie; Liang, Yi			Fibrillization of Human Tau Is Accelerated by Exposure to Lead via Interaction with His-330 and His-362	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; PROTEIN-TAU; ALZHEIMERS-DISEASE; NEUROFIBRILLARY CHANGES; DEVELOPMENTAL ORIGIN; CHILDHOOD; PB; PATHOLOGY; ACID	Background: Neurofibrillary tangles, mainly consisted of bundles of filaments formed by the microtubule-associated protein Tau, are a hallmark of Alzheimer disease. Lead is a potent neurotoxin for human being especially for the developing children, and Pb2+ at high concentrations is found in the brains of patients with Alzheimer disease. However, it has not been reported so far whether Pb2+ plays a role in the pathology of Alzheimer disease through interaction with human Tau protein and thereby mediates Tau filament formation. In this study, we have investigated the effect of Pb2+ on fibril formation of recombinant human Tau fragment Tau(244-372) and its mutants at physiological pH. Methodology/Principal Findings: As revealed by thioflavin T and 8-anilino-1-naphthalene sulfonic acid fluorescence, the addition of 5-40 mu M Pb2+ significantly accelerates the exposure of hydrophobic region and filament formation of wild-type Tau(244-372) on the investigated time scale. As evidenced by circular dichroism and Fourier transform infrared spectroscopy, fibrils formed by wild-type Tau(244-372) in the presence of 5-40 mu M Pb2+ contain more beta-sheet structure than the same amount of fibrils formed by the protein in the absence of Pb2+. However, unlike wild-type Tau(244-372), the presence of 5-40 mu M Pb2+ has no obvious effects on fibrillization kinetics of single mutants H330A and H362A and double mutant H330A/H362A, and fibrils formed by such mutants in the absence and in the presence of Pb2+ contain similar amounts of beta-sheet structure. The results from isothermal titration calorimetry show that one Pb2+ binds to one Tau monomer via interaction with His-330 and His-362, with sub-micromolar affinity. Conclusions/Significance: We demonstrate for the first time that the fibrillization of human Tau protein is accelerated by exposure to lead via interaction with His-330 and His-362. Our results suggest the possible involvement of Pb2+ in the pathogenesis of Alzheimer disease and provide critical insights into the mechanism of lead toxicity.	[Zhu, Hai-Li; Meng, Sheng-Rong; Fan, Jun-Bao; Chen, Jie; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Zhu, HL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017; Fan, Jun-bao/E-7155-2012	Liang, Yi/0000-0002-7349-8300; Fan, Junbao/0000-0002-1709-3659	National Key Basic Research Foundation of China [2006CB910301]; National Natural Science Foundation of China [30970599, 30770421]; Fundamental Research Funds for the Central Universities [1104006]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by National Key Basic Research Foundation of China (http://www.most.gov.cn/ Grant no. 2006CB910301, Dr. Liang), National Natural Science Foundation of China (http://www.nsfc.gov.cn/ Grant nos. 30970599 and 30770421, Dr. Liang), and Fundamental Research Funds for the Central Universities (http://www.moe.edu.cn/ Grant no. 1104006, Dr. Liang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barghorn Stefan, 2004, V299, P35; Basha MR, 2005, J NEUROSCI, V25, P823, DOI 10.1523/JNEUROSCI.4335-04.2005; Basha R, 2005, FASEB J, V19, P2083, DOI 10.1096/fj.05-4375fje; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Bolin CM, 2006, FASEB J, V20, P788, DOI 10.1096/fj.05-5091fje; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Gisbert C, 2003, BIOCHEM BIOPH RES CO, V303, P440, DOI 10.1016/S0006-291X(03)00349-8; Haraguchi T, 2001, NEUROREPORT, V12, P3887, DOI 10.1097/00001756-200112210-00006; HESS K, 1974, SCHWEIZ RUNDSCH MED, V63, P177; Huang H, 2011, NEUROTOXICOLOGY, V32, P300, DOI 10.1016/j.neuro.2011.02.001; Kamel F, 2002, EPIDEMIOLOGY, V13, P311, DOI 10.1097/00001648-200205000-00012; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; Kitazawa M, 2009, J NEUROCHEM, V108, P1550, DOI 10.1111/j.1471-4159.2009.05901.x; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Li CC, 2008, TOXICOL APPL PHARM, V229, P351, DOI 10.1016/j.taap.2008.01.039; Liang Y, 2003, J BIOL CHEM, V278, P30098, DOI 10.1074/jbc.M304050200; Lone MI, 2008, J ZHEJIANG UNIV-SC B, V9, P210, DOI 10.1631/jzus.B0710633; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; NEEDLEMAN HL, 1990, NEW ENGL J MED, V322, P83, DOI 10.1056/NEJM199001113220203; NIKLOWITZ WJ, 1975, NEUROLOGY, V25, P927, DOI 10.1212/WNL.25.10.927; NIKLOWITZ WJ, 1975, J NEUROPATH EXP NEUR, V34, P445, DOI 10.1097/00005072-197509000-00006; Pichery C, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-44; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; SCHWARTZ J, 1994, ENVIRON RES, V65, P42, DOI 10.1006/enrs.1994.1020; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Seaward M. R. D., 1990, Heavy metal tolerance in plants: evolutionary aspects., P75; Vazquez A, 2004, TOXICOL APPL PHARM, V200, P27, DOI 10.1016/j.taap.2004.03.011; Verina T, 2007, NEUROSCIENCE, V145, P1037, DOI 10.1016/j.neuroscience.2006.12.040; Wasserman GA, 2003, CHILD NEUROPSYCHOL, V9, P22, DOI 10.1076/chin.9.1.22.14497; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wu J, 2008, J NEUROSCI, V28, P3, DOI 10.1523/JNEUROSCI.4405-07.2008; Wu JF, 2008, J MOL NEUROSCI, V34, P1, DOI 10.1007/s12031-007-0009-4; Yang F, 2006, J MOL BIOL, V362, P821, DOI 10.1016/j.jmb.2006.07.059; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691; Zukowska J, 2008, J FOOD SCI, V73, pR21, DOI 10.1111/j.1750-3841.2007.00648.x	39	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25020	10.1371/journal.pone.0025020	http://dx.doi.org/10.1371/journal.pone.0025020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966400	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100011
J	Sekizuka, T; Matsui, M; Yamane, K; Takeuchi, F; Ohnishi, M; Hishinuma, A; Arakawa, Y; Kuroda, M				Sekizuka, Tsuyoshi; Matsui, Mari; Yamane, Kunikazu; Takeuchi, Fumihiko; Ohnishi, Makoto; Hishinuma, Akira; Arakawa, Yoshichika; Kuroda, Makoto			Complete Sequencing of the bla(NDM-1)-Positive IncA/C Plasmid from Escherichia coli ST38 Isolate Suggests a Possible Origin from Plant Pathogens	PLOS ONE			English	Article							BETA-LACTAMASES; NDM-1; IDENTIFICATION; EMERGENCE; ALIGNMENT	The complete sequence of the plasmid pNDM-1_Dok01 carrying New Delhi metallo-beta-lactamase (NDM-1) was determined by whole genome shotgun sequencing using Escherichia coli strain NDM-1_Dok01 (multilocus sequence typing type: ST38) and the transconjugant E. coli DH10B. The plasmid is an IncA/C incompatibility type composed of 225 predicted coding sequences in 195.5 kb and partially shares a sequence with bla(CMY-2)-positive IncA/C plasmids such as E. coli AR060302 pAR060302 (166.5 kb) and Salmonella enterica serovar Newport pSN254 (176.4 kb). The bla(NDM-1) gene in pNDM-1_Dok01 is terminally flanked by two IS903 elements that are distinct from those of the other characterized NDM-1 plasmids, suggesting that the bla(NDM-1) gene has been broadly transposed, together with various mobile elements, as a cassette gene. The chaperonin groES and groEL genes were identified in the bla(NDM-1)-related composite transposon, and phylogenetic analysis and guanine-cytosine content (GC) percentage showed similarities to the homologs of plant pathogens such as Pseudoxanthomonas and Xanthomonas spp., implying that plant pathogens are the potential source of the bla(NDM-1) gene. The complete sequence of pNDM-1_Dok01 suggests that the bla(NDM-1) gene was acquired by a novel composite transposon on an extensively disseminated IncA/C plasmid and transferred to the E. coli ST38 isolate.	[Sekizuka, Tsuyoshi; Takeuchi, Fumihiko; Kuroda, Makoto] Natl Inst Infect Dis, Lab Bacterial Genom, Pathogen Genom Ctr, Tokyo, Japan; [Matsui, Mari; Yamane, Kunikazu; Arakawa, Yoshichika] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan; [Hishinuma, Akira] Dokkyo Med Univ, Dept Infect Control, Mibu, Tochigi, Japan; [Hishinuma, Akira] Dokkyo Med Univ, Clin Lab Med, Mibu, Tochigi, Japan; [Arakawa, Yoshichika] Nagoya Univ, Grad Sch Med, Dept Bacteriol, Nagoya, Aichi 4648601, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Dokkyo Medical University; Dokkyo Medical University; Nagoya University	Sekizuka, T (corresponding author), Natl Inst Infect Dis, Lab Bacterial Genom, Pathogen Genom Ctr, Tokyo, Japan.	makokuro@nih.go.jp	Arakawa, Yoshichika/P-5997-2015	Sekizuka, Tsuyoshi/0000-0002-1302-5472	Ministry of Health, Labor, and Welfare, Japan [H21 Shokuhin-Ippan-013]	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid (No.:H21 Shokuhin-Ippan-013) from the Ministry of Health, Labor, and Welfare, Japan (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bao H, 2009, BIOINFORMATICS, V25, P1554, DOI 10.1093/bioinformatics/btp255; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Call DR, 2010, ANTIMICROB AGENTS CH, V54, P590, DOI 10.1128/AAC.00055-09; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Chihara S, 2011, CLIN INFECT DIS, V52, P153, DOI 10.1093/cid/ciq054; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; D'Andrea MM, 2011, J CLIN MICROBIOL; Fluit AC, 1999, EUR J CLIN MICROBIOL, V18, P761, DOI 10.1007/s100960050398; GRINDLEY NDF, 1980, P NATL ACAD SCI-BIOL, V77, P7176, DOI 10.1073/pnas.77.12.7176; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lund PA, 2009, FEMS MICROBIOL REV, V33, P785, DOI 10.1111/j.1574-6976.2009.00178.x; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Muga A, 2008, CURR PROTEIN PEPT SC, V9, P552, DOI 10.2174/138920308786733903; Olson AB, 2005, ANTIMICROB AGENTS CH, V49, P2112, DOI 10.1128/AAC.49.5.2112-2115.2005; Peirano G, 2011, ANTIMICROB AGENTS CH, V55, P2986, DOI 10.1128/AAC.01763-10; Peirano G, 2011, DIAGN MICR INFEC DIS, V69, P449, DOI 10.1016/j.diagmicrobio.2010.11.011; Pfeifer Y, 2011, ANTIMICROB AGENTS CH, V55, P1318, DOI 10.1128/AAC.01585-10; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P4914, DOI 10.1128/AAC.00878-10; Rodriguez MM, 2004, ANTIMICROB AGENTS CH, V48, P4895, DOI 10.1128/AAC.48.12.4895-4897.2004; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Samuelsen O, 2011, J ANTIMICROB CHEMOTH, V66, P670, DOI 10.1093/jac/dkq483; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463; Tamura K, 2011, MOL BIOL EVOLUTION; van der Bij AK, 2011, ANTIMICROB AGENTS CH, V55, P3576, DOI 10.1128/AAC.00074-11; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Yamamoto T, 2011, J INFECT CHEMOTHER, V17, P435, DOI 10.1007/s10156-011-0232-3; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zheng BW, 2011, PROTEIN CELL, V2, P250, DOI 10.1007/s13238-011-1027-0	39	79	81	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25334	10.1371/journal.pone.0025334	http://dx.doi.org/10.1371/journal.pone.0025334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966500	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100046
J	Suzuki, K; Murphy, SH; Xia, YF; Yokota, M; Nakagomi, DK; Liu, F; Verma, IM; Nakajima, H				Suzuki, Kotaro; Murphy, Samantha H.; Xia, Yifeng; Yokota, Masaya; Nakagomi, Daiki; Liu, Fei; Verma, Inder M.; Nakajima, Hiroshi			Tumor Suppressor p53 Functions as a Negative Regulator in IgE-Mediated Mast Cell Activation	PLOS ONE			English	Article							NF-KAPPA-B; IKK-BETA; IN-VIVO; TRANSCRIPTION; DETERMINANTS; APOPTOSIS; RESPONSES; PROTEINS; PATHWAY	Mast cells are known to play a pivotal role in allergic diseases such as allergic rhinitis, asthma, and atopic dermatitis by releasing granules containing histamine, LTC4, and other preformed chemical mediators. Previous reports have demonstrated that IKK2 (also called IKK beta), a central intracellular component of NF-kappa B activation pathways, plays a critical role in IgE-mediated degranulation of mast cells and anaphylaxis in mice. In this study, we show that protein levels of tumor suppressor p53 are up-regulated upon IgE-mediated activation in mast cells and lack of p53 results in enhanced responses in both early and late phase anaphylaxis. p53 inhibits not only the catalytic activity of IKK2 presumably through the modulation of glycosylation but also p65 (RelA)-mediated transactivation. Our findings are the first to demonstrate that p53 functions as a negative regulator in mast cells.	[Suzuki, Kotaro; Murphy, Samantha H.; Xia, Yifeng; Liu, Fei; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Suzuki, Kotaro; Yokota, Masaya; Nakagomi, Daiki; Nakajima, Hiroshi] Chiba Univ, Dept Mol Genet, Grad Sch Med, Chiba, Japan	Salk Institute; Chiba University	Suzuki, K (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	suzuki_k@faculty.chiba-u.jp	Nakajima, Hiroshi/AFU-9313-2022; Xia, Yifeng/G-9850-2011	Nakajima, Hiroshi/0000-0001-8595-9381; 	Ministry of Education, Culture, Sports, Science, and Technology; Japanese Government; (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan; Grants-in-Aid for Scientific Research [23659496, 21390255] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048034, R01AI048034] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government; (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	K.S. is supported in part by Grants-in Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, the Japanese Government and by Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Suzuki K, 2003, J EXP MED, V198, P1717, DOI 10.1084/jem.20031701; Suzuki K, 2002, J EXP MED, V196, P27, DOI 10.1084/jem.20011682; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106	30	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25412	10.1371/journal.pone.0025412	http://dx.doi.org/10.1371/journal.pone.0025412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966524	Green Published, gold, Green Submitted			2022-12-25	WOS:000295267100058
J	Lortie, CL; Guitton, MJ				Lortie, Catherine L.; Guitton, Matthieu J.			Judgment of the Humanness of an Interlocutor Is in the Eye of the Beholder	PLOS ONE			English	Article							COMPUTER-MEDIATED COMMUNICATION; TURING TEST; DIMENSIONS; RESPONSES; LANGUAGE; AVATARS; ERRORS; USERS	Despite tremendous advances in artificial language synthesis, no machine has so far succeeded in deceiving a human. Most research focused on analyzing the behavior of "good'' machine. We here choose an opposite strategy, by analyzing the behavior of "bad'' humans, i.e., humans perceived as machine. The Loebner Prize in Artificial Intelligence features humans and artificial agents trying to convince judges on their humanness via computer-mediated communication. Using this setting as a model, we investigated here whether the linguistic behavior of human subjects perceived as non-human would enable us to identify some of the core parameters involved in the judgment of an agents' humanness. We analyzed descriptive and semantic aspects of dialogues in which subjects succeeded or failed to convince judges of their humanness. Using cognitive and emotional dimensions in a global behavioral characterization, we demonstrate important differences in the patterns of behavioral expressiveness of the judges whether they perceived their interlocutor as being human or machine. Furthermore, the indicators of interest displayed by the judges were predictive of the final judgment of humanness. Thus, we show that the judgment of an interlocutor's humanness during a social interaction depends not only on his behavior, but also on the judge himself. Our results thus demonstrate that the judgment of humanness is in the eye of the beholder.	[Lortie, Catherine L.; Guitton, Matthieu J.] Univ Laval Robert Giffard CRULRG, Ctr Rech, Quebec City, PQ, Canada; [Lortie, Catherine L.; Guitton, Matthieu J.] Univ Laval, Fac Pharm, Quebec City, PQ, Canada	Laval University; Laval University	Lortie, CL (corresponding author), Univ Laval Robert Giffard CRULRG, Ctr Rech, Quebec City, PQ, Canada.	matthieu.guitton@pha.ulaval.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [371644]; Fonds de la Recherche en Sante du Quebec (FRSQ); Fond d'Enseignement et de Recherches (FER) of the Faculty of Pharmacy of Laval University; Centre de Recherche Sur le Cerveau, le Comportement et la Neuropsychiatrie (CRCN)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Fond d'Enseignement et de Recherches (FER) of the Faculty of Pharmacy of Laval University; Centre de Recherche Sur le Cerveau, le Comportement et la Neuropsychiatrie (CRCN)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC Grant Number 371644). MJG holds a Career Grant from the "Fonds de la Recherche en Sante du Quebec'' (FRSQ). CLL is supported by a Fellowship from the "Fond d'Enseignement et de Recherches" (FER) of the Faculty of Pharmacy of Laval University, and by the "Centre de Recherche Sur le Cerveau, le Comportement et la Neuropsychiatrie" (CRCN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alissandrakis A., 2004, INTERACTION STUDIES, V5, P3; Antheunis ML, 2007, CYBERPSYCHOL BEHAV, V10, P831, DOI 10.1089/cpb.2007.9945; Ardissono L, 2000, INT J HUM-COMPUT ST, V52, P583, DOI 10.1006/ijhc.1999.0347; Bailenson JN, 2005, PSYCHOL SCI, V16, P814, DOI 10.1111/j.1467-9280.2005.01619.x; Barak A, 2007, CYBERPSYCHOL BEHAV, V10, P407, DOI 10.1089/cpb.2006.9938; Bradac JJ, 1980, LANGUAGE SOCIAL PSYC, P217; CAPPELLA JN, 1981, HUM COMMUN RES, V7, P117, DOI 10.1111/j.1468-2958.1981.tb00564.x; Dautenhahn K., 2002, COGNITIVE SYSTEMS RE, V3, P397, DOI [10.1016/S1389-0417(02)00050-5, DOI 10.1016/S1389-0417(02)00050-5]; Dautenhahn K, 2007, PHILOS T R SOC B, V362, P679, DOI 10.1098/rstb.2006.2004; Dino A, 2009, J LANG SOC PSYCHOL, V28, P85, DOI 10.1177/0261927X08325916; French RM, 2000, TRENDS COGN SCI, V4, P115, DOI 10.1016/S1364-6613(00)01453-4; Giard F, 2010, COMPUT HUM BEHAV, V26, P1748, DOI 10.1016/j.chb.2010.07.001; GILES H, 1973, SPEECH MONOGR, V40, P330; Giles H., 1991, CONTEXTS ACCOMMODATI, DOI [10.1017/CBO9780511663673.001, DOI 10.1017/CBO9780511663673.001]; Holtgraves TM, 2007, COMPUT HUM BEHAV, V23, P2163, DOI 10.1016/j.chb.2006.02.017; Jessmer S. L., 2001, N AM J PSYCHOL, V3, P331; Kahn JH, 2007, AM J PSYCHOL, V120, P263, DOI 10.2307/20445398; Korukonda AR, 2003, INT J HUM-COMPUT ST, V58, P240, DOI 10.1016/S1071-5819(02)00139-8; Kreiner DS, 2002, J GEN PSYCHOL, V129, P5, DOI 10.1080/00221300209602029; Ku J, 2005, CYBERPSYCHOL BEHAV, V8, P493, DOI 10.1089/cpb.2005.8.493; Lea M., 1992, Journal of Organizational Computing, V2, P321, DOI 10.1080/10919399209540190; Lee EJ, 2010, COMPUT HUM BEHAV, V26, P665, DOI 10.1016/j.chb.2010.01.003; LEVELT WJM, 1982, COGNITIVE PSYCHOL, V14, P78, DOI 10.1016/0010-0285(82)90005-6; MacDorman KF, 2006, INTERACT STUD, V7, P297, DOI 10.1075/is.7.3.03mac; Mayer RE, 2006, INT J HUM-COMPUT ST, V64, P36, DOI 10.1016/j.ijhcs.2005.07.001; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; Nass C, 1997, J APPL SOC PSYCHOL, V27, P864, DOI 10.1111/j.1559-1816.1997.tb00275.x; Pennebaker J. W., 2007, DEV PSYCHOMETRIC PRO; Pfeil U, 2009, COMPUT HUM BEHAV, V25, P643, DOI 10.1016/j.chb.2008.08.015; PROVINE RR, 1992, B PSYCHONOMIC SOC, V30, P1; Robins B, 2006, INTERACT STUD, V7, P479; Rollman JB, 2000, CYBERPSYCHOL BEHAV, V3, P161, DOI 10.1089/109493100316003; Suzuki N, 2003, SPEECH COMMUN, V40, P559, DOI 10.1016/S0167-6393(02)00180-2; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Tinwell A., 2011, GAME SOUND TECHNOLOG, P213, DOI DOI 10.4018/978-1-61692-828-5.CH011; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; Vignovic JA, 2010, J APPL PSYCHOL, V95, P265, DOI 10.1037/a0018628; von der Putten AM, 2010, COMPUT HUM BEHAV, V26, P1641, DOI 10.1016/j.chb.2010.06.012; Walther JB, 2007, COMPUT HUM BEHAV, V23, P2538, DOI 10.1016/j.chb.2006.05.002; WEIZENBAUM J, 1966, COMMUN ACM, V9, P36, DOI 10.1145/357980.357991; Whalen TE, 2003, CYBERPSYCHOL BEHAV, V6, P537, DOI 10.1089/109493103769710569	41	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25085	10.1371/journal.pone.0025085	http://dx.doi.org/10.1371/journal.pone.0025085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825IJ	21966420	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100052
J	Thu, YM; Su, Y; Yang, J; Splittgerber, R; Na, S; Boyd, A; Mosse, C; Simons, C; Richmond, A				Thu, Y. M.; Su, Y.; Yang, J.; Splittgerber, R.; Na, S.; Boyd, A.; Mosse, C.; Simons, C.; Richmond, A.			NF-kappa B inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the beta-catenin pathway	ONCOGENE			English	Article						NIK; beta-catenin; melanoma; tumorigenesis; survival factors	INDUCED APOPTOSIS; TUMOR-GROWTH; C-MYC; ALPHA; TNF; ACTIVATION; CELLS; THERAPY; TARGET; INHIBITION	Nuclear factor-kappa B (NF-kappa B) inducing kinase (NIK) is a MAP3K that regulates the activation of NF-kappa B. NIK is often highly expressed in tumor cells, including melanoma, but the significance of this in melanoma progression has been unclear. Tissue microarray analysis of NIK expression reveals that dysplastic nevi (n = 22), primary (n = 15) and metastatic melanoma (n = 13) lesions showed a statistically significant elevation in NIK expression when compared with benign nevi (n = 30). Moreover, when short hairpin RNA techniques were used to knock-down NIK, the resultant NIK-depleted melanoma cell lines exhibited decreased proliferation, increased apoptosis, delayed cell cycle progression and reduced tumor growth in a mouse xenograft model. As expected, when NIK was depleted there was decreased activation of the non-canonical NF-kappa B pathway, whereas canonical NF-kappa B activation remained intact. NIK depletion also resulted in reduced expression of genes that contribute to tumor growth, including CXCR4, c-MYC and c-MET, and pro-survival factors such as BCL2 and survivin. These changes in gene expression are not fully explained by the attenuation of the non-canonical NF-kappa B pathway. Shown here for the first time is the demonstration that NIK modulates beta-catenin-mediated transcription to promote expression of survivin. NIK-depleted melanoma cells exhibited downregulation of survivin as well as other beta-catenin regulated genes including c-MYC, c-MET and CCND2. These data indicate that NIK mediates both beta-catenin and NF-kappa B regulated transcription to modulate melanoma survival and growth. Thus, NIK may be a promising therapeutic target for melanoma. Oncogene (2012) 31, 2580-2592; doi:10.1038/onc.2011.427; published online 3 October 2011	[Thu, Y. M.; Su, Y.; Yang, J.; Splittgerber, R.; Richmond, A.] Vanderbilt Univ, Dept Canc Biol, Sch Med, Nashville, TN 37232 USA; [Na, S.] Eli Lilly & Co, Oncol Res, Indianapolis, IN 46285 USA; [Boyd, A.] Vanderbilt Univ, Sch Med, Div Dermatol, Nashville, TN 37232 USA; [Mosse, C.; Simons, C.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Richmond, A.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Eli Lilly; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Richmond, A (corresponding author), Vanderbilt Univ, Dept Canc Biol, Sch Med, 771 PRB,2220 Pierce Ave, Nashville, TN 37232 USA.	ann.richmond@vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	NIH [CA 098807-01]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA098807, R01CA116021, P30CA068485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Dr Robert Schreiber (Washington University) for generously sharing Nik<SUP>-/-</SUP> MEFs, and Vanderbilt Functional Genomic Shared Resource Core, VA Flow Cytometry Core and Vanderbilt Immunohistochemistry Core for technical help. We thank Dr Joseph T Roland (Epithelial Biology Center) for assistance with the ariol scanning and quantitation of TMAs. We thank Dr Mark Kelly and Vanderbilt melanoma group for providing melanoma tissues and Dr Sara Kantrow for reviewing some of the TMA slides. We thank Dr Fiona Yull and Dr Punita Dhawan for thoughtful discussion and Vanderbilt Editor Club for careful reading of the manuscript. Grant Support: This work is supported by NIH, CA 098807-01 and the Department of Veterans Affairs, Career Scientist Award and Merit Award (to AR).	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; BALENTIEN E, 1991, ONCOGENE, V6, P1115; Boon EMJ, 2002, CANCER RES, V62, P5126; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Chin L, 1998, GENE DEV, V12, P3467, DOI 10.1101/gad.12.22.3467; Cole AM, 2010, CANCER RES, V70, P8149, DOI 10.1158/0008-5472.CAN-10-0315; Conze DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000518; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Devalaraja MN, 1999, CANCER RES, V59, P1372; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Dhomen N, 2009, HEMATOL ONCOL CLIN N, V23, P529, DOI 10.1016/j.hoc.2009.04.001; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Grossman D, 2001, P NATL ACAD SCI USA, V98, P635, DOI 10.1073/pnas.230450097; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hilmi C, 2008, J INVEST DERMATOL, V128, P1499, DOI 10.1038/sj.jid.5701185; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Lecis D, 2010, BRIT J CANCER, V102, P1707, DOI 10.1038/sj.bjc.6605687; Lev DC, 2003, MOL CANCER THER, V2, P753; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Malbon Craig C, 2005, Sci STKE, V2005, ppe35, DOI 10.1126/stke.2922005pe35; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; McGary EC, 2002, CANCER BIOL THER, V1, P459, DOI 10.4161/cbt.1.5.158; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Moore SR, 2008, CLIN CANCER RES, V14, P2927, DOI 10.1158/1078-0432.CCR-07-4068; Neely RJ, 2011, ONCOGENE, V30, P87, DOI 10.1038/onc.2010.396; Ng KCP, 2004, J INVEST DERMATOL, V123, P1127, DOI 10.1111/j.0022-202X.2004.23467.x; Pastorino F, 2003, CLIN CANCER RES, V9, P4595; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Plenchette S, 2007, CURR OPIN INVEST DR, V8, P469; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Puzanov I, 2010, SEMIN CUTAN MED SURG, V29, P196, DOI 10.1016/j.sder.2010.06.005; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Saitoh Y, 2008, BLOOD, V111, P5118, DOI 10.1182/blood-2007-09-110635; Saitoh Y, 2010, LUNG CANCER, V70, P263, DOI 10.1016/j.lungcan.2010.03.001; Scala S, 2006, CLIN CANCER RES, V12, P2427, DOI 10.1158/1078-0432.CCR-05-1940; Scala S, 2005, CLIN CANCER RES, V11, P1835, DOI 10.1158/1078-0432.CCR-04-1887; Sinnberg T, 2010, CANCER RES, V70, P6999, DOI 10.1158/0008-5472.CAN-10-0645; Smith C, 2001, J IMMUNOL, V167, P5895, DOI 10.4049/jimmunol.167.10.5895; Sullivan RJ, 2009, EXPERT REV ANTICANC, V9, P567, DOI [10.1586/era.09.20, 10.1586/ERA.09.20]; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang DZ, 2000, ONCOGENE, V19, P4647, DOI 10.1038/sj.onc.1203820; Yang JM, 2007, CANCER RES, V67, P3127, DOI 10.1158/0008-5472.CAN-06-3547; Yang JM, 2010, J CLIN INVEST, V120, P2563, DOI 10.1172/JCI42358; Yang JM, 2006, CLIN CANCER RES, V12, P950, DOI 10.1158/1078-0432.CCR-05-1220; Yang JM, 2001, CANCER RES, V61, P4901; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zhang T, 2001, CANCER RES, V61, P8664	61	34	39	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	20					2580	2592		10.1038/onc.2011.427	http://dx.doi.org/10.1038/onc.2011.427			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	944ID	21963849	Green Accepted			2022-12-25	WOS:000304191800008
J	Artsimovitch, I; Svetlov, V; Nemetski, SM; Epshtein, V; Cardozo, T; Nudler, E				Artsimovitch, Irina; Svetlov, Vladimir; Nemetski, Sondra Maureen; Epshtein, Vitaly; Cardozo, Timothy; Nudler, Evgeny			Tagetitoxin Inhibits RNA Polymerase through Trapping of the Trigger Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; ESCHERICHIA-COLI; TRANSCRIPTION TERMINATION; ACTIVE-CENTER; ALPHA-AMANITIN; BETA-SUBUNIT; ELONGATION; STREPTOLYDIGIN; MECHANISM; CATALYSIS	Tagetitoxin (Tgt) inhibits multisubunit chloroplast, bacterial, and some eukaryotic RNA polymerases (RNAPs). A crystallographic structure of Tgt bound to bacterial RNAP apoenzyme shows that Tgt binds near the active site but does not explain why Tgt acts only at certain sites. To understand the Tgt mechanism, we constructed a structural model of Tgt bound to the transcription elongation complex. In this model, Tgt interacts with the beta' subunit trigger loop (TL), stabilizing it in an inactive conformation. We show that (i) substitutions of the Arg residue of TL contacted by Tgt confer resistance to inhibitor; (ii) Tgt inhibits RNAP translocation, which requires TL movements; and (iii) paused complexes and a "slow" enzyme, in which the TL likely folds into an altered conformation, are resistant to Tgt. Our studies highlight the role of TL as a target through which accessory proteins and antibiotics can alter the elongation complex dynamics.	[Artsimovitch, Irina] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Artsimovitch, Irina] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Nemetski, Sondra Maureen; Cardozo, Timothy] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Svetlov, Vladimir; Epshtein, Vitaly; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; New York University; New York University	Artsimovitch, I (corresponding author), Ohio State Univ, Dept Microbiol, 270 Aronoff,318 W 12th Ave, Columbus, OH 43210 USA.	artsimovitch.1@osu.edu; evgeny.nudler@nyumc.org	Artsimovitch, Irina/L-3467-2019	Nudler, Evgeny/0000-0002-8811-3071	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grants (to I. A., E. N., S. M. N., and T. C.).	Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Belogurov GA, 2009, NATURE, V457, P332, DOI 10.1038/nature07510; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; FISHER RF, 1983, J BIOL CHEM, V258, P8146; Hwang W, 2009, CELL BIOCHEM BIOPHYS, V54, P11, DOI 10.1007/s12013-009-9049-4; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; MATHEWS DE, 1990, J BIOL CHEM, V265, P493; MATHEWS DE, 1994, BIOCHEMISTRY-US, V33, P11987, DOI 10.1021/bi00205a038; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Roghanian M, 2011, NUCLEIC ACIDS RES, V39, P4352, DOI 10.1093/nar/gkq1359; STEINBERG TH, 1992, J BIOL CHEM, V267, P20204; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; WEILBAECHER R, 1994, GENE DEV, V8, P2913, DOI 10.1101/gad.8.23.2913; Yidirim Y, 2004, J BIOMOL STRUCT DYN, V22, P267, DOI 10.1080/07391102.2004.10507000; Yuzenkova Y, 2010, P NATL ACAD SCI USA, V107, P10878, DOI 10.1073/pnas.0914424107; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732; Zhu R, 2008, THEOR CHEM ACC, V120, P479, DOI 10.1007/s00214-008-0440-9	33	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40395	40400		10.1074/jbc.M111.300889	http://dx.doi.org/10.1074/jbc.M111.300889			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21976682	hybrid, Green Published			2022-12-25	WOS:000296925700070
J	Agarwal, M; Guzman, MG; Morales-Matos, C; Diaz, RAD; Abramson, CI; Giray, T				Agarwal, Maitreyi; Guzman, Manuel Giannoni; Morales-Matos, Carla; Del Valle Diaz, Rafael Alejandro; Abramson, Charles I.; Giray, Tugrul			Dopamine and Octopamine Influence Avoidance Learning of Honey Bees in a Place Preference Assay	PLOS ONE			English	Article							STING EXTENSION REFLEX; APIS-MELLIFERA BRAIN; DIVISION-OF-LABOR; JUVENILE-HORMONE; BEHAVIORAL-DEVELOPMENT; FUNCTIONAL EXPRESSION; OLFACTORY MEMORIES; TYRAMINE; REWARD; RECEPTOR	Biogenic amines are widely characterized in pathways evaluating reward and punishment, resulting in appropriate aversive or appetitive responses of vertebrates and invertebrates. We utilized the honey bee model and a newly developed spatial avoidance conditioning assay to probe effects of biogenic amines octopamine (OA) and dopamine (DA) on avoidance learning. In this new protocol non-harnessed bees associate a spatial color cue with mild electric shock punishment. After a number of experiences with color and shock the bees no longer enter the compartment associated with punishment. Intrinsic aspects of avoidance conditioning are associated with natural behavior of bees such as punishment (lack of food, explosive pollination mechanisms, danger of predation, heat, etc.) and their association to floral traits or other spatial cues during foraging. The results show that DA reduces the punishment received whereas octopamine OA increases the punishment received. These effects are dose-dependent and specific to the acquisition phase of training. The effects during acquisition are specific as shown in experiments using the antagonists Pimozide and Mianserin for DA and OA receptors, respectively. This study demonstrates the integrative role of biogenic amines in aversive learning in the honey bee as modeled in a novel non-appetitive avoidance learning assay.	[Agarwal, Maitreyi] Univ Puerto Rico, Dept Chem, San Juan, PR 00936 USA; [Guzman, Manuel Giannoni; Morales-Matos, Carla; Del Valle Diaz, Rafael Alejandro; Giray, Tugrul] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Abramson, Charles I.] Oklahoma State Univ, Lab Behav Biol & Comparat Psychol, Stillwater, OK 74078 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Oklahoma State University System; Oklahoma State University - Stillwater	Agarwal, M (corresponding author), Univ Puerto Rico, Dept Chem, San Juan, PR 00936 USA.	tgiray2@yahoo.com	Abramson, Charles/AAD-5709-2019; Giray, Tugrul/K-9570-2013	Abramson, Charles/0000-0001-8961-3089; Giray, Tugrul/0000-0003-4383-4681	National Science Foundation, United States of America [OISE-1043057, DBI-0851651]; National Aeronautics and Space Administration Puerto Rico Space Grant Consortium [NASA-IDEAS-PR-08]; Direct For Biological Sciences [0851651] Funding Source: National Science Foundation; Office Of Internatl Science &Engineering [1043057] Funding Source: National Science Foundation	National Science Foundation, United States of America(National Science Foundation (NSF)); National Aeronautics and Space Administration Puerto Rico Space Grant Consortium; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	Parts of this work and its publication have been supported by grants from National Science Foundation, United States of America (OISE-1043057 to CA and TG and DBI-0851651), and National Aeronautics and Space Administration Puerto Rico Space Grant Consortium (NASA-IDEAS-PR-08 to TG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2009, ANIM BEHAV, V78, P633, DOI 10.1016/j.anbehav.2009.05.029; Abramson CI, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.12201; ABRAMSON CI, 1988, J EXP ANAL BEHAV, V50, P483, DOI 10.1901/jeab.1988.50-483; ABRAMSON CI, 1981, J GEN PSYCHOL, V104, P29, DOI 10.1080/00221309.1981.9921017; ABRAMSON CI, 1995, J COMP PSYCHOL, V109, P390, DOI 10.1037/0735-7036.109.4.390; ABRAMSON CI, 1986, J COMP PSYCHOL, V100, P108, DOI 10.1037/0735-7036.100.2.108; Arenas A, 2008, J COMP PHYSIOL A, V194, P629, DOI 10.1007/s00359-008-0337-z; Avargues-Weber A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015370; Barron AB, 2005, J COMP PHYSIOL A, V191, P659, DOI 10.1007/s00359-005-0619-7; Barron AB, 2007, J INSECT PHYSIOL, V53, P187, DOI 10.1016/j.jinsphys.2006.11.009; Barron AB, 2007, P NATL ACAD SCI USA, V104, P1703, DOI 10.1073/pnas.0610506104; Barron AB, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00163; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Bischof LJ, 2004, INSECT BIOCHEM MOLEC, V34, P511, DOI 10.1016/j.ibmb.2004.02.003; Blenau W, 2000, J NEUROCHEM, V74, P900, DOI 10.1046/j.1471-4159.2000.0740900.x; Blenau W, 1998, J NEUROCHEM, V70, P15; Cakmak I, 2010, J INSECT BEHAV, V23, P100, DOI 10.1007/s10905-009-9199-7; CAMPBELL BA, PUNISHMENT AVERSIVE; Carcaud J, 2009, J EXP BIOL, V212, P620, DOI 10.1242/jeb.026641; CHEN WY, 1970, ANIM BEHAV, V18, P725, DOI 10.1016/0003-3472(70)90018-7; De Marco RJ, 2006, J EXP BIOL, V209, P421, DOI 10.1242/jeb.02025; DISTERHOFT JF, 1971, PHYSIOL BEHAV, V7, P359, DOI 10.1016/0031-9384(71)90314-3; DISTERHOFT JF, 1972, J COMP PHYSIOL PSYCH, V79, P1, DOI 10.1037/h0032557; Farooqui T, 2004, J INSECT PHYSIOL, V50, P701, DOI 10.1016/j.jinsphys.2004.04.014; Farooqui T, 2003, J NEUROSCI, V23, P5370; Fussnecker BL, 2006, J INSECT PHYSIOL, V52, P1083, DOI 10.1016/j.jinsphys.2006.07.008; Giray T, 1996, P NATL ACAD SCI USA, V93, P11718, DOI 10.1073/pnas.93.21.11718; Giray T, 2005, P NATL ACAD SCI USA, V102, P3330, DOI 10.1073/pnas.0409560102; GIRAY T, 1994, BEHAV ECOL SOCIOBIOL, V35, P13, DOI 10.1007/BF00167054; Giray T, 2007, J INSECT PHYSIOL, V53, P691, DOI 10.1016/j.jinsphys.2007.03.016; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Giurfa M, 2009, LEARN MEMORY, V16, P761, DOI 10.1101/lm.1603009; Grohmann L, 2000, EUR J NEUROSCI, V12, P94; Harano K, 2008, J INSECT PHYSIOL, V54, P848, DOI 10.1016/j.jinsphys.2008.03.003; Hawes JJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1864, DOI 10.1038/sj.npp.1301579; Hunt GJ, 2007, J INSECT PHYSIOL, V53, P399, DOI 10.1016/j.jinsphys.2007.01.010; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; KOLMES SA, 1989, J NEW YORK ENTOMOL S, V97, P218; Lange AB, 2009, GEN COMP ENDOCR, V162, P18, DOI 10.1016/j.ygcen.2008.05.021; Libersat F, 2004, BIOSCIENCE, V54, P17, DOI 10.1641/0006-3568(2004)054[0017:MATOOB]2.0.CO;2; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004694; Mustard JA, 2010, J INSECT PHYSIOL, V56, P422, DOI 10.1016/j.jinsphys.2009.11.018; Nagaya Y, 2002, NEUROSCI LETT, V329, P324, DOI 10.1016/S0304-3940(02)00596-7; Niggebrugge C, 2009, J EXP BIOL, V212, P1344, DOI 10.1242/jeb.021881; OSHEA M, 1979, J EXP BIOL, V79, P169; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; RAGLAND RS, 1965, PSYCHON SCI, V3, P117; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; ROEDER T, 1990, EUR J PHARMACOL, V191, P221, DOI 10.1016/0014-2999(90)94151-M; Sandoz JC, 2001, LEARN MEMORY, V8, P286, DOI 10.1101/lm.41401; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; Schulz DJ, 2002, HORM BEHAV, V42, P222, DOI 10.1006/hbeh.2002.1806; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Seefeldt S, 2008, J EXP BIOL, V211, P3392, DOI 10.1242/jeb.017624; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; SMITH BH, 1991, J COMP PSYCHOL, V105, P345, DOI 10.1037/0735-7036.105.4.345; Sokal R. R., 2012, BIOMETRY; Srinivasan MV, 2010, ANNU REV ENTOMOL, V55, P267, DOI 10.1146/annurev.ento.010908.164537; Takahashi T, 2009, J NEUROSCI METH, V179, P9, DOI 10.1016/j.jneumeth.2009.01.002; TAYLOR R C, 1971, Journal of Biological Psychology, V13, P36; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Younger J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013309	72	70	73	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25371	10.1371/journal.pone.0025371	http://dx.doi.org/10.1371/journal.pone.0025371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980435	Green Published, Green Submitted, gold			2022-12-25	WOS:000295941300026
J	Zhang, Y; Johansson, E; Miller, ML; Janicke, RU; Ferguson, DJ; Plas, D; Meller, J; Anderson, MW				Zhang, Yu; Johansson, Elisabet; Miller, Marian L.; Jaenicke, Reiner U.; Ferguson, Donald J.; Plas, David; Meller, Jarek; Anderson, Marshall W.			Identification of a Conserved Anti-Apoptotic Protein That Modulates the Mitochondrial Apoptosis Pathway	PLOS ONE			English	Article							DRUG-INDUCED APOPTOSIS; KINASE-C INHIBITOR; PHASE-I TRIAL; ACTIVATION; COMBINATION; CASPASE-8; UCN-01; CELLS; 7-HYDROXYSTAUROSPORINE; CLEAVAGE	Here we identified an evolutionarily highly conserved and ubiquitously expressed protein ( C9orf82) that shows structural similarities to the death effector domain of apoptosis-related proteins. RNAi knockdown of C9orf82 induced apoptosis in A-549 and MCF7/casp3-10b lung and breast carcinoma cells, respectively, but not in cells lacking caspase-3, caspase-10 or both. Apoptosis was associated with activated caspases-3, -8, -9 and -10, and inactivation of caspases 10 or 3 was sufficient to block apoptosis in this pathway. Apoptosis upon knockdown of C9orf82 was associated with increased caspase-10 expression and activation, which was required for the generation of an 11 kDa tBid fragment and activation of Caspase-9. These data suggest that C9orf82 functions as an anti-apoptotic protein that modulates a caspase-10 dependent mitochondrial caspase-3/9 feedback amplification loop. We designate this ubiquitously expressed and evolutionarily conserved anti-apoptotic protein Conserved Anti-Apoptotic Protein (CAAP). We also demonstrated that treatment of MCF7/casp3-10b cells with staurosporine and etoposides induced apoptosis and knockdown of CAAP expression. This implies that the CAAP protein could be a target for chemotherapeutic agents.	[Zhang, Yu] Univ Cincinnati, Sch Pharm, Cincinnati, OH 45221 USA; [Johansson, Elisabet; Miller, Marian L.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Jaenicke, Reiner U.] Univ Dusseldorf, Lab Mol Radiooncol, Clin & Policlin Radiat Therapy & Radiooncol, Ctr Clin, Dusseldorf, Germany; [Ferguson, Donald J.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Plas, David] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH USA; [Meller, Jarek] Univ Cincinnati, Med Ctr, Childrens Hosp, Div Biomed Informat,Dept Environm Hlth, Cincinnati, OH 45267 USA; [Meller, Jarek] Univ Cincinnati, Med Ctr, Childrens Hosp, Div Biomed Informat,Dept Biomed Engn, Cincinnati, OH 45267 USA; [Anderson, Marshall W.] Med Coll Wisconsin, Dept Med, Ctr Canc, Milwaukee, WI 53226 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Heinrich Heine University Dusseldorf; University System of Ohio; Miami University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Medical College of Wisconsin	Zhang, Y (corresponding author), Univ Cincinnati, Sch Pharm, Cincinnati, OH 45221 USA.	mwanderson@mcw.edu	Meller, Jaroslaw/A-1971-2011	Meller, Jaroslaw/0000-0002-1162-8253	University of Cincinnati College of Medicine; National Institute of Environmental Health Sciences (NIEHS) [P30 ES06096]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	University of Cincinnati College of Medicine; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the University of Cincinnati College of Medicine and by a grant from the National Institute of Environmental Health Sciences (NIEHS) to the Center for Environmental Genetics (P30 ES06096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Engels IH, 2005, MOL CELL BIOL, V25, P2808, DOI 10.1128/MCB.25.7.2808-2818.2005; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Filomenko R, 2006, ONCOGENE, V25, P7635, DOI 10.1038/sj.onc.1209733; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fischer U, 2006, ONCOGENE, V25, P152, DOI 10.1038/sj.onc.1209015; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hill JM, 2004, J BIOL CHEM, V279, P1474, DOI 10.1074/jbc.M304996200; Hotte SJ, 2006, ANN ONCOL, V17, P334, DOI 10.1093/annonc/mdj076; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jimeno A, 2008, CANCER CHEMOTH PHARM, V61, P423, DOI 10.1007/s00280-007-0485-9; Kortmansky J, 2005, J CLIN ONCOL, V23, P1875, DOI 10.1200/JCO.2005.03.116; Kummar S, 2010, CANCER CHEMOTH PHARM, V65, P383, DOI 10.1007/s00280-009-1154-y; Lee HJ, 2007, NAT CELL BIOL, V9, P1303, DOI 10.1038/ncb1650; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MANNS J, 2011, FASEB J; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Monnerat C, 2004, ANN ONCOL, V15, P316, DOI 10.1093/annonc/mdh052; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rikhof B, 2003, CANCER BIOL THER, V2, P707; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sampath D, 2006, BLOOD, V107, P2517, DOI 10.1182/blood-2005-08-3351; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; SHIIO Y, 1992, P NATL ACAD SCI USA, V89, P5206, DOI 10.1073/pnas.89.12.5206; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; WIEST JS, 1977, CANCER RES, V57, P1; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5	37	13	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25284	10.1371/journal.pone.0025284	http://dx.doi.org/10.1371/journal.pone.0025284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980415	Green Submitted, Green Published, gold			2022-12-25	WOS:000295941300023
J	Guesdon, V; Bertin, A; Houdelier, C; Lumineau, S; Formanek, L; Kotrschal, K; Mostl, E; Richard-Yris, MA				Guesdon, Vanessa; Bertin, Aline; Houdelier, Cecilia; Lumineau, Sophie; Formanek, Laureline; Kotrschal, Kurt; Moestl, Erich; Richard-Yris, Marie-Annick			A Place to Hide in the Home-Cage Decreases Yolk Androgen Levels and Offspring Emotional Reactivity in Japanese Quail	PLOS ONE			English	Article							AMONG-CLUTCH VARIATION; TESTOSTERONE LEVELS; ENVIRONMENTAL ENRICHMENT; MATERNAL TESTOSTERONE; CORTICOSTERONE LEVELS; DEVELOPMENTAL STRESS; STEROID-HORMONES; WITHIN-CLUTCH; BEHAVIOR; EGGS	An animal's emotional responses are the result of its cognitive appraisal of a situation. This appraisal is notably influenced by the possibility of an individual to exert control over an aversive event. Although the fact that environment controllability decreases emotional responses in animals is well established, far less is known about its potential trans-generational effects. As the levels of avian yolk hormones can vary according to the mother's environment, we hypothesized that housing environment of mothers would modulate the quality of her eggs and in turn her offspring's behaviour. Two groups of female japanese quail were constituted: a group that had access to a place to hide in their home-cage (Hd, n = 20) and a group that had nowhere to hide (NoHd, n = 20) when stressed. Both groups were submitted to daily human disturbances for a twenty-day-period. Hd females produced eggs with both less testosterone and androstenedione than did NoHd females. The emotional and social reactivity of Hd female's offspring were lower and their growth wes slower than those of NoHd females' offspring. Our results show that a minor difference in housing environment had substantial effects on eggs and offspring. The presence of a shelter probably helped quail to cope with daily human disturbances, producing less reactive offspring. This transgenerational effect caused by an opportunity to hide could lead to applications in care of laboratory animals, conservation biology and animal welfare.	[Guesdon, Vanessa; Houdelier, Cecilia; Lumineau, Sophie; Formanek, Laureline; Richard-Yris, Marie-Annick] Univ Rennes 1, UMR CNRS 6552, Rennes, France; [Bertin, Aline; Kotrschal, Kurt] Univ Vienna, Konrad Lorenz Forsch Stelle, Grunau, Austria; [Moestl, Erich] Univ Vet Med, Dept Nat Sci, Vienna, Austria	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; University of Vienna; University of Veterinary Medicine Vienna	Guesdon, V (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	vguesdon@tours.inra.fr		Lumineau, Sophie/0000-0002-2076-9947	Foundation Fyssen; FWF (Fonds zur Forderung der Wissenschaftlichen Forschung) [P 18601-017]	Foundation Fyssen; FWF (Fonds zur Forderung der Wissenschaftlichen Forschung)(Austrian Science Fund (FWF))	This work was partly funded by the Foundation Fyssen and the FWF (Fonds zur Forderung der Wissenschaftlichen Forschung: The Austrian Science Fund) Project P 18601-017. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2004, J EVOLUTION BIOL, V17, P501, DOI 10.1111/j.1420-9101.2004.00706.x; Archer J., 1976, P231; AUBRAIS O, 1986, Gibier Faune Sauvage, V3, P317; Bassett L, 2007, APPL ANIM BEHAV SCI, V102, P223, DOI 10.1016/j.applanim.2006.05.029; Bertin A, 2009, BEHAVIOUR, V146, P757, DOI 10.1163/156853909X446190; Bertin A, 2008, HORM BEHAV, V54, P396, DOI 10.1016/j.yhbeh.2008.04.012; Bertin A, 2009, HORM BEHAV, V56, P416, DOI 10.1016/j.yhbeh.2009.07.008; Bruggeman V, 2002, COMP BIOCHEM PHYS A, V131, P839, DOI 10.1016/S1095-6433(02)00022-3; Calandreau L, 2011, BEHAV BRAIN RES, V217, P104, DOI 10.1016/j.bbr.2010.10.004; Daisley JN, 2005, HORM BEHAV, V47, P185, DOI 10.1016/j.yhbeh.2004.09.006; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Eising CM, 2003, ANIM BEHAV, V66, P1027, DOI 10.1006/anbe.2003.2287; Eising CM, 2006, BIOL LETTERS, V2, P20, DOI 10.1098/rsbl.2005.0391; FAURE JM, 1983, BIOL BEHAV, V8, P103; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gil D, 2004, J EXP BIOL, V207, P2215, DOI 10.1242/jeb.01013; Gil D, 2003, ARDEOLA, V50, P281; Gil D, 2007, J EXP ZOOL PART A, V307A, P91, DOI 10.1002/jez.a.340; Greiveldinger L, 2009, PSYCHONEUROENDOCRINO, V34, P805, DOI 10.1016/j.psyneuen.2008.10.025; Groothuis TG, 2002, FUNCT ECOL, V16, P281; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Guibert F, 2011, APPL ANIM BEHAV SCI, V132, P51, DOI 10.1016/j.applanim.2011.03.012; Guibert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014069; Guyomarc'h J.C., 1998, BWP UPDATE, V2, P27; Hackl R, 2003, J COMP PHYSIOL B, V173, P327, DOI 10.1007/s00360-003-0339-7; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Hegyi G, 2010, J AVIAN BIOL, V41, P258, DOI 10.1111/j.1600-048X.2009.04787.x; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Hirschenhauser K, 1999, GEN COMP ENDOCR, V114, P67, DOI 10.1006/gcen.1998.7236; Janczak AM, 2009, ACTA AGR SCAND A-AN, V59, P80, DOI 10.1080/09064700903023348; Janczak AM, 2007, APPL ANIM BEHAV SCI, V107, P66, DOI 10.1016/j.applanim.2006.09.016; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; LAUNAY F, 1993, PHYSIOL BEHAV, V54, P111, DOI 10.1016/0031-9384(93)90051-G; LAUNAY F, 1993, THESIS U RENNES 1 FR; Lipar JL, 1999, GEN COMP ENDOCR, V115, P220, DOI 10.1006/gcen.1999.7296; Love OP, 2008, HORM BEHAV, V53, P104, DOI 10.1016/j.yhbeh.2007.09.007; Love OP, 2011, J EVOLUTION BIOL, V24, P1497, DOI 10.1111/j.1420-9101.2011.02282.x; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mazuc J, 2003, ECOL LETT, V6, P1084, DOI 10.1046/j.1461-0248.2003.00535.x; Mills A. D., 1994, COMPORTEMENT BIEN ET, P127; MILLS AD, 1986, BIOL BEHAV, V11, P235; MILLS AD, 1987, BRIT POULTRY SCI, V28, P177, DOI 10.1080/00071668708416950; MILLS AD, 1993, PHYSIOL BEHAV, V53, P183, DOI 10.1016/0031-9384(93)90029-F; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Muller W, 2002, P ROY SOC B-BIOL SCI, V269, P2249, DOI 10.1098/rspb.2002.2159; Natt D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006405; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; North M.O., 1984, COMMERCIAL CHICKEN P; Odabasi AZ, 2007, POULTRY SCI, V86, P356, DOI 10.1093/ps/86.2.356; Okuliarova M, 2007, ACTA VET BRNO, V76, P325, DOI 10.2754/avb200776030325; Okuliarova M., 2006, NEW INSIGHTS FUNDAME, P173; Okuliarova M, 2010, GEN COMP ENDOCR, V165, P91, DOI 10.1016/j.ygcen.2009.06.007; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Pilz KM, 2004, FUNCT ECOL, V18, P58, DOI 10.1111/j.1365-2435.2004.00811.x; Puppe B, 2007, APPL ANIM BEHAV SCI, V105, P75, DOI 10.1016/j.applanim.2006.05.016; Rettenbacher S, 2005, ANN NY ACAD SCI, V1046, P193, DOI 10.1196/annals.1343.016; Rettenbacher S, 2009, GEN COMP ENDOCR, V164, P125, DOI 10.1016/j.ygcen.2009.05.019; Rubolini D, 2005, HORM BEHAV, V47, P592, DOI 10.1016/j.yhbeh.2005.01.006; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Saint-Dizier H, 2008, APPL ANIM BEHAV SCI, V112, P297, DOI 10.1016/j.applanim.2007.09.005; Scherer K.R., 1999, HDB COGNITION EMOTIO, P637, DOI [10.1002/0470013494.ch30, DOI 10.1002/0470013494.CH30]; Schwabl H, 1996, J EXP ZOOL, V276, P157, DOI 10.1002/(SICI)1097-010X(19961001)276:2<157::AID-JEZ9>3.3.CO;2-Y; Schwabl H, 1997, NATURWISSENSCHAFTEN, V84, P406, DOI 10.1007/s001140050418; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Smiseth PT, 2011, ANIM BEHAV, V81, P507, DOI 10.1016/j.anbehav.2010.11.029; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Tobler M, 2007, HORM BEHAV, V52, P640, DOI 10.1016/j.yhbeh.2007.07.016; Verboven N, 2003, P ROY SOC B-BIOL SCI, V270, P2223, DOI 10.1098/rspb.2003.2496; von Engelhardt N, 2009, GEN COMP ENDOCR, V163, P175, DOI 10.1016/j.ygcen.2009.04.004; Weinberg J, 1980, COPING HLTH, P39; WEISS JM, 1972, SCI AM, V226, P104, DOI 10.1038/scientificamerican0672-104; Wells DL, 2009, APPL ANIM BEHAV SCI, V118, P1, DOI 10.1016/j.applanim.2009.01.002; Young RJ, 2003, ENV ENRICHMENT CAPTI, DOI DOI 10.1002/9780470751046	77	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e23941	10.1371/journal.pone.0023941	http://dx.doi.org/10.1371/journal.pone.0023941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980338	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600002
J	Denapaite, D; Hakenbeck, R				Denapaite, Dalia; Hakenbeck, Regine			A New Variant of the Capsule 3 Cluster Occurs in Streptococcus pneumoniae from Deceased Wild Chimpanzees	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; INVASIVE-DISEASE; SEQUENCE TYPES; TYPE-3; GENES; SEROTYPES; MENINGOENCEPHALITIS; PNEUMOCOCCUS; PHOSPHOGLUCOMUTASE; TRANSFORMATION	The presence of new Streptococcus pneumoniae clones in dead wild chimpanzees from the Tai National Park, Cote d'Ivoire, with previous respiratory problems has been demonstrated recently by DNA sequence analysis from samples obtained from the deceased apes. In order to broadenour understanding on the relatedness of these pneumococcal clones to those from humans, the gene locus responsible for biosynthesis of the capsule polysaccharide (CPS) has now been characterized. DNA sequence analysis of PCR fragments identified a cluster named cps3(Tai) containing the four genes typical for serotype 3 CPS, but lacking a 5'-region of >= 2 kb which is degenerated in other cps3 loci and not required for type 3 biosynthesis. CPS3 is composed of a simple disaccharide repeat unit comprising glucose and glucuronic acid (GlcUA). The two genes ugd responsible for GlcUA synthesis and wchE encoding the type 3 synthase are essential for CPS3 biosynthesis, whereas both, galU and the 3'-truncated gene pgm are not required due to the presence of homologues elsewhere in the genome. The DNA sequence of cps3Tai " diverged considerably from those of other cps3 loci. Also, the gene pgm(Tai) " represents a full length version with a nonsense mutation at codon 179. The two genes ugd(Tai) " and wchE(Tai) " including the promoter region were transformed into a nonencapsulated laboratory strain S. pneumoniae R6. Transformants which expressed type 3 capsule polysaccharide were readily obtained, documenting that the gene products are functional. In summary, the data indicate that cps3(Tai) evolved independent from other cps3 loci, suggesting the presence of specialized serotype 3 S. pneumoniae clones endemic to the Tai National Park area.	[Denapaite, Dalia; Hakenbeck, Regine] Univ Kaiserslautern, Dept Microbiol, Kaiserslautern, Germany	University of Kaiserslautern	Denapaite, D (corresponding author), Univ Kaiserslautern, Dept Microbiol, Kaiserslautern, Germany.	hakenb@rhrk.uni-kl.de	Denapaite, Dalia/E-2657-2018	Denapaite, Dalia/0000-0002-0700-3437	Stiftung Rheinland Pfalz fur Innovation [838]; Network of Excellence EuroPathoGenomics [LSHB-CT-2005-512061]	Stiftung Rheinland Pfalz fur Innovation; Network of Excellence EuroPathoGenomics	This work was supported by the Stiftung Rheinland Pfalz fur Innovation (Project 838) and the Network of Excellence EuroPathoGenomics, LSHB-CT-2005-512061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Alloing G, 1996, MOL MICROBIOL, V21, P471; ARRECUBIETA C, 1994, J BACTERIOL, V176, P6375, DOI 10.1128/jb.176.20.6375-6383.1994; AUSTRIAN R, 1981, REV INFECT DIS, V3, pS1; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; BENSON CE, 1984, J CLIN MICROBIOL, V20, P1028, DOI 10.1128/JCM.20.6.1028-1030.1984; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bratcher PE, 2009, MICROBIOL-SGM, V155, P576, DOI 10.1099/mic.0.024521-0; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; BRUYN GAW, 1992, CLIN INFECT DIS, V14, P251, DOI 10.1093/clinids/14.1.251; BURCHALL JJ, 1965, MOL PHARMACOL, V1, P126; Caimano MJ, 1998, MICROB DRUG RESIST, V4, P11, DOI 10.1089/mdr.1998.4.11; Chi F, 2007, J BACTERIOL, V189, P6085, DOI 10.1128/JB.00468-07; Clarke SC, 2004, J CLIN MICROBIOL, V42, P4449, DOI 10.1128/JCM.42.10.4449-4452.2004; COFFEY TJ, 1991, MOL MICROBIOL, V5, P2255, DOI 10.1111/j.1365-2958.1991.tb02155.x; Coffey TJ, 1999, MICROBIOL-SGM, V145, P2023, DOI 10.1099/13500872-145-8-2023; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; DAI JB, 1992, J BIOL CHEM, V267, P6322; Denapaite D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009426; DILLARD JP, 1995, J EXP MED, V181, P973, DOI 10.1084/jem.181.3.973; Domenech M, 2009, ENVIRON MICROBIOL, V11, P2542, DOI 10.1111/j.1462-2920.2009.01979.x; FOX JG, 1971, LAB ANIM SCI, V21, P558; FOX JG, 1971, J AM VET MED ASSOC, V159, P1595; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Hardy GG, 2001, INFECT IMMUN, V69, P2309, DOI 10.1128/IAI.69.4.2309-2317.2001; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; HUBER L, 1988, CAN VET J, V29, P665; Iannelli F, 1999, J BACTERIOL, V181, P2652, DOI 10.1128/JB.181.8.2652-2654.1999; Kerr AR, 2004, INFECT IMMUN, V72, P3902, DOI 10.1128/IAI.72.7.3902-3906.2004; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; LAIBLE G, 1989, MOL MICROBIOL, V3, P1337, DOI 10.1111/j.1365-2958.1989.tb00115.x; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mascher T, 2003, J BACTERIOL, V185, P60, DOI 10.1128/JB.185.1.60-70.2003; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Mollerach M, 1998, J EXP MED, V188, P2047, DOI 10.1084/jem.188.11.2047; Mothibeli KM, 2010, J CLIN MICROBIOL, V48, P184, DOI 10.1128/JCM.01011-09; Nesin M, 1998, J INFECT DIS, V177, P707, DOI 10.1086/514242; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Reeves RE, 1941, J BIOL CHEM, V139, P511; Sadowy E, 2006, CLIN VACCINE IMMUNOL, V13, P139, DOI 10.1128/CVI.13.1.139-144.2006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 1989, MOL CLONING LAB MANU; SOLLEVELD HA, 1984, LAB ANIM SCI, V34, P86; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van der Linden M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008286; Watson D A, 1999, Semin Respir Infect, V14, P198; Whatmore AM, 1999, INFECT IMMUN, V67, P2776, DOI 10.1128/IAI.67.6.2776-2782.1999; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25119	10.1371/journal.pone.0025119	http://dx.doi.org/10.1371/journal.pone.0025119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969869	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900024
J	Weisberg, E; Ray, A; Nelson, E; Adamia, S; Barrett, R; Sattler, M; Zhang, CS; Daley, JF; Frank, D; Fox, E; Griffin, JD				Weisberg, Ellen; Ray, Arghya; Nelson, Erik; Adamia, Sophia; Barrett, Rosemary; Sattler, Martin; Zhang, Chengsheng; Daley, John F.; Frank, David; Fox, Edward; Griffin, James D.			Reversible Resistance Induced by FLT3 Inhibition: A Novel Resistance Mechanism in Mutant FLT3-Expressing Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITOR; INTERNAL TANDEM DUPLICATION; ACTIVATING MUTATION; POINT MUTATIONS; CONSTITUTIVE ACTIVATION; CLINICAL RESISTANCE; THERAPEUTIC TARGET; IN-VITRO; GENE	Objectives: Clinical responses achieved with FLT3 kinase inhibitors in acute myeloid leukemia (AML) are typically transient and partial. Thus, there is a need for identification of molecular mechanisms of clinical resistance to these drugs. In response, we characterized MOLM13 AML cell lines made resistant to two structurally-independent FLT3 inhibitors. Methods: MOLM13 cells were made drug resistant via prolonged exposure to midostaurin and HG-7-85-01, respectively. Cell proliferation was determined by Trypan blue exclusion. Protein expression was assessed by immunoblotting, immunoprecipitation, and flow cytometry. Cycloheximide was used to determine protein half-life. RT-PCR was performed to determine FLT3 mRNA levels, and FISH analysis was performed to determine FLT3 gene expression. Results and Conclusions: We found that MOLM13 cells readily developed cross-resistance when exposed to either midostaurin or HG-7-85-01. Resistance in both lines was associated with dramatically elevated levels of cell surface FLT3 and elevated levels of phosphor-MAPK, but not phospho-STAT5. The increase in FLT3-ITD expression was at least in part due to reduced turnover of the receptor, with prolonged half-life. Importantly, the drug-resistant phenotype could be rapidly reversed upon withdrawal of either inhibitor. Consistent with this phenotype, no significant evidence of FLT3 gene amplification, kinase domain mutations, or elevated levels of mRNA was observed, suggesting that protein turnover may be part of an auto-regulatory pathway initiated by FLT3 kinase activity. Interestingly, FLT3 inhibitor resistance also correlated with resistance to cytosine arabinoside. Over-expression of FLT3 protein in response to kinase inhibitors may be part of a novel mechanism that could contribute to clinical resistance.	[Weisberg, Ellen; Ray, Arghya; Nelson, Erik; Adamia, Sophia; Barrett, Rosemary; Sattler, Martin; Frank, David; Griffin, James D.] Dana Farber Canc Inst, Dept Med Oncol Hematol Neoplasia, Boston, MA 02115 USA; [Zhang, Chengsheng] Dana Farber Canc Inst, Cytogenet Core Facil, Boston, MA 02115 USA; [Daley, John F.] Dana Farber Canc Inst, Hematol Neoplasia Flow Cytometry Facil, Boston, MA 02115 USA; [Fox, Edward] Dana Farber Canc Inst, Mol Diagnost Lab, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Weisberg, E (corresponding author), Dana Farber Canc Inst, Dept Med Oncol Hematol Neoplasia, Boston, MA 02115 USA.	ellen_weisberg@dfci.harvard.edu	Adamia, Sophia/AAG-7502-2020		National Institutes of Health (NIH) [CA66996, CA134660-03]; NATIONAL CANCER INSTITUTE [R01CA134660, P01CA066996] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JDG is supported by National Institutes of Health (NIH) grant CA66996 and MS is supported by NIH grant CA134660-03. JDG has a financial interest with Novartis Pharma AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DH, 2006, MOL CANCER THER, V5, P995, DOI 10.1158/1535-7163.MCT-05-0410; Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; Chu SH, 2009, DRUG RESIST UPDATE, V12, P8, DOI 10.1016/j.drup.2008.12.001; Cools J, 2004, CANCER RES, V64, P6385, DOI 10.1158/0008-5472.CAN-04-2148; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Horiike S, 1997, LEUKEMIA, V11, P1442, DOI 10.1038/sj.leu.2400770; Jiang JR, 2004, BLOOD, V104, P1855, DOI 10.1182/blood-2004-02-0712; Jin GL, 2009, BIOCHEM BIOPH RES CO, V390, P1001, DOI 10.1016/j.bbrc.2009.10.094; Kang HJ, 2010, J KOREAN MED SCI, V25, P841, DOI 10.3346/jkms.2010.25.6.841; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kindler T, 2005, BLOOD, V105, P335, DOI 10.1182/blood-2004-02-0660; Kiyoi H, 1998, LEUKEMIA, V12, P1333, DOI 10.1038/sj.leu.2401130; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kondo M, 1999, MED PEDIATR ONCOL, V33, P525; Kuchenbauer F, 2005, HAEMATOLOGICA, V90, P1617; Levis M, 2004, BLOOD, V104, P1145, DOI 10.1182/blood-2004-01-0388; Levis M, 2002, BLOOD, V99, P3885, DOI 10.1182/blood.V99.11.3885; Martelli AM, 2010, ONCOTARGET, V1, P89, DOI 10.18632/oncotarget.114; Nakao M, 1996, LEUKEMIA, V10, P1911; Piloto O, 2007, BLOOD, V109, P1643, DOI 10.1182/blood-2006-05-023804; Pratz KW, 2010, BLOOD, V115, P1425, DOI 10.1182/blood-2009-09-242859; Pratz KW, 2009, BLOOD, V113, P3938, DOI 10.1182/blood-2008-09-177030; Ray A, 2007, BLOOD, V109, P5011, DOI 10.1182/blood-2006-01-015347; Reindl C, 2006, BLOOD, V107, P3700, DOI 10.1182/blood-2005-06-2596; Rombouts WJC, 2000, LEUKEMIA, V14, P675, DOI 10.1038/sj.leu.2401731; Ruggeri B, 2003, CANCER RES, V63, P5978; Sato TKS, 2009, BLOOD, V114; Schittenhelm MM, 2009, CELL CYCLE, V8, P2621, DOI 10.4161/cc.8.16.9355; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shankar DB, 2007, BLOOD, V109, P3400, DOI 10.1182/blood-2006-06-029579; Shi L, 2010, ONCOTARGET, V1, P22, DOI 10.18632/oncotarget.105; Siendones E, 2007, HEMATOL ONCOL, V25, P30, DOI 10.1002/hon.805; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Stolzel F, 2010, ANN HEMATOL, V89, P653, DOI 10.1007/s00277-009-0889-1; Stone R. M., 2004, Annals of Hematology, V83, pS89; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; von Bubnoff N, 2006, BLOOD, V108, P1328, DOI 10.1182/blood-2005-12-010132; von Bubnoff N, 2009, CANCER RES, V69, P3032, DOI 10.1158/0008-5472.CAN-08-2923; Vora HH, 2010, ASIA-PAC J CLIN ONCO, V6, P306, DOI 10.1111/j.1743-7563.2010.01322.x; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Weisberg E, 2010, MOL CANCER THER, V9, P2468, DOI 10.1158/1535-7163.MCT-10-0232; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zhou JB, 2009, BLOOD, V113, P4052, DOI 10.1182/blood-2008-05-156422	44	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25351	10.1371/journal.pone.0025351	http://dx.doi.org/10.1371/journal.pone.0025351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980431	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900054
J	Jeisy-Scott, V; Davis, WG; Patel, JR; Bowzard, JB; Shieh, WJ; Zaki, SR; Katz, JM; Sambhara, S				Jeisy-Scott, Victoria; Davis, William G.; Patel, Jenish R.; Bowzard, John Bradford; Shieh, Wun-Ju; Zaki, Sherif R.; Katz, Jacqueline M.; Sambhara, Suryaprakash			Increased MDSC Accumulation and Th2 Biased Response to Influenza A Virus Infection in the Absence of TLR7 in Mice	PLOS ONE			English	Article							INNATE IMMUNE-SYSTEM; SUPPRESSOR-CELLS; ALVEOLAR MACROPHAGES; STRANDED-RNA; RIG-I; DENDRITIC CELLS; AVIAN H5N1; CROSS-TALK; TNF-ALPHA; RECOGNITION	Toll-like receptors (TLRs) play an important role in the induction of innate and adaptive immune response against influenza A virus (IAV) infection; however, the role of Toll-like receptor 7 (TLR7) during the innate immune response to IAV infection and the cell types affected by the absence of TLR7 are not clearly understood. In this study, we show that myeloid derived suppressor cells (MDSC) accumulate in the lungs of TLR7 deficient mice more so than in wild-type C57Bl/6 mice, and display increased cytokine expression. Furthermore, there is an increase in production of Th2 cytokines by TLR7(-/-) compared with wildtype CD4+ T-cells in vivo, leading to a Th2 polarized humoral response. Our findings indicate that TLR7 modulates the accumulation of MDSCs during an IAV infection in mice, and that lack of TLR7 signaling leads to a Th2-biased response.	[Jeisy-Scott, Victoria; Davis, William G.; Patel, Jenish R.; Bowzard, John Bradford; Katz, Jacqueline M.; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp, Atlanta, GA 30333 USA; [Shieh, Wun-Ju; Zaki, Sherif R.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Jeisy-Scott, Victoria] Emory Univ, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University	Jeisy-Scott, V (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp, Atlanta, GA 30333 USA.	ssambhara@cdc.gov	Sambhara, Suryaprakash/AAC-4428-2021	Jeisy-Scott, Victoria/0000-0002-3967-5764; Patel, Jenish/0000-0001-5310-8160; Tripp, Ralph/0000-0002-2924-9956				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ARORA M, 2010, MUCOSAL IMMUNOL; Bessa J, 2009, J IMMUNOL, V183, P3788, DOI 10.4049/jimmunol.0804004; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Crozat K, 2009, IMMUNOL REV, V227, P129, DOI 10.1111/j.1600-065X.2008.00736.x; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Diebold SS, 2006, EUR J IMMUNOL, V36, P3256, DOI 10.1002/eji.200636617; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Haverkamp JM, 2011, EUR J IMMUNOL, V41, P749, DOI 10.1002/eji.201041069; Hayes KS, 2007, PARASITE IMMUNOL, V29, P583, DOI 10.1111/j.1365-3024.2007.00980.x; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; HERNANDEZPANDO R, 1994, IMMUNOLOGY, V82, P591; Ichinohe T, 2008, EXPERT REV VACCINES, V7, P1435, DOI 10.1586/14760584.7.9.1435; Ichinohe T, 2010, EXPERT REV VACCINES, V9, P1315, DOI 10.1586/ERV.10.118; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; KOERNER P, 2010, INFLAMM RES; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Lopez CB, 2004, J IMMUNOL, V173, P6882, DOI 10.4049/jimmunol.173.11.6882; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mueller Uwe, 2008, V15, P21, DOI 10.1159/000135684; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Perrone LA, 2010, J INFECT DIS, V202, P1161, DOI 10.1086/656365; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ranjan P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-102; Ranjan P, 2009, TRENDS MOL MED, V15, P359, DOI 10.1016/j.molmed.2009.06.003; Reed M. J., 1938, AM J HYG, V27, P493; Ribechini E, 2010, MED MICROBIOL IMMUN, V199, P273, DOI 10.1007/s00430-010-0151-4; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Seo SU, 2010, J VIROL, V84, P12713, DOI 10.1128/JVI.01675-10; SEO SU, 2010, J VIROL; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Wang JP, 2007, CELL MICROBIOL, V9, P1641, DOI 10.1111/j.1462-5822.2007.00961.x; WEI CJ, SCI TRANSL MED, V2; Zoglmeier C, 2011, CLIN CANCER RES, V17, P1765, DOI 10.1158/1078-0432.CCR-10-2672	58	52	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25242	10.1371/journal.pone.0025242	http://dx.doi.org/10.1371/journal.pone.0025242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966467	Green Published, gold			2022-12-25	WOS:000295267100033
J	Mahendran, V; Riordan, SM; Grimm, MC; Thi, ATT; Major, J; Kaakoush, NO; Mitchell, H; Zhang, L				Mahendran, Vikneswari; Riordan, Stephen M.; Grimm, Michael C.; Thi Anh Tuyet Tran; Major, Joelene; Kaakoush, Nadeem O.; Mitchell, Hazel; Zhang, Li			Prevalence of Campylobacter Species in Adult Crohn's Disease and the Preferential Colonization Sites of Campylobacter Species in the Human Intestine	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CONCISUS; IDENTIFICATION; DIARRHEA; JEJUNI; HEALTH; PCR	Introduction: Crohn's disease (CD) and ulcerative colitis (UC) are the two major forms of inflammatory bowel disease (IBD). A high prevalence of Campylobacter concisus was previously detected in paediatric CD and adult UC. Currently, the prevalence of C. concisus in adult CD and the preferential colonization sites of Campylobacter species in the human intestine are unknown. In this study, we examined the prevalence of Campylobacter species in biopsies collected from multiple anatomic sites of adult patients with IBD and controls. Methods: Three hundred and one biopsies collected from ileum, caecum, descending colon and rectum of 28 patients IBD (15 CD and 13 UC) and 33 controls were studied. Biopsies were used for DNA extraction and detection of Campylobacter species by PCR-sequencing and Campylobacter cultivation. Results: A significantly higher prevalence of C. concisus in colonic biopsies of patients with CD (53%) was detected as compared with the controls (18%). Campylobacter genus-PCR positivity and C. concisus positivity in patients with UC were 85% and 77% respectively, being significantly higher than that in the controls (48% and 36%). C. concisus was more often detected in descending colonic and rectal biopsies from patients with IBD in comparison to the controls. C. concisus was isolated from patients with IBD. Conclusion: The high intestinal prevalence of C. concisus in patients with IBD, particularly in the proximal large intestine, suggests that future studies are needed to investigate the possible involvement of C. concisus in a subgroup of human IBD. To our knowledge, this is the first report of the association between adult CD and C. concisus as well as the first study of the preferential colonization sites of C. concisus in the human intestine.	[Mahendran, Vikneswari; Thi Anh Tuyet Tran; Major, Joelene; Kaakoush, Nadeem O.; Mitchell, Hazel; Zhang, Li] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Riordan, Stephen M.] Prince Wales Hosp, Gastrointestinal & Liver Unit, Sydney, NSW, Australia; [Riordan, Stephen M.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Grimm, Michael C.] Univ New S Wales, St George Clin Sch, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Mahendran, V (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	L.Zhang@unsw.edu.au	Kaakoush, Nadeem/ABG-9499-2020	Zhang, Li/0000-0001-7506-8278; Kaakoush, Nadeem Omar/0000-0003-4017-1077; Grimm, Michael/0000-0001-9426-3917	Broad Foundation [IBD0273-R]	Broad Foundation	This work was supported by the Broad Medical Research Program of the Broad Foundation (Grant No: IBD0273-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2005, J CLIN MICROBIOL, V43, P5091, DOI 10.1128/JCM.43.10.5091-5096.2005; Aabenhus R, 2002, SCAND J INFECT DIS, V34, P248, DOI 10.1080/00365540110080566; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; BASTYNS K, 1995, MOL CELL PROBE, V9, P247, DOI 10.1016/S0890-8508(95)90114-0; CUMMINGS JH, 1983, LANCET, V1, P1206; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Engberg J, 2005, CLIN MICROBIOL INFEC, V11, P288, DOI 10.1111/j.1469-0691.2005.01111.x; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Guslandi M, 2005, EUR J GASTROEN HEPAT, V17, P145, DOI 10.1097/00042737-200502000-00003; Inglis GD, 2005, APPL ENVIRON MICROB, V71, P5145, DOI 10.1128/AEM.71.9.5145-5153.2005; Istivan TS, 2004, J MED MICROBIOL, V53, P483, DOI 10.1099/jmm.0.45554-0; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Lastovica AJ, 2006, CLIN MICROBIOL NEWSL, V28, P7; LEVITT MD, 1969, NEW ENGL J MED, V281, P122, DOI 10.1056/NEJM196907172810303; Linton D, 1996, RES MICROBIOL, V147, P707, DOI 10.1016/S0923-2508(97)85118-2; Macuch PJ, 2000, J DENT RES, V79, P785, DOI 10.1177/00220345000790021301; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Matsheka MI, 2001, J CLIN MICROBIOL, V39, P3684, DOI 10.1128/JCM.39.10.3684-3689.2001; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021490; Newell DG, 2005, EUR J GASTROEN HEPAT, V17, P1013, DOI 10.1097/00042737-200510000-00001; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Snijders F, 1997, CLIN INFECT DIS, V24, P1107, DOI 10.1086/513643; TANNER ACR, 1981, INT J SYST BACTERIOL, V31, P432, DOI 10.1099/00207713-31-4-432; VANDAMME P, 1989, J CLIN MICROBIOL, V27, P1775, DOI 10.1128/JCM.27.8.1775-1781.1989; Vandamme P, 2005, BERGEYS MANUAL SYSTE, V2, P1147; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	34	87	87	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25417	10.1371/journal.pone.0025417	http://dx.doi.org/10.1371/journal.pone.0025417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966525	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100059
J	Karen, J; Rodriguez, A; Friman, T; Dencker, L; Sundberg, C; Scholz, B				Karen, Jakob; Rodriguez, Alejandro; Friman, Tomas; Dencker, Lennart; Sundberg, Christian; Scholz, Birger			Effects of the Histone Deacetylase Inhibitor Valproic Acid on Human Pericytes In Vitro	PLOS ONE			English	Article							COLLAGEN-PRODUCING CELLS; VEIN ENDOTHELIAL-CELLS; MICROVASCULAR PERICYTES; STEM-CELLS; EXTRACELLULAR-MATRIX; MONOCLONAL-ANTIBODY; VESSEL MATURATION; HEALING WOUNDS; TRICHOSTATIN-A; STELLATE CELLS	Microvascular pericytes are of key importance in neoformation of blood vessels, in stabilization of newly formed vessels as well as maintenance of angiostasis in resting tissues. Furthermore, pericytes are capable of differentiating into pro-fibrotic collagen type I producing fibroblasts. The present study investigates the effects of the histone deacetylase (HDAC) inhibitor valproic acid (VPA) on pericyte proliferation, cell viability, migration and differentiation. The results show that HDAC inhibition through exposure of pericytes to VPA in vitro causes the inhibition of pericyte proliferation and migration with no effect on cell viability. Pericyte exposure to the potent HDAC inhibitor Trichostatin A caused similar effects on pericyte proliferation, migration and cell viability. HDAC inhibition also inhibited pericyte differentiation into collagen type I producing fibroblasts. Given the importance of pericytes in blood vessel biology a qPCR array focusing on the expression of mRNAs coding for proteins that regulate angiogenesis was performed. The results showed that HDAC inhibition promoted transcription of genes involved in vessel stabilization/maturation in human microvascular pericytes. The present in vitro study demonstrates that VPA influences several aspects of microvascular pericyte biology and suggests an alternative mechanism by which HDAC inhibition affects blood vessels. The results raise the possibility that HDAC inhibition inhibits angiogenesis partly through promoting a pericyte phenotype associated with stabilization/maturation of blood vessels.	[Karen, Jakob; Rodriguez, Alejandro; Friman, Tomas; Sundberg, Christian] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Dencker, Lennart; Scholz, Birger] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Sundberg, Christian] Univ Uppsala Hosp, Dept Women & Childrens Hlth, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University Hospital	Karen, J (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	christian.sundberg@imbim.uu.se			Swedish Children's Cancer Foundation; Swedish Cancer Foundation; Swedish Medical Research Council; Lions Cancer Foundation; EU Project ReProTect	Swedish Children's Cancer Foundation; Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Lions Cancer Foundation; EU Project ReProTect	This work was supported by the Swedish Children's Cancer Foundation (CS), the Swedish Cancer Foundation (CS), the Swedish Medical Research Council (CS), The Lions Cancer Foundation (CS), and the EU Project ReProTect (LD). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Airoldi I, 2007, P NATL ACAD SCI USA, V104, P3996, DOI 10.1073/pnas.0609028104; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bulow R, 2007, BIOCHEM PHARMACOL, V74, P1747, DOI 10.1016/j.bcp.2007.08.023; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chung YL, 2004, MOL CANCER THER, V3, P317; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crosby JR, 1999, AM J PATHOL, V154, P1315, DOI 10.1016/S0002-9440(10)65384-9; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; DIAZFLORES L, 1991, ANAT REC, V229, P1, DOI 10.1002/ar.1092290102; Dichter MA, 1996, NEW ENGL J MED, V334, P1583, DOI 10.1056/NEJM199606133342407; Eickholt BJ, 2005, MOL PHARMACOL, V67, P1426, DOI 10.1124/mol.104.009308; Eikel D, 2006, DRUG METAB DISPOS, V34, P612, DOI 10.1124/dmd.105.008078; Eikel D, 2006, CHEM RES TOXICOL, V19, P272, DOI 10.1021/tx0502241; Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FORSBERG K, 1993, P NATL ACAD SCI USA, V90, P393, DOI 10.1073/pnas.90.2.393; Freidkin I, 2010, AM J PHYSIOL-RENAL, V298, pF426, DOI 10.1152/ajprenal.00107.2009; Fuchs D, 2010, INT J CANCER, V126, P2773, DOI 10.1002/ijc.25206; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Gao DX, 2007, INT J UROL, V14, P838, DOI 10.1111/j.1442-2042.2007.01823.x; Garfinkel S, 1996, J CELL BIOL, V134, P783, DOI 10.1083/jcb.134.3.783; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hantash BM, 2008, FRONT BIOSCI-LANDMRK, V13, P51, DOI 10.2741/2559; Isenberg JS, 2007, BRIT J PHARMACOL, V151, P142, DOI 10.1038/sj.bjp.0707198; Ivarsson M, 1996, EXP CELL RES, V229, P336, DOI 10.1006/excr.1996.0379; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jergil M, 2011, TOXICOL SCI, V121, P328, DOI 10.1093/toxsci/kfr070; Karberg S, 2009, CELL, V139, P1029, DOI 10.1016/j.cell.2009.11.038; Keane MP, 1998, P ASSOC AM PHYSICIAN, V110, P288; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Li AH, 2002, MICROVASC RES, V64, P476, DOI 10.1006/mvre.2002.2442; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Lindahl P, 1998, CURR OPIN LIPIDOL, V9, P407, DOI 10.1097/00041433-199810000-00004; Lyons AB, 1999, IMMUNOL CELL BIOL, V77, P509, DOI 10.1046/j.1440-1711.1999.00864.x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; Michaelis M, 2006, CELL DEATH DIFFER, V13, P446, DOI 10.1038/sj.cdd.4401759; Michaelis M, 2004, MOL PHARMACOL, V65, P520, DOI 10.1124/mol.65.3.520; Monnier J, 2010, CANCER LETT, V296, P144, DOI 10.1016/j.canlet.2010.06.011; PIERCE GF, 1991, AM J PATHOL, V138, P629; Plouffe BD, 2009, FASEB J, V23, P3309, DOI 10.1096/fj.09-130260; Rajkumar VS, 1999, ARTHRITIS RHEUM-US, V42, P930, DOI 10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1; RHODIN JAG, 1968, J ULTRA MOL STRUCT R, V25, P452, DOI 10.1016/S0022-5320(68)80098-X; Riebeling C, 2011, TOXICOL SCI, V120, P360, DOI 10.1093/toxsci/kfr001; Rodriguez A, 2009, J CELL MOL MED, V13, P3449, DOI 10.1111/j.1582-4934.2008.00638.x; Rombouts K, 2002, EXP CELL RES, V278, P184, DOI 10.1006/excr.2002.5577; Rombouts K, 2001, ACTA GASTRO-ENT BELG, V64, P239; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; SCHLINGEMANN RO, 1990, AM J PATHOL, V136, P1393; SCHLINGEMANN RO, 1991, AM J PATHOL, V138, P1335; Sevigny J, 2002, BLOOD, V99, P2801, DOI 10.1182/blood.V99.8.2801; Shabbeer S, 2007, PROSTATE, V67, P1099, DOI 10.1002/pros.20587; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; SINGER KH, 1989, J INVEST DERMATOL, V92, P166, DOI 10.1111/1523-1747.ep12276685; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Soderholm J, 2005, CHEM BIOL, V12, P263, DOI 10.1016/j.chembiol.2005.03.001; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Suhardja A, 2003, MICROSC RES TECHNIQ, V60, P70, DOI 10.1002/jemt.10245; SUNDBERG C, 1993, AM J PATHOL, V143, P1377; Sundberg C, 2002, LAB INVEST, V82, P387, DOI 10.1038/labinvest.3780433; Sundberg C, 1996, LAB INVEST, V74, P452; Surani MA, 2008, COLD SH Q B, V73, P9, DOI 10.1101/sqb.2008.73.015; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamagishi S, 2005, INT J TISSUE REACT, V27, P125; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599	77	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24954	10.1371/journal.pone.0024954	http://dx.doi.org/10.1371/journal.pone.0024954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966390	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100034
J	Lang, GI; Botstein, D				Lang, Gregory I.; Botstein, David			A Test of the Coordinated Expression Hypothesis for the Origin and Maintenance of the GAL Cluster in Yeast	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; SACCHAROMYCES-CEREVISIAE; SELFISH OPERONS; EVOLUTION; FUNGI; DIVERSIFICATION; INITIATION; PLANTS	Metabolic gene clusters-functionally related and physically clustered genes-are a common feature of some eukaryotic genomes. Two hypotheses have been advanced to explain the origin and maintenance of metabolic gene clusters: coordinated gene expression and genetic linkage. Here we test the hypothesis that selection for coordinated gene expression underlies the clustering of GAL genes in the yeast genome. We find that, although clustering coordinates the expression of GAL1 and GAL10, disrupting the GAL cluster does not impair fitness, suggesting that other mechanisms, such as genetic linkage, drive the origin and maintenance metabolic gene clusters.	[Lang, Gregory I.] Princeton Univ, Dept Mol & Cell Biol, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University	Lang, GI (corresponding author), Princeton Univ, Dept Mol & Cell Biol, Princeton, NJ 08544 USA.	glang@princeton.edu			National Institute of General Medical Sciences (NIGMS) Centers of Excellence [GM071508]; National Institutes of Health (NIH) [GM046406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046406, R37GM046406, P50GM071508] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) Centers of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (NIGMS) Centers of Excellence grant GM071508 (to DB) and the individual National Institutes of Health (NIH) grant GM046406 (to DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Hall C, 2007, GENETICS, V177, P2293, DOI 10.1534/genetics.107.074963; Hartl :D. L, 2000, PRIMER POPULATION GE; Hittinger CT, 2010, NATURE, V464, P54, DOI 10.1038/nature08791; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Khaldi N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003036; Lang GI, 2009, P NATL ACAD SCI USA, V106, P5755, DOI 10.1073/pnas.0901620106; Lawrence J, 1999, CURR OPIN GENET DEV, V9, P642, DOI 10.1016/S0959-437X(99)00025-8; Lawrence JG, 1996, GENETICS, V143, P1843; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Patron NJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-174; Pedley KF, 2001, P NATL ACAD SCI USA, V98, P14174, DOI 10.1073/pnas.231491298; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; Slot JC, 2011, CURR BIOL, V21, P134, DOI 10.1016/j.cub.2010.12.020; Slot JC, 2010, P NATL ACAD SCI USA, V107, P10136, DOI 10.1073/pnas.0914418107; STAHL FW, 1966, GENETICS, V53, P569; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Walton JD, 2000, FUNGAL GENET BIOL, V30, P167, DOI 10.1006/fgbi.2000.1224; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584	26	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25290	10.1371/journal.pone.0025290	http://dx.doi.org/10.1371/journal.pone.0025290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966486	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100083
J	Lin, BV; Huntley, D; AbuAli, G; Langley, SR; Sindelar, G; Petretto, E; Butcher, S; Grimm, S				Lin, Bevan; Huntley, Derek; AbuAli, Ghada; Langley, Sarah R.; Sindelar, George; Petretto, Enrico; Butcher, Sarah; Grimm, Stefan			Determining Signalling Nodes for Apoptosis by a Genetic High-Throughput Screen	PLOS ONE			English	Article							PERMEABILITY TRANSITION-PORE; CELL-DEATH; REGULATES APOPTOSIS; BH3-ONLY PROTEIN; PLASMID DNA; CANCER; IDENTIFICATION; INDUCTION; COMPONENT; BIOLOGY	Background: With the ever-increasing information emerging from the various sequencing and gene annotation projects, there is an urgent need to elucidate the cellular functions of the newly discovered genes. The genetically regulated cell suicide of apoptosis is especially suitable for such endeavours as it is governed by a vast number of factors. Methodology/Principal Findings: We have set up a high-throughput screen in 96-well microtiter plates for genes that induce apoptosis upon their individual transfection into human cells. Upon screening approximately 100,000 cDNA clones we determined 74 genes that initiate this cellular suicide programme. A thorough bioinformatics analysis of these genes revealed that 91% are novel apoptosis regulators. Careful sequence analysis and functional annotation showed that the apoptosis factors exhibit a distinct functional distribution that distinguishes the cell death process from other signalling pathways. While only a minority of classic signal transducers were determined, a substantial number of the genes fall into the transporter- and enzyme-category. The apoptosis factors are distributed throughout all cellular organelles and many signalling circuits, but one distinct signalling pathway connects at least some of the isolated genes. Comparisons with microarray data suggest that several genes are dysregulated in specific types of cancers and degenerative diseases. Conclusions/Significance: Many unknown genes for cell death were revealed through our screen, supporting the enormous complexity of cell death regulation. Our results will serve as a repository for other researchers working with genomics data related to apoptosis or for those seeking to reveal novel signalling pathways for cell suicide.	[Lin, Bevan; AbuAli, Ghada; Sindelar, George; Grimm, Stefan] Univ London Imperial Coll Sci Technol & Med, Div Expt Med, London, England; [Huntley, Derek; Butcher, Sarah] Univ London Imperial Coll Sci Technol & Med, Bioinformat Support Serv, London, England; [Langley, Sarah R.; Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London, England; [Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Lin, BV (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Expt Med, London, England.	s.grimm@imperial.ac.uk	Langley, Sarah R/E-4481-2019		Medical Research Council (MRC); Department of Health, UK; Wellcome Trust [P14515]; Medical Research Council, UK; MRC [MC_U120097112] Funding Source: UKRI; Medical Research Council [MC_U120097112] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health, UK; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	B.L. was supported by a grant from the Medical Research Council (MRC) and G. S. by a grant from the Department of Health, UK. E. P. acknowledges funding from the Medical Research Council, UK. E. P. is a Research Councils UK fellow; S. R. L. acknowledges funding from the Wellcome Trust (P14515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albayrak T, 2003, MOL BIOL CELL, V14, P3082, DOI 10.1091/mbc.e02-10-0631; Albayrak T, 2003, BIOCHEM BIOPH RES CO, V304, P772, DOI 10.1016/S0006-291X(03)00653-3; Alcala S, 2008, ONCOGENE, V27, P44, DOI 10.1038/sj.onc.1210600; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brachat A, 2000, ONCOGENE, V19, P5073, DOI 10.1038/sj.onc.1203882; Brachat A, 2002, ONCOGENE, V21, P8361, DOI 10.1038/sj.onc.1206016; Bratton SB, 2001, TRENDS PHARMACOL SCI, V22, P306, DOI 10.1016/S0165-6147(00)01718-1; Brecht K, 2005, APOPTOSIS, V10, P1043, DOI 10.1007/s10495-005-0617-9; Bredesen DE, 2000, J NEUROTRAUM, V17, P801, DOI 10.1089/neu.2000.17.801; Calore F, 2010, CELL DEATH DIFFER, V17, P1707, DOI 10.1038/cdd.2010.42; Cowin PA, 2010, ANNU REV GENOM HUM G, V11, P133, DOI 10.1146/annurev-genom-082509-141536; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fleischer A, 2004, FEBS LETT, V557, P283, DOI 10.1016/S0014-5793(03)01519-9; Fleischer A, 2002, EUR J IMMUNOL, V32, P3498, DOI 10.1002/1521-4141(200212)32:12<3498::AID-IMMU3498>3.0.CO;2-C; Fu YX, 2001, J BIOL CHEM, V276, P43004, DOI 10.1074/jbc.M106946200; Garrido C, 2004, CURR OPIN CELL BIOL, V16, P639, DOI 10.1016/j.ceb.2004.09.008; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gewies A, 2003, BRIT J CANCER, V89, P1574, DOI 10.1038/sj.bjc.6601297; Greenbaum D, 2001, GENOME RES, V11, P1463, DOI 10.1101/gr.207401; Grimm S, 1997, J EXP MED, V185, P1137, DOI 10.1084/jem.185.6.1137; Grimm S, 2004, NAT REV GENET, V5, P179, DOI 10.1038/nrg1291; Grimm S, 2002, BIOTECHNIQUES, V32, P670, DOI 10.2144/02323dd04; Grimm S, 2009, FRONT BIOSCI-LANDMRK, V14, P1471, DOI 10.2741/3318; Henry-Mowatt J, 2004, ONCOGENE, V23, P2850, DOI 10.1038/sj.onc.1207534; Hicks SW, 2005, BBA-MOL CELL RES, V1744, P406, DOI 10.1016/j.bbamcr.2005.03.002; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Irshad S, 2009, CELL DEATH DIFFER, V16, P890, DOI 10.1038/cdd.2009.21; IWASAWA R, GRIMM S FISL BAP31 B; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Kachel V, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-9; KAN Z, DIVERSE SOMATIC MUTA; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Koenig-Hoffmann K, 2005, INT J CANCER, V113, P434, DOI 10.1002/ijc.20601; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEMARIE A, 2010, CELL DEATH DIFFER; Lv BF, 2006, APOPTOSIS, V11, P1489, DOI 10.1007/s10495-006-8882-9; Mi H, NUCL ACIDS RES, V38, pD204; Mund T, 2003, FASEB J, V17, P696, DOI 10.1096/fj.02-0657fje; Neudecker F, 2000, BIOTECHNIQUES, V28, P107; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Park KM, 2007, MOL CELLS, V23, P170; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Schoenfeld N, 2004, FASEB J, V18, P158, DOI 10.1096/fj.03-0420fje; Schubert A, 2004, CANCER RES, V64, P85, DOI 10.1158/0008-5472.CAN-03-0476; SCHULZEOSTHOFF K, 1994, J CELL BIOL, V127, P15, DOI 10.1083/jcb.127.1.15; Schwender H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-144; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Stenzinger A, 2009, INT REV CEL MOL BIO, V275, P183, DOI 10.1016/S1937-6448(09)75006-3; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vaux DL, 2002, TOXICOLOGY, V181, P3, DOI 10.1016/S0300-483X(02)00248-2; Vidal R, 1999, NATURE, V399, P776; Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001; Xu XM, 2002, J BIOL CHEM, V277, P48913, DOI 10.1074/jbc.M209613200; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang L, 2010, TECHNOL CANCER RES T, V9, P107, DOI 10.1177/153303461000900201; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200	67	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25023	10.1371/journal.pone.0025023	http://dx.doi.org/10.1371/journal.pone.0025023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966401	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100041
J	Berardi, S; Caivano, A; Ria, R; Nico, B; Savino, R; Terracciano, R; De Tullio, G; Ferrucci, A; De Luisi, A; Moschetta, M; Mangialardi, G; Catacchio, I; Basile, A; Guarini, A; Zito, A; Ditonno, P; Musto, P; Dammacco, F; Ribatti, D; Vacca, A				Berardi, S.; Caivano, A.; Ria, R.; Nico, B.; Savino, R.; Terracciano, R.; De Tullio, G.; Ferrucci, A.; De Luisi, A.; Moschetta, M.; Mangialardi, G.; Catacchio, I.; Basile, A.; Guarini, A.; Zito, A.; Ditonno, P.; Musto, P.; Dammacco, F.; Ribatti, D.; Vacca, A.			Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets	ONCOGENE			English	Article						angiogenesis; antiangiogenesis; endothelial cells; multiple myeloma; proteomic analysis	ALPHA-B-CRYSTALLIN; BONE-MARROW; LUNG-CANCER; VIMENTIN; ADHESION; FILAMIN; ANGIOGENESIS; NUCLEAR; MICROENVIRONMENT; LOCALIZATION	Bone marrow (BM) angiogenesis has an important role in the initiation and progression of multiple myeloma (MM). We looked at novel mechanisms of vessel formation in patients with MM through a comparative proteomic analysis between BM endothelial cells (ECs) of patients with active MM (MMECs) and ECs of patients with monoclonal gammopathy of undetermined significance (MGECs) and of subjects with benign anemia (normal ECs). Four proteins were found overexpressed in MMECs: filamin A, vimentin, alpha-crystallin B and 14-3-3 zeta/delta protein, not yet linked to overangiogenic phenotype. These proteins gave a typical distribution in the BM of MM patients and in MMECs versus MGECs, plausibly according to a different functional state. Their expression was enhanced by vascular endothelial growth factor, fibroblast growth factor 2, hepatocyte growth factor and MM plasma cell conditioned medium in step with enhancement of MMEC angiogenesis. Their silencing RNA knockdown affected critical MMEC angiogenesis-related functions, such as spreading, migration and tubular morphogenesis. A gradual stabilization of 14-33 zeta/delta protein was observed, with transition from normal ECs to MGECs and MMECs that may be a critical step for the angiogenic switch in MMECs and maintenance of the cell overangiogenic phenotype. These proteins were substantially impacted by anti-MM drugs, such as bortezomib, lenalidomide and panobinostat. Results suggest that these four proteins could be new targets for the antiangiogenic management of MM patients. Oncogene (2012) 31, 2258-2269; doi:10.1038/onc.2011.412; published online 3 October 2011	[Berardi, S.; Ria, R.; De Tullio, G.; Ferrucci, A.; De Luisi, A.; Moschetta, M.; Catacchio, I.; Basile, A.; Dammacco, F.; Vacca, A.] Univ Bari, Dept Biomed Sci & Human Oncol, Sch Med, I-70124 Bari, Italy; [Caivano, A.] IRCCS Referral Basilicata Canc Ctr, Dept Oncohematol, Mol Oncol Unit, Potenza, Italy; [Nico, B.; Ribatti, D.] Univ Bari, Dept Human Anat Histol & Embryol, Sch Med, I-70124 Bari, Italy; [Savino, R.; Terracciano, R.] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Mangialardi, G.] Univ Bristol, Bristol Heart Inst, Dept Expt Cardiovasc Med, Bristol, Avon, England; [Guarini, A.] Natl Canc Inst Giovanni Paolo II, Hematol Unit, Bari, Italy; [Zito, A.] Di Venere Hosp, Pathol Unit, Bari, Italy; [Ditonno, P.] De Venere Hosp, Hematol Unit, Bari, Italy; [Musto, P.] IRCCS Referral Basilicata Canc Ctr, Unit Hematol & Stem Cell Transplantat, Potenza, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Magna Graecia University of Catanzaro; University of Bristol; IRCCS Istituto Tumori Bari Giovanni Paolo II	Vacca, A (corresponding author), Univ Bari, Dept Internal Med & Clin Oncol, Sch Med, Piazza Giulio Cesare 11, I-70124 Bari, Italy.	a.vacca@dimo.uniba.it	Terracciano, Rosa/AAO-8649-2020; Vacca, Angelo/AAC-9558-2022; Zito, Francesco/AAQ-8972-2020; CAIVANO, ANTONELLA/J-8120-2018; DITONNO, PAOLO/AAG-5684-2020; Dammacco, Franco/ABG-5728-2020; Guarini, Attilio/AAK-3156-2020; Ria, Roberto/I-4263-2015	Vacca, Angelo/0000-0002-4567-8216; Zito, Francesco/0000-0003-4140-4020; Dammacco, Franco/0000-0003-2149-5471; Guarini, Attilio/0000-0002-9304-6651; Musto, Pellegrino/0000-0003-3277-6594; Savino, Rocco/0000-0002-4046-1472; Ria, Roberto/0000-0002-1515-0090; CAIVANO, ANTONELLA/0000-0003-2502-4060; Terracciano, Rosa/0000-0002-5175-1758	Associazione Italiana per la Ricerca sul Cancro; Investigator Grant and Special Program Molecular Clinical Oncology 5 per mille, Milan [9965]; Ministry of Health, Progetto Oncologia, Humanitas Mirasole S.p.A., Rome, Italy	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Investigator Grant and Special Program Molecular Clinical Oncology 5 per mille, Milan; Ministry of Health, Progetto Oncologia, Humanitas Mirasole S.p.A., Rome, Italy	This work was supported by Associazione Italiana per la Ricerca sul Cancro, Investigator Grant and Special Program Molecular Clinical Oncology 5 per mille n. 9965, Milan, and the Ministry of Health, Progetto Oncologia 2006, Humanitas Mirasole S.p.A., Rome, Italy. The sponsors of this study are public or non-profit organizations that support science in general. They had no role in gathering, analyzing or interpreting the data. The authors are fully responsible for the content and editorial decisions for this manuscript. We thank Dr Maurilio Ponzoni, San Raffaele Institute, Milan, Italy, for collaboration on the mouse model.	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Bedolla RG, 2009, CLIN CANCER RES, V15, P788, DOI 10.1158/1078-0432.CCR-08-1402; Chan W, 2002, EUR J CELL BIOL, V81, P692, DOI 10.1078/0171-9335-00281; Coluccia AML, 2008, BLOOD, V112, P1346, DOI 10.1182/blood-2007-10-116590; De Luisi A, 2011, CLIN CANCER RES, V17, P1935, DOI 10.1158/1078-0432.CCR-10-2381; Dimberg A, 2008, BLOOD, V111, P2015, DOI 10.1182/blood-2007-04-087841; Dutsch-Wicherek M, 2010, AM J REPROD IMMUNOL, V63, P181, DOI 10.1111/j.1600-0897.2009.00803.x; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Fan T, 2007, CANCER RES, V67, P7901, DOI 10.1158/0008-5472.CAN-07-0090; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Ge F, 2009, J PROTEOME RES, V8, P3006, DOI 10.1021/pr9001004; Gilles C, 1999, J CELL SCI, V112, P4615; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; Gruvberger Saal SK, 2006, J CLIN INVEST, V116, P30; Head MW, 2000, NEUROREPORT, V11, P361, DOI 10.1097/00001756-200002070-00028; Hellebrekers DMEI, 2006, CANCER RES, V66, P10770, DOI 10.1158/0008-5472.CAN-06-1609; Hishiya A, 2008, ONCOGENE, V27, P6489, DOI 10.1038/onc.2008.314; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kase S, 2010, BLOOD, V115, P3398, DOI 10.1182/blood-2009-01-197095; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Lee JW, 2008, EUR J CELL BIOL, V87, P377, DOI 10.1016/j.ejcb.2008.03.006; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CH, 2010, J PROTEOM BIOINFORM, V3, P5; Maiso P, 2006, CANCER RES, V66, P5781, DOI 10.1158/0008-5472.CAN-05-4186; Matrone MA, 2010, CANCER RES, V70, P7737, DOI 10.1158/0008-5472.CAN-10-1569; Meriane M, 2000, J BIOL CHEM, V275, P33046, DOI 10.1074/jbc.M001566200; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; Obermeyer N, 2003, ENDOTHELIUM-J ENDOTH, V10, P167, DOI 10.1080/713715224; Podar K, 2001, BLOOD, V98, P428, DOI 10.1182/blood.V98.2.428; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Ria R, 2009, CLIN CANCER RES, V15, P5369, DOI 10.1158/1078-0432.CCR-09-0040; Ribatti D, 2006, ONCOGENE, V25, P4257, DOI 10.1038/sj.onc.1209456; Roccaro AM, 2006, CANCER RES, V66, P184, DOI 10.1158/0008-5472.CAN-05-1195; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sluchanko NN, 2008, ARCH BIOCHEM BIOPHYS, V477, P305, DOI 10.1016/j.abb.2008.05.020; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Vacca A, 2003, BLOOD, V102, P3340, DOI 10.1182/blood-2003-04-1338; VACCA A, 1994, BRIT J HAEMATOL, V87, P503, DOI 10.1111/j.1365-2141.1994.tb08304.x; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; van den IJssel P, 2003, EXP CELL RES, V287, P249, DOI 10.1016/S0014-4827(03)00092-2; van Rijk AF, 2003, EUR J CELL BIOL, V82, P361, DOI 10.1078/0171-9335-00321; Wang ZH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-308; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	49	22	22	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	18					2258	2269		10.1038/onc.2011.412	http://dx.doi.org/10.1038/onc.2011.412			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	936SR	21963844				2022-12-25	WOS:000303610800002
J	Lay, CS; Ludlow, LE; Stapleton, D; Bellamy-McIntyre, AK; Ramsland, PA; Drummer, HE; Poumbourios, P				Lay, Chan-Sien; Ludlow, Louise E.; Stapleton, David; Bellamy-McIntyre, Anna K.; Ramsland, Paul A.; Drummer, Heidi E.; Poumbourios, Pantelis			Role for the Terminal Clasp of HIV-1 gp41 Glycoprotein in the Initiation of Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; ALPHA-HELIX PROPENSITY; ENVELOPE GLYCOPROTEIN; ENTRY INHIBITORS; MONOCLONAL-ANTIBODIES; ATOMIC-STRUCTURE; MEDIATED FUSION; 6-HELIX BUNDLE; GP120	The binding by HIV-1 gp120 to CD4 and a chemokine receptor activates the membrane fusion glycoprotein, gp41. The fusion function of gp41 involves the refolding of its core into a 6-helix bundle, which apposes the lipophilic termini (the fusion peptide and transmembrane domain) and the associated cell and viral membranes, leading to their fusion. In this study, we examined the functional role of the polar segment and membrane proximal external region (MPER), which link the fusion peptide and transmembrane domain, respectively, to the core domain and interact to form a terminal clasp adjacent to the core. Limited proteolysis indicated that the terminal clasp is destabilized by simultaneous I535A/V539G; mutations within the polar segment and mutations within the MPER. The destabilizing effects of I535A/V539G correlated with defective cell-cell fusion, viral entry, and viral replication. By using lipophilic and cytoplasmic fluorescent dye transfer assays, we found that terminal clasp destabilization is linked to a block in the lipid mixing/hemifusion phase of the membrane fusion cascade. Because the biosynthesis of the prefusion gp120-gp41 complex did not appear to be affected by I535A/V539G, we infer that the hemifusion block is due to a specific effect on the trimer of hairpins conformation of gp41. By contrast, the decreased fusion function of the MPER mutants correlated with a decrease in the interfacial hydropathy of the MPER sequence, suggesting that the prefusion Ens' complex had been adversely affected in these cases. These findings reveal a novel conserved functional target for the discovery of fusion inhibitors.	[Lay, Chan-Sien; Bellamy-McIntyre, Anna K.; Ramsland, Paul A.; Drummer, Heidi E.; Poumbourios, Pantelis] Burnet Inst, Virus Fus Lab, Melbourne, Vic 3004, Australia; [Stapleton, David] Univ Melbourne, Dept Physiol, Melbourne, Vic 3010, Australia; [Ludlow, Louise E.; Drummer, Heidi E.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Bellamy-McIntyre, Anna K.; Drummer, Heidi E.; Poumbourios, Pantelis] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Ramsland, Paul A.] Univ Melbourne, Dept Surg Austin Hlth, Heidelberg, Vic 3084, Australia	Burnet Institute; University of Melbourne; University of Melbourne; Monash University; Monash University; Austin Research Institute; University of Melbourne	Poumbourios, P (corresponding author), GPO Box 2284, Melbourne, Vic 3001, Australia.	apoumbourios@burnet.edu.au		Ramsland, Paul/0000-0002-2107-2738; Drummer, Heidi/0000-0002-0042-6277	National Health and Medical Research Council [543125, 433929]; Australian Centre for HIV and Hepatitis Virology Research	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Virology Research	This work was supported by National Health and Medical Research Council Grants 543125 and 433929 and the Australian Centre for HIV and Hepatitis Virology Research.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Bellamy-Mclntyre AK, 2007, J BIOL CHEM, V282, P23104, DOI 10.1074/jbc.M703485200; Bjorndal A, 1997, J VIROL, V71, P7478; BLABER M, 1994, J MOL BIOL, V235, P600, DOI 10.1006/jmbi.1994.1016; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Center RJ, 2002, J VIROL, V76, P7863, DOI 10.1128/JVI.76.15.7863-7867.2002; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Ghaffari G, 2005, J VIROL, V79, P13250, DOI 10.1128/JVI.79.21.13250-13261.2005; HATCH WC, 1992, J IMMUNOL, V148, P3055; Hill MK, 2003, J VIROL, V77, P8329, DOI 10.1128/JVI.77.15.8329-8335.2003; Huang W, 2008, J VIROL, V82, P5584, DOI 10.1128/JVI.02676-07; Ji H, 1999, J VIROL, V73, P8578, DOI 10.1128/JVI.73.10.8578-8586.1999; Kilgore NR, 2003, J VIROL, V77, P7669, DOI 10.1128/JVI.77.13.7669-7672.2003; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lay CS, 2004, FEBS LETT, V567, P183, DOI 10.1016/j.febslet.2004.04.054; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Musich T, 2011, J VIROL, V85, P2397, DOI 10.1128/JVI.02187-10; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; PAGE KA, 1992, J VIROL, V66, P524, DOI 10.1128/JVI.66.1.524-533.1992; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Reeves JD, 2005, DRUGS, V65, P1747, DOI 10.2165/00003495-200565130-00002; Root MJ, 2004, CURR PHARM DESIGN, V10, P1805, DOI 10.2174/1381612043384448; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Sackett K, 2003, J MOL BIOL, V333, P47, DOI 10.1016/j.jmb.2003.07.008; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Saez-Cirion A, 2003, BIOPHYS J, V85, P3769, DOI 10.1016/S0006-3495(03)74792-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; STEIN BS, 1990, J BIOL CHEM, V265, P2640; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Takikawa S, 2000, J VIROL, V74, P5066, DOI 10.1128/JVI.74.11.5066-5074.2000; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005	62	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41331	41343		10.1074/jbc.M111.299826	http://dx.doi.org/10.1074/jbc.M111.299826			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21976663	hybrid, Green Published			2022-12-25	WOS:000298057500020
J	Walter, GM; Smith, MC; Wisen, S; Basrur, V; Elenitoba-Johnson, KSJ; Duennwald, ML; Kumar, A; Gestwicki, JE				Walter, Gladis M.; Smith, Matthew C.; Wisen, Susanne; Basrur, Venkatesha; Elenitoba-Johnson, Kojo S. J.; Duennwald, Martin L.; Kumar, Anuj; Gestwicki, Jason E.			Ordered Assembly of Heat Shock Proteins, Hsp26, Hsp70 Hsp90, and Hsp104, on Expanded Polyglutamine Fragments Revealed by Chemical Probes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP104; HEAT-SHOCK-PROTEIN-70 HSP70; PRION; AGGREGATION; HUNTINGTIN; TOXICITY; ATPASE; SUP35; DISAGGREGATION; ELIMINATION	In Saccharomyces cerevisae, expanded polyglutamine (polyQ) fragments are assembled into discrete cytosolic aggregates in a process regulated by the molecular chaperones Hsp26, Hsp70, Hsp90, and Hsp104. To better understand how the different chaperones might cooperate during polyQ aggregation, we used sequential immunoprecipitations and mass spectrometry to identify proteins associated with either soluble (Q25) or aggregation-prone (Q103) fragments at both early and later times after induction of their expression. We found that Hsp26, Hsp70, Hsp90, and other chaperones interact with Q103, but not Q25, within the first 2 h. Further, Hsp70 and Hsp90 appear to be partially released from Q103 prior to the maturation of the aggregates and before the recruitment of Hsp104. To test the importance of this seemingly ordered process, we used a chemical probe to artificially enhance Hsp70 binding to Q103. This treatment retained both Hsp70 and Hsp90 on the polyQ fragment and, interestingly, limited subsequent exchange for Hsp26 and Hsp104, resulting in incomplete aggregation. Together, these results suggest that partial release of Hsp70 may be an essential step in the continued processing of expanded polyQ fragments in yeast.	[Walter, Gladis M.; Smith, Matthew C.; Wisen, Susanne; Kumar, Anuj; Gestwicki, Jason E.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Walter, Gladis M.; Smith, Matthew C.; Wisen, Susanne; Basrur, Venkatesha; Elenitoba-Johnson, Kojo S. J.; Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Kumar, Anuj] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Duennwald, Martin L.] Boston Biomed Res Inst, Watertown, MA 02472 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Boston Biomedical Research Institute	Gestwicki, JE (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	gestwick@umich.edu	Smith, Matthew/B-6787-2011	Smith, Matthew/0000-0001-8939-0161; Kumar, Anuj/0000-0002-8923-297X; Elenitoba-Johnson, Kojo/0000-0002-1082-1545	NIH [NS059690, AG000114]; AFAR; Wood Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFAR; Wood Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Grant NS059690 (to J. E. G.) and grants from AFAR and the Wood Foundation (to M. L. D.).; Supported by NIH Predoctoral Fellowship AG000114.	Bagriantsev SN, 2008, MOL BIOL CELL, V19, P2433, DOI 10.1091/mbc.E08-01-0078; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BALZI E, 1994, J BIOL CHEM, V269, P2206; Bosl B, 2006, J STRUCT BIOL, V156, P139, DOI 10.1016/j.jsb.2006.02.004; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Grimminger-Marquardt V, 2010, BIOPOLYMERS, V93, P252, DOI 10.1002/bip.21301; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Masison DC, 2009, PRION, V3, P65, DOI 10.4161/pri.3.2.9134; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Moosavi B, 2010, YEAST, V27, P167, DOI 10.1002/yea.1742; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patury S, 2009, CURR TOP MED CHEM, V9, P1337, DOI 10.2174/156802609789895674; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Reidy M, 2010, MOL CELL BIOL, V30, P3542, DOI 10.1128/MCB.01292-09; Rikhvanov EG, 2007, PRION, V1, P217, DOI 10.4161/pri.1.4.5058; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Schirmer EC, 1997, P NATL ACAD SCI USA, V94, P13932, DOI 10.1073/pnas.94.25.13932; Sherman MY, 2003, NEUROMOL MED, V4, P133, DOI 10.1385/NMM:4:1-2:133; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Song YT, 2005, J BIOL CHEM, V280, P34178, DOI 10.1074/jbc.M505420200; Summers DW, 2009, PRION, V3, P59, DOI 10.4161/pri.3.2.9062; Urakov VN, 2010, PRION, V4, P45, DOI 10.4161/pri.4.1.11074; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Wang Y, 2007, PRION, V1, P128, DOI 10.4161/pri.1.2.4440; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Wiederhold E, 2010, MOL CELL PROTEOMICS, V9, P431, DOI 10.1074/mcp.R900002-MCP200; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Wisen S, 2008, BIOORG MED CHEM LETT, V18, P60, DOI 10.1016/j.bmcl.2007.11.027; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Wiwatwattana N, 2007, NUCLEIC ACIDS RES, V35, pD810, DOI 10.1093/nar/gkl1000; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200	54	21	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40486	40493		10.1074/jbc.M111.284448	http://dx.doi.org/10.1074/jbc.M111.284448			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969373	Green Published, hybrid			2022-12-25	WOS:000297315400008
J	Yang, XY; Zhang, XD; Heckmann, BL; Lu, X; Liu, J				Yang, Xingyuan; Zhang, Xiaodong; Heckmann, Bradlee L.; Lu, Xin; Liu, Jun			Relative Contribution of Adipose Triglyceride Lipase and Hormone-sensitive Lipase to Tumor Necrosis Factor-alpha (TNF-alpha)-induced Lipolysis in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RELATED KINASE; TNF-ALPHA; PERILIPIN-A; STIMULATED LIPOLYSIS; MEDIATED LIPOLYSIS; 3T3-L1 ADIPOCYTES; PROTEIN; TISSUE; ACTIVATION; OVEREXPRESSION	TNF-alpha potently stimulates basal lipolysis in adipocytes, which may contribute to hyperlipidemia and peripheral insulin resistance in obesity. Recent studies show that adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) act sequentially in catalyzing the first two steps of adipose lipolysis in response to beta-adrenergic stimulation. Here, we sought to determine their functional roles in TNF-alpha-induced lipolysis. Silencing of ATGL expression in adipocytes almost completely abolished basal and TNF-alpha-induced glycerol release. In comparison, the glycerol release under the same conditions was only partially decreased upon reduction in expression of either HSL or the ATGL coactivator CGI-58. Interestingly, overexpression of ATGL restored the lipolytic rates in cells with silenced HSL or CGI-58, indicating a predominant role for ATGL. While expression of ATGL, HSL and CGI-58 remains mostly unaffected, TNF-alpha treatment caused a rapid abrogation of the ATGL inhibitory protein G0S2. TNF-alpha drastically decreased the level of G0S2 mRNA, and the level of G0S2 protein could be maintained by inhibiting proteasomal protein degradation using MG-132. Furthermore, coexpression of G0S2 was able to significantly decrease TNF-alpha-stimulated lipolysis mediated by overexpressed ATGL or CGI-58. We propose that the early reduction in G0S2 content is permissive for TNF-alpha-induced lipolysis.	[Yang, Xingyuan; Zhang, Xiaodong; Heckmann, Bradlee L.; Liu, Jun] Mayo Clin, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA; [Yang, Xingyuan; Zhang, Xiaodong; Heckmann, Bradlee L.; Liu, Jun] Mayo Clin, Mayo ASU Ctr Metab & Vasc Biol, Scottsdale, AZ 85259 USA; Univ Kentucky, Coll Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA	Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Mayo Clinic; Mayo Clinic Phoenix; University of Kentucky	Liu, J (corresponding author), MCCRB 3-054,13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	liu.jun@mayo.edu		Heckmann, Bradlee/0000-0002-3271-7183	National Institutes of Health [DK089178]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089178, R56DK089178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK089178. This work was also supported by a Junior Faculty Award from the American Diabetes Association (to J. L.).	Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596; DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Fortier M, 2004, AM J PHYSIOL-ENDOC M, V287, pE282, DOI 10.1152/ajpendo.00203.2003; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Green A, 2004, DIABETES, V53, P74, DOI 10.2337/diabetes.53.1.74; GREEN A, 1994, ENDOCRINOLOGY, V134, P2581, DOI 10.1210/en.134.6.2581; Greenberg CC, 2003, J BIOL CHEM, V278, P30835, DOI 10.1074/jbc.M303846200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Landstrom TR, 2000, BIOCHEM J, V346, P337, DOI 10.1042/bj3460337; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lien CC, 2009, ENDOCRINOLOGY, V150, P4892, DOI 10.1210/en.2009-0403; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Okazaki H, 2002, DIABETES, V51, P3368, DOI 10.2337/diabetes.51.12.3368; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Plomgaard P, 2008, J CLIN ENDOCR METAB, V93, P543, DOI 10.1210/jc.2007-1761; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; Ren TT, 2006, J MOL ENDOCRINOL, V37, P175, DOI 10.1677/jme.1.02061; RIZACK MA, 1964, J BIOL CHEM, V239, P392; Ryden M, 2004, BIOCHEM BIOPH RES CO, V318, P168, DOI 10.1016/j.bbrc.2004.04.010; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sethi JK, 2000, FEBS LETT, V469, P77, DOI 10.1016/S0014-5793(00)01250-3; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Unger R. H, 2010, BIOCHIM BIOPHYS ACTA, V1801, P209; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VAUGHAN M, 1964, J BIOL CHEM, V239, P401; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; YEAMAN SJ, 1994, ADV ENZYME REGUL, V34, P355, DOI 10.1016/0065-2571(94)90022-1; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479	55	75	76	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40477	40485		10.1074/jbc.M111.257923	http://dx.doi.org/10.1074/jbc.M111.257923			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969372	Green Published, hybrid			2022-12-25	WOS:000297315400007
J	Garmire, LX; Garmire, DG; Huang, W; Yao, J; Glass, CK; Subramaniam, S				Garmire, Lana X.; Garmire, David G.; Huang, Wendy; Yao, Joyee; Glass, Christopher K.; Subramaniam, Shankar			A Global Clustering Algorithm to Identify Long Intergenic Non-Coding RNA - with Applications in Mouse Macrophages	PLOS ONE			English	Article							GENE-EXPRESSION; POL-II; IDENTIFICATION; CHIP; PREDICTION; MEDIATORS; REVEALS; CELLS	Identification of diffuse signals from the chromatin immunoprecipitation and high-throughput massively parallel sequencing (ChIP-Seq) technology poses significant computational challenges, and there are few methods currently available. We present a novel global clustering approach to enrich diffuse CHIP-Seq signals of RNA polymerase II and histone 3 lysine 4 trimethylation (H3K4Me3) and apply it to identify putative long intergenic non-coding RNAs (lincRNAs) in macrophage cells. Our global clustering method compares favorably to the local clustering method SICER that was also designed to identify diffuse CHIP-Seq signals. The validity of the algorithm is confirmed at several levels. First, 8 out of a total of 11 selected putative lincRNA regions in primary macrophages respond to lipopolysaccharides (LPS) treatment as predicted by our computational method. Second, the genes nearest to lincRNAs are enriched with biological functions related to metabolic processes under resting conditions but with developmental and immune-related functions under LPS treatment. Third, the putative lincRNAs have conserved promoters, modestly conserved exons, and expected secondary structures by prediction. Last, they are enriched with motifs of transcription factors such as PU.1 and AP.1, previously shown to be important lineage determining factors in macrophages, and 83% of them overlap with distal enhancers markers. In summary, GCLS based on RNA polymerase II and H3K4Me3 CHIP-Seq method can effectively detect putative lincRNAs that exhibit expected characteristics, as exemplified by macrophages in the study.	[Garmire, Lana X.; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, Jacobs Sch Engn, La Jolla, CA 92093 USA; [Garmire, David G.] Univ Hawaii Manoa, Dept Elect Engn, Honolulu, HI 96822 USA; [Huang, Wendy; Yao, Joyee; Glass, Christopher K.; Subramaniam, Shankar] Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California San Diego	Garmire, LX (corresponding author), Univ Calif San Diego, Dept Bioengn, Jacobs Sch Engn, La Jolla, CA 92093 USA.	shankar@ucsd.edu	Huang, Wendy Jia Men/AAF-2030-2021; Glass, Christopher/AAI-3933-2021	Huang, Wendy Jia Men/0000-0001-7425-8280; Glass, Christopher/0000-0003-4344-3592; Garmire, David/0000-0002-6913-6550	National Institutes of Health (NIH) [P01DK074868]; National Institute of General Medical Sciences (NIGMS) [U54 GM069338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants P01DK074868 and National Institute of General Medical Sciences (NIGMS) Large Scale Collaborative "Glue" Grant U54 GM069338 to CKG. and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Costa FF, 2007, GENE, V386, P1, DOI 10.1016/j.gene.2006.09.028; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; De Keyzer D, 2009, ARTERIOSCL THROM VAS, V29, P2041, DOI 10.1161/ATVBAHA.109.196592; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Eskay R L, 1990, Adv Exp Med Biol, V274, P331; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 2006, ARCH PHARM RES, V29, P890, DOI 10.1007/BF02973911; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; LANA X, 2010, 2010 IEEE INT C BIOI, P1; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Maurya MR, 2007, ADV EXP MED BIOL, V598, P62; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Shibata N, 2009, J LIPID RES, V50, pS277, DOI 10.1194/jlr.R800063-JLR200; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wermeling F, 2009, AUTOIMMUN REV, V9, P49, DOI 10.1016/j.autrev.2009.03.004; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	37	28	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24051	10.1371/journal.pone.0024051	http://dx.doi.org/10.1371/journal.pone.0024051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980340	Green Submitted, Green Published, gold			2022-12-25	WOS:000295941300003
J	Langen, K; Schwarzer, J; Kullmann, H; Bakker, TCM; Thunken, T				Langen, Kathrin; Schwarzer, Julia; Kullmann, Harald; Bakker, Theo C. M.; Thuenken, Timo			Microsatellite Support for Active Inbreeding in a Cichlid Fish	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; MUTUAL MATE CHOICE; NO EVIDENCE; POPULATION-STRUCTURE; NATURAL-POPULATION; GENOTYPING ERRORS; KIN RECOGNITION; NULL ALLELES; DEPRESSION; AVOIDANCE	In wild animal populations, the degree of inbreeding differs between species and within species between populations. Because mating with kin often results in inbreeding depression, observed inbreeding is usually regarded to be caused by limited outbreeding opportunities due to demographic factors like small population size or population substructuring. However, theory predicts inclusive benefits from mating with kin, and thus part of the observed variation in inbreeding might be due to active inbreeding preferences. Although some recent studies indeed report kin mating preferences, the evidence is still highly ambiguous. Here, we investigate inbreeding in a natural population of the West African cichlid fish Pelvicachromis taeniatus which showed clear kin mating preferences in standardized laboratory experiments but no inbreeding depression. The presented microsatellite analysis reveals that the natural population has, in comparison to two reference populations, a reduced allelic diversity (A = 3) resulting in a low heterozygosity (H-o = 0.167) pointing to a highly inbred population. Furthermore, we found a significant heterozygote deficit not only at population (F-is = 0.116) but also at subpopulation level (F-is = 0.081) suggesting that inbreeding is not only a by-product of population substructuring but possibly a consequence of behavioral kin preferences.	[Langen, Kathrin; Bakker, Theo C. M.; Thuenken, Timo] Univ Bonn, Inst Evolutionary Biol & Ecol, D-5300 Bonn, Germany; [Schwarzer, Julia] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Kullmann, Harald] Univ Munster, Zentrum Didakt Biol, Munster, Germany	University of Bonn; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Munster	Langen, K (corresponding author), Univ Bonn, Inst Evolutionary Biol & Ecol, D-5300 Bonn, Germany.	klangen@evolution.uni-bonn.de	Bakker, Theo/AAI-3587-2020		Deutsche Forschungsgemeinschaft [BA 2885/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft (www.dfg.de) (BA 2885/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese JF, 2008, MAR GENOM, V1, P103, DOI 10.1016/j.margen.2008.10.004; Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; Baldauf SA, 2011, BEHAV ECOL, V22, P478, DOI 10.1093/beheco/arq226; Baldauf SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-129; BARRETT SCH, 1991, NATURE, V352, P522, DOI 10.1038/352522a0; Bateson P., 1983, P257; BENGTSSON BO, 1978, J THEOR BIOL, V73, P439, DOI 10.1016/0022-5193(78)90151-0; Bilde T, 2005, EVOLUTION, V59, P160, DOI 10.1111/j.0014-3820.2005.tb00903.x; Boakes EH, 2007, HEREDITY, V98, P172, DOI 10.1038/sj.hdy.6800923; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BURLEY N, 1990, ANIM BEHAV, V39, P775, DOI 10.1016/S0003-3472(05)80389-6; Castric V, 2002, HEREDITY, V89, P27, DOI 10.1038/sj.hdy.6800089; Chandler CH, 2008, MOL ECOL, V17, P1564, DOI 10.1111/j.1365-294X.2007.03614.x; Chapman TW, 1996, HEREDITY, V76, P65, DOI 10.1038/hdy.1996.8; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Cohen LB, 2004, ANIM BEHAV, V68, P1229, DOI 10.1016/j.anbehav.2003.12.021; Cornuet JM, 1996, GENETICS, V144, P2001; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Cowan DP, 2004, P NATL ACAD SCI USA, V101, P10374, DOI 10.1073/pnas.0402481101; Coyne JA, 2004, SPECIATION, V37; CRAIG JL, 1988, AM NAT, V131, P58, DOI 10.1086/284773; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DeWoody JA, 2006, MOL ECOL NOTES, V6, P951, DOI 10.1111/j.1471-8286.2006.01449.x; Dobson FS, 1997, EVOLUTION, V51, P970, DOI 10.1111/j.1558-5646.1997.tb03677.x; Duarte LC, 2003, EVOLUTION, V57, P638; Earl D.A., 2011, STRUCTURE HARVESTER; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; FAULKES CG, 1990, J ZOOL, V221, P87, DOI 10.1111/j.1469-7998.1990.tb03778.x; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Fox CW, 2008, EVOLUTION, V62, P2236, DOI 10.1111/j.1558-5646.2008.00441.x; Frankham R., 2002, INTRO CONSERVATION G; Frommen JG, 2006, BIOL LETTERS, V2, P232, DOI 10.1098/rsbl.2005.0432; Glemin S, 2003, EVOLUTION, V57, P2678; Gow JL, 2008, MOL ECOL, V17, P1399, DOI 10.1111/j.1365-294X.2008.03691.x; GRAZIANO AM, RAULIN ML RANDOM NUM; Gross R, 2007, AQUACULTURE, V272, pS139, DOI 10.1016/j.aquaculture.2007.08.004; Gulisija D, 2007, EVOLUTION, V61, P1043, DOI 10.1111/j.1558-5646.2007.00088.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; Hansson B, 2007, BEHAV ECOL, V18, P157, DOI 10.1093/beheco/arl062; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hedrick P. W., 2011, GENETICS POPULATIONS; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; HEDRICK PW, 1994, HEREDITY, V73, P363, DOI 10.1038/hdy.1994.183; Hinrichs D, 2007, HEREDITY, V99, P81, DOI 10.1038/sj.hdy.6800968; Holand O, 2007, BIOL LETTERS, V3, P36, DOI 10.1098/rsbl.2006.0575; Honeycutt R.L., 1991, P195; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keane B, 1996, BEHAV ECOL, V7, P480, DOI 10.1093/beheco/7.4.480; Keller LF, 1998, AM NAT, V152, P380, DOI 10.1086/286176; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kleven O, 2005, BIOL LETT-UK, V1, P389, DOI 10.1098/rsbl.2005.0376; Koch M, 2008, MOL ECOL, V17, P4500, DOI 10.1111/j.1365-294X.2008.03925.x; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Kristensen TN, 2005, ANIM SCI, V80, P121, DOI 10.1079/ASC41960121; Lacy RC, 1998, EVOLUTION, V52, P900, DOI [10.2307/2411285, 10.1111/j.1558-5646.1998.tb03715.x]; Lane JE, 2007, ANIM BEHAV, V74, P611, DOI 10.1016/j.anbehav.2006.12.017; Leberg PL, 2008, MOL ECOL, V17, P334, DOI 10.1111/j.1365-294X.2007.03433.x; Lee BY, 2005, GENETICS, V170, P237, DOI 10.1534/genetics.104.035022; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Li BS, 2009, HUM HERED, V67, P104, DOI 10.1159/000179558; Lubin Y, 2007, ADV STUD BEHAV, V37, P83, DOI 10.1016/S0065-3454(07)37003-4; Mehlis M, 2008, ANIM COGN, V11, P643, DOI 10.1007/s10071-008-0154-3; Miller PS, 2001, J EVOLUTION BIOL, V14, P595, DOI 10.1046/j.1420-9101.2001.00303.x; Neff BD, 2000, T AM FISH SOC, V129, P584, DOI 10.1577/1548-8659(2000)129&lt;0584:MMIF&gt;2.0.CO;2; Park S.D.E., 2001, THESIS; Parker G.A., 1979, P123; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Poulet N, 2009, GENETICA, V135, P77, DOI 10.1007/s10709-008-9260-z; Pouyaud L, 1999, MOL ECOL, V8, P803; Pritchard JK, 2000, GENETICS, V155, P945; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; RATTI O, 1995, BEHAV ECOL SOCIOBIOL, V37, P419, DOI 10.1007/BF00170590; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REEVE HK, 1990, P NATL ACAD SCI USA, V87, P2496, DOI 10.1073/pnas.87.7.2496; ROBERTSON A, 1984, GENETICS, V107, P703; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; ROWLEY I, 1986, ANIM BEHAV, V34, P939, DOI 10.1016/S0003-3472(86)80086-0; Schjorring S, 2007, EVOLUTION, V61, P423, DOI 10.1111/j.1558-5646.2007.00028.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schultz JK, 2009, J HERED, V100, P25, DOI 10.1093/jhered/esn077; Sefc KM, 2008, MOL ECOL, V17, P2531, DOI 10.1111/j.1365-294X.2008.03763.x; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sherman CDH, 2008, P R SOC B, V275, P971, DOI 10.1098/rspb.2007.1626; Shields William M., 1993, P143; Shirak A, 2006, J IMMUNOL, V176, P390, DOI 10.4049/jimmunol.176.1.390; Simmons LW, 2008, BIOL LETTERS, V4, P183, DOI 10.1098/rsbl.2007.0578; SLATER PJB, 1981, Z TIERPSYCHOL, V57, P201; SMITH RH, 1979, HEREDITY, V43, P205, DOI 10.1038/hdy.1979.75; Stiver KA, 2008, BEHAV ECOL, V19, P816, DOI 10.1093/beheco/arn031; Stiver KA, 2007, MOL ECOL, V16, P2974, DOI 10.1111/j.1365-294X.2007.03350.x; Swindell WR, 2006, J EVOLUTION BIOL, V19, P1257, DOI 10.1111/j.1420-9101.2005.01074.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Taylor MI, 2001, P ROY SOC B-BIOL SCI, V268, P803, DOI 10.1098/rspb.2000.1580; Thunken T, 2007, ETHOLOGY, V113, P1107, DOI 10.1111/j.1439-0310.2007.01422.x; Thunken T, 2007, CURR BIOL, V17, P225, DOI 10.1016/j.cub.2006.11.053; Thunken T, 2010, ANIM BEHAV, V80, P69, DOI 10.1016/j.anbehav.2010.04.001; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Viken A, 2006, ETHOLOGY, V112, P716, DOI 10.1111/j.1439-0310.2006.01225.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Waldman Bruce, 1993, P250; Waller Donald M., 1993, P97; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir BS, 1996, GENETIC DATA ANAL; Wilson GA, 2003, GENETICS, V163, P1177	119	37	37	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24689	10.1371/journal.pone.0024689	http://dx.doi.org/10.1371/journal.pone.0024689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980351	Green Submitted, Green Published, gold			2022-12-25	WOS:000295941300008
J	Bargues, MD; Artigas, P; Khoubbane, M; Flores, R; Gloer, P; Rojas-Garcia, R; Ashrafi, K; Falkner, G; Mas-Coma, S				Dolores Bargues, Maria; Artigas, Patricio; Khoubbane, Messaoud; Flores, Rosmary; Gloeer, Peter; Rojas-Garcia, Raul; Ashrafi, Keyhan; Falkner, Gerhard; Mas-Coma, Santiago			Lymnaea schirazensis, an Overlooked Snail Distorting Fascioliasis Data: Genotype, Phenotype, Ecology, Worldwide Spread, Susceptibility, Applicability	PLOS ONE			English	Article							GEOGRAPHIC INFORMATION-SYSTEM; NORTHERN BOLIVIAN ALTIPLANO; RIBOSOMAL-SUBUNIT RNA; HIGH-ALTITUDE; SEQUENCE CHARACTERIZATION; TRUNCATULA GASTROPODA; EVOLUTIONARY GENETICS; PHYLOGENETIC ANALYSIS; COUSINI JOUSSEAUME; MITOCHONDRIAL-DNA	Background: Lymnaeid snails transmit medical and veterinary important trematodiases, mainly fascioliasis. Vector specificity of fasciolid parasites defines disease distribution and characteristics. Different lymnaeid species appear linked to different transmission and epidemiological patterns. Pronounced susceptibility differences to absolute resistance have been described among lymnaeid populations. When assessing disease characteristics in different endemic areas, unexpected results were obtained in studies on lymnaeid susceptibility to Fasciola. We undertook studies to understand this disease transmission heterogeneity. Methodology/Principal Findings: A ten-year study in Iran, Egypt, Spain, the Dominican Republic, Mexico, Venezuela, Ecuador and Peru, demonstrated that such heterogeneity is not due to susceptibility differences, but to a hitherto overlooked cryptic species, Lymnaea schirazensis, confused with the main vector Galba truncatula and/or other Galba/Fossaria vectors. Nuclear rDNA and mtDNA sequences and phylogenetic reconstruction highlighted an old evolutionary divergence from other Galba/Fossaria species, and a low intraspecific variability suggesting a recent spread from one geographical source. Morphometry, anatomy and egg cluster analyses allowed for phenotypic differentiation. Selfing, egg laying, and habitat characteristics indicated a migration capacity by passive transport. Studies showed that it is not a vector species (n = 8572 field collected, 20 populations): snail finding and penetration by F. hepatica miracidium occur but never lead to cercarial production (n = 338 experimentally infected). Conclusions/Significance: This species has been distorting fasciolid specificity/susceptibility and fascioliasis geographical distribution data. Hence, a large body of literature on G. truncatula should be revised. Its existence has henceforth to be considered in research. Genetic data on livestock, archeology and history along the 10,000-year post-domestication period explain its wide spread from the Neolithic Fertile Crescent. It is an efficient biomarker for the follow-up of livestock movements, a crucial aspect in fascioliasis emergence. It offers an outstanding laboratory model for genetic studies on susceptibility/resistance in F. hepatica/lymnaeid interaction, a field of applied research with disease control perspectives.	[Dolores Bargues, Maria; Artigas, Patricio; Khoubbane, Messaoud; Flores, Rosmary; Mas-Coma, Santiago] Univ Valencia, Fac Farm, Dept Parasitol, E-46010 Valencia, Spain; [Gloeer, Peter] Friedrich Held Gesell, Munchner Malakol Mitteilungen Heldia, Hetlingen, Germany; [Rojas-Garcia, Raul] Benemerita Univ Autonoma Puebla, Escuela Biol, Lab Biol Parasitos & Vectores, Puebla, Mexico; [Ashrafi, Keyhan] Guilan Univ Med Sci, Sch Med, Dept Med Microbiol & Parasitol, Rasht, Iran; [Falkner, Gerhard] Staatliches Museum Nat Kunde Stuttgart, Stuttgart, Germany; [Falkner, Gerhard] Museum Natl Hist Nat, UMS Taxon & Collect, Dept Systemat & Evolut, F-75231 Paris, France	University of Valencia; Benemerita Universidad Autonoma de Puebla; Museum National d'Histoire Naturelle (MNHN)	Bargues, MD (corresponding author), Univ Valencia, Fac Farm, Dept Parasitol, E-46010 Valencia, Spain.	M.D.Bargues@uv.es	Bargues, Maria Dolores/L-8259-2014; Artigas, Patricio/L-6122-2014; Ashrafi, Keyhan/G-5868-2017; khoubbane, messaoud/L-6346-2014; Artigas, Patricio/AAW-2964-2020; Rostami-Nejad, Mohammad/I-8708-2019	Artigas, Patricio/0000-0002-2815-1324; Ashrafi, Keyhan/0000-0002-1742-1245; Artigas, Patricio/0000-0002-2815-1324; Rostami-Nejad, Mohammad/0000-0003-2495-1831; Ashrafi, Keyhan/0000-0002-2102-0284; Mas-Coma, Santiago/0000-0002-1685-7004; BARGUES, MARIA DOLORES/0000-0003-2347-7269	Ministry of Education and Ministry of Science and Innovation, Madrid [PM97-0099, BOS2000-0570-C02-02, BOS2002-01978, SAF2006-09278, SAF2010-20805]; Direccion General de Cooperacion al Desarrollo, Generalitat Valenciana, Valencia [3006/99]; Fondo de Investigacion Sanitaria (FIS), Ministry of Health, Madrid [PI030545]; Red de Investigacion de Centros de Enfermedades Tropicales, FIS, Ministry of Health, Madrid, Spain [C03/04, ISCIII2005-PI050574, ISCIII-RETIC RD06/0021/0017]; International Atomic Energy Agency (IAEA)(Animal Production and Health Section, Joint Food and Agriculture Organization/IAEA Division of Nuclear Techniques in Food and Agriculture. [RLA5049]; Agencia Espanola de Cooperacion Internacional, Ministry of Foreign Affairs, Madrid, Spain	Ministry of Education and Ministry of Science and Innovation, Madrid; Direccion General de Cooperacion al Desarrollo, Generalitat Valenciana, Valencia(Center for Forestry Research & Experimentation (CIEF)); Fondo de Investigacion Sanitaria (FIS), Ministry of Health, Madrid(Instituto de Salud Carlos III); Red de Investigacion de Centros de Enfermedades Tropicales, FIS, Ministry of Health, Madrid, Spain; International Atomic Energy Agency (IAEA)(Animal Production and Health Section, Joint Food and Agriculture Organization/IAEA Division of Nuclear Techniques in Food and Agriculture.(International Atomic Energy Agency); Agencia Espanola de Cooperacion Internacional, Ministry of Foreign Affairs, Madrid, Spain	Studies were funded by Projects No. PM97-0099, No. BOS2000-0570-C02-02, No. BOS2002-01978, No. SAF2006-09278 and No. SAF2010-20805 of the Ministry of Education and Ministry of Science and Innovation, Madrid; Project No. 3006/99 of the Direccion General de Cooperacion al Desarrollo, Generalitat Valenciana, Valencia; Project No. PI030545 of the Fondo de Investigacion Sanitaria (FIS), Ministry of Health, Madrid; and by the Red de Investigacion de Centros de Enfermedades Tropicales (Projects No. C03/04, No. ISCIII2005-PI050574 and No. ISCIII-RETIC RD06/0021/0017 of the Programa de Redes Tematicas de Investigacion Cooperativa RETICS/FEDER), FIS, Ministry of Health, Madrid, Spain. Joint coordination activities with Mexico, Venezuela and Peru were carried out within the frame of Project No. RLA5049 of the International Atomic Energy Agency (IAEA)(Animal Production and Health Section, Joint Food and Agriculture Organization/IAEA Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, IAEA Headquaters Vienna, Austria). Part of this work was made possible thanks to a personal fellowship granted to PA by the Agencia Espanola de Cooperacion Internacional, Ministry of Foreign Affairs, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding and supporting agencies.	Adema Coen M., 1997, P229; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albrecht C, 2008, HYDROBIOLOGIA, V615, P103, DOI 10.1007/s10750-008-9558-y; Andrews SJ, 1999, FASCIOLOSIS, P1; [Anonymous], 2001, PROVEN SOLUTION IMAG, p8/1; Ashrafi K, 2007, IRAN J PUBLIC HEALTH, V36, P42; Ballard JWO, 2005, ANNU REV ECOL EVOL S, V36, P621, DOI 10.1146/annurev.ecolsys.36.091704.175513; Bargues MD, 2007, ANN TROP MED PARASIT, V101, P621, DOI 10.1179/136485907X229077; Bargues MD, 2001, INFECT GENET EVOL, V1, P85, DOI 10.1016/S1567-1348(01)00019-3; Bargues M.D., 2006, Heldia, V6, P29; Bargues MD, 1997, MOL BIOL EVOL, V14, P569, DOI 10.1093/oxfordjournals.molbev.a025794; Bargues MD, 1997, J PARASITOL, V83, P1086, DOI 10.2307/3284367; Bargues MD, 2005, J HELMINTHOL, V79, P257, DOI 10.1079/JOH2005297; Bargues MD, 2003, PARASITE, V10, P243, DOI 10.1051/parasite/2003103243; Bargues MD, 2011, PLOS ONE IN PRESS; Bellini, 1904, Journal of Conchology, Vxi, P33; Bokonyi S, 2004, HIST HUMANIDAD PREHI, V1, P392; Boray J. C., 1969, Adv. Parasitol., V7, P95, DOI 10.1016/S0065-308X(08)60435-2; BORAY JC, 1978, VET PARASITOL, V4, P127, DOI 10.1016/0304-4017(78)90004-3; BORAY JC, 1966, ANN TROP MED PARASIT, V60, P114, DOI 10.1080/00034983.1966.11686394; Bourguignat JR, 1863, MALACOLOGIE ALGERIE, V1, P1; BROWN DS, 1994, FRESHWATER SNAILS AF; Brusina S, 1866, CONTRIBUZIONE PELLA, V16; Bulliet RW, 2004, HIST HUMANIDAD SIGO, V4, P95; BURCH J B, 1968, Malacological Review, V1, P15; BURCH J B, 1973, Malacological Review, V6, P61; Burch J.B., 1982, Walkerana, V1, P217; Burch JB, 1982, FRESHWATER SNAILS; Burch JB, 1987, CLAVE GENERICA IDENT; Chen SY, 2006, GENE, V376, P216, DOI 10.1016/j.gene.2006.03.009; Clark D, 2004, HIST HUMANIDAD PREHI, V1, P210; Claxton John R., 1997, Parasitology International, V46, P281, DOI 10.1016/S1383-5769(97)00039-1; Claxton JR, 1999, VET J, V157, P166, DOI 10.1053/tvjl.1998.0293; Clessin S, 1880, NEUE FOLGE, V3, P7745; Clessin S, 1879, MALAKOZOOLOGISCHE BL, V1, P3; Cramp S, 1977, P1; CRUZREYES A, 1987, VET PARASITOL, V24, P203, DOI 10.1016/0304-4017(87)90041-0; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; de Benavente T, 1994, RELACIONES NUEVA ESP; de Folin L, 1878, J CONCHYLIOL PARIS, V18, P329; De la Brosse G., 2008, LATLAS MIGRATIONS RO, P38; DeJong RJ, 2001, MOL BIOL EVOL, V18, P2225, DOI 10.1093/oxfordjournals.molbev.a003769; DERIJK P, 1992, NUCLEIC ACIDS RES, V20, P2075, DOI 10.1093/nar/20.suppl.2075; Diaz del Castillo Bernal, 1955, HIST VERDADERA CONQU; Bargues MD, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-132; Duchemin I, 2008, ATLAS MIGRAGION LES, P24; Durr PA, 2005, PREV VET MED, V71, P157, DOI 10.1016/j.prevetmed.2005.07.013; Dutra LH, 2010, VET PARASITOL, V169, P76, DOI 10.1016/j.vetpar.2009.12.015; FALKNER G, 2002, PATRIMOINES NATURELS, V52, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fuentes MV, 2001, ACTA TROP, V79, P87, DOI 10.1016/S0001-706X(01)00106-1; Fuentes MV, 1999, ANN TROP MED PARASIT, V93, P835, DOI 10.1080/00034989957844; Gamrasni M., 2008, LATLAS MIGRATIONS RO, P28; Gasnier N, 2000, INT J PARASITOL, V30, P573, DOI 10.1016/S0020-7519(00)00038-2; Giber P, 1998, SUSSWASSERMOLLUSKEN; Gittenberger E, 2006, NATURE, V439, P409, DOI 10.1038/439409a; GOMEZ JD, 1986, NAUTILUS, V100, P130; Gutierrez A, 2003, EXP PARASITOL, V105, P211, DOI 10.1016/j.exppara.2003.12.006; Gutierrez A, 2003, PARASITOL RES, V90, P129, DOI 10.1007/s00436-002-0824-z; HUBENDICK BENGT, 1951, K SVENSKA VETENSKAPSAKAD HANDL, V3, P1; Huh OK, 2001, ACTA TROP, V79, P35, DOI 10.1016/S0001-706X(01)00101-2; International Commission on Zoological Nomenclature (ICZN), 1998, B ZOOL NOMENCLATURE, V55, P123; Jackiewicz Maria, 1998, Genus (Wroclaw), V9, P1; Kalbe M, 1997, PARASITOL RES, V83, P806, DOI 10.1007/s004360050344; Kear J, 2005, BIRD FAMILIES WORLD; KENDALL S. B., 1959, ANN TROP MED AND PARASITOL, V53, P220; Krister HC, 1862, SYSTEMATISCHES CONCH, P1; Kruglov N.D., 2005, MOLLUSCS FAMILY LYMN; KRUGLOV ND, 1985, ZOOL ZH, V64, P24; Lavalle B, 2005, FRANCISCO PIZARRO CO; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Lockyer AE, 2004, CAN J ZOOL, V82, P251, DOI [10.1139/z03-215, 10.1139/Z03-215]; Longo M, 2005, REV ASOC COL CIENCIA, V17, P47; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; MacHugh DE, 2001, P NATL ACAD SCI USA, V98, P5382, DOI 10.1073/pnas.111163198; MADSEN H, 1989, ACTA TROP, V46, P139, DOI 10.1016/0001-706X(89)90030-2; Malek EA, 1985, SNAIL HOSTS SCHISTOS; Malone JB, 1998, VET PARASITOL, V78, P87, DOI 10.1016/S0304-4017(98)00137-X; Malone JB, 1999, FASCIOLOSIS, P151; MALONE JB, 1987, AM J VET RES, V48, P1167; Mas-Coma S, 2008, REV SCI TECH OIE, V27, P443, DOI 10.20506/rst.27.2.1822; Mas-Coma S, 2005, J HELMINTHOL, V79, P207, DOI 10.1079/JOH2005296; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; Mas-Coma S., 1987, P253; Mas-Coma S, 2001, PARASITOLOGY, V123, pS115, DOI 10.1017/S0031182001008034; Mas-Coma S, 2009, ACTA TROP, V110, P112, DOI 10.1016/j.actatropica.2008.10.013; Mas-Coma S, 1999, TROP MED INT HEALTH, V4, P454, DOI 10.1046/j.1365-3156.1999.00418.x; Mas-Coma S, 2009, ADV PARASIT, V69, P41, DOI 10.1016/S0065-308X(09)69002-3; Mas-Coma S, 2009, VET PARASITOL, V163, P264, DOI 10.1016/j.vetpar.2009.03.024; Mazzotti L., 1955, Revista del Instituto de Salubridad y Enfermedades Tropicales Mexico, V15, P163; McCRAW BRUCE M., 1961, TRANS AMER MICROSC SOC, V80, P16, DOI 10.2307/3223701; Sierra RMY, 2009, VET PARASITOL, V166, P73, DOI 10.1016/j.vetpar.2009.08.001; Meunier C, 2004, MOL ECOL, V13, P2535, DOI 10.1111/j.1365-294X.2004.02242.x; Meunier C, 2004, HEREDITY, V92, P316, DOI 10.1038/sj.hdy.6800410; Meunier C, 2001, MOL ECOL, V10, P1333, DOI 10.1046/j.1365-294X.2001.01284.x; Mirol PM, 2003, HEREDITY, V91, P248, DOI 10.1038/sj.hdy.6800312; MORALES G, 1983, ANN PARASIT HUM COMP, V58, P27, DOI 10.1051/parasite/1983581027; Mousson A, 1874, J CONCHYLIOL, V22, P5; Moya Pons F, 2008, HIST CARIBE AZUCAR P; Ollerenshaw C. B., 1969, Adv. Parasitol., V7, P283; OLLERENSHAW C B, 1974, P33; Oviedo, 1965, HIST CONQUISTA POBLA, V2, p[82, 233]; Pallary P, 1922, J CONCHYLIOL, V66, P89; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Pereira F, 2005, MOL ECOL, V14, P2313, DOI 10.1111/j.1365-294X.2005.02594.x; Pereira F, 2006, MOL BIOL EVOL, V23, P1420, DOI 10.1093/molbev/msl007; PEREZ-REYES R, 1985, Revista Latinoamericana de Microbiologia, V27, P367; Pointier JP, 2009, MEM I OSWALDO CRUZ, V104, P790, DOI 10.1590/S0074-02762009000500022; Pointier JP, 2007, PARASITOL RES, V101, P1389, DOI 10.1007/s00436-007-0656-y; Pointier JP, 2004, MEM I OSWALDO CRUZ, V99, P567, DOI 10.1590/S0074-02762004000600005; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puslednik L, 2009, MOL PHYLOGENET EVOL, V52, P643, DOI 10.1016/j.ympev.2009.03.033; Rapsch C, 2008, VET PARASITOL, V154, P242, DOI 10.1016/j.vetpar.2008.03.030; Remigio EA, 1997, J MOLLUS STUD, V63, P173, DOI 10.1093/mollus/63.2.173; Remigio EA, 1997, CAN J ZOOL, V75, P1540, DOI 10.1139/z97-779; Remigio EA, 2003, MOL PHYLOGENET EVOL, V29, P641, DOI 10.1016/S1055-7903(03)00140-4; Remigio EA, 2002, PARASITOL RES, V88, P687, DOI 10.1007/s00436-002-0658-8; Robart G, 1976, HALIOTIS, V8, P159; Rojas-Garcia R, 2000, THESIS BENEMERITA U; Rollinson D., 1985, Linnean Society Symposium Series, P91; RONDELAUD D, 1993, B SOC ZOOL FR, V118, P185; Rondelaud D, 1997, REV MED VET-TOULOUSE, V148, P329; Rondelaud D, 2009, LIMNEE TRONQUEE UNMO; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samadi S, 2000, J MOLLUS STUD, V66, P31, DOI 10.1093/mollus/66.1.31; Sambrook J, 1989, MOL CLONING LAB MANU, VIII, P1647; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sambrook J, 1989, MOL CLONING LAB MANU, VII, P1647; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLICKUM W R, 1974, Archiv fuer Molluskenkunde, V104, P73; Serrera RM, 1990, HIST ESPANA, V8, P127; Simon C., 1991, NATO ASI Series Series H Cell Biology, V57, P329; Simon P, 1992, NOTICIAS HIST VENEZU, VII; Sowerby II GB, 1872, CONCHOLOGIA ICONICA, V18; Staden R, 2001, Methods Biochem Anal, V43, P303; Stothard JR, 2000, J ZOOL, V252, P303, DOI 10.1111/j.1469-7998.2000.tb00625.x; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trouve S, 2005, J EVOLUTION BIOL, V18, P358, DOI 10.1111/j.1420-9101.2004.00831.x; Tum S, 2007, VET PARASITOL, V143, P364, DOI 10.1016/j.vetpar.2006.08.033; UENO H, 1975, NATL I ANIM HEALTH Q, V15, P61; Valero MA, 2005, J HELMINTHOL, V79, P217, DOI 10.1079/JOH2005301; Valero MA, 1998, VIE MILIEU, V48, P73; Valero MA, 2001, VET PARASITOL, V102, P85, DOI 10.1016/S0304-4017(01)00499-X; Valero MA, 2000, FOLIA PARASIT, V47, P17, DOI 10.14411/fp.2000.004; Van Damme D., 1984, FRESHWATER MOLLUSCA; Villavicencio A, 2005, MEM I OSWALDO CRUZ, V100, P735, DOI 10.1590/S0074-02762005000700010; Westerlund CA, 1885, FAUNA PAAARCTISCHEN, P49; Wethington AR, 2007, J MOLLUS STUD, V73, P241, DOI 10.1093/mollus/eym021; WINNEPENNICKX B, 1992, FEBS LETT, V309, P123, DOI 10.1016/0014-5793(92)81078-Z; World Health Organization (WHO), 1995, WHO TECHN REP SER, V849, P1; Wright CA, 1973, FLUKES SNAILS; Yong M, 1995, J MED APPL MALACOL, V7, P17	156	62	68	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e24567	10.1371/journal.pone.0024567	http://dx.doi.org/10.1371/journal.pone.0024567			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980347	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600004
J	Huang, T; Chen, L; Cai, YD; Chou, KC				Huang, Tao; Chen, Lei; Cai, Yu-Dong; Chou, Kuo-Chen			Classification and Analysis of Regulatory Pathways Using Graph Property, Biochemical and Physicochemical Property, and Functional Property	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN SECONDARY STRUCTURE; SUPPORT VECTOR MACHINE; SUBCELLULAR LOCATION; METABOLIC PATHWAYS; ENZYME DATA; MULTIORGANISM DATABASE; PROBABILISTIC NETWORKS; KYOTO ENCYCLOPEDIA; GENE ONTOLOGY	Given a regulatory pathway system consisting of a set of proteins, can we predict which pathway class it belongs to? Such a problem is closely related to the biological function of the pathway in cells and hence is quite fundamental and essential in systems biology and proteomics. This is also an extremely difficult and challenging problem due to its complexity. To address this problem, a novel approach was developed that can be used to predict query pathways among the following six functional categories: (i) "Metabolism", (ii) "Genetic Information Processing", (iii) "Environmental Information Processing", (iv) "Cellular Processes", (v) "Organismal Systems", and (vi) "Human Diseases". The prediction method was established trough the following procedures: (i) according to the general form of pseudo amino acid composition (PseAAC), each of the pathways concerned is formulated as a 5570-D (dimensional) vector; (ii) each of components in the 5570-D vector was derived by a series of feature extractions from the pathway system according to its graphic property, biochemical and physicochemical property, as well as functional property; (iii) the minimum redundancy maximum relevance (mRMR) method was adopted to operate the prediction. A cross-validation by the jackknife test on a benchmark dataset consisting of 146 regulatory pathways indicated that an overall success rate of 78.8% was achieved by our method in identifying query pathways among the above six classes, indicating the outcome is quite promising and encouraging. To the best of our knowledge, the current study represents the first effort in attempting to identity the type of a pathway system or its biological function. It is anticipated that our report may stimulate a series of follow-up investigations in this new and challenging area.	[Huang, Tao; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Maritime University	Huang, T (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009; Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTHAUS IW, 1993, J BIOL CHEM, V268, P14875; ALTHAUS IW, 1993, J BIOL CHEM, V268, P6119; ALTHAUS IW, 1993, BIOCHEMISTRY-US, V32, P6548, DOI 10.1021/bi00077a008; Andraos J, 2008, CAN J CHEM, V86, P342, DOI 10.1139/V08-020; BAIROCH A, 1994, NUCLEIC ACIDS RES, V22, P3626, DOI 10.1093/nar/22.17.3626; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bouckaert R.R., 2004, BAYESIAN NETWORK CLA; Buntine W, 1996, IEEE T KNOWL DATA EN, V8, P195, DOI 10.1109/69.494161; Cai YD, 2003, BIOCHEM BIOPH RES CO, V305, P407, DOI 10.1016/S0006-291X(03)00775-7; Cai YD, 2008, BIOCHEM BIOPH RES CO, V372, P862, DOI 10.1016/j.bbrc.2008.05.143; Cai YD, 2010, MOL DIVERS, V14, P551, DOI 10.1007/s11030-009-9182-4; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Chakrabarti D, 2005, TOOLS LARGE GRAPH MI; Chang M, 2011, BMB REP, V44, P423, DOI 10.5483/BMBRep.2011.44.7.423; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chen L, 2010, MOLECULES, V15, P8177, DOI 10.3390/molecules15118177; Chen L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-293; Chen L, 2010, J COMPUT CHEM, V31, P1766, DOI 10.1002/jcc.21467; Chen L, 2009, J PROTEOME RES, V8, P5212, DOI 10.1021/pr900554a; Chen L, 2009, J COMPUT CHEM, V30, P2248, DOI 10.1002/jcc.21230; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cheng J, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P101; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CHOU KC, 1980, EUR J BIOCHEM, V113, P195; Chou KC, 2006, J PROTEOME RES, V5, P316, DOI 10.1021/pr050331g; Chou KC, 1997, PROTEINS, V28, P99, DOI 10.1002/(SICI)1097-0134(199705)28:1<99::AID-PROT10>3.0.CO;2-C; CHOU KC, 1989, J BIOL CHEM, V264, P12074; CHOU KC, 1990, BIOPHYS CHEM, V35, P1, DOI 10.1016/0301-4622(90)80056-D; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, CURR DRUG METAB, V11, P369, DOI 10.2174/138920010791514261; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Dale JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-15; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Frishman D, 1997, PROTEINS, V27, P329, DOI 10.1002/(SICI)1097-0134(199703)27:3<329::AID-PROT1>3.0.CO;2-8; Gao CF, 2011, PROTEIN PEPTIDE LETT, V18, P831, DOI 10.2174/092986611795713916; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Klukas C, 2007, BIOINFORMATICS, V23, P344, DOI 10.1093/bioinformatics/btl611; Krieger CJ, 2004, NUCLEIC ACIDS RES, V32, pD438, DOI 10.1093/nar/gkh100; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lobanova YS, 2007, BIOCHEMISTRY-MOSCOW+, V72, P320, DOI 10.1134/S0006297907030108; Lu L, 2010, MOL DIVERS, V14, P81, DOI 10.1007/s11030-009-9149-5; Lu L, 2009, PEPTIDES, V30, P359, DOI 10.1016/j.peptides.2008.09.020; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pharkya P, 2003, METAB ENG, V5, P71, DOI 10.1016/S1096-7176(03)00008-9; Platt J., FAST TRAINING SUPPOR; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Qi Y, 2008, BIOINFORMATICS, V24, pI250, DOI 10.1093/bioinformatics/btn164; Qiu JD, 2010, PROTEIN PEPTIDE LETT, V17, P715, DOI 10.2174/092986610791190372; SALZBERG S, 1992, J MOL BIOL, V227, P371, DOI 10.1016/0022-2836(92)90892-N; Schomburg I, 2002, TRENDS BIOCHEM SCI, V27, P54, DOI 10.1016/S0968-0004(01)02027-8; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Witten I. H., 2005, DATA MINING PRACTICA; Wu ZC, 2010, J THEOR BIOL, V267, P29, DOI 10.1016/j.jtbi.2010.08.007; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015; ZHOU GP, 1984, BIOCHEM J, V222, P169, DOI 10.1042/bj2220169; Zhou GP, 2011, J THEOR BIOL, V284, P142, DOI 10.1016/j.jtbi.2011.06.006; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	91	83	83	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25297	10.1371/journal.pone.0025297	http://dx.doi.org/10.1371/journal.pone.0025297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980418	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900048
J	Li, RT; Xie, L; Zhu, ZS; Liu, Q; Hu, Y; Jiang, XQ; Yu, LX; Qian, XP; Guo, WH; Ding, YT; Liu, BR				Li, Rutian; Xie, Li; Zhu, Zhenshu; Liu, Qin; Hu, Yong; Jiang, Xiqun; Yu, Lixia; Qian, Xiaoping; Guo, Wanhua; Ding, Yitao; Liu, Baorui			Reversion of pH-Induced Physiological Drug Resistance: A Novel Function of Copolymeric Nanoparticles	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; ANTICANCER DRUGS; PHASE-I; DELIVERY; PACLITAXEL; TUMOR; NANOMEDICINE; THERAPEUTICS; CYTOTOXICITY; NANOCARRIERS	Aims: The extracellular pH of cancer cells is lower than the intracellular pH. Weakly basic anticancer drugs will be protonated extracellularly and display a decreased intracellular concentration. In this study, we show that copolymeric nanoparticles (NPs) are able to overcome this "pH-induced physiological drug resistance" (PIPDR) by delivering drugs to the cancer cells via endocytosis rather than passive diffussion. Materials and Methods: As a model nanoparticle, Tetradrine (Tet, Pka 7.80) was incorporated into mPEG-PCL. The effectiveness of free Tet and Tet-NPs were compared at different extracellular pHs (pH values 6.8 and 7.4, respectively) by MTT assay, morphological observation and apoptotic analysis in vitro and on a murine model by tumor volume measurement, PET-CT scanning and side effect evaluation in vivo. Results: The cytotoxicity of free Tet decreased prominently (P<0.05) when the extracellular pH decreased from 7.4 to 6.8. Meanwhile, the cytotoxicity of Tet-NPs was not significantly influenced by reduced pH. In vivo experiment also revealed that Tet-NPs reversed PIPDR more effectively than other existing methods and with much less side effects. Conclusion: The reversion of PIPDR is a new discovered mechanism of copolymeric NPs. This study emphasized the importance of cancer microenvironmental factors in anticancer drug resistance and revealed the superiority of nanoscale drug carrier from a different aspect.	[Li, Rutian; Xie, Li; Liu, Qin; Yu, Lixia; Qian, Xiaoping; Ding, Yitao; Liu, Baorui] Nanjing Univ, Drum Tower Hosp, Sch Med, Ctr Comprehens Canc, Nanjing 210008, Peoples R China; [Li, Rutian; Xie, Li; Liu, Qin; Yu, Lixia; Qian, Xiaoping; Ding, Yitao; Liu, Baorui] Nanjing Univ, Clin Canc Inst, Nanjing 210008, Peoples R China; [Li, Rutian] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Peoples R China; [Zhu, Zhenshu; Jiang, Xiqun] Nanjing Univ, Coll Chem & Chem Engn, Dept Polymer Sci & Engn, Nanjing 210008, Peoples R China; [Zhu, Zhenshu; Jiang, Xiqun] Nanjing Univ, Coll Chem & Chem Engn, Lab Mesoscop Chem, Nanjing 210008, Peoples R China; [Hu, Yong] Nanjing Univ, Dept Mat Sci & Engn, Natl Lab Solid State Microstruct, Nanjing 210008, Peoples R China; [Guo, Wanhua] Nanjing Univ, Drum Tower Hosp, Sch Med, Dept Nucl Med, Nanjing 210008, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Li, RT (corresponding author), Nanjing Univ, Drum Tower Hosp, Sch Med, Ctr Comprehens Canc, Nanjing 210008, Peoples R China.	yitaoding_gy@163.com; baoruiliu@nju.edu.cn	Jiang, Xiqun/I-8128-2014	Jiang, Xiqun/0000-0003-0483-0282	National Natural Science Foundation of China [30872471, 81071815]; Science Foundation of Jiangsu Province [BK2008064]; Social Development Foundation of Nanjing for Young Scientist [YKK10070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Jiangsu Province; Social Development Foundation of Nanjing for Young Scientist	This work was supported by the National Natural Science Foundation of China (no. 30872471, 81071815), the Science Foundation of Jiangsu Province (no. BK2008064) and the Social Development Foundation of Nanjing for Young Scientist (no. YKK10070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgeois H, 2006, AM J CLIN ONCOL-CANC, V29, P267, DOI 10.1097/01.coc.0000217552.69036.16; Gerweck LE, 1996, CANCER RES, V56, P1194; Hall JB, 2007, NANOMEDICINE-UK, V2, P789, DOI 10.2217/17435889.2.6.789; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; Hoffman AS, 2008, J CONTROL RELEASE, V132, P153, DOI 10.1016/j.jconrel.2008.08.012; Ibrahim NK, 2005, J CLIN ONCOL, V23, P6019, DOI 10.1200/JCO.2005.11.013; Kojima C, 2010, EXPERT OPIN DRUG DEL, V7, P307, DOI 10.1517/17425240903530651; Lee CM, 2006, BRIT J CANCER, V94, P863, DOI 10.1038/sj.bjc.6603010; Lee MJE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009536; Li RT, 2009, INT J PHARMACEUT, V379, P158, DOI 10.1016/j.ijpharm.2009.06.007; Li XL, 2008, EUR J PHARM BIOPHARM, V70, P726, DOI 10.1016/j.ejpb.2008.06.016; Liu R, 2011, J CONTROL RELEASE, V152, P49, DOI 10.1016/j.jconrel.2011.02.031; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Matsumura Y, 2008, ADV DRUG DELIVER REV, V60, P899, DOI 10.1016/j.addr.2007.11.010; McCarron PA, 2010, NANOMEDICINE-UK, V5, P3, DOI 10.2217/NNM.09.89; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Nishiyama N, 2007, NAT NANOTECHNOL, V2, P203, DOI 10.1038/nnano.2007.88; Nyman DW, 2005, J CLIN ONCOL, V23, P7785, DOI 10.1200/JCO.2004.00.6148; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Raghunand N, 2001, Novartis Found Symp, V240, P199; Raghunand N, 1999, BRIT J CANCER, V80, P1005, DOI 10.1038/sj.bjc.6690455; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P309, DOI 10.1016/S0006-2952(98)00306-2; Raghunand N, 2000, DRUG RESIST UPDATE, V3, P39, DOI 10.1054/drup.2000.0119; Rosen H, 2005, NAT REV DRUG DISCOV, V4, P381, DOI 10.1038/nrd1721; ROTIN D, 1987, CANCER RES, V47, P1497; Sanhai WR, 2008, NAT NANOTECHNOL, V3, P242, DOI 10.1038/nnano.2008.114; Segal E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005233; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Vukovic V, 1997, BRIT J CANCER, V75, P1167, DOI 10.1038/bjc.1997.201; Wang YJ, 2008, NANO LETT, V8, P1741, DOI 10.1021/nl080877c; Xiao K, 2009, BIOMATERIALS, V30, P6006, DOI 10.1016/j.biomaterials.2009.07.015; Zhu ZS, 2010, J CONTROL RELEASE, V142, P438, DOI 10.1016/j.jconrel.2009.11.002	32	21	25	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e24172	10.1371/journal.pone.0024172	http://dx.doi.org/10.1371/journal.pone.0024172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966359	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100002
J	Di Garbo, A; Mainardi, M; Chillemi, S; Maffei, L; Caleo, M				Di Garbo, Angelo; Mainardi, Marco; Chillemi, Santi; Maffei, Lamberto; Caleo, Matteo			Environmental Enrichment Modulates Cortico-Cortical Interactions in the Mouse	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; RAT VISUAL-CORTEX; SYNCHRONY; BRAIN; EXPERIENCE; BEHAVIOR; SYSTEMS; MODEL	Environmental enrichment (EE) is an experimental protocol based on a complex sensorimotor stimulation that dramatically affects brain development. While it is widely believed that the effects of EE result from the unique combination of different sensory and motor stimuli, it is not known whether and how cortico-cortical interactions are shaped by EE. Since the primary visual cortex (V1) is one of the best characterized targets of EE, we looked for direct cortico-cortical projections impinging on V1, and we identified a direct monosynaptic connection between motor cortex and V1 in the mouse brain. To measure the interactions between these areas under standard and EE rearing conditions, we used simultaneous recordings of local field potentials (LFPs) in awake, freely moving animals. LFP signals were analyzed by using different methods of linear and nonlinear analysis of time series (cross-correlation, mutual information, phase synchronization). We found that EE decreases the level of coupling between the electrical activities of the two cortical regions with respect to the control group. From a functional point of view, our results indicate, for the first time, that an enhanced sensorimotor experience impacts on the brain by affecting the functional crosstalk between different cortical areas.	[Di Garbo, Angelo; Chillemi, Santi] CNR, Inst Biophys, Natl Res Council, I-56100 Pisa, Italy; [Mainardi, Marco; Maffei, Lamberto; Caleo, Matteo] CNR, Natl Res Council, Inst Neurosci, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Di Garbo, A (corresponding author), CNR, Inst Biophys, Natl Res Council, I-56100 Pisa, Italy.	caleo@in.cnr.it	Mainardi, Marco/AAY-4025-2020	CALEO, MATTEO/0000-0002-4333-6378	Compagnia di San Paolo (Torino, Italy); Fondazione Cassa di Risparmio di Pisa (Pisa, Italy); Fondazione Cassa di Risparmio di Pisa	Compagnia di San Paolo (Torino, Italy)(Compagnia di San Paolo); Fondazione Cassa di Risparmio di Pisa (Pisa, Italy); Fondazione Cassa di Risparmio di Pisa	This work was supported by a Compagnia di San Paolo (Torino, Italy) grant to MC and by a Fondazione Cassa di Risparmio di Pisa (Pisa, Italy) grant to LM. MM is the recipient of a post-doctoral fellowship from Fondazione Cassa di Risparmio di Pisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H.D.I., 1996, ANAL OBSERVED CHAOTI; Antonucci F, 2008, EXP NEUROL, V210, P388, DOI 10.1016/j.expneurol.2007.11.012; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Cover TM, 1991, ELEMENTS INFORM THEO; Faes L, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026201; Guandalini P, 1998, BRAIN RES BULL, V47, P377, DOI 10.1016/S0361-9230(98)00122-1; Kantz H., 1997, NONLINEAR TIME SERIE; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kreuz T, 2007, PHYSICA D, V225, P29, DOI 10.1016/j.physd.2006.09.039; Mainardi M, 2010, J NEUROSCI RES, V88, P3048, DOI 10.1002/jnr.22461; Mormann F, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021912; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Piche M, 2007, NEUROSCIENCE, V145, P1144, DOI 10.1016/j.neuroscience.2006.12.050; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Press W., 1986, NUMERICAL RECIPES; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; ROSENZWEIG M R, 1969, Developmental Psychobiology, V2, P87, DOI 10.1002/dev.420020208; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Schiff SJ, 1996, PHYS REV E, V54, P6708, DOI 10.1103/PhysRevE.54.6708; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001	30	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25285	10.1371/journal.pone.0025285	http://dx.doi.org/10.1371/journal.pone.0025285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966482	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100080
J	Facchin, F; Vitale, L; Bianconi, E; Piva, F; Frabetti, F; Strippoli, P; Casadei, R; Pelleri, MC; Piovesan, A; Canaider, S				Facchin, Federica; Vitale, Lorenza; Bianconi, Eva; Piva, Francesco; Frabetti, Flavia; Strippoli, Pierluigi; Casadei, Raffaella; Pelleri, Maria Chiara; Piovesan, Allison; Canaider, Silvia			Complexity of Bidirectional Transcription and Alternative Splicing at Human RCAN3 Locus	PLOS ONE			English	Article							HUMAN NEUROENDOCRINE TUMORS; CYTOKINE GENE-EXPRESSION; SYNDROME CRITICAL REGION; DSCR1L2 MESSENGER-RNA; MUSCLE FIBER-TYPE; DOWN-SYNDROME; HUMAN GENOME; INDUCED APOPTOSIS; TROPONIN-I; CALCINEURIN	Human RCAN3 (regulator of calcineurin 3) belongs to the human RCAN gene family. In this study we provide, with in silico and in vitro analyses, the first detailed description of the human multi-transcript RCAN3 locus. Its analysis revealed that it is composed of a multigene system that includes at least 21 RCAN3 alternative spliced isoforms (16 of them identified here for the first time) and a new RCAN3 antisense gene (RCAN3AS). In particular, we cloned RCAN3-1,3,4,5 (lacking exon 2), RCAN3-1a, 2,3,4,5, RCAN3-1a, 3,4,5, RCAN3-1b, 2,3,4,5, RCAN3-1c, 2,3,4,5, RCAN3-1c, 2,4,5 and RCAN3-1c, 3,4,5, isoforms that present a different 59 untranslated region when compared to RCAN3. Moreover, in order to verify the possible 59 incompleteness of previously identified cDNA isoforms with the reference exon 1, ten more alternative isoforms were retrieved. Bioinformatic searches allowed us to identify RCAN3AS, which overlaps in part with exon 1a, on the opposite strand, for which four different RCAN3AS isoforms were cloned. In order to analyze the different expression patterns of RCAN3 alternative first exons and of RCAN3AS mRNA isoforms, RT-PCR was performed in 17 human tissues. Finally, analyses of RCAN3 and RCAN3AS genomic sequences were performed to identify possible promoter regions, to examine donor and acceptor splice sequences and to compare evolutionary conservation, in particular of alternative exon 1 or 1c - exon 2 junctions in different species. The description of its number of transcripts, of their expression patterns and of their regulatory regions can be important to clarify the functions of RCAN3 gene in different pathways and cellular processes.	[Facchin, Federica; Vitale, Lorenza; Bianconi, Eva; Frabetti, Flavia; Strippoli, Pierluigi; Casadei, Raffaella; Pelleri, Maria Chiara; Piovesan, Allison; Canaider, Silvia] Univ Bologna, Ctr Res Mol Genet, Fdn CARISBO, Dept Histol Embryol & Appl Biol, Bologna, Italy; [Piva, Francesco] Polytech Univ Marche, Dept Biochem Biol & Genet, Ancona, Italy	University of Bologna; Marche Polytechnic University	Facchin, F (corresponding author), Univ Bologna, Ctr Res Mol Genet, Fdn CARISBO, Dept Histol Embryol & Appl Biol, Bologna, Italy.	federica.facchin2@unibo.it	BIANCONI, EVA/AAC-4968-2022; Casadei, Raffaella/K-1730-2015; PIOVESAN, Allison/M-6783-2019	BIANCONI, EVA/0000-0001-8572-6297; Casadei, Raffaella/0000-0001-9595-8577; PIOVESAN, Allison/0000-0001-7038-5557; PIVA, Francesco/0000-0003-1850-2482; STRIPPOLI, PIERLUIGI/0000-0001-8769-8832	"Fondazione CARISBO'', Bologna, Italy	"Fondazione CARISBO'', Bologna, Italy	This work was funded by a grant from "Fondazione CARISBO'', Bologna, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Aubareda A, 2006, CELL SIGNAL, V18, P1430, DOI 10.1016/j.cellsig.2005.11.006; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Berkeley Drosophila Genome Project, NEUR NETW PROM PRED; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bueno OF, 2004, CIRC RES, V94, P91, DOI 10.1161/01.RES.0000107197.99679.77; Canaider S, 2006, GENE, V372, P128, DOI 10.1016/j.gene.2005.12.029; Canaider S, 2010, INT J MOL MED, V26, P913, DOI 10.3892/ijmm_00000542; Cao X, 2002, BIOCHEM J, V367, P459, DOI 10.1042/BJ20011797; Mulero M, 2007, BBA-MOL CELL RES, V1773, P330, DOI 10.1016/j.bbamcr.2006.12.007; Carninci P, 2008, CURR OPIN CELL BIOL, V20, P274, DOI 10.1016/j.ceb.2008.03.008; Casadei R, 2003, GENE, V321, P185, DOI 10.1016/S0378-1119(03)00835-7; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; CUMMINS P, 1978, BIOCHEM J, V171, P251, DOI 10.1042/bj1710251; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Davis LG, 1994, BASIC METHODS MOL BI; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; ENGELS WR, 1993, TRENDS BIOCHEM SCI, V18, P448, DOI 10.1016/0968-0004(93)90148-G; Facchin F, 2008, GENE, V407, P159, DOI 10.1016/j.gene.2007.10.006; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Hiller M, 2008, TRENDS GENET, V24, P246, DOI 10.1016/j.tig.2008.03.003; Hiller M, 2007, NUCLEIC ACIDS RES, V35, pD188, DOI 10.1093/nar/gkl762; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Kim H, 2004, NAT GENET, V36, P915, DOI 10.1038/ng0904-915; Kim N, 2005, GENOME RES, V15, P566, DOI 10.1101/gr.3030405; Kim YS, 2009, KOREAN J PHYSIOL PHA, V13, P483, DOI 10.4196/kjpp.2009.13.6.483; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lee JI, 2004, MOL CELLS, V17, P390; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Mader RM, 2001, J LAB CLIN MED, V137, P422, DOI 10.1067/mlc.2001.115452; Miyazaki T, 1996, J BIOL CHEM, V271, P14567, DOI 10.1074/jbc.271.24.14567; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Riva A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-33; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Sales KJ, 2010, AM J PATHOL, V176, P435, DOI 10.2353/ajpath.2010.090403; *SHANGH I BIOL SCI, NEUR NETW PROM PRED; Sharrocks Andrew D., 1994, P5; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Strippoli P, 2002, MAMM GENOME, V13, P456, DOI 10.1007/s00335-001-2157-0; Strippoli P, 2000, GENOMICS, V64, P252, DOI 10.1006/geno.2000.6127; STRIPPOLI P, 2009, BIOL CELLULARE GENET; Vitale L, 2006, ONCOL REP, V15, P1249; Vitale L, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-66; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	53	8	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24508	10.1371/journal.pone.0024508	http://dx.doi.org/10.1371/journal.pone.0024508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961037	Green Published, gold			2022-12-25	WOS:000295265100010
J	Mantopoulos, D; Murakami, Y; Comander, J; Thanos, A; Roh, M; Miller, JW; Vavvas, DG				Mantopoulos, Dimosthenis; Murakami, Yusuke; Comander, Jason; Thanos, Aristomenis; Roh, Miin; Miller, Joan W.; Vavvas, Demetrios G.			Tauroursodeoxycholic Acid (TUDCA) Protects Photoreceptors from Cell Death after Experimental Retinal Detachment	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; BILE-ACID; INDUCED APOPTOSIS; RAT HEPATOCYTES; HUNTINGTONS-DISEASE; EXPERIMENTAL-MODEL; DEGENERATION; ACTIVATION; NECROSIS; CYTOLYSIS	Background: Detachment of photoreceptors from the underlying retinal pigment epithelium is seen in various retinal disorders such as retinal detachment and age-related macular degeneration and leads to loss of photoreceptors and vision. Pharmacologic inhibition of photoreceptor cell death may prevent this outcome. This study tests whether systemic administration of tauroursodeoxycholic acid (TUDCA) can protect photoreceptors from cell death after experimental retinal detachment in rodents. Methodology/Principal Findings: Retinal detachment was created in rats by subretinal injection of hyaluronic acid. The animals were treated daily with vehicle or TUDCA (500 mg/kg). TUNEL staining was used to evaluate cell death. Photoreceptor loss was evaluated by measuring the relative thickness of the outer nuclear layer (ONL). Macrophage recruitment, oxidative stress, cytokine levels, and caspase levels were also quantified. Three days after detachment, TUDCA decreased the number of TUNEL-positive cells compared to vehicle (651 +/- 68/mm(2) vs. 1314 +/- 68/mm(2), P = 0.001) and prevented the reduction of ONL thickness ratio (0.84 +/- 0.03 vs. 0.65 +/- 0.03, P = 0.002). Similar results were obtained after 5 days of retinal detachment. Macrophage recruitment and expression levels of TNF-a and MCP-1 after retinal detachment were not affected by TUDCA treatment, whereas increases in activity of caspases 3 and 9 as well as carbonyl-protein adducts were almost completely inhibited by TUDCA treatment. Conclusions/Significance: Systemic administration of TUDCA preserved photoreceptors after retinal detachment, and was associated with decreased oxidative stress and caspase activity. TUDCA may be used as a novel therapeutic agent for preventing vision loss in diseases that are characterized by photoreceptor detachment.	[Mantopoulos, Dimosthenis; Murakami, Yusuke; Comander, Jason; Thanos, Aristomenis; Roh, Miin; Miller, Joan W.; Vavvas, Demetrios G.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Retina Serv,Angiogenesis Lab,Dept Ophthalmol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Mantopoulos, D (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Retina Serv,Angiogenesis Lab,Dept Ophthalmol, Boston, MA USA.	vavvas@meei.harvard.edu		Comander, Jason/0000-0002-4257-7145; Miller, Joan/0000-0003-2046-3996; Roh, Miin/0000-0003-3346-754X; Vavvas, Demetrios/0000-0002-8622-6478	Research to Prevent Blindness Foundation; Lions Eye Research Fund; Onassis Foundation; National Eye Institute [EY014104]; Yeatts Family Fund; NATIONAL EYE INSTITUTE [P30EY014104] Funding Source: NIH RePORTER	Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Lions Eye Research Fund; Onassis Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Yeatts Family Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The Research to Prevent Blindness Foundation, the Lions Eye Research Fund (D. G. V.), the Onassis Foundation (D. G. V.), National Eye Institute Grant EY014104 (Massachusetts Eye and Ear Infirmary core grant), and Yeatts Family Fund (D. G. V. and J.W.M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JG, 2005, AM J OPHTHALMOL, V139, P605, DOI 10.1016/j.ajo.2004.11.046; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Benz C, 1998, J HEPATOL, V28, P99, DOI 10.1016/S0168-8278(98)80208-0; Benz C, 1998, EUR J CLIN INVEST, V28, P577; Boatright JH, 2006, MOL VIS, V12, P1706; Boatright Jeffrey H, 2009, J Ocul Biol Dis Infor, V2, P149; Boisgerault F, 1996, P NATL ACAD SCI USA, V93, P3466, DOI 10.1073/pnas.93.8.3466; Campo RV, 1999, OPHTHALMOLOGY, V106, P1811, DOI 10.1016/S0161-6420(99)90353-6; Cardoso I, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-74; CHANG CJ, 1995, ARCH OPHTHALMOL-CHIC, V113, P880, DOI 10.1001/archopht.1995.01100070054025; Colell A, 2001, HEPATOLOGY, V34, P964, DOI 10.1053/jhep.2001.28510; COOK B, 1995, INVEST OPHTH VIS SCI, V36, P990; Duan WM, 2002, CELL TRANSPLANT, V11, P195; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; HAIMANN MH, 1982, ARCH OPHTHALMOL-CHIC, V100, P289; Hisatomi T, 2001, AM J PATHOL, V158, P1271, DOI 10.1016/S0002-9440(10)64078-3; Hisatomi T, 2008, J CLIN INVESTIGATION; Keene CD, 2002, P NATL ACAD SCI USA, V99, P10671, DOI 10.1073/pnas.162362299; Keene CD, 2001, EXP NEUROL, V171, P351, DOI 10.1006/exnr.2001.7755; Lamireau T, 2003, LIFE SCI, V72, P1401, DOI 10.1016/S0024-3205(02)02408-6; Lecleire-Collet A, 2005, RETINA-J RET VIT DIS, V25, P44, DOI 10.1097/00006982-200501000-00006; Liu H, 2010, EYE, V24, P137, DOI 10.1038/eye.2009.20; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Nakazawa T, 2006, MOL VIS, V12, P867; Nakazawa T, 2011, INVEST OPHTH VIS SCI, V52, P1384, DOI 10.1167/iovs.10-6509; Oveson BC, 2011, J NEUROCHEM, V116, P144, DOI 10.1111/j.1471-4159.2010.07092.x; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Phillips MJ, 2008, INVEST OPHTH VIS SCI, V49, P2148, DOI 10.1167/iovs.07-1012; Ramalho RM, 2006, J NEUROCHEM, V98, P1610, DOI 10.1111/j.1471-4159.2006.04007.x; Rodrigues CMP, 1998, MOL MED, V4, P165, DOI 10.1007/BF03401914; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Rodrigues TMP, 2002, J CEREBR BLOOD F MET, V22, P463, DOI 10.1097/00004647-200204000-00010; Roh MMY, 2011, EDARAVONE ROS SCAVEN; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Sugata K, 1996, J GASTROEN HEPATOL, V11, P451, DOI 10.1111/j.1440-1746.1996.tb00290.x; Trichonas G, 2010, P NATL ACAD SCI US; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; WILKES SR, 1982, AM J OPHTHALMOL, V94, P670, DOI 10.1016/0002-9394(82)90013-7; Zacks DN, 2003, INVEST OPHTH VIS SCI, V44, P1262, DOI 10.1167/iovs.02-0492; Zacks DN, 2004, INVEST OPHTH VIS SCI, V45, P4563, DOI 10.1167/iovs.04-0598	42	80	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24245	10.1371/journal.pone.0024245	http://dx.doi.org/10.1371/journal.pone.0024245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961034	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100006
J	Wang, ZQ; Zhang, S; Luo, C; Wu, QZ; Liu, QL; Zhou, YH; Hu, YL				Wang, Zhiqun; Zhang, Shu; Luo, Chao; Wu, Qianzhen; Liu, Qilan; Zhou, Yi-Hua; Hu, Yali			Transplacentally Acquired Maternal Antibody against Hepatitis B Surface Antigen in Infants and its Influence on the Response to Hepatitis B Vaccine	PLOS ONE			English	Article							IMMUNE-RESPONSE; HBS ANTIBODIES; VIRUS; IMMUNIZATION; IMMUNOGENICITY; INDIVIDUALS; INFECTION; EFFICACY; MICE; LIFE	Background: Passively acquired maternal antibodies in infants may inhibit active immune responses to vaccines. Whether maternal antibody against hepatitis B surface antigen (anti-HBs) in infants may influence the long-term immunogenicity of hepatitis B vaccine remains unknown. Methodology/Principal Findings: Totally 338 pairs of mothers and children were enrolled. All infants were routinely vaccinated against hepatitis B based on 0-, 1- and 6-month schedule. We characterized the transplacental transfer of maternal anti-HBs, and compared anti-HBs response in children of mothers with or without anti-HBs. In a prospective observation, all 63 anti-HBs positive mothers transferred anti-HBs to their infants; 84.1% of the infants had higher anti-HBs concentrations than their mothers. One and half years after vaccination with three doses of hepatitis B vaccine, the positive rate and geometric mean concentration (GMC) of anti-HBs in 32 infants with maternal anti-HBs were comparable with those in 32 infants without maternal antibody (90.6% vs 87.5%, P = 0.688, and 74.5 vs 73.5 mIU/ml, P = 0.742, respectively). In a retrospective analysis, five and half years after vaccination with three doses vaccine, the positive rates of anti-HBs in 88 children of mothers with anti-HBs >= 1000 mIU/ml, 94 children of mothers with anti-HBs 10-999 mIU/ml, and 61 children of mothers with anti-HBs,10 mIU/ml were 72.7%, 69.2%, and 63.9% (P = 0.521), respectively; anti-HBs GMC in these three groups were 38.9, 43.9, and 31.7 mIU/ml (P = 0.726), respectively. Conclusions/Significance: The data demonstrate that maternal anti-HBs in infants, even at high concentrations, does not inhibit the long-term immunogenicity of hepatitis B vaccine. Thus, current hepatitis B vaccination schedule for infants will be still effective in the future when most infants are positive for maternal anti-HBs due to the massive vaccination against hepatitis B.	[Wang, Zhiqun; Zhang, Shu; Luo, Chao; Wu, Qianzhen; Hu, Yali] Nanjing Univ, Sch Med, Dept Obstet & Gynecol, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Liu, Qilan] Jiangsu Family Planning Inst, Nanjing, Jiangsu, Peoples R China; [Zhou, Yi-Hua] Nanjing Univ, Sch Med, Dept Lab Med, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Zhou, Yi-Hua] Nanjing Univ, Sch Med, Dept Infect Dis, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Zhou, Yi-Hua; Hu, Yali] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Wang, ZQ (corresponding author), Nanjing Univ, Sch Med, Dept Obstet & Gynecol, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.	yzh20061111@yahoo.com; dtylhu@126.com			Health Bureau of Nanjing City [ZKM06050]; Health Department of Jiangsu Province [LJ200628, RC2007005, XK200709]; Jiangsu Science and Technology Department [BK2008501]; Population Family Planning Commission of Jiangsu Province [2011208]; National Key Basic Research Project (973 Planning), China [2010CB945104]	Health Bureau of Nanjing City; Health Department of Jiangsu Province; Jiangsu Science and Technology Department; Population Family Planning Commission of Jiangsu Province; National Key Basic Research Project (973 Planning), China(National Basic Research Program of China)	This study was supported by a grant (ZKM06050 to YHZ) for the Development of Medical Sciences from the Health Bureau of Nanjing City, by Special Grants for Leading Principal Investigators (LJ200628 to YH), for Principal Investigators (RC2007005 to YHZ), and for Maternal-Fetal Medicine (XK200709 to YH) from the Health Department of Jiangsu Province, by Natural Science grant (BK2008501 to QL) from Jiangsu Science and Technology Department, and by a research grant (2011208) from Population Family Planning Commission of Jiangsu Province, and by a grant (2010CB945104 to YH) from the National Key Basic Research Project (973 Planning), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P405; AYOOLA EA, 1987, INT J GYNECOL OBSTET, V25, P297, DOI 10.1016/0020-7292(87)90289-X; Bell BP, 2007, PEDIATR INFECT DIS J, V26, P116, DOI 10.1097/01.inf.0000253253.85640.cc; But DYK, 2008, VACCINE, V26, P6587, DOI 10.1016/j.vaccine.2008.09.034; Dagan R, 2000, PEDIATR INFECT DIS J, V19, P1045, DOI 10.1097/00006454-200011000-00004; ESTEBAN JI, 1986, J MED VIROL, V18, P381, DOI 10.1002/jmv.1890180411; Glezen WP, 2003, VACCINE, V21, P3389, DOI 10.1016/S0264-410X(03)00339-6; Hartter HK, 2000, PEDIATR INFECT DIS J, V19, P635, DOI 10.1097/00006454-200007000-00010; HEIJTINK RA, 1995, HEPATOLOGY, V22, P1078, DOI 10.1016/0270-9139(95)90612-6; Hu YL, 2008, VACCINE, V26, P6064, DOI 10.1016/j.vaccine.2008.09.014; Johansson E, 2008, VACCINE, V26, P778, DOI 10.1016/j.vaccine.2007.11.089; Junqueira ALN, 2011, MEM I OSWALDO CRUZ, V106, P113, DOI 10.1590/S0074-02762011000100018; Kurubi J, 2009, TROP MED INT HEALTH, V14, P167, DOI 10.1111/j.1365-3156.2008.02214.x; Poovorawan Y, 2011, J VIRAL HEPATITIS, V18, P369, DOI 10.1111/j.1365-2893.2010.01312.x; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Saffar MJ, 2009, EUR J CLIN MICROBIOL, V28, P845, DOI 10.1007/s10096-009-0702-z; Shokrgozar MA, 2002, VACCINE, V20, P2215, DOI 10.1016/S0264-410X(02)00116-0; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; van Nunen AB, 2002, J VIRAL HEPATITIS, V9, P221, DOI 10.1046/j.1365-2893.2002.00337.x; Wang LN, 2005, MED MICROBIOL IMMUN, V194, P33, DOI 10.1007/s00430-004-0225-2; Weeratna RD, 2001, FEMS IMMUNOL MED MIC, V30, P241, DOI 10.1016/S0928-8244(01)00231-0; XU ZY, 1995, J INFECT DIS, V171, P54, DOI 10.1093/infdis/171.1.54; Zhang S, 2010, INT J GYNECOL OBSTET, V109, P194, DOI 10.1016/j.ijgo.2010.01.002; 无, 2007, [江苏医药, Jiangsu Medical Journal], V33, P1218	26	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25130	10.1371/journal.pone.0025130	http://dx.doi.org/10.1371/journal.pone.0025130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966434	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100063
J	Southern, SL; Collard, TJ; Urban, BC; Skeen, VR; Smartt, HJ; Hague, A; Oakley, F; Townsend, PA; Perkins, ND; Paraskeva, C; Williams, AC				Southern, S. L.; Collard, T. J.; Urban, B. C.; Skeen, V. R.; Smartt, H. J.; Hague, A.; Oakley, F.; Townsend, P. A.; Perkins, N. D.; Paraskeva, C.; Williams, A. C.			BAG-1 interacts with the p50-p50 homodimeric NF-kappa B complex: implications for colorectal carcinogenesis	ONCOGENE			English	Article						NF-kappa B; BAG-1; p50 homodimers; colorectal cancer; EGFR; COX2	ALTERNATIVE TRANSLATION INITIATION; SQUAMOUS-CELL CARCINOMA; DNA-BINDING; CANCER-CELLS; TRANSCRIPTIONAL ACTIVATION; ONCOPROTEIN BCL-3; P50 HOMODIMERS; PROTEIN; EXPRESSION; RECEPTOR	Understanding the mechanisms that promote aberrant tumour cell survival is critical for the determination of novel strategies to combat colorectal cancer (CRC). We have recently shown that the anti-apoptotic protein BAG-1, highly expressed in pre-malignant and CRC tissue, can potentiate cell survival through regulating NF-kappa B transcriptional activity. In this study, we identify a novel complex between BAG-1 and the p50-p50 NF-kappa B homodimers, implicating BAG-1 as a co-regulator of an atypical NF-kappa B pathway. Importantly, the BAG-1-p50 complex was detected at gene regulatory sequences including the epidermal growth factor receptor (EGFR) and COX-2 (PTGS2) genes. Suppression of BAG-1 expression using small interfering RNA was shown to increase EGFR and suppress COX-2 expression in CRC cells. Furthermore, mouse embryonic fibroblasts derived from the NF-kappa B1 (p105/p50) knock-out mouse were used to demonstrate that p50 expression was required for BAG-1 to suppress EGFR expression. This was shown to be functionally relevant as attenuation of BAG-1 expression increased ligand activated phosphorylation of EGFR in CRC cells. In summary, this paper identifies a novel role for BAG-1 in modulating gene expression through interaction with the p50-p50 NF-kappa B complexes. Data presented led us to propose that BAG-1 can act as a selective regulator of p50-p50 NF-kappa B responsive genes in colorectal tumour cells, potentially important for the promotion of cell survival in the context of the fluctuating tumour microenvironment. As BAG-1 expression is increased in the developing adenoma through to metastatic lesions, understanding the function of the BAG-1-p50 NF-kappa B complexes may aid in identifying strategies for both the prevention and treatment of CRC. Oncogene (2012) 31, 2761-2772; doi: 10.1038/onc.2011.452; published online 3 October 2011	[Southern, S. L.; Collard, T. J.; Urban, B. C.; Skeen, V. R.; Smartt, H. J.; Paraskeva, C.; Williams, A. C.] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Hague, A.] Univ Bristol, Sch Oral & Dent Sci, Bristol BS8 1TD, Avon, England; [Oakley, F.; Perkins, N. D.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci ICaMB, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Townsend, P. A.] Univ Southampton, Sch Med, Southampton Gen Hosp, Div Canc Sci, Southampton, Hants, England	University of Bristol; University of Bristol; Newcastle University - UK; University of Southampton	Williams, AC (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	Ann.C.Williams@bristol.ac.uk	Townsend, Paul/AAF-8234-2020	Williams, Ann/0000-0002-6009-7137; Oakley, Fiona/0000-0001-8692-1836; Townsend, Paul/0000-0001-8956-9508; Urban, Bettina/0000-0002-9015-7583	Cancer Research UK; Citrina Foundation; Wellcome Trust; James Bristol Foundation; Medical Research Council; MRC [G0900535] Funding Source: UKRI; Cancer Research UK [11975] Funding Source: researchfish; Medical Research Council [G0900535] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Citrina Foundation; Wellcome Trust(Wellcome Trust); James Bristol Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Cancer Research UK programme grant, the Citrina Foundation, The Wellcome Trust and by the John James Bristol Foundation. We thank the Medical Research Council for providing an Infrastructure Award to establish the School of Medical Sciences Cell Imaging Facility at the University of Bristol.	Arhel NJ, 2003, INT J CANCER, V106, P364, DOI 10.1002/ijc.11257; Arlt A, 2002, CANCER RES, V62, P910; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Barnes JD, 2005, APOPTOSIS, V10, P301, DOI 10.1007/s10495-005-0804-8; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Brimmell M, 1999, BRIT J CANCER, V81, P1042, DOI 10.1038/sj.bjc.6690805; Cancer Research UK, 2007, BOW CANC FACTSH; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Clemo NK, 2008, CARCINOGENESIS, V29, P849, DOI 10.1093/carcin/bgn004; Cutress RI, 2003, ONCOGENE, V22, P4973, DOI 10.1038/sj.onc.1206688; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; DUCKETT CS, 1993, MOL CELL BIOL, V13, P1315, DOI 10.1128/MCB.13.3.1315; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Froesch BA, 1998, J BIOL CHEM, V273, P11660, DOI 10.1074/jbc.273.19.11660; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Gehring U, 2009, INT J MOL SCI, V10, P906, DOI 10.3390/ijms10030906; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GILMORE TD, 1988, J VIROL, V62, P703, DOI 10.1128/JVI.62.3.703-714.1988; Glass CK, 2000, GENE DEV, V14, P121; Hinitt CAM, 2010, EXP CELL RES, V316, P2042, DOI 10.1016/j.yexcr.2010.04.016; Hou SH, 2003, J BIOL CHEM, V278, P45994, DOI 10.1074/jbc.M307971200; Inan MS, 2000, AM J PHYSIOL-GASTR L, V279, pG1282, DOI 10.1152/ajpgi.2000.279.6.G1282; Jiang YX, 2009, CANCER-AM CANCER SOC, V115, P3609, DOI 10.1002/cncr.24434; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; KAMENS J, 1990, MOL CELL BIOL, V10, P2840, DOI 10.1128/MCB.10.6.2840; Karst AM, 2009, INT J CANCER, V124, P494, DOI 10.1002/ijc.23973; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; Kikuchi R, 2002, BRIT J CANCER, V87, P1136, DOI 10.1038/sj.bjc.6600579; Knowlden JM, 2008, BREAST CANCER RES TR, V111, P79, DOI 10.1007/s10549-007-9763-9; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Liu R, 1998, J BIOL CHEM, V273, P16985, DOI 10.1074/jbc.273.27.16985; Maier JV, 2010, BIOCHEM BIOPH RES CO, V401, P406, DOI 10.1016/j.bbrc.2010.09.067; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Niyaz Y, 2001, J CELL SCI, V114, P1839; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rorke S, 2001, INT J CANCER, V95, P317, DOI 10.1002/1097-0215(20010920)95:5<317::AID-IJC1055>3.0.CO;2-J; Rosati A, 2007, J CELL PHYSIOL, V210, P676, DOI 10.1002/jcp.20865; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sharp Adam, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007537; Shindoh M, 2000, ORAL ONCOL, V36, P444, DOI 10.1016/S1368-8375(00)00025-7; Smartt HJM, 2003, BRIT J CANCER, V89, P1358, DOI 10.1038/sj.bjc.6601266; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Takayama S, 1998, CANCER RES, V58, P3116; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Thornburg NJ, 2003, CANCER RES, V63, P8293; Tong X, 2004, MOL CELL BIOCHEM, V265, P171, DOI 10.1023/B:MCBI.0000044394.66951.4d; Townsend PA, 2005, INT J BIOCHEM CELL B, V37, P251, DOI 10.1016/j.biocel.2004.03.016; Weldon CB, 2001, SURGERY, V130, P143, DOI 10.1067/msy.2001.115512; WILLIAMS AC, 1993, ONCOGENE, V8, P3063; Wood J, 2009, ORAL ONCOL, V45, P94, DOI 10.1016/j.oraloncology.2008.07.013; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yang XL, 1998, ONCOGENE, V17, P981, DOI 10.1038/sj.onc.1202032; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zeiner M, 1999, P NATL ACAD SCI USA, V96, P10194, DOI 10.1073/pnas.96.18.10194; ZEINER M, 1995, P NATL ACAD SCI USA, V92, P11465, DOI 10.1073/pnas.92.25.11465; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	66	22	24	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	22					2761	2772		10.1038/onc.2011.452	http://dx.doi.org/10.1038/onc.2011.452			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	952DB	21963853	Green Accepted			2022-12-25	WOS:000304769000006
J	Wang, ZW; Li, YH; During, HJ; Li, LH				Wang, Zhengwen; Li, Yuanheng; During, Heinjo J.; Li, Linghao			Do Clonal Plants Show Greater Division of Labour Morphologically and Physiologically at Higher Patch Contrasts?	PLOS ONE			English	Article							ENVIRONMENTAL HETEROGENEITY; FRAGARIA-CHILOENSIS; PHOTOSYNTHETIC CAPACITY; RECIPROCAL PATCHINESS; STOLONIFEROUS HERB; GLECHOMA-HEDERACEA; LIGHT; INTEGRATION; PLASTICITY; GROWTH	Background: When growing in reciprocal patches in terms of availability of different resources, connected ramets of clonal plants will specialize to acquire and exchange locally abundant resources more efficiently. This has been termed division of labour. We asked whether division of labour can occur physiologically as well as morphologically and will increase with patch contrasts. Methodology/Principal Findings: We subjected connected and disconnected ramet pairs of Potentilla anserina to Control, Low, Medium and High patch contrast by manipulating light and nutrient levels for ramets in each pair. Little net benefit of inter-ramet connection in terms of biomass was detected. Shoot-root ratio did not differ significantly between paired ramets regardless of connection under Control, Low and Medium. Under High, however, disconnected shaded ramets with ample nutrients showed significantly larger shoot-root ratios (2.8 similar to 6.5 fold) than fully-lit but nutrient-deficient ramets, and than their counterparts under any other treatment; conversely, fully-lit but nutrient-deficient ramets, when connected to shaded ramets with ample nutrients, had significantly larger shoot-root ratios (2.0 similar to 4.9 fold) than the latter and than their counterparts under any other treatment. Only under High patch contrast, fully-lit ramets, if connected to shaded ones, had 8.9% higher chlorophyll content than the latter, and 22.4% higher chlorophyll content than their isolated counterparts; the similar pattern held for photosynthetic capacity under all heterogeneous treatments. Conclusions/Significance: Division of labour in clonal plants can be realized by ramet specialization in morphology and in physiology. However, modest ramet specialization especially in morphology among patch contrasts may suggest that division of labour will occur when the connected ramets grow in reciprocal patches between which the contrast exceeds a threshold. Probably, this threshold patch contrast is the outcome of the clone-wide cost-benefit tradeoff and is significant for risk-avoidance, especially in the disturbance-prone environments.	[Wang, Zhengwen] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Wang, Zhengwen; Li, Linghao] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Changes, Beijing, Peoples R China; [Li, Yuanheng] Inner Mongolia Agr Univ, Coll Ecol & Environm Sci, Hohhot, Peoples R China; [During, Heinjo J.] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Inner Mongolia Agricultural University; Utrecht University	Wang, ZW (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	wangzw@iae.ac.cn	Wang, Zhengwen/A-8292-2011		State Key Basic Research Development Program of China [2007CB106800]; Natural Science Foundation of China [30521002, 30370268]	State Key Basic Research Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Basic Research Development Program of China (2007CB106800) and Natural Science Foundation of China (30521002, 30370268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P137; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 2003, J ECOL, V91, P27, DOI 10.1046/j.1365-2745.2003.00737.x; Alpert P, 2002, FUNCT ECOL, V16, P191, DOI 10.1046/j.1365-2435.2002.00610.x; Anten NPR, 1996, FUNCT ECOL, V10, P491, DOI 10.2307/2389942; BAI B, 1994, MAIZE SCI, V2, P44; BIRCH CPD, 1994, J ECOL, V82, P653, DOI 10.2307/2261272; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; CARACO T, 1991, ECOLOGY, V72, P81, DOI 10.2307/1938904; Chu Y, 2006, J INTEGR PLANT BIOL, V48, P400, DOI 10.1111/j.1744-7909.2006.00237.x; de Kroon H, 2006, TRENDS ECOL EVOL, V21, P113, DOI 10.1016/j.tree.2005.11.021; de Kroon H, 2007, SCIENCE, V318, P1562, DOI 10.1126/science.1150726; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; Du J, 2009, ANN BOT-LONDON, V104, P335, DOI 10.1093/aob/mcp130; Eriksson O., 1990, CLONAL GROWTH PLANTS, P79; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; FRIEDMAN D, 1991, OECOLOGIA, V86, P76, DOI 10.1007/BF00317392; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; Huang BR, 2000, BOOK SOIL P, P39; Hutchings Michael J., 1999, Plant Species Biology, V14, P1, DOI 10.1046/j.1442-1984.1999.00001.x; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchings MJ, 2004, ANN BOT-LONDON, V94, P1, DOI 10.1093/aob/mch111; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Ikegami M, 2008, PLANT ECOL, V199, P55, DOI 10.1007/s11258-008-9411-4; Ikegami M, 2008, ECOL MODEL, V213, P156, DOI 10.1016/j.ecolmodel.2007.11.016; JACKSON RB, 1990, NATURE, V344, P58, DOI 10.1038/344058a0; Katahata SI, 2007, TREE PHYSIOL, V27, P199, DOI 10.1093/treephys/27.2.199; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Liao MJ, 2003, ACTA OECOL, V24, P231, DOI 10.1016/j.actao.2003.07.001; Liu J, 2008, PHOTOSYNTHETICA, V46, P299, DOI 10.1007/s11099-008-0054-4; Magyar G, 2007, NEW PHYTOL, V174, P182, DOI 10.1111/j.1469-8137.2007.01969.x; Marshall C., 1990, CLONAL GROWTH PLANTS, P23; Pate J. S., 1983, Nitrogen as an ecological factor, P225; PATE JS, 1980, ANNU REV PLANT PHYS, V31, P313, DOI 10.1146/annurev.pp.31.060180.001525; Pilon J, 2002, J ECOL, V90, P859, DOI 10.1046/j.1365-2745.2002.00716.x; Pitelka L.F., 1985, POPULATION BIOL EVOL, P399; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; SAS Institute Inc, 2004, SAS 9 1 2 QUAL TOOLS; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; SEEMANN JR, 1987, PLANT PHYSIOL, V84, P796, DOI 10.1104/pp.84.3.796; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; Stuefer JF, 1996, FUNCT ECOL, V10, P328, DOI 10.2307/2390280; Stuefer JF, 1998, ECOL MODEL, V111, P171, DOI 10.1016/S0304-3800(98)00101-X; Stuefer JF, 1999, ECOL LETT, V2, P135; STUEFER JF, 1994, OECOLOGIA, V100, P302, DOI 10.1007/BF00316958; van Kleunen M, 1999, OIKOS, V85, P135, DOI 10.2307/3546799; Wijesinghe DK, 1999, J ECOL, V87, P860, DOI 10.1046/j.1365-2745.1999.00395.x; Yu FH, 2002, ACTA BOT SIN, V44, P468	53	29	39	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25401	10.1371/journal.pone.0025401	http://dx.doi.org/10.1371/journal.pone.0025401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980447	gold, Green Published, Green Submitted			2022-12-25	WOS:000295941300029
J	Huynh, C; Poliseno, L; Segura, MF; Medicherla, R; Haimovic, A; Menendez, S; Shang, SL; Pavlick, A; Shao, YZ; Darvishian, F; Boylan, JF; Osman, I; Hernando, E				Chanh Huynh; Poliseno, Laura; Segura, Miguel F.; Medicherla, Ratna; Haimovic, Adele; Menendez, Silvia; Shang, Shulian; Pavlick, Anna; Shao, Yongzhao; Darvishian, Farbod; Boylan, John F.; Osman, Iman; Hernando, Eva			The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST-CANCER; EXPRESSION; NOTCH; RESISTANCE; BRAF; SUBPOPULATION; PROGRESSION; PATHWAYS; TARGET	Several reports have demonstrated a role for aberrant NOTCH signaling in melanoma genesis and progression, prompting us to explore if targeting this pathway is a valid therapeutic approach against melanoma. We targeted NOTCH signaling using RO4929097, a novel inhibitor of gamma secretase, which is a key component of the enzymatic complex that cleaves and activates NOTCH. The effects of RO4929097 on the oncogenic and stem cell properties of a panel of melanoma cell lines were tested both in vitro and in vivo, using xenograft models. In human primary melanoma cell lines, RO4929097 decreased the levels of NOTCH transcriptional target HES1. This was accompanied by reduced proliferation and impaired ability to form Colonies in soft agar and to organize in tridimensional spheres. Moreover, RO4929097 affected the growth of human primary melanoma xenograft in NOD/SCID/IL2gammaR-/- mice and inhibited subsequent formation in a serial xenotransplantation model, suggesting that inhibition of NOTCH signaling suppresses the tumor initiating potential of melanoma cells. In addition, RO4929097 decreased tumor volume and blocked the invasive growth pattern of metastatic melanoma cell lines in vivo. Finally, increased gene expression of NOTCH signaling components correlated with shorter post recurrence survival in metastatic melanoma cases. Our data support NOTCH inhibition as a promising therapeutic strategy against melanoma.	[Chanh Huynh; Pavlick, Anna; Osman, Iman] NYU, Sch Med, Dept Med, New York, NY 10012 USA; [Poliseno, Laura; Medicherla, Ratna; Haimovic, Adele; Osman, Iman] NYU, Sch Med, Dept Dermatol, New York, NY USA; [Segura, Miguel F.; Menendez, Silvia; Darvishian, Farbod; Hernando, Eva] NYU, Sch Med, Dept Pathol, New York, NY USA; [Shang, Shulian; Shao, Yongzhao] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Chanh Huynh; Poliseno, Laura; Segura, Miguel F.; Medicherla, Ratna; Haimovic, Adele; Menendez, Silvia; Pavlick, Anna; Osman, Iman; Hernando, Eva] NYU, Sch Med, Interdisciplinary Melanoma Cooperat Grp, New York, NY USA; [Boylan, John F.] Hoffmann La Roche Inc, Discovery Oncol, Nutley, NJ 07110 USA	New York University; New York University; New York University; New York University; New York University; Roche Holding	Huynh, C (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10012 USA.	Iman.Osman@nyumc.org; Eva.Hernando-Monge@nyumc.org	Shang, Shulian/A-2173-2013; Segura, Miguel F/J-4749-2013; Poliseno, Laura/B-5711-2012	Segura, Miguel F/0000-0003-0916-3618; Hernando, Eva/0000-0003-1023-0312; Poliseno, Laura/0000-0001-6557-955X	New York University; National Cancer Center; National Institute of Health [T32 CA09454-19]; New York University CCGS [5 P30 CA016087]; Chemotherapy Foundation; Marc Jacobs campaign; NIH/NCI [P30 CA016087-30]; NATIONAL CANCER INSTITUTE [P30CA016087, T32CA009454] Funding Source: NIH RePORTER	New York University; National Cancer Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University CCGS; Chemotherapy Foundation; Marc Jacobs campaign; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CH has been supported by the New York University Physician Scientist Training Program, a National Cancer Center Postdoctoral fellowship and the National Institute of Health T32 CA09454-19 fellowship training grant. MFS is supported by a National Cancer Center Postdoctoral fellowship. This work was funded by the New York University CCGS support grant (5 P30 CA016087), Chemotherapy Foundation and the Marc Jacobs campaign to support melanoma research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the NYU Histopathology and Immunohistochemistry cores (supported in part by NIH/NCI P30 CA016087-30 grant at the NYU Cancer Institute) for tissue processing and histological staining, and Robert S. Kerbel (University of Toronto) for providing us WM239/131/4-5B1 (5B1) cells.	Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chang HH, 2010, CLIN CANCER RES, V16, P4411, DOI 10.1158/1078-0432.CCR-09-3360; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Gilbert CA, 2010, CANCER RES, V70, P6870, DOI 10.1158/0008-5472.CAN-10-1378; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Grudzien P, 2010, ANTICANCER RES, V30, P3853; Handolias D, 2010, BRIT J CANCER, V102, P1219, DOI 10.1038/sj.bjc.6605635; Hardy KM, 2010, CANCER RES, V70, P10340, DOI 10.1158/0008-5472.CAN-10-0705; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kirkwood JM, 2004, CLIN CANCER RES, V10, P1670, DOI 10.1158/1078-0432.CCR-1103-3; Klein JP, 2002, CANC TREAT, V113, P37; Klein WM, 2007, MODERN PATHOL, V20, P102, DOI 10.1038/modpathol.3800720; Ko JM, 2011, J PATHOL, V223, P241, DOI 10.1002/path.2804; Kwong Lawrence, 2007, Adv Dermatol, V23, P99, DOI 10.1016/j.yadr.2007.07.015; La Porta CAM, 2009, CURR CANCER DRUG TAR, V9, P391, DOI 10.2174/156800909788166574; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Luistro L, 2009, CANCER RES, V69, P7672, DOI 10.1158/0008-5472.CAN-09-1843; Massi D, 2006, MODERN PATHOL, V19, P246, DOI 10.1038/modpathol.3800526; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Molife R, 2002, CRIT REV ONCOL HEMAT, V44, P81, DOI 10.1016/S1040-8428(02)00014-8; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Postovit LM, 2008, PIGM CELL MELANOMA R, V21, P348, DOI 10.1111/j.1755-148X.2008.00463.x; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Qin JZ, 2004, MOL CANCER THER, V3, P895; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rose AE, 2011, CANCER RES, V71, P2561, DOI 10.1158/0008-5472.CAN-10-2958; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Shackleton M, 2010, MOL ONCOL, V4, P451, DOI 10.1016/j.molonc.2010.06.006; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Thurber AE, 2011, ONCOGENE, V30, P3036, DOI 10.1038/onc.2011.33; Yao K, 2011, INT J SURG PATHOL	53	47	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25264	10.1371/journal.pone.0025264	http://dx.doi.org/10.1371/journal.pone.0025264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980408	gold, Green Submitted, Green Published			2022-12-25	WOS:000295939600017
J	Simm, C; Luan, CH; Weiss, E; O'Halloran, T				Simm, Claudia; Luan, Chi-Hao; Weiss, Eric; O'Halloran, Thomas			High-Throughput Screen for Identifying Small Molecules That Target Fungal Zinc Homeostasis	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; UPTAKE SYSTEM; TRANSCRIPTIONAL ACTIVATOR; INTRACELLULAR ZINC; CANDIDA-ALBICANS; YEAST; SUSCEPTIBILITY; VIRULENCE; GROWTH	Resistance to traditional antifungal drugs has increased significantly over the past three decades making identification of novel antifungal agents and new targets an emerging priority. Based on the extraordinary zinc requirement of several fungal pathogens and their well-established sensitivity to zinc deprivation, we developed an efficient cell-based screen to identify new antifungal drugs that target the zinc homeostasis machinery. The screen is based on the zinc-regulated transcription factor Zap1 of Saccharomyces cerevisiae, which regulates transcription of genes like the high-affinity zinc transporter ZRT1. We generated a genetically modified strain of S. cerevisae that reports intracellular zinc deficiency by placing the coding sequence of green fluorescent protein (GFP) under the control of the Zap1-regulated ZRT1 promoter. After showing that the GFP fluorescence signal correlates with low intracellular zinc concentrations in this strain, a protocol was developed for screening small-molecule libraries for compounds that induce Zap1-dependent GFP expression. Comparison of control compounds and known modulators of metal metabolism from the library reveals a robust screen (Z' = 0.74) and validates this approach to the discovery of new classes of antifungal compounds that interfere with the intracellular zinc homeostasis. Given that growth of many pathogenic organisms is significantly impaired by zinc limitation; these results identify new types of antifungal drugs that target critical nutrient acquisition pathways.	[Simm, Claudia; Luan, Chi-Hao; Weiss, Eric; O'Halloran, Thomas] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Luan, Chi-Hao; Weiss, Eric; O'Halloran, Thomas] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [O'Halloran, Thomas] Northwestern Univ, Dept Chem, Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University	Simm, C (corresponding author), Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA.	t-ohalloran@northwestern.edu	O'Halloran, Thomas/ABE-6125-2021	O'Halloran, Thomas/0000-0001-8732-5059	Viamet Pharmaceuticals, Inc.; National Institutes of Health [R37 GM038784]; NASA [NNA04CC36G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038784, R37GM038784] Funding Source: NIH RePORTER	Viamet Pharmaceuticals, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this study was provided by grants from Viamet Pharmaceuticals, Inc. and National Institutes of Health grant R37 GM038784 (to TVO). Use of the ICP-MS in the Northwestern University Quantitative Bioelemental Imaging Center was supported by a grant from NASA (NNA04CC36G). Viamet Pharmaceuticals, Inc. provided advice on selection of the commercially available compound library. None of the funders provided input on data collection, evaluation, analysis or preparation of the manuscript.	Ammendola S, 2007, INFECT IMMUN, V75, P5867, DOI 10.1128/IAI.00559-07; Chen CY, 2001, FEMS MICROBIOL LETT, V202, P67, DOI 10.1111/j.1574-6968.2001.tb10781.x; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Fahrni CJ, 1999, J AM CHEM SOC, V121, P11448, DOI 10.1021/ja992709f; Frommer WB, 2009, CHEM SOC REV, V38, P2833, DOI 10.1039/b907749a; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Gow Neil A. R., 1997, Current Topics in Medical Mycology, V8, P43; ISMAIL A, 1986, MYCOPATHOLOGIA, V94, P45, DOI 10.1007/BF00437261; Kalliopi B, 2009, REV MED MICROBIOL, V20, P91, DOI 10.1097/MRM.0b013e3283341397; Kim MJ, 2008, J MICROBIOL BIOTECHN, V18, P242; Kim S, 2004, J VET MED SCI, V66, P1059, DOI 10.1292/jvms.66.1059; Lamore SD, 2011, BIOMETALS; Lee JY, 2004, J BIOL CHEM, V279, P8602, DOI 10.1074/jbc.M309730200; Li C, 2010, J ALZHEIMER IN PRESS; Lulloff SJ, 2004, J LAB CLIN MED, V144, P208, DOI 10.1016/j.lab.2004.07.007; Misteli T, 1997, NAT BIOTECHNOL, V15, P961, DOI 10.1038/nbt1097-961; Mondal R, 2009, ANTIVIR RES, V82, P82, DOI 10.1016/j.antiviral.2008.12.012; Moreno MA, 2007, MOL MICROBIOL, V64, P1182, DOI 10.1111/j.1365-2958.2007.05726.x; Nguyen MH, 1996, AM J MED, V100, P617, DOI 10.1016/S0002-9343(95)00010-0; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sangamwar AT, 2008, INDIAN J PHARM SCI, V70, P423, DOI 10.4103/0250-474X.44588; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sensi SL, 1997, J NEUROSCI, V17, P9554; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Sucher AJ, 2009, ANN PHARMACOTHER, V43, P1647, DOI 10.1345/aph.1M237; Taki M, 2004, J AM CHEM SOC, V126, P712, DOI 10.1021/ja039073j; Thompson ED, 2002, J EXP BIOL, V205, P3367; Vicentefranqueira R, 2005, EUKARYOT CELL, V4, P837, DOI 10.1128/EC.4.5.837-848.2005; Weston BF, 2009, INFECT IMMUN, V77, P2840, DOI 10.1128/IAI.01299-08; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Winters MS, 2010, J INFECT DIS; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; YAMAGUCHI H, 1975, J GEN MICROBIOL, V86, P370, DOI 10.1099/00221287-86-2-370; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhu M, 2000, ANAL BIOCHEM, V287, P210, DOI 10.1006/abio.2000.4875	39	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25136	10.1371/journal.pone.0025136	http://dx.doi.org/10.1371/journal.pone.0025136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980385	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600011
J	Nacev, BA; Liu, JO				Nacev, Benjamin A.; Liu, Jun O.			Synergistic Inhibition of Endothelial Cell Proliferation, Tube Formation, and Sprouting by Cyclosporin A and Itraconazole	PLOS ONE			English	Article							GROWTH-FACTOR; CANDIDA-ALBICANS; ANGIOGENESIS; CALCINEURIN; EFFICACY; TARGET; CYP51	Pathological angiogenesis contributes to a number of diseases including cancer and macular degeneration. Although angiogenesis inhibitors are available in the clinic, their efficacy against most cancers is modest due in part to the existence of alternative and compensatory signaling pathways. Given that angiogenesis is dependent on multiple growth factors and a broad signaling network in vivo, we sought to explore the potential of multidrug cocktails for angiogenesis inhibition. We have screened 741 clinical drug combinations for the synergistic inhibition of endothelial cell proliferation. We focused specifically on existing clinical drugs since the re-purposing of clinical drugs allows for a more rapid and cost effective transition to clinical studies when compared to new drug entities. Our screen identified cyclosporin A (CsA), an immunosuppressant, and itraconazole, an antifungal drug, as a synergistic pair of inhibitors of endothelial cell proliferation. In combination, the IC50 dose of each drug is reduced by 3 to 9 fold. We also tested the ability of the combination to inhibit endothelial cell tube formation and sprouting, which are dependent on two essential processes in angiogenesis, endothelial cell migration and differentiation. We found that CsA and itraconazole synergistically inhibit tube network size and sprout formation. Lastly, we tested the combination on human foreskin fibroblast viability as well as Jurkat T cell and HeLa cell proliferation, and found that endothelial cells are selectively targeted. Thus, it is possible to combine existing clinical drugs to synergistically inhibit in vitro models of angiogenesis. This strategy may be useful in pursuing the next generation of antiangiogenesis therapy.	[Nacev, Benjamin A.; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Nacev, Benjamin A.] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD 21205 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Nacev, BA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	joliu@jhu.edu			NCI [RO1 CA122814]; National Center for Research Resources (NCRR); National Institutes of Health (NIH) [T32GM07309]; NIH Roadmap for Medical Research [UL1 RR 025005]; Flight Attendant Medical Research Institute; Keck Foundation; Walsh Prostate Cancer Fund; Commonwealth Foundation; NATIONAL CANCER INSTITUTE [R01CA122814] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; Keck Foundation(W.M. Keck Foundation); Walsh Prostate Cancer Fund; Commonwealth Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NCI [Grant RO1 CA122814], the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research [Grant UL1 RR 025005], the Flight Attendant Medical Research Institute Fund, the Keck Foundation, the Walsh Prostate Cancer Fund, and the Commonwealth Foundation (J.O.L.), and by the NIH Medical Scientist Training Program [Grant T32GM07309] (B.A.N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benelli U, 1997, INVEST OPHTH VIS SCI, V38, P274; Blansfield JA, 2008, CLIN CANCER RES, V14, P270, DOI 10.1158/1078-0432.CCR-07-1562; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chong CR, 2006, J MED CHEM, V49, P2677, DOI 10.1021/jm051225t; Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Giavazzi R, 2003, AM J PATHOL, V162, P1913, DOI 10.1016/S0002-9440(10)64325-8; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Korff T, 1999, J CELL SCI, V112, P3249; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; Lamb DC, 1999, YEAST, V15, P755, DOI 10.1002/(SICI)1097-0061(19990630)15:9&lt;755::AID-YEA417&gt;3.0.CO;2-8; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Nacev BA, 2011, J PHARMACOL EXP THER, V338, P466, DOI 10.1124/jpet.111.180851; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; SHARPE RJ, 1989, ARCH DERMATOL, V125, P1359, DOI 10.1001/archderm.125.10.1359; Shim JS, 2010, JNCI-J NATL CANCER I, V102, P1855, DOI 10.1093/jnci/djq457; Trosken ER, 2006, TOXICOLOGY, V228, P24, DOI 10.1016/j.tox.2006.08.007; Webb JL, 1961, ENZYMES METABOL INH, V1, P66; Wei S, 2010, ACS MED CHEM LETT, V1, P155; Welti JC, 2011, ONCOGENE, V30, P1183, DOI 10.1038/onc.2010.503; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	37	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24793	10.1371/journal.pone.0024793	http://dx.doi.org/10.1371/journal.pone.0024793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969860	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900011
J	Zhang, GH; Lv, MM; Wang, S; Chen, L; Qian, NS; Tang, Y; Zhang, XD; Ren, PC; Gao, CJ; Sun, XD; Xu, LX				Zhang, Gui-He; Lv, Miao-Miao; Wang, Shuang; Chen, Lei; Qian, Nian-Song; Tang, Yu; Zhang, Xu-Dong; Ren, Peng-Cheng; Gao, Chang-Jun; Sun, Xu-De; Xu, Li-Xian			Spinal Astrocytic Activation Is Involved in a Virally-Induced Rat Model of Neuropathic Pain	PLOS ONE			English	Article							VARICELLA-ZOSTER-VIRUS; PERIPHERAL-NERVE INJURY; DORSAL-ROOT GANGLIA; POSTHERPETIC NEURALGIA; NITRIC-OXIDE; GLIAL ACTIVATION; PERSISTENT PAIN; HERPES-ZOSTER; PROINFLAMMATORY CYTOKINES; INFLAMMATORY HYPERALGESIA	Postherpetic neuralgia (PHN), the most common complication of herpes zoster (HZ), plays a major role in decreased life quality of HZ patients. However, the neural mechanisms underlying PHN remain unclear. Here, using a PHN rat model at 2 weeks after varicella zoster virus infection, we found that spinal astrocytes were dramatically activated. The mechanical allodynia and spinal central sensitization were significantly attenuated by intrathecally injected L-alpha-aminoadipate (astrocytic specific inhibitor) whereas minocycline (microglial specific inhibitor) had no effect, which indicated that spinal astrocyte but not microglia contributed to the chronic pain in PHN rat. Further study was taken to investigate the molecular mechanism of astrocyte-incudced allodynia in PHN rat at post-infection 2 weeks. Results showed that nitric oxide (NO) produced by inducible nitric oxide synthase mediated the development of spinal astrocytic activation, and activated astrocytes dramatically increased interleukin-1 beta expression which induced N-methyl-D-aspartic acid receptor (NMDAR) phosphorylation in spinal dorsal horn neurons to strengthen pain transmission. Taken together, these results suggest that spinal activated astrocytes may be one of the most important factors in the pathophysiology of PHN and "NO-Astrocyte-Cytokine-NMDAR-Neuron'' pathway may be the detailed neural mechanisms underlying PHN. Thus, inhibiting spinal astrocytic activation may represent a novel therapeutic strategy for clinical management of PHN.	[Zhang, Gui-He; Gao, Chang-Jun; Sun, Xu-De] Fourth Mil Med Univ, Dept Anesthesiol, Tangdu Hosp, Xian 710032, Peoples R China; [Zhang, Gui-He; Lv, Miao-Miao; Xu, Li-Xian] Fourth Mil Med Univ, Dept Anesthesiol, Sch Stomatol, Xian 710032, Peoples R China; [Wang, Shuang] Fourth Mil Med Univ, Cent Lab, Xian 710032, Peoples R China; [Chen, Lei] Naval Gen Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China; [Qian, Nian-Song] Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Tang, Yu] PLA 302 Hosp, Dept Ultrasound, Beijing, Peoples R China; [Zhang, Xu-Dong; Ren, Peng-Cheng] Fourth Mil Med Univ, Dept Orthopaed, Tangdu Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Air Force Military Medical University	Zhang, GH (corresponding author), Fourth Mil Med Univ, Dept Anesthesiol, Tangdu Hosp, Xian 710032, Peoples R China.	gaocj74@163.com; sunxd65@163.com; hangguihefmmu@163.com			National Natural Science Foundation of China [81071527, 30972833]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (Nos. 81071527, 30972833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bowsher D, 1995, NEUROLOGY, V45, pS56, DOI 10.1212/WNL.45.12_Suppl_8.S56; Bowsher D, 1997, POSTGRAD MED J, V73, P623, DOI 10.1136/pgmj.73.864.623; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brenner GJ, 2004, EUR J NEUROSCI, V20, P375, DOI 10.1111/j.1460-9568.2004.03506.x; Chen SR, 2000, NEUROSCIENCE, V101, P759, DOI 10.1016/S0306-4522(00)00415-2; Cho IH, 2006, BRAIN RES, V1072, P208, DOI 10.1016/j.brainres.2005.12.039; Christoph T, 2006, NEUROPHARMACOLOGY, V51, P12, DOI 10.1016/j.neuropharm.2006.02.007; Coyle DE, 1998, GLIA, V23, P75; Dalziel RG, 2004, BRAIN RES REV, V46, P234, DOI 10.1016/j.brainresrev.2004.07.008; Dayer JM, 2003, RHEUMATOLOGY, V42, P3, DOI 10.1093/rheumatology/keg326; Delaney A, 2009, NEUROTHERAPEUTICS, V6, P630, DOI 10.1016/j.nurt.2009.07.005; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; Dworkin RH, 1996, PAIN, V67, P241, DOI 10.1016/0304-3959(96)03122-3; Feng QX, 2010, NEUROSCIENCE, V167, P501, DOI 10.1016/j.neuroscience.2010.02.005; Fleetwood-Walker SM, 1999, J GEN VIROL, V80, P2433, DOI 10.1099/0022-1317-80-9-2433; Garry EM, 2005, PAIN, V118, P97, DOI 10.1016/j.pain.2005.08.003; GILDEN DH, 1994, NEW ENGL J MED, V330, P932, DOI 10.1056/NEJM199403313301312; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hao JX, 1999, ACTA ANAESTH SCAND, V43, P1027, DOI 10.1034/j.1399-6576.1999.431010.x; Holguin A, 2004, PAIN, V110, P517, DOI 10.1016/j.pain.2004.02.018; Hua XY, 2005, EUR J NEUROSCI, V22, P2431, DOI 10.1111/j.1460-9568.2005.04451.x; Jin SX, 2003, J NEUROSCI, V23, P4017; Khurgel M, 1996, GLIA, V16, P351, DOI 10.1002/(SICI)1098-1136(199604)16:4<351::AID-GLIA7>3.0.CO;2-2; Liao YH, 2011, BRAIN RES, V1368, P324, DOI 10.1016/j.brainres.2010.10.044; Liu J, 2007, NEUROSCI LETT, V412, P268, DOI 10.1016/j.neulet.2006.11.022; Lydick E, 1995, NEUROLOGY, V45, pS52, DOI 10.1212/WNL.45.12_Suppl_8.S52; Medhurst SJ, 2008, PAIN, V138, P61, DOI 10.1016/j.pain.2007.11.006; Mei XP, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-50; MELLER ST, 1993, PAIN, V52, P127, DOI 10.1016/0304-3959(93)90124-8; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Rowbotham MC, 1996, BRAIN, V119, P347, DOI 10.1093/brain/119.2.347; SADZOTDELVAUX C, 1990, J NEUROSCI RES, V26, P83, DOI 10.1002/jnr.490260110; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Sweitzer S, 2001, NEUROSCIENCE, V103, P529, DOI 10.1016/S0306-4522(00)00574-1; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Ultenius C, 2006, NEUROSCI LETT, V399, P85, DOI 10.1016/j.neulet.2006.01.018; Viviani B, 2003, J NEUROSCI, V23, P8692; Wang W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006973; Watkins LR, 2003, ADV EXP MED BIOL, V521, P1; Watkins LR, 2001, PAIN, V93, P201, DOI 10.1016/S0304-3959(01)00359-1; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zanchet EM, 2004, BRAIN RES, V1021, P101, DOI 10.1016/j.brainres.2004.06.041; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023; Zhang RX, 2005, PAIN, V118, P125, DOI 10.1016/j.pain.2005.08.001; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	52	30	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e23059	10.1371/journal.pone.0023059	http://dx.doi.org/10.1371/journal.pone.0023059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969850	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900001
J	Eber, MR; Shardell, M; Schweizer, ML; Laxminarayan, R; Perencevich, EN				Eber, Michael R.; Shardell, Michelle; Schweizer, Marin L.; Laxminarayan, Ramanan; Perencevich, Eli N.			Seasonal and Temperature-Associated Increases in Gram-Negative Bacterial Bloodstream Infections among Hospitalized Patients	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ACINETOBACTER; SYSTEMS	Background: Knowledge of seasonal trends in hospital-associated infection incidence may improve surveillance and help guide the design and evaluation of infection prevention interventions. We estimated seasonal variation in the frequencies of inpatient bloodstream infections (BSIs) caused by common bacterial pathogens and examined associations of monthly BSI frequencies with ambient outdoor temperature, precipitation, and humidity levels. Methods: A database containing blood cultures from 132 U. S. hospitals collected between January 1999 and September 2006 was assembled. The database included monthly counts of inpatient blood cultures positive for several clinically important Gram-negative bacteria (Acinetobacter spp, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa) and Gram-positive bacteria (Enterococcus spp and Staphylococcus aureus). Monthly mean temperature, total precipitation, and mean relative humidity in the postal ZIP codes of participating hospitals were obtained from national meteorological databases. Results: A total of 211,697 inpatient BSIs were reported during 9,423 hospital-months. Adjusting for long-term trends, BSIs caused by each Gram-negative organism examined were more frequent in summer months compared with winter months, with increases ranging from 12.2% for E. coli (95% CI 9.2-15.4) to 51.8% for Acinetobacter (95% CI 41.1-63.2). Summer season was associated with 8.7% fewer Enterococcus BSIs (95% CI 11.0-5.8) and no significant change in S. aureus BSI frequency relative to winter. Independent of season, monthly humidity, monthly precipitation, and long-term trends, each 5.6 degrees C (10 degrees F) rise in mean monthly temperature corresponded to increases in Gram-negative bacterial BSI frequencies ranging between 3.5% for E. coli (95% CI 2.1-4.9) to 10.8% for Acinetobacter (95% CI 6.9-14.7). The same rise in mean monthly temperature corresponded to an increase of 2.2% in S. aureus BSI frequency (95% CI 1.3-3.2) but no significant change in Enterococcus BSI frequency. Conclusions: Summer season and higher mean monthly outdoor temperature are associated with substantially increased	[Eber, Michael R.; Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Shardell, Michelle] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Schweizer, Marin L.; Perencevich, Eli N.] Univ Iowa, Carver Sch Med, Iowa City, IA USA; [Laxminarayan, Ramanan] Princeton Environm Inst, Princeton, NJ USA; [Perencevich, Eli N.] Iowa City VA Med Ctr, Iowa City, IA USA	University System of Maryland; University of Maryland Baltimore; University of Iowa; Princeton University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Eber, MR (corresponding author), Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90089 USA.	mre_001@usc.edu	Laxminarayan, Ramanan/ABD-5050-2021	Schweizer, Marin/0000-0002-3604-0093; Perencevich, Eli/0000-0002-3721-3355	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	The funding source for this study was the Robert Wood Johnson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2008, J INFECT DIS, V197, P752, DOI 10.1086/527486; [Anonymous], OVERVIEW NATIONWIDE; Fisman DN, 2005, J INFECT DIS, V192, P2066, DOI 10.1086/498248; Freeman J, 2009, INFECT CONT HOSP EP, V30, P813, DOI 10.1086/597506; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864; Kaier K, 2010, INFECT CONT HOSP EP, V31, P1154, DOI 10.1086/656748; Magnus G., 1844, ANN PHYS CHEM, V61, P225, DOI [10.1002/andp.18441370202, DOI 10.1002/ANDP.18441370202]; MAKI DG, 1982, NEW ENGL J MED, V307, P1562, DOI 10.1056/NEJM198212163072507; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; McDonald LC, 1999, CLIN INFECT DIS, V29, P1133, DOI 10.1086/313441; McDonald LC, 1998, PEDIATR INFECT DIS J, V17, P716, DOI 10.1097/00006454-199808000-00011; Mermel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017925; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RATKOWSKY DA, 1983, J BACTERIOL, V154, P1222, DOI 10.1128/JB.154.3.1222-1226.1983; Sahm DF, 1999, CLIN INFECT DIS, V29, P259, DOI 10.1086/520195; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; SMITH PW, 1977, JAMA-J AM MED ASSOC, V237, P795, DOI 10.1001/jama.237.8.795; Smith TL, 2002, INFECT CONT HOSP EP, V23, P239, DOI 10.1086/502042; Tetens O., 1930, Z GEOPHYS, V6, P297, DOI DOI 10.1016/J.FOODCHEM.2008.07.023; Trent MS, 2004, BIOCHEM CELL BIOL, V82, P71, DOI 10.1139/o03-070	22	98	99	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25298	10.1371/journal.pone.0025298	http://dx.doi.org/10.1371/journal.pone.0025298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966489	Green Submitted, gold, Green Published			2022-12-25	WOS:000295932100034
J	Namba, T; Mochizuki, H; Suzuki, R; Onodera, M; Yamaguchi, M; Namiki, H; Shioda, S; Seki, T				Namba, Takashi; Mochizuki, Hideki; Suzuki, Ryusuke; Onodera, Masafumi; Yamaguchi, Masahiro; Namiki, Hideo; Shioda, Seiji; Seki, Tatsunori			Time-Lapse Imaging Reveals Symmetric Neurogenic Cell Division of GFAP-Expressing Progenitors for Expansion of Postnatal Dentate Granule Neurons	PLOS ONE			English	Article							NEURAL STEM-CELLS; ADULT HIPPOCAMPAL NEUROGENESIS; CENTRAL-NERVOUS-SYSTEM; SLICE CULTURES; RADIAL GLIA; RAT HIPPOCAMPUS; INTERMEDIATE PROGENITORS; TRANSCRIPTION FACTORS; PRECURSOR CELLS; IN-VIVO	Granule cells in the hippocampus, a region critical for memory and learning, are generated mainly during the early postnatal period but neurogenesis continues in adulthood. Postnatal neuronal production is carried out by primary progenitors that express glial fibrillary acidic protein (GFAP) and they are assumed to function as stem cells. A central question regarding postnatal dentate neurogenesis is how astrocyte-like progenitors produce neurons. To reveal cell division patterns and the process of neuronal differentiation of astrocyte-like neural progenitors, we performed time-lapse imaging in cultured hippocampal slices from early postnatal transgenic mice with mouse GFAP promoter-controlled enhanced green fluorescent protein (mGFAP-eGFP Tg mice) in combination with a retrovirus carrying a red fluorescent protein gene. Our results showed that the majority of GFAP-eGFP+ progenitor cells that express GFAP, Sox2 and nestin divided symmetrically to produce pairs of GFAP+ cells (45%) or pairs of neuron-committed cells (45%), whereas a minority divided asymmetrically to generate GFAP+ cells and neuron-committed cells (10%). The present results suggest that a substantial number of GFAP-expressing progenitors functions as transient amplifying progenitors, at least in an early postnatal dentate gyrus, although a small population appears to be stem cell-like progenitors. From the present data, we discuss possible cell division patterns of adult GFAP+ progenitors.	[Namba, Takashi; Seki, Tatsunori] Juntendo Univ, Sch Med, Dept Anat, Tokyo 113, Japan; [Namba, Takashi; Namiki, Hideo] Waseda Univ, Sch Sci & Engn, Tokyo 169, Japan; [Mochizuki, Hideki] Kitasato Univ, Sch Med, Dept Neurol, Kanagawa, Japan; [Suzuki, Ryusuke; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan; [Onodera, Masafumi] Univ Tsukuba, Dept Hematol, Inst Clin Med, Ibaraki, Japan; [Yamaguchi, Masahiro] Univ Tokyo, Dept Otolaryngol, Tokyo 113, Japan; [Yamaguchi, Masahiro] Univ Tokyo, Dept Physiol, Grad Sch Med, Tokyo, Japan; [Seki, Tatsunori] Tokyo Med & Dent Univ, Dept Histol & Neuroanat, Tokyo, Japan	Juntendo University; Waseda University; Kitasato University; Showa University; University of Tsukuba; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU)	Namba, T (corresponding author), Juntendo Univ, Sch Med, Dept Anat, Tokyo 113, Japan.	sekit@tokyo-med.ac.jp	Namba, Takashi/AAE-4439-2022; Namba, Takashi/ABF-4571-2020	Namba, Takashi/0000-0003-4875-666X	Japan Society for the Promotion of Science [17500238, 22500306]; Japanese Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [22500306] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (17500238 and 22500306) and in part by a High Technology Research Center Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Hodge RD, 2011, DEV NEUROBIOL, V71, P680, DOI 10.1002/dneu.20882; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Kamada M, 2004, EUR J NEUROSCI, V20, P2499, DOI 10.1111/j.1460-9568.2004.03721.x; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Mathews EA, 2010, J COMP NEUROL, V518, P4479, DOI 10.1002/cne.22489; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Muramatsu R, 2007, NEUROSCIENCE, V148, P593, DOI 10.1016/j.neuroscience.2007.06.040; Nacher J, 2001, EUR J NEUROSCI, V13, P512, DOI 10.1046/j.0953-816x.2000.01424.x; Namba T, 2005, EUR J NEUROSCI, V22, P1928, DOI 10.1111/j.1460-9568.2005.04396.x; Namba T, 2007, J NEUROSCI RES, V85, P1704, DOI 10.1002/jnr.21295; Namba T, 2009, GLIA, V57, P1082, DOI 10.1002/glia.20831; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2007, ARCH NEUROL-CHICAGO, V64, P639, DOI 10.1001/archneur.64.5.639; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Ozen I, 2007, EUR J NEUROSCI, V25, P2591, DOI 10.1111/j.1460-9568.2007.05541.x; Parent JM, 1997, J NEUROSCI, V17, P3727; Raineteau O, 2004, MOL CELL NEUROSCI, V26, P241, DOI 10.1016/j.mcn.2004.01.003; Raineteau O, 2006, MOL CELL NEUROSCI, V32, P344, DOI 10.1016/j.mcn.2006.05.006; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seki T, 2007, J COMP NEUROL, V502, P275, DOI 10.1002/cne.21301; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Suzuki A, 2002, J NEUROCHEM, V82, P953, DOI 10.1046/j.1471-4159.2002.01048.x; Suzuki R, 2003, MOL BRAIN RES, V115, P10, DOI 10.1016/S0169-328X(03)00172-4; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yokose J, 2011, NEUROSCI RES, V69, P223, DOI 10.1016/j.neures.2010.11.010; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	56	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25303	10.1371/journal.pone.0025303	http://dx.doi.org/10.1371/journal.pone.0025303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966492	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100043
J	Skapski, A; Hygonenq, MC; Sagne, E; Guiral, S; Citti, C; Baranowski, E				Skapski, Agnes; Hygonenq, Marie-Claude; Sagne, Eveline; Guiral, Sebastien; Citti, Christine; Baranowski, Eric			Genome-Scale Analysis of Mycoplasma agalactiae Loci Involved in Interaction with Host Cells	PLOS ONE			English	Article							SIGNATURE-TAGGED MUTAGENESIS; TRANSPOSON MUTAGENESIS; STRESS TOLERANCE; TRIGGER FACTOR; CLUSTER; GENES; TRANSCRIPTION; IDENTIFICATION; PATHOGENICITY; GALLISEPTICUM	Mycoplasma agalactiae is an important pathogen of small ruminants, in which it causes contagious agalactia. It belongs to a large group of "minimal bacteria" with a small genome and reduced metabolic capacities that are dependent on their host for nutrients. Mycoplasma survival thus relies on intimate contact with host cells, but little is known about the factors involved in these interactions or in the more general infectious process. To address this issue, an assay based on goat epithelial and fibroblastic cells was used to screen a M. agalactiae knockout mutant library. Mutants with reduced growth capacities in cell culture were selected and 62 genomic loci were identified as contributing to this phenotype. As expected for minimal bacteria, "transport and metabolism" was the functional category most commonly implicated in this phenotype, but 50% of the selected mutants were disrupted in coding sequences (CDSs) with unknown functions, with surface lipoproteins being most commonly represented in this category. Since mycoplasmas lack a cell wall, lipoproteins are likely to be important in interactions with the host. A few intergenic regions were also identified that may act as regulatory sequences under co-culture conditions. Interestingly, some mutants mapped to gene clusters that are highly conserved across mycoplasma species but located in different positions. One of these clusters was found in a transcriptionally active region of the M. agalactiae chromosome, downstream of a cryptic promoter. A possible scenario for the evolution of these loci is discussed. Finally, several CDSs identified here are conserved in other important pathogenic mycoplasmas, and some were involved in horizontal gene transfer with phylogenetically distant species. These results provide a basis for further deciphering functions mediating mycoplasma-host interactions.	[Skapski, Agnes; Hygonenq, Marie-Claude; Sagne, Eveline; Guiral, Sebastien; Citti, Christine; Baranowski, Eric] IHAP, INRA, UMR1225, F-31931 Toulouse, France; [Skapski, Agnes; Hygonenq, Marie-Claude; Sagne, Eveline; Guiral, Sebastien; Citti, Christine; Baranowski, Eric] Univ Toulouse, INP, ENVT, IHAP,UMR1225, Toulouse, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Skapski, A (corresponding author), IHAP, INRA, UMR1225, F-31931 Toulouse, France.	e.baranowski@envt.fr	Baranowski, Eric/I-2655-2013	Baranowski, Eric/0000-0003-0660-1854; Citti, Christine/0000-0003-4754-6003	INRA; CIRAD; DGER	INRA; CIRAD; DGER	This work was supported by a joint grant from INRA (www.inra.fr) and CIRAD (www.cirad.fr) and by a doctoral fellowship to AS from INRA and DGER (www.envt.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Baranowski E, 2010, INFECT IMMUN, V78, P1542, DOI 10.1128/IAI.01195-09; Barre A, 2004, NUCLEIC ACIDS RES, V32, pD307, DOI 10.1093/nar/gkh114; Bergonier D, 1997, REV SCI TECH OIE, V16, P848, DOI 10.20506/rst.16.3.1062; Bigot A, 2006, APPL ENVIRON MICROB, V72, P6623, DOI 10.1128/AEM.00624-06; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; Burrack LS, 2007, CURR OPIN MICROBIOL, V10, P4, DOI 10.1016/j.mib.2006.11.004; Chopra-Dewasthaly R, 2005, FEMS MICROBIOL LETT, V253, P89, DOI 10.1016/j.femsle.2005.09.021; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; Citti C, 2010, FUTURE MICROBIOL, V5, P1073, DOI 10.2217/FMB.10.71; EDWARD DG, 1967, SCIENCE, V155, P1694, DOI 10.1126/science.155.3770.1694; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Frey J, 2002, MOL BIOL PATHOGENICI, P73; Gardner SW, 2010, MICROBIOL-SGM, V156, P2305, DOI 10.1099/mic.0.038760-0; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Hasselbring BA, 2006, J BACTERIOL, V188, P6335, DOI 10.1128/JB.00698-06; Hudson P, 2006, INFECT IMMUN, V74, P931, DOI 10.1128/IAI.74.2.931-939.2006; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lluch-Senar M, 2007, MICROBIOL-SGM, V153, P2743, DOI 10.1099/mic.0.2006/007559-0; Marenda M, 2006, J BACTERIOL, V188, P4137, DOI 10.1128/JB.00114-06; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; Mselli-Lakhal L, 2001, VET RES, V32, P429, DOI 10.1051/vetres:2001135; Mudahi-Orenstein S, 2003, INFECT IMMUN, V71, P3812, DOI 10.1128/IAI.71.7.3812-3820.2003; Nouvel LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-86; Pettersson B, 1996, INT J SYST BACTERIOL, V46, P1093, DOI 10.1099/00207713-46-4-1093; Pfutzner H, 1996, REV SCI TECH OIE, V15, P1477, DOI 10.20506/rst.15.4.987; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rincon-Enriquez G, 2008, MOL MICROBIOL, V67, P1257, DOI 10.1111/j.1365-2958.2008.06118.x; Runyen-Janecky L, 2008, INFECT IMMUN, V76, P1083, DOI 10.1128/IAI.01211-07; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Sirand-Pugnet P, 2007, RES MICROBIOL, V158, P754, DOI 10.1016/j.resmic.2007.09.007; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Teixeira MFD, 1997, AM J VET RES, V58, P579; Uchiyama I, 2003, NUCLEIC ACIDS RES, V31, P58, DOI 10.1093/nar/gkg109; Weiner J, 2000, NUCLEIC ACIDS RES, V28, P4488, DOI 10.1093/nar/28.22.4488; Wen ZT, 2005, INFECT IMMUN, V73, P219, DOI 10.1128/IAI.73.1.219-225.2005; Zimmerman CU, 2005, FEMS MICROBIOL LETT, V253, P315, DOI 10.1016/j.femsle.2005.09.054	42	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25291	10.1371/journal.pone.0025291	http://dx.doi.org/10.1371/journal.pone.0025291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966487	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100041
J	Alvarez-Rueda, N; Desselle, A; Cochonneau, D; Chaumette, T; Clemenceau, B; Leprieur, S; Bougras, G; Supiot, S; Mussini, JM; Barbet, J; Saba, J; Paris, F; Aubry, J; Birkle, S				Alvarez-Rueda, Nidia; Desselle, Ariane; Cochonneau, Denis; Chaumette, Tanguy; Clemenceau, Beatrice; Leprieur, Stephanie; Bougras, Gwenola; Supiot, Stephane; Mussini, Jean-Marie; Barbet, Jacques; Saba, Julie; Paris, Francois; Aubry, Jacques; Birkle, Stephane			A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; ISOTYPE-SWITCH VARIANTS; PHASE-I TRIAL; ANTI-GD2 ANTIBODY; FLOW-CYTOMETRY; O-ACETYLATION; NEUROBLASTOMA; CELLS; CANCER; APOPTOSIS	Background: Monoclonal antibodies (mAb) against GD2 ganglioside have been shown to be effective for the treatment of neuroblastoma. Beneficial actions are, however, associated with generalized pain due to the binding of anti-GD2 mAbs to peripheral nerve fibers followed by complement activation. Neuroblastoma cells that express GD2 also express its O-acetyl derivative, O-acetyl-GD2 ganglioside (OAcGD2). Hence, we investigated the distribution of OAcGD2 in human tissues using mAb 8B6 to study the cross-reactivity of mAb 8B6 with human tissues. Methodology/Principal Findings: The distribution of OAcGD2 was performed in normal and malignant tissues using an immunoperoxydase technique. Anti-tumor properties of mAb 8B6 were studied in vitro and in vivo in a transplanted tumor model in mice. We found that OAcGD2 is not expressed by peripheral nerve fibers. Furthermore, we demonstrated that mAb 8B6 was very effective in the in vitro and in vivo suppression of the growth of tumor cells. Importantly, mAb 8B6 anti-tumor efficacy was comparable to that of mAb 14G2a specific to GD2. Conclusion/Significance: Development of therapeutic antibodies specific to OAcGD2 may offer treatment options with reduced adverse side effects, thereby allowing dose escalation of antibodies.	[Alvarez-Rueda, Nidia] Univ Nantes, Dept Parasitol & Mycol Med,Ctr Rech Cancerol Nant, UFR Sci Pharmaceut & Biolog,Inserm, IICiMED UPRES EA 1155,Nantes Atlantique Univ, Nantes, France; [Mussini, Jean-Marie] Ctr Hospitalier Univ Nantes, Ctr Reference Maladies Neuro Musculaires Rares Na, Nantes, France; [Saba, Julie] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Alvarez-Rueda, N (corresponding author), Univ Nantes, Dept Parasitol & Mycol Med,Ctr Rech Cancerol Nant, UFR Sci Pharmaceut & Biolog,Inserm, IICiMED UPRES EA 1155,Nantes Atlantique Univ, Nantes, France.	Stephane.Birkle@univ-nantes.fr	Supiot, Stéphane/M-1586-2015; Chaumette, Tanguy/C-4219-2019; CLEMENCEAU, Béatrice BC/L-2605-2015; Barbet, Jacques/AAE-7089-2020; Paris, francois E/L-4915-2015; Barbet, Jacques/L-4866-2015	Supiot, Stéphane/0000-0003-2094-1708; Barbet, Jacques/0000-0002-9188-984X; Paris, francois E/0000-0002-0176-7348; Barbet, Jacques/0000-0002-9188-984X; ALVAREZ RUEDA, Nidia/0000-0002-5629-1930; Chaumette, Tanguy/0000-0002-5830-8767	Agence Nationale pour la Recherche; Comite Departemental du Maine et Loire et de la Vendee de la Ligue Nationale Contre le Cancer; Institut National du Cancer and Canceropole Grand Ouest; Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Comite Departemental du Maine et Loire et de la Vendee de la Ligue Nationale Contre le Cancer; Institut National du Cancer and Canceropole Grand Ouest(Institut National du Cancer (INCA) France); Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale pour la Recherche (to NAR); Comite Departemental du Maine et Loire et de la Vendee de la Ligue Nationale Contre le Cancer; Institut National du Cancer and Canceropole Grand Ouest (MAB IMPACT, IMProving ACTivation of FcgRIIIa-expressing effector cells, pharmacogenetic-based optimistation of monoclonal antibody therapy for cancer, federative project) (to GB); the Ministere de l'Enseignement Superieur et de la Recherche (to AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aixinjueluo W, 2005, J BIOL CHEM, V280, P29828, DOI 10.1074/jbc.M414041200; Alvarez-Rueda N, 2007, CLIN CANCER RES, V13, p5613S, DOI 10.1158/1078-0432.CCR-07-1057; AZEREDO DS, 2002, J EXP MED, V195, P665; Bergman I, 2000, CANCER IMMUNOL IMMUN, V49, P259, DOI 10.1007/s002620000120; CAHAN LD, 1982, P NATL ACAD SCI-BIOL, V79, P7629, DOI 10.1073/pnas.79.24.7629; Cerato E, 1997, HYBRIDOMA, V16, P307, DOI 10.1089/hyb.1997.16.307; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen HY, 2002, J EXP MED, V196, P1529, DOI 10.1084/jem.20021915; CHERESH DA, 1986, CANCER RES, V46, P5112; Cheung NKV, 2006, J CLIN ONCOL, V24, P2885, DOI 10.1200/JCO.2005.04.6011; CHEUNG NKV, 1987, J CLIN ONCOL, V5, P1430, DOI 10.1200/JCO.1987.5.9.1430; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Erdmann M, 2006, GLYCOCONJUGATE J, V23, P627, DOI 10.1007/s10719-006-9000-5; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; GUNJI Y, 1989, J IMMUNOL, V142, P1748; HANDGRETINGER R, 1992, CANCER IMMUNOL IMMUN, V35, P199, DOI 10.1007/BF01756188; Imai M, 2005, CANCER RES, V65, P10562, DOI 10.1158/0008-5472.CAN-05-1894; Kohla G, 2002, NEUROCHEM RES, V27, P583, DOI 10.1023/A:1020211714104; Kowalczyk A, 2009, CANCER LETT, V281, P171, DOI 10.1016/j.canlet.2009.02.040; Lode HN, 1997, J NATL CANCER I, V89, P1586, DOI 10.1093/jnci/89.21.1586; Lynch CM, 2009, MABS-AUSTIN, V1, P2, DOI 10.4161/mabs.1.1.7377; Martinez C, 2007, BLOOD, V109, P4245, DOI 10.1182/blood-2006-08-039347; MATTHAY KK, 1993, J CLIN ONCOL, V11, P2226, DOI 10.1200/JCO.1993.11.11.2226; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Matthay KK, 1997, ONCOLOGY, V11, P1869; MUJOO K, 1989, CANCER RES, V49, P2857; Mukherjee K, 2008, J CELL BIOCHEM, V105, P724, DOI 10.1002/jcb.21867; MURRAY JL, 1994, J CLIN ONCOL, V12, P184, DOI 10.1200/JCO.1994.12.1.184; Nakamura K, 2001, CANCER IMMUNOL IMMUN, V50, P275, DOI 10.1007/PL00006689; Ravindranath MH, 2007, BIOCHEM BIOPH RES CO, V353, P251, DOI 10.1016/j.bbrc.2006.12.001; SALEH MN, 1992, CANCER RES, V52, P4342; SCATCHARD G, 1949, CHEM REV, V44, P7, DOI 10.1021/cr60137a002; SCHULZ G, 1984, CANCER RES, V44, P5914; SJOBERG ER, 1992, J BIOL CHEM, V267, P16200; SJOGREN HO, 1965, EXP CELL RES, V40, P208, DOI 10.1016/0014-4827(65)90319-8; *SOC AC, 2009, CANC FACTS FIG 2009; Sorkin LS, 2010, PAIN, V149, P135, DOI 10.1016/j.pain.2010.01.024; VANHOOIJDONK CAEM, 1994, CYTOMETRY, V17, P185, DOI 10.1002/cyto.990170212; Wilkinson RW, 2001, J IMMUNOL METHODS, V258, P183, DOI 10.1016/S0022-1759(01)00474-4; YE JN, 1992, INT J CANCER, V50, P197, DOI 10.1002/ijc.2910500207; Yoshida S, 2001, CANCER RES, V61, P4244; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Yuki N, 1997, J NEUROL SCI, V149, P127, DOI 10.1016/S0022-510X(97)05390-2; Zeng GC, 1999, BIOCHEMISTRY-US, V38, P8762, DOI 10.1021/bi9906726; Zeng Y, 2005, MOL IMMUNOL, V42, P1311, DOI 10.1016/j.molimm.2004.12.018; Zhang H, 1998, CANCER RES, V58, P2844	46	59	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25220	10.1371/journal.pone.0025220	http://dx.doi.org/10.1371/journal.pone.0025220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966461	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100073
J	Menju, T; Hashimoto, S; Hashimoto, A; Otsuka, Y; Handa, H; Ogawa, E; Toda, Y; Wada, H; Date, H; Sabe, H				Menju, Toshi; Hashimoto, Shigeru; Hashimoto, Ari; Otsuka, Yutaro; Handa, Haruka; Ogawa, Eiji; Toda, Yoshinobu; Wada, Hiromi; Date, Hiroshi; Sabe, Hisataka			Engagement of Overexpressed Her2 with GEP100 Induces Autonomous Invasive Activities and Provides a Biomarker for Metastases of Lung Adenocarcinoma	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; HER-2/NEU OVEREXPRESSION; GENE AMPLIFICATION; CANCER; EXPRESSION; ARF6; TRASTUZUMAB; ACTIVATION; MUTATIONS; CARCINOMA	Overexpression of Her2/ErbB2/Neu in cancer is often correlated with recurrent distant metastasis, although the mechanism still remains largely elusive. We have previously shown that EGFR, when tyrosine-phosphorylated, binds to GEP100/BRAG2 to activate Arf6, which induces cancer invasion and metastasis. We now show that overexpressed Her2 in lung adenocarcinoma cells also employs GEP100. Like EGFR-GEP100 binding, this association is primarily mediated by the pleckstrin homology (PH) domain of GEP100 and Tyr1139/Tyr1196 of Her2. Tyr1139/Tyr1196 are autonomously phosphorylated, when Her2 is overexpressed. Accordingly, invasive activities mediated by the Her2-GEP100 pathway are not dependent on external factors. Blocking Her2-GEP100 binding, as well as its signaling pathway all inhibit cancer invasive activities. Moreover, our clinical study indicates that co-overexpression of Her2 with GEP100 in primary lung adenocarcinomas of patients is correlated with the presence of their node-metastasis with a statistical significance. Since the GEP100 PH domain interacts with both Her2 and EGFR, targeting this domain may provide novel cancer therapeutics.	[Menju, Toshi; Wada, Hiromi; Date, Hiroshi] Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto, Japan; [Hashimoto, Shigeru; Hashimoto, Ari; Otsuka, Yutaro; Handa, Haruka; Sabe, Hisataka] Hokkaido Univ, Dept Mol Biol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Ogawa, Eiji; Toda, Yoshinobu] Kyoto Univ Hosp, Lab Diagnost Pathol, Kyoto 606, Japan	Kyoto University; Hokkaido University; Kyoto University	Menju, T (corresponding author), Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto, Japan.	sabeh@med.hokudai.ac.jp	Hashimoto, Shigeru/D-7138-2012; Hashimoto, Ari/D-7125-2012; Sabe, Hisataka/A-4066-2012; Sabe, Hisataka/GPF-4385-2022	Handa, Haruka/0000-0002-8557-7479; Menju, Toshi/0000-0002-7341-6002	Ministry of Education, Science, Sports and Culture of Japan (MESSC); Takeda Foundation for Promotion of Science; Grants-in-Aid for Scientific Research [23590323] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan (MESSC)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Foundation for Promotion of Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (MESSC) and Takeda Foundation for Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bunn PA, 2001, CLIN CANCER RES, V7, P3239; Clamon G, 2005, CANCER-AM CANCER SOC, V103, P1670, DOI 10.1002/cncr.20950; Cox G, 2001, INT J CANCER, V92, P480, DOI 10.1002/ijc.1214; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Giatromanolaki A, 1996, ANTICANCER RES, V16, P3819; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hirsch FR, 2004, SEMIN ONCOL, V31, P75, DOI 10.1053/j.seminoncol.2003.12.018; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Hutcheson IR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1754; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; KERN JA, 1990, CANCER RES, V50, P5184; Kim IY, 2009, CANCER LETT, V275, P227, DOI 10.1016/j.canlet.2008.10.013; Lader AS, 2004, CANCER BIOL THER, V3, P624, DOI 10.4161/cbt.3.7.914; Meert AP, 2003, BRIT J CANCER, V89, P959, DOI 10.1038/sj.bjc.6601252; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Motoyama AB, 2002, CANCER RES, V62, P3151; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nakamura H, 2005, CANCER-AM CANCER SOC, V103, P1865, DOI 10.1002/cncr.20957; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Park DI, 2007, INT J COLORECTAL DIS, V22, P491, DOI 10.1007/s00384-006-0192-8; Park DI, 2006, DIGEST DIS SCI, V51, P1371, DOI 10.1007/s10620-005-9057-1; Potti A, 2003, CLIN CANCER RES, V9, P4872; Riou G, 2001, INT J CANCER, V95, P266, DOI 10.1002/1097-0215(20010720)95:4<266::AID-IJC1045>3.0.CO;2-E; SAMANTA A, 1994, P NATL ACAD SCI USA, V91, P1711, DOI 10.1073/pnas.91.5.1711; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Sonobe M, 2006, J MOL DIAGN, V8, P351, DOI 10.2353/jmoldx.2006.050132; Swanton C, 2006, CLIN CANCER RES, V12, p4377S, DOI 10.1158/1078-0432.CCR-06-0115; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Thomas M, 1999, EUR RESPIR J, V13, P424, DOI 10.1183/09031936.99.13242499; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yokotsuka M, 2011, BREAST CANCER RES TR, V126, P311, DOI 10.1007/s10549-010-0896-x; YU DH, 1994, CANCER RES, V54, P3260	40	29	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25301	10.1371/journal.pone.0025301	http://dx.doi.org/10.1371/journal.pone.0025301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966491	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100084
J	Wu, C; Li, GX; Zhu, J; Cui, YH				Wu, Cen; Li, Gengxin; Zhu, Jun; Cui, Yuehua			Functional Mapping of Dynamic Traits with Robust t-Distribution	PLOS ONE			English	Article							GENETIC ARCHITECTURE; MODEL; EM; SHAPE	Functional mapping has been a powerful tool in mapping quantitative trait loci (QTL) underlying dynamic traits of agricultural or biomedical interest. In functional mapping, multivariate normality is often assumed for the underlying data distribution, partially due to the ease of parameter estimation. The normality assumption however could be easily violated in real applications due to various reasons such as heavy tails or extreme observations. Departure from normality has negative effect on testing power and inference for QTL identification. In this work, we relax the normality assumption and propose a robust multivariate t-distribution mapping framework for QTL identification in functional mapping. Simulation studies show increased mapping power and precision with the t distribution than that of a normal distribution. The utility of the method is demonstrated through a real data analysis.	[Wu, Cen; Li, Gengxin] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA; [Zhu, Jun; Cui, Yuehua] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Michigan State University; Zhejiang University	Wu, C (corresponding author), Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA.	cui@stt.msu.edu	Cui, Yuehua/E-8004-2010; Zhu, Jun/B-9945-2009; Cui, Yuehua/A-3529-2008	Cui, Yuehua/0000-0001-8099-1753; Cui, Yuehua/0000-0001-8099-1753	National Science Foundation [DMS-0707031]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant DMS-0707031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHURCHILL GA, 1994, GENETICS, V138, P963; Cui YH, 2008, STAT APPL GENET MOL, V7; Cui YH, 2006, PHYSIOL GENOMICS, V25, P458, DOI 10.1152/physiolgenomics.00181.2005; Cui YH, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-6; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; GABRIEL KR, 1962, ANN MATH STAT, V33, P201, DOI 10.1214/aoms/1177704724; Huang N, 1997, MOL BREEDING, V3, P105, DOI 10.1023/A:1009683603862; Jaffrezic F, 2003, GENET RES, V82, P55, DOI 10.1017/S0016672303006281; JIANG CJ, 1995, GENETICS, V140, P1111; KIRKPATRICK M, 1989, J MATH BIOL, V27, P429, DOI 10.1007/BF00290638; LANDER ES, 1989, GENETICS, V121, P185; Lin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-138; LIU CH, 1995, STAT SINICA, V5, P19; Ma CX, 2002, GENETICS, V161, P1751; Peng J, 2006, MAPPING QUANTI UNPUB; Pletcher SD, 1999, GENETICS, V153, P825; Shoham S, 2002, PATTERN RECOGN, V35, P1127, DOI 10.1016/S0031-3203(01)00080-2; von Rohr P, 2002, GENET SEL EVOL, V34, P1, DOI [10.1186/1297-9686-34-1-1, 10.1051/gse:2001001]; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; Wu R., 2007, STAT GENETICS QUANTI; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Wu RL, 2004, GENETICS, V166, P1541, DOI 10.1534/genetics.166.3.1541; Wu S, 2007, BIOINFORMATICS, V23, pI569, DOI 10.1093/bioinformatics/btm164; Yan JQ, 1998, THEOR APPL GENET, V97, P267, DOI 10.1007/s001220050895; Yang J, 2009, BIOMETRICS, V65, P30, DOI 10.1111/j.1541-0420.2008.01063.x; Yap JS, 2009, BIOMETRICS, V65, P1068, DOI 10.1111/j.1541-0420.2009.01222.x; Zhao W, 2005, BIOINFORMATICS, V21, P2469, DOI 10.1093/bioinformatics/bti382	27	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24902	10.1371/journal.pone.0024902	http://dx.doi.org/10.1371/journal.pone.0024902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966378	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100026
J	Zang, YG; Kammerer, B; Eisenkolb, M; Lohr, K; Kiefer, H				Zang, Yuguo; Kammerer, Bernd; Eisenkolb, Maike; Lohr, Katrin; Kiefer, Hans			Towards Protein Crystallization as a Process Step in Downstream Processing of Therapeutic Antibodies: Screening and Optimization at Microbatch Scale	PLOS ONE			English	Article							STABILITY; MACROMOLECULES; PURIFICATION; NUCLEATION; CRYSTALS; INSULIN; PHASE	Crystallization conditions of an intact monoclonal IgG4 (immunoglobulin G, subclass 4) antibody were established in vapor diffusion mode by sparse matrix screening and subsequent optimization. The procedure was transferred to microbatch conditions and a phase diagram was built showing surprisingly low solubility of the antibody at equilibrium. With up-scaling to process scale in mind, purification efficiency of the crystallization step was investigated. Added model protein contaminants were excluded from the crystals to more than 95%. No measurable loss of Fc-binding activity was observed in the crystallized and redissolved antibody. Conditions could be adapted to crystallize the antibody directly from concentrated and diafiltrated cell culture supernatant, showing purification efficiency similar to that of Protein A chromatography. We conclude that crystallization has the potential to be included in downstream processing as a low-cost purification or formulation step.	[Zang, Yuguo; Eisenkolb, Maike] Biberach Univ Appl Sci, Inst Pharmaceut Biotechnol, Biberach, Germany; [Lohr, Katrin] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany	Boehringer Ingelheim	Zang, YG (corresponding author), Biberach Univ Appl Sci, Inst Pharmaceut Biotechnol, Biberach, Germany.	zang@hochschule-bc.de		Kiefer, Hans/0000-0002-8574-9867	BMBF (Federal Ministry of Education and Research, Germany) [0315338A]; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; Boehringer Ingelheim GmbH	BMBF (Federal Ministry of Education and Research, Germany)(Federal Ministry of Education & Research (BMBF)); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany(Boehringer Ingelheim); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	This program is supported by BMBF (Federal Ministry of Education and Research, Germany), grant no. 0315338A (http://www.bmbf.de/en/index.php), and Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany (http://www.boehringer-ingelheim.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KL is employed at Boehringer Ingelheim GmbH, who contributed material (antibody mAb04c) and a minor part of financial support (<15%) to this project. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahamed T, 2007, BIOPHYS J, V93, P610, DOI 10.1529/biophysj.106.098293; Basu SK, 2004, EXPERT OPIN BIOL TH, V4, P301, DOI 10.1517/eobt.4.3.301.27331; Bergfors T., 2009, PROTEIN CRYSTALLIZAT; BOISTELLE R, 1988, J CRYST GROWTH, V90, P14, DOI 10.1016/0022-0248(88)90294-1; Bonnete F, 2002, ACTA CRYSTALLOGR D, V58, P1571, DOI 10.1107/S090744490201418X; BRANGE J, 1992, PHARMACEUT RES, V9, P715, DOI 10.1023/A:1015835017916; Brange J., 1987, GALENICS INSULIN; GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216; Jacobsen C, 1998, BIOTECHNOL BIOENG, V57, P666, DOI 10.1002/(SICI)1097-0290(19980320)57:6<666::AID-BIT4>3.0.CO;2-J; JUDGE RA, 1995, BIOTECHNOL BIOENG, V48, P316, DOI 10.1002/bit.260480404; Klyushnichenko V, 2003, CURR OPIN DRUG DISC, V6, P848; Kuznetsov YG, 2001, J CRYST GROWTH, V232, P30, DOI 10.1016/S0022-0248(01)01058-2; LACMANN R, 1958, GROWTH PERFECTION CR; Lewus RA, 2011, BIOTECHNOL PROGR, V27, P280, DOI 10.1002/btpr.536; Mullin J. W., 1993, CRYSTALLIZATION; MYERSON AS, 1990, ACS S SERIES, V438; NAONO H, 1965, B CHEM SOC JPN, V38, P80, DOI 10.1246/bcsj.38.80; Ng JD, 1996, J CRYST GROWTH, V168, P50, DOI 10.1016/0022-0248(96)00362-4; PANEC M, 2006, MICROBELIBRARY PLAQU; Peters J, 2005, PROTEIN EXPRES PURIF, V39, P43, DOI 10.1016/j.pep.2004.09.011; Pikal MJ, 1997, PHARMACEUT RES, V14, P1379, DOI 10.1023/A:1012164520429; Shenoy B, 2001, BIOTECHNOL BIOENG, V73, P358, DOI 10.1002/bit.1069; Vitzthum F, 1999, ANAL BIOCHEM, V276, P59, DOI 10.1006/abio.1999.4298	23	34	36	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25282	10.1371/journal.pone.0025282	http://dx.doi.org/10.1371/journal.pone.0025282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966480	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100079
J	Huang, M; Anand, S; Murphy, EA; Desgrosellier, JS; Stupack, DG; Shattil, SJ; Schlaepfer, DD; Cheresh, DA				Huang, M.; Anand, S.; Murphy, E. A.; Desgrosellier, J. S.; Stupack, D. G.; Shattil, S. J.; Schlaepfer, D. D.; Cheresh, D. A.			EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation	ONCOGENE			English	Article						pancreatic cancer; Rap1; CAS; EGFR; metastasis; tyrosine phosphorylation	GROWTH-FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION SITES; DOWN-REGULATION; INTEGRIN ACTIVATION; TUMOR PROGRESSION; CANCER-CELLS; CROSS-TALK; EXPRESSION; MIGRATION; RAS	Tyrosine kinase receptors have an essential role in various aspects of tumor progression. In particular, epidermal growth factor receptor (EGFR) and its ligands have been implicated in the growth and dissemination of a wide array of human carcinomas. Here, we describe an EGFR-mediated signaling pathway that regulates human pancreatic carcinoma cell invasion and metastasis, yet does not influence the growth of primary tumors. In fact, ligation/activation of EGFR induces Src-dependent phosphorylation of two critical tyrosine residues of p130CAS, leading to the assembly of a Crk-associated substrate (CAS)/Nck1 complex that promotes Ras-associated protein-1 (Rap1) signaling. Importantly, GTP loading of Rap1 is specifically required for pancreatic carcinoma cell migration on vitronectin but not on collagen. Furthermore, Rap1 activation is required for EGFR-mediated metastasis in vivo without impacting primary tumor growth. These findings identify a molecular pathway that promotes the invasive/metastatic properties of human pancreatic carcinomas driven by EGFR. Oncogene (2012) 31, 2783-2793; doi: 10.1038/onc.2011.450; published online 3 October 2011	[Huang, M.; Anand, S.; Murphy, E. A.; Desgrosellier, J. S.; Stupack, D. G.; Cheresh, D. A.] Moores Univ Calif San Diego, Ctr Canc, Dept Pathol, La Jolla, CA 92093 USA; [Shattil, S. J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Cheresh, DA (corresponding author), Moores Univ Calif San Diego, Ctr Canc, Dept Pathol, Room 2344,3855 Hlth Sci Dr,MC 0803, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu	ANAND, SUDARSHAN/I-5316-2019; Desgrosellier, Jay S/A-8756-2008	ANAND, SUDARSHAN/0000-0002-4969-6884; Huang, Miller/0000-0002-3371-0100	NIH [CA107263, HL56595, HL47900, CA102310, CA045726]; NATIONAL CANCER INSTITUTE [R01CA095262, R01CA045726, R01CA107263, T32CA121938, R01CA102310] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056595] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr Steven K Hanks for the donation of the CAS mutant plasmids and Dr David J Shields for helpful discussion. This work was supported by NIH Grants CA107263 (DGS), HL56595 and HL47900 (SJS), CA102310 (DDS), and CA045726 (DAC).	Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Brooks PC, 1997, J CLIN INVEST, V99, P1390, DOI 10.1172/JCI119298; Bruns CJ, 2000, CANCER RES, V60, P2926; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Faller BA, 2009, BIOL-TARGETS THER, V3, P419; Frische EW, 2010, DEV BIOL, V340, P1, DOI 10.1016/j.ydbio.2009.12.043; Furstenau DK, 2011, BREAST CANCER RES TR, V129, P361, DOI 10.1007/s10549-010-1227-y; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Goldberg GS, 2003, J BIOL CHEM, V278, P46533, DOI 10.1074/jbc.M307526200; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Jenei V, 2005, EXP CELL RES, V310, P463, DOI 10.1016/j.yexcr.2005.08.010; Kim H, 1999, EXP CELL RES, V253, P78, DOI 10.1006/excr.1999.4706; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Lotz M, 2003, J SURG RES, V109, P123, DOI 10.1016/S0022-4804(02)00100-2; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Matsumoto S, 2006, INT J CANCER, V119, P1491, DOI 10.1002/ijc.21940; Mitra RS, 2008, CANCER RES, V68, P3959, DOI 10.1158/0008-5472.CAN-07-2755; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Morgan MA, 2008, CLIN CANCER RES, V14, P5142, DOI 10.1158/1078-0432.CCR-07-4072; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Ohba Y, 2003, EMBO J, V22, P859, DOI 10.1093/emboj/cdg087; Papouchado B, 2005, MODERN PATHOL, V18, P1329, DOI 10.1038/modpathol.3800427; Payne SL, 2006, J CELL BIOCHEM, V98, P827, DOI 10.1002/jcb.20792; Peace BE, 2003, EXP CELL RES, V289, P317, DOI 10.1016/S0014-4827(03)00280-5; Pryczynicz A, 2008, ANTICANCER RES, V28, P1399; Retta SF, 2006, EUR J CELL BIOL, V85, P283, DOI 10.1016/j.ejcb.2005.09.007; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Rivera F, 2009, CANCER TREAT REV, V35, P335, DOI 10.1016/j.ctrv.2008.11.007; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Sakakibara A, 2002, J CELL SCI, V115, P4915, DOI 10.1242/jcs.00207; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Thomas RM, 2007, CANCER RES, V67, P6075, DOI 10.1158/0008-5472.CAN-06-4128; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Tsygankova OA, 2007, MOL CELL BIOL, V27, P6647, DOI 10.1128/MCB.00155-07; Tsygankova OM, 2010, MOL CELL BIOL, V30, P3262, DOI 10.1128/MCB.01345-09; Ueno Y, 2008, INT J CANCER, V123, P340, DOI 10.1002/ijc.23465; Wolpin BM, 2007, CANCER RES, V67, P7923, DOI 10.1158/0008-5472.CAN-07-0373; Xu JG, 2007, CELL SIGNAL, V19, P1575, DOI 10.1016/j.cellsig.2007.02.004; Yaman E, 2009, FEBS J, V276, P4607, DOI 10.1111/j.1742-4658.2009.07166.x; Zhang LZ, 2006, CANCER RES, V66, P898, DOI 10.1158/0008-5472.CAN-05-3025	51	47	49	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	22					2783	2793		10.1038/onc.2011.450	http://dx.doi.org/10.1038/onc.2011.450			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	952DB	21963850	Green Accepted			2022-12-25	WOS:000304769000008
J	Terashima, T; Kojima, H; Chan, L				Terashima, Tomoya; Kojima, Hideto; Chan, Lawrence			Bone marrow expression of poly(ADP-ribose) polymerase underlies diabetic neuropathy via hematopoietic-neuronal cell fusion	FASEB JOURNAL			English	Article						dorsal root ganglion; DRG; polyploid; proinsulin; oxidative stress; TNF-alpha	TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; INSULIN-PRODUCING CELLS; PURKINJE NEURONS; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; DEFICIENT MICE; STEM-CELLS; ACTIVATION; INFLAMMATION	Diabetic neuropathy is the most common diabetic complication. The pathogenetic pathways include oxidative stress, advanced glycation end product (AGE) formation, protein kinase C, and NF-kappa B activation, as well as increased polyol flux. These metabolic perturbations affect neurons, Schwann cells, and vasa nervorum, which are held to be the primary cell types involved. We hypothesize that diabetes induces the appearance of abnormal bone marrow-derived cells (BMDCs) that fuse with neurons in the dorsal root ganglia (DRG) of mice, leading to diabetic neuropathy. Neuronal poly(ADP-ribose) polymerase-1 (PARP-1) activation in diabetes is known to generate free radical and oxidant-induced injury and poly(ADP-ribose) polymer formation, resulting in neuronal death and dysfunction, culminating in neuropathy. We further hypothesize that BM-specific PARP expression plays a determining role in disease pathogenesis. Here we show that bone marrow transplantation (BMT) of PARP-knockout (PARPKO) cells to wild-type mice protects against, whereas BMT of wild-type cells to PARPKO mice, which are normally "neuropathy-resistant," confers susceptibility to, diabetic neuropathy. The pathogenetic process involving hyperglycemia, BMDCs, and BMDC-neuron fusion can be recapitulated in vitro. Incubation in high, but not low, glucose confers fusogenicity to BMDCs, which are characterized by proinsulin (PI) and TNF-alpha coexpression; coincubation of isolated DRG neurons with PI-BMDCs in high glucose leads to spontaneous fusion between the 2 cell types, while the presence of a PARP inhibitor or use of PARPKO BMDCs in the incubation protects against BMDC-neuron fusion. These complementary in vivo and in vitro experiments indicate that BMDC-PARP expression promotes diabetic neuropathy via BMDC-neuron fusion.-Terashima, T., Kojima, H., Chan, L. Bone marrow expression of poly(ADPribose) polymerase underlies diabetic neuropathy via hematopoietic-neuronal cell fusion. FASEB J. 26, 295-308 (2012). www.fasebj.org	[Terashima, Tomoya; Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Kojima, Hideto; Chan, Lawrence] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Kojima, Hideto; Chan, Lawrence] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Chan, Lawrence] St Lukes Episcopal Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Saint Lukes Episcopal Hospital	Chan, L (corresponding author), Baylor Coll Med, Dept Med, 1 Baylor Plaza, Houston, TX 77030 USA.	lchan@bcm.tmc.edu			U.S. National Institutes of Health [HL-51586, P30DK079638]; St. Luke's Episcopal Hospital; T. T. & W. F. Chao Global Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Luke's Episcopal Hospital; T. T. & W. F. Chao Global Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Manami Hara (University of Chicago, Chicago, IL, USA) for providing MIP-GFP mice, Eric Buras for intellectual and technical assistance, Weiqin Chen for histochemical analysis, and Leslie Wu and Yu-Chih Ku for manuscript preparation. This study was supported by U.S. National Institutes of Health grants HL-51586 (to L. C.) and P30DK079638 for the Diabetes and Endocrinology Research Center at Baylor College of Medicine. L. C. was also supported by the Betty Rutherford Chair for Diabetes Research from St. Luke's Episcopal Hospital and the T. T. & W. F. Chao Global Foundation.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Brownlee M, 2008, WILLIAMS TXB ENDOCRI, P1417; Calcutt NA, 2009, NAT REV DRUG DISCOV, V8, P417, DOI 10.1038/nrd2476; Cameron NE, 2001, DIABETOLOGIA, V44, P1973, DOI 10.1007/s001250100001; Chan Lawrence, 2006, Trans Am Clin Climatol Assoc, V117, P341; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Drel VR, 2010, ENDOCRINOLOGY, V151, P2547, DOI 10.1210/en.2009-1342; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; Espejel S, 2009, ANN NEUROL, V66, P100, DOI 10.1002/ana.21670; Figueroa-Romero C, 2008, REV ENDOCR METAB DIS, V9, P301, DOI 10.1007/s11154-008-9104-2; Fujimiya M, 2007, P NATL ACAD SCI USA, V104, P4030, DOI 10.1073/pnas.0700220104; Gonzalez F, 2006, J ENDOCRINOL, V188, P521, DOI 10.1677/joe.1.06579; Gonzalez-Clemente JM, 2005, CLIN ENDOCRINOL, V63, P525, DOI 10.1111/j.1365-2265.2005.02376.x; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Ilnytska O, 2006, DIABETES, V55, P1686, DOI 10.2337/db06-0067; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Kemp K, 2011, NEUROPATH APPL NEURO, V37, P166, DOI 10.1111/j.1365-2990.2010.01122.x; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Larsson LI, 2008, HISTOCHEM CELL BIOL, V129, P551, DOI 10.1007/s00418-008-0411-1; Li F, 2005, DIABETES, V54, P1514, DOI 10.2337/diabetes.54.5.1514; Lluis F, 2010, J CELL PHYSIOL, V223, P6, DOI 10.1002/jcp.22003; Magrassi L, 2007, J NEUROSCI, V27, P9885, DOI 10.1523/JNEUROSCI.2539-07.2007; Mitsui Y, 1999, BRAIN RES, V844, P192, DOI 10.1016/S0006-8993(99)01830-2; Nagley P, 2010, BBA-MOL BASIS DIS, V1802, P167, DOI 10.1016/j.bbadis.2009.09.004; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Obrosova IG, 2005, DIABETES, V54, P3435, DOI 10.2337/diabetes.54.12.3435; Obrosova IG, 2004, DIABETES, V53, P711, DOI 10.2337/diabetes.53.3.711; Obrosova IG, 2009, BBA-MOL BASIS DIS, V1792, P931, DOI 10.1016/j.bbadis.2008.11.005; Oh SH, 2004, LAB INVEST, V84, P607, DOI 10.1038/labinvest.3700074; Okamoto K, 2001, EXP NEUROL, V169, P386, DOI 10.1006/exnr.2001.7677; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Pacher P, 2002, DIABETES, V51, P514, DOI 10.2337/diabetes.51.2.514; Peters SO, 2002, J IMMUNOL METHODS, V260, P109, DOI 10.1016/S0022-1759(01)00525-7; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Pieper AA, 1999, P NATL ACAD SCI USA, V96, P3059, DOI 10.1073/pnas.96.6.3059; Pugatsch T, 1996, BONE MARROW TRANSPL, V17, P273; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; Singec I, 2008, NAT CELL BIOL, V10, P503, DOI 10.1038/ncb0508-503; Skundric Dusanka S, 2003, Exp Diabesity Res, V4, P303, DOI 10.1155/EDR.2003.303; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Southan GJ, 2003, CURR MED CHEM, V10, P321, DOI 10.2174/0929867033368376; Szabo C, 2005, PHARMACOL RES, V52, P60, DOI 10.1016/j.phrs.2005.02.015; Szabo C, 2002, CIRCULATION, V106, P2680, DOI 10.1161/01.CIR.0000038365.78031.9C; TANAKA S, 1992, CLIN IMMUNOL IMMUNOP, V62, P258, DOI 10.1016/0090-1229(92)90100-3; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Terashima T, 2005, P NATL ACAD SCI USA, V102, P12525, DOI 10.1073/pnas.0505717102; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Wagner R, 1996, NEUROSCIENCE, V73, P625, DOI 10.1016/0306-4522(96)00127-3; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wiersema A, 2008, STEM CELL RES, V1, P150, DOI 10.1016/j.scr.2008.02.001; Yasuda H, 2003, PROG NEUROBIOL, V69, P229, DOI 10.1016/S0301-0082(03)00034-0; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646; Zheng L, 2004, DIABETES, V53, P2960, DOI 10.2337/diabetes.53.11.2960; Zochodne DW, 2008, CURR OPIN NEUROL, V21, P527, DOI 10.1097/WCO.0b013e32830b84cb	66	16	18	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					295	308		10.1096/fj.11-186262	http://dx.doi.org/10.1096/fj.11-186262			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21978940	Green Published			2022-12-25	WOS:000299202200030
J	Johnston, WA; Hunter, DJB; Noble, CJ; Hanson, GR; Stok, JE; Hayes, MA; De Voss, JJ; Gillam, EMJ				Johnston, Wayne A.; Hunter, Dominic J. B.; Noble, Christopher J.; Hanson, Graeme R.; Stok, Jeanette E.; Hayes, Martin A.; De Voss, James J.; Gillam, Elizabeth M. J.			Cytochrome P450 Is Present in Both Ferrous and Ferric Forms in the Resting State within Intact Escherichia coli and Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIN-STATE; ELECTRON-TRANSFER; DRUG-METABOLISM; RESONANCE RAMAN; WATER BINDING; ACTIVE-SITE; KINETICS; EXPRESSION; P450; REDUCTION	Cytochrome P450 enzymes (P450s) are exceptionally versatile monooxygenases, mediating hydroxylations of unactivated C H bonds, epoxidations, dealkylations, and N- and S-oxidations as well as other less common reactions. In the conventional view of the catalytic cycle, based upon studies of P450s in vitro, substrate binding to the Fe(III) resting state facilitates the first 1-electron reduction of the heme. However, the resting state of P450s in vivo has not been examined. In the present study, whole cell difference spectroscopy of bacterial (CYP101A1 and CYP176A1, i.e. P450cam and P450cin) and mammalian (CYP1A2, CYP2C9, CYP2A6, CYP2C19, and CYP3A4) P450s expressed within intact Escherichia coli revealed that both Fe(III) and Fe(II) forms of the enzyme are present in the absence of substrates. The relevance of this finding was supported by similar observations of Fe(II) P450 heme in intact rat hepatocytes. Electron paramagnetic resonance (EPR) spectroscopy of the bacterial forms in intact cells showed that a proportion of the P450 in cells was in an EPR-silent form in the native state consistent with the presence of Fe(II) P450. Coexpression of suitable cognate electron donors increased the degree of endogenous reduction to over 80%. A significant proportion of intracellular P450 remained in the Fe(II) form after vigorous aeration of cells. The addition of substrates increased the proportion of Fe(II) heme, suggesting a kinetic gate to heme reduction in the absence of substrate. In summary, these observations suggest that the resting state of P450s should be regarded as a mixture of Fe(III) and Fe(II) forms in both aerobic and oxygen-limited conditions.	[Hunter, Dominic J. B.; Stok, Jeanette E.; De Voss, James J.; Gillam, Elizabeth M. J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Johnston, Wayne A.; Gillam, Elizabeth M. J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Noble, Christopher J.; Hanson, Graeme R.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia; [Hayes, Martin A.] AstraZeneca R&D, Cardiovasc & Gastrointestinal Innovat Med, Drug Metab & Pharmacokinet, SE-43183 Molndal, Sweden	University of Queensland; University of Queensland; University of Queensland; AstraZeneca	Gillam, EMJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	e.gillam@uq.edu.au	/C-3940-2008; Hunter, Dominic/R-8894-2016; GILLAM, ELIZABETH/D-1011-2016; Hunter, Dominic/Q-4226-2019; Hunter, Dominic/H-7955-2019; Johnston, Wayne/D-2095-2017	/0000-0003-0306-4360; Hunter, Dominic/0000-0002-1826-6902; GILLAM, ELIZABETH/0000-0003-0378-793X; Hunter, Dominic/0000-0002-1826-6902; Stok, Jeanette/0000-0002-8759-3931; Johnston, Wayne/0000-0002-7485-8363	Australian Research Council (ARC) [DP0210635, LP0560595]; AstraZeneca RD	Australian Research Council (ARC)(Australian Research Council); AstraZeneca RD(AstraZeneca)	This work was supported in part by Australian Research Council (ARC) Discovery Project Grant DP0210635 (to E. M. J. G. and J. J. D. V.) and ARC Linkage Project Grant LP0560595 funded in partnership with AstraZeneca R&D (to E. M. J. G., J. J. D. V., and M. A. H.).	BACKES WL, 1982, BIOCHEMISTRY-US, V21, P1324, DOI 10.1021/bi00535a034; Cryle M. J., 2007, UBIQUITOUS CYTOCHROM, V3, P397; Cuttle L, 2000, DRUG METAB DISPOS, V28, P945; Das A, 2007, J AM CHEM SOC, V129, P13778, DOI 10.1021/ja074864x; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Denisov IG, 2006, J BIOL CHEM, V281, P23313, DOI 10.1074/jbc.M605511200; DIXON M, 1971, BIOCHIM BIOPHYS ACTA, V226, P241, DOI 10.1016/0005-2728(71)90092-2; EBEL RE, 1977, ARCH BIOCHEM BIOPHYS, V183, P317, DOI 10.1016/0003-9861(77)90445-3; FISHER CW, 1992, FASEB J, V6, P759, DOI 10.1096/fasebj.6.2.1537466; FISHER MT, 1985, J AM CHEM SOC, V107, P5018, DOI 10.1021/ja00303a045; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; Goldfarb D, 1996, J AM CHEM SOC, V118, P2686, DOI 10.1021/ja951307e; Guengerich F. Peter, 1994, P1259; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Hanson GR, 2004, J INORG BIOCHEM, V98, P903, DOI 10.1016/j.jinorgbio.2004.02.003; Hawkes DB, 2010, CHEMBIOCHEM, V11, P1107, DOI 10.1002/cbic.201000119; Hawkes DB, 2002, J BIOL CHEM, V277, P27725, DOI 10.1074/jbc.M203382200; Hlavica P, 2007, CURR DRUG METAB, V8, P594; HOLMAN DA, 1994, J PHYS CHEM-US, V98, P13300, DOI 10.1021/j100101a032; Honeychurch MJ, 1999, FEBS LETT, V451, P351, DOI 10.1016/S0014-5793(99)00610-9; Huang W, 2007, ARCH BIOCHEM BIOPHYS, V467, P193, DOI 10.1016/j.abb.2007.08.023; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; JENKINS CM, 1994, J BIOL CHEM, V269, P27401; Johnston WA, 2008, J BIOMOL SCREEN, V13, P135, DOI 10.1177/1087057107312780; KOGA H, 1986, J BACTERIOL, V166, P1089, DOI 10.1128/jb.166.3.1089-1095.1986; Kumar D, 2011, FARADAY DISCUSS, V148, P373, DOI 10.1039/c004950f; LAMBETH DO, 1973, J BIOL CHEM, V248, P6095; Lochner M, 2003, ADV SYNTH CATAL, V345, P743, DOI 10.1002/adsc.200303011; Luthra A, 2011, ARCH BIOCHEM BIOPHYS, V507, P26, DOI 10.1016/j.abb.2010.12.008; Mak PJ, 2008, BIOCHEMISTRY-US, V47, P3950, DOI 10.1021/bi800034b; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Nelson DR, 2011, BBA-PROTEINS PROTEOM, V1814, P14, DOI 10.1016/j.bbapap.2010.08.008; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Nouri-Nigjeh E, 2011, CURR DRUG METAB, V12, P359, DOI 10.2174/138920011795202929; OMURA T, 1962, J BIOL CHEM, V237, P1375; Otey Christopher R., 2003, V230, P137; Parikh A, 1997, NAT BIOTECHNOL, V15, P784, DOI 10.1038/nbt0897-784; Peterson JA, 1986, CYTOCHROME P 450 STR, P89; RINKER RG, 1960, J PHYS CHEM-US, V64, P573, DOI 10.1021/j100834a015; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shaik S, 2010, CHEM REV, V110, P949, DOI 10.1021/cr900121s; SONO M, 1982, J BIOL CHEM, V257, P5496; Soucek P, 1999, ARCH BIOCHEM BIOPHYS, V370, P190, DOI 10.1006/abbi.1999.1388; THOMANN H, 1995, J AM CHEM SOC, V117, P8243, DOI 10.1021/ja00136a023; Tomita T, 2001, J BIOL CHEM, V276, P36261, DOI 10.1074/jbc.M104932200; Yim SK, 2010, J MICROBIOL BIOTECHN, V20, P712, DOI 10.4014/jmb.0910.10043; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	48	21	20	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40750	40759		10.1074/jbc.M111.300871	http://dx.doi.org/10.1074/jbc.M111.300871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21976668	hybrid, Green Published			2022-12-25	WOS:000297315400036
J	Li, CL; Li, J; Cai, XY; Sun, HL; Jiao, JJ; Bai, T; Zhou, XW; Chen, XW; Gill, DL; Tang, XD				Li, Changlin; Li, Jing; Cai, Xiangyu; Sun, Haili; Jiao, Jinjin; Bai, Ting; Zhou, Xing Wang; Chen, Xiongwen; Gill, Donald L.; Tang, Xiang D.			Protein Kinase D3 Is a Pivotal Activator of Pathological Cardiac Hypertrophy by Selectively Increasing the Expression of Hypertrophic Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II HISTONE DEACETYLASES; HEART-FAILURE; GENE-EXPRESSION; RAT-HEART; DELTA; MEF2; DYSFUNCTION; RECRUITMENT; INHIBITORS; CHANNELS	Fetal cardiac gene reactivation is a hallmark of pathological cardiac hypertrophy (PCH) driven by cardiac transcription factors (TFs) such as nuclear factor of activated T-cells (NFATs). Nuclear import of dephosphorylated NFATs catalyzed by calcineurin (CaN) is a well-established hypertrophic mechanism. Here we report that NFATc4 expression is also up-regulated by newly expressed protein kinase D3 (PKD3) to induce PCH. In both in vitro and in vivo cardiac hypertrophic models, the normally undetectable PKD3 was profoundly up-regulated by isoproterenol followed by overt expression of cardiac TFs including NFATc4, NK family of transcription factor 2.5 (Nkx2.5), GATA4 and myocyte enhancer factor 2 (MEF2). Using gene silencing approaches, we demonstrate PKD3 is required for increasing the expression of NFATc4, Nkx2.5, and GATA4 while PKD1 is required for the increase in MEF2D expression. Upstream induction of PKD3 is driven by nuclear entry of CaN-activated NFATc1 and c3 but not c4. Therefore, PKD3 is a pivotal mediator of the CaN-NFATc1/c3-PKD3-NFATc4 hypertrophic signaling cascade and a potential new drug target for the PCH.	[Li, Changlin; Li, Jing; Cai, Xiangyu; Sun, Haili; Jiao, Jinjin; Bai, Ting; Tang, Xiang D.] Nankai Univ, Sch Med, Dept Pharmacol, Tianjin 300071, Peoples R China; [Tang, Xiang D.] Nankai Univ, Sch Med, MOE Key Lab Bioact Mat, Tianjin 300071, Peoples R China; [Zhou, Xing Wang] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China; Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Chen, Xiongwen] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Gill, Donald L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Nankai University; Nankai University; Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Li, J (corresponding author), Nankai Univ, Sch Med, Dept Pharmacol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	stellarli@nankai.edu.cn; stang@nankai.edu.cn	zhou, xt/GWZ-9212-2022; Chen, Xiongwen/D-5988-2012	Chen, Xiongwen/0000-0002-3829-5815	National Institutes of Health [HL55426, AI058173]; Tianjin Science and Technology [08ZCKFSH04500]; Tianjin Natural Science Foundation [10JCYBJC14800]; NSFC [30871011, 81072629, 30870988]; Project "973" grant [2010CB945001]; Chinese Ministry of Education (MOE) [200800550036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088243, R01HL055426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tianjin Science and Technology; Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); NSFC(National Natural Science Foundation of China (NSFC)); Project "973" grant; Chinese Ministry of Education (MOE)(Ministry of Education, China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants (HL55426 and AI058173, to D. L G.), grants from the Tianjin Science and Technology Support Project (08ZCKFSH04500, to X. D. T.), Tianjin Natural Science Foundation (10JCYBJC14800, to J. L), NSFC Grants (30871011, to X. D. T.; 81072629 to J. L; 30870988, to X. W. Z.), The Project "973" grant (2010CB945001, to X. D. T.), and Chinese Ministry of Education (MOE) Doctorial Training Funds (200800550036, to X. D. T.).	Ago T, 2010, J CARDIOVASC TRANSL, V3, P304, DOI 10.1007/s12265-010-9182-x; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Barrick D, 2006, CELL, V124, P883, DOI 10.1016/j.cell.2006.02.028; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Ellwanger K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-47; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Goodall MH, 2010, J BIOL CHEM, V285, P41686, DOI 10.1074/jbc.M110.179648; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Heather LC, 2009, J PHYSIOL PHARMACOL, V60, P31; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Jepsen K, 2002, J CELL SCI, V115, P689; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Li CL, 2011, BIOCHEM BIOPH RES CO, V409, P125, DOI 10.1016/j.bbrc.2011.04.128; Luedde Mark, 2006, Recent Pat Cardiovasc Drug Discov, V1, P1, DOI 10.2174/157489006775244290; MacDonald MR, 2008, EUR HEART J, V29, P1224, DOI 10.1093/eurheartj/ehn156; Mathew J, 2001, CIRCULATION, V104, P1615, DOI 10.1161/hc3901.096700; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Morisco C, 2001, J MOL CELL CARDIOL, V33, P561, DOI 10.1006/jmcc.2000.1332; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Nishida W, 2002, J BIOL CHEM, V277, P7308, DOI 10.1074/jbc.M111824200; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Putt ME, 2009, CIRC-CARDIOVASC GENE, V2, P212, DOI 10.1161/CIRCGENETICS.108.816686; Sambrano GR, 2002, NATURE, V420, P712, DOI 10.1038/nature01306; Schug J, 2008, CURR PROTOC BIOINFOR, V21, P261, DOI DOI 10.1002/; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200	41	20	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40782	40791		10.1074/jbc.M111.263046	http://dx.doi.org/10.1074/jbc.M111.263046			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21971046	Green Published, hybrid			2022-12-25	WOS:000297315400039
J	Morrow, KA; Das, S; Metge, BJ; Ye, KQ; Mulekar, MS; Tucker, JA; Samant, RS; Shevde, LA				Morrow, K. Adam; Das, Shamik; Metge, Brandon J.; Ye, Keqiang; Mulekar, Madhuri S.; Tucker, J. Allan; Samant, Rajeev S.; Shevde, Lalita A.			Loss of Tumor Suppressor Merlin in Advanced Breast Cancer Is due to Post-translational Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF2 GENE; AKT PHOSPHORYLATION; MDA-MB-435 CELLS; M14 MELANOMA; OSTEOPONTIN; GROWTH; METASTASIS; ACTIVATION; EXPRESSION; INHIBITION	Unlike malignancies of the nervous system, there have been no mutations identified in Merlin in breast cancer. As such, the role of the tumor suppressor, Merlin, has not been investigated in breast cancer. We assessed Merlin expression in breast cancer tissues by immunohistochemistry and by real-time PCR. The expression of Merlin protein (assessed immunohistochemically) was significantly decreased in breast cancer tissues (although the transcript levels were comparable) simultaneous with increased expression of the tumor-promoting protein, osteopontin (OPN). We further demonstrate that the loss of Merlin in breast cancer is brought about, in part, due to OPN-initiated Akt-mediated phosphorylation of Merlin leading to its proteasomal degradation. Restoring expression of Merlin resulted in reduced malignant attributes of breast cancer, characterized by reduced invasion, migration, motility, and impeded tumor (xenograft) growth in immunocompromised mice. The possibility of developing a model using the relationship between OPN and Merlin was tested with a logistic regression model applied to immunohistochemistry data. This identified consistent loss of immunohistochemical expression of Merlin in breast tumor tissues. Thus, we demonstrate for the first time a role for Merlin in impeding breast malignancy, identify a novel mechanism for the loss of Merlin protein in breast cancer, and have developed a discriminatory model using Merlin and OPN expression in breast tumor tissues.	[Morrow, K. Adam; Das, Shamik; Metge, Brandon J.; Samant, Rajeev S.; Shevde, Lalita A.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA; [Mulekar, Madhuri S.] Univ S Alabama, Dept Math & Stat, Mobile, AL 36604 USA; [Tucker, J. Allan] Univ S Alabama, Dept Pathol, Mobile, AL 36604 USA; [Ye, Keqiang] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	University of South Alabama; University of South Alabama; University of South Alabama; Emory University	Shevde, LA (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Springhill Ave, Mobile, AL 36604 USA.	lsamant@usouthal.edu		Samant, Rajeev/0000-0001-5681-4976	National Institutes of Health [CA138850, CA140472]; Mayer Mitchell Award; University of South Alabama (USA) Mitchell Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA140472, R01CA138850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayer Mitchell Award; University of South Alabama (USA) Mitchell Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA138850 (to L. A. S.) and CA140472 (to R. S. S.). This work was also supported by the Mayer Mitchell Award (to L. A. S.) and a grant from the University of South Alabama (USA) Mitchell Cancer Institute.	ARAKAWA H, 1994, HUM MOL GENET, V3, P565, DOI 10.1093/hmg/3.4.565; Bai Y, 2007, ONCOGENE, V26, P836, DOI 10.1038/sj.onc.1209849; Begnami MD, 2007, HUM PATHOL, V38, P1345, DOI 10.1016/j.humpath.2007.01.027; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; CRAIG AM, 1988, BIOCHEM BIOPH RES CO, V157, P166, DOI 10.1016/S0006-291X(88)80028-7; Dai JL, 2004, ONCOGENE, V23, P8681, DOI 10.1038/sj.onc.1207962; Das R, 2003, J BIOL CHEM, V278, P28593, DOI 10.1074/jbc.M303445200; Fouladi M, 2003, CANCER-AM CANCER SOC, V98, P2232, DOI 10.1002/cncr.11783; Furger Kara A., 2001, Current Molecular Medicine (Hilversum), V1, P621, DOI 10.2174/1566524013363339; Gao CJ, 2007, J IMMUNOL, V178, P1870, DOI 10.4049/jimmunol.178.3.1870; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Kim H, 2002, MOL CELLS, V14, P108; Kim Youn Wha, 1998, Journal of Korean Medical Science, V13, P652; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Lacroix M, 2009, CANCER CHEMOTH PHARM, V63, P567, DOI 10.1007/s00280-008-0776-9; Lasota J, 2003, LAB INVEST, V83, P1361, DOI 10.1097/01.LAB.0000087591.29639.E3; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Metge BJ, 2008, CLIN EXP METASTAS, V25, P753, DOI 10.1007/s10585-008-9187-x; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Muranen T, 2007, HUM MOL GENET, V16, P1742, DOI 10.1093/hmg/ddm122; Nunes F, 2005, CANCER GENET CYTOGEN, V162, P135, DOI 10.1016/j.cancergencyto.2005.04.003; Okada M, 2009, CANCER RES, V69, P4043, DOI 10.1158/0008-5472.CAN-08-3931; Philip S, 2004, GLYCOCONJUGATE J, V21, P429, DOI 10.1007/s10719-004-5533-7; Poulikakos PI, 2006, ONCOGENE, V25, P5960, DOI 10.1038/sj.onc.1209587; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rangaswami H, 2006, GLYCOCONJUGATE J, V23, P221, DOI 10.1007/s10719-006-7927-1; Robertson BW, 2010, EXP CELL RES, V316, P1, DOI 10.1016/j.yexcr.2009.10.012; Rodrigues LR, 2007, CANCER EPIDEM BIOMAR, V16, P1087, DOI 10.1158/1055-9965.EPI-06-1008; Rudland PS, 2002, CANCER RES, V62, P3417; Rushing EJ, 2007, J NEURO-ONCOL, V85, P297, DOI 10.1007/s11060-007-9411-6; Sainio M, 1997, J CELL SCI, V110, P2249; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Shevde LA, 2006, CLIN EXP METASTAS, V23, P123, DOI 10.1007/s10585-006-9013-2; Singhal H, 1997, CLIN CANCER RES, V3, P605; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tuck AB, 1998, INT J CANCER, V79, P502, DOI 10.1002/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO;2-3; Tuck AB, 2001, J MAMMARY GLAND BIOL, V6, P419, DOI 10.1023/A:1014734930781; Wallace AJ, 2004, GENET TEST, V8, P368, DOI 10.1089/gte.2004.8.368; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; YAEGASHI S, 1995, JPN J CANCER RES, V86, P929, DOI 10.1111/j.1349-7006.1995.tb03003.x; Yang YL, 2009, CANCER SCI, V100, P24, DOI 10.1111/j.1349-7006.2008.01013.x; Ye KQ, 2007, CELL ADHES MIGR, V1, P196, DOI 10.4161/cam.1.4.5192; Zhang GX, 2003, MOL CELL BIOL, V23, P6507, DOI 10.1128/MCB.23.18.6507-6519.2003	45	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40376	40385		10.1074/jbc.M111.250035	http://dx.doi.org/10.1074/jbc.M111.250035			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965655	hybrid, Green Published			2022-12-25	WOS:000296925700068
J	Wang, D; Wengrod, J; Gardner, LB				Wang, Ding; Wengrod, Jordan; Gardner, Lawrence B.			Overexpression of the c-myc Oncogene Inhibits Nonsense-mediated RNA Decay in B Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATED STRESS-RESPONSE; PROTEIN-SYNTHESIS; TARGET GENE; IN-VIVO; TUMORIGENESIS; EXPRESSION; REPRESSION; DISEASE; CELLS; P53	The Myc transcription factor plays a vital role in both normal cellular physiology and in many human cancers. We have recently demonstrated that nonsense-mediated RNA decay (NMD), a mechanism that rapidly degrades select mRNAs, is inhibited by the stress-induced phosphorylation of translation initiation factor eIF2 alpha, and this inhibition stabilizes many transcripts necessary for tumorigenesis. Here, we demonstrate that NMD is inhibited by high Myc expression. We show that the phosphorylation of eIF2 alpha, likely due to the ability of Myc to generate reactive oxygen species and augment endoplasmic reticulum stress, is necessary for the inhibition of NMD by Myc. The inhibition of NMD both stabilizes and up-regulates multiple Myc targets, suggesting that the inhibition of NMD may play an important role in the dynamic regulation of genes by Myc.	[Gardner, Lawrence B.] NYU, Div Hematol & Med Oncol, Sch Med, Dept Med, New York, NY 10016 USA; [Wengrod, Jordan; Gardner, Lawrence B.] NYU, Dept Pharmacol, Sch Med, New York, NY 10016 USA; [Gardner, Lawrence B.] NYU, New York Univ Canc Inst, Sch Med, New York, NY 10016 USA	New York University; New York University; New York University	Gardner, LB (corresponding author), NYU, Div Hematol & Med Oncol, Sch Med, Dept Med, 550 1st Ave, New York, NY 10016 USA.	lawrence.gardner@nyumc.org		Gardner, Lawrence/0000-0003-0191-0172	National Institutes of Health [DK08164, 5T32GM066704]; Feldstein Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feldstein Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK08164. This work was also supported by the Feldstein Medical Foundation (to L. B. G.) and National Institutes of Health Grant 5T32GM066704 (to J. W.).	Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fan JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009691; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Nemetski SM, 2007, J BIOL CHEM, V282, P240, DOI 10.1074/jbc.M607275200; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Ruiz-Vela A, 2008, BLOOD, V111, P1665, DOI 10.1182/blood-2007-09-110601; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang D, 2011, MOL CELL BIOL, V31, P3670, DOI 10.1128/MCB.05704-11; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Yustein JT, 2010, P NATL ACAD SCI USA, V107, P3534, DOI 10.1073/pnas.0901230107; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	24	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40038	40043		10.1074/jbc.M111.266361	http://dx.doi.org/10.1074/jbc.M111.266361			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21969377	Green Published, hybrid			2022-12-25	WOS:000296925700036
J	Nadezhdin, EV; Brody, MS; Price, CW				Nadezhdin, Eugene V.; Brody, Margaret S.; Price, Chester W.			An alpha/beta Hydrolase and Associated Per-ARNT-Sim Domain Comprise a Bipartite Sensing Module Coupled with Diverse Output Domains	PLOS ONE			English	Article							SIGMA(B) TRANSCRIPTION FACTOR; ENERGY STRESS ACTIVATION; BACILLUS-SUBTILIS; PAS DOMAIN; SIGNALING MECHANISM; CRYSTAL-STRUCTURES; PHOSPHATASE 2C; PROTEIN; OXYGEN; DIMERIZATION	The RsbQ alpha/beta hydrolase and RsbP serine phosphatase form a signaling pair required to activate the general stress factor sigma(B) of Bacillus subtilis in response to energy limitation. RsbP has a predicted N-terminal Per-ARNT-Sim (PAS) domain, a central coiled-coil, and a C-terminal protein phosphatase M (PPM) domain. Previous studies support a model in which RsbQ provides an activity needed for PAS to regulate the phosphatase domain via the coiled-coil. RsbQ and the PAS domain (RsbP-PAS) therefore appear to form a sensory module. Here we test this hypothesis using bioinformatic and genetic analysis. We found 45 RsbQ and RsbP-PAS homologues encoded by adjacent genes in diverse bacteria, with PAS and a predicted coiled-coil fused to one of three output domains: PPM phosphatase (Gram positive bacteria), histidine protein kinase (Gram negative bacteria), and diguanylate cyclase (both lineages). Multiple alignment of the RsbP-PAS homologues suggested nine residues that distinguish the class. Alanine substitutions at four of these conferred a null phenotype in B. subtilis, indicating their functional importance. The F55A null substitution lay in the F alpha helix of an RsbP-PAS model. F55A inhibited interaction of RsbP with RsbQ in yeast two-hybrid and pull-down assay but did not significantly affect interaction of RsbP with itself. We propose that RsbQ directly contacts the PAS domains of an RsbP oligomer to provide the activating signal, which is propagated to the phosphatase domains via the coiled-coil. A similar mechanism would allow the RsbQ-PAS module to convey a common input signal to structurally diverse output domains, controlling a variety of physiological responses.	[Nadezhdin, Eugene V.; Brody, Margaret S.; Price, Chester W.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA	University of California System; University of California Davis	Nadezhdin, EV (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	cwprice@ucdavis.edu	Price, Chester/M-6900-2019	Nadezhdin, Eugene/0000-0002-8682-1189	National Institute of General Medical Sciences [GM42077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042077] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Public Health Service grant GM42077 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper S, 1996, J MOL BIOL, V260, P165, DOI 10.1006/jmbi.1996.0390; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antelmann H, 2010, SENSORY MECHANISMS IN BACTERIA: MOLECULAR ASPECTS OF SIGNAL RECOGNITION, P199; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Avila-Perez M, 2010, J BACTERIOL, V192, P755, DOI 10.1128/JB.00826-09; BENSON AK, 1993, J BACTERIOL, V175, P2347, DOI 10.1128/JB.175.8.2347-2356.1993; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bork P, 1996, PROTEIN SCI, V5, P1421, DOI 10.1002/pro.5560050720; BOYLAN SA, 1992, J BACTERIOL, V174, P3695, DOI 10.1128/JB.174.11.3695-3706.1992; BOYLAN SA, 1993, J BACTERIOL, V175, P7931, DOI 10.1128/JB.175.24.7931-7937.1993; Brody MS, 2009, MOL MICROBIOL, V72, P1221, DOI 10.1111/j.1365-2958.2009.06722.x; Brody MS, 2001, J BACTERIOL, V183, P6422, DOI 10.1128/JB.183.21.6422-6428.2001; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delumeau O, 2002, J BACTERIOL, V184, P5583, DOI 10.1128/JB.184.20.5583-5589.2002; Eymann C, 2001, FEMS MICROBIOL LETT, V199, P221, DOI 10.1111/j.1574-6968.2001.tb10678.x; Glaser P, 2001, SCIENCE, V294, P849; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Kaneko T, 2005, PROTEIN SCI, V14, P558, DOI 10.1110/ps.041170005; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lee J, 2008, BIOCHEMISTRY-US, V47, P4051, DOI 10.1021/bi7021156; Makino M, 2009, ACTA CRYSTALLOGR F, V65, P559, DOI 10.1107/S1744309109014158; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Miyatake H, 2000, J MOL BIOL, V301, P415, DOI 10.1006/jmbi.2000.3954; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moglich A, 2010, J MOL BIOL, V400, P477, DOI 10.1016/j.jmb.2010.05.019; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Ondrusch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016151; Park HJ, 2004, BIOCHEMISTRY-US, V43, P2738, DOI 10.1021/bi035980p; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PIGGOT PJ, 1973, J BACTERIOL, V114, P1241, DOI 10.1128/JB.114.3.1241-1253.1973; Price CW, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P301; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Serebriiskii IG, 2000, ANAL BIOCHEM, V285, P1, DOI 10.1006/abio.2000.4672; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x; Zhang SY, 2005, J BACTERIOL, V187, P7554, DOI 10.1128/JB.187.22.7554-7560.2005; Zhang WW, 2004, MICROBIOL-SGM, V150, P4189, DOI 10.1099/mic.0.27480-0; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25418	10.1371/journal.pone.0025418	http://dx.doi.org/10.1371/journal.pone.0025418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980452	gold, Green Published, Green Submitted			2022-12-25	WOS:000295939600024
J	Campione, NE; Evans, DC				Campione, Nicolas E.; Evans, David C.			Cranial Growth and Variation in Edmontosaurs (Dinosauria: Hadrosauridae): Implications for Latest Cretaceous Megaherbivore Diversity in North America	PLOS ONE			English	Article							ORNITHOPODA; EXTINCTION; PHYLOGENY; TAXA	The well-sampled Late Cretaceous fossil record of North America remains the only high-resolution dataset for evaluating patterns of dinosaur diversity leading up to the terminal Cretaceous extinction event. Hadrosaurine hadrosaurids (Dinosauria: Ornithopoda) closely related to Edmontosaurus are among the most common megaherbivores in latest Campanian and Maastrichtian deposits of western North America. However, interpretations of edmontosaur species richness and biostratigraphy have been in constant flux for almost three decades, although the clade is generally thought to have undergone a radiation in the late Maastrichtian. We address the issue of edmontosaur diversity for the first time using rigorous morphometric analyses of virtually all known complete edmontosaur skulls. Results suggest only two valid species, Edmontosaurus regalis from the late Campanian, and E. annectens from the late Maastrichtian, with previously named taxa, including the controversial Anatotitan copei, erected on hypothesized transitional morphologies associated with ontogenetic size increase and allometric growth. A revision of North American hadrosaurid taxa suggests a decrease in both hadrosaurid diversity and disparity from the early to late Maastrichtian, a pattern likely also present in ceratopsid dinosaurs. A decline in the disparity of dominant megaherbivores in the latest Maastrichtian interval supports the hypothesis that dinosaur diversity decreased immediately preceding the end Cretaceous extinction event.	[Campione, Nicolas E.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Evans, David C.] Royal Ontario Museum, Dept Palaeobiol, Toronto, ON M5S 2C6, Canada	University of Toronto; Royal Ontario Museum	Campione, NE (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	nicolas.campione@utoronto.ca	Campione, Nicolas/R-6862-2018	Campione, Nicolas/0000-0002-4205-9794	National Sciences and Engineering Research Council; Royal Ontario Museum Louise Hawley Stone Charitable Trust	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Royal Ontario Museum Louise Hawley Stone Charitable Trust	Funding for this project was provided by a National Sciences and Engineering Research Council Post-Graduate Scholarship (to N.E.C.), a National Sciences and Engineering Research Council Discovery Grant (to D. C. E.), and the Royal Ontario Museum Louise Hawley Stone Charitable Trust (to D.C.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bakker RT., 1986, DINOSAUR HERESIES; Bakker RT, 1977, PATTERNS EVOLUTION I, P441; Barrett PM, 2009, P ROY SOC B-BIOL SCI, V276, P2667, DOI 10.1098/rspb.2009.0352; Bell PR, 2011, CRETACEOUS RES, V32, P30, DOI 10.1016/j.cretres.2010.10.002; Boyd CA, 2009, J VERTEBR PALEONTOL, V29, P758, DOI 10.1671/039.029.0328; BRETTSURMAN MK, 1979, NATURE, V277, P560, DOI 10.1038/277560a0; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; Chapman R.E., 1990, P163, DOI 10.1017/CBO9780511608377.015; Cope E., 1883, P NATL ACAD NAT SCI, V35, P97; Cope E.D., 1869, T AM PHIL SOC, V14, P1; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Farke AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016196; Fastovsky DE, 2004, GEOLOGY, V32, P877, DOI 10.1130/G20695.1; FOOTE M, 1993, PALEOBIOLOGY, V19, P403, DOI 10.1017/S0094837300014056; Gangloff RA, 2010, PALAIOS, V25, P299, DOI 10.2110/palo.2009.p09-103r; Gates TA, 2007, J VERTEBR PALEONTOL, V27, P917, DOI 10.1671/0272-4634(2007)27[917:VCANLH]2.0.CO;2; Gilmore CW, 1924, CANADA DEP MINES B G, V43, P13; Henderson Donald M., 2010, P293; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; HORNER JR, 1992, NATURE, V358, P59, DOI 10.1038/358059a0; Lambe L. M., 1917, Ottawa Naturalist, V31; Legendre P, 2008, MODEL 2 REGRESSION, V1; Lillegraven JA, 1986, AM MUS NOVIT, V2840, p1 ; Lloyd GT, 2011, BIOL LETT; Longrich Nick, 2008, P135; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Marsh O. C., 1892, American Journal of Science, V(3), P449; Marsh O.C., 1881, AM J SCI, V21, P167, DOI DOI 10.2475/AJS.S3-21.122.167; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Ripley B.D., 2002, STAT COMPUTING MODER; Rohlf F. J., 2010, TPSDIG 2 16; Rohlf FJ, 2010, TPSRELW 1 49; Roy K, 1997, TRENDS ECOL EVOL, V12, P277, DOI 10.1016/S0169-5347(97)81026-9; Russell DA, 2002, GEOL S AM S, P169; RUSSELL DALE A., 1967, NAT MUS CAN NATUR HIST PAP, V35., P1; Rybczynski N, 2008, PALAEONTOL ELECTRON, V11, P14; Sampson SD, 2005, J VERTEBR PALEONTOL, V25, P469, DOI 10.1671/0272-4634(2005)025[0469:TRFTUC]2.0.CO;2; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; SHEEHAN PM, 1991, SCIENCE, V254, P835, DOI 10.1126/science.11536489; Sheets H. D., 2004, IMP INTEGRATED MORPH; SLOAN RE, 1986, SCIENCE, V232, P629, DOI 10.1126/science.232.4750.629; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; STERNBERG C. M., 1926, CANADA DEPT MINES GEOL SURV BULL, V44, P73; Sullivan Robert M., 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P403; Wang SC, 2006, P NATL ACAD SCI USA, V103, P13601, DOI 10.1073/pnas.0606028103; Weishampel D.B., 1990, P534; Wills MA, 2002, FOSSILS PHYLOGENY FO, P55; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	54	112	113	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25186	10.1371/journal.pone.0025186	http://dx.doi.org/10.1371/journal.pone.0025186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969872	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900030
J	Akil, H; Perraud, A; Melin, C; Jauberteau, MO; Mathonnet, M				Akil, Hussein; Perraud, Aurelie; Melin, Carole; Jauberteau, Marie-Odile; Mathonnet, Muriel			Fine-Tuning Roles of Endogenous Brain-Derived Neurotrophic Factor, TrkB and Sortilin in Colorectal Cancer Cell Survival	PLOS ONE			English	Article							HUMAN NEUROBLASTOMA-CELLS; NERVE GROWTH-FACTOR; KINASE-B; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; FACTOR ACTIVATION; MULTIPLE-MYELOMA; PROSTATE-CANCER; RECEPTOR TRKB; IN-VIVO	Background: Neurotrophin receptors were initially identified in neural cells. They were recently detected in some cancers in association with invasiveness, but the function of these tyrosine kinase receptors was not previously investigated in colorectal cancer (CRC) cells. Methods and Findings: We report herein that human CRC cell lines synthesize the neural growth factor Brain-derived neurotrophic factor (BDNF) under stress conditions (serum starvation). In parallel, CRC cells expressed high- (TrkB) and low-affinity (p75(NTR)) receptors at the plasma membrane, whereas TrkA and TrkC, two other high affinity receptors for NGF and NT-3, respectively, were undetectable. We demonstrate that BDNF induced cell proliferation and had an anti-apoptotic effect mediated through TrkB, as assessed by K252a, a Trk pharmacologic inhibitor. It suppressed both cell proliferation and survival of CRC cells that do not express TrkA nor TrkC. In parallel to the increase of BDNF secretion, sortilin, a protein acting as a neurotrophin transporter as well as a co-receptor for p75(NTR), was increased in the cytoplasm of primary and metastatic CRC cells, which suggests that sortilin could regulate neurotrophin transport in these cells. However, pro-BDNF, also detected in CRC cells, was co-expressed with p75(NTR) at the cell membrane and co-localized with sortilin. In contrast to BDNF, exogenous pro-BDNF induced CRC apoptosis, which suggests that a counterbalance mechanism is involved in the control of CRC cell survival, through sortilin as the co-receptor for p75(NTR), the high affinity receptor for pro-neurotrophins. Likewise, we show that BDNF and TrkB transcripts (and not p75(NTR)) are overexpressed in the patients' tumors by comparison with their adjacent normal tissues, notably in advanced stages of CRC. Conclusion: Taken together, these results highlight that BDNF and TrkB are essential for CRC cell growth and survival in vitro and in tumors. This autocrine loop could be of major importance to define new targeted therapies.	[Akil, Hussein; Perraud, Aurelie; Melin, Carole; Jauberteau, Marie-Odile; Mathonnet, Muriel] Univ Limoges, Lab EA 3842, Fac Med & Pharm, Limoges, France; [Akil, Hussein; Perraud, Aurelie; Melin, Carole; Jauberteau, Marie-Odile; Mathonnet, Muriel] Univ Limoges, Inst Federatif Rech GEIST Genom Environm Immunite, Limoges, France; [Perraud, Aurelie; Mathonnet, Muriel] CHU Limoges, Serv Chirurg Digest Gen & Endocrinienne, Limoges, France	Universite de Limoges; Universite de Limoges; CHU Limoges	Akil, H (corresponding author), Univ Limoges, Lab EA 3842, Fac Med & Pharm, Limoges, France.	m-o.jauberteau-marchan@unilim.fr	Mathonnet, Muriel/ABD-3021-2020	Mathonnet, Muriel/0000-0002-9127-3068; AKIL, Hussein/0000-0002-8177-6833; Perraud, Aurelie/0000-0001-7882-0613; Jauberteau, Marie-Odile/0000-0002-8811-8948	Ligue contre le Cancer and Conseil Regional du Limousin	Ligue contre le Cancer and Conseil Regional du Limousin	This work was supported by Ligue contre le Cancer and Conseil Regional du Limousin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama M, 2001, CANCER LETT, V164, P51, DOI 10.1016/S0304-3835(00)00715-1; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Au CWH, 2009, CANCER LETT, V281, P151, DOI 10.1016/j.canlet.2009.02.025; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bronzetti E, 2008, ONCOL REP, V19, P969; Carim-Todd L, 2009, J NEUROSCI, V29, P678, DOI 10.1523/JNEUROSCI.5060-08.2009; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; D'Onofrio M, 2000, EUR CYTOKINE NETW, V11, P283; De Armas R, 2010, CLIN BIOCHEM, V43, P827, DOI 10.1016/j.clinbiochem.2010.03.017; de Farias CB, 2010, ONCOLOGY-BASEL, V79, P430, DOI 10.1159/000326564; Dechant G, 2001, CELL TISSUE RES, V305, P229, DOI 10.1007/s004410100378; Dimaras H, 2006, MOL CARCINOGEN, V45, P333, DOI 10.1002/mc.20179; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Feng X, 2001, J NEUROSCI RES, V64, P355, DOI 10.1002/jnr.1086; Frade JM, 1996, NATURE, V383, P166; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Hu Y, 2007, CANCER GENET CYTOGEN, V178, P1, DOI 10.1016/j.cancergencyto.2007.05.028; Hu Y, 2006, CANCER GENET CYTOGEN, V169, P12, DOI 10.1016/j.cancergencyto.2006.02.018; Islekel H, 2007, CELL BIOCHEM FUNCT, V25, P433, DOI 10.1002/cbf.1325; Jaboin J, 2002, CANCER RES, V62, P6756; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kaebisch A, 1996, BRIT J HAEMATOL, V95, P102, DOI 10.1046/j.1365-2141.1996.d01-1874.x; Kawamura N, 2010, ENDOCRINOLOGY, V151, P3006, DOI 10.1210/en.2009-1378; Ketterer K, 2003, CLIN CANCER RES, V9, P5127; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; Lai PC, 2010, ONCOL REP, V24, P1265, DOI 10.3892/or_00000981; Lam CT, 2011, CLIN CANCER RES, V17, P3123, DOI 10.1158/1078-0432.CCR-10-2802; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li ZK, 2009, CANCER RES, V69, P7851, DOI 10.1158/0008-5472.CAN-08-4002; MATSUMOTO K, 1995, CANCER RES, V55, P1798; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Middlemas DS, 1999, J BIOL CHEM, V274, P16451, DOI 10.1074/jbc.274.23.16451; Middlemas DS, 1999, J NEURO-ONCOL, V45, P27, DOI 10.1023/A:1006342423175; Montano X, 2004, FEBS LETT, V571, P1, DOI 10.1016/j.febslet.2004.06.088; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Navarro V, 2002, BIOCHEM BIOPH RES CO, V298, P760, DOI 10.1016/S0006-291X(02)02564-0; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; NOGUCHI P, 1979, IN VITRO CELL DEV B, V15, P401; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Qiu LH, 2006, INT J ONCOL, V29, P1003; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Schramm A, 2005, CANCER LETT, V228, P143, DOI 10.1016/j.canlet.2005.02.051; Schulte JH, 2009, INT J CANCER, V124, P2488, DOI 10.1002/ijc.24204; Sclabas GM, 2005, CLIN CANCER RES, V11, P440; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; SEMPLE TU, 1978, CANCER RES, V38, P1345; SMIT MA, 2011, ONCOGENE; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Streppel M, 2002, EUR J NEUROSCI, V15, P1327, DOI 10.1046/j.1460-9568.2002.01971.x; Strohmaier C, 1996, EMBO J, V15, P3332, DOI 10.1002/j.1460-2075.1996.tb00698.x; Tajima Y, 1998, ACTA NEUROPATHOL, V95, P325, DOI 10.1007/s004010050806; TAPLEY P, 1992, ONCOGENE, V7, P371; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Terry J, 2011, ARCH PATHOL LAB MED, V135, P433, DOI 10.1043/2010-0038-OA.1; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Vaegter CB, 2011, NAT NEUROSCI, V14, P54, DOI 10.1038/nn.2689; Wang W, 2009, EJSO-EUR J SURG ONC, V35, P826, DOI 10.1016/j.ejso.2008.10.013; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Yang ZF, 2005, CANCER RES, V65, P219; Yu YJ, 2010, APMIS, V118, P188, DOI 10.1111/j.1600-0463.2009.02577.x	69	66	70	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25097	10.1371/journal.pone.0025097	http://dx.doi.org/10.1371/journal.pone.0025097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966426	gold, Green Published			2022-12-25	WOS:000295932100017
J	Cifuentes-Diaz, C; Chareyre, F; Garcia, M; Devaux, J; Carnaud, M; Levasseur, G; Niwa-Kawakita, M; Harroch, S; Girault, JA; Giovannini, M; Goutebroze, L				Cifuentes-Diaz, Carmen; Chareyre, Fabrice; Garcia, Marta; Devaux, Jerome; Carnaud, Michele; Levasseur, Gregoire; Niwa-Kawakita, Michiko; Harroch, Sheila; Girault, Jean-Antoine; Giovannini, Marco; Goutebroze, Laurence			Protein 4.1B Contributes to the Organization of Peripheral Myelinated Axons	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; K+-CHANNELS; MOLECULAR-ORGANIZATION; JUXTAPARANODAL REGIONS; POTASSIUM CHANNELS; GLIA INTERACTIONS; FOCAL EXPRESSION; NERVOUS-SYSTEM; BREAST-CANCER; LUNG-CANCER	Neurons are characterized by extremely long axons. This exceptional cell shape is likely to depend on multiple factors including interactions between the cytoskeleton and membrane proteins. In many cell types, members of the protein 4.1 family play an important role in tethering the cortical actin-spectrin cytoskeleton to the plasma membrane. Protein 4.1B is localized in myelinated axons, enriched in paranodal and juxtaparanodal regions, and also all along the internodes, but not at nodes of Ranvier where are localized the voltage-dependent sodium channels responsible for action potential propagation. To shed light on the role of protein 4.1B in the general organization of myelinated peripheral axons, we studied 4.1B knockout mice. These mice displayed a mildly impaired gait and motility. Whereas nodes were unaffected, the distribution of Caspr/paranodin, which anchors 4.1B to the membrane, was disorganized in paranodal regions and its levels were decreased. In juxtaparanodes, the enrichment of Caspr2, which also interacts with 4.1B, and of the associated TAG-1 and Kv1.1, was absent in mutant mice, whereas their levels were unaltered. Ultrastructural abnormalities were observed both at paranodes and juxtaparanodes. Axon calibers were slightly diminished in phrenic nerves and preterminal motor axons were dysmorphic in skeletal muscle. beta II spectrin enrichment was decreased along the axolemma. Electrophysiological recordings at 3 post-natal weeks showed the occurrence of spontaneous and evoked repetitive activity indicating neuronal hyperexcitability, without change in conduction velocity. Thus, our results show that in myelinated axons 4.1B contributes to the stabilization of membrane proteins at paranodes, to the clustering of juxtaparanodal proteins, and to the regulation of the internodal axon caliber.	[Cifuentes-Diaz, Carmen; Garcia, Marta; Carnaud, Michele; Levasseur, Gregoire; Girault, Jean-Antoine; Goutebroze, Laurence] INSERM, UMR S 839, Paris, France; [Cifuentes-Diaz, Carmen; Garcia, Marta; Carnaud, Michele; Levasseur, Gregoire; Girault, Jean-Antoine; Goutebroze, Laurence] Univ Paris 06, Paris, France; [Cifuentes-Diaz, Carmen; Garcia, Marta; Carnaud, Michele; Levasseur, Gregoire; Girault, Jean-Antoine; Goutebroze, Laurence] Inst Fer Moulin, Paris, France; [Chareyre, Fabrice; Niwa-Kawakita, Michiko; Giovannini, Marco] Inst Univ Hematol, INSERM, U674, Paris, France; [Devaux, Jerome] Univ Paul Cezanne, IFR Jean Roche, Univ Mediterranee, Dept Signalisat Neuronale,CNRS,CRN2M,UMR 6231, Marseille, France; [Harroch, Sheila] Inst Pasteur, Dept Neurosci, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cifuentes-Diaz, C (corresponding author), INSERM, UMR S 839, Paris, France.	jean-antoine.girault@inserm.fr	Girault, Jean-Antoine/F-7518-2013; Devaux, jerome/X-8581-2019	Girault, Jean-Antoine/0000-0002-7900-1705; Devaux, jerome/0000-0001-6383-4334; Goutebroze, laurence/0000-0002-8712-000X; marta, garcia/0000-0003-1367-6459; Kawakita, Michiko/0000-0002-9450-583X; Cifuentes Diaz, Carmen/0000-0003-2563-2082	Inserm; ARSEP; NMSS [RG 3535-A-1]; AFM [E11054A/S01334]; ANR [ANR-05-NEUR-003-01]; Association pour la Recherche sur le Cancer [7905]; Neuropole de Recherche Francilien; U.S. Army Medical Research and Materiel Command [DAMD17-02-1-0645]; Association Neurofibromatoses et Recklinghausen	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ARSEP; NMSS(National Multiple Sclerosis Society); AFM(Association Francaise contre les Myopathies); ANR(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Neuropole de Recherche Francilien; U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Association Neurofibromatoses et Recklinghausen	This work was supported in part by Inserm and grants from ARSEP, NMSS (RG 3535-A-1), AFM (E11054A/S01334), ANR (ANR-05-NEUR-003-01), Association pour la Recherche sur le Cancer (7905), Neuropole de Recherche Francilien, U.S. Army Medical Research and Materiel Command (DAMD17-02-1-0645 to MG), and Association Neurofibromatoses et Recklinghausen (MG). The group of JAG is affiliated to the Paris School of Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bonnon C, 2007, MOL BIOL CELL, V18, P229, DOI 10.1091/mbc.E06-06-0570; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Buttermore ED, 2011, J NEUROSCI, V31, P8013, DOI 10.1523/JNEUROSCI.1015-11.2011; Chang B J, 2000, J Vet Sci, V1, P67; Charboneau AL, 2002, INT J CANCER, V100, P181, DOI 10.1002/ijc.10470; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Denisenko N, 2008, J NEUROSCI, V28, P10472, DOI 10.1523/JNEUROSCI.2537-08.2008; Denisenko-Nehrbass N, 2003, EUR J NEUROSCI, V17, P411, DOI 10.1046/j.1460-9568.2003.02441.x; Devaux J, 2002, J NEUROPHYSIOL, V87, P1376, DOI 10.1152/jn.00646.2001; Devaux JJ, 2010, J PHYSIOL-LONDON, V588, P4719, DOI 10.1113/jphysiol.2010.196022; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Diakowski W, 2006, FOLIA HISTOCHEM CYTO, V44, P231; FANNON AM, 1995, J CELL BIOL, V129, P189, DOI 10.1083/jcb.129.1.189; FRAPPIER T, 1991, BIOCHEM J, V275, P521, DOI 10.1042/bj2750521; FRIEDE RL, 1983, J NEUROL SCI, V60, P89, DOI 10.1016/0022-510X(83)90129-6; Gascard P, 2004, BBA-GENE STRUCT EXPR, V1680, P71, DOI 10.1016/j.bbaexp.2004.08.006; Girault JA, 1998, MOL MED, V4, P751, DOI 10.1007/BF03401769; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Gollan L, 2002, J CELL BIOL, V157, P1247, DOI 10.1083/jcb.200203050; Goutebroze L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-29; Gutmann DH, 2000, HUM MOL GENET, V9, P1495, DOI 10.1093/hmg/9.10.1495; Heller G, 2007, BREAST CANCER RES TR, V103, P283, DOI 10.1007/s10549-006-9377-7; Horresh I, 2010, J NEUROSCI, V30, P2480, DOI 10.1523/JNEUROSCI.5225-09.2010; Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008; Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; LANGLEY RC, 1987, CELL MOTIL CYTOSKEL, V8, P165, DOI 10.1002/cm.970080208; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Macioce P, 1999, EXP CELL RES, V250, P142, DOI 10.1006/excr.1999.4479; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Ni XH, 2003, J HUM GENET, V48, P101, DOI 10.1007/s100380300015; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Ogawa Y, 2010, J NEUROSCI, V30, P1038, DOI 10.1523/JNEUROSCI.4661-09.2010; Ohara R, 2000, MOL BRAIN RES, V85, P41, DOI 10.1016/S0169-328X(00)00233-3; Ohno N, 2004, HISTOCHEM CELL BIOL, V122, P579, DOI 10.1007/s00418-004-0716-7; Ozmen S, 2002, PLAST RECONSTR SURG, V109, P1760; Parra M, 2000, J BIOL CHEM, V275, P3247, DOI 10.1074/jbc.275.5.3247; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 2001, J NEUROSCI, V21, P7568, DOI 10.1523/JNEUROSCI.21-19-07568.2001; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Singh PK, 2002, MODERN PATHOL, V15, P526, DOI 10.1038/modpathol.3880558; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Sun XY, 2009, J NEUROPATH EXP NEUR, V68, P1207, DOI 10.1097/NEN.0b013e3181be2e96; Susuki K, 2008, CURR OPIN CELL BIOL, V20, P616, DOI 10.1016/j.ceb.2008.09.007; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Tran YK, 1999, CANCER RES, V59, P35; Vabnick I, 1999, J NEUROSCI, V19, P747; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Wong SY, 2007, P NATL ACAD SCI USA, V104, P12784, DOI 10.1073/pnas.0705499104; Yageta M, 2002, CANCER RES, V62, P5129; Yamakawa H, 1999, MOL BRAIN RES, V70, P197, DOI 10.1016/S0169-328X(99)00139-4; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004; Yi CL, 2005, MOL CELL BIOL, V25, P10052, DOI 10.1128/MCB.25.22.10052-10059.2005; Yoshimura K, 1996, NEUROSCI RES, V25, P41, DOI 10.1016/0168-0102(96)01026-7; Zhou L, 1998, J NEUROSCI, V18, P7200; Zhou ZF, 1999, J CARDIOVASC ELECTR, V10, P836, DOI 10.1111/j.1540-8167.1999.tb00264.x; Zonta B, 2008, J CELL BIOL, V181, P1169, DOI 10.1083/jcb.200712154	65	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25043	10.1371/journal.pone.0025043	http://dx.doi.org/10.1371/journal.pone.0025043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966409	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100014
J	Hirokawa, J; Sadakane, O; Sakata, S; Bosch, M; Sakurai, Y; Yamamori, T				Hirokawa, Junya; Sadakane, Osamu; Sakata, Shuzo; Bosch, Miquel; Sakurai, Yoshio; Yamamori, Tetsuo			Multisensory Information Facilitates Reaction Speed by Enlarging Activity Difference between Superior Colliculus Hemispheres in Rats	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; VISUAL-AUDITORY INTERACTIONS; NIGRA PARS RETICULATA; NEURONAL-ACTIVITY; TARGET SELECTION; ELECTRICAL-STIMULATION; SUBSTANTIA-NIGRA; FIXATION CELLS; SENSORY INPUTS; REACTION-TIME	Animals can make faster behavioral responses to multisensory stimuli than to unisensory stimuli. The superior colliculus (SC), which receives multiple inputs from different sensory modalities, is considered to be involved in the initiation of motor responses. However, the mechanism by which multisensory information facilitates motor responses is not yet understood. Here, we demonstrate that multisensory information modulates competition among SC neurons to elicit faster responses. We conducted multiunit recordings from the SC of rats performing a two-alternative spatial discrimination task using auditory and/or visual stimuli. We found that a large population of SC neurons showed direction-selective activity before the onset of movement in response to the stimuli irrespective of stimulation modality. Trial-by-trial correlation analysis showed that the premovement activity of many SC neurons increased with faster reaction speed for the contraversive movement, whereas the premovement activity of another population of neurons decreased with faster reaction speed for the ipsiversive movement. When visual and auditory stimuli were presented simultaneously, the premovement activity of a population of neurons for the contraversive movement was enhanced, whereas the premovement activity of another population of neurons for the ipsiversive movement was depressed. Unilateral inactivation of SC using muscimol prolonged reaction times of contraversive movements, but it shortened those of ipsiversive movements. These findings suggest that the difference in activity between the SC hemispheres regulates the reaction speed of motor responses, and multisensory information enlarges the activity difference resulting in faster responses.	[Hirokawa, Junya; Sadakane, Osamu; Bosch, Miquel; Yamamori, Tetsuo] Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan; [Hirokawa, Junya] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sakata, Shuzo] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Sakata, Shuzo] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Bosch, Miquel] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; [Sakurai, Yoshio] Kyoto Univ, Dept Psychol, Kyoto, Japan; [Sakurai, Yoshio] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Cold Spring Harbor Laboratory; Rutgers State University Newark; Rutgers State University New Brunswick; University of Strathclyde; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Kyoto University; Japan Science & Technology Agency (JST)	Hirokawa, J (corresponding author), Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan.	yamamori@nibb.ac.jp	Yamamori, Tetsuo/N-6536-2015; Bosch, Miquel/B-4928-2011; Hirokawa, Junya/GSE-5964-2022	Yamamori, Tetsuo/0000-0001-5016-0078; Bosch, Miquel/0000-0002-7103-2574; Hirokawa, Junya/0000-0003-1238-5713; Sakata, Shuzo/0000-0001-6796-411X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (Molecular Brain Science) to T.Y. and a Grant-in-Aid for Young Scientists (B) to J.H. from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the CREST Program from the Japan Science and Technology Agency (Y.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado JC, 2007, J NEUROPHYSIOL, V97, P3193, DOI 10.1152/jn.00018.2007; BANKMAN IN, 1993, IEEE T BIO-MED ENG, V40, P836, DOI 10.1109/10.238472; BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Basso MA, 2002, J NEUROSCI, V22, P1883, DOI 10.1523/JNEUROSCI.22-05-01883.2002; Basso MA, 1998, J NEUROSCI, V18, P7519; Bell AH, 2005, J NEUROPHYSIOL, V93, P3659, DOI 10.1152/jn.01214.2004; Burnett LR, 2004, NEUROSCIENCE, V124, P535, DOI 10.1016/j.neuroscience.2003.12.026; Carello CD, 2004, NEURON, V43, P575, DOI 10.1016/j.neuron.2004.07.026; Cooper BG, 1998, HIPPOCAMPUS, V8, P340, DOI 10.1002/(SICI)1098-1063(1998)8:4<340::AID-HIPO4>3.0.CO;2-L; DEAN P, 1988, NEUROSCIENCE, V24, P491, DOI 10.1016/0306-4522(88)90344-2; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 1997, J NEUROSCI, V17, P8566; EDWARDS SB, 1977, J COMP NEUROL, V173, P23, DOI 10.1002/cne.901730103; Everling S, 1999, J NEUROSCI, V19, P2740; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; Frens MA, 1998, BRAIN RES BULL, V46, P211, DOI 10.1016/S0361-9230(98)00007-0; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Green DM, 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1285, DOI 10.1152/jn.1983.49.5.1285; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P266, DOI 10.1152/jn.1985.53.1.266; Hirokawa J, 2008, NEUROSCIENCE, V153, P1402, DOI 10.1016/j.neuroscience.2008.01.011; Isa T, 2009, J NEUROPHYSIOL, V102, P2581, DOI 10.1152/jn.00498.2009; Jiang H, 2003, NATURE, V423, P982, DOI 10.1038/nature01698; Jiang W, 2002, J COGNITIVE NEUROSCI, V14, P1240, DOI 10.1162/089892902760807230; Kadunce DC, 1997, J NEUROPHYSIOL, V78, P2834, DOI 10.1152/jn.1997.78.6.2834; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; KILPATRICK IC, 1982, NEUROSCIENCE, V7, P207, DOI 10.1016/0306-4522(82)90161-0; Kim B, 2008, J NEUROSCI, V28, P2991, DOI 10.1523/JNEUROSCI.5424-07.2008; KING AJ, 1983, J PHYSIOL-LONDON, V342, P361, DOI 10.1113/jphysiol.1983.sp014856; KING AJ, 1985, EXP BRAIN RES, V60, P492; Krauzlis RJ, 2003, J NEUROSCI, V23, P4333; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Marino RA, 2008, J NEUROPHYSIOL, V100, P2564, DOI 10.1152/jn.90688.2008; Martin JH, 1999, J NEUROSCI METH, V86, P145, DOI 10.1016/S0165-0270(98)00163-0; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; MCHAFFIE JG, 1982, BRAIN RES, V247, P243, DOI 10.1016/0006-8993(82)91249-5; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; McPeek RM, 2008, J NEUROPHYSIOL, V99, P2694, DOI 10.1152/jn.00591.2007; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Meredith MA, 1998, J NEUROPHYSIOL, V79, P1597, DOI 10.1152/jn.1998.79.3.1597; MUNOZ DP, 1992, J NEUROPHYSIOL, V67, P1000, DOI 10.1152/jn.1992.67.4.1000; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2334, DOI 10.1152/jn.1995.73.6.2334; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P576, DOI 10.1152/jn.1993.70.2.576; Munoz DP, 2002, PROG BRAIN RES, V140, P3; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Peck CK, 1996, PROG BRAIN RES, V112, P167; PECK CK, 1987, BRAIN RES, V420, P162, DOI 10.1016/0006-8993(87)90253-8; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; SAHIBZADA N, 1986, J NEUROSCI, V6, P723; Sakata S, 2005, NEUROSCIENCE, V134, P1099, DOI 10.1016/j.neuroscience.2005.05.018; Sakata S, 2004, EXP BRAIN RES, V159, P409, DOI 10.1007/s00221-004-1962-6; Sakurai Y, 1996, J NEUROSCI, V16, P2809; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Skaliora I, 2004, J NEUROPHYSIOL, V92, P2933, DOI 10.1152/jn.00450.2004; Sparks D L, 1989, Rev Oculomot Res, V3, P213; Sparks DL, 1999, CURR OPIN NEUROBIOL, V9, P698, DOI 10.1016/S0959-4388(99)00039-2; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; STEIN BE, 1979, J COMP NEUROL, V183, P269, DOI 10.1002/cne.901830205; STEIN BE, 1981, BEHAV BRAIN RES, V3, P175, DOI 10.1016/0166-4328(81)90046-2; Stein BE., 1993, MERGING SENSES; Takahashi M, 2007, J NEUROPHYSIOL, V98, P2664, DOI 10.1152/jn.00696.2007; Takahashi M, 2005, J NEUROPHYSIOL, V94, P1707, DOI 10.1152/jn.00347.2005; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wallace MT, 1998, J NEUROPHYSIOL, V80, P1006, DOI 10.1152/jn.1998.80.2.1006; Wang S, 1997, NEUROSCIENCE, V81, P967, DOI 10.1016/S0306-4522(97)00191-7; Watanabe M, 2005, J NEUROPHYSIOL, V93, P519, DOI 10.1152/jn.00558.2004; Wilkinson LK, 1996, EXP BRAIN RES, V112, P1; Zahar Y, 2009, J NEUROPHYSIOL, V101, P2380, DOI 10.1152/jn.91193.2008	86	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25283	10.1371/journal.pone.0025283	http://dx.doi.org/10.1371/journal.pone.0025283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966481	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000295932100032
J	Zhang, YQ; Gao, H; Wang, L; Xiao, X; Tan, YF; Guo, ZB; Zhou, DS; Yang, RF				Zhang, Yiquan; Gao, He; Wang, Li; Xiao, Xiao; Tan, Yafang; Guo, Zhaobiao; Zhou, Dongsheng; Yang, Ruifu			Molecular Characterization of Transcriptional Regulation of rovA by PhoP and RovA in Yersinia pestis	PLOS ONE			English	Article							RECEPTOR PROTEIN; VIRULENCE; EXPRESSION; GENE; PSEUDOTUBERCULOSIS; INVASIN; REGULON; ENTEROCOLITICA; SURVIVAL; BIOVAR	Background: Yersinia pestis is the causative agent of plague. The two transcriptional regulators, PhoP and RovA, are required for the virulence of Y. pestis through the regulation of various virulence-associated loci. They are the global regulators controlling two distinct large complexes of cellular pathways. Methodology/Principal Findings: Based on the LacZ fusion, primer extension, gel mobility shift, and DNase I footprinting assays, RovA is shown to recognize both of the two promoters of its gene in Y. pestis. The autoregulation of RovA appears to be a conserved mechanism shared by Y. pestis and its closely related progenitor, Y. pseudotuberculosis. In Y. pestis, the PhoP regulator responds to low magnesium signals and then negatively controls only one of the two promoters of rovA through PhoP-promoter DNA association. Conclusions/Significance: RovA is a direct transcriptional activator for its own gene in Y. pestis, while PhoP recognizes the promoter region of rovA to repress its transcription. The direct regulatory association between PhoP and RovA bridges the PhoP and RovA regulons in Y. pestis.	[Zhang, Yiquan; Gao, He; Wang, Li; Xiao, Xiao; Tan, Yafang; Guo, Zhaobiao; Zhou, Dongsheng; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Gao, He] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, YQ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	dongshengzhou1977@gmail.com; ruifuyang@gmail.com	Zhang, Yiquan/AAP-3311-2021; Yang, Ruifu/A-2273-2011	Zhang, Yiquan/0000-0003-3935-4079; Yang, Ruifu/0000-0003-3219-7269; Zhou, Dongsheng/0000-0003-3827-5969	National Natural Science Foundation of China [30930001, 30900823, 30771179]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support for this study came from the National Natural Science Foundation of China (30930001, 30900823, and 30771179) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Derbise A, 2007, MOL MICROBIOL, V63, P1145, DOI 10.1111/j.1365-2958.2006.05570.x; Dube PH, 2003, INFECT IMMUN, V71, P3512, DOI 10.1128/IAI.71.6.3512-3520.2003; El-Robh MS, 2002, BIOCHEM J, V368, P835, DOI 10.1042/BJ20021003; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Ellison DW, 2004, TRENDS MICROBIOL, V12, P296, DOI 10.1016/j.tim.2004.04.006; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; Heroven AK, 2006, MOL MICROBIOL, V62, P1469, DOI 10.1111/j.1365-2958.2006.05458.x; Hitchen PG, 2002, MOL MICROBIOL, V44, P1637, DOI 10.1046/j.1365-2958.2002.02990.x; Huang XZ, 2004, INFECT IMMUN, V72, P7212, DOI 10.1128/IAI.72.12.7212-7219.2004; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Kong W, 2008, J BIOL CHEM, V283, P16612, DOI 10.1074/jbc.M800547200; Lawrenz MB, 2007, J BACTERIOL, V189, P5963, DOI 10.1128/JB.00528-07; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; Li YL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-128; Li YL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-143; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Norte VA, 2003, J BACTERIOL, V185, P3508, DOI 10.1128/JB.185.12.3508-3514.2003; O'Loughlin JL, 2010, INFECT IMMUN, V78, P773, DOI 10.1128/IAI.00718-09; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Perez JC, 2009, P NATL ACAD SCI USA, V106, P4319, DOI 10.1073/pnas.0810343106; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Simonet M, 1996, INFECT IMMUN, V64, P375, DOI 10.1128/IAI.64.1.375-379.1996; Skurnik M, 2000, MOL MICROBIOL, V37, P316, DOI 10.1046/j.1365-2958.2000.01993.x; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Song HW, 2008, J BIOL CHEM, V283, P28158, DOI 10.1074/jbc.M801058200; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; Yang FK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012840; Zhan LJ, 2008, INFECT IMMUN, V76, P5028, DOI 10.1128/IAI.00370-08; Zhou DS, 2005, FEMS MICROBIOL LETT, V250, P85, DOI 10.1016/j.femsle.2005.06.053; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004	47	43	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25484	10.1371/journal.pone.0025484	http://dx.doi.org/10.1371/journal.pone.0025484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966533	Green Published, Green Submitted, gold			2022-12-25	WOS:000295932100042
J	Dronamraju, R; Mason, JM				Dronamraju, Raghuvar; Mason, James M.			MU2 and HP1a Regulate the Recognition of Double Strand Breaks in Drosophila melanogaster	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; HETEROCHROMATIN PROTEIN-1; CHROMATIN-STRUCTURE; GAMMA-H2AX FOCI; CELL-CYCLE; IONIZING-RADIATION; GENE; ATM; TRANSCRIPTION; MITOSIS	Chromatin structure regulates the dynamics of the recognition and repair of DNA double strand breaks; open chromatin enhances the recruitment of DNA damage response factors, while compact chromatin is refractory to the assembly of radiation-induced repair foci. MU2, an orthologue of human MDC1, a scaffold for ionizing radiation-induced repair foci, is a widely distributed chromosomal protein in Drosophila melanogaster that moves to DNA repair foci after irradiation. Here we show using yeast 2 hybrid screens and co-immunoprecipitation that MU2 binds the chromoshadow domain of the heterochromatin protein HP1 in untreated cells. We asked what role HP1 plays in the formation of repair foci and cell cycle control in response to DNA damage. After irradiation repair foci form in heterochromatin but are shunted to the edge of heterochromatic regions an HP1-dependent manner, suggesting compartmentalized repair. Hydroxyurea-induced repair foci that form at collapsed replication forks, however, remain in the heterochromatic compartment. HP1a depletion in irradiated imaginal disc cells increases apoptosis and disrupts G2/M arrest. Further, cells irradiated in mitosis produced more and brighter repair foci than to cells irradiated during interphase. Thus, the interplay between MU2 and HP1a is dynamic and may be different in euchromatin and heterochromatin during DNA break recognition and repair.	[Dronamraju, Raghuvar; Mason, James M.] NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dronamraju, R (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	masonj@niehs.nih.gov			National Institutes of Health, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES021054] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2005, SCIENCE, V308, P510, DOI 10.1126/science.1112069; ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Andreyeva EN, 2008, CHROMOSOME RES, V16, P851, DOI 10.1007/s10577-008-1244-4; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayoub N, 2009, CELL CYCLE, V8, P2945; Ayoub N, 2009, CELL CYCLE, V8, P1494, DOI 10.4161/cc.8.10.8501; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; BIESSMANN H, 1988, EMBO J, V7, P1081, DOI 10.1002/j.1460-2075.1988.tb02916.x; Bradbury JM, 2003, BIOCHEM SOC T, V31, P40, DOI 10.1042/bst0310040; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Ciapponi L, 2006, GENETICS, V173, P1447, DOI 10.1534/genetics.106.058081; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; DeGrado-Warren J, 2008, BIOTECHNIQUES, V44, P265, DOI 10.2144/000112674; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Dronamraju R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000473; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fernandez-Capetillo O, 2008, MOL CELL, V31, P303, DOI 10.1016/j.molcel.2008.07.004; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2009, BIOCHEM SOC T, V37, P569, DOI 10.1042/BST0370569; Hunter N, 2008, CELL, V132, P731, DOI 10.1016/j.cell.2008.02.026; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; Kasravi A, 1999, GENETICS, V152, P1025; Kato TA, 2008, MUTAT RES-FUND MOL M, V639, P108, DOI 10.1016/j.mrfmmm.2007.11.006; KELLUM R, 1995, J CELL SCI, V108, P1407; Kruhlak Michael J., 2009, V523, P125, DOI 10.1007/978-1-59745-190-1_9; Liu LP, 2005, NAT GENET, V37, P1361, DOI 10.1038/ng1662; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Mason J M, 1989, Prog Clin Biol Res, V318, P73; MASON JM, 1984, P NATL ACAD SCI-BIOL, V81, P6090, DOI 10.1073/pnas.81.19.6090; Mason JM, 1997, GENETICS, V146, P1381; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Mueller H. -Arno J., 2008, V420, P207, DOI 10.1007/978-1-59745-583-1_12; Oikemus SR, 2006, PLOS GENET, V2, P693, DOI 10.1371/journal.pgen.0020071; Oikemus SR, 2004, GENE DEV, V18, P1850, DOI 10.1101/gad.1202504; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; SAWADA N, 1988, CANCER RES, V48, P1618; Scott SP, 2006, J CELL BIOCHEM, V99, P1463, DOI 10.1002/jcb.21067; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137	60	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25439	10.1371/journal.pone.0025439	http://dx.doi.org/10.1371/journal.pone.0025439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966530	Green Submitted, Green Published, gold			2022-12-25	WOS:000295267100061
J	Hisano, M; Connolly, SR; Robbins, WD				Hisano, Mizue; Connolly, Sean R.; Robbins, William D.			Population Growth Rates of Reef Sharks with and without Fishing on the Great Barrier Reef: Robust Estimation with Multiple Models	PLOS ONE			English	Article							DEMOGRAPHIC-ANALYSIS; NATURAL MORTALITY; FISHES; UNCERTAINTY; MANAGEMENT; PARAMETER; ISLANDS; DENSITY; ATOLLS; AGE	Overfishing of sharks is a global concern, with increasing numbers of species threatened by overfishing. For many sharks, both catch rates and underwater visual surveys have been criticized as indices of abundance. In this context, estimation of population trends using individual demographic rates provides an important alternative means of assessing population status. However, such estimates involve uncertainties that must be appropriately characterized to credibly and effectively inform conservation efforts and management. Incorporating uncertainties into population assessment is especially important when key demographic rates are obtained via indirect methods, as is often the case for mortality rates of marine organisms subject to fishing. Here, focusing on two reef shark species on the Great Barrier Reef, Australia, we estimated natural and total mortality rates using several indirect methods, and determined the population growth rates resulting from each. We used bootstrapping to quantify the uncertainty associated with each estimate, and to evaluate the extent of agreement between estimates. Multiple models produced highly concordant natural and total mortality rates, and associated population growth rates, once the uncertainties associated with the individual estimates were taken into account. Consensus estimates of natural and total population growth across multiple models support the hypothesis that these species are declining rapidly due to fishing, in contrast to conclusions previously drawn from catch rate trends. Moreover, quantitative projections of abundance differences on fished versus unfished reefs, based on the population growth rate estimates, are comparable to those found in previous studies using underwater visual surveys. These findings appear to justify management actions to substantially reduce the fishing mortality of reef sharks. They also highlight the potential utility of rigorously characterizing uncertainty, and applying multiple assessment methods, to obtain robust estimates of population trends in species threatened by overfishing.	[Hisano, Mizue; Connolly, Sean R.; Robbins, William D.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Connolly, Sean R.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	James Cook University; James Cook University	Hisano, M (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia.	Mizue.Hisano@jcu.edu.au	Connolly, Sean R./E-7773-2011	Connolly, Sean R./0000-0003-1537-0859; Robbins, William/0000-0003-1106-1733	Australian Research Council; James Cook University	Australian Research Council(Australian Research Council); James Cook University	This work was supported by the Australian Research Council and James Cook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annan JD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025259; Ayling AM, 2008, RES PUBLICATION GR N; Barker MJ, 2005, AQUAT CONSERV, V15, P325, DOI 10.1002/aqc.660; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Beverton R.J., 1957, FISHERY INVESTIGAT 2, VXIX; Blakesley JA, 2010, WILDLIFE MONOGR, P1; Bromhead D, 2005, BYPRODUCT CATCH EC C; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; C?lix M., 2018, EUROPEAN RED LIST SA; Campana Steven E., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P891; Cavanagh R.D., 2003, IUCN RED LIST THREAT; Charnov Eric L., 1993, P1; Chen PM, 2006, FISH RES, V78, P374, DOI 10.1016/j.fishres.2006.01.007; CHEN S, 1989, NIPPON SUISAN GAKK, V55, P205; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Compagno LJV, 1984, SHARKS WORLD ANNOTAT; Davison AC, 1997, CAMBRIDGE SERIES STA, V1; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Efron B, 1998, INTRO BOOTSTRAP; Ellis J, 2005, J MAR BIOL ASSOC UK, V85, P1025, DOI 10.1017/S0025315405012099; Fischer AJ, 2005, FISH B-NOAA, V103, P307; Fowler SL, 2005, SHARKS RAYS CHIMAERA; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Grueber CE, 2010, CONSERV BIOL, V24, P1617, DOI 10.1111/j.1523-1739.2010.01549.x; Heupel MR, 2009, FISH RES, V95, P350, DOI 10.1016/j.fishres.2008.10.005; Hewit DA, 2007, T AM FISH SOC, V136, P1030, DOI 10.1577/T06-078.1; Hilborn Ray, 1997, V28; HOBSON EDMUND S., 1963, PACIFIC SCI, V17, P171; HOENIG JM, 1983, FISH B-NOAA, V81, P898; Jensen AL, 1996, CAN J FISH AQUAT SCI, V53, P820, DOI 10.1139/cjfas-53-4-820; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Lack M., 2006, WORLD SHARK CATCH PR; Lack M., 2009, TRENDS GLOBAL SHARK; Lough J., 2007, CLIMATE CHANGE GREAT, P15; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; PAULY D, 1980, J CONSEIL, V39, P175; Quiroz JC, 2010, FISH RES, V102, P297, DOI 10.1016/j.fishres.2010.01.001; RANDALL JE, 1977, PAC SCI, V31, P143; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Salini J. P., 2007, SPECIES IDENTIFICATI; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Savage VM, 2006, SCIENCE, V312, p198B, DOI 10.1126/science.1123679; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Smith WD, 2008, MAR FRESHWATER RES, V59, P575, DOI 10.1071/MF07020; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Tsai WP, 2010, MAR FRESHWATER RES, V61, P1056, DOI 10.1071/MF09303; van der Sluijs JP, 2007, ENVIRON MODELL SOFTW, V22, P590, DOI 10.1016/j.envsoft.2005.12.020; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; WATSON RA, 1995, ECOL MODEL, V77, P205, DOI 10.1016/0304-3800(93)E0085-H; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249	54	48	48	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25028	10.1371/journal.pone.0025028	http://dx.doi.org/10.1371/journal.pone.0025028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966402	Green Accepted, Green Published, gold			2022-12-25	WOS:000295267100017
J	Li, XD; Garcia, K; Sun, ZF; Xiao, ZG				Li, Xiangdong; Garcia, Karla; Sun, Zhifeng; Xiao, Zhengguo			Temporal Regulation of Rapamycin on Memory CTL Programming by IL-12	PLOS ONE			English	Article							CD8 T-CELLS; CLONAL EXPANSION; MAMMALIAN TARGET; PRECURSOR FREQUENCY; EFFECTOR FUNCTION; GAMMA PRODUCTION; VIRAL-INFECTION; I IFN; MTOR; DIFFERENTIATION	Mammalian target of rapamycin (mTOR) is a master regulator of cell growth. Recent reports have defined its important role in memory cytotoxic T lymphocyte (CTL) differentiation in infections and memory programming. We report that rapamycin regulated memory CTL programming by IL-12 to a similar level in a wide range of concentrations, and the enhanced memory CTLs by rapamycin were functional and provided similar protection against Listeria Monocytogenes challenge compared to the control. In addition, rapamycin-experienced CTLs went through substantially enhanced proliferation after transfer into recipients. Furthermore, the regulatory function of rapamycin on CD62L expression in memory CTLs was mainly contributed by the presence of rapamycin in the first 24-hr of stimulation in vitro, whereas the effective window of rapamycin on the size of memory CTLs was determined between 24 to 72 hrs. In conclusion, rapamycin regulates IL-12-driven programming of CTLs to a similar level in a wide range of concentrations, and regulates the phenotype and the size of memory CTLs in different temporal windows.	[Li, Xiangdong; Garcia, Karla; Sun, Zhifeng; Xiao, Zhengguo] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Li, XD (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	xiao0028@umd.edu	; li, xiangdong/T-6019-2017	Xiao, Zhengguo/0000-0002-3359-6491; li, xiangdong/0000-0002-4635-1602				Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; [Anonymous], 2007, HIV VACCINE FAILURE, V449, P390; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Berstein G, 2008, NAT IMMUNOL, V9, P455, DOI 10.1038/ni0508-455; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Colombetti S, 2006, J IMMUNOL, V176, P2730, DOI 10.4049/jimmunol.176.5.2730; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kroczynska B, 2009, CYTOKINE, V48, P138, DOI 10.1016/j.cyto.2009.07.009; Kusaba H, 2005, J BIOL CHEM, V280, P1037, DOI 10.1074/jbc.M405204200; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Mondino A, 2007, SEMIN IMMUNOL, V19, P162, DOI 10.1016/j.smim.2007.02.008; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Prlic M, 2009, NATURE, V460, P41, DOI 10.1038/460041a; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Salmond RJ, 2009, J IMMUNOL, V183, P7388, DOI 10.4049/jimmunol.0902294; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Vodenik B, 2009, Transplant Proc, V41, pS31, DOI 10.1016/j.transproceed.2009.06.159; Way SS, 2007, J IMMUNOL, V178, P4498, DOI 10.4049/jimmunol.178.7.4498; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Whitmire JK, 2006, J IMMUNOL, V176, P3028, DOI 10.4049/jimmunol.176.5.3028; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yea SS, 2011, SCIENCE, V332, P1270, DOI 10.1126/science.1208071	42	45	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25177	10.1371/journal.pone.0025177	http://dx.doi.org/10.1371/journal.pone.0025177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966447	Green Published, gold, Green Submitted			2022-12-25	WOS:000295267100024
J	Brust, B; Lecoufle, M; Tuaillon, E; Dedieu, L; Canaan, S; Valverde, V; Kremer, L				Brust, Belinda; Lecoufle, Melanie; Tuaillon, Edouard; Dedieu, Luc; Canaan, Stephane; Valverde, Viviane; Kremer, Laurent			Mycobacterium tuberculosis Lipolytic Enzymes as Potential Biomarkers for the Diagnosis of Active Tuberculosis	PLOS ONE			English	Article							CUTINASE-LIKE PROTEINS; ANTIBODY-RESPONSES; PULMONARY TUBERCULOSIS; IN-VITRO; ANTIGEN; TRIACYLGLYCEROL; PURIFICATION; EXPRESSION; SMEGMATIS; TESTS	Background: New diagnosis tests are urgently needed to address the global tuberculosis (TB) burden and to improve control programs especially in resource-limited settings. An effective in vitro diagnostic of TB based on serological methods would be regarded as an attractive progress because immunoassays are simple, rapid, inexpensive, and may offer the possibility to detect cases missed by standard sputum smear microscopy. However, currently available serology tests for TB are highly variable in sensitivity and specificity. Lipolytic enzymes have recently emerged as key factors in lipid metabolization during dormancy and/or exit of the non-replicating growth phase, a prerequisite step of TB reactivation. The focus of this study was to analyze and compare the potential of four Mycobacterium tuberculosis lipolytic enzymes (LipY, Rv0183, Rv1984c and Rv3452) as new markers in the serodiagnosis of active TB. Methods: Recombinant proteins were produced and used in optimized ELISA aimed to detect IgG and IgM serum antibodies against the four lipolytic enzymes. The capacity of the assays to identify infection was evaluated in patients with either active TB or latent TB and compared with two distinct control groups consisting of BCG-vaccinated blood donors and hospitalized non-TB individuals. Results: A robust humoral response was detected in patients with active TB whereas antibodies against lipolytic enzymes were infrequently detected in either uninfected groups or in subjects with latent infection. High specifity levels, ranging from 93.9% to 97.5%, were obtained for all four antigens with sensitivity values ranging from 73.4% to 90.5%, with Rv3452 displaying the highest performances. Patients with active TB usually exhibited strong IgG responses but poor IgM responses. Conclusion: These results clearly indicate that the lipolytic enzymes tested are strongly immunogenic allowing to distinguish active from latent TB infections. They appear as potent biomarkers providing high sensitivity and specificity levels for the immunodiagnosis of active TB.	[Brust, Belinda; Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, Montpellier, France; [Brust, Belinda; Kremer, Laurent] Univ Montpellier I, CNRS, UMR 5235, Montpellier, France; [Kremer, Laurent] INSERM, DIMNP, Montpellier, France; [Tuaillon, Edouard] Univ Montpellier I, INSERM, Dept Bacteriol Virol, Inst Rech Biotherapie,Ctr Hosp,U1058, Montpellier, France; [Dedieu, Luc; Canaan, Stephane] Univ Aix Marseille, Marseille, France; [Brust, Belinda; Lecoufle, Melanie; Valverde, Viviane] Bio Rad Labs Inc, Div Clin Microbiol, Steenvoorde, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite	Brust, B (corresponding author), Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, Montpellier, France.	laurent.kremer@univ-montp2.fr	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Tuaillon, Edouard/0000-0001-5866-9530	Institut National de la Sante et de la Recherche Medicale/French Directorate for Hospitalization and Care Organization 'Recherche Clinique Translationnelle' [A10053FS]; French National Research Agency [ANR-09-MIEN-009-02]; Bio-Rad Laboratories; French National Research Center [Nu31203]	Institut National de la Sante et de la Recherche Medicale/French Directorate for Hospitalization and Care Organization 'Recherche Clinique Translationnelle'(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Research Agency(French National Research Agency (ANR)); Bio-Rad Laboratories; French National Research Center(Centre National de la Recherche Scientifique (CNRS))	This study was funded by the Institut National de la Sante et de la Recherche Medicale/French Directorate for Hospitalization and Care Organization 'Recherche Clinique Translationnelle' (A10053FS) and the FoamyTub program from the French National Research Agency (ANR-09-MIEN-009-02) to LK and SC. The authors wish to thank the Association Nationale de la Recherche et de la Technologie. The authors also wish to thank the Bio-Rad Laboratories for support to BB. BB, ML and VV are employees of CMD Division, Bio-Rad Laboratories, route de Cassel, 59114 Steenwoorde, France and contributed to all aspects of the study. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Bio-Rad Laboratories with which a scientific program has been established with the French National Research Center (contract Nu31203). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. There are no patents, products in development or marketed products to declare from Bio-Rad.	Achkar JM, 2006, CLIN VACCINE IMMUNOL, V13, P1291, DOI 10.1128/CVI.00158-06; Barnes PF, 1997, AM J RESP CRIT CARE, V155, P1497, DOI 10.1164/ajrccm.155.5.9154847; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cotes K, 2008, APPL MICROBIOL BIOT, V78, P741, DOI 10.1007/s00253-008-1397-2; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daugelat S, 2003, MICROBES INFECT, V5, P1082, DOI 10.1016/S1286-4579(03)00205-3; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Dhouib R, 2011, BBA-MOL CELL BIOL L, V1811, P234, DOI 10.1016/j.bbalip.2011.01.001; Dhouib R, 2010, J BACTERIOL, V192, P4776, DOI 10.1128/JB.00261-10; Dye C, 2002, J INFECT DIS, V185, P1197, DOI 10.1086/339818; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fu RL, 2009, CLIN VACCINE IMMUNOL, V16, P686, DOI 10.1128/CVI.00486-08; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; GARBE T, 1993, INFECT IMMUN, V61, P260, DOI 10.1128/IAI.61.1.260-267.1993; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Grover A, 2006, PROTEIN EXPRES PURIF, V48, P274, DOI 10.1016/j.pep.2006.03.010; GUPTA S, 1995, TUBERCLE LUNG DIS, V76, P418, DOI 10.1016/0962-8479(95)90008-X; Hoff ST, 2007, CLIN INFECT DIS, V45, P575, DOI 10.1086/520662; Houghton RL, 2002, CLIN DIAGN LAB IMMUN, V9, P883, DOI 10.1128/CDLI.9.4.883-891.2002; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Imaz MS, 2004, J CLIN MICROBIOL, V42, P884, DOI 10.1128/JCM.42.2.884-887.2004; Kassa-Kelembho E, 2006, CLIN VACCINE IMMUNOL, V13, P702, DOI 10.1128/CVI.00194-05; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Kolattukudy PE, 2001, ADV BIOCHEM ENG BIOT, V71, P1; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; LJUNGQVIST L, 1990, TROP MED PARASITOL, V41, P333; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; MANNESSE MLM, 1995, BIOCHEMISTRY-US, V34, P6400, DOI 10.1021/bi00019a020; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Morris K, 2011, LANCET, V377, P113, DOI 10.1016/S0140-6736(11)60005-6; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Mustafa AS, 2002, MOL IMMUNOL, V39, P113, DOI 10.1016/S0161-5890(02)00048-2; N'Goma JCB, 2010, BBA-MOL CELL BIOL L, V1801, P1305, DOI 10.1016/j.bbalip.2010.08.007; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Parkash O, 2009, SCAND J IMMUNOL, V70, P345, DOI 10.1111/j.1365-3083.2009.02312.x; Parker SK, 2007, J BACTERIOL, V189, P4153, DOI 10.1128/JB.01909-06; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pottumarthy S, 2000, J CLIN MICROBIOL, V38, P2227; Roche PW, 1996, CLIN EXP IMMUNOL, V103, P226, DOI 10.1046/j.1365-2249.1996.d01-613.x; Samanich K, 2001, INFECT IMMUN, V69, P4600, DOI 10.1128/IAI.69.7.4600-4609.2001; Sartain MJ, 2006, MOL CELL PROTEOMICS, V5, P2102, DOI 10.1074/mcp.M600089-MCP200; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Vincentelli R, 2004, PROTEIN SCI, V13, P2782, DOI 10.1110/ps.04806004; Wang BL, 2005, INT J TUBERC LUNG D, V9, P1327; Weldingh K, 1999, FEMS IMMUNOL MED MIC, V23, P159, DOI 10.1111/j.1574-695X.1999.tb01235.x; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; World Health Organization, 2010, GLOB TUB CONTR WHO R; Wu XQ, 2010, CLIN VACCINE IMMUNOL, V17, P372, DOI [10.1128/CVI.00287-09, 10.3785/j.issn.1006-754X.2010.05.011]	54	48	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25078	10.1371/journal.pone.0025078	http://dx.doi.org/10.1371/journal.pone.0025078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966416	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100049
J	Cavalcanti, MG; Mesquita, JS; Madi, K; Feijo, DF; Assuncao-Miranda, I; Souza, HSP; Bozza, MT				Cavalcanti, Marta G.; Mesquita, Jacilene S.; Madi, Kalil; Feijo, Daniel F.; Assuncao-Miranda, Iranaia; Souza, Heitor S. P.; Bozza, Marcelo T.			MIF Participates in Toxoplasma gondii-Induced Pathology Following Oral Infection	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; SMALL-INTESTINE; PERORAL INFECTION; HOST-RESISTANCE; C57BL/6 MICE; IFN-GAMMA; MACROPHAGE; CYTOKINE; NECROSIS; CELLS	Background: Macrophage migration inhibitory factor (MIF) is essential for controlling parasite burden and survival in a model of systemic Toxoplasma gondii infection. Peroral T. gondii infection induces small intestine necrosis and death in susceptible hosts, and in many aspects resembles inflammatory bowel disease (IBD). Considering the critical role of MIF in the pathogenesis of IBD, we hypothesized that MIF participates in the inflammatory response induced by oral infection with T. gondii. Methodology/Principal Findings: Mif deficient (Mif(-/-)) and wild-type mice in the C57Bl/6 background were orally infected with T. gondii strain ME49. Mif(-/-) mice had reduced lethality, ileal inflammation and tissue damage despite of an increased intestinal parasite load compared to wt mice. Lack of MIF caused a reduction of TNF-alpha, IL-12, IFN-gamma and IL-23 and an increased expression of IL-22 in ileal mucosa. Moreover, suppressed pro-inflammatory responses at the ileal mucosa observed in Mif(-/-) mice was not due to upregulation of IL-4, IL-10 or TGF-beta. MIF also affected the expression of matrix metalloproteinase-9 (MMP-9) but not MMP-2 in the intestine of infected mice. Signs of systemic inflammation including the increased concentrations of inflammatory cytokines in the plasma and liver damage were less pronounced in Mif(-/-) mice compared to wild-type mice. Conclusion/Significance: In conclusion, our data suggested that in susceptible hosts MIF controls T. gondii infection with the cost of increasing local and systemic inflammation, tissue damage and death.	[Cavalcanti, Marta G.; Mesquita, Jacilene S.; Feijo, Daniel F.; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [Cavalcanti, Marta G.] Univ Fed Rio de Janeiro, Serv Doencas Infecciosas & Parasitarias, Rio De Janeiro, Brazil; [Souza, Heitor S. P.; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Dept Clin Med, Lab Multidisciplinar Pesquisa, Rio De Janeiro, Brazil; [Madi, Kalil] Univ Fed Rio de Janeiro, Dept Patol, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil; [Madi, Kalil] Lab Sergio Franco, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Cavalcanti, MG (corresponding author), Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.	cavalcanti.marta66@gmail.com; mbozza@micro.ufrj.br	Ferreira Feijó, Daniel/Y-6067-2018; de Souza, Heitor Siffert Pereira/G-3297-2012	de Souza, Heitor Siffert Pereira/0000-0002-3647-7324; Bozza, Marcelo/0000-0003-3683-7550; Miranda, Iranaia/0000-0001-5684-4788	CNPq; FAPERJ; Pronex (Programa de Apoio a Nucleos de Excelencia - Pronex/FAPERJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Pronex (Programa de Apoio a Nucleos de Excelencia - Pronex/FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by CNPq, FAPERJ and Pronex (Programa de Apoio a Nucleos de Excelencia - Pronex/FAPERJ (www.faperj.br/interna.phtml?ctx_cod = 1.11)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assuncao-Miranda I, 2010, J MED VIROL, V82, P164, DOI 10.1002/jmv.21649; Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469; Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Brembilla NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018741; Bucala R, 1996, FASEB J, V10, P1607, DOI 10.1096/fasebj.10.14.9002552; Buzoni-Gatel D, 2006, CELL MICROBIOL, V8, P535, DOI 10.1111/j.1462-5822.2006.00692.x; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dunne DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011343; Flores M, 2008, FASEB J, V22, P3661, DOI 10.1096/fj.08-111666; Garg P, 2009, AM J PHYSIOL-GASTR L, V296, pG175, DOI 10.1152/ajpgi.90454.2008; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gomes AD, 2011, AM J PATHOL, V178, P2792, DOI 10.1016/j.ajpath.2011.02.005; He XX, 2009, MOL MED, V15, P1, DOI 10.2119/molmed.2008.00107; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Kompalic-Cristo A, 2007, PARASITOL RES, V101, P619, DOI 10.1007/s00436-007-0524-9; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; Magalhaes ES, 2007, EUR J IMMUNOL, V37, P1097, DOI 10.1002/eji.200635968; Magalhaes ES, 2009, FASEB J, V23, P1262, DOI 10.1096/fj.08-124248; McDevitt MA, 2006, J EXP MED, V193, P1; Mennechet FJD, 2002, J IMMUNOL, V168, P2988, DOI 10.4049/jimmunol.168.6.2988; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Neves ES, 2009, MEM I OSWALDO CRUZ, V104, P393, DOI 10.1590/S0074-02762009000200039; Nickdel MB, 2004, PARASITE IMMUNOL, V26, P75, DOI 10.1111/j.0141-9838.2004.00686.x; Ohkawara T, 2006, IMMUNOL LETT, V107, P148, DOI 10.1016/j.imlet.2006.09.002; Paiva CN, 2009, J LEUKOCYTE BIOL, V85, P855, DOI 10.1189/jlb.0108009; Pakozdi A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2021; Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461; Reischl U, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-7; Reyes JL, 2006, INFECT IMMUN, V72, P3571; Roberts CW, 1996, INFECT IMMUN, V64, P897, DOI 10.1128/IAI.64.3.897-904.1996; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; Tait ED, 2009, MEM I OSWALDO CRUZ, V104, P201, DOI 10.1590/S0074-02762009000200013; Terrazas CA, 2010, EXP PARASITOL, V126, P348, DOI 10.1016/j.exppara.2010.03.009; Ferro EAV, 2008, AM J PATHOL, V172, P50, DOI 10.2353/ajpath.2008.070432; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	54	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25259	10.1371/journal.pone.0025259	http://dx.doi.org/10.1371/journal.pone.0025259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21977228	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100077
J	Chou, YH; Woon, PY; Chen, WC; Hsu, YW; Chang, JM; Hwang, DY; Chiu, YC; Kuo, HC; Chang, WP; Hou, MF; Liu, ME; Chang, JG; Chang, WC				Chou, Yii-Her; Woon, Peng Yeong; Chen, Wei-Chiao; Hsu, Yu-Wen; Chang, Jer-Ming; Hwang, Daw-Yang; Chiu, Yi-Ching; Kuo, Ho-Chang; Chang, Wei-Pin; Hou, Ming-Feng; Liu, Mu-En; Chang, Jan-Gowth; Chang, Wei-Chiao			A Genetic Polymorphism (rs17251221) in the Calcium-Sensing Receptor Gene (CASR) Is Associated with Stone Multiplicity in Calcium Nephrolithiasis	PLOS ONE			English	Article							KIDNEY-STONES; DISEASE; HYPERCALCIURIA; TAIWAN; HEALTH	Calcium nephrolithiasis is one of the most common causes of renal stones. While the prevalence of this disease has increased steadily over the last 3 decades, its pathogenesis is still unclear. Previous studies have indicated that a genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with the total serum calcium levels. In this study, we collected DNA samples from 480 Taiwanese subjects (189 calcium nephrolithiasis patients and 291 controls) for genotyping the CASR gene. Our results indicated no significant association between the CASR polymorphism (rs17251221) and the susceptibility of calcium nephrolithiasis. However, we found a significant association between rs17251221 and stone multiplicity. The risk of stone multiplicity was higher in patients with the GG+GA genotype than in those with the AA genotype (chi-square test: P = 0.008; odds ratio = 4.79;95% confidence interval, 1.44-15.92;Yates' correction for chi-square test: P = 0.013). In conclusion, our results provide evidence supporting the genetic effects of CASR on the pathogenesis of calcium nephrolithiasis.	[Chou, Yii-Her] Kaohsiung Med Univ, Coll Med, Dept Urol, Kaohsiung, Taiwan; [Chou, Yii-Her] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Chen, Wei-Chiao; Hsu, Yu-Wen; Chiu, Yi-Ching; Liu, Mu-En; Chang, Wei-Chiao] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan; [Hou, Ming-Feng; Chang, Jan-Gowth; Chang, Wei-Chiao] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chang, Wei-Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan; [Chang, Jan-Gowth] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Woon, Peng Yeong] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chang, Jer-Ming; Hwang, Daw-Yang] Kaohsiung Med Univ Hosp, Div Nephrol, Dept Med, Kaohsiung, Taiwan; [Kuo, Ho-Chang] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Div Allergy Immunol & Rheumatol, Kaohsiung, Taiwan; [Kuo, Ho-Chang] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Div Cardiol, Dept Pediat, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Coll Med, Dept Surg, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ, Ctr Resources Res & Dev, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Tzu Chi University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chou, YH (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Urol, Kaohsiung, Taiwan.	wcc@kmu.edu.tw	Kuo, Ho-Chang/AAQ-6644-2020	Kuo, Ho-Chang/0000-0002-3295-2984; Hou, Ming-Feng/0000-0001-6030-9702; Chang, Wei-Chiao/0000-0002-8573-5924	Department of Health, Executive Yuan, Taiwan, Republic of China [DOH100-TD-C-111-002]; National Science Council, Taiwan, Republic of China [NSC100-2320-B-037-002, NSC99-2314-B-037-019-MY3]; Kaohsiung Medical University [Q-Q100005]	Department of Health, Executive Yuan, Taiwan, Republic of China; National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University	This study was partly supported by an excellence for cancer research center grant, Department of Health, Executive Yuan, Taiwan, Republic of China (NO.DOH100-TD-C-111-002), by grants (NSC100-2320-B-037-002; NSC99-2314-B-037-019-MY3) from the National Science Council, Taiwan, Republic of China and by a grant (Q-Q100005) from Kaohsiung Medical University. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN EM, 1995, NEW ENGL J MED, V333, P234, DOI 10.1056/NEJM199507273330407; Brown EM, 1998, ANNU REV MED, V49, P15, DOI 10.1146/annurev.med.49.1.15; Chou YH, 2007, KAOHSIUNG J MED SCI, V23, P63, DOI 10.1016/S1607-551X(09)70376-6; D'Souza-Li Lília, 2006, Arq Bras Endocrinol Metab, V50, P628, DOI 10.1590/S0004-27302006000400008; Hoenderop JGJ, 2005, J AM SOC NEPHROL, V16, P15, DOI 10.1681/ASN.2004070523; Kapur K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001035; Latta K, 2010, NEW ENGL J MED, V363, P2470, DOI 10.1056/NEJMc1011349; Lee YH, 2002, UROL INT, V68, P172, DOI 10.1159/000048445; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; O'Seaghdha CM, 2010, HUM MOL GENET, V19, P4296, DOI 10.1093/hmg/ddq342; Pasch A, 2008, NEPHROL DIAL TRANSPL, V23, P2563, DOI 10.1093/ndt/gfn091; Reh CMS, 2011, J CLIN ENDOCR METAB, V96, pE707, DOI 10.1210/jc.2010-1306; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; ROBERTSON WG, 1980, NEPHRON, V26, P105, DOI 10.1159/000181963; Scillitani A, 2007, J CLIN ENDOCR METAB, V92, P277, DOI 10.1210/jc.2006-0857; Shakhssalim N, 2010, SCAND J UROL NEPHROL, V44, P406, DOI 10.3109/00365599.2010.497770; Tasca A, 2011, CURR OPIN UROL, V21, P129, DOI 10.1097/MOU.0b013e3283435cbc; Vezzoli G, 2007, KIDNEY INT, V71, P1155, DOI 10.1038/sj.ki.5002156; VEZZOLI G, 2010, GENETICS CALCIUM NEP	19	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25227	10.1371/journal.pone.0025227	http://dx.doi.org/10.1371/journal.pone.0025227			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966463	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100074
J	Nasu, A; Marusawa, H; Ueda, Y; Nishijima, N; Takahashi, K; Osaki, Y; Yamashita, Y; Inokuma, T; Tamada, T; Fujiwara, T; Sato, F; Shimizu, K; Chiba, T				Nasu, Akihiro; Marusawa, Hiroyuki; Ueda, Yoshihide; Nishijima, Norihiro; Takahashi, Ken; Osaki, Yukio; Yamashita, Yukitaka; Inokuma, Tetsuro; Tamada, Takashi; Fujiwara, Takeshi; Sato, Fumiaki; Shimizu, Kazuharu; Chiba, Tsutomu			Genetic Heterogeneity of Hepatitis C Virus in Association with Antiviral Therapy Determined by Ultra-Deep Sequencing	PLOS ONE			English	Article							TREATMENT-NAIVE PATIENTS; INTERFERON-ALPHA; IN-VIVO; INFECTION; GENOME; MUTATIONS; PROTEASE; POLYMERASE; RESISTANCE; INHIBITORS	Background and Aims: The hepatitis C virus (HCV) invariably shows wide heterogeneity in infected patients, referred to as a quasispecies population. Massive amounts of genetic information due to the abundance of HCV variants could be an obstacle to evaluate the viral genetic heterogeneity in detail. Methods: Using a newly developed massive-parallel ultra-deep sequencing technique, we investigated the viral genetic heterogeneity in 27 chronic hepatitis C patients receiving peg-interferon (IFN) alpha 2b plus ribavirin therapy. Results: Ultra-deep sequencing determined a total of more than 10 million nucleotides of the HCV genome, corresponding to a mean of more than 1000 clones in each specimen, and unveiled extremely high genetic heterogeneity in the genotype 1b HCV population. There was no significant difference in the level of viral complexity between immediate virologic responders and non-responders at baseline (p = 0.39). Immediate virologic responders (n = 8) showed a significant reduction in the genetic complexity spanning all the viral genetic regions at the early phase of IFN administration (p = 0.037). In contrast, non-virologic responders (n = 8) showed no significant changes in the level of viral quasispecies (p = 0.12), indicating that very few viral clones are sensitive to IFN treatment. We also demonstrated that clones resistant to direct-acting antivirals for HCV, such as viral protease and polymerase inhibitors, preexist with various abundances in all 27 treatment-naive patients, suggesting the risk of the development of drug resistance against these agents. Conclusion: Use of the ultra-deep sequencing technology revealed massive genetic heterogeneity of HCV, which has important implications regarding the treatment response and outcome of antiviral therapy.	[Nasu, Akihiro; Marusawa, Hiroyuki; Ueda, Yoshihide; Nishijima, Norihiro; Takahashi, Ken; Chiba, Tsutomu] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto, Japan; [Osaki, Yukio] Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan; [Yamashita, Yukitaka] Wakayama Red Cross Hosp, Dept Gastroenterol & Hepatol, Wakayama, Japan; [Inokuma, Tetsuro] Gen Hosp, Kobe City Med Ctr, Dept Gastroenterol, Kobe, Hyogo, Japan; [Tamada, Takashi] Takatsuki Red Cross Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan; [Fujiwara, Takeshi; Sato, Fumiaki; Shimizu, Kazuharu] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan	Kyoto University; Osaka Red Cross Hospital; Kobe City Medical Center General Hospital; Kyoto University	Nasu, A (corresponding author), Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto, Japan.	maru@kuhp.kyoto-u.ac.jp	Nishijima, Norihiro/GMX-2899-2022; Ueda, Yoshihide/S-7620-2016	Ueda, Yoshihide/0000-0003-3196-3494; Marusawa, Hiroyuki/0000-0002-4286-2712	Japan Society for the Promotion of Science (JSPS); Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [21229009, 23659610] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-aid for Scientific Research, and Health and Labour Sciences Research Grants for Research, and Research on Hepatitis from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2007, J HEPATOL, V46, P403, DOI 10.1016/j.jhep.2006.09.019; Argentini C, 2009, FUTURE MICROBIOL, V4, P359, DOI [10.2217/fmb.09.8, 10.2217/FMB.09.8]; Bartels DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Colson P, 2008, HEPATOLOGY, V47, P766, DOI 10.1002/hep.22122; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Farci P, 2002, P NATL ACAD SCI USA, V99, P3081, DOI 10.1073/pnas.052712599; Fishman SL, 2009, INFECT GENET EVOL, V9, P1158, DOI 10.1016/j.meegid.2009.07.011; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; HIJIKATA M, 1991, BIOCHEM BIOPH RES CO, V175, P220, DOI 10.1016/S0006-291X(05)81223-9; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Iwai A, 2006, J VIRAL HEPATITIS, V13, P523, DOI 10.1111/j.1365-2893.2006.00760.x; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lopez-Labrador FX, 2008, ANTIVIR THER, V13, P481; Lu LJ, 2007, ANTIMICROB AGENTS CH, V51, P1889, DOI 10.1128/AAC.01004-06; Mardis ER, 2009, GENOME MED, V1, DOI 10.1186/gm40; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Marusawa H, 2000, HEPATOLOGY, V31, P488, DOI 10.1002/hep.510310232; Marusawa H, 1999, J VIROL, V73, P4713, DOI 10.1128/JVI.73.6.4713-4720.1999; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; OKAMOTO H, 1992, VIROLOGY, V190, P894, DOI 10.1016/0042-6822(92)90933-G; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Pawlotsky JM, 2006, CURR TOP MICROBIOL, V299, P261; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJV, 2009, J VIRAL HEPATITIS, V16, P377, DOI 10.1111/j.1365-2893.2009.01124.x; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Wang GP, 2010, J VIROL, V84, P6218, DOI 10.1128/JVI.02271-09; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Xu ZK, 2008, J VIROL, V82, P9417, DOI 10.1128/JVI.00896-08	42	74	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24907	10.1371/journal.pone.0024907	http://dx.doi.org/10.1371/journal.pone.0024907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966381	gold, Green Submitted, Green Published			2022-12-25	WOS:000295265100028
J	Kang, K; Schmahl, J; Lee, JM; Garcia, K; Patil, K; Chen, A; Keene, M; Murphy, A; Sleeman, MW				Kang, Kihwa; Schmahl, Jennifer; Lee, Jong-Min; Garcia, Karen; Patil, Ketan; Chen, Amelia; Keene, Michelle; Murphy, Andrew; Sleeman, Mark W.			Mouse ghrelin-O-acyltransferase (GOAT) plays a critical role in bile acid reabsorption	FASEB JOURNAL			English	Article						intestine; ISBT; metabolomics	STIMULATES INSULIN-SECRETION; DES-ACYL GHRELIN; BETA-CELLS; FOOD-INTAKE; RAT ISLETS; ENDOCRINE; GLUCOSE; HORMONE; MICE; PANCREAS	Ghrelin is a unique peptide gut hormone that requires post-translational modification to stimulate both feeding and growth hormone release. Ghrelin O-acyltransferase (GOAT) was identified as a specific acyl-transferase for ghrelin, and recent genetic deletion studies of the Goat gene (Goat(-/-)) uncovered the role of ghrelin in the regulation of glucose homeostasis. To further understand the physiological functions of the GOAT/ghrelin system, we have conducted a metabolomic and microarray profile of Goat-null mice, as well as determined Goat expression in different tissues using the lacZ reporter gene. Serum metabolite profile analysis revealed that Goat(-/-) mice exhibited increased secondary bile acids > 2.5-fold. This was attributed to increased mRNA and protein expression of the ileal sodium-dependent bile acid transporter (ISBT) in the intestinal and biliary tract. Increased expression of additional solute carrier proteins, including Slc5a12 (> 10-fold) were also detected in the small intestine and bile duct. Goat staining was consistently observed in the pituitary glands, stomach, and intestines, and to a lesser extent in the gallbladder and pancreatic duct. This is the first report that the GOAT/ghrelin system regulates bile acid metabolism, and these findings suggest a novel function of GOAT in the regulation of intestinal bile acid reabsorption.-Kang, K., Schmahl, J., Lee, J. -M., Garcia, K., Patil, K., Chen, A., Keene, M., Murphy, A., Sleeman, M. W. Mouse ghrelin-O-acyltransferase (GOAT) plays a critical role in bile acid reabsorption. FASEB J. 26, 259-271 (2012). www.fasebj.org	[Kang, Kihwa; Schmahl, Jennifer; Garcia, Karen; Patil, Ketan; Chen, Amelia; Keene, Michelle; Murphy, Andrew; Sleeman, Mark W.] Regeneron Pharmaceut, Tarrytown, NY USA; [Lee, Jong-Min] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Regeneron; Harvard University; Massachusetts General Hospital	Kang, K (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	kihwa.kang@regeneron.com; mark.sleeman@regeneron.com						Adeghate E, 2002, J NEUROENDOCRINOL, V14, P555, DOI 10.1046/j.1365-2826.2002.00811.x; Akamizu T, 2004, EUR J ENDOCRINOL, V150, P447, DOI 10.1530/eje.0.1500447; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; Chen CY, 2005, GASTROENTEROLOGY, V129, P8, DOI 10.1053/j.gastro.2005.04.015; Colombo M, 2003, PANCREAS, V27, P161, DOI 10.1097/00006676-200308000-00009; Date Y, 2002, DIABETES, V51, P124, DOI 10.2337/diabetes.51.1.124; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Dezaki K, 2004, DIABETES, V53, P3142, DOI 10.2337/diabetes.53.12.3142; Dezaki K, 2006, DIABETES, V55, P3486, DOI 10.2337/db06-0878; Doi A, 2006, P NATL ACAD SCI USA, V103, P885, DOI 10.1073/pnas.0502470102; Gahete MD, 2010, MOL CELL ENDOCRINOL, V317, P154, DOI 10.1016/j.mce.2009.12.023; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Inui A, 2004, FASEB J, V18, P439, DOI 10.1096/fj.03-0641rev; Irako T, 2006, DIABETOLOGIA, V49, P1264, DOI 10.1007/s00125-006-0226-3; Kang K, 2011, PEPTIDES, V32, P2236, DOI 10.1016/j.peptides.2011.04.028; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lee HM, 2002, ENDOCRINOLOGY, V143, P185, DOI 10.1210/en.143.1.185; MARCUS SN, 1986, GUT, V27, P550, DOI 10.1136/gut.27.5.550; Pfluger PT, 2008, AM J PHYSIOL-GASTR L, V294, pG610, DOI 10.1152/ajpgi.00321.2007; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Roberts RE, 2011, CLIN ENDOCRINOL, V74, P67, DOI 10.1111/j.1365-2265.2010.03886.x; Sakata I, 2009, AM J PHYSIOL-ENDOC M, V297, pE134, DOI 10.1152/ajpendo.90859.2008; Shneider BL, 2001, J PEDIATR GASTR NUTR, V32, P407, DOI 10.1097/00005176-200104000-00002; Srinivas SR, 2005, BIOCHEM J, V392, P655, DOI 10.1042/BJ20050927; Sun YX, 2007, NEUROENDOCRINOLOGY, V86, P215, DOI 10.1159/000109094; Teramae H, 2010, BIOMED RES-TOKYO, V31, P239, DOI 10.2220/biomedres.31.239; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Wierup N, 2004, J HISTOCHEM CYTOCHEM, V52, P301, DOI 10.1177/002215540405200301; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhang WZ, 2008, ENDOCRINOLOGY, V149, P4710, DOI 10.1210/en.2008-0263; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	43	23	25	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					259	271		10.1096/fj.11-191460	http://dx.doi.org/10.1096/fj.11-191460			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21965605				2022-12-25	WOS:000299202200027
J	Lim, JH; Park, SY; Kim, SY; Kim, DJ; Choi, JE; Kim, MH; Choi, JS; Kim, MY; Yang, JH; Ryu, HM				Lim, Ji Hyae; Park, So Yeon; Kim, Shin Young; Kim, Do Jin; Choi, Ji Eun; Kim, Min Hyoung; Choi, Jun Seek; Kim, Moon Young; Yang, Jae Hyug; Ryu, Hyun Mee			Effective detection of fetal sex using circulating fetal DNA in first-trimester maternal plasma	FASEB JOURNAL			English	Article						epigenetic biomarker; methylation-specific PCR; multiplex quantitative PCR; phosphodiesterases gene	NONINVASIVE PRENATAL-DIAGNOSIS; REAL-TIME PCR; HYPERMETHYLATED RASSF1A; QUANTITATIVE-ANALYSIS; BLOOD; QUANTIFICATION; AMNIOCENTESIS; RELIABILITY; EXTRACTION; PREDICTION	The aim of this study was to develop a simple and effective method for noninvasively detecting fetal sex using circulating fetal DNA from first-trimester maternal plasma. A study was conducted with maternal plasma collected from 203 women between 5 and 12 wk of gestation. The presence of circulating fetal DNA was confirmed by a quantitative methylation-specific polymerase chain reaction of the unmethylated-PDE9A gene (U-PDE9A). Multiplex real-time PCR was used to simultaneously quantify the amount of DYS14 and GAPDH in maternal plasma. The results were confirmed by phenotype at birth. Pregnancy outcomes and U-PDE9A concentrations were obtained in all cases, including 99 male-bearing and 104 female-bearing participants. At equivalent specificity (100%), the false-negative rate was 9.1% for DYS14 quantification cycle, 7.1% for DYS14 concentration, and 0.0% for the concentration ratio of DYS14/GAPDH, respectively. In male-bearing participants, DYS14, U-PDE9A, and GAPDH concentrations were significantly lower in the false-negative case than in correct case (P<0.001 in all). Moreover, DYS14, U-PDE9A, and GAPDH concentrations showed significantly positive associations with each other (P <= 0.001 in all). The ratio of DYS14/GAPDH in maternal plasma was an effective biomarker for noninvasive fetal sex detection during the first trimester, indicating that it could be useful for clinical application.-Lim, J. H., Park, S. Y., Kim, S. Y., Kim, D. J., Choi, J. E., Kim, M. H., Choi, J. S., Kim, M. Y., Yang, J. H., Ryu, H. M. Effective detection of fetal sex using circulating fetal DNA in first-trimester maternal plasma. FASEB J. 26, 250-258 (2012). www.fasebj.org	[Ryu, Hyun Mee] KwanDong Univ, Sch Med, Dept Obstet & Gynecol, Cheil Gen Hosp & Womens Healthcare Ctr,Coll Med, Seoul 100380, South Korea; [Lim, Ji Hyae; Park, So Yeon; Kim, Shin Young; Kim, Do Jin; Choi, Ji Eun; Ryu, Hyun Mee] KwanDong Univ, Cheil Gen Hosp & Womens Healthcare Ctr, Coll Med, Lab Med Genet,Med Res Inst, Seoul 100380, South Korea	Catholic Kwandong University; Catholic Kwandong University	Ryu, HM (corresponding author), KwanDong Univ, Sch Med, Dept Obstet & Gynecol, Cheil Gen Hosp & Womens Healthcare Ctr,Coll Med, 1-19 Mookjung Dong, Seoul 100380, South Korea.	hmryu@yahoo.com	Lim, Ji Hyae/N-4634-2013	Lim, Ji Hyae/0000-0002-1105-7235	Life Insurance Philanthropy Foundation	Life Insurance Philanthropy Foundation	This study was supported by a research grant of the Life Insurance Philanthropy Foundation. The authors thank the following physicians and their associated staff who took the time and effort to participate in this study: Dr. Joung Yeol Han, Dr. Hyun Kyong Ahn, Dr. Jin Hoon Chung, Dr. Si Won Lee, Dr. Da Eun Lee, Jin Woo Kim, Bom Yi Lee, Mi Jin Kim, Ju Yeon Park, Eun Young Choi, Yeon Woo Lee, Ah Rum Oh, Shin Yeong Lee, and So Min Seo. The authors thank Dr. Sung Won Park, Dr. Daehun Peah, and Dr. In Soo Kang for statistical analysis of the data.	Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; Bustamante-Aragones A, 2010, EXPERT REV MOL DIAGN, V10, P197, DOI [10.1586/erm.09.86, 10.1586/ERM.09.86]; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Clausen FB, 2007, PRENATAL DIAG, V27, P6, DOI 10.1002/pd.1605; Costa JM, 2002, NEW ENGL J MED, V346, P1502, DOI 10.1056/NEJM200205093461918; Dhallan R, 2004, JAMA-J AM MED ASSOC, V291, P1114, DOI 10.1001/jama.291.9.1114; Finning KM, 2008, SEMIN FETAL NEONAT M, V13, P69, DOI 10.1016/j.siny.2007.12.007; Honda H, 2002, HUM GENET, V110, P75, DOI 10.1007/s00439-001-0649-3; Johnson KL, 2004, CLIN CHEM, V50, P516, DOI 10.1373/clinchem.2003.024380; Legler TJ, 2007, PRENATAL DIAG, V27, P824, DOI 10.1002/pd.1783; Lim JH, 2008, OBSTET GYNECOL, V111, P1403, DOI 10.1097/AOG.0b013e3181719b7a; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Odeh M, 2009, OBSTET GYNECOL SURV, V64, P50, DOI 10.1097/OGX.0b013e318193299b; Page-Christiaens GCML, 2006, ANN NY ACAD SCI, V1075, P123, DOI 10.1196/annals.1368.016; Picchiassi E, 2008, PRENATAL DIAG, V28, P525, DOI 10.1002/pd.2018; Scheffer PG, 2010, OBSTET GYNECOL, V115, P117, DOI 10.1097/AOG.0b013e3181c3c938; TABOR A, 1986, LANCET, V1, P1287; Tjoa ML, 2006, AM J PATHOL, V169, P400, DOI 10.2353/ajpath.2006.060161; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047; Zejskova L, 2010, EXP MOL PATHOL, V89, P241, DOI 10.1016/j.yexmp.2010.09.002; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235	28	9	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					250	258		10.1096/fj.11-191429	http://dx.doi.org/10.1096/fj.11-191429			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21965598				2022-12-25	WOS:000299202200026
J	Das, S; Jena, S; Levasseur, DN				Das, Satyabrata; Jena, Snehalata; Levasseur, Dana N.			Alternative Splicing Produces Nanog Protein Variants with Different Capacities for Self-renewal and Pluripotency in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL NETWORK; SUSTAINING FACTOR; GENE-EXPRESSION; X-INACTIVATION; MOUSE EPIBLAST; OCT4; CLONING; IDENTIFICATION; DERIVATION; LINES	Embryonic stem (ES) cells are distinguished by their ability to undergo unlimited self-renewal although retaining pluripotency, the capacity to specify cells of all germ layers. Alternative splicing contributes to these biological processes by vastly increasing the protein coding repertoire, enabling genes to code for novel variants that may confer different biological functions. The homeodomain transcription factor Nanog acts collaboratively with core factors Oct4 and Sox2 to govern the maintenance of pluripotency. We have discovered that Nanog is regulated by alternative splicing. Two novel exons and six subexons have been identified that extend the known Nanog gene structure and protein coding capacity. Alternative splicing results in two novel Nanog protein variants with attenuated capacities for self-renewal and pluripotency in ES cells. Our previous results have implicated the C-terminal domain, including the tryptophan-rich (WR) domain of Nanog, to be important for the function of Nanog (Wang, J., Levasseur, D.N., and Orkin, S.H. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 6326-6331). Using point mutation analyses, serine 2 (Ser-2) of Nanog has been identified as critical for ES cell self-renewal and for stabilizing a pluripotent gene signature. An inducible conditional knock-out was created to test the ability of new Nanog variants to genetically complement Nanog null ES cells. These results reveal for the first time an expanded Nanog protein coding capacity. We further reveal that a short region of the N-terminal domain and a single phosphorylatable Ser-2 is essential for the maintenance of self-renewal and pluripotency, demonstrating that this region of the protein is highly regulated.	[Das, Satyabrata; Jena, Snehalata; Levasseur, Dana N.] Univ Iowa, Dept Internal Med, Roy J & A Lucille Carver Coll Med, Iowa City, IA 52242 USA; [Levasseur, Dana N.] Univ Iowa, Program Mol & Cellular Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Levasseur, DN (corresponding author), 285 Newton Rd,Carver Biomed Res Bldg,Rm 3270C, Iowa City, IA 52242 USA.	dana-levasseur@uiowa.edu	Das, Satyabrata/J-2629-2019		Department of Internal Medicine; March of Dimes [5-FY10-45]	Department of Internal Medicine; March of Dimes(March of Dimes)	This work was supported by the Department of Internal Medicine and a Basil O'Connor Starter Scholar Research Award Grant 5-FY10-45 from the March of Dimes.	Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kunarso G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-155; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Nagy A., 2002, MANIPULATING MOUSE E; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Oh JH, 2005, EXP MOL MED, V37, P250, DOI 10.1038/emm.2005.33; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pan GJ, 2003, CELL RES, V13, P499, DOI 10.1038/sj.cr.7290193; Pritsker M, 2005, P NATL ACAD SCI USA, V102, P14290, DOI 10.1073/pnas.0502132102; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Salomonis N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000553; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wang J, 2007, P NATL ACAD SCI USA, V104, P20850, DOI 10.1073/pnas.0710565105; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang SH, 2003, GENE EXPR PATTERNS, V3, P99, DOI 10.1016/S1567-133X(03)00005-X; Wang X, 2009, STEM CELLS, V27, P1265, DOI 10.1002/stem.58; Wang Z, 2008, J BIOL CHEM, V283, P4480, DOI 10.1074/jbc.M706009200; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yates A, 2005, BIOCHEM SOC T, V33, P1518, DOI 10.1042/BST0331518; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	63	52	57	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42690	42703		10.1074/jbc.M111.290189	http://dx.doi.org/10.1074/jbc.M111.290189			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21969378	Green Published, hybrid			2022-12-25	WOS:000298180900076
J	Crouch, E; Nikolaidis, N; McCormack, FX; McDonald, B; Allen, K; Rynkiewicz, MJ; Cafarella, TM; White, M; Lewnard, K; Leymarie, N; Zaia, J; Seaton, BA; Hartshorn, KL				Crouch, Erika; Nikolaidis, Nikolaos; McCormack, Francis X.; McDonald, Barbara; Allen, Kimberly; Rynkiewicz, Michael J.; Cafarella, Tanya M.; White, Mitchell; Lewnard, Kara; Leymarie, Nancy; Zaia, Joseph; Seaton, Barbara A.; Hartshorn, Kevan L.			Mutagenesis of Surfactant Protein D Informed by Evolution and X-ray Crystallography Enhances Defenses against Influenza A Virus in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL ACTIVITY; LIGAND-BINDING; LECTIN DOMAINS; RECOGNITION; HEMAGGLUTININ; GLYCOSYLATION; COLLECTINS; CLEARANCE; INSIGHTS; OPSONIN	The recognition of influenza A virus (LAY) by surfactant protein D (SP-D) is mediated by interactions between the SP-D carbohydrate recognition domains (CRD) and glycans displayed on envelope glycoproteins. Although native human SP-D shows potent antiviral and aggregating activity, trimeric recombinant neck + CRDs (NCRDs) show little or no capacity to influence IAV infection. A mutant trimeric NCRD, D325A/R343V, showed marked hemagglutination inhibition and viral neutralization, with viral aggregation and aggregation-dependent viral uptake by neutrophils. D325A/R343V exhibited glucose-sensitive binding to Phil82 hemagglutinin trimer (HA) by surface plasmon resonance. By contrast, there was very low binding to the HA trimer from another virus (PR8) that lacks glycans on the HA head. Mass spectrometry demonstrated the presence of high mannose glycans on the Phi182 HA at positions known to contribute to LAY binding. Molecular modeling predicted an enhanced capacity for bridging interactions between HA glycans and D325A/R343V. Finally, the trimeric D325A/R343V NCRD decreased morbidity and increased viral clearance in a murine model of IAV infection using a reassortant A/WSN/33 virus with a more heavily glycosylated HA. The combined data support a model in which altered binding by a truncated mutant SP-D to LAY HA glycans facilitates viral aggregation, leading to significant viral neutralization in vitro and in vivo. These studies demonstrate the potential utility of homology modeling and protein structure analysis for engineering effective collectin antivirals as in vivo therapeutics.	[Crouch, Erika; McDonald, Barbara; Allen, Kimberly] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Nikolaidis, Nikolaos; McCormack, Francis X.; Lewnard, Kara] Univ Cincinnati, Div Pulm Crit Care & Sleep Med, Cincinnati, OH 45267 USA; [Leymarie, Nancy; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Spectrometry, Boston, MA 02118 USA; [Rynkiewicz, Michael J.; Cafarella, Tanya M.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Phys & Biophys, Boston, MA 02118 USA; [White, Mitchell; Hartshorn, Kevan L.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Washington University (WUSTL); University System of Ohio; University of Cincinnati; Boston University; Boston University; Boston University	Crouch, E (corresponding author), WA Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	crouch@path.wustl.edu	McCormack, Francis X./ABE-8398-2020; Zaia, Joseph/U-7850-2019	McCormack, Francis X./0000-0001-7168-9464; Zaia, Joseph/0000-0001-9497-8701; Rynkiewicz, Michael/0000-0002-4717-5700; Seaton, Barbara/0000-0003-4654-7709; Hartshorn, Kevan/0000-0002-7196-7433	National Institutes of Health [AI083222, HL069031, P41RR10888, S10RR020946]; Veterans Administration Merit Award; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020946, P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI083222 (to B. A. S.), HL069031 (to K. L H.), and P41RR10888 and S10RR020946 (to J. Z.). This work was also supported by a Veterans Administration Merit Award (to F. X. M.).	Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Carlson TK, 2009, GLYCOBIOLOGY, V19, P1473, DOI 10.1093/glycob/cwp122; Crouch E, 2005, J BIOL CHEM, V280, P17046, DOI 10.1074/jbc.M413932200; Crouch E. C., 2006, ENCY RESP MED, V4, P152; Crouch E, 2007, BIOCHEMISTRY-US, V46, P5160, DOI 10.1021/bi700037x; Crouch E, 2006, J BIOL CHEM, V281, P18008, DOI 10.1074/jbc.M601749200; Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703; Crouch EC, 2006, AM J RESP CELL MOL, V35, P84, DOI 10.1165/rcmb.2005-0462OC; Duverger E, 2010, METHODS MOL BIOL, V627, P157, DOI 10.1007/978-1-60761-670-2_10; Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Hartshorn KL, 2010, SCAND J IMMUNOL, V72, P22, DOI 10.1111/j.1365-3083.2010.02409.x; Hartshorn KL, 2010, AM J PHYSIOL-LUNG C, V298, pL79, DOI 10.1152/ajplung.00223.2009; Hartshorn KL, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-65; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; HARTSHORN KL, 1993, J IMMUNOL, V151, P6265; Hartshorn KL, 2002, BIOCHEM J, V366, P87, DOI 10.1042/BJ20011868; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Hawgood S, 2004, J VIROL, V78, P8565, DOI 10.1128/JVI.78.16.8565-8572.2004; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Leth-Larsen R, 2005, J IMMUNOL, V174, P1532, DOI 10.4049/jimmunol.174.3.1532; LeVine AM, 2004, AM J RESP CELL MOL, V31, P193, DOI 10.1165/rcmb.2003-0107OC; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Lin KW, 2010, J IMMUNOL, V184, P6343, DOI 10.4049/jimmunol.0901947; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Perlman DH, 2009, CIRC RES, V104, P796, DOI 10.1161/CIRCRESAHA.108.187005; Reading PC, 1998, J GEN VIROL, V79, P2255, DOI 10.1099/0022-1317-79-9-2255; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076; Shrive AK, 2009, J MOL BIOL, V394, P776, DOI 10.1016/j.jmb.2009.09.057; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Smee DF, 2008, ANTIVIR RES, V80, P266, DOI 10.1016/j.antiviral.2008.06.003; Tecle T, 2008, BIOCHEM J, V412, P323, DOI 10.1042/BJ20071663; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; Wear MA, 2005, ANAL BIOCHEM, V345, P214, DOI 10.1016/j.ab.2005.06.037; White M, 2008, J IMMUNOL, V181, P7936, DOI 10.4049/jimmunol.181.11.7936; White MR, 2010, J INNATE IMMUN, V2, P267, DOI 10.1159/000272313; Whitsett JA, 2005, BIOL NEONATE, V88, P175, DOI 10.1159/000087580; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Zhang LQ, 2002, J BIOL CHEM, V277, P22453, DOI 10.1074/jbc.M201632200	45	34	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40681	40692		10.1074/jbc.M111.300673	http://dx.doi.org/10.1074/jbc.M111.300673			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965658	Green Published, hybrid			2022-12-25	WOS:000297315400029
J	Singh, MK; Lu, MM; Massera, D; Epstein, JA				Singh, Manvendra K.; Lu, Min Min; Massera, Daniele; Epstein, Jonathan A.			MicroRNA-processing Enzyme Dicer Is Required in Epicardium for Coronary Vasculature Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; NEURAL CREST; PROGENITOR CELLS; MOUSE DEVELOPMENT; ARTERY FORMATION; CHICK-EMBRYOS; HEART; MUSCLE; DIFFERENTIATION; CARDIOMYOCYTE	The epicardium is a sheet of epithelial cells covering the heart during early cardiac development. In recent years, the epicardium has been identified as an important contributor to cardiovascular development, and epicardium-derived cells have the potential to differentiate into multiple cardiac cell lineages. Some epicardium-derived cells that undergo epithelial-to-mesenchymal transition and delaminate from the surface of the developing heart subsequently invade the myocardium and differentiate into vascular smooth muscle of the developing coronary vasculature. MicroRNAs (miRNAs) have been implicated broadly in tissue patterning and development, including in the heart, but a role in epicardium is unknown. To examine the role of miRNAs during epicardial development, we conditionally deleted the miRNA-processing enzyme Dicer in the proepicardium using Gata5-Cre mice. Epicardial Dicer mutant mice are born in expected Mendelian ratios but die immediately after birth with profound cardiac defects, including impaired coronary vessel development. We found that loss of Dicer leads to impaired epicardial epithelial-to-mesenchymal transition and a reduction in epicardial cell proliferation and differentiation into coronary smooth muscle cells. These results demonstrate a critical role for Dicer, and by implication miRNAs, in murine epicardial development.	[Singh, Manvendra K.; Massera, Daniele; Epstein, Jonathan A.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Singh, Manvendra K.; Lu, Min Min; Epstein, Jonathan A.] Univ Penn, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Singh, MK (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, 1139 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	masingh@mail.med.upenn.edu; epsteinj@mail.med.upenn.edu	Singh, Manvendra K./AHE-0676-2022	Epstein, Jonathan/0000-0001-8637-4465; Massera, Daniele/0000-0002-9499-6456; Singh, Manvendra K./0000-0002-2884-0074	National Institutes of Health [U01 HL100405]; Spain for cardiovascular regenerative biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spain for cardiovascular regenerative biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant U01 HL100405. This work was also supported by the Grant from Spain for cardiovascular regenerative biology (to J. A. E.).	Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Major Robert J, 2007, Drug Discov Today Dis Models, V4, P219, DOI 10.1016/j.ddmod.2007.09.002; Manner J, 2005, DEV DYNAM, V233, P1454, DOI 10.1002/dvdy.20487; MANNER J, 1993, ANAT EMBRYOL, V187, P281; Manner J, 2001, CELLS TISSUES ORGANS, V169, P89, DOI 10.1159/000047867; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Pan YQ, 2011, BIOCHEM BIOPH RES CO, V408, P369, DOI 10.1016/j.bbrc.2011.02.119; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Saxena A, 2010, P NATL ACAD SCI USA, V107, P87, DOI 10.1073/pnas.0912870107; Singh MK, 2008, ENDOCRINOLOGY, V149, P3933, DOI 10.1210/en.2008-0109; Singh MK, 2010, J BIOL CHEM, V285, P1765, DOI 10.1074/jbc.M109.038539; Singh MK, 2005, MECH DEVELOP, V122, P131, DOI 10.1016/j.mod.2004.10.011; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2003, CURR OPIN GENET DEV, V13, P365, DOI 10.1016/S0959-437X(03)00088-1; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van Tuyn J, 2007, STEM CELLS, V25, P271, DOI 10.1634/stemcells.2006-0366; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Wu MF, 2010, DEV CELL, V19, P114, DOI 10.1016/j.devcel.2010.06.011; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zamora M, 2007, P NATL ACAD SCI USA, V104, P18109, DOI 10.1073/pnas.0702415104; Zehir A, 2010, DEV BIOL, V340, P459, DOI 10.1016/j.ydbio.2010.01.039; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zhou L, 2009, P NATL ACAD SCI USA, V106, P10266, DOI 10.1073/pnas.0811119106	60	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41036	41045		10.1074/jbc.M111.268573	http://dx.doi.org/10.1074/jbc.M111.268573			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969379	Green Published, hybrid			2022-12-25	WOS:000297315400063
J	Tharmalingam, S; Daulat, AM; Antflick, JE; Ahmed, SM; Nemeth, EF; Angers, S; Conigrave, AD; Hampson, DR				Tharmalingam, Sujeenthar; Daulat, Avais M.; Antflick, Jordan E.; Ahmed, Syed M.; Nemeth, Edward F.; Angers, Stephane; Conigrave, Arthur D.; Hampson, David R.			Calcium-sensing Receptor Modulates Cell Adhesion and Migration via Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY-THYROID CARCINOMA; METABOTROPIC GLUTAMATE-RECEPTOR; PROTEIN-COUPLED RECEPTORS; EXTRACELLULAR CALCIUM; CA2+-SENSING RECEPTOR; FUNCTIONAL EXPRESSION; PARATHYROID-HORMONE; KINASE INHIBITION; CA2+ RECEPTOR; CANCER-CELLS	The calcium-sensing receptor (CaSR) is a family C G protein-coupled receptor that is activated by elevated levels of extracellular divalent cations. The CaSR couples to members of the G(q) family of G proteins, and in the endocrine system this receptor is instrumental in regulating the release of parathyroid hormone from the parathyroid gland and calcitonin from thyroid cells. Here, we demonstrate that in medullary thyroid carcinoma cells, the CaSR promotes cellular adhesion and migration via coupling to members of the integrin family of extracellular matrix-binding proteins. Immunopurification and mass spectrometry, co-immunoprecipitation, and co-localization studies showed that the CaSR and beta 1-containing integrins are components of a macromolecular protein complex. In fibronectin-based cell adhesion and migration assays, the CaSR-positive allosteric modulator NPS R-568 induced a concentration-dependent increase in cell adhesion and migration; both of these effects were blocked by a specific CaSR-negative allosteric modulator. These effects were mediated by integrins because they were blocked by a peptide inhibitor of integrin binding to fibronectin and beta 1 knockdown experiments. An analysis of intracellular signaling pathways revealed a key role for CaSR-induced phospholipase C activation and the release of intracellular calcium. These results demonstrate for the first time that an ion-sensing G protein-coupled receptor functionally couples to the integrins and, in conjunction with intracellular calcium release, promotes cellular adhesion and migration in tumor cells. The significance of this interaction is further highlighted by studies implicating the CaSR in cancer metastasis, axonal growth, and stein cell attachment, functions that rely on integrin-mediated cell adhesion.	[Tharmalingam, Sujeenthar; Daulat, Avais M.; Antflick, Jordan E.; Ahmed, Syed M.; Nemeth, Edward F.; Angers, Stephane; Hampson, David R.] Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada; [Conigrave, Arthur D.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Toronto; University of Sydney	Hampson, DR (corresponding author), Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, 144 Coll St, Toronto, ON M5S 3M2, Canada.	d.hampson@utoronto.ca	Ahmed, Mukhtar/ABE-8477-2020; Angers, Stephane/E-1432-2014	Angers, Stephane/0000-0001-7241-9044; Ahmed, Syed Mukhtar/0000-0002-9183-9957; Conigrave, Arthur/0000-0002-7232-3891; Daulat, Avais/0000-0002-3076-2132	Natural Sciences and Engineering Research Council of Canada; National Health and Medical Research Council of Australia	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Natural Sciences and Engineering Research Council of Canada and by the National Health and Medical Research Council of Australia.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Ahmed SM, 2011, METHODS MOL BIOL, V756, P357, DOI 10.1007/978-1-61779-160-4_22; Ahmed SM, 2010, J BIOL CHEM, V285, P6538, DOI 10.1074/jbc.M109.069948; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bergholm U, 1997, CANCER-AM CANCER SOC, V79, P132, DOI 10.1002/(SICI)1097-0142(19970101)79:1<132::AID-CNCR19>3.0.CO;2-5; Bouschet T, 2007, J CELL SCI, V120, P2489, DOI 10.1242/jcs.03469; Broadhead GK, 2011, J BIOL CHEM, V286, P8786, DOI 10.1074/jbc.M110.149724; Brown E M, 2000, Rev Endocr Metab Disord, V1, P307, DOI 10.1023/A:1026570518919; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Brust-Mascher I, 1998, BIOPHYS J, V75, P1669, DOI 10.1016/S0006-3495(98)77609-X; CLARK MS, 1995, J NEUROSCI, V15, P6167; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2010, PHARMACOL THERAPEUT, V127, P252, DOI 10.1016/j.pharmthera.2010.04.007; Davies SL, 2006, AM J PHYSIOL-CELL PH, V290, pC1543, DOI 10.1152/ajpcell.00482.2005; Doyle AD, 2002, BIOTECHNIQUES, V33, P358, DOI 10.2144/02332rr02; Fafet P, 2008, ENDOCRINOLOGY, V149, P4475, DOI 10.1210/en.2008-0253; FAJTOVA VT, 1991, AM J PHYSIOL, V261, pE151, DOI 10.1152/ajpendo.1991.261.1.E151; GAGEL RF, 1980, ENDOCRINOLOGY, V107, P516, DOI 10.1210/endo-107-2-516; Gama L, 1998, J BIOL CHEM, V273, P29712, DOI 10.1074/jbc.273.45.29712; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; Hampson David R., 2008, P363, DOI 10.1007/978-1-59745-055-3_9; Hauache OM, 2000, ENDOCRINOLOGY, V141, P4156, DOI 10.1210/en.141.11.4156; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang CF, 2004, AM J PHYSIOL-CELL PH, V286, pC22, DOI 10.1152/ajpcell.00229.2003; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Kuang DH, 2003, J BIOL CHEM, V278, P42551, DOI 10.1074/jbc.M307120200; Lam BS, 2011, BLOOD, V117, P1167, DOI 10.1182/blood-2010-05-286294; Lester RD, 2005, J BIOL CHEM, V280, P39273, DOI 10.1074/jbc.M509446200; Liao JH, 2006, CANCER RES, V66, P9065, DOI 10.1158/0008-5472.CAN-06-0317; Lin B, 2003, J NEUROPHYSIOL, V89, P2874, DOI 10.1152/jn.00783.2002; Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Magno AL, 2011, ENDOCR REV, V32, P3, DOI 10.1210/er.2009-0043; Mamillapalli R, 2008, J BIOL CHEM, V283, P24435, DOI 10.1074/jbc.M801738200; McNeil SE, 1998, J BIOL CHEM, V273, P1114, DOI 10.1074/jbc.273.2.1114; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Modigliani E, 1998, CLIN ENDOCRINOL, V48, P265, DOI 10.1046/j.1365-2265.1998.00392.x; Moley JF, 1999, ANN SURG, V229, P880, DOI 10.1097/00000658-199906000-00016; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Puklin-Faucher E, 2009, J BIOL CHEM, V284, P36557, DOI 10.1074/jbc.M109.041194; RICCARDI D, 1995, P NATL ACAD SCI USA, V92, P131, DOI 10.1073/pnas.92.1.131; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Saidak Z, 2009, EXP CELL RES, V315, P2072, DOI 10.1016/j.yexcr.2009.03.003; Saidak Z, 2009, ENDOCR REV, V30, P178, DOI 10.1210/er.2008-0041; Sjaastad MD, 1996, MOL BIOL CELL, V7, P1025, DOI 10.1091/mbc.7.7.1025; Takaoka S, 2010, HORM METAB RES, V42, P627, DOI 10.1055/s-0030-1255091; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Valeyev Najl V., 2006, In Silico Biology, V6, P545; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Vorup-Jensen T, 2007, BBA-PROTEINS PROTEOM, V1774, P1148, DOI 10.1016/j.bbapap.2007.06.014; Vyleta NP, 2011, J NEUROSCI, V31, P4593, DOI 10.1523/JNEUROSCI.6398-10.2011; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200; Wong R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-15; Yao Y, 2003, J NEUROCHEM, V86, P947, DOI 10.1046/j.1471-4159.2003.01906.x; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	68	48	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40922	40933		10.1074/jbc.M111.265454	http://dx.doi.org/10.1074/jbc.M111.265454			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969374	hybrid, Green Published			2022-12-25	WOS:000297315400052
J	Helbig, R; Nickerl, J; Neinhuis, C; Werner, C				Helbig, Ralf; Nickerl, Julia; Neinhuis, Christoph; Werner, Carsten			Smart Skin Patterns Protect Springtails	PLOS ONE			English	Article							SURFACES; ROUGHNESS; WATER; SUPERHYDROPHOBICITY; COLLEMBOLA	Springtails, arthropods who live in soil, in decaying material, and on plants, have adapted to demanding conditions by evolving extremely effective and robust anti-adhesive skin patterns. However, details of these unique properties and their structural basis are still unknown. Here we demonstrate that collembolan skin can resist wetting by many organic liquids and at elevated pressures. We show that the combination of bristles and a comb-like hexagonal or rhombic mesh of interconnected nanoscopic granules distinguish the skin of springtails from anti-adhesive plant surfaces. Furthermore, the negative overhang in the profile of the ridges and granules were revealed to be a highly effective, but as yet neglected, design principle of collembolan skin. We suggest an explanation for the non-wetting characteristics of surfaces consisting of such profiles irrespective of the chemical composition. Many valuable opportunities arise from the translation of the described comb-like patterns and overhanging profiles of collembolan skin into man-made surfaces that combine stability against wear and friction with superior non-wetting and anti-adhesive characteristics.	[Helbig, Ralf; Werner, Carsten] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat, Dresden, Germany; [Nickerl, Julia; Neinhuis, Christoph] Tech Univ Dresden, Inst Bot, Dresden, Germany; [Neinhuis, Christoph; Werner, Carsten] Tech Univ Dresden, CUBE Innovat Ctr Mol Bioengn B, Dresden, Germany	Leibniz Institut fur Polymerforschung Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden	Helbig, R (corresponding author), Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat, Dresden, Germany.	werner@ipfdd.de	Werner, Carsten/AAF-1510-2019; Neinhuis, Christoph/AAT-9137-2020; Werner, Carsten/F-8127-2010	Neinhuis, Christoph/0000-0001-9965-4394; Werner, Carsten/0000-0003-0189-3448				Bayley M, 1999, SCIENCE, V285, P1909, DOI 10.1126/science.285.5435.1909; Boreyko JB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.184501; CASSAGNAU P, 1985, REV ECOL BIOL SOL, V22, P381; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Cortese B, 2008, LANGMUIR, V24, P2712, DOI 10.1021/la702764x; Dunger W., 1983, TIERE BODEN; HALE W. G., 1966, REV ECOL BIOL SOL, V3, P343; Herminghaus S, 2000, EUROPHYS LETT, V52, P165, DOI 10.1209/epl/i2000-00418-8; HINTON HE, 1976, J INSECT PHYSIOL, V22, P1061, DOI 10.1016/0022-1910(76)90114-1; Hinton HE, 1960, J INSECT PHYSL, V4, P138; Holmstrup M, 2002, P NATL ACAD SCI USA, V99, P5716, DOI 10.1073/pnas.082580699; Hopkin S. P., 1997, BIOL SPRINGTAILS; Jeong HE, 2010, LANGMUIR, V26, P2223, DOI 10.1021/la904290g; Kim S, 2009, LANGMUIR, V25, P7196, DOI 10.1021/la900732h; KING PE, 1990, J NAT HIST, V24, P673, DOI 10.1080/00222939000770461; Koch K, 2009, PROG MATER SCI, V54, P137, DOI 10.1016/j.pmatsci.2008.07.003; LAWRENCE P N, 1973, Revue d'Ecologie et de Biologie du Sol, V10, P77; Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u; Marmur A, 2003, LANGMUIR, V19, P8343, DOI 10.1021/la0344682; MASSOUD Z, 1969, MUSEUM NATL HIST NAT, V10, P1407; Moore PD, 2002, NATURE, V418, P381, DOI 10.1038/418381a; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; NOBLENESBITT J, 1963, J EXP BIOL, V40, P681; Patankar NA, 2004, LANGMUIR, V20, P8209, DOI 10.1021/la048629t; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; THORPE WH, 1947, J EXP BIOL, V24, P227; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Tuteja A, 2008, P NATL ACAD SCI USA, V105, P18200, DOI 10.1073/pnas.0804872105; Wagner P, 2003, J EXP BOT, V54, P1295, DOI 10.1093/jxb/erg127; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]	32	109	111	9	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25105	10.1371/journal.pone.0025105	http://dx.doi.org/10.1371/journal.pone.0025105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980383	Green Submitted, Green Published, gold			2022-12-25	WOS:000295941300019
J	Nascimento, DS; Valente, M; Esteves, T; de Pina, MD; Guedes, JG; Freire, A; Quelhas, P; Pinto-do-O, P				Nascimento, Diana S.; Valente, Mariana; Esteves, Tiago; de Pina, Maria de Fatima; Guedes, Joana G.; Freire, Ana; Quelhas, Pedro; Pinto-do-O, Perpetua			MIQuant - Semi-Automation of Infarct Size Assessment in Models of Cardiac Ischemic Injury	PLOS ONE			English	Article							LATE GADOLINIUM ENHANCEMENT; MYOCARDIAL-INFARCTION; STEM-CELLS; GENE DELIVERY; HEART-DISEASE; MICE; REGENERATION; MULTIPOTENT; RATS	Background: The cardiac regenerative potential of newly developed therapies is traditionally evaluated in rodent models of surgically induced myocardial ischemia. A generally accepted key parameter for determining the success of the applied therapy is the infarct size. Although regarded as a gold standard method for infarct size estimation in heart ischemia, histological planimetry is time-consuming and highly variable amongst studies. The purpose of this work is to contribute towards the standardization and simplification of infarct size assessment by providing free access to a novel semiautomated software tool. The acronym MIQuant was attributed to this application. Methodology/Principal Findings: Mice were subject to permanent coronary artery ligation and the size of chronic infarcts was estimated by area and midline-length methods using manual planimetry and with MIQuant. Repeatability and reproducibility of MIQuant scores were verified. The validation showed high correlation (r midline length = 0.981; r area = 0.970) and agreement (Bland-Altman analysis), free from bias for midline length and negligible bias of 1.21% to 3.72% for area quantification. Further analysis demonstrated that MIQuant reduced by 4.5-fold the time spent on the analysis and, importantly, MIQuant effectiveness is independent of user proficiency. The results indicate that MIQuant can be regarded as a better alternative to manual measurement. Conclusions: We conclude that MIQuant is a reliable and an easy-to-use software for infarct size quantification. The widespread use of MIQuant will contribute towards the standardization of infarct size assessment across studies and, therefore, to the systematization of the evaluation of cardiac regenerative potential of emerging therapies.	[Nascimento, Diana S.; Valente, Mariana; Esteves, Tiago; de Pina, Maria de Fatima; Guedes, Joana G.; Freire, Ana; Quelhas, Pedro; Pinto-do-O, Perpetua] Univ Porto, INEB, P-4100 Oporto, Portugal; [Valente, Mariana] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Esteves, Tiago; Freire, Ana; Quelhas, Pedro] Univ Porto, Fac Engn, P-4100 Oporto, Portugal; [de Pina, Maria de Fatima] Univ Porto, Dept Epidemiol Clin Med Predit & Saude Publ, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Nascimento, DS (corresponding author), Univ Porto, INEB, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	perpetua@ineb.up.pt	Pinto-do-Ó, Perpetua/ABD-7205-2020; Valente, Mariana/D-9692-2014; Nascimento, Diana S/J-8532-2013; Pinto-do-Ó, Perpetua/K-3742-2012; Pina, Maria de Fatima/N-7574-2014	Pinto-do-Ó, Perpetua/0000-0002-6477-6030; Valente, Mariana/0000-0002-0735-6814; Nascimento, Diana S/0000-0001-6402-4245; Pinto-do-Ó, Perpetua/0000-0002-6477-6030; Gusmao Guedes, Joana/0000-0002-4082-1853; Goncalves Freire, Ana Sofia/0000-0001-9527-6082; Pina, Maria de Fatima/0000-0002-1521-7865	Fundacao para a Ciencia e a Tecnologia (FCT); Fundo Europeu de Desenvolvimento Regional (FEDER); Programa Operacional Factores de competitividade-COMPETE; Quadro de Referencia Estrategico Nacional (QREN) [PTDC/SAU-OSM-68473/2006]; Boehringer Ingelheim Fonds; APBRF-American Portuguese Biomedical Research Fund;  [SFRH/BD/64715/2009];  [SFRH/BPD/42254/2007];  [SFRH/BD/74218/2010]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); Programa Operacional Factores de competitividade-COMPETE; Quadro de Referencia Estrategico Nacional (QREN); Boehringer Ingelheim Fonds(Boehringer Ingelheim); APBRF-American Portuguese Biomedical Research Fund; ; ; 	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT), Fundo Europeu de Desenvolvimento Regional (FEDER), Programa Operacional Factores de competitividade-COMPETE, Quadro de Referencia Estrategico Nacional (QREN) [grant PTDC/SAU-OSM-68473/2006], and by the grants SFRH/BD/64715/2009 to Dr. Freire, SFRH/BPD/42254/2007 to Dr. Nascimento, and SFRH/BD/74218/2010 to Dr. Valente. Dr. Pinto-do-O and Dr. Quelhas are Ciencia2007 and Ciencia2008 awardees, respectively. Travel funds were awarded by Boehringer Ingelheim Fonds to Dr. Nascimento, and by APBRF-American Portuguese Biomedical Research Fund to Dr. Pinto-do-O and to Dr. Nascimento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RPH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008576; Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bohl S, 2009, AM J PHYSIOL-HEART C, V296, pH1200, DOI 10.1152/ajpheart.01294.2008; Dawson D, 2004, CIRCULATION, V110, P1632, DOI 10.1161/01.CIR.0000142049.14227.AD; ESTEVES T, 2011, P IB C PATT REC IM A; FISHBEIN MC, 1978, AM J PATHOL, V90, P57; Gao XM, 2000, CARDIOVASC RES, V45, P330, DOI 10.1016/S0008-6363(99)00274-6; Gonzales C, 2009, EXP CELL RES, V315, P3077, DOI 10.1016/j.yexcr.2009.09.006; Gonzalez R.C., 2010, DIGITAL IMAGE PROCES, V2nd; Hanneman SK, 2008, AACN ADV CRIT CARE, V19, P223, DOI 10.1097/01.AACN.0000318125.41512.a3; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Minicucci MF, 2007, ARQ BRAS CARDIOL, V89, P93, DOI 10.1590/S0066-782X2007001400004; Patten RD, 1998, AM J PHYSIOL-HEART C, V274, pH1812, DOI 10.1152/ajpheart.1998.274.5.H1812; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Protti A, 2010, J MAGN RESON IMAGING, V32, P878, DOI 10.1002/jmri.22325; Ramani R, 2011, CTS-CLIN TRANSL SCI, V4, P24, DOI 10.1111/j.1752-8062.2010.00252.x; Smits AM, 2009, CARDIOVASC RES, V83, P527, DOI 10.1093/cvr/cvp146; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; WU Q, 1996, MICROSCOPE IMAGE PRO; Yang ZQ, 2004, CIRCULATION, V109, P1161, DOI 10.1161/01.CIR.0000118495.88442.32; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V93, P434, DOI 10.1590/S0066-782X2009001000018	31	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25045	10.1371/journal.pone.0025045	http://dx.doi.org/10.1371/journal.pone.0025045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980376	gold, Green Published			2022-12-25	WOS:000295941300016
J	Stanojcic, S; Gimenez, S; Permal, E; Cousserans, F; Quesneville, H; Fournier, P; d'Alencon, E				Stanojcic, Slavica; Gimenez, Sylvie; Permal, Emmanuelle; Cousserans, Francois; Quesneville, Hadi; Fournier, Philippe; d'Alencon, Emmanuelle			Correlation of LNCR rasiRNAs Expression with Heterochromatin Formation during Development of the Holocentric Insect Spodoptera frugiperda	PLOS ONE			English	Article							REPEATED DNA-SEQUENCE; SMALL RNAS; DROSOPHILA-MELANOGASTER; MOLECULAR CHARACTERIZATION; PATHWAY; RETROTRANSPOSONS; CHROMOSOMES; PIWI; ELEMENTS; ASSOCIATION	Repeat-associated small interfering RNAs (rasiRNAs) are derived from various genomic repetitive elements and ensure genomic stability by silencing endogenous transposable elements. Here we describe a novel subset of 46 rasiRNAs named LNCR rasiRNAs due to their homology with one long non-coding RNA (LNCR) of Spodoptera frugiperda. LNCR operates as the intermediate of an unclassified transposable element (TE-LNCR). TE-LNCR is a very invasive transposable element, present in high copy numbers in the S. frugiperda genome. LNCR rasiRNAs are single-stranded RNAs without a prominent nucleotide motif, which are organized in two distinct, strand-specific clusters. The expression of LNCR and LNCR rasiRNAs is developmentally regulated. Formation of heterochromatin in the genomic region where three copies of the TE-LNCR are embedded was followed by chromatin immunoprecipitation (ChIP) and we observed this chromatin undergo dynamic changes during development. In summary, increased LNCR expression in certain developmental stages is followed by the appearance of a variety of LNCR rasiRNAs which appears to correlate with subsequent accumulation of a heterochromatic histone mark and silencing of the genomic region with TE-LNCR. These results support the notion that a repeat-associated small interfering RNA pathway is linked to heterochromatin formation and/or maintenance during development to establish repression of the TE-LNCR transposable element. This study provides insights into the rasiRNA silencing pathway and its role in the formation of fluctuating heterochromatin during the development of one holocentric organism.	[Stanojcic, Slavica; Gimenez, Sylvie; Cousserans, Francois; Fournier, Philippe; d'Alencon, Emmanuelle] Univ Montpellier 2, INRA UMR1333, Montpellier, France; [Permal, Emmanuelle; Quesneville, Hadi] Ctr Rech Versailles, INRA, UR1164, Versailles, France	INRAE; Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Stanojcic, S (corresponding author), Univ Montpellier 2, INRA UMR1333, Montpellier, France.	alencon@supagro.inra.fr	d'Alençon, Emmanuelle/AAD-3069-2020; Quesneville, Hadi/AAG-1048-2020	Quesneville, Hadi/0000-0003-3001-4908	French National Research Agency [ANR-07-BLAN-0057-01]	French National Research Agency(French National Research Agency (ANR))	This work was supported by the French National Research Agency grant (ANR-07-BLAN-0057-01; http://www.agence-nationale-recherche.fr/). SS and EP held postdoctoral fellowships through the same grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; Carone DM, 2009, CHROMOSOMA, V118, P113, DOI 10.1007/s00412-008-0181-5; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Criniti A, 2005, GENETICA, V124, P93, DOI 10.1007/s10709-004-8154-y; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; d'Alencon E, 2010, P NATL ACAD SCI USA, V107, P7680, DOI 10.1073/pnas.0910413107; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Du YQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000835; Fagegaltier D, 2009, P NATL ACAD SCI USA, V106, P21258, DOI 10.1073/pnas.0809208105; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Gerbal M, 2000, IN VITRO CELL DEV-AN, V36, P117, DOI 10.1290/1071-2690(2000)036<0117:AOAICL>2.0.CO;2; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kawaoka S, 2008, INSECT BIOCHEM MOLEC, V38, P1058, DOI 10.1016/j.ibmb.2008.03.007; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Lee HR, 2006, MOL BIOL EVOL, V23, P2505, DOI 10.1093/molbev/msl127; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Lu BY, 1998, DEVELOPMENT, V125, P2223; Lu Y.-J., 1994, Insect Molecular Biology, V3, P123, DOI 10.1111/j.1365-2583.1994.tb00159.x; Mandrioli M, 1999, CHROMOSOMA, V108, P436, DOI 10.1007/s004120050395; Mandrioli M, 2007, CHROMOSOME RES, V15, P1015, DOI 10.1007/s10577-007-1176-4; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; MURAKAMI A, 1974, CHROMOSOMA, V47, P167, DOI 10.1007/BF00331804; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Shpiz S, 2009, NUCLEIC ACIDS RES, V37, P268, DOI 10.1093/nar/gkn960; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807	50	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24746	10.1371/journal.pone.0024746	http://dx.doi.org/10.1371/journal.pone.0024746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980354	Green Published, Green Submitted, gold			2022-12-25	WOS:000295941300009
J	Atwood, AA; Jerrell, R; Sealy, L				Atwood, Allison A.; Jerrell, Rachel; Sealy, Linda			Negative Regulation of C/EBPbeta1 by Sumoylation in Breast Cancer Cells	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; PHOSPHORYLATION; SUMO; ALPHA; DIFFERENTIATION; PROLIFERATION; ISOFORMS; PATHWAY	Sumoylation is a post-translational modification that is oftentimes deregulated in diseases such as cancer. Transcription factors are frequent targets of sumoylation and modification by SUMO can affect subcellular localization, transcriptional activity, and stability of the target protein. C/EBPbeta1 is one such transcription factor that is modified by SUMO-2/3. Non-sumoylated C/EBPbeta1, p52-C/EBPbeta1, is expressed in normal mammary epithelial cells but not breast cancer cell lines and plays a role in oncogene-induced senescence, a tumor suppressive mechanism. Although p52-C/EBPbeta1 is not observed via immunoblot in breast cancer cell lines, higher molecular weight bands are observed when breast cancer cell lines are subjected to immunoblot analysis with a C/EBPbeta1-specific antibody. We show that exogenously expressed C/EBPbeta1 is sumoylated in breast cancer cells, and that the higher molecular weight bands we observe in anti-C/EBPbeta1 immunoblots of breast cancer cell lines is sumoylated C/EBPbeta1. Phosphorylation oftentimes enhances sumoylation, and phosphorylation cascades are activated in breast cancer cells. We demonstrate that phosphorylation of C/EBPbeta1Thr235 by Erk-2 enhances sumoylation of C/EBPbeta1 in vitro. In addition, sumoylated C/EBPbeta1 is phosphorylated on Thr235 and mutation of Thr235 to alanine leads to a decrease in sumoylation of C/EBPbeta1. Finally, using a C/EBPbeta1-SUMO fusion protein we show that constitutive sumoylation of C/EBPbeta1 completely blocks its capability to induce senescence in WI38 fibroblasts expressing hTERT. Thus, sumolylation of C/EBPbeta1 in breast cancer cells may be a mechanism to circumvent oncogene-induced senescence.	[Atwood, Allison A.; Sealy, Linda] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Jerrell, Rachel; Sealy, Linda] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Atwood, AA (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	linda.sealy@vanderbilt.edu			National Institutes of Health, NIH [GM69634]; Cell Biology and Molecular Sciences training grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069634] Funding Source: NIH RePORTER	National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Biology and Molecular Sciences training grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health, NIH GM69634, and the Cell Biology and Molecular Sciences training grant to Vanderbilt University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MM, 2010, EXP CELL RES, V316, P3227, DOI 10.1016/j.yexcr.2010.07.021; Atwood AA, 2010, ONCOGENE, V29, P6004, DOI 10.1038/onc.2010.336; Atwood AA, 2011, SMALL GTPASES, V2, P1; Baer M, 2000, J BIOL CHEM, V275, P26582, DOI 10.1074/jbc.M004268200; Bundy L, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-43; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Calkhoven CF, 2000, GENE DEV, V14, P1920; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Grignani F, 1998, CANCER RES, V58, P14; Hanlon M, 2001, J BIOL CHEM, V276, P38449, DOI 10.1074/jbc.M102165200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Horie R, 2007, MICROBES INFECT, V9, P721, DOI 10.1016/j.micinf.2007.02.017; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; Kim KI, 2009, INT REV CEL MOL BIO, V273, P265, DOI 10.1016/S1937-6448(08)01807-8; Koslowski M, 2009, J BIOL CHEM, V284, P28607, DOI 10.1074/jbc.M109.031120; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; Lincoln AJ, 1998, J BIOL CHEM, V273, P9552, DOI 10.1074/jbc.273.16.9552; Malaney S, 2001, J MAMMARY GLAND BIOL, V6, P101, DOI 10.1023/A:1009572700317; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; Vanhatupa S, 2008, BIOCHEM J, V409, P179, DOI 10.1042/BJ20070620; Vu EH, 2007, BIOCHEMISTRY-US, V46, P9795, DOI 10.1021/bi700316g; Wang CY, 2008, DIABETES-METAB RES, V24, P93, DOI 10.1002/dmrr.797; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25205	10.1371/journal.pone.0025205	http://dx.doi.org/10.1371/journal.pone.0025205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980398	gold, Green Submitted, Green Published			2022-12-25	WOS:000295936900033
J	Nishimura, Y; Onoe, H; Onoe, K; Morichika, Y; Tsukada, H; Isa, T				Nishimura, Yukio; Onoe, Hirotaka; Onoe, Kayo; Morichika, Yosuke; Tsukada, Hideo; Isa, Tadashi			Neural Substrates for the Motivational Regulation of Motor Recovery after Spinal-Cord Injury	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; MEDIAL FRONTAL-CORTEX; EVENT-RELATED FMRI; MAJOR DEPRESSION; PARKINSONS-DISEASE; REWARD PREDICTION; PREFRONTAL CORTEX; DOPAMINE; NUCLEUS	It is believed that depression impedes and motivation enhances functional recovery after neuronal damage such as spinal-cord injury and stroke. However, the neuronal substrate underlying such psychological effects on functional recovery remains unclear. A longitudinal study of brain activation in the non-human primate model of partial spinal-cord injury using positron emission tomography (PET) revealed a contribution of the primary motor cortex (M1) to the recovery of finger dexterity through the rehabilitative training. Here, we show that activity of the ventral striatum, including the nucleus accumbens (NAc), which plays a critical role in processing of motivation, increased and its functional connectivity with M1 emerged and was progressively strengthened during the recovery. In addition, functional connectivities among M1, the ventral striatum and other structures belonging to neural circuits for processing motivation, such as the orbitofrontal cortex, anterior cingulate cortex and pedunculopontine tegmental nucleus were also strengthened during the recovery. These results give clues to the neuronal substrate for motivational regulation of motor learning required for functional recovery after spinal-cord injury.	[Nishimura, Yukio; Morichika, Yosuke; Isa, Tadashi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan; [Nishimura, Yukio] Japan Sci & Technol Agcy, Tokyo, Japan; [Nishimura, Yukio; Onoe, Hirotaka; Tsukada, Hideo; Isa, Tadashi] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan; [Onoe, Hirotaka] RIKEN, Ctr Mol Imaging Sci, Funct Probe Res Lab, Kobe, Hyogo, Japan; [Onoe, Kayo] RIKEN, Ctr Mol Imaging Sci, Mol Dynam Lab, Kobe, Hyogo, Japan; [Tsukada, Hideo] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Nishimura, Yukio; Isa, Tadashi] Grad Univ Adv Studies SOKENDAI, Hayama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); RIKEN; RIKEN; Hamamatsu Photonics; Graduate University for Advanced Studies - Japan	Nishimura, Y (corresponding author), Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan.	yukio@nips.ac.jp			Precursory Research for Embryonic Science and Technology (PRESTO); Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Nakayama Foundation for Human Science; Grants-in-Aid for Scientific Research [21300205] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology (PRESTO); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakayama Foundation for Human Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The research was supported by Precursory Research for Embryonic Science and Technology (PRESTO) and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), the Molecular Imaging Program on "Research Base for Exploring New Drugs" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Nakayama Foundation for Human Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman RM, 2000, BIOL PSYCHIAT, V47, P332, DOI 10.1016/S0006-3223(99)00243-7; Chemerinski E, 2001, STROKE, V32, P113, DOI 10.1161/01.STR.32.1.113; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Doyon WM, 2005, J NEUROCHEM, V93, P1469, DOI 10.1111/j.1471-4159.2005.03137.x; George MS, 1997, AM J PSYCHIAT, V154, P1752, DOI 10.1176/ajp.154.12.1752; Graves DE, 2008, J SPINAL CORD MED, V31, P177, DOI 10.1080/10790268.2008.11760709; Higo N, 2009, J COMP NEUROL, V516, P493, DOI 10.1002/cne.22121; HORWITZ B, 1990, INT J BIOMED COMPUT, V26, P149, DOI 10.1016/0020-7101(90)90039-W; HORWITZ B, 1991, J CEREBRAL BLOOD FLO, V11, P114; Juckel G, 2006, PSYCHOPHARMACOLOGY, V187, P222, DOI 10.1007/s00213-006-0405-4; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Kobayashi Y, 2007, ANN NY ACAD SCI, V1104, P310, DOI 10.1196/annals.1390.003; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; Miyachi S, 2006, NEUROSCI RES, V56, P300, DOI 10.1016/j.neures.2006.07.012; NAUTA WJH, 1984, CIBA F SYMP, V107, P3; NISHIMURA Y, 2011, EXP NEUROL; Nishimura Y, 2007, NEUROSCI RES, V59, P243, DOI 10.1016/j.neures.2007.07.003; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Nishimura Y, 2009, NEUROSCIENTIST, V15, P436, DOI 10.1177/1073858408331375; Nishimura Y, 2009, BRAIN, V132, P709, DOI 10.1093/brain/awn338; Ohnishi T, 2004, BIOL PSYCHIAT, V55, P484, DOI 10.1016/j.biopsych.2003.09.016; Osteraker AL, 2005, SPINAL CORD, V43, P223, DOI 10.1038/sj.sc.3101703; Paquet F, 2008, EXP BRAIN RES, V185, P227, DOI 10.1007/s00221-007-1147-1; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Saxena SK, 2007, ACTA NEUROL SCAND, V115, P339, DOI 10.1111/j.1600-0404.2006.00751.x; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Teulings HL, 2002, J NEUROL NEUROSUR PS, V72, P315, DOI 10.1136/jnnp.72.3.315; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Walton ME, 2003, J NEUROSCI, V23, P6475; Walton ME, 2002, J NEUROSCI, V22, P10996	34	27	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24854	10.1371/journal.pone.0024854	http://dx.doi.org/10.1371/journal.pone.0024854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969864	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900015
J	Thumkeo, D; Shinohara, R; Watanabe, K; Takebayashi, H; Toyoda, Y; Tohyama, K; Ishizaki, T; Furuyashiki, T; Narumiya, S				Thumkeo, Dean; Shinohara, Ryota; Watanabe, Keisuke; Takebayashi, Hirohide; Toyoda, Yosuke; Tohyama, Kiyoshi; Ishizaki, Toshimasa; Furuyashiki, Tomoyuki; Narumiya, Shuh			Deficiency of mDia, an Actin Nucleator, Disrupts Integrity of Neuroepithelium and Causes Periventricular Dysplasia	PLOS ONE			English	Article							VENTRAL BODY-WALL; PROTEIN-KINASE; ADHERENS JUNCTIONS; RHO-GTPASES; ROCK-I; LOCALIZATION; ORGANIZATION; HETEROTOPIA; MECHANISM; MOVEMENT	During development of the central nervous system, the apical-basal polarity of neuroepithelial cells is critical for homeostasis of proliferation and differentiation of neural stem cells. While adherens junctions at the apical surface of neuroepithelial cells are important for maintaining the polarity, the molecular mechanism regulating integrity of these adherens junctions remains largely unknown. Given the importance of actin cytoskeleton in adherens junctions, we have analyzed the role of mDia, an actin nucleator and a Rho effector, in the integrity of the apical adherens junction. Here we show that mDia1 and mDia3 are expressed in the developing brain, and that mDia3 is concentrated in the apical surface of neuroepithelium. Mice deficient in both mDia1 and mDia3 develop periventricular dysplastic mass widespread throughout the developing brain, where neuroepithelial cell polarity is impaired with attenuated apical actin belts and loss of apical adherens junctions. In addition, electron microscopic analysis revealed abnormal shrinkage and apical membrane bulging of neuroepithelial cells in the remaining areas. Furthermore, perturbation of Rho, but not that of ROCK, causes loss of the apical actin belt and adherens junctions similarly to mDia-deficient mice. These results suggest that actin cytoskeleton regulated by Rho-mDia pathway is critical for the integrity of the adherens junctions and the polarity of neuroepithelial cells, and that loss of this signaling induces aberrant, ectopic proliferation and differentiation of neural stem cells.	[Thumkeo, Dean; Shinohara, Ryota; Toyoda, Yosuke; Tohyama, Kiyoshi; Ishizaki, Toshimasa; Furuyashiki, Tomoyuki; Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan; [Watanabe, Keisuke; Takebayashi, Hirohide] Kumamoto Univ, Dept Morphol Neural Sci, Grad Sch Med Sci, Kumamoto, Japan	Kyoto University; Kumamoto University	Thumkeo, D (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan.	snaru@mfour.med.kyoto-u.ac.jp	Furuyashiki, Tomoyuki/B-8760-2014; Furuyashiki, Tomoyuki/AAG-5283-2019; Takebayashi, Hirohide/AAO-1693-2020; Shinohara, Ryota/AAN-1274-2021	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Shinohara, Ryota/0000-0001-5279-2642; Toyoda, Yosuke/0000-0002-2245-4666	Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology, Japan(Core Research for Evolutional Science and Technology (CREST))	This work was supported by a Grant-in-aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by Core Research for Evolutional Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSON DL, 1992, NEUROSCIENCE, V46, P825, DOI 10.1016/0306-4522(92)90188-8; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; de Wit OA, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-4; Eda M, 2001, J CELL SCI, V114, P3273; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Herzog D, 2011, J NEUROSCI, V31, P5120, DOI 10.1523/JNEUROSCI.4807-10.2011; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Katayama KI, 2011, P NATL ACAD SCI USA, V108, P7607, DOI 10.1073/pnas.1101347108; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; Lu J, 2005, EPILEPSY BEHAV, V7, P143, DOI 10.1016/j.yebeh.2005.05.001; MORII N, 1995, METHOD ENZYMOL, V256, P196; Mullin JP, 2010, J NEUROSURG-PEDIATR, V6, P267, DOI 10.3171/2010.5.PEDS10220; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Parrini E, 2006, BRAIN, V129, P1892, DOI 10.1093/brain/awl125; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	42	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25465	10.1371/journal.pone.0025465	http://dx.doi.org/10.1371/journal.pone.0025465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980468	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900069
J	Diaz-Moralli, S; Tarrado-Castellarnau, M; Alenda, C; Castells, A; Cascante, M				Diaz-Moralli, Santiago; Tarrado-Castellarnau, Miriam; Alenda, Cristina; Castells, Antoni; Cascante, Marta			Transketolase-Like 1 Expression Is Modulated during Colorectal Cancer Progression and Metastasis Formation	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; CELL-PROLIFERATION; METABOLIC-CONTROL; DNA-METHYLATION; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; RIBOSE SYNTHESIS; TUMOR-CELLS; TKTL1; HYPOXIA	Background: Transketolase-like 1 (TKTL1) induces glucose degradation through anaerobic pathways, even in presence of oxygen, favoring the malignant aerobic glycolytic phenotype characteristic of tumor cells. As TKTL1 appears to be a valid biomarker for cancer prognosis, the aim of the current study was to correlate its expression with tumor stage, probability of tumor recurrence and survival, in a series of colorectal cancer patients. Methodolody/Principal Findings: Tumor tissues from 63 patients diagnosed with colorectal cancer at different stages of progression were analyzed for TKTL1 by immunohistochemistry. Staining was quantified by computational image analysis, and correlations between enzyme expression, local growth, lymph-node involvement and metastasis were assessed. The highest values for TKTL1 expression were detected in the group of stage III tumors, which showed significant differences from the other groups (Kruskal-Wallis test, P = 0.000008). Deeper analyses of T, N and M classifications revealed a weak correlation between local tumor growth and enzyme expression (Mann-Whitney test, P = 0.029), a significant association of the enzyme expression with lymph-node involvement (Mann-Whitney test, P = 0.0014) and a significant decrease in TKTL1 expression associated with metastasis (Mann-Whitney test, P = 0.0004). Conclusions/Significance: To our knowledge, few studies have explored the association between variations in TKTL1 expression in the primary tumor and metastasis formation. Here we report downregulation of enzyme expression when metastasis appears, and a correlation between enzyme expression and regional lymph-node involvement in colon cancer. This finding may improve our understanding of metastasis and lead to new and more efficient therapies against cancer.	[Diaz-Moralli, Santiago; Tarrado-Castellarnau, Miriam; Cascante, Marta] Univ Barcelona IBUB, Inst Biomed, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Diaz-Moralli, Santiago; Tarrado-Castellarnau, Miriam; Cascante, Marta] Univ Barcelona, IDIBAPS Hosp Clin, Barcelona, Spain; [Alenda, Cristina] Hosp Gen Univ Alicante, Dept Pathol, Alicante, Spain; [Castells, Antoni] Univ Barcelona, Dept Gastroenterol, Hosp Clin, IDIBAPS,CIBEREHD, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; General University Hospital of Alicante; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Diaz-Moralli, S (corresponding author), Univ Barcelona IBUB, Inst Biomed, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain.	martacascante@ub.edu	Tarrado-Castellarnau, Míriam/E-4419-2018; CASCANTE, MARTA/AFK-5991-2022; Castells, Antoni/ABC-1002-2021; Alenda, Cristina/AAR-3433-2020; CASCANTE, MARTA/AAG-4355-2022	Tarrado-Castellarnau, Míriam/0000-0001-9757-2686; CASCANTE, MARTA/0000-0002-2062-4633; Castells, Antoni/0000-0001-8431-2033; CASCANTE, MARTA/0000-0002-2062-4633; Diaz-Moralli, Santiago/0000-0002-2729-0613; Alenda, Cristina/0000-0002-0560-1759	regional autonomous Government of Catalonia (Generalitat) through the "Agencia de Gestio ad'juts Universitaris i de Recerca" [2009 SGR 849, 2009 SGR 1308]; Ministerio de Ciencia e Innovacion-Spanish Government; European Regional Development Funds (ERDF) "Una manera de hacer Europa" [SAF2010-19273, SAF2011-25726]; Instituto de Salud Carlos III [RD06_0020_0046]; CIBEREHD; "Asociacion Espanola contra el Cancer" ("Fundacion Cientifica y Junta de Barcelona"); ICREA Academia; ICREA foundation-Generalitat de Catalunya	regional autonomous Government of Catalonia (Generalitat) through the "Agencia de Gestio ad'juts Universitaris i de Recerca"; Ministerio de Ciencia e Innovacion-Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Funds (ERDF) "Una manera de hacer Europa"(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIBEREHD; "Asociacion Espanola contra el Cancer" ("Fundacion Cientifica y Junta de Barcelona"); ICREA Academia(ICREA); ICREA foundation-Generalitat de Catalunya(ICREA)	This study was supported by the regional autonomous Government of Catalonia (Generalitat) through the "Agencia de Gestio ad'juts Universitaris i de Recerca" (2009 SGR 849 and 2009 SGR 1308), the Ministerio de Ciencia e Innovacion-Spanish Government and European Regional Development Funds (ERDF) "Una manera de hacer Europa" (SAF2010-19273 and SAF2011-25726), "Instituto de Salud Carlos III" through ISCIII-RTICC (RD06_0020_0046) and CIBEREHD, and "Asociacion Espanola contra el Cancer" ("Fundacion Cientifica y Junta de Barcelona"). MC acknowledges the support received through the prize "ICREA Academia" for excellence in research, funded by ICREA foundation-Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafian H, 2006, LANCET, V367, P618, DOI 10.1016/S0140-6736(06)68228-7; Atsumi T, 2002, CANCER RES, V62, P5881; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Boren J, 2006, J HISTOCHEM CYTOCHEM, V54, P191, DOI 10.1369/jhc.5A6745.2005; Boren J, 2002, MOL BIOL REP, V29, P7, DOI 10.1023/A:1020333730485; Boros LG, 2001, PANCREAS, V23, P141, DOI 10.1097/00006676-200108000-00004; Boros LG, 2001, PANCREAS, V22, P1, DOI 10.1097/00006676-200101000-00001; Boros LG, 1997, CANCER RES, V57, P4242; Chen H, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-43; Comin-Anduix B, 2002, J BIOL CHEM, V277, P46408, DOI 10.1074/jbc.M206150200; Comin-Anduix B, 2001, EUR J BIOCHEM, V268, P4177, DOI 10.1046/j.1432-1327.2001.02329.x; Coy JF, 2005, CLIN LAB, V51, P257; Du MX, 2004, J BIOMOL SCREEN, V9, P427, DOI 10.1177/1087057104263913; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Foldi M, 2007, ONCOL REP, V17, P841; Frederiks WM, 2008, INT J EXP PATHOL, V89, P232, DOI 10.1111/j.1365-2613.2008.00582.x; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Helmlinger G, 2002, CLIN CANCER RES, V8, P1284; Hidvegi M, 1999, CANCER BIOTHER RADIO, V14, P277, DOI 10.1089/cbr.1999.14.277; Hou P, 2008, CANCER, V113, P2440, DOI 10.1002/cncr.23869; Hu LH, 2007, ANTI-CANCER DRUG, V18, P427, DOI 10.1097/CAD.0b013e328013d99e; Jakab F, 2003, BRIT J CANCER, V89, P465, DOI 10.1038/sj.bjc.6601153; Kohrenhagen N, 2008, J OBSTET GYNAECOL RE, V34, P293, DOI 10.1111/j.1447-0756.2008.00749.x; KOLE HK, 1991, ARCH BIOCHEM BIOPHYS, V286, P586, DOI 10.1016/0003-9861(91)90084-V; Krockenberger M, 2007, INT J GYNECOL CANCER, V17, P101, DOI 10.1111/j.1525-1438.2007.00799.x; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327; Mazon Pelaez I, 2010, INT J BIOCH CELL BIO; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; NEWELL K, 1993, P NATL ACAD SCI USA, V90, P1127, DOI 10.1073/pnas.90.3.1127; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; Patra SK, 2008, CANCER METAST REV, V27, P315, DOI 10.1007/s10555-008-9118-y; Patra SK, 2008, EXP CELL RES, V314, P1193, DOI 10.1016/j.yexcr.2008.01.012; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Rais B, 1999, FEBS LETT, V456, P113, DOI 10.1016/S0014-5793(99)00924-2; Ramos-Montoya A, 2006, INT J CANCER, V119, P2733, DOI 10.1002/ijc.22227; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; ROULEAU J, 1995, J BIOL CHEM, V270, P1595, DOI 10.1074/jbc.270.4.1595; SCHLAPPACK OK, 1991, BRIT J CANCER, V64, P663, DOI 10.1038/bjc.1991.378; Schmidt M, 2008, EUR J OBSTET GYN R B, V139, P72, DOI 10.1016/j.ejogrb.2008.02.009; Schmidt M, 2010, J CANCER RES CLIN, V136, P219, DOI 10.1007/s00432-009-0652-y; Schultz H, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-35; Smallbone K, 2007, J THEOR BIOL, V244, P703, DOI 10.1016/j.jtbi.2006.09.010; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Staiger WI, 2006, ONCOL REP, V16, P657; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; SZYF M, 1995, J BIOL CHEM, V270, P12690, DOI 10.1074/jbc.270.21.12690; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Van Noorden CJF, 1992, ENZYME HISTOCHEMISTR; Vizan P, 2008, METABOLOMICS, V4, P1, DOI 10.1007/s11306-007-0101-3; Vizan P, 2009, INT J CANCER, V124, P2789, DOI 10.1002/ijc.24262; Warburg O, 1924, BIOCHEM Z, V152, P309; Xu XJ, 2009, INT J CANCER, V124, P1330, DOI 10.1002/ijc.24078; Zerilli M, 2008, CANCER, V113, P936, DOI 10.1002/cncr.23683; Zhang S, 2007, CANCER LETT, V253, P108, DOI 10.1016/j.canlet.2007.01.010; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	65	44	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25323	10.1371/journal.pone.0025323	http://dx.doi.org/10.1371/journal.pone.0025323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980427	gold, Green Submitted, Green Published			2022-12-25	WOS:000295933700027
J	Ananiev, G; Williams, EC; Li, HD; Chang, Q				Ananiev, Gene; Williams, Emily Cunningham; Li, Hongda; Chang, Qiang			Isogenic Pairs of Wild Type and Mutant Induced Pluripotent Stem Cell (iPSC) Lines from Rett Syndrome Patients as In Vitro Disease Model	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; NEURAL DEVELOPMENT; MOUSE MODELS; MECP2; MUTATIONS; NEURONS; METHYLATION; MORPHOLOGY	Rett syndrome (RTT) is an autism spectrum developmental disorder caused by mutations in the X-linked methyl-CpG binding protein 2 (MECP2) gene. Excellent RTT mouse models have been created to study the disease mechanisms, leading to many important findings with potential therapeutic implications. These include the identification of many MeCP2 target genes, better understanding of the neurobiological consequences of the loss-or mis-function of MeCP2, and drug testing in RTT mice and clinical trials in human RTT patients. However, because of potential differences in the underlying biology between humans and common research animals, there is a need to establish cell culture-based human models for studying disease mechanisms to validate and expand the knowledge acquired in animal models. Taking advantage of the nonrandom pattern of X chromosome inactivation in female induced pluripotent stem cells (iPSC), we have generated isogenic pairs of wild type and mutant iPSC lines from several female RTT patients with common and rare RTT mutations. R294X (arginine 294 to stop codon) is a common mutation carried by 5-6% of RTT patients. iPSCs carrying the R294X mutation has not been studied. We differentiated three R294X iPSC lines and their isogenic wild type control iPSC into neurons with high efficiency and consistency, and observed characteristic RTT pathology in R294X neurons. These isogenic iPSC lines provide unique resources to the RTT research community for studying disease pathology, screening for novel drugs, and testing toxicology.	[Ananiev, Gene; Williams, Emily Cunningham; Chang, Qiang] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Ananiev, Gene; Li, Hongda; Chang, Qiang] Univ Wisconsin, Stem Cell & Regenerat Med Ctr, Madison, WI 53705 USA; [Williams, Emily Cunningham; Li, Hongda; Chang, Qiang] Univ Wisconsin, Genet Training Program, Madison, WI 53705 USA; [Chang, Qiang] Univ Wisconsin, Dept Genet & Neurol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ananiev, G (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	qchang@waisman.wisc.edu	Li, Hongda/F-3034-2017	Li, Hongda/0000-0001-6754-5150	Friends of the Waisman Center [5T32GM07133]; Stem Cell and Regenerative Medicine Center at University of Wisconsin at Madison; National Institutes of Health [P30HD03352];  [T32AG027566]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG027566] Funding Source: NIH RePORTER	Friends of the Waisman Center; Stem Cell and Regenerative Medicine Center at University of Wisconsin at Madison; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	GA was supported by a postdoctoral training grant (T32AG027566). ECW was supported by a predoctoral training grant (5T32GM07133) and a graduate student fellowship from the Friends of the Waisman Center. HL was supported by a predoctoral fellowship from the Stem Cell and Regenerative Medicine Center at University of Wisconsin at Madison. This work was partially supported by a grant from National Institutes of Health (P30HD03352 to the Waisman Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amenduni M, 2011, EUR J HUM GENET, V19, P1246, DOI 10.1038/ejhg.2011.131; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Belichenko NP, 2008, J COMP NEUROL, V508, P184, DOI 10.1002/cne.21673; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hagberg B, 1997, EUR CHILD ADOLES PSY, V6, P5; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Jugloff DGM, 2005, NEUROBIOL DIS, V19, P18, DOI 10.1016/j.nbd.2004.11.002; Katz DM, 2009, RESP PHYSIOL NEUROBI, V168, P101, DOI 10.1016/j.resp.2009.04.017; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, AM J MED GENET, V111, P164, DOI 10.1002/ajmg.10557; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	35	152	161	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25255	10.1371/journal.pone.0025255	http://dx.doi.org/10.1371/journal.pone.0025255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966470	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100030
J	Kakimoto, A; Kamekawa, Y; Ito, S; Yoshikawa, E; Okada, H; Nishizawa, S; Minoshima, S; Ouchi, Y				Kakimoto, Akihiro; Kamekawa, Yuichi; Ito, Shigeru; Yoshikawa, Etsuji; Okada, Hiroyuki; Nishizawa, Sadahiko; Minoshima, Satoshi; Ouchi, Yasuomi			New Computer-Aided Diagnosis of Dementia Using Positron Emission Tomography: Brain Regional Sensitivity-Mapping Method	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CEREBRAL GLUCOSE-METABOLISM; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; FDG-PET; MCI; PREDICTION; DECLINE	Purpose: We devised a new computer-aided diagnosis method to segregate dementia using one estimated index (Total Z score) derived from the Brodmann area (BA) sensitivity map on the stereotaxic brain atlas. The purpose of this study is to investigate its accuracy to differentiate patients with Alzheimer's disease (AD) or mild cognitive impairment (MCI) from normal adults (NL). Methods: We studied 101 adults (NL: 40, AD: 37, MCI: 24) who underwent (18)FDG positron emission tomography (PET) measurement. We divided NL and AD groups into two categories: a training group with (Category A) and a test group without (Category B) clinical information. In Category A, we estimated sensitivity by comparing the standard uptake value per BA (SUVR) between NL and AD groups. Then, we calculated a summated index (Total Z score) by utilizing the sensitivity-distribution maps and each BA z-score to segregate AD patterns. To confirm the validity of this method, we examined the accuracy in Category B. Finally, we applied this method to MCI patients. Results: In Category A, we found that the sensitivity and specificity of differentiation between NL and AD were all 100%. In Category B, those were 100% and 95%, respectively. Furthermore, we found this method attained 88% to differentiate AD-converters from non-converters in MCI group. Conclusions: The present automated computer-aided evaluation method based on a single estimated index provided good accuracy for differential diagnosis of AD and MCI. This good differentiation power suggests its usefulness not only for dementia diagnosis but also in a longitudinal study.	[Kakimoto, Akihiro; Kamekawa, Yuichi; Ito, Shigeru; Yoshikawa, Etsuji; Okada, Hiroyuki] Hamamatsu Photon KK, Cent Res Lab, PET Med Applicat Grp, Branch 5000, Hamamatsu, Shizuoka, Japan; [Nishizawa, Sadahiko] Hamamatsu Med Photon Fdn, Hamamatsu Med Imaging Ctr, Branch 5000, Hamamatsu, Shizuoka, Japan; [Minoshima, Satoshi] Univ Washington, Sch Med, Dept Radiol, Image Guided Biomol Intervent Sect, Seattle, WA 98195 USA; [Kakimoto, Akihiro; Ouchi, Yasuomi] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Dept Biofunct Imaging, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu Photonics; Hamamatsu Photonics; University of Washington; University of Washington Seattle; Hamamatsu University School of Medicine	Kakimoto, A (corresponding author), Hamamatsu Photon KK, Cent Res Lab, PET Med Applicat Grp, Branch 5000, Hamamatsu, Shizuoka, Japan.	ouchi@hama-med.ac.jp		Minoshima, Satoshi/0000-0002-0043-3047; Kakimoto, Akihiro/0000-0001-7452-629X	Japanese Ministry of Health, Labor and Welfare (MHLW); Ministry of Economy, Trade and Industry (METI); New Energy and Industrial Technology Development Organization (NEDO); Takeda Science Foundation; Grants-in-Aid for Scientific Research [23659562] Funding Source: KAKEN	Japanese Ministry of Health, Labor and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Ministry of Economy, Trade and Industry (METI); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the grants from several national and nongovernmental research foundations: the Japanese Ministry of Health, Labor and Welfare (MHLW) (Grant for the Study on Diagnosis of Early Alzheimer's Disease Japan or SEAD-J), Ministry of Economy, Trade and Industry (METI), New Energy and Industrial Technology Development Organization (NEDO), and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Albin RL, 1996, NEUROLOGY, V47, P462, DOI 10.1212/WNL.47.2.462; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P143; Anchisi D, 2005, ARCH NEUROL-CHICAGO, V62, P1728, DOI 10.1001/archneur.62.11.1728; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Cummings JL, 2000, AM J PSYCHIAT, V157, P4, DOI 10.1176/ajp.157.1.4; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; De Santi S, 2001, NEUROBIOL AGING, V22, P529, DOI 10.1016/S0197-4580(01)00230-5; Diehl-Schmid J, 2007, NEUROBIOL AGING, V28, P42, DOI 10.1016/j.neurobiolaging.2005.11.002; Drzezga A, 2005, J NUCL MED, V46, P1625; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; FRISTON K, 2006, STAT PARAMETRIC MAPP, P92; Ishii K, 1998, J NUCL MED, V39, P1875; Jeong Y, 2005, J NUCL MED, V46, P233; LAURENCE J, 2005, BRODMANNS LOCALISATI, P105; Li Y, 2008, EUR J NUCL MED MOL I, V35, P2169, DOI 10.1007/s00259-008-0833-y; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MINOSHIMA S, 1995, J NUCL MED, V36, P1238; MINOSHIMA S, 1994, J NUCL MED, V35, P1528; Minoshima S, 2001, ANN NEUROL, V50, P358, DOI 10.1002/ana.1133; Mosconi L, 2006, EUR J NUCL MED MOL I, V33, P210, DOI 10.1007/s00259-005-1956-z; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Nobili F, 2008, EUR J NUCL MED MOL I, V35, P2191, DOI 10.1007/s00259-008-0869-z; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Prince M, 2009, WORLD ALZHEIMER REPO; Ritchie Karen, 2004, Dialogues Clin Neurosci, V6, P401; Rodriguez G, 1999, J NUCL MED, V40, P522; Salmon E, 2009, NEUROBIOL AGING, V30, P186, DOI 10.1016/j.neurobiolaging.2007.06.010; Scarmeas N, 2004, NEUROIMAGE, V23, P35, DOI 10.1016/j.neuroimage.2004.04.032; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Shidahara M, 2006, ANN NUCL MED, V20, P605, DOI 10.1007/BF02984658; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Silverman DHS, 2002, J NUCL MED, V43, P253; TALAIRACH J, 1988, COPLANAR STEREOTAXIC, P9; Watanabe M, 2002, IEEE T NUCL SCI, V49, P634, DOI 10.1109/TNS.2002.1039541	41	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25033	10.1371/journal.pone.0025033	http://dx.doi.org/10.1371/journal.pone.0025033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966405	gold, Green Published, Green Submitted			2022-12-25	WOS:000295932100013
J	Lira-Navarrete, E; Valero-Gonzalez, J; Villanueva, R; Martinez-Julvez, M; Tejero, T; Merino, P; Panjikar, S; Hurtado-Guerrero, R				Lira-Navarrete, Erandi; Valero-Gonzalez, Jessika; Villanueva, Raquel; Martinez-Julvez, Marta; Tejero, Tomas; Merino, Pedro; Panjikar, Santosh; Hurtado-Guerrero, Ramon			Structural Insights into the Mechanism of Protein O-Fucosylation	PLOS ONE			English	Article							THROMBOSPONDIN TYPE-1 REPEATS; GROWTH FACTOR-LIKE; NOTCH-DELTA INTERACTIONS; LIGAND-BINDING DOMAIN; HUMAN ALPHA-1,3-FUCOSYL-TRANSFERASE; CRYSTAL-STRUCTURE; C-MANNOSYLATION; LINKED FUCOSE; TRANSFERASE; CLUSPRO	Protein O-fucosylation is an essential post-translational modification, involved in the folding of target proteins and in the role of these target proteins during embryonic development and adult tissue homeostasis, among other things. Two different enzymes are responsible for this modification, Protein O-fucosyltransferase 1 and 2 (POFUT1 and POFUT2, respectively). Both proteins have been characterised biologically and enzymatically but nothing is known at the molecular or structural level. Here we describe the first crystal structure of a catalytically functional POFUT1 in an apo-form and in complex with GDP-fucose and GDP. The enzyme belongs to the GT-B family and is not dependent on manganese for activity. GDP-fucose/GDP is localised in a conserved cavity connected to a large solvent exposed pocket, which we show is the binding site of epidermal growth factor (EGF) repeats in the extracellular domain of the Notch Receptor. Through both mutational and kinetic studies we have identified which residues are involved in binding and catalysis and have determined that the Arg240 residue is a key catalytic residue. We also propose a novel S(N)1-like catalytic mechanism with formation of an intimate ion pair, in which the glycosidic bond is cleaved before the nucleophilic attack; and theoretical calculations at a DFT (B3LYP/6-31+G(d,p) support this mechanism. Thus, the crystal structure together with our mutagenesis studies explain the molecular mechanism of POFUT1 and provide a new starting point for the design of functional inhibitors to this critical enzyme in the future.	[Lira-Navarrete, Erandi; Valero-Gonzalez, Jessika; Villanueva, Raquel; Martinez-Julvez, Marta; Hurtado-Guerrero, Ramon] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, Zaragoza, Spain; [Martinez-Julvez, Marta] Univ Zaragoza, Dept Biochem & Mol & Cellular Biol, Zaragoza, Spain; [Tejero, Tomas; Merino, Pedro] Univ Zaragoza, CSIC, Dept Organ Chem, Inst Chem Synth & Homogenoeus Catalysis ISQCH, Zaragoza, Spain; [Panjikar, Santosh] EMBL Hamburt Outstn, Hamburg, Germany; [Hurtado-Guerrero, Ramon] Diputac Gen Aragon, Fdn ARAID, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC-UZA - Instituto de Sintesis Quimica y Catalisis Homogenea (ISQCH); University of Zaragoza; European Molecular Biology Laboratory (EMBL)	Lira-Navarrete, E (corresponding author), Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, Zaragoza, Spain.	rhurtado@bifi.es	Lira-Navarrete, Erandi/L-5359-2015; Valero, Jessika/P-4888-2017; Panjikar, Santosh/D-2709-2012; Martinez-Julvez, Marta M/G-5392-2012; Merino, Pedro/K-2742-2014; Martinez-Julvez, Marta/G-3839-2017; /F-3830-2016	Panjikar, Santosh/0000-0001-7429-3879; Martinez-Julvez, Marta M/0000-0001-9047-0046; Merino, Pedro/0000-0002-2202-3460; Martinez-Julvez, Marta/0000-0001-9047-0046; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; /0000-0003-3433-6701	Fundacion ARAID (Gobierno de Aragon); Ministerio de Educacion y Ciencia [BFU2010-19504]; Ministerio de Ciencia e Innovacion [CTQ2010-19606]	Fundacion ARAID (Gobierno de Aragon)(Gobierno de Aragon); Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Fundacion ARAID (Gobierno de Aragon), Ministerio de Educacion y Ciencia (Project BFU2010-19504) and Ministerio de Ciencia e Innovacion (Project CTQ2010-19606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2000, DEV DYNAM, V218, P280; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; APPELLA E, 1988, FEBS LETT, V231, P1, DOI 10.1016/0014-5793(88)80690-2; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Brzezinski K, 2007, ACTA BIOCHIM POL, V54, P537, DOI 10.18388/abp.2007_3227; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chazalet V, 2001, J BACTERIOL, V183, P7067, DOI 10.1128/JB.183.24.7067-7075.2001; Chen DP, 2004, ANN CLIN LAB SCI, V34, P437; Comeau SR, 2005, PROTEINS, V60, P239, DOI 10.1002/prot.20564; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; DAVIS C G, 1990, New Biologist, V2, P410; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; HALLGREN P, 1975, J BIOL CHEM, V250, P5312; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Jafar-Nejad H, 2010, GLYCOBIOLOGY, V20, P931, DOI 10.1093/glycob/cwq053; Jundt F, 2008, CURR MOL MED, V8, P51, DOI 10.2174/156652408783565540; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KLINGER MM, 1981, J BIOL CHEM, V256, P7932; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee LV, 2003, J AM CHEM SOC, V125, P9588, DOI 10.1021/ja0302836; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; Loriol C, 2007, FEBS J, V274, P1202, DOI 10.1111/j.1742-4658.2007.05663.x; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Murray BW, 1997, BIOCHEMISTRY-US, V36, P823, DOI 10.1021/bi962284z; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Pancewicz J, 2010, P NATL ACAD SCI USA, V107, P16619, DOI 10.1073/pnas.1010722107; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; RAea Laskowski, 1993, J APPL CRYST, V26; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shao L, 2003, CELL MOL LIFE SCI, V60, P241, DOI 10.1007/s000180300019; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200	60	70	73	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25365	10.1371/journal.pone.0025365	http://dx.doi.org/10.1371/journal.pone.0025365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966509	Green Published, Green Submitted, gold			2022-12-25	WOS:000295932100036
J	Zimmermann, D; Motaal, BA; von Voithenberg, LV; Schliwa, M; Okten, Z				Zimmermann, Dennis; Motaal, Basma Abdel; von Voithenberg, Lena Voith; Schliwa, Manfred; Oekten, Zeynep			Diffusion of Myosin V on Microtubules: A Fine-Tuned Interaction for Which E-Hooks Are Dispensable	PLOS ONE			English	Article							ONE-DIMENSIONAL DIFFUSION; PROCESSIVE RUN-LENGTH; XENOPUS MELANOPHORES; MOLECULAR MOTORS; KINESIN MOTOR; WEAK BINDING; ACTIN; TUBULIN; TRANSPORT; DYNAMICS	Organelle transport in eukaryotes employs both microtubule and actin tracks to deliver cargo effectively to their destinations, but the question of how the two systems cooperate is still largely unanswered. Recently, in vitro studies revealed that the actin-based processive motor myosin V also binds to, and diffuses along microtubules. This biophysical trick enables cells to exploit both tracks for the same transport process without switching motors. The detailed mechanisms underlying this behavior remain to be solved. By means of single molecule Total Internal Reflection Microscopy (TIRFM), we show here that electrostatic tethering between the positively charged loop 2 and the negatively charged C-terminal E-hooks of microtubules is dispensable. Furthermore, our data indicate that in addition to charge-charge interactions, other interaction forces such as non-ionic attraction might account for myosin V diffusion. These findings provide evidence for a novel way of myosin tethering to microtubules that does not interfere with other E-hook-dependent processes.	[Zimmermann, Dennis; Motaal, Basma Abdel; von Voithenberg, Lena Voith; Schliwa, Manfred; Oekten, Zeynep] Univ Munich, Inst Anat & Cell Biol, Munich, Germany	University of Munich	Zimmermann, D (corresponding author), Univ Munich, Inst Anat & Cell Biol, Munich, Germany.	zoekten@ph.tum.de		Voith von Voithenberg, Lena/0000-0002-8646-2817	Long Term European Molecular Biology Organization (EMBO) [1134-2006]; Deutsche Forschungsgemeinschaft (DFG) [OE 501/1-1]; Friedrich-Baur-Stiftung [01/09];  [SFB 863]	Long Term European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich-Baur-Stiftung; 	This work was supported by a Long Term European Molecular Biology Organization (EMBO) fellowship to ZO (#1134-2006) and grants from the Deutsche Forschungsgemeinschaft (DFG, #OE 501/1-1) and the Friedrich-Baur-Stiftung (#01/09) to ZO and MS. Z.O. acknowledges support from SFB 863. URL EMBO: http://www.embo.org; URL DFG: http://www.dfg.de; URL Friedrich-Baur-Stiftung: http://www.baur-stiftung.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Alonso MC, 1998, EMBO J, V17, P945, DOI 10.1093/emboj/17.4.945; AUDEBERT S, 1994, J CELL SCI, V107, P2313; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Brunstein M, 2009, BIOPHYS J, V97, P1548, DOI 10.1016/j.bpj.2009.06.048; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Claesson PM, 2006, PHYS CHEM CHEM PHYS, V8, P5501, DOI 10.1039/b610295f; Cooper JR, 2010, NAT STRUCT MOL BIOL, V17, P77, DOI 10.1038/nsmb.1728; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Graneli A, 2006, P NATL ACAD SCI USA, V103, P1221, DOI 10.1073/pnas.0508366103; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; HUANG TG, 1994, J BIOL CHEM, V269, P16493; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Joel PB, 2003, BIOCHEMISTRY-US, V42, P9160, DOI 10.1021/bi034415j; KUZNETSOV SA, 1992, NATURE, V356, P722, DOI 10.1038/356722a0; Lakamper S, 2005, BIOPHYS J, V89, P3223, DOI 10.1529/biophysj.104.057505; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107; Lu HL, 2009, TRAFFIC, V10, P1429, DOI 10.1111/j.1600-0854.2009.00964.x; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; MANDELKOW EM, 1985, J MOL BIOL, V185, P311, DOI 10.1016/0022-2836(85)90406-1; MEEUSEN RL, 1979, J CELL BIOL, V82, P57, DOI 10.1083/jcb.82.1.57; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Minoura I, 2010, BIOPHYS J, V98, P1589, DOI 10.1016/j.bpj.2009.12.4323; Nishikawa M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.128103; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Okada Y, 1999, MOL BIOL CELL, V10, p236A; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Trybus KM, 2007, J BIOL CHEM, V282, P23316, DOI 10.1074/jbc.M701636200; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Tuszynski JA, 2005, MATH COMPUT MODEL, V41, P1055, DOI 10.1016/j.mcm.2005.05.002; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	54	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25473	10.1371/journal.pone.0025473	http://dx.doi.org/10.1371/journal.pone.0025473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966532	gold, Green Published, Green Submitted			2022-12-25	WOS:000295932100041
J	Berg, D; Wolff, C; Langer, R; Schuster, T; Feith, M; Slotta-Huspenina, J; Malinowsky, K; Becker, KF				Berg, Daniela; Wolff, Claudia; Langer, Rupert; Schuster, Tibor; Feith, Marcus; Slotta-Huspenina, Julia; Malinowsky, Katharina; Becker, Karl-Friedrich			Discovery of New Molecular Subtypes in Oesophageal Adenocarcinoma	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; SHOCK-PROTEIN 27; MICROARRAYS; SURVIVAL; HER2; AMPLIFICATION; CHEMOTHERAPY; EXPRESSION; CARCINOMA; ONCOGENE	A large number of patients suffering from oesophageal adenocarcinomas do not respond to conventional chemotherapy; therefore, it is necessary to identify new predictive biomarkers and patient signatures to improve patient outcomes and therapy selections. We analysed 87 formalin-fixed and paraffin-embedded (FFPE) oesophageal adenocarcinoma tissue samples with a reverse phase protein array (RPPA) to examine the expression of 17 cancer-related signalling molecules. Protein expression levels were analysed by unsupervised hierarchical clustering and correlated with clinicopathological parameters and overall patient survival. Proteomic analyses revealed a new, very promising molecular subtype of oesophageal adenocarcinoma patients characterised by low levels of the HSP27 family proteins and high expression of those of the HER family with positive lymph nodes, distant metastases and short overall survival. After confirmation in other independent studies, our results could be the foundation for the development of a Her2-targeted treatment option for this new patient subgroup of oesophageal adenocarcinoma.	[Berg, Daniela; Wolff, Claudia; Langer, Rupert; Slotta-Huspenina, Julia; Malinowsky, Katharina; Becker, Karl-Friedrich] Tech Univ Munich, Inst Pathol, Munich, Germany; [Schuster, Tibor] Tech Univ Munich, Inst Med Stat & Epidemiol, Munich, Germany; [Feith, Marcus] Tech Univ Munich, Dept Surg, Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Berg, D (corresponding author), Tech Univ Munich, Inst Pathol, Munich, Germany.	kf.becker@lrz.tum.de	Langer, Rupert/AAU-1174-2021; Becker, Karl-Friedrich/D-3636-2015	Langer, Rupert/0000-0001-9491-3609; Becker, Karl-Friedrich/0000-0002-6801-4498	Deutsche Forschungsgemeinschaft (DFG) [LA 2706]; Bundesministerium fur Bildung und Forschung (BMBF) [01GR0805]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported in part by Deutsche Forschungsgemeinschaft (DFG), www.dfg.de, grant number LA 2706 and Nationale Genomforschungsnetz (NGFN) project of the Bundesministerium fur Bildung und Forschung (BMBF), www.ngfn.de, grant number 01GR0805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Brien TP, 2000, HUM PATHOL, V31, P35, DOI 10.1016/S0046-8177(00)80195-1; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; DeMeester SR, 2006, ANN SURG ONCOL, V13, P12, DOI 10.1245/ASO.2005.12.025; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emens Leisha A, 2005, Am J Ther, V12, P243; Geisler JP, 1999, GYNECOL ONCOL, V72, P347, DOI 10.1006/gyno.1998.5283; Grubb RL, 2003, PROTEOMICS, V3, P2142, DOI 10.1002/pmic.200300598; Gulmann C, 2006, J PATHOL, V208, P595, DOI 10.1002/path.1958; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Hothorn T, 2002, R NEWS, V2, P3; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kang SH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-286; Kawanishi K, 1999, CANCER, V85, P1649, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1649::AID-CNCR2>3.0.CO;2-V; Kubo A, 2006, CANCER EPIDEM BIOMAR, V15, P872, DOI 10.1158/1055-9965.EPI-05-0860; Langer R, 2011, MODERN PATHOL, V24, P908, DOI 10.1038/modpathol.2011.52; Langer R, 2008, CLIN CANCER RES, V14, P8279, DOI 10.1158/1078-0432.CCR-08-0679; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Lordick Florian, 2005, Gastric Cancer, V8, P78, DOI 10.1007/s10120-005-0321-z; LUBSEN J, 1978, METHOD INFORM MED, V17, P127; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; PERA M, 1993, GASTROENTEROLOGY, V104, P510, DOI 10.1016/0016-5085(93)90420-H; Piccart M, 2001, ONCOLOGY-BASEL, V61, P73, DOI 10.1159/000055405; Powell J, 2002, INT J CANCER, V102, P422, DOI 10.1002/ijc.10721; SCHNEIDER A, 2011, J HLTH ENG, V2, P287; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Walsh TN, 1996, NEW ENGL J MED, V335, P462, DOI 10.1056/NEJM199608153350702; Wolff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016353; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485; Zhang DH, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-52	33	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e23985	10.1371/journal.pone.0023985	http://dx.doi.org/10.1371/journal.pone.0023985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966358	gold, Green Published			2022-12-25	WOS:000295267100004
J	Papadopoulos, A				Papadopoulos, Anthony			Stochastic Ontogenetic Allometry: The Statistical Dynamics of Relative Growth	PLOS ONE			English	Article							HETEROCHRONY; SIZE	Background: In the absence of stochasticity, allometric growth throughout ontogeny is axiomatically described by the logarithm-transformed power-law model, theta(t) = log(a) b + k phi(t), where theta(t): theta(t) and phi(t): phi(t) are the logarithmic sizes of two traits at any given time t. Realistically, however, stochasticity is an inherent property of ontogenetic allometry. Due to the inherent stochasticity in both theta(t) and phi(t), the ontogenetic allometry coefficients, log(a) b and k, can vary with t and have intricate temporal distributions that are governed by the central and mixed moments of the random ontogenetic growth functions, theta(t) and phi(t). Unfortunately, there is no probabilistic model for analyzing these informative ontogenetic statistical moments. Methodology/Principal Findings: This study treats theta(t) and phi(t) as correlated stochastic processes to formulate the exact probabilistic version of each of the ontogenetic allometry coefficients. In particular, the statistical dynamics of relative growth is addressed by analyzing the allometric growth factors that affect the temporal distribution of the probabilistic version of the relative growth rate, k = Dt(u <Omega(t)>)/D-t(v <Omega(t)>, where <Omega(t)> is the expected value of the ratio of stochastic theta(t) to stochastic phi(t), and u <Omega(t)> and nu <Omega(t)> are the numerator and the denominator of <Omega(t)>, respectively. These allometric growth factors, which provide important insight into ontogenetic allometry but appear only when stochasticity is introduced, describe the central and mixed moments of theta(t) and phi(t) as differentiable real-valued functions of t. Conclusions/Significance: Failure to account for the inherent stochasticity in both theta(t) and phi(t) leads not only to the miscalculation of k, but also to the omission of all of the informative ontogenetic statistical moments that affect the size of traits and the timing and rate of development of traits. Furthermore, even though the stochastic process theta(t) and the stochastic process phi(t) are linearly related, k can vary with t.	Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Papadopoulos, A (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	anthony.papadopoulos@ttu.edu			National Science Foundation (NSF) [DEB-0616942]	National Science Foundation (NSF)(National Science Foundation (NSF))	Support for this study was provided by National Science Foundation (NSF) award DEB-0616942 to Sean H. Rice. NSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; [Anonymous], 1991, HETEROCHRONY EVOLUTI; ATCHLEY WR, 1984, AM NAT, V123, P519, DOI 10.1086/284220; Azarina S. V, 2009, INT J DIFFERENCE EQU, V4, P27; Bervian G, 2006, J FISH BIOL, V68, P196, DOI 10.1111/j.0022-1112.2006.00890.x; Heijmans R, 1999, STAT PAP, V40, P107, DOI 10.1007/BF02927114; Huxley J., 1932, PROBLEMS RELATIVE GR; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Huxley JS, 1924, NATURE, V114, P895, DOI 10.1038/114895a0; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; KLINGENBERG CP, 1993, EVOLUTION, V47, P1834, DOI [10.2307/2410225, 10.1111/j.1558-5646.1993.tb01273.x]; KLINGENBERG CP, 1992, AM NAT, V140, P601, DOI 10.1086/285430; LAIRD AK, 1965, GROWTH, V29, P249; LAIRD AK, 1968, GROWTH, V32, P347; Li HY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001245; Lutes L.D., 2004, RANDOM VIBRATIONS AN; NELSON E, 1966, PHYS REV, V150, P1079, DOI 10.1103/PhysRev.150.1079; Nelson E., 1967, DYNAMICAL THEORY BRO; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Pleasants AB, 1997, J AUST MATH SOC B, V38, P477, DOI 10.1017/S0334270000000813; Rice SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007130; Stevens Charles F, 2009, J Biol, V8, P14, DOI 10.1186/jbiol119; West D, 2011, EPL, V94, P1	23	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25267	10.1371/journal.pone.0025267	http://dx.doi.org/10.1371/journal.pone.0025267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966474	Green Published, gold, Green Submitted			2022-12-25	WOS:000295267100035
J	Sutherland, JS; Hill, PC; Adetifa, IM; de Jong, BC; Donkor, S; Joosten, SA; Opmeer, L; Haks, MC; Ottenhoff, THM; Adegbola, RA; Ota, MOC				Sutherland, Jayne S.; Hill, Philip C.; Adetifa, Ifedayo M.; de Jong, Bouke C.; Donkor, Simon; Joosten, Simone A.; Opmeer, Lizet; Haks, Marielle C.; Ottenhoff, Tom H. M.; Adegbola, Richard A.; Ota, Martin O. C.			Identification of Probable Early-Onset Biomarkers for Tuberculosis Disease Progression	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PREDICTIVE-VALUE; INFECTION; EXPRESSION; ASSAY	Determining what constitutes protective immunity to TB is critical for the development of improved diagnostics and vaccines. The comparison of the immune system between contacts of TB patients, who later develop TB disease (progressors), versus contacts who remain healthy (non-progressors), allows for identification of predictive markers of TB disease. This study provides the first comprehensive analysis of the immune system of progressors and non-progressors using a well-characterised TB case-contact (TBCC) platform in The Gambia, West Africa. 22 progressors and 31 non-progressors were analysed at recruitment, 3 months and 18 months (time to progression: median[IQR] of 507[187-714] days). Immunophenotyping of PBMC, plasma cytokine levels and RT-MLPA analysis of whole blood-derived RNA was performed to capture key immune system parameters. At recruitment, progressors had lower PBMC proportions of CD4+ T cells, NKT cells and B cells relative to non-progressors. Analysis of the plasma showed higher levels of IL-18 in progressors compared to non-progressors and analysis of the RNA showed significantly lower gene expression of Bcl2 but higher CCR7 in progressors compared to non-progressors. This study shows several markers that may predict the onset of active TB at a very early stage after infection. Once these markers have been validated in larger studies, they provide avenues to prospectively identify people at risk of developing TB, a key issue in the testing of new TB vaccines.	[Sutherland, Jayne S.; Hill, Philip C.; Adetifa, Ifedayo M.; de Jong, Bouke C.; Donkor, Simon; Adegbola, Richard A.; Ota, Martin O. C.] MRC Unit, Vaccinol Theme Grp, Fajara, Gambia; [Joosten, Simone A.; Opmeer, Lizet; Haks, Marielle C.; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	University of London; London School of Hygiene & Tropical Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sutherland, JS (corresponding author), MRC Unit, Vaccinol Theme Grp, Fajara, Gambia.	jsutherland@mrc.gm	Joosten, Simone/E-4731-2011; de Jong, Bouke/A-3636-2013; Joosten, Simone A/F-1357-2011	de Jong, Bouke/0000-0002-1017-4675; Joosten, Simone A/0000-0002-9878-0863; Sutherland, Jayne/0000-0002-7083-4997	MRC Unit, The Gambia; Medical Research Council [MC_UP_A900_1122, MC_U190071468] Funding Source: researchfish; MRC [MC_U190071468, MC_UP_A900_1122] Funding Source: UKRI	MRC Unit, The Gambia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the MRC Unit, The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2010, EUR J IMMUNOL, V40, P291, DOI 10.1002/eji.200939856; Adolfo RBV, 2006, EUR J IMMUNOL, V36, P345, DOI 10.1002/eji.200535202; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Doherty M, 2009, CURR OPIN PULM MED, V15, P181, DOI 10.1097/MCP.0b013e328326f42c; Eldering E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng153; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X; Hoogerwerf JJ, 2010, J INNATE IMMUN, V2, P461, DOI 10.1159/000317035; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Joosten SA, 2011, GENES IMMUN IN PRESS; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Kaufmann SHE, 2008, CELL HOST MICROBE, V4, P219, DOI 10.1016/j.chom.2008.08.002; Kaufmann SHE, 2011, LANCET INFECT DIS, V11, P633, DOI 10.1016/S1473-3099(11)70146-3; Lienhardt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010508; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Parida SK, 2010, DRUG DISCOV TODAY, V15, P148, DOI 10.1016/j.drudis.2009.10.005; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Schultz H, 2007, CLIN CHIM ACTA, V384, P12, DOI 10.1016/j.cca.2007.07.005; Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531; STOP TB Partnership, GLOB PLAN STOP TB 20; Sutherland JS, 2009, TUBERCULOSIS, V89, P398, DOI 10.1016/j.tube.2009.07.004; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; Yamada G, 2000, AM J RESP CRIT CARE, V161, P1786, DOI 10.1164/ajrccm.161.6.9911054	29	37	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25230	10.1371/journal.pone.0025230	http://dx.doi.org/10.1371/journal.pone.0025230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966464	Green Published, gold, Green Submitted			2022-12-25	WOS:000295267100031
J	Svensen, N; Diaz-Mochon, JJ; Bradley, M				Svensen, Nina; Diaz-Mochon, Juan Jose; Bradley, Mark			Microarray Generation of Thousand-Member Oligonucleotide Libraries	PLOS ONE			English	Article							ENCODED COMBINATORIAL CHEMISTRY; RNA INTERFERENCE; COMPUTATIONAL DESIGN; CHEMICAL LIBRARIES; PEPTIDE LIBRARY; DNA; SELECTION; ARRAYS; LONG; AMPLIFICATION	The ability to efficiently and economically generate libraries of defined pieces of DNA would have a myriad of applications, not least in the area of defined or directed sequencing and synthetic biology, but also in applications associated with encoding and tagging. In this manuscript DNA microarrays were used to allow the linear amplification of immobilized DNA sequences from the array followed by PCR amplification. Arrays of increasing sophistication (1, 10, 3,875, 10,000 defined sequences) were used to validate the process, with sequences verified by selective hybridization to a complementary DNA microarray and DNA sequencing, which demonstrated a PCR error rate of 9.7 x 10(-3)/site/duplication. This technique offers an economical and efficient way of producing specific DNA libraries of hundreds to thousands of members with the DNA-arrays being used as "factories'' allowing specific DNA oligonucleotide pools to be generated. We also found substantial variance observed between the sequence frequencies found via Solexa sequencing and microarray analysis, highlighting the care needed in the interpretation of profiling data.	[Svensen, Nina; Diaz-Mochon, Juan Jose; Bradley, Mark] Univ Edinburgh, Sch Chem, Edinburgh, Midlothian, Scotland	University of Edinburgh	Svensen, N (corresponding author), Univ Edinburgh, Sch Chem, Edinburgh, Midlothian, Scotland.	Mark.Bradley@ed.ac.uk	Diaz-Mochon, Juan/Q-1065-2019; Diaz-Mochon, Juan/A-4297-2009	Diaz-Mochon, Juan/0000-0002-3599-1954; Diaz-Mochon, Juan/0000-0002-3599-1954	Engineering and Physical Sciences Research Council (EPSRC) [EP/1016627/1]; Engineering and Physical Sciences Research Council [EP/E027660/1] Funding Source: researchfish; EPSRC [EP/E027660/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC), grant number EP/1016627/1 (www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adessi C, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e87; Baum PD, 2011, ANAL BIOCHEM, V411, P106, DOI 10.1016/j.ab.2010.11.035; Beaucage SL, 2001, CURR MED CHEM, V8, P1213, DOI 10.2174/0929867013372463; Ben-Dor A, 2000, J COMPUT BIOL, V7, P503, DOI 10.1089/106652700750050916; Borovkov AY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq677; BRENNER S, 1992, P NATL ACAD SCI USA, V89, P5381, DOI 10.1073/pnas.89.12.5381; Cho EJ, 2009, ANNU REV ANAL CHEM, V2, P241, DOI 10.1146/annurev.anchem.1.031207.112851; Clark MA, 2009, NAT CHEM BIOL, V5, P647, DOI 10.1038/nchembio.211; Cohen BA, 1998, P NATL ACAD SCI USA, V95, P14272, DOI 10.1073/pnas.95.24.14272; Dawson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015204; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Fedurco M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj023; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Franch T., 2007, Patent Application, Patent No. [2007/062664A2, 2007062664, WO/2007/062664]; Gartel AL, 2006, BIOMOL ENG, V23, P17, DOI 10.1016/j.bioeng.2006.01.002; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Keiding N, 2008, INTERDISCIPLINARY ST; Khan Z, 2008, ANAL BIOCHEM, V375, P391, DOI 10.1016/j.ab.2008.01.021; Khoury GA, 2009, PROTEIN SCI, V18, P2125, DOI 10.1002/pro.227; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lausted C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r58; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; LI C, 2003, STAT ANAL GENE EXPRE, P1; Liu RH, 2006, EXPERT REV MOL DIAGN, V6, P253, DOI 10.1586/14737159.6.2.253; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Mallikaratchy PR, 2004, NUCL ACIDS RES, DOI 101093/nar/gkq996; McCalla SE, 2009, LANGMUIR, V25, P6168, DOI 10.1021/la804144s; Melkko S, 2004, NAT BIOTECHNOL, V22, P568, DOI 10.1038/nbt961; Morgan B, 2005, [No title captured], Patent No. [WO2005058479, 2005058479]; Muer UR, 2005, MICROARRAY TECHNOLOG; NEEDELS MC, 1993, P NATL ACAD SCI USA, V90, P10700, DOI 10.1073/pnas.90.22.10700; Neylon C, 2004, NUCLEIC ACIDS RES, V32, P1448, DOI 10.1093/nar/gkh315; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; NIELSEN J, 1993, J AM CHEM SOC, V115, P9812, DOI 10.1021/ja00074a063; Owczarzy R, 1997, BIOPOLYMERS, V44, P217, DOI 10.1002/(SICI)1097-0282(1997)44:3<217::AID-BIP3>3.0.CO;2-Y; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; Pirrung MC, 2002, ANGEW CHEM INT EDIT, V41, P1277, DOI 10.1002/1521-3773(20020415)41:8<1276::AID-ANIE1276>3.0.CO;2-2; Pouchain D, 2007, ACS CHEM BIOL, V2, P810, DOI 10.1021/cb700199k; Scheuermann J, 2006, J BIOTECHNOL, V126, P568, DOI 10.1016/j.jbiotec.2006.05.018; Shapero MH, 2001, GENOME RES, V11, P1926, DOI 10.1101/gr.205001; Shchepinov MS, 1997, NUCLEIC ACIDS RES, V25, P1155, DOI 10.1093/nar/25.6.1155; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027	47	8	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e24906	10.1371/journal.pone.0024906	http://dx.doi.org/10.1371/journal.pone.0024906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966380	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100014
J	Verma, S; Mehta, A; Shaha, C				Verma, Smriti; Mehta, Ashish; Shaha, Chandrima			CYP5122A1, a Novel Cytochrome P450 Is Essential for Survival of Leishmania donovani	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNELS; LIPID-METABOLISM; PARASITE; TRYPANOSOMA; INHIBITION; RESISTANCE; MILTEFOSINE; CHOLESTEROL; ERGOSTEROL; APOPTOSIS	Background: Cytochrome P450s (CYP450s) are hemoproteins catalysing diverse biochemical reactions important for metabolism of xenobiotics and synthesis of physiologically important compounds such as sterols. Therefore, they are functionally important for survival of invading pathogens. One such opportunistic pathogen Leishmania donovani causes visceral leishmaniasis worldwide, which is an important public health problem due to significant disease burden. The parasite genome database, Gene DB, annotates 3 CYP450s in Leishmania, however, the functional role of cytochrome P450 enzymes in Leishmania spp. remains elusive. Methodology/Principal Findings: A CYP450-like gene cloned from Leishmania donovani was identified as a novel CYP450, the CYP5122A1. Upon co-localization with organelle specific markers, CYP5122A1 distribution was shown to be localized in the promastigote ER, mitochondria and the glycosomes. Replacement of one allele of CYP5122A1 with either neomycin or hygromycin gene by homologous recombination in Leishmania promastigotes induced substantial reduction of CYP5122A1 expression. These parasites showed impaired growth, lower mitochondrial Ca2+ and membrane potential resulting in low ATP generation. Also, these parasites were less infective in vitro and in vivo than their wild-type counterparts as assessed by incubation of Leishmania promastigotes with macrophages in vitro as well as through administration of parasites into hamsters. The HKOs were more susceptible to drugs like miltefosine and antimony, but showed reduced sensitivity to amphotericin B. Removal of two alleles of CYP5122A1 did not allow the parasites to survive. The mutant parasites showed 3.5 times lower ergosterol level as compared to the wild-type parasites when estimated by Gas chromatography/mass spectrometry. Complementation of CYP5122A1 through episomal expression of protein by using pXG-GFP+2 vector partially rescued CYP5122A1 expression and restored ergosterol levels by 1.8 times. Phenotype reversal included restored growth pattern and lesser drug susceptibility. Conclusions/Significance: In summary, this study establishes CYP5122A1 as an important molecule linked to processes like cell growth, infection and ergosterol biosynthesis in Leishmania donovani.	[Verma, Smriti; Mehta, Ashish; Shaha, Chandrima] Natl Inst Immunol, Ctr Mol Med, Cell Death & Differentiat Res Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Verma, S (corresponding author), Natl Inst Immunol, Ctr Mol Med, Cell Death & Differentiat Res Lab, New Delhi 110067, India.	cshaha@nii.ac.in	Verma, Smriti/J-9950-2019; Mehta, Ashish/A-5537-2011	Verma, Smriti/0000-0002-3760-8090; Mehta, Ashish/0000-0002-0187-4477	Department of Biotechnology, New Delhi, India; National Institute of Immunology [BT/03/033/88]; Centre for Molecular Medicine, New Delhi [BT/PR/14549/MED/14/1291]; Council of Scientific and Industrial Research (CSIR), India [9/485(142)/05-EMR-I]; Life Science Research Board, New Delhi [DLS/81/48222/LSRB-169/ID/2008]	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); National Institute of Immunology; Centre for Molecular Medicine, New Delhi; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Life Science Research Board, New Delhi	This work was supported by grants from the Department of Biotechnology, New Delhi, India (http://dbtindia.nic.in/index.asp) to the National Institute of Immunology (Grant No. BT/03/033/88) and Centre for Molecular Medicine, New Delhi (Grant No. BT/PR/14549/MED/14/1291). The author SV was supported by a fellowship from the Council of Scientific and Industrial Research (CSIR), India (Award No. 9/485(142)/05-EMR-I). The author AM was supported by fellowship from Life Science Research Board, New Delhi (Grant No. DLS/81/48222/LSRB-169/ID/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Arora A, 2004, BIOCHEM BIOPH RES CO, V318, P920, DOI 10.1016/j.bbrc.2004.04.118; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; BERGER BJ, 1993, BIOCHEM PHARMACOL, V46, P149, DOI 10.1016/0006-2952(93)90359-5; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Chen CK, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000372; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cohen BE, 1998, INT J PHARM, V162, P95, DOI 10.1016/S0378-5173(97)00417-1; Conklin KA, 2004, J NUTR, V134, p3201S, DOI 10.1093/jn/134.11.3201S; Croft SL, 2006, T ROY SOC TROP MED H, V100, pS4, DOI 10.1016/j.trstmh.2006.03.009; Croft SL, 2006, INDIAN J MED RES, V123, P399; Fonseca-Silva F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014666; Galea AM, 2009, FREE RADICAL BIO MED, V47, P880, DOI 10.1016/j.freeradbiomed.2009.06.027; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Iyer JP, 2008, MOL MICROBIOL, V68, P372, DOI 10.1111/j.1365-2958.2008.06154.x; Jain R, 2010, CELL MICROBIOL, V12, P432, DOI 10.1111/j.1462-5822.2009.01406.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Krauth-Siegel RL, 2003, BIOL CHEM, V384, P539, DOI 10.1515/BC.2003.062; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva G, 2008, LIPIDS, V43, P1117, DOI 10.1007/s11745-008-3225-y; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mbongo N, 1998, ANTIMICROB AGENTS CH, V42, P352; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mukherjee SB, 2002, J BIOL CHEM, V277, P24717, DOI 10.1074/jbc.M201961200; Nelson David R., 2009, Human Genomics, V4, P59; Olsher M, 2005, BIOCHEMISTRY-US, V44, P2080, DOI 10.1021/bi047710s; Ouellette M, 2004, DRUG RESIST UPDATE, V7, P257, DOI 10.1016/j.drup.2004.07.002; Ouellette Marc, 2008, P159; Panwar SL, 2001, YEAST, V18, P1117, DOI 10.1002/yea.762; Rakotomanga M, 2007, ANTIMICROB AGENTS CH, V51, P1425, DOI 10.1128/AAC.01123-06; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; SACKS DL, 1985, J IMMUNOL, V135, P564; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Sundar S, 2006, INDIAN J MED RES, V123, P345; Urbina JA, 1997, PARASITOLOGY, V114, pS91, DOI 10.1017/S0031182097001194; van Hellemond JJ, 2006, FEBS LETT, V580, P5552, DOI 10.1016/j.febslet.2006.07.056; Venkateswarlu K, 1997, J MED VET MYCOL, V35, P19	43	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25273	10.1371/journal.pone.0025273	http://dx.doi.org/10.1371/journal.pone.0025273			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966477	Green Published, Green Submitted, gold			2022-12-25	WOS:000295267100037
J	Bou-Torrent, J; Martinez-Garcia, JF; Garcia-Martinez, JL; Prat, S				Bou-Torrent, Jordi; Martinez-Garcia, Jaime F.; Luis Garcia-Martinez, Jose; Prat, Salome			Gibberellin A(1) Metabolism Contributes to the Control of Photoperiod-Mediated Tuberization in Potato	PLOS ONE			English	Article							PISUM-SATIVUM-L; SOLANUM-TUBEROSUM; GENE-EXPRESSION; CORTICAL MICROTUBULES; FEEDBACK-REGULATION; FRUIT-DEVELOPMENT; DE-ETIOLATION; PHYTOCHROME-B; STEM LENGTH; BIOSYNTHESIS	Some potato species require a short-day (SD) photoperiod for tuberization, a process that is negatively affected by gibberellins (GAs). Here we report the isolation of StGA3ox2, a gene encoding a GA 3-oxidase, whose expression is increased in the aerial parts and is repressed in the stolons after transfer of photoperiod-dependent potato plants to SD conditions. Over-expression of StGA3ox2 under control of constitutive or leaf-specific promoters results in taller plants which, in contrast to StGA20ox1 over-expressers previously reported, tuberize earlier under SD conditions than the controls. By contrast, StGA3ox2 tuber-specific over-expression results in non-elongated plants with slightly delayed tuber induction. Together, our experiments support that StGA3ox2 expression and gibberellin metabolism significantly contribute to the tuberization time in strictly photoperiod-dependent potato plants.	[Bou-Torrent, Jordi; Martinez-Garcia, Jaime F.; Prat, Salome] CSIC IRTA UAB, CRAG, Bellaterra, Spain; [Martinez-Garcia, Jaime F.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Luis Garcia-Martinez, Jose] UPV CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Prat, Salome] Ctr Nacl Biotecol CSIC, Madrid, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; ICREA; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC)	Bou-Torrent, J (corresponding author), CSIC IRTA UAB, CRAG, Bellaterra, Spain.	jordi.bou@cragenomica.es	Bou-Torrent, Jordi/B-2919-2009; Bou-Torrent, Jordi/O-3649-2014; Prat, Salome/L-9240-2014; Martinez-Garcia, Jaime F/H-6868-2015	Bou-Torrent, Jordi/0000-0002-6605-738X; Prat, Salome/0000-0003-2684-5485; Martinez-Garcia, Jaime F/0000-0003-1516-0341	Ministerio de Educacion y Ciencia - FEDER; Generalitat de Catalunya [BIO96-0532-C02-02, BIO99-0961, BIO2005-07284, BIO2009-07968, BIO2008-00169, 2005SGR-00284]; Xarxa de Referencia en Biotecnologia; ICREA Funding Source: Custom	Ministerio de Educacion y Ciencia - FEDER(Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Xarxa de Referencia en Biotecnologia; ICREA(ICREA)	This work was supported by grants from the Ministerio de Educacion y Ciencia - FEDER and the Generalitat de Catalunya to SP (BIO96-0532-C02-02, BIO99-0961, BIO2005-07284), to JLGM (BIO2009-07968) and to JFMG (BIO2008-00169, 2005SGR-00284, Xarxa de Referencia en Biotecnologia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Ali T, 1999, PLANT PHYSIOL, V121, P783, DOI 10.1104/pp.121.3.783; BAMBERG JB, 1991, AM POTATO J, V68, P45, DOI 10.1007/BF02893340; Bjorklund S, 2007, PLANT J, V52, P499, DOI 10.1111/j.1365-313X.2007.03250.x; Carrera E, 1999, PLANT PHYSIOL, V119, P765, DOI 10.1104/pp.119.2.765; Carrera E, 2000, PLANT J, V22, P247, DOI 10.1046/j.1365-313x.2000.00736.x; CHIANG HH, 1995, PLANT CELL, V7, P195, DOI 10.1105/tpc.7.2.195; CYR RJ, 1994, ANNU REV CELL BIOL, V10, P153, DOI 10.1146/annurev.cb.10.110194.001101; Eriksson S, 2006, PLANT CELL, V18, P2172, DOI 10.1105/tpc.106.042317; Ewing E. E., 1992, Horticultural Reviews, V14, P89; FUJINO K, 1995, PLANT CELL PHYSIOL, V36, P891, DOI 10.1093/oxfordjournals.pcp.a078835; GARCIAMARTINEZ JL, 1991, PLANTA, V184, P53, DOI 10.1007/BF00208236; GarciaMartinez JL, 1997, PLANT MOL BIOL, V33, P1073, DOI 10.1023/A:1005715722193; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; HOFGEN R, 1990, PLANT SCI, V66, P221, DOI 10.1016/0168-9452(90)90207-5; Jackson SD, 1996, PHYSIOL PLANTARUM, V98, P407, DOI 10.1034/j.1399-3054.1996.980224.x; Jackson SD, 1996, PLANT J, V9, P159, DOI 10.1046/j.1365-313X.1996.09020159.x; Kamiya Y, 1999, CURR OPIN PLANT BIOL, V2, P398, DOI 10.1016/S1369-5266(99)00012-6; Kloosterman B, 2007, PLANT J, V52, P362, DOI 10.1111/j.1365-313X.2007.03245.x; Krauss A., 1985, Potato physiology, P209; Lester DR, 1997, PLANT CELL, V9, P1435, DOI 10.1105/tpc.9.8.1435; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Machackova I, 1998, PHYSIOL PLANTARUM, V102, P272, DOI 10.1034/j.1399-3054.1998.1020215.x; Martin DN, 1996, PLANTA, V200, P159, DOI 10.1007/BF00208304; Martin DN, 1997, P NATL ACAD SCI USA, V94, P8907, DOI 10.1073/pnas.94.16.8907; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Martinez-Garcia JF, 2001, J PLANT GROWTH REGUL, V20, P377, DOI 10.1007/s003440010036; Martinez-Garcia JF, 2000, PHYSIOL PLANTARUM, V108, P426, DOI 10.1034/j.1399-3054.2000.t01-1-100413.x; MENZEL CM, 1983, ANN BOT-LONDON, V52, P697, DOI 10.1093/oxfordjournals.aob.a086627; PROEBSTING WM, 1992, PLANT PHYSIOL, V100, P1354, DOI 10.1104/pp.100.3.1354; Rebers M, 1999, PLANT J, V17, P241, DOI 10.1046/j.1365-313X.1999.00366.x; Reid JB, 2002, PLANT PHYSIOL, V128, P734, DOI 10.1104/pp.010607; ROCHASOSA M, 1989, EMBO J, V8, P23, DOI 10.1002/j.1460-2075.1989.tb03344.x; Rodriguez-Falcon M, 2006, ANNU REV PLANT BIOL, V57, P151, DOI 10.1146/annurev.arplant.57.032905.105224; Ross JJ, 1999, PHYSIOL PLANTARUM, V105, P532, DOI 10.1034/j.1399-3054.1999.105319.x; SHIBAOKA H, 1994, ANNU REV PLANT PHYS, V45, P527, DOI 10.1146/annurev.pp.45.060194.002523; STOCKHAUS J, 1989, EMBO J, V8, P2445, DOI 10.1002/j.1460-2075.1989.tb08379.x; Stupar RM, 2006, GENETICS, V172, P1263, DOI 10.1534/genetics.105.051219; Toyomasu T, 1998, PLANT PHYSIOL, V118, P1517, DOI 10.1104/pp.118.4.1517; VANDENBERG JH, 1995, J PLANT PHYSIOL, V146, P467, DOI 10.1016/S0176-1617(11)82010-9; WOOLLEY DJ, 1972, NEW PHYTOL, V71, P1015, DOI 10.1111/j.1469-8137.1972.tb01979.x; Wu KQ, 1996, PLANT PHYSIOL, V110, P547, DOI 10.1104/pp.110.2.547; Xu X, 1998, PLANT PHYSIOL, V117, P575, DOI 10.1104/pp.117.2.575; Xu X, 1998, J EXP BOT, V49, P573, DOI 10.1093/jexbot/49.320.573; Xu YL, 1997, PLANT PHYSIOL, V114, P1471, DOI 10.1104/pp.114.4.1471; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yamaguchi S, 2000, PLANT CELL PHYSIOL, V41, P251, DOI 10.1093/pcp/41.3.251; ZEEVAART JAD, 1993, PLANT PHYSIOL, V101, P25, DOI 10.1104/pp.101.1.25	48	37	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24458	10.1371/journal.pone.0024458	http://dx.doi.org/10.1371/journal.pone.0024458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961036	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100009
J	Gutierrez, E; Tkachenko, E; Besser, A; Sundd, P; Ley, K; Danuser, G; Ginsberg, MH; Groisman, A				Gutierrez, Edgar; Tkachenko, Eugene; Besser, Achim; Sundd, Prithu; Ley, Klaus; Danuser, Gaudenz; Ginsberg, Mark H.; Groisman, Alex			High Refractive Index Silicone Gels for Simultaneous Total Internal Reflection Fluorescence and Traction Force Microscopy of Adherent Cells	PLOS ONE			English	Article							SUBSTRATE STIFFNESS; FOCAL ADHESIONS; LOCOMOTION; MATRICES; GROWTH; TIRF	Substrate rigidity profoundly impacts cellular behaviors such as migration, gene expression, and cell fate. Total Internal Reflection Fluorescence (TIRF) microscopy enables selective visualization of the dynamics of substrate adhesions, vesicle trafficking, and biochemical signaling at the cell-substrate interface. Here we apply high-refractive-index silicone gels to perform TIRF microscopy on substrates with a wide range of physiological elastic moduli and simultaneously measure traction forces exerted by cells on the substrate.	[Gutierrez, Edgar; Tkachenko, Eugene; Groisman, Alex] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Tkachenko, Eugene; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Besser, Achim; Danuser, Gaudenz] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Sundd, Prithu; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; La Jolla Institute for Immunology	Gutierrez, E (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	agroisman@ucsd.edu	Groisman, Alexander/AAU-7843-2021; Tkachenko, Eugene/A-9779-2012	Tkachenko, Eugene/0000-0002-7964-484X; Danuser, Gaudenz/0000-0001-8583-2014	National Institutes of Health [P01 HL078784, NIH AR 27214, NIH HL57900, NIH GM071868]; Deutsche Forschungsgemeinschaft [BE4547/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078784, P01HL057900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027214, R37AR027214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health P01 HL078784, NIH AR 27214, NIH HL57900, NIH GM071868, and Deutsche Forschungsgemeinschaft Fellowship BE4547/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Brown AEX, 2009, CURR BIOL, V19, pR781, DOI 10.1016/j.cub.2009.06.054; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Gutierrez E, 2011, MEASUREMENTS E UNPUB; HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Iwadate Y, 2008, J CELL SCI, V121, P1314, DOI 10.1242/jcs.021576; Iwadate Y, 2008, BIOTECHNIQUES, V44, P739, DOI 10.2144/000112752; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; Krndija D, 2010, ONCOGENE, V29, P2724, DOI 10.1038/onc.2010.25; Mark J.E., 1999, POLYM DATA HDB; Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; REICHERT WM, 1990, J CELL SCI, V96, P219; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; Stricker J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194104; Sundd P, 2010, NAT METHODS, V7, P821, DOI [10.1038/NMETH.1508, 10.1038/nmeth.1508]; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	33	37	37	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e23807	10.1371/journal.pone.0023807	http://dx.doi.org/10.1371/journal.pone.0023807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961031	Green Published, gold, Green Submitted			2022-12-25	WOS:000295265100003
J	Omar, SV; Roth, A; Ismail, NA; Erasmus, L; Ehlers, M; Kock, M; Paulse, N; Said, HM; Hoosen, AA; Reischl, U				Omar, Shaheed V.; Roth, Andreas; Ismail, Nazir A.; Erasmus, Linda; Ehlers, Marthie; Kock, Marleen; Paulse, Nuraan; Said, Halima M.; Hoosen, Anwar A.; Reischl, Udo			Analytical Performance of the Roche LightCycler (R) Mycobacterium Detection Kit for the Diagnosis of Clinically Important Mycobacterial Species	PLOS ONE			English	Article							REAL-TIME PCR; NONTUBERCULOUS MYCOBACTERIA; RAPID DETECTION; TUBERCULOSIS; DIFFERENTIATION; DNA	Background: The LightCycler (R) Mycobacterium Detection Kit based on real-time PCR technology for the detection of Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium kansasii was recently developed. This study evaluated its analytical sensitivity, specificity and reproducibility. Methodology/Principal Findings: Plasmid standards were prepared and used to determine the limit of detection. The assay was also performed against organisms other than mycobacteria, other mycobacterial strains and interfering substances to exclude cross-reactivity and interference. Reference standards were prepared and tested to assess the assay's reproducibility. All PCR assays were performed using the LightCycler (R) 2.0 Instrument. The detection limit for M. tuberculosis was 28 copies per microlitre. Neither cross-reactivity nor interference occurred with non-mycobacterial organisms and substances tested. Overall reproducibility for consecutive measurements, run-to-run, lot-to-lot, day-to-day and laboratory-to-laboratory achieved a coefficient of variance of less than two percent. Significance: The LightCycler (R) Mycobacterium Detection kit has shown to be a robust and accurate assay with the potential to be used as a rapid TB diagnostic test.	[Omar, Shaheed V.; Ismail, Nazir A.; Ehlers, Marthie; Kock, Marleen; Said, Halima M.; Hoosen, Anwar A.] Univ Pretoria, Dept Med Microbiol, ZA-0002 Pretoria, South Africa; [Roth, Andreas] HELIOS Klinikum E v Behring, Lab Mol Diagnostik & Mikrobiol, Berlin, Germany; [Erasmus, Linda] Natl Inst Communicable Dis, Natl TB Reference Lab, Johannesburg, South Africa; [Paulse, Nuraan] Natl Hlth Lab Serv, Kimberley, South Africa; [Reischl, Udo] Univ Klinikum Regensburg, Inst Med Mikrobiol & Hyg, Regensburg, Germany	University of Pretoria; Helios Kliniken; National Institute for Communicable Diseases (NICD); University of Regensburg	Omar, SV (corresponding author), Univ Pretoria, Dept Med Microbiol, ZA-0002 Pretoria, South Africa.	shaheed.vally@gmail.com	Said, Halima/GWV-3962-2022; Omar, Shaheed Vally/AAB-5071-2020; Kock, Martha/ABD-7182-2021	Said, Halima/0000-0003-4843-9541; Omar, Shaheed Vally/0000-0001-6983-1636; Ehlers, Marthie/0000-0003-2199-6970; Kock, Marleen/0000-0002-1768-9268				Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Corbett EL, 1999, AM J RESP CRIT CARE, V160, P15, DOI 10.1164/ajrccm.160.1.9812080; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Flores E, 2009, APMIS, V117, P592, DOI 10.1111/j.1600-0463.2009.02508.x; Grandjean L, 2008, CURR OPIN INFECT DIS, V21, P454, DOI 10.1097/QCO.0b013e32830ce783; Green C, 2009, LANCET INFECT DIS, V9, P505, DOI 10.1016/S1473-3099(09)70149-5; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Johnson MM, 2008, CURR OPIN PULM MED, V14, P203, DOI 10.1097/MCP.0b013e3282f9e650; KUBICA GP, 1963, AM REV RESPIR DIS, V87, P775; Lay MJ, 1997, CLIN CHEM, V43, P2262; Logan J., 2009, REAL TIME PCR CURREN, P284; McGrath EE, 2008, INT J CLIN PRACT, V62, P1947, DOI 10.1111/j.1742-1241.2008.01891.x; Nahid Payam, 2006, Proc Am Thorac Soc, V3, P103, DOI 10.1513/pats.200511-119JH; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Schaaf HS, 2009, TUBERCULOSIS COMPREH; Shrestha NK, 2003, J CLIN MICROBIOL, V41, P5121, DOI 10.1128/JCM.41.11.5121-5126.2003; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Vollmer T, 2008, J CLIN MICROBIOL, V46, P1919, DOI 10.1128/JCM.02178-07; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; *WHO, 2010, GLOB TUB CONTR 2010, P218	21	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24789	10.1371/journal.pone.0024789	http://dx.doi.org/10.1371/journal.pone.0024789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961045	Green Submitted, Green Published, gold			2022-12-25	WOS:000295265100020
J	Pal, M; Tan, MJ; Huang, RL; Goh, YY; Wang, XL; Tang, MBY; Tan, NS				Pal, Mintu; Tan, Ming Jie; Huang, Royston-Luke; Goh, Yan Yih; Wang, Xiao Ling; Tang, Mark Boon Yang; Tan, Nguan Soon			Angiopoietin-Like 4 Regulates Epidermal Differentiation	PLOS ONE			English	Article							WOUND-HEALING DRUGS; SIGNAL-TRANSDUCTION; KERATINOCYTE GROWTH; PPAR-BETA/DELTA; ADIPOSE-TISSUE; CELL-ADHESION; PROTEINS; MIGRATION; TARGET; EXPRESSION	The nuclear hormone receptor PPAR beta/delta is integral to efficient wound re-epithelialization and implicated in epidermal maturation. However, the mechanism underlying the latter process of epidermal differentiation remains unclear. We showed that ligand-activated PPAR beta/delta indirectly stimulated keratinocyte differentiation, requiring de novo gene transcription and protein translation. Using organotypic skin cultures constructed from PPAR beta/delta- and angiopoietin-like 4 (ANGPTL4)-knockdown human keratinocytes, we showed that the expression of ANGPTL4, a PPAR beta/delta target gene, is essential for the receptor mediated epidermal differentiation. The pro-differentiation effect of PPAR beta/delta agonist GW501516 was also abolished when keratinocytes were co-treated with PPAR beta/delta antagonist GSK0660 and similarly in organotypic skin culture incubated with blocking ANGPTL4 monoclonal antibody targeted against the C-terminal fibrinogen-like domain. Our focused real-time PCR gene expression analysis comparing the skin biopsies from wildtype and ANGPTL4-knockout mice confirmed a consistent down-regulation of numerous genes involved in epidermal differentiation and proliferation in the ANGPTL4-knockout skin. We further showed that the deficiency of ANGPTL4 in human keratinocytes and mice skin have diminished expression of various protein kinase C isotypes and phosphorylated transcriptional factor activator protein-1, which are well-established for their roles in keratinocyte differentiation. Chromatin immunoprecipitation confirmed that ANGPTL4 stimulated the activation and binding of JUNB and c-JUN to the promoter region of human involucrin and transglutaminase type 1 genes, respectively. Taken together, we showed that PPAR beta/delta regulates epidermal maturation via ANGPTL4-mediated signalling pathway.	[Pal, Mintu; Tan, Ming Jie; Huang, Royston-Luke; Goh, Yan Yih; Wang, Xiao Ling; Tan, Nguan Soon] Nanyang Technol Univ, Sch Biol Sci, Coll Sci, Singapore, Singapore; [Tang, Mark Boon Yang] Natl Skin Ctr, Singapore 1130, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Skin Centre	Pal, M (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Coll Sci, Singapore, Singapore.	nstan@ntu.edu.sg	Goh, Yan Yih/J-1926-2015; Tan, Nguan Soon/A-2220-2011	Goh, Yan Yih/0000-0002-8922-9869; Tan, Nguan Soon/0000-0003-0136-7341	National Medical Research Council (NMRC) [IRG10MAY017]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore)	This work was supported by a grant from National Medical Research Council (NMRC) (IRG10MAY017) to N.S.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Dutton S, 2008, BRIT J NUTR, V100, P18, DOI 10.1017/S0007114507882961; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Hanley K, 1997, PEDIATR RES, V42, P610, DOI 10.1203/00006450-199711000-00010; Ito Y, 2003, CANCER RES, V63, P6651; Kamioka N, 2010, BIOCHEM BIOPH RES CO, V394, P106, DOI 10.1016/j.bbrc.2010.02.125; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Komuves LG, 1998, J INVEST DERMATOL, V111, P429, DOI 10.1046/j.1523-1747.1998.00296.x; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Maas-Szabowski N, 2001, J INVEST DERMATOL, V116, P816, DOI 10.1046/j.1523-1747.2001.01349.x; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Rutberg SE, 1996, ONCOGENE, V13, P167; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Shearer BG, 2008, MOL ENDOCRINOL, V22, P523, DOI 10.1210/me.2007-0190; Stapleton CM, 2010, EXP CELL RES, V316, P507, DOI 10.1016/j.yexcr.2009.12.004; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Tan NS, 2007, MOL CELL BIOL, V27, P7161, DOI 10.1128/MCB.00436-07; Tan NS, 2005, J BIOL CHEM, V280, P18163, DOI 10.1074/jbc.M412829200; Tan NS, 2004, EXPERT OPIN THER TAR, V8, P39, DOI 10.1517/eott.8.1.39.26404; Tan NS, 2003, AM J CLIN DERMATOL, V4, P523, DOI 10.2165/00128071-200304080-00001; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tan SH, 2009, J BIOL CHEM, V284, P18047, DOI 10.1074/jbc.M109.002691; Yeung YG, 2009, ANAL BIOCHEM, V389, P89, DOI 10.1016/j.ab.2009.03.017; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	41	27	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25377	10.1371/journal.pone.0025377	http://dx.doi.org/10.1371/journal.pone.0025377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966511	Green Published, gold			2022-12-25	WOS:000295265100095
J	Delval, S; Taminiau, A; Lamy, J; Lallemand, C; Gilles, C; Noel, A; Rezsohazy, R				Delval, Stephanie; Taminiau, Arnaud; Lamy, Juliette; Lallemand, Cecile; Gilles, Christine; Noel, Agnes; Rezsohazy, Rene			The Pbx Interaction Motif of Hoxa1 Is Essential for Its Oncogenic Activity	PLOS ONE			English	Article							HUMAN GROWTH-HORMONE; MAMMARY-CARCINOMA CELLS; HUMAN BREAST-CANCER; COOPERATIVE DNA-BINDING; TALE HOMEOBOX GENES; IN-VIVO; HOMEODOMAIN PROTEINS; TRANSCRIPTIONAL ACTIVATION; GLAND DEVELOPMENT; P53 EXPRESSION	Hoxa1 belongs to the Hox family of homeodomain transcription factors involved in patterning embryonic territories and governing organogenetic processes. In addition to its developmental functions, Hoxa1 has been shown to be an oncogene and to be overexpressed in the mammary gland in response to a deregulation of the autocrine growth hormone. It has therefore been suggested that Hoxa1 plays a pivotal role in the process linking autocrine growth hormone misregulation and mammary carcinogenesis. Like most Hox proteins, Hoxa1 can interact with Pbx proteins. This interaction relies on a Hox hexapeptidic sequence centred on conserved Tryptophan and Methionine residues. To address the importance of the Hox-Pbx interaction for the oncogenic activity of Hoxa1, we characterized here the properties of a Hoxa1 variant with substituted residues in the hexapeptide and demonstrate that the Hoxa1 mutant lost its ability to stimulate cell proliferation, anchorage-independent cell growth, and loss of contact inhibition. Therefore, the hexapeptide motif of Hoxa1 is required to confer its oncogenic activity, supporting the view that this activity relies on the ability of Hoxa1 to interact with Pbx.	[Delval, Stephanie; Taminiau, Arnaud; Lamy, Juliette; Rezsohazy, Rene] Catholic Univ Louvain, Mol & Cellular Anim Embryol Grp, Life Sci Inst ISV, B-1348 Louvain, Belgium; [Lallemand, Cecile; Gilles, Christine; Noel, Agnes] Univ Liege, Lab Biol Tumors & Dev, GIGA Canc, Liege, Belgium; [Lallemand, Cecile; Gilles, Christine; Noel, Agnes] Ctr Hosp Univ, Liege, Belgium	Universite Catholique Louvain; University of Liege; University of Liege	Delval, S (corresponding author), Catholic Univ Louvain, Mol & Cellular Anim Embryol Grp, Life Sci Inst ISV, B-1348 Louvain, Belgium.	rene.rezsohazy@uclouvain.be		Noel, Agnes/0000-0002-7670-6179	Belgian Fund for Scientific Research (FNRS) [3.4.536.06.F]; "Direction Generale des Technologies, de la Recherche et de l'Energie" of the Walloon Region [516054]; Fonds Speciaux de Recherche (FSR) of the Universite catholique de Louvain (UCL); FNRS	Belgian Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); "Direction Generale des Technologies, de la Recherche et de l'Energie" of the Walloon Region; Fonds Speciaux de Recherche (FSR) of the Universite catholique de Louvain (UCL); FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Belgian Fund for Scientific Research (FNRS, http://www1.frs-fnrs.be/, FRSM grant no3.4.536.06.F), the "Direction Generale des Technologies, de la Recherche et de l'Energie" of the Walloon Region (http://recherche-technologie.wallonie.be/, WALEOII grant no516054), and the Fonds Speciaux de Recherche (FSR) of the Universite catholique de Louvain (UCL). SD held a Televie fellowship from the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Aulisa L, 2009, ACTA BIOMATER, V5, P842, DOI 10.1016/j.actbio.2008.11.002; Barrow JR, 2000, DEVELOPMENT, V127, P933; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Burglin TR, 1998, DEV GENES EVOL, V208, P113, DOI 10.1007/s004270050161; Cantile M, 2003, EUR J CANCER, V39, P257, DOI 10.1016/S0959-8049(02)00599-3; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Chariot A, 1996, BIOCHEM BIOPH RES CO, V222, P292, DOI 10.1006/bbrc.1996.0737; Chen F, 1999, P NATL ACAD SCI USA, V96, P541, DOI 10.1073/pnas.96.2.541; Chen HX, 2003, J MAMMARY GLAND BIOL, V8, P159, DOI 10.1023/A:1025996707117; Chen J, 1998, J BIOL CHEM, V273, P24670, DOI 10.1074/jbc.273.38.24670; Chu MC, 2004, CANCER BIOL THER, V3, P568, DOI 10.4161/cbt.3.6.848; CILLO C, 2007, GENE EXPRESSION, P121; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; Fernandez CC, 2009, J CELL BIOCHEM, V106, P427, DOI 10.1002/jcb.22023; Fernandez LC, 2008, CANCER LETT, V266, P144, DOI 10.1016/j.canlet.2008.02.042; Foronda D, 2009, INT J DEV BIOL, V53, P1409, DOI 10.1387/ijdb.072462df; FRIEDMANN Y, 1994, CANCER RES, V54, P5981; Gilbert PM, 2010, J CLIN INVEST, V120, P1535, DOI 10.1172/JCI39534; Goudet G, 1999, J BIOL CHEM, V274, P4067, DOI 10.1074/jbc.274.7.4067; Graichen R, 2002, J BIOL CHEM, V277, P26662, DOI 10.1074/jbc.M109931200; Huang H, 2005, J BIOL CHEM, V280, P10119, DOI 10.1074/jbc.M413963200; Hwang JH, 2009, CLONING STEM CELLS, V11, P269, DOI 10.1089/clo.2008.0068; Ji T, 2004, BIOORG MED CHEM LETT, V14, P3875, DOI 10.1016/j.bmcl.2004.05.068; KNOEPFLER PS, 1995, MOL CELL BIOL, V15, P5811; Krosl J, 1998, ONCOGENE, V16, P3403, DOI 10.1038/sj.onc.1201883; Lampe X, 2008, NUCLEIC ACIDS RES, V36, P3214, DOI 10.1093/nar/gkn148; LAROSA GJ, 1988, MOL CELL BIOL, V8, P3906, DOI 10.1128/MCB.8.9.3906; LAUGHON A, 1991, BIOCHEMISTRY-US, V30, P11357, DOI 10.1021/bi00112a001; Lewis MT, 2000, BREAST CANCER RES, V2, P158, DOI 10.1186/bcr49; MAGLI MC, 1991, P NATL ACAD SCI USA, V88, P6348, DOI 10.1073/pnas.88.14.6348; MALLO M, 2010, DEV BIOL; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Matis C, 2001, FEBS LETT, V499, P92, DOI 10.1016/S0014-5793(01)02532-7; Medina-Martinez O, 2003, DEV BIOL, V264, P77, DOI 10.1016/j.ydbio.2003.07.020; Mertani HC, 2001, J BIOL CHEM, V276, P21464, DOI 10.1074/jbc.M100437200; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Mohankumar KM, 2007, ONCOGENE, V26, P3998, DOI 10.1038/sj.onc.1210180; Mohankumar KM, 2008, ENDOCRINOLOGY, V149, P2219, DOI 10.1210/en.2007-1320; Morgan R, 2007, CANCER RES, V67, P5806, DOI 10.1158/0008-5472.CAN-06-4231; Morgan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-89; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101; MURPHY P, 1991, DEVELOPMENT, V111, P61; Narita Y, 2009, CURR TOP DEV BIOL, V88, P139, DOI 10.1016/S0070-2153(09)88005-8; Neuteboom STC, 1997, MOL CELL BIOL, V17, P4696, DOI 10.1128/MCB.17.8.4696; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; PELLERIN I, 1994, MOL CELL BIOL, V14, P4532, DOI 10.1128/MCB.14.7.4532; Pfeifer GP, 2009, SEMIN CANCER BIOL, V19, P181, DOI 10.1016/j.semcancer.2009.02.008; Phelan ML, 1997, J BIOL CHEM, V272, P8635, DOI 10.1074/jbc.272.13.8635; PHELAN ML, 1995, MOL CELL BIOL, V15, P3989; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Plowright L, 2009, BRIT J CANCER, V100, P470, DOI 10.1038/sj.bjc.6604857; Prince F, 2008, DEVELOPMENT, V135, P1669, DOI 10.1242/dev.018028; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Remacle S, 2004, MOL CELL BIOL, V24, P8567, DOI 10.1128/MCB.24.19.8567-8575.2004; Remacle S, 2002, NUCLEIC ACIDS RES, V30, P2663, DOI 10.1093/nar/gkf372; Rice KL, 2007, J CLIN INVEST, V117, P865, DOI 10.1172/JCI31861; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shen WF, 1996, NUCLEIC ACIDS RES, V24, P898, DOI 10.1093/nar/24.5.898; Shen WF, 1997, J BIOL CHEM, V272, P8198, DOI 10.1074/jbc.272.13.8198; Svingen T, 2003, CANCER BIOL THER, V2, P518, DOI 10.4161/cbt.2.5.441; Waters MJ, 2004, P NATL ACAD SCI USA, V101, P14992, DOI 10.1073/pnas.0406396101; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Zelinski DP, 2001, CANCER RES, V61, P2301; Zhang X, 2006, J BIOL CHEM, V281, P6471, DOI 10.1074/jbc.M512666200; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200	72	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25247	10.1371/journal.pone.0025247	http://dx.doi.org/10.1371/journal.pone.0025247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957483	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100043
J	Karasneh, GA; Ali, M; Shukla, D				Karasneh, Ghadah A.; Ali, Mohamed; Shukla, Deepak			An Important Role for Syndecan-1 in Herpes Simplex Virus Type-1 Induced Cell-to-Cell Fusion and Virus Spread	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; EPITHELIAL-CELLS; GLYCOPROTEIN-B; GD RECEPTOR; PILR-ALPHA; IN-VIVO; ENTRY; EXPRESSION; SURFACE; INFECTION	Herpes simplex virus type-1 (HSV-1) is a common human pathogen that relies heavily on cell-to-cell spread for establishing a lifelong latent infection. Molecular aspects of HSV-1 entry into host cells have been well studied; however, the molecular details of the spread of the virus from cell-to-cell remain poorly understood. In the past, the role of heparan sulfate proteoglycans (HSPG) during HSV-1 infection has focused solely on the role of HS chains as an attachment receptor for the virus, while the core protein has been assumed to perform a passive role of only carrying the HS chains. Likewise, very little is known about the involvement of any specific HSPGs in HSV-1 lifecycle. Here we demonstrate that a HSPG, syndecan-1, plays an important role in HSV-1 induced membrane fusion and cell-to-cell spread. Interestingly, the functions of syndecan-1 in fusion and spread are independent of the presence of HS on the core protein. Using a mutant CHO-K1 cell line that lacks all glycosaminoglycans (GAGs) on its surface (CHO-745) we demonstrate that the core protein of syndecan-1 possesses the ability to modulate membrane fusion and viral spread. Altogether, we identify a new role for syndecan-1 in HSV-1 pathogenesis and demonstrate HS-independent functions of its core protein in viral spread.	[Karasneh, Ghadah A.; Ali, Mohamed; Shukla, Deepak] Univ Illinois, Coll Med, Dept Ophthalmol, Chicago, IL 60607 USA; [Karasneh, Ghadah A.; Ali, Mohamed; Shukla, Deepak] Univ Illinois, Coll Med, Dept Visual Sci, Chicago, IL USA; [Karasneh, Ghadah A.; Shukla, Deepak] Univ Illinois, Coll Med, Dept Microbiol, Chicago, IL USA; [Karasneh, Ghadah A.; Shukla, Deepak] Univ Illinois, Coll Med, Dept Immunol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Karasneh, GA (corresponding author), Univ Illinois, Coll Med, Dept Ophthalmol, Chicago, IL 60607 USA.	dshukla@uic.edu		Shukla, Deepak/0000-0002-3039-6953; Ali, Mohamed/0000-0001-8085-7132	National Institues of Health [AI057860, AI081869, EY01792]; NATIONAL EYE INSTITUTE [P30EY001792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057860, K02AI081869] Funding Source: NIH RePORTER	National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institues of Health grants AI057860 (D. Shukla), AI081869 (D. Shukla), and a Core Grant EY01792. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Bacsa S, 2011, J GEN VIROL, V92, P733, DOI 10.1099/vir.0.027052-0; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Carbone A, 1998, BLOOD, V91, P747; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; Cheshenko N, 2007, MOL BIOL CELL, V18, P3119, DOI 10.1091/mbc.E07-01-0062; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Eizuru Yoshito, 2003, Antiviral Chemistry & Chemotherapy, V14, P299; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; Farooq AV, 2011, FUTURE VIROL, V6, P101, DOI 10.2217/FVL.10.74; Filla MS, 2004, EXP EYE RES, V79, P61, DOI 10.1016/j.exer.2004.02.010; Gaidano G, 1997, BLOOD, V90, P4894; Geraghty RJ, 2000, VIROLOGY, V268, P147, DOI 10.1006/viro.1999.0157; Gianni T, 2010, P NATL ACAD SCI USA, V107, P22260, DOI 10.1073/pnas.1014923108; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; HEROLD BC, 1994, J GEN VIROL, V75, P1211, DOI 10.1099/0022-1317-75-6-1211; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Loutsch JM, 1999, J VIROL, V73, P767, DOI 10.1128/JVI.73.1.767-771.1999; McQuade KJ, 2003, J BIOL CHEM, V278, P46607, DOI 10.1074/jbc.M304775200; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31; Muto Taro, 2007, J Med Invest, V54, P331, DOI 10.2152/jmi.54.331; O'Donnell Christopher D, 2008, Virol Sin, V23, P383, DOI 10.1007/s12250-008-2992-1; O'Donnell CD, 2009, J BIOL CHEM, V284, P29654, DOI 10.1074/jbc.M109.037960; Oh JH, 2010, INT J GYNECOL CANCER, V20, P751, DOI 10.1111/IGC.0b013e3181e02faa; Oh MJ, 2010, BIOCHEM BIOPH RES CO, V391, P176, DOI 10.1016/j.bbrc.2009.11.027; Pertel PE, 1997, J VIROL, V71, P8024, DOI 10.1128/JVI.71.10.8024-8028.1997; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Roller RJ, 1997, J VIROL, V71, P5805, DOI 10.1128/JVI.71.8.5805-5813.1997; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Scanlan PM, 2003, VIROLOGY, V312, P14, DOI 10.1016/S0042-6822(03)00176-4; Schleiss Mark R, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P7, DOI 10.1016/j.cppeds.2008.10.003; Schofield KP, 1999, BIOCHEM J, V343, P663, DOI 10.1042/0264-6021:3430663; Shafti-Keramat S, 2003, J VIROL, V77, P13125, DOI 10.1128/JVI.77.24.13125-13135.2003; Shah A, 2010, MOL VIS, V16, P2476; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Shukla SY, 2009, INVEST OPHTH VIS SCI, V50, P2878, DOI 10.1167/iovs.08-2981; Tiwari V, 2004, J GEN VIROL, V85, P805, DOI 10.1099/vir.0.19641-0; Tiwari V, 2011, J BIOL CHEM, V286, P25406, DOI 10.1074/jbc.M110.201103; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Wilhelmus KR, 1998, NEW ENGL J MED, V339, P300, DOI 10.1056/NEJM199807303390503; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Zhe R, 2008, ARCH VIROL, V153, P1401, DOI 10.1007/s00705-008-0110-1; Zheng M, 2001, J VIROL, V75, P9828, DOI 10.1128/JVI.75.20.9828-9835.2001; Zhou Y, 2009, NEUROL RES, V31, P910, DOI 10.1179/174313209X383222; Zong F, 2010, CELL PROLIFERAT, V43, P29, DOI 10.1111/j.1365-2184.2009.00651.x	59	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25252	10.1371/journal.pone.0025252	http://dx.doi.org/10.1371/journal.pone.0025252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957484	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100044
J	Kim, JK; Lee, E; Shin, S; Jeong, KW; Lee, JY; Bae, SY; Kim, SH; Lee, J; Kim, SR; Lee, DG; Hwang, JS; Kim, Y				Kim, Jin-Kyoung; Lee, Eunjung; Shin, Soyoung; Jeong, Ki-Woong; Lee, Jee-Young; Bae, Su-Young; Kim, Soo-Hyun; Lee, Juneyoung; Kim, Seong Ryul; Lee, Dong Gun; Hwang, Jae-Sam; Kim, Yangmee			Structure and Function of Papiliocin with Antimicrobial and Anti-inflammatory Activities Isolated from the Swallowtail Butterfly, Papilio xuthus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-DEFENSE PEPTIDES; GRAM-NEGATIVE BACTERIA; CELL-FREE IMMUNITY; NF-KAPPA-B; NMR-SPECTROSCOPY; ANTIBACTERIAL PEPTIDES; HYALOPHORA-CECROPIA; ESCHERICHIA-COLI; INSECT IMMUNITY; INNATE IMMUNITY	Papiliocin is a novel 37-residue cecropin-like peptide isolated recently from the swallowtail butterfly, Papilio xuthus. With the aim of identifying a potent antimicrobial peptide, we tested papiliocin in a variety of biological and biophysical assays, demonstrating that the peptide possesses very low cytotoxicity against mammalian cells and high bacterial cell selectivity, particularly against Gram-negative bacteria as well as high anti-inflammatory activity. Using LPS-stimulated macrophage RAW264.7 cells, we found that papiliocin exerted its anti-inflammatory activities by inhibiting nitric oxide (NO) production and secretion of tumor necrosis factor (TNF)-alpha and macrophage inflammatory protein (MIP)-2, producing effects comparable with those of the antimicrobial peptide LL-37. We also showed that the innate defense response mechanisms engaged by papiliocin involve Toll-like receptor pathways that culminate in the nuclear translocation of NF-kappa B. Fluorescent dye leakage experiments showed that papiliocin targets the bacterial cell membrane. To understand structure-activity relationships, we determined the three-dimensional structure of papiliocin in 300 mm dodecylphosphocholine micelles by NMR spectroscopy, showing that papiliocin has an alpha-helical structure from Lys(3) to Lys(21) and from Ala(25) to Val(36), linked by a hinge region. Interactions between the papiliocin and 1,PS studied using tryptophan blue-shift data, and saturation transfer difference-NMR experiments revealed that Trp(2) and Phe(5) at the N-terminal helix play an important role in attracting papiliocin to the cell membrane of Gram-negative bacteria. In conclusion, we have demonstrated that papiliocin is a potent peptide antibiotic with both anti-inflammatory and antibacterial activities, and we have laid the groundwork for future studies of its mechanism of action.	[Kim, Jin-Kyoung; Lee, Eunjung; Shin, Soyoung; Jeong, Ki-Woong; Lee, Jee-Young; Kim, Yangmee] Konkuk Univ, BMIC, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Bae, Su-Young; Kim, Soo-Hyun] Konkuk Univ, Coll Med, Inst Biomed Sci & Technol, Lab Cytokine Immunol, Seoul 143701, South Korea; [Lee, Juneyoung; Lee, Dong Gun] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Kim, Seong Ryul; Hwang, Jae-Sam] Natl Acad Agr Sci, Rural Dev Adm, Suwon 441100, South Korea	Konkuk University; Konkuk University; Konkuk University Medical Center; Kyungpook National University; Rural Development Administration (RDA)	Kim, Y (corresponding author), Konkuk Univ, BMIC, Dept Biosci & Biotechnol, Seoul 143701, South Korea.	ymkim@konkuk.ac.kr			Rural Development Administration, Republic of Korea [20080401-034-017]; Basic Science Research Program [2011-0022873]; Priority Research Center through the National Research Foundation of Korea [2009-0093824]; Ministry of Education, Science and Technology	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Basic Science Research Program; Priority Research Center through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by BioGreen21 Program Grant 20080401-034-017 from the Rural Development Administration, Republic of Korea, and by Basic Science Research Program Grant 2011-0022873 and Priority Research Centers Program Grant 2009-0093824 through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bhunia A, 2009, J BIOL CHEM, V284, P21991, DOI 10.1074/jbc.M109.013573; Blondelle SE, 1999, BBA-BIOMEMBRANES, V1462, P89, DOI 10.1016/S0005-2736(99)00202-3; BOMAN HG, 1985, DEV COMP IMMUNOL, V9, P551, DOI 10.1016/0145-305X(85)90018-7; BOMAN HG, 1991, EUR J BIOCHEM, V201, P23, DOI 10.1111/j.1432-1033.1991.tb16252.x; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cole AM, 2000, ANTIMICROB AGENTS CH, V44, P2039, DOI 10.1128/AAC.44.8.2039-2045.2000; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEROME AE, 1990, J MAGN RESON, V88, P177, DOI 10.1016/0022-2364(90)90123-Q; Dimarcq JL, 1998, BIOPOLYMERS, V47, P465, DOI 10.1002/(SICI)1097-0282(1998)47:6<465::AID-BIP5>3.0.CO;2-#; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gennis R.B., 1989, BIOMEMBRANES MOL STR, p[20, 154]; Ghiselli R, 2004, ANN SURG, V239, P251, DOI 10.1097/01.sla.0000108673.25385.03; Ghosh AK, 1997, BIOCHEMISTRY-US, V36, P14291, DOI 10.1021/bi971933j; Goddard T. D. and Kneller D. G ., 2002, SPARKY; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gregory SM, 2008, BIOPHYS J, V94, P1667, DOI 10.1529/biophysj.107.118760; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HOLAK TA, 1988, BIOCHEMISTRY-US, V27, P7620, DOI 10.1021/bi00420a008; HULTMARK D, 1980, EUR J BIOCHEM, V106, P7, DOI 10.1111/j.1432-1033.1980.tb05991.x; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Jeon YJ, 1999, IMMUNOPHARMACOLOGY, V43, P1, DOI 10.1016/S0162-3109(99)00032-6; Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017; Kim SR, 2010, MOL CELLS, V29, P419, DOI 10.1007/s10059-010-0050-y; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Liang YL, 2006, DEV COMP IMMUNOL, V30, P249, DOI 10.1016/j.dci.2005.04.005; Lopez L, 2003, INSECT BIOCHEM MOLEC, V33, P439, DOI 10.1016/S0965-1748(03)00008-0; Marassi FM, 1999, BIOPHYS J, V77, P3152, DOI 10.1016/S0006-3495(99)77145-6; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; MORISHIMA I, 1990, COMP BIOCHEM PHYS B, V95, P551, DOI 10.1016/0305-0491(90)90019-P; Mueller M, 2004, J BIOL CHEM, V279, P26307, DOI 10.1074/jbc.M401231200; Nell MJ, 2006, PEPTIDES, V27, P649, DOI 10.1016/j.peptides.2005.09.016; Nijnik A, 2009, Emerg Health Threats J, V2, pe1, DOI 10.3134/ehtj.09.001; Otvos L, 2000, J PEPT SCI, V6, P497; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; PIERS KL, 1994, ANTIMICROB AGENTS CH, V38, P2311, DOI 10.1128/AAC.38.10.2311; PLISKA V, 1981, J CHROMATOGR, V216, P79, DOI 10.1016/S0021-9673(00)82337-7; Porcelli F, 2006, BIOCHEMISTRY-US, V45, P5793, DOI 10.1021/bi0601813; QU XM, 1982, EUR J BIOCHEM, V127, P219, DOI 10.1111/j.1432-1033.1982.tb06858.x; Ramamoorthy A, 2010, BBA-BIOMEMBRANES, V1798, P223, DOI 10.1016/j.bbamem.2009.08.012; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Saito A, 2005, COMP BIOCHEM PHYS B, V142, P317, DOI 10.1016/j.cbpb.2005.08.001; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Silvestro L, 2000, ANTIMICROB AGENTS CH, V44, P602, DOI 10.1128/AAC.44.3.602-607.2000; Silvestro L, 1997, BIOCHEMISTRY-US, V36, P11452, DOI 10.1021/bi9630826; SIPOS D, 1992, EUR J BIOCHEM, V209, P163, DOI 10.1111/j.1432-1033.1992.tb17273.x; Srisailam S, 2000, BBA-PROTEIN STRUCT M, V1479, P275, DOI 10.1016/S0167-4838(00)00008-X; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Teng WY, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/473276; Wang L, 2007, COMP BIOCHEM PHYS B, V148, P417, DOI 10.1016/j.cbpb.2007.07.010; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wu JM, 2009, PEPTIDES, V30, P839, DOI 10.1016/j.peptides.2009.02.004; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P130; Xiao YJ, 2006, FEBS J, V273, P2581, DOI 10.1111/j.1742-4658.2006.05261.x; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yu K, 2000, J PEPT RES, V55, P51, DOI 10.1034/j.1399-3011.2000.00146.x; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	86	83	89	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41296	41311		10.1074/jbc.M111.269225	http://dx.doi.org/10.1074/jbc.M111.269225			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965682	hybrid, Green Published			2022-12-25	WOS:000298057500017
J	Mohamed, TMA; Oceandy, D; Zi, M; Prehar, S; Alatwi, N; Wang, YW; Shaheen, MA; Abou-Leisa, R; Schelcher, C; Hegab, Z; Baudoin, F; Emerson, M; Mamas, M; Di Benedetto, G; Zaccolo, M; Lei, M; Cartwright, EJ; Neyses, L				Mohamed, Tamer M. A.; Oceandy, Delvac; Zi, Min; Prehar, Sukhpal; Alatwi, Nasser; Wang, Yanwen; Shaheen, Mohamed A.; Abou-Leisa, Riham; Schelcher, Celine; Hegab, Zeinab; Baudoin, Florence; Emerson, Michael; Mamas, Mamas; Di Benedetto, Giulietta; Zaccolo, Manuela; Lei, Ming; Cartwright, Elizabeth J.; Neyses, Ludwig			Plasma Membrane Calcium Pump (PMCA4)-Neuronal Nitric-oxide Synthase Complex Regulates Cardiac Contractility through Modulation of a Compartmentalized Cyclic Nucleotide Microdomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART; CA2+; OVEREXPRESSION; TRANSPORT; ATPASE; HEALTH; SIGNAL; CAMP	Identification of the signaling pathways that regulate cyclic nucleotide microdomains is essential to our understanding of cardiac physiology and pathophysiology. Although there is growing evidence that the plasma membrane Ca2+/calmodulinde-pendent ATPase 4 (PMCA4) is a regulator of neuronal nitricoxide synthase, the physiological consequence of this regulation is unclear. We therefore tested the hypothesis that PMCA4 has a key structural role in tethering neuronal nitric-oxide synthase to a highly compartmentalized domain in the cardiac cell membrane. This structural role has functional consequences on cAMP and cGMP signaling in a PMCA4-governed microdomain, which ultimately regulates cardiac contractility. In vivo contractility and calcium amplitude were increased in PMCA4 knock-out animals (PMCA4(-/-)) with no change in diastolic relaxation or the rate of calcium decay, showing that PMCA4 has a function distinct from beat-to-beat calcium transport. Surprisingly, in PMCA4(-/-), over 36% of membrane-associated neuronal nitric-oxide synthase (nNOS) protein and activity was delocalized to the cytosol with no change in total nNOS protein, resulting in a significant decrease in microdomain cGMP, which in turn led to a significant elevation in local cAMP levels through a decrease in PDE2 activity (measured by FRET-based sensors). This resulted in increased L-type calcium channel activity and ryanodine receptor phosphorylation and hence increased contractility. In the heart, in addition to subsarcolemmal calcium transport, PMCA4 acts as a structural molecule that maintains the spatial and functional integrity of the nNOS signaling complex in a defined microdomain. This has profound consequences for the regulation of local cyclic nucleotide and hence cardiac (beta-adrenergic signaling.	[Mohamed, Tamer M. A.; Oceandy, Delvac; Zi, Min; Prehar, Sukhpal; Alatwi, Nasser; Wang, Yanwen; Shaheen, Mohamed A.; Abou-Leisa, Riham; Schelcher, Celine; Hegab, Zeinab; Baudoin, Florence; Mamas, Mamas; Lei, Ming; Cartwright, Elizabeth J.; Neyses, Ludwig] Univ Manchester, Cardiovasc Med Res Grp, Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England; [Mohamed, Tamer M. A.] Zagazig Univ, Fac Pharm, Dept Biochem, Zagazig 44519, Egypt; [Emerson, Michael] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Platelet Biol Grp, London SW7 2AZ, England; [Di Benedetto, Giulietta] Venetian Inst Mol Med, I-35100 Padua, Italy; [Zaccolo, Manuela] Univ Glasgow, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland	University of Manchester; Egyptian Knowledge Bank (EKB); Zagazig University; Imperial College London; Veneto Institute Molecular Medicine; University of Glasgow	Neyses, L (corresponding author), Univ Manchester, Cardiovasc Med Res Grp, Manchester Acad Hlth Sci Ctr, Room 1,302 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Ludwig.Neyses@cmft.nhs.uk	Oceandy, Delvac/G-9911-2015; Di Benedetto, Giulietta/L-9842-2019; Zaccolo, Manuela/AAP-6706-2020; Wang, Yanwen/I-1654-2015; Mamas, Mamas Andreas/A-2549-2019; Lei, Ming/S-7209-2016; Neyses, Ludwig/AGY-7446-2022	Oceandy, Delvac/0000-0002-6242-6491; Di Benedetto, Giulietta/0000-0002-1489-3896; Zaccolo, Manuela/0000-0002-0934-3662; Wang, Yanwen/0000-0002-7986-4500; Mamas, Mamas Andreas/0000-0001-9241-8890; Lei, Ming/0000-0002-0928-341X; Baudoin, Florence/0000-0002-2300-1490; Prehar, Sukhpal/0000-0002-4334-7931; Cartwright, Elizabeth/0000-0002-6836-7795; Hegab, Zeinab/0000-0001-7381-4425	Medical Research Council (MRC) [G0200020, G0500025, G0802004]; British Heart Foundation (BHF) [PG/05/082]; National Institute for Health Research, Manchester Biomedical Research Centre; Egyptian Postgraduate Research Scholarships; MRC [G0802004, G0500025] Funding Source: UKRI; Medical Research Council [G0200020, G0802004, G0500025] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation (BHF)(British Heart Foundation); National Institute for Health Research, Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Egyptian Postgraduate Research Scholarships; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (MRC) International Appointee Grant (G0200020), MRC Programme/Research Grants (G0500025 and G0802004) (to L N.), and a British Heart Foundation (BHF) Project Grant (PG/05/082) (to D. O. and E. J. C.).; Supported by a BHF Intermediate Basic Science Research Fellowship (FS/09/046).; We acknowledge the bioimaging and electron microscopy facilities in the University of Manchester for help and advice. We thank Dr. Yatong Li, University of Manchester for help during the manuscript preparation. We thank Dr. Martin Lohse for providing the Epac I FRET plasmid, The L. Neyses laboratory is supported by the National Institute for Health Research, Manchester Biomedical Research Centre Funding Scheme.; Recipients of Egyptian Postgraduate Research Scholarships.	Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Beigi F, 2009, NITRIC OXIDE-BIOL CH, V21, P226, DOI 10.1016/j.niox.2009.09.005; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; BERS DM, 1993, CARDIOVASC RES, V27, P1772, DOI 10.1093/cvr/27.10.1772; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bito V, 2008, CARDIOVASC RES, V77, P315, DOI 10.1093/cvr/cvm063; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Buch MH, 2005, J BIOL CHEM, V280, P29479, DOI 10.1074/jbc.M501326200; Burkard N, 2007, CIRC RES, V100, pE32, DOI 10.1161/01.RES.0000259042.04576.6a; CARAFOLI E, 1990, PROG CLIN BIOL RES, V332, P181; Cartwright EJ, 2005, J MOL CELL CARDIOL, V39, P403, DOI 10.1016/j.yjmcc.2005.04.007; Cartwright EJ, 2007, ANN NY ACAD SCI, V1099, P247, DOI 10.1196/annals.1387.007; Chang KC, 2008, P NATL ACAD SCI USA, V105, P4477, DOI 10.1073/pnas.0709118105; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Damy T, 2004, LANCET, V363, P1365, DOI 10.1016/S0140-6736(04)16048-0; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Gros R, 2003, CIRC RES, V93, P614, DOI 10.1161/01.RES.0000092142.19896.D9; Hammes A, 1998, CIRC RES, V83, P877; Hammes A, 1996, J BIOL CHEM, V271, P30816, DOI 10.1074/jbc.271.48.30816; Hare JM, 1999, NAT MED, V5, P273, DOI 10.1038/6486; HAYAKAWA K, 1994, J MOL BIOL, V235, P357, DOI 10.1016/S0022-2836(05)80039-7; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lee D, 2010, BMB REP, V43, P151, DOI 10.5483/BMBRep.2010.43.3.151; Mohamed TMA, 2009, J BIOL CHEM, V284, P12091, DOI 10.1074/jbc.M809112200; Molkentin JD, 2006, J CLIN INVEST, V116, P623, DOI 10.1172/JCI27824; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oceandy D, 2007, CIRCULATION, V115, P483, DOI 10.1161/CIRCULATIONAHA.106.643791; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Saraiva RM, 2006, CURR OPIN CARDIOL, V21, P221, DOI 10.1097/01.hco.0000221584.56372.dc; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Schuh K, 2003, J BIOL CHEM, V278, P41246, DOI 10.1074/jbc.M307606200; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Sears CE, 2004, PHILOS T R SOC B, V359, P1021, DOI 10.1098/rstb.2004.1477; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Stangherlin A, 2011, CIRC RES, V108, P929, DOI 10.1161/CIRCRESAHA.110.230698; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Williams JC, 2006, J BIOL CHEM, V281, P23341, DOI 10.1074/jbc.M513341200; Xu KY, 2003, J BIOL CHEM, V278, P41798, DOI 10.1074/jbc.M306865200; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798	45	63	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41520	41529		10.1074/jbc.M111.290411	http://dx.doi.org/10.1074/jbc.M111.290411			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965681	hybrid, Green Published			2022-12-25	WOS:000298057500038
J	Atianand, MK; Harton, JA				Atianand, Maninjay K.; Harton, Jonathan A.			Uncoupling of Pyrin-only Protein 2 (POP2)-mediated Dual Regulation of NF-kappa B and the Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NOD-LIKE RECEPTORS; DEATH-DOMAIN-FOLD; CASPASE-1 ACTIVATION; NEGATIVE REGULATOR; CUTTING EDGE; INTERLEUKIN-1-BETA; RECRUITMENT; ASC; INHIBITOR	Activation of transcription factor NF-kappa B and inflammasome-directed caspase-1 cleavage of IL-1 beta are key processes in the inflammatory response to pathogen or host-derived signals. Pyrin-only proteins (POPs) are restricted to Old World monkeys, apes, and humans and have previously been shown to impair inflammasome assembly and/or NF-kappa B p65 transcriptional activity in transfected epithelial cells. However, the biological role of POP2 and the molecular basis for its observed functions are not well understood. In this report we demonstrate that POP2 regulates TNF alpha and IL-1 beta responses in human monocytic THP-1 cells and in stable transfectants of mouse J774A.1 macrophages. Deletion analysis of POP2 revealed that the first a-helix (residues 1-19) is necessary and sufficient for both inflammasome and NF-kappa B inhibitory functions. Further, key acidic residues Glue, Asps, and Glum, believed critical for Pyrin/Pyrin domain interaction, are important for inflammasome inhibition. Moreover, these mutations did not reduce the effect of POP2 upon NF-kappa B, indicating that the inflammasome and NF-kappa B inhibitory properties of POP2 can be uncoupled mechanistically. Collectively, these data demonstrate that POP2 acts as a regulator of inflammatory signals and exerts its two known functions through distinct modalities employed by its first a-helix.	[Atianand, Maninjay K.; Harton, Jonathan A.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College	Harton, JA (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, 47 New Scotland Ave,MC 151, Albany, NY 12208 USA.	hartonj@mail.amc.edu	Harton, Jonathan A/AAW-5283-2021; Atianand, Maninjay/AAF-7823-2019; Harton, Jonathan/F-2848-2010	Harton, Jonathan A/0000-0002-0350-1877; Atianand, Maninjay/0000-0003-4135-2515; Harton, Jonathan/0000-0002-0350-1877	National Institutes of Health [R01AI072259]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI072259 (to J. A. H.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Atianand MK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-56; Barton GM, 2002, CURR TOP MICROBIOL, V270, P81; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Bewry NN, 2007, J BIOL CHEM, V282, P26178, DOI 10.1074/jbc.M611747200; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Dinarello CA, 1997, J BIOL REG HOMEOS AG, V11, P91; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Dorfleutner A, 2007, VIRUS GENES, V35, P685, DOI 10.1007/s11262-007-0141-9; Dorfleutner A, 2007, INFECT IMMUN, V75, P1484, DOI 10.1128/IAI.01315-06; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; Fairbrother WJ, 2001, PROTEIN SCI, V10, P1911, DOI 10.1110/ps.13801; Fiorentino L, 2002, J BIOL CHEM, V277, P35333, DOI 10.1074/jbc.M200446200; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Freundt EC, 2008, CELL, V133, P401, DOI 10.1016/j.cell.2008.04.017; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lamkanfi M, 2004, J BIOL CHEM, V279, P51729, DOI 10.1074/jbc.M407891200; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Lee SH, 2001, J BIOL CHEM, V276, P34495, DOI 10.1074/jbc.M101415200; Li NX, 2000, METHOD ENZYMOL, V319, P273; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu T, 2003, PROTEIN SCI, V12, P1872, DOI 10.1110/ps.0359603; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Pinheiro AS, 2010, J BIOL CHEM, V285, P27402, DOI 10.1074/jbc.M110.113191; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Rahman MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000635; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Su JM, 2009, J INNATE IMMUN, V1, P164, DOI 10.1159/000158541; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang J, 2009, MICROBES INFECT, V11, P321, DOI 10.1016/j.micinf.2008.12.011; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wang YT, 2004, INT IMMUNOL, V16, P777, DOI 10.1093/intimm/dxh081; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	79	29	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40536	40547		10.1074/jbc.M111.274290	http://dx.doi.org/10.1074/jbc.M111.274290			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21976665	Green Published, hybrid			2022-12-25	WOS:000297315400013
J	Chaves, OM; Stoner, KE; Angeles-Campos, S; Arroyo-Rodriguez, V				Chaves, Oscar M.; Stoner, Kathryn E.; Angeles-Campos, Sergio; Arroyo-Rodriguez, Victor			Wood Consumption by Geoffroyi's Spider Monkeys and Its Role in Mineral Supplementation	PLOS ONE			English	Article							ALOUATTA-SENICULUS; BARK CONSUMPTION; ATELES-GEOFFROYI; COLOBUS-GUEREZA; DIET; FOREST; WILD; PATTERNS; PRIMATES; PROTEIN	Wood consumption is a rare behavior in frugivorous primates; however, it can be necessary for nutritional balancing as it may provide macro and/or micronutrients that are scarce in the most frequently eaten items (fruits). We tested this hypothesis in six spider monkey (Ateles geoffroyi) communities inhabiting continuous and fragmented rainforests in Lacandona, Mexico. We investigated the importance of both live and decayed wood in the diet of the monkeys, and assessed if wood consumption is related to the nutritional composition of these items. In general, wood consumption was focused on trees of Licania platypus (Chrysobalanaceae) and Ficus spp. (Moraceae), and was similar in continuous forest and in fragments (mean +/- SD; 24 +/- 20% vs 18 +/- 16% of total feeding time, respectively), but marginally higher in females than in males (16 +/- 14% vs 5 +/- 4%, respectively). Live and decayed wood were both poorer in lipids, proteins, total nonstructural carbohydrates, and total digestible nutrients compared to mature and immature fruits. Moreover, decayed wood of L. platypus showed consistently higher levels of sodium and calcium compared to fruits. In conclusion, our findings suggest that wood from decaying trees of L. platypus and Ficus spp. and young branch piths of L. platypus represents an important source of sodium and/or calcium in the diet of spider monkeys, particularly in the case of females. The protection of decaying trees within forests and fragments is therefore necessary for the appropriate management and conservation of this endangered primate species.	[Chaves, Oscar M.] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil; [Chaves, Oscar M.; Stoner, Kathryn E.; Arroyo-Rodriguez, Victor] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Stoner, Kathryn E.] Texas A&M Univ, Dept Biol & Hlth Sci, Kingsville, TX USA; [Angeles-Campos, Sergio] Univ Nacl Autonoma Mexico, Dept Nutr Anim & Bioquim, Fac Med Vet & Zootecn, Delegacion Coyoacan, Mexico	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidad Nacional Autonoma de Mexico; Texas A&M University System; Texas A&M University Kingsville; Universidad Nacional Autonoma de Mexico	Chaves, OM (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil.	ochaba@gmail.com	Stoner, Kathryn E/E-1510-2015; Arroyo-Rodríguez, Víctor/C-9255-2009; Chaves, Óscar M./AAF-1886-2021; Chaves, Óscar/I-6028-2015	Stoner, Kathryn E/0000-0002-9964-1697; Arroyo-Rodríguez, Víctor/0000-0002-0858-0324; Chaves, Óscar M./0000-0001-6246-1265; 	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [CB-2005-51043, CB-2006-56799]; Secretaria de Relaciones Exteriores de Mexico (SRE)	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Relaciones Exteriores de Mexico (SRE)	This research was supported by a grant from the Consejo Nacional de Ciencia y Tecnologia to K. E. Stoner (CONACyT Grant CB-2005-51043 and CB-2006-56799) and by a scholarship to O. M. Chaves provided by the Secretaria de Relaciones Exteriores de Mexico (SRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana AM, 2009, THESIS CBM SWEDISH B; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2003, MINERALS ANIMAL HUMA, DOI DOI 10.1016/B978-0-444-51367-0.50006-4; Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Arroyo-Rodriguez V, 2006, INT J PRIMATOL, V27, P1079, DOI 10.1007/s10764-006-9061-0; Beeson KC, 1976, SOIL FACTOR NUTR ANI; Blake JG, 2010, INT J PRIMATOL, V31, P471, DOI 10.1007/s10764-010-9407-5; Calegaro-Marques C., 1994, ACTA BIOL LEOPOLD, V16, P69; Cant J.G.H., 1990, Human Evolution, V5, P269, DOI 10.1007/BF02437243; Chapman CA, 2003, INT J PRIMATOL, V24, P317, DOI 10.1023/A:1023049200150; CHAPMAN CA, 1990, BEHAV ECOL SOCIOBIOL, V26, P409; Chaves OM, 2012, BIOTROPICA, V44, P105, DOI 10.1111/j.1744-7429.2011.00766.x; Conklin-Brittain NL, 1999, J CHEM ECOL, V25, P2601, DOI 10.1023/A:1020835120701; Cristobal-Azkarate J, 2007, AM J PRIMATOL, V69, P1013, DOI 10.1002/ajp.20420; Deblauwe I, 2008, AM J PHYS ANTHROPOL, V135, P42, DOI 10.1002/ajpa.20703; Dew JL, 2005, INT J PRIMATOL, V26, P1107, DOI 10.1007/s10764-005-6461-5; Di Fiore A, 2008, CAM S BIO EVOL ANTHR, V55, P81; Dimov M, 2010, J PHYS ACT HEALTH, V7, P239, DOI 10.1123/jpah.7.2.239; Fashing PJ, 2007, INT J PRIMATOL, V28, P673, DOI 10.1007/s10764-006-9096-2; Felton AM, 2008, INT J PRIMATOL, V29, P379, DOI 10.1007/s10764-008-9241-1; Felton AM, 2009, INT J PRIMATOL, V30, P675, DOI 10.1007/s10764-009-9367-9; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; Ghiglieri M.P., 1984, CHIMPANZEES KIBALE F; HANSSON L, 1991, J CHEM ECOL, V17, P735, DOI 10.1007/BF00994196; Helrich K., 1990, ASS OFFICIAL ANAL CH; Holdridge L.R., 1971, FOREST ENV TROPICAL; Huffman Michael A., 1994, P129; IZAWA K, 1993, INT J PRIMATOL, V14, P229, DOI 10.1007/BF02192633; JULLIOT C, 1993, INT J PRIMATOL, V14, P527, DOI 10.1007/BF02215446; Kalkwarf HJ, 1999, J CLIN ENDOCR METAB, V84, P464, DOI 10.1210/jc.84.2.464; Klein L. L, 1977, P153; Krebs J. C., 1999, ECOLOGICAL METHODOLO; Krishnamani R, 2000, ANIM BEHAV, V59, P899, DOI 10.1006/anbe.1999.1376; Lambert JE, 1998, EVOL ANTHROPOL, V7, P8, DOI 10.1002/(SICI)1520-6505(1998)7:1<8::AID-EVAN3>3.3.CO;2-J; Lambert JE, 2000, AFR J ECOL, V38, P360, DOI 10.1046/j.1365-2028.2000.00219.x; Lehman A., 2005, JMP BASIC UNIVARIATE; MILTON K, 1981, AM NAT, V117, P496, DOI 10.1086/283730; Milton K, 2003, COMP BIOCHEM PHYS A, V136, P47, DOI 10.1016/S1095-6433(03)00084-9; National Research Council US, 2003, NUTR REQ NONH PRIM; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; NRC (National Research Council), 1989, REC DIET ALL, V10th; OATES JF, 1978, BIOTROPICA, V10, P241, DOI 10.2307/2387676; Pinto LP, 2004, INT J PRIMATOL, V25, P1197, DOI 10.1023/B:IJOP.0000043958.75534.7f; Reynolds V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006194; Riley EP, 2007, INT J PRIMATOL, V28, P107, DOI 10.1007/s10764-006-9104-6; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rode KD, 2003, INT J PRIMATOL, V24, P541, DOI 10.1023/A:1023788330155; Rothman JM, 2007, J TROP ECOL, V23, P673, DOI 10.1017/S0266467407004555; Rothman JM, 2008, AM J PRIMATOL, V70, P690, DOI 10.1002/ajp.20540; Rothman JM, 2006, BIOL LETTERS, V2, P321, DOI 10.1098/rsbl.2006.0480; Sandstrom B, 2001, BRIT J NUTR, V85, pS181, DOI 10.1079/BJN2000312; Simmen B, 1996, INT J PRIMATOL, V17, P661, DOI 10.1007/BF02735260; Slater KY, 2009, AM J PRIMATOL, V71, P21, DOI 10.1002/ajp.20618; Stephens SA, 2006, BIOTROPICA, V38, P617, DOI 10.1111/j.1744-7429.2006.00197.x; Suarez SA, 2006, INT J PRIMATOL, V27, P411, DOI 10.1007/s10764-006-9023-6; Underwood EJ, 1999, MINERAL NUTR LIVE ST; Van Wambeke A., 1992, SOILS TROPICS PROPER; Yanai J, 2009, SOIL SCI PLANT NUTR, V55, P215, DOI 10.1111/j.1747-0765.2008.00346.x; Zimmerman JK, 2007, J TROP ECOL, V23, P231, DOI 10.1017/S0266467406003890	59	9	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25070	10.1371/journal.pone.0025070	http://dx.doi.org/10.1371/journal.pone.0025070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969868	gold, Green Submitted, Green Published			2022-12-25	WOS:000295936900021
J	Jurvansuu, JM; Goldman, A				Jurvansuu, Jaana M.; Goldman, Adrian			Obesity Risk Gene TMEM18 Encodes a Sequence-Specific DNA-Binding Protein	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CELL LINES; LOCI; VARIANTS; MC4R; MASS; BMI	Transmembrane protein 18 (TMEM18) has previously been connected to cell migration and obesity. However, the molecular function of the protein has not yet been described. Here we show that TMEM18 localises to the nuclear membrane and binds to DNA in a sequence-specific manner. The protein binds DNA with its positively charged C-terminus that contains also a nuclear localisation signal. Increase in the amount of TMEM18 in cells suppresses expression from a reporter vector with the TMEM18 target sequence. TMEM18 is a small protein of 140 residues and is predicted to be mostly alpha-helical with three transmembrane parts. As a consequence the DNA binding by TMEM18 would bring the chromatin very near to nuclear membrane. We speculate that this closed perinuclear localisation of TMEM18-bound DNA might repress transcription from it.	[Jurvansuu, Jaana M.; Goldman, Adrian] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki	Jurvansuu, JM (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	jaana.jurvansuu@helsinki.fi	Jurvansuu, Jaana/H-1599-2012; Jurvansuu, Jaana/AAZ-8835-2020	Jurvansuu, Jaana/0000-0002-7801-3237; Goldman, Adrian/0000-0001-8032-9700	Academy of Finland [1128207, 1114752]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by Academy of Finland (1128207 to J.M.J., 1114752 to A.G., www.aka.fi); and the Sigrid Juselius Foundation (www.sigridjuselius.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004470; Almen MS, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-58; den Hoed M, 2010, DIABETES, V59, P2980, DOI 10.2337/db10-0370; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Haupt A, 2010, OBESITY, V18, P1212, DOI 10.1038/oby.2009.413; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Holzapfel C, 2010, INT J OBESITY, V34, P1538, DOI 10.1038/ijo.2010.79; Hotta K, 2009, J HUM GENET, V54, P727, DOI 10.1038/jhg.2009.106; Jurvansuu J, 2008, CANCER RES, V68, P4614, DOI 10.1158/0008-5472.CAN-07-5291; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Laukkanen ML, 1996, BIOCHEM BIOPH RES CO, V226, P755, DOI 10.1006/bbrc.1996.1425; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; Moriuchi M, 1999, J IMMUNOL, V162, P5986; Orkunoglu-Suer FE, 2011, OBESITY, V19, P662, DOI 10.1038/oby.2010.180; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Ratajewski M, 2009, GENOMICS, V94, P407, DOI 10.1016/j.ygeno.2009.08.014; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yamashita R, 2008, NUCLEIC ACIDS RES, V36, P3707, DOI 10.1093/nar/gkn248; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	30	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25317	10.1371/journal.pone.0025317	http://dx.doi.org/10.1371/journal.pone.0025317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980424	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900052
J	Tang, XR; Yang, Y; Amar, S				Tang, Xiaoren; Yang, Yu; Amar, Salomon			Novel Regulation of CCL2 Gene Expression by Murine LITAF and STAT6B	PLOS ONE			English	Article							TARGETING INFLAMMATORY PATHWAYS; TNF-ALPHA FACTOR; TRANSCRIPTION FACTOR; PREVENTION; LIPOPOLYSACCHARIDE; CYTOKINE; BINDING; SIGNAL	Inflammation is a multifaceted process: beneficial as a defense mechanism but also detrimental depending on its severity and duration. At the site of injury, inflammatory cells are activated by a cascade of mediators, one of which is LITAF, a transcription regulator known to upregulate TNF-alpha. We previously showed that human LITAF forms a complex with human STAT6B, which translocates into the nucleus to upregulate cytokine transcription. To dissect the molecular implications of this complex, a murine model was developed and interactions between mouse STAT6B (mSTAT6B) and mouse LITAF (mLITAF) were analyzed. Both mLITAF and mSTAT6B expression were MyD88- and TLR ligand-dependent. Furthermore, mLITAF was found to mediate LPS-induced CCL2 gene transcription with the cooperation of mSTAT6B leading to CCL2 protein expression. In LITAF-deficient mice, mLITAF-mediated CCL2 production in macrophages was significantly reduced compared to the wild-type control animals. Mice knockdown for mSTAT6B by 6BsiRNA1 tail vein injection resulted in a decrease in serum TNF-alpha and CCL2 production. mLITAF/mSTAT6B complex is proposed to play a role in LPS-induced CCL2 expression and possibly other cytokines.	[Tang, Xiaoren; Yang, Yu; Amar, Salomon] Boston Univ, Sch Dent Med, Ctr Antiinflammatory Therapeut, Boston, MA 02215 USA	Boston University	Tang, XR (corresponding author), Boston Univ, Sch Dent Med, Ctr Antiinflammatory Therapeut, Boston, MA 02215 USA.	samar@bu.edu		Tang, Xiaoren/0000-0002-2402-3659; Amar, Salomon/0000-0002-0017-5930	National Institutes of Health-National Institute of Dental and Craniofacial [RO1 14079]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014079] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Dental and Craniofacial; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by National Institutes of Health-National Institute of Dental and Craniofacial Research grant #RO1 14079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Chen YF, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10420; Chung CP, 2007, CLIN RHEUMATOL, V26, P1228, DOI 10.1007/s10067-007-0548-7; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Englmeier L, 1999, CURR BIOL, V9, P30, DOI 10.1016/S0960-9822(99)80044-X; Fassett RG, 2009, FUTUR CARDIOL, V5, P333, DOI [10.2217/fca.09.19, 10.2217/FCA.09.19]; Irvine KM, 2009, J LEUKOCYTE BIOL, V85, P278, DOI 10.1189/jlb.0808497; Klein R, 2010, ARCH DERMATOL, V146, P780, DOI 10.1001/archdermatol.2010.142; La Cava A, 2010, IMMUNOTHERAPY-UK, V2, P575, DOI 10.2217/IMT.10.29; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Oberbach A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010882; Oyegunwa AO, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-59; Pamukcu B, 2010, ANN MED, V42, P394, DOI 10.3109/07853890.2010.497767; Patel BKR, 1998, GENOMICS, V52, P192, DOI 10.1006/geno.1998.5436; Peters M, 2010, J ALLERGY CLIN IMMUN, V126, P648, DOI 10.1016/j.jaci.2010.05.011; Prasad S, 2010, PLANTA MED, V76, P1044, DOI 10.1055/s-0030-1250111; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Tang XR, 2005, P NATL ACAD SCI USA, V102, P5132, DOI 10.1073/pnas.0501159102; Tang XR, 2003, P NATL ACAD SCI USA, V100, P4096, DOI 10.1073/pnas.0630562100; Weyrich AS, 2009, AM J THER, V16, P164, DOI 10.1097/MJT.0b013e31814b17bf; Yang SJ, 2009, DIABETOLOGIA, V52, P972, DOI 10.1007/s00125-009-1309-8; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	23	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25083	10.1371/journal.pone.0025083	http://dx.doi.org/10.1371/journal.pone.0025083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980379	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900022
J	Tokumoto, T; Yamaguchi, T; Ii, S; Tokumoto, M				Tokumoto, Toshinobu; Yamaguchi, Toshiya; Ii, Sanae; Tokumoto, Mika			In Vivo Induction of Oocyte Maturation and Ovulation in Zebrafish	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; MEMBRANE PROGESTIN RECEPTOR; GERMINAL VESICLE BREAKDOWN; MEIOTIC MATURATION; FISH OOCYTES; IDENTIFICATION; INTERMEDIARY; CLONING; TROUT; VITRO	The maturation of fish oocytes is a well-characterized system induced by progestins via non-genomic actions. In a previous study, we demonstrated that diethylstilbestrol (DES), a non-steroidal estrogen, induces fish oocyte maturation via the membrane progestin receptor (mPR). Here, we attempted to evaluate the effect of DES as an environmental endocrine disrupting chemical (EDC) upon fish oocyte maturation using live zebrafish. DES triggered oocyte maturation within several hours in vivo when administrated directly into the surrounding water. The natural teleost maturation-inducing hormone, 17alpha, 20beta-dihydroxy-4-pregnen-3-one (17,20beta-DHP) also induced oocyte maturation in vivo. Steroids such as testosterone, progesterone or 17alpha-hydroxyprogesterone were also effective in vivo. Further studies indicated that externally applied 17,20beta-DHP even induced ovulation. In contrast to 17,20beta -DHP, DES induced maturation but not ovulation. Theoretically this assay system provides a means to distinguish pathways involved in the induction of ovulation, which are known to be induced by genomic actions from the pathway normally involved in the induction of oocyte maturation, a typical non-genomic action-dependent pathway. In summary, we have demonstrated the effect of EDCs on fish oocyte maturation in vivo. To address the effects, we have explored a conceptually new approach to distinguish between the genomic and non-genomic actions induced by steroids. The assay can be applied to screens of progestin-like effects upon oocyte maturation and ovulation for small molecules of pharmacological agents or EDCs.	[Tokumoto, Toshinobu; Yamaguchi, Toshiya; Ii, Sanae; Tokumoto, Mika] Shizuoka Univ, Dept Biol, Fac Sci, Natl Univ Corp, Shizuoka, Japan	Shizuoka University	Tokumoto, T (corresponding author), Shizuoka Univ, Dept Biol, Fac Sci, Natl Univ Corp, Shizuoka, Japan.	sbttoku@ipc.shizuoka.ac.jp	Tokumoto, Toshinobu/R-7653-2019	Tokumoto, Toshinobu/0000-0001-9086-3608	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Environmental Agency; Naito Foundation; Suntory Institute for Bioorganic Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Environmental Agency; Naito Foundation(Naito Memorial Foundation); Suntory Institute for Bioorganic Research(Suntory Foundation for Life Sciences)	This work was supported by the Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Japanese Environmental Agency (ExTEND2005 FS to T. T.), a grant from The Naito Foundation (to T. T.) and a SUNBOR grant from Suntory Institute for Bioorganic Research (to T. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobe J, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-39; Bonnet E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-55; Das S, 1999, ENDOCRINOLOGY, V140, P1953, DOI 10.1210/en.140.4.1953; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; EATON RC, 1974, COPEIA, P195; Fort DJ, 2002, DRUG CHEM TOXICOL, V25, P293, DOI 10.1081/DCT-120005892; GOETZ FW, 1979, GEN COMP ENDOCR, V37, P273, DOI 10.1016/0016-6480(79)90001-7; Hanna RN, 2011, MOL CELL ENDOCRINOL, V337, P80, DOI 10.1016/j.mce.2011.02.004; HISAOKA KK, 1962, COPEIA, P788; NAGAHAMA Y, 1995, CURR TOP DEV BIOL, V30, P103, DOI 10.1016/S0070-2153(08)60565-7; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Ogiwara K, 2005, P NATL ACAD SCI USA, V102, P8442, DOI 10.1073/pnas.0502423102; Pickford DB, 1999, ENVIRON HEALTH PERSP, V107, P285, DOI 10.2307/3434595; Pinter J, 1999, GEN COMP ENDOCR, V115, P200, DOI 10.1006/gcen.1999.7312; Tokumoto M, 2006, GEN COMP ENDOCR, V145, P101, DOI 10.1016/j.ygcen.2005.07.002; Tokumoto T, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-69; Tokumoto T, 2004, P NATL ACAD SCI USA, V101, P3686, DOI 10.1073/pnas.0400072101; Tokumoto T, 2008, MAR ENVIRON RES, V66, P372, DOI 10.1016/j.marenvres.2008.05.011; Tokumoto T, 2007, ENDOCRINOLOGY, V148, P3459, DOI 10.1210/en.2006-1694; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	21	40	41	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25206	10.1371/journal.pone.0025206	http://dx.doi.org/10.1371/journal.pone.0025206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980399	Green Published, gold			2022-12-25	WOS:000295936900034
J	Girard, MB; Kasumovic, MM; Elias, DO				Girard, Madeline B.; Kasumovic, Michael M.; Elias, Damian O.			Multi-Modal Courtship in the Peacock Spider, Maratus volans (OP-Cambridge, 1874)	PLOS ONE			English	Article							MALE JUMPING SPIDERS; SEXUAL SELECTION; SOUND PRODUCTION; SEISMIC SIGNALS; MATE-CHOICE; SONG ELABORATION; WOLF SPIDERS; ARANEAE; COMMUNICATION; SALTICIDAE	The peacock spider, Maratus volans, has one of the most elaborate courtship displays in arthropods. Using regular and highspeed video segments captured in the lab, we provide detailed descriptions of complete male courtship dances. As research on jumping spiders has demonstrated that males of some species produce vibrations concurrently with visual displays, we also used laser vibrometry to uncover such elements for this species. Our recordings reveal and describe for the first time, that M. volans males use vibratory signals in addition to complex body ornaments and motion displays. The peacock spider and other closely related species are outstanding study organisms for testing hypotheses about the evolution and functional significance of complex displays, thus, this descriptive study establishes a new model system for behavioral ecology, one that certainly stands to make important contributions to the field.	[Girard, Madeline B.; Elias, Damian O.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Kasumovic, Michael M.] Univ New S Wales, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	University of California System; University of California Berkeley; University of New South Wales Sydney	Girard, MB (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	maddiegirard34@berkeley.edu	Elias, Damian O/C-4954-2013	Kasumovic, Michael/0000-0003-0158-5517	National Science Foundation [IOS-1021385]; Direct For Biological Sciences [1021385] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a National Science Foundation Grant to DOE (IOS-1021385) and an NSF Graduate Research Fellowship Program to MBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Badyaev AV, 2002, EVOLUTION, V56, P412; Bro-Jorgensen J, 2010, TRENDS ECOL EVOL, V25, P292, DOI 10.1016/j.tree.2009.11.003; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Clark DL, 2001, P ROY SOC B-BIOL SCI, V268, P2461, DOI 10.1098/rspb.2001.1819; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Dunn R. A., 1947, Memoirs of the National Museum of Victoria, VNo. 16, P82; EDWARDS G B, 1981, Psyche (Cambridge), V88, P199, DOI 10.1155/1981/56173; Elias D.O., 2011, USE VIBRATIONS COMMU; Elias DO, 2006, J ARACHNOL, V34, P545, DOI 10.1636/S05-77.1; Elias DO, 2006, BEHAV ECOL, V17, P765, DOI 10.1093/beheco/arl005; Elias DO, 2006, J COMP PHYSIOL A, V192, P785, DOI 10.1007/s00359-006-0116-7; Elias DO, 2005, ANIM BEHAV, V69, P931, DOI 10.1016/j.anbehav.2004.06.024; Elias DO, 2003, J EXP BIOL, V206, P4029, DOI 10.1242/jeb.00634; Elias DO, 2004, J EXP BIOL, V207, P4105, DOI 10.1242/jeb.01261; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Foelix R. F., 2011, BIOL SPIDERS; Gibson JS, 2008, ANIM BEHAV, V75, P1253, DOI 10.1016/j.anbehav.2007.09.026; GWYNNE DT, 1985, J ZOOL, V207, P35; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hill David E., 2011, Peckhamia, V89.1, P1; Hill David E., 2009, Peckhamia, V75.1, P1; Hill David Edwin, 2009, Peckhamia, V74.1, P1; Huber BA, 2005, BIOL REV, V80, P363, DOI 10.1017/S1464793104006700; IWASA Y, 1994, EVOLUTION, V48, P853, DOI 10.1111/j.1558-5646.1994.tb01367.x; Jackson RR, 1982, SPIDER COMMUNICATION; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Li JJ, 2008, CURR BIOL, V18, P699, DOI 10.1016/j.cub.2008.04.020; Lim MLM, 2008, BEHAV ECOL, V19, P61, DOI 10.1093/beheco/arm100; Maddison W, 2003, SYST ENTOMOL, V28, P1, DOI 10.1046/j.1365-3113.2003.00195.x; Maddison W, 2000, SYST BIOL, V49, P400, DOI 10.1080/10635159950127312; MADDISON WP, 1988, J ARACHNOL, V16, P267; Maddison WP, 2003, INVERTEBR SYST, V17, P529, DOI 10.1071/IS02044; MADDISON WP, 1988, J ARACHNOL, V16, P199; Masta SE, 2002, P NATL ACAD SCI USA, V99, P4442, DOI 10.1073/pnas.072493099; Masta SE, 2000, EVOLUTION, V54, P1699; Noordam Aart P., 2002, Entomologische Berichten (Amsterdam), V62, P17; Otto Juergen C., 2010, Peckhamia, V79.1, P1; PARRY DA, 1957, Q J MICROSC SCI, V98, P331; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Pomiankowski A, 1998, P NATL ACAD SCI USA, V95, P5106, DOI 10.1073/pnas.95.9.5106; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Scheffer SJ, 1996, BEHAV ECOL SOCIOBIOL, V38, P17, DOI 10.1007/s002650050212; SHUTLER D, 1990, EVOLUTION, V44, P1967, DOI 10.1111/j.1558-5646.1990.tb04303.x; Sivalinghem S, 2010, BEHAV ECOL, V21, P1308, DOI 10.1093/beheco/arq150; Snell-Rood EC, 2008, OECOLOGIA, V157, P545, DOI 10.1007/s00442-008-1092-0; Taylor LA, 2007, CURR BIOL, V17, pR592, DOI 10.1016/j.cub.2007.05.064; Uhl G, 2011, SPIDER BEHAV FLEXIBI; ZABKA M, 1987, Annales Zoologici (Warsaw), V40, P451	51	85	88	5	186	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25390	10.1371/journal.pone.0025390	http://dx.doi.org/10.1371/journal.pone.0025390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980440	Green Published, gold, Green Submitted			2022-12-25	WOS:000295933700030
J	Lahiry, P; Lee, LJ; Frey, BJ; Rupar, CA; Siu, VM; Blencowe, BJ; Hegele, RA				Lahiry, Piya; Lee, Leo J.; Frey, Brendan J.; Rupar, C. Anthony; Siu, Victoria M.; Blencowe, Benjamin J.; Hegele, Robert A.			Transcriptional Profiling of Endocrine Cerebro-Osteodysplasia Using Microarray and Next-Generation Sequencing	PLOS ONE			English	Article							RNA-SEQ; HUMAN-DISEASE; KINASE; IDENTIFICATION; GENES; MRK	Background: Transcriptome profiling of patterns of RNA expression is a powerful approach to identify networks of genes that play a role in disease. To date, most mRNA profiling of tissues has been accomplished using microarrays, but next-generation sequencing can offer a richer and more comprehensive picture. Methodology/Principal Findings: ECO is a rare multi-system developmental disorder caused by a homozygous mutation in ICK encoding intestinal cell kinase. We performed gene expression profiling using both cDNA microarrays and next-generation mRNA sequencing (mRNA-seq) of skin fibroblasts from ECO-affected subjects. We then validated a subset of differentially expressed transcripts identified by each method using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Finally, we used gene ontology (GO) to identify critical pathways and processes that were abnormal according to each technical platform. Methodologically, mRNA-seq identifies a much larger number of differentially expressed genes with much better correlation to qRT-PCR results than the microarray (r(2) = 0.794 and 0.137, respectively). Biologically, cDNA microarray identified functional pathways focused on anatomical structure and development, while the mRNA-seq platform identified a higher proportion of genes involved in cell division and DNA replication pathways. Conclusions/Significance: Transcriptome profiling with mRNA-seq had greater sensitivity, range and accuracy than the microarray. The two platforms generated different but complementary hypotheses for further evaluation.	[Lahiry, Piya; Hegele, Robert A.] Robarts Res Inst, London, ON N6A 5C1, Canada; [Lahiry, Piya; Hegele, Robert A.] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON, Canada; [Rupar, C. Anthony; Hegele, Robert A.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Rupar, C. Anthony; Siu, Victoria M.] Univ Western Ontario, Dept Pediat, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada; [Lee, Leo J.; Frey, Brendan J.; Blencowe, Benjamin J.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Lee, Leo J.; Frey, Brendan J.; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Lee, Leo J.; Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Rupar, C. Anthony; Siu, Victoria M.] Lawson Hlth Res Inst, Childrens Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; University of Toronto; University of Toronto; Western University (University of Western Ontario)	Lahiry, P (corresponding author), Robarts Res Inst, London, ON N6A 5C1, Canada.	hegele@robarts.ca	Hegele, Robert/G-3301-2011; Hegele, Robert/AAF-6482-2020	Hegele, Robert/0000-0003-2861-5325	Canadian Institutes of Health Research [CTP-79853]; Heart and Stroke Foundation of Ontario; Genome Canada through the Ontario Genomics Institute; Jacob J. Wolfe Distinguished Medical Research Chair; Edith Schulich Vinet Canada Research Chair in Human Genetics (Tier I); Martha G. Blackburn Chair in Cardiovascular Research; Scriver Family MD/PhD Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Genome Canada through the Ontario Genomics Institute(Genome Canada); Jacob J. Wolfe Distinguished Medical Research Chair; Edith Schulich Vinet Canada Research Chair in Human Genetics (Tier I); Martha G. Blackburn Chair in Cardiovascular Research; Scriver Family MD/PhD Scholarship	This work was supported by a team grant from the Canadian Institutes of Health Research (CTP-79853), the Heart and Stroke Foundation of Ontario and Genome Canada through the Ontario Genomics Institute. Dr. Hegele is supported by the Jacob J. Wolfe Distinguished Medical Research Chair, the Edith Schulich Vinet Canada Research Chair in Human Genetics (Tier I), the Martha G. Blackburn Chair in Cardiovascular Research, and operating grants from the Canadian Institutes for Health Research, the Heart and Stroke Foundation of Ontario, and Genome Canada through the Ontario Genomics Institute. Dr. Lahiry is supported by the Scriver Family MD/PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1995, ONCOGENE, V11, P2187; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Greene JG, 2010, NEUROBIOL DIS; Illumina Inc, 2008, MRNA EXPR AN ILL; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turaga K, 2010, CANCER CONTROL, V17, P177, DOI 10.1177/107327481001700306; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Yang T, 2002, BIOMOL ENG, V19, P1, DOI 10.1016/S1389-0344(02)00002-3	22	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25400	10.1371/journal.pone.0025400	http://dx.doi.org/10.1371/journal.pone.0025400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980446	Green Published, Green Submitted, gold			2022-12-25	WOS:000295933700032
J	Kawaguchi, K; Yurimoto, H; Oku, M; Sakai, Y				Kawaguchi, Kosuke; Yurimoto, Hiroya; Oku, Masahide; Sakai, Yasuyoshi			Yeast Methylotrophy and Autophagy in a Methanol-Oscillating Environment on Growing Arabidopsis thaliana Leaves	PLOS ONE			English	Article							CANDIDA-BOIDINII; PHYSIOLOGICAL-ROLE; METHYLOBACTERIUM-EXTORQUENS; SP NOV.; METABOLISM; SYSTEM; GENE; DEHYDROGENASE; FORMALDEHYDE; PEROXISOMES	The yeast Candida boidinii capable of growth on methanol proliferates and survives on the leaves of Arabidopsis thaliana. The local methanol concentration at the phyllosphere of growing A. thaliana exhibited daily periodicity, and yeast cells responded by altering both the expression of methanol-inducible genes and peroxisome proliferation. Even under these dynamically changing environmental conditions, yeast cells proliferated 3 to 4 times in 11 days. Among the C1-metabolic enzymes, enzymes in the methanol assimilation pathway, but not formaldehyde dissimilation or anti-oxidizing enzymes, were necessary for yeast proliferation at the phyllosphere. Furthermore, both peroxisome assembly and pexophagy, a selective autophagy pathway that degrades peroxisomes, were necessary for phyllospheric proliferation. Thus, the present study sheds light on the life cycle and physiology of yeast in the natural environment at both the molecular and cellular levels.	[Kawaguchi, Kosuke; Yurimoto, Hiroya; Oku, Masahide; Sakai, Yasuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan; [Sakai, Yasuyoshi] Kyoto Univ, Res Unit Physiol Chem, Ctr Promot Interdisciplinary Educ & Res, Kyoto, Japan; [Sakai, Yasuyoshi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Kawaguchi, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan.	ysakai@kais.kyoto-u.ac.jp	Yurimoto, Hiroya/N-6538-2018; Oku, Masahide/AAW-4752-2021; Oku, Masahide/R-9389-2019	Yurimoto, Hiroya/0000-0001-7506-6184; Oku, Masahide/0000-0001-5991-6281; Oku, Masahide/0000-0001-5991-6281; Kawaguchi, Kosuke/0000-0002-5115-7169	Ministry of Education, Culture, Sports, Science and Technology of Japan [22380052, 18076002, 22310046]; Science and Technology Agency of Japan; Grants-in-Aid for Scientific Research [22380052] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Agency of Japan(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) 22380052, Grants-in-Aid for Scientific Research on Priority Areas 18076002, and Grants-in-Aid for Scientific Research (B) 22310046 from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a CREST grant from the Science and Technology Agency of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; Asakura M, 2009, PLANT CELL, V21, P1291, DOI 10.1105/tpc.108.060996; Barnett J. A., 1983, YEASTS CHARACTERISTI; Fall R, 1996, TRENDS PLANT SCI, V1, P296, DOI 10.1016/S1360-1385(96)88175-0; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; HOAGLAND DR, 1950, AGR EXP STN CIRC, V347, P1036; Horiguchi H, 2001, J BIOL CHEM, V276, P14279, DOI 10.1074/jbc.M011661200; Horiguchi H, 2001, J BACTERIOL, V183, P6372, DOI 10.1128/JB.183.21.6372-6383.2001; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ivanova E G, 2001, Mikrobiologiia, V70, P452; Ivanova EG, 2000, MICROBIOLOGY+, V69, P646, DOI 10.1023/A:1026693805653; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Lee B, 2002, MICROBIOL-SGM, V148, P2697, DOI 10.1099/00221287-148-9-2697; Limtong S, 2008, INT J SYST EVOL MICR, V58, P302, DOI 10.1099/ijs.0.65380-0; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Mukaiyama H, 2004, MOL BIOL CELL, V15, P58, DOI 10.1091/mbc.e03-05-0340; Nakagawa T, 2000, APPL ENVIRON MICROB, V66, P4253, DOI 10.1128/AEM.66.10.4253-4257.2000; Nakagawa T, 1999, YEAST, V15, P1223, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1223::AID-YEA450>3.3.CO;2-O; NEMECEKMARSHALL M, 1995, PLANT PHYSIOL, V108, P1359, DOI 10.1104/pp.108.4.1359; OGATA K, 1969, AGR BIOL CHEM TOKYO, V33, P1519, DOI 10.1080/00021369.1969.10859497; Omer ZS, 2004, PLANT GROWTH REGUL, V43, P93, DOI 10.1023/B:GROW.0000038360.09079.ad; Peter G, 2009, FEMS YEAST RES, V9, P936, DOI 10.1111/j.1567-1364.2009.00547.x; Sakai Y, 1998, J BACTERIOL, V180, P5885, DOI 10.1128/JB.180.22.5885-5890.1998; Sakai Y, 1997, J BACTERIOL, V179, P4480, DOI 10.1128/jb.179.14.4480-4485.1997; SAKAI Y, 1991, J BACTERIOL, V173, P7458, DOI 10.1128/jb.173.23.7458-7463.1991; Sakai Y, 1998, YEAST, V14, P1175, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1175::AID-YEA319>3.3.CO;2-Z; Sakai Y, 1996, J CELL BIOL, V134, P37, DOI 10.1083/jcb.134.1.37; SAKAI Y, 1988, APPL ENVIRON MICROB, V54, P485, DOI 10.1128/AEM.54.2.485-489.1988; Sakai Y, 2006, BBA-MOL CELL RES, V1763, P1767, DOI 10.1016/j.bbamcr.2006.08.023; Sy A, 2005, APPL ENVIRON MICROB, V71, P7245, DOI 10.1128/AEM.71.11.7245-7252.2005; Thauer RK, 2010, ANGEW CHEM INT EDIT, V49, P6712, DOI 10.1002/anie.201002967; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1453, DOI 10.1016/j.bbamcr.2006.07.016; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yurimoto H, 2000, BBA-GENE STRUCT EXPR, V1493, P56, DOI 10.1016/S0167-4781(00)00157-3; Yurimoto H, 2003, MICROBIOL-SGM, V149, P1971, DOI 10.1099/mic.0.26320-0	40	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25257	10.1371/journal.pone.0025257	http://dx.doi.org/10.1371/journal.pone.0025257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966472	gold, Green Published, Green Submitted			2022-12-25	WOS:000295932100031
J	Satler, JD; Starrett, J; Hayashi, CY; Hedin, M				Satler, Jordan D.; Starrett, James; Hayashi, Cheryl Y.; Hedin, Marshal			Inferring Species Trees from Gene Trees in a Radiation of California Trapdoor Spiders (Araneae, Antrodiaetidae, Aliatypus)	PLOS ONE			English	Article							SALAMANDERS PLETHODONTIDAE; COMPARATIVE PHYLOGEOGRAPHY; LINEAGE DIVERSIFICATION; ENSATINA-ESCHSCHOLTZII; POPULATION SUBDIVISION; MULTIPLE ALIGNMENTS; NICHE CONSERVATISM; BAYESIAN-INFERENCE; NATURAL-HISTORY; SIERRA-NEVADA	Background: The California Floristic Province is a biodiversity hotspot, reflecting a complex geologic history, strong selective gradients, and a heterogeneous landscape. These factors have led to high endemic diversity across many lifeforms within this region, including the richest diversity of mygalomorph spiders (tarantulas, trapdoor spiders, and kin) in North America. The trapdoor spider genus Aliatypus encompasses twelve described species, eleven of which are endemic to California. Several Aliatypus species show disjunct distributional patterns in California (some are found on both sides of the vast Central Valley), and the genus as a whole occupies an impressive variety of habitats. Methodology/Principal Findings: We collected specimens from 89 populations representing all described species. DNA sequence data were collected from seven gene regions, including two newly developed for spider systematics. Bayesian inference (in individual gene tree and species tree approaches) recovered a general "3 clade" structure for the genus (A. gulosus, californicus group, erebus group), with three other phylogenetically isolated species differing slightly in position across different phylogenetic analyses. Because of extremely high intraspecific divergences in mitochondrial COI sequences, the relatively slowly evolving 28S rRNA gene was found to be more useful than mitochondrial data for identification of morphologically indistinguishable immatures. For multiple species spanning the Central Valley, explicit hypothesis testing suggests a lack of monophyly for regional populations (e.g., western Coast Range populations). Phylogenetic evidence clearly shows that syntopy is restricted to distant phylogenetic relatives, consistent with ecological niche conservatism. Conclusions/Significance: This study provides fundamental insight into a radiation of trapdoor spiders found in the biodiversity hotspot of California. Species relationships are clarified and undescribed lineages are discovered, with more geographic sampling likely to lead to additional species diversity. These dispersal-limited taxa provide novel insight into the biogeography and Earth history processes of California.	[Satler, Jordan D.; Hedin, Marshal] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Starrett, James; Hayashi, Cheryl Y.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	California State University System; San Diego State University; University of California System; University of California Riverside	Satler, JD (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jsatle1@tigers.lsu.edu			American Arachnological Society; Vincent Roth Research Funds; Army Research Office [W911NF-06-1-0455]; National Science Foundation [DEB-0910365, DEB 0108575]	American Arachnological Society; Vincent Roth Research Funds; Army Research Office; National Science Foundation(National Science Foundation (NSF))	Funding was provided by the American Arachnological Society (American Arachnological Society and Vincent Roth Research Funds to JDS), the Army Research Office (W911NF-06-1-0455 to CYH), and the National Science Foundation (DEB-0910365 to CYH and JS). Some fieldwork was supported by a National Science Foundation grant to M. Hedin and Jason Bond (DEB 0108575). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnedo MA, 2007, CONSERV GENET, V8, P1147, DOI 10.1007/s10592-006-9270-2; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2002, ZOOL J LINN SOC-LOND, V136, P487, DOI 10.1046/j.1096-3642.2002.00035.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chatzimanolis S, 2007, EVOLUTION, V61, P2127, DOI 10.1111/j.1558-5646.2007.00186.x; COYLE F A, 1974, Psyche (Cambridge), V81, P431, DOI 10.1155/1974/69634; COYLE FA, 1994, J ARACHNOL, V22, P218; COYLE FA, 1994, J ARACHNOL, V22, P225; Cranston KA, 2007, SYST BIOL, V56, P578, DOI 10.1080/10635150701485091; Davis EB, 2008, MOL ECOL, V17, P120, DOI 10.1111/j.1365-294X.2007.03469.x; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Degnan JH, 2009, TRENDS ECOLOGY EVOLU, V24; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Drummond AJ, 2010, GENEIOUS V5 3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupre WR, 1990, GEOLOGY TECTONICS CE, P185; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Feldman CR, 2006, MOL ECOL, V15, P2201, DOI 10.1111/j.1365-294X.2006.02930.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall CAJ, 2002, GEOL SOC AM SPECIAL, V489, P357; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; Hedin M, 2011, ZOOTAXA, P55; Hedin M, 2010, MOL PHYLOGENET EVOL, V54, P107, DOI 10.1016/j.ympev.2009.08.020; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hendrixson BE, 2005, MOL PHYLOGENET EVOL, V36, P405, DOI 10.1016/j.ympev.2005.01.021; Hendrixson BE, 2007, MOL PHYLOGENET EVOL, V42, P738, DOI 10.1016/j.ympev.2006.09.010; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jockusch EL, 2002, BIOL J LINN SOC, V76, P361, DOI 10.1046/j.1095-8312.2002.d01-6.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowles LL, 2010, ESTIMATING SPECIES T, P1; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Kuchta SR, 2006, BIOL J LINN SOC, V89, P213, DOI 10.1111/j.1095-8312.2006.00665.x; Kuchta SR, 2009, J BIOGEOGR, V36, P982, DOI 10.1111/j.1365-2699.2008.02052.x; Kuchta SR, 2009, MOL PHYLOGENET EVOL, V50, P240, DOI 10.1016/j.ympev.2008.10.019; Lapointe FJ, 2005, AM NAT, V166, P290, DOI 10.1086/431283; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Martinez-Solano I, 2007, MOL ECOL, V16, P4335, DOI 10.1111/j.1365-294X.2007.03527.x; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Matocq MD, 2002, MOL ECOL, V11, P229, DOI 10.1046/j.0962-1083.2001.01430.x; McGuire G, 2000, BIOINFORMATICS, V16, P130, DOI 10.1093/bioinformatics/16.2.130; McGuire G, 1997, MOL BIOL EVOL, V14, P1125, DOI 10.1093/oxfordjournals.molbev.a025722; Miller RE, 2002, SYST BIOL, V51, P740, DOI 10.1080/10635150290102401; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Parham JF, 2009, CONSERV GENET, V10, P169, DOI 10.1007/s10592-008-9544-y; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 5; Ramirez MG, 2004, BIOL J LINN SOC, V82, P27, DOI 10.1111/j.1095-8312.2004.00312.x; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; RIVAS LR, 1964, SYST ZOOL, V13, P42, DOI 10.2307/2411436; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rovito SM, 2010, MOL ECOL, V19, P4554, DOI 10.1111/j.1365-294X.2010.04825.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Spinks PQ, 2005, MOL ECOL, V14, P2047, DOI 10.1111/j.1365-294X.2005.02564.x; Starrett J, 2007, MOL ECOL, V16, P583, DOI 10.1111/j.1365-294X.2006.03164.x; Stockman AK, 2007, MOL ECOL, V16, P3374, DOI 10.1111/j.1365-294X.2007.03389.x; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Thomson RC, 2008, MOL PHYLOGENET EVOL, V49, P514, DOI 10.1016/j.ympev.2008.08.006; Wakabayashi J, 2001, J GEOL, V109, P539, DOI 10.1086/321962; Wake DB, 2006, ANN MO BOT GARD, V93, P8, DOI 10.3417/0026-6493(2006)93[8:PWSPAP]2.0.CO;2; WAKE DB, 1986, EVOLUTION, V40, P702, DOI 10.1111/j.1558-5646.1986.tb00532.x; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; Wilm A, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-19; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	77	37	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25355	10.1371/journal.pone.0025355	http://dx.doi.org/10.1371/journal.pone.0025355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966507	Green Published, gold, Green Submitted			2022-12-25	WOS:000295932100035
J	Torres, R; Swift, RV; Chim, N; Wheatley, N; Lan, BS; Atwood, BR; Pujol, C; Sankaran, B; Bliska, JB; Amaro, RE; Goulding, CW				Torres, Rodrigo; Swift, Robert V.; Chim, Nicholas; Wheatley, Nicole; Lan, Benson; Atwood, Brian R.; Pujol, Celine; Sankaran, Banu; Bliska, James B.; Amaro, Rommie E.; Goulding, Celia W.			Biochemical, Structural and Molecular Dynamics Analyses of the Potential Virulence Factor RipA from Yersinia pestis	PLOS ONE			English	Article							GLUTACONATE COA-TRANSFERASE; PIG-HEART; PROTEIN STRUCTURES; IDENTIFICATION; SIMULATION; INTERMEDIATE; PURIFICATION; REPLICATION; MACROPHAGES; METABOLISM	Human diseases are attributed in part to the ability of pathogens to evade the eukaryotic immune systems. A subset of these pathogens has developed mechanisms to survive in human macrophages. Yersinia pestis, the causative agent of the bubonic plague, is a predominately extracellular pathogen with the ability to survive and replicate intracellularly. A previous study has shown that a novel rip (required for intracellular proliferation) operon (ripA, ripB and ripC) is essential for replication and survival of Y. pestis in postactivated macrophages, by playing a role in lowering macrophage-produced nitric oxide (NO) levels. A bioinformatics analysis indicates that the rip operon is conserved among a distally related subset of macrophage-residing pathogens, including Burkholderia and Salmonella species, and suggests that this previously uncharacterized pathway is also required for intracellular survival of these pathogens. The focus of this study is ripA, which encodes for a protein highly homologous to 4-hydroxybutyrate-CoA transferase; however, biochemical analysis suggests that RipA functions as a butyryl-CoA transferase. The 1.9 angstrom X-ray crystal structure reveals that RipA belongs to the class of Family I CoA transferases and exhibits a unique tetrameric state. Molecular dynamics simulations are consistent with RipA tetramer formation and suggest a possible gating mechanism for CoA binding mediated by Val227. Together, our structural characterization and molecular dynamic simulations offer insights into acyl-CoA specificity within the active site binding pocket, and support biochemical results that RipA is a butyryl-CoA transferase. We hypothesize that the end product of the rip operon is butyrate, a known anti-inflammatory, which has been shown to lower NO levels in macrophages. Thus, the results of this molecular study of Y. pestis RipA provide a structural platform for rational inhibitor design, which may lead to a greater understanding of the role of RipA in this unique virulence pathway.	[Torres, Rodrigo; Chim, Nicholas; Wheatley, Nicole; Lan, Benson; Goulding, Celia W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Swift, Robert V.; Atwood, Brian R.; Amaro, Rommie E.; Goulding, Celia W.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92717 USA; [Amaro, Rommie E.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92717 USA; [Amaro, Rommie E.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Pujol, Celine; Bliska, James B.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Pujol, Celine; Bliska, James B.] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA; [Sankaran, Banu] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Torres, R (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	celia.goulding@uci.edu	Pacific-Southwest, RCE/B-6155-2009		National Institutes of Health [AI-65359]; New Innovator Award Program [1-DP2-OD007237]; National Science Foundation through TeraGrid Supercomputer resources [TG-CHE060073N to REA]; Northeast Biodefense Center [U54-AI057158-Lipkin, AI055621]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, U54AI057158, P01AI055621] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Innovator Award Program; National Science Foundation through TeraGrid Supercomputer resources(National Science Foundation (NSF)); Northeast Biodefense Center; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Institutes of Health (AI-65359, PI: Alan Barbour, subaward to CWG and REA), in part by the Director's New Innovator Award Program (1-DP2-OD007237 to REA), the National Science Foundation through TeraGrid Supercomputer resources provided by TACC Ranger and RAC (TG-CHE060073N to REA), and the Northeast Biodefense Center (U54-AI057158-Lipkin and AI055621 awarded to JBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Advanced Light Source (ALS) at Berkeley National Laboratories for their invaluable help in data collection. We would also like to thank all of the staff at Stanford Synchrotron Radiation Lightsource (SSRL) for their invaluable help in data collection. Portions of this research were carried out at the national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. We also thank Lance Palmer for assistance with bioinformatics analysis of Rip homologs in other bacteria, and Li-Wei Hung and Jeff Habel for collecting SAXS data at ALS beamline 12.3.1, and Prof. Richard Chamberlin for advice and help in synthesizing 4-HB.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aden J, 2007, J AM CHEM SOC, V129, P14003, DOI 10.1021/ja075055g; BOTT M, 1994, MOL MICROBIOL, V14, P347, DOI 10.1111/j.1365-2958.1994.tb01295.x; BOURGUIGNON JJ, 1988, J MED CHEM, V31, P893, DOI 10.1021/jm00400a001; BUCKEL W, 1981, EUR J BIOCHEM, V118, P315, DOI 10.1111/j.1432-1033.1981.tb06404.x; Butler T, 2009, CLIN INFECT DIS, V49, P736, DOI 10.1086/604718; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Charrier C, 2006, MICROBIOL-SGM, V152, P179, DOI [10.1099/mic.0.28412-0, 10.1099/MIC.0.28412-0]; Coker SF, 2010, ACTA CRYSTALLOGR D, V66, P797, DOI 10.1107/S0907444910018366; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Coros AM, 2004, ACTA CRYSTALLOGR D, V60, P1717, DOI 10.1107/S0907444904017974; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fraser ME, 2010, BIOCHEMISTRY-US, V49, P10319, DOI 10.1021/bi100659s; Haneda T, 2009, FEMS MICROBIOL LETT, V297, P241, DOI 10.1111/j.1574-6968.2009.01686.x; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; Heider J, 2001, FEBS LETT, V509, P345, DOI 10.1016/S0014-5793(01)03178-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacob U, 1997, STRUCTURE, V5, P415, DOI 10.1016/S0969-2126(97)00198-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LIN TW, 1992, J BIOL CHEM, V267, P975; Macieira S, 2009, BIOL CHEM, V390, P1251, DOI 10.1515/BC.2009.147; McCammon JA, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-4; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JS, 2007, INT IMMUNOPHARMACOL, V7, P70, DOI 10.1016/j.intimp.2006.08.015; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Rangarajan ES, 2005, J BIOL CHEM, V280, P42919, DOI 10.1074/jbc.M510522200; Roediger WE, 2000, MOL CELL BIOCHEM, V206, P159, DOI 10.1023/A:1007034417320; Roediger WEW, 2001, NITRIC OXIDE-BIOL CH, V5, P83, DOI 10.1006/niox.2001.0336; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; SCHERF U, 1991, APPL ENVIRON MICROB, V57, P2699, DOI 10.1128/AEM.57.9.2699-2702.1991; Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200; SOLOMON F, 1969, J BIOL CHEM, V244, P1079; SRAMEK SJ, 1975, ARCH BIOCHEM BIOPHYS, V171, P14, DOI 10.1016/0003-9861(75)90002-8; Stempelj M, 2007, J BIOL CHEM, V282, P9797, DOI 10.1074/jbc.M609426200; Suydam IT, 2006, SCIENCE, V313, P200, DOI 10.1126/science.1127159; Swift RV, 2009, J AM CHEM SOC, V131, P5126, DOI 10.1021/ja808064g; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WHITE H, 1976, J BIOL CHEM, V251, P1688	55	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25084	10.1371/journal.pone.0025084	http://dx.doi.org/10.1371/journal.pone.0025084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966419	Green Submitted, Green Published, gold			2022-12-25	WOS:000295932100016
J	John, L; Thomas, S; Herchenroder, O; Putzer, BM; Schaefer, S				John, Lijo; Thomas, Saijo; Herchenroeder, Ottmar; Puetzer, Brigitte M.; Schaefer, Stephan			Hepatitis E Virus ORF2 Protein Activates the Pro-Apoptotic Gene CHOP and Anti-Apoptotic Heat Shock Proteins	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FAST INTERACTION REFINEMENT; MAMMALIAN-CELLS; MONOCLONAL-ANTIBODIES; TRANSCRIPTION FACTOR; CHAPERONE FUNCTION; MOLECULAR DOCKING; SENSITIZES CELLS; CAPSID PROTEIN; EXPRESSION	Background: Hepatitis E virus (HEV) is a non-enveloped plus-strand RNA virus that causes acute hepatitis. The capsid protein open reading frame 2 (ORF2) is known to induce endoplasmic reticulum stress in ORF2 expressing cells. Methodology/Principal Findings: In this study we found that HEV ORF2 activates the expression of the pro-apoptotic gene C/EBP homologous protein (CHOP). ORF2 stimulates the CHOP promoter mainly through AARE (amino acid response elements) and to a minor extent the ERSE (endoplasmic reticulum stress response elements). Activating transcription factor 4 (ATF4) protein binds and activates the AARE regulatory sites of the CHOP promoter. ORF2 expression also leads to increased phosphorylation of eukaryotic initiation factor 2 alpha (eIF2 alpha) that in turn initiates the translation of ATF4 mRNA. The pro-apoptotic gene CHOP is an important trigger to initiate endoplasmic reticulum stress induced apoptosis. However, the activation of CHOP by ORF2 in this study did not induce apoptosis, nor did BCL2-associated X protein (Bax) translocate to mitochondria. Microarray analysis revealed an ORF2 specific increased expression of chaperones Hsp72, Hsp70B', and cochaperone Hsp40. Co-immunoprecipitation (Co-IP) and in silico molecular docking analysis suggests that HEV ORF2 interacts with Hsp72. In addition, Hsp72 shows nuclear accumulation in ORF2 expressing cells. Conclusions/Significance: These data provide new insight into simultaneously occurring counter-acting effects of HEV ORF2 that may be part of a strategy to prevent host suicide before completion of the viral replication cycle.	[John, Lijo; Thomas, Saijo; Herchenroeder, Ottmar; Puetzer, Brigitte M.; Schaefer, Stephan] Univ Rostock, Sch Med, Dept Vectorol & Expt Gene Therapy, Biomed Res Ctr, Rostock, Germany	University of Rostock	John, L (corresponding author), Univ Rostock, Sch Med, Dept Vectorol & Expt Gene Therapy, Biomed Res Ctr, Rostock, Germany.	brigitte.puetzer@med.uni-rostock.de			Marie Curie Fellowship; DAAD	Marie Curie Fellowship(European Commission); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	Lijo John was supported by Marie Curie Fellowship and Saijo Thomas by a DAAD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2009, J GASTROEN HEPATOL, V24, P1484, DOI 10.1111/j.1440-1746.2009.05933.x; AHMAD I, 2011, VIRUS RES; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Chandra V, 2008, J BIOSCIENCES, V33, P451, DOI 10.1007/s12038-008-0064-1; Chow AM, 2009, CELL STRESS CHAPERON, V14, P253, DOI 10.1007/s12192-008-0079-4; Ciccaglione AR, 2007, VIRUS RES, V126, P128, DOI 10.1016/j.virusres.2007.02.006; Creagh EM, 2000, EXP CELL RES, V257, P58, DOI 10.1006/excr.2000.4856; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dimcheff DE, 2004, J BIOL CHEM, V279, P33782, DOI 10.1074/jbc.M403304200; Emerson SU, 2001, P NATL ACAD SCI USA, V98, P15270, DOI 10.1073/pnas.251555098; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; Hageman J, 2007, J BIOL CHEM, V282, P34334, DOI 10.1074/jbc.M703876200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; John K, 2011, CELL DEATH DIFFER, V18, P874, DOI 10.1038/cdd.2010.153; Kato K, 1999, BIOL PHARM BULL, V22, P1185; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Knowlton AA, 2000, AM J PHYSIOL-HEART C, V278, pH2143, DOI 10.1152/ajpheart.2000.278.6.H2143; Kwok SCM, 2008, MOL CELL BIOCHEM, V319, P203, DOI 10.1007/s11010-008-9893-3; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Minakshi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008342; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Mushahwar IK, 2008, J MED VIROL, V80, P646, DOI 10.1002/jmv.21116; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Offman MN, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-34; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703; Riddell MA, 2000, J VIROL, V74, P8011, DOI 10.1128/JVI.74.17.8011-8017.2000; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schofield DJ, 2003, VACCINE, V22, P257, DOI 10.1016/j.vaccine.2003.07.008; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Surjit M, 2007, J VIROL, V81, P3339, DOI 10.1128/JVI.02039-06; Thomas S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-327; Tirosh B, 2005, J VIROL, V79, P2768, DOI 10.1128/JVI.79.5.2768-2779.2005; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsarev SA, 1997, VACCINE, V15, P1834, DOI 10.1016/S0264-410X(97)00145-X; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Ubeda M, 2000, NUCLEIC ACIDS RES, V28, P4987, DOI 10.1093/nar/28.24.4987; Volloch V, 1998, CELL STRESS CHAPERON, V3, P265, DOI 10.1054/csac.1998.0120; von dem Bussche A, 2010, J HEPATOL, V53, P797, DOI 10.1016/j.jhep.2010.05.022; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yamazaki T, 2010, LIFE SCI, V87, P294, DOI 10.1016/j.lfs.2010.07.006; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young P, 2008, J GEN VIROL, V89, P866, DOI 10.1099/vir.0.83414-0; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Yu H, 2011, J MOL MODEL, V17, P987, DOI 10.1007/s00894-010-0794-5; Zafrullah M, 1999, J VIROL, V73, P4074, DOI 10.1128/JVI.73.5.4074-4082.1999; Zhang MD, 2001, VACCINE, V20, P853, DOI 10.1016/S0264-410X(01)00399-1; Zheng ZZ, 2010, J GEN VIROL, V91, P1728, DOI 10.1099/vir.0.019323-0; Zhou YH, 2004, VACCINE, V22, P2578, DOI 10.1016/j.vaccine.2003.12.017; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	69	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25378	10.1371/journal.pone.0025378	http://dx.doi.org/10.1371/journal.pone.0025378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966512	gold, Green Published, Green Submitted			2022-12-25	WOS:000295267100050
J	Turbic, A; Leong, SY; Turnley, AM				Turbic, Alisa; Leong, Soo Yuen; Turnley, Ann M.			Chemokines and Inflammatory Mediators Interact to Regulate Adult Murine Neural Precursor Cell Proliferation, Survival and Differentiation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; STEM-CELLS; PROGENITOR CELLS; SPINAL-CORD; SUBVENTRICULAR ZONE; INTERFERON-GAMMA; IFN-GAMMA; OLIGODENDROCYTE PRECURSORS; NEURONAL DIFFERENTIATION	Adult neural precursor cells (NPCs) respond to injury or disease of the CNS by migrating to the site of damage or differentiating locally to replace lost cells. Factors that mediate this injury induced NPC response include chemokines and pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF alpha) and interferon-gamma (IFN gamma), which we have shown previously promotes neuronal differentiation. RT-PCR was used to compare expression of chemokines and their receptors in normal adult mouse brain and in cultured NPCs in response to IFN gamma and TNF alpha. Basal expression of many chemokines and their receptors was found in adult brain, predominantly in neurogenic regions, with OB >> SVZ > hippocampus and little or no expression in non-neurogenic regions, such as cortex. Treatment of SVZ-derived NPCs with IFN gamma and TNF alpha (alone and in combination) resulted in significant upregulation of expression of specific chemokines, with CXCL1, CXCL9 and CCL2 most highly upregulated and CCL19 downregulated. Unlike IFN gamma, chemokine treatment of NPCs in vitro had little or no effect on survival, proliferation or migration. Neuronal differentiation was promoted by CXCL9, CCL2 and CCL21, while astrocyte and total oligodendrocyte differentiation was not affected. However, IFN gamma, CXCL1, CXCL9 and CCL2 promoted oligodendrocyte maturation. Therefore, not only do NPCs express chemokine receptors, they also produce several chemokines, particularly in response to inflammatory mediators. This suggests that autocrine or paracrine production of specific chemokines by NPCs in response to inflammatory mediators may regulate differentiation into mature neural cell types and may alter NPC responsiveness to CNS injury or disease.	[Turbic, Alisa; Leong, Soo Yuen; Turnley, Ann M.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia	University of Melbourne	Turbic, A (corresponding author), Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia.	turnley@unimelb.edu.au		Turnley, Ann/0000-0002-8442-127X; Turbic, Alisa/0000-0002-9703-2484	National Health and Medical Research Council of Australia [454384, 350226]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health and Medical Research Council of Australia Project grant (#454384) and Fellowship to AMT (#350226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Babcock AA, 2003, J NEUROSCI, V23, P7922; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Berman JW, 1996, J IMMUNOL, V156, P3017; Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Carter SL, 2007, GLIA, V55, P1728, DOI 10.1002/glia.20587; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Chintawar S, 2009, STEM CELLS, V27, P838, DOI 10.1002/stem.25; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; Dziembowska M, 2005, GLIA, V50, P258, DOI 10.1002/glia.20170; Edman LC, 2008, EXP CELL RES, V314, P2123, DOI 10.1016/j.yexcr.2008.02.019; Filipovic R, 2008, GLIA, V56, P1, DOI 10.1002/glia.20582; Gomez-Nicola D, 2010, J NEUROIMMUNOL, V227, P87, DOI 10.1016/j.jneuroim.2010.06.018; Gordon RJ, 2009, MOL CELL NEUROSCI, V41, P219, DOI 10.1016/j.mcn.2009.03.001; Guan YT, 2008, EXP MOL PATHOL, V85, P232, DOI 10.1016/j.yexmp.2008.07.003; Hattermann K, 2008, MOL CELL NEUROSCI, V39, P133, DOI 10.1016/j.mcn.2008.03.009; Hiroi M, 2003, J BIOL CHEM, V278, P651, DOI 10.1074/jbc.M204544200; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Ji JF, 2004, NEUROSCI LETT, V355, P236, DOI 10.1016/j.neulet.2003.11.024; Kasemeier-Kulesa JC, 2010, J NEUROSCI, V30, P13078, DOI 10.1523/JNEUROSCI.0892-10.2010; Knerlich-Lukoschus F, 2010, GLIA, V58, P916, DOI 10.1002/glia.20974; Krathwohl MD, 2004, STEM CELLS, V22, P109, DOI 10.1634/stemcells.22-1-109; Lalor SJ, 2010, J NEUROIMMUNOL, V224, P56, DOI 10.1016/j.jneuroim.2010.05.017; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; Liu XS, 2008, BRAIN RES, V1226, P18, DOI 10.1016/j.brainres.2008.06.013; Liu XS, 2007, J NEUROSCI RES, V85, P2120, DOI 10.1002/jnr.21359; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum M, 2009, J NEUROIMMUNOL, V206, P32, DOI 10.1016/j.jneuroim.2008.10.009; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; Ni HT, 2004, DEV BRAIN RES, V152, P159, DOI 10.1016/j.devbrainres.2004.06.015; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Owens T, 2005, BRAIN RES REV, V48, P178, DOI 10.1016/j.brainresrev.2004.12.007; Padovani-Claudio DA, 2006, GLIA, V54, P471, DOI 10.1002/glia.20383; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Peng H, 2004, J NEUROSCI RES, V76, P35, DOI 10.1002/jnr.20045; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Robinson S, 1998, J NEUROSCI, V18, P10457; Suyama T, 2005, CANCER-AM CANCER SOC, V103, P258, DOI 10.1002/cncr.20747; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Weiss N, 2010, J NEUROIMMUNOL, V223, P131, DOI 10.1016/j.jneuroim.2010.03.009; Widera D, 2004, EUR J CELL BIOL, V83, P381, DOI 10.1078/0171-9335-00403; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009	53	54	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25406	10.1371/journal.pone.0025406	http://dx.doi.org/10.1371/journal.pone.0025406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966521	gold, Green Published			2022-12-25	WOS:000295267100057
J	Boukary, AR; Thys, E; Abatih, E; Gamatie, D; Ango, I; Yenikoye, A; Saegerman, C				Boukary, Abdou Razac; Thys, Eric; Abatih, Emmanuel; Gamatie, Djibo; Ango, Issoufou; Yenikoye, Alhassane; Saegerman, Claude			Bovine Tuberculosis Prevalence Survey on Cattle in the Rural Livestock System of Torodi (Niger)	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; RISK-FACTORS; EPIDEMIOLOGY; INFECTION; DIAGNOSIS; ETHIOPIA; ANIMALS; TOWN	Background: Bovine tuberculosis (BTB) is a widespread zoonosis in developing countries but has received little attention in sub-Saharan Africa, especially in Niger. Recent investigations confirmed the high incidence of the disease in cattle slaughtered in an abattoir in Niamey. The fact that most of the animals in which M. bovis has been identified were from the rural area of Torodi implied the existence of a probable source of BTB in this region. This study aimed to determine the prevalence of BTB infection in cattle and to identify risk factors for infection in human and cattle populations in Torodi. Methods and Principal Findings: A survey was carried out at the level of households keeping livestock (n = 51). The questionnaire was related to the potential risk factors and the presence of clinical signs of TB both in animals and humans. Comparative Intradermal Tuberculin Test was conducted to determine the TB status in cattle (n = 393). The overall apparent individual animal prevalence of tuberculin reactors was 3.6% (CI: 95%, 1.9-5.9), whereas the individual true prevalence was estimated at 0.8% (CI: 95%, 0.0-5.0). Using a multivariate logistic regression analysis and a classification tree analysis, the only household level risk factor that significantly influenced the presence of BTB in cattle was the presence of animals coughing in the herd (OR = 4.7, 95% CI: 1.12-19.71, p-value = 0.034). The lack of the practice of quarantine was borderline significant (OR = 4.2, 95% CI: 0.96-18.40, p-value = 0.056). Conclusion/Significance: The study confirmed that BTB is endemic in cattle in Torodi and the risk of the transmission of the disease to humans is potentially high. For the control of the disease in livestock, slaughtering of infected animals and the compensation of the owners is needed. Collaboration between the veterinary and the medical sectors, in the diagnosis, monitoring, prevention and control of BTB is strongly encouraged.	[Boukary, Abdou Razac] ONG Karkara, Dept Anim Hlth & Livestock Promot, Niamey, Niger; [Boukary, Abdou Razac; Thys, Eric; Abatih, Emmanuel] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Boukary, Abdou Razac; Yenikoye, Alhassane] Univ Niamey, Fac Agron, Niamey, Niger; [Boukary, Abdou Razac; Saegerman, Claude] Univ Liege, Dept Infect & Parasit Dis, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, Liege, Belgium; [Gamatie, Djibo] Minist Agr & Livestock, Cent Vet Lab, Niamey, Niger; [Ango, Issoufou] Minist Agr & Livestock, Direct Anim Prod, Niamey, Niger	Institute of Tropical Medicine (ITM); University of Liege	Boukary, AR (corresponding author), ONG Karkara, Dept Anim Hlth & Livestock Promot, Niamey, Niger.	Claude.Saegerman@ulg.ac.be		Saegerman, Claude/0000-0001-9087-7436	Belgian Directorate General for Development Cooperation (DGDC)	Belgian Directorate General for Development Cooperation (DGDC)	The authors wish to thank the Belgian Directorate General for Development Cooperation (DGDC) for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alambedji AI, 1984, THESIS EISMV DAKAR S, P48; Ameni G, 2007, REV SCI TECH OIE, V26, P711, DOI 10.20506/rst.26.3.1778; Ameni G, 2008, CLIN VACCINE IMMUNOL, V15, P1272, DOI 10.1128/CVI.00114-08; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; Asseged B., 2000, Bulletin of Animal Health and Production in Africa, V48, P71; Asseged B, 2004, TROP ANIM HEALTH PRO, V36, P537, DOI 10.1023/B:TROP.0000040934.32330.44; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Bloch N, 1991, Rev Elev Med Vet Pays Trop, V44, P117; Boschiroli ML, 2010, INFECT PARASITIC DIS, P1075; Boukary AR., 2007, REV ELEV MED VET PAY, V60, P113; Boukary AR, 2011, TRANSBOUNDARY UNPUB; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Cadmus SIB, 2010, TROP ANIM HEALTH PRO, V42, P547, DOI 10.1007/s11250-009-9463-z; Cadmus SIB, 2004, VET MED-CZECH, V49, P406, DOI 10.17221/5730-VETMED; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; COSIVI O, 1995, REV SCI TECH OIE, V14, P733, DOI 10.20506/rst.14.3.875; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Delafosse A., 2002, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V55, P5; Diguimbaye C, 2006, J CLIN MICROBIOL, V44, P1575, DOI 10.1128/JCM.44.4.1575-1577.2006; Diguimbaye C, 2004, THESIS PHILOS NATURW; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; Ibrahim S, 2010, TROP ANIM HEALTH PRO, V42, P1333, DOI 10.1007/s11250-010-9599-x; Kazwala RR, 2001, VET RES COMMUN, V25, P609, DOI 10.1023/A:1012757011524; Maher D, 2006, INT J TUBERC LUNG D, V10, P240; Menzies FD, 2000, VET J, V160, P92, DOI 10.1053/tvjl.2000.0482; Michel AL, 2009, VET MICROBIOL, V133, P335, DOI 10.1016/j.vetmic.2008.07.023; Muller B, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-26; Njanpop-Lafourcade BM, 2001, J CLIN MICROBIOL, V39, P222, DOI 10.1128/JCM.39.1.222-227.2001; OIE, 2004, MAN DIAGN TESTS VACC; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Regassa A, 2008, VET J, V178, P119, DOI 10.1016/j.tvjl.2007.06.019; Regassa A, 2010, TROP ANIM HEALTH PRO, V42, P915, DOI 10.1007/s11250-009-9507-4; RGP/H (Recensement General de la Population et de l'Habitat), 2001, RAPP PROV EX 3 RGP H; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; SCHELLING E., 2005, EPIDEMIOL SANTE ANIM, V48, P81; Sidibe S. S., 2003, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V56, P115; Stata Corp, 2009, STAT STAT SOFTW STAT; Steinberg D., 1995, CART TREE STRUCTURED; Traore Amadou, 2004, Biotechnologie Agronomie Societe et Environnement, V8, P3; Tschopp R, 2009, PREV VET MED, V89, P205, DOI 10.1016/j.prevetmed.2009.02.006	41	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24629	10.1371/journal.pone.0024629	http://dx.doi.org/10.1371/journal.pone.0024629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21961039	Green Published, gold			2022-12-25	WOS:000295265100012
J	Kim, SJ; Shin, JY; Lee, KD; Bae, YK; Choi, IJ; Park, SH; Chun, KH				Kim, Seok-Jun; Shin, Ji-Young; Lee, Kang-Duck; Bae, Young-Ki; Choi, Il-Ju; Park, Seok Hee; Chun, Kyung-Hee			Galectin-3 Facilitates Cell Motility in Gastric Cancer by Up-Regulating Protease-Activated Receptor-1(PAR-1) and Matrix Metalloproteinase-1(MMP-1)	PLOS ONE			English	Article							TUMOR PROGRESSION; GROWTH-FACTOR; EXPRESSION; METASTASIS; INVASION; SURVIVAL; RECEPTOR; MMP-1; GENE; TRANSCRIPTION	Background: Galectin-3 is known to regulate cancer metastasis. However, the underlying mechanism has not been defined. Through the DNA microarray studies after galectin-3 silencing, we demonstrated here that galectin-3 plays a key role in up-regulating the expressions of protease-activated receptor-1(PAR-1) and matrix metalloproteinase-1(MMP-1) PAR-1 thereby promoting gastric cancer metastasis. Methodology/Principal Findings: We examined the expression levels of Galectin-3, PAR-1, and MMP-1 in gastric cancer patient tissues and also the effects of silencing these proteins with specific siRNAs and of over-expressing them using specific lenti-viral constructs. We also employed zebrafish embryo model for analysis of in vivo gastric cancer cell invasion. These studies demonstrated that: a) galectin-3 silencing decreases the expression of PAR-1. b) galectin-3 over-expression increases cell migration and invasion and this increase can be reversed by PAR-1 silencing, indicating that galectin-3 increases cell migration and invasion via PAR-1 up-regulation. c) galectin-3 directly interacts with AP-1 transcriptional factor, and this complex binds to PAR-1 promoter and drives PAR-1 transcription. d) galectin-3 also amplifies phospho-paxillin, a PAR-1 downstream target, by increasing MMP-1 expression. MMP-1 silencing blocks phospho-paxillin amplification and cell invasion caused by galectin-3 over-expression. e) Silencing of either galectin-3, PAR-1 or MMP-1 significantly reduced cell migration into the vessels in zebrafish embryo model. f) Galectin-3, PAR-1, and MMP-1 are highly expressed and co-localized in malignant tissues from gastric cancer patients. Conclusions/Significance: Galectin-3 plays the key role of activating cell surface receptor through production of protease and boosts gastric cancer metastasis. Galectin-3 has the potential to serve as a useful pharmacological target for prevention of gastric cancer metastasis.	[Kim, Seok-Jun; Shin, Ji-Young; Lee, Kang-Duck; Choi, Il-Ju; Chun, Kyung-Hee] Natl Canc Ctr Res Inst & Hosp, Gastr Canc Branch, Div Translat & Clin Res 1, Goyang Si, Gyeonggi Do, South Korea; [Bae, Young-Ki] Natl Canc Ctr, Canc Expt Recourses Branch, Div Canc Biol, Goyang Si, Gyeonggi Do, South Korea; [Kim, Seok-Jun; Park, Seok Hee] Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU)	Kim, SJ (corresponding author), Natl Canc Ctr Res Inst & Hosp, Gastr Canc Branch, Div Translat & Clin Res 1, Goyang Si, Gyeonggi Do, South Korea.	khchun@ncc.re.kr			National Cancer Center (NCC) of Republic of Korea [NCC-0910150, NCC-0810060]; Innovative Research Institute for Cell Therapy, Republic of Korea [A062260]; National Research Foundation (NRF); Ministry of Education, Science and Technology, Republic of Korea [1031790-1]	National Cancer Center (NCC) of Republic of Korea; Innovative Research Institute for Cell Therapy, Republic of Korea; National Research Foundation (NRF); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by National Cancer Center (NCC) of Republic of Korea grant (NCC-0910150 and NCC-0810060), Innovative Research Institute for Cell Therapy, Republic of Korea (A062260) and this research was supported by the Basic442 Science Research Program through the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology (1031790-1), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshaiah P, 2007, CANCER RES, V67, P6204, DOI 10.1158/0008-5472.CAN-06-4687; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bertazza L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-111; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Buergy D, 2009, INT J CANCER, V125, P894, DOI 10.1002/ijc.24462; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; Cheong TC, 2009, CANC SCI; D'Andrea MR, 2001, AM J PATHOL, V158, P2031, DOI 10.1016/S0002-9440(10)64675-5; Desiderio MA, 2007, CELL MOL LIFE SCI, V64, P1341, DOI 10.1007/s00018-007-7050-x; Fujimoto D, 2008, ANTICANCER RES, V28, P847; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hippo Y, 2001, CANCER RES, V61, P889; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Kamata I, 2009, J GASTROEN HEPATOL, V24, P1527, DOI 10.1111/j.1440-1746.2009.05810.x; Kim SJ, 2011, CLIN EXP METASTASIS; Kim SJ, 2009, GASTROENTEROLOGY; Kim YW, 2010, SCAND J GASTROENTERO, V45, P217, DOI 10.3109/00365520903453158; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu ZW, 2001, INT J CANCER, V91, P638, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1102>3.0.CO;2-Y; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Meneses-Garcia Abelardo, 2008, World J Surg Oncol, V6, P114, DOI 10.1186/1477-7819-6-114; Nangia-Makker P, 2007, J BIOENERG BIOMEMBR, V39, P79, DOI 10.1007/s10863-006-9063-9; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Okuyama N, 2008, ONCOL REP, V20, P1497, DOI 10.3892/or_00000171; Salah Z, 2007, MOL CANCER RES, V5, P229, DOI 10.1158/1541-7786.MCR-06-0261; Sato H, 2005, CANCER SCI, V96, P212, DOI 10.1111/j.1349-7006.2005.00039.x; Song SM, 2005, GASTROENTEROLOGY, V129, P1581, DOI 10.1053/j.gastro.2005.09.002; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Takeda H, 1999, Tanpakushitsu Kakusan Koso, V44, P803; Tellez C, 2003, ONCOGENE, V22, P3130, DOI 10.1038/sj.onc.1206453; Vincenti MP, 1996, CRIT REV EUKAR GENE, V6, P391, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.40; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Yin YJ, 2003, ARTERIOSCL THROM VAS, V23, P940, DOI 10.1161/01.ATV.0000066878.27340.22	37	16	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25103	10.1371/journal.pone.0025103	http://dx.doi.org/10.1371/journal.pone.0025103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966428	Green Published, Green Submitted, gold			2022-12-25	WOS:000295265100059
J	Tian, J; Dang, HN; Yong, J; Chui, WS; Dizon, MPG; Yaw, CKY; Kaufman, DL				Tian, Jide; Dang, Hoa N.; Yong, Jing; Chui, Wing-Sheung; Dizon, Matthew P. G.; Yaw, Catherine K. Y.; Kaufman, Daniel L.			Oral Treatment with gamma-Aminobutyric Acid Improves Glucose Tolerance and Insulin Sensitivity by Inhibiting Inflammation in High Fat Diet-Fed Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; OBESITY; RESISTANCE; CELLS; ADIPOCYTOKINES; COMPLICATIONS; RESPONSES; GABA	Adipocyte and beta-cell dysfunction and macrophage-related chronic inflammation are critical for the development of obesity-related insulin resistance and type 2 diabetes mellitus (T2DM), which can be negatively regulated by Tregs. Our previous studies and those of others have shown that activation of gamma-aminobutyric acid (GABA) receptors inhibits inflammation in mice. However, whether GABA could modulate high fat diet (HFD)-induced obesity, glucose intolerance and insulin resistance has not been explored. Here, we show that although oral treatment with GABA does not affect water and food consumption it inhibits the HFD-induced gain in body weights in C57BL/6 mice. Furthermore, oral treatment with GABA significantly reduced the concentrations of fasting blood glucose, and improved glucose tolerance and insulin sensitivity in the HFD-fed mice. More importantly, after the onset of obesity and T2DM, oral treatment with GABA inhibited the continual HFD-induced gain in body weights, reduced the concentrations of fasting blood glucose and improved glucose tolerance and insulin sensitivity in mice. In addition, oral treatment with GABA reduced the epididymal fat mass, adipocyte size, and the frequency of macrophage infiltrates in the adipose tissues of HFD-fed mice. Notably, oral treatment with GABA significantly increased the frequency of CD4(+) Foxp3(+) Tregs in mice. Collectively, our data indicated that activation of peripheral GABA receptors inhibited the HFD-induced glucose intolerance, insulin resistance, and obesity by inhibiting obesity-related inflammation and up-regulating Treg responses in vivo. Given that GABA is safe for human consumption, activators of GABA receptors may be valuable for the prevention of obesity and intervention of T2DM in the clinic.	[Tian, Jide; Dang, Hoa N.; Yong, Jing; Chui, Wing-Sheung; Dizon, Matthew P. G.; Yaw, Catherine K. Y.; Kaufman, Daniel L.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Tian, J (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	jtian@mednet.ucla.edu	Kaufman, Daniel/AAU-1228-2021; Yong, Jing/I-2150-2012	Kaufman, Daniel/0000-0002-9844-5918; Yong, Jing/0000-0001-8579-1558	NIDDK NIH HHS [R21 DK080461, R21 DK075070] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075070, R21DK080461] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bansal P, 2008, AM J PHYSIOL-ENDOC M, V295, pE751, DOI 10.1152/ajpendo.90295.2008; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; Bluestone JA, 2004, P NATL ACAD SCI USA, V101, P14622, DOI 10.1073/pnas.0405234101; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dyck DJ, 2009, APPL PHYSIOL NUTR ME, V34, P396, DOI 10.1139/H09-037; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; LeRoith D, 2008, EXP CLIN ENDOCR DIAB, V116, pS4, DOI 10.1055/s-2008-1081488; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Nicolaysen A, 2007, J LIPID RES, V48, P2123, DOI 10.1194/jlr.M700021-JLR200; Qatanani M, 2009, J CLIN INVEST, V119, P531, DOI 10.1172/JCI37273; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Reyes-Garcia MG, 2007, J NEUROIMMUNOL, V188, P64, DOI 10.1016/j.jneuroim.2007.05.013; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shoelson SE, 2009, NAT MED, V15, P373, DOI 10.1038/nm0409-373; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tian J, 1999, J NEUROIMMUNOL, V96, P21, DOI 10.1016/S0165-5728(98)00264-1; TIAN J, 2011, PLOS ONE IN PRESS; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; Tian JD, 2011, AUTOIMMUNITY, V44, P465, DOI 10.3109/08916934.2011.571223; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001	32	106	118	8	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25338	10.1371/journal.pone.0025338	http://dx.doi.org/10.1371/journal.pone.0025338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966503	gold, Green Published, Green Submitted			2022-12-25	WOS:000295265100092
J	Li, YC; Chen, CC; Chen, JH				Li, Yi-Chia; Chen, Chien-Chung; Chen, Jyh-Horng			Impact of Visual Repetition Rate on Intrinsic Properties of Low Frequency Fluctuations in the Visual Network	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; CEREBRAL HEMODYNAMICS; FMRI; SIGNAL; OSCILLATIONS; ACTIVATION; COHERENCE; AMPLITUDE; CORTEX	Background: Visual processing network is one of the functional networks which have been reliably identified to consistently exist in human resting brains. In our work, we focused on this network and investigated the intrinsic properties of low frequency (0.01-0.08 Hz) fluctuations (LFFs) during changes of visual stimuli. There were two main questions to be discussed in this study: intrinsic properties of LFFs regarding (1) interactions between visual stimuli and resting-state; (2) impact of repetition rate of visual stimuli. Methodology/Principal Findings: We analyzed scanning sessions that contained rest and visual stimuli in various repetition rates with a novel method. The method included three numerical approaches involving ICA (Independent Component Analyses), fALFF (fractional Amplitude of Low Frequency Fluctuation), and Coherence, to respectively investigate the modulations of visual network pattern, low frequency fluctuation power, and interregional functional connectivity during changes of visual stimuli. We discovered when resting-state was replaced by visual stimuli, more areas were involved in visual processing, and both stronger low frequency fluctuations and higher interregional functional connectivity occurred in visual network. With changes of visual repetition rate, the number of areas which were involved in visual processing, low frequency fluctuation power, and interregional functional connectivity in this network were also modulated. Conclusions/Significance: To combine the results of prior literatures and our discoveries, intrinsic properties of LFFs in visual network are altered not only by modulations of endogenous factors (eye-open or eye-closed condition; alcohol administration) and disordered behaviors (early blind), but also exogenous sensory stimuli (visual stimuli with various repetition rates). It demonstrates that the intrinsic properties of LFFs are valuable to represent physiological states of human brains.	[Li, Yi-Chia] Natl Taiwan Univ, Grad Inst Biomed Engn & Bioinformat, Taipei 10764, Taiwan; [Li, Yi-Chia; Chen, Jyh-Horng] Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan; [Chen, Chien-Chung] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Chen, Chien-Chung] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Li, YC (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Engn & Bioinformat, Taipei 10764, Taiwan.	d97945006@ntu.edu.tw	; Chen, Zhiwei/B-7793-2019	Chen, Chien-Chung/0000-0002-3848-0180; Chen, Zhiwei/0000-0002-4511-2888	National Science Council [NSC 99-2321-B-002-007]	National Science Council(Ministry of Science and Technology, Taiwan)	The research was supported by the National Science Council grant NSC 99-2321-B-002-007 to Jyh-Horng Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2008, AM J NEURORADIOL, V29, P1722, DOI 10.3174/ajnr.A1220; Anderson SJ, 1996, P ROY SOC B-BIOL SCI, V263, P423, DOI 10.1098/rspb.1996.0064; Bartley S.H., 1968, CONTRIBUTIONS SENSOR, V3, P82; Beall EB, 2007, NEUROIMAGE, V37, P1286, DOI 10.1016/j.neuroimage.2007.07.004; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chu C, 2011, NEUROIMAGE, V56, P662, DOI 10.1016/j.neuroimage.2010.03.058; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Emir UE, 2008, NEUROSCI LETT, V436, P185, DOI 10.1016/j.neulet.2008.03.021; Esposito F, 2010, NEUROIMAGE, V53, P534, DOI 10.1016/j.neuroimage.2010.06.061; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; Fylan F, 1997, NEUROIMAGE, V6, P47, DOI 10.1006/nimg.1997.0273; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; GRUSSER OJ, 1957, PFLUG ARCH GES PHYS, V263, P668, DOI 10.1007/BF00362854; Guntekin B, 2007, INT J PSYCHOPHYSIOL, V65, P294, DOI 10.1016/j.ijpsycho.2007.03.009; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hu HH, 1999, J CEREBR BLOOD F MET, V19, P460, DOI 10.1097/00004647-199904000-00012; Huettel SA, 2009, FUNCTIONAL MAGNETIC; Huk AC, 2002, J NEUROSCI, V22, P7195; Kikuchi M, 2000, CLIN ELECTROENCEPHAL, V31, P170, DOI 10.1177/155005940003100404; KOURTZI Z, 2005, FITTING MIND WORLD A, pCH6; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Liu XA, 2011, NEUROIMAGE, V54, P2278, DOI 10.1016/j.neuroimage.2010.10.001; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parkes LM, 2004, NEUROIMAGE, V21, P236, DOI 10.1016/j.neuroimage.2003.08.025; Pastor MA, 2003, J NEUROSCI, V23, P11621; Ross MH, 1997, NEUROLOGY, V48, P173, DOI 10.1212/WNL.48.1.173; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; Schopf V, 2010, MAGN RESON MATER PHY, V23, P317, DOI 10.1007/s10334-010-0212-0; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Singh M, 2003, MAGNET RESON MED, V49, P108, DOI 10.1002/mrm.10335; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Tse CY, 2010, BIOL PSYCHOL, V85, P79, DOI 10.1016/j.biopsycho.2010.05.007; Ungerleider L.G., 1982, ANAL VISUAL BEHAV; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	40	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e18954	10.1371/journal.pone.0018954	http://dx.doi.org/10.1371/journal.pone.0018954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21966483	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005800002
J	Santens, S; Goossens, S; Verguts, T				Santens, Seppe; Goossens, Sofie; Verguts, Tom			Distance in Motion: Response Trajectories Reveal the Dynamics of Number Comparison	PLOS ONE			English	Article							SPACE; MODEL	Cognitive and neuroscientific evidence has challenged the widespread view that perception, cognition and action constitute independent, discrete stages. For example, in continuous response trajectories toward a target response location, evidence suggests that a decision on which target to reach for (i.e., the cognition stage) is not reached before the movement starts (i.e., the action stage). As a result, instead of a straight trajectory to the correct target response, movement trajectories may curve toward competing responses or away from inhibited responses. In the present study, we examined response trajectories during a number comparison task. Participants had to decide whether a target number was smaller or larger than 5. They had to respond by moving to a left or a right response location. Replicating previous results, response trajectories were more curved toward the incorrect response location when distance to 5 was small (e. g., target number 4) than when distance to 5 was large (e. g., target number 1). Importantly, we manipulated the response mapping, which allowed us to demonstrate that this response trajectory effect results from the relative amount of evidence for the available responses across time. In this way, the present study stresses the tight coupling of number representations (i.e., cognition) and response related processes (i.e., action) and shows that these stages are not separable in time.	[Santens, Seppe; Goossens, Sofie; Verguts, Tom] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Ghent University	Santens, S (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	Seppe.Santens@ugent.be	Verguts, Tom/A-4792-2008; Mira, Antonio/E-5715-2010; Carvalho, Filipe/E-4902-2010	Verguts, Tom/0000-0002-7783-4754; Lauwereyns, Jan/0000-0003-0551-2550; Santos, Sara/0000-0003-4931-1080; Mira, Antonio/0000-0001-6152-0454; Carvalho, Filipe/0000-0003-2161-5293	Ghent University Research Council [01J01406]; Research Foundation Flanders; Ghent University [BOF08/GOA/011]	Ghent University Research Council(Ghent University); Research Foundation Flanders(FWO); Ghent University(Ghent University)	This work was supported by the Ghent University Research Council BOF Grant 01J01406 and a postdoctoral fellowship by the Research Foundation Flanders (to Seppe Santens), and Ghent University BOF/GOA Grant BOF08/GOA/011 and the Ghent University Multidisciplinary Research Partnership "The Inegrative Neuroscience of Behavioral Control" (to Tom Verguts). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS RA, 1991, SCIENCE, V253, P1227, DOI 10.1126/science.253.5025.1227; Buetti S, 2009, J EXP PSYCHOL HUMAN, V35, P816, DOI 10.1037/a0011092; Chen Q, 2010, COGNITIVE PSYCHOL, V60, P218, DOI 10.1016/j.cogpsych.2010.01.001; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Dale R, 2007, MEM COGNITION, V35, P15, DOI 10.3758/BF03195938; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Gevers W, 2006, J EXP PSYCHOL HUMAN, V32, P32, DOI 10.1037/0096-1523.32.1.32; Gevers W, 2010, J EXP PSYCHOL GEN, V139, P180, DOI 10.1037/a0017688; James W., 1890, PRINCIPLES PSYCHOL; McKinstry C, 2008, PSYCHOL SCI, V19, P22, DOI 10.1111/j.1467-9280.2008.02041.x; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Posner MI, 1976, CHRONOMETRIC EXPLORA; Santens S, 2008, COGNITION, V108, P263, DOI 10.1016/j.cognition.2008.01.002; Santens S, 2011, COGNITION, V118, P94, DOI 10.1016/j.cognition.2010.10.014; Song JH, 2008, COGNITION, V106, P994, DOI 10.1016/j.cognition.2007.03.014; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Stevens M, 2006, BEHAV RES METHODS, V38, P280, DOI 10.3758/BF03192779; Thelen E, 2001, BEHAV BRAIN SCI, V24, P1, DOI 10.1017/S0140525X01003910; Verguts T, 2005, PSYCHON B REV, V12, P66, DOI 10.3758/BF03196349	21	82	94	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25429	10.1371/journal.pone.0025429	http://dx.doi.org/10.1371/journal.pone.0025429			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825IZ	21980437	Green Published, gold, Green Submitted			2022-12-25	WOS:000295267100060
J	Singh, AV; Vyas, V; Patil, R; Sharma, V; Scopelliti, PE; Bongiorno, G; Podesta, A; Lenardi, C; Gade, WN; Milani, P				Singh, Ajay Vikram; Vyas, Varun; Patil, Rajendra; Sharma, Vimal; Scopelliti, Pasquale Emanuele; Bongiorno, Gero; Podesta, Alessandro; Lenardi, Cristina; Gade, Wasudev Namdev; Milani, Paolo			Quantitative Characterization of the Influence of the Nanoscale Morphology of Nanostructured Surfaces on Bacterial Adhesion and Biofilm Formation	PLOS ONE			English	Article							CLUSTER BEAM DEPOSITION; ADSORBED PROTEINS; QUANTIFICATION; CELLS; FILMS; TIO2	Bacterial infection of implants and prosthetic devices is one of the most common causes of implant failure. The nanostructured surface of biocompatible materials strongly influences the adhesion and proliferation of mammalian cells on solid substrates. The observation of this phenomenon has led to an increased effort to develop new strategies to prevent bacterial adhesion and biofilm formation, primarily through nanoengineering the topology of the materials used in implantable devices. While several studies have demonstrated the influence of nanoscale surface morphology on prokaryotic cell attachment, none have provided a quantitative understanding of this phenomenon. Using supersonic cluster beam deposition, we produced nanostructured titania thin films with controlled and reproducible nanoscale morphology respectively. We characterized the surface morphology; composition and wettability by means of atomic force microscopy, X-ray photoemission spectroscopy and contact angle measurements. We studied how protein adsorption is influenced by the physico-chemical surface parameters. Lastly, we characterized Escherichia coli and Staphylococcus aureus adhesion on nanostructured titania surfaces. Our results show that the increase in surface pore aspect ratio and volume, related to the increase of surface roughness, improves protein adsorption, which in turn downplays bacterial adhesion and biofilm formation. As roughness increases up to about 20 nm, bacterial adhesion and biofilm formation are enhanced; the further increase of roughness causes a significant decrease of bacterial adhesion and inhibits biofilm formation. We interpret the observed trend in bacterial adhesion as the combined effect of passivation and flattening effects induced by morphology-dependent protein adsorption. Our findings demonstrate that bacterial adhesion and biofilm formation on nanostructured titanium oxide surfaces are significantly influenced by nanoscale morphological features. The quantitative information, provided by this study about the relation between surface nanoscale morphology and bacterial adhesion points towards the rational design of implant surfaces that control or inhibit bacterial adhesion and biofilm formation.	[Singh, Ajay Vikram; Vyas, Varun; Sharma, Vimal] IFOM IEO, European Sch Mol Med SEMM, Milan, Italy; [Singh, Ajay Vikram; Vyas, Varun; Scopelliti, Pasquale Emanuele; Podesta, Alessandro; Lenardi, Cristina; Milani, Paolo] Univ Milan, Dept Phys, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy; [Patil, Rajendra; Gade, Wasudev Namdev] Univ Pune, Dept Biotechnol, Pune, Maharashtra, India; [Sharma, Vimal; Scopelliti, Pasquale Emanuele; Bongiorno, Gero; Lenardi, Cristina; Milani, Paolo] Fdn Filarete, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan; Savitribai Phule Pune University	Singh, AV (corresponding author), IFOM IEO, European Sch Mol Med SEMM, Milan, Italy.	wngade@unipune.ernet.in; pmilani@mi.infn.it	Lenardi, Cristina/J-5872-2012; Patil, Rajendra H/L-5521-2013; Singh, Ajay Vikram/AAM-3665-2020; Singh, Ajay/AAF-4414-2020; Milani, Paolo/AAN-5069-2021; Podestà, Alessandro/E-6568-2010; Vyas, Varun/AAA-7983-2021	Lenardi, Cristina/0000-0002-5522-6803; Podestà, Alessandro/0000-0002-4169-6679; Vyas, Varun/0000-0001-7008-7349; Patil, Rajendra/0000-0003-0534-7356; Singh, Abhalaxmi/0000-0003-0407-3154	European School of Molecular Medicine; Umberto Veronesi Foundation; University of Milan	European School of Molecular Medicine; Umberto Veronesi Foundation(Fondazione Umberto Veronesi); University of Milan	This work was financially supported by the European School of Molecular Medicine, by Umberto Veronesi Foundation and by the University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004; Anagnostou F, 2006, BIOMATERIALS, V27, P3912, DOI 10.1016/j.biomaterials.2006.03.004; Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001; Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0; Barborini E, 1999, J PHYS D APPL PHYS, V32, pL105, DOI 10.1088/0022-3727/32/21/102; Barborini E, 2003, EUR PHYS J D, V24, P277, DOI 10.1140/epjd/e2003-00189-2; Belicchi M, 2010, BIOMATERIALS, V31, P5385, DOI 10.1016/j.biomaterials.2010.03.021; Carbone R, 2006, BIOMATERIALS, V27, P3221, DOI 10.1016/j.biomaterials.2006.01.056; Collins TJ, 2007, MICROSC MICROANAL, V13, P1674, DOI [10.1017/S1431927607072911, DOI 10.1017/S1431927607072911]; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Giorgetti L, 2008, LANGMUIR, V24, P11637, DOI 10.1021/la801910p; Hannig M, 2010, NAT NANOTECHNOL, V5, P565, DOI [10.1038/NNANO.2010.83, 10.1038/nnano.2010.83]; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; HUNTER RJ, 1995, FDN COLLOID SCI; Katsikogianni M, 2008, COLLOID SURFACE B, V65, P257, DOI 10.1016/j.colsurfb.2008.04.017; Kholmanov IN, 2003, NANOTECHNOLOGY, V14, P1168, DOI 10.1088/0957-4484/14/11/002; Kinnari TJ, 2005, OTOL NEUROTOL, V26, P380, DOI 10.1097/01.mao.0000169767.85549.87; Lavenus S, 2010, NANOMEDICINE-UK, V5, P937, DOI [10.2217/nnm.10.54, 10.2217/NNM.10.54]; Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006; Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001; Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012; Milani P, 2001, DIAM RELAT MATER, V10, P240, DOI 10.1016/S0925-9635(00)00474-X; Padial-Molina M, 2011, ACTA BIOMATER, V7, P771, DOI 10.1016/j.actbio.2010.08.024; Page AJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.065701; Piseri P, 2001, REV SCI INSTRUM, V72, P2261, DOI 10.1063/1.1361082; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]; Podesta A, 2009, J PHYS CHEM C, V113, P18264, DOI 10.1021/jp905930r; Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081; Rizzello L, 2011, ACS NANO, V5, P1865, DOI 10.1021/nn102692m; RONALD RM, 2004, HDB MICROBIOLOGICAL; Salmeron-Sanchez M, 2010, TISSUE ENGINEERING, P77; Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862; SCOPELLITI PE, 2011, COMB CHEM HIGH T SCR, V14, P10; Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071; Variola F, 2009, SMALL, V5, P996, DOI 10.1002/smll.200801186; Wegner K, 2006, J PHYS D APPL PHYS, V39, pR439, DOI 10.1088/0022-3727/39/22/R02; WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015; Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.11.010; Whitehead KA, 2007, INT BIODETER BIODEGR, V60, P74, DOI 10.1016/j.ibiod.2006.11.009; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Xavier JB, 2003, WATER SCI TECHNOL, V47, P31, DOI 10.2166/wst.2003.0273	45	262	266	1	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25029	10.1371/journal.pone.0025029	http://dx.doi.org/10.1371/journal.pone.0025029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966403	Green Published, Green Submitted, gold			2022-12-25	WOS:000295932100012
J	Cook, S; Conrad, C; Fowlkes, AL; Mohebbi, MH				Cook, Samantha; Conrad, Corrie; Fowlkes, Ashley L.; Mohebbi, Matthew H.			Assessing Google Flu Trends Performance in the United States during the 2009 Influenza Virus A (H1N1) Pandemic	PLOS ONE			English	Article								Background: Google Flu Trends (GFT) uses anonymized, aggregated internet search activity to provide near-real time estimates of influenza activity. GFT estimates have shown a strong correlation with official influenza surveillance data. The 2009 influenza virus A (H1N1) pandemic [pH1N1] provided the first opportunity to evaluate GFT during a non-seasonal influenza outbreak. In September 2009, an updated United States GFT model was developed using data from the beginning of pH1N1. Methodology/Principal Findings: We evaluated the accuracy of each U. S. GFT model by comparing weekly estimates of ILI (influenza-like illness) activity with the U. S. Outpatient Influenza-like Illness Surveillance Network (ILINet). For each GFT model we calculated the correlation and RMSE (root mean square error) between model estimates and ILINet for four time periods: pre-H1N1, Summer H1N1, Winter H1N1, and H1N1 overall (Mar 2009-Dec 2009). We also compared the number of queries, query volume, and types of queries (e. g., influenza symptoms, influenza complications) in each model. Both models' estimates were highly correlated with ILINet pre-H1N1 and over the entire surveillance period, although the original model underestimated the magnitude of ILI activity during pH1N1. The updated model was more correlated with ILINet than the original model during Summer H1N1 (r = 0.95 and 0.29, respectively). The updated model included more search query terms than the original model, with more queries directly related to influenza infection, whereas the original model contained more queries related to influenza complications. Conclusions: Internet search behavior changed during pH1N1, particularly in the categories "influenza complications'' and "term for influenza.'' The complications associated with pH1N1, the fact that pH1N1 began in the summer rather than winter, and changes in health-seeking behavior each may have played a part. Both GFT models performed well prior to and during pH1N1, although the updated model performed better during pH1N1, especially during the summer months.	[Cook, Samantha; Mohebbi, Matthew H.] Google Inc, New York, NY USA; [Conrad, Corrie] Google Inc, London, England; [Fowlkes, Ashley L.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Google Incorporated; Google Incorporated; Centers for Disease Control & Prevention - USA	Cook, S (corresponding author), Google Inc, New York, NY USA.	cconrad@google.com		Behmer, Spencer/0000-0002-5038-1046; Cook, Samantha/0000-0002-2173-4471	Google.org; Google Inc.	Google.org; Google Inc.(Google Incorporated)	This research was funded by Google.org, the non-profit arm of Google Inc. This funder played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Three of the authors (SC, CC, MM) are employees of one of the funders of the study (Google Inc.) and were involved with the study design, data collection and analysis, decision to publish, and preparation of the manuscript.; Yes, the authors have the following competing interest. This study was supported by funding from Google Inc., and three of the authors (SC, CC, MM) are employees of Google Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Brammer L, 2011, CLIN INFECT DIS, V52, pS27, DOI 10.1093/cid/ciq009; *CDC, 2007, MMWR-MORBID MORTAL W, V57, P692; *CDC, CDC SEAS INFL FLU FL; *CDCP CDC, INF 2009 H1N1 IMP RA; DEAN J, 2004, OSDI 60 S OP SYST DE; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Google.org, 2009, GOOGL FLU TRENDS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed C, 2011, CLIN INFECT DIS, V52, pS90, DOI 10.1093/cid/ciq024; Wilson N, 2009, EUROSURVEILLANCE, V14; [No title captured]	13	225	237	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23610	10.1371/journal.pone.0023610	http://dx.doi.org/10.1371/journal.pone.0023610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886802	gold, Green Submitted, Green Published			2022-12-25	WOS:000294128100022
J	Liu, WS; Baker, SS; Baker, RD; Nowak, NJ; Zhu, LX				Liu, Wensheng; Baker, Susan S.; Baker, Robert D.; Nowak, Norma J.; Zhu, Lixin			Upregulation of Hemoglobin Expression by Oxidative Stress in Hepatocytes and Its Implication in Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GENE-EXPRESSION; PATHOGENESIS; MECHANISMS; INSIGHTS; NEURONS; GLOBIN; RAT	Recent studies revealed that hemoglobin is expressed in some non-erythrocytes and it suppresses oxidative stress when overexpressed. Oxidative stress plays a critical role in the pathogenesis of non-alcoholic steatohepatitis (NASH). This study was designed to investigate whether hemoglobin is expressed in hepatocytes and how it is related to oxidative stress in NASH patients. Analysis of microarray gene expression data revealed a significant increase in the expression of hemoglobin alpha (HBA1) and beta (HBB) in liver biopsies from NASH patients. Increased hemoglobin expression in NASH was validated by quantitative real time PCR. However, the expression of hematopoietic transcriptional factors and erythrocyte specific marker genes were not increased, indicating that increased hemoglobin expression in NASH was not from erythropoiesis, but could result from increased expression in hepatocytes. Immunofluorescence staining demonstrated positive HBA1 and HBB expression in the hepatocytes of NASH livers. Hemoglobin expression was also observed in human hepatocellular carcinoma HepG2 cell line. Furthermore, treatment with hydrogen peroxide, a known oxidative stress inducer, increased HBA1 and HBB expression in HepG2 and HEK293 cells. Importantly, hemoglobin overexpression suppressed oxidative stress in HepG2 cells. We concluded that hemoglobin is expressed by hepatocytes and oxidative stress upregulates its expression. Suppression of oxidative stress by hemoglobin could be a mechanism to protect hepatocytes from oxidative damage in NASH.	[Liu, Wensheng; Baker, Susan S.; Baker, Robert D.; Zhu, Lixin] SUNY Buffalo, Digest Dis & Nutr Ctr, Dept Pediat, Buffalo, NY 14260 USA; [Nowak, Norma J.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Nowak, Norma J.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Nowak, Norma J.] Roswell Pk Canc Inst, Microarray & Genom Facil, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Liu, WS (corresponding author), SUNY Buffalo, Digest Dis & Nutr Ctr, Dept Pediat, Buffalo, NY 14260 USA.	lixinzhu@buffalo.edu	liu, wen/HGE-3071-2022	Zhu, Lixin/0000-0001-7904-1769	Peter and Tommy Fund, Inc., Buffalo, NY	Peter and Tommy Fund, Inc., Buffalo, NY	This work was supported by an unrestricted grant from the Peter and Tommy Fund, Inc., Buffalo, NY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SS, 2010, PLOS ONE, V5, pA82, DOI 10.1371/journal.pone.0009570; Baskol G, 2007, CLIN BIOCHEM, V40, P776, DOI 10.1016/j.clinbiochem.2007.02.006; Bauer M, 2002, ANTIOXID REDOX SIGN, V4, P749, DOI 10.1089/152308602760598891; Bhaskaran M, 2005, BIOCHEM BIOPH RES CO, V333, P1348, DOI 10.1016/j.bbrc.2005.06.042; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Grattagliano I, 2008, J NUTR BIOCHEM, V19, P491, DOI 10.1016/j.jnutbio.2007.06.011; Grek CL, 2011, AM J RESP CELL MOL, V44, P439, DOI 10.1165/rcmb.2009-0307OC; Kaser S, 2010, INT J CLIN PRACT, V64, P968, DOI 10.1111/j.1742-1241.2009.02327.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kojima H, 2008, HEPATOL RES, V38, P202, DOI 10.1111/j.1872-034X.2007.00209.x; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Krawczyk M, 2010, BEST PRACT RES CL GA, V24, P695, DOI 10.1016/j.bpg.2010.08.005; Larter CZ, 2010, J GASTROEN HEPATOL, V25, P672, DOI 10.1111/j.1440-1746.2010.06253.x; Leclercq IA, 2004, CLIN SCI, V106, P235, DOI 10.1042/CS20030368; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; Malaguarnera M, 2009, J MOL MED, V87, P679, DOI 10.1007/s00109-009-0464-1; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Ney PA, 2006, CURR OPIN HEMATOL, V13, P203, DOI 10.1097/01.moh.0000231415.18333.2c; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Pasumarthy L, 2010, SOUTH MED J, V103, P547, DOI 10.1097/SMJ.0b013e3181de0ce0; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; Schwinnner JB, 2005, HEPATOLOGY, V42, P641, DOI 10.1002/hep.20842; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Tezel G, 2010, INVEST OPHTH VIS SCI, V51, P907, DOI 10.1167/iovs.09-4014; Tezel TH, 2009, INVEST OPHTH VIS SCI, V50, P1911, DOI 10.1167/iovs.07-1372; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Trak-Smayra V, 2009, GUT, V58, P825, DOI 10.1136/gut.2007.140087; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Tsutsui M, 2010, J CLIN GASTROENTEROL, V44, P440, DOI 10.1097/MCG.0b013e3181bdefe2; Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285; Widmer CC, 2010, ANTIOXID REDOX SIGN, V12, P185, DOI 10.1089/ars.2009.2826; Xu L, 2009, GUT, V58, P1706, DOI 10.1136/gut.2009.186668; Zhu LX, 2011, METABOLISM, V60, P1001, DOI 10.1016/j.metabol.2010.10.003	44	136	141	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24363	10.1371/journal.pone.0024363	http://dx.doi.org/10.1371/journal.pone.0024363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21980346	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803200016
J	Qiu, C; Tian, D; Wan, YM; Zhang, WJ; Qiu, CL; Zhu, ZQ; Ye, RQ; Song, ZG; Zhou, MZ; Yuan, SH; Shi, BS; Wu, M; Liu, Y; Gu, SM; Wei, J; Zhou, ZT; Zhang, XY; Zhang, ZY; Hu, YW; Yuan, ZH; Xu, JQ				Qiu, Chao; Tian, Di; Wan, Yanmin; Zhang, Wanju; Qiu, Chenli; Zhu, Zhaoqin; Ye, Ruiqi; Song, Zhigang; Zhou, Mingzhe; Yuan, Songhua; Shi, Bisheng; Wu, Min; Liu, Yi; Gu, Shimin; Wei, Jun; Zhou, Zhitong; Zhang, Xiaoyan; Zhang, Zhiyong; Hu, Yunwen; Yuan, Zhenghong; Xu, Jianqing			Early Adaptive Humoral Immune Responses and Virus Clearance in Humans Recently Infected with Pandemic 2009 H1N1 Influenza Virus	PLOS ONE			English	Article							ORIGIN; ANTIBODIES	Few studies on the humoral immune responses in human during natural influenza infection have been reported. Here, we used serum samples from pandemic 2009 H1N1 influenza infected patients to characterize the humoral immune responses to influenza during natural infection in humans. We observed for the first time that the pandemic 2009 H1N1 influenza induced influenza A-specific IgM within days after symptoms onset, whereas the unit of IgG did not changed. The magnitude of influenza A-specific IgM antibodies might have a value in predicting the rate of virus clearance to some degree. However, the newly developed IgM was not associated with hemagglutination inhibition (HI) activities in the same samples but correlated with HI activities of subsequently collected sera which were mediated by IgG antibodies, indicating that IgM was critical for influenza infection and influences subsequent IgG antibody responses. These findings provide new important insights on the human immunity to natural influenza infection.	[Qiu, Chao; Tian, Di; Wan, Yanmin; Zhang, Wanju; Qiu, Chenli; Zhu, Zhaoqin; Ye, Ruiqi; Song, Zhigang; Zhou, Mingzhe; Yuan, Songhua; Shi, Bisheng; Wu, Min; Liu, Yi; Gu, Shimin; Zhou, Zhitong; Zhang, Xiaoyan; Zhang, Zhiyong; Hu, Yunwen; Yuan, Zhenghong; Xu, Jianqing] Fudan Univ, Inst Biomed Sci, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Zhang, Xiaoyan; Yuan, Zhenghong; Xu, Jianqing] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ Hlth, Shanghai 200433, Peoples R China; [Zhang, Xiaoyan; Xu, Jianqing] China CDC, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wei, Jun] Yuncheng CDC, Yuncheng, Peoples R China	Fudan University; Fudan University; Chinese Center for Disease Control & Prevention	Qiu, C (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	zhyuan@shaphc.org; jianqingxu2008@gmail.com	Zhou, Mingzhe/AED-5236-2022; Qiu, Chao/M-6702-2014; , yanmin/GQH-2789-2022	Qiu, Chao/0000-0001-9401-5219; , yanmin/0000-0001-5027-9423; Zhang, Wanju/0000-0001-9913-8584; Zhou, Mingzhe/0000-0002-5518-7330; Zhou, Shi-Rong/0000-0003-2594-3198	National Grand Program on Key Infectious Disease Control [2008ZX10001-002, 2009ZX10602-11]; China Ministry of Health; China National Program on Key Basic Research Projects (973 Program) [2005CB522903]; China Ministry of Science and Technology, China; Key Basic Research Project [10JC1413600]; Science and Technology Commission of Shanghai Municipality, Shanghai	National Grand Program on Key Infectious Disease Control; China Ministry of Health; China National Program on Key Basic Research Projects (973 Program)(National Basic Research Program of China); China Ministry of Science and Technology, China(Ministry of Science and Technology, China); Key Basic Research Project; Science and Technology Commission of Shanghai Municipality, Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by the National Grand Program on Key Infectious Disease Control (Grant #2008ZX10001-002 and 2009ZX10602-11), China Ministry of Health, and by the China National Program on Key Basic Research Projects (973 Program) (No. 2005CB522903), the China Ministry of Science and Technology, China, and by the Key Basic Research Project (10JC1413600), Science and Technology Commission of Shanghai Municipality, Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P249; [Anonymous], MMWR MORB MORTAL WKL; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; McCracken J, 2009, LANCET, V373, P2107, DOI 10.1016/S0140-6736(09)61141-7; PALLADINO G, 1995, J VIROL, V69, P2075, DOI 10.1128/JVI.69.4.2075-2081.1995; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Zhang H, 2009, LANCET INFECT DIS, V9, P456, DOI 10.1016/S1473-3099(09)70181-1	12	66	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22603	10.1371/journal.pone.0022603	http://dx.doi.org/10.1371/journal.pone.0022603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21966459	gold, Green Submitted, Green Published			2022-12-25	WOS:000294253500001
J	Du, J; Xu, R; Hu, ZZ; Tian, YH; Zhu, YC; Gu, L; Zhou, L				Du, Jun; Xu, Rui; Hu, Zhenzhen; Tian, Yinhui; Zhu, Yichao; Gu, Luo; Zhou, Lei			PI3K and ERK-Induced Rac1 Activation Mediates Hypoxia-Induced HIF-1 alpha Expression in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROXIMAL TUBULE CELLS; ANGIOGENESIS IN-VITRO; INDUCIBLE FACTOR-1-ALPHA; GENE-TRANSCRIPTION; EPITHELIAL-CELLS; NADPH OXIDASE; UP-REGULATION; TUMOR-GROWTH; ROS	Background: Hypoxia-inducible factor 1 (HIF-1 alpha) expression induced by hypoxia plays a critical role in promoting tumor angiogenesis and metastasis. However, the molecular mechanisms underlying the induction of HIF-1 alpha in tumor cells remain unknown. Methodology/Principal Findings: In this study, we reported that hypoxia could induce HIF-1 alpha and VEGF expression accompanied by Rac1 activation in MCF-7 breast cancer cells. Blockade of Rac1 activation with ectopic expression of an inactive mutant form of Rac1 (T17N) or Rac1 siRNA downregulated hypoxia-induced HIF-1 alpha and VEGF expression. Furthermore, Hypoxia increased PI3K and ERK signaling activity. Both PI3K inhibitor LY294002 and ERK inhibitor U0126 suppressed hypoxia-induced Rac1 activation as well as HIF-1 alpha expression. Moreover, hypoxia treatment resulted in a remarkable production of reactive oxygen species (ROS). N-acetyl-L-cysteine, a scavenger of ROS, inhibited hypoxia-induced ROS generation, PI3K, ERK and Rac1 activation as well as HIF-1 alpha expression. Conclusions/Significance: Taken together, our study demonstrated that hypoxia-induced HIF-1 alpha expression involves a cascade of signaling events including ROS generation, activation of PI3K and ERK signaling, and subsequent activation of Rac1.	[Du, Jun; Xu, Rui; Hu, Zhenzhen; Tian, Yinhui; Gu, Luo] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China; [Xu, Rui; Hu, Zhenzhen; Tian, Yinhui] Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China; [Zhu, Yichao; Gu, Luo] Nanjing Med Univ, Ctr Canc, Nanjing, Peoples R China; [Zhou, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Du, J (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China.	lgu@njmu.edu.cn; zhoulei7005@hotmail.com			National Natural Science Foundation of China [30872926]; Program for Advanced Talents within Six Industries of Jiangsu Province [08-D]; Postdoctoral Science Foundation of Jiangsu Province; Science Development Foundation of Nanjing Medical University [2010NJMUZ35]; School of Basic Medical Sciences, Nanjing Medical University; State Key Laboratory of Reproductive Medicine, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Advanced Talents within Six Industries of Jiangsu Province; Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation); Science Development Foundation of Nanjing Medical University; School of Basic Medical Sciences, Nanjing Medical University; State Key Laboratory of Reproductive Medicine, China	This work was supported by grants from the National Natural Science Foundation of China (No. 30872926) and the Program for Advanced Talents within Six Industries of Jiangsu Province (08-D) to Dr. Luo Gu, the Postdoctoral Science Foundation of Jiangsu Province, the Science Development Foundation of Nanjing Medical University (2010NJMUZ35) and the Research Program funded by the School of Basic Medical Sciences, Nanjing Medical University to Dr. Jun Du. This work was also partially supported by a research grant from State Key Laboratory of Reproductive Medicine, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros P, 2009, MOL CELL BIOL, V29, P4156, DOI 10.1128/MCB.01813-08; Blanchetot C, 2008, CRIT REV EUKAR GENE, V18, P35, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.30; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Chen MJ, 2007, J CELL BIOCHEM, V101, P1316, DOI 10.1002/jcb.21254; Choi UJ, 2009, CELL BIOCHEM FUNCT, V27, P40, DOI 10.1002/cbf.1532; Chung BH, 2008, BIOCHEM BIOPH RES CO, V376, P404, DOI 10.1016/j.bbrc.2008.09.001; Chung BH, 2010, PHYTOTHER RES, V24, P934, DOI 10.1002/ptr.3063; Colley NJ, 2000, SCIENCE, V290, P1902, DOI 10.1126/science.290.5498.1902; Criss AK, 2001, J CELL SCI, V114, P1331; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; Desireddi JR, 2010, ANTIOXID REDOX SIGN, V12, P595, DOI 10.1089/ars.2009.2862; Diebold I, 2009, CIRC RES, V104, P1169, DOI 10.1161/CIRCRESAHA.109.196592; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Du J, 2010, CELL PHYSIOL BIOCHEM, V25, P501, DOI 10.1159/000303055; Farooqui R, 2006, EXP CELL RES, V312, P1514, DOI 10.1016/j.yexcr.2006.01.018; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Grider MH, 2009, J NEUROSCI RES, V87, P3033, DOI 10.1002/jnr.22140; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Grimshaw MJ, 2007, ENDOCR-RELAT CANCER, V14, P233, DOI 10.1677/ERC-07-0057; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Han G, 2008, ONCOL REP, V20, P929, DOI 10.3892/or_00000093; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hess AR, 2003, CANCER RES, V63, P4757; Holmquist L, 2006, ADV EXP MED BIOL, V587, P179; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Kim J, 2008, MOL BIOL CELL, V19, P433, DOI 10.1091/mbc.E07-02-0182; Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Lee TK, 2006, CLIN CANCER RES, V12, P5082, DOI 10.1158/1078-0432.CCR-05-2794; Li SM, 2010, ENDOCRINOLOGY, V151, P5315, DOI 10.1210/en.2010-0178; Lim JH, 2004, ONCOGENE, V23, P9427, DOI 10.1038/sj.onc.1208003; McDonald P, 2007, AM J PHYSIOL-CELL PH, V292, pC1216, DOI 10.1152/ajpcell.00467.2006; Nijmeh J, 2010, AM J PHYSIOL-LUNG C, V299, pL535, DOI 10.1152/ajplung.00002.2010; Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43; PARK JH, 2011, ONCOGENE; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Rathore R, 2008, FREE RADICAL BIO MED, V45, P1223, DOI 10.1016/j.freeradbiomed.2008.06.012; Ribatti D, 2010, STEM CELLS DEV, V19, P1, DOI 10.1089/scd.2009.0402; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Sawada N, 2008, CIRC RES, V103, P360, DOI 10.1161/CIRCRESAHA.108.178897; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734; Tobar N, 2008, CANCER LETT, V267, P125, DOI 10.1016/j.canlet.2008.03.011; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Vamesu S, 2008, ROM J MORPHOL EMBRYO, V49, P181; Vermeulen PB, 2010, CANCER-AM CANCER SOC, V116, P2748, DOI 10.1002/cncr.25169; Whaley-Connell AT, 2007, AM J NEPHROL, V27, P15, DOI 10.1159/000098432; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Xue Y, 2006, INT J CANCER, V118, P2965, DOI 10.1002/ijc.21763; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200; Yuan LP, 2010, CLIN EXP METASTAS, V27, P481, DOI 10.1007/s10585-010-9337-9; Yuan YG, 2011, AM J PHYSIOL-RENAL, V300, pF393, DOI 10.1152/ajprenal.00418.2010; Zhang Jun, 2007, Cancer Ther, V5, P273; ZHANG L, 2011, J PHARM EXP THER; Zhang L, 2011, PHARMACOLOGY, V87, P265, DOI 10.1159/000326082	61	128	136	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25213	10.1371/journal.pone.0025213	http://dx.doi.org/10.1371/journal.pone.0025213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980400	gold, Green Published, Green Submitted			2022-12-25	WOS:000295933700021
